Citrus Sinensis ID: 038137
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 549 | 2.2.26 [Sep-21-2011] | |||||||
| Q5R8M1 | 465 | Serine/threonine-protein | yes | no | 0.795 | 0.939 | 0.503 | 1e-124 | |
| Q15208 | 465 | Serine/threonine-protein | yes | no | 0.795 | 0.939 | 0.503 | 1e-124 | |
| Q2LZZ7 | 458 | Serine/threonine-protein | yes | no | 0.794 | 0.951 | 0.509 | 1e-123 | |
| Q6TGC6 | 507 | Serine/threonine-protein | N/A | no | 0.806 | 0.873 | 0.473 | 1e-123 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | no | no | 0.790 | 0.935 | 0.501 | 1e-123 | |
| A2VDV2 | 465 | Serine/threonine-protein | yes | no | 0.795 | 0.939 | 0.501 | 1e-123 | |
| Q9NBK5 | 463 | Serine/threonine-protein | yes | no | 0.786 | 0.933 | 0.498 | 1e-122 | |
| Q91VJ4 | 465 | Serine/threonine-protein | yes | no | 0.795 | 0.939 | 0.498 | 1e-122 | |
| Q5AP53 | 732 | Serine/threonine-protein | N/A | no | 0.806 | 0.605 | 0.470 | 1e-121 | |
| Q7TSE6 | 464 | Serine/threonine-protein | no | no | 0.790 | 0.935 | 0.492 | 1e-121 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 223/443 (50%), Positives = 302/443 (68%), Gaps = 6/443 (1%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
SN TK++V K +EN Y + EER+ R+ LEK + + + +EE+ +K
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
H++AER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTEEE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ETVLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L ++ E N
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE----FYRN 248
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
L+ +L SD + + + W+RNRR LA+STVGTPDYIAPEV ++ GY CDWW
Sbjct: 249 LNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 306
Query: 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQ 402
SLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI + C E
Sbjct: 307 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILRFCCEWEH 366
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKS 462
R+G G +EIK++ +F+G++W+ + + AA E+ DT NF++F E+D T A S
Sbjct: 367 RIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVATS 426
Query: 463 GPWRKMLSSKDINFVGYTYKNFE 485
+KD F+ YTYK FE
Sbjct: 427 NHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 223/443 (50%), Positives = 302/443 (68%), Gaps = 6/443 (1%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
SN TK++V K +EN Y + EER+ R+ LEK + + + +EE+ +K
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
H++AER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTEEE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ETVLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L ++ E N
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE----FYRN 248
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
L+ +L SD + + + W+RNRR LA+STVGTPDYIAPEV ++ GY CDWW
Sbjct: 249 LNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 306
Query: 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQ 402
SLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI + C E
Sbjct: 307 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILRFCCEWEH 366
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKS 462
R+G G +EIK++ +F+G++W+ + + AA E+ DT NF++F E+D T A S
Sbjct: 367 RIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVATS 426
Query: 463 GPWRKMLSSKDINFVGYTYKNFE 485
+KD F+ YTYK FE
Sbjct: 427 NHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 230/451 (50%), Positives = 308/451 (68%), Gaps = 15/451 (3%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
S+ T K AK +EN+Y + ERK+R LE +L D ++E ++ +K
Sbjct: 16 SDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTESQRQEKRLQHAQK 75
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 76 ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVA 135
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
HV+AER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM+KDTL+EE +FY
Sbjct: 136 HVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFY 195
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ET LAI+SIHK +IHRDIKPDNLLLD GH+KLSDFGLC L S+ DF +
Sbjct: 196 ISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKSH--RTDFY--RD 251
Query: 283 LSGALQSD--GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340
LS A SD G +P +++ + + W+RNRR LAYSTVGTPDYIAPEV L+ GYG CD
Sbjct: 252 LSQAKPSDFIGTCASPMDSKR-RAESWKRNRRALAYSTVGTPDYIAPEVFLQTGYGPACD 310
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNV 400
WWSLG IMYEML+GYPPF SD P T RK++NWR L FP E +S EAK+ I K C
Sbjct: 311 WWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEAKETIIKFCCEA 370
Query: 401 EQRLGT-KGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTS 459
++RLG+ +G +++K+ P+F+G++W+ + + AA EV DT NF++F + +I ++
Sbjct: 371 DRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDEFPDVSLEIPSA 430
Query: 460 --AKSGPWRKMLSSKDINFVGYTYKNFEIVN 488
+ G +KD F+ YTYK FE+ N
Sbjct: 431 PIPQGGE-----IAKDWVFINYTYKRFEVRN 456
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1137), Expect = e-123, Method: Compositional matrix adjust.
Identities = 216/456 (47%), Positives = 309/456 (67%), Gaps = 13/456 (2%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
+ T ++ A+ K +E+ YK ++ ER +RR E KLA SEE + L L +K
Sbjct: 50 TKTTHERAASVKLKLEHLYKVTVEQTVERNQRRMDFEAKLAQDRGSEERKKRQLNSLGQK 109
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
E++++RL+R K+ +DF + +IGKGAFGEVR+ ++ TG +YAMK L KSEM ++ Q+
Sbjct: 110 ESQFLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAMKTLLKSEMFKKDQLA 169
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
HVKAER++LAE DS +V LY SFQD +YLYLIME+LPGGD+MT+L++ DT +E+ RFY
Sbjct: 170 HVKAERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY 229
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN--------LQE 274
+ E +LAIE++HK +IHRDIKPDN+L+D+ GH+KLSDFGL ++ +
Sbjct: 230 IAECILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGFHKTHDNAYYQRLFES 289
Query: 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334
K + S+ +L D ++ + ++++ W++NRR++AYSTVGTPDYIAPE+ + G
Sbjct: 290 KINTSTSSTQNSLMVD--TISLTMSSKDKIATWKKNRRIMAYSTVGTPDYIAPEIFTQHG 347
Query: 335 YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLIS 394
YG ECDWWSLGAIM+E L+G+PPF S+ T RKI+NWR +L FPE+ LS EA+DLI
Sbjct: 348 YGQECDWWSLGAIMFECLIGWPPFCSENAHETYRKIINWRENLYFPEDLHLSAEAEDLIR 407
Query: 395 KLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADN 454
KLL + +QRLG GA++IK HP+F+G+ WD + +I A FIP++ DT FE+ + N
Sbjct: 408 KLLTSADQRLGRYGANDIKLHPFFRGVNWDTIREINAPFIPQLKSITDTSYFEEIDTIPN 467
Query: 455 QIQTSAKSGPWRKMLSSKDIN--FVGYTYKNFEIVN 488
I ++ K+ S D N FVGYTYK F+++
Sbjct: 468 -ITMNSPPVLQNKIPSDVDQNLAFVGYTYKRFDMMT 502
|
Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating. Pneumocystis carinii (taxid: 4754) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 222/443 (50%), Positives = 299/443 (67%), Gaps = 9/443 (2%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
SN T+++V AK +EN Y + EER+ R+ LE + + +++EE+ +K
Sbjct: 14 SNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARK 73
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETE++RL+R ++G DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+KS+ML + QV
Sbjct: 74 ETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKSDMLEKEQVA 133
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
H++AER++L E D +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTEEE +FY
Sbjct: 134 HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 193
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ETVLAI++IH+ +IHRDIKPDNLLLD GH+KLSDFGLC L ++ E N
Sbjct: 194 ISETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE----FYRN 249
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
L+ SD + + + W++NRR LAYSTVGTPDYIAPEV ++ GY CDWW
Sbjct: 250 LTHNPPSDFS--FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 307
Query: 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQ 402
SLG IMYEML+GYPPF S+ P T RK++NW+ L FP E +S +AKDLI + + E
Sbjct: 308 SLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCIDSEN 367
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKS 462
R+G G +EIK HP+F+G++W+ + + AA E+ DT NF+ F E+D +
Sbjct: 368 RIGNSGVEEIKGHPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDDFPESDILQPVPNTT 427
Query: 463 GPWRKMLSSKDINFVGYTYKNFE 485
P K SKD F+ YTYK FE
Sbjct: 428 EPDYK---SKDWVFLNYTYKRFE 447
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-123, Method: Compositional matrix adjust.
Identities = 222/443 (50%), Positives = 301/443 (67%), Gaps = 6/443 (1%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
S+ TK++V K +EN Y + EER+ R+ LEK + + + +EE+ +K
Sbjct: 13 SSHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
H++AER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTEEE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ETVLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L ++ E N
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE----FYRN 248
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
L+ +L SD + + + W+RNRR LA+STVGTPDYIAPEV ++ GY CDWW
Sbjct: 249 LNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 306
Query: 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQ 402
SLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI + C E
Sbjct: 307 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILRFCCEWEH 366
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKS 462
R+G G +EIK + +F+G++W+ + + AA E+ DT NF++F E+D T A S
Sbjct: 367 RIGAPGVEEIKNNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVATS 426
Query: 463 GPWRKMLSSKDINFVGYTYKNFE 485
+KD F+ YTYK FE
Sbjct: 427 NHPDTDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1128), Expect = e-122, Method: Compositional matrix adjust.
Identities = 229/459 (49%), Positives = 305/459 (66%), Gaps = 27/459 (5%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
S+ T K AK +EN+Y + ERK+R LE +L D +SE ++ +K
Sbjct: 17 SDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLSEAQRQEKRLQHAQK 76
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 77 ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQVA 136
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
HV+AER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM+KDTL+EE +FY
Sbjct: 137 HVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQFY 196
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL----------DCSNL 272
+ ET LAI+SIHK +IHRDIKPDNLLLD GH+KLSDFGLC L D S
Sbjct: 197 ISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKSHRTDFYRDLSQA 256
Query: 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332
+ DF IG+ S + P+ +R + + W+RNRR LAYSTVGTPDYIAPEV L+
Sbjct: 257 KPSDF-IGTCASLSCS----PMDSKR----RAESWKRNRRALAYSTVGTPDYIAPEVFLQ 307
Query: 333 KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDL 392
GYG CDWWSLG IMYEML+GYPPF SD P T RK++NWR L FP E +S EAK+
Sbjct: 308 TGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEAKET 367
Query: 393 ISKLLCNVEQRLGT-KGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEE 451
I C ++RLG+ +G +++K+ P+F+G++W+ + + AA EV DT NF++F +
Sbjct: 368 IINFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDEFPD 427
Query: 452 ADNQIQTS--AKSGPWRKMLSSKDINFVGYTYKNFEIVN 488
+I ++ + G +KD F+ YTYK FE+ N
Sbjct: 428 VSLEIPSAPIPQGGE-----IAKDWVFINYTYKRFEVRN 461
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91VJ4|STK38_MOUSE Serine/threonine-protein kinase 38 OS=Mus musculus GN=Stk38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-122, Method: Compositional matrix adjust.
Identities = 221/443 (49%), Positives = 299/443 (67%), Gaps = 6/443 (1%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
SN TK++V K +EN Y + EER+ R+ LEK + + + +EE+ +K
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLRRSAHARK 72
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
H++AER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTEEE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ETVLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L ++ E N
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE----FYRN 248
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
L+ +L SD + + + W+RNRR LA+STVGTPDYIAPEV ++ GY CDWW
Sbjct: 249 LNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 306
Query: 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQ 402
SLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AK LI + C E
Sbjct: 307 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPVSEKAKGLILRFCCEWEH 366
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKS 462
R+G G +EIK + +F+G++W+ + + AA E+ DT NF++F E+D T S
Sbjct: 367 RIGAPGVEEIKNNLFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVTTS 426
Query: 463 GPWRKMLSSKDINFVGYTYKNFE 485
+KD F+ YTYK FE
Sbjct: 427 SHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5AP53|CBK1_CANAL Serine/threonine-protein kinase CBK1 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) GN=CBK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1123), Expect = e-121, Method: Compositional matrix adjust.
Identities = 222/472 (47%), Positives = 316/472 (66%), Gaps = 29/472 (6%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEV--SEEEQNNLLKYLE 100
S T+ K A+ K +EN+Y + ER +RR LE K+A+ ++ SEE +N L+ L
Sbjct: 257 SKTTQDKAASIKLTLENYYTSSVSHAIERNQRRLELENKIANEDIGSSEERKNRQLQNLG 316
Query: 101 KKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ 160
KKE++++RL+R K+ +DF + +IGKGAFGEVR+ ++K TG +YAMK L KSEM + Q
Sbjct: 317 KKESQFLRLKRTKLALEDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFNKDQ 376
Query: 161 VEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEAR 220
+ HVKAER++LA DS IV LY SFQD +YLYLIME+LPGGD+MT+L+R + TE+ R
Sbjct: 377 LAHVKAERDVLAGSDSPWIVALYYSFQDSQYLYLIMEFLPGGDLMTMLIRWEVFTEDITR 436
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN-------LQ 273
FY+ E VLAIE+IHK +IHRDIKPDN+L+D GH+KLSDFGL ++ L
Sbjct: 437 FYIAECVLAIEAIHKLGFIHRDIKPDNILIDNRGHVKLSDFGLSTGFHKTHDSNYYNKLL 496
Query: 274 EKDFSIGSNLSGALQSDGR------PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327
EK+ S ++L + GR + + ++ +Q W+++RR++AYSTVGTPDYIAP
Sbjct: 497 EKEPS-NTHLQPNQLTSGRNSVMVDAIHLTMSNRQTMQTWRKSRRLMAYSTVGTPDYIAP 555
Query: 328 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSP 387
E+ + +GYG ECDWWSLGAIM+E L+G+PPF S+ P T RKI+NW+ + PE+ LSP
Sbjct: 556 EIFIHQGYGQECDWWSLGAIMFECLIGWPPFCSENPHDTYRKILNWQESFQIPEDVHLSP 615
Query: 388 EAKDLISKLLCNVEQRLGT-KGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNF 446
EA+DLI + L + E R+G GA+EIK HP+F+G++WD + ++A F+P ++ DT++F
Sbjct: 616 EAEDLIKRFLTSAENRIGRYGGAEEIKQHPFFRGVDWDSIRGVQAPFVPRLSSMTDTRHF 675
Query: 447 EKFEEA---DN--------QIQTSAKSGPWRKMLSSKDINFVGYTYKNFEIV 487
+ A DN Q + AK+G RK +D+ F+GYTY F+ +
Sbjct: 676 PTDDLASVPDNPAMSKAMEQRELDAKNGGGRKN-PKEDLPFIGYTYSRFDYL 726
|
Serine/threonine-protein kinase required for wild-type hyphal growth and transcriptional regulation of cell-wall-associated genes. Involved in the biofilm formation through phosphorylation of the master regulator of biofilm formation BCR1. Candida albicans (strain SC5314 / ATCC MYA-2876) (taxid: 237561) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus GN=Stk38l PE=1 SV=2 | Back alignment and function description |
|---|
Score = 436 bits (1121), Expect = e-121, Method: Compositional matrix adjust.
Identities = 218/443 (49%), Positives = 298/443 (67%), Gaps = 9/443 (2%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
SN T+++V AK +EN Y + EER+ R+ LE + + +++EE+ +K
Sbjct: 14 SNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHARK 73
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETE++RL+R ++G DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+K++ML + QV
Sbjct: 74 ETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVA 133
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
H++AER++L E D +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTEEE +FY
Sbjct: 134 HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 193
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ETVLAI++IH+ +IHRD+KPDNLLLD GH+KLSDFGLC L ++ E N
Sbjct: 194 ISETVLAIDAIHQLGFIHRDVKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE----FYRN 249
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
L+ SD + + + W++NRR LAYSTVGTPDYIAPEV ++ GY CDWW
Sbjct: 250 LTHNPPSDFS--FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 307
Query: 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQ 402
SLG IMYEML+G+PPF S+ P T RK+++W+ L FP E +S +AKDLI + + E
Sbjct: 308 SLGVIMYEMLIGFPPFCSETPQETYRKVMSWKETLAFPPEVPVSEKAKDLILRFCTDSEN 367
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKS 462
R+G G +EIK HP+F+G++W + + AA E+ DT NF+ F E+D +
Sbjct: 368 RIGNGGVEEIKGHPFFEGVDWGHIRERPAAIPIEIRSIDDTSNFDDFPESDILQPVPNTT 427
Query: 463 GPWRKMLSSKDINFVGYTYKNFE 485
P K SKD F+ YTYK FE
Sbjct: 428 EPDYK---SKDWVFLNYTYKRFE 447
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 549 | ||||||
| 449458830 | 551 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.983 | 0.900 | 0.0 | |
| 147815455 | 550 | hypothetical protein VITISV_001730 [Viti | 0.989 | 0.987 | 0.901 | 0.0 | |
| 225433165 | 550 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.987 | 0.901 | 0.0 | |
| 224099921 | 551 | predicted protein [Populus trichocarpa] | 0.990 | 0.987 | 0.895 | 0.0 | |
| 62857016 | 547 | Ser/Thr protein kinase [Lotus japonicus] | 0.987 | 0.990 | 0.886 | 0.0 | |
| 356533751 | 544 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.987 | 0.896 | 0.0 | |
| 356533350 | 547 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.990 | 0.882 | 0.0 | |
| 224107433 | 543 | predicted protein [Populus trichocarpa] | 0.987 | 0.998 | 0.895 | 0.0 | |
| 356501683 | 547 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.990 | 0.873 | 0.0 | |
| 356576521 | 543 | PREDICTED: serine/threonine-protein kina | 0.976 | 0.987 | 0.894 | 0.0 |
| >gi|449458830|ref|XP_004147149.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Cucumis sativus] gi|449498613|ref|XP_004160584.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1031 bits (2666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/543 (90%), Positives = 521/543 (95%), Gaps = 1/543 (0%)
Query: 1 MDSARCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M++ R WFNK RSKDK KPS KE+ G+ ++ S+A TSE+VPSNVTKQKVAAAKQYIENH
Sbjct: 1 MEATRRWFNKFRSKDKPKPSTNKESTGNARDPSRAPTSEDVPSNVTKQKVAAAKQYIENH 60
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YKKQMKSLEER+ERR++LEKKLADAEVS+EEQ+NLLK+LEKKETEYMRLQRHKMGADDFE
Sbjct: 61 YKKQMKSLEERRERRHVLEKKLADAEVSQEEQSNLLKHLEKKETEYMRLQRHKMGADDFE 120
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIG+GAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 121 PLTMIGRGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+EYLYLIMEYLPGGDMMTLLMRKDTLTE+EARFYVGETVLAIESIHKHNYIH
Sbjct: 181 KLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYIH 240
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLD++GHMKLSDFGLCKPLDCSNLQEKDFS GSNLSGALQSDGRPVA +RTQ
Sbjct: 241 RDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQEKDFSQGSNLSGALQSDGRPVASKRTQ 300
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQLQHWQ+NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PPFYS
Sbjct: 301 QEQLQHWQKNRRYLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFYS 360
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG
Sbjct: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
IEWDKLYQ+KAAFIPEVNDELDTQNFEKFEE +N +QTS+KSGPWRKMLSSKDINFVGYT
Sbjct: 421 IEWDKLYQMKAAFIPEVNDELDTQNFEKFEETENALQTSSKSGPWRKMLSSKDINFVGYT 480
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESATVNQPVHGGSFLNLLPPQIEV 540
YKNFEI++D+QLPGIAELKKKS K KRPSIKSLF++ESA NQPV GSFL LLPPQ+EV
Sbjct: 481 YKNFEIIDDNQLPGIAELKKKSAKSKRPSIKSLFDNESAMANQPVQ-GSFLKLLPPQLEV 539
Query: 541 PEK 543
PEK
Sbjct: 540 PEK 542
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815455|emb|CAN61876.1| hypothetical protein VITISV_001730 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1027 bits (2655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/546 (90%), Positives = 520/546 (95%), Gaps = 3/546 (0%)
Query: 1 MDSARCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M S CWFNKL+S+DK K S KKE +GKE SKA TSEE PSNVTKQKVAAAKQYIENH
Sbjct: 1 MKSIGCWFNKLKSRDKAK-SSKKEATNNGKEGSKAVTSEEAPSNVTKQKVAAAKQYIENH 59
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YK+QMK+L+ERKERRNILEKKLADAEVSEEEQNNLLK+LEKKETEYMRLQRHKMGADDFE
Sbjct: 60 YKEQMKNLQERKERRNILEKKLADAEVSEEEQNNLLKHLEKKETEYMRLQRHKMGADDFE 119
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIGKGAFGEVRVCREK TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 120 PLTMIGKGAFGEVRVCREKKTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 179
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+E+LYL+MEYLPGGDMMTLLMRKDTLTE+EARFYVGETVLAIESIHKHNYIH
Sbjct: 180 KLYCSFQDEEFLYLVMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYIH 239
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLDR GHMKLSDFGLCKPLDCSNL EKDFS+G+NLSGALQSDGRP APRRTQ
Sbjct: 240 RDIKPDNLLLDRYGHMKLSDFGLCKPLDCSNLHEKDFSLGNNLSGALQSDGRPAAPRRTQ 299
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS
Sbjct: 300 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
DEPM+TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNV+QRLGTKGADEIKAHPWF+G
Sbjct: 360 DEPMTTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVDQRLGTKGADEIKAHPWFQG 419
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
++WDKLYQI+AAFIPEVNDELDTQNFEKFEEAD+QIQTS+K+GPWRKMLSSKDINFVGYT
Sbjct: 420 VDWDKLYQIEAAFIPEVNDELDTQNFEKFEEADDQIQTSSKAGPWRKMLSSKDINFVGYT 479
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDES-ATVNQPVHGGSFLNLLPPQIE 539
YKNFEIVND +PGIAELKKKSTK KRPSIKSLF+DES A N+PV GSFLNLLPP++E
Sbjct: 480 YKNFEIVNDQPVPGIAELKKKSTKTKRPSIKSLFDDESGAAANEPVQ-GSFLNLLPPKLE 538
Query: 540 VPEKEG 545
V +K G
Sbjct: 539 VSQKHG 544
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433165|ref|XP_002285280.1| PREDICTED: serine/threonine-protein kinase tricorner [Vitis vinifera] gi|296083669|emb|CBI23658.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1026 bits (2653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 492/546 (90%), Positives = 520/546 (95%), Gaps = 3/546 (0%)
Query: 1 MDSARCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M S CWFNKL+S+DK K S KKE +GKE SKA TSEE PSNVTKQKVAAAKQYIENH
Sbjct: 1 MKSIGCWFNKLKSRDKAK-SSKKEATNNGKEGSKAVTSEEAPSNVTKQKVAAAKQYIENH 59
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YK+QMK+L+ERKERRNILEKKLADAEVSEEEQNNLLK+LEKKETEYMRLQRHKMGADDFE
Sbjct: 60 YKEQMKNLQERKERRNILEKKLADAEVSEEEQNNLLKHLEKKETEYMRLQRHKMGADDFE 119
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIGKGAFGEVRVCREK TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 120 PLTMIGKGAFGEVRVCREKKTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 179
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+E+LYL+MEYLPGGDMMTLLMRKDTLTE+EARFYVGETVLAIESIHKHNYIH
Sbjct: 180 KLYCSFQDEEFLYLVMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYIH 239
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLDR GHMKLSDFGLCKPLDCSNL EKDFS+G+NLSGALQSDGRP APRRTQ
Sbjct: 240 RDIKPDNLLLDRYGHMKLSDFGLCKPLDCSNLHEKDFSLGNNLSGALQSDGRPAAPRRTQ 299
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS
Sbjct: 300 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
DEPM+TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNV+QRLGTKGADEIKAHPWF+G
Sbjct: 360 DEPMTTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVDQRLGTKGADEIKAHPWFEG 419
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
++WDKLYQI+AAFIPEVNDELDTQNFEKFEEAD+QIQTS+K+GPWRKMLSSKDINFVGYT
Sbjct: 420 VDWDKLYQIEAAFIPEVNDELDTQNFEKFEEADDQIQTSSKAGPWRKMLSSKDINFVGYT 479
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDES-ATVNQPVHGGSFLNLLPPQIE 539
YKNFEIVND +PGIAELKKKSTK KRPSIKSLF+DES A N+PV GSFLNLLPP++E
Sbjct: 480 YKNFEIVNDQPVPGIAELKKKSTKTKRPSIKSLFDDESGAAANEPVQ-GSFLNLLPPKLE 538
Query: 540 VPEKEG 545
V +K G
Sbjct: 539 VSQKHG 544
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099921|ref|XP_002311675.1| predicted protein [Populus trichocarpa] gi|222851495|gb|EEE89042.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/546 (89%), Positives = 518/546 (94%), Gaps = 2/546 (0%)
Query: 1 MDSARCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M+S CWFN+L+SKDK+K +K+K+T +GKE +KA SEE PSNVTKQKVAAAKQ+IENH
Sbjct: 1 MESTGCWFNRLKSKDKLKSAKQKDTTCNGKEGTKAPNSEEAPSNVTKQKVAAAKQFIENH 60
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YKKQMK L+ER+ERRN+LEKKLADAEVSEEE NNLLK+LEKKETEYMRLQRHKMGADDFE
Sbjct: 61 YKKQMKDLQERQERRNVLEKKLADAEVSEEEHNNLLKFLEKKETEYMRLQRHKMGADDFE 120
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIGKGAFGEVRVCREK+TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 121 PLTMIGKGAFGEVRVCREKSTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+EYLYLIMEYLPGGDMMTLLMRKDTLTE+EARFYVGETVLAIESIHKHNYIH
Sbjct: 181 KLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYIH 240
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLDRNGHMKLSDFGLCKPLDCS LQEKDFS + LSGALQSDGRP P+RTQ
Sbjct: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSTLQEKDFSAANKLSGALQSDGRPAVPKRTQ 300
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PPFYS
Sbjct: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFYS 360
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
DEPMSTCRKIVNWR HLKFPEEAKLS EAKDLISKLLCNV+QRLGTKGADEIKAHPWFKG
Sbjct: 361 DEPMSTCRKIVNWRDHLKFPEEAKLSSEAKDLISKLLCNVDQRLGTKGADEIKAHPWFKG 420
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEAD+QIQTSAKSGPWRKMLSSKDINFVGYT
Sbjct: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADDQIQTSAKSGPWRKMLSSKDINFVGYT 480
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESA-TVNQPVHGGSFLNLLPPQIE 539
YKNFEI+NDHQLPGIAELKKKSTK KRPSIKSLFEDESA N+PV GSFL+LLPP+++
Sbjct: 481 YKNFEIINDHQLPGIAELKKKSTKSKRPSIKSLFEDESAEPPNEPVK-GSFLSLLPPKLD 539
Query: 540 VPEKEG 545
E+ G
Sbjct: 540 SSEQSG 545
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857016|dbj|BAD95893.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 1005 bits (2599), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 482/544 (88%), Positives = 509/544 (93%), Gaps = 2/544 (0%)
Query: 1 MDSARCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M+S R WF+K ++ DK KPSK KE G KE + T+EE PSNVT+QKV AAKQYIENH
Sbjct: 1 MESTRRWFSKFKAMDKTKPSKNKEDTGMAKEGLQPPTNEETPSNVTQQKVEAAKQYIENH 60
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YKKQM+SL+ERKERRN+LEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE
Sbjct: 61 YKKQMQSLQERKERRNMLEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+E LYLIMEYLPGGDMMTLLMRKD LTE+EARFYVGETVLAIESIHKHNYIH
Sbjct: 181 KLYCSFQDEENLYLIMEYLPGGDMMTLLMRKDILTEDEARFYVGETVLAIESIHKHNYIH 240
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLDR+GHMKLSDFGLCKPLDCSNLQEKDFS SN SGALQSDGRP AP+RTQ
Sbjct: 241 RDIKPDNLLLDRHGHMKLSDFGLCKPLDCSNLQEKDFSAMSNRSGALQSDGRPAAPKRTQ 300
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQLQHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYS
Sbjct: 301 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYS 360
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
DEPM TCRKIVNWRTHLKFPEEAKLSPEAKDLI +LLCNVEQRLGTKGADEIKAHPWF G
Sbjct: 361 DEPMQTCRKIVNWRTHLKFPEEAKLSPEAKDLICRLLCNVEQRLGTKGADEIKAHPWFDG 420
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
IEWDKLYQ+KAAFIPEVNDELDTQNFEKFEEAD Q + SAK+GPWRKML SKDINFVGYT
Sbjct: 421 IEWDKLYQMKAAFIPEVNDELDTQNFEKFEEADKQTEPSAKAGPWRKMLPSKDINFVGYT 480
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESA-TVNQPVHGGSFLNLLPPQIE 539
YKNFEIVN++++PGIAELKKKSTK KRPSIK+LF+DESA NQPV GSFLNLLPPQ+E
Sbjct: 481 YKNFEIVNENEIPGIAELKKKSTKSKRPSIKALFDDESAMAANQPVK-GSFLNLLPPQME 539
Query: 540 VPEK 543
VPEK
Sbjct: 540 VPEK 543
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356533751|ref|XP_003535423.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/540 (89%), Positives = 504/540 (93%), Gaps = 3/540 (0%)
Query: 5 RCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENHYKKQ 64
RCWFNK + KDK + SK KET G KE SK T+EE PSNVTKQKVAAAKQYIENHYKKQ
Sbjct: 3 RCWFNKFKPKDKTQSSKNKETKGIAKEGSKPLTNEEAPSNVTKQKVAAAKQYIENHYKKQ 62
Query: 65 MKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTM 124
MK LEER+ERRN+LEKKLADAEVSEEEQNNLLKY EKKE EYMRL+RHKMGADDFEPLTM
Sbjct: 63 MKDLEERQERRNMLEKKLADAEVSEEEQNNLLKYFEKKEREYMRLKRHKMGADDFEPLTM 122
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IGKGAFGEVRVCREK TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC
Sbjct: 123 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 182
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
SFQD+EYLYLIMEYLPGGDMMTLLMRKD LTE+EARFYVGETVLAIESIHKHNYIHRDIK
Sbjct: 183 SFQDEEYLYLIMEYLPGGDMMTLLMRKDILTEDEARFYVGETVLAIESIHKHNYIHRDIK 242
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN SGALQSDGRPVAP+R+QQEQL
Sbjct: 243 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNRSGALQSDGRPVAPKRSQQEQL 302
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
QHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM
Sbjct: 303 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 362
Query: 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWD 424
TCRKIVNWR++LKFPEE KLS EAKDLIS+LLCNV+QRLGTKGADEIKAHPWFKGIEWD
Sbjct: 363 LTCRKIVNWRSYLKFPEEVKLSAEAKDLISRLLCNVDQRLGTKGADEIKAHPWFKGIEWD 422
Query: 425 KLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNF 484
KLYQ+KAAFIPEVNDELDTQNFEKFEE DNQ Q S+KSGPWRKMLSSKD+NFVGYTYKN+
Sbjct: 423 KLYQMKAAFIPEVNDELDTQNFEKFEEVDNQTQPSSKSGPWRKMLSSKDVNFVGYTYKNY 482
Query: 485 EIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESATV-NQPVHGGSFLNLLPPQIEVPEK 543
EIVND QLP IAEL KKSTKPKRPSIK+LF DESAT NQP GSFL LLP Q EVPEK
Sbjct: 483 EIVNDDQLPEIAEL-KKSTKPKRPSIKTLFYDESATTANQPAQ-GSFLKLLPTQPEVPEK 540
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356533350|ref|XP_003535228.1| PREDICTED: serine/threonine-protein kinase 38-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1003 bits (2592), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/544 (88%), Positives = 510/544 (93%), Gaps = 2/544 (0%)
Query: 1 MDSARCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M++ R WF+K +S DK+K K KET G KE S+ T+EE PSNVTKQ+V AAKQYIENH
Sbjct: 1 METTRRWFSKFKSNDKMKSEKNKETTGVTKEGSRPPTNEEAPSNVTKQRVEAAKQYIENH 60
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YKKQM+SL+ERKERRN+LEKKLADAEVSEEEQ+NLL++LEKKE E MRLQRHKMGADDFE
Sbjct: 61 YKKQMQSLQERKERRNMLEKKLADAEVSEEEQHNLLQHLEKKEREIMRLQRHKMGADDFE 120
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIGKGAFGEVR+CREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 121 PLTMIGKGAFGEVRICREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+EYLYLIMEYLPGGDMMTLLMRKD LTE+EARFYVGETVLAIESIHKHNYIH
Sbjct: 181 KLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDILTEDEARFYVGETVLAIESIHKHNYIH 240
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS+G N SGALQSDGRPVAP+RTQ
Sbjct: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSVGMNRSGALQSDGRPVAPKRTQ 300
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQLQHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYS
Sbjct: 301 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYS 360
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
DEPM TCRKIVNWRT LKFPEEAKLS EAKDLI +LLCNVEQRLGTKGADEIKAHPWFKG
Sbjct: 361 DEPMLTCRKIVNWRTTLKFPEEAKLSAEAKDLICRLLCNVEQRLGTKGADEIKAHPWFKG 420
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
+EWDKLYQ+KAAFIPEVNDELDTQNFEKFEEAD Q S+K+GPWRKML SKDINFVGYT
Sbjct: 421 VEWDKLYQMKAAFIPEVNDELDTQNFEKFEEADKQTVPSSKAGPWRKMLPSKDINFVGYT 480
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESAT-VNQPVHGGSFLNLLPPQIE 539
YKNFEIVND ++PGIAELKKKSTKPKRPSIKSLF+DESAT NQPV GSFLNLLPPQ+E
Sbjct: 481 YKNFEIVNDPEIPGIAELKKKSTKPKRPSIKSLFDDESATAANQPVR-GSFLNLLPPQME 539
Query: 540 VPEK 543
VPEK
Sbjct: 540 VPEK 543
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224107433|ref|XP_002314478.1| predicted protein [Populus trichocarpa] gi|222863518|gb|EEF00649.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2591), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/544 (89%), Positives = 519/544 (95%), Gaps = 2/544 (0%)
Query: 1 MDSARCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M+S CWFN+L+SKDK+K +KKK+TAG+ KE SKA SEE PSNVT+QKVAAAKQYIENH
Sbjct: 1 MESTGCWFNRLKSKDKLKSAKKKDTAGNEKEGSKAPNSEEAPSNVTRQKVAAAKQYIENH 60
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YKKQMK L+ERKERRN+LEKKLADAEVSEEEQ+NLLKYLEKKETEYMRLQRHKMGADDFE
Sbjct: 61 YKKQMKDLQERKERRNVLEKKLADAEVSEEEQDNLLKYLEKKETEYMRLQRHKMGADDFE 120
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIGKGAFGEVR+CREK+TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 121 PLTMIGKGAFGEVRICREKSTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+EYLYLIMEYLPGGDMMTLLMRKDTLTE+EARFYVGETVLAIESIHKHNYIH
Sbjct: 181 KLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYIH 240
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS+ +NLSGALQS+G P AP+RTQ
Sbjct: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSVANNLSGALQSNGCPAAPKRTQ 300
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS+GAIMYEMLVGYPPFYS
Sbjct: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSIGAIMYEMLVGYPPFYS 360
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
D+PMSTCRKIVNWR HLKFPEEAKLSPEAK LISKLLCNV+QRLGTKG DEIKAHPWF+G
Sbjct: 361 DDPMSTCRKIVNWRNHLKFPEEAKLSPEAKYLISKLLCNVDQRLGTKGVDEIKAHPWFEG 420
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
EW+KLYQ+KAAFIPEVNDELDTQNFEKFEEAD+QIQTSAKSGPWRKMLSSKDINFVGYT
Sbjct: 421 TEWEKLYQMKAAFIPEVNDELDTQNFEKFEEADDQIQTSAKSGPWRKMLSSKDINFVGYT 480
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESATV-NQPVHGGSFLNLLPPQIE 539
YKNFEIVNDHQLPGIAELKKKSTK +RPSIKSLFEDES NQPV GSFL+LLPP+++
Sbjct: 481 YKNFEIVNDHQLPGIAELKKKSTKSERPSIKSLFEDESVEAPNQPVK-GSFLSLLPPKLD 539
Query: 540 VPEK 543
E+
Sbjct: 540 ASEQ 543
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501683|ref|XP_003519653.1| PREDICTED: serine/threonine-protein kinase 38-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 996 bits (2576), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/544 (87%), Positives = 507/544 (93%), Gaps = 2/544 (0%)
Query: 1 MDSARCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M++ R WF+K +S DK+ +K KET G KE SK TSEE PSNVTKQ+V AAKQYIENH
Sbjct: 1 METTRRWFSKFKSNDKMNSAKDKETTGMTKEGSKPPTSEEAPSNVTKQRVEAAKQYIENH 60
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YKKQM+SL+ERKERRN+LEKKLADAEVSEEEQ+NLL++LEKKE E MRLQRHKMGADDFE
Sbjct: 61 YKKQMQSLQERKERRNMLEKKLADAEVSEEEQHNLLQHLEKKEREIMRLQRHKMGADDFE 120
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIGKGAFGEVR+CREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 121 PLTMIGKGAFGEVRICREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKD LTE+EARFYVGETVLAIESIHKHNYIH
Sbjct: 181 KLYCSFQDEEFLYLIMEYLPGGDMMTLLMRKDILTEDEARFYVGETVLAIESIHKHNYIH 240
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS+G N SGALQSDGRP AP RTQ
Sbjct: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSVGINRSGALQSDGRPAAPNRTQ 300
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQLQHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYS
Sbjct: 301 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYS 360
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
DEPM TCRKIV WRT LKFPEEAKLS EAKDLI +LLCNVEQRLGTKGADEIKAHPWFKG
Sbjct: 361 DEPMLTCRKIVTWRTTLKFPEEAKLSAEAKDLICRLLCNVEQRLGTKGADEIKAHPWFKG 420
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
+EWDKLYQ++AAFIPEVNDELDTQNFEKFEE D Q S+K+GPWRKML SKDINFVGYT
Sbjct: 421 VEWDKLYQMQAAFIPEVNDELDTQNFEKFEEGDKQTVPSSKAGPWRKMLPSKDINFVGYT 480
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESAT-VNQPVHGGSFLNLLPPQIE 539
YKNFEIVNDH++PGIAELKKK+TKPKRPSIK+LF+DESAT NQPV GSFLNLLPPQ+E
Sbjct: 481 YKNFEIVNDHEIPGIAELKKKNTKPKRPSIKALFDDESATAANQPVR-GSFLNLLPPQME 539
Query: 540 VPEK 543
VPEK
Sbjct: 540 VPEK 543
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576521|ref|XP_003556379.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 995 bits (2573), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/540 (89%), Positives = 503/540 (93%), Gaps = 4/540 (0%)
Query: 5 RCWFNKLRSKDKVKPSKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENHYKKQ 64
RCWFNK + KDK SK KET G K SK T++E PSNVTKQKVAAAKQYIENHYKKQ
Sbjct: 3 RCWFNKFKPKDKTPSSKNKET-GIAKG-SKPPTNDEAPSNVTKQKVAAAKQYIENHYKKQ 60
Query: 65 MKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTM 124
M+ L+ERKERRN+LEKKLADAEVSEEEQNNLLKY EKKE EYMRL+RHKMGADDFEPLTM
Sbjct: 61 MQDLQERKERRNMLEKKLADAEVSEEEQNNLLKYFEKKEREYMRLKRHKMGADDFEPLTM 120
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY
Sbjct: 121 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYY 180
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
SFQD+EYLYLIMEYLPGGDMMTLLMRKD LTE EARFYVGETVLAIESIHKHNYIHRDIK
Sbjct: 181 SFQDEEYLYLIMEYLPGGDMMTLLMRKDILTENEARFYVGETVLAIESIHKHNYIHRDIK 240
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN SGALQSDGRPVAP+R+QQEQL
Sbjct: 241 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNRSGALQSDGRPVAPKRSQQEQL 300
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
QHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM
Sbjct: 301 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 360
Query: 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWD 424
TCRKIVNWR +LKFPEE K+S EAKDLIS+LLCNV+QRLGTKGADEIKAHPWFKGIEWD
Sbjct: 361 LTCRKIVNWRNYLKFPEEVKISAEAKDLISRLLCNVDQRLGTKGADEIKAHPWFKGIEWD 420
Query: 425 KLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNF 484
KLYQIKAAFIPEVNDELDTQNFEKFEEADNQ Q S+KSGPWRKMLSSKD+NFVGYTYKN+
Sbjct: 421 KLYQIKAAFIPEVNDELDTQNFEKFEEADNQTQPSSKSGPWRKMLSSKDVNFVGYTYKNY 480
Query: 485 EIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESAT-VNQPVHGGSFLNLLPPQIEVPEK 543
EIVND QLP IAELKKKSTKPKRPSIK+LF+DESAT NQP GSFL LLP Q EVPEK
Sbjct: 481 EIVNDDQLPEIAELKKKSTKPKRPSIKTLFDDESATAANQPTQ-GSFLKLLPTQPEVPEK 539
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 549 | ||||||
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.996 | 0.963 | 0.823 | 1.2e-246 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.996 | 0.992 | 0.817 | 2.5e-246 | |
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.992 | 0.957 | 0.723 | 1.6e-221 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.870 | 0.840 | 0.805 | 2.3e-218 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.934 | 0.912 | 0.685 | 1.9e-193 | |
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.877 | 0.928 | 0.663 | 8e-172 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.897 | 0.935 | 0.624 | 3.3e-166 | |
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.867 | 0.922 | 0.623 | 2.4e-163 | |
| UNIPROTKB|E1C8Z7 | 465 | STK38 "Uncharacterized protein | 0.795 | 0.939 | 0.505 | 1.2e-115 | |
| UNIPROTKB|Q2LZZ7 | 458 | trc "Serine/threonine-protein | 0.795 | 0.954 | 0.517 | 1.2e-115 |
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2376 (841.5 bits), Expect = 1.2e-246, P = 1.2e-246
Identities = 454/551 (82%), Positives = 488/551 (88%)
Query: 1 MDSARCWFNXXXXXXXXXXXXXXETA-GHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIEN 59
MD+AR W ET+ G+ KE SK EE SNVTKQK AAAKQYIEN
Sbjct: 1 MDTARAWLKKLKSKGKEKSSNKKETSRGNVKEGSKTAGGEEAVSNVTKQKAAAAKQYIEN 60
Query: 60 HYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDF 119
HYKKQ++S ++RKERR++LE KLA AEVSEEEQ NLLK LEKKETEYMR QRHKMG DDF
Sbjct: 61 HYKKQVQSQQQRKERRDMLENKLAAAEVSEEEQKNLLKDLEKKETEYMRRQRHKMGTDDF 120
Query: 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
EPLTMIGKGAFGEVR+CREK TG+VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI
Sbjct: 121 EPLTMIGKGAFGEVRICREKTTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 180
Query: 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYI 239
VKLYCSFQD+EYLYLIMEYLPGGDMMTLLMRKDTLTE+EARFYVGETVLAIESIHKHNYI
Sbjct: 181 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYI 240
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
HRDIKPDNLLLDR+GHMKLSDFGLCKPLDCS LQEKDF + NLSGALQSDGRPVAPRRT
Sbjct: 241 HRDIKPDNLLLDRSGHMKLSDFGLCKPLDCSILQEKDFVVAHNLSGALQSDGRPVAPRRT 300
Query: 300 --QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
Q EQLQ+WQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PP
Sbjct: 301 RSQMEQLQNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPP 360
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPW 417
FYSDEPM+TCRKIVNW+ +LKFP+E +LSPEAKDLI +LLCNVEQR+GTKGA+EIK HPW
Sbjct: 361 FYSDEPMTTCRKIVNWKNYLKFPDEVRLSPEAKDLICRLLCNVEQRIGTKGANEIKEHPW 420
Query: 418 FKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFV 477
F G+EW+KLYQ+KAAFIP+VNDELDTQNFEKFEE D Q+ + KSGPWRKMLSSKDINFV
Sbjct: 421 FSGVEWEKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVPKTPKSGPWRKMLSSKDINFV 480
Query: 478 GYTYKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESATVNQPVHGGSFLNLLPPQ 537
GYTYKN EIVN QLPGIAELKKKSTKPKRPSIKSLFEDESA+ + H GSF+ LLP Q
Sbjct: 481 GYTYKNVEIVNHDQLPGIAELKKKSTKPKRPSIKSLFEDESAS-STTSHQGSFMKLLPTQ 539
Query: 538 IEVPEKEGKSS 548
IEVPEKE KSS
Sbjct: 540 IEVPEKEDKSS 550
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2373 (840.4 bits), Expect = 2.5e-246, P = 2.5e-246
Identities = 448/548 (81%), Positives = 483/548 (88%)
Query: 1 MDSARCWFNXXXXXXXXXXXXXXETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENH 60
M++A+ W + E + KE K EE SN+TK+K AAAK YIENH
Sbjct: 1 METAKAWLSKLKSKDKVKSSKKKEATSNVKEGPKTAGGEEALSNITKEKAAAAKLYIENH 60
Query: 61 YKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFE 120
YK QM+SL+ERKERR +LEKKLA AEVSEEEQNNLLK LE KETEYMR QRHKMGADDFE
Sbjct: 61 YKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLKDLEMKETEYMRRQRHKMGADDFE 120
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
PLTMIGKGAFGEVR+CREK TG+VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV
Sbjct: 121 PLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLYCSFQD+EYLYLIMEYLPGGDMMTLLMRKDTLTE+EARFY+GETVLAIESIHKHNYIH
Sbjct: 181 KLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYIGETVLAIESIHKHNYIH 240
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKPDNLLLD++GHMKLSDFGLCKPLDCSNLQEKDF++ N+SGALQSDGRPVA RRTQ
Sbjct: 241 RDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQEKDFTVARNVSGALQSDGRPVATRRTQ 300
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
QEQL +WQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PPFYS
Sbjct: 301 QEQLLNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFYS 360
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKG 420
D+PM+TCRKIVNWR +LKFP+E +LSPEAKDLI +LLCNVEQRLGTKGADEIK HPWF+G
Sbjct: 361 DDPMTTCRKIVNWRNYLKFPDEVRLSPEAKDLICRLLCNVEQRLGTKGADEIKGHPWFRG 420
Query: 421 IEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYT 480
EW KLYQ+KAAFIP+VNDELDTQNFEKFEE D Q+ SAKSGPWRKMLSSKDINFVGYT
Sbjct: 421 TEWGKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVPKSAKSGPWRKMLSSKDINFVGYT 480
Query: 481 YKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDESATVNQPVHGGSFLNLLPPQIEV 540
YKN EIVND Q+PGIAELKKKS KPKRPSIKSLFEDE++ H GSFLNLLP QIE
Sbjct: 481 YKNVEIVNDDQIPGIAELKKKSNKPKRPSIKSLFEDETSG-GTTTHQGSFLNLLPTQIED 539
Query: 541 PEKEGKSS 548
PEKEG S
Sbjct: 540 PEKEGSKS 547
|
|
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2139 (758.0 bits), Expect = 1.6e-221, P = 1.6e-221
Identities = 413/571 (72%), Positives = 474/571 (83%)
Query: 1 MDSARCWFNXXXXXXXXXXXXXXETAGHGKEVSKA-----QTSEEVPSNVTKQKVAAAKQ 55
MDSA+ WF AG G A +T EE SN TKQKVAAAKQ
Sbjct: 1 MDSAKGWFQKRQMRGGSRYKGASGGAGGGGSNGSADEHNVETDEEAVSNTTKQKVAAAKQ 60
Query: 56 YIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMG 115
YIENHYK+QMK L+ERKERR++LE+KLADA+VSEE+QNNLLK+LEKKETEYMRLQRHK+G
Sbjct: 61 YIENHYKEQMKILQERKERRSMLEQKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKLG 120
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
DF+ LTMIGKGAFGEVRVCREK TG VYAMKKLKK+EMLRRGQVEHV+AERNLLAEVD
Sbjct: 121 VADFDLLTMIGKGAFGEVRVCREKTTGQVYAMKKLKKAEMLRRGQVEHVRAERNLLAEVD 180
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
SN IVKLYCSFQDD++LYL+MEYLPGGDMMTLLMRKDTLTEEEA+FYV ETVLAIESIH+
Sbjct: 181 SNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLLMRKDTLTEEEAKFYVAETVLAIESIHR 240
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
HNYIHRDIKPDNLLLDR GH++LSDFGLCKPLDCS + E DFS SN G+ + + A
Sbjct: 241 HNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSAIGENDFSNNSN--GSTEQEAGSTA 298
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
P+RTQQEQL+HWQRNRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY
Sbjct: 299 PKRTQQEQLEHWQRNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 358
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAH 415
PPFYSD+PMSTCRKIVNW++HLKFPEEA LS EAKDLI+ LLC+V +RLG+KGADE+KAH
Sbjct: 359 PPFYSDDPMSTCRKIVNWKSHLKFPEEAILSREAKDLINSLLCSVRRRLGSKGADELKAH 418
Query: 416 PWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDIN 475
WF+ ++WD ++ + AAF+PEVND+LDTQNFEKF+E++++ QTS+KSGPWRKMLSSKDIN
Sbjct: 419 TWFETVDWDTIFDMDAAFVPEVNDDLDTQNFEKFDESESETQTSSKSGPWRKMLSSKDIN 478
Query: 476 FVGYTYKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFE-------DESATVNQP---- 524
FVGYTYKNFEIVND+Q+PG+AELKKK K RP +KSLF+ D S T ++P
Sbjct: 479 FVGYTYKNFEIVNDYQVPGMAELKKKK-KSTRPMVKSLFDNGSSETSDSSETTSRPPCDR 537
Query: 525 ------VHGGSFLNLLPPQIEV-PEKEGKSS 548
V GSFL LLPP++EV P++EG +
Sbjct: 538 PPPAPPVVQGSFLKLLPPELEVRPKQEGSEA 568
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2091 (741.1 bits), Expect = 2.3e-218, Sum P(2) = 2.3e-218
Identities = 386/479 (80%), Positives = 437/479 (91%)
Query: 40 EVPSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYL 99
E SN TKQKVAAAKQYIENHYK+QMK+L ERKERR LEKKLADA+V EE+Q NL+K+L
Sbjct: 58 EALSNSTKQKVAAAKQYIENHYKEQMKNLNERKERRTTLEKKLADADVCEEDQTNLMKFL 117
Query: 100 EKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRG 159
EKKETEYMRLQRHKMGADDFE LTMIGKGAFGEVRV RE TGHV+AMKKLKKSEMLRRG
Sbjct: 118 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVREINTGHVFAMKKLKKSEMLRRG 177
Query: 160 QVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEA 219
QVEHV+AERNLLAEVDSNCIVKLYCSFQD+EYLYLIMEYLPGGDMMTLLMRKDTL+E+EA
Sbjct: 178 QVEHVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEYLPGGDMMTLLMRKDTLSEDEA 237
Query: 220 RFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
+FY+ E+VLAIESIH NYIHRDIKPDNLLLDR GH++LSDFGLCKPLDCS + +DF++
Sbjct: 238 KFYIAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSVIDGEDFTV 297
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 339
G+ SG S+ P+R+QQEQL+HWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMEC
Sbjct: 298 GNAGSGG-GSESVSTTPKRSQQEQLEHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 356
Query: 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCN 399
DWWSLGAIMYEMLVGYPPFY+D+PMSTCRKIVNW+THLKFPEE++LS A+DLI KLLC+
Sbjct: 357 DWWSLGAIMYEMLVGYPPFYADDPMSTCRKIVNWKTHLKFPEESRLSRGARDLIGKLLCS 416
Query: 400 VEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTS 459
V QRLG+ GA +IKAHPWF+G++W+K+YQ++AAFIPEVND+LDTQNFEKF+E DNQ Q
Sbjct: 417 VNQRLGSTGASQIKAHPWFEGVQWEKIYQMEAAFIPEVNDDLDTQNFEKFDEEDNQTQAP 476
Query: 460 AKSGPWRKMLSSKDINFVGYTYKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDES 518
+++GPWRKMLSSKDINFVGYTYKNFEIVND+Q+PGIAELKKK +K KRPS+KSLFE ES
Sbjct: 477 SRTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGIAELKKKESKSKRPSVKSLFESES 535
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1874 (664.7 bits), Expect = 1.9e-193, P = 1.9e-193
Identities = 355/518 (68%), Positives = 420/518 (81%)
Query: 2 DSARCWFNXXXXXXXXXXXXXXETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENHY 61
+ R WF G+ K + + ++ PSN TKQKVAAAKQYIENHY
Sbjct: 4 EPTRSWFQIRQQKPDKSSPTKKGQEGNVKNLGRPPMND-APSNATKQKVAAAKQYIENHY 62
Query: 62 KKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEP 121
K Q KSL+ERKERR+ILE+ LADA+V+ E++ ++LK EKKE EYMRLQR KMG DDFE
Sbjct: 63 KIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKKEMEYMRLQRQKMGVDDFEL 122
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
L++IG+GAFGEVR+C+EK+TG VYAMKKLKKSEMLRRGQVEHVKAERN+LAEVDS IVK
Sbjct: 123 LSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVEHVKAERNVLAEVDSPFIVK 182
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
L SFQDDE+LYLIMEYLPGGDMMTLLMRKDTL E+E RFYV +T+LAIESIHKHNY+HR
Sbjct: 183 LCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFYVAQTILAIESIHKHNYVHR 242
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE-KDFSIGSNLSGALQSDGR---PVAPR 297
DIKPDNLL+ RNGH+KLSDFGL K L+ N + K + + A + D P APR
Sbjct: 243 DIKPDNLLITRNGHIKLSDFGLSKSLESKNFPDFKAELVDRSTKPAAEHDRLSKPPSAPR 302
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
RTQQEQL HWQ+NRR LA+STVGTPDYIAPEVLLKKGYGMECDWWSLGAIM+EMLVG+PP
Sbjct: 303 RTQQEQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMFEMLVGFPP 362
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPW 417
FYS+EP++TCRKIVNW+T LKFP+EAKLS E KDLI +LLCNVEQRLGTKG EIKAHPW
Sbjct: 363 FYSEEPLATCRKIVNWKTCLKFPDEAKLSIEVKDLIRRLLCNVEQRLGTKGVHEIKAHPW 422
Query: 418 FKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFV 477
F+G+EW++LY+ A +IP+V ELDTQNFEKF+E + QTS+KS PWRKM+SSKD NF+
Sbjct: 423 FRGVEWERLYESNAPYIPQVKHELDTQNFEKFDEVPSTCQTSSKSSPWRKMISSKDANFL 482
Query: 478 GYTYKNFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFE 515
GYT+KN EIV++H +PG+AELK+KS +PS+K+LFE
Sbjct: 483 GYTFKNLEIVDEHHIPGMAELKRKSKTANKPSLKTLFE 520
|
|
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1670 (592.9 bits), Expect = 8.0e-172, P = 8.0e-172
Identities = 329/496 (66%), Positives = 394/496 (79%)
Query: 37 TSEEV-PSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNL 95
T EEV S++T +KVAAAKQYIENHYK Q K+++ERKERR ILE+KLA + V +EEQ N+
Sbjct: 11 TDEEVLGSSLTMEKVAAAKQYIENHYKAQNKNIQERKERRWILERKLASSGVPKEEQINM 70
Query: 96 LKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM 155
+K LE+KETE+MRL+R+K+ DDFE LT+IG+GAFGEVR+CRE+ +G++YAMKKLKKSEM
Sbjct: 71 IKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNIYAMKKLKKSEM 130
Query: 156 LRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLT 215
+ RGQVEHV+AERNLLAEV+S+ IVKLY SFQD EYLYLIMEYLPGGDMMTLLMR+DTL
Sbjct: 131 VMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMREDTLR 190
Query: 216 EEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL--- 272
E+ ARFY+ ++VLAIESIH++NYIHRDIKPDNLLLD++GHMKLSDFGLCKPLDC NL
Sbjct: 191 EDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNLPSI 250
Query: 273 QEKDFSIGSNLSGALQSDGR-PVAPR----RTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327
QE + +S + D P R+ QEQLQHWQ NRR LA+STVGTPDYIAP
Sbjct: 251 QENRATDDETMSEPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPDYIAP 310
Query: 328 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSP 387
EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY+D+P+STCRKIV+WR HLKFPE+AK S
Sbjct: 311 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPISTCRKIVHWRNHLKFPEDAKFSS 370
Query: 388 EAKDLISKLLCNVEQRLGTKG-ADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNF 446
EAKDLI +LLCNV+ RLGT G A +IK HPWFK + W+KLY+++AA+ PEVNDELDTQNF
Sbjct: 371 EAKDLICRLLCNVDHRLGTGGGAQQIKDHPWFKDVVWEKLYEMEAAYKPEVNDELDTQNF 430
Query: 447 EKFEEADNQIQTSAKSGPWRKML-SSKDINFVGYTYKNFEIVND--HQLPGIAELKKKST 503
KF+E ++ +SG RKML + KD++FVGYTYKNF+ V H L +A
Sbjct: 431 MKFDEVNSPAPERTRSGLSRKMLLAPKDLSFVGYTYKNFDAVKGLRHSLE-MARTMSLDR 489
Query: 504 KPKRPSIKSLFEDESA 519
P L E+A
Sbjct: 490 SPAEAMPVELISGEAA 505
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1617 (574.3 bits), Expect = 3.3e-166, P = 3.3e-166
Identities = 319/511 (62%), Positives = 392/511 (76%)
Query: 31 EVSKAQTSEEVPSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEE 90
EV E + SN T +KVAAAK+YIENHY ++M+ +++RKERR +LE+K+A +VSE+
Sbjct: 17 EVEDNFEDEGLVSNSTLEKVAAAKKYIENHYNRRMRHIQQRKERRWVLEQKIASLDVSEK 76
Query: 91 EQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKL 150
EQ LL+ L++KETEY RL R+++ DDF+ L++IG+GAFGEVR+CREK TG++YAMKKL
Sbjct: 77 EQLELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEVRLCREKKTGNIYAMKKL 136
Query: 151 KKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR 210
KKSEML RGQVEHV+AERNLLAEV S+CIVKLY SFQD EYLYLIMEYL GGD+MTLLMR
Sbjct: 137 KKSEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLYLIMEYLSGGDVMTLLMR 196
Query: 211 KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270
++TLTE ARFY+ ++VLAIESIHKHNY+HRDIKPDNLLLD+ GHMKLSDFGLCKPLDC
Sbjct: 197 EETLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKYGHMKLSDFGLCKPLDCR 256
Query: 271 NLQE-------KDFSIGSNLSGALQ-SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTP 322
N+ D +I ++ G S GR ++ EQLQHWQ NRR LAYSTVGTP
Sbjct: 257 NISAMNVNEPLNDENINESIDGDENCSIGRRGRRWKSPLEQLQHWQINRRKLAYSTVGTP 316
Query: 323 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE 382
DYIAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYSD+P++TCRKIV+WRTHL FPE
Sbjct: 317 DYIAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVSWRTHLVFPEG 376
Query: 383 AKLSPEAKDLISKLLCNVEQRLGTKGA--DEIKAHPWFKGIEWDKLYQIKAAFIPEVNDE 440
A+L+PEA+DLI +LLC+ E RLG+ GA ++IKAH WFK +EW+KLY++ AAF P VN E
Sbjct: 377 ARLTPEARDLICRLLCDSEHRLGSHGAGAEQIKAHTWFKDVEWEKLYEMDAAFKPVVNGE 436
Query: 441 LDTQNFEKFEEADNQIQTSAKSGP-WRKMLSSKDINFVGYTYKNFEIVND--HQLPGIAE 497
LDTQNF KF+E + SGP W+ ++ ++INFVGYTY+NF+ V H L +
Sbjct: 437 LDTQNFMKFDEVECPKPARTGSGPSWKVSITPQNINFVGYTYRNFDAVRGSRHSL----D 492
Query: 498 LKKKSTKPKRPSIKSLFEDESATVNQPVHGG 528
+K S P R S S D + + GG
Sbjct: 493 IKG-SVSPPRSSTDSTRSDSAIDYTKLSTGG 522
|
|
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1590 (564.8 bits), Expect = 2.4e-163, P = 2.4e-163
Identities = 303/486 (62%), Positives = 378/486 (77%)
Query: 34 KAQTSEEVPSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQN 93
+ +T V S VT+QK AAAKQ+IENHYK ++ L ER ERR ++K+ +A++ EEQ+
Sbjct: 17 ETETDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHERMERRREFQRKVQEAQLPVEEQD 76
Query: 94 NLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKS 153
+++ L ++ETEYMRLQR K+G DDFE LT+IGKGAFGEVR+CR ++T VYAMKKLKK+
Sbjct: 77 EMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLCRLRSTSEVYAMKKLKKT 136
Query: 154 EMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT 213
EML RGQVEHV++ERNLLAEVDS IVKL+ SFQD E LYLIMEYLPGGD+MTLLMR+D
Sbjct: 137 EMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIMEYLPGGDIMTLLMREDI 196
Query: 214 LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD---CS 270
L+E+ ARFY+ E++LAI SIH+HNY+HRDIKPDNL+LD++GH+KLSDFGLCKPLD S
Sbjct: 197 LSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHLKLSDFGLCKPLDDKYSS 256
Query: 271 NLQEKDFSIGS---NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327
L E D + N SG +D AP + +EQL W+RNRR LAYSTVGT DY+AP
Sbjct: 257 LLLEDDEMLSQDSENQSGKSDADK---APWQMPKEQLLQWKRNRRALAYSTVGTLDYMAP 313
Query: 328 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSP 387
EVLLKKGYGMECDWWSLGAI+YEMLVGYPPF SD+P TCRKI+NWR LKFPEE K+S
Sbjct: 314 EVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKIINWRVCLKFPEEPKISD 373
Query: 388 EAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFE 447
EA+DLI +LLC+V+ RLGT+G +EIK+HPWFKG WDKLY ++AA+ P V+ ELDTQNFE
Sbjct: 374 EARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYDMEAAYRPIVDGELDTQNFE 433
Query: 448 KFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFEIVNDHQLPGIAELKKKSTKPKR 507
KF E + + + GPWRKML+SKD NF+G+T+K +I + G A++K + +
Sbjct: 434 KFPEVEGSPSEAPQVGPWRKMLTSKDTNFIGFTFKKSDITRSMESSGSADMKSNGSG-EA 492
Query: 508 PSIKSL 513
PS+ SL
Sbjct: 493 PSLISL 498
|
|
| UNIPROTKB|E1C8Z7 STK38 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1140 (406.4 bits), Expect = 1.2e-115, P = 1.2e-115
Identities = 224/443 (50%), Positives = 304/443 (68%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKK 102
SN TK++V K +EN Y + EER+ R+ LE+ + + + +EE+ +K
Sbjct: 13 SNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEQMMEEEGLKDEEKRIRRSAHAQK 72
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
ETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 73 ETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG 132
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
H++AER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTEEE +FY
Sbjct: 133 HIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY 192
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ETVLAI+SIH+ +IHRDIKPDNLLLD GH+KLSDFGLC L ++ E F N
Sbjct: 193 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE--FY--RN 248
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
L+ +L SD + + + W+RNRR LA+STVGTPDYIAPEV ++ GY CDWW
Sbjct: 249 LNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 306
Query: 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQ 402
SLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI + C E
Sbjct: 307 SLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISDKAKDLILRFCCEWEH 366
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKS 462
R+G G +EIK++P+F+G++W+ + + AA E+ DT NF++F E+D T A S
Sbjct: 367 RIGASGVEEIKSNPFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVATS 426
Query: 463 GPWRKMLSSKDINFVGYTYKNFE 485
+KD F+ YTYK FE
Sbjct: 427 NHPETDYKNKDWVFINYTYKRFE 449
|
|
| UNIPROTKB|Q2LZZ7 trc "Serine/threonine-protein kinase tricorner" [Drosophila pseudoobscura pseudoobscura (taxid:46245)] | Back alignment and assigned GO terms |
|---|
Score = 1140 (406.4 bits), Expect = 1.2e-115, P = 1.2e-115
Identities = 233/450 (51%), Positives = 311/450 (69%)
Query: 43 SNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEE-QNNLLKYLEK 101
S+ T K AK +EN+Y + ERK+R LE +L D ++E + Q L++ +K
Sbjct: 16 SDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTESQRQEKRLQHAQK 75
Query: 102 KETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQV 161
ETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 76 -ETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQV 134
Query: 162 EHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARF 221
HV+AER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM+KDTL+EE +F
Sbjct: 135 AHVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQF 194
Query: 222 YVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
Y+ ET LAI+SIHK +IHRDIKPDNLLLD GH+KLSDFGLC L S+ DF
Sbjct: 195 YISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKSH--RTDFY--R 250
Query: 282 NLSGALQSD--GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 339
+LS A SD G +P +++ + + W+RNRR LAYSTVGTPDYIAPEV L+ GYG C
Sbjct: 251 DLSQAKPSDFIGTCASPMDSKR-RAESWKRNRRALAYSTVGTPDYIAPEVFLQTGYGPAC 309
Query: 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCN 399
DWWSLG IMYEML+GYPPF SD P T RK++NWR L FP E +S EAK+ I K C
Sbjct: 310 DWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEAKETIIKFCCE 369
Query: 400 VEQRLGT-KGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQT 458
++RLG+ +G +++K+ P+F+G++W+ + + AA EV DT NF++F + +I
Sbjct: 370 ADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDEFPDVSLEIP- 428
Query: 459 SAKSGPWRKMLSSKDINFVGYTYKNFEIVN 488
SA ++ +KD F+ YTYK FE+ N
Sbjct: 429 SAPIPQGGEI--AKDWVFINYTYKRFEVRN 456
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5R8M1 | STK38_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.5033 | 0.7959 | 0.9397 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.5099 | 0.7941 | 0.9519 | yes | no |
| A2VDV2 | STK38_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.5011 | 0.7959 | 0.9397 | yes | no |
| Q15208 | STK38_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5033 | 0.7959 | 0.9397 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 549 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-178 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-158 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-140 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-137 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-136 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-120 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-119 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-117 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-114 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-113 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-113 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-112 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-108 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-107 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-102 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-99 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-98 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-97 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-92 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-90 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-88 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-88 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-87 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-87 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-85 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-83 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-78 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-78 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-74 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-74 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-72 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-71 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-71 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-71 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-70 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-69 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-69 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-67 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-67 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-63 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-61 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-59 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-58 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-58 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-58 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-57 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-57 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-56 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-55 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-55 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-53 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-53 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-52 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-52 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-51 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-51 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-51 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-49 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-48 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-46 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-45 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-45 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-43 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-42 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-41 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-41 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-41 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-40 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-40 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-39 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-38 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-37 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-36 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-35 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-35 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-35 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-34 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-32 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-31 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-29 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-28 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-25 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-23 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-22 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-22 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-21 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-21 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-21 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-20 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-20 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-19 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-19 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-19 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-06 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 3e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-05 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.002 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 646 bits (1669), Expect = 0.0
Identities = 223/369 (60%), Positives = 273/369 (73%), Gaps = 5/369 (1%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DDFE + +IG+GAFGEVR+ ++K TGH+YAMKKL+KSEML + QV HV+AER++LAE D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+VKLY SFQD+ YLYLIMEYLPGGDMMTLLM+KDT TEEE RFY+ ET+LAI+SIHK
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
YIHRDIKPDNLLLD GH+KLSDFGLC L S+ E + L ++
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF---ISK 177
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
+ + + + W+RNRR LAYSTVGTPDYIAPEV L+ GY ECDWWSLG IMYEMLVGYP
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHP 416
PF SD P T RKI+NW+ L+FP+E LSPEAKDLI +L C E+RLG G +EIK+HP
Sbjct: 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHP 297
Query: 417 WFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINF 476
+FKG++W+ + + A IPE+ DT NF+ FEE D + TS GP R + SKD+ F
Sbjct: 298 FFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTSP--GPPRGKIKSKDLAF 355
Query: 477 VGYTYKNFE 485
+GYTYK FE
Sbjct: 356 IGYTYKRFE 364
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 505 bits (1302), Expect = e-178
Identities = 190/366 (51%), Positives = 253/366 (69%), Gaps = 16/366 (4%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DDFE + +IG+GAFGEV + R+K TG VYAMK L+KS+M++R Q+ HV+AER++LA+ DS
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IVKLY SFQD+E+LYL+MEY+PGGD+M LL+RKD EE ARFY+ E VLA++S+HK
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+IHRDIKPDN+L+D +GH+KL+DFGLCK + +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK------------KMNKAKDREYYLNDSHNLL 168
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
R + + RR+ A STVGTPDYIAPEVL YG+ECDWWSLG I+YEML G+P
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHP 416
PFYSD T KI+NW+ L+FP + +SPEA DLI +LLC+ E RLG+ +EIK+HP
Sbjct: 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS--FEEIKSHP 286
Query: 417 WFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINF 476
+FKGI+W+ L + K F+PE++ LDT NF+ FE D++ + S +K+ K + F
Sbjct: 287 FFKGIDWENLRETKPPFVPELSSPLDTSNFDDFE--DDKDLSDYLSQNSKKLNKGKQLAF 344
Query: 477 VGYTYK 482
VG+TYK
Sbjct: 345 VGFTYK 350
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 455 bits (1173), Expect = e-158
Identities = 191/377 (50%), Positives = 261/377 (69%), Gaps = 8/377 (2%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+DF + +IGKGAFGEVR+ ++K TG +YAMK L KSEM ++ Q+ HVKAER++LAE DS
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+V LY SFQD +YLYLIME+LPGGD+MT+L++ DT +E+ RFY+ E VLAIE++HK
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCK---PLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+IHRDIKPDN+L+DR GH+KLSDFGL S +K SN + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 294 VAP---RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
V + ++Q+ W++NRR++AYSTVGTPDYIAPE+ L++GYG ECDWWSLGAIM+E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGAD 410
L+G+PPF S+ T RKI+NWR L FP++ LS EA+DLI +L+ N E RLG GA
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAH 300
Query: 411 EIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNF--EKFEEADNQIQTSAKSGPWRKM 468
EIK+HP+F+G++WD + QI+A FIP++ DT F ++ E+ + ++
Sbjct: 301 EIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEE 360
Query: 469 LSSKDINFVGYTYKNFE 485
D+ F+GYTYK F+
Sbjct: 361 SVELDLAFIGYTYKRFD 377
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 409 bits (1053), Expect = e-140
Identities = 180/381 (47%), Positives = 239/381 (62%), Gaps = 23/381 (6%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F + IG GAFGEV + R+ T +YAMK L+K+++L R Q HVKAER++LAE D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
+VKLY SFQD + LY +M+Y+PGGDMM+LL+R E+ ARFY+ E AIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPL----DCSNLQEKD------FSIGSNLSGALQ 288
IHRDIKPDN+L+DR+GH+KL+DFGLC D Q+ D S +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
+P+ RR +Q Q R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I+
Sbjct: 183 CRLKPLERRRKRQHQ--------RCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234
Query: 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKG 408
YEMLVG PPF +D P T K++NW T L P +AKLS EA DLI +L C E RLG G
Sbjct: 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNG 294
Query: 409 ADEIKAHPWFKGIEWDKLY-QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRK 467
ADEIKAHP+FKGI++ L + KA +IP++ DT NF+ + + S +S P R
Sbjct: 295 ADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRN 354
Query: 468 MLSSK----DINFVGYTYKNF 484
+ + + F +T++ F
Sbjct: 355 VKPNNRKRTEHAFYEFTFRRF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 400 bits (1030), Expect = e-137
Identities = 194/369 (52%), Positives = 255/369 (69%), Gaps = 9/369 (2%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+K++ML + QV H++AER++L E D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+VK++ SFQD LYLIME+LPGGDMMTLLM+KDTL+EE +FY+ ETVLAI++IH+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+IHRDIKPDNLLLD GH+KLSDFGLC L ++ E NL+ SD
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE----FYRNLTHNPPSDFS--FQ 174
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
+ + + W++NRR LAYSTVGTPDYIAPEV ++ GY CDWWSLG IMYEML+GYP
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHP 416
PF S+ P T RK++NW+ L FP E +S +AKDLI + + E R+G+ G +EIK+HP
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHP 294
Query: 417 WFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINF 476
+F+G++W + + AA E+ DT NF++F E+D P K SKD F
Sbjct: 295 FFEGVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYK---SKDWVF 351
Query: 477 VGYTYKNFE 485
+ YTYK FE
Sbjct: 352 LNYTYKRFE 360
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 400 bits (1028), Expect = e-136
Identities = 197/369 (53%), Positives = 259/369 (70%), Gaps = 6/369 (1%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV H++AER++L E DS
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTEEE +FY+ ETVLAI+SIH+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+IHRDIKPDNLLLD GH+KLSDFGLC L ++ E NL+ +L SD
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE----FYRNLNHSLPSDF--TFQ 174
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
+ + + W+RNRR LA+STVGTPDYIAPEV ++ GY CDWWSLG IMYEML+GYP
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHP 416
PF S+ P T +K++NW+ L FP E +S +AKDLI + C E R+G G +EIK +P
Sbjct: 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294
Query: 417 WFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINF 476
+F+G++W+ + + AA E+ DT NF++F ++D T A S +KD F
Sbjct: 295 FFEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVF 354
Query: 477 VGYTYKNFE 485
+ YTYK FE
Sbjct: 355 INYTYKRFE 363
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 355 bits (913), Expect = e-120
Identities = 136/338 (40%), Positives = 197/338 (58%), Gaps = 53/338 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DDFE + +G G+FG V + R K +G YA+K L K+++++ QVEHV E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+V LY SFQDD LYL+MEY+PGG++ + L + E ARFY + VLA+E +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+ ++RD+KP+NLLLD +G++K++DFG K + GR
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----------------------KGR---- 154
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
Y+ GTP+Y+APE++L KGYG DWW+LG ++YEML GYP
Sbjct: 155 ------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGT--KGADEIK 413
PF+ D P+ KI+ + ++FP + SP+AKDLI LL ++ +RLG G ++IK
Sbjct: 197 PFFDDNPIQIYEKILEGK--VRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252
Query: 414 AHPWFKGIEWDKLYQ--IKAAFIPEVNDELDTQNFEKF 449
HPWF GI+W L Q I+A FIP+V DT NF+ +
Sbjct: 253 NHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDDY 290
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 351 bits (904), Expect = e-119
Identities = 130/295 (44%), Positives = 182/295 (61%), Gaps = 46/295 (15%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+GKG+FG+V + R+K TG +YAMK LKK ++++R +VEH ERN+L+ ++ IVKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
+FQ +E LYL++EY PGG++ + L ++ +EE ARFY E VLA+E +H I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P+N+LLD +GH+KL+DFGL K L
Sbjct: 121 PENILLDADGHIKLTDFGLAKELS------------------------------------ 144
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
+ + GTP+Y+APEVLL KGYG DWWSLG ++YEML G PPFY+++
Sbjct: 145 -----SEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199
Query: 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
KI+ L+FPE LSPEA+DLIS LL + +RLG+ GA+EIKAHP+F
Sbjct: 200 EIYEKILKDP--LRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 351 bits (902), Expect = e-117
Identities = 158/396 (39%), Positives = 239/396 (60%), Gaps = 51/396 (12%)
Query: 94 NLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKS 153
N+ +L + E ++ + +M A+DF+ + +IG+GAFGEV++ R K++ VYAMK L K
Sbjct: 20 NIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79
Query: 154 EMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT 213
EM++R ER+++A +S IV+L+ +FQDD+YLY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 214 LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273
+ E+ ARFY E VLA+++IH +IHRD+KPDN+LLD++GH+KL+DFG C +D
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA---- 194
Query: 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333
+G ++ D + VGTPDYI+PEVL +
Sbjct: 195 ----------NGMVRCD--------------------------TAVGTPDYISPEVLKSQ 218
Query: 334 G----YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEA 389
G YG ECDWWS+G +YEMLVG PFY+D + T KI++ + L FP++ ++S +A
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278
Query: 390 KDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEW--DKLYQIKAAFIPEVNDELDTQNFE 447
KDLI L + E RLG G DEIK+HP+FK +W D + + A +PE++ ++DT NF+
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFD 338
Query: 448 KFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKN 483
E+ D +T P K + + F+G+TY
Sbjct: 339 DIEDDDKNEETF----PLPKAFAGNQLPFIGFTYSK 370
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 342 bits (879), Expect = e-114
Identities = 160/372 (43%), Positives = 219/372 (58%), Gaps = 49/372 (13%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DDFE L +IG+GAFGEV V + K TG VYAMK L K EML+R + + ER++L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHK 235
I L+ +FQD+ LYL+M+Y GGD++TLL + +D L E+ ARFY+ E VLAI+S+H+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
Y+HRDIKPDN+LLD+NGH++L+DFG C L D ++ SN++
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL------ADGTVQSNVA----------- 163
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 350
VGTPDYI+PE+L K YG ECDWWSLG MYE
Sbjct: 164 -----------------------VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200
Query: 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFP-EEAKLSPEAKDLISKLLCNVEQRLGTKGA 409
ML G PFY++ + T KI+N + H +FP + +S EAKDLI +L+C+ E RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGL 260
Query: 410 DEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKML 469
+ K HP+F+GI+WD + A ++PEV+ DT NF+ ++ T +
Sbjct: 261 QDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDLR--NTESLPPSSHGAF 318
Query: 470 SSKDINFVGYTY 481
S + FVG+TY
Sbjct: 319 SGNHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 341 bits (876), Expect = e-113
Identities = 176/388 (45%), Positives = 233/388 (60%), Gaps = 31/388 (7%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F + +G GAFGEV + R+ T +YAMK L+K ++L R QV HVKAER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
+V+LY SFQD + LY +M+Y+PGGDMM+LL+R E+ ARFY+ E A+ES+HK +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPL------------DCSNLQEKDFSIGSNLSGA 286
IHRDIKPDN+L+DR+GH+KL+DFGLC D DFS
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 287 LQSDGR--PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344
+ R P+ R +Q Q R LA+S VGTP+YIAPEVLL+ GY CDWWS+
Sbjct: 183 CRCGDRLKPLERRAARQHQ--------RCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRL 404
G I+YEMLVG PPF + P+ T K++NW+T L P +AKLSPEA DLI KL E RL
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRL 294
Query: 405 GTKGADEIKAHPWFKGIEWDK-LYQIKAAFIPEVNDELDTQNFEKF-------EEADNQI 456
G GADEIKAHP+FK I++ L Q A +IP++ DT NF+ ++
Sbjct: 295 GKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGN 354
Query: 457 QTSAKSGPWRKMLSSKDINFVGYTYKNF 484
+G W K + F +T++ F
Sbjct: 355 VNDTLNG-WYKNGKHPEHAFYEFTFRRF 381
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 340 bits (874), Expect = e-113
Identities = 173/383 (45%), Positives = 238/383 (62%), Gaps = 22/383 (5%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F + +G GAFGEV + + T +YAMK L+K ++L R QV HVKAER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
+VKLY SFQD + LY +M+Y+PGGDMM+LL+R + E ARFY+ E LAIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP----- 293
IHRDIKPDN+L+D +GH+KL+DFGLC ++ K + GS++ Q P
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH-NSKYYQKGSHIR---QDSMEPSDLWD 178
Query: 294 ------VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
R EQ Q ++R LA+S VGTP+YIAPEVLL+KGY CDWWS+G I
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQ-HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTK 407
++EMLVG PPF + P T K++NW L P + KLSPEA DLI+KL C+ E+RLG
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297
Query: 408 GADEIKAHPWFKGIEWDK-LYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSG-PW 465
GAD+IKAHP+F +++ + A ++P+++ +DT NF+ EE S S W
Sbjct: 298 GADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTW 357
Query: 466 RKMLSSKDIN----FVGYTYKNF 484
+ S + F +T++ F
Sbjct: 358 DTLCSPNGKHPEHAFYEFTFRRF 380
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 335 bits (861), Expect = e-112
Identities = 133/300 (44%), Positives = 191/300 (63%), Gaps = 36/300 (12%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
I KGA+G V + ++K+TG +YA+K +KK++M+R+ QV+ V ER++L++ S +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
SFQ + LYL+MEYLPGGD+ +LL +L E+ AR Y+ E VLA+E +H + IHRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
PDN+L+D NGH+KL+DFGL K +G + + ++
Sbjct: 121 PDNILIDSNGHLKLTDFGLSK-------------VGLV----RRQINLNDDEKEDKR--- 160
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
VGTPDYIAPEV+L +G+ DWWSLG I+YE LVG PPF+ + P
Sbjct: 161 -------------IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423
+ I+N + +++PE+ ++S EA DLISKLL + E+RLG K +EIK HP+FKGI+W
Sbjct: 208 EIFQNILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 325 bits (836), Expect = e-108
Identities = 142/378 (37%), Positives = 212/378 (56%), Gaps = 60/378 (15%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
DF+ LT +G+G +G+V + ++K TG + A+K++KKS + + +V HV ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
+VKL +FQDDEYLYL MEY+PGGD TLL L+E+ ARFY+ E A++++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
YIHRD+KP+N L+D +GH+KL+DFGL K G +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-------------------GIVT--------- 153
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
A S VG+PDY+APEVL KGY D+WSLG ++YE L G+PP
Sbjct: 154 ----------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
Query: 358 FYSDEPMSTCRKIVNWRTHLKFP----EEAKLSPEAKDLISKLLCNVEQRLGTKGADEIK 413
F P T + W+ L+ P LS EA DLI+KL+ + +R G+ ++IK
Sbjct: 198 FSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSL--EDIK 255
Query: 414 AHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADN---------QIQTSAKSGP 464
HP+FK ++W++L ++K F+PE+ E+DT F+ FE D+ + + + K G
Sbjct: 256 NHPFFKEVDWNELRELKPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGGA 315
Query: 465 WRKMLSSKDINFVGYTYK 482
+ FVG+T++
Sbjct: 316 NGRD-PGNRRKFVGFTFR 332
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 324 bits (833), Expect = e-107
Identities = 147/372 (39%), Positives = 214/372 (57%), Gaps = 50/372 (13%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DF+ +++G+G FGEV+V REKATG +YAMK +KKS +L + V + ER++L+ +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHK 235
I +L +FQD + LYL+MEY PGGD+++LL R +D E+ A+FY+ E VLAI S+H+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
Y+HRDIKP+N+L+DR GH+KL+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSLGAIMY 349
N+ + + VGTPDYIAPEVL K YG+ECDWWSLG I Y
Sbjct: 154 -------------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGA 409
EM+ G PF+ T I+N++ LKFPE+ K+S + DLI LLC ++RLG +G
Sbjct: 201 EMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEG- 259
Query: 410 DEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKML 469
+ HP+F I+W+ + F+P + + DT NF++ E+ + S+ +
Sbjct: 260 --LCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGF 317
Query: 470 SSKDINFVGYTY 481
S KD+ FVG+++
Sbjct: 318 SGKDLPFVGFSF 329
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = e-102
Identities = 114/301 (37%), Positives = 168/301 (55%), Gaps = 48/301 (15%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+E L +G+G+FG+V + R+K TG + A+K +KK ++ + E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
IV+LY F+D++ LYL+MEY GGD+ LL ++ L+E+EARFY+ + + A+E +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HRD+KP+N+LLD +GH+KL+DFGL + L +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------QLDPGEK------ 152
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
+ VGTP+Y+APEVLL KGYG D WSLG I+YE+L G PPF
Sbjct: 153 ----------------LTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF 196
Query: 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417
D+ + K + P E +SPEAKDLI KLL + E+RL A+E HP+
Sbjct: 197 PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPF 253
Query: 418 F 418
F
Sbjct: 254 F 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 303 bits (777), Expect = 3e-99
Identities = 158/374 (42%), Positives = 220/374 (58%), Gaps = 53/374 (14%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DDFE + +IG+GAFGEV V + K T +YAMK L K EML+R + + ERN+L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHK 235
I L+ +FQD+ YLYL+M+Y GGD++TLL + +D L E+ ARFY+ E VLAI SIH+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+Y+HRDIKPDN+LLD NGH++L+DFG C + N G +QS
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM--------------NQDGTVQSS----- 161
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL--LKKG---YGMECDWWSLGAIMYE 350
VGTPDYI+PE+L ++ G YG ECDWWSLG MYE
Sbjct: 162 ---------------------VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLCNVEQRLGTKGA 409
ML G PFY++ + T KI+N +FP +S EAKDLI +L+C+ E+RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGI 260
Query: 410 DEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGP--WRK 467
++ K H +F+GI+W+ + ++A +IP+V+ DT NF + D+ + + + P
Sbjct: 261 EDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNF----DVDDDVLRNPEIAPPSSHT 316
Query: 468 MLSSKDINFVGYTY 481
S + FVG+TY
Sbjct: 317 GFSGLHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 301 bits (772), Expect = 7e-98
Identities = 156/397 (39%), Positives = 233/397 (58%), Gaps = 51/397 (12%)
Query: 91 EQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKL 150
+ N+ +L + + +++ +M A+D+E + +IG+GAFGEV++ R K+T VYAMK L
Sbjct: 17 KNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 151 KKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR 210
K EM++R ER+++A +S +V+L+ +FQDD YLY++MEY+PGGD++ L+
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 136
Query: 211 KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270
D + E+ ARFY E VLA+++IH +IHRD+KPDN+LLD++GH+KL+DFG C +
Sbjct: 137 YD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--- 192
Query: 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330
N G ++ D + VGTPDYI+PEVL
Sbjct: 193 -----------NKEGMVRCD--------------------------TAVGTPDYISPEVL 215
Query: 331 LKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLS 386
+G YG ECDWWS+G +YEMLVG PFY+D + T KI+N + L FP++ +S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275
Query: 387 PEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIE--WDKLYQIKAAFIPEVNDELDTQ 444
EAK+LI L + E RLG G +EIK H +FK + W+ L A +P+++ ++DT
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTS 335
Query: 445 NFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTY 481
NF+ EE + +T P K + FVG+TY
Sbjct: 336 NFDDIEEDKGEEETF----PIPKAFVGNQLPFVGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 300 bits (770), Expect = 1e-97
Identities = 151/397 (38%), Positives = 236/397 (59%), Gaps = 51/397 (12%)
Query: 91 EQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKL 150
+ N+ +L + E ++++ +M A+D++ + +IG+GAFGEV++ R K++ VYAMK L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 151 KKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR 210
K EM++R ER+++A +S +V+L+C+FQDD+YLY++MEY+PGGD++ L+
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN 136
Query: 211 KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270
D + E+ A+FY E VLA+++IH IHRD+KPDN+LLD++GH+KL+DFG C +D +
Sbjct: 137 YD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195
Query: 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330
+ D + VGTPDYI+PEVL
Sbjct: 196 GMVRCD----------------------------------------TAVGTPDYISPEVL 215
Query: 331 LKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLS 386
+G YG ECDWWS+G ++EMLVG PFY+D + T KI++ + L FPE+ ++S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275
Query: 387 PEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIE--WDKLYQIKAAFIPEVNDELDTQ 444
AK+LI L + E RLG G +EIK HP+FK + WD + + A +PE++ ++D+
Sbjct: 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSS 335
Query: 445 NFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTY 481
NF+ E+ ++T P K + F+G+TY
Sbjct: 336 NFDDIEDDKGDVETF----PIPKAFVGNQLPFIGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 285 bits (731), Expect = 2e-92
Identities = 155/372 (41%), Positives = 217/372 (58%), Gaps = 49/372 (13%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+DFE L +IG+GAFGEV V + K V+AMK L K EML+R + + ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHK 235
I L+ +FQD+ LYL+M+Y GGD++TLL + +D L E+ ARFY+ E V+AI+S+H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+Y+HRDIKPDN+L+D NGH++L+DFG C L E G +QS
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-----SCLKLME---------DGTVQSS----- 161
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 350
VGTPDYI+PE+L K YG ECDWWSLG MYE
Sbjct: 162 ---------------------VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200
Query: 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLCNVEQRLGTKGA 409
ML G PFY++ + T KI+N + +FP + +S +AKDLI +L+C+ E RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGI 260
Query: 410 DEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKML 469
++ K HP+F GI+WD + +A +IPEV+ DT NF+ ++ +T P
Sbjct: 261 EDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPP--PSHTAF 318
Query: 470 SSKDINFVGYTY 481
S + FVG+TY
Sbjct: 319 SGHHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 1e-90
Identities = 113/306 (36%), Positives = 166/306 (54%), Gaps = 49/306 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FG V + + K+ +A+K +KK ++ GQ EH+ +E+ +L E + IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
+F+D +Y+Y++MEY GG++ T+L + E ARFY+ VLA E +H I+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P+NLLLD NG++KL DFG K +L
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-------------------------------------KL 143
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE-- 362
+ Q+ ++ GTP+Y+APE++L KGY D+WSLG ++YE+L G PPF D+
Sbjct: 144 KSGQK-----TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFK 419
PM I+ L+FP + AKDLI +LL N E+RLG G +IK H WF
Sbjct: 199 PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
Query: 420 GIEWDK 425
G +W+
Sbjct: 257 GFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 2e-88
Identities = 133/334 (39%), Positives = 199/334 (59%), Gaps = 32/334 (9%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+DFE + +I GA+G V + R K T +AMKK+ K ++ R Q++ V ER++L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+V ++CSF+ +L ++MEY+ GGD TLL L + AR Y ETVLA+E +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL-SGALQSDGRPVA 295
+HRD+KPDNLL+ GH+KL+DFGL K L S+ +NL G ++ D R
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSK----IGL----MSLTTNLYEGHIEKDTR--- 169
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
+ Q GTP+YIAPEV+L++GYG DWW++G I+YE LVG
Sbjct: 170 -------EFLDKQ---------VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLL-CNVEQRLGTKGADEIK 413
PF+ D P ++++ +++PE + L +A+DLIS+LL N +RLGT GA E+K
Sbjct: 214 VPFFGDTPEELFGQVIS--DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271
Query: 414 AHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFE 447
H +F G++W+ L + KA FIP++ E DT F+
Sbjct: 272 QHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 273 bits (699), Expect = 4e-88
Identities = 122/339 (35%), Positives = 184/339 (54%), Gaps = 53/339 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DD E + +G G FG V + R++ + H YA+K + E++R Q +HV E+ +L EV
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I++L+ + D +LY++MEY+PGG++ + L + FY E V A+E +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
++RD+KP+N+LLD+ GH+KL+DFG K L
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----------------------------- 151
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
R+R ++ GTP+Y+APEV+ KG+ DWW+LG ++YEMLVGYP
Sbjct: 152 ------------RDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVE-QRLGT--KGADEIK 413
PF+ D P KI+ + L+FP L AKDLI KLL +RLG GAD++K
Sbjct: 197 PFFDDNPFGIYEKILAGK--LEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252
Query: 414 AHPWFKGIEWDKLYQ--IKAAFIPEVNDELDTQNFEKFE 450
H WFK ++WD + Q +K +P+V+ + DT NF+ +
Sbjct: 253 NHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDYP 291
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (698), Expect = 2e-87
Identities = 124/331 (37%), Positives = 179/331 (54%), Gaps = 26/331 (7%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
F+ + ++GKG G V + R K TG ++A+K L K EM++R +V+ V E+ +LA +D
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIH 234
+ LY SFQ + YL L+M+Y PGG++ LL R+ L+EE ARFY E +LA+E +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
++RD+KP+N+LL +GH+ LSDF L K D S
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV--------------EPPPVSKALRK 166
Query: 295 APRRTQQEQLQHWQR----NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
RR+ + + R + S VGT +YIAPEV+ G+G DWW+LG ++YE
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFR--SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224
Query: 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK-G 408
ML G PF T I+ + FP +S A+DLI KLL + +RLG+K G
Sbjct: 225 MLYGTTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG 282
Query: 409 ADEIKAHPWFKGIEWDKLYQIKAAFIPEVND 439
A EIK HP+F+G+ W + IP +D
Sbjct: 283 AAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 270 bits (692), Expect = 2e-87
Identities = 129/307 (42%), Positives = 182/307 (59%), Gaps = 51/307 (16%)
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAER-NLLAEVDSNCIV 180
L I KGAFG V + ++++TG +A+K LKKS+M+ + QV +VKAER ++ + +S +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
KLY SFQ +YLYL+MEYL GGD +L+ L E+ A+ Y+ E VL +E +H+ IH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKP+NLL+D+ GH+KL+DFGL + + L+ K F
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSR----NGLENKKF----------------------- 153
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
VGTPDY+APE +L G DWWSLG +++E L GYPPF++
Sbjct: 154 ------------------VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAK--LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417
+ P + I++ R + +PEE K SPEA DLI++LLC + +RLG G EIK+HP+
Sbjct: 196 ETPDAVFDNILSRR--INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253
Query: 418 FKGIEWD 424
FK I WD
Sbjct: 254 FKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 266 bits (681), Expect = 7e-85
Identities = 133/362 (36%), Positives = 193/362 (53%), Gaps = 64/362 (17%)
Query: 98 YLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR 157
K +T +L DFE +G G+FG VR+ + K TG YA+K LKK E+L+
Sbjct: 6 MFTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK 58
Query: 158 RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEE 217
QV+HV E+++L E+ IV + CSFQD+ +Y ++E++ GG++ T L + +
Sbjct: 59 MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND 118
Query: 218 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
A+FY E VLA E +H + I+RD+KP+NLLLD GH+K++DFG K +
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV---------- 168
Query: 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337
P RT ++ GTP+Y+APEV+ KG+G
Sbjct: 169 ------------------PDRT----------------FTLCGTPEYLAPEVIQSKGHGK 194
Query: 338 ECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISK 395
DWW++G ++YE + GYPPF+ D P KI+ R LKFP + + A+DL+
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGR----ARDLVKG 248
Query: 396 LL-CNVEQRLGT--KGADEIKAHPWFKGIEWDKLYQIK-AAFIP-EVNDELDTQNFEKFE 450
LL + +RLGT G ++K HP+F G WDKLY A IP V DT NFEK+
Sbjct: 249 LLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKYP 308
Query: 451 EA 452
++
Sbjct: 309 DS 310
|
Length = 329 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 260 bits (666), Expect = 4e-83
Identities = 115/305 (37%), Positives = 177/305 (58%), Gaps = 28/305 (9%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DDF+ +IG+G+F V + +EK T YA+K L K ++++ +V++VK E+ +L ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 177 N-CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
+ I+KLY +FQD+E LY ++EY P G+++ + + +L E+ RFY E +LA+E +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
IHRD+KP+N+LLD++ H+K++DFG K LD + P +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD--------------------PNSSPES 160
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
+ ++NRR A S VGT +Y++PE+L +K G D W+LG I+Y+ML G
Sbjct: 161 NKGDATNIDSQIEKNRRRFA-SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK-GADEIK 413
PPF T +KI+ FP P+AKDLI KLL + + RLG G DE+K
Sbjct: 220 PPFRGSNEYLTFQKILK--LEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
Query: 414 AHPWF 418
AHP+F
Sbjct: 276 AHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 247 bits (632), Expect = 2e-78
Identities = 106/305 (34%), Positives = 152/305 (49%), Gaps = 50/305 (16%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+E L +G G+FG V + K TG + A+K LKK + E +L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
IV+L +F+D ++LYL+MEY GGD+ L R L+E+EA+ + + +E +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRD+KP+N+LLD NG +K++DFGL K L S+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-------------------------- 153
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPP 357
+ VGTP Y+APEVLL GYG + D WSLG I+YE+L G PP
Sbjct: 154 ---------------SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
Query: 358 FYSD---EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413
F + + + R+I+ P+ + S EAKDLI K L + +R A+EI
Sbjct: 199 FSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEIL 255
Query: 414 AHPWF 418
HPWF
Sbjct: 256 QHPWF 260
|
Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 3e-78
Identities = 138/371 (37%), Positives = 196/371 (52%), Gaps = 62/371 (16%)
Query: 122 LTMIGKGAFGEV---RVCREKATGHVYAMKKLKKSEMLRRGQ-VEHVKAERNLLAEVDSN 177
L ++GKG +G+V R TG ++AMK LKK+ ++R + H KAERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
IV L +FQ LYLI+EYL GG++ L R+ E+ A FY+ E LA+E +H+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
I+RD+KP+N+LLD GH+KL+DFGLCK SI
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKE-----------SI------------------ 151
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
+ + H + GT +Y+APE+L++ G+G DWWSLGA+MY+ML G PP
Sbjct: 152 --HEGTVTH----------TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKA 414
F ++ T KI+ + L P L+PEA+DL+ KLL N RLG A E+++
Sbjct: 200 FTAENRKKTIDKIL--KGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255
Query: 415 HPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFE-KFEEADNQIQTSAKSGPWRKMLSS 471
HP+F+ + WD L +++ F P + E D F+ KF QT S P LS
Sbjct: 256 HPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTR-----QTPVDS-PDDSTLSE 309
Query: 472 KDIN-FVGYTY 481
F+G+TY
Sbjct: 310 SANQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 1e-74
Identities = 129/368 (35%), Positives = 186/368 (50%), Gaps = 55/368 (14%)
Query: 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN-LLAEVDSNCIVK 181
+IGKG+FG+V + + KA G YA+K L+K +L++ + +H+ AERN LL V +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
L+ SFQ + LY +++Y+ GG++ L R+ + E ARFY E A+ +H N I+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
D+KP+N+LLD GH+ L+DFGLCK + +T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--------------------------EGIEHSKTT- 153
Query: 302 EQLQHWQRNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
ST GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 154 ---------------STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA-DEIKAHPWF 418
+ I+N LK +S A+ L+ LL + +RLG K EIK H +F
Sbjct: 199 RDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
Query: 419 KGIEWDKLYQ--IKAAFIPEVNDELDTQNFEKF---EEADNQIQTSAKSGPWRKMLSSKD 473
I WD L I F P V+ +D ++F+ E N + S S + D
Sbjct: 255 SSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD 314
Query: 474 INFVGYTY 481
F+G++Y
Sbjct: 315 DAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 2e-74
Identities = 126/335 (37%), Positives = 184/335 (54%), Gaps = 50/335 (14%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IGKG+FG+V R++ T +YA+K ++K+ ++ R +V H AER +LA+V+ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
SFQ E LYL++ ++ GG++ L R+ ARFY E + A+E++HK N I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P+N+LLD GH+ L DFGLCK L+ + + +
Sbjct: 121 PENILLDYQGHIALCDFGLCK-LNMKDDDKTN---------------------------- 151
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
+ GTP+Y+APE+LL GY DWW+LG ++YEML G PPFY +
Sbjct: 152 ------------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199
Query: 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423
RKI+ + L+FP+ +AKDL+ LL + +RLG GA EIK HP+F + W
Sbjct: 200 EMYRKIL--QEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255
Query: 424 DKLY--QIKAAFIPEVNDELDTQNFEKFEEADNQI 456
KL I+ F P V+ +DT NF+ EE +
Sbjct: 256 KKLLMKGIQPPFKPAVSSAIDTSNFD--EEFTREK 288
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 9e-72
Identities = 120/329 (36%), Positives = 177/329 (53%), Gaps = 52/329 (15%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGH----VYAMKKLKKSEMLRRGQV-EHVKAERNLLA 172
+FE L ++G GA+G+V + R K GH +YAMK LKK+ ++++ + EH + ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 173 EVDSN-CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
V +V L+ +FQ D L+LI++Y+ GG++ T L +++ TE E R Y+ E VLA++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
+H+ I+RDIK +N+LLD GH+ L+DFGL K +
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER----------------- 162
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGAIMY 349
AYS GT +Y+APEV+ G+ DWWSLG + +
Sbjct: 163 -----------------------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408
E+L G PF D ++ +I K P +S EA+D I KLL + ++RLG G
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 409 ADEIKAHPWFKGIEWDKLY--QIKAAFIP 435
ADEIK HP+F+GI+WD L +I A F P
Sbjct: 260 ADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 3e-71
Identities = 132/376 (35%), Positives = 193/376 (51%), Gaps = 65/376 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL---AEVDSNCIVK 181
IGKG FG+V R+K T +YAMK L K E++ + +V H ERN+L +S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
L SFQ D LYL+ +Y+ GG++ L ++ +E+ A+FY+ E VLA+E +HK++ ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
D+KP+N+LLD GH+ L DFGL K NL +
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA----NLTDNK------------------------- 151
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
+ GT +Y+APEVLL +KGY D+WSLG +++EM G+ PFY+
Sbjct: 152 ------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG-TKGADEIKAHPWF 418
++ R I + ++FP+ LS E + + LL N + RLG + A E+K HP+F
Sbjct: 200 EDTQQMYRNIAFGK--VRFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
Query: 419 KGIEWDKLY--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKML------- 469
I+WD L QI F P V+ + D NF+ E N +A PW +
Sbjct: 257 ADIDWDLLSKKQITPPFKPIVDSDEDVSNFDP--EFTNSSLLNAGIVPWEDVPGLPGANS 314
Query: 470 ----SSKDINFVGYTY 481
SS NF G+T+
Sbjct: 315 TPLSSSVQENFRGFTF 330
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 4e-71
Identities = 115/339 (33%), Positives = 177/339 (52%), Gaps = 56/339 (16%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN- 177
F L ++G+G FG+V + K TG +YA+K LKK +++ R +VE + E+ + +S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 178 --CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
+V L+ FQ ++++ +MEY GGD+M + + D +E A FY VL ++ +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+ ++RD+K DNLLLD G +K++DFGLCK
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK------------------------------ 149
Query: 296 PRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
E + R ST GTP+++APEVL + Y DWW LG ++YEMLVG
Sbjct: 150 ------EGMGFGDRT------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADE 411
PF D+ IVN +++P LS EA ++ +LL N E+RLG+ K A++
Sbjct: 198 ESPFPGDDEEEVFDSIVN--DEVRYPRF--LSREAISIMRRLLRRNPERRLGSGEKDAED 253
Query: 412 IKAHPWFKGIEWDKLYQ--IKAAFIPEVNDELDTQNFEK 448
+K P+F+ I WD L IK F+P + D NF++
Sbjct: 254 VKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDE 292
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 7e-71
Identities = 115/332 (34%), Positives = 168/332 (50%), Gaps = 51/332 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKL 182
++GKG+FG+V + K T +YA+K LKK +L+ VE E+ +LA + + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ FQ + L+ +MEY+ GGD+M + R E ARFY E VL ++ +H+ I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN+LLD GH+K++DFG+CK + F
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF------------------------- 156
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
GTPDYIAPE+L + YG DWW+LG ++YEML G PF D+
Sbjct: 157 ----------------CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG--TKGADEIKAHPWFK 419
+ I+ +P LS EAK ++ L N E+RLG G +IK HP+F+
Sbjct: 201 EDELFQSILEDEVR--YPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 420 GIEWDKL--YQIKAAFIPEVNDELDTQNFEKF 449
I+WDKL +IK F P++ D NF+
Sbjct: 257 EIDWDKLERKEIKPPFKPKIKGRFDVSNFDDE 288
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 9e-70
Identities = 108/306 (35%), Positives = 159/306 (51%), Gaps = 55/306 (17%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
FE L +IGKGAFG+V + +++ T ++AMK + K + + +G V +V ER +L E++
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
+V L+ SFQD+E +YL+++ L GGD+ L +K +EE+ +F++ E VLA+E +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRDIKPDN+LLD GH+ ++DF +A +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFN-------------------------------IATKV 150
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
T ST GTP Y+APEVL ++GY + DWWSLG YE L G P+
Sbjct: 151 TPDTLTT-----------STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
Query: 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSP-----EAKDLISKLL-CNVEQRLGTKGADEI 412
R I + K L P EA D I+KLL + ++RLG ++
Sbjct: 200 RGHS-----RTIRDQIRA-KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDL 252
Query: 413 KAHPWF 418
K HP+F
Sbjct: 253 KNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 2e-69
Identities = 125/365 (34%), Positives = 189/365 (51%), Gaps = 56/365 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKL 182
++GKG+FG+V + K T +A+K LKK +L VE ER +LA + + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+C+FQ E+L+ +MEYL GGD+M + E ARFY E + ++ +HK I+RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN+LLD++GH+K++DFG+CK
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKE------------------------------------ 145
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
N A + GTPDYIAPE+L + Y DWWS G ++YEML+G PF+ ++
Sbjct: 146 -----NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421
I+N R H FP +S EAKD +SKL + +RLG G +I+ HP+F+GI
Sbjct: 201 EDELFDSILNDRPH--FPR--WISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGI 254
Query: 422 EWDKL--YQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDIN-FVG 478
+W++L +I F P+V D NF++ + + S +K+L+S D F G
Sbjct: 255 DWERLEKREIPPPFKPKVKSPSDASNFDR----EFTNEKVRLSPVDKKLLASMDQEQFRG 310
Query: 479 YTYKN 483
+++ N
Sbjct: 311 FSFTN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 3e-69
Identities = 122/366 (33%), Positives = 183/366 (50%), Gaps = 51/366 (13%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY 183
++GKG FG+V + REKATG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDI 243
SFQ + L +MEY GG++ L R+ +E+ ARFY E V A+ +H + ++RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 244 KPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQ 303
K +NL+LD++GH+K++DFGLCK + S G+ +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK---------EGISDGATMK------------------- 153
Query: 304 LQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEP 363
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ +
Sbjct: 154 -------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 364 MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL--GTKGADEIKAHPWFKG 420
I+ ++FP LSPEAK L++ LL + +QRL G + A EI H +F
Sbjct: 201 EKLFELIL--MEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256
Query: 421 IEWDKLYQ--IKAAFIPEVNDELDTQNF-EKFEEADNQIQTSAKSGPWRKMLSSKDINFV 477
I W + Q ++ F P+V E DT+ F E+F I + + + +F
Sbjct: 257 INWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFP 316
Query: 478 GYTYKN 483
++Y
Sbjct: 317 QFSYSA 322
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 1e-67
Identities = 134/376 (35%), Positives = 210/376 (55%), Gaps = 59/376 (15%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKA---TGHVYAMKKLKKSEMLRRGQ-VEHVKAERNLLAE 173
+FE L ++G GA+G+V + R+ TG +YAMK L+K+ ++++ + VEH + ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 174 V-DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES 232
V S +V L+ +FQ + L+LI++Y+ GG+M T L ++D +E+E RFY GE +LA+E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+HK ++RDIK +N+LLD GH+ L+DFGL K L E+
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEK---------------- 160
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 351
RT YS GT +Y+APE++ K G+G DWWSLG +++E+
Sbjct: 161 ----ERT----------------YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200
Query: 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KG 408
L G PF + +T ++ P + + PEA+DL+ KLL + ++RLG +G
Sbjct: 201 LTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQG 260
Query: 409 ADEIKAHPWFKGIEWDKL--YQIKAAFIPEVNDELDTQNF-EKFEEADNQIQTSAKSGPW 465
A EIK HP+FKG++W+ L ++ F P + +ELD NF E+F + + + A + P
Sbjct: 261 ASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLE-PVYSPAGTPP- 318
Query: 466 RKMLSSKDINFVGYTY 481
S F GY++
Sbjct: 319 -----SGARVFQGYSF 329
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 8e-67
Identities = 127/334 (38%), Positives = 185/334 (55%), Gaps = 54/334 (16%)
Query: 122 LTMIGKGAFGEVRVCRE---KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
L ++G+G+FG+V + R+ G +YAMK LKK+ + R +V K ER++LAEV+
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
IVKL+ +FQ + LYLI+++L GGD+ T L ++ TEE+ +FY+ E LA++ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
I+RD+KP+N+LLD GH+KL+DFGL K
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK--------------------------------- 146
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
E + H ++ AYS GT +Y+APEV+ ++G+ DWWS G +M+EML G PF
Sbjct: 147 ---ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
Query: 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAH 415
+ T I+ + L P+ LSPEA+ L+ L N RLG G +EIK H
Sbjct: 199 QGKDRKETMTMIL--KAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254
Query: 416 PWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFE 447
P+F I+W+KLY +IK F P V DT F+
Sbjct: 255 PFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFD 288
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 2e-63
Identities = 119/348 (34%), Positives = 188/348 (54%), Gaps = 54/348 (15%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHV-YAMKKLKKSEMLRRGQVEHVKAER 168
+++KM +DF + +G G+FG V + K A+K+ +KS+++++ QV+HV +ER
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 169 NLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL 228
+L ++ V LY SF+D+ YLYL++E++ GG+ T L R + FY + VL
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
E + N ++RD+KP+NLLLD++G +K++DFG K +D
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT------------------- 183
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
RT Y+ GTP+YIAPE+LL G+G DWW+LG +
Sbjct: 184 ---------RT----------------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218
Query: 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT- 406
YE+LVG PPFY++EP+ +KI+ + FP+ L K L+ KLL ++ +R G
Sbjct: 219 YEILVGCPPFYANEPLLIYQKILEGIIY--FPK--FLDNNCKHLMKKLLSHDLTKRYGNL 274
Query: 407 -KGADEIKAHPWFKGIEWDKLYQ--IKAAFIPEVNDELDTQNFEKFEE 451
KGA +K HPWF I+W L ++ + P+ + D+ NFE+ +E
Sbjct: 275 KKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQE 322
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 2e-61
Identities = 117/333 (35%), Positives = 168/333 (50%), Gaps = 53/333 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA-EVDSNCIVKL 182
++GKG+FG+V + K T VYA+K LKK +L+ V+ E+ +LA + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+C FQ + L+ +MEY+ GGD+M + R E +RFY E LA+ +H+H I+RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN+LLD GH KL+DFG+CK G L
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCK------------------EGILNG------------- 150
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
+ + GTPDYIAPE+L + YG DWW+LG +MYEM+ G PPF +D
Sbjct: 151 ----------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG----TKGADEIKAHPW 417
I++ + +P LS EA ++ + N +RLG G D IK HP+
Sbjct: 201 EDDLFESILH--DDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
Query: 418 FKGIEWDKLYQ--IKAAFIPEVNDELDTQNFEK 448
FK I+W L Q IK F P++ + D NF++
Sbjct: 257 FKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ 289
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 3e-59
Identities = 119/329 (36%), Positives = 168/329 (51%), Gaps = 50/329 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY 183
++GKG FG+V + REKATG YAMK L+K ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDI 243
+FQ + L +MEY GG++ L R+ TEE ARFY E V A+E +H + ++RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 244 KPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQ 303
K +NL+LD++GH+K++DFGLCK K F
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-------------------------- 155
Query: 304 LQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEP 363
GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ +
Sbjct: 156 ---------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 364 MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRL--GTKGADEIKAHPWFKG 420
I+ ++FP LSPEAK L++ LL + +QRL G A E+ H +F
Sbjct: 201 ERLFELIL--MEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256
Query: 421 IEWDKLYQIK--AAFIPEVNDELDTQNFE 447
I W + Q K F P+V E+DT+ F+
Sbjct: 257 INWQDVVQKKLLPPFKPQVTSEVDTRYFD 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 130/365 (35%), Positives = 186/365 (50%), Gaps = 54/365 (14%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN-LLAEVDSNCIVKL 182
+IGKG+FG+V + + K+ G YA+K L+K +L++ + H+ AERN LL + +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ SFQ E LY +++Y+ GG++ L R+ E ARFY E AI +H N I+RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+KP+N+LLD GH+ L+DFGLCK V P T
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK--------------------------EGVEPEETTS- 154
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
+ GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS +
Sbjct: 155 --------------TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD--EIKAHPWFK 419
I++ L+ P + A DL+ LL + +RLG K AD EIK H +F
Sbjct: 201 VSQMYDNILH--KPLQLP--GGKTVAACDLLVGLLHKDQRRRLGAK-ADFLEIKNHVFFS 255
Query: 420 GIEWDKLY--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDIN-F 476
I WD LY +I + P V D ++F+ E + +S P SS + F
Sbjct: 256 PINWDDLYHKRITPPYNPNVAGPADLRHFDP-EFTQEAVSSSVGQTPDLTASSSSASSAF 314
Query: 477 VGYTY 481
+G++Y
Sbjct: 315 LGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 7e-58
Identities = 109/331 (32%), Positives = 167/331 (50%), Gaps = 52/331 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKL 182
++GKG+FG+V + R K +G +YA+K LKK +L+ VE E+ +L+ ++ + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
YC FQ + L+ +ME++ GGD+M + + E ARFY E A+ +H I+RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN+LLD GH KL+DFG+CK + F
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF------------------------- 156
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
GTPDYIAPE+L + YG DWW++G ++YEML G+ PF ++
Sbjct: 157 ----------------CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPWF 418
I+N + +P LS +A D++ + N RLG+ G + I HP+F
Sbjct: 201 EDDLFEAILN--DEVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
Query: 419 KGIEWDKLY--QIKAAFIPEVNDELDTQNFE 447
K ++W+KL QI+ F P + D NF+
Sbjct: 257 KELDWEKLNRRQIEPPFRPRIKSREDVSNFD 287
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 8e-58
Identities = 125/365 (34%), Positives = 182/365 (49%), Gaps = 52/365 (14%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY 183
++GKG FG+V + +EKATG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH-KHNYIHRD 242
SFQ + L +MEY GG++ L R+ +E+ ARFY E V A++ +H + N ++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K +NL+LD++GH+K++DFGLCK K F
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------------------------- 156
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ +
Sbjct: 157 ----------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRL--GTKGADEIKAHPWFK 419
I+ ++FP LSPEAK L+S LL + +QRL G A EI H +F
Sbjct: 201 HEKLFELIL--MEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256
Query: 420 GIEWDKLYQIKAA--FIPEVNDELDTQNF-EKFEEADNQIQTSAKSGPWRKMLSSKDINF 476
GI W +Y+ K F P+V E DT+ F E+F I + + + + +F
Sbjct: 257 GIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDNERRPHF 316
Query: 477 VGYTY 481
++Y
Sbjct: 317 PQFSY 321
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-57
Identities = 112/372 (30%), Positives = 180/372 (48%), Gaps = 54/372 (14%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS- 176
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY E + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
I+RD+K DN++LD GH+K++DFG+CK N+ +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTT------------------ 158
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
RT GTPDYIAPE++ + YG DWW+ G ++YEML G P
Sbjct: 159 -RT------------------FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIK 413
PF ++ + I+ ++ +P+ LS EA + LL + +RLG G +I+
Sbjct: 200 PFDGEDEDELFQSIME--HNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIR 255
Query: 414 AHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSS 471
H +F+ I+W+KL +I+ F P+V +NF+KF + + +
Sbjct: 256 EHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFF---TREPPVLTPPDKLVIANI 312
Query: 472 KDINFVGYTYKN 483
F G+++ N
Sbjct: 313 DQSEFQGFSFVN 324
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 2e-57
Identities = 120/369 (32%), Positives = 184/369 (49%), Gaps = 59/369 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKL 182
M+GKG+FG+V + K T +A+K LKK +L VE E+ +L+ + + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
YC+FQ E L+ +MEYL GGD+M + A FY E + ++ +H ++RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN+LLD +GH+K++DFG+CK N+ G ++
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK---------------ENMLGDAKTC------------ 154
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
+ GTPDYIAPE+LL + Y DWWS G ++YEML+G PF+ +
Sbjct: 155 --------------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421
+ I R L+ EAKD++ KL E+RLG KG +I+ HP+F+ I
Sbjct: 201 EEELFQSI---RMDNPCYPRW-LTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREI 254
Query: 422 EWDKL--YQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGY 479
+W L +I+ F P+V D NF+K E + + + S R +++S D N
Sbjct: 255 DWSALEEREIEPPFKPKVKSANDCSNFDK-EFLNEKPRLSVTD---RMLINSMDQNM--- 307
Query: 480 TYKNFEIVN 488
++NF +N
Sbjct: 308 -FENFSFIN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 2e-56
Identities = 124/366 (33%), Positives = 178/366 (48%), Gaps = 53/366 (14%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN-LLAEVDSNCIVKL 182
+IGKG+FG+V + + K G YA+K L+K +L R + +H+ AERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ SFQ E LY +++++ GG++ L R+ + E ARFY E A+ +H N ++RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+KP+N+LLD GH+ L+DFGLCK G QSD
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK------------------EGIAQSD------------ 151
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
+ GTP+Y+APEV+ K+ Y DWW LGA++YEML G PPFY +
Sbjct: 152 -----------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGTKGA-DEIKAHPWFKG 420
I+ H S A ++ +LL + ++RLG K EI+ HP+F+
Sbjct: 201 VAEMYDNIL----HKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256
Query: 421 IEWDKLYQ--IKAAFIPEVNDELDTQNFE-KFEEADNQIQTSAKSGPW--RKMLSSKDIN 475
+ W L Q I F P V D NF+ F E S + D
Sbjct: 257 LSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDA 316
Query: 476 FVGYTY 481
FVG++Y
Sbjct: 317 FVGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 8e-56
Identities = 89/299 (29%), Positives = 141/299 (47%), Gaps = 49/299 (16%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY 183
++G+G+FG V + +K TG + A+K ++ S ++E ++ E +L+ + IV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 184 CSFQDDE--YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
S +D+E L + +EY+ GG + +LL + L E R Y + + + +H + +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
DIK N+L+D +G +KL+DFG K L E
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT------------------------- 160
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY-S 360
S GTP ++APEV+ + YG D WSLG + EM G PP+
Sbjct: 161 --------------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
PM+ KI + + PE LS EAKD + K L + ++R ADE+ HP+
Sbjct: 207 GNPMAALYKIGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 1e-55
Identities = 117/332 (35%), Positives = 183/332 (55%), Gaps = 56/332 (16%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKA---TGHVYAMKKLKKSEMLRRGQV-EHVKAERNLLAE 173
+FE L ++G GA+G+V + R+ + +G +YAMK LKK+ ++++ + EH + ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 174 V-DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES 232
+ S +V L+ +FQ D L+LI++Y+ GG++ T L +++ E+E + Y GE VLA+E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+HK I+RDIK +N+LLD NGH+ L+DFGL K
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF------------------------- 155
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSLGAIMYE 350
H R AYS GT +Y+AP+++ G+ DWWS+G +MYE
Sbjct: 156 -------------HEDEVER--AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 351 MLVGYPPFYSDEPMSTCRKIVN--WRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT- 406
+L G PF D ++ +I ++ +P+E +S AKD+I +LL + ++RLG
Sbjct: 201 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCG 258
Query: 407 -KGADEIKAHPWFKGIEWDKLY--QIKAAFIP 435
ADEIK HP+F+ I WD L ++ A F P
Sbjct: 259 PSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 5e-55
Identities = 125/366 (34%), Positives = 182/366 (49%), Gaps = 53/366 (14%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN-LLAEVDSNCIVKL 182
+IGKG+FG+V + R KA YA+K L+K +L++ + +H+ +ERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ SFQ + LY +++Y+ GG++ L R+ E ARFY E A+ +H N ++RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+KP+N+LLD GH+ L+DFGLCK + T
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK--------------------------ENIEHNGTTS- 154
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
+ GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 155 --------------TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA-DEIKAHPWFKG 420
I+N LK ++ A+ L+ LL + +RLG K EIK H +F
Sbjct: 201 TAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256
Query: 421 IEWDKLY--QIKAAFIPEVNDELDTQNFE-KF--EEADNQIQTSAKSGPWRKMLSSKDIN 475
I WD L +I F P V+ D ++F+ +F E N I S S +
Sbjct: 257 INWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTASVKEAAEA 316
Query: 476 FVGYTY 481
F+G++Y
Sbjct: 317 FLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 2e-53
Identities = 115/330 (34%), Positives = 166/330 (50%), Gaps = 50/330 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY 183
++GKG FG+V + REKA+G YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDI 243
SFQ + L +MEY+ GG++ L R+ +E+ RFY E V A++ +H ++RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 244 KPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQ 303
K +NL+LD++GH+K++DFGLCK K F
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-------------------------- 155
Query: 304 LQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEP 363
GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ +
Sbjct: 156 ---------------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 364 MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL--GTKGADEIKAHPWFKG 420
I+ +KFP LS +AK L+S LL + +RL G A EI H +F G
Sbjct: 201 EKLFELIL--MEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256
Query: 421 IEWDKLYQIK--AAFIPEVNDELDTQNFEK 448
+ W +Y K F P+V E DT+ F++
Sbjct: 257 VNWQDVYDKKLVPPFKPQVTSETDTRYFDE 286
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 94/296 (31%), Positives = 133/296 (44%), Gaps = 85/296 (28%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G+G FG V + R+K TG A+K +KK + +E + E +L +++ IVKLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDI 243
F+D+ +LYL+MEY GG + LL + L+E+E + + + +E +H + IHRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 244 KPDNLLLD-RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
KP+N+LLD NG +KL+DFGL K L K
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI------------------------- 153
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361
VGTP Y+APEVLL K Y + D WSLG I+YE+
Sbjct: 154 ----------------VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------- 187
Query: 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416
PE KDLI K+L + E+R A EI H
Sbjct: 188 -------------------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 4e-53
Identities = 105/322 (32%), Positives = 161/322 (50%), Gaps = 55/322 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+GKG FGEV C+ KATG +YA KKL K + +R + E+ +L +V S IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIHKHNYIHRD 242
+F+ + L L+M + GGD+ + E A FY + + +E +H+ ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+KP+N+LLD +G++++SD GL L G+ + R
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVEL---------------------KGGKKIKGR----- 154
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
GTP Y+APEVL + Y DW++LG +YEM+ G PF
Sbjct: 155 ----------------AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF-RQR 197
Query: 363 PMSTCRKIVNWRT---HLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG--ADEIKAHP 416
++ + RT +++P+ K SPEAKDL LL + E+RLG +G ADE++ HP
Sbjct: 198 KEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255
Query: 417 WFKGIEWDKLY--QIKAAFIPE 436
FK + W +L ++ FIP+
Sbjct: 256 LFKDLNWRRLEAGMLEPPFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 9e-53
Identities = 92/304 (30%), Positives = 131/304 (43%), Gaps = 55/304 (18%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
FE L IGKG FGEV R K TG A+K +K ++ E + E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGG---DMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
IVK Y S+ + L+++ME+ GG D++ + TLTE + + E + +E +H
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLH 115
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
+ IHRDIK N+LL +G +KL DFGL
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------- 146
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
Q + + VGTP ++APEV+ K Y + D WSLG E+ G
Sbjct: 147 -------------QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413
PP+ PM KI K S E KD + K L N E+R A+++
Sbjct: 194 KPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLL 249
Query: 414 AHPW 417
HP+
Sbjct: 250 KHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 1e-52
Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 49/284 (17%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
+E + IGKG+FG+V + R K+ G +Y +K++ S M + E E +L +++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL----MRKDTLTEEEARFYVGETVLAIESI 233
I+K Y SF++ L ++MEY GGD+ + EE+ + + LA++ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H +HRDIKP N+ L NG +KL DFG+ K L S +
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVD-------------------- 158
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
LA + VGTP Y++PE+ K Y + D WSLG ++YE+
Sbjct: 159 --------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL 397
PF + + KI+ + P + S E ++L+S LL
Sbjct: 199 LKHPFEGENLLELALKILK-GQYPPIPS--QYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 113/329 (34%), Positives = 166/329 (50%), Gaps = 51/329 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKL 182
++GKG+FG+V + K G +A+K LKK +L VE E+ +LA N + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
YC+FQ E+L+ +ME+L GGD+M + K A FY E V ++ +H I+RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN++LDR+GH+K++DFG+CK N+ G
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK---------------ENVFG----------------- 149
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
NR A + GTPDYIAPE+L Y DWWS G ++YEML+G PF+ D+
Sbjct: 150 ------DNR---ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFKGI 421
I H +P ++ E+KD++ KL + +RLG G I+ HP+FK I
Sbjct: 201 EDELFESIRVDTPH--YPRW--ITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTI 254
Query: 422 EWDKL--YQIKAAFIPEVNDELDTQNFEK 448
W L ++ F P+V D NF++
Sbjct: 255 NWTALEKRELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 1e-51
Identities = 103/340 (30%), Positives = 169/340 (49%), Gaps = 57/340 (16%)
Query: 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVK 181
+IG+G++ +V + K T +YAMK +KK + ++ V+ E+++ ++ +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
L+ FQ + L+ ++E++ GGD+M + R+ L EE ARFY E LA+ +H+ I+R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
D+K DN+LLD GH+KL+D+G+CK ++ D
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGD------------------------- 151
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF--- 358
+ GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 152 ------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
Query: 359 -YSDEPMSTCRKI---VNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK---GAD 410
SD P V ++ P LS +A ++ L + ++RLG G
Sbjct: 200 GMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFR 257
Query: 411 EIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFEK 448
+IK+HP+F+ I+WD L Q+ + P + + D NF+
Sbjct: 258 DIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 92/303 (30%), Positives = 146/303 (48%), Gaps = 51/303 (16%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
++ L IG+GA GEV ++ATG A+KK++ LR+ E + E ++ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHN 237
IV Y S+ + L+++MEY+ GG + ++ + + E + + E + +E +H N
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
IHRDIK DN+LL ++G +KL+DFG L
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQL------------------------------ 166
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
T+++ +RN S VGTP ++APEV+ +K YG + D WSLG + EM G PP
Sbjct: 167 -TKEKS----KRN------SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416
+ + P+ I K SPE KD ++K L + E+R A+E+ HP
Sbjct: 216 YLREPPLRALFLITTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKR---PSAEELLQHP 271
Query: 417 WFK 419
+ K
Sbjct: 272 FLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 4e-51
Identities = 108/338 (31%), Positives = 173/338 (51%), Gaps = 52/338 (15%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA D
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 178 -CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+ +L+ FQ + LY +MEY+ GGD+M + + E +A FY E + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
I+RD+K DN++LD GH+K++DFG+CK + + F
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF------------------- 161
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
GTPDYIAPE++ + YG DWW+ G ++YEML G P
Sbjct: 162 ----------------------CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNV-EQRLGT--KGADEIK 413
PF ++ + I+ ++ +P+ LS EA + L+ +RLG +G +I+
Sbjct: 200 PFDGEDEDELFQSIM--EHNVSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIR 255
Query: 414 AHPWFKGIEWDKL--YQIKAAFIPEVNDELDTQNFEKF 449
H +F+ I+WDKL +I+ F P+V + +NF+KF
Sbjct: 256 EHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 2e-49
Identities = 108/336 (32%), Positives = 177/336 (52%), Gaps = 55/336 (16%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKL 182
+IG+G++ +V + R K +YAMK +KK + ++ V+ E+++ + SN +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ FQ L+L++EY+ GGD+M + R+ L EE ARFY E +A+ +H+ I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN+LLD +GH+KL+D+G+CK + P T
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK--------------------------EGLGPGDTTS- 154
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF--YS 360
+ GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF +
Sbjct: 155 --------------TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200
Query: 361 DEP-MSTCRKI--VNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK---GADEIK 413
D P M+T + V ++ P LS +A ++ L + ++RLG + G +IK
Sbjct: 201 DNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIK 258
Query: 414 AHPWFKGIEWDKL--YQIKAAFIPEVNDELDTQNFE 447
+H +F+ I+WD L Q+ F P++ D+ +NF+
Sbjct: 259 SHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFD 294
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 4e-48
Identities = 104/338 (30%), Positives = 169/338 (50%), Gaps = 52/338 (15%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA-EVDS 176
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY E + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
I+RD+K DN++LD GH+K++DFG+CK + K F
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF------------------- 161
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
GTPDYIAPE++ + YG DWW+ G ++YEML G
Sbjct: 162 ----------------------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIK 413
PF ++ + I+ ++ +P+ +S EA + L+ + +RLG +G +IK
Sbjct: 200 PFEGEDEDELFQSIM--EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 255
Query: 414 AHPWFKGIEWDKL--YQIKAAFIPEVNDELDTQNFEKF 449
H +F+ I+W+KL +++ + P+ D +NF+KF
Sbjct: 256 EHAFFRYIDWEKLERKEVQPPYKPKACGR-DAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 2e-46
Identities = 104/337 (30%), Positives = 169/337 (50%), Gaps = 55/337 (16%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKL 182
+IG+G++ +V + R K T +YAMK +KK + ++ V+ E+++ + ++ +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ FQ + L+ ++EY+ GGD+M + R+ L EE ARFY E LA+ +H+ I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN+LLD GH+KL+D+G+CK L+ D +
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTT------------------------ 153
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF---- 358
+ GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 154 -------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
Query: 359 YSDEPMSTCRKI---VNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLG---TKGADEI 412
SD P V ++ P + A L S L + ++RLG G +I
Sbjct: 201 SSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA-ASVLKSFLNKDPKERLGCHPQTGFADI 259
Query: 413 KAHPWFKGIEWDKL--YQIKAAFIPEVNDELDTQNFE 447
+ HP+F+ ++WD + Q+ F P ++ E NF+
Sbjct: 260 QGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFD 296
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 96/325 (29%), Positives = 155/325 (47%), Gaps = 58/325 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+GKG FGEV C+ +ATG +YA KKL K + +R E E+ +LA+V S IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDT----LTEEEARFYVGETVLAIESIHKHNYIH 240
+FQ L L+M + GGD+ + D E A FY + + +E +H+ I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RD+KP+N+LLD +G++++SD GL L + K ++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA---------------------- 158
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
GTP ++APE+L + Y D+++LG +YEM+ PF +
Sbjct: 159 -------------------GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199
Query: 361 D----EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA--DEIK 413
E ++I+N + +P+ K SP +K LL + E+RLG + D ++
Sbjct: 200 RGEKVENKELKQRILN--DSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR 255
Query: 414 AHPWFKGIEWDKLYQ--IKAAFIPE 436
HP F+ + W +L + F+P+
Sbjct: 256 THPLFRDLNWRQLEAGMLPPPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+GAFG V TG A+K++ + ++ ++ + E +LL + IVK
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
S + + LY+I+EY G + ++ + E YV + + + +H+ IHRDIK
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK 126
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
N+L ++G +KL+DFG+ + L+ + D
Sbjct: 127 AANILTTKDGVVKLADFGVA----------------TKLNDVSKDD-------------- 156
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
S VGTP ++APEV+ G D WSLG + E+L G PP+Y PM
Sbjct: 157 -----------ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205
Query: 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
+ +IV H PE SPE KD + + + R A ++ HPW
Sbjct: 206 AALFRIVQ-DDHPPLPEGI--SPELKDFLMQCFQKDPNLR---PTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 96/319 (30%), Positives = 152/319 (47%), Gaps = 59/319 (18%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F ++GKG FGEV C+ +ATG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKH 236
+V L +++ + L L++ + GGD+ + M EE A FY E +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
++RD+KP+N+LLD GH+++SD GL + +G +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEI---------------------PEGETIRG 160
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
R VGT Y+APEV+ + Y DWW LG ++YEM+ G
Sbjct: 161 R---------------------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 357 PFYSDEPMSTCRKIVNW----RTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTK-- 407
PF ++ V R + EE K S A+ + +LL + RLG +
Sbjct: 200 PFRQR------KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGE 253
Query: 408 GADEIKAHPWFKGIEWDKL 426
GA+E+KAHP+F+ + +L
Sbjct: 254 GAEEVKAHPFFRTANFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 98/316 (31%), Positives = 159/316 (50%), Gaps = 55/316 (17%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NC--IV 180
+IG+G FGEV CR+ TG +YAMK L K + + ER +L+ V + +C IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
+ +F + L I++ + GGD+ L + +E E RFY E +L +E +H ++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RD+KP N+LLD +GH+++SD GL C DFS
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----C------DFS---------------------- 148
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPF- 358
+ +++VGT Y+APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 149 -----------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
Query: 359 -YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG--TKGADEIKA 414
+ + ++ ++ P+ SPE + L+ LL +V +RLG +GA E+K
Sbjct: 198 QHKTKDKHEIDRMT-LTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254
Query: 415 HPWFKGIEWDKLYQIK 430
HP+F+ ++W ++ K
Sbjct: 255 HPFFRSLDWQMVFLQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 158 bits (399), Expect = 3e-43
Identities = 112/417 (26%), Positives = 166/417 (39%), Gaps = 60/417 (14%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS- 176
+ L +G+G+FGEV + R++ + A+K L K + +VE E +LA ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEARFYVGETVLAIESI 233
IVKLY FQD+ LYL+MEY+ GG + LL RK L+E EA F + + + A+E +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 234 HKHNYIHRDIKPDNLLLDRNGHM-KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
H IHRDIKP+N+LLDR+G + KL DFGL K L
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI---------------- 161
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMY 349
L ++VGTP Y+APEVLL D WSLG +Y
Sbjct: 162 -------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE---------EAKLSPEAKDLISKLL-CN 399
E+L G PPF ++ S + + L P +S A DL+ KLL +
Sbjct: 203 ELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD 262
Query: 400 VEQRLGTKGA--DEIKAHPWFKGIEWDKL-YQIKAAFIPEVNDELDTQNFEKFEEADNQI 456
+ RL + ++ AH K + L +A +
Sbjct: 263 PKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISG 322
Query: 457 QTSAKSGPW-RKMLSSKDINFVGYTYKNFEIVNDHQLPGIAELKKKSTKPKRPSIKS 512
K L+ ++ + + + + P S S
Sbjct: 323 SDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSLPKISARSSPSSLSSSS 379
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 6e-42
Identities = 94/307 (30%), Positives = 140/307 (45%), Gaps = 58/307 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ F+ L +G+G++G V K TG V A+K + + ++ + E ++L + DS
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PV--EEDLQEIIKEISILKQCDS 57
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGG---DMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
IVK Y S+ + L+++MEY G D+M + TLTEEE + +T+ +E +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H + IHRDIK N+LL+ G KL+DFG
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFG------------------------------- 144
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
V+ QL R + +GTP ++APEV+ + GY + D WSLG EM
Sbjct: 145 VS------GQLTDTMAKRN----TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE 194
Query: 354 GYPPFYSDEPMSTCRKIVNWRTH-LKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411
G PP+ PM I N L PE K SPE D + K L + E+R A +
Sbjct: 195 GKPPYSDIHPMRAIFMIPNKPPPTLSDPE--KWSPEFNDFVKKCLVKDPEER---PSAIQ 249
Query: 412 IKAHPWF 418
+ HP+
Sbjct: 250 LLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 90/290 (31%), Positives = 134/290 (46%), Gaps = 50/290 (17%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
DFE L IGKG+FG V KA VYAMK++ S+M RR + E + E +LA++DS+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEA-RFYVGETVLAIESIH 234
I++ Y SF D L ++MEY GD+ LL R L E++ RF++ + +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
+HRDIK NL LD ++K+ D G+ K L +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---------------------- 156
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
A + VGTP Y++PE+ K Y + D W+LG ++YE G
Sbjct: 157 -------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
PF ++ + KI+ P S + LI + L + QR
Sbjct: 198 KHPFDANNQGALILKIIRGVFP---PVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 97/325 (29%), Positives = 160/325 (49%), Gaps = 49/325 (15%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F ++GKG FGEV C+ +ATG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKH 236
+V L +++ + L L++ + GGD+ + M + E A FY E +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
++RD+KP+N+LLD +GH+++SD GL + +G+ +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHV---------------------PEGQTIKG 160
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
R VGT Y+APEV+ + Y DWW+LG ++YEM+ G
Sbjct: 161 R---------------------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG--ADEIK 413
PF + ++ ++ K SP+A+ L LLC + ++RLG +G A E+K
Sbjct: 200 PFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK 259
Query: 414 AHPWFKGIEWDKLYQ--IKAAFIPE 436
HP FK I + +L ++ F P+
Sbjct: 260 EHPLFKQINFKRLEAGMLEPPFKPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 97/325 (29%), Positives = 159/325 (48%), Gaps = 49/325 (15%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F ++GKG FGEV C+ +ATG +YA K+L+K + +R E+ +L +V+S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKH 236
+V L +++ + L L++ + GGD+ + M EE A FY E + +E +H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
N ++RD+KP+N+LLD GH+++SD GL + +G +
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKI---------------------PEGESIRG 160
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
R VGT Y+APEVL + Y + D+W LG ++YEM+ G
Sbjct: 161 R---------------------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIK 413
PF + ++ + AK S EAK + LL + +QRLG + GA E+K
Sbjct: 200 PFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK 259
Query: 414 AHPWFKGIEWDKLYQ--IKAAFIPE 436
HP+F+ + + +L + F+P+
Sbjct: 260 RHPFFRNMNFKRLEAGMLDPPFVPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 102/313 (32%), Positives = 164/313 (52%), Gaps = 55/313 (17%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEM-LRRGQVEHVKAERNLLAEVDS-NC--I 179
+IG+G FGEV CR+ TG +YAMK L K + +++G+ + ER +L+ V + +C I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIMLSLVSTGDCPFI 59
Query: 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYI 239
V + +F + L I++ + GGD+ L + +E+E RFY E +L +E +H +
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
+RD+KP N+LLD +GH+++SD GL C DFS
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA----C------DFS--------------------- 148
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPF 358
+ +++VGT Y+APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 149 ------------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
Query: 359 YSDEPMSTCR-KIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKA 414
+ + +++ P+ SPE K L+ LL +V +RLG +GA E+K
Sbjct: 197 RQHKTKDKHEIDRMTLTVNVELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254
Query: 415 HPWFKGIEWDKLY 427
H +FKGI+W ++Y
Sbjct: 255 HVFFKGIDWQQVY 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 6e-40
Identities = 67/149 (44%), Positives = 97/149 (65%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
++F + I +GAFG+V + R+K +YA+K +KK++M+ + V V+AER+ LA S
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV LY S Q +YL+MEYL GGD+ +LL EE A Y+ E LA++ +H+H
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
IHRD+KPDN+L+ GH+KL+DFGL K
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 7e-40
Identities = 80/312 (25%), Positives = 134/312 (42%), Gaps = 55/312 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEMLRRGQVEHVKAERNLLAEVD 175
D E + ++G+G+ G V R K TG +YA+KK+ + R Q+ E L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCE 57
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH- 234
S +VK Y +F + + +++EY+ GG + LL + + E + + + ++ +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
K + IHRDIKP NLL++ G +K++DFG+ K L+ + Q
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--------------------- 156
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
+ VGT Y++PE + + Y D WSLG + E +G
Sbjct: 157 --------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196
Query: 355 YPPFYSDE---PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
PF + I + + SPE +D IS L + ++R A
Sbjct: 197 KFPFLPPGQPSFFELMQAICD--GPPPSLPAEEFSPEFRDFISACLQKDPKKRP---SAA 251
Query: 411 EIKAHPWFKGIE 422
E+ HP+ K +
Sbjct: 252 ELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLK--KSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
++G+GAFG V +C + TG A+K++ + +V ++ E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
Y +DDE L + MEY+PGG + L LTE R Y + + +E +H + +HR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
DIK N+L D G++KL DFG K L + + V
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSS--------------GTGMKSV------- 167
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361
GTP +++PEV+ +GYG + D WS+G + EML PP+
Sbjct: 168 -----------------TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
Query: 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
E M+ KI T+ + P +SP+A++ + + N ++R A+E+ H +
Sbjct: 211 EAMAAIFKIATQPTNPQLPSH--VSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 88/297 (29%), Positives = 138/297 (46%), Gaps = 51/297 (17%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMK--KLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
++G G+FG V G +A+K L + V+ ++ E LL+++ IV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
+ ++++ LY+ +E +PGG + LL + + E R Y + +L +E +H N +HR
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
DIK N+L+D NG +KL+DFG+ K Q +FS
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAK-------QVVEFS----------------------- 156
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPFYS 360
A S G+P ++APEV+ ++G YG+ D WSLG + EM G PP+
Sbjct: 157 ------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHP 416
E ++ KI + P+ LS EAKD I K L + R A E+ HP
Sbjct: 205 LEGVAAVFKIGRSKELPPIPDH--LSDEAKDFILKCLQRDPSLRP---TAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 97/314 (30%), Positives = 151/314 (48%), Gaps = 49/314 (15%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F ++GKG FGEV C+ +ATG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKH 236
+V L +++ + L L++ + GGD+ + M E+ A FY E +E + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
++RD+KP+N+LLD GH+++SD GL + +G V
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQI---------------------PEGETVRG 160
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
R VGT Y+APEV+ + Y DWW LG ++YEM+ G
Sbjct: 161 R---------------------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEA-KLSPEAKDLISKLLC-NVEQRLGTK--GADEI 412
PF + R+ V+ R E + K S +AK + LL N ++RLG + GA +
Sbjct: 200 PFRKRKE-RVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258
Query: 413 KAHPWFKGIEWDKL 426
K HP FK I + +L
Sbjct: 259 KQHPIFKNINFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 99/310 (31%), Positives = 138/310 (44%), Gaps = 62/310 (20%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKK--LKKSEMLRRGQVEHVKAERNLLAEV 174
+ F L IGKG+FGEV +K T V A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
S I K Y SF L++IMEY GG + LL + L E F + E +L +E +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
+ IHRDIK N+LL G +KL+DFG +SG
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFG--------------------VSG--------- 146
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
QL R + VGTP ++APEV+ + GY + D WSLG E+ G
Sbjct: 147 --------QLTSTMSKRN----TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
Query: 355 YPPFYSD-EPMSTCRKIVNWRTHLKFP---EEAKLSPEAKDLISKLLC-NVEQRLGTKGA 409
PP SD PM I P E K S KD +S L + ++R A
Sbjct: 195 EPP-LSDLHPMRVLFLIPK-----NNPPSLEGNKFSKPFKDFVSLCLNKDPKERP---SA 245
Query: 410 DEIKAHPWFK 419
E+ H + K
Sbjct: 246 KELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 92/309 (29%), Positives = 146/309 (47%), Gaps = 62/309 (20%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
+ IG+G+ G V + +K+TG A+KK+ + RR E + E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHP 76
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGG---DMMTLLMRKDTLTEEEARFYVGETVL-AIESI 233
IV++Y S+ + L+++ME+L GG D++T T EE V VL A+ +
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-----HTRMNEEQIATVCLAVLKALSFL 131
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H IHRDIK D++LL +G +KLSDFG C + +
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFC--------------------AQVSKE--- 168
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
PRR S VGTP ++APEV+ + YG E D WSLG ++ EM+
Sbjct: 169 -VPRRK-----------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD 210
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHL--KFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
G PP++++ P+ ++I R +L K K+SP + + ++L + QR A
Sbjct: 211 GEPPYFNEPPLQAMKRI---RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR---ATAA 264
Query: 411 EIKAHPWFK 419
E+ HP+
Sbjct: 265 ELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 75/253 (29%), Positives = 116/253 (45%), Gaps = 53/253 (20%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
D+E L IGKG+FG VR R K+ G + K++ M + + + + +E N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 178 CIVKLYCSFQD--DEYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIE 231
IV+ Y D ++ LY++MEY GGD+ L+ + + + EE + + +LA+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 232 SIH-----KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
H + +HRD+KP N+ LD N ++KL DFGL K L
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG------------------ 161
Query: 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346
+ A + VGTP Y++PE L Y + D WSLG
Sbjct: 162 -----------------------HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198
Query: 347 IMYEMLVGYPPFY 359
++YE+ PPF
Sbjct: 199 LIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 83/305 (27%), Positives = 126/305 (41%), Gaps = 61/305 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG G FG+V TG + A+K+++ + ++ + E +L + +VK Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
E +Y+ MEY GG + LL L E R Y + + + +H H +HRDIK
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P N+ LD NG +KL DFG L T E++
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKL--------------------------KNNTTTMGEEV 160
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVGYPPFYSD 361
Q GTP Y+APEV+ KG+G D WSLG ++ EM G P+
Sbjct: 161 QSL-----------AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
Query: 362 EPMSTCRKIVNWRTHLK--------FPEEAKLSPEAKDLISK-LLCNVEQRLGTKGADEI 412
+ ++ P+ +LSPE KD + + L + ++R A E+
Sbjct: 210 DN--------EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASEL 258
Query: 413 KAHPW 417
HP+
Sbjct: 259 LQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 95/337 (28%), Positives = 140/337 (41%), Gaps = 92/337 (27%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK--------KSEMLRRGQVEHVKAERNL 170
+E L +G+G +G V R+K TG + A+KK++ S LR E +L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR---------EISL 51
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLA 229
L E+ IVKL + LYL+ EY D+ L R L+ + + + +
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+ H H +HRD+KP N+L++R+G +KL+DFGL + F I
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARA----------FGI---------- 150
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLGAI 347
P + Y+ V T Y APE+LL K Y D WS+G I
Sbjct: 151 ---P-------------------LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCI 188
Query: 348 MYEMLVGYPPFYSDEPMSTCRKI------------------VNWRTHL-KFPEEA----- 383
EM+ G P F D + KI +++ KFP +
Sbjct: 189 FAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL 248
Query: 384 -KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
+L PE DL+SK+L N +R+ A E HP+F
Sbjct: 249 PRLDPEGIDLLSKMLQYNPAKRI---SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 93/321 (28%), Positives = 148/321 (46%), Gaps = 53/321 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+GKG FGEV + K TG +YA KKL K + ++ + E+ +L +V+S IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEAR--FYVGETVLAIESIHKHNYIHRD 242
+F+ +L L+M + GGD+ + E R Y + I +H + ++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+KP+N+LLD G+ +LSD GL L DG+ + R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVEL---------------------KDGKTITQR----- 154
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
GT Y+APE+L ++ Y DW+++G +YEM+ G PF D
Sbjct: 155 ----------------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF-KDH 197
Query: 363 PMSTCRKIVNWRT---HLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA-DEIKAHPW 417
++ + RT +KF E + E+KD+ L E RLG++ D+ + H +
Sbjct: 198 KEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEF 256
Query: 418 FKGIEWDKLYQ--IKAAFIPE 436
FK I + +L I F+P+
Sbjct: 257 FKTINFPRLEAGLIPPPFVPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 82/330 (24%), Positives = 125/330 (37%), Gaps = 88/330 (26%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR--GQVEHVKA-ERNLLAEVDSNCIVK 181
IG+GA G V +++ TG A+KK+ LRR G + + E L +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
L F L+MEY+P L + L E + + Y+ + + +H + +HR
Sbjct: 64 LLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHR 123
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
D+KP NLL+ +G +K++DFGL + + + R + +
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFS-------------------EEEPRLYSHQ---- 160
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYP---- 356
V T Y APE+L + Y D W++G I E+L G P
Sbjct: 161 -----------------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203
Query: 357 ----------------------PFYSDEP-----MSTCRKIVNWRTHLKFPEEAKLSPEA 389
P + P K + FP+ SPEA
Sbjct: 204 ENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI--FPDA---SPEA 258
Query: 390 KDLISKLL-CNVEQRLGTKGADEIKAHPWF 418
DL+ LL + +RL A E HP+F
Sbjct: 259 LDLLKGLLVYDPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 81/311 (26%), Positives = 131/311 (42%), Gaps = 53/311 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DD+E + +IG GA V A+K++ + + V+ ++ E +++ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGG---DMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+VK Y SF + L+L+M YL GG D+M + L E + E + +E +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H + IHRDIK N+LL +G +K++DFG+ S +L G
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGV--------------------SASLADGG-- 156
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIMYEML 352
R R++ + VGTP ++APEV+ GY + D WS G E+
Sbjct: 157 --------------DRTRKVR-KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201
Query: 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEA---KLSPEAKDLISKLLCNVEQRLGTK-- 407
G P+ PM + A K S + +IS L Q+ +K
Sbjct: 202 TGAAPYSKYPPMKVLMLTLQ-NDPPSLETGADYKKYSKSFRKMISLCL----QKDPSKRP 256
Query: 408 GADEIKAHPWF 418
A+E+ H +F
Sbjct: 257 TAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 90/330 (27%), Positives = 139/330 (42%), Gaps = 77/330 (23%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN--LLAEVDS 176
++ L IG+G +G V R+K TG + A+KK+K + A R LL E++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I+KL F+ LYL+ E++ + R+ L E + Y+ + + + H H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+HRD+KP+NLL++ G +KL+DFGL + + S RP
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLAR--------------------SFGSPVRPYTH 157
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 355
V T Y APE+LL KGY D WS+G I E+L
Sbjct: 158 Y---------------------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
Query: 356 PPF----YSDEPMSTCRKI-----VNWR--------THLKFPEEAK---------LSPEA 389
P F D+ R + W FP++A SP+A
Sbjct: 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQA 256
Query: 390 KDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
DL+S++L + +R+ A++ AHP+F
Sbjct: 257 LDLLSQMLHYDPHKRI---TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 99/333 (29%), Positives = 144/333 (43%), Gaps = 80/333 (24%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKS---EMLRRGQVEHVKAERNLLAEVD 175
+E L ++G+GA+G V CR KATG + A+KK K+S E +++ + VK R L E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-- 60
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
N IV L +F+ LYL+ EY+ + L L + R Y+ + + AI H
Sbjct: 61 -N-IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
HN IHRDIKP+N+L+ +G +KL DFG + L S L+
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARP--------ASPLT----------- 159
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 354
V T Y APE+L+ YG D W++G IM E+L G
Sbjct: 160 ---------------------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
Query: 355 YPPFYSD---EPMSTCRKIV-------------NWRTH-LKFPE-----------EAKLS 386
P F D + + +K + N R + FPE K+S
Sbjct: 199 EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVS 258
Query: 387 PEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
A D + L + ++RL DE+ HP+F
Sbjct: 259 SPALDFLKACLRMDPKERL---TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 96/313 (30%), Positives = 154/313 (49%), Gaps = 56/313 (17%)
Query: 113 KMGADDFEPLTM------IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKA 166
+M D +P ++ IG+G+ G V + REK +G A+K + + RR E +
Sbjct: 11 RMVVDQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFN 67
Query: 167 ERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGET 226
E ++ + +V++Y S+ E L+++ME+L GG +T ++ + L EE+ V E+
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG-ALTDIVSQTRLNEEQIA-TVCES 125
Query: 227 VL-AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
VL A+ +H IHRDIK D++LL +G +KLSDFG C + KD
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------SKD--------- 170
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
P+R S VGTP ++APEV+ + YG E D WSLG
Sbjct: 171 ---------VPKRK-----------------SLVGTPYWMAPEVISRTPYGTEVDIWSLG 204
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLG 405
++ EM+ G PP++SD P+ +++ + K K+SP +D + ++L Q
Sbjct: 205 IMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPPKLKNAHKISPVLRDFLERMLTREPQERA 263
Query: 406 TKGADEIKAHPWF 418
T A E+ HP+
Sbjct: 264 T--AQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 91/339 (26%), Positives = 139/339 (41%), Gaps = 95/339 (28%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK-----SEMLRRGQVEHVKAERNLLAE 173
++ + +G G FG V + R K TG + A+KK+KK E + + VK+ R L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEH 57
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL--LMRKDT---LTEEEARFYVGETVL 228
IVKL F++++ LY + EY+ G L LM+ +E R + + +
Sbjct: 58 P---NIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+ IHKH + HRD+KP+NLL+ +K++DFGL + +
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI--------------------- 149
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRML-AYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGA 346
R+R Y V T Y APE+LL+ Y D W+LG
Sbjct: 150 --------------------RSRPPYTDY--VSTRWYRAPEILLRSTSYSSPVDIWALGC 187
Query: 347 IMYEMLVGYPPFYSDEPMSTCRKIV---------NW--------RTHLKFPEEAKL---- 385
IM E+ P F + KI +W + +FP+ A
Sbjct: 188 IMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQ 247
Query: 386 -----SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
SPEA DLI +L + ++R A + HP+F
Sbjct: 248 LIPNASPEAIDLIKDMLRWDPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 82/307 (26%), Positives = 135/307 (43%), Gaps = 56/307 (18%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV---D 175
++ L +IG+GA+G V + TG V A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
I K Y S+ L++IMEY GG + TL M+ + E+ + E ++A++ IHK
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
IHRDIK N+L+ G++KL DFG+ L+ ++ + F
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF------------------ 161
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 354
VGTP ++APEV+ + K Y + D WSLG +YEM G
Sbjct: 162 -----------------------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFP--EEAKLSPEAKDLISKLLCNVEQRLGTKGADEI 412
PP+ + + + K P E+ S ++ ++ L + + A+E+
Sbjct: 199 NPPYSDVDAF----RAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLS--AEEL 252
Query: 413 KAHPWFK 419
W K
Sbjct: 253 LKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 86/332 (25%), Positives = 142/332 (42%), Gaps = 77/332 (23%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+E + IG+G +G+V R K TG + A+KK++ E + G E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRM-ENEKEGFPITAIREIKLLQKLRHPN 59
Query: 179 IVKLYCSFQDDEY--LYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHK 235
IV+L +Y++ EY+ D+ LL + TE + + Y+ + + ++ +H
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+ +HRDIK N+L++ +G +KL+DFGL +P + D++
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYT----------------- 159
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVG 354
NR V T Y PE+LL YG E D WS+G I+ E+ +G
Sbjct: 160 --------------NR-------VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
Query: 355 YPPFYSDEPMSTCRKI-----------------VNWRTHLKFPEEAK----------LSP 387
P F + KI + W +LK + K + P
Sbjct: 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDP 258
Query: 388 EAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
A DL+ KLL + ++R+ AD+ H +F
Sbjct: 259 SALDLLDKLLTLDPKKRI---SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 90/297 (30%), Positives = 142/297 (47%), Gaps = 52/297 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+GA G V + ATG A+K++ + ++ E + E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
S+ + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
DN+LL +G +KL+DFG C Q+
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA-------------------------------------QI 165
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
Q R + VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ ++ P+
Sbjct: 166 TPEQSKRSTM----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 365 STCRKI-VNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
I N L+ PE KLS +D +++ L +VE+R A E+ HP+ K
Sbjct: 222 RALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 64/245 (26%), Positives = 112/245 (45%), Gaps = 48/245 (19%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
DF+ L +GKG++G V + + YA+K++ M ++ + + V R +LA V+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHP 59
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL----MRKDTLTEEEARFYVGETVLAIESI 233
I+ +F D L ++MEY P GD+ + ++ + E+E + + ++++
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H+ +HRD+K N+LL N +K+ D G+ K L
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-------------------------- 153
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
++ +A + +GTP Y+APEV + Y + D WSLG ++YEM
Sbjct: 154 -----------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
Query: 354 GYPPF 358
PPF
Sbjct: 197 FAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 96/322 (29%), Positives = 140/322 (43%), Gaps = 72/322 (22%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
FE + +IG+G +G+V R K TG + A+K + + + E +K E N+L +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 176 S--NCIVKLYCSF-------QDDEYLYLIMEYLPGG---DMM-TLLMRKDTLTEEEARFY 222
+ N I Y +F DD+ L+L+ME GG D++ L + L EE +
Sbjct: 61 NHPN-IATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ET+ + +H++ IHRDIK N+LL +N +KL DFG+ LD
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-------------- 164
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-----LKKGYGM 337
T +RN + +GTP ++APEV+ Y
Sbjct: 165 ---------------STLG------RRN------TFIGTPYWMAPEVIACDEQPDASYDA 197
Query: 338 ECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIV-NWRTHLKFPEEAKLSPEAKDLISKL 396
D WSLG E+ G PP PM KI N LK PE S + D IS+
Sbjct: 198 RSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE--NWSKKFNDFISEC 255
Query: 397 LC-NVEQRLGTKGADEIKAHPW 417
L N EQR +E+ HP+
Sbjct: 256 LIKNYEQR---PFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 79/290 (27%), Positives = 126/290 (43%), Gaps = 53/290 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+F+ IGKG F V G V A+KK++ EM+ + E +LL ++D
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEARF-YVGETVLAIES 232
++K SF ++ L +++E GD+ ++ ++ L E + Y + A+E
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+H +HRDIKP N+ + G +KL D GL G S
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGL----------------GRFFS-------- 157
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
++ A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 158 -----------------SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200
Query: 353 VGYPPFYSDEP--MSTCRKIVNWRTHLKFP--EEAKLSPEAKDLISKLLC 398
PFY D+ S C+KI +P S E +DL+S+ +
Sbjct: 201 ALQSPFYGDKMNLYSLCKKI----EKCDYPPLPADHYSEELRDLVSRCIN 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 53/302 (17%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+ P+ ++GKGAFGE + R + K++ + + + + E +L+ +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPN 60
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEE-ARFYVGETVLAIESIHKH 236
I+ Y F DD L + MEY GG + ++R K L EEE +Y+ + V A+ IHK
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+HRDIK N+ L + G +KL DFG+ K L GS S
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKIL------------GSEYSM----------- 157
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
A + VGTP Y++PE+ Y + D W+LG ++YE+L
Sbjct: 158 ------------------AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
Query: 357 PFYSDEPMSTCRKIV--NWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKA 414
F + P++ KIV N+ P + S E L+ LL ++ T ADE+
Sbjct: 200 TFDATNPLNLVVKIVQGNYT-----PVVSVYSSELISLVHSLLQQDPEKRPT--ADEVLD 252
Query: 415 HP 416
P
Sbjct: 253 QP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 70/252 (27%), Positives = 113/252 (44%), Gaps = 48/252 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+D+E + IG G +G+V R+ ATG + A+K +K E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDM-MTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
IV + S+ + L+++MEY GG + + + L+E + + ET+ + +H+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
IHRDIK N+LL +G +KL+DFG+ L + + K F
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF------------------ 161
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLGAIMYEML 352
+GTP ++APEV K GY +CD W+LG E+
Sbjct: 162 -----------------------IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198
Query: 353 VGYPPFYSDEPM 364
PP + PM
Sbjct: 199 ELQPPMFDLHPM 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 84/307 (27%), Positives = 141/307 (45%), Gaps = 56/307 (18%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLK-------KSEMLRRGQVEHVKAERNLLAEVDS 176
+IGKG +G V + TG + A+K+++ + + ++ V+ +++E L ++D
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 177 NCIVKLYCSFQD-DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
IV+ Y F+ +EYL + +EY+PGG + + L E+ RF+ + + + +H
Sbjct: 68 LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+HRD+K DNLL+D +G K+SDFG+ K + D I N
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISK-------KSDD--IYDNDQ----------- 166
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEV--LLKKGYGMECDWWSLGAIMYEMLV 353
S G+ ++APEV +GY + D WSLG ++ EM
Sbjct: 167 -------------------NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKD-LISKLLCNVEQRLGTKGAD 410
G P+ +E ++ K+ N R+ P + LSP A D L + N + R A
Sbjct: 208 GRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR---PTAR 264
Query: 411 EIKAHPW 417
E+ HP+
Sbjct: 265 ELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 90/297 (30%), Positives = 148/297 (49%), Gaps = 52/297 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+GA G V + ATG A+K++ + ++ + E + E ++ E+ + IV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
SF + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 84 SFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
DN+LL +G +KL+DFG C + P ++++ +
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCA---------------------------QITPEQSKRSTM 175
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ ++ P+
Sbjct: 176 --------------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 365 STCRKI-VNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
I N L+ PE KLSP +D +++ L +VE+R A E+ HP+ K
Sbjct: 222 RALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 84/298 (28%), Positives = 134/298 (44%), Gaps = 47/298 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLK--KSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
++G+GAFG V +C + TG A K+++ +V ++ E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 182 LYCSFQD--DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYI 239
Y +D ++ L + MEY+PGG + L LTE R Y + + + +H + +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
HRDIK N+L D G++KL DFG K L + G+ +
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMS------GTGIR--------------- 167
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 359
S GTP +++PEV+ +GYG + D WSLG + EML PP+
Sbjct: 168 -----------------SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210
Query: 360 SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPW 417
E M+ KI T+ + P + +S A+D + + R A+E+ HP+
Sbjct: 211 EYEAMAAIFKIATQPTNPQLP--SHISEHARDFLGCIFVEARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 87/330 (26%), Positives = 133/330 (40%), Gaps = 90/330 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN-LLAEVD 175
DD E L +G G G V + TG + A+K + ++E +A + +L E+D
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---------RLEINEAIQKQILRELD 51
Query: 176 ----SNC--IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
N IV Y +F ++ + + MEY+ GG + +L E +G+ +A
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPER---ILGKIAVA 108
Query: 230 IES-----IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+ KH IHRD+KP N+L++ G +KL DFG +S
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFG--------------------VS 148
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344
G L + LA + VGT Y+APE + Y ++ D WSL
Sbjct: 149 GQLVNS-----------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSL 185
Query: 345 GAIMYEMLVG---YPP--FYSDEPMSTCRKIVNWRTHLKFPEEA------KLSPEAKDLI 393
G + E+ G YPP D + IVN E K SP+ +D +
Sbjct: 186 GLSLIELATGRFPYPPENDPPDGIFELLQYIVN--------EPPPRLPSGKFSPDFQDFV 237
Query: 394 SKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422
+ L + +R K E+ HP+ K E
Sbjct: 238 NLCLIKDPRERPSYK---ELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 83/302 (27%), Positives = 126/302 (41%), Gaps = 72/302 (23%)
Query: 128 GAFGEVRVCREKATGHVYAMKKLKKS-----EMLRRGQVEHV-KAERNLLAEVDSNCIVK 181
G FG+V V + K T ++ K +K E + V + K N +K
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPM----VHQLMKDNPNF---------IK 73
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
LY S + LIM+Y+ GD+ LL ++ L+E E + + + V A+ +HKHN IH
Sbjct: 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHN 133
Query: 242 DIKPDNLLLDRN-GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
DIK +N+L DR + L D+GLCK + + +
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------------------------- 167
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF-- 358
GT DY +PE + Y + DWW++G + YE+L G PF
Sbjct: 168 -------------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
Query: 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417
DE + + + R K P +S A D + +L N+ RL +EI HP+
Sbjct: 209 DEDEELDL--ESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN--YNEIIKHPF 264
Query: 418 FK 419
K
Sbjct: 265 LK 266
|
Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 85/296 (28%), Positives = 141/296 (47%), Gaps = 52/296 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+G+ G V + K++G + A+KK+ + RR E + E ++ + +V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
S+ + L+++ME+L GG +T ++ + EE+ + A+ +H IHRDIK
Sbjct: 85 SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
D++LL +G +KLSDFG C + PRR
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKE------------------------VPRRK----- 174
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
S VGTP ++APE++ + YG E D WSLG ++ EM+ G PP++++ P+
Sbjct: 175 ------------SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
Query: 365 STCRKIVNWRTHL--KFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWF 418
+ I R +L K K+SP K + +LL + T A E+ HP+
Sbjct: 223 KAMKMI---RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT--AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 76/282 (26%), Positives = 131/282 (46%), Gaps = 48/282 (17%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+E + IG+G+FG++ + + K+ +K++ ++M + + E K E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKH 236
IV + SFQ++ L+++MEY GGD+M + R+ +E++ + + L ++ IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 237 NYIHRDIKPDNLLLDRNGHM-KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+HRDIK N+ L +NG + KL DFG+ + L+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--------------------------- 153
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
+ LAY+ VGTP Y++PE+ + Y + D WSLG ++YE+
Sbjct: 154 --------------DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL 397
PF + KI P S + + LIS+L
Sbjct: 200 HPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSLISQLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 85/297 (28%), Positives = 140/297 (47%), Gaps = 52/297 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+G+ G V + EK TG A+KK+ + RR E + E ++ + +V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHENVVDMYN 86
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
S+ + L+++ME+L GG +T ++ + EE+ + A+ +H IHRDIK
Sbjct: 87 SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
D++LL +G +KLSDFG C + P+R
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKE------------------------VPKRK----- 176
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
S VGTP ++APEV+ + YG E D WSLG ++ EM+ G PP++++ P+
Sbjct: 177 ------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224
Query: 365 STCRKIVNWRTHL--KFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFK 419
R+I R +L + + K+S + + +L + T A E+ HP+ K
Sbjct: 225 QAMRRI---RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT--AQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 51/283 (18%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+E + ++G+GAFG V +CR KA + +K++ +M + + + E +L +
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPN 60
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM--RKDTLTEEEARFYVGETVLAIESIHKH 236
I++ Y +F +D+ L ++MEY PGG + + L E+ + + +LA+ +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 237 NYIHRDIKPDNLLLDRNGH-MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+HRD+K N+LLD++ +K+ DFG+ K L
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL---------------------------- 152
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
+ + AY+ VGTP YI+PE+ K Y + D W+LG ++YE+
Sbjct: 153 --------------SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLK 198
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKF-PEEAKLSPEAKDLISKLL 397
F + + KI F P + SP+ + LI +L
Sbjct: 199 RAFEAANLPALVLKI----MSGTFAPISDRYSPDLRQLILSML 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 79/303 (26%), Positives = 135/303 (44%), Gaps = 48/303 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ---VEHVKAERNLLAEVDSNCIV 180
+G GAF R+ TG + A+K++ Q VE ++ E L+A ++ I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
++ + +D + L +E++ GG + LL + E Y + + + +H++ IH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 241 RDIKPDNLLLDRNGH-MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
RD+K NLL+D G ++++DFG L + +GA + G
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARL------------AAKGTGAGEFQG-------- 166
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 359
QL +GT ++APEVL + YG CD WS+G ++ EM PP+
Sbjct: 167 ---QL--------------LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
Query: 360 SDE---PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHP 416
+++ ++ KI + T PE LSP +D+ L C Q + E+ HP
Sbjct: 210 AEKHSNHLALIFKIASATTAPSIPEH--LSPGLRDVT--LRCLELQPEDRPPSRELLKHP 265
Query: 417 WFK 419
F+
Sbjct: 266 VFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 89/330 (26%), Positives = 139/330 (42%), Gaps = 74/330 (22%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAER--NLLAEVDS 176
+E +G+G + V R+K TG + A+KK+K E + A R LL E+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHK 235
I+ L F + L+ E++ D+ ++ K LT + + Y+ T+ +E +H
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+ +HRD+KP+NLL+ +G +KL+DFGL + S GS P
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLAR------------SFGS-----------P-- 155
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVG 354
NR+M V T Y APE+L + YG+ D WS+G I E+L+
Sbjct: 156 --------------NRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR 199
Query: 355 YPPFYSDEPMSTCRKIV---------NWRTHLKFPEEAKLSP---------------EAK 390
P D + KI NW P+ + P +A
Sbjct: 200 VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDAL 259
Query: 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
DL+ +LL N +R+ + A E HP+F
Sbjct: 260 DLLQRLLTLNPNKRITARQALE---HPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 47/296 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLK--KSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
++G+GAFG V +C + TG A+K+++ +V ++ E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 182 LYCSFQD--DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYI 239
Y +D + L + ME++PGG + L LTE R Y + + + +H + +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
HRDIK N+L D G++KL DFG K L L G+ +
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLS------GTGMK--------------- 167
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 359
S GTP +++PEV+ +GYG + D WS+G + EML PP+
Sbjct: 168 -----------------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210
Query: 360 SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAH 415
E M+ KI T+ P +S +D + ++ + R ADE+ H
Sbjct: 211 EFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLR---PSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 52/303 (17%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLK------KSEMLRRGQVEHVKAERNLLAEVDSN 177
+IG G+FG V + ++G + A+K+++ S+ +R ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
IV+ S D ++L + +EY+PGG + LL E R +V + + + +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
IHRDIK N+L+D G +K+SDFG+ K L+ ++L K
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK---------------------T 165
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
+ LQ G+ ++APEV+ + Y + D WSLG ++ EML G P
Sbjct: 166 NGARPSLQ--------------GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL---CNVEQRLGTKGADEIKA 414
F + KI + P S EA D + K N A E+
Sbjct: 212 FPDCTQLQAIFKI-GENASPEIPSNI--SSEAIDFLEKTFEIDHNKR-----PTAAELLK 263
Query: 415 HPW 417
HP+
Sbjct: 264 HPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 85/296 (28%), Positives = 143/296 (48%), Gaps = 50/296 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+GA G V + ATG A+K++ + ++ E + E ++ E + IV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 83
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
S+ + L+++MEYL GG + T ++ + + E + E + A++ +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
DN+LL +G +KL+DFG C + P ++++ +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA---------------------------QITPEQSKRSTM 175
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ ++ P+
Sbjct: 176 --------------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 365 STCRKI-VNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFK 419
I N L+ PE +LS +D +++ L R G+ A E+ HP+ K
Sbjct: 222 RALYLIATNGTPELQNPE--RLSAVFRDFLNRCLEMDVDRRGS--AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 86/297 (28%), Positives = 144/297 (48%), Gaps = 52/297 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+GA G V + ATG A++++ + ++ E + E ++ E + IV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
S+ + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 85 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
DN+LL +G +KL+DFG C + P ++++ +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCA---------------------------QITPEQSKRSTM 176
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ ++ P+
Sbjct: 177 --------------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 365 STCRKI-VNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
I N L+ PE KLS +D +++ L +VE+R A E+ H + K
Sbjct: 223 RALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKR---GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 83/342 (24%), Positives = 127/342 (37%), Gaps = 97/342 (28%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE--------MLRRGQVEHVKAERNL 170
+E L IG+GA+G V R+ TG A+KK++ LR E L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR---------EIAL 51
Query: 171 LAEVDS-NC--IVKLY--CSFQDDE---YLYLIMEYLPGGDMMTLLMR--KDTLTEEEAR 220
L +++S IV+L C + L L+ E++ D+ T L + K L E +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK 110
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
+ + + ++ +H H +HRD+KP N+L+ +G +K++DFGL +
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS------------ 158
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340
M S V T Y APEVLL+ Y D
Sbjct: 159 ------------------------------FEMALTSVVVTLWYRAPEVLLQSSYATPVD 188
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKI-----------------VNWRT-HLKFPEE 382
WS+G I E+ P F KI + + P
Sbjct: 189 MWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRS 248
Query: 383 AK-----LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
K + E DL+ K+L N +R+ A HP+F
Sbjct: 249 FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA---LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 80/298 (26%), Positives = 133/298 (44%), Gaps = 44/298 (14%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKK--LKKSEMLR-RGQVEHVKAERNLLAEVDSNCIV 180
++GKGA+G V C G + A+K+ L S +L + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
+ + DD + + ME++PGG + ++L R L E Y + + + +H + +H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIK +N++L NG +KL DFG + L L T
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG------------------------TH 161
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
L+ S GTP ++APEV+ + GYG + D WS+G ++EM G PP S
Sbjct: 162 SNMLK-----------SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
Query: 361 DEPMSTCRKIVNWRTHL-KFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPW 417
+ ++ I R + + P+ S A D ++ C + A ++ H +
Sbjct: 211 MDRLAAMFYIGAHRGLMPRLPD--SFSAAAIDFVT--SCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 74/245 (30%), Positives = 108/245 (44%), Gaps = 49/245 (20%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMK--KLKKSEMLRRGQVEHVKAERNLLAEVD 175
+ L ++G+G+FG + + + YAMK +L KS VE + E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL--LMRKDTLTEEEARFYVGETVLAIESI 233
IV SF+ D +LY++MEY GGD+M L R E+ + + L ++ I
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H+ +HRDIK N+ L +NG +KL DFG + L P
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-----------------------TSP 153
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
A A + VGTP Y+ PE+ Y + D WSLG I+YE+
Sbjct: 154 GA------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
Query: 354 GYPPF 358
PF
Sbjct: 196 LKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 88/346 (25%), Positives = 143/346 (41%), Gaps = 95/346 (27%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKK--------------LKKSEMLRRGQVEHV 164
+E L IG GA+G V +K TG A+KK L++ ++LR + E++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 165 KAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVG 224
++L F D +Y++ E + D+ ++ LT++ ++++
Sbjct: 62 IGLLDILRPPSPE-------DFND---VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLY 110
Query: 225 ETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+ + ++ +H N IHRD+KP N+L++ N +K+ DFGL + +D D L+
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP------DEDEKGFLT 164
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 343
V R W R APE+LL Y D WS
Sbjct: 165 EY-------VVTR---------WYR----------------APELLLSSSRYTKAIDIWS 192
Query: 344 LGAIMYEMLVGYPPF----Y--------------SDEPMS--TCRKIVNWRTHLKFPEEA 383
+G I E+L P F Y S+E + T K N+ L +
Sbjct: 193 VGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKK 252
Query: 384 KL-------SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421
L SPEA DL+ K+L + ++R+ T ADE AHP+ +
Sbjct: 253 PLSKLFPGASPEAIDLLEKMLVFDPKKRI-T--ADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKL--KKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
++G+GAFGEV +C + TG A+K++ +V ++ E LL + + IV+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 182 LYCSFQDDEY--LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYI 239
Y +D E L + +EY+PGG + L LTE R Y + + + +H + +
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
HRDIK N+L D G++KL DFG K + + G+ +
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMS------GTGIK--------------- 167
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 359
S GTP +++PEV+ +GYG + D WS+ + EML PP+
Sbjct: 168 -----------------SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
Query: 360 SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHP 416
E M+ KI T P+ +S +D + ++ E+R T A+ + HP
Sbjct: 211 EYEAMAAIFKIATQPTKPMLPD--GVSDACRDFLKQIFVE-EKRRPT--AEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 74/246 (30%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
+ K Y S+ L++IMEYL GG + LL R E + + E + ++ +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRDIK N+LL G +KL+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
Query: 359 YSDEPM 364
PM
Sbjct: 202 SDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 7e-25
Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 65/295 (22%)
Query: 128 GAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187
G +V + + T + +K L+KS R ER + +V L+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 188 DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDN 247
++ ++L++++ GG + + + + + EE + + E V+A++++H+ + RD+ P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 248 LLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHW 307
+LLD GH++L+ F S +++ DG V
Sbjct: 116 ILLDDRGHIQLTYFS-----RWSEVED-------------SCDGEAVE------------ 145
Query: 308 QRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTC 367
M Y APEV CDWWSLGAI++E+L G + + C
Sbjct: 146 ----NM----------YCAPEVGGISEETEACDWWSLGAILFELLTG-------KTLVEC 184
Query: 368 RKI-VNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGTKGA--DEIKAHPWF 418
+N T L PE +S EA+ L+ +LL N +RLG A ++IK+HP+F
Sbjct: 185 HPSGINTHTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 79/308 (25%), Positives = 131/308 (42%), Gaps = 68/308 (22%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVY-AMKKLK-KSEMLRRGQVEHVKAERNLLAEVD- 175
+ L +G GAFG V R+K G A+K++ + + + E K+ ++++EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 176 -------SNCIVKLYCSFQDDEYLYLIMEYLPGGDM----MTLLMRKDTLTEEEARFYVG 224
N IV+ Y +F +++ LY++M+ + G + +L +K TEE
Sbjct: 62 IKEQLRHPN-IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 225 ETVLAIESIHKHNYI-HRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ VLA+ +HK I HRD+ P+N++L + + ++DFGL K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343
Q+ S VGT Y PE++ + YG + D W+
Sbjct: 163 ------------------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWA 198
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQR 403
G I+Y+M PPFYS +S KIV EA P + + S+ + +V
Sbjct: 199 FGCILYQMCTLQPPFYSTNMLSLATKIV----------EAVYEPLPEGMYSEDVTDVITS 248
Query: 404 LGTKGADE 411
T A+
Sbjct: 249 CLTPDAEA 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 73/257 (28%), Positives = 119/257 (46%), Gaps = 49/257 (19%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE---MLRRGQVEHVKAERNLLAEVD 175
+E L ++G+G++G V C+ K TG + A+KK +SE M+++ + ++ +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
+V L F+ + LYL+ E++ + L + L E R Y+ + + IE H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
HN IHRDIKP+N+L+ ++G +KL DFG + L D+ VA
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY----------------VA 162
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVG 354
R W R APE+L+ YG D W++G ++ EML G
Sbjct: 163 TR---------WYR----------------APELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
Query: 355 YPPFYSDEPMSTCRKIV 371
P F D + I+
Sbjct: 198 EPLFPGDSDIDQLYHII 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 56/131 (42%), Positives = 78/131 (59%), Gaps = 7/131 (5%)
Query: 319 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLK 378
+GTPDY+APE+LL K +G DWW+LG ++E L G PPF + P + I+N +
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN--RDIP 598
Query: 379 FPE-EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPE 436
+PE E KLS A++ I LL + +R G K E+K HP F G++W+ L FIP+
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLK---ELKQHPLFHGVDWENLQNQTMPFIPQ 655
Query: 437 VNDELDTQNFE 447
+DE DT FE
Sbjct: 656 PDDETDTSYFE 666
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 82/277 (29%), Positives = 127/277 (45%), Gaps = 53/277 (19%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY 183
++GKG +G V R+ +T A+K++ + + R Q H E L + + IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLH--EEIALHSYLKHRNIVQYL 71
Query: 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEA--RFYVGETVLAIESIHKHNYIH 240
S ++ + + ME +PGG + LL K L + E FY + + ++ +H + +H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 241 RDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
RDIK DN+L++ +G +K+SDFG K L N + F+
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--------------------- 170
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 357
GT Y+APEV+ K +GYG D WSLG + EM G PP
Sbjct: 171 --------------------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 358 FYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLI 393
F EP + K+ ++ H + PE LS EAK+ I
Sbjct: 211 FIELGEPQAAMFKVGMFKIHPEIPES--LSAEAKNFI 245
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 75/246 (30%), Positives = 111/246 (45%), Gaps = 44/246 (17%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
+ K Y S+ D L++IMEYL GG + LL L E + + E + ++ +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRDIK N+LL +G +KL+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
Query: 359 YSDEPM 364
PM
Sbjct: 202 SELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 74/246 (30%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
I + Y S+ L++IMEYL GG + LL + L E + E + ++ +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRDIK N+LL G +KL+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
Query: 359 YSDEPM 364
PM
Sbjct: 202 SDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 61/291 (20%)
Query: 125 IGKGAFGEV-----RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+G+GAFGEV + E V A+K LK+ + E E +++ ++ I
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEE--EREEFLEEASIMKKLSHPNI 63
Query: 180 VKLY--CSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKH 236
V+L C+ E LY++ EY+PGGD++ L + LT ++ + +E +
Sbjct: 64 VRLLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
N++HRD+ N L+ N +K+SDFGL + ++ E D+ + G +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSR-----DIYEDDYY--------RKRGGGKLPI 168
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGY 355
+ W +APE L + + D WS G +++E+ +G
Sbjct: 169 K---------W-----------------MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC---NVEQR 403
P+ + + L PE E +L+ L C + E R
Sbjct: 203 QPYPGMSNEEVLELLED-GYRLPRPENC--PDELYELM--LQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 92/340 (27%), Positives = 140/340 (41%), Gaps = 97/340 (28%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK--------KSEMLRRGQVEHVKAERNL 170
++ + IG+G +G V R+K TG + A+KK++ S +R E +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---------EISL 51
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM-MTLLMR---KDTLTEEEARFYVGET 226
L E++ IV+L + LYL+ E+L D+ + M L + Y+ +
Sbjct: 52 LKELNHPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 227 VLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
+ I H H +HRD+KP NLL+DR G +KL+DFGL + F +
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA----------FGV------- 151
Query: 287 LQSDGRPVAPRRT-QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 344
P RT E + W R APE+LL + Y D WS+
Sbjct: 152 ---------PVRTYTHEVVTLWYR----------------APEILLGSRQYSTPVDIWSI 186
Query: 345 GAIMYEMLVGYPPFYSDEPMSTCRKI---------VNWR--THL-----KFPEEAK---- 384
G I EM+ P F D + +I W T L FP+ A+
Sbjct: 187 GCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLS 246
Query: 385 -----LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
L + DL+SK+L + +R+ K A + HP+F
Sbjct: 247 KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 57/291 (19%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHV----YAMKKLKKSEMLRRGQVEHVKAERNLLAE 173
+F+ IG+G F EV +AT + A+KK++ EM+ + E +LL +
Sbjct: 3 NFQIEKKIGRGQFSEVY----RATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ 58
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM----RKDTLTEEEARFYVGETVLA 229
++ ++K SF +D L +++E GD+ ++ +K + E Y + A
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+E +H +HRDIKP N+ + G +KL D GL
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------------------------- 152
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
GR + + T A+S VGTP Y++PE + + GY + D WSLG ++Y
Sbjct: 153 -GRFFSSKTTA--------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197
Query: 350 EMLVGYPPFYSDEP--MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC 398
EM PFY D+ S C+KI + P E S + ++L+S +
Sbjct: 198 EMAALQSPFYGDKMNLFSLCQKIEQC-DYPPLPTE-HYSEKLRELVSMCIY 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 68/281 (24%), Positives = 129/281 (45%), Gaps = 47/281 (16%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+ + IG+G+FG+ + + K G Y +K++ S+M + + E + E +L+ +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPN 60
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKH 236
IV+ SF+++ LY++M+Y GGD+ + R E++ + + LA++ +H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+HRDIK N+ L ++G +KL DFG+ + L+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN---------------------------- 152
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
+ LA + +GTP Y++PE+ + Y + D W+LG ++YEM
Sbjct: 153 -------------STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL 397
F + + KI+ P + S + ++L+S+L
Sbjct: 200 AFEAGNMKNLVLKIIRGSYP---PVSSHYSYDLRNLVSQLF 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 8e-23
Identities = 83/316 (26%), Positives = 133/316 (42%), Gaps = 63/316 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D+ E L +GKG +G V + TG AMK+++ L + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEARFYVGETVLAIESI 233
IV Y +F + +Y+ MEY+ G + L + + + E+ R V ++ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 234 -HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+HN IHRD+KP N+L++ NG +KL DFG +SG L +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG--------------------VSGNLVAS-- 156
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG------YGMECDWWSLGA 346
LA + +G Y+APE + G Y ++ D WSLG
Sbjct: 157 ---------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195
Query: 347 IMYEMLVG---YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQR 403
+ EM +G YPP + IV+ P S +A+D ++K L + R
Sbjct: 196 SILEMALGRYPYPPETYANIFAQLSAIVD-GDPPTLPSG--YSDDAQDFVAKCLNKIPNR 252
Query: 404 LGTKGADEIKAHPWFK 419
T ++ HPW
Sbjct: 253 RPTYA--QLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 8e-23
Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 52/244 (21%)
Query: 124 MIGKGAFGEVRVCREKATGHVY----AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+G+GAFGEV + K G A+K LK+ Q+E E ++ ++D +
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLDHPNV 63
Query: 180 VKLY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKH 236
VKL C+ ++E LY++MEY+ GGD+++ L + L+ + + + +E +
Sbjct: 64 VKLLGVCT--EEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
N+IHRD+ N L+ N +K+SDFGL + L + K G L P+
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR---GGKL---------PIR- 168
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGY 355
W +APE L + + + D WS G +++E+ +G
Sbjct: 169 ----------W-----------------MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE 201
Query: 356 PPFY 359
P+
Sbjct: 202 QPYP 205
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 65/245 (26%), Positives = 108/245 (44%), Gaps = 53/245 (21%)
Query: 124 MIGKGAFGEVRVCREKATGHVY----AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+G+GAFGEV K G A+K LK+ + Q+E E ++ ++D I
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLDHPNI 63
Query: 180 VKLY--CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHK 235
VKL C+ ++E L ++MEY+PGGD++ L R L+ + + + +E +
Sbjct: 64 VKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
N+IHRD+ N L+ N +K+SDFGL + L + + G L P+
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK---GGKL---------PIR 169
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VG 354
W +APE L + + + D WS G +++E+ +G
Sbjct: 170 -----------W-----------------MAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 355 YPPFY 359
P+
Sbjct: 202 EEPYP 206
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 87/346 (25%), Positives = 140/346 (40%), Gaps = 101/346 (29%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEM-------LRRGQVEHVKAER 168
D++E L I +G +G V R+K TG + A+KKLK + E LR E
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR---------EI 55
Query: 169 NLLAEVDSNCIVKL----YCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYV 223
N+L ++ IV + S D +Y++MEY+ D+ +L+ K + E + +
Sbjct: 56 NILLKLQHPNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ + + +H + +HRD+K NLLL+ G +K+ DFGL
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL-------------------- 152
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWW 342
R L+ + + V T Y APE+LL K Y D W
Sbjct: 153 -------AREY------GSPLKPYTQL--------VVTLWYRAPELLLGAKEYSTAIDMW 191
Query: 343 SLGAIMYEML---------------------VGYP-----PFYSDEPMSTCRKIVN---W 373
S+G I E+L +G P P +S+ P + +
Sbjct: 192 SVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYN 251
Query: 374 RTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
+ KFP LS DL+++LL + +R+ + A + HP+F
Sbjct: 252 QLRKKFP-ALSLSDNGFDLLNRLLTYDPAKRISAEDALK---HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 47/252 (18%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+G F EV G A+KK++ +++ E +LL +++ ++K Y
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLM----RKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
SF +D L +++E GD+ ++ +K + E+ Y + A+E +H +H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RDIKP N+ + G +KL D GL GR + + T
Sbjct: 130 RDIKPANVFITATGVVKLGDLGL---------------------------GRFFSSKTTA 162
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
A+S VGTP Y++PE + + GY + D WSLG ++YEM PFY
Sbjct: 163 --------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
Query: 361 DEP--MSTCRKI 370
D+ S C+KI
Sbjct: 209 DKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 87/342 (25%), Positives = 134/342 (39%), Gaps = 78/342 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAER--NLLAEV 174
D+E L +G+G FGEV R+ TG V A+KK+ M + A R +L ++
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILKKL 64
Query: 175 DSNCIVKLYCSFQD--DEYL------YLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGE 225
+V L + D+ Y++ Y+ D+ LL LTE + + Y+ +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQ 123
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ I +H+++ +HRDIK N+L+D G +K++DFGL +P D G
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD----------------G 167
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAY-STVGTPDYIAPEVLL-KKGYGMECDWWS 343
+ Y + V T Y PE+LL ++ Y D W
Sbjct: 168 PPPNPKGGGGGGTR---------------KYTNLVVTRWYRPPELLLGERRYTTAVDIWG 212
Query: 344 LGAIMYEMLVGYPPFY------------------SDEPMSTCRKIVNWRTHLKFP----- 380
+G + EM P ++E R + F
Sbjct: 213 IGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT 272
Query: 381 -EE--AKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWF 418
EE KL PE DL+SKLL + +RL A HP+F
Sbjct: 273 LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA---LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 59/303 (19%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMK--KLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKL 182
+G GAFG+V + K TG A K +++ E ++E E ++L+E IV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----ELEDFMVEIDILSECKHPNIVGL 67
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHKHNYIHR 241
Y ++ + L++++E+ GG + ++++ + LTE + R+ + + A+ +H H IHR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
D+K N+LL +G +KL+DFG+ + S LQ++D
Sbjct: 128 DLKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRD------------------------- 161
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEMLVGYP 356
+ +GTP ++APEV+ Y + D WSLG + E+ P
Sbjct: 162 ---------------TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415
P + PM KI+ + +K S D + L + + R A E+ H
Sbjct: 207 PHHELNPMRVLLKILKSEPP-TLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKH 262
Query: 416 PWF 418
P+
Sbjct: 263 PFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 79/246 (32%), Positives = 114/246 (46%), Gaps = 49/246 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKA----ERNLLA 172
+ FE L ++G+GA+G V CR K T + A+KK K SE + E VK E +L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-----ENEEVKETTLRELKMLR 55
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES 232
+ IV+L +F+ LYL+ EY+ + L + + E+ R Y+ + + AI
Sbjct: 56 TLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
HK++ +HRDIKP+NLL+ N +KL DFG + NL E GSN +
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFAR-----NLSE-----GSNANYT------ 159
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
V T Y +PE+LL YG D WS+G I+ E+
Sbjct: 160 ------------------------EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELS 195
Query: 353 VGYPPF 358
G P F
Sbjct: 196 DGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 93/339 (27%), Positives = 137/339 (40%), Gaps = 95/339 (28%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEMLRRGQVEHVKAERNLLAEVDSN 177
F+ + IG+G +G V R K TG V A+KK++ +E G E +LL E++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHP 59
Query: 178 CIVKLYCSFQDDEYLYLIMEYL-----------PGGDMMTLLMRKDTLTEEEARFYVGET 226
IVKL + LYL+ E+L P + L++ Y+ +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YLFQL 109
Query: 227 VLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
+ + H H +HRD+KP NLL++ G +KL+DFGL +
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------------------- 150
Query: 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 345
G PV R E + W R APE+LL K Y D WSLG
Sbjct: 151 ----GVPV--RTYTHEVVTLWYR----------------APEILLGCKYYSTAVDIWSLG 188
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKI---------VNWR--THLK-----FPEEAK----- 384
I EM+ F D + +I V W T L FP+ A+
Sbjct: 189 CIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK 248
Query: 385 ----LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
L + +DL+S++L + +R+ K A AHP+F
Sbjct: 249 VVPPLDEDGRDLLSQMLHYDPNKRISAKAA---LAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-22
Identities = 87/328 (26%), Positives = 146/328 (44%), Gaps = 57/328 (17%)
Query: 106 YMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEMLRRGQVEHV 164
Y ++R + +E + +G GAFG+V + K TG + A K ++ KSE ++E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDY 56
Query: 165 KAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYV 223
E +LA + IVKL +F D L++++E+ PGG + +++ D LTE + +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ + A++ +H IHRD+K N+LL +G +KL+DFG+ + LQ +D
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRD------- 168
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGME 338
S +GTP ++APEV++ Y +
Sbjct: 169 ---------------------------------SFIGTPYWMAPEVVMCETMKDTPYDYK 195
Query: 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL- 397
D WSLG + EM PP + PM KI + +K S E +D + L
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKWSMEFRDFLKTALD 254
Query: 398 CNVEQRLGTKGADEIKAHPWFKGIEWDK 425
+ E R A ++ HP+ + ++
Sbjct: 255 KHPETR---PSAAQLLEHPFVSSVTSNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 89/329 (27%), Positives = 134/329 (40%), Gaps = 79/329 (24%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-------KSEMLRRGQVEHVKAERN 169
+ L+ +G+GA G V CR K TG ++A+K + + ++LR E
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---------ELE 51
Query: 170 LLAEVDSNCIVKLYCSFQDDE--YLYLIMEYLPGGDMMTLL--MRKDT-LTEEEARFYVG 224
+ S IVK Y +F D+ + + MEY GG + ++ ++K E+ +
Sbjct: 52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIA 111
Query: 225 ETVL-AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
E+VL + +H IHRDIKP N+LL R G +KL DFG +
Sbjct: 112 ESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG--------------------V 151
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343
SG L + LA + GT Y+APE + K Y + D WS
Sbjct: 152 SGELVNS-----------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWS 188
Query: 344 LGAIMYEMLVGYPPFYSDE-----PMSTCRKIVNWRT-HLKFPEEAKL--SPEAKDLISK 395
LG + E+ PF + P+ IVN LK + S E KD I +
Sbjct: 189 LGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQ 248
Query: 396 LLCNVEQRLGTK--GADEIKAHPWFKGIE 422
L ++ T+ ++ HPW K
Sbjct: 249 CL----EKDPTRRPTPWDMLEHPWIKAQM 273
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 85/309 (27%), Positives = 142/309 (45%), Gaps = 57/309 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKL-KKSEMLRRGQVEHVKAERNLLAEVD 175
+ +E + +G GAFG+V + K TG + A K + KSE ++E E ++LA D
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCD 60
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIH 234
IVKL +F + L++++E+ GG + +++ + LTE + R +T+ A+ +H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
++ IHRD+K N+L +G +KL+DFG+ + +Q +D
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRD------------------ 161
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 349
S +GTP ++APEV++ + Y + D WSLG +
Sbjct: 162 ----------------------SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL-CNVEQRLGTKG 408
EM PP + PM KI + ++ S E KD + K L NV+ R T
Sbjct: 200 EMAQIEPPHHELNPMRVLLKIAKSEPP-TLAQPSRWSSEFKDFLKKCLEKNVDARWTTT- 257
Query: 409 ADEIKAHPW 417
++ HP+
Sbjct: 258 --QLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 68/252 (26%), Positives = 110/252 (43%), Gaps = 49/252 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ-VEHVKAERNLLAEVD 175
+DFE + IG G +G+V R TG + A+K +K L G+ V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMKDCK 64
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
+ IV + S+ + L++ ME+ GG + + L+E + + ET+ + +H
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+HRDIK N+LL NGH+KL+DFG+ + + + K F
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF------------------ 166
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 352
+GTP ++APEV K GY CD W++G E+
Sbjct: 167 -----------------------IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203
Query: 353 VGYPPFYSDEPM 364
PP + PM
Sbjct: 204 ELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 99/375 (26%), Positives = 150/375 (40%), Gaps = 115/375 (30%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN--------- 169
+E L +GKGA+G V ++ T V A+KK+ A RN
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------------FDAFRNATDAQRTFR 55
Query: 170 ---LLAEVDSNC--IVKLYCSF--QDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEA 219
L E+ + IVKL ++D+ +YL+ EY M T L +R + L +
Sbjct: 56 EIMFLQEL-GDHPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHK 109
Query: 220 RFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
R+ + + + A++ IH N IHRD+KP N+LL+ + +KL+DFGL + L +
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS---------EL 160
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 338
N + +D VA R W R APE+LL Y
Sbjct: 161 EENPENPVLTD--YVATR---------WYR----------------APEILLGSTRYTKG 193
Query: 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIV------------------------NWR 374
D WS+G I+ EML+G P F ++ KI+ +
Sbjct: 194 VDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLP 253
Query: 375 THLKFPEEAKL---SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK-----GIEWDK 425
+ + P + L S +A DL+ KLL N +RL + A E HP+ E
Sbjct: 254 SRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE---HPYVAQFHNPSDEPVL 310
Query: 426 LYQIKAAFIPEVNDE 440
Y I ++D
Sbjct: 311 PYPIT----IPLDDN 321
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 86/298 (28%), Positives = 128/298 (42%), Gaps = 63/298 (21%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL-AEV 174
+D +E + IGKG +G+V K G A+K L + E ++AE N+L A
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALS 72
Query: 175 DSNCIVKLYCSF-----QDDEYLYLIMEYLPGGDMMTL----LMRKDTLTEEEARFYVGE 225
D +VK Y + ++ + L+L++E GG + L L R + + E + + E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
++ ++ +H + IHRD+K +N+LL G +KL DFG+ L + L
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL------------- 179
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 340
+RN ++VGTP ++APEV+ L Y CD
Sbjct: 180 ----------------------RRN------TSVGTPFWMAPEVIACEQQLDSTYDARCD 211
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIV-NWRTHLKFPEEAKLSPEAKDLISKLL 397
WSLG E+ G PP PM KI N L PE S E D I K L
Sbjct: 212 VWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE--LWSNEFNDFIRKCL 267
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 90/399 (22%), Positives = 155/399 (38%), Gaps = 111/399 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ-VEHVKA---ERNLLA 172
D ++ L+ +G GA+G+V + TG A+KKL R Q H K E LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-----SRPFQSAIHAKRTYRELRLLK 69
Query: 173 EVDSNCIVKLYCSFQDDEYL------YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGET 226
+D ++ L F L YL+ L G D+ + ++ L+++ +F V +
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQI 127
Query: 227 VLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
+ ++ IH IHRD+KP N+ ++ + +K+ DFGL + D
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD------------------ 169
Query: 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLG 345
M Y V T Y APE++L Y D WS+G
Sbjct: 170 ------------------------DEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVG 203
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNW-----------------RTHLK-FPEEAK--- 384
IM E+L G F + + ++I+N R +++ P+ K
Sbjct: 204 CIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDF 263
Query: 385 ------LSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEV 437
+P A DL+ K+L + ++R+ A E AHP+ E
Sbjct: 264 KEVFSGANPLAIDLLEKMLVLDPDKRI---TAAEALAHPYLA----------------EY 304
Query: 438 NDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINF 476
+D D ++++ + W++++ + +NF
Sbjct: 305 HDPEDEPVAPPYDQSFESRDLTVDE--WKELVYKEIMNF 341
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 76/251 (30%), Positives = 104/251 (41%), Gaps = 53/251 (21%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEMLRRGQVEHVKAERNLLAEVDS 176
D+ + IG+G +G V R K TG + AMKK++ +SE G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDM-----MTLLMRKDTLTEEEARFYVGETVLAIE 231
IV L + LYLI E+L M + L + + E + Y+ + + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
H +HRD+KP NLL+D G +KL+DFGL + G
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-----------------------G 152
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYE 350
PV R E + W R APEVLL Y D WS+G I E
Sbjct: 153 IPV--RVYTHEVVTLWYR----------------APEVLLGSPRYSTPVDIWSIGTIFAE 194
Query: 351 MLVGYPPFYSD 361
M P F+ D
Sbjct: 195 MATKKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 81/332 (24%), Positives = 140/332 (42%), Gaps = 68/332 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEM------LRR--GQVE-HVKAERNL--LAE 173
+G+G +G+V + TG + A+KK+K E+ R+ G H R L + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+ I+ L + + +++ L+M+ + D+ ++ RK LTE + + + + + + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
HK ++HRD+ P N+ ++ G K++DFGL + P
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP----------------------P 173
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 352
+ ++ E + QR M S V T Y APE+L+ + Y D WS+G I E+L
Sbjct: 174 YSDTLSKDETM---QRREEMT--SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
Query: 353 VGYPPFYSDEPMSTCRKIV---------NWRTHLKFPEEAKLSPEAK------------- 390
G P F + + +I NW K P + +P
Sbjct: 229 TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDD 288
Query: 391 --DLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
DL+ LL N +R+ K A + H +FK
Sbjct: 289 AIDLLQSLLKLNPLERISAKEALK---HEYFK 317
|
Length = 335 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 68/253 (26%), Positives = 107/253 (42%), Gaps = 69/253 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-------KSEMLRRGQVEHVKAERN 169
DDFE L +G G G V + +G + A K + +++++R +V H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH------ 54
Query: 170 LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
E +S IV Y +F D + + ME++ GG + +L + + E +G+ +A
Sbjct: 55 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN----ILGKISIA 107
Query: 230 IES-----IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+ KH +HRD+KP N+L++ G +KL DFG +S
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG--------------------VS 147
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344
G L +A S VGT Y++PE L Y ++ D WSL
Sbjct: 148 GQLIDS-----------------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSL 184
Query: 345 GAIMYEMLVG-YP 356
G + EM +G YP
Sbjct: 185 GLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 70/280 (25%), Positives = 127/280 (45%), Gaps = 48/280 (17%)
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+ ++GKG++GEV + R + G Y +KKL RR + + + E LL+++ IV
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIVA 63
Query: 182 LYCSFQ-DDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKHNY 238
S++ +D LY++M + GGD+ L + L E + + + +A++ +H+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HRD+K N+ L R +K+ D G+ + L+
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE------------------------------ 153
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
N+ +A + +GTP Y++PE+ K Y + D W+LG +YEM F
Sbjct: 154 -----------NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202
Query: 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC 398
+ + S +I+ + P SPE +LI+ +L
Sbjct: 203 NAKDMNSLVYRIIEGKLP---PMPKDYSPELGELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 74/261 (28%), Positives = 109/261 (41%), Gaps = 61/261 (23%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN- 177
FE + ++G G +G+V R TG + A+K + +E + E +K E N+L + +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 178 CIVKLYCSF-------QDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVL 228
I Y +F DD+ L+L+ME+ G + L+ + + L E+ + E +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+ +H H IHRDIK N+LL N +KL DFG+ LD
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-------------------- 172
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 343
R V R T +GTP ++APEV+ Y D WS
Sbjct: 173 ---RTVGRRNT------------------FIGTPYWMAPEVIACDENPDATYDYRSDIWS 211
Query: 344 LGAIMYEMLVGYPPFYSDEPM 364
LG EM G PP PM
Sbjct: 212 LGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 90/339 (26%), Positives = 134/339 (39%), Gaps = 82/339 (24%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D +E + IG+G +G V R++ T A+KK++ E G E +LL E+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTE-----EEARFYVGETVLAIE 231
IV+L ++ LYL+ EYL + L D+ + + Y+ + + I
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 232 SIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
H H +HRD+KP NLL+DR +KL+DFGL +
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF----------------------- 153
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 349
G PV R E + W R APE+LL + Y D WS+G I
Sbjct: 154 GIPV--RTFTHEVVTLWYR----------------APEILLGSRHYSTPVDIWSVGCIFA 195
Query: 350 EMLVGYPPFYSDEPMSTCRKIVN---------WR----------THLKFPEE------AK 384
EM+ P F D + KI W K+P +
Sbjct: 196 EMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPT 255
Query: 385 LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422
L P DL+SK+L + +R+ + A E H +FK +
Sbjct: 256 LEPAGVDLLSKMLRLDPSKRITARAALE---HEYFKDLG 291
|
Length = 294 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 82/345 (23%), Positives = 136/345 (39%), Gaps = 91/345 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL-----L 171
++P+ IG GA+G V + +G A+KK+ + A+R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA------FDVPTLAKRTLRELKIL 58
Query: 172 AEVDSNCIVKLYCSFQ----DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETV 227
+ I+ + + D + +Y++M+ L D+ ++ LTEE R+++ + +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
++ IH N IHRD+KP NLL++ + +++ DFG+ + L S + K F
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF---------- 167
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 346
M Y V T Y APE+LL Y D WS+G
Sbjct: 168 -------------------------MTEY--VATRWYRAPELLLSLPEYTTAIDMWSVGC 200
Query: 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEA----------------------- 383
I EML F + + I+ + L P E
Sbjct: 201 IFAEMLGRRQLFPGKNYVHQLKLIL---SVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPV 257
Query: 384 -------KLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFKG 420
K SPEA DL+S++L + E+R+ ++ HP+
Sbjct: 258 PWSKIFPKASPEALDLLSQMLQFDPEERI---TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 74/260 (28%), Positives = 110/260 (42%), Gaps = 59/260 (22%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN- 177
FE + ++G G +G+V R TG + A+K + + + E +K E N+L + +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 178 CIVKLYCSFQD------DEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLA 229
I Y +F D+ L+L+ME+ G + L+ + +TL EE + E +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+ +H+H IHRDIK N+LL N +KL DFG+ LD
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--------------------- 162
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSL 344
R V R T +GTP ++APEV+ Y + D WSL
Sbjct: 163 --RTVGRRNT------------------FIGTPYWMAPEVIACDENPDATYDFKSDLWSL 202
Query: 345 GAIMYEMLVGYPPFYSDEPM 364
G EM G PP PM
Sbjct: 203 GITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 84/345 (24%), Positives = 140/345 (40%), Gaps = 120/345 (34%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-------- 176
IG+G F EV + + TG YA+K +K + + N L E+ +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK--------KHFKSLEQVNNLREIQALRRLSPHP 58
Query: 177 NCIVKLYCSFQDDEYLY--------LIMEYLPGGDM-MTLLM--RKDTLTEEEARFYVGE 225
N I++L E L+ L+ E + DM + L+ RK L E+ + Y+ +
Sbjct: 59 N-ILRL------IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYMYQ 108
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ +++ +H++ HRDIKP+N+L+ + +KL+DFG C+ +
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS---------------- 151
Query: 286 ALQSDGRP-----VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMEC 339
+P ++ R W R APE LL G YG +
Sbjct: 152 ------KPPYTEYISTR---------WYR----------------APECLLTDGYYGPKM 180
Query: 340 DWWSLGAIMYEMLVGYPPFY-SDE--------------PMSTCRKIVNWR-THLKFPEE- 382
D W++G + +E+L +P F ++E +K R + FP +
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKK 240
Query: 383 ----AKL----SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
KL S E DL+ KLL + ++R+ K A HP+F
Sbjct: 241 GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR---HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 60/270 (22%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
D +E + IGKG +G+V K G + A+K L E ++AE N+L +
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLP 76
Query: 176 SN-CIVKLYCSF-QDDEY----LYLIMEYLPGGDMMTL----LMRKDTLTEEEARFYVGE 225
++ +VK Y F + D+ L+L++E GG + L L+ L E + +
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+L ++ +H + IHRD+K +N+LL G +KL DFG+ L + L
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL------------- 183
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 340
+RN ++VGTP ++APEV+ Y CD
Sbjct: 184 ----------------------RRN------TSVGTPFWMAPEVIACEQQYDYSYDARCD 215
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKI 370
WSLG E+ G PP + P+ T KI
Sbjct: 216 VWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 66/251 (26%), Positives = 106/251 (42%), Gaps = 49/251 (19%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ-VEHVKAERNLLAEVDS 176
D+E + +G G +G+V R TG + A+K +K L G ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV + S+ E L++ MEY GG + + L+E + + ET+ + +H
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+HRDIK N+LL NG +KL+DFG+ + + + K F
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF------------------- 166
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGAIMYEMLV 353
+GTP ++APEV + GY CD W++G E+
Sbjct: 167 ----------------------IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE 204
Query: 354 GYPPFYSDEPM 364
PP + PM
Sbjct: 205 LQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 94/340 (27%), Positives = 138/340 (40%), Gaps = 84/340 (24%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-D 175
D +E L IG+G +G+V R+K TG + A+KK + EM G E +LL + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 176 SNCIVKLYCSFQDDE-----YLYLIMEYLPGGDM---MTLLMRKDT--LTEEEARFYVGE 225
S IV+L +E LYL+ EYL D+ M R L + + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+ + HKH +HRD+KP NLL+D+ G +K++D GL + FSI
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL----------GRAFSI----- 163
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWS 343
PV + E + W R APEVLL Y D WS
Sbjct: 164 --------PV--KSYTHEIVTLWYR----------------APEVLLGSTHYSTPVDIWS 197
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIV------------------NWRTHLKFPEE--- 382
+G I EM P F D + I +W ++ +
Sbjct: 198 VGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLS 257
Query: 383 ---AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
LSPE DL+ K+L + +R+ K A HP+F
Sbjct: 258 RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT---HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 55/241 (22%), Positives = 101/241 (41%), Gaps = 57/241 (23%)
Query: 125 IGKGAFGEVRVCR---EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+G+GAFGEV + + A+K LK+ + + E ++ ++ +V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVR 60
Query: 182 LY--CSFQDDEYLYLIMEYLPGGDMMTLL---------MRKDTLTEEEARFYVGETVLAI 230
L C+ ++E LYL++EY+ GGD++ L K TL+ ++ + + +
Sbjct: 61 LLGVCT--EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
E + ++HRD+ N L+ + +K+SDFGL + + + K
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-------------T 165
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
G + P R W M APE L + + D WS G +++E
Sbjct: 166 GGKL-PIR--------W-----M------------APESLKDGIFTSKSDVWSFGVLLWE 199
Query: 351 M 351
+
Sbjct: 200 I 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 86/330 (26%), Positives = 137/330 (41%), Gaps = 79/330 (23%)
Query: 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV 174
A+D + L IG+GAFG V K +G + A+K++ R V+ K ++ LL ++
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-------RSTVDE-KEQKRLLMDL 53
Query: 175 D-----SNC--IVKLYCSFQDDEYLYLIMEYLPGGDM------MTLLMRKDTLTEEEARF 221
D S+C IVK Y + + ++ ME + D+ + ++ EE
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELM---DISLDKFYKYVYEVLKSVIPEEILG 110
Query: 222 YVG-ETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
+ TV A+ + + IHRD+KP N+LLDRNG++KL DFG+ L S + +D
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD--- 167
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYG 336
G Y+APE + + GY
Sbjct: 168 ---------------------------------------AGCRPYMAPERIDPSARDGYD 188
Query: 337 MECDWWSLGAIMYEMLVG---YPPFYSDEPMSTCRKIVNWRT-HLKFPEEAKLSPEAKDL 392
+ D WSLG +YE+ G YP + + ++V L EE + SP +
Sbjct: 189 VRSDVWSLGITLYEVATGKFPYPKW--NSVFDQLTQVVKGDPPILSNSEEREFSPSFVNF 246
Query: 393 ISKLLCNVEQRLGTKGADEIKAHPWFKGIE 422
I+ LC ++ E+ HP+ K E
Sbjct: 247 IN--LCLIKDESKRPKYKELLEHPFIKDYE 274
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 69/251 (27%), Positives = 114/251 (45%), Gaps = 51/251 (20%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE---MLRRGQVEHVKAERNLLAE 173
+ +E L+ IG+G++G V CR + TG + A+KK +SE ++++ + ++ +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+ +V L F+ L+L+ EY + L + E + + +T+ A+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
HKHN IHRD+KP+N+L+ + G +KL DFG + L D+
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY---------------- 160
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 352
VA R W R APE+L+ YG D W++G + E+L
Sbjct: 161 VATR---------WYR----------------APELLVGDTQYGPPVDVWAIGCVFAELL 195
Query: 353 VGYP--PFYSD 361
G P P SD
Sbjct: 196 TGQPLWPGKSD 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 70/257 (27%), Positives = 112/257 (43%), Gaps = 48/257 (18%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEM--LRRGQVEHVKAERNLLAEVDSNCIVKL 182
+GKG+FG V + ++K +K LK+ + L + E LL+++D IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 183 YCSFQDDEYLYLIMEYLPGGDM----MTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
+ SF + + +I EY G D+ L TL+E + + + +L + +H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HRD+K N+ L +N +K+ DFG+ + +GS D
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSR-----------LLMGS-------CD-------- 160
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
LA + GTP Y++PE L +GY + D WSLG I+YEM F
Sbjct: 161 ---------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205
Query: 359 YSDEPMSTCRKIVNWRT 375
+S +IV T
Sbjct: 206 EGQNFLSVVLRIVEGPT 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-18
Identities = 69/222 (31%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 142 GHVYAMKKLKKSEMLR-RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLP 200
G K + K ML Q + ++E + LA D IVK + F+ D+ L LIMEY
Sbjct: 89 GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148
Query: 201 GGDMMTLLMR--KDTL--TEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHM 256
GGD+ + + K+ L E E + VLA++ +H +HRD+K N+ L G +
Sbjct: 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGII 208
Query: 257 KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAY 316
KL DFG K S ++ D +A
Sbjct: 209 KLGDFGFSK----------------QYSDSVSLD-----------------------VAS 229
Query: 317 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
S GTP Y+APE+ +K Y + D WSLG I+YE+L + PF
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 70/250 (28%), Positives = 102/250 (40%), Gaps = 48/250 (19%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F L IG G+FG V R+ T V A+KK+ S + + + E L ++
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
++ + + +L+MEY G L + K L E E + + +H H
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRDIK N+LL G +KL+DFG S +L V+P
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFG---------------------SASL------VSP-- 167
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 355
A S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 168 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 356 PPFYSDEPMS 365
PP ++ MS
Sbjct: 212 PPLFNMNAMS 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 86/336 (25%), Positives = 130/336 (38%), Gaps = 89/336 (26%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK--------KSEMLRRGQVEHVKAERNL 170
+E L IG+G +G V + + T + A+K+++ S LR E L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EICL 52
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAI 230
L E+ IV+LY D+ L L+ EY + E + ++ + + +
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
H HN +HRD+KP NLL+++NG +KL+DFGL +
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF----------------------- 149
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 349
G PV R E + W R P+VL K Y D WS G I
Sbjct: 150 GIPV--RCYSAEVVTLWYR----------------PPDVLFGAKLYSTSIDMWSAGCIFA 191
Query: 350 EML-VGYPPFYSDEPMSTCRKIV---------NWRTHLKFPEE----------------A 383
E+ G P F ++ ++I +W K P+
Sbjct: 192 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVP 251
Query: 384 KLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWF 418
KL+ +DL+ LL CN QR+ A+E HP+F
Sbjct: 252 KLNSTGRDLLQNLLVCNPVQRI---SAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 84/347 (24%), Positives = 141/347 (40%), Gaps = 101/347 (29%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKK-------------LKKSEMLRRGQVE 162
++ L+ IG+GA+G V K TG A+KK L++ ++LRR + E
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
++ +++ + SF D +Y++ E + D+ L+ + L+ + +++
Sbjct: 64 NIIGILDIIRPPS-------FESFND---VYIVQELMET-DLYKLI-KTQHLSNDHIQYF 111
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ + + ++ IH N +HRD+KP NLLL+ N +K+ DFGL +
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR----------------- 154
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 341
+ D + Y V T Y APE++L KGY D
Sbjct: 155 -IADPEHDH------------------TGFLTEY--VATRWYRAPEIMLNSKGYTKAIDI 193
Query: 342 WSLGAIMYEMLVGYPPF----YSDEPMS-------------TCRKIVNWRTHLK------ 378
WS+G I+ EML P F Y + C + R ++K
Sbjct: 194 WSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKP 253
Query: 379 -------FPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417
FP P+A DL+ K+L N +R+ +E AHP+
Sbjct: 254 KVPWNKLFP---NADPKALDLLDKMLTFNPHKRI---TVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 83/331 (25%), Positives = 127/331 (38%), Gaps = 79/331 (23%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEMLRRGQVEHVKAERNLLAEVDSN 177
F+ L +G+G + V R + TG + A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDM---MTLLMRKDTLTEEEARFYVGETVLAIESIH 234
IV+L+ + L L+ EY+ D+ M + L + + + + I H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
++ +HRD+KP NLL+++ G +KL+DFGL + G PV
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAF-----------------------GIPV 154
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 353
E + W R AP+VLL + Y D WS+G IM EM+
Sbjct: 155 --NTFSNEVVTLWYR----------------APDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
Query: 354 GYPPFYSDEPMSTCRKIVN---------WRTHLKFPEEAKLSPEAK-------------- 390
G P F KI W + PE P
Sbjct: 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPL 256
Query: 391 --DLISKLL-CNVEQRLGTKGADEIKAHPWF 418
DL+ +LL N E R+ A + HPWF
Sbjct: 257 GIDLLHRLLQLNPELRI---SAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 83/344 (24%), Positives = 138/344 (40%), Gaps = 84/344 (24%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
K D F+ + IG+G +G+V R+K TG + A+KK++ + + G E +L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILR 61
Query: 173 EVDSNCIVKLYCSFQDD----------EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARF 221
+++ IV L D YL+ EY+ D+M LL +E+ +
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKS 120
Query: 222 YVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
++ + + + HK N++HRDIK N+LL+ G +KL+DFGL + L +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR------LYNSE----- 169
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECD 340
+ RP + V T Y PE+LL ++ YG D
Sbjct: 170 --------ESRPYTNK---------------------VITLWYRPPELLLGEERYGPAID 200
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKI---------VNWRTHLKFP----------- 380
WS G I+ E+ P F +++ ++ I W +K P
Sbjct: 201 VWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQY 260
Query: 381 ------EEAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPW 417
E + + A DL+ +L + +R A+E PW
Sbjct: 261 RRRLREEFSFIPTPALDLLDHMLTLDPSKRC---TAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 68/253 (26%), Positives = 109/253 (43%), Gaps = 69/253 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-------KSEMLRRGQVEHVKAERN 169
DDFE ++ +G G G V + K +G + A K + +++++R QV H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ 58
Query: 170 LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
E +S IV Y +F D + + ME++ GG + +L + EE +G+ +A
Sbjct: 59 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE----ILGKVSIA 111
Query: 230 IES-----IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+ KH +HRD+KP N+L++ G +KL DFG +S
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG--------------------VS 151
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344
G L +A S VGT Y++PE L Y ++ D WS+
Sbjct: 152 GQLIDS-----------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 345 GAIMYEMLVG-YP 356
G + E+ +G YP
Sbjct: 189 GLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 70/253 (27%), Positives = 106/253 (41%), Gaps = 55/253 (21%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN--LLAEV 174
+E L IG+G FGEV R K T + A+KK+ M + + A R +L +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLL 68
Query: 175 DSNCIVKLY--CSFQDDEY------LYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGE 225
+V L C + Y YL+ E+ D+ LL K+ T E + +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ + IH++ +HRD+K N+L+ ++G +KL+DFGL + FS+ N
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA----------FSLSKNS-- 175
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWS 343
+ NR Y+ V T Y PE+LL ++ YG D W
Sbjct: 176 ----------------------KPNR----YTNRVVTLWYRPPELLLGERDYGPPIDMWG 209
Query: 344 LGAIMYEMLVGYP 356
G IM EM P
Sbjct: 210 AGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 69/301 (22%), Positives = 121/301 (40%), Gaps = 73/301 (24%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKL---KKSEMLRRGQVEHVKAERNLLA 172
+D E ++ +G G G V + TG V A K + KS + ++ + E ++
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMH 58
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES 232
E S IV Y +F ++ + + ME++ G + + + + E +G+ +A+
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE----ILGKIAVAVVE 114
Query: 233 -----IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+ H +HRDIKP N+L++ G +KL DFG +SG L
Sbjct: 115 GLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG--------------------VSGEL 154
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
+ +A + VGT Y++PE + Y ++ D WSLG
Sbjct: 155 INS-----------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 348 MYEMLVGYPPF--------YSDEPMST---CRKIVNWRTHLKFPEEAKLSPEAKDLISKL 396
+ E+ +G PF D+PM ++IV + P + +D +
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRLPSS-DFPEDLRDFVDAC 249
Query: 397 L 397
L
Sbjct: 250 L 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-17
Identities = 77/290 (26%), Positives = 121/290 (41%), Gaps = 59/290 (20%)
Query: 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKL 182
++G GA G V + + G +A+K + E + +AE L D IVK
Sbjct: 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 183 YCSF-----QDDE---YLYLIMEYLPGGDMMTLLMRKD----TLTEEEARFYVGETVLAI 230
+ F ++ E + L+++Y GD+ + + T E EA + +LA+
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
+H + IHRDIK N+LL NG +KL DFG K + A SD
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-----------------MYAATVSD 199
Query: 291 --GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
GR + GTP Y+APE+ +K Y + D +SLG ++
Sbjct: 200 DVGR------------------------TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLL 235
Query: 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC 398
YE+L PF + K + R P +SPE +++++ LL
Sbjct: 236 YELLTLKRPFDGENMEEVMHKTLAGRYD---PLPPSISPEMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 65/246 (26%), Positives = 104/246 (42%), Gaps = 49/246 (19%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
+FE L IG+G +G V R+ +G + A+KK++ + R G E LL +
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNLRHP 66
Query: 178 CIVKLYCSFQDD--EYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESI 233
IV+L + ++L+MEY D+ +LL M +E + + + + + ++ +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYL 124
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H++ IHRD+K NLLL G +K++DFGL + G P
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY-----------------------GLP 161
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 352
P V T Y APE+LL Y D W++G I+ E+L
Sbjct: 162 AKPMT------------------PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
Query: 353 VGYPPF 358
P
Sbjct: 204 AHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 91/337 (27%), Positives = 136/337 (40%), Gaps = 96/337 (28%)
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKK---SEML-RRGQVE-----HVKAERNLLA 172
L +G GA+G V +K TG A+KKL + SE+ +R E H++ E N++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-NVIG 78
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAI 230
+D FQD YL+M Y M T L + L+E++ ++ V + + +
Sbjct: 79 LLDVFTSAVSGDEFQD---FYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
+ IH IHRD+KP NL ++ + +K+ DFGL + D
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--------------------- 169
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349
M Y V T Y APEV+L Y D WS+G IM
Sbjct: 170 ---------------------EMTGY--VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTH---------------------LKFPEE------ 382
EML G F + + +I+ K+P +
Sbjct: 207 EMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF 266
Query: 383 AKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWF 418
K SP+A DL+ K+L +V++RL A E HP+F
Sbjct: 267 PKASPQAVDLLEKMLELDVDKRL---TATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 53/238 (22%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKK---SEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+G GAFG V R++ TG A+KK+ K + +L + +K ++L E + +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE-NIISLSD 76
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
++ S +D +Y + E L G D+ LL + L ++ ++++ + + ++ +H +HR
Sbjct: 77 IFISPLED--IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHR 132
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
D+KP N+L++ N +K+ DFGL + D
Sbjct: 133 DLKPSNILINENCDLKICDFGLARIQD--------------------------------- 159
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPF 358
+M Y V T Y APE++L + Y +E D WS G I EML G P F
Sbjct: 160 ---------PQMTGY--VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 67/253 (26%), Positives = 108/253 (42%), Gaps = 68/253 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-------KSEMLRRGQVEHVKAERN 169
DDFE ++ +G G G V K +G + A K + +++++R QV H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ 58
Query: 170 LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
E +S IV Y +F D + + ME++ GG + +L + + E+ +G+ +A
Sbjct: 59 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----ILGKVSIA 111
Query: 230 IES-----IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+ KH +HRD+KP N+L++ G +KL DFG +S
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG--------------------VS 151
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344
G L +A S VGT Y++PE L Y ++ D WS+
Sbjct: 152 GQLIDS-----------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 345 GAIMYEMLVGYPP 357
G + EM +G P
Sbjct: 189 GLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-16
Identities = 87/341 (25%), Positives = 139/341 (40%), Gaps = 91/341 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK---SEMLRRGQVEHVKAERNLLAE 173
D + L +G GA+G V ++ TG A+KKL + SE+ + E LL
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK----RAYRELRLLKH 70
Query: 174 VDSNCIVKLYCSFQDDEYL------YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETV 227
+ ++ L F D L YL+M ++ G + LM+ + L+E+ +F V + +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
++ IH IHRD+KP NL ++ + +K+ DFGL +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------------------- 166
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 346
Q + M Y V T Y APEV+L Y D WS+G
Sbjct: 167 --------------------QTDSEMTGY--VVTRWYRAPEVILNWMHYTQTVDIWSVGC 204
Query: 347 IMYEMLVGYPPFYSDEPMSTCRKIV-----------------NWRTHLK-FPEEAK---- 384
IM EML G P F + + +I+ + + ++K P K
Sbjct: 205 IMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR 264
Query: 385 -----LSPEAKDLISK-LLCNVEQRLGTKGADEIKAHPWFK 419
+P A +++ K L+ + E R+ A E AHP+F+
Sbjct: 265 SLLPNANPLAVNVLEKMLVLDAESRI---TAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 53/282 (18%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK----SEMLRRGQVEHVKAERNLLAEV 174
++ + +IGKG GEV + + A+KK+++ + +L++ + K + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAK----IAADL 59
Query: 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM---RKDTLTEEEARFYVGETVLA-- 229
IV +Y D + +Y M Y+ G + +LL +K++L++E A +V A
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA---EKTSVGAFL 116
Query: 230 ---------IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
IE +H +HRD+KPDN+LL G + + D+G E++ +
Sbjct: 117 SIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI----FKKLEEEDLLD 172
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340
++ P + VGTPDY+APE LL D
Sbjct: 173 IDVDERNICYSSMTIPGK-------------------IVGTPDYMAPERLLGVPASESTD 213
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE 382
++LG I+Y+ML P+ + RKI +R + P E
Sbjct: 214 IYALGVILYQMLTLSFPYRRKKG----RKIS-YRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 70/255 (27%), Positives = 101/255 (39%), Gaps = 48/255 (18%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F L IG G+FG V R+ T V A+KK+ S + + + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
++ + + +L+MEY G L + K L E E + + +H HN
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRDIK N+LL G +KL+DFG S ++ S
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG---------------------SASIASP-------- 177
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 355
A S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 178 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
Query: 356 PPFYSDEPMSTCRKI 370
PP ++ MS I
Sbjct: 222 PPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 79/270 (29%), Positives = 113/270 (41%), Gaps = 80/270 (29%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
Q++ +D E L IG G G+V R K TGHV A+K+ M R G E K
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQ-----MRRTGNKEENK---R 59
Query: 170 LLAEVD-----SNC--IVKLYCSFQDDEYLYLIMEYLPGGDMMT----LLMRKDTLTEEE 218
+L ++D +C IVK Y F D +++ ME M T LL R E
Sbjct: 60 ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL-----MSTCLDKLLKRIQGPIPE- 113
Query: 219 ARFYVGE-TVLAIESIH----KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273
+G+ TV ++++H KH IHRD+KP N+LLD +G++KL DFG+
Sbjct: 114 --DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI---------- 161
Query: 274 EKDFSIGSNLSGALQSDGRPVAPR-RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-- 330
GR V + +T+ G Y+APE +
Sbjct: 162 ----------------SGRLVDSKAKTRS-----------------AGCAAYMAPERIDP 188
Query: 331 --LKKGYGMECDWWSLGAIMYEMLVGYPPF 358
Y + D WSLG + E+ G P+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 77/297 (25%), Positives = 123/297 (41%), Gaps = 78/297 (26%)
Query: 121 PLTMIGKGAFGEVRVCREKATGHVYAMKK--------------LKKSEMLRRGQVEHVKA 166
P+ IG+GA+G V + T A+KK L++ ++LR H+
Sbjct: 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR-----HLDH 63
Query: 167 ERNLLAEVDSNCIVKLYC--SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVG 224
E N++A D I+ +F D +Y++ E L D+ ++ TL+++ ++++
Sbjct: 64 E-NVIAIKD---IMPPPHREAFND---VYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLY 115
Query: 225 ETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+ + ++ IH N +HRD+KP NLLL+ N +K+ DFGL
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-------------------- 155
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 343
RT E+ M Y V T Y APE+LL Y D WS
Sbjct: 156 -------------RTTSEKGDF------MTEY--VVTRWYRAPELLLNCSEYTTAIDVWS 194
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKL----SPEAKDLISKL 396
+G I E+L P F + + + I L P E L + +A+ I L
Sbjct: 195 VGCIFAELLGRKPLFPGKDYVHQLKLITEL---LGSPSEEDLGFIRNEKARRYIRSL 248
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 88/322 (27%), Positives = 135/322 (41%), Gaps = 76/322 (23%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD- 175
DD E + +G+GA+G V R TG + A+K++ R V + +R LL ++D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVNSQEQKR-LLMDLDI 52
Query: 176 ----SNC--IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-------MRKDTLTEEE--AR 220
+C V Y + + +++ ME M T L K E+ +
Sbjct: 53 SMRSVDCPYTVTFYGALFREGDVWICMEV-----MDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 221 FYVGETVLAIESIH-KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
V V A+E +H K + IHRD+KP N+L++RNG +KL DFG+ L + K
Sbjct: 108 IAVS-IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDA 164
Query: 280 GSNLSGALQSDGRP-VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME 338
G +P +AP R E Q KGY ++
Sbjct: 165 GC----------KPYMAPERINPELNQ---------------------------KGYDVK 187
Query: 339 CDWWSLGAIMYEMLVGYPPFYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL 397
D WSLG M E+ G P+ S P +++V + P E K SPE +D ++K L
Sbjct: 188 SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAE-KFSPEFQDFVNKCL 245
Query: 398 CNVEQRLGTKGADEIKAHPWFK 419
+ E+ HP+F+
Sbjct: 246 KKNYKERPN--YPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 67/255 (26%), Positives = 98/255 (38%), Gaps = 48/255 (18%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
++ + + +L+MEY G L + K L E E + + +H HN
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRD+K N+LL G +KL DFG +AP
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG---------------------------SASIMAP-- 167
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 355
A VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 168 ----------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 356 PPFYSDEPMSTCRKI 370
PP ++ MS I
Sbjct: 212 PPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 69/255 (27%), Positives = 99/255 (38%), Gaps = 48/255 (18%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F L IG G+FG V T V A+KK+ S + + + E L ++
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
++ + + +L+MEY G L + K L E E + + +H HN
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRDIK N+LL G +KL+DFG S + S
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFG---------------------SASKSSP-------- 173
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 355
A S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 174 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217
Query: 356 PPFYSDEPMSTCRKI 370
PP ++ MS I
Sbjct: 218 PPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IGKG FG+V K V A+K + L E +L + D IVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDI 243
+ +Y++ME +PGG ++T L + K+ LT ++ + +E + N IHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 244 KPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQ 303
N L+ N +K+SDFG+ + E++ I + SDG P +
Sbjct: 120 AARNCLVGENNVLKISDFGMSR--------EEEGGIYT------VSDGLKQIPIK----- 160
Query: 304 LQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
+ APE L Y E D WS G +++E
Sbjct: 161 --------------------WTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 77/311 (24%), Positives = 121/311 (38%), Gaps = 68/311 (21%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK---KSEMLRRGQVEHVKAERNLLAEVD 175
+EP+ IG GA+G V R+ +GH A+K ++ + L V V + L D
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL-EAFD 60
Query: 176 SNCIVKLY----CSFQDDEY-LYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVL 228
IV+L S D E + L+ E++ D+ T L + L E + + + +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
++ +H + +HRD+KP+N+L+ G +KL+DFGL + C
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC------------------- 160
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
+M V T Y APEVLL+ Y D WS+G I
Sbjct: 161 -----------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197
Query: 349 YEMLVGYPPFYSDEPMSTCRKIVN---------WRTHLKFPEEAKLSPEAKDLISKLLCN 399
EM P F + KI + W + P A SP + ++
Sbjct: 198 AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA-FSPRGPRPVQSVVPE 256
Query: 400 VEQRLGTKGAD 410
+E+ GA
Sbjct: 257 IEE----SGAQ 263
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 79/319 (24%), Positives = 127/319 (39%), Gaps = 84/319 (26%)
Query: 119 FEPLTMIGKGAFGEVRVCREKAT--GHVYAMKKL----KKSEMLRRGQVE-----HVKAE 167
+E + +G+GA+G V R T A+KK+ K + +R E H +
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 168 RNLLAEVDSNCIVKLYCSFQDDEYLYL-IMEYLPGGDMMTLLMRKDTLTEEEARFYVGET 226
+N+ D + IV +F ++ YLY +ME D+ ++ LT+ + ++ +
Sbjct: 62 KNITCLYDMD-IV-FPGNF-NELYLYEELMEA----DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 227 VLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
+ ++ IH N +HRD+KP NLL++ + +K+ DFGL + FS
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLA----------RGFSEN------ 158
Query: 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 345
E M Y V T Y APE++L + Y D WS+G
Sbjct: 159 -------------PGENAGF------MTEY--VATRWYRAPEIMLSFQSYTKAIDVWSVG 197
Query: 346 AIMYEMLVGYPPF----YSDE-----------PMSTCRKI-----VNWRTHLKFPEEAKL 385
I+ E+L P F Y D+ T +I N+ L +
Sbjct: 198 CILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF 257
Query: 386 -------SPEAKDLISKLL 397
+P A DL+ KLL
Sbjct: 258 ESIFPNANPLALDLLEKLL 276
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 65/304 (21%)
Query: 119 FEPLTMIGKGAFGEVRVCRE-KATGHVYAMKKLK---KSEMLRRGQVEHVKAERNLLAEV 174
+E + IG+GA+G+V R+ K G A+K+++ E + + V R+L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 175 DSNCIVKLY----CSFQDDEY-LYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETV 227
N +V+L+ S D E L L+ E++ D+ T L + + + E + + + +
Sbjct: 63 HPN-VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
++ +H H +HRD+KP N+L+ +G +KL+DFGL +
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---------------------- 158
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
+ +Q M S V T Y APEVLL+ Y D WS+G I
Sbjct: 159 ----------------IYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIV---------NWRTHLKFPEEAKLSPEAKDLISKLLC 398
EM P F + KI+ +W + P +A ++ I K +
Sbjct: 199 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA-FHSKSAQPIEKFVT 257
Query: 399 NVEQ 402
++++
Sbjct: 258 DIDE 261
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 58/242 (23%)
Query: 122 LTMIGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
+ +GKG FG V +CR + TG V A+KKL+ S + + E +L + +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 178 CIVKL--YCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIH 234
IVK C L L+MEYLP G + L + ++ L + Y + +E +
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
Y+HRD+ N+L++ +K+ DFGL K L Q+K+
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP----QDKE------------------ 163
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPD-----YIAPEVLLKKGYGMECDWWSLGAIMY 349
Y V P + APE L + + + D WS G ++Y
Sbjct: 164 ---------------------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
Query: 350 EM 351
E+
Sbjct: 203 EL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 68/269 (25%), Positives = 101/269 (37%), Gaps = 55/269 (20%)
Query: 122 LTMIGKGAFGEVRVCR----EKATGHVYAMKKLKKS--EMLRRGQVEHVKAERNLLAEVD 175
+ +G+G FG+V +CR TG A+K L S E R + E +L +D
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD----FEREIEILRTLD 64
Query: 176 SNCIVKL-YCSFQDDEY-LYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIES 232
IVK + L LIMEYLP G + L R +D + + + + ++
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+ YIHRD+ N+L++ +K+SDFGL K L ++KD+
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP----EDKDYYYVKEP------GES 174
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
P+ W Y APE L + D WS G +YE+
Sbjct: 175 PI-----------FW--------Y---------APECLRTSKFSSASDVWSFGVTLYELF 206
Query: 353 VGYPPFYSDEP----MSTCRKIVNWRTHL 377
P S M + T L
Sbjct: 207 TYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 49/149 (32%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 125 IGKGAFGEVRVCR----EKATGHVYAMKKLKK--SEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+G FG+V + TG + A+K LK+ + G K E N+L +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGW----KKEINILKTLYHEN 67
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IVK CS Q + L LIMEY+P G + L K L + + + + +H
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+YIHRD+ N+LLD + +K+ DFGL K
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 49/254 (19%)
Query: 125 IGKGAFGEVRVCREKA----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+G+G FG+V +CR TG A+K LK + +K E +L + IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 181 KL--YCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHN 237
K C+ + LIME+LP G + L R K+ + ++ Y + ++ +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
Y+HRD+ N+L++ +K+ DFGL K ++ ++ +++ +L PV
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDLDS-------PVF-- 177
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
+ APE L++ + + D WS G +YE+L
Sbjct: 178 --------------------------WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211
Query: 358 FYSDEPMSTCRKIV 371
S PM+ K++
Sbjct: 212 ESS--PMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 80/340 (23%), Positives = 139/340 (40%), Gaps = 91/340 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK---------KSEMLRRGQVEHVKAE 167
+ ++ L+ +G GA+G V + TG A+KKL K ++H+K E
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 168 RNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETV 227
N++ +D + F D +YL+ +L G D+ ++ + LT++ +F + + +
Sbjct: 77 -NVIGLLDVFTPARSLEEFND---VYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQIL 130
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
++ IH + IHRD+KP NL ++ + +K+ DFGL
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----------------------- 167
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 346
R T E M Y V T Y APE++L Y D WS+G
Sbjct: 168 ---------RHTDDE----------MTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 347 IMYEMLVGYPPFYSDEPMSTCRKIVNW-----------------RTHLK-FPEEAKL--- 385
IM E+L G F + + + I+ R +++ + K+
Sbjct: 207 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 266
Query: 386 ------SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
+P A DL+ K+L + ++R+ A + AH +F
Sbjct: 267 NVFIGANPLAVDLLEKMLVLDSDKRI---TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 62/256 (24%), Positives = 102/256 (39%), Gaps = 62/256 (24%)
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKA-------ERNLLAEV 174
L +G+G + V R K T ++ A+K+++ +EH + E +LL +
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIR---------LEHEEGAPCTAIREVSLLKNL 60
Query: 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
IV L+ + L L+ EYL L + ++ + ++ + + + H
Sbjct: 61 KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
K +HRD+KP NLL++ G +KL+DFGL + + V
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLAR-------------------------AKSV 155
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 353
+ E + W R P+VLL Y D W +G I+YEM
Sbjct: 156 PTKTYSNEVVTLWYR----------------PPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
Query: 354 GYPPFYSDEPMSTCRK 369
G P F P ST ++
Sbjct: 200 GRPMF----PGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 64/273 (23%), Positives = 110/273 (40%), Gaps = 72/273 (26%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
D EP IG GAFG V + G A+KK+ +++ + + + E+
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFREL--- 50
Query: 178 CIVKLYCSFQDD-----------------EYLYLIMEYLPGGDMMTLLMRKDTLTEEEAR 220
K+ C F+ D E +Y++ E L D+ +++ L+ + +
Sbjct: 51 ---KMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQPLSSDHVK 106
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
++ + + ++ +H +HRDIKP NLL++ N +K+ DFGL + ++E D S
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR------VEEPDES-- 158
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMEC 339
+ QE V T Y APE+L+ + Y
Sbjct: 159 ----------------KHMTQE----------------VVTQYYRAPEILMGSRHYTSAV 186
Query: 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVN 372
D WS+G I E+L F + P+ I +
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 60/244 (24%), Positives = 94/244 (38%), Gaps = 44/244 (18%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
AD +E L +G+G++ V + K G + A+K ++ E G E +LL +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLK 61
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
IV L+ E L L+ EY+ + L E + ++ + + + IH+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+HRD+KP NLL+ G +KL+DFGL + + V
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR-------------------------AKSVP 156
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC-DWWSLGAIMYEMLVG 354
E + W R P+VLL C D W +G I EM+ G
Sbjct: 157 SHTYSNEVVTLWYR----------------PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
Query: 355 YPPF 358
F
Sbjct: 201 VAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 56/238 (23%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
L +G+G + V R K T ++ A+K+++ G E +LL ++ IV
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
L+ D+ L L+ EYL + + ++ + ++ + + + H+ +HR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
D+KP NLL++ G +KL+DFGL + + V +
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR-------------------------AKSVPTKTYSN 163
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPF 358
E + W R P+VLL Y + D W +G I +EM G P F
Sbjct: 164 EVVTLWYR----------------PPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 75/326 (23%), Positives = 127/326 (38%), Gaps = 76/326 (23%)
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
L +G+G + V R K T ++ A+K+++ G E +LL ++ IV
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
L+ ++ L L+ EYL L +++ + ++ + + + H+ +HR
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
D+KP NLL++ G +KL+DFGL + + + +
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR-------------------------AKSIPTKTYSN 163
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
E + W R P++LL Y + D W +G I YEM G P F
Sbjct: 164 EVVTLWYR----------------PPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207
Query: 361 ---DEPMSTCRKIVNWRTHLKFP-----EE------------------AKLSPEAKDLIS 394
+E + +I+ T +P EE +L + +L+S
Sbjct: 208 STVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLS 267
Query: 395 KLLCNVEQRLGTK--GADEIKAHPWF 418
KLL Q G K A+E HP+F
Sbjct: 268 KLL----QFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 1e-11
Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 49/262 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+++E + IG G FGEV + + K T + K + + R + + V E N++ E+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELKH 71
Query: 177 NCIVKLYCSF--QDDEYLYLIMEYLPGGDMMTLLMRKDTL---TEEEARFYVGETVL-AI 230
IV+ F + ++ LY++ME+ GD+ + + + EE A + +L A+
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 231 ESIHK-------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
H +HRD+KP N+ L IG
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR----------------------HIGKIT 169
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRM----LAYSTVGTPDYIAPEVLL--KKGYGM 337
+ A +GRP+A ++ + ++ + +A+S VGTP Y +PE+LL K Y
Sbjct: 170 AQANNLNGRPIA-------KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD 222
Query: 338 ECDWWSLGAIMYEMLVGYPPFY 359
+ D W+LG I+YE+ G PF+
Sbjct: 223 KSDMWALGCIIYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 62/252 (24%), Positives = 107/252 (42%), Gaps = 64/252 (25%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKL--KKSEMLRRGQVEHVKAERNLLAEVD 175
+ E + IG GA G V + TG +YA+K + + +RR + E +L +V+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEILRDVN 130
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
+VK + F + + +++E++ GG + + + + AR + + I +H+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHR 186
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFG----LCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
+ +HRDIKP NLL++ ++K++DFG L + +D N
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN-------------------- 226
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL---LKKGY--GMECDWWSLGA 346
S+VGT Y++PE + L G G D WSLG
Sbjct: 227 -------------------------SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV 261
Query: 347 IMYEMLVGYPPF 358
+ E +G PF
Sbjct: 262 SILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 62/240 (25%), Positives = 101/240 (42%), Gaps = 51/240 (21%)
Query: 124 MIGKGAFGEVR--VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
++GKG FGEV ++K V K+ E+ + +E +L + D IVK
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYI 239
L + +Y++ME +PGGD ++ L +K + T++ +F + + + + N I
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCI 115
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
HRD+ N L+ N +K+SDFG+ + QE D G S G P +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-------QEDD--------GIYSSSGLKQIPIK- 159
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 358
+ APE L Y E D WS G +++E +G P+
Sbjct: 160 ------------------------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 84/347 (24%), Positives = 135/347 (38%), Gaps = 96/347 (27%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
++ +IGKG++G V + TG A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLR 54
Query: 179 IVK-----------LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETV 227
+++ L S ++ + +Y++ E L D+ ++ D LT E +F++ + +
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLL 113
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
A++ IH N HRD+KP N+L + + +K+ DFGL + + +
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-----------AFNDTPTAIF 162
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEV---LLKKGYGMECDWWSL 344
+D VA R W R APE+ K Y D WS+
Sbjct: 163 WTD--YVATR---------WYR----------------APELCGSFFSK-YTPAIDIWSI 194
Query: 345 GAIMYEMLVGYPPF---------------YSDEPMSTCRKIVN--WRTHL---------- 377
G I E+L G P F T ++ N R +L
Sbjct: 195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254
Query: 378 ---KFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGI 421
KFP P A L+ +LL + T A+E A P+FKG+
Sbjct: 255 FSQKFP---NADPLALRLLERLLAFDPKDRPT--AEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 48/234 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-------SN 177
IGKG FG+V + + G A+K LK + A + LAE N
Sbjct: 14 IGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAEASVMTTLRHPN 61
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHK 235
+ L Q + LY++ EY+ G ++ L + +T + + + +E + +
Sbjct: 62 LVQLLGVVLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGL----CKPLDCSN----------LQEKDFSIGS 281
N++HRD+ N+L+ + K+SDFGL + D L+EK FS S
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 282 N------LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEV 329
+ L + S GR PR ++ + H ++ RM A P+ PEV
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA------PEGCPPEV 228
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 39/146 (26%), Positives = 72/146 (49%), Gaps = 6/146 (4%)
Query: 125 IGKGAFGEVR--VCREKATGHV-YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+G G FG V V K+ V A+K LK+ + + E +++A++D CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVR 60
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
L + E L L+ME P G ++ L ++ + + + + + + + +++HR
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 242 DIKPDNLLLDRNGHMKLSDFGLCKPL 267
D+ N+LL K+SDFG+ + L
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 55/220 (25%), Positives = 82/220 (37%), Gaps = 38/220 (17%)
Query: 141 TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ-DDEYLYLIMEYL 199
TGH A+K L+ Q + E L A + IV L S + L+ + EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 200 PGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HM 256
PG + +L L E + + + A+ H +HRD+KP N+++ + G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 257 KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAY 316
K+ DFG IG+ L G +D
Sbjct: 122 KVLDFG----------------IGTLLPGVRDAD------------------VATLTRTT 147
Query: 317 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
+GTP Y APE L + D ++ G I E L G
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 53/243 (21%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMK--KLKKSEMLRRGQVEHVKAERNLLAEVD 175
D + ++G G G V T + A+K L + L++ + +E +L + D
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCD 57
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
S I+ Y +F + + + E++ GG +L + + R V V + +
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGG---SLDVYRKIPEHVLGRIAVA-VVKGLTYLWS 113
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+HRD+KP N+L++ G +KL DFG+ L S
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------------------------- 148
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
+A + VGT Y+APE + + YG+ D WSLG E+ +G
Sbjct: 149 ------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
Query: 356 PPF 358
P+
Sbjct: 191 FPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 63/263 (23%), Positives = 111/263 (42%), Gaps = 60/263 (22%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM----LRRGQVE-----HVKAERN 169
++ LT +G GA+G V + A+KKL + RR E H+K E N
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE-N 75
Query: 170 LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
++ +D + S ++ +YL+ L G D+ ++ + L++E +F + + +
Sbjct: 76 VIGLLD---VFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRG 130
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
++ IH IHRD+KP N+ ++ + +++ DFGL +
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------ 166
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348
Q + M Y V T Y APE++L Y D WS+G IM
Sbjct: 167 ------------------QADDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206
Query: 349 YEMLVGYPPFYSDEPMSTCRKIV 371
E+L G F ++ + ++I+
Sbjct: 207 AELLKGKALFPGNDYIDQLKRIM 229
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 66/261 (25%), Positives = 105/261 (40%), Gaps = 56/261 (21%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL--LAEVDS 176
++ L IG GA G V + G A+KKL + + Q +A R L L V+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNH 79
Query: 177 NCIVKLYCSF------QDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAI 230
I+ L F ++ + +YL+ME + + M D E + + + + I
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD---HERMSYLLYQMLCGI 136
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
+ +H IHRD+KP N+++ + +K+ DFGL + C+N
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-CTNFM----------------- 178
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
M Y V T Y APEV+L GY D WS+G IM E
Sbjct: 179 ----------------------MTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 351 MLVGYPPFYSDEPMSTCRKIV 371
++ G F + + K++
Sbjct: 215 LVKGSVIFQGTDHIDQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 60/254 (23%), Positives = 109/254 (42%), Gaps = 60/254 (23%)
Query: 124 MIGKGAFGEVRVCREK-----ATGHV-YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
+G GAFGEV +G + A+K L+K + + E +K E +L++ +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNHP 59
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETV-LAIE----- 231
IVKL +E Y+IME + GGD+++ L + E + + ++
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 232 -SIHKHNYIHRDIKPDNLLLDRNGH-----MKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ + ++IHRD+ N L+ G+ +K+ DFGL + ++ + D+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDY-------- 166
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
+ +G + P R ++APE LL + + D WS G
Sbjct: 167 -YRKEGEGLLPVR-------------------------WMAPESLLDGKFTTQSDVWSFG 200
Query: 346 AIMYEML-VGYPPF 358
+M+E+L +G P+
Sbjct: 201 VLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 58/256 (22%), Positives = 98/256 (38%), Gaps = 55/256 (21%)
Query: 122 LTMIGKGAFGE--VRVCREKATGHVYAMKKL----KKSEMLRRGQVEHVKAERNLLAEVD 175
LT+IGK V + + K T + A+KK+ E L+ Q E ++
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ-----QEIITSRQLQ 57
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESI 233
I+ SF D LY++ + G LL + L E F + + + A++ I
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H +IHR +K ++LL +G + LS
Sbjct: 118 HSKGFIHRSVKASHILLSGDGKVVLSGL-------------------------------- 145
Query: 294 VAPRRTQQEQLQHWQRNRRMLAY---STVGTPDYIAPEVLLK--KGYGMECDWWSLGAIM 348
R ++H +R R + + S P +++PEVL + +GY + D +S+G
Sbjct: 146 ----RYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGITA 200
Query: 349 YEMLVGYPPFYSDEPM 364
E+ G+ PF
Sbjct: 201 CELANGHVPFKDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 57/251 (22%), Positives = 104/251 (41%), Gaps = 51/251 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FGEV + + V A+K LK M V+ E NL+ + + +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+E +Y+I EY+ G ++ L + + + + + + I + NYIHRD
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
++ N+L+ + K++DFGL + I N A + P+
Sbjct: 129 LRAANVLVSESLMCKIADFGLAR------------VIEDNEYTAREGAKFPI-------- 168
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML----VGYPPF 358
+ APE + + ++ D WS G ++YE++ + YP
Sbjct: 169 --------------------KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208
Query: 359 YSDEPMSTCRK 369
+ + MS ++
Sbjct: 209 SNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FGEV + V A+K LK+ M E AE NL+ ++ +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLY- 67
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLL-------MRKDTLTEEEARFYVGETVLAIESIHKHN 237
+ E +Y+I EY+ G ++ L + + L + A+ + E + IE + N
Sbjct: 68 AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ--IAEGMAFIE---RKN 122
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD------------------FSI 279
YIHRD++ N+L+ K++DFGL + ++ + ++ F+I
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 280 GSNL--SGALQSD----GRPVAPRRTQQEQLQHWQRNRRM 313
S++ G L ++ GR P T E +Q+ +R RM
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 97/361 (26%), Positives = 134/361 (37%), Gaps = 113/361 (31%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ-VEHVKA---ERNLLAEV 174
++ L IG GA G V + TG A+KKL R Q V H K E L+ V
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLV 72
Query: 175 DSNCIVKL---------YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGE 225
+ I+ L FQD +YL+ME + + M D E + + +
Sbjct: 73 NHKNIIGLLNVFTPQKSLEEFQD---VYLVMELMDANLCQVIQMDLD---HERMSYLLYQ 126
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ I+ +H IHRD+KP N+++ + +K+ DFGL
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 165
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
RT M Y V T Y APEV+L GY D WS+G
Sbjct: 166 ------------RTAGTSFM-------MTPY--VVTRYYRAPEVILGMGYKENVDIWSVG 204
Query: 346 AIMYEMLVGYPPFY------------------SDEPMS----TCRKIVNWRTHLK----- 378
IM EM+ G F SDE MS T R V R
Sbjct: 205 CIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFE 264
Query: 379 -------FPEEA----KLSPE-AKDLISKLLC-NVEQRLGTKGADEIKAHP----WFKGI 421
FP ++ KL A+DL+SK+L + E+R+ D+ HP W+
Sbjct: 265 ELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV---DDALQHPYINVWYDPS 321
Query: 422 E 422
E
Sbjct: 322 E 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 79/343 (23%), Positives = 130/343 (37%), Gaps = 95/343 (27%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKA-------ER 168
+ ++ L +G+G++ V R K TG + A+K+++ +EH + E
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIREA 54
Query: 169 NLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETV 227
+LL ++ IV L+ + L L+ EYL D+ + L+ R ++ + +
Sbjct: 55 SLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+ H+ +HRD+KP NLL+ G +KL+DFGL + S+
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAK----------SV-------- 155
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 345
P +T YS V T Y P+VLL Y D W +G
Sbjct: 156 --------PSKT----------------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVG 191
Query: 346 AIMYEMLVGYPPF----YSDEPMSTCRKIV------NWRTHLKFPEEAKLS--------- 386
I YEM G P F ++ + +++ W PE S
Sbjct: 192 CIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPL 251
Query: 387 ----------PEAKDLISKLL-CNVEQRLGTKGADEIKAHPWF 418
P ++L K L ++R+ A E HP+F
Sbjct: 252 INHAPRLDRIPHGEELALKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 57/246 (23%), Positives = 92/246 (37%), Gaps = 48/246 (19%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMK--KLKKSEMLRRGQVEHVKAERNLLAE 173
A + L +G+G++ V + G + A+K +K E + + E +LL
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKG 59
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+ IV L+ E L + EY+ ++ L R ++ + + + I
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H + +HRD+KP NLL+ G +KL+DFGL + +
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLAR-------------------------AKS 154
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 352
+ + E + W R P+VLL Y D W G I EML
Sbjct: 155 IPSQTYSSEVVTLWYR----------------PPDVLLGATDYSSALDIWGAGCIFIEML 198
Query: 353 VGYPPF 358
G P F
Sbjct: 199 QGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 64/264 (24%), Positives = 105/264 (39%), Gaps = 64/264 (24%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ-VEHVKAERNLLAEVDS 176
D PL G G+ G V + A+KK+ +L Q V+H E ++ +D
Sbjct: 9 DLRPL---GCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLDH 61
Query: 177 NCIVKLY-----CSFQDDEYL---------YLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
+ IVK+Y E + Y++ EY+ + ++ + L+EE AR +
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLF 119
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHM-KLSDFGLCKPLDCSNLQEKDFSIGS 281
+ + + ++ IH N +HRD+KP N+ ++ + K+ DFGL + +D +S
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD------PHYSHKG 173
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECD 340
LS L + W Y +P +LL Y D
Sbjct: 174 YLSEGLVT----------------KW----------------YRSPRLLLSPNNYTKAID 201
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPM 364
W+ G I EML G P F +
Sbjct: 202 MWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 64/242 (26%), Positives = 97/242 (40%), Gaps = 57/242 (23%)
Query: 118 DFEPLTMI---GKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV 174
D + LT + G G FG V+ + + V A+K +K+ M +E K L E
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEK 60
Query: 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEE--EARFYVGETVLAI 230
+V+LY +Y++ EY+ G ++ L K + E V E + +
Sbjct: 61 ----LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK-PLDCSNLQEKDFSIGSNLSGALQS 289
ES +IHRD+ N L+D G +K+SDFGL + LD E S+GS
Sbjct: 117 ES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD----DEYTSSVGSKF------ 163
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
PV W PEVLL + + D W+ G +M+
Sbjct: 164 ---PV-----------RWS-----------------PPEVLLYSKFSSKSDVWAFGVLMW 192
Query: 350 EM 351
E+
Sbjct: 193 EV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 65/259 (25%), Positives = 103/259 (39%), Gaps = 44/259 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+G FGEV R +A A+K + E L E +L + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHKHNYIHRDI 243
+ +Y++ME + GGD +T L + L +E V +E + + IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 244 KPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQ 303
N L+ +K+SDFG+ + +E+D S +G ++ PV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-------EEEDGVYAS--TGGMKQ--IPV--------- 160
Query: 304 LQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYSDE 362
+ APE L Y E D WS G +++E +G P Y++
Sbjct: 161 -------------------KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP-YANL 200
Query: 363 PMSTCRKIVNWRTHLKFPE 381
R+ + L PE
Sbjct: 201 SNQQTREAIEQGVRLPCPE 219
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 61/322 (18%), Positives = 109/322 (33%), Gaps = 80/322 (24%)
Query: 84 DAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGH 143
A S+++ ++ L ++K E + +G + LT G+ G V V +
Sbjct: 40 SASESDDDDDDGLIPTKQKAREVV----ASLGYTVIKTLT---PGSEGRVFVATKPGQPD 92
Query: 144 VYAMK------KLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197
+K L ++ +L+ V ++ L C+V + + D Y YL
Sbjct: 93 PVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH--YSSDLYTYLTKR 150
Query: 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMK 257
L L E+ + + +H IHRD+K +N+ ++ +
Sbjct: 151 -------SRPLPIDQALIIEKQ------ILEGLRYLHAQRIIHRDVKTENIFINDVDQVC 197
Query: 258 LSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYS 317
+ D G + + F
Sbjct: 198 IGDLGAAQ----FPVVAPAF--------------------------------------LG 215
Query: 318 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP-PFYSDEPMSTCRKIVNWRTH 376
GT + APEVL + Y + D WS G +++EML YP + D P + + + +H
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSH 274
Query: 377 LK--------FPEEAKLSPEAK 390
L PEE P ++
Sbjct: 275 LLKIISTLKVHPEEFPRDPGSR 296
|
Length = 357 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 6/143 (4%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G +GEV K A+K LK+ M +VE E ++ E+ +V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ Y+I E++ G+++ L + + + + A+E + K N+IHRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 243 IKPDNLLLDRNGHMKLSDFGLCK 265
+ N L+ N +K++DFGL +
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 125 IGKGAFGEVR--VCREKATGHVYAMKKLK-------KSEMLRRGQVEHVKAERNLLAEVD 175
+G G FG V+ V + + A+K LK + EM+R ++ H ++D
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLD 53
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIH 234
+ IV++ + E L L+ME GG + L +KD +T + + + ++ +
Sbjct: 54 NPYIVRM-IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267
N++HRD+ N+LL + K+SDFGL K L
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 63/276 (22%)
Query: 87 VSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYA 146
+S +++N +E ++ + L+R ++ L IG GA G V + A
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAILERNVA 53
Query: 147 MKKLKKSEMLRRGQVEHVKAERNL--LAEVDSNCIVKLYCSF------QDDEYLYLIMEY 198
+KKL + + Q +A R L + V+ I+ L F ++ + +Y++ME
Sbjct: 54 IKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKL 258
+ + M D E + + + + I+ +H IHRD+KP N+++ + +K+
Sbjct: 111 MDANLCQVIQMELD---HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST 318
DFGL + S +
Sbjct: 168 LDFGLARTAGTSFMMTPY------------------------------------------ 185
Query: 319 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
V T Y APEV+L GY D WS+G IM EM+ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-08
Identities = 11/50 (22%), Positives = 20/50 (40%), Gaps = 3/50 (6%)
Query: 436 EVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFE 485
+V DT NF+ ++ + + S + F G++Y N E
Sbjct: 1 KVKSPTDTSNFDPEFTSEPPKLSP---PDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 60/240 (25%), Positives = 92/240 (38%), Gaps = 52/240 (21%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
++ L IG GA G V + A+KKL + + + E L+ V+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKN 77
Query: 179 IVKLYCSFQDDEYL------YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES 232
I+ L F + L YL+ME + + M D E + + + + I+
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIKH 134
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+H IHRD+KP N+++ + +K+ DFGL + S +
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-------------------- 174
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
M Y V T Y APEV+L GY D WS+G IM EM+
Sbjct: 175 --------------------MTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 125 IGKGAFGEVR--VCREKATGHVYAMKKLK--------KSEMLRRGQVEHVKAERNLLAEV 174
+G G FG V+ + + K + A+K LK K E+LR E N++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---------EANVMQQL 53
Query: 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
D+ IV++ + E L+ME G + L + +TE+ V + + ++ +
Sbjct: 54 DNPYIVRM-IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267
+ N++HRD+ N+LL + K+SDFGL K L
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 49/239 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FG V + + +A V A+K + + M +E K ++ ++ +V+LY
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQLYG 66
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL-AIESIHKHNYIHRDI 243
+ LY++ E++ G ++ L ++ ++ + + V +E + ++++IHRD+
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 244 KPDNLLLDRNGHMKLSDFGLCK-PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
N L+ G +K+SDFG+ + LD D S SGA PV
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLD-------DEYTSS--SGA----KFPV-------- 165
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 360
+ PEV Y + D WS G +M+E+ G PF
Sbjct: 166 --------------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 68/249 (27%), Positives = 100/249 (40%), Gaps = 64/249 (25%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKL------KKSEMLRRGQVEHVKAERNLLAEVD-- 175
+IG G+FG V T A+KK+ K E+L + H+ N++ D
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NIIFLKDYY 128
Query: 176 -SNCIVKLYCSFQDDEYLYLIMEYLPGG--DMMTLLMRKD-TLTEEEARFYVGETVLAIE 231
+ C K + + +L ++ME++P M R + L + Y + A+
Sbjct: 129 YTECFKK----NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGH-MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
IH HRD+KP NLL+D N H +KL DFG K NL +S
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK----------------NLLAGQRS- 227
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 349
S + + Y APE++L Y D WSLG I+
Sbjct: 228 -------------------------VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIA 262
Query: 350 EMLVGYPPF 358
EM++GYP F
Sbjct: 263 EMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 51/229 (22%), Positives = 88/229 (38%), Gaps = 48/229 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FG V + + + V A+K +++ M +E K L +V+LY
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKLSHPN----LVQLYG 66
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL-AIESIHKHNYIHRDI 243
++++ EY+ G ++ L + E + V A+E + + +IHRD+
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 244 KPDNLLLDRNGHMKLSDFGLCK-PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
N L+ + +K+SDFGL + LD + S G+ PV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKF---------PV-------- 165
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351
W PEV + + D WS G +M+E+
Sbjct: 166 ---KWA-----------------PPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 62/273 (22%), Positives = 105/273 (38%), Gaps = 71/273 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHV-YAMKKLKKSEMLRRGQVEHVKA----ERNLL 171
++ E + IG+GAFG RV + +A G + Y + +ML+ ++A E L+
Sbjct: 5 NNIEYVRDIGQGAFG--RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALM 62
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEE-------EARFYVG 224
AE D IVKL + + L+ EY+ GD+ L + + AR G
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC-G 121
Query: 225 ETVLAIESIHK----------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
L + + ++HRD+ N L+ N +K++DFGL +
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR--- 178
Query: 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328
N+ D+ S ++D P+ W + PE
Sbjct: 179 --NIYSADYYKAS------ENDAIPI-----------RW-----------------MPPE 202
Query: 329 VLLKKGYGMECDWWSLGAIMYEML-VGYPPFYS 360
+ Y E D W+ G +++E+ G P+Y
Sbjct: 203 SIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 62/250 (24%), Positives = 97/250 (38%), Gaps = 63/250 (25%)
Query: 124 MIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+IG G FGEV R K G A+K LK + Q +E +++ + D I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNII 68
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI------- 233
L + + ++ EY+ G + L + D +F V + V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
Y+HRD+ N+L++ N K+SDFG LS L+ D P
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFG--------------------LSRVLEDD--P 160
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTP---DYIAPEVLLKKGYGMECDWWSLGAIMYE 350
A AY+T G + APE + + + D WS G +M+E
Sbjct: 161 EA-------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201
Query: 351 -MLVGYPPFY 359
M G P++
Sbjct: 202 VMSYGERPYW 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 49/236 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSE--MLRRGQVEHVKAERNLLAEVDSNCIVKL 182
I K F + A G +A K E +++ GQ E ++L ++ I++L
Sbjct: 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQL 148
Query: 183 YCSFQDDEYLYLIMEYLP--GGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
+F +++ LI LP D+ L K + + + AI+ +H++ IH
Sbjct: 149 KGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIH 205
Query: 241 RDIKPDNLLLDRNGHMKLSDFG-LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
RDIK +N+ ++ G + L DFG C P+D +
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAACFPVDIN----------------------------- 236
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
N+ Y GT APE+L + YG D WS G +++EM +
Sbjct: 237 ---------ANKY---YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 17/148 (11%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FGEV T V A+K LK M + AE ++ ++ +++LY
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKD-------TLTEEEARFYVGETVLAIESIHKHN 237
+E +Y++ E + G ++ L L + A+ G L N
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-----EAQN 123
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
YIHRD+ N+L+ N K++DFGL +
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 32/215 (14%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G+G FGEV + T V A+K LK M+ ++ E ++ ++ + +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKLVPLY- 67
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ +E +Y++ E++ G ++ L D L + + + I + NYIHRD
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD------------------FSIGSN-- 282
++ N+L+ N K++DFGL + ++ + + F+I S+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 283 ----LSGALQSDGRPVAPRRTQQEQLQHWQRNRRM 313
L L + GR P +E L+ +R RM
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 25/165 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVY----------AMKKLKKSEMLRRGQVEHVKA 166
+D IG+G FG+V VY A+K K E
Sbjct: 6 EDITLGRCIGEGQFGDVYQ-------GVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQ 56
Query: 167 ERNLLAEVDSNCIVKL--YCSFQDDEYLYLIMEYLPGGDM-MTLLMRKDTLTEEEARFYV 223
E ++ + D IVKL + + ++++ME P G++ L + K +L Y
Sbjct: 57 EAYIMRQFDHPHIVKLIGVIT---ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
+ A+ + ++HRDI N+L+ +KL DFGL + L+
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FGEV + T V A+K LK M E E ++ ++ + +V+LY
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES--------IHKH 236
++E +Y++ EY+ G ++ D L E + ++ + + +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLL------DFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGL 263
NYIHRD+ N+L+ N K++DFGL
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 49/228 (21%)
Query: 140 ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-----SNC-IVKLYCSFQDDEYLY 193
+ G V+ K E ++ V+ V + E+D S+ I+ L +++ +
Sbjct: 104 SEGEVFVCTK-HGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVC 162
Query: 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL-AIESIHKHNYIHRDIKPDNLLLDR 252
++M D+ T + R L E+A + +L A+ +H IHRD+K +N+ LD
Sbjct: 163 MVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE 220
Query: 253 NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRR 312
+ L DFG A + D P P+
Sbjct: 221 PENAVLGDFG----------------------AACKLDAHPDTPQ--------------- 243
Query: 313 MLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
Y GT + +PE+L Y + D WS G +++EM V +
Sbjct: 244 --CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 63/249 (25%), Positives = 103/249 (41%), Gaps = 59/249 (23%)
Query: 124 MIGKGAFGEVRVCREKATG---HVYAMKKLKK--SEMLRRGQVEHVKAERNLLAEVDSNC 178
+IG G FGEV R K G A+K LK +E RR + +E +++ + D
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL----SEASIMGQFDHPN 66
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI----- 233
I+ L + +I E++ G + + L + D +F V + V + I
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMK 120
Query: 234 --HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
+ NY+HRD+ N+L++ N K+SDFGL + L+ D + S+L G +
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT---SDPTYTSSLGGKI---- 173
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE- 350
P R + APE + + + D WS G +M+E
Sbjct: 174 ----PIR-------------------------WTAPEAIAYRKFTSASDVWSYGIVMWEV 204
Query: 351 MLVGYPPFY 359
M G P++
Sbjct: 205 MSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 52/265 (19%), Positives = 99/265 (37%), Gaps = 63/265 (23%)
Query: 125 IGKGAFGEV-----RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+G+GAFG+V + + A+K LK E + + E LL I
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELLTNFQHENI 70
Query: 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--------------TLTEEEARFYVGE 225
VK Y + + ++ EY+ GD+ L LT + +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ + +++HRD+ N L+ + +K+ DFG+ + + ++ + +G
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY----YRVG----- 181
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
G + P R ++ PE ++ + + E D WS G
Sbjct: 182 -----GHTMLPIR-------------------------WMPPESIMYRKFTTESDVWSFG 211
Query: 346 AIMYEMLV-GYPPFY--SDEPMSTC 367
+++E+ G P+Y S+E + C
Sbjct: 212 VVLWEIFTYGKQPWYGLSNEEVIEC 236
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 18/151 (11%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G+G FGEV + T V A+K LK M ++ + + L E +V+LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEK----LVQLY- 67
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLL-------MRKDTLTEEEARFYVGETVLAIESIHKHN 237
+ +E +Y++ EY+ G ++ L +R L + A+ G + + + N
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG-----MAYVERMN 122
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
Y+HRD++ N+L+ N K++DFGL + ++
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 47/253 (18%), Positives = 96/253 (37%), Gaps = 63/253 (24%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKS--------EMLRRGQVEHVK----AERNLLA 172
+G+G FGEV +C + + +MLR + + E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD------------TLTEEEAR 220
+ + I++L D+ L +I EY+ GD+ L +++ +++
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
+ + ++ + N++HRD+ N L+ + +K++DFG+ + NL D+
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-----NLYSGDY--- 184
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340
+ GR V P R ++A E +L + D
Sbjct: 185 ------YRIQGRAVLPIR-------------------------WMAWESILLGKFTTASD 213
Query: 341 WWSLGAIMYEMLV 353
W+ G ++EM
Sbjct: 214 VWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 57/268 (21%), Positives = 96/268 (35%), Gaps = 67/268 (25%)
Query: 108 RLQRHKMGADDFEPLTMIGKGAFGEVRVC--------REKATGHVYAMKKLKKSEML--- 156
+L+ F + + GAFG++ +C E G + K E L
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198
Query: 157 --RRGQVEHVKAERNLLA--EVDSNCIVKLYCSFQDDEYLYLIME--------YLPGGDM 204
+ G ++ E +LA ++ I+K+ + + Y+I + ++
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA- 257
Query: 205 MTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264
KD ++ R + + + A+E IH IHRDIK +N+ L+ +G + L DFG
Sbjct: 258 ---FDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDY 324
P + + Y VGT
Sbjct: 315 MPFE-----------------------KEREAFD-----------------YGWVGTVAT 334
Query: 325 IAPEVLLKKGYGMECDWWSLGAIMYEML 352
+PE+L GY D WS G I+ +ML
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 46/253 (18%), Positives = 96/253 (37%), Gaps = 60/253 (23%)
Query: 117 DDFEPLTMIGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL 170
+ + +G+G+FG V V + + V A+K + ++ +R + E ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRV-AIKTVNENASMR--ERIEFLNEASV 62
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY-------- 222
+ E + + +V+L + ++ME + GD+ + L R E
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKF 121
Query: 223 ---VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
E + + ++HRD+ N ++ + +K+ DFG+ + ++ E D+
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDY-- 174
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 339
+ G+ + P R W +APE L + +
Sbjct: 175 -------YRKGGKGLLPVR--------W-----------------MAPESLKDGVFTTKS 202
Query: 340 DWWSLGAIMYEML 352
D WS G +++EM
Sbjct: 203 DVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + + +G G FGEV + V A+K LK M +E E ++ ++
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-------MRKDTLTEEEARFYVGETVLA 229
+ +V+LY + +E +Y++ EY+ G ++ L ++ L + A+ G
Sbjct: 61 DKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG----- 114
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+ I + NYIHRD++ N+L+ K++DFGL +
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 58/250 (23%), Positives = 108/250 (43%), Gaps = 58/250 (23%)
Query: 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE 173
+ + + L IGKG FG+V + + G+ A+K +K + AE +++ +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 174 VDSNCIVKLY-CSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVL-AI 230
+ + +V+L ++ LY++ EY+ G ++ L R ++ + V A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
E + +N++HRD+ N+L+ + K+SDFGL K + S+ Q+ +G L
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD---------TGKL--- 161
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
PV + APE L +K + + D WS G +++E
Sbjct: 162 --PV----------------------------KWTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 351 ML----VGYP 356
+ V YP
Sbjct: 192 IYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 42/174 (24%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVY--AMKKLKKSEMLRRGQVEHVKAERNLLAEV 174
+D + +IG+G FG+V R K G A+K++K+ + +H R+ E+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDH----RDFAGEL 58
Query: 175 DSNC-------IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK---------------- 211
+ C I+ L + + YLYL +EY P G+++ L +
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 212 DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
TL+ ++ + + ++ + + +IHRD+ N+L+ N K++DFGL +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FGEV + V A+K +K M VE AE N++ + + +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 67
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARF--YVGETVLAIESIHKHNYIHRD 242
+ E +Y+I E++ G ++ L + + + + + + I + NYIHRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLD 268
++ N+L+ + K++DFGL + ++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE 153
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 62/249 (24%), Positives = 96/249 (38%), Gaps = 62/249 (24%)
Query: 125 IGKGAFGEVRVCREKATG---HVYAMKKLKK--SEMLRRGQVEHVKAERNLLAEVDSNCI 179
IG G FGEV R K G A+K LK S+ R + E +++ + D I
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL----TEASIMGQFDHPNI 67
Query: 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI------ 233
++L + +I EY+ G + L D +F VG+ V + I
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKY 121
Query: 234 -HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+ NY+HRD+ N+L++ N K+SDFGL + L+ S + G
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE-------------ATYTTKGG 168
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE-M 351
+ R T APE + + + D WS G +M+E M
Sbjct: 169 KIPIRWT--------------------------APEAIAYRKFTSASDVWSFGIVMWEVM 202
Query: 352 LVGYPPFYS 360
G P++
Sbjct: 203 SYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 57/255 (22%), Positives = 103/255 (40%), Gaps = 63/255 (24%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+GAFG+V +C E+ V A+K LK + R H +AE LL +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILV-AVKTLKDASDNARKDF-HREAE--LLTNLQHEH 68
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK-------------DTLTEEEARFYVGE 225
IVK Y + + L ++ EY+ GD+ L LT+ + +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ + +++HRD+ N L+ N +K+ DFG+ + + ++ + +G
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY----YRVG----- 179
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
G + P R ++ PE ++ + + E D WSLG
Sbjct: 180 -----GHTMLPIR-------------------------WMPPESIMYRKFTTESDVWSLG 209
Query: 346 AIMYEMLV-GYPPFY 359
+++E+ G P+Y
Sbjct: 210 VVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 60/258 (23%), Positives = 103/258 (39%), Gaps = 74/258 (28%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKK------------LKKSEMLRRGQVEHVKAERNLLA 172
+G+G FGEV +C +A G M K L +MLR ++ A + L
Sbjct: 13 LGEGQFGEVHLC--EAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN--ARNDFLK 68
Query: 173 EV-------DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR---KDTLTEEEARFY 222
E+ D N I++L + L +I EY+ GD+ L R ++ + +
Sbjct: 69 EIKIMSRLKDPN-IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 223 VGETVL----AIESIHKH----NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274
T++ I S K+ N++HRD+ N L+ +N +K++DFG+ + NL
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYS 182
Query: 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334
D+ + GR V P R +++ E +L
Sbjct: 183 GDY---------YRIQGRAVLPIR-------------------------WMSWESILLGK 208
Query: 335 YGMECDWWSLGAIMYEML 352
+ D W+ G ++E+L
Sbjct: 209 FTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 31/166 (18%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC----- 178
+IG+G FG+V R K G ++ + ++ + R+ E++ C
Sbjct: 2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHH 55
Query: 179 --IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARF--------------- 221
I+ L + + YLYL +EY P G+++ L RK + E + F
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 222 --YVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+ + ++ + + +IHRD+ N+L+ N K++DFGL +
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-06
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 5/67 (7%)
Query: 419 KGIEWDKLYQ--IKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINF 476
+GI+WDKL I+ F+P++ DT NF+ + + T S + F
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEP---F 57
Query: 477 VGYTYKN 483
G++Y
Sbjct: 58 RGFSYVF 64
|
Length = 64 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 40/165 (24%), Positives = 75/165 (45%), Gaps = 29/165 (17%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC----- 178
+IG+G FG+V K G +K +ML+ E+ R+ E++ C
Sbjct: 9 VIGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASEN--DHRDFAGELEVLCKLGHH 62
Query: 179 --IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEAR 220
I+ L + ++ YLY+ +EY P G+++ L + TLT ++
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+ + ++ + + +IHRD+ N+L+ N K++DFGL +
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 60/272 (22%), Positives = 105/272 (38%), Gaps = 64/272 (23%)
Query: 125 IGKGAFGEVRV--CREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+G+GAFG+V + C + + A+K LK + R + E LL + I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHEHI 69
Query: 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD----TLTEEEARFYVGE----TVLAIE 231
VK Y D + L ++ EY+ GD+ L L + + R GE +L I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 232 S--------IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
S + +++HRD+ N L+ N +K+ DFG+ + + ++ + +G
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY----YRVG--- 182
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343
G + P R ++ PE ++ + + E D WS
Sbjct: 183 -------GHTMLPIR-------------------------WMPPESIMYRKFTTESDVWS 210
Query: 344 LGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWR 374
G I++E+ G P++ I R
Sbjct: 211 FGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 62/271 (22%), Positives = 105/271 (38%), Gaps = 81/271 (29%)
Query: 123 TMIGKGAFGEVRVCREKATGH---------VYAMKKLKKSEMLRRGQVEHVKAERNLLAE 173
+G+G FG+V KAT A+K LK++ ++ + +E NLL +
Sbjct: 6 KTLGEGEFGKVV----KATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQ 59
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL----------MRKDTLTEEEARFYV 223
V+ ++KLY + D L LI+EY G + + L + D
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 224 GETVL--------------AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269
E L ++ + + +HRD+ N+L+ MK+SDFGL +
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR---- 175
Query: 270 SNLQEKDFSIGSNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328
++ E+D S +S GR PV ++A E
Sbjct: 176 -DVYEED-------SYVKRSKGRIPV----------------------------KWMAIE 199
Query: 329 VLLKKGYGMECDWWSLGAIMYEML-VGYPPF 358
L Y + D WS G +++E++ +G P+
Sbjct: 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 59/289 (20%), Positives = 112/289 (38%), Gaps = 82/289 (28%)
Query: 125 IGKGAFGEVRVCREKATGHVY----------AMKKLKKSEMLRRGQVEHVKAERNLLAEV 174
+G+ AFG++ GH+Y A+K LK ++ Q + E +L+AE+
Sbjct: 13 LGECAFGKIY------KGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64
Query: 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMT-LLMR----------------KDTLTEE 217
IV L ++ + ++ EYL GD+ L+MR K +L
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 218 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
+ + +E + H ++H+D+ N+L+ H+K+SD GL + + ++ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY----Y 180
Query: 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337
+ + P R ++ PE ++ +
Sbjct: 181 RVQPK----------SLLPIR-------------------------WMPPEAIMYGKFSS 205
Query: 338 ECDWWSLGAIMYEML-VGYPPFY---SDEPMSTCRKIVNWRTHLKFPEE 382
+ D WS G +++E+ G P+Y + E + RK R L E+
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK----RQLLPCSED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 44/199 (22%), Positives = 80/199 (40%), Gaps = 39/199 (19%)
Query: 125 IGKGAFGEVRVCR-EKATGHVYAMKKLKKS---------EMLRRGQVEHVKA----ERNL 170
+G+G FGEV +C + + ++LR ++ + E +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR---KDTLTEEEARFYVGETV 227
L+ + I +L D L +IMEY+ GD+ L + + + ++ T+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 228 L----AIESIHKH----NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
L I S ++ N++HRD+ N L+ +N +K++DFG+ NL D+
Sbjct: 133 LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM-----SRNLYSSDYY- 186
Query: 280 GSNLSGALQSDGRPVAPRR 298
+ GR P R
Sbjct: 187 --------RVQGRAPLPIR 197
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 34/164 (20%), Positives = 74/164 (45%), Gaps = 24/164 (14%)
Query: 120 EPLTMIGKGAFGEVRVCREKATGH-----VYAMKKLKKSEMLRRGQVEHV----KAERNL 170
+ +T +G+G FGEV + + K + +K L+K++ E++ + E ++
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------DENLQSEFRRELDM 61
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL---------MRKDTLTEEEARF 221
++ +V+L ++ E Y+I+EY GD+ L ++ L+ ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 222 YVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+ L ++ + ++HRD+ N L+ +K+S L K
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 124 MIGKGAFGEVR---VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
M+GKG FG VR + E + A+K LK +++ +E E + E D ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 181 KLY-CSFQDDEYLYL-----IMEYLPGGDMMTLLMRKD------TLTEEEARFYVGETVL 228
KL S + L I+ ++ GD+ T L+ TL + ++ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+E + N+IHRD+ N +L+ N + ++DFGL K
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 19/87 (21%), Positives = 37/87 (42%), Gaps = 10/87 (11%)
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY-- 238
K+ S + D + YL+ME++ G L +E+ + E + +H+
Sbjct: 57 KVLASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDIAEQLAE---LLAKLHQLPLLV 109
Query: 239 -IHRDIKPDNLLLDRNGHMKLSDFGLC 264
H D+ P N+L+D + + D+
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 38/132 (28%), Positives = 50/132 (37%), Gaps = 39/132 (29%)
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
AI+ IH IHRDIK +N+L++ + L DFG C F+ GS +
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA----C-------FARGSWST---- 316
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
P Y GT D APEVL Y D WS G ++
Sbjct: 317 ----PF--------------------HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVI 352
Query: 349 YEMLVGYPPFYS 360
+E V +S
Sbjct: 353 FEAAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 36/159 (22%), Positives = 68/159 (42%), Gaps = 20/159 (12%)
Query: 124 MIGKGAFGEVRVCREKA----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
++G+G FG V + V A+K +K ++E +E + + D +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYS-EIEEFLSEAACMKDFDHPNV 63
Query: 180 VKLY-CSFQDDEYLYL-----IMEYLPGGDMMTLLMRKDTLTEEE-------ARFYVGET 226
+KL F+ + I+ ++ GD+ + L+ E +F V +
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV-DI 122
Query: 227 VLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
L +E + N+IHRD+ N +L + + ++DFGL K
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 58/244 (23%), Positives = 97/244 (39%), Gaps = 51/244 (20%)
Query: 124 MIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+IG G FGEV K G A+K LK + Q + +E +++ + + I+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNII 69
Query: 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH---- 236
+L + +I EY+ G + L D E + + + + I + K+
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
NY+HRD+ N+L++ N K+SDFGL + L+ D G + G +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLE-------DDP-----EGTYTTSGGKIPI 174
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE-MLVGY 355
R T APE + + + D WS G +M+E M G
Sbjct: 175 RWT--------------------------APEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
Query: 356 PPFY 359
P++
Sbjct: 209 RPYW 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 57/275 (20%), Positives = 103/275 (37%), Gaps = 84/275 (30%)
Query: 117 DDFEPLTMIGKGAFGEV-------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
D +G+GAFG+V + + A+K LK K +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETS--TVAVKMLKDDA--------TEKDLSD 61
Query: 170 LLAEVD--------SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK---------- 211
L++E++ N I L Q+ LY+++EY G++ L +
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPD 120
Query: 212 ------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+TLT+++ + + +E + IHRD+ N+L+ + MK++DFGL +
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
Query: 266 PLDCSNLQEKDFSIGSNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDY 324
+ + K ++GR PV +
Sbjct: 181 DIHHIDYYRK------------TTNGRLPV----------------------------KW 200
Query: 325 IAPEVLLKKGYGMECDWWSLGAIMYE-MLVGYPPF 358
+APE L + Y + D WS G +++E +G P+
Sbjct: 201 MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 125 IGKGAFGEVR------VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G GAFG+V + + A V A+K LK + + E + +E +++ + ++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTA--HSSEREALMSELKIMSHLGNHE 99
Query: 179 -IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIHK 235
IV L + + +I EY GD++ L RK LT E+ + + + +
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 236 HNYIHRDIKPDNLLLDRNGHM-KLSDFGLCK 265
N IHRD+ N+LL +G + K+ DFGL +
Sbjct: 160 KNCIHRDLAARNVLLT-HGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 20/155 (12%)
Query: 125 IGKGAFGEVRVCREKA-TGHVY--AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+G G+FG VR G V A+K LK S+ L + +K E ++ +D +++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLK-EAAIMHSLDHENLIR 60
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL--------AIESI 233
LY L ++ E P G ++ D L ++ ++ T+ + +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLL------DRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
+IHRD+ N+LL + +K+ DFGL + L
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALP 148
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 51/237 (21%), Positives = 92/237 (38%), Gaps = 49/237 (20%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ-VEHVKAERNLLAEVDS 176
+F +G G FGEV K V A+K LK ++L++ + V+A + L +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKH-- 63
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIH 234
++ L+ E +Y+I E + G ++ L + L + + +
Sbjct: 64 --LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
+ N IHRD+ N+L+ + K++DFGL + L ++D + S+
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLAR------LIKEDVYLSSDKK---------- 165
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351
P + + APE + + D WS G ++YEM
Sbjct: 166 IPYK-------------------------WTAPEAASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 54/258 (20%), Positives = 99/258 (38%), Gaps = 64/258 (24%)
Query: 125 IGKGAFGEVRVC------REKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+G FG+V + ++K V K+ K + + + V +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK-----------DTLTEEEARFY----- 222
I+ L + D LY+I+EY G++ L + + +E+ F
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ +E + IHRD+ N+L+ N MK++DFGL + ++ + +K
Sbjct: 143 TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK------- 195
Query: 283 LSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341
++GR PV ++APE L + Y + D
Sbjct: 196 -----TTNGRLPV----------------------------KWMAPEALFDRVYTHQSDV 222
Query: 342 WSLGAIMYEML-VGYPPF 358
WS G +M+E+ +G P+
Sbjct: 223 WSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 117 DDFEPLTMIGKGAFGEV-----RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
D L +G GAFGEV R A A+K L E E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIM 63
Query: 172 AEVDSNCIVKLY-CSFQDDEYLYLIMEYLPGGDMMTLL-------MRKDTLTEEEARFYV 223
++ + IV+L SF+ ++++E + GGD+ + L R +LT ++ F
Sbjct: 64 SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGLCK 265
+ + + ++++IHRDI N LL G K++DFG+ +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 53/259 (20%), Positives = 100/259 (38%), Gaps = 69/259 (26%)
Query: 125 IGKGAFGEVRVCR-----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+G+GAFG+V + + + A+K LK++ R + + E LL + I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR---QDFQREAELLTVLQHQHI 69
Query: 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGETVLA------- 229
V+ Y + L ++ EY+ GD+ L + G+ L
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 230 --------IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
+ S+H ++HRD+ N L+ + +K+ DFG+ + + ++ + +G
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY----YRVG- 181
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341
GR + P R ++ PE +L + + E D
Sbjct: 182 ---------GRTMLPIR-------------------------WMPPESILYRKFTTESDI 207
Query: 342 WSLGAIMYEMLV-GYPPFY 359
WS G +++E+ G P+Y
Sbjct: 208 WSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 58/248 (23%), Positives = 104/248 (41%), Gaps = 47/248 (18%)
Query: 120 EPLTMIGKG--AFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
E LT+IG+G V + R K TG ++++ E V ++ E ++ +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHK 235
IV +F D L+++ ++ G L+ D ++E + + + A++ IH
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
Y+HR +K ++L+ +G + LS + SNLS
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLS------------------GLRSNLS----------- 150
Query: 296 PRRTQQEQLQHWQRNRRML---AYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 350
+ H QR R + YS P +++PEVL + +GY + D +S+G E
Sbjct: 151 -------MINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACE 202
Query: 351 MLVGYPPF 358
+ G+ PF
Sbjct: 203 LANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 57/261 (21%), Positives = 99/261 (37%), Gaps = 72/261 (27%)
Query: 125 IGKGAFGEVRVCREKATGHV------YAMKK----LKKSEMLRRGQVEHVKA----ERNL 170
+G+G FGEV +C + + ++K L ++LR ++ + E +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTL-TEEEARFYVGE---- 225
L+ + I++L D++ L +I EY+ GD+ L EE V
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 226 ----------TVLAIESIHKH----NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271
L I S K+ N++HRD+ N L+ N +K++DFG+ + N
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR-----N 187
Query: 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL 331
L D+ + GR V P R ++A E +L
Sbjct: 188 LYAGDY---------YRIQGRAVLPIR-------------------------WMAWECIL 213
Query: 332 KKGYGMECDWWSLGAIMYEML 352
+ D W+ G ++E+L
Sbjct: 214 MGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 56/263 (21%), Positives = 101/263 (38%), Gaps = 75/263 (28%)
Query: 125 IGKGAFGEVRVCREKATGHVY-----------AMKKLKKSEMLRRGQVEHVKAERNLLAE 173
+G+GAFG+V G + A+K LK++ + + + E L+++
Sbjct: 13 LGEGAFGKVY------KGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSD 64
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR----------------KDTLTEE 217
+ IV L ++ ++ EYL GD+ L+R K +L
Sbjct: 65 LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 218 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
+ + +E + H+++HRD+ N L+ +K+SDFGL +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR------------ 172
Query: 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337
I S +QS + + P R ++ PE +L +
Sbjct: 173 DIYSADYYRVQS--KSLLPVR-------------------------WMPPEAILYGKFTT 205
Query: 338 ECDWWSLGAIMYEML-VGYPPFY 359
E D WS G +++E+ G P+Y
Sbjct: 206 ESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 46/175 (26%)
Query: 211 KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270
K LT E+ Y + +E + IHRD+ N+LL N +K+ DFGL + +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI--- 229
Query: 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330
++ D+ + D R P + ++APE +
Sbjct: 230 -YKDPDY--------VRKGDAR--LPLK-------------------------WMAPETI 253
Query: 331 LKKGYGMECDWWSLGAIMYEML-VG---YPPFYSDEPMSTCRKIVNWRTHLKFPE 381
+ Y ++ D WS G +++E+ +G YP DE CR++ T ++ P+
Sbjct: 254 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKE-GTRMRAPD 305
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 31/157 (19%)
Query: 125 IGKGAFGEVRVCREKATGHVYA---MKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
IG G FG+V + E +G+ A +K+L+ S V+ + L E ++
Sbjct: 3 IGNGWFGKV-ILGEVNSGYTPAQVVVKELRVSA--------SVQEQMKFLEEAQPYRSLQ 53
Query: 182 ----LYCSFQDDE---YLYLIMEYLPGGDMMTLL--------MRKDTLTEEEARFYVGET 226
L C Q E YL L+ME+ P GD+ L M D T + E
Sbjct: 54 HSNLLQCLGQCTEVTPYL-LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC---EI 109
Query: 227 VLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263
L + +HK+N+IH D+ N LL + +K+ D+GL
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 55/243 (22%), Positives = 111/243 (45%), Gaps = 39/243 (16%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK-SEMLRRGQVEHVKAERNLLAEV-DS 176
F+ L+++G+G FG+V ++ A+K ++ + R ++E E+ A+ D
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 177 NCIVKLYCSFQDDE-YLYLIM-EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
++K+ FQ++ ++ ++M +Y P ++ +M+ + + +T +A++ H
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPC--LLDWIMKHGPFSHRHLAQIIFQTGVALDYFH 248
Query: 235 KH-NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+ +H D+KP+N+L++ + D + + AL P
Sbjct: 249 TELHLMHTDLKPENILMETS----------------------DTVVDPVTNRAL-----P 281
Query: 294 VAPRRTQQEQLQHW--QRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351
P R + L +R+ R + V T Y +PEV+L G+ D WS+G I+YE+
Sbjct: 282 PDPCRVRICDLGGCCDERHSRT---AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338
Query: 352 LVG 354
G
Sbjct: 339 YTG 341
|
Length = 467 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 37/145 (25%), Positives = 64/145 (44%), Gaps = 12/145 (8%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG G FG V + V A+K +++ M E E ++ ++ +V+LY
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY----VGETVLAIESIHKHNYIH 240
+ + L+ E++ G + L + +E V E + +ES N IH
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIH 123
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCK 265
RD+ N L+ N +K+SDFG+ +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 10/156 (6%)
Query: 119 FEPLTMIGKGAFGEV-----RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE 173
E + ++G GAFG V EK V A+K L++ + + E ++A
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPV-AIKVLREET--SPKANKEILDEAYVMAS 65
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIES 232
VD +V+L + LI + +P G ++ + KD + + + + +
Sbjct: 66 VDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
+ + +HRD+ N+L+ H+K++DFGL K LD
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 15/38 (39%), Positives = 26/38 (68%)
Query: 225 ETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFG 262
+ + + +H+ +HRDIKP+NLL+ +G +K+ DFG
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 64/271 (23%), Positives = 94/271 (34%), Gaps = 79/271 (29%)
Query: 119 FEPLTMIGKGAFGEVRVCREKA--TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+E IG+G +G V + K G YA+KK K + G + E LL E+
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 177 NCIVKLYCSFQDDEY--LYLIMEYL-------------PGGDMMTLLMRKDTLTEEEARF 221
+V L F + +YL+ +Y + M K L +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----- 116
Query: 222 YVGETVL-AIESIHKHNYIHRDIKPDNLLLDRNGHM----KLSDFGLC----KPLDCSNL 272
+L + +H + +HRD+KP N+L+ G K+ D GL PL
Sbjct: 117 -----ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL----- 166
Query: 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL- 331
+D PV V T Y APE+LL
Sbjct: 167 -------------KPLADLDPV------------------------VVTIWYRAPELLLG 189
Query: 332 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
+ Y D W++G I E+L P F E
Sbjct: 190 ARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.002
Identities = 43/154 (27%), Positives = 63/154 (40%), Gaps = 24/154 (15%)
Query: 121 PLTMIGKGAFGEVRVCREKATGHV--------YAMKKLKKSEMLRRGQVEHVKAERNLLA 172
P +IGKGA +++ V Y +L E LR E +AE LL+
Sbjct: 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPEL--DERLRT---ERTRAEARLLS 391
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY-VGETVLAIE 231
E + D E ++MEY+ G D+ KD L VGE +
Sbjct: 392 EARRAGVPTPVIYDVDPEEKTIVMEYIGGKDL------KDVLEGNPELVRKVGE---IVA 442
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+HK +H D+ N ++ R+ + L DFGL K
Sbjct: 443 KLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 22/76 (28%), Positives = 31/76 (40%), Gaps = 9/76 (11%)
Query: 189 DEYLYLI-MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDN 247
D LI MEY+ G + L E VG+ +HK +H D+ N
Sbjct: 70 DPDNGLIVMEYIEGELLKDALEEARPDLLREVGRLVGK-------LHKAGIVHGDLTTSN 122
Query: 248 LLLDRNGHMKLSDFGL 263
++L G + DFGL
Sbjct: 123 IIL-SGGRIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 42/210 (20%), Positives = 80/210 (38%), Gaps = 57/210 (27%)
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL----------------MRKDTLTEEEARFY 222
I+ L + D LY+++EY G++ L + ++ LT ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ +E + IHRD+ N+L+ + MK++DFGL + + + +K
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK------- 192
Query: 283 LSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341
++GR PV ++APE L + Y + D
Sbjct: 193 -----TTNGRLPV----------------------------KWMAPEALFDRVYTHQSDV 219
Query: 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIV 371
WS G +++E+ Y P+ K++
Sbjct: 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 16/44 (36%), Positives = 25/44 (56%), Gaps = 1/44 (2%)
Query: 320 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEP 363
P ++APEV+ + Y + D +SLG +YE L P Y++E
Sbjct: 66 PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP-YNEER 108
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 549 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.17 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.11 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.1 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.92 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.75 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.58 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.57 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.57 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.39 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.36 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 97.15 | |
| PLN02236 | 344 | choline kinase | 96.95 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.93 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.69 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.68 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.58 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.53 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.98 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.92 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.9 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.89 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.86 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.64 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 95.55 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.67 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.65 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.55 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.03 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-118 Score=922.04 Aligned_cols=458 Identities=68% Similarity=1.050 Sum_probs=423.6
Q ss_pred cccCCCChhhHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHhhhccCCHHHHHHHHHHHHhhhhhhhhhhcccCCC
Q 038137 37 TSEEVPSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGA 116 (549)
Q Consensus 37 ~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~r~~r~~~~e~~~~~~~~~~ee~~~~~~~~~~~e~~~~~~~~~~~~~ 116 (549)
..+...++.|+++++++|.|++++|+.++....+|++|+..+++.++..+++++++.+.++.+..+|++|+|++|.++..
T Consensus 61 ~~~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~~ 140 (550)
T KOG0605|consen 61 EYEFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLSL 140 (550)
T ss_pred ccccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCCc
Confidence 33678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+||+++++||+||||+||+|+.+.||++||||+|+|+.|..+++++|++.|++||...++||||+|||+|||.+++||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc-
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK- 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~- 275 (549)
||+||||++++|++.+.|+|+.++||++|+++||+.||++|||||||||+|+|||..|||||+|||||+.+.+....+.
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~ 300 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESY 300 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999988876543221
Q ss_pred --cccccCCCcCCccCCCCC-CCCc--cchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 276 --DFSIGSNLSGALQSDGRP-VAPR--RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 276 --~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
+.....+.+.....+... .+++ +...+++++|+++|+.+++++||||+||||||+++++|+..||||||||||||
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyE 380 (550)
T KOG0605|consen 301 RLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYE 380 (550)
T ss_pred cchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHH
Confidence 111122222222233322 1233 34789999999999999999999999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCcccccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIK 430 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~ 430 (549)
||+|+|||+++++.++|++|++|+..+.||.+..+|++|+|||.+|||||++|+|..|++||++||||++|+|+.|+++.
T Consensus 381 mLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 381 MLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLREMP 460 (550)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccccccccCCccccccc-------ccccccccceeeCccccCCCCCch
Q 038137 431 AAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLS-------SKDINFVGYTYKNFEIVNDHQLPG 494 (549)
Q Consensus 431 ~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~f~g~~~~~~~~~~~~~~~~ 494 (549)
|||+|.+++++|++||++|++++...+++...++|+++.. +++.+|+||||++++.++..+.+.
T Consensus 461 apfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~~~~~~~~~~ 531 (550)
T KOG0605|consen 461 APFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFDGLNKANSLL 531 (550)
T ss_pred CCCCCCCCCcccccccccCcccccCcccccccccchhhhhcccccCCcccccccceeeecccccccccccc
Confidence 9999999999999999999999988888888888888655 577889999999999998887764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-86 Score=692.86 Aligned_cols=430 Identities=44% Similarity=0.785 Sum_probs=377.4
Q ss_pred HHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHhhhccCCHHHHHHHHHHHHhhhhhhhhhhcccCCCCCeeeeeeeeecC
Q 038137 50 VAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGA 129 (549)
Q Consensus 50 ~~~~k~~~~~~~~~~~~~~~~r~~r~~~~e~~~~~~~~~~ee~~~~~~~~~~~e~~~~~~~~~~~~~~~f~~~~~IG~G~ 129 (549)
-.+-|.|+|.|..+.++..++|..|++.||++|...++.+..++...+.|..+|..|+||+|.++...-|..++.||-|+
T Consensus 562 PqafkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGA 641 (1034)
T KOG0608|consen 562 PQAFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGA 641 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeecccc
Confidence 45788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCchhhHhh
Q 038137 130 FGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM 209 (549)
Q Consensus 130 fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~ 209 (549)
||+|++|+..+|...||||.|+|.+++.++++.|+++|++||++.+++|||+||++|||+++||+||+|++||||+++|.
T Consensus 642 FGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI 721 (1034)
T KOG0608|consen 642 FGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 721 (1034)
T ss_pred cceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc----ccccccccCCCc-
Q 038137 210 RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL----QEKDFSIGSNLS- 284 (549)
Q Consensus 210 ~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~----~~~~~~~~~~~~- 284 (549)
+.+.|.|+.|+||++++.+||+++|+.|+|||||||+|||||.+|||||+|||||..+.+... ..++-....+..
T Consensus 722 rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep 801 (1034)
T KOG0608|consen 722 RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEP 801 (1034)
T ss_pred HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCC
Confidence 999999999999999999999999999999999999999999999999999999997754311 111111000000
Q ss_pred CCccCCCCCCCCccchHHHHHH--HhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCC
Q 038137 285 GALQSDGRPVAPRRTQQEQLQH--WQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362 (549)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~ 362 (549)
.....+-.++ -..|.. .+..+|.++.+.|||+.|+|||||...+|+..|||||.|||||||++|++||.+++
T Consensus 802 ~~e~~d~~~~------lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 802 SPEWADISKC------LKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred chhhcccccc------chHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCC
Confidence 0000000011 111111 23456788999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccccccCCCcccCCCccc
Q 038137 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELD 442 (549)
Q Consensus 363 ~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p~~~~~~d 442 (549)
+.++..+|++|+..|.||....+|++|.|||.+|+|+++.|+|..++++|++||||++|||..|++..+||||.+..+.|
T Consensus 876 p~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptD 955 (1034)
T KOG0608|consen 876 PGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTD 955 (1034)
T ss_pred CCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccCCcccccccccccccccceeeCcc
Q 038137 443 TQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFE 485 (549)
Q Consensus 443 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 485 (549)
|+|||.++.+......+...+.|...-.--.-.|..|||..|-
T Consensus 956 TSNFdpvdpeklwnddses~~~~~~~nkhpehaFyEFTfRrFF 998 (1034)
T KOG0608|consen 956 TSNFDPVDPEKLWNDDSESPNVRDTLNKHPEHAFYEFTFRRFF 998 (1034)
T ss_pred cccCCcCCccccccccccCCCcccccccCCccceeEeeeehhc
Confidence 9999999886555444443333332222234689999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-81 Score=690.79 Aligned_cols=347 Identities=47% Similarity=0.858 Sum_probs=309.9
Q ss_pred HHHHHHhhhhhhhhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc
Q 038137 95 LLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV 174 (549)
Q Consensus 95 ~~~~~~~~e~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l 174 (549)
+.+++...+.-...+...++..+||+++++||+|+||+|.+++++.|+++||||+++|-+|.++.....|..|++||...
T Consensus 53 i~~fl~~~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ 132 (1317)
T KOG0612|consen 53 IAEFLNRYKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG 132 (1317)
T ss_pred HHHHHHHhHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC
Confidence 34455555555556677788999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCceeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC
Q 038137 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG 254 (549)
Q Consensus 175 ~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g 254 (549)
+++|||.|+|+|||+.++|+||||||||||.+++.+.+.++|+.|+||+++|+.||..||+.|+|||||||+|||||..|
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC
Confidence 99999999999999999999999999999999999988999999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-- 332 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-- 332 (549)
||||+|||.|-.++..+ . ......||||+|++||+|..
T Consensus 213 HikLADFGsClkm~~dG--------------------~--------------------V~s~~aVGTPDYISPEvLqs~~ 252 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADG--------------------T--------------------VRSSVAVGTPDYISPEVLQSQG 252 (1317)
T ss_pred cEeeccchhHHhcCCCC--------------------c--------------------EEeccccCCCCccCHHHHHhhc
Confidence 99999999998775321 0 01225799999999999973
Q ss_pred ---CCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCH
Q 038137 333 ---KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGA 409 (549)
Q Consensus 333 ---~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~ 409 (549)
+.||..||||||||+|||||+|.+|||+++-.+||.+|++.+..+.||....+|++++|||.+|||+|+.|+|++|+
T Consensus 253 ~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngi 332 (1317)
T KOG0612|consen 253 DGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGI 332 (1317)
T ss_pred CCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccH
Confidence 46999999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred HHHHcCCcccCCCccccccccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceeeC
Q 038137 410 DEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKN 483 (549)
Q Consensus 410 ~eil~HpfF~~i~w~~l~~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 483 (549)
++|+.||||.+++|+.|+...|||+|+++++.||+||+..++......+. +....+.++..++.|+||||..
T Consensus 333 edik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~--p~~~~~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 333 EDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDAETF--PPRIPKAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred HHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccccccccccchhhcc--CCCCCCCCcCCcCCeeeeeecc
Confidence 99999999999999999999999999999999999996543322211111 1112245677899999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-79 Score=612.28 Aligned_cols=293 Identities=48% Similarity=0.862 Sum_probs=271.8
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
....++|+++++||+|+||+|++|+.++|++.||||+|+|..+..++.++|+.+|++||..++||+||+|+++||+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|||+||++||+|+.+|.+.+.|+|+.++||+++|++||.|||++|||||||||||||||.+|||+|+|||||+.......
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999996421110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.+.++|||+.|||||++.+.+|+.+||||||||+|||||
T Consensus 181 -----------------------------------------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML 219 (357)
T KOG0598|consen 181 -----------------------------------------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEML 219 (357)
T ss_pred -----------------------------------------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHh
Confidence 012689999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-CCHHHHHcCCcccCCCccccc--c
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-KGADEIKAHPWFKGIEWDKLY--Q 428 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~HpfF~~i~w~~l~--~ 428 (549)
+|.+||++.+...++.+|+..+ +.++. ..+|.+++|||++||. ||++|+|. .++++|++||||++|+|+.+. .
T Consensus 220 ~G~pPF~~~~~~~~~~~I~~~k--~~~~p-~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~ 296 (357)
T KOG0598|consen 220 TGKPPFYAEDVKKMYDKILKGK--LPLPP-GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKK 296 (357)
T ss_pred hCCCCCcCccHHHHHHHHhcCc--CCCCC-ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcC
Confidence 9999999999999999999743 33332 2599999999999999 99999973 579999999999999999997 4
Q ss_pred ccCCCcccCCCcccccccccc
Q 038137 429 IKAAFIPEVNDELDTQNFEKF 449 (549)
Q Consensus 429 ~~~pf~p~~~~~~d~~~f~~~ 449 (549)
+.|||+|.+.+..|+++|+..
T Consensus 297 l~PpF~P~~~~~~~~~~Fd~e 317 (357)
T KOG0598|consen 297 LSPPFKPNVTGLEDTSNFDNE 317 (357)
T ss_pred CCCCeecCCCCccccccccHH
Confidence 899999999999999999973
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-77 Score=581.11 Aligned_cols=292 Identities=45% Similarity=0.930 Sum_probs=278.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...+||++++.||.|+||.|.+++++.+|..||||++.|..+.+..+++|+.+|+.||+.+.||++++|+++|+|..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
|||||++||.|+++|++.+.|+|..|+||++||++||+|||+++||||||||||||||++||+||+|||+|+.+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998641
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.+++.||||+|+|||++..++|+.++|||||||++|||+.
T Consensus 197 ----------------------------------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla 236 (355)
T KOG0616|consen 197 ----------------------------------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA 236 (355)
T ss_pred ----------------------------------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc
Confidence 1458999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--c
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--Q 428 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~ 428 (549)
|++||++.++..++.+|+. ..+.||. .+|++++|||++||+ |-.+|+|. +|..+|++||||++++|+.+. .
T Consensus 237 G~pPF~~~~~~~iY~KI~~--~~v~fP~--~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ 312 (355)
T KOG0616|consen 237 GYPPFYDDNPIQIYEKILE--GKVKFPS--YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRK 312 (355)
T ss_pred CCCCCcCCChHHHHHHHHh--CcccCCc--ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhcc
Confidence 9999999999999999998 6789996 899999999999999 99999986 589999999999999999997 4
Q ss_pred ccCCCcc-cCCCcccccccccccccc
Q 038137 429 IKAAFIP-EVNDELDTQNFEKFEEAD 453 (549)
Q Consensus 429 ~~~pf~p-~~~~~~d~~~f~~~~~~~ 453 (549)
+++||+| .+..+.|++||+.+.+.+
T Consensus 313 ie~P~~pp~~~~~gdtsnfd~y~e~~ 338 (355)
T KOG0616|consen 313 IEPPFEPPNIHGPGDTSNFDDYEEED 338 (355)
T ss_pred ccCCCCCccccCCccccccccccccc
Confidence 8999998 889999999999987654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-73 Score=605.38 Aligned_cols=323 Identities=37% Similarity=0.720 Sum_probs=289.5
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~ 190 (549)
.++..++|.++++||+|+||+|++|..+.+++.||||+++|..++.+..++..+.|..|+.... ||+++.||++||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4788999999999999999999999999999999999999999999999999999999998875 999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
++|+||||+.||| +.+++..+.|+|..|+||+++|++||.|||++||||||||.+|||||.+||+||+||||||.....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999999 555567789999999999999999999999999999999999999999999999999999975311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. ..+.++||||.|||||+|.+..|+.++|||||||+|||
T Consensus 522 g-----------------------------------------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlye 560 (694)
T KOG0694|consen 522 G-----------------------------------------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYE 560 (694)
T ss_pred C-----------------------------------------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHH
Confidence 1 11348999999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~ 427 (549)
||+|.+||.+++..+.+..|++ ..+.+|. ++|.++.+++++||+ +|++|+|+ .++++|++||||+.|+|+.|+
T Consensus 561 ML~Gq~PF~gddEee~FdsI~~--d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~ 636 (694)
T KOG0694|consen 561 MLVGESPFPGDDEEEVFDSIVN--DEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL 636 (694)
T ss_pred HHcCCCCCCCCCHHHHHHHHhc--CCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHh
Confidence 9999999999999999999998 5677775 899999999999999 99999997 579999999999999999997
Q ss_pred --cccCCCcccCCCccccccccccccccccccccccCCccccccc-ccccccccceeeCc
Q 038137 428 --QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLS-SKDINFVGYTYKNF 484 (549)
Q Consensus 428 --~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~~ 484 (549)
+++|||+|.++++.|.+|||+....+.+..+.... ..+. ..+..|.||+|.+.
T Consensus 637 ~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~----~~l~~~~q~~F~~Fs~~~~ 692 (694)
T KOG0694|consen 637 NRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDP----RPLTEEEQEAFRDFSFVAE 692 (694)
T ss_pred hccCCCCCCcccCChhhhcccchhhhcCCCccCCCCc----cccchhhHHHhcCccccCC
Confidence 48999999999999999999855544444333221 2222 35568999999764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-69 Score=541.85 Aligned_cols=330 Identities=37% Similarity=0.629 Sum_probs=272.9
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
+...+..++|++++.||+|.-|+||+|+.+.++..+|||+|.|..+..+....++..|++||+.++||+++.||..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44567788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
++.|||||||+||||..+++++ +.|++..|+||+++++.||+|||.+|||+||||||||||-++|||.|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999764 67999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCc-CCccC-CCCCCCCcc--chH----------HHHHHH-hhhcccceeecccCCCCCCchhhcc
Q 038137 268 DCSNLQEKDFSIGSNLS-GALQS-DGRPVAPRR--TQQ----------EQLQHW-QRNRRMLAYSTVGTPDYIAPEVLLK 332 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~--~~~----------~~~~~~-~~~~~~~~~s~vGT~~Y~APEvl~~ 332 (549)
.....-....+...... ..-.. ......++. ..+ ..+... -........++|||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 32110000000000000 00000 000000000 000 000000 0111233458999999999999999
Q ss_pred CCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-CCHH
Q 038137 333 KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-KGAD 410 (549)
Q Consensus 333 ~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~ 410 (549)
.+++.++|||+|||++||||+|..||.|.+..+++.+|+. ..+.||..+.+|..|+|||++||. ||.+|+|+ .||.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 9999999999999999999999999999999999999997 789999988999999999999999 99999997 6899
Q ss_pred HHHcCCcccCCCccccccccCCCcccCCCcc
Q 038137 411 EIKAHPWFKGIEWDKLYQIKAAFIPEVNDEL 441 (549)
Q Consensus 411 eil~HpfF~~i~w~~l~~~~~pf~p~~~~~~ 441 (549)
||++||||++++|.-++...||+||...+..
T Consensus 388 eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 388 EIKRHPFFEGVNWALIRCARPPEIPKPVDGG 418 (459)
T ss_pred HhhcCccccCCChhheeccCCCcCCCccccC
Confidence 9999999999999988889999999876543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-70 Score=532.69 Aligned_cols=330 Identities=38% Similarity=0.697 Sum_probs=291.0
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
..+.++..++|+.+++||+|.||+|-+|+.+.||+.||||+++|..++.+..+.|...|-.+|...+||++..|.|+||+
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 35667889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+.+|+||||+.||+|+.+|.+...|+|+.++||-++|+.||.|||+.+||+||||.+|+|||++|||||+|||||+.-.
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999642
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.. | ....++||||.|+|||+|....|+.++|||.+||+|
T Consensus 320 ~~--------------------g---------------------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVM 358 (516)
T KOG0690|consen 320 KY--------------------G---------------------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVM 358 (516)
T ss_pred cc--------------------c---------------------ceeccccCChhhcCchhhccccccceeehhhhhHHH
Confidence 11 0 012378999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~ 425 (549)
|||++|+.||++.+....+..|+. ..++||. .+|++|+.|+..||. ||.+|+|. .+|.||.+|+||.+|+|+.
T Consensus 359 YEMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 359 YEMMCGRLPFYNKDHEKLFELILM--EDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred HHHHhccCcccccchhHHHHHHHh--hhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 999999999999999999988886 6789996 899999999999999 99999986 3699999999999999999
Q ss_pred cc--cccCCCcccCCCcccccccccccccccccccc-ccCCcccccccccccccccceeeC
Q 038137 426 LY--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTS-AKSGPWRKMLSSKDINFVGYTYKN 483 (549)
Q Consensus 426 l~--~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~f~g~~~~~ 483 (549)
++ ++.|||.|.+.++.|+++||+........-+. ...++...+-.....+|.-|+|.+
T Consensus 435 ~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~ 495 (516)
T KOG0690|consen 435 TYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSA 495 (516)
T ss_pred HHHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccchhhhhccCCcceeeec
Confidence 87 48999999999999999999743332211111 122221112223456788888864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-67 Score=544.38 Aligned_cols=285 Identities=40% Similarity=0.733 Sum_probs=258.7
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCce
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 191 (549)
+....||.+.+.||.|+|++|++|+++.|++.||||++.|..+.+...+..+.+|+++|..+ .||.||+||+.|||+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45688999999999999999999999999999999999999999999999999999999999 89999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+|+||+++|+|.++|.+.+.|+|..+|+|++||+.||+|||++|||||||||||||||.+||+||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987553
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
...... ..+... .....++|||..|.+||+|.....+..||+|+||||||.|
T Consensus 229 ~~~~~~----------------~~~~~a------------~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQm 280 (604)
T KOG0592|consen 229 KSQENP----------------VDPNQA------------SSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQM 280 (604)
T ss_pred ccccCc----------------cCcccc------------cCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHH
Confidence 221110 000000 0002379999999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccccccc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIK 430 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~ 430 (549)
+.|.|||.+.++.-++++|+. -...||+ .+++.++|||.+||. ||.+|+ |+++|++||||.+|+|++|.+..
T Consensus 281 laG~PPFra~NeyliFqkI~~--l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rl---t~~qIk~HpFF~~Vdw~nlw~~~ 353 (604)
T KOG0592|consen 281 LAGQPPFRAANEYLIFQKIQA--LDYEFPE--GFPEDARDLIKKLLVRDPSDRL---TSQQIKAHPFFEGVDWENLWQQT 353 (604)
T ss_pred hcCCCCCccccHHHHHHHHHH--hcccCCC--CCCHHHHHHHHHHHccCccccc---cHHHHhhCcccccCChhhhhhcC
Confidence 999999999999999999997 4566775 899999999999999 999999 79999999999999999999876
Q ss_pred CC
Q 038137 431 AA 432 (549)
Q Consensus 431 ~p 432 (549)
||
T Consensus 354 PP 355 (604)
T KOG0592|consen 354 PP 355 (604)
T ss_pred CC
Confidence 65
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-66 Score=525.73 Aligned_cols=358 Identities=33% Similarity=0.610 Sum_probs=296.3
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+..+.++.+.|...++||+||||+||-|+.+.||+.||+|++.|..+.++.......+|+.||..+++++||.|-|+|++
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 56678899999999999999999999999999999999999999999888888899999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.+.+||||..|.||||..+|.+.+ .|+|..++||++||++||++||..+||+|||||+|||||+.|||+|+|+|||..
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999999999997755 899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
+... .++ .+.|||.+|||||++.+..|+.++|||||||
T Consensus 337 i~~g---------------------~~~---------------------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGC 374 (591)
T KOG0986|consen 337 IPEG---------------------KPI---------------------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGC 374 (591)
T ss_pred cCCC---------------------Ccc---------------------ccccCcccccCHHHHcCCcccCCccHHHHHh
Confidence 6422 111 1469999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCc----hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCccc
Q 038137 347 IMYEMLVGYPPFYSDEP----MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFK 419 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~----~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~ 419 (549)
++|||+.|+.||..... .+.-+.++. ....+|+ .+|+++++|++.||+ ||++|+|+ .+++++++||||+
T Consensus 375 llYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~--kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk 450 (591)
T KOG0986|consen 375 LLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSD--KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK 450 (591)
T ss_pred HHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhccc--ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence 99999999999976432 234444554 4566774 899999999999999 99999998 4799999999999
Q ss_pred CCCccccc--cccCCCcccC-----CCccccccccc-----cccccc----cccccccCCcccc-cccccccccccceee
Q 038137 420 GIEWDKLY--QIKAAFIPEV-----NDELDTQNFEK-----FEEADN----QIQTSAKSGPWRK-MLSSKDINFVGYTYK 482 (549)
Q Consensus 420 ~i~w~~l~--~~~~pf~p~~-----~~~~d~~~f~~-----~~~~~~----~~~~~~~~~~~~~-~~~~~~~~f~g~~~~ 482 (549)
++||.+++ .++|||+|+. ++.+|+.+|+. ++..+. .+.+.+.+.||++ |+++.- |.-.
T Consensus 451 ~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VKGV~ld~~D~~fy~~F~tg~vsipWQnE~~ET~~-----f~el 525 (591)
T KOG0986|consen 451 DLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVKGVKLDDTDTDFYKNFATGSVSIPWQNEMIETEC-----FEEL 525 (591)
T ss_pred cCCHhHHhccCCCCCCCCCccccchhhhhhhhhcccccceecccccHHHHHhccCCcccchHHHHHHHhhh-----HHHh
Confidence 99999998 4899999986 56778888885 233322 4577788999997 544411 1111
Q ss_pred CccccCCCCCchhhhhhcccCCCCCCccccccccCC
Q 038137 483 NFEIVNDHQLPGIAELKKKSTKPKRPSIKSLFEDES 518 (549)
Q Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 518 (549)
|-+.. +...++......++..++++...++|....
T Consensus 526 nv~~~-~~~~~~d~~~~~p~~~~~~~~~~~l~~~~~ 560 (591)
T KOG0986|consen 526 NVFGD-DGAKNPDLRYLFPNRLEKRGEGPRLFTMKN 560 (591)
T ss_pred hcccc-ccccCcchhcccCCccccCCCCcccccccc
Confidence 11111 112222222334555667777778887543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-67 Score=522.80 Aligned_cols=331 Identities=35% Similarity=0.666 Sum_probs=296.2
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCC
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDD 189 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~ 189 (549)
+..+...||.++.+||+|+||+|.+|..+.|.+.||||+++|..++....++....|..+|+.. +-|++|.|+.+||+-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3456788999999999999999999999999999999999999988888899999999999887 468999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
+.+|+||||+.||||+.+++..+.|.|..|.||+++|+.||-+||++|||+||||.+|||||.+|||||+|||+|+.-..
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999996422
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. ..+.++||||+|||||++...+|+.++||||+||+||
T Consensus 503 ~~-----------------------------------------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLy 541 (683)
T KOG0696|consen 503 DG-----------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 541 (683)
T ss_pred CC-----------------------------------------cceeeecCCCcccccceEEecccccchhHHHHHHHHH
Confidence 11 1133789999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCcccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~~l 426 (549)
|||.|.+||.+++..+.++.|+. ....+|. .+|.+|.+++..+|+ .|.+|+|+. +-.+|..||||+.|||+++
T Consensus 542 EmlaGQpPFdGeDE~elF~aI~e--hnvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 542 EMLAGQPPFDGEDEDELFQAIME--HNVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL 617 (683)
T ss_pred HHHcCCCCCCCCCHHHHHHHHHH--ccCcCcc--cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence 99999999999999999999997 5677886 899999999999999 999999973 5688999999999999999
Q ss_pred c--cccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceeeCccccCC
Q 038137 427 Y--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFEIVND 489 (549)
Q Consensus 427 ~--~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~ 489 (549)
+ ++.|||.|.++...+++|||++........+. ..+.-|.+-.+..|.||+|.|.++|..
T Consensus 618 E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTP---pD~~v~~nldq~eF~gFsfvNpefv~~ 679 (683)
T KOG0696|consen 618 ERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTP---PDKLVMMNLDQSEFEGFSFVNPEFVKP 679 (683)
T ss_pred hhccCCCCCCCccccCCchhhhhHHHhcCCCCCCC---chHHHHhcCchhhcCceeeeChhhcCC
Confidence 7 58999999999999999999977655433322 223335555777899999999987753
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-62 Score=514.11 Aligned_cols=364 Identities=61% Similarity=1.070 Sum_probs=302.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||+||+|+++.+|+.||||++.+..+.......++.+|+.+|..++||||++++++|++.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 57999999999999999999999999999999998876666677788999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876432111000
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
........... ................|...++...++.+||+.|+|||++.+.+|+.++|||||||++|||++|.+
T Consensus 161 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 161 RILSHALPSNF---LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccc---cccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 00000000000 000000111122234566666666778899999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccccccCCCccc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPE 436 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p~ 436 (549)
||.+.+....+.++++|...+.+|....+|+++++||.+||++|.+|+++.++++++.||||++++|+.+....+|++|.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 99999988899999998888888887788999999999999999999976779999999999999999998889999999
Q ss_pred CCCccccccccccccccccccccccCCcccccccccccccccceeeCcc
Q 038137 437 VNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFE 485 (549)
Q Consensus 437 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 485 (549)
+.+..|.++|+.+++.......+. ........+++..|+||+|++|+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 318 LKSITDTSNFDDFEEIDLDVPTSP--GPPRGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred CCCchhhhhccccccccccccCCC--ccccccccccCCCCCCCeeeCCC
Confidence 999999999998876654433322 11222345689999999999885
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-62 Score=511.07 Aligned_cols=362 Identities=54% Similarity=0.949 Sum_probs=291.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||+||+|+++.+|+.||||++.+..........++.+|+.++..++||||++++++|++...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998877666667788999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||+||+|.+++.+.+.+++..++.|+.|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~-- 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE-- 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc--
Confidence 999999999999888999999999999999999999999999999999999999999999999999998654221000
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
+.. ........+... ...........|.+++.....+.+||+.|+|||++.+.+|+.++|||||||++|||++|++
T Consensus 159 ~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 159 FYR--NLNHSLPSDFTF--QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccc--cccccccccccc--cccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 000 000000000000 0000001112344444445567899999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccccccCCCccc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPE 436 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p~ 436 (549)
||.+.+..+.+.+|++|...+.+|....+|+++++||.+|+|+|.+|+++.+++||++||||++++|+.+....++..+.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 314 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIE 314 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCcc
Confidence 99999999999999998888888877779999999999999999999988899999999999999999998766666667
Q ss_pred CCCccccccccccccccccccccccCCcccccccccccccccceeeCc
Q 038137 437 VNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNF 484 (549)
Q Consensus 437 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~ 484 (549)
+....|+++|+.+........+...+..-.......+..|.||||+.|
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (363)
T cd05628 315 IKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKRF 362 (363)
T ss_pred CCCcchhhccCCCCccccccccccccCCcccccCcCCcccCCceeecC
Confidence 788889999998765443222111110001123345567999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-61 Score=504.92 Aligned_cols=369 Identities=51% Similarity=0.935 Sum_probs=293.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||+||+|.++.+|+.||||++.+..........++.+|+.+|..++|||||+++++|++..++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998876656667788999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc--
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE-- 274 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~-- 274 (549)
||++||+|..++...+.+++..+++++.|++.||+|||++||+||||||+|||++.+|++||+|||+|+.+.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999997543211000
Q ss_pred ccccccCCC----cCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 275 KDFSIGSNL----SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 275 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.....+... ....................+..|...+.....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 000000000 0000000000000111122334455555555557899999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCcccccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIK 430 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~ 430 (549)
|++|.+||.+.+..+.+.+|..|...+.+|....+|.++++||.+||++|.+|+++.++.+++.||||++++|+.+..+.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~ 320 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIR 320 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHHHccCC
Confidence 99999999998888888999988888888877789999999999999999999988899999999999999999999999
Q ss_pred CCCcccCCCccccccccccccccccccccccC-Ccc-cccccccccccccceeeCcc
Q 038137 431 AAFIPEVNDELDTQNFEKFEEADNQIQTSAKS-GPW-RKMLSSKDINFVGYTYKNFE 485 (549)
Q Consensus 431 ~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~f~g~~~~~~~ 485 (549)
+|++|.+....++.+|................ .+. .......+..|+||||+.|+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (377)
T cd05629 321 APFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRFD 377 (377)
T ss_pred CCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCCC
Confidence 99999999988888886533322111111110 010 11233467899999999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-62 Score=492.24 Aligned_cols=263 Identities=33% Similarity=0.554 Sum_probs=234.6
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc----hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR----RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
..+.|.+.+.||+|+||.|.+|..+.||+.||||++++..... ......+.+|++||+.++|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4566889999999999999999999999999999999865543 223445789999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC---CcEEEeecCccccc
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN---GHMKLSDFGLCKPL 267 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~---g~vKL~DFGlak~~ 267 (549)
+.||||||+.||+|++.+..++.+.|...+.|+.|++.||.|||+.||+||||||+|||+..+ .++||+||||||..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999877 78999999999976
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC---Ccccccchh
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY---GMECDWWSL 344 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y---~~~~DiWSl 344 (549)
.... ...+.||||.|.||||+.++++ ..++|+|||
T Consensus 330 g~~s------------------------------------------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl 367 (475)
T KOG0615|consen 330 GEGS------------------------------------------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL 367 (475)
T ss_pred ccce------------------------------------------ehhhhcCCccccChhheecCCeecccchheeeec
Confidence 4211 1237899999999999998764 558899999
Q ss_pred hHHHHHHhhCCCCCCCCCchh-hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 345 GAIMYEMLVGYPPFYSDEPMS-TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~-~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
||+||-||+|+|||.+..... ...+|...+..+.-|.+..+|.+++|||.+||. ||++|+ +++|+|+||||+.++
T Consensus 368 GcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~---s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 368 GCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP---SADEALNHPWFKDAP 444 (475)
T ss_pred cceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc---CHHHHhcChhhhccc
Confidence 999999999999998876555 778888876666667778999999999999999 999999 899999999999765
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-63 Score=508.53 Aligned_cols=300 Identities=37% Similarity=0.744 Sum_probs=281.8
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
..+...+++.+..||-||||.|=++........+|+|+|+|..+.+..+.+|+..|++||..+++|+||+||-.|.|+.+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 35667889999999999999999999877666799999999999999999999999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+.||-|-||+|++.|..++.|++..++||++.++.|++|||++|||+|||||+|+|||.+|.+||.|||+||.+....
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999875321
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.+.++||||.|.|||++++++++.++|+||||+++|||
T Consensus 575 ------------------------------------------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~EL 612 (732)
T KOG0614|consen 575 ------------------------------------------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYEL 612 (732)
T ss_pred ------------------------------------------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHH
Confidence 23489999999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCC--CCCHHHHHcCCcccCCCccccc-
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG--TKGADEIKAHPWFKGIEWDKLY- 427 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~--~~~~~eil~HpfF~~i~w~~l~- 427 (549)
|+|.|||.+.+++.+|..|+.....+.||. .++..+.+||++|.. +|.+|+| ++++.+|++|.||.++||+.|+
T Consensus 613 L~G~pPFs~~dpmktYn~ILkGid~i~~Pr--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~ 690 (732)
T KOG0614|consen 613 LTGSPPFSGVDPMKTYNLILKGIDKIEFPR--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRS 690 (732)
T ss_pred HcCCCCCCCCchHHHHHHHHhhhhhhhccc--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhh
Confidence 999999999999999999999988899995 899999999999887 9999999 5899999999999999999997
Q ss_pred -cccCCCcccCCCcccccccccccccccc
Q 038137 428 -QIKAAFIPEVNDELDTQNFEKFEEADNQ 455 (549)
Q Consensus 428 -~~~~pf~p~~~~~~d~~~f~~~~~~~~~ 455 (549)
.++|||+|.+.++.|++||+.|....+.
T Consensus 691 ~~L~pPi~~~va~ptD~s~Fd~~p~dnd~ 719 (732)
T KOG0614|consen 691 RTLPPPIIPSVANPTDVSNFDNFPPDNDE 719 (732)
T ss_pred ccCCCCccccCCCcccchhccCCCcccCC
Confidence 5899999999999999999998765543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-60 Score=505.39 Aligned_cols=366 Identities=46% Similarity=0.806 Sum_probs=288.1
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++++.||+|+||.||+|+++.+++.||||++.+..........++.+|+.+|+.++|||||+++++|++++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999998776667778899999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc----
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ---- 273 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~---- 273 (549)
||+||+|.+++.+.+.+++..++++++||+.||.|||++|||||||||+|||++.+|++||+|||+|..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999988889999999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccC--CCcCCccCC-CCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 274 EKDFSIGS--NLSGALQSD-GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 274 ~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
..+..... ..+...... ...........+....+ ........+.+||+.|+|||++.+.+|+.++|||||||++||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAAR-QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhcc-ccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00000000 000000000 00000000000000000 011122346799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCcccc-ccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKL-YQI 429 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l-~~~ 429 (549)
|++|++||.+.++.+...++++|...+.+|....+|+++++||.+|+++|.+|+++.++++|+.||||++++|... .+.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~ 320 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQ 320 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHHHHhcC
Confidence 9999999999998888899998888888887778999999999998779999998878999999999999999874 567
Q ss_pred cCCCcccCCCccccccccccccccccccc------cccCCcccccccccccccccceeeCc
Q 038137 430 KAAFIPEVNDELDTQNFEKFEEADNQIQT------SAKSGPWRKMLSSKDINFVGYTYKNF 484 (549)
Q Consensus 430 ~~pf~p~~~~~~d~~~f~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~f~g~~~~~~ 484 (549)
.+|++|.+..+.|+++|+.++..+..... ......|......++..|.||||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (382)
T cd05625 321 SAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHPEHAFYEFTFRRF 381 (382)
T ss_pred CCCccCcCCCcchhhhcCCCCccccccccccccccccccccccccccccCcccccceeccc
Confidence 88999999999999999876543321110 01111233334457789999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-61 Score=504.13 Aligned_cols=257 Identities=39% Similarity=0.635 Sum_probs=242.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
.+|...+.||+|||+.||.+++..+|+.||+|++.|+.+.+..+.+.+.+|++|.+.++|||||++|++|+|.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|+|+.|+|+.++.+...|+|.+|++|+.||+.||.|||+++|||||||..||+|+.+.+|||+|||||..+....-
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E---- 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE---- 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998753210
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
...+.||||.|+||||+.+.+++.++||||+|||||-||+|+|
T Consensus 174 -------------------------------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~P 216 (592)
T KOG0575|consen 174 -------------------------------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRP 216 (592)
T ss_pred -------------------------------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCC
Confidence 1137899999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc-cCC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF-KGI 421 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF-~~i 421 (549)
||...+-.+++.+|.. ....+|. .+|.+|+|||.+||. ||.+|+ ++++|+.|+|| ++.
T Consensus 217 PFetk~vkety~~Ik~--~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rp---sl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 217 PFETKTVKETYNKIKL--NEYSMPS--HLSAEAKDLIRKLLRPNPSERP---SLDEVLDHPFFKSGF 276 (592)
T ss_pred CcccchHHHHHHHHHh--cCccccc--ccCHHHHHHHHHHhcCCcccCC---CHHHHhcCHhhhCCC
Confidence 9999999999999987 5677776 899999999999999 999999 89999999999 444
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-60 Score=495.16 Aligned_cols=360 Identities=52% Similarity=0.932 Sum_probs=290.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.++..++||||++++++|++.+++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998876666677788999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||+||+|.+++.+.+.+++..++++++|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+........-
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999865422100000
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
..... .......-... ........|..++...+++.+||+.|+|||++.+.+|+.++|||||||++|||++|++
T Consensus 161 ~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 161 RNLTH--NPPSDFSFQNM----NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccc--CCccccccccc----ccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00000 00000000000 0000111233444455567899999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccccccCCCccc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPE 436 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p~ 436 (549)
||.+.++...+.+|++|...+.+|....+|+++++||.+|+.+|.+|+++.++++|+.||||++++|..+....++..+.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 314 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIE 314 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCcc
Confidence 99999999999999988877888876678999999999976699999988889999999999999999998766555566
Q ss_pred CCCccccccccccccccccccccccCCcccccccccccccccceeeCcc
Q 038137 437 VNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFE 485 (549)
Q Consensus 437 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 485 (549)
+....|+++|+.+.+........... ..-..+++..|.+|+|+.++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 315 IKSIDDTSNFDEFPESDILQPAENTI---EPDYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred CCCcchhhhcCCCCcccccCCCcccc---ccccCcCCcccCCceeecCC
Confidence 77888999998776554322221111 12345677889999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-59 Score=494.88 Aligned_cols=364 Identities=46% Similarity=0.846 Sum_probs=282.9
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|++++.||+|+||+||+|+++.+++.||||++.+..........++.+|+.+|..++|||||+++++|.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999998777677778889999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
||+||+|.+++.+.+.+++..++++++||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+....... .+
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~-~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK-YY 160 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc-cc
Confidence 99999999999888899999999999999999999999999999999999999999999999999987553211000 00
Q ss_pred cccCCC------cCCccCCCCCCC-CccchHHHHH--HHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 278 SIGSNL------SGALQSDGRPVA-PRRTQQEQLQ--HWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 278 ~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..+... ......+..... ..+. ..+. .........+.+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRL--KTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccCccccccccccccccccc--chhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 000000 000000000000 0000 0000 0000111223467999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccc-
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLY- 427 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~- 427 (549)
|||++|.+||.+.+......+++.|...+.+|....+|+++++||.+|||.+.+|.++.++++|++||||.+++|....
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~~~ 318 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIR 318 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHHhh
Confidence 9999999999998888888888888777888877789999999999999866666666699999999999999998754
Q ss_pred cccCCCcccCCCcccccccccccccccccccc-ccCCccccccc----ccccccccceeeCc
Q 038137 428 QIKAAFIPEVNDELDTQNFEKFEEADNQIQTS-AKSGPWRKMLS----SKDINFVGYTYKNF 484 (549)
Q Consensus 428 ~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~f~g~~~~~~ 484 (549)
...+|++|.+..+.++++|+.+++.......+ .....|....+ .....|.||||+.|
T Consensus 319 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (381)
T cd05626 319 TQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRRF 380 (381)
T ss_pred cCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeecc
Confidence 56789999999999999998765433211111 11112222211 23568999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-60 Score=465.64 Aligned_cols=327 Identities=34% Similarity=0.659 Sum_probs=275.5
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
+.+..+||.++++||+|+|++|.+++.+.|.++||||+++|.-....+.+.-+..|..+.... +||++|-|+.+||++.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 457789999999999999999999999999999999999987777777888899999998765 7999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+++|.||++||||+.++++...|+|++|+||.++|++||.|||+.|||+||||.+|+|||..||+||+|+|+|+..-.
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~- 403 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG- 403 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999996321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
..+ .+.++||||.|+|||+|.+..|++++|||+|||+|||
T Consensus 404 ---~gd-------------------------------------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfe 443 (593)
T KOG0695|consen 404 ---PGD-------------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 443 (593)
T ss_pred ---CCc-------------------------------------ccccccCCCcccchhhhcccccCceehHHHHHHHHHH
Confidence 111 1237899999999999999999999999999999999
Q ss_pred HhhCCCCCCC---CC----chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC---CCHHHHHcCCccc
Q 038137 351 MLVGYPPFYS---DE----PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPWFK 419 (549)
Q Consensus 351 ml~G~~PF~~---~~----~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~HpfF~ 419 (549)
|+.|+.||.- ++ ..+.+.+|+- ..++++|. .+|-.|..+++..|. ||.+|+|+ .+..+|+.||||+
T Consensus 444 mmagrspfdivgm~n~d~ntedylfqvil-ekqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 444 MMAGRSPFDIVGMDNPDMNTEDYLFQVIL-EKQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred HHcCCCCcceecCCCcccchhHHHHHHHh-hhcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 9999999952 22 2222333332 24567775 788999999999999 99999997 3799999999999
Q ss_pred CCCcccccc--ccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceeeCcc
Q 038137 420 GIEWDKLYQ--IKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFE 485 (549)
Q Consensus 420 ~i~w~~l~~--~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 485 (549)
.|||+.+.+ +.|||.|.+.++.+..||+.-...+....+......++ .-.+..|.||.|.|.-
T Consensus 521 ~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i~---ridqsefegfeyinpl 585 (593)
T KOG0695|consen 521 SIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIK---RIDQSEFEGFEYINPL 585 (593)
T ss_pred hCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCHHHHH---hcchhhcCcceecchh
Confidence 999999985 78999999999999999996333332222221111111 1134579999998854
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-57 Score=481.20 Aligned_cols=366 Identities=47% Similarity=0.828 Sum_probs=283.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
.+|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|..++||||+++++.|++++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc--
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE-- 274 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~-- 274 (549)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987543211000
Q ss_pred --ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 275 --KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 275 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.....................+.... . ...-.........+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPL-E-RRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccch-h-hhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00000000000000000000000000 0 0000000112233578999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCcccc-ccccC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKL-YQIKA 431 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l-~~~~~ 431 (549)
+|++||.+.++.+...++..|...+.+|....+|+++.+||.+|+++|.+|++..+++++++||||++++|..+ ..+.+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~ 318 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKA 318 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCC
Confidence 99999999988888888888877777777678999999999998779999998778999999999999999888 46788
Q ss_pred CCcccCCCccccccccccccccccccccccCCcccc----cccccccccccceeeCc
Q 038137 432 AFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRK----MLSSKDINFVGYTYKNF 484 (549)
Q Consensus 432 pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~f~g~~~~~~ 484 (549)
|++|.+..+.|+++|+...........+..+.++.. ........|.-|+|.+|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (376)
T cd05598 319 PYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFRRF 375 (376)
T ss_pred CCCCcCCCcchhhhcCCCCcccccccccccccccccccccccccCCcccccceeccc
Confidence 999999999999999876544332222211111111 11223456777777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-57 Score=476.76 Aligned_cols=329 Identities=44% Similarity=0.890 Sum_probs=277.1
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+.+..+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 34456677899999999999999999999999999999999988666555566778899999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+..+|+|||||+||+|.+++.. ..+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999999998854 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC----CCcccccchh
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSL 344 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~----y~~~~DiWSl 344 (549)
.... ....+.+||+.|+|||++.+.+ |+.++|||||
T Consensus 194 ~~~~----------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05621 194 ETGM----------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred cCCc----------------------------------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEee
Confidence 2110 0012468999999999998643 7899999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCcc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
||++|||++|.+||.+.+....+.+|+.....+.+|....+|..+++||.+||+++..|+++.+++|+++||||++..|+
T Consensus 234 G~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 234 GVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 99999999999999999888888888876666778877778999999999999988888877799999999999986654
Q ss_pred --ccccccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceee
Q 038137 425 --KLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYK 482 (549)
Q Consensus 425 --~l~~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 482 (549)
.+....+|++|.+....|.++|+..++...... ....| .........|.||+|-
T Consensus 314 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~ 369 (370)
T cd05621 314 WDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVE--TFPIP--KAFVGNQLPFIGFTYY 369 (370)
T ss_pred hHhcCCCCCCcCCCCCCcchhhhcCCccccccccc--cCCCC--ccccccccccCCCEec
Confidence 455678999999999999999987654432211 11111 2122235899999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-57 Score=474.18 Aligned_cols=349 Identities=56% Similarity=0.998 Sum_probs=286.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|..++||||++++++|++++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999999877666677788999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876432200000
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
....... ........ .......+.......+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 161 ~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 161 LNDSHNL---LFRDNVLV---------RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccccccc---cccccccc---------cccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 0000000 00000000 00000011122335689999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCC-HHHHHcCCcccCCCccccccccCCCcc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKG-ADEIKAHPWFKGIEWDKLYQIKAAFIP 435 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~-~~eil~HpfF~~i~w~~l~~~~~pf~p 435 (549)
||.+.+....+.++..|...+.+|....+++++++||.+||++|.+|+ + ++++++||||++++|+......+|++|
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~---~s~~~ll~hp~~~~~~~~~~~~~~~~~~~ 305 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRL---GSFEEIKSHPFFKGIDWENLRETKPPFVP 305 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcC---CCHHHHhcCCCcCCCCHHHHhhCCCCcCC
Confidence 999999888999999988888888877789999999999999999999 5 999999999999999999988999999
Q ss_pred cCCCccccccccccccccccccccccCCcccccccccccccccceee
Q 038137 436 EVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYK 482 (549)
Q Consensus 436 ~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 482 (549)
.+..+.++.+|+..+........ .+....+.-.....+|+||+|+
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 350 (350)
T cd05573 306 ELSSPLDTSNFDDFEDDKDLSDY--LSQNSKKLNKGKQLAFVGFTYK 350 (350)
T ss_pred CCCCchhhhhcCCCCcccccccc--cccccccccccccCccCCCccC
Confidence 99999999999987665432211 1111112223456789999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-57 Score=474.73 Aligned_cols=329 Identities=46% Similarity=0.871 Sum_probs=279.5
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45567778999999999999999999999999999999999987766566666778899999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+.++|+|||||+||+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999999998854 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC----CCcccccchh
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSL 344 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~----y~~~~DiWSl 344 (549)
..... ...+.+||+.|||||++.+.. |+.++|||||
T Consensus 194 ~~~~~----------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSl 233 (371)
T cd05622 194 KEGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (371)
T ss_pred cCCcc----------------------------------------cccCcccCccccCHHHHhccCCCccCCCccceeeh
Confidence 21100 012468999999999997643 8899999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCC--
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIE-- 422 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~-- 422 (549)
||++|||++|.+||.+.+....+.+|+.....+.+|....+|.++++||.+||.+|..|+++.++++|++||||++.+
T Consensus 234 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 234 GVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 999999999999999999888899998766667788777899999999999999888998888999999999999865
Q ss_pred ccccccccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceee
Q 038137 423 WDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYK 482 (549)
Q Consensus 423 w~~l~~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 482 (549)
|+.+....+|++|.+....++++|++.........+. +....+.+....|.||+|.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 369 (371)
T cd05622 314 WETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETF----PIPKAFVGNQLPFVGFTYY 369 (371)
T ss_pred HHhcCCCCCCCCCCCCCcchhhhcCCCcccccccccC----CCCccccccccccCCCeec
Confidence 4566678899999999999999998765433211111 1112333345899999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-56 Score=469.37 Aligned_cols=328 Identities=46% Similarity=0.884 Sum_probs=274.3
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
....+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+.+++.++||||++++++|.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34456788999999999999999999999999999999999887665666667788999999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||++||+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998854 5689999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC----CCCcccccchhh
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK----GYGMECDWWSLG 345 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~----~y~~~~DiWSlG 345 (549)
.... .....+||+.|+|||++.+. .|+.++||||||
T Consensus 195 ~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlG 234 (370)
T cd05596 195 NGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (370)
T ss_pred CCcc----------------------------------------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehh
Confidence 1100 01146899999999999754 388999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccc
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
|++|||++|++||.+.+....+.+|+.....+.+|....+|.++++||.+||+++.+|+++.++++|++||||++.+|..
T Consensus 235 vilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~~ 314 (370)
T cd05596 235 VFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTF 314 (370)
T ss_pred HHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChhh
Confidence 99999999999999998888888898766677888777899999999999999444555556999999999999988864
Q ss_pred --cccccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceee
Q 038137 426 --LYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYK 482 (549)
Q Consensus 426 --l~~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 482 (549)
+....+|++|.+....++.+|++.........+. ..| .........|.||+|.
T Consensus 315 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~ 369 (370)
T cd05596 315 DNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEETF--PLP--KAFAGNQLPFIGFTYS 369 (370)
T ss_pred HHhcCCCcCccCcCCCcchhhhcCCccccccccccC--CCc--cccccccCccCCCeec
Confidence 4467789999999999999998765543211111 111 1223345679999884
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=464.76 Aligned_cols=322 Identities=45% Similarity=0.834 Sum_probs=276.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||+|+||+||+|+++.+|+.||||++++...........+..|+.++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998876555556677899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--- 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc---
Confidence 999999999999775 7899999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc------cCCCCcccccchhhHHHH
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~------~~~y~~~~DiWSlGvily 349 (549)
......+||+.|+|||++. +..|+.++|||||||++|
T Consensus 158 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 200 (330)
T cd05601 158 -------------------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200 (330)
T ss_pred -------------------------------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence 0011357999999999997 456889999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQI 429 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~ 429 (549)
||++|..||.+.+....+.+|++....+.+|....+++++++||.+||++|.+|+ ++++++.||||..++|..+...
T Consensus 201 el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~---t~~~l~~h~~~~~~~~~~~~~~ 277 (330)
T cd05601 201 EMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERL---GYEGLCCHPFFSKIDWNNIRNS 277 (330)
T ss_pred eeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCC---CHHHHhCCCCcCCCCHHHHhhC
Confidence 9999999999988888888888876677788777899999999999999999999 8999999999999999999988
Q ss_pred cCCCcccCCCccccccccccccccccccccccCCccccccccccccccccee
Q 038137 430 KAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTY 481 (549)
Q Consensus 430 ~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~ 481 (549)
.+|++|.+....|+++|+...........+..........+.++..|+||+|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (330)
T cd05601 278 LPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSF 329 (330)
T ss_pred CCCccCcCCCcchhhhcCCCccccccccccccccCCCcCCCCCCCCccCcee
Confidence 8999999999889999876443332211111111111235668899999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-56 Score=460.39 Aligned_cols=293 Identities=42% Similarity=0.828 Sum_probs=262.6
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
......++|++.+.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|..++||||++++++|.+++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN 91 (329)
T ss_pred cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence 34556789999999999999999999999999999999998876666666778999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
..+.+||+.|+|||++.+..++.++|||||||++||
T Consensus 172 --------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 207 (329)
T PTZ00263 172 --------------------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYE 207 (329)
T ss_pred --------------------------------------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHH
Confidence 114589999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~ 427 (549)
|++|++||.+.+....+.+|.. ..+.+|. .++..+++||.+||+ ||.+|+++ .++++|+.||||++++|+.+.
T Consensus 208 lltg~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 208 FIAGYPPFFDDTPFRIYEKILA--GRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred HHcCCCCCCCCCHHHHHHHHhc--CCcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 9999999999888888888876 3455664 689999999999999 99999964 468999999999999999886
Q ss_pred c--ccCCCcccCCCcccccccccccc
Q 038137 428 Q--IKAAFIPEVNDELDTQNFEKFEE 451 (549)
Q Consensus 428 ~--~~~pf~p~~~~~~d~~~f~~~~~ 451 (549)
. ..+|+.+.+....++.+|..+.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (329)
T PTZ00263 284 ARYYPAPIPVRVKSPGDTSNFEKYPD 309 (329)
T ss_pred hCCCCCCcCCCCCCcccchhccCCcc
Confidence 3 66788888888888999887654
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-56 Score=459.14 Aligned_cols=281 Identities=41% Similarity=0.749 Sum_probs=250.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg 202 (549)
++||+|+||.||+|+++.+|+.||||++.+..........++.+|..+|..++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876656666778889999999999999999999999999999999999999
Q ss_pred chhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCC
Q 038137 203 DMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282 (549)
Q Consensus 203 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~ 282 (549)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---------- 150 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCC
Q 038137 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362 (549)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~ 362 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -------------------------------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 0114689999999999999999999999999999999999999999888
Q ss_pred chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCccccc--cccCCCcccC
Q 038137 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLY--QIKAAFIPEV 437 (549)
Q Consensus 363 ~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~~l~--~~~~pf~p~~ 437 (549)
.......+.. ....+|. .+++++.+||.+||+ ||.+|++.. ++.+|++||||.+++|..+. .+.+|+.|.+
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05571 200 HEKLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQV 275 (323)
T ss_pred HHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 7777776665 3455664 789999999999999 999999642 69999999999999999886 4778999999
Q ss_pred CCccccccccc
Q 038137 438 NDELDTQNFEK 448 (549)
Q Consensus 438 ~~~~d~~~f~~ 448 (549)
....|+.+|+.
T Consensus 276 ~~~~~~~~~~~ 286 (323)
T cd05571 276 TSETDTRYFDE 286 (323)
T ss_pred CCcchhhhcCc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-55 Score=455.31 Aligned_cols=324 Identities=47% Similarity=0.872 Sum_probs=272.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.++..++|+||++++++|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998766656666677889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--- 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--- 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc---
Confidence 99999999999976 46899999999999999999999999999999999999999999999999999876431110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccchhhHHHHH
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiWSlGvilyE 350 (549)
......+||+.|+|||++. ...|+.++|||||||++||
T Consensus 158 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 158 -------------------------------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred -------------------------------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHH
Confidence 0011357999999999996 3468999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCC-cCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQI 429 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~-~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~ 429 (549)
|++|++||.+.+..+.+.+|........+|.. ..+|+++++||.+||+.+.+|+++.+++++++||||.+++|+.+...
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~~ 280 (332)
T cd05623 201 MLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNC 280 (332)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhhC
Confidence 99999999999888888888875555556543 36899999999999997778888889999999999999999999999
Q ss_pred cCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceee
Q 038137 430 KAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYK 482 (549)
Q Consensus 430 ~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 482 (549)
.+|++|....+.++++++...+......+. ..+.....+.....|.||||.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 331 (332)
T cd05623 281 EAPYIPEVSSPTDTSNFDVDDDCLKNSETM--PPPSHTAFSGHHLPFVGFTYT 331 (332)
T ss_pred CCCccCCCCCCcccccCCCCcccccccCCC--CCCCccccccCCCCcCCeeec
Confidence 999999999999988876543322111111 111112234457788999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=460.27 Aligned_cols=294 Identities=40% Similarity=0.825 Sum_probs=262.1
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATG-HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
....+..++|++++.||+|+||.||+|.++.++ ..||+|++.+...........+.+|+.++..++|||||+++++|.+
T Consensus 23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD 102 (340)
T ss_pred cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence 345567889999999999999999999977655 7899999988766666677889999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
...+|+||||++||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.. ..+.+||+.|+|||++.+..++.++|||||||++
T Consensus 183 ~~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 218 (340)
T PTZ00426 183 TR--------------------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218 (340)
T ss_pred CC--------------------------------------------cceecCChhhcCHHHHhCCCCCccccccchhhHH
Confidence 11 1146899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~ 425 (549)
|||++|.+||.+.++...+.++.. ....+|. .+++++++||++||. ||.+|++. .+++++++||||.+++|..
T Consensus 219 ~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 219 YEILVGCPPFYANEPLLIYQKILE--GIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999999999999888888888876 3445554 689999999999999 99999864 4899999999999999998
Q ss_pred cc--cccCCCcccCCCcccccccccccc
Q 038137 426 LY--QIKAAFIPEVNDELDTQNFEKFEE 451 (549)
Q Consensus 426 l~--~~~~pf~p~~~~~~d~~~f~~~~~ 451 (549)
+. .+.+|++|.+....+.++|+.+.+
T Consensus 295 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (340)
T PTZ00426 295 LLHKNVEVPYKPKYKNVFDSSNFERVQE 322 (340)
T ss_pred HHhCCCCCCcCCCCCCCcchhhcCCCcc
Confidence 76 478999999999888888876444
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=456.92 Aligned_cols=289 Identities=46% Similarity=0.860 Sum_probs=260.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|++..+|+.||||++.+..........++.+|+.+|..++||||++++++|++.+++|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876555556778899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ 154 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998764310
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 155 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 155 --------------------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred --------------------------------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence 114689999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCc----CCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccccccC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEA----KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKA 431 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~----~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~ 431 (549)
||.+.+..+.+..+..|...+..|... .+|+++++||.+||. +|.+|+ ++++|++||||.+++|..+....+
T Consensus 197 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~---s~~~ll~h~~~~~~~~~~~~~~~~ 273 (333)
T cd05600 197 PFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG---SLEDIKNHPFFKEVDWNELRELKP 273 (333)
T ss_pred CCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC---CHHHHHhCcccCCCCHHHHhhCCC
Confidence 999988888888888776655555432 579999999999999 677776 799999999999999999999999
Q ss_pred CCcccCCCccccccccccccc
Q 038137 432 AFIPEVNDELDTQNFEKFEEA 452 (549)
Q Consensus 432 pf~p~~~~~~d~~~f~~~~~~ 452 (549)
||+|.+....+..+|+++...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~ 294 (333)
T cd05600 274 PFVPELESEIDTGYFDDFENE 294 (333)
T ss_pred CCCCCCCCcchhhhccCCCCc
Confidence 999999998888888765443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-56 Score=447.31 Aligned_cols=259 Identities=30% Similarity=0.520 Sum_probs=232.4
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce-E
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY-L 192 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~-l 192 (549)
+..++.+.+..||+|+.|+||+|+++.|++.||+|++.-. .+....+.+.+|++|+..++||+||.+|++|.++.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 5566888899999999999999999999999999999432 345556779999999999999999999999999985 9
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+||||.||+|..++...+.++|.....++.+|+.||.|||. ++||||||||+|||++..|.|||||||.++.+..+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999988999999999999999999999995 99999999999999999999999999999876422
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.|.++|||..|||||.+.+..|+.++||||||+.++||
T Consensus 233 ------------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 233 ------------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLEL 270 (364)
T ss_pred ------------------------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHH
Confidence 35589999999999999999999999999999999999
Q ss_pred hhCCCCCCCC-----CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 352 LVGYPPFYSD-----EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 352 l~G~~PF~~~-----~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
++|+.||... +..+.+..|+.. ....+|.. .+|+++++||..||. ||.+|. ++.|+++|||++...
T Consensus 271 a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~---s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 271 AIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEG-EFSPEFRSFVSCCLRKDPSERP---SAKQLLQHPFIKKFE 342 (364)
T ss_pred hhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcc-cCCHHHHHHHHHHhcCCcccCC---CHHHHhcCHHHhhcc
Confidence 9999999875 455667777763 45566653 599999999999999 999999 899999999998653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-55 Score=455.42 Aligned_cols=324 Identities=47% Similarity=0.862 Sum_probs=269.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|+.++..++|+||++++++|++.+++|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998766555666677889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++||+|..++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-- 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--
Confidence 99999999999976 568999999999999999999999999999999999999999999999999999765321100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----CCCCcccccchhhHHHHH
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----~~y~~~~DiWSlGvilyE 350 (549)
.....+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~e 200 (331)
T cd05624 159 --------------------------------------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200 (331)
T ss_pred --------------------------------------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhh
Confidence 0013579999999999976 468899999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCC-cCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQI 429 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~-~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~ 429 (549)
|++|++||.+.+..+.+.+|......+.+|.. ..+++++++||.+||+.+.+|+++.+++++++||||++++|+.+...
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~ 280 (331)
T cd05624 201 MLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNL 280 (331)
T ss_pred hhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhC
Confidence 99999999998888888888876555556543 35799999999999997678887779999999999999999999999
Q ss_pred cCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceee
Q 038137 430 KAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYK 482 (549)
Q Consensus 430 ~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 482 (549)
.+|++|....+.+..+|+.-++.... +...+.++....+.....+.||||.
T Consensus 281 ~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (331)
T cd05624 281 EAPYIPDVSSPSDTSNFDVDDDVLRN--PEIAPPSSHTGFSGLHLPFVGFTYT 331 (331)
T ss_pred CCCccCCCCCcchhhhcCCccccccc--cccCCCccccccCCCCcCCCCceeC
Confidence 99999999888888888643221111 1111111222333344457888873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-55 Score=454.12 Aligned_cols=324 Identities=48% Similarity=0.879 Sum_probs=271.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+.++..++|+||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998876666667778899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-- 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998765321100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----CCCCcccccchhhHHHHH
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----~~y~~~~DiWSlGvilyE 350 (549)
.....+||+.|+|||++.. ..++.++|||||||++||
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (331)
T cd05597 159 --------------------------------------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200 (331)
T ss_pred --------------------------------------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHH
Confidence 0012479999999999973 457899999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCC-cCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCCccccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQI 429 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~-~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~ 429 (549)
|++|+.||.+.+..+.+.+|+.....+.+|.. ..+|+++++||++|||.|.+|+++.++++++.||||.+++|..+...
T Consensus 201 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~ 280 (331)
T cd05597 201 MLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNS 280 (331)
T ss_pred HhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhhC
Confidence 99999999998888888888876555555543 35899999999999998888888889999999999999999999988
Q ss_pred cCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceee
Q 038137 430 KAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYK 482 (549)
Q Consensus 430 ~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 482 (549)
.+|++|......++.+|+..+.......+. ..+-.....+....+.||+|.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 331 (331)
T cd05597 281 TAPYVPEVSSPTDTSNFDVDDDDLRNTESL--PPSSHGAFSGNHLPFVGFTYT 331 (331)
T ss_pred CCCccCcCCCcchhhhcCCccccccccccc--CCCCcCcCCcCCCCCCceeeC
Confidence 899999999999998887543322111111 111111234456778898884
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-56 Score=448.86 Aligned_cols=260 Identities=33% Similarity=0.584 Sum_probs=235.5
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
...+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .+..++.+..|+.||+.++|||||.|++++.+++++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999988765 55667889999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC------CcEEEeecCcccccC
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN------GHMKLSDFGLCKPLD 268 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~------g~vKL~DFGlak~~~ 268 (549)
|||||.||||..+|.+.+.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999875 468999999999875
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.. .++.+.||||-|||||++....|+.++|+||+|+|+
T Consensus 167 ~~------------------------------------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 167 PG------------------------------------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTIL 204 (429)
T ss_pred ch------------------------------------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHH
Confidence 32 124478999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|+|++|++||...+..+....|-......+++. ..+|..+.+|+..+|+ ++.+|. +.++-..|||...-
T Consensus 205 yq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~---~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 205 YQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRI---SFEDFFDHPFLAAN 274 (429)
T ss_pred HHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccC---chHHhhhhhhcccC
Confidence 999999999999999999888876655555554 3678888899999999 999999 68888999988653
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=448.45 Aligned_cols=317 Identities=35% Similarity=0.688 Sum_probs=266.4
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCceEEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lylVm 196 (549)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|+.++..+.| ++|++++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999988765555667788899999999976 56889999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----- 155 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-----
Confidence 999999999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
......+||+.|+|||++.+..|+.++|||||||++|||++|++
T Consensus 156 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (324)
T cd05587 156 ------------------------------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199 (324)
T ss_pred ------------------------------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 00124689999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--cccC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIKA 431 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~~~ 431 (549)
||.+.+..+.+..+... ...+|. .+++++++||.+||. ||.+|++. ...++++.||||+.++|..+. .+.+
T Consensus 200 pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~ 275 (324)
T cd05587 200 PFDGEDEDELFQSIMEH--NVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275 (324)
T ss_pred CCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCC
Confidence 99998888888877753 344554 689999999999999 99999965 246899999999999999886 3678
Q ss_pred CCcccCCCccccccccccccccccccccccCCcccccc-cccccccccceeeC
Q 038137 432 AFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKML-SSKDINFVGYTYKN 483 (549)
Q Consensus 432 pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~g~~~~~ 483 (549)
|+.|.+....+.++|+.+........+. +-+..+ +.....|.+|+|.|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 276 PFKPKVKGRRSAENFDKFFTREPPVLTP----PDKLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred CccCcCCCcchhhhcCcccccCccccCC----CCccccccccccccCCCcccC
Confidence 9999998888999998865443322211 111222 33445777887764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=448.62 Aligned_cols=316 Identities=34% Similarity=0.678 Sum_probs=265.1
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+|++++.||+|+||.||+|+++.+++.||||++.+..............|+.++..+ .|++|++++++|++.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999886655555666778888888777 5899999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|..++...+.+++..+.+++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC----
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++
T Consensus 157 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 199 (323)
T cd05616 157 -------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199 (323)
T ss_pred -------------------------------------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence 0114689999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--cccC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIKA 431 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~~~ 431 (549)
||.+.+....+..|.. ....+|. .+++++.+||.+||+ +|.+|++. .+..+++.||||+.++|+.+. .+.+
T Consensus 200 Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05616 200 PFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQP 275 (323)
T ss_pred CCCCCCHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCC
Confidence 9999888888887776 3455554 689999999999999 99999975 357999999999999999987 4788
Q ss_pred CCcccCCCccccccccccccccccccccccCCcccc-cccccccccccceeeC
Q 038137 432 AFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRK-MLSSKDINFVGYTYKN 483 (549)
Q Consensus 432 pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~f~g~~~~~ 483 (549)
|+.|... ..|..+|+.|........+. +.+. +.......|.||+|.|
T Consensus 276 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 276 PYKPKAC-GRDAENFDKFFTRHPPVLTP----PDQEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred CcCCcCC-CchhhhcCchhccCCccCCC----CCccccccccccccCCCcccC
Confidence 9999875 47888888876533222111 1122 2333446788888764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-55 Score=444.84 Aligned_cols=285 Identities=42% Similarity=0.868 Sum_probs=256.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+|..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998766555556677899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------ 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998764311
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 155 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 155 --------------------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred --------------------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 014579999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--cccC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIKA 431 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~~~ 431 (549)
||.+.+....+..+... .+.+|. .+++.+++||.+||. ||.+|++. .++++++.||||..++|..+. ...+
T Consensus 197 pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~ 272 (291)
T cd05612 197 PFFDDNPFGIYEKILAG--KLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKP 272 (291)
T ss_pred CCCCCCHHHHHHHHHhC--CcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCC
Confidence 99998888888888763 445554 679999999999999 99999964 369999999999999999876 4678
Q ss_pred CCcccCCCcccccccccc
Q 038137 432 AFIPEVNDELDTQNFEKF 449 (549)
Q Consensus 432 pf~p~~~~~~d~~~f~~~ 449 (549)
|++|.+....|+.||+..
T Consensus 273 ~~~p~~~~~~~~~~~~~~ 290 (291)
T cd05612 273 PIVPKVSHDGDTSNFDDY 290 (291)
T ss_pred CEeCCCCCccccccccCC
Confidence 899999999999998753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=445.31 Aligned_cols=279 Identities=44% Similarity=0.832 Sum_probs=250.3
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCch
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L 204 (549)
||+|+||.||+|+++.+++.||+|++.+..........++.+|+.+|..++|||||+++++|.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999877665666778889999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCc
Q 038137 205 MTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284 (549)
Q Consensus 205 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~ 284 (549)
..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------------ 148 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------------ 148 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------------
Confidence 99998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCch
Q 038137 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364 (549)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~ 364 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 149 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~ 199 (312)
T cd05585 149 -----------------------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199 (312)
T ss_pred -----------------------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH
Confidence 011468999999999999999999999999999999999999999998887
Q ss_pred hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc--cccCCCcccCCCcc
Q 038137 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDEL 441 (549)
Q Consensus 365 ~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~--~~~~pf~p~~~~~~ 441 (549)
..+.++.. ..+.+|. .+++++++||.+||. ||.+|++..++.+++.||||..++|..+. .+.+|+.|.+.+..
T Consensus 200 ~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (312)
T cd05585 200 EMYRKILQ--EPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAI 275 (312)
T ss_pred HHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 77777775 4455664 689999999999999 99999987789999999999999998765 46789999999888
Q ss_pred ccccccc
Q 038137 442 DTQNFEK 448 (549)
Q Consensus 442 d~~~f~~ 448 (549)
++++|+.
T Consensus 276 ~~~~~~~ 282 (312)
T cd05585 276 DTSNFDE 282 (312)
T ss_pred chhhcCc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=444.98 Aligned_cols=282 Identities=38% Similarity=0.735 Sum_probs=248.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||.||+|+++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999887655556677788899988876 799999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.+...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--------- 151 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--------- 151 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 152 --------------------------------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred --------------------------------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 011458999999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC---CCHHHHHcCCcccCCCccccc--cccCCCcc
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPWFKGIEWDKLY--QIKAAFIP 435 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~HpfF~~i~w~~l~--~~~~pf~p 435 (549)
+....+..|.. ....+|. .+++++++||.+||+ ||.+|++. .+.++++.||||.+++|+.+. .+.|||.|
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 275 (320)
T cd05590 200 NEDDLFEAILN--DEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRP 275 (320)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 88888888776 3344453 689999999999999 99999964 234999999999999999876 47899999
Q ss_pred cCCCcccccccccc
Q 038137 436 EVNDELDTQNFEKF 449 (549)
Q Consensus 436 ~~~~~~d~~~f~~~ 449 (549)
.+....|.+||+..
T Consensus 276 ~~~~~~~~~~~~~~ 289 (320)
T cd05590 276 RIKSREDVSNFDPD 289 (320)
T ss_pred CCCCcchhhhcCcc
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=453.77 Aligned_cols=259 Identities=37% Similarity=0.649 Sum_probs=234.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch--hhHHHHHHHHHHHHhcC-CCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR--GQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~ 190 (549)
.....|.+.+.||+|+||+|++|.+..+|..||+|++.+...... ...+.+.+|+.+++.+. ||||++++.++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456789999999999999999999999999999998877533212 34567889999999999 999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC-CcEEEeecCcccccC-
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLD- 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~-g~vKL~DFGlak~~~- 268 (549)
.+|+|||||.||+|++++.+.+.++|..+++|+.|++.||+|||++||+||||||+|||+|.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998652
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-C-CcccccchhhH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-Y-GMECDWWSLGA 346 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-y-~~~~DiWSlGv 346 (549)
.. ....+.||||.|+|||++.+.+ | +.++|+||+||
T Consensus 174 ~~------------------------------------------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GV 211 (370)
T KOG0583|consen 174 ED------------------------------------------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGV 211 (370)
T ss_pred CC------------------------------------------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHH
Confidence 11 0123689999999999999988 9 69999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCC-ChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKL-SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~-s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||.|++|+.||.+.+...++.+|.. ..+.+|. .+ |+++++||++||. ||.+|+ ++.+|+.||||+.-
T Consensus 212 iLy~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~---t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 212 ILYVLLCGRLPFDDSNVPNLYRKIRK--GEFKIPS--YLLSPEARSLIEKMLVPDPSTRI---TLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHhc--CCccCCC--CcCCHHHHHHHHHHcCCCcccCC---CHHHHhhChhhccC
Confidence 99999999999999999999999876 5677886 56 9999999999999 999999 89999999999863
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-54 Score=443.23 Aligned_cols=281 Identities=41% Similarity=0.758 Sum_probs=247.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||.||+|+++.+|+.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999887655556667788899999865 899999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--------- 151 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 152 --------------------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred --------------------------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 011457999999999999999999999999999999999999999999
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC----CHHHHHcCCcccCCCcccccc--ccCCCc
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK----GADEIKAHPWFKGIEWDKLYQ--IKAAFI 434 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~----~~~eil~HpfF~~i~w~~l~~--~~~pf~ 434 (549)
+....+..+.. ....+|. .+++++.+||.+||. ||.+|++.. +++++++||||.+++|..+.. ..+||.
T Consensus 200 ~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~ 275 (321)
T cd05591 200 NEDDLFESILH--DDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFK 275 (321)
T ss_pred CHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCC
Confidence 88888888876 3344553 689999999999999 999999752 699999999999999998863 678899
Q ss_pred ccCCCccccccccc
Q 038137 435 PEVNDELDTQNFEK 448 (549)
Q Consensus 435 p~~~~~~d~~~f~~ 448 (549)
|......+..+|+.
T Consensus 276 ~~~~~~~~~~~~~~ 289 (321)
T cd05591 276 PKIKTKRDVNNFDQ 289 (321)
T ss_pred CCCCCcchhhhcCC
Confidence 99888888888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-54 Score=443.06 Aligned_cols=282 Identities=41% Similarity=0.749 Sum_probs=249.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg 202 (549)
++||+|+||.||+|+++.+|..||+|++.+..........++.+|..++..++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876555566777889999999999999999999999999999999999999
Q ss_pred chhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCC
Q 038137 203 DMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282 (549)
Q Consensus 203 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~ 282 (549)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------- 150 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCC
Q 038137 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362 (549)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~ 362 (549)
.....+||+.|+|||++.+..|+.++|+|||||++|||++|+.||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -------------------------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 0114579999999999999999999999999999999999999999888
Q ss_pred chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcccccc--ccCCCcccC
Q 038137 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLYQ--IKAAFIPEV 437 (549)
Q Consensus 363 ~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~~--~~~pf~p~~ 437 (549)
.......+.. ....+|. .+++++++||.+||+ ||.+|++. .++.++++||||.+++|..+.. +.||+.|.+
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05595 200 HERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 275 (323)
T ss_pred HHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 7777777664 3445554 789999999999999 99999864 3799999999999999998764 668999999
Q ss_pred CCcccccccccc
Q 038137 438 NDELDTQNFEKF 449 (549)
Q Consensus 438 ~~~~d~~~f~~~ 449 (549)
..+.++..|+..
T Consensus 276 ~~~~~~~~~~~~ 287 (323)
T cd05595 276 TSEVDTRYFDDE 287 (323)
T ss_pred CChhhhhhcCcc
Confidence 999999988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=440.39 Aligned_cols=316 Identities=36% Similarity=0.707 Sum_probs=262.1
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVm 196 (549)
+|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+..|..++..+. |++|++++++|++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999998876555566677888999998885 578889999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc----
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (323)
T cd05615 157 -------------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199 (323)
T ss_pred -------------------------------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCC
Confidence 0114579999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCcccccc--ccC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLYQ--IKA 431 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~~l~~--~~~ 431 (549)
||.+.+....+..|.. ....+|. .++.++.+||.+||+ +|.+|++.. +.++++.||||.+++|..+.. +.+
T Consensus 200 pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~ 275 (323)
T cd05615 200 PFDGEDEDELFQSIME--HNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQP 275 (323)
T ss_pred CCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCc
Confidence 9999888888887775 3445554 689999999999999 999999752 578999999999999998864 678
Q ss_pred CCcccCCCccccccccccccccccccccccCCcccccccccc-cccccceeeC
Q 038137 432 AFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKD-INFVGYTYKN 483 (549)
Q Consensus 432 pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~f~g~~~~~ 483 (549)
||.|..... ...+|+++.......... |....+...+ ..|.||+|.|
T Consensus 276 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 276 PFKPKVCGK-GAENFDKFFTRGQPVLTP----PDQLVIANIDQADFEGFSYVN 323 (323)
T ss_pred CccCccCCC-chhhcCccccccCCCCCC----CcccccccccccccCCCcccC
Confidence 999976553 577888765433221111 1112233333 3677887754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=441.37 Aligned_cols=281 Identities=40% Similarity=0.760 Sum_probs=249.0
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg 202 (549)
++||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876655666778899999999999999999999999999999999999999
Q ss_pred chhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCC
Q 038137 203 DMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282 (549)
Q Consensus 203 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~ 282 (549)
+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----------- 149 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----------- 149 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-----------
Confidence 999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred CcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCC
Q 038137 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362 (549)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~ 362 (549)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus 150 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 150 ------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ------------------------------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 00114689999999999999999999999999999999999999999887
Q ss_pred chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--cccCCCcccC
Q 038137 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIKAAFIPEV 437 (549)
Q Consensus 363 ~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~~~pf~p~~ 437 (549)
.......+.. ....+|. .+++++.+||.+||+ ||.+|++. .++.+|++||||.+++|..+. .+.+|+.|..
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~ 275 (328)
T cd05593 200 HEKLFELILM--EDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQV 275 (328)
T ss_pred HHHHHHHhcc--CCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence 7776666654 3455554 789999999999999 99999864 479999999999999998876 3678999999
Q ss_pred CCccccccccc
Q 038137 438 NDELDTQNFEK 448 (549)
Q Consensus 438 ~~~~d~~~f~~ 448 (549)
..+.++.+|+.
T Consensus 276 ~~~~~~~~~~~ 286 (328)
T cd05593 276 TSETDTRYFDE 286 (328)
T ss_pred CCcchhhhcCc
Confidence 99999888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-53 Score=439.65 Aligned_cols=314 Identities=39% Similarity=0.697 Sum_probs=257.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHH-HHhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL-LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
+.||+|+||+||+|+++.+|+.||||++.+..........++..|+.+ ++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999987665555555666667664 5779999999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--------- 151 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 152 --------------------------------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred --------------------------------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 011458999999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-CCHHHHHcCCcccCCCccccc--cccCCCcccC
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-KGADEIKAHPWFKGIEWDKLY--QIKAAFIPEV 437 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~HpfF~~i~w~~l~--~~~~pf~p~~ 437 (549)
+..+.+.++... .+.++ ..+++++.+||.+||+ ||.+|++. ..+.+++.||||..++|..+. .+.+|+.|.+
T Consensus 200 ~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05575 200 DTAEMYDNILNK--PLRLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNV 275 (323)
T ss_pred CHHHHHHHHHcC--CCCCC--CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCC
Confidence 888888887763 33343 3679999999999999 99999965 356899999999999999886 4788999999
Q ss_pred CCcccccccccc-cccccccc--ccccCCccccccccccccccccee
Q 038137 438 NDELDTQNFEKF-EEADNQIQ--TSAKSGPWRKMLSSKDINFVGYTY 481 (549)
Q Consensus 438 ~~~~d~~~f~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~f~g~~~ 481 (549)
....+.++|+.. .+...+.. .+..+..........+..|.||+|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05575 276 SGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSY 322 (323)
T ss_pred CCcchhhhcCccccccccccccCCCcccccccccccccccccCCCcc
Confidence 888888888752 22111111 111111111223446778999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=439.40 Aligned_cols=315 Identities=37% Similarity=0.698 Sum_probs=261.4
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHH---hcCCCceeeeeeeecCCceEEEE
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA---EVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
|++++.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.++. .++||||++++++|.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999998876555556677888887764 56799999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++||+|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 155 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---- 155 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC----
Confidence 99999999998874 4679999999999999999999999999999999999999999999999999987532110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
......+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 156 -------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~ 198 (324)
T cd05589 156 -------------------------------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198 (324)
T ss_pred -------------------------------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence 0011468999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--ccc
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIK 430 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~~ 430 (549)
+||.+.+.......+... ...+|. .+++++.+||.+||. ||.+|++. .++.+++.||||++++|..+. .+.
T Consensus 199 ~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~ 274 (324)
T cd05589 199 SPFPGDDEEEVFDSIVND--EVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274 (324)
T ss_pred CCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCC
Confidence 999998887777777663 344554 689999999999999 99999965 369999999999999998875 467
Q ss_pred CCCcccCCCccccccccccccccccccccccCCccccccccccccccccee
Q 038137 431 AAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTY 481 (549)
Q Consensus 431 ~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~ 481 (549)
+|++|.+....|.++|+.-.....+..+... +-+....+.+..|.+|+|
T Consensus 275 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 323 (324)
T cd05589 275 PPFVPTIKGPEDVSNFDEEFTSEAPVLTPPR--EPRLLTEEEQELFRGFDY 323 (324)
T ss_pred cCccCCCCCcchhhhcCccccccccccCCCc--cccccchhhhcccCCccc
Confidence 8999999988898888753222222222211 112233446677888876
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-53 Score=437.88 Aligned_cols=310 Identities=38% Similarity=0.730 Sum_probs=257.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh-cCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE-VDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||+||+|++..+++.||||++++..............|+.++.. .+||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987655444555666778888765 4899999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------- 150 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999997542110
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 151 -------------------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred -------------------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 0011468999999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc--cccCCCcccCC
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY--QIKAAFIPEVN 438 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~--~~~~pf~p~~~ 438 (549)
+....+..+.. ....+| ..++.++.+||.+||. +|.+|++. +.+++.||||..++|+.+. .+.+||.|...
T Consensus 200 ~~~~~~~~i~~--~~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd05592 200 DEDELFDSILN--DRPHFP--RWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVK 273 (316)
T ss_pred CHHHHHHHHHc--CCCCCC--CCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCC
Confidence 88777777765 233444 3689999999999999 99999942 5689999999999998876 47889999999
Q ss_pred CccccccccccccccccccccccCCcccccccc-cccccccceeeC
Q 038137 439 DELDTQNFEKFEEADNQIQTSAKSGPWRKMLSS-KDINFVGYTYKN 483 (549)
Q Consensus 439 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~~ 483 (549)
...+..+|+..........+... .....+ ....|.||.|.|
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05592 274 SPSDASNFDREFTNEKVRLSPVD----KKLLASMDQEQFRGFSFTN 315 (316)
T ss_pred CcchhhhcCcccccccccCCCcc----ccccccccccccCCCcccC
Confidence 99999999864333322211111 122222 456889998875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=439.48 Aligned_cols=282 Identities=35% Similarity=0.694 Sum_probs=242.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||+||+|+++.+++.||+|++.+...........+..|+.++..+ +||+|++++++|++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887665566677889999999888 699999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------- 150 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---------- 150 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 151 -------------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred -------------------------------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 0012468999999999999999999999999999999999999999642
Q ss_pred Cc------h-hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC---CCHHHHHcCCcccCCCccccc--c
Q 038137 362 EP------M-STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPWFKGIEWDKLY--Q 428 (549)
Q Consensus 362 ~~------~-~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~HpfF~~i~w~~l~--~ 428 (549)
.. . .....+.. ....+|. .+|..+.+||.+||. ||.+|++. .++++|+.||||++++|+.+. .
T Consensus 200 ~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~ 275 (327)
T cd05617 200 TDNPDMNTEDYLFQVILE--KPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQ 275 (327)
T ss_pred CCCcccccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCC
Confidence 21 1 12233332 3344554 689999999999999 99999964 368999999999999999886 4
Q ss_pred ccCCCcccCCCcccccccccc
Q 038137 429 IKAAFIPEVNDELDTQNFEKF 449 (549)
Q Consensus 429 ~~~pf~p~~~~~~d~~~f~~~ 449 (549)
..+||.|.+.+..+.++|+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~ 296 (327)
T cd05617 276 VTPPFKPQITDDYGLENFDTQ 296 (327)
T ss_pred CCCCccCCCCCCcchhhcCCc
Confidence 678999999888888888753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=441.16 Aligned_cols=266 Identities=38% Similarity=0.680 Sum_probs=232.0
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch-----------hhHHHHHHHHHHHHhcCCCceee
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR-----------GQVEHVKAERNLLAEVDSNCIVK 181 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~-----------~~~~~~~~E~~iL~~l~hp~Iv~ 181 (549)
....++|++++.||+|.||+|.+|++..+++.||||++.|...... ..++.+++|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3457889999999999999999999999999999999988765322 23568999999999999999999
Q ss_pred eeeeecCC--ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEe
Q 038137 182 LYCSFQDD--EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLS 259 (549)
Q Consensus 182 l~~~f~d~--~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~ 259 (549)
|+.+..|. +.+|||+|||..|.+...-.....|++.+|++|+..+++||+|||.+|||||||||+|+||+.+|+|||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99999875 6799999999999887654333449999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC---CC-
Q 038137 260 DFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK---GY- 335 (549)
Q Consensus 260 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~---~y- 335 (549)
|||.|-.......... ..++. .++|||.|||||.+.+. .|
T Consensus 253 DFGVs~~~~~~~~~~~-------------------------d~~L~-----------~tvGTPAF~APE~c~~~~~~~~~ 296 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGS-------------------------DDQLS-----------RTVGTPAFFAPELCSGGNSFSYS 296 (576)
T ss_pred ccceeeecccCCcccc-------------------------HHHHh-----------hcCCCccccchHhhcCCCCcccc
Confidence 9999876543211100 11111 37999999999999873 23
Q ss_pred CcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 336 GMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+.+.|||||||+||.|+.|..||.++...+++.+|++ ..+.||..+.+.+.++|||.+||+ ||++|+ ++.+|+.
T Consensus 297 g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri---~l~~ik~ 371 (576)
T KOG0585|consen 297 GFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRI---TLPDIKL 371 (576)
T ss_pred chhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhhee---ehhhhee
Confidence 7899999999999999999999999999999999998 789999988899999999999999 999999 7999999
Q ss_pred CCccc
Q 038137 415 HPWFK 419 (549)
Q Consensus 415 HpfF~ 419 (549)
|||..
T Consensus 372 Hpwvt 376 (576)
T KOG0585|consen 372 HPWVT 376 (576)
T ss_pred cceec
Confidence 99975
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=430.34 Aligned_cols=275 Identities=33% Similarity=0.644 Sum_probs=235.1
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|..++|++|++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987665444455667899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++||+|..++.. ...+++..+.+++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 9999999988754 3469999999999999999999999999999999999999999999999999987643110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 157 --------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 198 (285)
T cd05631 157 --------------------------------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198 (285)
T ss_pred --------------------------------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhcc--ccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcccccc--
Q 038137 356 PPFYSDEPMSTCRKIVNWR--THLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLYQ-- 428 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~~-- 428 (549)
+||.+.+.......+.... ....++ ..+|+++.+||.+||+ ||.+|++. .+++++++||||.+++|+.+.+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~ 276 (285)
T cd05631 199 SPFRKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANM 276 (285)
T ss_pred CCCCCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCc
Confidence 9998765533322222211 122333 3689999999999999 99999964 3699999999999999999985
Q ss_pred ccCCCccc
Q 038137 429 IKAAFIPE 436 (549)
Q Consensus 429 ~~~pf~p~ 436 (549)
++|||+|+
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05631 277 LEPPFCPD 284 (285)
T ss_pred CCcCCCCC
Confidence 68999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=456.19 Aligned_cols=260 Identities=31% Similarity=0.576 Sum_probs=239.3
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
...-|++.+.||+|+-|.|.+|++..||+..|||++.+..-....+...+.+|+-||+.+.||||++||+++.+..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 35668999999999999999999999999999999998755566677789999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|.||++||.|+++|.++++|+|.+|+.|+.||+.|+.|+|..+|+||||||+|+|||..+.|||+|||+|.......
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--- 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--- 166 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999997643221
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~ 353 (549)
+..+-||+|.|.|||++.|.+| |.++||||.|||||.||+
T Consensus 167 ---------------------------------------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt 207 (786)
T KOG0588|consen 167 ---------------------------------------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT 207 (786)
T ss_pred ---------------------------------------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh
Confidence 1236799999999999999999 899999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
|+.||.+++....+.|+.. +.+.+|. .+|++|+|||++||. ||+.|+ +.+||++|||+.+..-
T Consensus 208 G~LPFdDdNir~LLlKV~~--G~f~MPs--~Is~eaQdLLr~ml~VDp~~Ri---T~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 208 GKLPFDDDNIRVLLLKVQR--GVFEMPS--NISSEAQDLLRRMLDVDPSTRI---TTEEILKHPFLSGYTS 271 (786)
T ss_pred CCCCCCCccHHHHHHHHHc--CcccCCC--cCCHHHHHHHHHHhccCccccc---cHHHHhhCchhhcCCC
Confidence 9999999998888888876 5677774 899999999999999 999999 8999999999998753
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=439.16 Aligned_cols=282 Identities=35% Similarity=0.689 Sum_probs=241.0
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||.||+|+++.+++.||||++++...........+..|+.++..+ +||||++++++|.+...+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999887655555667788999999888 799999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---------- 150 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987431100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
......+||+.|+|||++.+..|+.++|+|||||++|||++|++||...
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 151 -------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred -------------------------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence 0011468999999999999999999999999999999999999999632
Q ss_pred Cc--------h-hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC---CCHHHHHcCCcccCCCcccccc
Q 038137 362 EP--------M-STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 362 ~~--------~-~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~HpfF~~i~w~~l~~ 428 (549)
.. . .....+.. ..+.+|. .+++++++||.+||+ ||.+|++. .+++++++||||..++|+.+..
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~ 275 (329)
T cd05588 200 GMSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ 275 (329)
T ss_pred cccccccccchHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence 11 1 12233332 3445554 689999999999999 99999964 3589999999999999998863
Q ss_pred --ccCCCcccCCCcccccccccc
Q 038137 429 --IKAAFIPEVNDELDTQNFEKF 449 (549)
Q Consensus 429 --~~~pf~p~~~~~~d~~~f~~~ 449 (549)
..||+.|.+....+..+|+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~ 298 (329)
T cd05588 276 KQVLPPYKPNIESDRDLDNFDPQ 298 (329)
T ss_pred CCCCCCccccCCCcchhhhcCCc
Confidence 678899999888888888753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=438.36 Aligned_cols=315 Identities=37% Similarity=0.658 Sum_probs=258.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHH-HHhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL-LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|+.+ ++.++||||++++++|.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987655445555566667654 6779999999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--------- 151 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--------- 151 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 152 --------------------------------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred --------------------------------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 011468999999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-CCHHHHHcCCcccCCCcccccc--ccCCCcccC
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-KGADEIKAHPWFKGIEWDKLYQ--IKAAFIPEV 437 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~HpfF~~i~w~~l~~--~~~pf~p~~ 437 (549)
+..+.+.+++.. .+.++ ..++.++.++|.+||+ +|.+|++. .++.+++.||||.+++|..+.. +.+|+.|..
T Consensus 200 ~~~~~~~~~~~~--~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05604 200 DVAEMYDNILHK--PLVLR--PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNV 275 (325)
T ss_pred CHHHHHHHHHcC--CccCC--CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence 888888887763 33333 2689999999999999 99999975 4678999999999999988764 678999999
Q ss_pred CCccccccccccccccccccccc-cCC--cccccccccccccccceee
Q 038137 438 NDELDTQNFEKFEEADNQIQTSA-KSG--PWRKMLSSKDINFVGYTYK 482 (549)
Q Consensus 438 ~~~~d~~~f~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~f~g~~~~ 482 (549)
....|.++|+.....+....... .+. .........+..|.||+|.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (325)
T cd05604 276 EGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYA 323 (325)
T ss_pred CCcchhhhcCCccccCCcccCcccccccccccccccccccccCCCEec
Confidence 98889999985322221111111 111 1111233457789999886
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-55 Score=411.88 Aligned_cols=259 Identities=38% Similarity=0.634 Sum_probs=240.0
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
.....++|++.+.||+|-||.||+|+.+.++.+||+|++.|+++...+....+++|++|-+.++||||+++|++|.|+..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 45678999999999999999999999999999999999999998777777779999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 192 LYLIMEYLPGGDMMTLLM--RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
+||++||.++|+|+..|. +...|+|..+..|+.|++.||.|+|.+++|||||||+|+|++..|.+||+|||.+...++
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 667899999999999999999999999999999999999999999999999998765331
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
+ +| .+.|||.+|.+||...+.+++..+|+|++|++.|
T Consensus 177 ~----------------------------------------kR---~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 177 N----------------------------------------KR---KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCY 213 (281)
T ss_pred C----------------------------------------Cc---eeeecccccCCHhhcCCCCccchhhHHHHHHHHH
Confidence 1 11 2689999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|+|+|.+||.+.+..+++++|.. ..+.+| ..+|.+|+|||.+||. +|.+|+ ...|++.|||...
T Consensus 214 eflvg~ppFes~~~~etYkrI~k--~~~~~p--~~is~~a~dlI~~ll~~~p~~r~---~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRK--VDLKFP--STISGGAADLISRLLVKNPIERL---ALTEVMDHPWIVA 278 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHH--ccccCC--cccChhHHHHHHHHhccCccccc---cHHHHhhhHHHHh
Confidence 99999999999999999999987 456677 4899999999999999 999999 7999999999853
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-53 Score=435.31 Aligned_cols=310 Identities=35% Similarity=0.670 Sum_probs=254.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh-cCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE-VDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||.||+|+++.+|+.||||++++..............|+.++.. .+||+|++++++|++.+++|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999987655444556667788888875 4899999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 151 -------------------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred -------------------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 0012468999999999999999999999999999999999999999988
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc--cccCCCcccCC
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY--QIKAAFIPEVN 438 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~--~~~~pf~p~~~ 438 (549)
+.......+.. ....+|. .++.++++||.+||. ||.+|++. +++++.||||++++|..+. .+.+|+.|...
T Consensus 200 ~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd05620 200 DEDELFESIRV--DTPHYPR--WITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVK 273 (316)
T ss_pred CHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 87777776654 2334443 689999999999999 99999942 4789999999999998875 46789999999
Q ss_pred CccccccccccccccccccccccCCccccccc-ccccccccceeeC
Q 038137 439 DELDTQNFEKFEEADNQIQTSAKSGPWRKMLS-SKDINFVGYTYKN 483 (549)
Q Consensus 439 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~ 483 (549)
.+.+..+|+.-.....+.. +. .....+. ..+..|.||+|.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05620 274 SPSDYSNFDREFLSEKPRL--SY--SDKNLIDSMDQSAFAGFSFIN 315 (316)
T ss_pred CcchhhhcCccccccCccc--CC--CcccccccccccCcCCCcccC
Confidence 8888888875222211111 11 1111222 2445788888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-53 Score=434.65 Aligned_cols=309 Identities=37% Similarity=0.684 Sum_probs=255.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh-cCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE-VDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
+.||+|+||+||+|++..+++.||||++.+..............|..++.. ++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987654444455667778888876 4999999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987532110
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
....+.+||+.|+|||++.+..|+.++|+|||||++|||++|.+||.+.
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 151 -------------------------------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred -------------------------------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 0012468999999999999999999999999999999999999999988
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCH-HHHHcCCcccCCCccccc--cccCCCcccC
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA-DEIKAHPWFKGIEWDKLY--QIKAAFIPEV 437 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~-~eil~HpfF~~i~w~~l~--~~~~pf~p~~ 437 (549)
+..+....+... ...+|. .++.++++||.+||+ ||.+|+ ++ ++++.||||+.++|..+. .+.+|+.|..
T Consensus 200 ~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~P~~R~---~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~ 272 (316)
T cd05619 200 DEEELFQSIRMD--NPCYPR--WLTREAKDILVKLFVREPERRL---GVKGDIRQHPFFREIDWSALEEREIEPPFKPKV 272 (316)
T ss_pred CHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHhccCHhhcC---CChHHHHcCcccCCCCHHHHHhCCCCCCcCCCC
Confidence 877777666542 234443 689999999999999 999999 55 489999999999999875 4789999999
Q ss_pred CCccccccccccccccccccccccCCcccccccccccc-cccceeeC
Q 038137 438 NDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDIN-FVGYTYKN 483 (549)
Q Consensus 438 ~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-f~g~~~~~ 483 (549)
.+..+.++|++......... +. .....+.+.+.+ |.||+|.+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05619 273 KSANDCSNFDKEFLNEKPRL-SV---TDRMLINSMDQNMFENFSFIN 315 (316)
T ss_pred CCccchhhcChhhhcCCccc-CC---CcccccccccccccCCCcccC
Confidence 99999999987433322211 11 111234454444 77776653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-53 Score=434.29 Aligned_cols=310 Identities=38% Similarity=0.739 Sum_probs=257.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||+||+|+++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999987665556667788899999877 799999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--------- 151 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
.....+||+.|+|||++.+..|+.++|+|||||++|+|++|+.||.+.
T Consensus 152 --------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 152 --------------------------------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred --------------------------------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 011458999999999999999999999999999999999999999988
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--cccCCCccc
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIKAAFIPE 436 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~~~pf~p~ 436 (549)
+.......+.. ....+|. .+++++.+||.+||. ||.+|++. ..+.+++.||||+.++|.... .+.+|+.|.
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (318)
T cd05570 200 DEDELFQSILE--DEVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPK 275 (318)
T ss_pred CHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 87777777765 3344553 689999999999999 99999932 112999999999999998765 478899999
Q ss_pred CCCccccccccc-cccccccccccccCCccccccccccccccccee
Q 038137 437 VNDELDTQNFEK-FEEADNQIQTSAKSGPWRKMLSSKDINFVGYTY 481 (549)
Q Consensus 437 ~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~ 481 (549)
+....+.++|+. |.... ...+.... . .+-.-+...|.||+|
T Consensus 276 ~~~~~~~~~~~~~~~~~~-~~~~~~~~-~--~~~~~~~~~~~~~~~ 317 (318)
T cd05570 276 IKGRFDVSNFDDEFTKEK-PVLTPPDE-A--IIRNIDQEEFRGFSY 317 (318)
T ss_pred CCCcchhhhcCchhccCc-ccCCCCcc-c--ccccccccccCCCCC
Confidence 999889999874 32222 11111111 1 122334568999988
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=418.40 Aligned_cols=260 Identities=31% Similarity=0.508 Sum_probs=221.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+.|+.+..+|+|+||.||+|+++.||++||||++..++- +....+-..+|+.+|++++|||+|.|+.+|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 468889999999999999999999999999999976542 2233345789999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||...-|..+-.....++++.++.|+.|++.|+.|+|++++||||||||||||+.+|.+||||||+|+.+...+..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~--- 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN--- 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch---
Confidence 99976544444444578999999999999999999999999999999999999999999999999999987522100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G~ 355 (549)
-..+|.|.||+|||.+.+ ..|+.++||||+||++.||++|.
T Consensus 158 --------------------------------------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~ 199 (396)
T KOG0593|consen 158 --------------------------------------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE 199 (396)
T ss_pred --------------------------------------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence 014699999999999998 89999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhcc-----------------ccccCCCC----------cCCChhHHHHHHHhhh-cccccCCCC
Q 038137 356 PPFYSDEPMSTCRKIVNWR-----------------THLKFPEE----------AKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~-----------------~~l~~p~~----------~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
|.|.+.++.+.+..|...- ..+.+|+. +.+|.-+.||+.+||. ||.+|+
T Consensus 200 pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~--- 276 (396)
T KOG0593|consen 200 PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL--- 276 (396)
T ss_pred cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc---
Confidence 9999999888877775311 11223321 4678899999999999 999999
Q ss_pred CHHHHHcCCcccCC
Q 038137 408 GADEIKAHPWFKGI 421 (549)
Q Consensus 408 ~~~eil~HpfF~~i 421 (549)
+.++++.||||.++
T Consensus 277 sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 277 SCEQLLHHPYFDGF 290 (396)
T ss_pred cHHHHhcChHHHHH
Confidence 79999999999553
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=434.04 Aligned_cols=281 Identities=35% Similarity=0.704 Sum_probs=238.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||.||+|+++.+++.||+|++.+...........+..|..++..+ +|||||+++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999886555555667788899998776 899999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--------- 151 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--------- 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (329)
T cd05618 152 --------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccC
Confidence 011468999999999999999999999999999999999999999531
Q ss_pred Cc---------hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC---CCHHHHHcCCcccCCCccccc-
Q 038137 362 EP---------MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPWFKGIEWDKLY- 427 (549)
Q Consensus 362 ~~---------~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~HpfF~~i~w~~l~- 427 (549)
.. ......+.. ....+|. .++.++++||.+||. ||.+|++. .+++++++||||++++|+.+.
T Consensus 200 ~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~ 275 (329)
T cd05618 200 GSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ 275 (329)
T ss_pred CCcCCcccccHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc
Confidence 11 112223332 3445564 689999999999999 99999964 257999999999999998775
Q ss_pred -cccCCCcccCCCccccccccc
Q 038137 428 -QIKAAFIPEVNDELDTQNFEK 448 (549)
Q Consensus 428 -~~~~pf~p~~~~~~d~~~f~~ 448 (549)
++.+|+.|.+.+..+..+|+.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
T cd05618 276 KQVVPPFKPNISGEFGLDNFDA 297 (329)
T ss_pred CCCCcCccCCCCCcccchhcCc
Confidence 477899999888777777764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=432.89 Aligned_cols=287 Identities=43% Similarity=0.812 Sum_probs=242.5
Q ss_pred CeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLR-RGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~l 192 (549)
+|++++.||+|+||.||+|++. .+|+.||+|++.+..... ....+++..|+.+|..+ +||+|++++++|.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 578999999998765432 33456788999999999 589999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999876431100
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEm 351 (549)
......+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 161 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 200 (332)
T cd05614 161 ----------------------------------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200 (332)
T ss_pred ----------------------------------------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhh
Confidence 001246899999999999875 589999999999999999
Q ss_pred hhCCCCCCCCCchh----hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCcc
Q 038137 352 LVGYPPFYSDEPMS----TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWD 424 (549)
Q Consensus 352 l~G~~PF~~~~~~~----~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~ 424 (549)
++|..||....... ....+.. ....+| ..+++.+++||.+||. ||.+|++.. +++++++||||++++|.
T Consensus 201 ltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 201 LTGASPFTLEGERNTQSEVSRRILK--CDPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred hcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99999997543322 2233333 223333 3689999999999999 999999765 79999999999999998
Q ss_pred ccc--cccCCCcccCCCccccccccc
Q 038137 425 KLY--QIKAAFIPEVNDELDTQNFEK 448 (549)
Q Consensus 425 ~l~--~~~~pf~p~~~~~~d~~~f~~ 448 (549)
.+. .+.+||.|......+..+|..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (332)
T cd05614 277 ALALRKVNPPFRPSIRNELDVGNFAE 302 (332)
T ss_pred HHHhCCCCCCcCCCCCCcchhhhcCc
Confidence 875 467899999988888888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-55 Score=422.05 Aligned_cols=257 Identities=34% Similarity=0.575 Sum_probs=226.7
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeee-eecCCce
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC-SFQDDEY 191 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~f~d~~~ 191 (549)
.....+|+++++||+|+||+||+|++..+|..+|.|.+. -.+.+......+..|+.+|++++|||||+.|+ .|.++..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 345667999999999999999999999999999999998 45556666778899999999999999999998 7776655
Q ss_pred -EEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--eeecCCCCCCeEEcCCCcEEEeecC
Q 038137 192 -LYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHK--HN--YIHRDIKPDNLLLDRNGHMKLSDFG 262 (549)
Q Consensus 192 -lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~--~g--iiHRDLKPeNILld~~g~vKL~DFG 262 (549)
++||||||.+|||..+++. +..++|..++.|+.|++.||..+|+ .. |+||||||.||+|+.+|.|||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999999954 4679999999999999999999998 45 9999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccc
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiW 342 (549)
|++.+... ...|.+.||||.||+||++...+|++++|||
T Consensus 174 L~r~l~s~-----------------------------------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiW 212 (375)
T KOG0591|consen 174 LGRFLSSK-----------------------------------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIW 212 (375)
T ss_pred hHhHhcch-----------------------------------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHH
Confidence 99987532 1235589999999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||||++|||+.-.+||++++-.+.+.+|.+. ...+.|. ...|.++..||..||+ ||+.||++ ||++..+
T Consensus 213 slGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~-~~YS~~l~~li~~ci~vd~~~RP~t--------~~~v~di 282 (375)
T KOG0591|consen 213 SLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPD-EHYSTDLRELINMCIAVDPEQRPDT--------VPYVQDI 282 (375)
T ss_pred HHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcH-HHhhhHHHHHHHHHccCCcccCCCc--------chHHHHH
Confidence 9999999999999999999999999999985 3334553 3789999999999999 99999963 5666544
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=431.30 Aligned_cols=281 Identities=41% Similarity=0.739 Sum_probs=242.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHH-HHHhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN-LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
+.||+|+||+||+|+++.+++.||+|++.+..........++..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998765544444455555554 56788999999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--------- 151 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--------- 151 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 152 --------------------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred --------------------------------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 011468999999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC-CHHHHHcCCcccCCCccccc--cccCCCcccC
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK-GADEIKAHPWFKGIEWDKLY--QIKAAFIPEV 437 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~-~~~eil~HpfF~~i~w~~l~--~~~~pf~p~~ 437 (549)
+..+.+..+... ...++ ..+++++++||.+||. +|.+|++.. .+.++++|+||..++|+.+. ...+|+.|.+
T Consensus 200 ~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05602 200 NTAEMYDNILNK--PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNV 275 (325)
T ss_pred CHHHHHHHHHhC--CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCC
Confidence 888888877753 33333 3689999999999999 999999753 57799999999999999986 3678889998
Q ss_pred CCccccccccc
Q 038137 438 NDELDTQNFEK 448 (549)
Q Consensus 438 ~~~~d~~~f~~ 448 (549)
..+.+..+|+.
T Consensus 276 ~~~~~~~~~~~ 286 (325)
T cd05602 276 SGPNDLRHFDP 286 (325)
T ss_pred CCcchhhhcCC
Confidence 88888888864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-55 Score=411.57 Aligned_cols=260 Identities=32% Similarity=0.607 Sum_probs=237.0
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.+.|++-.+||+|+|+.||.|.++.||+.||+|++.-..+..+ ..+.+.+|+.|-..++|||||+|..+++.+.+.|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4678889999999999999999999999999999987655444 567799999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC---CcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN---GHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~---g~vKL~DFGlak~~~~~~~ 272 (549)
+|+|.||+|..-+-.+-.++|..+-.|+.||+.||.|+|.+||||||+||+|+||-+. --+||+|||+|..+...
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-- 166 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-- 166 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc--
Confidence 9999999999888777889999999999999999999999999999999999999543 36999999999976411
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
..+..++|||.|||||++...+|+..+||||.|||||-||
T Consensus 167 ----------------------------------------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 167 ----------------------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred ----------------------------------------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 1134689999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
.|++||++.+....+..|+.....+.-|.++.+|++|+|||++||. ||.+|+ ++.|+|+|||..+-
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI---ta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI---TADEALKHPWICNR 273 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhc---cHHHHhCCchhcch
Confidence 9999999999999999999977777777889999999999999999 999999 89999999999753
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=431.03 Aligned_cols=281 Identities=42% Similarity=0.764 Sum_probs=247.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg 202 (549)
+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876555556677888999999999999999999999999999999999999
Q ss_pred chhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 203 DMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 203 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
+|..++.+...+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--------- 151 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---------
Confidence 999999888899999999999999999999997 7999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
.....+||+.|+|||++.+..|+.++|+|||||++|||++|..||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 152 --------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred --------------------------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 011457999999999999999999999999999999999999999988
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcccccc--ccCCCccc
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLYQ--IKAAFIPE 436 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~~--~~~pf~p~ 436 (549)
+.......+.. ....+|. .+++++.+||.+||+ ||.+|++. .++.++++||||.++.|..... ..+|+.|.
T Consensus 200 ~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05594 200 DHEKLFELILM--EEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQ 275 (325)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 87777666654 3455664 689999999999999 99999854 3799999999999999998763 66889999
Q ss_pred CCCccccccccc
Q 038137 437 VNDELDTQNFEK 448 (549)
Q Consensus 437 ~~~~~d~~~f~~ 448 (549)
...+.++.+|+.
T Consensus 276 ~~~~~~~~~~~~ 287 (325)
T cd05594 276 VTSETDTRYFDE 287 (325)
T ss_pred CCCcchhhhcCc
Confidence 888888888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=428.83 Aligned_cols=281 Identities=41% Similarity=0.746 Sum_probs=243.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHH-HHHhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN-LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
++||+|+||.||+|+++.+|+.||+|++.+...........+..|+. +++.++|||||+++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998766544445555666665 57889999999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---------- 150 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---------- 150 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
......+||+.|+|||++.+..|+.++|+|||||++|||++|.+||.+.
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 151 -------------------------------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred -------------------------------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 0011458999999999999999999999999999999999999999998
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-CCHHHHHcCCcccCCCccccc--cccCCCcccC
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-KGADEIKAHPWFKGIEWDKLY--QIKAAFIPEV 437 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~HpfF~~i~w~~l~--~~~~pf~p~~ 437 (549)
+....+..+.. ..+.+|. ..+.++.++|.+||. +|.+|++. .++.++++||||..++|..+. .+.+|+.|..
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T cd05603 200 DVSQMYDNILH--KPLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNV 275 (321)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCC
Confidence 87777777765 3445553 678999999999999 99999975 367899999999999999876 3678888888
Q ss_pred CCccccccccc
Q 038137 438 NDELDTQNFEK 448 (549)
Q Consensus 438 ~~~~d~~~f~~ 448 (549)
....+...|+.
T Consensus 276 ~~~~~~~~~~~ 286 (321)
T cd05603 276 AGPADLRHFDP 286 (321)
T ss_pred CCcchhhhcCC
Confidence 88878877764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-52 Score=427.42 Aligned_cols=282 Identities=43% Similarity=0.807 Sum_probs=243.7
Q ss_pred eeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhh-chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 122 LTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEML-RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
++.||+|+||.||+|++. .+++.||||++.+.... ......++.+|+.+|..++||||++++++|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 57899999999876543 23345668899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 154 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG------ 154 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC------
Confidence 99999999999888899999999999999999999999999999999999999999999999999987532110
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
......+||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 155 -----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~p 199 (323)
T cd05584 155 -----------------------------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199 (323)
T ss_pred -----------------------------------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCC
Confidence 001145799999999999999999999999999999999999999
Q ss_pred CCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--cccCC
Q 038137 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIKAA 432 (549)
Q Consensus 358 F~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~~~p 432 (549)
|.+.+....+.++... .+.+|. .+++++.+||.+||+ +|++|++. .++++++.||||...+|+.+. ...+|
T Consensus 200 f~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05584 200 FTAENRKKTIDKILKG--KLNLPP--YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPP 275 (323)
T ss_pred CCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCC
Confidence 9998887777777753 344553 689999999999999 99999853 369999999999999998886 36678
Q ss_pred CcccCCCccccccccc
Q 038137 433 FIPEVNDELDTQNFEK 448 (549)
Q Consensus 433 f~p~~~~~~d~~~f~~ 448 (549)
+.|......|.+.|+.
T Consensus 276 ~~~~~~~~~~~~~~~~ 291 (323)
T cd05584 276 FKPLLQSEEDVSQFDS 291 (323)
T ss_pred cCCCCCCcchhhhcCc
Confidence 8888877777777764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=440.32 Aligned_cols=254 Identities=34% Similarity=0.611 Sum_probs=232.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|.+...||+|+||.||+|+.|.|.+.||||.+.|..- ....+..+++|++|++.++|||||.++.+|++..++++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 578999999999999999999999999999999988653 3456788999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||.| +|.++|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+.+|++|+||||+|+.+....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99976 999999999999999999999999999999999999999999999999999999999999999764211
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
....+.-|||-|||||++.+..|+..+|.||||||+|||++|+|
T Consensus 155 ------------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 155 ------------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred ------------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 11236789999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||+........+.|+. .+...|. .+|.++++||..||. ||.+|+ +..+++.|||.++
T Consensus 199 PF~a~si~~Lv~~I~~--d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rl---tW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 199 PFYARSITQLVKSILK--DPVKPPS--TASSSFVNFLQGLLIKDPAQRL---TWTDLLGHPFWKG 256 (808)
T ss_pred CchHHHHHHHHHHHhc--CCCCCcc--cccHHHHHHHHHHhhcChhhcc---cHHHHhcChHHhh
Confidence 9999988888888876 5555664 899999999999999 999999 8999999999876
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=432.63 Aligned_cols=280 Identities=43% Similarity=0.783 Sum_probs=243.1
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCceEEEEEeecCC
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV---DSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
||+|+||+||+|+++.+|+.||||++.+..........+...|..++... +||+|++++.+|.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999877665555566677788888765 699999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--------- 151 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--------- 151 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYS 360 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~~PF~~ 360 (549)
.....+||+.|+|||++.+. .|+.++|+|||||++|||++|+.||.+
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 152 --------------------------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred --------------------------------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 01146899999999999764 589999999999999999999999999
Q ss_pred CCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-CCHHHHHcCCcccCCCccccc--cccCCCccc
Q 038137 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-KGADEIKAHPWFKGIEWDKLY--QIKAAFIPE 436 (549)
Q Consensus 361 ~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~HpfF~~i~w~~l~--~~~~pf~p~ 436 (549)
.+..+.+.+|.. ....+|. ..+++++++||.+||+ ||.+|++. .++++++.||||..++|+.+. .+.+|+.|.
T Consensus 200 ~~~~~~~~~i~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 276 (330)
T cd05586 200 EDTQQMYRNIAF--GKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPI 276 (330)
T ss_pred CCHHHHHHHHHc--CCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCC
Confidence 888777777765 3345554 2589999999999999 99999975 479999999999999998876 367899999
Q ss_pred CCCccccccccc
Q 038137 437 VNDELDTQNFEK 448 (549)
Q Consensus 437 ~~~~~d~~~f~~ 448 (549)
+....+.++|+.
T Consensus 277 ~~~~~~~~~~~~ 288 (330)
T cd05586 277 VDSDEDVSNFDP 288 (330)
T ss_pred CCCCcchhhcCc
Confidence 988888888864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=432.42 Aligned_cols=274 Identities=30% Similarity=0.483 Sum_probs=234.2
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--c
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--E 190 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~ 190 (549)
....+.|+.+..||+|.||.||+|++..||++||+|++.... .+.+......+|+.||+.++||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 345678999999999999999999999999999999998754 3566777889999999999999999999988766 6
Q ss_pred eEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|||+|||+ -||..++... -.|++.+++.|+.|++.||+|||++||+|||||.+|||||.+|.+||+|||||+.++.
T Consensus 192 siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 8999999995 4999998664 4799999999999999999999999999999999999999999999999999997754
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
.... ...+.|-|.||+|||+|++ ..|+.++|+||+||||
T Consensus 271 ~~~~----------------------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl 310 (560)
T KOG0600|consen 271 SGSA----------------------------------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCIL 310 (560)
T ss_pred CCCc----------------------------------------ccccceEEeeccChHHhcCCcccccceeehhhhHHH
Confidence 3210 0125789999999999998 6799999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhh---------ccccccCCC-----------------CcCCChhHHHHHHHhhh-ccc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVN---------WRTHLKFPE-----------------EAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~---------~~~~l~~p~-----------------~~~~s~~~~dLI~~lL~-dp~ 401 (549)
.||++|+|.|.+.+..+.+.+|.. |. ...+|. -..+++.+.+|+..||| ||.
T Consensus 311 ~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~ 389 (560)
T KOG0600|consen 311 AELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPD 389 (560)
T ss_pred HHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcc
Confidence 999999999999999999999975 43 223331 02578999999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCCCccccccccCCCccc
Q 038137 402 QRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPE 436 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p~ 436 (549)
+|. +|.++|.|+||... .....|+.+|.
T Consensus 390 kR~---tA~~aL~seyF~t~----p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 390 KRG---TASSALQSEYFTTE----PLPCDPSSLPK 417 (560)
T ss_pred ccc---cHHHHhcCcccccC----CCCCCcccCCC
Confidence 999 89999999999432 23344455554
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=408.42 Aligned_cols=262 Identities=35% Similarity=0.631 Sum_probs=235.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-----RRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
..|+.-++||+|..+.|..|.++.||+.+|+|+|.-.... .....+....|+.||+++ .||+|++|.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3466678899999999999999999999999998642211 223345577899999987 7999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
++++|+|.|+.|.|+++|...-.++|..++.++.|++.|++|||.++||||||||+|||+|++..|||+|||+|..+...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999877532
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc------cCCCCcccccchh
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSL 344 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~------~~~y~~~~DiWSl 344 (549)
. ++ ...||||+|+|||.+. ..+|+..+|.||+
T Consensus 177 e-------------------------------kL-----------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 177 E-------------------------------KL-----------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC 214 (411)
T ss_pred h-------------------------------hH-----------HHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence 1 11 1479999999999986 3689999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
|||||.||.|.|||+.....-+++.|+.++..+.-|++..+|.+++|||++||+ ||.+|+ +++|+|+||||..+--
T Consensus 215 GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ri---take~LaHpff~q~~~ 291 (411)
T KOG0599|consen 215 GVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRI---TAKEALAHPFFIQIAQ 291 (411)
T ss_pred HHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcc---cHHHHhcChHHHHHHH
Confidence 999999999999999999999999999988888889999999999999999999 999999 8999999999976643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=429.74 Aligned_cols=260 Identities=36% Similarity=0.617 Sum_probs=237.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lyl 194 (549)
.+.|++.+.||+|.||.||.|+++.||+.||+|++.|..+......+.+.+|+.||..+. |||||.++++|.+...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456999999999999999999999999999999999988766666778999999999998 9999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC----CcEEEeecCcccccCCC
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN----GHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~----g~vKL~DFGlak~~~~~ 270 (549)
|||+|.||+|++.+... .++|..+..++.|++.|+.|||+.||+||||||+|||+... +.+|++|||+++.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999776 49999999999999999999999999999999999999643 57999999999876421
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
......||||.|+|||++...+|+..+|+||+||++|.
T Consensus 193 ------------------------------------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yi 230 (382)
T KOG0032|consen 193 ------------------------------------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYI 230 (382)
T ss_pred ------------------------------------------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHH
Confidence 11236899999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|++|.+||.+.+...+..+|......+..+.+..+|..|+|||++||+ ||..|+ +|.++|+|||+++.
T Consensus 231 LL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~---ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 231 LLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL---TAAQALQHPWIKSI 299 (382)
T ss_pred HhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC---CHHHHhcCccccCC
Confidence 999999999999999999999866666666678899999999999999 999999 89999999998865
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=419.05 Aligned_cols=281 Identities=43% Similarity=0.762 Sum_probs=241.4
Q ss_pred eeeeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 122 LTMIGKGAFGEVRVCRE---KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~---k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
++.||+|+||.||+|++ +.+|+.||+|++.+.... ......+..|+.+|..++||||++++++|.+...+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 468899999999876532 22345577899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
++||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------- 152 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE------- 152 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence 9999999999888889999999999999999999999999999999999999999999999999987543110
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF 358 (549)
....+.+||+.|+|||++.+..++.++|+|||||++|||++|+.||
T Consensus 153 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 198 (318)
T cd05582 153 ----------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198 (318)
T ss_pred ----------------------------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence 0112568999999999999999999999999999999999999999
Q ss_pred CCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCC--HHHHHcCCcccCCCcccccc--ccCCC
Q 038137 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG--ADEIKAHPWFKGIEWDKLYQ--IKAAF 433 (549)
Q Consensus 359 ~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~--~~eil~HpfF~~i~w~~l~~--~~~pf 433 (549)
.+.+.......+.. ....+|. .+++++++||.+||. ||.+|+.... +++++.||||..++|..+.. ..+|+
T Consensus 199 ~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (318)
T cd05582 199 QGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPF 274 (318)
T ss_pred CCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCc
Confidence 98888777777765 3344554 689999999999999 9999996533 89999999999999998763 67888
Q ss_pred cccCCCccccccccc
Q 038137 434 IPEVNDELDTQNFEK 448 (549)
Q Consensus 434 ~p~~~~~~d~~~f~~ 448 (549)
.|......+..+|+.
T Consensus 275 ~~~~~~~~~~~~~~~ 289 (318)
T cd05582 275 KPAVGRPDDTFYFDP 289 (318)
T ss_pred CCCCCCcchhhhcCc
Confidence 888776666665553
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=431.23 Aligned_cols=254 Identities=33% Similarity=0.595 Sum_probs=227.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
..|.....||+|+.|.||.|+...+++.||||.+......++ +-+.+|+.+|+..+|+|||+++.+|.-.+.+++||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 457888899999999999999999999999999987654333 45889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||.||+|.+++. ...++|.+++.++.+++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.+...
T Consensus 350 Eym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---- 424 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---- 424 (550)
T ss_pred eecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC----
Confidence 9999999888874 45699999999999999999999999999999999999999999999999999998764311
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
. -.+.||||+|||||++..+.|+.++||||||+++.||+-|.|
T Consensus 425 --------------------K-----------------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 425 --------------------K-----------------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred --------------------c-----------------cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCC
Confidence 1 126899999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
||..+++...+..|... +.+++.....+|++++||+.+||+ |+++|. +|.|+|.||||+
T Consensus 468 PYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kdFL~~cL~~dv~~Ra---sA~eLL~HpFl~ 527 (550)
T KOG0578|consen 468 PYLNENPLRALYLIATN-GTPKLKNPEKLSPELKDFLDRCLVVDVEQRA---SAKELLEHPFLK 527 (550)
T ss_pred CccCCChHHHHHHHhhc-CCCCcCCccccCHHHHHHHHHHhhcchhcCC---CHHHHhcChhhh
Confidence 99999998888777653 445555556999999999999999 999999 899999999995
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=408.09 Aligned_cols=275 Identities=33% Similarity=0.652 Sum_probs=234.6
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999987655444445567889999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+++++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 99999999888543 469999999999999999999999999999999999999999999999999987643110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
...+.+||+.|+|||++.+..++.++|+||+||++|||++|.
T Consensus 157 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 157 --------------------------------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred --------------------------------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 001357999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhcc--ccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCcccccc--
Q 038137 356 PPFYSDEPMSTCRKIVNWR--THLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLYQ-- 428 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~~l~~-- 428 (549)
+||.+.+.......+.... ....+| ..+++.+.+||.+||. ||.+|+++. ++++++.||||...+|+.+..
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05605 199 SPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276 (285)
T ss_pred CCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCC
Confidence 9998866544333332211 122333 3689999999999999 999999876 799999999999999998874
Q ss_pred ccCCCccc
Q 038137 429 IKAAFIPE 436 (549)
Q Consensus 429 ~~~pf~p~ 436 (549)
+.|||.|.
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05605 277 LEPPFCPD 284 (285)
T ss_pred CCCCCCCC
Confidence 67889884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=407.22 Aligned_cols=268 Identities=34% Similarity=0.657 Sum_probs=226.4
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCch
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L 204 (549)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+|..++||||++++++|.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876655555566788899999999999999999999999999999999999999
Q ss_pred hhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccccc
Q 038137 205 MTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280 (549)
Q Consensus 205 ~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~ 280 (549)
..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-------- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--------
Confidence 887743 35699999999999999999999999999999999999999999999999999876532110
Q ss_pred CCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCC
Q 038137 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360 (549)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~ 360 (549)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 153 ---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 153 ---------------------------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred ---------------------------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 00135799999999999999999999999999999999999999987
Q ss_pred CCchhhhhhhhhc--cccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcccccc--ccCCC
Q 038137 361 DEPMSTCRKIVNW--RTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLYQ--IKAAF 433 (549)
Q Consensus 361 ~~~~~~~~~I~~~--~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~~--~~~pf 433 (549)
.........+... .....+| ..+|+++.+||.+||+ ||++|++. .+++++++||||++++|..+.. +.+||
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~ 277 (280)
T cd05608 200 RGEKVENKELKQRILNDSVTYP--DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPF 277 (280)
T ss_pred CCcchhHHHHHHhhcccCCCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCC
Confidence 5433222222211 1223333 3689999999999999 99999964 3689999999999999998864 67788
Q ss_pred cc
Q 038137 434 IP 435 (549)
Q Consensus 434 ~p 435 (549)
.|
T Consensus 278 ~~ 279 (280)
T cd05608 278 VP 279 (280)
T ss_pred CC
Confidence 76
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-52 Score=422.64 Aligned_cols=258 Identities=30% Similarity=0.527 Sum_probs=222.6
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCc-eE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDE-YL 192 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~-~l 192 (549)
..++|.+++.||.|+||.||+|+.+.+|..||||.|++.-.. - +.-.-.+|+..|++++ |||||+|++++.|.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-H-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 356799999999999999999999999999999999875422 1 2223467999999998 999999999999988 99
Q ss_pred EEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|+||||| ..+|+.++.. ...|+|..++.|+.||+.||+|+|++|+.||||||||||+..+..|||+|||||+.+....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred eeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence 9999999 5689999854 5689999999999999999999999999999999999999989999999999999875331
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 350 (549)
- -+.+|.|.||+|||+|+. .-|+.++|+||+||||+|
T Consensus 165 P------------------------------------------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aE 202 (538)
T KOG0661|consen 165 P------------------------------------------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAE 202 (538)
T ss_pred C------------------------------------------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHH
Confidence 0 114799999999999987 557999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhh---------cc--------ccccCCCC---------cCCChhHHHHHHHhhh-ccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVN---------WR--------THLKFPEE---------AKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~---------~~--------~~l~~p~~---------~~~s~~~~dLI~~lL~-dp~~R 403 (549)
+.+-+|.|.|.+..+.+.+|+. |. -.+.||.- +..++++.+||.+||. ||.+|
T Consensus 203 l~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kR 282 (538)
T KOG0661|consen 203 LYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKR 282 (538)
T ss_pred HHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccC
Confidence 9999999999999999888864 11 12333321 2468999999999999 99999
Q ss_pred CCCCCHHHHHcCCcccC
Q 038137 404 LGTKGADEIKAHPWFKG 420 (549)
Q Consensus 404 l~~~~~~eil~HpfF~~ 420 (549)
+ +|.|+|+||||+.
T Consensus 283 p---TA~~al~~pffq~ 296 (538)
T KOG0661|consen 283 P---TASQALQHPFFQV 296 (538)
T ss_pred c---cHHHHhcCccccc
Confidence 9 8999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=410.19 Aligned_cols=260 Identities=34% Similarity=0.550 Sum_probs=219.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc--eEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE--YLY 193 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~--~ly 193 (549)
..++...+.||+|+||.||++.++.+|..+|||.+.... ....+.+.+|+.||..++|||||+.++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888899999999999999999999999999987652 122567899999999999999999999755444 699
Q ss_pred EEEeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-CCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-~g~vKL~DFGlak~~~~~~ 271 (549)
+.|||++||+|.+++.+.+ .|+|..++.|.+||+.||.|||++|||||||||+|||++. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998876 7999999999999999999999999999999999999999 7999999999998764200
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-CCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-y~~~~DiWSlGvilyE 350 (549)
... ....+..|||.|||||++.+.. -+.++|||||||++.|
T Consensus 173 ~~~--------------------------------------~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 173 TKS--------------------------------------DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred ccc--------------------------------------cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 000 0012578999999999999622 2349999999999999
Q ss_pred HhhCCCCCCC-CCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 351 MLVGYPPFYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 351 ml~G~~PF~~-~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|+||.+||.. ......+.+|........+|. .+|++++|||.+|+. +|++|+ +|+++|.|||....
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~--~ls~~a~~Fl~~C~~~~p~~Rp---ta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLPEIPD--SLSDEAKDFLRKCFKRDPEKRP---TAEELLEHPFLKQN 282 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHhhcCcccCc---CHHHHhhChhhhcc
Confidence 9999999987 455555556655433445664 799999999999999 999999 89999999999764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=387.53 Aligned_cols=259 Identities=32% Similarity=0.569 Sum_probs=225.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|..++.||+|.||.||+|++..||+.||||+++.... +.+......+|+.+|++++|+||+.|.++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 468888999999999999999999999999999987643 3344456889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||+ .||...+..+ -.|+..+++.|+.+++.||+|||++.|+||||||.|+|++.+|.+||+|||||+.+....-
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--- 156 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--- 156 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc---
Confidence 9995 5999998654 5799999999999999999999999999999999999999999999999999998753210
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G 354 (549)
..+ ..|-|.+|+|||.|.| ..|+..+|+||+|||+.||+.|
T Consensus 157 -------------------------------------~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 157 -------------------------------------IQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred -------------------------------------ccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc
Confidence 001 2389999999999997 6799999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhh---------ccccccCCC---------C------cCCChhHHHHHHHhhh-cccccCCCCCH
Q 038137 355 YPPFYSDEPMSTCRKIVN---------WRTHLKFPE---------E------AKLSPEAKDLISKLLC-NVEQRLGTKGA 409 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~---------~~~~l~~p~---------~------~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 409 (549)
.|-|.|+++.+.+..|.. |.+--.+|+ . +..|+++.||+.+|+. ||.+|+ +|
T Consensus 199 ~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri---ta 275 (318)
T KOG0659|consen 199 VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI---TA 275 (318)
T ss_pred CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc---cH
Confidence 999999999999888874 433222222 1 2458899999999999 999999 89
Q ss_pred HHHHcCCcccCC
Q 038137 410 DEIKAHPWFKGI 421 (549)
Q Consensus 410 ~eil~HpfF~~i 421 (549)
.|+++||||+..
T Consensus 276 ~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 276 SQALKHPYFKSL 287 (318)
T ss_pred HHHhcchhhhcC
Confidence 999999999864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=402.05 Aligned_cols=285 Identities=47% Similarity=0.936 Sum_probs=256.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998877666667788999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|.+++.+.+.+++..+..++.|++.||.|||+.||+||||+|+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765311
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
....+||+.|+|||.+.+..++.++|+|||||++|+|++|.+
T Consensus 155 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 196 (290)
T cd05580 155 --------------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196 (290)
T ss_pred --------------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 013579999999999998889999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCccccc--cccC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLY--QIKA 431 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~~l~--~~~~ 431 (549)
||...+......++.. ....+|. .+++.++++|.+||+ +|.+|+.+. +++|+++||||+.++|..+. .+.+
T Consensus 197 p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 272 (290)
T cd05580 197 PFFDDNPIQIYEKILE--GKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEA 272 (290)
T ss_pred CCCCCCHHHHHHHHhc--CCccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCC
Confidence 9988877666777764 3445554 679999999999999 999999764 89999999999999999887 4789
Q ss_pred CCcccCCCcccccccccc
Q 038137 432 AFIPEVNDELDTQNFEKF 449 (549)
Q Consensus 432 pf~p~~~~~~d~~~f~~~ 449 (549)
|+.|...++.|.+.|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05580 273 PFIPKVKGPGDTSNFDDY 290 (290)
T ss_pred CccCCCCCccccccccCC
Confidence 999999999999888753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=398.45 Aligned_cols=262 Identities=29% Similarity=0.474 Sum_probs=225.2
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec--CCceE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ--DDEYL 192 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~l 192 (549)
..+.|+.+..|++|+||.||.|+++.|+++||+|+++... .+.+.--...+|+++|..++|||||.+-.+.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3578999999999999999999999999999999997543 34455555789999999999999999988776 34569
Q ss_pred EEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|||||||. -||.+++..- .+|...+++.++.|++.||.|||.+.|+||||||+|+|++..|.+||+|||||+.+....
T Consensus 153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99999995 5999999765 489999999999999999999999999999999999999999999999999999875321
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 350 (549)
. .....|-|.||+|||+|++ ..|+.++|+||+|||+.|
T Consensus 232 k-----------------------------------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE 270 (419)
T KOG0663|consen 232 K-----------------------------------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAE 270 (419)
T ss_pred c-----------------------------------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHH
Confidence 0 0125789999999999998 679999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhh---------cccc--------ccCCCC-----------cCCChhHHHHHHHhhh-ccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVN---------WRTH--------LKFPEE-----------AKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~---------~~~~--------l~~p~~-----------~~~s~~~~dLI~~lL~-dp~ 401 (549)
|++++|.|.|....+...+|+. |.+. ..|+.. ..+|+.+.||+..||+ ||.
T Consensus 271 ~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~ 350 (419)
T KOG0663|consen 271 LLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG 350 (419)
T ss_pred HHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc
Confidence 9999999999999999999875 3322 122211 1267999999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCCC
Q 038137 402 QRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+|+ +|+|.|+|+||.+..
T Consensus 351 kR~---tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 351 KRI---TAEDGLKHEYFRETP 368 (419)
T ss_pred ccc---cHHHhhcccccccCC
Confidence 999 899999999998753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=404.85 Aligned_cols=263 Identities=30% Similarity=0.494 Sum_probs=222.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-----Cc
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-----DE 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-----~~ 190 (549)
...|..++.||+|+||.|+.|.++.||+.||||++... ....-..++..+|+.+|+.++|+||+.+++++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566689999999999999999999999999998642 2344556788999999999999999999999875 34
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+|+|+| +.||...+.....|++++++++++||+.||.|+|+.||+||||||.|+|++.+..+||||||||+..+..
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 599999999 7899999988888999999999999999999999999999999999999999999999999999986532
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
... ...+..|.|.+|+|||+++. ..|+.++||||+|||+.
T Consensus 179 --~~~-------------------------------------~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~A 219 (359)
T KOG0660|consen 179 --FED-------------------------------------GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILA 219 (359)
T ss_pred --Ccc-------------------------------------cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHH
Confidence 000 01125799999999999985 78999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccc---------------------cccCCC------CcCCChhHHHHHHHhhh-ccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRT---------------------HLKFPE------EAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~---------------------~l~~p~------~~~~s~~~~dLI~~lL~-dp~ 401 (549)
|||+|+|.|.|.+....+..|+..-+ ....|. -+..++.|.||+.+||. ||.
T Consensus 220 EmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~ 299 (359)
T KOG0660|consen 220 EMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPK 299 (359)
T ss_pred HHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCcc
Confidence 99999999999888777766653110 001111 13679999999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCCC
Q 038137 402 QRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+|+ ||+|+|+||||....
T Consensus 300 kRi---ta~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 300 KRI---TAEEALAHPYLAPYH 317 (359)
T ss_pred ccC---CHHHHhcChhhhhhc
Confidence 999 899999999998764
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=400.15 Aligned_cols=274 Identities=35% Similarity=0.689 Sum_probs=231.1
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|++|+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 99999999988543 469999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus 157 --------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 157 --------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred --------------------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 001357999999999999999999999999999999999999
Q ss_pred CCCCCCCchh---hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCcccccc-
Q 038137 356 PPFYSDEPMS---TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLYQ- 428 (549)
Q Consensus 356 ~PF~~~~~~~---~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~~l~~- 428 (549)
+||....... ....+... ....++ ..+++++++||.+||+ ||.+|++.. +++|+++||||+.++|..+..
T Consensus 199 ~Pf~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05630 199 SPFQQRKKKIKREEVERLVKE-VQEEYS--EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAG 275 (285)
T ss_pred CCCCCCCccchHHHHHhhhhh-hhhhcC--ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcC
Confidence 9998754322 12222211 111233 3688999999999999 999999532 399999999999999998874
Q ss_pred -ccCCCccc
Q 038137 429 -IKAAFIPE 436 (549)
Q Consensus 429 -~~~pf~p~ 436 (549)
+.|||.|+
T Consensus 276 ~~~~~~~~~ 284 (285)
T cd05630 276 MLEPPFKPD 284 (285)
T ss_pred CCCCCCCCC
Confidence 77899986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=403.91 Aligned_cols=253 Identities=29% Similarity=0.593 Sum_probs=233.0
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
..+|++.+.||+|.||+|-+|.+...|+.||||.|+|..+......-|+++|++||..++||+|+.+|.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46799999999999999999999999999999999999998888899999999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||..||+|++++...+.|+|.+++.+++||+.|+.|+|+++++|||||.+|||||.|+++||+||||+..+....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---- 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---- 207 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~G 354 (549)
+..++||+|-|.+||++.+.+| +..+|.|||||+||-|+.|
T Consensus 208 --------------------------------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 208 --------------------------------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred --------------------------------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 2237899999999999999999 8999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
..||.+.+.....++|-+. ...-| .-+.+|.-||+.||. +|+.|. ++++|-.|=|.
T Consensus 250 tMPFDG~Dhk~lvrQIs~G--aYrEP---~~PSdA~gLIRwmLmVNP~RRA---TieDiAsHWWv 306 (668)
T KOG0611|consen 250 TMPFDGRDHKRLVRQISRG--AYREP---ETPSDASGLIRWMLMVNPERRA---TIEDIASHWWV 306 (668)
T ss_pred ccccCCchHHHHHHHhhcc--cccCC---CCCchHHHHHHHHHhcCcccch---hHHHHhhhhee
Confidence 9999999998888888763 33333 246789999999998 999998 89999999885
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=402.37 Aligned_cols=268 Identities=29% Similarity=0.495 Sum_probs=232.8
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
+..+..++|++..+||.|..+.||+|+...++.+||||++.-.... ..++.+++|...|+.++|||||+.+++|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 4567789999999999999999999999999999999999876543 33788999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+||.||.+|++.+++.. ...|+|..++.++.+++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999999966 3679999999999999999999999999999999999999999999999999987664
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGA 346 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGv 346 (549)
.+.. +.+-.. .+++|||+|||||+++. .+|+.++||||||+
T Consensus 178 ~~G~------------------------------------R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGI 220 (516)
T KOG0582|consen 178 DSGD------------------------------------RQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGI 220 (516)
T ss_pred ccCc------------------------------------eeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhH
Confidence 3210 111111 47899999999999764 78999999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhccccccCC--------CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFP--------EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p--------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
...||.+|..||....+...+..-++. .++.+ ....++...+.+|..||. ||.+|+ +|+++|+|+|
T Consensus 221 TA~ELA~G~aPf~k~pPmkvLl~tLqn--~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp---tAskLlkh~F 295 (516)
T KOG0582|consen 221 TACELAHGHAPFSKYPPMKVLLLTLQN--DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP---TASKLLKHAF 295 (516)
T ss_pred HHHHHhcCCCCcccCChHHHHHHHhcC--CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC---CHHHHhccHH
Confidence 999999999999998888876555552 33222 224678889999999999 999999 8999999999
Q ss_pred ccCCC
Q 038137 418 FKGIE 422 (549)
Q Consensus 418 F~~i~ 422 (549)
|+...
T Consensus 296 Fk~~k 300 (516)
T KOG0582|consen 296 FKKAK 300 (516)
T ss_pred Hhhcc
Confidence 98763
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=396.76 Aligned_cols=267 Identities=33% Similarity=0.600 Sum_probs=222.9
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCch
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L 204 (549)
||+|+||.||+|+.+.+|+.||+|++.+...........+..|+++|..++||||++++++|.++..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999876654444445567799999999999999999999999999999999999999
Q ss_pred hhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCC
Q 038137 205 MTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282 (549)
Q Consensus 205 ~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~ 282 (549)
..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 9888543 358999999999999999999999999999999999999999999999999987653210
Q ss_pred CcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCC
Q 038137 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362 (549)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~ 362 (549)
......||+.|+|||++.+..++.++|+|||||++|||++|++||.+..
T Consensus 150 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 150 -------------------------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred -------------------------------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 0013479999999999999899999999999999999999999997654
Q ss_pred ch----hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC-CHHHHHcCCcccCCCccccc--cccCCCc
Q 038137 363 PM----STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK-GADEIKAHPWFKGIEWDKLY--QIKAAFI 434 (549)
Q Consensus 363 ~~----~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~-~~~eil~HpfF~~i~w~~l~--~~~~pf~ 434 (549)
.. .....+.. ....++. ..+++++++||.+||. ||.+|++.. -.++++.||||++++|..+. ...+||+
T Consensus 199 ~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~ 275 (277)
T cd05607 199 EKVAKEELKRRTLE--DEVKFEH-QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFV 275 (277)
T ss_pred chhhHHHHHHHhhc--ccccccc-ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCC
Confidence 32 22222222 2222222 3689999999999999 999999532 13789999999999999988 4678887
Q ss_pred cc
Q 038137 435 PE 436 (549)
Q Consensus 435 p~ 436 (549)
|.
T Consensus 276 ~~ 277 (277)
T cd05607 276 PD 277 (277)
T ss_pred CC
Confidence 73
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=394.16 Aligned_cols=258 Identities=34% Similarity=0.496 Sum_probs=216.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|+++.+++.||||++..... .....+.+.+|+.++..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2334567888999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+.+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--- 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc---
Confidence 99998877666555678999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.....+||+.|+|||++.+..|+.++|+|||||++|||++|++
T Consensus 157 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 157 -------------------------------------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred -------------------------------------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence 0013579999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccc-----------------cccCCCC-----------cCCChhHHHHHHHhhh-cccccCCCC
Q 038137 357 PFYSDEPMSTCRKIVNWRT-----------------HLKFPEE-----------AKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~-----------------~l~~p~~-----------~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
||.+.+.......+..... ...+|.. ..+|++++|||++||. ||.+|+
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~--- 276 (287)
T cd07848 200 LFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY--- 276 (287)
T ss_pred CCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC---
Confidence 9988765544433322111 0111110 1378899999999999 999999
Q ss_pred CHHHHHcCCcc
Q 038137 408 GADEIKAHPWF 418 (549)
Q Consensus 408 ~~~eil~HpfF 418 (549)
+++++++||||
T Consensus 277 s~~~~l~hp~f 287 (287)
T cd07848 277 LTEQCLNHPAF 287 (287)
T ss_pred CHHHHhcCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=396.63 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=212.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||.|+||.||+|+++.+|+.||||++..... ......+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999976432 22234577899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||++ ++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 99995 577777654 46799999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 199 (303)
T cd07869 159 ---------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199 (303)
T ss_pred ---------------------------------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 0113578999999999876 458999999999999999999
Q ss_pred CCCCCCCCCch-hhhhhhhh---------cccccc------------CCC-------CcCCChhHHHHHHHhhh-ccccc
Q 038137 354 GYPPFYSDEPM-STCRKIVN---------WRTHLK------------FPE-------EAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 354 G~~PF~~~~~~-~~~~~I~~---------~~~~l~------------~p~-------~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
|.+||.+.... .....+.. |..... .|. ...++++++|||.+||+ ||.+|
T Consensus 200 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R 279 (303)
T cd07869 200 GVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNR 279 (303)
T ss_pred CCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhc
Confidence 99999875432 22222211 000000 000 01246789999999999 99999
Q ss_pred CCCCCHHHHHcCCcccCCCc
Q 038137 404 LGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 404 l~~~~~~eil~HpfF~~i~w 423 (549)
+ +++|+++||||+++.+
T Consensus 280 ~---s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 280 L---SAQAALSHEYFSDLPP 296 (303)
T ss_pred c---CHHHHhcCcccccCCh
Confidence 9 8999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=404.16 Aligned_cols=258 Identities=30% Similarity=0.554 Sum_probs=232.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
.=|.+-+.||+|-|+.|-+|++.-||..||||++.|..+. .-...|+..|+..|+.++|||||+||.+..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4488889999999999999999999999999999987653 344578999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE-cCCCcEEEeecCcccccCCCCccc
Q 038137 197 EYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL-DRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl-d~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|+-.||||+++|++. ..+.|+.++.|++||+.||.|+|++.+|||||||+|+.+ .+-|-|||+|||++..+.+..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 999999999999875 689999999999999999999999999999999999876 567999999999987664321
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCC-cccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~-~~~DiWSlGvilyEml~ 353 (549)
...+.||+..|-|||+|++..|+ +++||||||||||-|++
T Consensus 174 ---------------------------------------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 174 ---------------------------------------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC 214 (864)
T ss_pred ---------------------------------------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh
Confidence 12267999999999999999995 68999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|++||...+..+++..|+..+ ...|. .+|.+|+|||..||. ||.+|. +.++|-.|+|++.+|-.
T Consensus 215 Gq~PFqeANDSETLTmImDCK--YtvPs--hvS~eCrdLI~sMLvRdPkkRA---slEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 215 GQPPFQEANDSETLTMIMDCK--YTVPS--HVSKECRDLIQSMLVRDPKKRA---SLEEIVSTSWLQAGDRG 279 (864)
T ss_pred CCCccccccchhhhhhhhccc--ccCch--hhhHHHHHHHHHHHhcCchhhc---cHHHHhccccccCCCCC
Confidence 999999999999999999843 44554 899999999999999 999998 89999999999998743
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=391.74 Aligned_cols=303 Identities=43% Similarity=0.793 Sum_probs=252.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.++.+++.||+|.+.+...........+.+|++++..++||||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765544555677889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|..++...+.+++..+..++.+++.||.|||+.||+||||||+|||++.+|.+||+|||+++......... -
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~-~ 159 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN-L 159 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc-c
Confidence 999999999999888889999999999999999999999999999999999999999999999999987532110000 0
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
+ ........ .........|++.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 160 ~------~~~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 160 Y------EGHIEKDT-------------------REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred c------ccccccch-------------------hhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0 00000000 0000113578999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCC-cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccccccCCCc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFI 434 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~-~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~ 434 (549)
||.+.+..+....+... ....|.. ..+++++.+||.+||. +|.+|+.+.++.++++||||...+|..+.....+++
T Consensus 215 pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~ 292 (305)
T cd05609 215 PFFGDTPEELFGQVISD--DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFI 292 (305)
T ss_pred CCCCCCHHHHHHHHHhc--ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCC
Confidence 99988777766666553 2233322 2578999999999999 999999877899999999999999999888778999
Q ss_pred ccCCCcccccccc
Q 038137 435 PEVNDELDTQNFE 447 (549)
Q Consensus 435 p~~~~~~d~~~f~ 447 (549)
|.+....|.++|+
T Consensus 293 ~~~~~~~~~~~~~ 305 (305)
T cd05609 293 PQLESEDDTSYFD 305 (305)
T ss_pred CCCCCccccccCC
Confidence 9998888887764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=393.80 Aligned_cols=256 Identities=28% Similarity=0.473 Sum_probs=214.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||.|+||.||+|+++.++..||+|++..... ......+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5689999999999999999999999999999999975432 22334677899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||++| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 999975 898888654 4589999999999999999999999999999999999999999999999999875431100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 199 (288)
T cd07871 159 ---------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199 (288)
T ss_pred ---------------------------------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh
Confidence 0013578999999999876 568999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccc-----------------cccCCC---------CcCCChhHHHHHHHhhh-cccccCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~-----------------~l~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
|++||.+.+..+....+..... ...+|. ...++++++|||++||+ ||.+|+
T Consensus 200 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~-- 277 (288)
T cd07871 200 GRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI-- 277 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC--
Confidence 9999998877665555432110 011111 13578999999999999 999999
Q ss_pred CCHHHHHcCCcc
Q 038137 407 KGADEIKAHPWF 418 (549)
Q Consensus 407 ~~~~eil~HpfF 418 (549)
+++|+++||||
T Consensus 278 -t~~~~l~hp~f 288 (288)
T cd07871 278 -SAEAALRHSYF 288 (288)
T ss_pred -CHHHHhcCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=390.28 Aligned_cols=275 Identities=35% Similarity=0.660 Sum_probs=232.8
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|+..+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+|..++|++|+.++++|.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999987665444445667889999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence 99999999888543 469999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
......||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 157 --------------------------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred --------------------------------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 001357999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhcc--ccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--c
Q 038137 356 PPFYSDEPMSTCRKIVNWR--THLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--Q 428 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~ 428 (549)
+||.+.........+.... ....++ ..+++++.+||.+||. ||++|++. ..+.+++.||||+.++|+.+. +
T Consensus 199 ~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05632 199 SPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276 (285)
T ss_pred CCCCCCCHHHHHHHHHHhhhccccccC--ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCc
Confidence 9998766544333332211 112222 3688999999999999 99999954 238999999999999999876 4
Q ss_pred ccCCCccc
Q 038137 429 IKAAFIPE 436 (549)
Q Consensus 429 ~~~pf~p~ 436 (549)
+.|||+|.
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05632 277 LDPPFVPD 284 (285)
T ss_pred CCCCCCCC
Confidence 78999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=389.10 Aligned_cols=261 Identities=31% Similarity=0.521 Sum_probs=222.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc-eeeeeeeecCCc----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC-IVKLYCSFQDDE---- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~---- 190 (549)
...|+.++.||+|+||+||+|+.+.+|+.||+|+++-.... ++......+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34577888999999999999999999999999999765321 334456789999999999999 999999999887
Q ss_pred --eEEEEEeecCCCchhhHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 191 --YLYLIMEYLPGGDMMTLLMRKD----TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 191 --~lylVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
.+||||||+ .-||..++.... .++...++.++.||+.||+|||++||+||||||.||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 569999986644 6888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccch
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 343 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWS 343 (549)
+...-.. . ...+-++|.+|+|||+|++. .|+..+|+||
T Consensus 168 ra~~ip~---~--------------------------------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs 206 (323)
T KOG0594|consen 168 RAFSIPM---R--------------------------------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWS 206 (323)
T ss_pred HHhcCCc---c--------------------------------------cccccEEEeeccCHHHhcCCCcCCCCcchHh
Confidence 8653110 0 01245899999999999985 7999999999
Q ss_pred hhHHHHHHhhCCCCCCCCCchhhhhhhhh---------cccccc-------CCCC----------cCCChhHHHHHHHhh
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVN---------WRTHLK-------FPEE----------AKLSPEAKDLISKLL 397 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~~~~~I~~---------~~~~l~-------~p~~----------~~~s~~~~dLI~~lL 397 (549)
+|||++||+++++.|.+....+...+|.. |..... ||.. +..++++.||+.+||
T Consensus 207 ~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L 286 (323)
T KOG0594|consen 207 LGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLL 286 (323)
T ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHh
Confidence 99999999999999999999888888863 433222 2221 234569999999999
Q ss_pred h-cccccCCCCCHHHHHcCCcccCCC
Q 038137 398 C-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 398 ~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+ +|.+|. +|..++.||||..+.
T Consensus 287 ~y~p~~R~---Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 287 QYDPAKRI---SAKGALTHPYFSELP 309 (323)
T ss_pred ccCcccCc---CHHHHhcChhhcccc
Confidence 9 999999 899999999999874
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=382.92 Aligned_cols=253 Identities=35% Similarity=0.575 Sum_probs=217.4
Q ss_pred CCCeeee-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeec----CC
Q 038137 116 ADDFEPL-TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQ----DD 189 (549)
Q Consensus 116 ~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~----d~ 189 (549)
.+||.+- .+||-|-.|+|..|.++.||+.||+|++..+ ...++|+++.-.. .|||||.++++|. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 5677764 6899999999999999999999999998654 2366788776444 7999999998765 55
Q ss_pred ceEEEEEeecCCCchhhHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC---CcEEEeecCcc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN---GHMKLSDFGLC 264 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~---g~vKL~DFGla 264 (549)
..+.+|||.|.||+|++.+..++. |+|.+|..++.||..|+.|||+.+|.||||||+|+|.... ..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 779999999999999999987655 9999999999999999999999999999999999999754 47999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
|.-.... ...+.|-||.|.|||++....|+..||+||+
T Consensus 212 K~t~~~~------------------------------------------~L~TPc~TPyYvaPevlg~eKydkscdmwSl 249 (400)
T KOG0604|consen 212 KETQEPG------------------------------------------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_pred cccCCCc------------------------------------------cccCCcccccccCHHHhCchhcCCCCCccch
Confidence 9743211 1226799999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCC----chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 345 GAIMYEMLVGYPPFYSDE----PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~----~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
|||||-||+|+||||+.. ...+.++|......++-|++..+|..++|+|++||. +|.+|+ +++++++|||..
T Consensus 250 gVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl---TI~~~m~hpwi~ 326 (400)
T KOG0604|consen 250 GVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL---TIEEVMDHPWIN 326 (400)
T ss_pred hHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe---eHHHhhcCchhc
Confidence 999999999999999864 345677888755455555667899999999999998 999999 899999999997
Q ss_pred CC
Q 038137 420 GI 421 (549)
Q Consensus 420 ~i 421 (549)
+.
T Consensus 327 ~~ 328 (400)
T KOG0604|consen 327 QY 328 (400)
T ss_pred cc
Confidence 64
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=391.26 Aligned_cols=310 Identities=39% Similarity=0.712 Sum_probs=248.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.+..+++.||||.+.+...........+..|+.+|..++||+|+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998766554456677899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 197 EYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||+.|++|.+++.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998653 579999999999999999999999999999999999999999999999999998654321100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
.................. ..............+||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 161 SKALRKGSRRSSVNSIPS------------ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred ccccccccccccccccch------------hhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 000000000000000000 00000011112246899999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-CCHHHHHcCCcccCCCccccccccCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-KGADEIKAHPWFKGIEWDKLYQIKAA 432 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~HpfF~~i~w~~l~~~~~p 432 (549)
..||.+.+....+.++.. ....+|....++++++++|.+||+ +|++|+.. .++++++.||||++++|..+....+|
T Consensus 229 ~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~ 306 (316)
T cd05574 229 TTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPP 306 (316)
T ss_pred CCCCCCCchHHHHHHHhc--CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCC
Confidence 999998887777777764 345556544589999999999999 99999932 22999999999999999999988888
Q ss_pred CcccCCCc
Q 038137 433 FIPEVNDE 440 (549)
Q Consensus 433 f~p~~~~~ 440 (549)
-+|.+...
T Consensus 307 ~~~~~~~~ 314 (316)
T cd05574 307 IIPRPDDG 314 (316)
T ss_pred CCCCcccc
Confidence 88876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=392.44 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=212.7
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-----ceE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD-----EYL 192 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~~l 192 (549)
+|++.+.||+|+||.||+|+++.+|..||||++.... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 1223345678999999999999999999887532 358
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||| +++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 579999998888899999999999999999999999999999999999999999999999999986431100
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyE 350 (549)
.. ......+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 159 ~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~e 200 (338)
T cd07859 159 TA--------------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 200 (338)
T ss_pred cc--------------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHH
Confidence 00 00114589999999999976 678999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhc--------------------------cccccCC-CCcCCChhHHHHHHHhhh-cccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNW--------------------------RTHLKFP-EEAKLSPEAKDLISKLLC-NVEQ 402 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~--------------------------~~~l~~p-~~~~~s~~~~dLI~~lL~-dp~~ 402 (549)
|++|++||.+.+.......+... .....+. ....+++++.+||.+||+ ||.+
T Consensus 201 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 280 (338)
T cd07859 201 VLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD 280 (338)
T ss_pred HHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCccc
Confidence 99999999876643332221110 0000000 012468899999999999 9999
Q ss_pred cCCCCCHHHHHcCCcccCCCc
Q 038137 403 RLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 403 Rl~~~~~~eil~HpfF~~i~w 423 (549)
|+ +++|+++||||+++..
T Consensus 281 Rp---t~~e~l~hp~f~~~~~ 298 (338)
T cd07859 281 RP---TAEEALADPYFKGLAK 298 (338)
T ss_pred CC---CHHHHhcCchhhhcCc
Confidence 99 8999999999988653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=411.06 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=210.1
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC------
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD------ 188 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------ 188 (549)
...+|++++.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 4568999999999999999999999999999999886432 224579999999999999999887643
Q ss_pred --CceEEEEEeecCCCchhhHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeec
Q 038137 189 --DEYLYLIMEYLPGGDMMTLLM----RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDF 261 (549)
Q Consensus 189 --~~~lylVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DF 261 (549)
..++|+||||+++ +|..++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 2358899999975 5655553 346799999999999999999999999999999999999999765 6999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccc
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECD 340 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~D 340 (549)
|+|+.+.... ...+.+||+.|+|||++.+ ..|+.++|
T Consensus 216 Gla~~~~~~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~D 253 (440)
T PTZ00036 216 GSAKNLLAGQ------------------------------------------RSVSYICSRFYRAPELMLGATNYTTHID 253 (440)
T ss_pred ccchhccCCC------------------------------------------CcccCCCCcCccCHHHhcCCCCCCcHHH
Confidence 9998653211 0114589999999999876 47999999
Q ss_pred cchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccc---------------cccCCC----------CcCCChhHHHHHHH
Q 038137 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT---------------HLKFPE----------EAKLSPEAKDLISK 395 (549)
Q Consensus 341 iWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~---------------~l~~p~----------~~~~s~~~~dLI~~ 395 (549)
||||||++|||++|++||.+.+..+.+.+++.... .+.+|. +...|+++++||.+
T Consensus 254 iwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~ 333 (440)
T PTZ00036 254 LWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQ 333 (440)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHH
Confidence 99999999999999999999887766666653211 111221 12468899999999
Q ss_pred hhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 396 LLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 396 lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
||+ ||.+|+ ++.|+++||||..+..
T Consensus 334 ~L~~dP~~R~---ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 334 FLKYEPLKRL---NPIEALADPFFDDLRD 359 (440)
T ss_pred HCCCChhHCc---CHHHHhCChhHHhhhc
Confidence 999 999999 8999999999988754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=386.95 Aligned_cols=251 Identities=33% Similarity=0.563 Sum_probs=213.4
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-----CceE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-----DEYL 192 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-----~~~l 192 (549)
.|...+++|.|+||.||.|....+++.||||+.....- .-.+|..||..++|||||+|.++|.. .-++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 48889999999999999999999999999998865431 23469999999999999999988862 2367
Q ss_pred EEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC-CcEEEeecCccccc
Q 038137 193 YLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPL 267 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~-g~vKL~DFGlak~~ 267 (549)
.+||||||. +|...+.. +..++.-.++.|+.||+.||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 899999965 88888864 5789999999999999999999999999999999999999987 89999999999987
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 346 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGv 346 (549)
....- ..+..-|..|+|||.+.+ +.|+.++||||.||
T Consensus 177 ~~~ep------------------------------------------niSYicSRyYRaPELifga~~Yt~~IDiWSaGC 214 (364)
T KOG0658|consen 177 VKGEP------------------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGC 214 (364)
T ss_pred ccCCC------------------------------------------ceeEEEeccccCHHHHcCccccCceeEEhhhhH
Confidence 53210 016788999999999997 78999999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhcc---------------ccccCCC----------CcCCChhHHHHHHHhhh-cc
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWR---------------THLKFPE----------EAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~---------------~~l~~p~----------~~~~s~~~~dLI~~lL~-dp 400 (549)
+|.||+-|+|.|.|++..+++..|+.-- ....+|. ...+++++.||+.++|. +|
T Consensus 215 V~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P 294 (364)
T KOG0658|consen 215 VMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSP 294 (364)
T ss_pred HHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccCh
Confidence 9999999999999998888877776411 0112221 13568999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCC
Q 038137 401 EQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i 421 (549)
.+|+ ++.|++.||||..+
T Consensus 295 ~~R~---~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 295 SKRL---SALEALAHPFFDEL 312 (364)
T ss_pred hhcC---CHHHHhcchhhHHh
Confidence 9999 89999999999865
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=390.84 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=219.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||+|+||.||+|+++.+|..||+|++.... .......+.+|+.+|..++||||++++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999987542 2334567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH-NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|++||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999999998888899999999999999999999985 69999999999999999999999999987543110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
....+||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 159 ------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 196 (331)
T cd06649 159 ------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196 (331)
T ss_pred ------------------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 11357999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhc----------------------------------------------cccccCCCCcCCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNW----------------------------------------------RTHLKFPEEAKLS 386 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~----------------------------------------------~~~l~~p~~~~~s 386 (549)
+|+.||...+..+... ++.. ......+ ...++
T Consensus 197 tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 274 (331)
T cd06649 197 IGRYPIPPPDAKELEA-IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFT 274 (331)
T ss_pred hCCCCCCCCCHHHHHH-HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC-Ccccc
Confidence 9999997654432211 1110 0001111 12478
Q ss_pred hhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 387 PEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 387 ~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+++++||.+||. ||++|+ ++++|++||||+...
T Consensus 275 ~~l~~li~~~L~~~P~~Rp---t~~ell~h~~~~~~~ 308 (331)
T cd06649 275 PDFQEFVNKCLIKNPAERA---DLKMLMNHTFIKRSE 308 (331)
T ss_pred HHHHHHHHHHccCCcccCC---CHHHHhcChHHhhcc
Confidence 899999999999 999999 899999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=396.89 Aligned_cols=257 Identities=33% Similarity=0.524 Sum_probs=228.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
...|..+..||+|+||.||+|.+..|++.||||++.-.. ....++.+..|+.+|++++++||.+.|++|..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 456888899999999999999999999999999997654 345678899999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||||.||++.++|.....+.|..+..++.+++.||.|||..+.||||||+.|||+..+|.+||+|||.+..+....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---- 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV---- 165 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh----
Confidence 9999999999999888888999999999999999999999999999999999999999999999999988764211
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
....++||||.||||||+.+.+|+.++||||||++.|||++|.
T Consensus 166 -------------------------------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge 208 (467)
T KOG0201|consen 166 -------------------------------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE 208 (467)
T ss_pred -------------------------------------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCC
Confidence 0113789999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||+....++.....|-+. .+..+ +..+|+.+++||..||. ||+.|+ +|.++|+|+|.+..
T Consensus 209 PP~s~~hPmrvlflIpk~-~PP~L--~~~~S~~~kEFV~~CL~k~P~~Rp---sA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 209 PPHSKLHPMRVLFLIPKS-APPRL--DGDFSPPFKEFVEACLDKNPEFRP---SAKELLKHKFIKRA 269 (467)
T ss_pred CCCcccCcceEEEeccCC-CCCcc--ccccCHHHHHHHHHHhhcCcccCc---CHHHHhhhHHHHhc
Confidence 999999887666555431 11122 13789999999999999 999999 89999999999873
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=378.16 Aligned_cols=270 Identities=37% Similarity=0.676 Sum_probs=226.2
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCch
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L 204 (549)
||+|+||+||+|.+..+|+.||+|++.+...........+..|..+|..++||+|++++++|.+.+.+|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876554444556677899999999999999999999999999999999999999
Q ss_pred hhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCC
Q 038137 205 MTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282 (549)
Q Consensus 205 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~ 282 (549)
.+++.+.. .+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----------- 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----------- 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----------
Confidence 99987655 79999999999999999999999999999999999999999999999999987542110
Q ss_pred CcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCC
Q 038137 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362 (549)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~ 362 (549)
......|+..|+|||++.+..++.++|+|||||++|+|++|++||.+..
T Consensus 150 -------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 150 -------------------------------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred -------------------------------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 0013468899999999998889999999999999999999999998765
Q ss_pred chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-C-CHHHHHcCCcccCCCcccccc--ccCCCccc
Q 038137 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-K-GADEIKAHPWFKGIEWDKLYQ--IKAAFIPE 436 (549)
Q Consensus 363 ~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~-~~~eil~HpfF~~i~w~~l~~--~~~pf~p~ 436 (549)
.......+.........+....+++.+.+||.+||. +|.+|++. . ++.+++.||||..++|..+.. ..|||+|+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 277 (277)
T cd05577 199 EKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277 (277)
T ss_pred ccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCCC
Confidence 432222232211111222223679999999999999 99999965 2 699999999999999998864 67888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=395.90 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=217.4
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----eE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE-----YL 192 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-----~l 192 (549)
+|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.+.+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 22234466889999999999999999999998876 89
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999995 68888888888899999999999999999999999999999999999999999999999999976432110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEm 351 (549)
. .....+||+.|+|||++.+. .|+.++||||||||+|||
T Consensus 159 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 198 (372)
T cd07853 159 K----------------------------------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198 (372)
T ss_pred c----------------------------------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHH
Confidence 0 01134789999999999874 589999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccc---------------------cccCC-------CCcCCChhHHHHHHHhhh-cccc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRT---------------------HLKFP-------EEAKLSPEAKDLISKLLC-NVEQ 402 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~---------------------~l~~p-------~~~~~s~~~~dLI~~lL~-dp~~ 402 (549)
++|++||.+.++......|..... ....| ....+++++.+||.+||+ ||.+
T Consensus 199 ~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 278 (372)
T cd07853 199 LGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDK 278 (372)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhh
Confidence 999999998877666555543110 00011 112468899999999999 9999
Q ss_pred cCCCCCHHHHHcCCcccCCCc
Q 038137 403 RLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 403 Rl~~~~~~eil~HpfF~~i~w 423 (549)
|+ ++.|++.||||.+..+
T Consensus 279 R~---t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 279 RI---SAADALAHPYLDEGRL 296 (372)
T ss_pred Cc---CHHHHhcCHhhCCCcc
Confidence 99 8999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=398.37 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=210.8
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.+...+|++++.||+|+||.||+|++..+++.||||+... ..+.+|+.+|+.++|||||+++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 4556789999999999999999999999999999996532 2467899999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+|||++ +++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9999999 578999988888899999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 238 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 277 (391)
T PHA03212 238 ----------------------------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277 (391)
T ss_pred ----------------------------------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 0012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCCc-------hhhhhhhhhccc------------------------cc----cCCCC---cCCChhHHHHHH
Q 038137 353 VGYPPFYSDEP-------MSTCRKIVNWRT------------------------HL----KFPEE---AKLSPEAKDLIS 394 (549)
Q Consensus 353 ~G~~PF~~~~~-------~~~~~~I~~~~~------------------------~l----~~p~~---~~~s~~~~dLI~ 394 (549)
+|..||...+. ......|+.... .. ..|.. ..++.++.+||.
T Consensus 278 tg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~ 357 (391)
T PHA03212 278 TCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLIC 357 (391)
T ss_pred HCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHH
Confidence 99988865321 111111211000 00 00100 135678999999
Q ss_pred Hhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 395 KLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 395 ~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||+ ||.+|+ +|+|++.||||+.+
T Consensus 358 ~mL~~dP~~Rp---ta~elL~hp~f~~~ 382 (391)
T PHA03212 358 KMLAFDAHHRP---SAEALLDFAAFQDI 382 (391)
T ss_pred HHhcCChhhCC---CHHHHhcChhhccC
Confidence 9999 999999 89999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=378.42 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=209.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc---CCCceeeeeeeec-----
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKA-TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV---DSNCIVKLYCSFQ----- 187 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~-tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~----- 187 (549)
++|++++.||+|+||.||+|++.. +|..||+|++..... .........+|..++..+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 469999999999999999999854 578899999875432 222334556777777665 6999999999875
Q ss_pred CCceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
....+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 6898888653 468999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlG 345 (549)
...... .....+||+.|+|||++.+..|+.++|+||||
T Consensus 159 ~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 196 (290)
T cd07862 159 IYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 196 (290)
T ss_pred eccCCc------------------------------------------ccccccccccccChHHHhCCCCCCccchHHHH
Confidence 643110 01145799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhccc---------cccCCC--------------CcCCChhHHHHHHHhhh-ccc
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRT---------HLKFPE--------------EAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~~---------~l~~p~--------------~~~~s~~~~dLI~~lL~-dp~ 401 (549)
|++|||++|.+||.+.+..+.+.+|+.... ...++. .+.+++.+++||.+||+ ||+
T Consensus 197 ~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 197 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 999999999999999888777777764211 111110 02478889999999999 999
Q ss_pred ccCCCCCHHHHHcCCcc
Q 038137 402 QRLGTKGADEIKAHPWF 418 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF 418 (549)
+|+ ++.|+++||||
T Consensus 277 ~R~---s~~~~l~hp~f 290 (290)
T cd07862 277 KRI---SAYSALSHPYF 290 (290)
T ss_pred hcC---CHHHHhcCCCC
Confidence 999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=395.58 Aligned_cols=258 Identities=32% Similarity=0.506 Sum_probs=233.0
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce-EEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY-LYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~-lyl 194 (549)
.++|+.+++||+|+||.+++++++..++.|++|.+.-.....+. .+....|..+++++.|||||..+++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 47899999999999999999999999999999999876654443 3468899999999999999999999998877 999
Q ss_pred EEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 195 IMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
||+||.||+|...+.+. ..|+|+.+..|+.|++.||.|||+++|+|||||+.||+++.++.|||.|||+||.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999999999999654 469999999999999999999999999999999999999999999999999999875321
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.++.+.+|||.||.||++.+.+|+.++|||||||++|||+
T Consensus 161 ----------------------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 161 ----------------------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred ----------------------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 1345789999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+-+++|.+.+......+|.... -.|.+...|.+++.||..||. +|+.|+ +|.++|.+|.....
T Consensus 201 ~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RP---sa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 201 TLKPAFKASNMSELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRP---SALELLRRPHLLRY 264 (426)
T ss_pred hcccccCccchHHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCC---CHHHHhhChhhhhH
Confidence 9999999999999999998743 345556899999999999999 999999 89999999988743
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=373.57 Aligned_cols=260 Identities=33% Similarity=0.608 Sum_probs=217.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
..||+|+||.|--|....||..||||++.|..-. ...++.+|++++..+ .|+||+.|+.+|.|+..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 4799999999999999999999999999886432 346688999999988 699999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc---EEEeecCcccccCCCCccccccc
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~---vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
|.|..+|.+...|+|.+|..++.+|+.||.|||.+||.||||||+|||-....+ ||||||.|...+...+ +
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~----~-- 234 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN----D-- 234 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC----C--
Confidence 999999999999999999999999999999999999999999999999976654 7999999976543211 0
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccchhhHHHHHHhh
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiWSlGvilyEml~ 353 (549)
+.|-.+. ...+.||+..|||||++. ..-|+..||.||||||+|-||.
T Consensus 235 ---------------~spastP-------------~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 235 ---------------CSPASTP-------------ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred ---------------CCCCCCc-------------cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 0010000 123679999999999875 2568999999999999999999
Q ss_pred CCCCCCCC-------Cch---hh-----hhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 354 GYPPFYSD-------EPM---ST-----CRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 354 G~~PF~~~-------~~~---~~-----~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|++||.+. +.- .. +..|.. +.+.||+ +..+|.+++|||+.||. |+.+|+ ++.++++|
T Consensus 287 GYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE--GkYeFPdkdWahIS~eakdlisnLlvrda~~rl---sa~~vlnh 361 (463)
T KOG0607|consen 287 GYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE--GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL---SAAQVLNH 361 (463)
T ss_pred CCCCccCccCCcCCccCCCccHHHHHHHHHHHhc--cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh---hhhhccCC
Confidence 99999652 221 22 233333 5677876 46799999999999998 999999 79999999
Q ss_pred CcccCCCcc
Q 038137 416 PWFKGIEWD 424 (549)
Q Consensus 416 pfF~~i~w~ 424 (549)
||++.+.-+
T Consensus 362 Pw~~~~~~e 370 (463)
T KOG0607|consen 362 PWVQRCAPE 370 (463)
T ss_pred ccccccchh
Confidence 999987544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=418.86 Aligned_cols=152 Identities=44% Similarity=0.737 Sum_probs=143.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|.+++.||+|+||.||+|.+..+++.||||++.+...........+..|+.++..++||||+++++++.+..++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999887666666667889999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
|||++||+|..++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.+|++||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=376.17 Aligned_cols=254 Identities=29% Similarity=0.487 Sum_probs=208.2
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc---CCCceeeeeeeecC-----C
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV---DSNCIVKLYCSFQD-----D 189 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d-----~ 189 (549)
+|++++.||+|+||.||+|+++.+|+.||+|.+..... .......+.+|+.++..+ +||||++++++|.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48999999999999999999999999999999876432 222223455677777655 79999999998864 3
Q ss_pred ceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
..+|+||||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999997 4888888653 45999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
..... ....+||+.|+|||++.+..++.++|||||||+
T Consensus 159 ~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 196 (288)
T cd07863 159 SCQMA------------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196 (288)
T ss_pred cCccc------------------------------------------CCCccccccccCchHhhCCCCCCcchhhhHHHH
Confidence 32110 013578999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhcc---------ccccCCC--------------CcCCChhHHHHHHHhhh-ccccc
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWR---------THLKFPE--------------EAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~---------~~l~~p~--------------~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
+|+|++|++||.+........++.... .....+. .+.++..++|||.+||+ ||.+|
T Consensus 197 l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (288)
T cd07863 197 FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKR 276 (288)
T ss_pred HHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccC
Confidence 999999999998887766666655321 1111110 02467889999999999 99999
Q ss_pred CCCCCHHHHHcCCcc
Q 038137 404 LGTKGADEIKAHPWF 418 (549)
Q Consensus 404 l~~~~~~eil~HpfF 418 (549)
+ ++.|++.||||
T Consensus 277 ~---t~~~~l~hp~f 288 (288)
T cd07863 277 I---SAFRALQHPFF 288 (288)
T ss_pred C---CHHHHhcCCCC
Confidence 9 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=369.76 Aligned_cols=257 Identities=47% Similarity=0.849 Sum_probs=219.9
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHH-HhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL-AEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
+.||.|+||.||+|.+..+|+.||||++.+...........+..|..++ ...+|+||++++++|.+.+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999876554444444555666554 455899999999999999999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----------- 150 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----------- 150 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998753210
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
....|++.|+|||.+.+..++.++|||||||++|+|++|.+||...
T Consensus 151 ----------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 151 ----------------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ----------------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 1346889999999999888999999999999999999999999888
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
+.......+..............+++++.++|.+||. +|.+|++..+++|++.||||+.++|+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 197 TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 7776666665422111111223578999999999999 99999988889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=389.21 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=211.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999997543 2233456678899999999999999999988644
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||+++ +|...+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 358999999965 6766664 3589999999999999999999999999999999999999999999999999976432
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 179 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 179 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216 (364)
T ss_pred CC------------------------------------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHH
Confidence 10 011457999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhcccc----------------------------------ccCCC----CcCCChhHHH
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTH----------------------------------LKFPE----EAKLSPEAKD 391 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~----------------------------------l~~p~----~~~~s~~~~d 391 (549)
||++|++||.+.+....+.+++..... ..+|. ....+.+++|
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 296 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHH
Confidence 999999999988776666655431100 00110 0123568999
Q ss_pred HHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 392 LISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 392 LI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||.+||+ ||.+|+ +++|+++||||..
T Consensus 297 ll~~mL~~dP~~R~---t~~e~L~hp~~~~ 323 (364)
T cd07875 297 LLSKMLVIDASKRI---SVDEALQHPYINV 323 (364)
T ss_pred HHHHhcCcCcccCC---CHHHHhcCccccc
Confidence 9999999 999999 8999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=403.96 Aligned_cols=256 Identities=23% Similarity=0.425 Sum_probs=206.5
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC------Cceeeeeeeec
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS------NCIVKLYCSFQ 187 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~f~ 187 (549)
+..++|++++.||+|+||+||+|.+..+++.||||++++.. ........|+.++..+.| .+|++++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 45678999999999999999999999999999999996532 122345667777776654 45899998887
Q ss_pred CC-ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCC-----------
Q 038137 188 DD-EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNG----------- 254 (549)
Q Consensus 188 d~-~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g----------- 254 (549)
++ .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.+|
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 64 5799999998 88999999888899999999999999999999998 6999999999999998776
Q ss_pred -----cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchh
Q 038137 255 -----HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEV 329 (549)
Q Consensus 255 -----~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEv 329 (549)
.+||+|||+|...... ....+||+.|+|||+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~--------------------------------------------~~~~~gt~~Y~APE~ 316 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS--------------------------------------------RTAIVSTRHYRSPEV 316 (467)
T ss_pred CCCCceEEECCCCccccCccc--------------------------------------------cccccCCccccCcHH
Confidence 4999999987542110 114689999999999
Q ss_pred hccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhcccccc--------------------------CCC--
Q 038137 330 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLK--------------------------FPE-- 381 (549)
Q Consensus 330 l~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~--------------------------~p~-- 381 (549)
+.+..|+.++|||||||++|||++|++||.+.+..+....|......++ .|.
T Consensus 317 ~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (467)
T PTZ00284 317 VLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHL 396 (467)
T ss_pred hhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHH
Confidence 9999999999999999999999999999988776554443332111000 000
Q ss_pred ----------CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 382 ----------EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 382 ----------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
...-++.+.|||.+||+ ||.+|+ +++|+++||||...
T Consensus 397 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~---ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 397 ARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL---NARQMTTHPYVLKY 444 (467)
T ss_pred HhhhcccchhhhhchHHHHHHHHHhCCcChhhCC---CHHHHhcCcccccc
Confidence 00114567899999999 999999 89999999999753
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=373.20 Aligned_cols=266 Identities=36% Similarity=0.701 Sum_probs=214.4
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHH---hcCCCceeeeeeeecCCceEEEEEeecC
Q 038137 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA---EVDSNCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
+||+|+||.||+|.+..+|+.||+|.+.+.............+|..++. ..+||+|+.++++|.+.+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998765433332333444544443 3479999999999999999999999999
Q ss_pred CCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccccc
Q 038137 201 GGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280 (549)
Q Consensus 201 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~ 280 (549)
||+|..++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--------- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---------
Confidence 99999999888889999999999999999999999999999999999999999999999999986542110
Q ss_pred CCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-cCCCCcccccchhhHHHHHHhhCCCCCC
Q 038137 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFY 359 (549)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-~~~y~~~~DiWSlGvilyEml~G~~PF~ 359 (549)
.....||+.|+|||++. +..++.++|+||+||++|||++|..||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 152 ----------------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred ----------------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 01246999999999987 4668999999999999999999999997
Q ss_pred CCCchh--hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcccccc--ccCC
Q 038137 360 SDEPMS--TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLYQ--IKAA 432 (549)
Q Consensus 360 ~~~~~~--~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~~--~~~p 432 (549)
...... ...... ......+| ..+++++++||.+||. ||.+|+++ .++.++++||||++++|..... ..+|
T Consensus 198 ~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~ 274 (279)
T cd05633 198 QHKTKDKHEIDRMT-LTVNVELP--DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPP 274 (279)
T ss_pred CCCCcCHHHHHHHh-hcCCcCCc--cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCC
Confidence 654321 111111 11222333 3689999999999999 99999964 3699999999999999988753 3444
Q ss_pred Ccc
Q 038137 433 FIP 435 (549)
Q Consensus 433 f~p 435 (549)
-+|
T Consensus 275 ~~~ 277 (279)
T cd05633 275 LIP 277 (279)
T ss_pred CCC
Confidence 444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=386.29 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=217.1
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcE-EEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHV-YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE- 190 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~-vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~- 190 (549)
.+..+++.+...||+|+||+||.+.++. .. ||+|++......... .+.+.+|+.+|..++|||||++++++.+..
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3445566667779999999999999874 45 999999876544333 678999999999999999999999999887
Q ss_pred eEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCCCCeEEcCCC-cEEEeecCcccc
Q 038137 191 YLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHN-YIHRDIKPDNLLLDRNG-HMKLSDFGLCKP 266 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHRDLKPeNILld~~g-~vKL~DFGlak~ 266 (549)
.+++|||||++|+|..++.+ +..++...+..++.+|+.|++|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999977 689999999999999999999999999 99999999999999998 999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc--cCCCCcccccchh
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSL 344 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~--~~~y~~~~DiWSl 344 (549)
...... ...+..||+.|||||++. ...|+.++|||||
T Consensus 194 ~~~~~~-----------------------------------------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySF 232 (362)
T KOG0192|consen 194 KVISKT-----------------------------------------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSF 232 (362)
T ss_pred eccccc-----------------------------------------cccCCCCCccccChhhhcCCCCcCCccchhhhH
Confidence 542110 011368999999999999 6699999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
|++||||+||..||.+..+......++.....+.+|. .+++.+..||.+|+. ||..|+ +..+|.
T Consensus 233 gIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP---~f~ei~ 297 (362)
T KOG0192|consen 233 GIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRP---SFLEIV 297 (362)
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCC---CHHHHH
Confidence 9999999999999999988777777776555555564 489999999999998 999999 566655
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=366.42 Aligned_cols=259 Identities=33% Similarity=0.561 Sum_probs=224.2
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML--RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
++|++.+.||+|+||.||.|.+..+++.||||.+...... .......+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754322 22345678899999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.+|.++|+|||+++.+.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987653211000
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
. ......|++.|+|||++.+..++.++|+|||||++|||++|
T Consensus 162 ~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 162 T--------------------------------------GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred c--------------------------------------cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 0 00135688999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
++||.+.+......++........+|. .++.++.+||.+||. +|.+|+ ++.++++||||
T Consensus 204 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 263 (263)
T cd06625 204 KPPWAEFEAMAAIFKIATQPTNPQLPS--HVSPDARNFLRRTFVENAKKRP---SAEELLRHFFV 263 (263)
T ss_pred CCCccccchHHHHHHHhccCCCCCCCc--cCCHHHHHHHHHHhhcCcccCC---CHHHHhhCCCC
Confidence 999988777666666665444445553 689999999999999 999999 89999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.90 Aligned_cols=256 Identities=28% Similarity=0.470 Sum_probs=208.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
.++|++++.||+|+||.||+|.+..+|..||+|++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999997543 22334566788999999999999999999987543
Q ss_pred -eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999965 5665553 3589999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. .....+||+.|+|||++.+..|+.++|+|||||++|
T Consensus 176 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 213 (359)
T cd07876 176 NF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213 (359)
T ss_pred Cc------------------------------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHH
Confidence 10 011357999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhcc--------------------cccc--------------CCC----CcCCChhHHH
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWR--------------------THLK--------------FPE----EAKLSPEAKD 391 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~--------------------~~l~--------------~p~----~~~~s~~~~d 391 (549)
+|++|++||.+.+....+..++... .... +|. ....++++++
T Consensus 214 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 9999999998876544333322100 0000 110 0124678999
Q ss_pred HHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 392 LISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 392 LI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||.+||+ ||.+|+ ++.|++.||||..
T Consensus 294 li~~mL~~dP~~R~---t~~e~l~hp~~~~ 320 (359)
T cd07876 294 LLSKMLVIDPDKRI---SVDEALRHPYITV 320 (359)
T ss_pred HHHHHhccCcccCC---CHHHHhcCchhhh
Confidence 9999999 999999 8999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=387.96 Aligned_cols=255 Identities=26% Similarity=0.386 Sum_probs=208.1
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|+.++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++|+||++++++|.+.+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3567888999999999999999999999999999996542 23344678899999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||+.||+|... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999999998653 3467888899999999999999999999999999999999999999999999986532100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----CCCCcccccchhhHHHH
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----~~y~~~~DiWSlGvily 349 (549)
.....+||+.|+|||++.. ..++.++|||||||++|
T Consensus 224 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~ 264 (353)
T PLN00034 224 ---------------------------------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264 (353)
T ss_pred ---------------------------------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHH
Confidence 0114589999999999853 23467999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhh--hccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIV--NWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~--~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||++|+.||...........+. ........+ ..++.++++||.+||. ||++|+ ++.||++||||.+-
T Consensus 265 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rp---t~~ell~hp~~~~~ 334 (353)
T PLN00034 265 EFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP--ATASREFRHFISCCLQREPAKRW---SAMQLLQHPFILRA 334 (353)
T ss_pred HHHhCCCCCCCCCCccHHHHHHHHhccCCCCCC--CccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccccC
Confidence 9999999997433222111111 111112222 3688999999999999 999999 89999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=382.66 Aligned_cols=258 Identities=29% Similarity=0.445 Sum_probs=217.0
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||.|+||.||+|.++.+|..+|+|++.... .......+.+|+.+|..++|||||+++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45688999999999999999999999999999999987542 2334466889999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+||||++||+|.+++.+.+.+++..+..++.+++.||.|||+ .+|+||||||+|||++.+|.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999999999888889999999999999999999997 479999999999999999999999999987542110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
....+||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 159 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 196 (333)
T cd06650 159 ------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196 (333)
T ss_pred ------------------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 11357999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhh--------------------------------------------hhhccccccCCCCcCCChh
Q 038137 353 VGYPPFYSDEPMSTCRK--------------------------------------------IVNWRTHLKFPEEAKLSPE 388 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~--------------------------------------------I~~~~~~l~~p~~~~~s~~ 388 (549)
+|+.||........... +.+. ....++. ..++.+
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~ 274 (333)
T cd06650 197 IGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLPS-GVFGAE 274 (333)
T ss_pred HCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC-CCccCCC-CCcCHH
Confidence 99999976543222110 0000 0011111 246789
Q ss_pred HHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 389 AKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 389 ~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+++||.+||+ ||.+|+ +++|++.||||+..
T Consensus 275 ~~~li~~~L~~~P~~Rp---t~~ell~h~~~~~~ 305 (333)
T cd06650 275 FQDFVNKCLIKNPAERA---DLKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHHHhccCCcccCc---CHHHHhhCHHHhcC
Confidence 9999999999 999999 89999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=377.99 Aligned_cols=259 Identities=27% Similarity=0.480 Sum_probs=214.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|.+++.||+|+||.||+|+++.+++.||+|++..... ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999875432 22334567899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 999975 788777554 4689999999999999999999999999999999999999999999999999875431100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 160 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t 200 (309)
T cd07872 160 ---------------------------------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200 (309)
T ss_pred ---------------------------------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 0013478999999999876 568999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccc-----------------cccCCC---------CcCCChhHHHHHHHhhh-cccccCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~-----------------~l~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
|++||.+.+..+....+..... ...+|. ...++++++|||.+||+ ||.+|+
T Consensus 201 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-- 278 (309)
T cd07872 201 GRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI-- 278 (309)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC--
Confidence 9999988776555444432100 011111 12578999999999999 999999
Q ss_pred CCHHHHHcCCcccCC
Q 038137 407 KGADEIKAHPWFKGI 421 (549)
Q Consensus 407 ~~~~eil~HpfF~~i 421 (549)
+++|++.||||+++
T Consensus 279 -t~~e~l~h~~~~~~ 292 (309)
T cd07872 279 -SAEEAMKHAYFRSL 292 (309)
T ss_pred -CHHHHhcChhhhhc
Confidence 89999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=365.88 Aligned_cols=256 Identities=44% Similarity=0.858 Sum_probs=226.0
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCch
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L 204 (549)
||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+|+||||++||+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999877655555667899999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCc
Q 038137 205 MTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284 (549)
Q Consensus 205 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~ 284 (549)
.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||+++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999888889999999999999999999999999999999999999999999999999988653211
Q ss_pred CCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCC--
Q 038137 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE-- 362 (549)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~-- 362 (549)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.+||....
T Consensus 148 -----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 198 (262)
T cd05572 148 -----------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198 (262)
T ss_pred -----------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC
Confidence 0113578999999999998899999999999999999999999998776
Q ss_pred chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcc
Q 038137 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 363 ~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~ 424 (549)
+...+.++........+|. .++++++++|.+||+ +|.+|++. .+++|+++||||++.+|+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 199 PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 5566666664445556664 458999999999999 99999952 249999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=368.51 Aligned_cols=259 Identities=36% Similarity=0.689 Sum_probs=213.6
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHH---HHHhcCCCceeeeeeeecCCceEEEEEeecC
Q 038137 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN---LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~---iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
+||+|+||.||+|.+..+++.||||++.+..............|.. ++...+||+|++++++|.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999998764432222223344443 3444689999999999999999999999999
Q ss_pred CCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccccc
Q 038137 201 GGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280 (549)
Q Consensus 201 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~ 280 (549)
||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--------- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---------
Confidence 99999999888889999999999999999999999999999999999999999999999999987543110
Q ss_pred CCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhCCCCCC
Q 038137 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFY 359 (549)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G~~PF~ 359 (549)
....+||+.|+|||++.+ ..++.++|+||+||++|||++|+.||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 152 ----------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred ----------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 013479999999999975 468999999999999999999999998
Q ss_pred CCCch---hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCccccccc
Q 038137 360 SDEPM---STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLYQI 429 (549)
Q Consensus 360 ~~~~~---~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~~l~~~ 429 (549)
+.... .....+.. ....+|. .+|+++.+||.+||. +|.+|+.+. ++.++++||||++++|..+...
T Consensus 198 ~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 198 QHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred CCCccchHHHHHHhhc--cCCCCCC--cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 76322 22222221 2233443 579999999999999 999999765 8999999999999999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=390.06 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=216.3
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREK--ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
...+|++++.||+|+||.||+|... .++..||+|.+.+.. ...+|+.+|+.++|||||+++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3457999999999999999999864 356889999886532 245799999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||+ +++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||++..+.....
T Consensus 162 ~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9999999 478999887778999999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
. ......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 241 ~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 281 (392)
T PHA03207 241 T---------------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281 (392)
T ss_pred c---------------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 0 0012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCCch---hhhhhhhhcc--ccccCC-------------------------C---CcCCChhHHHHHHHhhh-
Q 038137 353 VGYPPFYSDEPM---STCRKIVNWR--THLKFP-------------------------E---EAKLSPEAKDLISKLLC- 398 (549)
Q Consensus 353 ~G~~PF~~~~~~---~~~~~I~~~~--~~l~~p-------------------------~---~~~~s~~~~dLI~~lL~- 398 (549)
+|..||.+.... ..+..|+... ..+.+| . ...++.++.+||.+||+
T Consensus 282 ~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~ 361 (392)
T PHA03207 282 VKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTF 361 (392)
T ss_pred HCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhcc
Confidence 999999876432 2222222100 011111 1 12357789999999999
Q ss_pred cccccCCCCCHHHHHcCCcccCCCcccccc
Q 038137 399 NVEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 399 dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~ 428 (549)
||.+|+ ++.|++.||||...+|+.+..
T Consensus 362 dp~~Rp---sa~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 362 DQEFRP---SAQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred ChhhCC---CHHHHhhCchhhccchhhhcC
Confidence 999999 899999999999999887754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=397.69 Aligned_cols=257 Identities=29% Similarity=0.431 Sum_probs=220.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCC-CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKAT-GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~t-g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
..|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4499999999999999999998877 788999977543 234456688899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 196 MEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 196 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|||++||+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999988743 3569999999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. ....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 224 ~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 264 (478)
T PTZ00267 224 SL---------------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264 (478)
T ss_pred cc---------------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHH
Confidence 00 001256899999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
++|++||.+.+..+....++... ...+| ..+++++++||.+||. +|.+|+ ++++++.|||++.+
T Consensus 265 ~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~--~~~s~~~~~li~~~L~~dP~~Rp---s~~~~l~~~~~~~~ 329 (478)
T PTZ00267 265 LTLHRPFKGPSQREIMQQVLYGK-YDPFP--CPVSSGMKALLDPLLSKNPALRP---TTQQLLHTEFLKYV 329 (478)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCC-CCCCC--ccCCHHHHHHHHHHhccChhhCc---CHHHHHhCHHHHHH
Confidence 99999999888777777776532 22233 3689999999999999 999999 89999999999754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=392.05 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=215.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-C-----CceeeeeeeecCCc
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-S-----NCIVKLYCSFQDDE 190 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h-----p~Iv~l~~~f~d~~ 190 (549)
-+|+++++||+|+||.|-+|.+..|++.||||+++.. .........|+.||..++ | -|||+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3689999999999999999999999999999999764 334556778999999986 3 48999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC--cEEEeecCcccc
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG--HMKLSDFGLCKP 266 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g--~vKL~DFGlak~ 266 (549)
++|||+|.+ +-+|.++|..+ .+|+...++.++.||+.||.+||++||||+|||||||||...+ .|||+|||+|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 77999999664 5799999999999999999999999999999999999997654 699999999876
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
... ..++.+-+..|+||||+++.+|+.++|+|||||
T Consensus 341 ~~q--------------------------------------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGC 376 (586)
T KOG0667|consen 341 ESQ--------------------------------------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGC 376 (586)
T ss_pred cCC--------------------------------------------cceeeeeccccccchhhccCCCCCccceeehhh
Confidence 431 124678999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhccc--------------------------------------------------c
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRT--------------------------------------------------H 376 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~--------------------------------------------------~ 376 (549)
|++||++|.|.|.|++..+.+..|+.-.+ .
T Consensus 377 IlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~ 456 (586)
T KOG0667|consen 377 ILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLE 456 (586)
T ss_pred hHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhccc
Confidence 99999999999999999888888863100 0
Q ss_pred ccCC-CC----c----CCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 377 LKFP-EE----A----KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 377 l~~p-~~----~----~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
...| .. . .-.....|||.+||. ||..|+ ++.++++||||.+..
T Consensus 457 ~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~---tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 457 RRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI---TPAQALNHPFLTGTS 509 (586)
T ss_pred ccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC---CHHHHhcCccccccc
Confidence 0011 00 0 012346999999999 999999 899999999998653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=398.44 Aligned_cols=263 Identities=29% Similarity=0.459 Sum_probs=223.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc--
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE-- 190 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-- 190 (549)
+...++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++|++|++++..|...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3456799999999999999999999999999999999976543 3344566889999999999999999988775322
Q ss_pred ------eEEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEee
Q 038137 191 ------YLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSD 260 (549)
Q Consensus 191 ------~lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~D 260 (549)
.+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.|||||||||+|||++.+|++||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 47899999999999998854 34799999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccc
Q 038137 261 FGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340 (549)
Q Consensus 261 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~D 340 (549)
||+++.+...... ....+.+||+.|+|||++.+..|+.++|
T Consensus 187 FGls~~~~~~~~~---------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 187 FGFSKMYAATVSD---------------------------------------DVGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred cccCeeccccccc---------------------------------------cccccccCCcceeCHHHhCCCCCCcHHH
Confidence 9999865321000 0012468999999999999999999999
Q ss_pred cchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 341 iWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
||||||++|||++|+.||.+.+....+.+++... ...+| ..+++++.+||.+||+ ||.+|+ ++.++++|||++
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~L~~dP~~RP---s~~ell~~p~~~ 301 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-YDPLP--PSISPEMQEIVTALLSSDPKRRP---SSSKLLNMPICK 301 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcccChhhCc---CHHHHHhCHHHH
Confidence 9999999999999999999888777777766532 12233 4789999999999999 999999 899999999998
Q ss_pred CC
Q 038137 420 GI 421 (549)
Q Consensus 420 ~i 421 (549)
..
T Consensus 302 ~~ 303 (496)
T PTZ00283 302 LF 303 (496)
T ss_pred Hh
Confidence 64
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=382.17 Aligned_cols=257 Identities=28% Similarity=0.487 Sum_probs=212.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
.++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4679999999999999999999999999999999976432 223345677899999999999999999988643
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|++||++ |++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4579999998 889987774 46799999999999999999999999999999999999999999999999999886431
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
. ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 171 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (343)
T cd07878 171 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred C--------------------------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHH
Confidence 1 014579999999999987 5789999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhcccc--------------------c-cCCC------CcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTH--------------------L-KFPE------EAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~--------------------l-~~p~------~~~~s~~~~dLI~~lL~-dp 400 (549)
|+|++|++||.+.+.......+...... + ..|. ....++.+.+||.+||+ ||
T Consensus 207 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp 286 (343)
T cd07878 207 AELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDS 286 (343)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCCh
Confidence 9999999999887665554444321110 0 0111 01357789999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCC
Q 038137 401 EQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
.+|+ ++.|++.||||....
T Consensus 287 ~~R~---s~~ell~hp~~~~~~ 305 (343)
T cd07878 287 DKRI---SASEALAHPYFSQYH 305 (343)
T ss_pred hhCC---CHHHHhcCcchhccC
Confidence 9999 899999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=381.42 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=208.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
.++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 5789999999999999999999999999999999875432 233445678899999999999999999988644
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||+++ +|...+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 357999999965 5666654 3589999999999999999999999999999999999999999999999999976432
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. .....+||+.|+|||++.+..|+.++|+|||||++|
T Consensus 172 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 209 (355)
T cd07874 172 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_pred cc------------------------------------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHH
Confidence 10 011457999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccc-------------------------ccc---------CCC----CcCCChhHHH
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRT-------------------------HLK---------FPE----EAKLSPEAKD 391 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~-------------------------~l~---------~p~----~~~~s~~~~d 391 (549)
+|++|++||.+.+....+..++.... .+. +|. ....+.++++
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T cd07874 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHH
Confidence 99999999988765544433321100 000 000 1124678899
Q ss_pred HHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 392 LISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 392 LI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||.+||. ||.+|+ ++.|+++||||..
T Consensus 290 li~~mL~~dP~~Rp---s~~ell~hp~~~~ 316 (355)
T cd07874 290 LLSKMLVIDPAKRI---SVDEALQHPYINV 316 (355)
T ss_pred HHHHHhcCCchhcC---CHHHHhcCcchhc
Confidence 9999999 999999 8999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=383.80 Aligned_cols=256 Identities=35% Similarity=0.647 Sum_probs=223.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg 202 (549)
++||.|-||+||-|.++.||+.||||+|.|..... ++...+++|+.||..+.||.||.|-+.|++.+.+++|||-+ .|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 68999999999999999999999999999877644 34578999999999999999999999999999999999999 66
Q ss_pred chhhHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEEeecCcccccCCCCcccccc
Q 038137 203 DMMTLLM--RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 203 ~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|+...+. .++.|+|..++|++.||+.||.|||-+||+|+||||+||||.+.. .+||||||+|+.+....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------ 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------ 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence 8877763 468999999999999999999999999999999999999997654 79999999999875321
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
+ ..+.||||.|+|||+|++++|+..-|+||+|||+|--|.|..|
T Consensus 722 -----------------------------F-------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 722 -----------------------------F-------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred -----------------------------h-------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEeccccc
Confidence 1 1278999999999999999999999999999999999999999
Q ss_pred CCCCCchhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC-ccccccc
Q 038137 358 FYSDEPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE-WDKLYQI 429 (549)
Q Consensus 358 F~~~~~~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~-w~~l~~~ 429 (549)
|..+.+ +-.+|.+ -.+-+|. +..+|++|.|||..||+ .-.+|. +++..+.|||+++.. |-.|+.+
T Consensus 766 FNEdEd--IndQIQN--AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRy---svdk~lsh~Wlq~yq~w~DLRel 834 (888)
T KOG4236|consen 766 FNEDED--INDQIQN--AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRY---SVDKSLSHPWLQDYQTWLDLREL 834 (888)
T ss_pred CCCccc--hhHHhhc--cccccCCCchhhcCHHHHHHHHHHHHHHHHHhc---chHhhccchhhhcchHHHHHHHH
Confidence 975543 3445655 3344554 35699999999999999 999999 899999999999875 8777753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=363.24 Aligned_cols=255 Identities=38% Similarity=0.628 Sum_probs=214.0
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|++++.||+|+||+||+|++..+++.||+|++......... .....+|+.++..++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999887543332 22345599999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
+++++|.+++.....+++..+..++.||+.||.+||++||+||||||+||+++.+|.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~------- 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN------- 152 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999888899999999999999999999999999999999999999999999999999987541110
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-cCCCCcccccchhhHHHHHHhhCCCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-~~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
......+||+.|+|||++. +..++.++|+|||||++|+|++|..|
T Consensus 153 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 153 ----------------------------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp ----------------------------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred ----------------------------------cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0011457999999999998 78899999999999999999999999
Q ss_pred CCCCC---chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 358 FYSDE---PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 358 F~~~~---~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|.... ......+................++++.+||.+||. ||.+|+ ++.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~---~~~~l~~~~~~ 260 (260)
T PF00069_consen 199 FEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRP---SAEELLKHPWF 260 (260)
T ss_dssp STTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST---THHHHHTSGGG
T ss_pred cccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCc---CHHHHhcCCCC
Confidence 99873 233333333211111222111234899999999999 999999 89999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=377.58 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=207.6
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCRE-----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSF 186 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 186 (549)
.+..++|++.+.||+|+||.||+|.+ ..++..||||++.... .......+.+|+.+|..+ +|||||+++++|
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45668899999999999999999975 3456789999987532 223456788999999999 899999999988
Q ss_pred cCC-ceEEEEEeecCCCchhhHhhhc------------------------------------------------------
Q 038137 187 QDD-EYLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 211 (549)
Q Consensus 187 ~d~-~~lylVmEy~~gg~L~~~l~~~------------------------------------------------------ 211 (549)
.+. ..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 754 4689999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCC
Q 038137 212 --------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283 (549)
Q Consensus 212 --------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~ 283 (549)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---------- 230 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 230 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch----------
Confidence 24788899999999999999999999999999999999999999999999999865311000
Q ss_pred cCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCC
Q 038137 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDE 362 (549)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~ 362 (549)
....+..+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+..
T Consensus 231 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 231 -----------------------------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred -----------------------------hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00013456789999999999999999999999999999997 999998866
Q ss_pred chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 363 ~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
........+........| ..+++++.+||.+||+ ||.+|+ ++.+|++
T Consensus 282 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~el~~ 329 (338)
T cd05102 282 INEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERP---TFSALVE 329 (338)
T ss_pred ccHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 544444444332333333 3678999999999999 999999 7888874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=366.43 Aligned_cols=266 Identities=29% Similarity=0.474 Sum_probs=224.8
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..+.|++++.||.|+||.||+|++..++..||+|++... .......+.+|+.+++.++||||++++++|..+..+|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 346799999999999999999999999999999998754 23445678889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||++|++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 9999999999887754 46799999999999999999999999999999999999999999999999999875321100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccchhhHHH
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIM 348 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiWSlGvil 348 (549)
......|++.|+|||++. ...++.++|+|||||++
T Consensus 166 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 166 ----------------------------------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred ----------------------------------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 011457899999999985 34578899999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
|||++|.+||...+......++.... ....+....++.++.+||.+||. +|++|+ ++++++.||||..++|.+..
T Consensus 206 ~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 206 IEMAQIEPPHHELNPMRVLLKIAKSE-PPTLSQPSKWSMEFRDFLKTALDKHPETRP---SAAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred HHHhcCCCCCccccHHHHHHHHhcCC-CccCCCCcccCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccccccchhH
Confidence 99999999998877666555554321 11222234688999999999999 999999 89999999999999998754
Q ss_pred c
Q 038137 428 Q 428 (549)
Q Consensus 428 ~ 428 (549)
+
T Consensus 282 ~ 282 (292)
T cd06644 282 R 282 (292)
T ss_pred H
Confidence 3
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=373.98 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=194.4
Q ss_pred eeeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec--CCceEEEEEe
Q 038137 122 LTMIGKGAFGEVRVCREK--ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ--DDEYLYLIME 197 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~lylVmE 197 (549)
.+.||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+|+.++||||++++++|. .+..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999976 4678999999865432 234678999999999999999999885 4567999999
Q ss_pred ecCCCchhhHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE----cCCCcEEEeecCcc
Q 038137 198 YLPGGDMMTLLMRK---------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLC 264 (549)
Q Consensus 198 y~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl----d~~g~vKL~DFGla 264 (549)
|+. ++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 994 5888776421 258999999999999999999999999999999999999 56689999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccch
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 343 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWS 343 (549)
+.+....... ......+||+.|+|||++.+ ..|+.++|+||
T Consensus 160 ~~~~~~~~~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 201 (317)
T cd07868 160 RLFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred eccCCCCccc--------------------------------------cccCCccccccccCCHHHcCCCCcCchhhHHH
Confidence 8653211000 00114689999999999987 45899999999
Q ss_pred hhHHHHHHhhCCCCCCCCCch---------hhhhhhhh---------ccccccCCC------------------------
Q 038137 344 LGAIMYEMLVGYPPFYSDEPM---------STCRKIVN---------WRTHLKFPE------------------------ 381 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~---------~~~~~I~~---------~~~~l~~p~------------------------ 381 (549)
|||++|||++|.+||.+.... ....++++ |.....+|.
T Consensus 202 lG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (317)
T cd07868 202 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 281 (317)
T ss_pred HHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHh
Confidence 999999999999999754321 11222211 000000000
Q ss_pred -CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 382 -EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 382 -~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
....+.++.|||.+||+ ||.+|+ +++|+++||||
T Consensus 282 ~~~~~~~~~~dli~~mL~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07868 282 HKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYF 317 (317)
T ss_pred cCCCCChHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 01235679999999999 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=369.22 Aligned_cols=261 Identities=27% Similarity=0.480 Sum_probs=215.3
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.++..+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875432 2233457789999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||++ ++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 999996 588888765 45799999999999999999999999999999999999999999999999999875431100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml 352 (549)
......+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 160 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 199 (301)
T cd07873 160 ----------------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199 (301)
T ss_pred ----------------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHH
Confidence 0013467899999999876 45889999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccc-----------------cccCCC---------CcCCChhHHHHHHHhhh-cccccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~-----------------~l~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
+|++||.+.+..+....+..... ...+|. ...+++++++||.+||+ ||.+|+
T Consensus 200 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~- 278 (301)
T cd07873 200 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI- 278 (301)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc-
Confidence 99999988776544433322100 011111 13578899999999999 999999
Q ss_pred CCCHHHHHcCCcccCCC
Q 038137 406 TKGADEIKAHPWFKGIE 422 (549)
Q Consensus 406 ~~~~~eil~HpfF~~i~ 422 (549)
+++|++.||||+.+.
T Consensus 279 --t~~eil~h~~f~~~~ 293 (301)
T cd07873 279 --SAEEAMKHPYFHCLG 293 (301)
T ss_pred --CHHHHhcCccccccc
Confidence 899999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=391.99 Aligned_cols=262 Identities=29% Similarity=0.482 Sum_probs=229.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.+-|+|+..||.|+||+||+|..+.++-..|-|+|... .....+.+..|++||+.++||+||+|+++|.-++.++|+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 35578899999999999999999999999999988543 356678899999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
.|||+||-...++.. ...|+|.+++.+++|++.||.|||+++|||||||..|||++.+|.|+|+|||.+......
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t---- 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST---- 183 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH----
Confidence 999999999887755 568999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccchhhHHHH
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiWSlGvily 349 (549)
+....+++|||+||||||+. ..+|++++||||||+.|.
T Consensus 184 -------------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI 226 (1187)
T KOG0579|consen 184 -------------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI 226 (1187)
T ss_pred -------------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence 01123789999999999986 478999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
||.-+.||-...+++..+-+|... .+..+-.+..+|....||+.+||. ||..|+ ++.++++||||.+++-.+
T Consensus 227 EMAqiEPPHhelnpMRVllKiaKS-ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp---~aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 227 EMAQIEPPHHELNPMRVLLKIAKS-EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRP---PAAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred HHhccCCCccccchHHHHHHHhhc-CCCcccCcchhhhHHHHHHHHHHhcCCccCC---CHHHHhhCcccccCCcch
Confidence 999999999999999988888763 333333445889999999999999 999999 799999999999887654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=358.35 Aligned_cols=260 Identities=31% Similarity=0.523 Sum_probs=218.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--ceE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM--LRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--EYL 192 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~l 192 (549)
.+|++.+.||+|+||.||+|.+..+|..||||.+..... ........+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864321 1234567789999999999999999999998864 578
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999886532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
... ......||..|+|||++.+..++.++|+|||||++|||+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 203 (265)
T cd06652 162 SGT--------------------------------------GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203 (265)
T ss_pred ccc--------------------------------------ccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence 000 001346999999999999989999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~ 419 (549)
+|++||...+......++.........| ..++..+.++|++|+.+|.+|+ ++++|+.|||++
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~p~~Rp---~~~~il~~~~~~ 265 (265)
T cd06652 204 TEKPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLRP---SADELLRHTFVH 265 (265)
T ss_pred hCCCCCCccchHHHHHHHhcCCCCCCCc--hhhCHHHHHHHHHHhcChhhCC---CHHHHhcCcccC
Confidence 9999998776655555544322222333 3678899999999999999999 799999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=363.21 Aligned_cols=268 Identities=41% Similarity=0.759 Sum_probs=222.8
Q ss_pred CeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLR-RGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~l 192 (549)
+|++.+.||.|+||.||+|.+. .+|..||+|++.+..... ....+++.+|+.+|..+ +|++|++++++|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999975 478999999997654322 23456788999999999 689999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++||+|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.+|++||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyE 350 (549)
. .....+|+..|+|||++.+ ..++.++|+|||||++|+
T Consensus 161 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ 200 (290)
T cd05613 161 E----------------------------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200 (290)
T ss_pred c----------------------------------------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHH
Confidence 0 0114579999999999975 357899999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhcc--ccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWR--THLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~ 425 (549)
|++|..||...........+.... ....+| ..+++.+.+||.+||. +|.+|+++ .++++++.||||..++|+.
T Consensus 201 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 201 LLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred HhcCCCCCCcCCccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 999999997554333333332211 122333 3688999999999999 99999854 4799999999999999988
Q ss_pred cc
Q 038137 426 LY 427 (549)
Q Consensus 426 l~ 427 (549)
+.
T Consensus 279 ~~ 280 (290)
T cd05613 279 LA 280 (290)
T ss_pred Hh
Confidence 74
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=385.35 Aligned_cols=259 Identities=31% Similarity=0.562 Sum_probs=233.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
......|.+++.||+|.|++|.+|++..||..||||.+.|+... .....++.+|++||..++|||||+||.+......+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34567799999999999999999999999999999999987653 33445588999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||+.||+++++|.+.+.+.+..++.++.|++.|++|||+++|||||||.+||||+.+-.+||+|||++..++....
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988763321
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEm 351 (549)
..+.||++.|.|||++.+..| +..+|+||||+++|-|
T Consensus 211 ------------------------------------------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 211 ------------------------------------------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred ------------------------------------------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence 126899999999999999888 8999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+.|.+||.+.+-.+...+++..+ +.+|. .+|.+|++||+++|. +|.+|. ++++|+.|.|....
T Consensus 249 V~GsLPFDG~~lk~Lr~rvl~gk--~rIp~--~ms~dce~lLrk~lvl~Pskr~---~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 249 VEGSLPFDGQNLKELRPRVLRGK--YRIPF--YMSCDCEDLLRKFLVLNPSKRG---PCDQIMKDRWRNDL 312 (596)
T ss_pred eecccccCCcccccccchheeee--ecccc--eeechhHHHHHHhhccCccccC---CHHHhhhhcccchh
Confidence 99999999998888877777643 44443 689999999999999 999998 79999999998643
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=368.03 Aligned_cols=255 Identities=29% Similarity=0.443 Sum_probs=214.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|++++..++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999986432 2334456888999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ .+|+||||||+|||++.+|.+||+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999999999888899999999999999999999997 699999999999999999999999999986542110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
..+.+|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 155 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 195 (308)
T cd06615 155 ---------------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195 (308)
T ss_pred ---------------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence 11457999999999998888999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhcc-----------------------------------ccccCCCCcCCChhHHHHHHHhhh-c
Q 038137 356 PPFYSDEPMSTCRKIVNWR-----------------------------------THLKFPEEAKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~-----------------------------------~~l~~p~~~~~s~~~~dLI~~lL~-d 399 (549)
+||...+.......+-... .....|. ..+++++++||.+||. +
T Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~ 274 (308)
T cd06615 196 YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKN 274 (308)
T ss_pred CCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCC
Confidence 9997655333221111000 0011111 1368899999999999 9
Q ss_pred ccccCCCCCHHHHHcCCcccC
Q 038137 400 VEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 400 p~~Rl~~~~~~eil~HpfF~~ 420 (549)
|++|+ ++.+|+.||||.+
T Consensus 275 P~~Rp---t~~~ll~~~~~~~ 292 (308)
T cd06615 275 PKERA---DLKELTKHPFIKR 292 (308)
T ss_pred hhhCc---CHHHHhcChhhhh
Confidence 99999 8999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=362.26 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=211.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|+++++||+|+||.||+|.+..+++.||||++.+.. .......+.+|+.+|..++||||++++++|.+.+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47889999999999999999999999999999987542 2334456889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+|.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----- 149 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----- 149 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----
Confidence 99999998654 467899999999999999999999999999999999999999999999999987653110
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
....+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 150 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 191 (279)
T cd06619 150 --------------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191 (279)
T ss_pred --------------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 013589999999999999999999999999999999999999
Q ss_pred CCCCCCch-------hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 357 PFYSDEPM-------STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 357 PF~~~~~~-------~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
||...... .....+... .....+ ...+++++++||.+||+ +|.+|+ ++++++.||||...+
T Consensus 192 pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp---~~~eil~~~~~~~~~ 260 (279)
T cd06619 192 PYPQIQKNQGSLMPLQLLQCIVDE-DPPVLP-VGQFSEKFVHFITQCMRKQPKERP---APENLMDHPFIVQYN 260 (279)
T ss_pred CchhhcccccccchHHHHHHHhcc-CCCCCC-CCcCCHHHHHHHHHHhhCChhhCC---CHHHHhcCccccccc
Confidence 99753321 111112211 111222 23578899999999999 999999 899999999998664
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=357.31 Aligned_cols=264 Identities=50% Similarity=0.901 Sum_probs=226.5
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCch
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L 204 (549)
||.|+||.||+|.+..+|+.||+|++.+...........+.+|.+++..++||||+++++.+.+...+|+||||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999877655556677899999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCc
Q 038137 205 MTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284 (549)
Q Consensus 205 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~ 284 (549)
.+++.+.+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99998878999999999999999999999999999999999999999999999999999875432110000
Q ss_pred CCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCch
Q 038137 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364 (549)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~ 364 (549)
..+ .......+|++.|+|||++.+..++.++|+|||||++|+|++|.+||......
T Consensus 152 ----~~~--------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 152 ----NDD--------------------EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred ----ccc--------------------cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 000 00011357899999999999888999999999999999999999999888877
Q ss_pred hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 365 ~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
.....+.. ....+|....+++.+.+||.+||+ +|.+|+...++.++++||||++++|
T Consensus 208 ~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 208 EIFQNILN--GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHHHhc--CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 77766655 334555544469999999999999 9999996666699999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=363.05 Aligned_cols=274 Identities=43% Similarity=0.777 Sum_probs=226.3
Q ss_pred CeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLR-RGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~l 192 (549)
+|++.+.||+|+||.||+|++. .++..||||++.+..... .....++.+|..++..+ +||+|++++++|.+...+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467899999998654432 23446788999999999 699999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++||+|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998778899999999999999999999999999999999999999999999999999876532100
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC--CCcccccchhhHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYE 350 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~--y~~~~DiWSlGvilyE 350 (549)
......+|++.|+|||.+.+.. ++.++|+||||+++||
T Consensus 161 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~e 200 (288)
T cd05583 161 ----------------------------------------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200 (288)
T ss_pred ----------------------------------------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHH
Confidence 0011357899999999987654 7899999999999999
Q ss_pred HhhCCCCCCCCCchhh----hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 351 MLVGYPPFYSDEPMST----CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~----~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
|++|..||........ ...+.. .....| ..+++++.+||.+||. +|++|+...++.++++||||+.++|+.
T Consensus 201 l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 201 LLTGASPFTVDGEQNSQSEISRRILK--SKPPFP--KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred HHhCCCCcccCcccchHHHHHHHHHc--cCCCCC--cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 9999999965433222 222222 122223 3688999999999999 999999777799999999999999998
Q ss_pred ccc--ccCCCcc
Q 038137 426 LYQ--IKAAFIP 435 (549)
Q Consensus 426 l~~--~~~pf~p 435 (549)
+.. ..+||.|
T Consensus 277 ~~~~~~~~~~~~ 288 (288)
T cd05583 277 LAAKRIPAPFKP 288 (288)
T ss_pred HhhhccCCCCCC
Confidence 863 5566643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=360.16 Aligned_cols=256 Identities=29% Similarity=0.501 Sum_probs=214.8
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|..+++.++||||+++++++.+.+.+|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3467999999999999999999999999999999987542 2234567889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-- 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999876531100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhhHHHHHH
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEm 351 (549)
.....+||+.|+|||++. ...++.++|+|||||++|+|
T Consensus 162 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l 202 (267)
T cd06645 162 ---------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred ---------------------------------------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHH
Confidence 001357999999999985 45689999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhcccc-ccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTH-LKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~-l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
++|.+||....+......+...... ........++..+.+||.+||+ +|++|+ ++++|+.|||
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---~~~~ll~~~~ 267 (267)
T cd06645 203 AELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP---TAEKLLQHPF 267 (267)
T ss_pred hcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCc---CHHHHhcCCC
Confidence 9999999876654433333221111 1111223578899999999999 999999 8999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=357.47 Aligned_cols=260 Identities=32% Similarity=0.550 Sum_probs=217.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--CceE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM--LRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD--DEYL 192 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~l 192 (549)
.+|+..+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999999875432 123455678899999999999999999998875 4678
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999886532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
... ......|+..|+|||++.+..++.++|+|||||++|||+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 162 SGT--------------------------------------GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred cCC--------------------------------------ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 000 001346899999999999989999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~ 419 (549)
+|++||.+.+......++........+|. .+++.+++||+.|+.+|++|+ +++||+.||||+
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~~~~p~~Rp---~~~eil~hp~~~ 265 (266)
T cd06651 204 TEKPPWAEYEAMAAIFKIATQPTNPQLPS--HISEHARDFLGCIFVEARHRP---SAEELLRHPFAQ 265 (266)
T ss_pred HCCCCccccchHHHHHHHhcCCCCCCCch--hcCHHHHHHHHHhcCChhhCc---CHHHHhcCcccc
Confidence 99999988766665555554333334443 578999999954444999999 899999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=351.33 Aligned_cols=253 Identities=28% Similarity=0.535 Sum_probs=215.4
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-CceEEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-DEYLYLIM 196 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-~~~lylVm 196 (549)
+|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999976432 23345668889999999999999999998874 45789999
Q ss_pred eecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 197 EYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 197 Ey~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||++|++|.+++.. ...+++.+++.++.+++.||.+||+.||+||||||+||+++.++.++|+|||+++.+.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 99999999998865 34689999999999999999999999999999999999999999999999999876532100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 158 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 158 ---------------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred ---------------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence 00135789999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
+.||.+.+.......+.... ....| ..+++++.+||.+||+ +|.+|+ ++.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 257 (257)
T cd08223 199 KHAFNAKDMNSLVYRIIEGK-LPPMP--KDYSPELGELIATMLSKRPEKRP---SVKSILRQPYI 257 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcC-CCCCc--cccCHHHHHHHHHHhccCcccCC---CHHHHhcCCCC
Confidence 99998877655555554421 11222 3688999999999999 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=362.96 Aligned_cols=241 Identities=21% Similarity=0.255 Sum_probs=210.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC----CceEEEEEee
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD----DEYLYLIMEY 198 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~~lylVmEy 198 (549)
..||+|++|.||+|.. +|+.||||++.+.........+.+.+|+.+|..++|||||+++++|.+ ...+|+||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6899999999999987 688999999987644344446778899999999999999999999876 4579999999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
++||+|..++.....+++..+..++.+++.||.|||+ .+++||||||+|||++.+|.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------ 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------ 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------
Confidence 9999999999888889999999999999999999998 599999999999999999999999999987643110
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHHHhhCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G~ 355 (549)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 178 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~ 219 (283)
T PHA02988 178 --------------------------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219 (283)
T ss_pred --------------------------------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCC
Confidence 13478999999999976 68999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
.||.+.+..+.+..++.....+.+| ..+++++++||.+||+ ||.+|+ ++.+|+.
T Consensus 220 ~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rp---s~~ell~ 274 (283)
T PHA02988 220 IPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRP---NIKEILY 274 (283)
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcCCcccCc---CHHHHHH
Confidence 9999888878777777654445554 3679999999999999 999999 7888874
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=359.90 Aligned_cols=255 Identities=33% Similarity=0.502 Sum_probs=209.0
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++++.||.|+||.||+|.++.+|..||||++.... ........+.+|+.++..++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986543 223344567889999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 198 YLPGGDMMTLLMR---KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 198 y~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|++ |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 997 588887754 25699999999999999999999999999999999999999999999999999875431100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+|++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 157 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 157 ---------------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred ---------------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 0013468899999999876 457999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhcccc----------------ccCC---------CCcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTH----------------LKFP---------EEAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~----------------l~~p---------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
|++||.+.+.......+...... ..++ ....+|+++++||.+||+ ||.+|+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp--- 274 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI--- 274 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC---
Confidence 99999877654333222110000 0000 012478999999999999 999999
Q ss_pred CHHHHHcCCcc
Q 038137 408 GADEIKAHPWF 418 (549)
Q Consensus 408 ~~~eil~HpfF 418 (549)
++.+|+.||||
T Consensus 275 t~~~ll~~~~~ 285 (285)
T cd07861 275 SAKKALNHPYF 285 (285)
T ss_pred CHHHHhcCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=355.46 Aligned_cols=255 Identities=42% Similarity=0.760 Sum_probs=219.7
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987765555667889999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|++|++|..++.....+++..+..++.|++.||.|||.+||+|+||+|+||+++.+|.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence 999999999998777999999999999999999999999999999999999999999999999999876532100
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 156 -------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 156 -------------------------------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred -------------------------------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 0134688999999999998899999999999999999999999
Q ss_pred CCCCCc--hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 358 FYSDEP--MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 358 F~~~~~--~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|...+. ...+.+.... ....+| ..++.++.++|.+||. ||.+|++.. +.|+++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 199 YRGHSRTIRDQIRAKQET-ADVLYP--ATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred CCCCCccHHHHHHHHhcc-ccccCc--ccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 987764 2222222221 223334 3678999999999999 999999422 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=405.40 Aligned_cols=263 Identities=28% Similarity=0.463 Sum_probs=218.8
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-- 188 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-- 188 (549)
......++|++++.||+|+||+||+|+++.++..||+|++....+ .......+..|+.+|..++|||||+++++|.+
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 445667899999999999999999999999999999999976543 33445678899999999999999999998854
Q ss_pred CceEEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CeeecCCCCCCeEEcC-----
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKH-------NYIHRDIKPDNLLLDR----- 252 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-------giiHRDLKPeNILld~----- 252 (549)
...+||||||+++|+|..+|.. ...|++..++.++.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4679999999999999999865 35799999999999999999999985 4999999999999964
Q ss_pred ------------CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeeccc
Q 038137 253 ------------NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVG 320 (549)
Q Consensus 253 ------------~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vG 320 (549)
.+.+||+|||+++.+.... .....+|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------------------------------------------~~~s~vG 203 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES------------------------------------------MAHSCVG 203 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc------------------------------------------cccccCC
Confidence 3459999999997653210 0114589
Q ss_pred CCCCCCchhhcc--CCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh
Q 038137 321 TPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC 398 (549)
Q Consensus 321 T~~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~ 398 (549)
|+.|+|||++.+ ..|+.++||||||||||||++|.+||...+.......++.... .+|. ...+.++.+||.+||.
T Consensus 204 Tp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p--~lpi-~~~S~eL~dLI~~~L~ 280 (1021)
T PTZ00266 204 TPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP--DLPI-KGKSKELNILIKNLLN 280 (1021)
T ss_pred CccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC--CCCc-CCCCHHHHHHHHHHhc
Confidence 999999999965 4589999999999999999999999987665555444443222 2222 2578999999999999
Q ss_pred -cccccCCCCCHHHHHcCCcccCCC
Q 038137 399 -NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 399 -dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+|.+|+ ++.|++.||||+.+.
T Consensus 281 ~dPeeRP---Sa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 281 LSAKERP---SALQCLGYQIIKNVG 302 (1021)
T ss_pred CChhHCc---CHHHHhccHHHhhcC
Confidence 999999 899999999998775
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=356.37 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=214.7
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.++..++||||+++++++.+...+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3568999999999999999999999999999999986542 2334567889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++..+......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK- 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999865311000
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhhHHHHHH
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEm 351 (549)
.....|++.|+|||++. ...++.++|+|||||++|||
T Consensus 163 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el 202 (267)
T cd06646 163 ----------------------------------------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred ----------------------------------------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHH
Confidence 01357999999999985 35578899999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhcccc-ccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTH-LKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~-l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
++|.+||...++......+...... ...+....++.++.+||++||+ +|++|+ ++++|++|+|
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~l~ 267 (267)
T cd06646 203 AELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP---TAERLLTHLF 267 (267)
T ss_pred HhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCc---CHHHHhcCCC
Confidence 9999999766554443333221111 1112223578999999999999 999999 8999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=368.48 Aligned_cols=264 Identities=22% Similarity=0.368 Sum_probs=209.0
Q ss_pred eeeeeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 121 PLTMIGKG--AFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 121 ~~~~IG~G--~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
++++||+| +||+||+|.++.+|+.||||++..... .......+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999975432 234456788899999999999999999999999999999999
Q ss_pred cCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 199 LPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 199 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
+++|+|.+++.. ...+++..++.++.|++.||.|||++|||||||||+|||++.++.++++|||.+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~- 159 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR- 159 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc-
Confidence 999999999865 35699999999999999999999999999999999999999999999999997654321100000
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHHHhhC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G 354 (549)
.. .......+++..|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 160 ----------~~-----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 160 ----------VV-----------------------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ----------cc-----------------------ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence 00 000012467888999999986 4699999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhcccc------------------------------------------ccCCCCcCCChhHHHH
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTH------------------------------------------LKFPEEAKLSPEAKDL 392 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~------------------------------------------l~~p~~~~~s~~~~dL 392 (549)
++||.................. ...|....+++++++|
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 9999765433322222110000 0001112457899999
Q ss_pred HHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 393 ISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 393 I~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
|.+||+ ||++|+ +++|+++||||+.+.
T Consensus 287 i~~~l~~dP~~Rp---t~~ell~~p~f~~~~ 314 (327)
T cd08227 287 VEQCLQRNPDARP---SASTLLNHSFFKQIK 314 (327)
T ss_pred HHHHHhhCchhcC---CHHHHhcChhhhhcc
Confidence 999999 999999 899999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=360.66 Aligned_cols=254 Identities=30% Similarity=0.509 Sum_probs=213.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|++..+|..||+|.+.... .......+.+|+.++..++||||++++++|...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999999999999986431 2334467889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 197 EYLPGGDMMTLLMRK---DTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
||++|++|..++... ..+++..++.++.+++.||.|||+ .||+||||||+||+++.++.+||+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999888653 379999999999999999999996 699999999999999999999999999987543110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC------CCCcccccchhhH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK------GYGMECDWWSLGA 346 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~------~y~~~~DiWSlGv 346 (549)
....+|++.|+|||++.+. .++.++|+|||||
T Consensus 158 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 195 (286)
T cd06622 158 ------------------------------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195 (286)
T ss_pred ------------------------------------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHH
Confidence 0134688999999998643 3588999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhh---hhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRK---IVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~---I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
++|+|++|..||...+....... +... ....+|. .+++++.+||.+||. +|.+|+ ++++++.||||...
T Consensus 196 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~~~~~~~~ 268 (286)
T cd06622 196 SILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPS--GYSDDAQDFVAKCLNKIPNRRP---TYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCCc--ccCHHHHHHHHHHcccCcccCC---CHHHHhcChhhhhc
Confidence 99999999999987655444333 2221 2233333 589999999999999 999999 89999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=357.77 Aligned_cols=255 Identities=31% Similarity=0.511 Sum_probs=216.2
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|++++.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||++++++|......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 577889999999999999999999999999986542 23456788899999999999999999999999999999999
Q ss_pred cCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-----
Confidence 999999988754 46799999999999999999999999999999999999999999999999999875431100
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccchhhHHHHHHh
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiWSlGvilyEml 352 (549)
......||+.|+|||++. +..++.++|+|||||++|||+
T Consensus 159 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 159 ------------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred ------------------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 011357999999999984 456788999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+|.+||.+.++.....++..... ...+.+..++.++++||.+||. +|.+|+ +++++++||||...
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~ 268 (282)
T cd06643 203 QIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPFVTVN 268 (282)
T ss_pred cCCCCccccCHHHHHHHHhhcCC-CCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCCCEecc
Confidence 99999988777666555554221 1222234688999999999998 999999 89999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=358.82 Aligned_cols=259 Identities=29% Similarity=0.493 Sum_probs=220.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||.|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||++++++|.++..+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 46799999999999999999999999999999998654 234456788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||++||+|..++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 999999999999866 35799999999999999999999999999999999999999999999999998765421100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccchhhHHHH
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiWSlGvily 349 (549)
......||+.|+|||++. ...++.++|+|||||++|
T Consensus 159 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 159 ---------------------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred ---------------------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 011457999999999985 345788999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+|++|++||.+.+......++... ....+..+..++.++.+||.+||+ +|.+|+ +++++++||||....
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~~ 269 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILKS-EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFVSDQS 269 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhcC-CCCCcCCcccCCHHHHHHHHHHhccChhhCc---CHHHHhcChhhcccc
Confidence 999999999887766655555432 112222234688999999999999 999999 899999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=374.59 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=203.2
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
...+|++++.||+|+||.||+|.+..++..||+|+..+.. ...|..+|..++|||||+++++|.+....|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3457999999999999999999999999999999864432 3468999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||+. |+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++......
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 999995 688887754 4679999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 212 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~ 251 (357)
T PHA03209 212 ----------------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251 (357)
T ss_pred ----------------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHH
Confidence 0114579999999999999999999999999999999998
Q ss_pred CCCC-CCCCCch---------hhhhhhhhc--cccccCC----------------------------CCcCCChhHHHHH
Q 038137 354 GYPP-FYSDEPM---------STCRKIVNW--RTHLKFP----------------------------EEAKLSPEAKDLI 393 (549)
Q Consensus 354 G~~P-F~~~~~~---------~~~~~I~~~--~~~l~~p----------------------------~~~~~s~~~~dLI 393 (549)
+..| |...... ....+++.. .....+| ....++.++.+||
T Consensus 252 ~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 331 (357)
T PHA03209 252 YPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLV 331 (357)
T ss_pred cCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHH
Confidence 5544 4332111 111111110 0001111 0124678899999
Q ss_pred HHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 394 SKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 394 ~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
.+||+ ||.+|+ +|.|+++||||+.+
T Consensus 332 ~~mL~~dP~~Rp---ta~e~l~hp~f~~~ 357 (357)
T PHA03209 332 HKMLTFDAAMRP---SAEEILNYPMFAQL 357 (357)
T ss_pred HHHHcCCcccCc---CHHHHhcCchhccC
Confidence 99999 999999 89999999999864
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=356.38 Aligned_cols=248 Identities=33% Similarity=0.548 Sum_probs=202.1
Q ss_pred Ceeeeeee--eecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh-cCCCceeeeeeeecCCceEEE
Q 038137 118 DFEPLTMI--GKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE-VDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 118 ~f~~~~~I--G~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lyl 194 (549)
+|++.+.+ |.|+||.||+|.++.++..||+|.+.+..... .|..+... .+||||++++++|.+.+.+|+
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 45565555 99999999999999999999999987653211 12222221 279999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~~~~~~~ 273 (549)
||||++||+|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999999999999998877999999999999999999999999999999999999999998 9999999998764311
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 164 ------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 201 (267)
T PHA03390 164 ------------------------------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201 (267)
T ss_pred ------------------------------------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 02468999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|..||............+........+....+|+.+.+||.+||+ +|.+|+. ++++|++||||++
T Consensus 202 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 202 GKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred CCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 999998654433211111111111122223689999999999999 9999994 2699999999974
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=356.56 Aligned_cols=257 Identities=30% Similarity=0.483 Sum_probs=214.2
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875432 2223355788999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++++.|..++.....+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--- 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc---
Confidence 99999999888877778999999999999999999999999999999999999999999999999999875422100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....|+..|+|||++.+ ..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 157 --------------------------------------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred --------------------------------------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 012468889999999876 56899999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhcc-----------------ccccCCC----------CcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 356 PPFYSDEPMSTCRKIVNWR-----------------THLKFPE----------EAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~-----------------~~l~~p~----------~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
+||.+.+..+....+.... .....|. ...++..+.+||.+||+ +|++|+
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--- 275 (286)
T cd07847 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL--- 275 (286)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC---
Confidence 9998776544433332110 0011111 12568899999999999 999999
Q ss_pred CHHHHHcCCcc
Q 038137 408 GADEIKAHPWF 418 (549)
Q Consensus 408 ~~~eil~HpfF 418 (549)
++.|++.||||
T Consensus 276 ~~~eil~~~~f 286 (286)
T cd07847 276 SCEELLEHPYF 286 (286)
T ss_pred CHHHHhcCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.75 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=220.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+|+.++|+||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999997654322 5677899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRK---DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||++|++|.+++... ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999663 46999999999999999999999999999999999999999999999999999876422100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml 352 (549)
. .......+|++.|+|||++... .++.++|+|||||++|+|+
T Consensus 159 ~-------------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 159 T-------------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201 (267)
T ss_pred c-------------------------------------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence 0 0001245799999999999876 7899999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCC---cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEE---AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~---~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
+|+.||...+....+.++... ....++.. ..+++++.+||.+||+ ||.+|+ ++++|+.||||
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~ll~~p~~ 267 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQN-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRP---TAEELLKHKFF 267 (267)
T ss_pred hCCCCccccChhhhHHHHhcC-CCCCcCCccccccccHHHHHHHHHHcCCChhhCc---CHHHHhhCCCC
Confidence 999999887776666555542 12222222 3678999999999999 999999 89999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=359.33 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=207.1
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++++.||+|+||.||+|+++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999976432 23334567789999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 198 YLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 198 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|++ ++|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---- 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---- 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC----
Confidence 996 577777754 56799999999999999999999999999999999999999999999999999876431100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~ 355 (549)
......+|+.|+|||++.+. .++.++|+|||||++|||++|.
T Consensus 155 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 155 -------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred -------------------------------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 00134688999999998774 4799999999999999999998
Q ss_pred CCCCC-CCchhhhhhhhhc---------------cccccCCC----------CcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 356 PPFYS-DEPMSTCRKIVNW---------------RTHLKFPE----------EAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 356 ~PF~~-~~~~~~~~~I~~~---------------~~~l~~p~----------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
.||.. .+....+..+... .....++. ...+|+++++||.+||. ||.+|+ +
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---t 274 (284)
T cd07839 198 RPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI---S 274 (284)
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC---C
Confidence 88643 3333333333210 00001110 12578999999999999 999999 8
Q ss_pred HHHHHcCCcc
Q 038137 409 ADEIKAHPWF 418 (549)
Q Consensus 409 ~~eil~HpfF 418 (549)
+++++.||||
T Consensus 275 ~~~il~h~~f 284 (284)
T cd07839 275 AEEALQHPYF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=352.18 Aligned_cols=260 Identities=31% Similarity=0.518 Sum_probs=219.0
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh------chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML------RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.++..++||||+++++++.+.++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999999999999999988754322 22345678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+||||++|++|..++.+.+.+++..++.++.|++.||.|||++|++||||+|+|||++.++.+||+|||+++.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998764211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
..... ........|++.|+|||++.+..++.++|+|||||++|+|
T Consensus 161 ~~~~~-----------------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l 205 (267)
T cd06628 161 LSTKT-----------------------------------NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205 (267)
T ss_pred ccCCc-----------------------------------cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHH
Confidence 00000 0000135689999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
++|+.||.+.+......++... ....+| ..++.++.+||.+||+ +|.+|+ ++.+|+.||||
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 267 (267)
T cd06628 206 LTGKHPFPDCTQLQAIFKIGEN-ASPEIP--SNISSEAIDFLEKTFEIDHNKRP---TAAELLKHPFL 267 (267)
T ss_pred hhCCCCCCCccHHHHHHHHhcc-CCCcCC--cccCHHHHHHHHHHccCCchhCc---CHHHHhhCCCC
Confidence 9999999877665555554432 122333 3678999999999999 999999 89999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.91 Aligned_cols=253 Identities=32% Similarity=0.524 Sum_probs=210.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQD------ 188 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d------ 188 (549)
.+.|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ +||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456888999999999999999999999999999987542 2335678899999988 79999999999874
Q ss_pred CceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
...+|+||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 35689999999999999998753 4689999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCccccc
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 341 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~Di 341 (549)
...... ......||+.|+|||++. +..|+.++|+
T Consensus 161 ~~~~~~-----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv 199 (272)
T cd06637 161 LDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 199 (272)
T ss_pred cccccc-----------------------------------------cCCcccccccccCHhHhccccCcCCCCCchhhH
Confidence 532100 001457999999999986 3468899999
Q ss_pred chhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|||||++|||++|.+||....+......+.. ..........++.++.+||.+||+ +|.+|+ ++.+|+.||||
T Consensus 200 ~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~~ 272 (272)
T cd06637 200 WSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NPAPRLKSKKWSKKFQSFIESCLVKNHSQRP---TTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHHHhCCCCccccCHHHHHHHHhc--CCCCCCCCCCcCHHHHHHHHHHcCCChhhCC---CHHHHhhCCCC
Confidence 9999999999999999987665444433332 222222223678999999999999 999999 89999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=347.38 Aligned_cols=253 Identities=34% Similarity=0.531 Sum_probs=219.3
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|.+.+.||+|+||.||+|.++.+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999998765433 3445678899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++|++|.+++... ..+++..+..++.+++.||.|||+.||+||||||+||+++.++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--- 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--- 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence 99999999998664 5799999999999999999999999999999999999999999999999999886542110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus 157 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 198 (256)
T cd08529 157 --------------------------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198 (256)
T ss_pred --------------------------------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence 001357899999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
.||...+......++... ....++. .++.++.++|.+||+ +|++|+ ++.+++.|||+
T Consensus 199 ~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 256 (256)
T cd08529 199 HPFDANNQGALILKIIRG-VFPPVSQ--MYSQQLAQLIDQCLTKDYRQRP---DTFQLLRNPSL 256 (256)
T ss_pred CCCCCCCHHHHHHHHHcC-CCCCCcc--ccCHHHHHHHHHHccCCcccCc---CHHHHhhCCCC
Confidence 999888766666666542 1122222 678999999999999 999999 89999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=351.43 Aligned_cols=260 Identities=29% Similarity=0.496 Sum_probs=216.7
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechh---hhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE---MLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~---~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
+|++.+.||+|+||+||+|.. .+|..+|+|.+.... .........+.+|+.+|+.++|+||++++++|.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578889999999999999986 578999999986432 1223445678999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||++||+|..++.+...+++..++.++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999887889999999999999999999999999999999999999999999999999988653211000
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
.. ........||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 160 ~~-----------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 160 TH-----------------------------------SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred cc-----------------------------------cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence 00 0001145799999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhcccc-ccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTH-LKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~-l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
.+||...+.......+...... ..+| ..++.++.+||.+||. +|.+|+ ++.+++.||||
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~ 265 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLP--DSFSAAAIDFVTSCLTRDQHERP---SALQLLRHDFL 265 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCC--CCCCHHHHHHHHHHhcCCcccCC---CHHHHhcCCCC
Confidence 9999876655544444432111 1233 3688999999999998 999999 89999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=354.69 Aligned_cols=257 Identities=35% Similarity=0.538 Sum_probs=220.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++|+||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999987543 2334566889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++|++|.+++... .+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||+++.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 153 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---- 153 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence 999999999998654 899999999999999999999999999999999999999999999999999987642110
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 154 -------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 154 -------------------------------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred -------------------------------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0113578999999999999889999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
||.+.++......+... .....+. ..+++++.++|.+||+ +|++|+ ++++++.||||....
T Consensus 197 p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rp---t~~~il~~~~~~~~~ 258 (274)
T cd06609 197 PLSDLHPMRVLFLIPKN-NPPSLEG-NKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIKKAK 258 (274)
T ss_pred CcccCchHHHHHHhhhc-CCCCCcc-cccCHHHHHHHHHHhhCChhhCc---CHHHHhhChhhcCCC
Confidence 99887766555544432 1222222 2378999999999998 999999 899999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=351.80 Aligned_cols=260 Identities=27% Similarity=0.490 Sum_probs=216.8
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc---hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR---RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
+|+..+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+|+.++|+||++++++|.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999997543211 2235678999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~~~~~~~ 273 (549)
||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.+| .+||+|||++..+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888999999999999999999999999999999999999998887 4999999998876422100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
... .....+||..|+|||++.+..++.++|+|||||++|+|++
T Consensus 161 ~~~-------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 161 AGE-------------------------------------FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred CCc-------------------------------------cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh
Confidence 000 0013578999999999998999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhc---cccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 354 GYPPFYSDEPMSTCRKIVNW---RTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~---~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
|.+||...+.......+... .....+| ..+++++.++|.+||. +|.+|+ ++.++++||||+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~ll~~~~~~ 268 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASATTAPSIP--EHLSPGLRDVTLRCLELQPEDRP---PSRELLKHPVFR 268 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhccCCCCCCc--hhhCHHHHHHHHHHcCCCcccCc---CHHHHhcCcccC
Confidence 99999765543333333221 1122233 3678999999999998 999999 899999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=350.78 Aligned_cols=259 Identities=30% Similarity=0.526 Sum_probs=216.5
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-------RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
.|.+.+.||.|+||.||+|....+|+.||+|.+...... .....+.+..|..++..++||||+++++++.+.+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999999999999999988642211 1223457888999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||++||+|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.+|.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998764311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC--CCcccccchhhHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIM 348 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~--y~~~~DiWSlGvil 348 (549)
... .......|+..|+|||++.... ++.++|+|||||++
T Consensus 162 ~~~---------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l 202 (272)
T cd06629 162 YDN---------------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202 (272)
T ss_pred ccc---------------------------------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence 000 0011356899999999998754 89999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCC--cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~--~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|+|++|..||...+......++........++.. ..++.++++||.+||. +|.+|+ ++++|++||||
T Consensus 203 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~ 272 (272)
T cd06629 203 LEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP---TARELLQHPFI 272 (272)
T ss_pred HHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC---CHHHHhhCCCC
Confidence 9999999999776655555444433233344432 2568999999999999 999999 79999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=355.54 Aligned_cols=264 Identities=19% Similarity=0.302 Sum_probs=216.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
.+..++|++.+.||+|+||.||+|..+. .+..||+|.+..... ......+.+|..+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3567889999999999999999997653 355899998865432 223345778999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEE
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK----------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMK 257 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vK 257 (549)
+....|+||||++||+|.+++.+. ..++...+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999999652 2346778899999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCc
Q 038137 258 LSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337 (549)
Q Consensus 258 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~ 337 (549)
|+|||+++.+....... ......++..|+|||.+.+..++.
T Consensus 160 L~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~ 200 (288)
T cd05061 160 IGDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMAPESLKDGVFTT 200 (288)
T ss_pred ECcCCcccccccccccc---------------------------------------ccCCCcccccccCHHHhccCCCCh
Confidence 99999988653211000 000235677899999999999999
Q ss_pred ccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc-
Q 038137 338 ECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA- 414 (549)
Q Consensus 338 ~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~- 414 (549)
++|+|||||++|||++ |.+||.+.+..+....+... ....+|. .+++.++++|.+||+ +|.+|+ ++.++++
T Consensus 201 ~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~ 274 (288)
T cd05061 201 SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYLDQPD--NCPERVTDLMRMCWQFNPKMRP---TFLEIVNL 274 (288)
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHHcCCChhHCc---CHHHHHHH
Confidence 9999999999999998 89999887766655555432 2233333 568899999999999 999999 7877766
Q ss_pred -----CCcccCCCc
Q 038137 415 -----HPWFKGIEW 423 (549)
Q Consensus 415 -----HpfF~~i~w 423 (549)
||||++++|
T Consensus 275 l~~~~~~~~~~~~~ 288 (288)
T cd05061 275 LKDDLHPSFPEVSF 288 (288)
T ss_pred HHhhcCCCCCCCCC
Confidence 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.39 Aligned_cols=257 Identities=32% Similarity=0.526 Sum_probs=215.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.++.+++.||||++.+.... ....+.+.+|+.+++.++||||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998765432 234456788999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++++.|..+......+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc----
Confidence 9999999988877667799999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+|+..|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 156 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~ 198 (286)
T cd07846 156 -------------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198 (286)
T ss_pred -------------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence 0013468999999999976 45789999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhcccc-----------------ccCCC----------CcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTH-----------------LKFPE----------EAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~-----------------l~~p~----------~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
+||.+....+....+..+... ...|. ...++..+.+||.+||. +|.+|+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp--- 275 (286)
T cd07846 199 PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP--- 275 (286)
T ss_pred CCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch---
Confidence 999877655544444321111 01111 12578899999999999 999999
Q ss_pred CHHHHHcCCcc
Q 038137 408 GADEIKAHPWF 418 (549)
Q Consensus 408 ~~~eil~HpfF 418 (549)
++.+|+.||||
T Consensus 276 ~~~~il~~~~~ 286 (286)
T cd07846 276 SSSQLLHHEFF 286 (286)
T ss_pred hHHHHhcCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=360.78 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=192.5
Q ss_pred eeeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec--CCceEEEEEee
Q 038137 123 TMIGKGAFGEVRVCREKA--TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ--DDEYLYLIMEY 198 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~--tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~lylVmEy 198 (549)
..||+|+||.||+|+.+. ++..||+|.+..... ...+.+|+.+|+.++||||++++++|. ++..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999764 668999999875432 234778999999999999999999884 46789999999
Q ss_pred cCCCchhhHhhh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE----cCCCcEEEeecCccc
Q 038137 199 LPGGDMMTLLMR---------KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLCK 265 (549)
Q Consensus 199 ~~gg~L~~~l~~---------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl----d~~g~vKL~DFGlak 265 (549)
++ ++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+|+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 577776632 1358999999999999999999999999999999999999 567899999999998
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 344 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSl 344 (549)
.+....... ......+||+.|+|||++.+ ..++.++|||||
T Consensus 161 ~~~~~~~~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 161 LFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred ccCCCcccc--------------------------------------cccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 654221000 00114589999999999987 458999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchh---------hhhhhhh---------ccc---cccCC----------------------C
Q 038137 345 GAIMYEMLVGYPPFYSDEPMS---------TCRKIVN---------WRT---HLKFP----------------------E 381 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~---------~~~~I~~---------~~~---~l~~p----------------------~ 381 (549)
||++|||++|.+||....... ...++.. |.. ...++ .
T Consensus 203 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (317)
T cd07867 203 GCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKH 282 (317)
T ss_pred HHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcc
Confidence 999999999999997543211 0111110 000 00000 0
Q ss_pred CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 382 EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 382 ~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
....+..+.+||.+||+ ||.+|+ +++|+++||||
T Consensus 283 ~~~~~~~~~~ll~~~l~~dP~~R~---t~~e~l~hp~f 317 (317)
T cd07867 283 KVKPDSKVFLLLQKLLTMDPTKRI---TSEQALQDPYF 317 (317)
T ss_pred cCCCChHHHHHHHHHhccCccccc---CHHHHhcCCCC
Confidence 11245678999999999 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=356.93 Aligned_cols=257 Identities=31% Similarity=0.530 Sum_probs=218.0
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
..+|++++.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.++..++||||+++++.|.+...+|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999999999999999876542 2346688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++||+|..++. ...+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 171 (296)
T cd06654 96 MEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (296)
T ss_pred ecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc---
Confidence 99999999999884 45689999999999999999999999999999999999999999999999999876431100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus 172 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~ 213 (296)
T cd06654 172 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (296)
T ss_pred --------------------------------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 001347999999999999988999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||...++......+... .....+....+++.+.+||.+||. +|.+|+ ++.+|+.||||...
T Consensus 214 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~eil~~~~~~~~ 276 (296)
T cd06654 214 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKIA 276 (296)
T ss_pred CCCCCCCHHHhHHHHhcC-CCCCCCCccccCHHHHHHHHHHCcCCcccCc---CHHHHhhChhhhcc
Confidence 999887765443333321 111222234688999999999999 999998 89999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=358.66 Aligned_cols=254 Identities=30% Similarity=0.534 Sum_probs=221.3
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|.++..||+|+||.||+|.++.+|+++|||.+.-. .....+..|+.||.++++|+||+.|++|.....+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 88889999999999999999999999999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCchhhHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|..|++.++++ ++.+|+|+++..++...+.||+|||...-||||||..||||+.+||.||+|||.|..+....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM------ 183 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM------ 183 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH------
Confidence 99999999885 46789999999999999999999999999999999999999999999999999987664210
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
. ...+.+|||.|||||++..-+|+..+||||||+...||..|+||
T Consensus 184 -------------------------------A----KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PP 228 (502)
T KOG0574|consen 184 -------------------------------A----KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPP 228 (502)
T ss_pred -------------------------------H----hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCC
Confidence 0 11268999999999999999999999999999999999999999
Q ss_pred CCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 358 F~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
|.+-.+.....-|-. ..+..|..+...|.+.-|||++||. .|++|- +|.++++|||.++-.
T Consensus 229 YsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~---TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 229 YSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK---TALRLCEHTFIKNAP 290 (502)
T ss_pred cccccccceeEeccC-CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH---HHHHHhhhhhhcCCC
Confidence 988777655443322 2233444444689999999999998 999998 899999999998653
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=378.97 Aligned_cols=253 Identities=24% Similarity=0.269 Sum_probs=205.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.++|+|||++++++......|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 5579999999999999999999999999999996422 2356799999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||++ +|+|..++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence 9999 4688888755 357999999999999999999999999999999999999999999999999999865321000
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
......+||+.|+|||++.+..|+.++|||||||+||||++|
T Consensus 317 --------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g 358 (461)
T PHA03211 317 --------------------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH 358 (461)
T ss_pred --------------------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHc
Confidence 001246899999999999999999999999999999999999
Q ss_pred CCCCCCCCc-------hhhhhhhhhcccc--ccCC-----------------------------CCcCCChhHHHHHHHh
Q 038137 355 YPPFYSDEP-------MSTCRKIVNWRTH--LKFP-----------------------------EEAKLSPEAKDLISKL 396 (549)
Q Consensus 355 ~~PF~~~~~-------~~~~~~I~~~~~~--l~~p-----------------------------~~~~~s~~~~dLI~~l 396 (549)
..|+.+... .....+++..... ..+| ....++.++.+||.+|
T Consensus 359 ~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 438 (461)
T PHA03211 359 TASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA 438 (461)
T ss_pred CCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHH
Confidence 877654321 1122223221110 0111 0114567899999999
Q ss_pred hh-cccccCCCCCHHHHHcCCcccC
Q 038137 397 LC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 397 L~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|. ||.+|+ ++.|||+||||+.
T Consensus 439 L~~DP~~RP---sa~elL~hp~f~~ 460 (461)
T PHA03211 439 LTFDGARRP---SAAELLRLPLFQS 460 (461)
T ss_pred cccChhhCc---CHHHHhhCcccCC
Confidence 99 999999 8999999999974
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=346.01 Aligned_cols=253 Identities=34% Similarity=0.552 Sum_probs=216.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++.+.||.|+||.||+|..+.++..||+|.+..... ...+.+|+.+++.++||||++++++|.+...+|+|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3679999999999999999999999999999999875432 56788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||++|++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.+||+|||++..+.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999865 46789999999999999999999999999999999999999999999999999886532110
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
......|+..|+|||++.+..++.++|+||||||+|+|++|
T Consensus 155 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g 195 (256)
T cd06612 155 ---------------------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195 (256)
T ss_pred ---------------------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC
Confidence 01134689999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
++||...++......+.... ...+.....++.++.++|.+||. +|.+|+ ++.||+.||||
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---s~~~il~~~~~ 256 (256)
T cd06612 196 KPPYSDIHPMRAIFMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKDPEERP---SAIQLLQHPFI 256 (256)
T ss_pred CCCCCCcchhhhhhhhccCC-CCCCCchhhcCHHHHHHHHHHHhcChhhCc---CHHHHhcCCCC
Confidence 99998766554443333211 11222223678899999999998 999999 89999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=355.84 Aligned_cols=257 Identities=33% Similarity=0.557 Sum_probs=219.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
..+|++++.||.|+||.||+|.+..+|+.||+|.+.... ......+.+|..+++.++||||++++++|.+.+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 356999999999999999999999999999999987543 23346688899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++||+|..++.. ..+++.++..++.+++.||.|||+.|++||||||+||+++.+|.+||+|||++..+.....
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--- 170 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--- 170 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc---
Confidence 999999999998854 5699999999999999999999999999999999999999999999999999876532100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus 171 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~ 212 (296)
T cd06655 171 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (296)
T ss_pred --------------------------------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 001347899999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||.+.++......+... ..........+++.+++||.+||. +|.+|+ ++.+|+.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~il~~~~~~~~ 275 (296)
T cd06655 213 PPYLNENPLRALYLIATN-GTPELQNPEKLSPIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKLA 275 (296)
T ss_pred CCCCCCCHHHHHHHHHhc-CCcccCCcccCCHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhhc
Confidence 999887765554444321 111222234689999999999999 999998 89999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=355.48 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=217.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.++..++||||+++++++.+...+|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 34578999999999999999999999999999999986542 2334567889999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+||||++||+|..++.+.+.+++..++.++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 999999999999999887889999999999999999999997 699999999999999999999999999986542110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
....+||..|+|||++.+..++.++|+|||||++|+|+
T Consensus 159 ------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 196 (284)
T cd06620 159 ------------------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196 (284)
T ss_pred ------------------------------------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHH
Confidence 01357999999999999889999999999999999999
Q ss_pred hCCCCCCCCCch-----------hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 353 VGYPPFYSDEPM-----------STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 353 ~G~~PF~~~~~~-----------~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+|.+||...... .....++.. ....++. ..++.++.+||.+||. ||.+|+ +++|+++||||..
T Consensus 197 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rp---t~~e~~~~~~~~~ 271 (284)
T cd06620 197 LGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPS-SDFPEDLRDFVDACLLKDPTERP---TPQQLCAMPPFIQ 271 (284)
T ss_pred hCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCCc-hhcCHHHHHHHHHHhcCCcccCc---CHHHHhcCccccc
Confidence 999999875542 222223221 1122222 2378899999999999 999999 8999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=356.79 Aligned_cols=257 Identities=31% Similarity=0.542 Sum_probs=217.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
..+|++++.||.|+||.||+|.+..+|+.||||.+..... ...+.+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3679999999999999999999999999999999875432 2345688899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++|++|..++. ...+++..+..++.+++.||.|||+.||+||||||+|||++.+|.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 95 MEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred ecccCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 99999999999885 456899999999999999999999999999999999999999999999999998764321100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 172 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~ 212 (297)
T cd06656 172 ---------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (297)
T ss_pred ---------------------------------------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 01346899999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||.+.++......+... ..........+++.+++||.+||. +|.+|+ ++++|+.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 275 (297)
T cd06656 213 PPYLNENPLRALYLIATN-GTPELQNPERLSAVFRDFLNRCLEMDVDRRG---SAKELLQHPFLKLA 275 (297)
T ss_pred CCCCCCCcchheeeeccC-CCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhccc
Confidence 999877654433322221 111111223678999999999999 999998 89999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=388.53 Aligned_cols=269 Identities=26% Similarity=0.385 Sum_probs=202.7
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCC-cEEEEE--------------EeechhhhchhhHHHHHHHHHHHHhcCCCce
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATG-HVYAMK--------------KLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg-~~vAiK--------------~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 179 (549)
..++|++++.||+|+||+||+|..+... ..++.| ++.+...........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999999875432 222222 1111111122334567899999999999999
Q ss_pred eeeeeeecCCceEEEEEeecCCCchhhHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC
Q 038137 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK-----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG 254 (549)
Q Consensus 180 v~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g 254 (549)
|++++++.+.+..|+|||++ +++|..++... .......++.++.||+.||.|||++|||||||||+||||+.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 56777766432 2345677889999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~ 334 (549)
.+||+|||+++.+..... ....+.+||+.|+|||++.+..
T Consensus 305 ~vkL~DFGla~~~~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 344 (501)
T PHA03210 305 KIVLGDFGTAMPFEKERE----------------------------------------AFDYGWVGTVATNSPEILAGDG 344 (501)
T ss_pred CEEEEeCCCceecCcccc----------------------------------------cccccccCCcCCCCchhhcCCC
Confidence 999999999986532110 0012468999999999999999
Q ss_pred CCcccccchhhHHHHHHhhCCCCCCCCC---chhhhhhhhhccc--cccCCC--------------------------Cc
Q 038137 335 YGMECDWWSLGAIMYEMLVGYPPFYSDE---PMSTCRKIVNWRT--HLKFPE--------------------------EA 383 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~G~~PF~~~~---~~~~~~~I~~~~~--~l~~p~--------------------------~~ 383 (549)
|+.++|||||||+||||++|..|+.+.. +...+.+++.... ...+|. ..
T Consensus 345 ~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 424 (501)
T PHA03210 345 YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL 424 (501)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc
Confidence 9999999999999999999876543322 2222222222100 001111 12
Q ss_pred CCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 384 KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 384 ~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
.++.++.++|.+||+ ||.+|+ ++.|++.||||....++.+.
T Consensus 425 ~~~~~~~~li~kmL~~DP~~Rp---sa~elL~hp~f~~~~~~~~~ 466 (501)
T PHA03210 425 GLPADFEYPLVKMLTFDWHLRP---GAAELLALPLFSAEEEEEIL 466 (501)
T ss_pred CCChHHHHHHHHHhccCcccCc---CHHHHhhChhhhcCCchHHH
Confidence 356788999999999 999999 89999999999988766654
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=351.63 Aligned_cols=258 Identities=31% Similarity=0.513 Sum_probs=211.8
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeee----
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSF---- 186 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f---- 186 (549)
.....++|++++.||+|+||.||+|.++.+++.||+|++.... .....+.+|..++..+ +||||+++++++
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3446789999999999999999999999999999999886532 1234577899999998 799999999987
Q ss_pred -cCCceEEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeec
Q 038137 187 -QDDEYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 187 -~d~~~lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DF 261 (549)
++...+|+||||++||+|..++.. ...+++..++.++.|++.||.|||+++|+||||||+||+++.+|.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 355789999999999999988742 357899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCC
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYG 336 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~ 336 (549)
|+++.+...... ....+||+.|+|||++. +..|+
T Consensus 169 g~~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~ 207 (286)
T cd06638 169 GVSAQLTSTRLR-----------------------------------------RNTSVGTPFWMAPEVIACEQQLDSTYD 207 (286)
T ss_pred CceeecccCCCc-----------------------------------------cccccCCCcccChhhhchhhhcccccc
Confidence 998865321100 01347999999999985 35589
Q ss_pred cccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 337 MECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
.++|||||||++|||++|++||..........++.... .........++..+.+||.+||+ +|++|+ ++.||++|
T Consensus 208 ~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~ 283 (286)
T cd06638 208 ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRP---TVSDLLQH 283 (286)
T ss_pred chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-CCcccCCCCcCHHHHHHHHHHccCCcccCC---CHHHHhhc
Confidence 99999999999999999999998776544443333221 11121223567899999999999 999999 89999999
Q ss_pred Ccc
Q 038137 416 PWF 418 (549)
Q Consensus 416 pfF 418 (549)
|||
T Consensus 284 ~~~ 286 (286)
T cd06638 284 VFI 286 (286)
T ss_pred ccC
Confidence 997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=371.09 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=209.7
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKAT-----GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSF 186 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 186 (549)
.+..++|++.+.||+|+||.||+|++..+ +..||||++..... ......+.+|+.+|+.+ +|+|||+++++|
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 45567899999999999999999986544 35799999976432 23456788999999999 899999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhc-------------------------------------------------------
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRK------------------------------------------------------- 211 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~------------------------------------------------------- 211 (549)
.+...+|+|||||++|+|.+++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999999999988542
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 212 ---------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 212 ---------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--- 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--- 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce---
Confidence 24788999999999999999999999999999999999999999999999999865321000
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~ 355 (549)
.......+++.|||||++.+..|+.++|||||||++|||++ |.
T Consensus 269 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~ 312 (374)
T cd05106 269 ------------------------------------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312 (374)
T ss_pred ------------------------------------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 00012345678999999999999999999999999999997 99
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+||.+........+++........| ..++++++++|.+||+ ||.+|+ ++++|.+
T Consensus 313 ~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RP---s~~~l~~ 367 (374)
T cd05106 313 SPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERP---TFSQISQ 367 (374)
T ss_pred CCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9998876555555555432223333 3578999999999999 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=364.67 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=209.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.++..++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 477999999999999999999999999999999986532 2233445677899999999999999999988744
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||+. ++|...+... +++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999995 5788877543 99999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
... .....||+.|+|||++.+..++.++|+|||||++|
T Consensus 171 ~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 208 (353)
T cd07850 171 SFM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (353)
T ss_pred CCC------------------------------------------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHH
Confidence 100 11347899999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhcccc----------------------------------ccCCC-----CcCCChhHH
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTH----------------------------------LKFPE-----EAKLSPEAK 390 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~----------------------------------l~~p~-----~~~~s~~~~ 390 (549)
+|++|+.||.+.+....+.+++..... ..+|. ....+++++
T Consensus 209 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
T cd07850 209 EMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288 (353)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHH
Confidence 999999999887765555444321000 00110 112466789
Q ss_pred HHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 391 dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
+||.+||+ ||.+|+ ++.|++.||||+
T Consensus 289 ~li~~~L~~dP~~R~---t~~eiL~~~~~~ 315 (353)
T cd07850 289 DLLSKMLVIDPEKRI---SVDDALQHPYIN 315 (353)
T ss_pred HHHHHHcCCChhhCc---CHHHHhcChhHh
Confidence 99999999 999999 899999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=346.17 Aligned_cols=255 Identities=32% Similarity=0.539 Sum_probs=216.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+|..+++.++||||+++++++.+...+|+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999997643 22456788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||++|++|..++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.+|.+||+|||++..+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999999998765 7899999999999999999999999999999999999999999999999999876531100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC---CCCcccccchhhHHHHHH
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~---~y~~~~DiWSlGvilyEm 351 (549)
.....+|+..|+|||++.+. .++.++|+|||||++|||
T Consensus 157 ---------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 157 ---------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197 (262)
T ss_pred ---------------------------------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHH
Confidence 00135789999999999877 889999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhcccc-ccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTH-LKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~-l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
++|.+||...++......+...... ........++.++.+||.+||+ +|..|+ ++.+|+.|||
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~~~ 262 (262)
T cd06613 198 AELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP---TATKLLQHPF 262 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCC---CHHHHhcCCC
Confidence 9999999887665554444332101 1111123567899999999999 999999 8999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.06 Aligned_cols=255 Identities=32% Similarity=0.505 Sum_probs=211.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeec-----
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQ----- 187 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~----- 187 (549)
.....|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||++++++|.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34578999999999999999999999999999999986542 2345678899999888 7999999999985
Q ss_pred -CCceEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 188 -DDEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 188 -d~~~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
....+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 35689999999999999999865 346899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCccc
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMEC 339 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~ 339 (549)
........ .....+|++.|+|||++. +..|+.++
T Consensus 169 ~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~ 207 (282)
T cd06636 169 AQLDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDYRS 207 (282)
T ss_pred hhhhcccc-----------------------------------------CCCcccccccccCHhhcCcccCcCcCCCccc
Confidence 75431100 001457999999999986 35688999
Q ss_pred ccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 340 DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|+|||||++|||++|.+||....+......+... ..... ....++.++.+||.+||. ||.+|+ ++.||+.||||
T Consensus 208 DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp---~~~ell~~~~~ 282 (282)
T cd06636 208 DIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKL-KSKKWSKKFIDFIEGCLVKNYLSRP---STEQLLKHPFI 282 (282)
T ss_pred chhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC-CCCCC-cccccCHHHHHHHHHHhCCChhhCc---CHHHHhcCCCC
Confidence 9999999999999999999876655444433321 11111 123578999999999999 999999 89999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.37 Aligned_cols=257 Identities=31% Similarity=0.524 Sum_probs=213.4
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCC---
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDD--- 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~--- 189 (549)
...++|++.+.||+|+||.||+|..+.+++.||+|++.... .....+.+|..++..+ +||||++++++|...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 34788999999999999999999999999999999986542 2234577899999888 899999999988643
Q ss_pred --ceEEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 190 --EYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 190 --~~lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 468999999999999998753 45799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-----CCCcc
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-----GYGME 338 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-----~y~~~ 338 (549)
+..+...... ....+|++.|+|||++... .++.+
T Consensus 175 ~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 213 (291)
T cd06639 175 SAQLTSTRLR-----------------------------------------RNTSVGTPFWMAPEVIACEQQYDYSYDAR 213 (291)
T ss_pred chhccccccc-----------------------------------------ccCccCCccccChhhhcCCCCcccccCCc
Confidence 8865321100 0134789999999998643 36899
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
+|+|||||++|||++|++||...++......+..+. ...+.....++.++++||.+||. +|++|+ ++.+|+.|||
T Consensus 214 ~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~ 289 (291)
T cd06639 214 CDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARP---SVTHLLEHPF 289 (291)
T ss_pred cchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC-CCCCCcccccCHHHHHHHHHHhhcChhhCc---CHHHHhcCcc
Confidence 999999999999999999998877666655554432 12222223577899999999999 999999 8999999999
Q ss_pred cc
Q 038137 418 FK 419 (549)
Q Consensus 418 F~ 419 (549)
|+
T Consensus 290 ~~ 291 (291)
T cd06639 290 IK 291 (291)
T ss_pred cC
Confidence 95
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=356.63 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=215.3
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--ceE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--EYL 192 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~l 192 (549)
..++|++++.||+|+||.||+|.++.+|..||+|++..... .......+.+|+.++..++|+||+++++++.+. +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999875432 222233466799999999999999999998755 579
Q ss_pred EEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.+|.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 578888765 4679999999999999999999999999999999999999999999999999988653210
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 350 (549)
. ......+++.|+|||++.+ ..++.++|+|||||++||
T Consensus 163 ~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 163 K-----------------------------------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred C-----------------------------------------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHH
Confidence 0 0012356889999999876 568999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccc-----------------cccCCCC---------cCCChhHHHHHHHhhh-ccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRT-----------------HLKFPEE---------AKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~-----------------~l~~p~~---------~~~s~~~~dLI~~lL~-dp~~R 403 (549)
|++|++||.+.+....+..+.+... ...++.. ..+++++.|||.+||+ ||++|
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhC
Confidence 9999999998888777766654211 0111110 1358999999999999 99999
Q ss_pred CCCCCHHHHHcCCcccCC
Q 038137 404 LGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 404 l~~~~~~eil~HpfF~~i 421 (549)
+ ++++++.||||++.
T Consensus 282 ~---t~~~il~h~~f~~~ 296 (309)
T cd07845 282 A---TAEEALESSYFKEK 296 (309)
T ss_pred c---CHHHHhcChhhccC
Confidence 9 89999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.13 Aligned_cols=258 Identities=30% Similarity=0.498 Sum_probs=208.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHH-HHhcCCCceeeeeeeecCCceEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL-LAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
++|++++.||+|+||.||+|.++.+|+.||||++.+... .... ..+..|..+ ++..+||||+++++++.++..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 579999999999999999999999999999999976532 1222 334445554 6677999999999999999999999
Q ss_pred EeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 196 MEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKH-NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 196 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
|||++ |+|..++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 677777643 35799999999999999999999997 9999999999999999999999999998764311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc----CCCCcccccchhhH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK----KGYGMECDWWSLGA 346 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~----~~y~~~~DiWSlGv 346 (549)
.. .....||..|+|||++.+ .+++.++|+|||||
T Consensus 158 ~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 195 (283)
T cd06617 158 VA------------------------------------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195 (283)
T ss_pred cc------------------------------------------cccccCCccccChhhcCCcccccccCccccchhhHH
Confidence 00 012468999999999865 56789999999999
Q ss_pred HHHHHhhCCCCCCCC-CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 347 IMYEMLVGYPPFYSD-EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 347 ilyEml~G~~PF~~~-~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
++|+|++|+.||... ...+....++.. ....+|. ..+|.++.+||.+||. +|.+|+ ++++|+.||||....+.
T Consensus 196 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 196 TMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPA-EKFSPEFQDFVNKCLKKNYKERP---NYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCCc-cccCHHHHHHHHHHccCChhhCc---CHHHHhcCchhhhcccc
Confidence 999999999999653 222333333331 2233332 2578999999999998 999999 89999999999876544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=351.65 Aligned_cols=257 Identities=31% Similarity=0.509 Sum_probs=215.4
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999976542 23445678899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 198 YLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 198 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|+ |++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.+|.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999854 46799999999999999999999999999999999999999999999999999886542110
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~ 355 (549)
......+||..|+|||++.+. .++.++|||||||++|||++|.
T Consensus 155 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (286)
T cd07832 155 ------------------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198 (286)
T ss_pred ------------------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence 001134799999999998764 4699999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccc-----------------cccCCCC---------cCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRT-----------------HLKFPEE---------AKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~-----------------~l~~p~~---------~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
+||.+.+....+..++..-. ...++.. ..++.++.+||.+||. +|.+|+ +
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~ 275 (286)
T cd07832 199 PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL---S 275 (286)
T ss_pred cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC---C
Confidence 99988776665555443110 1111111 2457899999999999 999999 8
Q ss_pred HHHHHcCCccc
Q 038137 409 ADEIKAHPWFK 419 (549)
Q Consensus 409 ~~eil~HpfF~ 419 (549)
+++++.||||.
T Consensus 276 ~~~~l~h~~~~ 286 (286)
T cd07832 276 AAEALRHPYFT 286 (286)
T ss_pred HHHHhhCcCcC
Confidence 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=350.38 Aligned_cols=274 Identities=41% Similarity=0.732 Sum_probs=227.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylV 195 (549)
++|.+.+.||+|+||.||+|.++.+|..||+|++.+..+........+..|..++..+. ||||++++++|.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998866555555677889999999998 99999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++|++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|+++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987643221100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
..... . .+. .... .........+|+..|+|||++....++.++|+|||||++|+|++|.
T Consensus 161 ~~~~~-----~--~~~--~~~~------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~ 219 (280)
T cd05581 161 NKGDA-----T--NID--SQIE------------KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219 (280)
T ss_pred CCCCC-----c--ccc--cccc------------ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 00000 0 000 0000 0001122567999999999999888999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCH----HHHHcCCcc
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA----DEIKAHPWF 418 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~----~eil~HpfF 418 (549)
+||...+....+..+.. ....+|. .+++.+.+||.+||. +|.+|+ ++ +++++||||
T Consensus 220 ~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~---~~~~~~~~ll~~~~~ 280 (280)
T cd05581 220 PPFRGSNEYLTFQKILK--LEYSFPP--NFPPDAKDLIEKLLVLDPQDRL---GVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccHHHHHHHHHh--cCCCCCC--ccCHHHHHHHHHHhcCCHhhCC---CcccCHHHHhcCCCC
Confidence 99998876666666653 3334443 678999999999999 999999 78 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=358.63 Aligned_cols=274 Identities=29% Similarity=0.468 Sum_probs=228.0
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechh----hhchhhHHHHHHHHHHHHhcCCCceeeeee
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE----MLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 184 (549)
+..+....++|-++.+||+|||++||+|.+....+.||+|+-.-.. -.+.+..+|..+|.+|.+.++||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 4566777889999999999999999999999999999999854321 123456789999999999999999999999
Q ss_pred eec-CCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCCCCCeEEcC---CCcEEE
Q 038137 185 SFQ-DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH--NYIHRDIKPDNLLLDR---NGHMKL 258 (549)
Q Consensus 185 ~f~-d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--giiHRDLKPeNILld~---~g~vKL 258 (549)
+|. |.+.+|-|+|||+|.||..+|.....++|.+|+.++.||+.||.||... .|||-||||.||||.. -|.|||
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 987 7788999999999999999999999999999999999999999999975 5999999999999954 478999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc----CC
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK----KG 334 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~----~~ 334 (549)
+||||++.++...... .+|. .++....||.||++||.+.- ..
T Consensus 615 TDFGLSKIMdddSy~~--------------vdGm--------------------eLTSQgAGTYWYLPPEcFvVgkePPK 660 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNS--------------VDGM--------------------ELTSQGAGTYWYLPPECFVVGKEPPK 660 (775)
T ss_pred eecchhhhccCCccCc--------------ccce--------------------eeecccCceeeecCcceeecCCCCCc
Confidence 9999999886432110 0110 12234689999999999873 24
Q ss_pred CCcccccchhhHHHHHHhhCCCCCCCCCchh---hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHH
Q 038137 335 YGMECDWWSLGAIMYEMLVGYPPFYSDEPMS---TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~G~~PF~~~~~~~---~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 410 (549)
.+.++||||+|||+|.+|.|+-||..+-... ...-|++. ..+.||..+.+|++|++||++||+ .-++|. ++.
T Consensus 661 IsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA-tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~---DV~ 736 (775)
T KOG1151|consen 661 ISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA-TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI---DVQ 736 (775)
T ss_pred cccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc-eeccCCCCCccCHHHHHHHHHHHHhhhhhhh---hHH
Confidence 6899999999999999999999997653322 12223432 467899888999999999999999 888998 899
Q ss_pred HHHcCCcccC
Q 038137 411 EIKAHPWFKG 420 (549)
Q Consensus 411 eil~HpfF~~ 420 (549)
++-.||||..
T Consensus 737 qLA~dpyllP 746 (775)
T KOG1151|consen 737 QLACDPYLLP 746 (775)
T ss_pred HHccCccccc
Confidence 9999999963
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=355.34 Aligned_cols=259 Identities=31% Similarity=0.503 Sum_probs=215.8
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML--RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
+|++++.||+|+||.||+|.+..+|+.||||.+...... .......+..|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999999999999999876543 123345577899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||+ +|+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||+++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 9999 999999997765 8999999999999999999999999999999999999999999999999999865421100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+++.|+|||++.+ ..++.++|+|||||++|||++
T Consensus 159 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 159 ----------------------------------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred ----------------------------------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc
Confidence 012357889999999865 567999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhcccc------------------ccCCC------CcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTH------------------LKFPE------EAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~------------------l~~p~------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
|.+||.+.+....+.++...... ...+. ...++.++.+||.+||. +|.+|+ +
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~---s 275 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI---T 275 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc---C
Confidence 99999887766655555321000 00000 02457899999999999 999999 8
Q ss_pred HHHHHcCCcccCC
Q 038137 409 ADEIKAHPWFKGI 421 (549)
Q Consensus 409 ~~eil~HpfF~~i 421 (549)
+.|++.||||.+.
T Consensus 276 ~~e~l~~~~~~~~ 288 (298)
T cd07841 276 ARQALEHPYFSND 288 (298)
T ss_pred HHHHhhCccccCC
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=344.40 Aligned_cols=260 Identities=31% Similarity=0.486 Sum_probs=220.9
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|.+.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++++.+.+.+|+|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 488899999999999999999999999999999866432 4567889999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|+++++|.+++.....+++..++.++.+++.||.|||+.||+||||+|+||+++.++.+||+|||++...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~-- 157 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG-- 157 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc--
Confidence 999999999998877899999999999999999999999999999999999999999999999999887642211000
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC---CCcccccchhhHHHHHHhhC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~---y~~~~DiWSlGvilyEml~G 354 (549)
.......|++.|+|||++.+.. ++.++|+|||||++|+|++|
T Consensus 158 -----------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g 202 (264)
T cd06626 158 -----------------------------------EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202 (264)
T ss_pred -----------------------------------ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhC
Confidence 0011356889999999998766 89999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
++||...+........+.......+|....+++.+.+||.+||. +|.+|+ ++.+|+.|||+
T Consensus 203 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---~~~~i~~~~~~ 264 (264)
T cd06626 203 KRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPFV 264 (264)
T ss_pred CCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC---CHHHHhcCCCC
Confidence 99997654333222222223445566655679999999999998 999999 89999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=345.59 Aligned_cols=259 Identities=30% Similarity=0.530 Sum_probs=218.2
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechh--hhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--ceE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE--MLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--EYL 192 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~l 192 (549)
.+|++.+.||+|+||.||+|.++.+|+.||||.+.... .........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999885432 11234456788999999999999999999998764 568
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998778899999999999999999999999999999999999999999999999999986532100
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.. .......||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 ~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 203 (264)
T cd06653 162 SG--------------------------------------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203 (264)
T ss_pred cC--------------------------------------ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence 00 0001356899999999999988999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF 418 (549)
+|++||..........++........+|. .+++++.++|.+||.+|..|+ ++.+++.|||.
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~~i~~~l~~~~~r~---~~~~~~~~~~~ 264 (264)
T cd06653 204 TEKPPWAEYEAMAAIFKIATQPTKPMLPD--GVSDACRDFLKQIFVEEKRRP---TAEFLLRHPFV 264 (264)
T ss_pred hCCCCCCccCHHHHHHHHHcCCCCCCCCc--ccCHHHHHHHHHHhcCcccCc---cHHHHhcCCCC
Confidence 99999987766665555554333333443 789999999999999888888 89999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=343.09 Aligned_cols=253 Identities=32% Similarity=0.540 Sum_probs=220.1
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|+++++||.|+||.||+++...+++.+|+|.+..... .......+.+|+.+|+.++|+||++++++|.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999875543 23445668899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999664 5689999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+||+.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 157 --------------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08221 157 --------------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198 (256)
T ss_pred --------------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCC
Confidence 011357999999999999888999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
.||...+..+....+.... +. +....++.++.++|.+||+ +|.+|+ ++.++++|||+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~i~~~l~~~p~~R~---s~~~ll~~~~l 256 (256)
T cd08221 199 RTFDATNPLNLVVKIVQGN--YT-PVVSVYSSELISLVHSLLQQDPEKRP---TADEVLDQPLL 256 (256)
T ss_pred CCCCCCCHHHHHHHHHcCC--CC-CCccccCHHHHHHHHHHcccCcccCC---CHHHHhhCcCC
Confidence 9999888777777776422 11 1124678999999999998 999998 89999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.20 Aligned_cols=254 Identities=33% Similarity=0.569 Sum_probs=216.6
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM--LRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
+|+..+.||+|+||+||+|....++..||+|.+..... ........+.+|+.+++.++|+||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36777899999999999999998999999999876432 1233456788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999887889999999999999999999999999999999999999999999999999987653211
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-CCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEml~G 354 (549)
......|++.|+|||.+.... ++.++|+|||||++|+|++|
T Consensus 157 --------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g 198 (258)
T cd06632 157 --------------------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198 (258)
T ss_pred --------------------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 001357899999999998776 99999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
.+||..........++........+| ..+++++++||.+||+ +|.+|+ ++.+++.|||+
T Consensus 199 ~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~~~~ 258 (258)
T cd06632 199 KPPWSQLEGVAAVFKIGRSKELPPIP--DHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPFV 258 (258)
T ss_pred CCCcccCcHHHHHHHHHhcccCCCcC--CCcCHHHHHHHHHHhhcCcccCc---CHHHHhcCCCC
Confidence 99997766544444443322222333 3678999999999999 999998 89999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=347.84 Aligned_cols=253 Identities=17% Similarity=0.280 Sum_probs=210.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
+...+|++.+.||+|+||.||+|..+ ..+..||+|.++... .......+.+|..++..++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34567999999999999999999875 456789999987542 2334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999998764 5799999999999999999999999999999999999999999999999998764321
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.... ......+|+.|+|||++.+..++.++|+|||||++|
T Consensus 160 ~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 199 (266)
T cd05064 160 EAIY----------------------------------------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMW 199 (266)
T ss_pred cchh----------------------------------------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHH
Confidence 1000 001234677899999999999999999999999999
Q ss_pred HHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 350 EMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 350 Eml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||++ |.+||.+.+.......+... ...|....++..+.++|.+|+. +|.+|+ ++++|++
T Consensus 200 ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~RP---~~~~i~~ 260 (266)
T cd05064 200 EVMSYGERPYWDMSGQDVIKAVEDG---FRLPAPRNCPNLLHQLMLDCWQKERGERP---RFSQIHS 260 (266)
T ss_pred HHhcCCCCCcCcCCHHHHHHHHHCC---CCCCCCCCCCHHHHHHHHHHcCCCchhCC---CHHHHHH
Confidence 9774 99999988776666655432 2233344788999999999999 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=341.93 Aligned_cols=253 Identities=27% Similarity=0.518 Sum_probs=218.9
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++++.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999999765432 3344678899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--- 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence 99999999988653 3589999999999999999999999999999999999999999999999999876532100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
......|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08218 157 --------------------------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198 (256)
T ss_pred --------------------------------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCC
Confidence 001346899999999999989999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
.||...+..+...+++.. .....| ..++.++.++|.+||. +|.+|+ ++.+|+.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~vl~~~~~ 256 (256)
T cd08218 199 HAFEAGNMKNLVLKIIRG-SYPPVS--SHYSYDLRNLVSQLFKRNPRDRP---SVNSILEKNFI 256 (256)
T ss_pred CCccCCCHHHHHHHHhcC-CCCCCc--ccCCHHHHHHHHHHhhCChhhCc---CHHHHhhCcCC
Confidence 999887777776666542 222233 3678999999999999 999999 89999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=351.49 Aligned_cols=257 Identities=33% Similarity=0.519 Sum_probs=209.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCce----
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEY---- 191 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~---- 191 (549)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999986542 22333456788999999995 6999999999987665
Q ss_pred -EEEEEeecCCCchhhHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-CCcEEEeecCcc
Q 038137 192 -LYLIMEYLPGGDMMTLLMRK-----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLC 264 (549)
Q Consensus 192 -lylVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-~g~vKL~DFGla 264 (549)
+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 788887542 35899999999999999999999999999999999999999 899999999998
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccch
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 343 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWS 343 (549)
+.+..... .....++++.|+|||++.+ ..++.++|+||
T Consensus 159 ~~~~~~~~-----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 197 (295)
T cd07837 159 RAFSIPVK-----------------------------------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197 (295)
T ss_pred eecCCCcc-----------------------------------------ccCCcccccCCCChHHhhCCCCCCchHHHHH
Confidence 76532100 0012367899999999875 56799999999
Q ss_pred hhHHHHHHhhCCCCCCCCCchhhhhhhhhcccc---------------ccCCC---------CcCCChhHHHHHHHhhh-
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTH---------------LKFPE---------EAKLSPEAKDLISKLLC- 398 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~---------------l~~p~---------~~~~s~~~~dLI~~lL~- 398 (549)
|||++|+|++|.+||.+.+....+.++...... ..+|. ...+++++.+||.+||.
T Consensus 198 lG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 277 (295)
T cd07837 198 VGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY 277 (295)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccC
Confidence 999999999999999988776665555431100 00110 02578999999999999
Q ss_pred cccccCCCCCHHHHHcCCccc
Q 038137 399 NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 399 dp~~Rl~~~~~~eil~HpfF~ 419 (549)
||.+|+ ++.|++.||||+
T Consensus 278 ~P~~R~---~~~eil~~~~~~ 295 (295)
T cd07837 278 DPAKRI---SAKAALTHPYFD 295 (295)
T ss_pred ChhhcC---CHHHHhcCCCcC
Confidence 999999 899999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=343.50 Aligned_cols=257 Identities=31% Similarity=0.542 Sum_probs=220.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||.|+||.||+|.+..+|+.||+|++...... .....+.+|+.++..++|+||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4799999999999999999999999999999998765421 34567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.+|.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 999999999999888899999999999999999999999 99999999999999999999999999998865421100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....|+..|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 ---------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~ 197 (264)
T cd06623 157 ---------------------------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197 (264)
T ss_pred ---------------------------------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 01346899999999999999999999999999999999999
Q ss_pred CCCCCCC---chhhhhhhhhccccccCCCCcC-CChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 356 PPFYSDE---PMSTCRKIVNWRTHLKFPEEAK-LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 356 ~PF~~~~---~~~~~~~I~~~~~~l~~p~~~~-~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+||.... .......+.. ......+ .. ++..+.++|.+||. +|.+|+ ++.+++.||||+.++
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~---~~~~ll~~~~~~~~~ 263 (264)
T cd06623 198 FPFLPPGQPSFFELMQAICD-GPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKKAD 263 (264)
T ss_pred CCCccccccCHHHHHHHHhc-CCCCCCC--cccCCHHHHHHHHHHccCChhhCC---CHHHHHhCHHHHhcc
Confidence 9998774 2333333332 1122222 24 78999999999999 999999 899999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=351.61 Aligned_cols=255 Identities=31% Similarity=0.507 Sum_probs=211.0
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++++.||.|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58999999999999999999999999999999865432 23334568889999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++ ++|..++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.+||+|||++..+.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 995 688888754 45789999999999999999999999999999999999999999999999999876532100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-CCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEml~G 354 (549)
......+++.|+|||++.+.. ++.++|+|||||++|||++|
T Consensus 156 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 156 --------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred --------------------------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 001236789999999987644 68999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccc----------------cCCC---------CcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHL----------------KFPE---------EAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l----------------~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
+.||.+.+......+++...... .++. ...+++++++||.+||+ ||.+|+ +
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t 274 (284)
T cd07860 198 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI---S 274 (284)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC---C
Confidence 99998877655554444321100 1111 12478999999999999 999999 8
Q ss_pred HHHHHcCCcc
Q 038137 409 ADEIKAHPWF 418 (549)
Q Consensus 409 ~~eil~HpfF 418 (549)
+++++.||||
T Consensus 275 ~~~~l~~~~f 284 (284)
T cd07860 275 AKAALAHPFF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=350.18 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=206.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||.|+||.||+|.++.+++.||||.+..... ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875431 22234467899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||+++ +|.+++.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++........
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 999974 899888653 57899999999999999999999999999999999999999999999999998754211000
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
....++++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 160 ----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 160 ----------------------------------------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred ----------------------------------------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 012357889999999876 568999999999999999999
Q ss_pred CCCCCCCCC-chhhhhhhhhc---------c--------ccccCC----C-----CcCCC--hhHHHHHHHhhh-ccccc
Q 038137 354 GYPPFYSDE-PMSTCRKIVNW---------R--------THLKFP----E-----EAKLS--PEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 354 G~~PF~~~~-~~~~~~~I~~~---------~--------~~l~~p----~-----~~~~s--~~~~dLI~~lL~-dp~~R 403 (549)
|++||.+.. ..+....+... . ....++ . ...++ .++.++|.+||+ +|.+|
T Consensus 200 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 279 (291)
T cd07844 200 GRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKR 279 (291)
T ss_pred CCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccc
Confidence 999997655 22222211110 0 000000 0 01344 889999999999 99999
Q ss_pred CCCCCHHHHHcCCcc
Q 038137 404 LGTKGADEIKAHPWF 418 (549)
Q Consensus 404 l~~~~~~eil~HpfF 418 (549)
+ ++.+++.||||
T Consensus 280 p---s~~e~l~~~~f 291 (291)
T cd07844 280 I---SAAEAMKHPYF 291 (291)
T ss_pred c---CHHHHhcCCCC
Confidence 9 79999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=352.86 Aligned_cols=263 Identities=28% Similarity=0.442 Sum_probs=211.7
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lyl 194 (549)
.++|+.++.||+|+||.||+|.+..+|+.||||.+.+.... .....+.+|..++..+. ||||+++++++.++...|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 45778888999999999999999999999999998765322 34456888999999886 9999999999999999999
Q ss_pred EEeecCCCchhhHh---h--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 195 IMEYLPGGDMMTLL---M--RKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 195 VmEy~~gg~L~~~l---~--~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
||||+.+ ++..+. . ....+++..+..++.+++.||+|||+ .||+||||||+|||++.+|.+||+|||+++.+.
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999854 544432 1 24679999999999999999999997 599999999999999999999999999987643
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC---CCCcccccchhh
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLG 345 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~---~y~~~~DiWSlG 345 (549)
.... .....||+.|+|||++.+. .++.++||||||
T Consensus 160 ~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG 197 (288)
T cd06616 160 DSIA------------------------------------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG 197 (288)
T ss_pred cCCc------------------------------------------cccccCccCccCHHHhccccccCCcchhhhhHHH
Confidence 2110 0134689999999999876 689999999999
Q ss_pred HHHHHHhhCCCCCCCCCc-hhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 346 AIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~-~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|++|||++|++||..... .+...++... ....++. ...++.++.+||.+||. +|.+|+ ++++|+.||||+..
T Consensus 198 ~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~i~~~~~~~~~ 273 (288)
T cd06616 198 ITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRP---KYKELLEHPFIKDY 273 (288)
T ss_pred HHHHHHHhCCCCchhcchHHHHHhhhcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCc---CHHHHhcChhhhch
Confidence 999999999999976542 1222222221 1112221 23588999999999999 999999 89999999999987
Q ss_pred Cccccc
Q 038137 422 EWDKLY 427 (549)
Q Consensus 422 ~w~~l~ 427 (549)
.|.+..
T Consensus 274 ~~~~~~ 279 (288)
T cd06616 274 EERNVD 279 (288)
T ss_pred hhcchh
Confidence 766543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=341.11 Aligned_cols=252 Identities=30% Similarity=0.564 Sum_probs=217.9
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++++.||+|+||.||+|.+..+++.||+|.+....+ .......+.+|+.+|+.++||||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 48999999999999999999999999999999976543 33456778899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeecCcccccCCCCccc
Q 038137 198 YLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 198 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~~~~~~~~ 274 (549)
|++|++|.+++... ..+++..+..++.+++.||.|||++||+||||+|+||+++.++ .+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999663 4589999999999999999999999999999999999998655 579999999986532110
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
....+|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~ 197 (256)
T cd08220 158 ----------------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL 197 (256)
T ss_pred ----------------------------------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence 0134789999999999988899999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
+.||.+.+.......+... ....+| ..++++++++|.+||. +|.+|+ ++.|+++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---t~~~ll~~p~~ 256 (256)
T cd08220 198 KRAFEAANLPALVLKIMSG-TFAPIS--DRYSPDLRQLILSMLNLDPSKRP---QLSQIMAQPIC 256 (256)
T ss_pred CCCcccCchHHHHHHHHhc-CCCCCC--CCcCHHHHHHHHHHccCChhhCC---CHHHHhhCCCC
Confidence 9999888776666666542 222333 3689999999999998 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.55 Aligned_cols=255 Identities=22% Similarity=0.380 Sum_probs=214.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCC-----cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATG-----HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+..++|++++.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34568999999999999999999986655 689999986542 23344568899999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR 252 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~ 252 (549)
....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999998654 45888999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc
Q 038137 253 NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332 (549)
Q Consensus 253 ~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~ 332 (549)
++.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY---------------------------------------RVQSKSLLPVRWMPPEAILY 200 (283)
T ss_pred CCcEEECCCcceeeccccccc---------------------------------------cccCCCcccccccCHHHhcc
Confidence 999999999999865321100 00013467899999999999
Q ss_pred CCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHH
Q 038137 333 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410 (549)
Q Consensus 333 ~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 410 (549)
..++.++|||||||++|||++ |..||.+.+..+....|... .....| ..+++++.+||.+||+ ||.+|+ ++.
T Consensus 201 ~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~l~~~c~~~~p~~Rp---~~~ 274 (283)
T cd05048 201 GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR-QLLPCP--EDCPARVYALMIECWNEIPARRP---RFK 274 (283)
T ss_pred CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCc--ccCCHHHHHHHHHHccCChhhCc---CHH
Confidence 999999999999999999997 99999998877776666542 222233 4789999999999999 999999 799
Q ss_pred HHHcC
Q 038137 411 EIKAH 415 (549)
Q Consensus 411 eil~H 415 (549)
+|++|
T Consensus 275 ~i~~~ 279 (283)
T cd05048 275 DIHTR 279 (283)
T ss_pred HHHHH
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.07 Aligned_cols=258 Identities=35% Similarity=0.564 Sum_probs=214.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++|+||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 469999999999999999999999999999999876432 3334567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++++.+..++.+...+++..+..++.+|+.||.|||..|++||||+|+||+++.+|.+||+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~--- 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--- 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc---
Confidence 99998888777766678999999999999999999999999999999999999999999999999998875422100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+|++.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus 157 -------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 199 (288)
T cd07833 157 -------------------------------------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199 (288)
T ss_pred -------------------------------------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 01135789999999999987 8899999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccc-----------------cccCCC-----------CcCCChhHHHHHHHhhh-cccccCCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRT-----------------HLKFPE-----------EAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~-----------------~l~~p~-----------~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
+||.+.+..+....+..... ...++. ...+++++++||.+||. +|++|+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-- 277 (288)
T cd07833 200 PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL-- 277 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc--
Confidence 99987655443333221000 001110 11358999999999999 999999
Q ss_pred CCHHHHHcCCcc
Q 038137 407 KGADEIKAHPWF 418 (549)
Q Consensus 407 ~~~~eil~HpfF 418 (549)
++++++.||||
T Consensus 278 -s~~~il~~~~f 288 (288)
T cd07833 278 -TCDELLQHPYF 288 (288)
T ss_pred -cHHHHhcCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=347.60 Aligned_cols=255 Identities=29% Similarity=0.499 Sum_probs=216.7
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+++++.++||||+++++++.+...+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468889999999999999999999999999999876532 234566889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 197 EYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||++|++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.+|.++|+|||++..+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999765 789999999999999999999999 999999999999999999999999999987542110
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
.....|+..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 156 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 156 ----------------------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred ----------------------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 0025789999999999999999999999999999999999
Q ss_pred CCCCCCCC-----chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 355 YPPFYSDE-----PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 355 ~~PF~~~~-----~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
..||...+ .......+... .....|.. .+++++++||.+||+ +|.+|+ ++.+++.||||+..
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~~~~ 263 (265)
T cd06605 196 RFPYPPENDPPDGIFELLQYIVNE-PPPRLPSG-KFSPDFQDFVNLCLIKDPRERP---SYKELLEHPFIKKY 263 (265)
T ss_pred CCCCCccccccccHHHHHHHHhcC-CCCCCChh-hcCHHHHHHHHHHcCCCchhCc---CHHHHhhCchhhcc
Confidence 99997642 22233333332 22233321 278999999999999 999999 89999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=350.37 Aligned_cols=260 Identities=32% Similarity=0.496 Sum_probs=213.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||+|+||.||+|.++.+|+.||||.+..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999866432 2234456788999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-CCcEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-~g~vKL~DFGlak~~~~~~~~ 273 (549)
||++ ++|..++.... .+++..++.++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 9995 57887775543 3588999999999999999999999999999999999985 55799999999975432100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml 352 (549)
.....+|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 159 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~ 198 (294)
T PLN00009 159 ----------------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198 (294)
T ss_pred ----------------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 0013468899999999876 45799999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccc-------------------cCCC------CcCCChhHHHHHHHhhh-cccccCCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHL-------------------KFPE------EAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l-------------------~~p~------~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
+|.+||.+.+..+...++....... .++. ...++++++++|.+||+ +|++|+
T Consensus 199 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-- 276 (294)
T PLN00009 199 NQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI-- 276 (294)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc--
Confidence 9999998877666655554311100 0000 13578999999999999 999999
Q ss_pred CCHHHHHcCCcccCCC
Q 038137 407 KGADEIKAHPWFKGIE 422 (549)
Q Consensus 407 ~~~~eil~HpfF~~i~ 422 (549)
++.+++.||||.+++
T Consensus 277 -s~~~~l~~~~~~~~~ 291 (294)
T PLN00009 277 -TARAALEHEYFKDLG 291 (294)
T ss_pred -CHHHHhcCchHhHHh
Confidence 899999999998764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.49 Aligned_cols=243 Identities=37% Similarity=0.624 Sum_probs=209.9
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh-cCCCceeeeeeeecCCceEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE-VDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~ly 193 (549)
..++|++...+|.|+||.|..|.+..+++.+|+|++.+.. ....+|..++.. -+||||++++..+.+..++|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3677899999999999999999999999999999998762 123456655544 48999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE-cCCCcEEEeecCcccccCCCCc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL-DRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl-d~~g~vKL~DFGlak~~~~~~~ 272 (549)
+|||++.||.+.+.+.....+. ..+..++++|+.|+.|||.+|+|||||||+|||+ +..||++|+|||.++....+
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999998887766666 8888999999999999999999999999999999 69999999999998875421
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
..+.|-|..|.|||++...+|+.+|||||||++||+||
T Consensus 470 ------------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML 507 (612)
T KOG0603|consen 470 ------------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEML 507 (612)
T ss_pred ------------------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHH
Confidence 11457899999999999999999999999999999999
Q ss_pred hCCCCCCCCCch-hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 353 VGYPPFYSDEPM-STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 353 ~G~~PF~~~~~~-~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
+|++||.+.... ++..+|. ..+|. ..+|.+|+|||++||+ ||.+|+ ++.+|+.||||
T Consensus 508 ~G~tp~~~~P~~~ei~~~i~----~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl---~~~~i~~h~w~ 566 (612)
T KOG0603|consen 508 TGRTLFAAHPAGIEIHTRIQ----MPKFS--ECVSDEAKDLLQQLLQVDPALRL---GADEIGAHPWF 566 (612)
T ss_pred hCCCccccCCchHHHHHhhc----CCccc--cccCHHHHHHHHHhccCChhhCc---ChhhhccCcch
Confidence 999999877665 3333332 23333 4899999999999999 999999 79999999999
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.45 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=208.0
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCRE-----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSF 186 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 186 (549)
.+..++|++.+.||+|+||.||+|.. ..++..||+|+++.... ....+.+.+|+.+|..+ +|||||+++++|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34456899999999999999999974 35677899999975432 23345688999999999 899999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhcC------------------------------------------------------
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRKD------------------------------------------------------ 212 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~~------------------------------------------------------ 212 (549)
.+....|+|||||+||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999885421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 213 ---------------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 213 ---------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47888899999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. .......+++.|+|||++.+..|+.++|||||||++|||
T Consensus 269 ~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~el 309 (375)
T cd05104 269 NY---------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309 (375)
T ss_pred cc---------------------------------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHH
Confidence 00 000023466789999999999999999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++ |.+||.+........+++........| ...+.++++||.+||+ ||.+|+ ++.+|++
T Consensus 310 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RP---s~~eil~ 369 (375)
T cd05104 310 FSLGSSPYPGMPVDSKFYKMIKEGYRMLSP--ECAPSEMYDIMKSCWDADPLKRP---TFKQIVQ 369 (375)
T ss_pred HhcCCCCCCCCCchHHHHHHHHhCccCCCC--CCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 97 999998765554444444322222222 3568899999999999 999999 7888875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=341.27 Aligned_cols=249 Identities=31% Similarity=0.529 Sum_probs=213.6
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||.|+||.||+|.++.++..||+|.+.... .....+.+..|..+++.++||||++++++|.+...+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986543 23345678889999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|++||+|..++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 9999999998854 34689999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 156 --------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~ 197 (255)
T cd08219 156 --------------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197 (255)
T ss_pred --------------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhcc
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
+||.+.+.......+... .....| ..++..+++||.+||. ||.+|+ ++.+|+.-
T Consensus 198 ~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---~~~~il~~ 252 (255)
T cd08219 198 HPFQANSWKNLILKVCQG-SYKPLP--SHYSYELRSLIKQMFKRNPRSRP---SATTILSR 252 (255)
T ss_pred CCCCCCCHHHHHHHHhcC-CCCCCC--cccCHHHHHHHHHHHhCCcccCC---CHHHHhhc
Confidence 999987766666655542 122233 3688999999999999 999999 79998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=352.47 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=214.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
...|++++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||++++++|.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35599999999999999999999999999999999765444445556788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||++ |++.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 99997 466666643 567999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhhHHHHHH
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEm 351 (549)
....|++.|+|||++. ...++.++|||||||++|||
T Consensus 169 -----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 169 -----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred -----------------------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 0346889999999985 35689999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
++|.+||.+.+.......+... .....+. ..++.++++||.+||. +|.+|+ ++.+|+.||||..
T Consensus 208 ~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 272 (307)
T cd06607 208 AERKPPLFNMNAMSALYHIAQN-DSPTLSS-NDWSDYFRNFVDSCLQKIPQDRP---SSEELLKHRFVLR 272 (307)
T ss_pred HcCCCCCCCccHHHHHHHHhcC-CCCCCCc-hhhCHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcc
Confidence 9999999887766555444432 1222221 2468899999999999 999999 8999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=344.57 Aligned_cols=255 Identities=33% Similarity=0.517 Sum_probs=213.2
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCC----
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDD---- 189 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~---- 189 (549)
..++|++.+.||.|+||.||+|.++.+++.||+|++..... ....+.+|..++..+ +|+||++++++|.+.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35789999999999999999999999999999999876432 335688999999998 799999999999654
Q ss_pred --ceEEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 190 --EYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 190 --~~lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
..+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 459999999999999998854 35799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----CCCCcc
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----KGYGME 338 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----~~y~~~ 338 (549)
+........ ......||+.|+|||++.. ..++.+
T Consensus 160 ~~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 198 (275)
T cd06608 160 SAQLDSTLG-----------------------------------------RRNTFIGTPYWMAPEVIACDEQPDASYDAR 198 (275)
T ss_pred ceecccchh-----------------------------------------hhcCccccccccCHhHhcccccccCCcccc
Confidence 876532100 0013579999999999864 357889
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
+|+|||||+||+|++|++||..........++... .....+....++.++++||.+||. ||.+|+ ++++++.|||
T Consensus 199 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---t~~~ll~~~~ 274 (275)
T cd06608 199 SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-PPPTLKSPENWSKKFNDFISECLIKNYEQRP---FMEELLEHPF 274 (275)
T ss_pred ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-CCCCCCchhhcCHHHHHHHHHHhhcChhhCc---CHHHHhcCCC
Confidence 99999999999999999999876665555555432 112222223478899999999999 999999 8999999999
Q ss_pred c
Q 038137 418 F 418 (549)
Q Consensus 418 F 418 (549)
+
T Consensus 275 ~ 275 (275)
T cd06608 275 I 275 (275)
T ss_pred C
Confidence 6
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=365.24 Aligned_cols=264 Identities=29% Similarity=0.490 Sum_probs=211.9
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCC
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDD 189 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~ 189 (549)
..++....|++++.||+||.++||+|...+ ...||+|++.-.. .+...+.-+++|+.+|.++ .|.+||.||++-..+
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 345667789999999999999999998654 4567777664322 3445567799999999999 589999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+++||||||= ..||..+|.++.. ++.-.+++|..||++|+.++|.+||||.||||.|+|+- .|.+||+|||+|+.+.
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 9999999975 6799999977654 44468999999999999999999999999999999995 6899999999999775
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-----------CCc
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-----------YGM 337 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-----------y~~ 337 (549)
..... ....+.|||+.||+||.+.... .+.
T Consensus 511 ~DTTs---------------------------------------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r 551 (677)
T KOG0596|consen 511 PDTTS---------------------------------------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISR 551 (677)
T ss_pred ccccc---------------------------------------eeeccccCcccccCHHHHhhccccccCCCcceeecC
Confidence 33211 1123679999999999997533 468
Q ss_pred ccccchhhHHHHHHhhCCCCCCCCC-chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 338 ECDWWSLGAIMYEMLVGYPPFYSDE-PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 338 ~~DiWSlGvilyEml~G~~PF~~~~-~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
++||||||||||+|+.|++||..-. ...-+..|..-...++||.-+. ..++.++++.||. ||.+|+ ++.++|+|
T Consensus 552 ~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~---si~eLLqh 627 (677)
T KOG0596|consen 552 KSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRW---SIPELLQH 627 (677)
T ss_pred ccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCC---CcHHHhcC
Confidence 8999999999999999999996532 3333444554334557775322 2349999999999 999999 89999999
Q ss_pred CcccCC
Q 038137 416 PWFKGI 421 (549)
Q Consensus 416 pfF~~i 421 (549)
||...+
T Consensus 628 pFl~~~ 633 (677)
T KOG0596|consen 628 PFLQIQ 633 (677)
T ss_pred cccccc
Confidence 999754
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=359.31 Aligned_cols=257 Identities=32% Similarity=0.516 Sum_probs=213.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
.++|++++.||+|+||.||+|.+..+|..||||++.+.. ........+.+|+.+|+.++||||++++++|.++.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 577999999999999999999999999999999986532 22233456789999999999999999999998654
Q ss_pred -eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|+||||+ |++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 469999999 789988775 46799999999999999999999999999999999999999999999999999875431
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
.. ....||+.|+|||++.+ ..++.++|+|||||++
T Consensus 171 ~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll 206 (343)
T cd07880 171 EM--------------------------------------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206 (343)
T ss_pred Cc--------------------------------------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 10 13468999999999976 4689999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccc------------------cCC---------CCcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHL------------------KFP---------EEAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l------------------~~p---------~~~~~s~~~~dLI~~lL~-dp 400 (549)
|+|++|.+||.+.+....+.+++...... ..| ....+++++.++|.+||+ ||
T Consensus 207 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 286 (343)
T cd07880 207 AEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDA 286 (343)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCCh
Confidence 99999999998877655555443311100 000 013578899999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCC
Q 038137 401 EQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
.+|+ ++.+++.||||+...
T Consensus 287 ~~R~---t~~~~l~~~~~~~~~ 305 (343)
T cd07880 287 ESRI---TAAEALAHPYFEEFH 305 (343)
T ss_pred hhCC---CHHHHhcCccHhhhc
Confidence 9999 899999999998763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.04 Aligned_cols=264 Identities=28% Similarity=0.469 Sum_probs=214.7
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec----CCceE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ----DDEYL 192 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~----d~~~l 192 (549)
++|++.+.||.|+||.||+|.++.+|..||+|++.+... .......+.+|+.+|..++||||++++++|. +...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999976432 2334566788999999999999999998886 34579
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||+. |+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999998778899999999999999999999999999999999999999999999999999976532211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEm 351 (549)
.. .......+||..|+|||++.+ ..++.++|+|||||++|||
T Consensus 163 ~~-------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el 205 (334)
T cd07855 163 EH-------------------------------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205 (334)
T ss_pred CC-------------------------------------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHH
Confidence 00 000113579999999999876 5689999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhc------------------------cccccCCC---CcCCChhHHHHHHHhhh-ccccc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNW------------------------RTHLKFPE---EAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~------------------------~~~l~~p~---~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
++|++||.+.+.......+... ......+. ...++++++++|.+||+ +|.+|
T Consensus 206 ~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred HcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence 9999999877654433322210 00001110 12468999999999999 99999
Q ss_pred CCCCCHHHHHcCCcccCCC
Q 038137 404 LGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 404 l~~~~~~eil~HpfF~~i~ 422 (549)
+ ++++++.||||.+..
T Consensus 286 p---t~~~~l~~~~~~~~~ 301 (334)
T cd07855 286 I---TVEQALQHPFLAQYH 301 (334)
T ss_pred c---CHHHHHhChhhhhcc
Confidence 9 899999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=354.23 Aligned_cols=256 Identities=31% Similarity=0.558 Sum_probs=216.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.++..++||||+++++.|.+.+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34555678999999999999999999999999986532 233456889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++|++|..++. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+.....
T Consensus 99 e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---- 173 (292)
T cd06658 99 EFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---- 173 (292)
T ss_pred eCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc----
Confidence 9999999999874 45799999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.....+||+.|+|||++.+..++.++|+|||||++|||++|+.
T Consensus 174 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~ 216 (292)
T cd06658 174 -------------------------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216 (292)
T ss_pred -------------------------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0013579999999999999899999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||.+.+.......+... ....++....++..+.+||.+||+ +|.+|+ ++++|++||||+..
T Consensus 217 p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~~~il~~~~~~~~ 278 (292)
T cd06658 217 PYFNEPPLQAMRRIRDN-LPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLKLA 278 (292)
T ss_pred CCCCCCHHHHHHHHHhc-CCCccccccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhhcc
Confidence 99887766555544332 122223334678999999999999 999999 89999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=351.40 Aligned_cols=256 Identities=18% Similarity=0.318 Sum_probs=205.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcC----------------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKA----------------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~----------------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp 177 (549)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|..++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence 345789999999999999999998632 34579999987542 233456788999999999999
Q ss_pred ceeeeeeeecCCceEEEEEeecCCCchhhHhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCe
Q 038137 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK-------------------DTLTEEEARFYVGETVLAIESIHKHNY 238 (549)
Q Consensus 178 ~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~-------------------~~l~e~~~~~~~~qi~~aL~~LH~~gi 238 (549)
||++++++|.+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999999988543 236778899999999999999999999
Q ss_pred eecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeec
Q 038137 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST 318 (549)
Q Consensus 239 iHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 318 (549)
+||||||+|||++.+|.+||+|||+++.+...... ......
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---------------------------------------~~~~~~ 200 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---------------------------------------RIQGRA 200 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCcee---------------------------------------EecCcC
Confidence 99999999999999999999999999865321100 000134
Q ss_pred ccCCCCCCchhhccCCCCcccccchhhHHHHHHhh--CCCCCCCCCchhhhhhhhhcc----ccccCCCCcCCChhHHHH
Q 038137 319 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDEPMSTCRKIVNWR----THLKFPEEAKLSPEAKDL 392 (549)
Q Consensus 319 vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~--G~~PF~~~~~~~~~~~I~~~~----~~l~~p~~~~~s~~~~dL 392 (549)
++|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.... ..........++..+.+|
T Consensus 201 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (304)
T cd05096 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYEL 280 (304)
T ss_pred CCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHH
Confidence 57889999999998899999999999999999986 678888766555444432210 111111123678899999
Q ss_pred HHHhhh-cccccCCCCCHHHHH
Q 038137 393 ISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 393 I~~lL~-dp~~Rl~~~~~~eil 413 (549)
|.+||. ||.+|+ ++++|.
T Consensus 281 i~~cl~~~p~~RP---s~~~i~ 299 (304)
T cd05096 281 MLQCWSRDCRERP---SFSDIH 299 (304)
T ss_pred HHHHccCCchhCc---CHHHHH
Confidence 999999 999999 788884
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=351.79 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=207.2
Q ss_pred CeeeeeeeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--ceEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKA--TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--EYLY 193 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~--tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~ly 193 (549)
.|++++.||+|+||.||+|.++. ++..||||.+.+...........+.+|+.++..++||||++++++|.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999875433344456678899999999999999999999988 8899
Q ss_pred EEEeecCCCchhhHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC----CCcEEEeecCcc
Q 038137 194 LIMEYLPGGDMMTLLMR-----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR----NGHMKLSDFGLC 264 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~----~g~vKL~DFGla 264 (549)
+||||+++ +|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 67666632 137899999999999999999999999999999999999999 999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccch
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 343 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWS 343 (549)
+.+....... ......+||+.|+|||++.+ ..++.++|+||
T Consensus 160 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 201 (316)
T cd07842 160 RLFNAPLKPL--------------------------------------ADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201 (316)
T ss_pred cccCCCcccc--------------------------------------cccCCccccccccCHHHHhCCCCCCcHHHHHH
Confidence 8654221000 00114578999999999876 46899999999
Q ss_pred hhHHHHHHhhCCCCCCCCCchh---------hhhhhhh------------------------ccccccCCC---------
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMS---------TCRKIVN------------------------WRTHLKFPE--------- 381 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~---------~~~~I~~------------------------~~~~l~~p~--------- 381 (549)
|||++|+|++|++||.+..... .+..++. ......++.
T Consensus 202 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (316)
T cd07842 202 IGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281 (316)
T ss_pred HHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHh
Confidence 9999999999999998655432 1111110 000111110
Q ss_pred CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 382 EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 382 ~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
....+.++.++|.+||. ||++|+ ++.|++.||||
T Consensus 282 ~~~~~~~~~~~i~~~l~~~P~~Rp---s~~eil~~~~f 316 (316)
T cd07842 282 HKKPDSQGFDLLRKLLEYDPTKRI---TAEEALEHPYF 316 (316)
T ss_pred ccCCCHHHHHHHHHHhcCCcccCc---CHHHHhcCCCC
Confidence 01467889999999999 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=339.77 Aligned_cols=253 Identities=33% Similarity=0.593 Sum_probs=215.9
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec--CCceEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ--DDEYLYLI 195 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~lylV 195 (549)
+|++++.||.|+||.||+|.+..+|..||+|++..... .....+.+..|+.+++.++||||+++++.+. ....+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999976543 3344567888999999999999999998775 45678999
Q ss_pred EeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 196 MEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIH-----KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 196 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH-----~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
|||+++++|.+++.+ ...+++..++.++.||+.||.||| +.+|+||||||+||+++.+|++||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 467999999999999999999999 89999999999999999999999999999887
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
...... .....+|++.|+|||++.+..++.++|+|||||
T Consensus 160 ~~~~~~-----------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~ 198 (265)
T cd08217 160 LGHDSS-----------------------------------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198 (265)
T ss_pred ccCCcc-----------------------------------------cccccccCCCccChhhhcCCCCCchhHHHHHHH
Confidence 542110 011357899999999999988999999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
++|+|++|..||...+.......+... ....+| ..++..+.+||.+||. +|.+|+ ++.+|++|||+
T Consensus 199 il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~il~~~~~ 265 (265)
T cd08217 199 LIYELCALSPPFTARNQLQLASKIKEG-KFRRIP--YRYSSELNEVIKSMLNVDPDKRP---STEELLQLPLI 265 (265)
T ss_pred HHHHHHHCCCcccCcCHHHHHHHHhcC-CCCCCc--cccCHHHHHHHHHHccCCcccCC---CHHHHhhCCCC
Confidence 999999999999887755555555432 122233 3678999999999999 999999 89999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=373.06 Aligned_cols=249 Identities=33% Similarity=0.581 Sum_probs=217.0
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCc
Q 038137 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGD 203 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~ 203 (549)
+||+|.||+||.|+++.|....|||-+... ....++-+..|+.+.+.++|.|||+..+++..++++-|.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999999999999999988643 23455668899999999999999999999999999999999999999
Q ss_pred hhhHhhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc-CCCcEEEeecCcccccCCCCcccccccc
Q 038137 204 MMTLLMRK-DTL--TEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD-RNGHMKLSDFGLCKPLDCSNLQEKDFSI 279 (549)
Q Consensus 204 L~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld-~~g~vKL~DFGlak~~~~~~~~~~~~~~ 279 (549)
|.++|..+ +++ .|..+.||..||+.||.|||.+.|||||||-+|+|++ -.|.+||+|||-||.+..-+
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-------- 730 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-------- 730 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--------
Confidence 99999764 788 8999999999999999999999999999999999996 57999999999999864110
Q ss_pred cCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHHHhhCCCC
Q 038137 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
|+ +.++.||..|||||++.. .+|+.++|||||||.+.||.||+||
T Consensus 731 -------------P~--------------------TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP 777 (1226)
T KOG4279|consen 731 -------------PC--------------------TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP 777 (1226)
T ss_pred -------------cc--------------------ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence 11 226789999999999985 5899999999999999999999999
Q ss_pred CCCC-CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 358 FYSD-EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 358 F~~~-~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|... ++.....++--.+.+.++|+ .+|.+|+.||.+|.. +|..|+ +|.++|..||++.-
T Consensus 778 F~ElgspqAAMFkVGmyKvHP~iPe--elsaeak~FilrcFepd~~~R~---sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 778 FVELGSPQAAMFKVGMYKVHPPIPE--ELSAEAKNFILRCFEPDPCDRP---SAKDLLQDPFLQHN 838 (1226)
T ss_pred eeecCChhHhhhhhcceecCCCCcH--HHHHHHHHHHHHHcCCCcccCc---cHHHhccCcccccC
Confidence 9764 34444455544556667776 799999999999999 999999 89999999999854
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=345.97 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=204.6
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCC--ceEEEE
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDD--EYLYLI 195 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~--~~lylV 195 (549)
|++++.||+|+||.||+|.++.+++.||+|++.+... ... ......|..++..+. |+||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999876431 112 223456888888884 99999999999987 899999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||++ |+|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++. |.+||+|||+++.+.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 99996 477777755 467999999999999999999999999999999999999999 9999999999986532110
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
.....||+.|+|||++.. ..++.++|+|||||++|||++
T Consensus 155 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 155 ----------------------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred ----------------------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 012468899999998765 557899999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhcc----------------ccccCCC---------CcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWR----------------THLKFPE---------EAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~----------------~~l~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
|.+||.+.+..+....+.... ....+|. ...+|.++.+||.+||. +|.+|+
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~--- 271 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI--- 271 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc---
Confidence 999998877655544443211 1112221 12468999999999999 999999
Q ss_pred CHHHHHcCCcc
Q 038137 408 GADEIKAHPWF 418 (549)
Q Consensus 408 ~~~eil~HpfF 418 (549)
++++++.||||
T Consensus 272 ~~~~~l~~~~~ 282 (282)
T cd07831 272 TAKQALRHPYF 282 (282)
T ss_pred CHHHHhhCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=347.31 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=204.7
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|.+++.||+|+||.||+|.++.+|..||||++..... ......+.+|+.+++.++|+||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865432 22234567899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||+. ++|...+.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence 99995 667666544 46789999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
.....++++.|+|||++.+ ..++.++|+|||||++|||++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 199 (291)
T cd07870 159 ---------------------------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199 (291)
T ss_pred ---------------------------------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh
Confidence 0013468999999999876 458999999999999999999
Q ss_pred CCCCCCCCCch-hhhhhhhhccc------------------c-c--cCCC-------CcCCChhHHHHHHHhhh-ccccc
Q 038137 354 GYPPFYSDEPM-STCRKIVNWRT------------------H-L--KFPE-------EAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 354 G~~PF~~~~~~-~~~~~I~~~~~------------------~-l--~~p~-------~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
|.+||.+.+.. +...++..... . . ..+. ....++++.+||.+||+ ||.+|
T Consensus 200 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R 279 (291)
T cd07870 200 GQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDR 279 (291)
T ss_pred CCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccC
Confidence 99999765432 21111111000 0 0 0000 01236789999999999 99999
Q ss_pred CCCCCHHHHHcCCcc
Q 038137 404 LGTKGADEIKAHPWF 418 (549)
Q Consensus 404 l~~~~~~eil~HpfF 418 (549)
+ ++.|++.||||
T Consensus 280 ~---t~~~~l~h~~~ 291 (291)
T cd07870 280 I---SAQDALLHPYF 291 (291)
T ss_pred c---CHHHHhcCCCC
Confidence 9 89999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=356.17 Aligned_cols=261 Identities=29% Similarity=0.496 Sum_probs=208.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-----c
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD-----E 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 190 (549)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+..|+.++..++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 478999999999999999999999999999999986422 223445678899999999999999999876543 4
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||+. ++|..++ ....+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 82 ~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999995 5888777 4467999999999999999999999999999999999999999999999999998865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
.... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 160 ~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~ 201 (336)
T cd07849 160 HDHT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILA 201 (336)
T ss_pred cccc--------------------------------------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHH
Confidence 1000 00113579999999998765 57899999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhcc--------------------cccc----CC---CCcCCChhHHHHHHHhhh-ccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWR--------------------THLK----FP---EEAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~--------------------~~l~----~p---~~~~~s~~~~dLI~~lL~-dp~ 401 (549)
+|++|++||.+.+.......+.... .... .+ ..+.+++++.+||.+||+ +|.
T Consensus 202 el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 281 (336)
T cd07849 202 EMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH 281 (336)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChh
Confidence 9999999997765433222221100 0000 00 012468899999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCC
Q 038137 402 QRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i 421 (549)
+|+ ++.|++.||||+.+
T Consensus 282 ~Rp---t~~e~l~hp~~~~~ 298 (336)
T cd07849 282 KRI---TVEEALAHPYLEQY 298 (336)
T ss_pred hCc---CHHHHhcCcccccc
Confidence 999 89999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=345.59 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=211.6
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++++.||.|++|.||+|++..+|..||||++..... ......+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2334567789999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 198 YLPGGDMMTLLMRK---DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 198 y~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|++| +|..++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9975 888887543 4689999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 156 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 156 ---------------------------------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred ---------------------------------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 0013468899999999876 457999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhcccc----------------ccCCC---------CcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTH----------------LKFPE---------EAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~----------------l~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
|++||.+.+..+.+.++...... ..+|. ...+++.++++|.+||+ ||.+|+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~--- 273 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI--- 273 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC---
Confidence 99999988776666655431100 00110 02468899999999999 999999
Q ss_pred CHHHHHcCCcc
Q 038137 408 GADEIKAHPWF 418 (549)
Q Consensus 408 ~~~eil~HpfF 418 (549)
++.+|++||||
T Consensus 274 ~~~~~l~~~~f 284 (284)
T cd07836 274 SAHDALQHPWF 284 (284)
T ss_pred CHHHHhcCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=351.22 Aligned_cols=252 Identities=23% Similarity=0.391 Sum_probs=208.4
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHV--YAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~--vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
+..++|++.+.||+|+||.||+|.++.+|.. +|+|.+... ........+.+|+.++..+ +||||+++++++.+++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4567899999999999999999999888765 577766532 2334456788899999999 8999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKD----------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG 254 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g 254 (549)
.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999986542 578999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~ 334 (549)
.+||+|||+++...... ......++..|+|||++.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 162 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred cEEeCccccCcccchhh------------------------------------------hcccCCCcccccCHHHHhccC
Confidence 99999999986421000 000123567899999998888
Q ss_pred CCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 335 YGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
++.++|+|||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. +|.+|+ +++++
T Consensus 200 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~i 273 (303)
T cd05088 200 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQI 273 (303)
T ss_pred CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHH
Confidence 9999999999999999998 99999887776665555321 122223 3578999999999999 999999 78988
Q ss_pred HcC
Q 038137 413 KAH 415 (549)
Q Consensus 413 l~H 415 (549)
+.+
T Consensus 274 l~~ 276 (303)
T cd05088 274 LVS 276 (303)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.47 Aligned_cols=256 Identities=32% Similarity=0.526 Sum_probs=209.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...+.+.....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.+|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34555666678999999999999999999999999887543 234567889999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-CCcEEEeecCcccccCC
Q 038137 194 LIMEYLPGGDMMTLLMRK-DTL--TEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-~g~vKL~DFGlak~~~~ 269 (549)
+||||++|++|..++... ..+ ++..+.+++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++..+..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999998754 456 88999999999999999999999999999999999986 67999999999875431
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC--CCCcccccchhhHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGAI 347 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~--~y~~~~DiWSlGvi 347 (549)
... ......|++.|+|||++.+. .++.++|+|||||+
T Consensus 162 ~~~-----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvv 200 (268)
T cd06624 162 INP-----------------------------------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCT 200 (268)
T ss_pred CCC-----------------------------------------ccccCCCCccccChhhhccccccCCchhhhHHHHHH
Confidence 110 00134689999999998764 48999999999999
Q ss_pred HHHHhhCCCCCCCCCchh-hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 348 MYEMLVGYPPFYSDEPMS-TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~-~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
+|+|++|++||....... ....+........+|. .+++++++||.+||. +|.+|+ ++.+++.||||
T Consensus 201 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~ll~~~~~ 268 (268)
T cd06624 201 IVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE--SLSAEAKNFILRCFEPDPDKRA---SAHDLLQDPFL 268 (268)
T ss_pred HHHHHhCCCCCccccChhhhHhhhhhhccCCCCCc--ccCHHHHHHHHHHcCCCchhCC---CHHHHHhCCCC
Confidence 999999999997643321 1112211112233443 688999999999999 999999 89999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=357.50 Aligned_cols=261 Identities=27% Similarity=0.450 Sum_probs=213.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-----c
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD-----E 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 190 (549)
..+|.+++.||+|+||.||+|.+..+|..||||.+.+... .......+.+|+.++..++|+||+++++++.+. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3579999999999999999999999999999999875422 233345677899999999999999999988654 3
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||+. ++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 789999888889999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
.. .....+||..|+|||++.+ ..++.++|+|||||++|
T Consensus 162 ~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 162 GD-----------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred cc-----------------------------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 10 0113578999999999875 56899999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhcccc--------------------c---cCC----CCcCCChhHHHHHHHhhh-ccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTH--------------------L---KFP----EEAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~--------------------l---~~p----~~~~~s~~~~dLI~~lL~-dp~ 401 (549)
+|++|++||.+.+.......+...... + ..+ ....+++++++||.+||+ +|.
T Consensus 201 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 280 (337)
T cd07858 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS 280 (337)
T ss_pred HHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh
Confidence 999999999876544333322210000 0 000 013578999999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCCC
Q 038137 402 QRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+|+ +++++++||||..+.
T Consensus 281 ~Rp---s~~ell~h~~~~~~~ 298 (337)
T cd07858 281 KRI---TVEEALAHPYLASLH 298 (337)
T ss_pred hcc---CHHHHHcCcchhhhc
Confidence 999 899999999998763
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=350.20 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=212.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--ceEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--EYLY 193 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~ly 193 (549)
.++|++.+.||.|+||.||+|.++.+++.||+|.++..... ......+.+|+.++..++||||+++++++.+. ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999765432 33344567899999999999999999998877 8999
Q ss_pred EEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 194 LIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999996 5898888654 4599999999999999999999999999999999999999999999999999886542110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEm 351 (549)
......|++.|+|||++.+. .++.++|+|||||++|||
T Consensus 162 -----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 200 (293)
T cd07843 162 -----------------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200 (293)
T ss_pred -----------------------------------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHH
Confidence 00134688999999998764 468999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhcccc-----------------------------ccCCCCcCCChhHHHHHHHhhh-ccc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTH-----------------------------LKFPEEAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~-----------------------------l~~p~~~~~s~~~~dLI~~lL~-dp~ 401 (549)
++|.+||.+.+....+.++...-.. -.+|. ..+++.+++||.+||+ +|+
T Consensus 201 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 201 LTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc-cCCChHHHHHHHHHhccCcc
Confidence 9999999988776666555421000 00111 0158899999999999 999
Q ss_pred ccCCCCCHHHHHcCCcc
Q 038137 402 QRLGTKGADEIKAHPWF 418 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF 418 (549)
+|+ ++.|++.||||
T Consensus 280 ~R~---t~~ell~~~~f 293 (293)
T cd07843 280 KRI---SAEDALKHPYF 293 (293)
T ss_pred ccC---CHHHHhcCCCC
Confidence 999 89999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=351.90 Aligned_cols=254 Identities=32% Similarity=0.579 Sum_probs=214.1
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|+....||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++..++||||++++++|..++..|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4455679999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
++|++|..++. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++..+.....
T Consensus 100 ~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~------ 172 (297)
T cd06659 100 LQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------ 172 (297)
T ss_pred CCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc------
Confidence 99999998774 46789999999999999999999999999999999999999999999999999875431100
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF 358 (549)
.....+|++.|+|||++.+..++.++|+|||||++|||++|++||
T Consensus 173 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 173 -----------------------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred -----------------------------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 011457999999999999989999999999999999999999999
Q ss_pred CCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 359 ~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
...+.......+.... .........+++.+.++|.+||+ +|.+|+ +++++++||||...
T Consensus 218 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rp---s~~~ll~~~~~~~~ 277 (297)
T cd06659 218 FSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERA---TAQELLDHPFLLQT 277 (297)
T ss_pred CCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHHHHhcCCcccCc---CHHHHhhChhhccC
Confidence 8877666555443321 11122223678899999999999 999999 89999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.67 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=221.1
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|.-++.||.|+||-||.|++..+.++||||++.-+.-.....-..+..|+..|..+.|||+|...++|-.+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66678899999999999999999999999999876555555567799999999999999999999999999999999999
Q ss_pred cCCCchhhHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|-| +-.+++. .+.++-|.++..++.+.+.||.|||+++.||||||..||||+..|.|||+|||.|....+
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------- 178 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence 954 5555553 357899999999999999999999999999999999999999999999999998876532
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchhhHHHHHHhhC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSlGvilyEml~G 354 (549)
+.++||||.||||||++. +.|+-++||||||++..||.-.
T Consensus 179 -------------------------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 179 -------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred -------------------------------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence 348999999999999984 6799999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+||+.+.+.+..+..|... ....++. ..+|...+.||..||. -|.+|+ +.++++.|+|...
T Consensus 222 kPPlFnMNAMSALYHIAQN-esPtLqs-~eWS~~F~~Fvd~CLqKipqeRp---tse~ll~H~fv~R 283 (948)
T KOG0577|consen 222 KPPLFNMNAMSALYHIAQN-ESPTLQS-NEWSDYFRNFVDSCLQKIPQERP---TSEELLKHRFVLR 283 (948)
T ss_pred CCCccCchHHHHHHHHHhc-CCCCCCC-chhHHHHHHHHHHHHhhCcccCC---cHHHHhhcchhcc
Confidence 9999999999888888763 3333333 3679999999999999 899999 8999999999864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=336.75 Aligned_cols=263 Identities=27% Similarity=0.472 Sum_probs=223.7
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCC
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDD 189 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~ 189 (549)
+.....++.+.+..||.|+.|.|++++.+.+|...|||.+.+.. +.....++....+++... ++|+||+.|++|..+
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 44556677888899999999999999999999999999998764 445566777777776555 589999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
..+++.||.| +.-+..+|.+ +++++|..+-.+...++.||.||.. +||||||+||+|||||..|.|||||||++..+
T Consensus 164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 9999999999 4456666644 6789999999999999999999985 69999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchh
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSL 344 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSl 344 (549)
..+.-. ....|-+.|||||.+.- ..|+..+|||||
T Consensus 243 vdSkAh------------------------------------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSl 280 (391)
T KOG0983|consen 243 VDSKAH------------------------------------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSL 280 (391)
T ss_pred eccccc------------------------------------------ccccCCccccCccccCCCCCCccchhhhhhhh
Confidence 533100 02379999999999973 579999999999
Q ss_pred hHHHHHHhhCCCCCCCC-CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 345 GAIMYEMLVGYPPFYSD-EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 345 GvilyEml~G~~PF~~~-~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
|+.++||.||..||.+. ...+++.+|++ ..+..+|....+|+...+|+..||+ |+.+|+ .-.++++|||+...+
T Consensus 281 GITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP---~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 281 GITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP---KYNKLLEHPFIKRYE 356 (391)
T ss_pred ccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCc---chHHHhcCcceeecc
Confidence 99999999999999874 56688888888 4556677767799999999999999 999999 689999999997653
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=346.07 Aligned_cols=256 Identities=32% Similarity=0.490 Sum_probs=217.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
..|+.++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357888999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|.+++. .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 156 (277)
T cd06640 82 EYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---- 156 (277)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence 9999999999885 46799999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
......|+..|+|||++.+..++.++|+|||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06640 157 -------------------------------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred -------------------------------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence 0013468899999999998899999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
||...++......+... ....++ ..++..+.+||.+||. +|.+|+ ++.+++.||||....
T Consensus 200 p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~ 260 (277)
T cd06640 200 PNSDMHPMRVLFLIPKN-NPPTLT--GEFSKPFKEFIDACLNKDPSFRP---TAKELLKHKFIVKNA 260 (277)
T ss_pred CCCCcChHhHhhhhhcC-CCCCCc--hhhhHHHHHHHHHHcccCcccCc---CHHHHHhChHhhhcc
Confidence 99877665544443221 112222 2568899999999999 999999 899999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=348.43 Aligned_cols=261 Identities=30% Similarity=0.445 Sum_probs=207.0
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4679999999999999999999999999999999865422 2223345678999999999999999999887543
Q ss_pred ---eEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 191 ---YLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 191 ---~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
..|+||||+. ++|..++... ..+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4699999995 5788877654 3799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhh
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 345 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlG 345 (549)
+........ ......+|+..|+|||++.+. .++.++|+||||
T Consensus 169 ~~~~~~~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 169 FSLSKNSKP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred ccCCcccCC-------------------------------------CCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 642210000 001134688999999998764 478999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhccc-----------------cccCCCC-----------cCCChhHHHHHHHhh
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRT-----------------HLKFPEE-----------AKLSPEAKDLISKLL 397 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~~-----------------~l~~p~~-----------~~~s~~~~dLI~~lL 397 (549)
|++|||++|++||.+.+.......+..... .+.+|.. ...++.+.|||.+||
T Consensus 212 ~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l 291 (310)
T cd07865 212 CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291 (310)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHh
Confidence 999999999999988765544333222100 0111111 123678899999999
Q ss_pred h-cccccCCCCCHHHHHcCCcc
Q 038137 398 C-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 398 ~-dp~~Rl~~~~~~eil~HpfF 418 (549)
+ ||.+|+ ++++++.||||
T Consensus 292 ~~~P~~R~---t~~e~l~h~~f 310 (310)
T cd07865 292 VLDPAKRI---DADTALNHDFF 310 (310)
T ss_pred cCChhhcc---CHHHHhcCCCC
Confidence 9 999999 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.97 Aligned_cols=255 Identities=31% Similarity=0.567 Sum_probs=217.4
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|...+.||.|++|.||+|.+..++..||+|++.... ....+.+.+|+.++..++||||++++++|...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4556689999999999999999999999999886432 2334568899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.+|.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~----- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-----
Confidence 9999999999866 6799999999999999999999999999999999999999999999999998765421100
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
.....+|++.|+|||++.+..++.++|+|||||++|||++|.+|
T Consensus 171 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p 214 (285)
T cd06648 171 ------------------------------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214 (285)
T ss_pred ------------------------------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 00135799999999999988899999999999999999999999
Q ss_pred CCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 358 F~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|.+.++.....++... .....+....++..+.+||.+||+ +|.+|+ ++.+++.||||+..
T Consensus 215 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~ 275 (285)
T cd06648 215 YFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLAKA 275 (285)
T ss_pred CcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHHcccChhhCc---CHHHHccCcccccC
Confidence 9988877766666543 112222223478999999999999 999998 89999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=345.48 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=211.4
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
..++|.+++.||+|+||.||+|.+.. ++..||||++.... .......+.+|+++|..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998753 46889999987542 222456789999999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK--------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH 255 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~ 255 (549)
..+|+||||++||+|..++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999998654 34889999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC
Q 038137 256 MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY 335 (549)
Q Consensus 256 vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y 335 (549)
+||+|||+++.+....... ......+++.|+|||++.+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYR---------------------------------------VGGHTMLPIRWMPPESIMYRKF 201 (280)
T ss_pred EEECCcccceecccCccee---------------------------------------cCCCCcccceecChhhhccCCc
Confidence 9999999987543111000 0012457889999999999999
Q ss_pred CcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 336 GMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
+.++|||||||++|||++ |..||.+.+..+....+... ....+ ...++..+++||.+||+ ||.+|+ ++.||+
T Consensus 202 ~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---~~~eil 275 (280)
T cd05049 202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG--RLLQR-PRTCPSEVYDIMLGCWKRDPQQRI---NIKDIH 275 (280)
T ss_pred chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CcCCC-CCCCCHHHHHHHHHHcCCCcccCC---CHHHHH
Confidence 999999999999999998 99999887777666666532 22221 23688999999999999 999999 788887
Q ss_pred c
Q 038137 414 A 414 (549)
Q Consensus 414 ~ 414 (549)
.
T Consensus 276 ~ 276 (280)
T cd05049 276 E 276 (280)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=316.50 Aligned_cols=257 Identities=32% Similarity=0.548 Sum_probs=219.5
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|...+.||+|.||+|++|+++.|+++||+|.++-.+ .+.+......+|+-+|++++|.|||+|++....+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4666778999999999999999999999999997654 234455678999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 198 YLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 198 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|| ..+|..+... ++.++.+.++.++.|++.||.++|+++++||||||.|+||+.+|.+||+|||+++.+.-.-
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----- 155 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----- 155 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-----
Confidence 99 5688887755 6789999999999999999999999999999999999999999999999999999764210
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhccccee-ecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh-
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAY-STVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV- 353 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~- 353 (549)
..+ .-|-|.+|.+|.++.+ +-|+.+.|+||.|||+.|+..
T Consensus 156 -------------------------------------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelana 198 (292)
T KOG0662|consen 156 -------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_pred -------------------------------------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhc
Confidence 011 2478999999999998 568999999999999999985
Q ss_pred CCCCCCCCCchhhhhhhhh---------ccccccCCCC----------------cCCChhHHHHHHHhhh-cccccCCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVN---------WRTHLKFPEE----------------AKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~---------~~~~l~~p~~----------------~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
|+|.|.+.+..+...+|.. |...-+.|+. +.++...+||+++||. +|.+|+
T Consensus 199 grplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri--- 275 (292)
T KOG0662|consen 199 GRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI--- 275 (292)
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc---
Confidence 9999999998888888863 4332222221 3456778999999995 999999
Q ss_pred CHHHHHcCCcccCC
Q 038137 408 GADEIKAHPWFKGI 421 (549)
Q Consensus 408 ~~~eil~HpfF~~i 421 (549)
+|+++++||||.+.
T Consensus 276 saeaalqhpyf~d~ 289 (292)
T KOG0662|consen 276 SAEAALQHPYFSDF 289 (292)
T ss_pred CHHHHhcCcccccc
Confidence 89999999999864
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=340.73 Aligned_cols=252 Identities=30% Similarity=0.500 Sum_probs=211.7
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||+|+||.||+|+++.+++.||||.+.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999987655555556677889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 197 EYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 197 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988853 35589999999999999999999999999999999999999999999999999876532100
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
......|++.|+|||++.+..++.++|+|||||++|||+
T Consensus 162 -----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 011357899999999999999999999999999999999
Q ss_pred hCCCCCCCCCc--hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 353 VGYPPFYSDEP--MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 353 ~G~~PF~~~~~--~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|+.||..... ......+.. ......+. ..++..+.+||.+||+ +|.+|+ ++.+|++
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rp---~~~~vl~ 260 (267)
T cd08228 201 ALQSPFYGDKMNLFSLCQKIEQ-CDYPPLPT-EHYSEKLRELVSMCIYPDPDQRP---DIGYVHQ 260 (267)
T ss_pred cCCCCCccccccHHHHHHHHhc-CCCCCCCh-hhcCHHHHHHHHHHCCCCcccCc---CHHHHHH
Confidence 99999976543 233333222 11112221 2577899999999999 999999 7888885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=348.43 Aligned_cols=257 Identities=32% Similarity=0.540 Sum_probs=218.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||++++++|.+.+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 468999999999999999999999999999999986432 23346688899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++||+|..++.+ ..+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--- 170 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---
Confidence 999999999998854 4689999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
......|++.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus 171 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~ 212 (293)
T cd06647 171 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (293)
T ss_pred --------------------------------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 001347999999999999888999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||.+.+.......+..+ ....++....++..+++||.+||. +|.+|+ ++.+++.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~h~~~~~~ 275 (293)
T cd06647 213 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHPFLKIA 275 (293)
T ss_pred CCCCCCChhhheeehhcC-CCCCCCCccccCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcC
Confidence 999877654443333222 223333334678899999999999 999998 89999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=385.17 Aligned_cols=272 Identities=24% Similarity=0.348 Sum_probs=209.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999997654333344567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 197 EYLPGGDMMTLLMRK-----------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
||++||+|.+++.+. ..++...+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999988541 234566778899999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlG 345 (549)
............... ..+. . ..........+||+.|||||++.+..++.++||||||
T Consensus 162 ~i~~~~~~~~~l~~~--~~~s-------~--------------~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLG 218 (932)
T PRK13184 162 FKKLEEEDLLDIDVD--ERNI-------C--------------YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG 218 (932)
T ss_pred ecccccccccccccc--cccc-------c--------------ccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHH
Confidence 763211000000000 0000 0 0000011246899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++|||++|.+||...+.......... .....+.....+++.+.++|.+||+ ||.+|++ ++++++.
T Consensus 219 VILyELLTG~~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s--s~eeLl~ 285 (932)
T PRK13184 219 VILYQMLTLSFPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYS--SVQELKQ 285 (932)
T ss_pred HHHHHHHHCCCCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcC--HHHHHHH
Confidence 999999999999987554332211110 1111222224688999999999999 9999985 3554443
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=343.52 Aligned_cols=257 Identities=31% Similarity=0.475 Sum_probs=211.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--CceEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD--DEYLYL 194 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~lyl 194 (549)
++|+.++.||.|++|.||+|.+..+++.||+|.+.+... ......+.+|+++++.++||||++++++|.+ ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999876432 2344668889999999999999999998865 447999
Q ss_pred EEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 195 IMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887643 356899999999999999999999999999999999999999999999999998754311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 159 ~-------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~ 195 (287)
T cd06621 159 L-------------------------------------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195 (287)
T ss_pred c-------------------------------------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 0 002467889999999999999999999999999999
Q ss_pred HhhCCCCCCCCCc-----hhhhhhhhhccccccCCC----CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 351 MLVGYPPFYSDEP-----MSTCRKIVNWRTHLKFPE----EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 351 ml~G~~PF~~~~~-----~~~~~~I~~~~~~l~~p~----~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|++|..||..... .+....+.... ...++. ...+++++.+||.+||. +|.+|+ ++.||+.||||+.
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~eil~~~~~~~ 271 (287)
T cd06621 196 VAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP---TPWDMLEHPWIKA 271 (287)
T ss_pred HHhCCCCCCcccCCCCChHHHHHHHhcCC-chhhccCCCCCCchHHHHHHHHHHHcCCCcccCC---CHHHHHhCccccc
Confidence 9999999986522 22333333211 111111 12356789999999998 999999 8999999999976
Q ss_pred CC
Q 038137 421 IE 422 (549)
Q Consensus 421 i~ 422 (549)
..
T Consensus 272 ~~ 273 (287)
T cd06621 272 QM 273 (287)
T ss_pred cc
Confidence 53
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.52 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=212.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+...+|++.+.||+|+||.||+|.++.+++.||+|++.+.. .....+.+|+.++..++||||+++++++..+..+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45667999999999999999999999999999999987542 23456888999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999998653 468999999999999999999999999999999999999999999999999987653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
... .....+++.|+|||++.+..++.++|||||||++|||
T Consensus 159 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 198 (263)
T cd05052 159 YTA----------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198 (263)
T ss_pred eec----------------------------------------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 000 0022356789999999999999999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||+ +|++|+ ++.++++
T Consensus 199 ~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~l~~ 257 (263)
T cd05052 199 ATYGMSPYPGIDLSQVYELLEKG-YRMERP--EGCPPKVYELMRACWQWNPSDRP---SFAEIHQ 257 (263)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 98 99999887776666666542 122333 4789999999999999 999999 7877764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=338.72 Aligned_cols=251 Identities=22% Similarity=0.413 Sum_probs=211.3
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.+..++|++++.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 356788999999999999999999865 556799998865432 346788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 193 YLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
|+||||++||+|.+++.+ ...+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999999865 356899999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... .....++..|+|||++.+..++.++|+|||||++|+
T Consensus 157 ~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 196 (261)
T cd05072 157 EYTA----------------------------------------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYE 196 (261)
T ss_pred ceec----------------------------------------cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHH
Confidence 1000 002346778999999998899999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++ |.+||.+.+.......+.. ....|....++.++.+||.+||. +|++|+ +++++..
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 256 (261)
T cd05072 197 IVTYGKIPYPGMSNSDVMSALQR---GYRMPRMENCPDELYDIMKTCWKEKAEERP---TFDYLQS 256 (261)
T ss_pred HHccCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 998 9999988777666665543 23334445688999999999999 999999 6777753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=343.89 Aligned_cols=254 Identities=20% Similarity=0.374 Sum_probs=210.5
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREK----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
..++|++.+.||+|+||.||+|... .++..||+|.+.... .......+.+|..+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999863 456789999987532 2334467889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK-----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN 253 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~-----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~ 253 (549)
..|+||||+++|+|.+++... ..+++..+..++.+++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 247889999999999999999999999999999999999999
Q ss_pred CcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC
Q 038137 254 GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333 (549)
Q Consensus 254 g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~ 333 (549)
+.+||+|||+++......... ...+..++..|+|||++.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYR---------------------------------------VQPKSLLPIRWMPPEAIMYG 201 (283)
T ss_pred CcEEeccccccccccCCccee---------------------------------------cccCCCccceecChHHhccC
Confidence 999999999998653221000 00134567889999999988
Q ss_pred CCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHH
Q 038137 334 GYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411 (549)
Q Consensus 334 ~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 411 (549)
.++.++|+|||||++|||++ |.+||.+.+.......+... ..+..| ..+++.++++|.+||+ +|.+|+ ++.+
T Consensus 202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~ 275 (283)
T cd05090 202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCS--EDCPPRMYSLMTECWQEGPSRRP---RFKD 275 (283)
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCc---CHHH
Confidence 99999999999999999998 99999887765555555432 223333 4689999999999999 999999 7888
Q ss_pred HHcC
Q 038137 412 IKAH 415 (549)
Q Consensus 412 il~H 415 (549)
|+++
T Consensus 276 i~~~ 279 (283)
T cd05090 276 IHTR 279 (283)
T ss_pred HHHH
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=347.99 Aligned_cols=256 Identities=32% Similarity=0.488 Sum_probs=215.5
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|+.++.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 47778899999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|++|++|..++. .+.+++..++.++.+++.||.|||+.|++|+||+|+||+++.+|.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06642 83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-----
Confidence 999999999875 46799999999999999999999999999999999999999999999999999876532110
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
......|+..|+|||++.+..++.++|+|||||++|||++|.+|
T Consensus 157 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06642 157 ------------------------------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred ------------------------------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCC
Confidence 00134689999999999999999999999999999999999999
Q ss_pred CCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 358 F~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
|....+......+... ....++ ..++.++.++|.+||. +|.+|+ ++.++++||||....+
T Consensus 201 ~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~~~~~~ 261 (277)
T cd06642 201 NSDLHPMRVLFLIPKN-SPPTLE--GQYSKPFKEFVEACLNKDPRFRP---TAKELLKHKFITRYTK 261 (277)
T ss_pred CcccchhhHHhhhhcC-CCCCCC--cccCHHHHHHHHHHccCCcccCc---CHHHHHHhHHHHHHhh
Confidence 9876554443333221 111122 2578899999999999 999999 8999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.35 Aligned_cols=253 Identities=32% Similarity=0.511 Sum_probs=215.3
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||++++++|.++..+|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 7788899999999999999999999999999865432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
++||+|..++. .+.+++..+..++.+++.||.|||+.|++|+||+|+||+++.+|.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~------ 156 (277)
T cd06641 84 LGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI------ 156 (277)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh------
Confidence 99999998885 45789999999999999999999999999999999999999999999999999876532100
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF 358 (549)
......|+..|+|||++.+..++.++|+|||||++|+|++|.+||
T Consensus 157 -----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (277)
T cd06641 157 -----------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201 (277)
T ss_pred -----------------------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 001346899999999999888999999999999999999999999
Q ss_pred CCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 359 ~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
...+.......+... ....++ ..++.++.++|.+||+ +|.+|+ ++.++++||||...
T Consensus 202 ~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~l~~~~~~~~ 259 (277)
T cd06641 202 SELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIVRF 259 (277)
T ss_pred CccchHHHHHHHhcC-CCCCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhhh
Confidence 876655544444321 122222 3578999999999998 999999 79999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.56 Aligned_cols=253 Identities=23% Similarity=0.400 Sum_probs=211.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+..++|.+.+.||+|+||+||+|... .++..||+|.+.+.. ......+.+|+.++..++||+|+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34578999999999999999999863 356679999987542 3345668899999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKD-------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH 255 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~ 255 (549)
.+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+|||++.+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999986443 4899999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC
Q 038137 256 MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY 335 (549)
Q Consensus 256 vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y 335 (549)
+||+|||+++.+...... .......|++.|+|||++.+..+
T Consensus 159 ~kl~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYY---------------------------------------RVGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred EEeccCCccccccCCcee---------------------------------------ecCCCCCccccccCHHHhccCCC
Confidence 999999998865321100 00012456889999999999999
Q ss_pred CcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 336 GMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
+.++|+|||||++|||++ |.+||.+.+.......+.+.. ....+ ..++.++.+||.+||. +|.+|+ ++.+++
T Consensus 200 ~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---t~~~v~ 273 (288)
T cd05093 200 TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP--RTCPKEVYDLMLGCWQREPHMRL---NIKEIH 273 (288)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHH
Confidence 999999999999999998 999998887777777776532 12222 3678999999999999 999999 788775
Q ss_pred c
Q 038137 414 A 414 (549)
Q Consensus 414 ~ 414 (549)
.
T Consensus 274 ~ 274 (288)
T cd05093 274 S 274 (288)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.24 Aligned_cols=256 Identities=31% Similarity=0.544 Sum_probs=214.3
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCceEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD---SNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d~~~lyl 194 (549)
.|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. ||||++++++|.+....|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999987542 2334567888999999986 9999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||++|++|..++.. +.+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.++|+|||++..+......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 9999999999998854 58999999999999999999999999999999999999999999999999998865422100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~ 353 (549)
....+|++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~ 197 (277)
T cd06917 158 ----------------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT 197 (277)
T ss_pred ----------------------------------------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh
Confidence 013479999999999875 457999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
|.+||.+.+.......+... ....++. ..++.++.++|.+||. ||.+|+ ++.+++.||||+...
T Consensus 198 g~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~---~~~~il~~~~~~~~~ 262 (277)
T cd06917 198 GNPPYSDVDAFRAMMLIPKS-KPPRLED-NGYSKLLREFVAACLDEEPKERL---SAEELLKSKWIKAHS 262 (277)
T ss_pred CCCCCCCCChhhhhhccccC-CCCCCCc-ccCCHHHHHHHHHHcCCCcccCc---CHHHHhhChHhhccc
Confidence 99999876654443333221 1122222 2378899999999999 999999 799999999998654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.67 Aligned_cols=249 Identities=52% Similarity=0.946 Sum_probs=218.6
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCch
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L 204 (549)
||.|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+.++..+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887665556777899999999999999999999999999999999999999999
Q ss_pred hhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCc
Q 038137 205 MTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284 (549)
Q Consensus 205 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~ 284 (549)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------------ 148 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------------ 148 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------------
Confidence 99998888899999999999999999999999999999999999999999999999999876532110
Q ss_pred CCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCch
Q 038137 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364 (549)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~ 364 (549)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+..
T Consensus 149 -----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 199 (250)
T cd05123 149 -----------------------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199 (250)
T ss_pred -----------------------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 011357899999999999888999999999999999999999999887766
Q ss_pred hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 365 STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 365 ~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
.....+.. ..+.+|. .++..+.++|.+||+ ||.+|+....+++++.||||
T Consensus 200 ~~~~~~~~--~~~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 200 EIYEKILK--DPLRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 66666654 3444554 678999999999999 99999943223999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=336.55 Aligned_cols=253 Identities=32% Similarity=0.571 Sum_probs=215.3
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||+|+||.||+|..+.+|..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+.+...+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999976543 22344567899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc-EEEeecCcccccCCCCccc
Q 038137 198 YLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH-MKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 198 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~-vKL~DFGlak~~~~~~~~~ 274 (549)
|++|++|..++.+.. .+++..+..++.+++.||.|||+.+++|+||||+||+++.++. +||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 999999999986543 5899999999999999999999999999999999999998865 69999999876532100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
......|++.|+|||++.+..++.++|+|||||++|||++|
T Consensus 158 ---------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 158 ---------------------------------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred ---------------------------------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 01134689999999999988899999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
..||.+.+.......+... .+ .+....++.+++++|.+||. +|++|+ ++.+|++||||
T Consensus 199 ~~p~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~~~~~ 257 (257)
T cd08225 199 KHPFEGNNLHQLVLKICQG--YF-APISPNFSRDLRSLISQLFKVSPRDRP---SITSILKRPFL 257 (257)
T ss_pred CCCCCCccHHHHHHHHhcc--cC-CCCCCCCCHHHHHHHHHHhccChhhCc---CHHHHhhCCCC
Confidence 9999887766655555432 11 12223678999999999999 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.21 Aligned_cols=255 Identities=18% Similarity=0.268 Sum_probs=209.7
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+..++|++.+.||+|+||.||+|.++ .++..||+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45678999999999999999999865 2457899999865321 2234568899999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEE
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK----------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKL 258 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL 258 (549)
....|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||+.|++||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999998652 23577889999999999999999999999999999999999999999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcc
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME 338 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~ 338 (549)
+|||+++.+....... ......+++.|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05062 161 GDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMSPESLKDGVFTTY 201 (277)
T ss_pred CCCCCccccCCcceee---------------------------------------cCCCCccCHhhcChhHhhcCCcCch
Confidence 9999988653221000 0002356788999999999999999
Q ss_pred cccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 339 CDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 339 ~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
+|+|||||++|||++ |.+||.+.+.......+... ....+| ..+++.+++||.+||+ +|.+|+ ++.|++.+
T Consensus 202 ~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 274 (277)
T cd05062 202 SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GLLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEIISS 274 (277)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 999999999999998 79999887776666555542 222333 3678899999999999 999999 78888764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=356.09 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=207.6
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSF 186 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 186 (549)
.+..++|++.+.||.|+||.||+|... .+++.||+|++.... .......+..|+.++..+ +|+||++++++|
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 445678999999999999999999754 356899999986432 223345678899999999 899999999987
Q ss_pred cC-CceEEEEEeecCCCchhhHhhhc------------------------------------------------------
Q 038137 187 QD-DEYLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 211 (549)
Q Consensus 187 ~d-~~~lylVmEy~~gg~L~~~l~~~------------------------------------------------------ 211 (549)
.. +..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 56799999999999999988532
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCc
Q 038137 212 -------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284 (549)
Q Consensus 212 -------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~ 284 (549)
..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+.......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---------- 230 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---------- 230 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----------
Confidence 268899999999999999999999999999999999999999999999999998653211000
Q ss_pred CCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCc
Q 038137 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEP 363 (549)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~ 363 (549)
......|+..|+|||++.+..|+.++|||||||++|||++ |.+||.+...
T Consensus 231 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 231 -----------------------------RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred -----------------------------hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 0013456788999999999999999999999999999997 9999987655
Q ss_pred hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 364 MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 364 ~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
.+.....+........| ..+++++.+++.+||+ +|++|+ +++||++|
T Consensus 282 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~p~~RP---s~~ell~~ 329 (337)
T cd05054 282 DEEFCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRP---TFSELVEI 329 (337)
T ss_pred cHHHHHHHhccCCCCCC--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 44444444322222333 3678999999999999 999999 79998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.23 Aligned_cols=249 Identities=21% Similarity=0.359 Sum_probs=209.0
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||+|+||.||+|..+. +..+|+|.+.+... ....+.+|+.+|+.++||||++++++|.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 34679999999999999999998764 56799998875432 13457889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||++||+|.+++.. .+.+++..+..++.+++.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999999999865 456899999999999999999999999999999999999999999999999998764311100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
. .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~ 196 (256)
T cd05114 157 S----------------------------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196 (256)
T ss_pred c----------------------------------------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHc
Confidence 0 002346678999999998999999999999999999999
Q ss_pred -CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 354 -GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 354 -G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++||...+..+....+.... ....| ...+.++.+||.+|++ +|.+|+ ++++|+.
T Consensus 197 ~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~~l~~ 253 (256)
T cd05114 197 EGKMPFEKKSNYEVVEMISRGF-RLYRP--KLASMTVYEVMYSCWHEKPEGRP---TFAELLR 253 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHCCC-CCCCC--CCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 999999888777777776521 22223 3568899999999999 999999 7888874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.33 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=211.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
.++|.+.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3689999999999999999999999999999999876432 223345678899999999999999999988754
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||+. ++|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 34699999995 4776654 34699999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
. ....+||+.|+|||++.+ ..++.++|+|||||++
T Consensus 170 ~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil 205 (342)
T cd07879 170 E--------------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM 205 (342)
T ss_pred C--------------------------------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHH
Confidence 1 013478999999999876 4689999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccc--------------------c-ccCCC------CcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRT--------------------H-LKFPE------EAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~--------------------~-l~~p~------~~~~s~~~~dLI~~lL~-dp 400 (549)
|||++|+.||.+.+.......++.... . ..++. .+.+++++.+||.+||+ ||
T Consensus 206 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 285 (342)
T cd07879 206 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDV 285 (342)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCCh
Confidence 999999999998776555554443110 0 00111 12467889999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCCcc
Q 038137 401 EQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
.+|+ ++++++.||||..+.+.
T Consensus 286 ~~R~---~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 286 DKRL---TATEALEHPYFDSFRDA 306 (342)
T ss_pred hhCc---CHHHHhcCcchhhcccc
Confidence 9999 89999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=343.26 Aligned_cols=254 Identities=32% Similarity=0.518 Sum_probs=210.9
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++||+|+++++++.+....|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999876432 233445678899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 199 LPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 199 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
++ ++|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+|.++|+|||++........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 95 68999887655 799999999999999999999999999999999999999999999999999875431100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....++++.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus 155 -------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 197 (283)
T cd07835 155 -------------------------------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197 (283)
T ss_pred -------------------------------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence 00123678999999998764 5799999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhcccc----------------ccCC---------CCcCCChhHHHHHHHhhh-cccccCCCCCH
Q 038137 356 PPFYSDEPMSTCRKIVNWRTH----------------LKFP---------EEAKLSPEAKDLISKLLC-NVEQRLGTKGA 409 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~----------------l~~p---------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 409 (549)
+||.+.+......+++.+... ..++ ....++.++.+||.+||+ +|.+|+ ++
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---t~ 274 (283)
T cd07835 198 PLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI---SA 274 (283)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc---CH
Confidence 999887765554444331100 0011 013578899999999999 999999 89
Q ss_pred HHHHcCCcc
Q 038137 410 DEIKAHPWF 418 (549)
Q Consensus 410 ~eil~HpfF 418 (549)
+||+.||||
T Consensus 275 ~~il~~~~~ 283 (283)
T cd07835 275 KAALQHPYF 283 (283)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=354.14 Aligned_cols=262 Identities=29% Similarity=0.465 Sum_probs=219.7
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----eE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE-----YL 192 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-----~l 192 (549)
+|++.+.||.|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999999999999999997643 22344567889999999999999999999998875 79
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++ ++|..++.+...+++..++.++.+|+.||.|||+.||+||||||+|||++.+|+++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999996 58999988777999999999999999999999999999999999999999999999999999987542210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEm 351 (549)
. ........||+.|+|||++.+. .++.++|+|||||++|+|
T Consensus 159 ~--------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l 200 (330)
T cd07834 159 E--------------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200 (330)
T ss_pred c--------------------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence 0 0001135789999999999987 899999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhcccccc------------------CC---------CCcCCChhHHHHHHHhhh-ccccc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLK------------------FP---------EEAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~------------------~p---------~~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
++|.+||.+.+..+.+..++....... .+ ....+++++.+||.+||+ +|.+|
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 280 (330)
T cd07834 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR 280 (330)
T ss_pred HcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhC
Confidence 999999998887766666654211100 00 012468899999999999 99999
Q ss_pred CCCCCHHHHHcCCcccCCC
Q 038137 404 LGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 404 l~~~~~~eil~HpfF~~i~ 422 (549)
+ ++++++.||||+++.
T Consensus 281 p---t~~~ll~~~~~~~~~ 296 (330)
T cd07834 281 I---TADEALAHPYLAQLH 296 (330)
T ss_pred C---CHHHHHhCccHHhhc
Confidence 9 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=347.15 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=213.1
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|..++.||+|+||.||+|.+..+|..||||++.............+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999999765444444556788899999999999999999999999999999999
Q ss_pred cCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
++ |+|..++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.+|.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~------- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA------- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-------
Confidence 96 567776654 567999999999999999999999999999999999999999999999999987532100
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhhHHHHHHhhC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEml~G 354 (549)
...+|+..|+|||++. ...++.++|+|||||++|+|++|
T Consensus 175 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 175 --------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred --------------------------------------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 1347899999999985 35688999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
.+||.+.+......++.... ....+ ...++..+++||.+||. +|.+|+ ++.+++.||||...+
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~~P~~Rp---~~~~~l~~~~~~~~~ 280 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQND-SPTLQ-SNEWTDSFRGFVDYCLQKIPQERP---ASAELLRHDFVRRDR 280 (313)
T ss_pred CCCCCCCChHHHHHHHHhcC-CCCCC-ccccCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCc
Confidence 99998877666555554321 11111 23577889999999999 999999 899999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=347.63 Aligned_cols=253 Identities=29% Similarity=0.427 Sum_probs=214.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
..|..++.||+|+||.||+|.+..+|..||+|++.+...........+.+|+.+++.++|||||++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999999999999999997654444445567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++| +|.+++.. ...+++..+..++.+++.||.|||+.||+||||+|+||+++.+|++||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence 99975 67776643 567999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhhHHHHHHh
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEml 352 (549)
....|++.|+|||++. ...++.++|+|||||++|||+
T Consensus 179 ----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~ 218 (317)
T cd06635 179 ----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218 (317)
T ss_pred ----------------------------------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHH
Confidence 0346899999999984 356899999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+|++||...+.......+..... .......+++.+++||.+||. +|.+|+ ++.+|+.|||+..
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~ 282 (317)
T cd06635 219 ERKPPLFNMNAMSALYHIAQNES--PTLQSNEWSDYFRNFVDSCLQKIPQDRP---TSEELLKHMFVLR 282 (317)
T ss_pred hCCCCCCCccHHHHHHHHHhccC--CCCCCccccHHHHHHHHHHccCCcccCc---CHHHHHhChhhhc
Confidence 99999988776666666654221 111223578899999999999 999999 8999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=340.47 Aligned_cols=253 Identities=31% Similarity=0.484 Sum_probs=209.5
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCce----
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV---DSNCIVKLYCSFQDDEY---- 191 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d~~~---- 191 (549)
|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++..+ +||||++++++|.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999999999999999975432 223344566788877666 69999999999998776
Q ss_pred -EEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 192 -LYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 192 -lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+|+||||++ ++|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++..+.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 4788888654 359999999999999999999999999999999999999999999999999987653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.... ....+|++.|+|||++.+..++.++|+|||||++
T Consensus 159 ~~~~------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 159 FEMA------------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred CCcc------------------------------------------cccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 2110 0134688999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccc---cccCC-----------C---------CcCCChhHHHHHHHhhh-cccccC
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRT---HLKFP-----------E---------EAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~---~l~~p-----------~---------~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
|||++|.+||.+.+..+.+.++..... ...++ . ...+++.+.+||.+||+ ||.+|+
T Consensus 197 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 999999999998887777666653211 00001 0 01457889999999999 999999
Q ss_pred CCCCHHHHHcCCcc
Q 038137 405 GTKGADEIKAHPWF 418 (549)
Q Consensus 405 ~~~~~~eil~HpfF 418 (549)
++++++.||||
T Consensus 277 ---~~~~il~~~~~ 287 (287)
T cd07838 277 ---SAFEALQHPYF 287 (287)
T ss_pred ---CHHHHhcCcCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=342.02 Aligned_cols=261 Identities=33% Similarity=0.557 Sum_probs=223.8
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.++..++|+||++++++|.+...+|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45679999999999999999999998999999999976532 45668889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||++|++|.+++.... .+++..+..++.+++.||.|||+.||+|+||+|+||+++.+|+++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999999998766 899999999999999999999999999999999999999999999999999865431100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
......|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 172 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~ 211 (286)
T cd06614 172 ----------------------------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE 211 (286)
T ss_pred ----------------------------------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh
Confidence 0013468899999999998899999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|.+||...++......+... ....++....++.++++||.+||+ +|..|+ ++.+|+.||||....|.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 212 GEPPYLREPPLRALFLITTK-GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLKKACPK 279 (286)
T ss_pred CCCCCCCCCHHHHHHHHHhc-CCCCCcchhhCCHHHHHHHHHHhccChhhCc---CHHHHhhChHhhccCch
Confidence 99999887766555555432 222333333478999999999999 999998 89999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=331.45 Aligned_cols=253 Identities=32% Similarity=0.573 Sum_probs=220.8
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|++++..++||+|+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999987643 23456789999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|++|++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999999999988889999999999999999999999999999999999999999999999999999876422100
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~P 357 (549)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|.+|
T Consensus 156 -------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p 198 (254)
T cd06627 156 -------------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198 (254)
T ss_pred -------------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 0134689999999999888899999999999999999999999
Q ss_pred CCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 358 F~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|...+......++... ....+| ..+++.+.++|.+||. +|++|+ ++.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~---~~~~~l~~~~~ 254 (254)
T cd06627 199 YYDLNPMAALFRIVQD-DHPPLP--EGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254 (254)
T ss_pred CCCccHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHHhCChhhCc---CHHHHhcCCCC
Confidence 9877655555444432 223333 3678999999999999 999998 89999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.37 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=212.2
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCC----------------cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATG----------------HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg----------------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 178 (549)
...+|++++.||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3467999999999999999999876544 5689999876532 245677889999999999999
Q ss_pred eeeeeeeecCCceEEEEEeecCCCchhhHhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCC
Q 038137 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-----------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDN 247 (549)
Q Consensus 179 Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeN 247 (549)
|++++++|.++..+|+||||+++++|..++.+.. .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997655 68999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCc
Q 038137 248 LLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327 (549)
Q Consensus 248 ILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~AP 327 (549)
|+++.++.++|+|||+++.+...... .......+|+.|+||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aP 201 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYY---------------------------------------RVQGRAPLPIRWMAW 201 (296)
T ss_pred eeecCCCceEEccccceeecccCcce---------------------------------------eecCcCCCCceecCH
Confidence 99999999999999998765321100 001134678899999
Q ss_pred hhhccCCCCcccccchhhHHHHHHhh--CCCCCCCCCchhhhhhhhhc----cccccCCCCcCCChhHHHHHHHhhh-cc
Q 038137 328 EVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDEPMSTCRKIVNW----RTHLKFPEEAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 328 Evl~~~~y~~~~DiWSlGvilyEml~--G~~PF~~~~~~~~~~~I~~~----~~~l~~p~~~~~s~~~~dLI~~lL~-dp 400 (549)
|++.+..++.++|+|||||++|||++ |..||...+.......+... ......+....++.++.+||.+||+ ||
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccCh
Confidence 99998899999999999999999998 78899877766666655432 1122223334678999999999999 99
Q ss_pred cccCCCCCHHHHHc
Q 038137 401 EQRLGTKGADEIKA 414 (549)
Q Consensus 401 ~~Rl~~~~~~eil~ 414 (549)
.+|+ ++.+|+.
T Consensus 282 ~~Rp---t~~el~~ 292 (296)
T cd05051 282 EDRP---TFREIHL 292 (296)
T ss_pred hcCC---CHHHHHH
Confidence 9999 7888854
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.07 Aligned_cols=255 Identities=18% Similarity=0.301 Sum_probs=212.9
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKAT-----GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
++..++|++.+.||+|+||.||+|..+.. +..||+|.+.... .......+.+|+.+|..++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 35567899999999999999999998654 4789999986543 2234456889999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEE
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK----------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMK 257 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vK 257 (549)
+...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 999999999999999999998542 2478889999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCc
Q 038137 258 LSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337 (549)
Q Consensus 258 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~ 337 (549)
|+|||+++.+....... ......||..|+|||++.+..++.
T Consensus 160 l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ 200 (277)
T cd05032 160 IGDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMAPESLKDGVFTT 200 (277)
T ss_pred ECCcccchhhccCcccc---------------------------------------cCCCCCccccccCHHHHhcCCCCc
Confidence 99999988653221000 001245788999999999889999
Q ss_pred ccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 338 ECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 338 ~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++|+|||||++|||++ |.+||.+.+..+....+. ......+|. .++.++.+||.+||+ +|.+|+ ++.+|++
T Consensus 201 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 273 (277)
T cd05032 201 KSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPE--NCPDKLLELMRMCWQYNPKMRP---TFLEIVS 273 (277)
T ss_pred ccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCCCCC--CCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 9999999999999998 999998877766666555 233344453 578999999999999 999999 7888875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=359.99 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=209.1
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKAT-----GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYC 184 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~ 184 (549)
+..+..++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|..+. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5566788899999999999999999987433 3579999996542 2334567899999999996 999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhc-----------------------------------------------------
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRK----------------------------------------------------- 211 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~----------------------------------------------------- 211 (549)
+|.+...+|||||||+||+|.++|...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999887542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 212 -------------------------------------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 212 -------------------------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2478888999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
|++.++.+||+|||+++.+...... .......|++.|+|||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE 309 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY---------------------------------------VSKGSTFLPVKWMAPE 309 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc---------------------------------------cccCCcCCCcceEChh
Confidence 9999999999999999865321100 0011346888999999
Q ss_pred hhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 329 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 329 vl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
++.+..++.++|||||||++|||++ |..||.+..........+.... ..+....++.++.+||.+||. +|++|+
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RP-- 385 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVYDIMVKCWNSEPEKRP-- 385 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCC--CCCCCccCCHHHHHHHHHHCccCHhHCc--
Confidence 9999999999999999999999997 9999987654444333333222 223334788999999999999 999999
Q ss_pred CCHHHHHc
Q 038137 407 KGADEIKA 414 (549)
Q Consensus 407 ~~~~eil~ 414 (549)
++.+|.+
T Consensus 386 -t~~~l~~ 392 (400)
T cd05105 386 -SFLHLSD 392 (400)
T ss_pred -CHHHHHH
Confidence 5666543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=340.83 Aligned_cols=255 Identities=21% Similarity=0.347 Sum_probs=211.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345779999999999999999999987 78899999886432 22334568889999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEE
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKD-------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKL 258 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL 258 (549)
....|+||||++||+|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.+| .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999986643 589999999999999999999999999999999999998765 6999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcc
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME 338 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~ 338 (549)
+|||+|+.+....... ......+++.|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05036 161 ADFGMARDIYRASYYR---------------------------------------KGGRAMLPIKWMPPEAFLDGIFTSK 201 (277)
T ss_pred ccCccccccCCcccee---------------------------------------cCCCCCccHhhCCHHHHhcCCcCch
Confidence 9999998753211000 0002234568999999999999999
Q ss_pred cccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 339 CDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 339 ~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
+|||||||++|||++ |.+||.+.+.......+... ....+| ..++.++.++|.+||+ +|++|+ ++.++++|
T Consensus 202 ~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~cl~~~p~~Rp---s~~~vl~~ 274 (277)
T cd05036 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPP--KGCPGPVYRIMTDCWQHTPEDRP---NFATILER 274 (277)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 999999999999997 99999987766665554432 223333 3688999999999999 999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=338.68 Aligned_cols=251 Identities=30% Similarity=0.511 Sum_probs=211.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||+|+||.||+|+++.+|+.||||.+.+...........+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999988766555556677889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 197 EYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 197 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
||++|++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.+|.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998853 35689999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.....+|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 200 (267)
T cd08229 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence 001357999999999999999999999999999999999
Q ss_pred hCCCCCCCCCch--hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 353 VGYPPFYSDEPM--STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 353 ~G~~PF~~~~~~--~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
+|..||.+.... .....+... .....+ ...+++++++||.+||. +|.+|+ ++.+|+
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~~i~ 259 (267)
T cd08229 201 ALQSPFYGDKMNLYSLCKKIEQC-DYPPLP-SDHYSEELRQLVNMCINPDPEKRP---DITYVY 259 (267)
T ss_pred hCCCCcccccchHHHHhhhhhcC-CCCCCC-cccccHHHHHHHHHhcCCCcccCC---CHHHHH
Confidence 999999765432 223333221 111122 13578999999999999 999999 788665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=353.75 Aligned_cols=261 Identities=21% Similarity=0.350 Sum_probs=205.9
Q ss_pred eeeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecC
Q 038137 123 TMIGKG--AFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 123 ~~IG~G--~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
..||+| +||+||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||++++++|++.+.+|+||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 999999999999999999999875432 23445778999999999999999999999999999999999999
Q ss_pred CCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccc
Q 038137 201 GGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 201 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
+|+|..++.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.++++|||.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~--- 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK--- 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence 99999998764 4589999999999999999999999999999999999999999999999987643321100000
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHHHhhCCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
. .........++..|+|||++.+ .+|+.++|+|||||++|||++|.+
T Consensus 160 ---------------~----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 160 ---------------V----------------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred ---------------c----------------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0 0000001246678999999986 457899999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccc-------------------------------------------cccCCCCcCCChhHHHHH
Q 038137 357 PFYSDEPMSTCRKIVNWRT-------------------------------------------HLKFPEEAKLSPEAKDLI 393 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~-------------------------------------------~l~~p~~~~~s~~~~dLI 393 (549)
||.+.........++.... .+..+....+++.+++||
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 288 (328)
T cd08226 209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288 (328)
T ss_pred CCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence 9987655444333322110 011111224678899999
Q ss_pred HHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 394 SKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 394 ~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
++||+ ||.+|+ +++|+++||||..+
T Consensus 289 ~~~l~~dP~~Rp---ta~e~l~~~~~~~~ 314 (328)
T cd08226 289 ELCLQQDPEKRP---SASSLLSHAFFKQV 314 (328)
T ss_pred HHHccCCcccCC---CHHHHhhCHHHHHH
Confidence 99999 999999 89999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=351.51 Aligned_cols=261 Identities=27% Similarity=0.453 Sum_probs=209.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
..+|.+.+.||.|+||.||+|.++.+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3689999999999999999999999999999999866532 4456788999999999999999999776643
Q ss_pred --------ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-CCcEEEee
Q 038137 190 --------EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSD 260 (549)
Q Consensus 190 --------~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-~g~vKL~D 260 (549)
..+|+||||++ ++|..++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 46899999996 58888774 457999999999999999999999999999999999999985 55789999
Q ss_pred cCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCccc
Q 038137 261 FGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 339 (549)
Q Consensus 261 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~ 339 (549)
||+++.+....... ......+||..|+|||++.+ ..++.++
T Consensus 159 fg~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 159 FGLARIVDPHYSHK--------------------------------------GYLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred cccceecCCccccc--------------------------------------cccccccccccccCHHHHhCccccCchh
Confidence 99987653211000 00012368999999998765 5689999
Q ss_pred ccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhcc-----------------------ccccCCC---CcCCChhHHHHH
Q 038137 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWR-----------------------THLKFPE---EAKLSPEAKDLI 393 (549)
Q Consensus 340 DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~-----------------------~~l~~p~---~~~~s~~~~dLI 393 (549)
|+|||||++|+|++|..||.+.++......++... .....|. ...++.++++||
T Consensus 201 DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 280 (342)
T cd07854 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFL 280 (342)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHH
Confidence 99999999999999999998876655544433210 0000000 125788999999
Q ss_pred HHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 394 SKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 394 ~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
.+||+ ||.+|+ ++++++.||||+.+.
T Consensus 281 ~~~L~~dP~~R~---t~~ell~h~~~~~~~ 307 (342)
T cd07854 281 EQILTFNPMDRL---TAEEALMHPYMSCYS 307 (342)
T ss_pred HHHhCCCchhcc---CHHHHhCCCcccccc
Confidence 99999 999999 899999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=336.58 Aligned_cols=249 Identities=20% Similarity=0.337 Sum_probs=207.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
..+|++.+.||+|+||.||+|.++ ++..+|+|++.+... ....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 457899999999999999999886 467899999875433 124577899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||++|++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|++||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999999999865 4578999999999999999999999999999999999999999999999999987643110000
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~- 353 (549)
.....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 158 ----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 158 ----------------------------------------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred ----------------------------------------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 001234567999999999999999999999999999998
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|.+||...+..+....+... ...+....+++++.++|.+||+ +|++|+ ++.++++.
T Consensus 198 g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~~~l~~ 254 (256)
T cd05059 198 GKMPYERFSNSEVVESVSAG---YRLYRPKLAPTEVYTIMYSCWHEKPEDRP---AFKKLLSQ 254 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcC---CcCCCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 89999887776666665432 2222234679999999999999 999999 79998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=344.53 Aligned_cols=268 Identities=31% Similarity=0.484 Sum_probs=210.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD------- 188 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 188 (549)
.++|++++.||.|+||.||+|.++.+++.||||++..... .......+.+|..+++.++||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5789999999999999999999999999999999876432 22223456789999999999999999987743
Q ss_pred -CceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 189 -DEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 189 -~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
...+|+||||+.+ +|...+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 3457999999964 67776654 45799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhh
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 345 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlG 345 (549)
.......... +... ........+||+.|+|||++.+ ..++.++|+||||
T Consensus 165 ~~~~~~~~~~--------------~~~~----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 214 (311)
T cd07866 165 YDGPPPNPKG--------------GGGG----------------GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG 214 (311)
T ss_pred ccCCCccccc--------------CCcc----------------cccccccceeccCcCChHHhhCCCccCchhHhHHHH
Confidence 5422110000 0000 0001124678999999999875 4589999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhccccc---------------------cCCC-----CcCCChhHHHHHHHhhh-
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL---------------------KFPE-----EAKLSPEAKDLISKLLC- 398 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~l---------------------~~p~-----~~~~s~~~~dLI~~lL~- 398 (549)
|++|||++|++||.+.+.......+....... ..|. ...+++++.+||.+||.
T Consensus 215 ~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 294 (311)
T cd07866 215 CVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294 (311)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHccc
Confidence 99999999999998887766655554321110 0000 02356789999999999
Q ss_pred cccccCCCCCHHHHHcCCcc
Q 038137 399 NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 399 dp~~Rl~~~~~~eil~HpfF 418 (549)
+|.+|+ ++.+++.||||
T Consensus 295 ~p~~R~---t~~ell~~~~f 311 (311)
T cd07866 295 DPYKRL---TASDALEHPYF 311 (311)
T ss_pred CcccCc---CHHHHhcCCCC
Confidence 999999 89999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=327.89 Aligned_cols=251 Identities=37% Similarity=0.571 Sum_probs=216.7
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|..+++.++|++|++++++|.++...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999999999999999976542 345678899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 198 YLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 198 y~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|++|++|.+++... ..+++..+..++.+++.||.+||..|++||||+|+||+++.+|.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999998765 6899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.....|+..|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 154 --------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 195 (253)
T cd05122 154 --------------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195 (253)
T ss_pred --------------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 013578999999999998889999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
||...+.......+.. .....++....++..+.++|.+||. ||.+|+ ++.+++.|||
T Consensus 196 p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~---t~~~~l~~~~ 253 (253)
T cd05122 196 PYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253 (253)
T ss_pred CCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCC---CHHHHhcCCC
Confidence 9987765544433332 2233344433458999999999999 999999 8999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=333.72 Aligned_cols=252 Identities=31% Similarity=0.518 Sum_probs=211.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|+.+++.++|++|++++++|.+.+..|+||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999998665555556778999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 197 EYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 197 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
||++||+|..++.. ...+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999998854 34589999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 011357899999999999999999999999999999999
Q ss_pred hCCCCCCCCCch--hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 353 VGYPPFYSDEPM--STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 353 ~G~~PF~~~~~~--~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|..||...... .....+... .....|. ..++.++.++|.+||. +|.+|+ ++.+|+.
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp---~~~~il~ 260 (267)
T cd08224 201 ALQSPFYGDKMNLYSLCKKIEKC-DYPPLPA-DHYSEELRDLVSRCINPDPEKRP---DISYVLQ 260 (267)
T ss_pred HCCCCcccCCccHHHHHhhhhcC-CCCCCCh-hhcCHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 999999765421 222222221 1122222 2578899999999999 999999 7877763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=339.71 Aligned_cols=255 Identities=31% Similarity=0.544 Sum_probs=212.2
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--ceEEEEE
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--EYLYLIM 196 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~lylVm 196 (549)
|++++.||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+. ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999998764 2344456688899999999999999999999988 8999999
Q ss_pred eecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++ ++|.+++.+. ..+++..++.++.||+.||.|||+.|++|+||||+||+++.+|.+||+|||++.........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 9997 4898888665 68999999999999999999999999999999999999999999999999998865422100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G 354 (549)
......++..|+|||.+.+ ..++.++|+|||||++|||++|
T Consensus 157 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 157 --------------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred --------------------------------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC
Confidence 0012467889999998775 4689999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccc---cCCCC-----------------------cC-CChhHHHHHHHhhh-cccccCCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHL---KFPEE-----------------------AK-LSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l---~~p~~-----------------------~~-~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
++||.+.+......++....... .++.. .. +++++.++|.+||+ +|.+|+
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-- 276 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI-- 276 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc--
Confidence 99999887766655554321100 00000 12 38899999999999 999999
Q ss_pred CCHHHHHcCCcc
Q 038137 407 KGADEIKAHPWF 418 (549)
Q Consensus 407 ~~~~eil~HpfF 418 (549)
++.+++.||||
T Consensus 277 -~~~~~l~~~~~ 287 (287)
T cd07840 277 -SADQALQHEYF 287 (287)
T ss_pred -CHHHHhhCcCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=346.92 Aligned_cols=254 Identities=20% Similarity=0.347 Sum_probs=208.7
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHV----YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
+...+|++++.||+|+||.||+|.+..+|.. ||||++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4567899999999999999999998776664 8999986432 233446688899999999999999999998865
Q ss_pred ceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..++|+||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999998764 568999999999999999999999999999999999999999999999999998754
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..... .......+|..|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~---------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l 201 (316)
T cd05108 161 ADEKE---------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201 (316)
T ss_pred CCCcc---------------------------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHH
Confidence 21100 000123456789999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||++ |.+||.+....+. ..++.... ..|....++.++.++|.+||. +|.+|+ ++.+++.+
T Consensus 202 ~el~t~g~~p~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~l~~~ 264 (316)
T cd05108 202 WELMTFGSKPYDGIPASEI-SSILEKGE--RLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 264 (316)
T ss_pred HHHHcCCCCCCCCCCHHHH-HHHHhCCC--CCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99997 9999987655443 34444322 334344678999999999999 999999 78888875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=348.88 Aligned_cols=274 Identities=27% Similarity=0.442 Sum_probs=216.2
Q ss_pred CCeee-eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchh-----------hHHHHHHHHHHHHhcCCCceeeeee
Q 038137 117 DDFEP-LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRG-----------QVEHVKAERNLLAEVDSNCIVKLYC 184 (549)
Q Consensus 117 ~~f~~-~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~-----------~~~~~~~E~~iL~~l~hp~Iv~l~~ 184 (549)
++|.. .+.||.|+||+||+|.++.+++.||+|++......... ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 47799999999999999999999999998765432210 0124678999999999999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
+|...+.+|+||||+. |+|..++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988888999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccch
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 343 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWS 343 (549)
............ .. +... . . +.......+++.|+|||++.+. .++.++|+||
T Consensus 167 ~~~~~~~~~~~~-------~~----~~~~--~-------------~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 219 (335)
T PTZ00024 167 RRYGYPPYSDTL-------SK----DETM--Q-------------R-REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219 (335)
T ss_pred eecccccccccc-------cc----cccc--c-------------c-cccccccccccCCCCChhcccCCCCCcHHHHHH
Confidence 876432211000 00 0000 0 0 0011234689999999999764 4799999999
Q ss_pred hhHHHHHHhhCCCCCCCCCchhhhhhhhhccc---------cccCC----------C-----CcCCChhHHHHHHHhhh-
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT---------HLKFP----------E-----EAKLSPEAKDLISKLLC- 398 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~---------~l~~p----------~-----~~~~s~~~~dLI~~lL~- 398 (549)
|||++|||++|.+||.+.+.......+..... ....| . ....+.++.+||.+||.
T Consensus 220 lG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 99999999999999998887776666543211 10000 0 12457889999999999
Q ss_pred cccccCCCCCHHHHHcCCcccCC
Q 038137 399 NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 399 dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+|++|+ +++|++.||||++.
T Consensus 300 ~P~~R~---s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 300 NPLERI---SAKEALKHEYFKSD 319 (335)
T ss_pred Cchhcc---CHHHHhcCcccCCC
Confidence 999999 89999999999854
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.56 Aligned_cols=257 Identities=29% Similarity=0.496 Sum_probs=214.8
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce---
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY--- 191 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~--- 191 (549)
..++|++++.||+|+||.||+|++..++..||||++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3678999999999999999999999999999999986542 223345667889999999999999999988876654
Q ss_pred ---EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 192 ---LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 192 ---lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+|+||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 99999999 7799888854 579999999999999999999999999999999999999999999999999987542
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 347 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvi 347 (549)
.. ....+||+.|+|||++.+ ..++.++|+|||||+
T Consensus 170 ~~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~ 205 (343)
T cd07851 170 DE--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205 (343)
T ss_pred cc--------------------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHH
Confidence 11 013478999999999876 468999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhccccc--------------------c------CCC-CcCCChhHHHHHHHhhh-c
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHL--------------------K------FPE-EAKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~l--------------------~------~p~-~~~~s~~~~dLI~~lL~-d 399 (549)
+|||++|++||.+.+....+..+.+..... . ++. ...+|+++.|||.+||+ +
T Consensus 206 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~ 285 (343)
T cd07851 206 MAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLD 285 (343)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCC
Confidence 999999999998887766666554421110 0 000 02468999999999999 9
Q ss_pred ccccCCCCCHHHHHcCCcccCC
Q 038137 400 VEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 400 p~~Rl~~~~~~eil~HpfF~~i 421 (549)
|.+|+ ++.+|+.||||...
T Consensus 286 P~~Rp---t~~ell~h~~~~~~ 304 (343)
T cd07851 286 PDKRI---TAAEALAHPYLAEY 304 (343)
T ss_pred hhhCC---CHHHHhcCCCcccc
Confidence 99999 89999999999854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=333.27 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=202.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg 202 (549)
+.||+|+||.||+|.++.+|+.||+|.+.+.. .......+.+|..+++.++||||+++++++.+...+|+||||++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36999999999999999999999999886432 2334567889999999999999999999999999999999999999
Q ss_pred chhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 203 DMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 203 ~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence 999998654 468999999999999999999999999999999999999999999999999987543110000
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 360 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~ 360 (549)
. .....++..|+|||++.+..++.++|+|||||++|||++ |.+||..
T Consensus 152 --------~------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 152 --------T------------------------GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred --------c------------------------CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 0 001123567999999999999999999999999999997 9999987
Q ss_pred CCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 361 ~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
.+.......+... ....+| ..++..+.+||.+||+ +|++|+ ++.++++
T Consensus 200 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 248 (252)
T cd05084 200 LSNQQTREAIEQG-VRLPCP--ELCPDAVYRLMERCWEYDPGQRP---SFSTVHQ 248 (252)
T ss_pred cCHHHHHHHHHcC-CCCCCc--ccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 6665555544432 222333 3678999999999999 999999 7888763
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=331.72 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=211.8
Q ss_pred eeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeec
Q 038137 123 TMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYL 199 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~ 199 (549)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+.++..++|++|+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8999999997654322 4677899999999999999999999999999999999999
Q ss_pred CCCchhhHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 200 PGGDMMTLLMRK---------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 200 ~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999775 78999999999999999999999999999999999999999999999999999876422
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
... .......+++.|+|||.+....++.++|+|||||++||
T Consensus 159 ~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 199 (262)
T cd00192 159 DYY---------------------------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199 (262)
T ss_pred ccc---------------------------------------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHH
Confidence 100 00113568899999999998899999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|++ |.+||.+.+.......+.. ......| ..+|+++.++|.+||+ +|.+|+ ++.+++.|
T Consensus 200 l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 260 (262)
T cd00192 200 IFTLGATPYPGLSNEEVLEYLRK-GYRLPKP--EYCPDELYELMLSCWQLDPEDRP---TFSELVER 260 (262)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHc-CCCCCCC--ccCChHHHHHHHHHccCCcccCc---CHHHHHHh
Confidence 999 6999998877777776664 2233334 3679999999999999 999999 89999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=350.29 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=210.6
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-----
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD----- 189 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~----- 189 (549)
..++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.++..++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 35889999999999999999999999999999999976422 222345678899999999999999999888643
Q ss_pred -ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 -EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 -~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..+|+|++++ |++|..++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 4578999987 8899887754 469999999999999999999999999999999999999999999999999987542
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 347 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvi 347 (549)
.. .....||+.|+|||++.+ ..++.++|+|||||+
T Consensus 172 ~~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i 207 (345)
T cd07877 172 DE--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207 (345)
T ss_pred cc--------------------------------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHH
Confidence 11 013478999999999876 578999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhcccc---------------------ccCCC------CcCCChhHHHHHHHhhh-c
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTH---------------------LKFPE------EAKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~---------------------l~~p~------~~~~s~~~~dLI~~lL~-d 399 (549)
+|||++|++||.+.+.......++..... ...|. ....++++++||.+||+ |
T Consensus 208 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 287 (345)
T cd07877 208 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 287 (345)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCC
Confidence 99999999999877665544444321100 01111 01358899999999999 9
Q ss_pred ccccCCCCCHHHHHcCCcccCC
Q 038137 400 VEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 400 p~~Rl~~~~~~eil~HpfF~~i 421 (549)
|.+|+ ++.+++.||||+..
T Consensus 288 p~~R~---t~~e~l~h~~f~~~ 306 (345)
T cd07877 288 SDKRI---TAAQALAHAYFAQY 306 (345)
T ss_pred hhhcC---CHHHHhcChhhhhc
Confidence 99999 79999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=328.50 Aligned_cols=256 Identities=34% Similarity=0.552 Sum_probs=218.0
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--ceEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--EYLYLI 195 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~lylV 195 (549)
+|.+.+.||+|++|.||+|.+..++..|++|++...... ......+.+|+.+++.++||||+++++.+.+. ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 478889999999999999999999999999999765432 34567789999999999999999999999988 899999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++|++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.+|.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988779999999999999999999999999999999999999999999999999998876432100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.......++..|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 158 -------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 158 -------------------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred -------------------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 0001357899999999999888999999999999999999999
Q ss_pred CCCCCCC-chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 356 PPFYSDE-PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 356 ~PF~~~~-~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
.||...+ .......+........+|. .++..+++||.+||. +|.+|+ ++.+++.||||
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 260 (260)
T cd06606 201 PPWSELGNPMAALYKIGSSGEPPEIPE--HLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260 (260)
T ss_pred CCCCCCCchHHHHHhccccCCCcCCCc--ccCHHHHHHHHHhCcCChhhCC---CHHHHhhCCCC
Confidence 9998765 2222233332222333443 668999999999999 999999 89999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=339.92 Aligned_cols=257 Identities=21% Similarity=0.358 Sum_probs=212.9
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKAT-----GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCS 185 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 185 (549)
..+..++|++.+.||+|+||.||+|..+.. ...||+|.+.... .......+.+|+.++..+ +|+||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 355667899999999999999999998644 3789999987542 223456688999999999 89999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeE
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMR----------------KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLL 249 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~----------------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNIL 249 (549)
+.++..+|+||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 9999999999999999999999854 246899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchh
Q 038137 250 LDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEV 329 (549)
Q Consensus 250 ld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEv 329 (549)
++.++.+||+|||+++.+....... ......+++.|+|||+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~ 205 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR---------------------------------------KTTNGRLPVKWMAPEA 205 (293)
T ss_pred EcCCCeEEeCcccccccccccccee---------------------------------------ccCCCCCCccccCHHH
Confidence 9999999999999998754221000 0001235678999999
Q ss_pred hccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 330 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 330 l~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
+.+..++.++|||||||++|||++ |..||.+.+..+.+..+... .....| ..++.++.+||.+||. +|.+|+
T Consensus 206 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp--- 279 (293)
T cd05053 206 LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRMEKP--QNCTQELYHLMRDCWHEVPSQRP--- 279 (293)
T ss_pred hccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCc---
Confidence 999999999999999999999997 99999887776666655432 222333 3678999999999999 999999
Q ss_pred CHHHHHcC
Q 038137 408 GADEIKAH 415 (549)
Q Consensus 408 ~~~eil~H 415 (549)
++.+++++
T Consensus 280 s~~eil~~ 287 (293)
T cd05053 280 TFKQLVED 287 (293)
T ss_pred CHHHHHHH
Confidence 79998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=337.62 Aligned_cols=253 Identities=19% Similarity=0.328 Sum_probs=207.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGH----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
+..++|++++.||+|+||.||+|.+..+|. .||+|++.... .......+.+|+.++..++||||+++++++.+.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 457889999999999999999999877776 48999986532 233345688899999999999999999998764
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..+++|||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+++...
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 57899999999999999966 4579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... ......+++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05109 161 IDETEY---------------------------------------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTV 201 (279)
T ss_pred ccccee---------------------------------------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHH
Confidence 211000 00022456789999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||...........+.. .. ..+....++.++.++|.+||. ||.+|+ ++.+++.
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rp---~~~~l~~ 263 (279)
T cd05109 202 WELMTFGAKPYDGIPAREIPDLLEK-GE--RLPQPPICTIDVYMIMVKCWMIDSECRP---RFRELVD 263 (279)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHC-CC--cCCCCccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99998 9999987665554443332 12 223334689999999999999 999999 7888874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.54 Aligned_cols=251 Identities=20% Similarity=0.339 Sum_probs=209.8
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
++..++|++.+.||+|+||.||+|.+.. ++.||||.+..... ..+.+.+|+.+++.++||||+++++++...+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence 3556789999999999999999998754 56899999876532 234578899999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
|+||||++|++|.+++.... .+++..+..++.+++.||.|||+.||+||||||+||+++.+|.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999996643 6899999999999999999999999999999999999999999999999999876411
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... .....++..|+|||++.+..++.++|+|||||++||
T Consensus 157 ~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 196 (261)
T cd05068 157 IYEA----------------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTE 196 (261)
T ss_pred cccc----------------------------------------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHH
Confidence 0000 001233468999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++ |++||.+.+.......+... ...+....++..+.++|.+||. +|.+|+ ++.+|..
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~P~~Rp---~~~~l~~ 256 (261)
T cd05068 197 IVTYGRMPYPGMTNAEVLQQVDQG---YRMPCPPGCPKELYDIMLDCWKEDPDDRP---TFETLQW 256 (261)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHhhcCcccCC---CHHHHHH
Confidence 999 99999988777666666532 2223334678999999999999 999999 6777653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.70 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=212.4
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
..++|++.+.||+|+||.||+|..+.+ ...||||++.... .......+.+|..++..++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 356899999999999999999998654 4589999987543 23345668889999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+|+||||++||+|.+++... +.+++..+..++.+++.||.|||++||+||||||+|||++.+++++|+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999998653 57999999999999999999999999999999999999999999999999999876411
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
... .......+++.|+|||.+.+..++.++|+|||||++|+
T Consensus 160 ~~~---------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~ 200 (266)
T cd05033 160 EAT---------------------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200 (266)
T ss_pred ccc---------------------------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHH
Confidence 000 00012345778999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|++ |..||...........+... ...|....+++.+.+||.+||. +|.+|+ ++.+|++|
T Consensus 201 l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~ei~~~ 261 (266)
T cd05033 201 VMSYGERPYWDMSNQDVIKAVEDG---YRLPPPMDCPSALYQLMLDCWQKDRNERP---TFSQIVST 261 (266)
T ss_pred HHccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 997 99999877766666666542 2223334679999999999999 999999 78888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=338.59 Aligned_cols=253 Identities=22% Similarity=0.396 Sum_probs=211.0
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+...+|.+.+.||+|+||.||+|... .++..+|+|.+.+.. ......+.+|++++..++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 44567899999999999999999753 356789999887542 3345678999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK---------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN 253 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~ 253 (549)
....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 99999999999999999998654 248999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC
Q 038137 254 GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333 (549)
Q Consensus 254 g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~ 333 (549)
+.+||+|||++......... .......+++.|+|||++.+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~ 199 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY---------------------------------------RVGGRTMLPIRWMPPESILYR 199 (280)
T ss_pred CCEEECCCCceeEcCCCcee---------------------------------------ecCCCccccccccCHHHhccC
Confidence 99999999998754311000 000123567899999999999
Q ss_pred CCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHH
Q 038137 334 GYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411 (549)
Q Consensus 334 ~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 411 (549)
.++.++|+|||||++|||++ |.+||...........+..+. ....| ..+++.+.+||.+||+ ||.+|+ ++++
T Consensus 200 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~P~~Rp---~~~~ 273 (280)
T cd05092 200 KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERP--RTCPPEVYAIMQGCWQREPQQRM---VIKD 273 (280)
T ss_pred CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHH
Confidence 99999999999999999998 999998877776666665532 22333 3688999999999999 999999 6887
Q ss_pred HHc
Q 038137 412 IKA 414 (549)
Q Consensus 412 il~ 414 (549)
|+.
T Consensus 274 l~~ 276 (280)
T cd05092 274 IHS 276 (280)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=332.01 Aligned_cols=231 Identities=30% Similarity=0.511 Sum_probs=195.2
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCchhhH
Q 038137 128 GAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL 207 (549)
Q Consensus 128 G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~ 207 (549)
|.||.||+|+++.+|+.||+|++.+... ...|+..+....||||+++++++++.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 23455555566799999999999999999999999999999999
Q ss_pred hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCc
Q 038137 208 LMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287 (549)
Q Consensus 208 l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~ 287 (549)
+.+...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++..+...
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------------- 138 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------------- 138 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------------
Confidence 988888999999999999999999999999999999999999999999999999987654311
Q ss_pred cCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhh
Q 038137 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTC 367 (549)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~ 367 (549)
.....++..|+|||++.+..++.++|+||+||++|||++|++||......
T Consensus 139 ---------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--- 188 (237)
T cd05576 139 ---------------------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--- 188 (237)
T ss_pred ---------------------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---
Confidence 01245678899999998888999999999999999999999998643211
Q ss_pred hhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcc
Q 038137 368 RKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWF 418 (549)
Q Consensus 368 ~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF 418 (549)
......+.+| ..+++.+++||.+||+ ||.+|++. .+++++++||||
T Consensus 189 ---~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 189 ---INTHTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ---cccccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1111223344 3689999999999999 99999964 357999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=333.04 Aligned_cols=244 Identities=24% Similarity=0.379 Sum_probs=202.4
Q ss_pred eeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 124 MIGKGAFGEVRVCRE--KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~--k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
.||+|+||.||+|.. +.++..||||++.... ......+.+.+|+.+++.++||||+++++++.+ +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 5678899999986543 233455778999999999999999999998864 567999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~------- 152 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY------- 152 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence 9999999887889999999999999999999999999999999999999999999999999998654221000
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 360 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~ 360 (549)
.......+++.|+|||++.+..++.++|+|||||++|||++ |.+||.+
T Consensus 153 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 153 -------------------------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred -------------------------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 00012345689999999988889999999999999999997 9999988
Q ss_pred CCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 361 ~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
.+.......+.+. .....| ..+++++++||.+||+ ||.+|+ ++++|.
T Consensus 202 ~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~~~~~p~~Rp---~~~~i~ 249 (257)
T cd05116 202 MKGNEVTQMIESG-ERMECP--QRCPPEMYDLMKLCWTYGVDERP---GFAVVE 249 (257)
T ss_pred CCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHhccCchhCc---CHHHHH
Confidence 7776666665542 233444 3689999999999999 999999 666664
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=334.13 Aligned_cols=251 Identities=21% Similarity=0.324 Sum_probs=206.2
Q ss_pred eeeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 119 FEPLTMIGKGAFGEVRVCREKA---TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
|.+.+.||+|+||.||.|.... ++..||||.++... ........+.+|+.+++.++||||+++++++.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5678899999999999998765 34789999987542 23344567899999999999999999998776544
Q ss_pred -eEEEEEeecCCCchhhHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRK------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
..++||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 389999999999999988432 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccch
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWS 343 (549)
++......... ......++..|+|||++.+..++.++||||
T Consensus 160 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~S 200 (273)
T cd05035 160 SKKIYSGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRVYTSKSDVWA 200 (273)
T ss_pred eeecccccccc---------------------------------------ccccccCCccccCHhhcccCCCCcccchHH
Confidence 98653221000 000224567899999998899999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 344 LGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 344 lGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||++|||++ |.+||.+.+..+....+... .....| ..++.++.++|.+||. ||.+|+ ++.+++.+
T Consensus 201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~e~~~~ 268 (273)
T cd05035 201 FGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQP--EDCLDELYDLMYSCWRADPKDRP---TFTKLREV 268 (273)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999999 99999888777766666543 233344 3689999999999999 999999 78888763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=342.04 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=212.0
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCRE-----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCS 185 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 185 (549)
.++..++|.+.+.||+|+||.||+|.+ ..++..||+|++++.. .....+.+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 456677899999999999999999975 3456689999987542 233456788999999999 79999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
|.+.+.+|+||||+++|+|..++.... .+++..+..++.+++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999986543 389999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccch
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWS 343 (549)
++.+...... .......+++.|+|||++.+..++.++||||
T Consensus 188 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 228 (302)
T cd05055 188 ARDIMNDSNY---------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWS 228 (302)
T ss_pred cccccCCCce---------------------------------------eecCCCCcccccCCHhhhccCCCCcHhHHHH
Confidence 9865321100 0001235678999999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 344 LGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 344 lGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++|||++ |.+||.+........+.+... ...+....+++++.+||.+||. +|++|+ ++.+++.
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ell~ 296 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG--YRMAQPEHAPAEIYDIMKTCWDADPLKRP---TFKQIVQ 296 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC--CcCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 9999999998 999998877665555554322 2222233678999999999998 999999 7888874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=340.98 Aligned_cols=260 Identities=30% Similarity=0.502 Sum_probs=211.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc---
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE--- 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~--- 190 (549)
...++|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|..+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 346789999999999999999999999999999999975432 2233456778999999999999999999987655
Q ss_pred -------eEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecC
Q 038137 191 -------YLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFG 262 (549)
Q Consensus 191 -------~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFG 262 (549)
.+|+||||+++ ++..++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999976 66666654 4579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCccccc
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 341 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~Di 341 (549)
++..+...... ......+++.|+|||++.+ ..++.++||
T Consensus 162 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 201 (302)
T cd07864 162 LARLYNSEESR----------------------------------------PYTNKVITLWYRPPELLLGEERYGPAIDV 201 (302)
T ss_pred ccccccCCccc----------------------------------------ccccceeccCccChHHhcCCCCCCchhHH
Confidence 99865422100 0012357889999999875 457999999
Q ss_pred chhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccc---cCC-----------------------CCcCCChhHHHHHHH
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL---KFP-----------------------EEAKLSPEAKDLISK 395 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l---~~p-----------------------~~~~~s~~~~dLI~~ 395 (549)
|||||++|||++|++||...+....+..+....... .+| ....+++.+.+||.+
T Consensus 202 ~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 281 (302)
T cd07864 202 WSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDH 281 (302)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHH
Confidence 999999999999999998877666555544311100 000 012468999999999
Q ss_pred hhh-cccccCCCCCHHHHHcCCcc
Q 038137 396 LLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 396 lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
||. +|.+|+ ++.+|+.||||
T Consensus 282 ~l~~~P~~Rp---~~~~il~~~~~ 302 (302)
T cd07864 282 MLTLDPSKRC---TAEEALNSPWL 302 (302)
T ss_pred HccCChhhCC---CHHHHhcCCCC
Confidence 999 999999 89999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=327.88 Aligned_cols=253 Identities=34% Similarity=0.602 Sum_probs=219.4
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||.|+||.||+|.+..++..||+|++..... .......+..|+++++.++|||++++++.+.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999999999999999976543 23445668899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 198 YLPGGDMMTLLMRK----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 198 y~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
|++|++|..++.+. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999998663 789999999999999999999999999999999999999999999999999987653211
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
......+|++.|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 158 ---------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 158 ---------------------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred ---------------------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc
Confidence 00124579999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|..||...+.......+... .....| ..++.++.++|.+||. +|.+|+ ++.+++.||||
T Consensus 199 g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---~~~~ll~~~~~ 258 (258)
T cd08215 199 LKHPFEGENLLELALKILKG-QYPPIP--SQYSSELRNLVSSLLQKDPEERP---SIAQILQSPFI 258 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCCCC
Confidence 99999887766665555442 222333 3688999999999999 999999 89999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=371.48 Aligned_cols=305 Identities=37% Similarity=0.634 Sum_probs=260.2
Q ss_pred eeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEEEeec
Q 038137 124 MIGKGAFGEVRVCRE---KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLIMEYL 199 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~---k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmEy~ 199 (549)
++|.|+||.|++|+. ...|..||||++++.....+... +...|+.++..++ ||++|++.+.||.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999999875 45688999999998776555444 8889999999997 999999999999999999999999
Q ss_pred CCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccc
Q 038137 200 PGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279 (549)
Q Consensus 200 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~ 279 (549)
.||+|.+.+.....+++...++|.++++.|++++|+.||||||+|++||+++.+||++++|||+++..-...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999999999999999999999999999999999999999999999999999999999999998653110
Q ss_pred cCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCC
Q 038137 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 359 (549)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~ 359 (549)
..|||..|||||++. ++..++||||+|+++|||++|..||.
T Consensus 152 -------------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 152 -------------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred -------------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 139999999999997 88999999999999999999999998
Q ss_pred CCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--cccCCCc
Q 038137 360 SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIKAAFI 434 (549)
Q Consensus 360 ~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~~~pf~ 434 (549)
+ ++...|.. ..+.+|. .++..+++++..|+. +|.+|+|. .+++||++|+||..++|..+. ...|||.
T Consensus 193 ~----~~~~~Il~--~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fk 264 (612)
T KOG0603|consen 193 G----DTMKRILK--AELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFK 264 (612)
T ss_pred h----HHHHHHhh--hccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCC
Confidence 8 66677765 3455554 799999999999999 99999998 489999999999999999876 5889999
Q ss_pred ccCCCccccccccccccccccccccccCCcccccccccccccccceeeCccccCC
Q 038137 435 PEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFEIVND 489 (549)
Q Consensus 435 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~ 489 (549)
|.+..+.|+.+|+.+.....+......+ ...+...-|.||+|..+.++-+
T Consensus 265 p~~~~e~~~~~fd~eft~~~P~dsp~~~-----~~~s~~~if~g~sfva~~il~~ 314 (612)
T KOG0603|consen 265 PGSITERDVAQFDPEFTSQVPADSPLLS-----ASGSDHTIFSGPSFVAPGVLED 314 (612)
T ss_pred CcccchhhhhhcCchhccCCcccCCCCC-----CCccccchhcCCCccChHHhhc
Confidence 9999999999999744433222211111 1122346789999988776554
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=392.96 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=221.3
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
++-...||.|.||.||-|.+..||...|||-++-.... ......+.+|..+|..++|||+|+.|++-.+.+.+||.|||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 44556899999999999999999999999988755443 44556788999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
|.||+|.+++...+..+|...+.|..|++.||.|||++|||||||||+||+|+.+|.+|++|||.|..+......
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~----- 1390 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT----- 1390 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc-----
Confidence 999999999998889999999999999999999999999999999999999999999999999999987533100
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchhhHHHHHHhhCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSlGvilyEml~G~ 355 (549)
. ...+ .+.+|||.|||||++.+ +|.+.+.|||||||++.||+||+
T Consensus 1391 ----------~-----------~~el-----------~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1391 ----------M-----------PGEL-----------QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred ----------C-----------CHHH-----------HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCC
Confidence 0 0011 25799999999999985 67899999999999999999999
Q ss_pred CCCCCCC-chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 356 PPFYSDE-PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 356 ~PF~~~~-~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
.||..-+ ...+..++-. ....++|+ .+|++.+|||.+||. ||..|. ++.||+.|.|=+
T Consensus 1439 rPW~~~dne~aIMy~V~~-gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw---~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1439 RPWAELDNEWAIMYHVAA-GHKPQIPE--RLSSEGRDFLEHCLEQDPKMRW---TASQLLEHAFGK 1498 (1509)
T ss_pred CchhhccchhHHHhHHhc-cCCCCCch--hhhHhHHHHHHHHHhcCchhhh---HHHHHHHhhccc
Confidence 9997644 3344444433 35667887 599999999999998 999998 788999999865
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=339.79 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=210.7
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
..+..++|++.+.||+|+||.||+|.+..+|+.||||.+.+... ......+..|..++... +||||++++++|.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 35667899999999999999999999999999999999976532 22234455677666555 5999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+||||++ ++|.+++.. ...+++..+..++.+++.||.|||+ .||+||||+|+||+++.++.+||+|||++..+.
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999984 577777655 4679999999999999999999997 699999999999999999999999999987653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC----CCcccccchh
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSL 344 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~----y~~~~DiWSl 344 (549)
.... .....|++.|+|||++.+.. ++.++|+|||
T Consensus 167 ~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 204 (296)
T cd06618 167 DSKA------------------------------------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204 (296)
T ss_pred CCCc------------------------------------------ccCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence 2100 01235888999999997553 8899999999
Q ss_pred hHHHHHHhhCCCCCCCCCc-hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 345 GAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||++|+|++|++||..... .+.+.+++.. ....++....++.++.+||.+||. ||.+|+ ++++|+.||||..
T Consensus 205 G~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~il~~~~~~~ 278 (296)
T cd06618 205 GISLVELATGQFPYKNCKTEFEVLTKILQE-EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP---KYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHhCCCCCCcchhHHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhc
Confidence 9999999999999976432 3344444432 222333333578999999999999 999999 8999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=342.55 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=212.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
..|+.++.||+|+||.||+|+++.++..||+|.+.............+.+|+.+++.++|+||+++++++.+....|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777889999999999999999999999999987543333444566788999999999999999999999999999999
Q ss_pred eecCCCchhhHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||+. |+|..++. ....+++..++.++.+++.||.|||+.|++||||||+|||++.+|.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 9996 57777664 3567999999999999999999999999999999999999999999999999998754211
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhhHHHHHHh
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEml 352 (549)
...+||+.|+|||++. ...++.++|||||||++|+|+
T Consensus 169 ----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 208 (308)
T cd06634 169 ----------------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208 (308)
T ss_pred ----------------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHH
Confidence 1346899999999985 356789999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+|..||...+.......+.... ........++..+++||.+||. +|.+|+ ++++++.||||...
T Consensus 209 ~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~Rp---~~~~ll~~~~~~~~ 273 (308)
T cd06634 209 ERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRE 273 (308)
T ss_pred cCCCCCccccHHHHHHHHhhcC--CCCcCcccccHHHHHHHHHHhhCCcccCC---CHHHHhhCcccccc
Confidence 9999998766555444444321 1111123678999999999999 999999 89999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=339.66 Aligned_cols=254 Identities=20% Similarity=0.319 Sum_probs=211.6
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKAT-----GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+...+|++++.||+|+||.||+|.+..+ +..||||++.... .....+.+..|..++..++||||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456788899999999999999987543 5789999997542 22334668899999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMR----------------KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR 252 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~----------------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~ 252 (549)
...+++++||+++++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 9999999999999999999842 235888999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc
Q 038137 253 NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332 (549)
Q Consensus 253 ~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~ 332 (549)
++.+||+|||+++........ .......+++.|+|||++.+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY---------------------------------------KLMGNSLLPIRWMSPEAIMY 200 (283)
T ss_pred CCceEecccccccccccchhe---------------------------------------eeccCccCCccccCHHHHhc
Confidence 999999999998865321100 00113457889999999998
Q ss_pred CCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHH
Q 038137 333 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410 (549)
Q Consensus 333 ~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 410 (549)
..++.++|||||||++|||++ |.+||.+.+..+....+... .....| ..++..+.+||.+||. +|.+|+ ++.
T Consensus 201 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~RP---~~~ 274 (283)
T cd05091 201 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR-QVLPCP--DDCPAWVYTLMLECWNEFPSRRP---RFK 274 (283)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHhCCCcccCC---CHH
Confidence 899999999999999999998 99999988777777766653 222333 3688999999999999 999999 799
Q ss_pred HHHc
Q 038137 411 EIKA 414 (549)
Q Consensus 411 eil~ 414 (549)
+|+.
T Consensus 275 ~i~~ 278 (283)
T cd05091 275 DIHS 278 (283)
T ss_pred HHHH
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.09 Aligned_cols=246 Identities=22% Similarity=0.411 Sum_probs=209.1
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.+....+.+++.||+|-||+||+|....+ ..||+|.++...+. .+.+.+|+.||+.++|++||+||+++..++.+
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 34444566789999999999999998743 37899999765432 35577999999999999999999999998899
Q ss_pred EEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 193 YLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
|||||||+.|+|.++|.. ...+...+...+++||+.|++||+++++|||||-..|||++.++.+||+|||||+.+..+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999999976 567999999999999999999999999999999999999999999999999999954422
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
..... . +.--..-|.|||.+....++.++|||||||+|||
T Consensus 357 ~Y~~~--------------~--------------------------~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E 396 (468)
T KOG0197|consen 357 EYTAS--------------E--------------------------GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWE 396 (468)
T ss_pred ceeec--------------C--------------------------CCCCCceecCHHHHhhCCcccccceeehhhhHHH
Confidence 11000 0 0112346999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
|+| |+.||.+.+..+....+-. -.++|.+..+++++-+++..|+. +|++||..
T Consensus 397 ~fT~G~~py~~msn~ev~~~le~---GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 397 LFTYGRVPYPGMSNEEVLELLER---GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTF 451 (468)
T ss_pred HhccCCCCCCCCCHHHHHHHHhc---cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCH
Confidence 998 9999999998888887765 34556666899999999999999 99999943
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=345.22 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=205.3
Q ss_pred eeeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecC
Q 038137 123 TMIGKG--AFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 123 ~~IG~G--~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
.+||+| ++|.||+++.+.+|+.||||++.... ........+..|+.+++.++||||++++++|.+.+.+|++|||++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 345554 56777888888899999999997653 234466789999999999999999999999999999999999999
Q ss_pred CCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccc
Q 038137 201 GGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 201 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
+|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||.+..+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~-- 160 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV-- 160 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc--
Confidence 99999998653 56899999999999999999999999999999999999999999999999998765321100000
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHHHhhCCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.........++..|+|||++.+ .+|+.++|+|||||++|||++|.+
T Consensus 161 --------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 161 --------------------------------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred --------------------------------cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 0000113568889999999976 468999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhcc------------------------------ccccCCCCcCCChhHHHHHHHhhh-cccccCC
Q 038137 357 PFYSDEPMSTCRKIVNWR------------------------------THLKFPEEAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~------------------------------~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
||.+..........+... .....+....++.++.+||.+||+ ||.+|+
T Consensus 209 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp- 287 (314)
T cd08216 209 PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP- 287 (314)
T ss_pred CCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc-
Confidence 998765433221111100 000001112346789999999999 999999
Q ss_pred CCCHHHHHcCCcccCC
Q 038137 406 TKGADEIKAHPWFKGI 421 (549)
Q Consensus 406 ~~~~~eil~HpfF~~i 421 (549)
+++++++||||+.+
T Consensus 288 --t~~~ll~~p~~~~~ 301 (314)
T cd08216 288 --SASQLLNHSFFKQC 301 (314)
T ss_pred --CHHHHhcCchHhhh
Confidence 89999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.63 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=210.5
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
...+|++.+.||+|+||.||+|.++.++. .||+|.+.... .......+.+|..++..++||||+++++++.+++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35679999999999999999999875543 79999986542 23345678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999764 56899999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... .......++..|+|||++.+..++.++|+|||||++||
T Consensus 160 ~~~~--------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~e 201 (267)
T cd05066 160 PEAA--------------------------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201 (267)
T ss_pred ccee--------------------------------------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHH
Confidence 1000 00001234678999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++ |..||...+..+....+... ...|....+++.+.++|.+||+ +|.+|+ ++.++++
T Consensus 202 ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 261 (267)
T cd05066 202 VMSYGERPYWEMSNQDVIKAIEEG---YRLPAPMDCPAALHQLMLDCWQKDRNERP---KFEQIVS 261 (267)
T ss_pred HhcCCCCCcccCCHHHHHHHHhCC---CcCCCCCCCCHHHHHHHHHHcccCchhCC---CHHHHHH
Confidence 886 99999887766666666542 2344445688999999999999 999999 6777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.78 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=206.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCc--EEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGH--VYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ly 193 (549)
++|++.++||+|+||.||+|..+.++. .+|+|.++.. ......+.+.+|+.++..+ +||||+++++++.+...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999987765 4688887632 2233456688899999988 7999999999999999999
Q ss_pred EEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEE
Q 038137 194 LIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMK 257 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vK 257 (549)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999998653 2588999999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCc
Q 038137 258 LSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337 (549)
Q Consensus 258 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~ 337 (549)
|+|||++....... . .....++..|+|||++.+..++.
T Consensus 160 l~dfg~~~~~~~~~--~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ 197 (297)
T cd05089 160 IADFGLSRGEEVYV--K----------------------------------------KTMGRLPVRWMAIESLNYSVYTT 197 (297)
T ss_pred ECCcCCCcccccee--c----------------------------------------cCCCCcCccccCchhhccCCCCc
Confidence 99999986422100 0 00112355799999999999999
Q ss_pred ccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 338 ECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 338 ~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
++|||||||++|||++ |.+||.+.+......++... ...+....+++++.+||.+||. +|.+|+ ++++|+..
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~~ 271 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRMEKPRNCDDEVYELMRQCWRDRPYERP---PFAQISVQ 271 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999999999997 99999988877766666542 2222223689999999999999 999999 78888753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.69 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=210.7
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-CceEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-DEYLY 193 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-~~~ly 193 (549)
..++|++++.||.|+||.||+|.++.+|+.||||++.+.. .......++..|+.++..++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4678999999999999999999999999999999987543 223345678889999999999999999999875 56899
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
+||||+ +++|..++. ...+++..+..++.|++.||.|||+.||+||||+|+|||++.+|++||+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999999 678888774 457899999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml 352 (549)
..+.+|++.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 162 -----------------------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred -----------------------------------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 013468899999999876 67899999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhcc------------------------ccccCCC---CcCCChhHHHHHHHhhh-cccccC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWR------------------------THLKFPE---EAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~------------------------~~l~~p~---~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
+|++||.+.+.......+...- .....|. ...+++++.++|.+||+ +|++|+
T Consensus 201 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 280 (328)
T cd07856 201 EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280 (328)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC
Confidence 9999998766533222221100 0001111 12478899999999999 999999
Q ss_pred CCCCHHHHHcCCcccCC
Q 038137 405 GTKGADEIKAHPWFKGI 421 (549)
Q Consensus 405 ~~~~~~eil~HpfF~~i 421 (549)
++++++.||||...
T Consensus 281 ---t~~ell~~~~~~~~ 294 (328)
T cd07856 281 ---SAAEALAHPYLAPY 294 (328)
T ss_pred ---CHHHHhcCCccccc
Confidence 89999999999744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=341.78 Aligned_cols=258 Identities=20% Similarity=0.346 Sum_probs=209.9
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKA-------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVK 181 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~ 181 (549)
.+..+..++|.+.+.||+|+||.||+|++.. ++..||+|.+.... .......+..|+.++..+ +||||++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3455667889999999999999999998643 33579999997542 223345688899999999 7999999
Q ss_pred eeeeecCCceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCC
Q 038137 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKP 245 (549)
Q Consensus 182 l~~~f~d~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKP 245 (549)
++++|.+.+.+|+||||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 999999999999999999999999999653 2488899999999999999999999999999999
Q ss_pred CCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCC
Q 038137 246 DNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYI 325 (549)
Q Consensus 246 eNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~ 325 (549)
+|||++.++.+||+|||+++.+....... ......+++.|+
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~ 209 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWM 209 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhh---------------------------------------ccccCCCcccee
Confidence 99999999999999999987653210000 000123557899
Q ss_pred CchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-ccccc
Q 038137 326 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 326 APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
|||++.+..++.++|+|||||++|||++ |.+||.+.+..+....+.. .....+| ..++.++++||.+||. +|.+|
T Consensus 210 aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~R 286 (307)
T cd05098 210 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GHRMDKP--SNCTNELYMMMRDCWHAVPSQR 286 (307)
T ss_pred ChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc-CCCCCCC--CcCCHHHHHHHHHHcccChhhC
Confidence 9999999999999999999999999998 8999987666555544432 2223333 3678999999999999 99999
Q ss_pred CCCCCHHHHHc
Q 038137 404 LGTKGADEIKA 414 (549)
Q Consensus 404 l~~~~~~eil~ 414 (549)
+ ++.+|+.
T Consensus 287 p---s~~evl~ 294 (307)
T cd05098 287 P---TFKQLVE 294 (307)
T ss_pred c---CHHHHHH
Confidence 9 7888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.08 Aligned_cols=253 Identities=21% Similarity=0.399 Sum_probs=211.0
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
.++|++++.||+|+||.||+|+.+. +.+.||+|.+.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999764 34689999886532 1224567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeec
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKD---------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DF 261 (549)
..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997655 6999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCccccc
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~Di 341 (549)
|+++........ ......+++.|+|||.+.+..++.++||
T Consensus 162 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di 201 (275)
T cd05046 162 SLSKDVYNSEYY----------------------------------------KLRNALIPLRWLAPEAVQEDDFSTKSDV 201 (275)
T ss_pred ccccccCccccc----------------------------------------ccCCceeEEeecChhhhccCCCCchhhH
Confidence 998754211000 0013467788999999998889999999
Q ss_pred chhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 342 WSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 342 WSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||||++|+|++ |.+||...........+... .+.++....++..+.++|.+||+ +|.+|+ ++.+++.+
T Consensus 202 ~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp---~~~~~l~~ 272 (275)
T cd05046 202 WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLELPVPEGCPSRLYKLMTRCWAVNPKDRP---SFSELVSA 272 (275)
T ss_pred HHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcCCCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHH
Confidence 999999999998 89999876666655555432 23333334688999999999999 999998 79998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.26 Aligned_cols=250 Identities=20% Similarity=0.355 Sum_probs=209.0
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||+|+||.||+|.... +..||+|.+..... ....+.+|..++..++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 34679999999999999999998754 44699999875432 23557889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999998663 47899999999999999999999999999999999999999999999999998764321100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
......++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 157 ----------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~ 196 (256)
T cd05113 157 ----------------------------------------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196 (256)
T ss_pred ----------------------------------------ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhc
Confidence 0002346678999999998889999999999999999998
Q ss_pred -CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 354 -GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 354 -G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|..||...+.......+.+.. ..+.....+..++++|.+||. +|.+|+ ++.+|+.+
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~ll~~ 254 (256)
T cd05113 197 LGKMPYERFNNSETVEKVSQGL---RLYRPHLASEKVYAIMYSCWHEKAEERP---TFQQLLSS 254 (256)
T ss_pred CCCCCcCcCCHHHHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcCCCcccCC---CHHHHHHh
Confidence 999998877766667676532 122223568999999999999 999999 79998864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=335.10 Aligned_cols=262 Identities=28% Similarity=0.443 Sum_probs=211.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-Cce
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATG----HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-DEY 191 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-~~~ 191 (549)
..|+.+..||+|.||.||+|..+.++ +.||||+++...- ..+.-....+|+.++++++|||||.|..+|-. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 45899999999999999999665554 3799999865421 22334568899999999999999999999987 889
Q ss_pred EEEEEeecCCCchhhHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC----CcEEEeecC
Q 038137 192 LYLIMEYLPGGDMMTLLMR-----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN----GHMKLSDFG 262 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~----g~vKL~DFG 262 (549)
++|++||.+ -||+.++.- ...++...++.++.||+.|+.|||++=|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999995 599988843 2468999999999999999999999999999999999999888 899999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCccccc
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 341 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~Di 341 (549)
+++.+...-.+-- .....|-|.+|+|||.|++ ..|+.++|+
T Consensus 182 laR~~~~plkpl~--------------------------------------s~d~VVVTiWYRAPELLLGa~hYT~AiDv 223 (438)
T KOG0666|consen 182 LARLFNNPLKPLA--------------------------------------SLDPVVVTIWYRAPELLLGARHYTKAIDV 223 (438)
T ss_pred HHHHhhccccccc--------------------------------------cCCceEEEEEecChHHhcccccccchhhh
Confidence 9998754311100 0114689999999999998 679999999
Q ss_pred chhhHHHHHHhhCCCCCCCCCc---------hhhhhhhhh---------ccccccCCCC------------c--------
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEP---------MSTCRKIVN---------WRTHLKFPEE------------A-------- 383 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~---------~~~~~~I~~---------~~~~l~~p~~------------~-------- 383 (549)
||+|||+.|||+-.|.|.+... .+...+|++ |..-..+|+. .
T Consensus 224 WAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~ 303 (438)
T KOG0666|consen 224 WAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYY 303 (438)
T ss_pred HHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHH
Confidence 9999999999999999977532 123445543 3333334432 0
Q ss_pred ----CCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 384 ----KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 384 ----~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
.-++.+.+|+.+||+ ||.+|+ +++++++|+||..-
T Consensus 304 ~~~k~k~~~a~~LL~klL~yDP~kRI---ta~qAleh~yF~~d 343 (438)
T KOG0666|consen 304 HKHKVKDPSALDLLQKLLTYDPIKRI---TAEQALEHPYFTED 343 (438)
T ss_pred HHhcCCCchHHHHHHHHhccCchhhc---cHHHHhcccccccC
Confidence 125679999999999 999999 89999999999864
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=331.50 Aligned_cols=255 Identities=21% Similarity=0.334 Sum_probs=211.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
+..++|+..+.||+|+||.||+|..+.++. .+|||.+.... .......+..|+.++..++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456789999999999999999999876665 79999986542 2233456889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..|+||||+++|+|..++.. .+.+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999865 36799999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
..... + ......+++.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~--~------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ 201 (268)
T cd05063 160 DPEGT--Y------------------------------------TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201 (268)
T ss_pred ccccc--e------------------------------------eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHH
Confidence 11000 0 000123456799999999889999999999999999
Q ss_pred HHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 350 EMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 350 Eml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||++ |+.||...+.......|... ...|....++.++.+||.+||. +|.+|+ ++.+|++
T Consensus 202 ell~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~i~~ 262 (268)
T cd05063 202 EVMSFGERPYWDMSNHEVMKAINDG---FRLPAPMDCPSAVYQLMLQCWQQDRARRP---RFVDIVN 262 (268)
T ss_pred HHHhCCCCCCCcCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 9997 99999887776666666542 2334444678999999999999 999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=346.70 Aligned_cols=264 Identities=33% Similarity=0.493 Sum_probs=212.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecC--CceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQD--DEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d--~~~l 192 (549)
.++|++.+.||+|+||.||+|.+..+|..||||++.+.. ........+..|+.++..+ +||||++++++|.. ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 567999999999999999999999999999999986532 2223445677899999999 99999999998864 3468
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++ ++|..++... .+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+++.+.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999996 5998888654 889999999999999999999999999999999999999999999999999986642210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEm 351 (549)
.. + .......+||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 163 ~~----------------~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el 206 (337)
T cd07852 163 NP----------------E--------------------NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206 (337)
T ss_pred cc----------------c--------------------CcchhcccccccccCceeeeccccccccchHHHHHHHHHHH
Confidence 00 0 000113579999999998865 5689999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhcccc--------------------------ccCCC-CcCCChhHHHHHHHhhh-ccccc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTH--------------------------LKFPE-EAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~--------------------------l~~p~-~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
++|++||.+........++...... ..+.. ...++.++.+||.+||. +|.+|
T Consensus 207 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 286 (337)
T cd07852 207 LLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR 286 (337)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccc
Confidence 9999999877665554444322110 00000 12368899999999999 99999
Q ss_pred CCCCCHHHHHcCCcccCC
Q 038137 404 LGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 404 l~~~~~~eil~HpfF~~i 421 (549)
+ ++.+++.||||+.+
T Consensus 287 p---s~~~il~~~~~~~~ 301 (337)
T cd07852 287 L---TAEEALEHPYVAQF 301 (337)
T ss_pred c---CHHHHhhChhhhhh
Confidence 9 89999999999876
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.27 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=204.6
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCc--EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC------Cc
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGH--VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD------DE 190 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------~~ 190 (549)
|.+.+.||+|+||.||+|....++. .||||.++... ......+.+..|..+++.++||||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3467889999999999999987775 59999887542 234556778899999999999999999986532 23
Q ss_pred eEEEEEeecCCCchhhHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 191 YLYLIMEYLPGGDMMTLLMR------KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
..++||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57999999999999988732 235899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+.+....... ......+++.|+|||++.+..++.++|||||
T Consensus 160 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 160 KKIYNGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred cccCccccee---------------------------------------cCCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 8653211000 0002346788999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 345 GAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 345 GvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
||++|||++ |.+||.+.........+.+.. .+.++ ..++..++++|.+||+ +|.+|+ ++++|+++
T Consensus 201 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~l~~~ 267 (272)
T cd05075 201 GVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQP--PDCLDGLYSLMSSCWLLNPKDRP---SFETLRCE 267 (272)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 999999999 899998877766666665432 22333 4688999999999999 999998 78888753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=355.71 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=208.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..+...-+.-||.|+.|.||+|+.+ ++.||||+++.- -..++.-|++++||||+.+.++|...-.+|
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 33444445678999999999999876 679999987431 123566788999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||||+.|.|.++|.....++......+..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++.....
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--- 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--- 265 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998865311
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
...-+++||..|||||++.+.+.+.++|||||||+||||||
T Consensus 266 ---------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT 306 (904)
T KOG4721|consen 266 ---------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT 306 (904)
T ss_pred ---------------------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh
Confidence 01127899999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|..||.+-+...++--+-. ..+.+|-+..+++.++=||++|+. .|.+|+ ++.+|+.|
T Consensus 307 ~EiPYkdVdssAIIwGVGs--NsL~LpvPstcP~GfklL~Kqcw~sKpRNRP---SFrqil~H 364 (904)
T KOG4721|consen 307 GEIPYKDVDSSAIIWGVGS--NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP---SFRQILLH 364 (904)
T ss_pred cCCCccccchheeEEeccC--CcccccCcccCchHHHHHHHHHHhcCCCCCc---cHHHHHHH
Confidence 9999987766554433322 345555555889999999999999 999999 79999988
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=327.54 Aligned_cols=251 Identities=29% Similarity=0.494 Sum_probs=216.8
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+|++.+.||.|+||.||+|.++.+++.||||.+.+..+. ......+..|..+++.++|+||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999999875542 3445667789999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 198 YLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 198 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
|++|++|..++.+ ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999999999865 3678999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.....|++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 158 -----------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 158 -----------------------------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -----------------------------------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh
Confidence 012468899999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|++||...+.......+... .....+ ..++.+++++|.+||. +|.+|+ ++.++++||+.
T Consensus 197 g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~~l~~p~~ 256 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRG-KYPPIP--PIYSQDLQNFIRSMLQVKPKLRP---NCDKILASPAV 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcC-CCCCCc--hhhCHHHHHHHHHHcCCCcccCC---CHHHHhcCCCC
Confidence 99999887766555554431 112222 3678999999999998 999999 89999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=333.45 Aligned_cols=249 Identities=21% Similarity=0.337 Sum_probs=212.2
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
...+|++++.||.|+||.||+|.++. +..+|+|++..... .....+..|+.+++.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34579999999999999999999987 88999999876542 234568889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 195 IMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
||||+++|+|.+++... ..+++..++.++.+|+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999653 4689999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
. ..+..+++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 160 ~-----------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~ 198 (261)
T cd05148 160 L-----------------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198 (261)
T ss_pred c-----------------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 0 01234677899999999899999999999999999999
Q ss_pred h-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 353 V-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 353 ~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+ |.+||.+.+..+....+.. ....|....+++++.++|.+||+ +|.+|+ ++.+|.+
T Consensus 199 ~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---t~~~l~~ 256 (261)
T cd05148 199 TYGQVPYPGMNNHEVYDQITA---GYRMPCPAKCPQEIYKIMLECWAAEPEDRP---SFKALRE 256 (261)
T ss_pred cCCCCCCCcCCHHHHHHHHHh---CCcCCCCCCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 8 8999988877777776664 22333335789999999999999 999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.42 Aligned_cols=253 Identities=31% Similarity=0.562 Sum_probs=211.9
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeec
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYL 199 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~ 199 (549)
+....||+|+||.||++..+.+|..||||++.... ......+.+|+.+++.++|+||+++++.|.+.+..|+||||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33567999999999999999999999999875322 233456888999999999999999999999999999999999
Q ss_pred CCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccc
Q 038137 200 PGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279 (549)
Q Consensus 200 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~ 279 (549)
++++|..++. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.+|+++|+|||++..+.....
T Consensus 100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------- 171 (292)
T cd06657 100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------- 171 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-------
Confidence 9999998774 45789999999999999999999999999999999999999999999999999875431100
Q ss_pred cCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCC
Q 038137 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 359 (549)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~ 359 (549)
.....+||+.|+|||++.+..++.++|+||+||++|+|++|.+||.
T Consensus 172 ----------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 172 ----------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred ----------------------------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0013578999999999988889999999999999999999999998
Q ss_pred CCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 360 SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 360 ~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+.+.......+... ....++....+++.+.++|.+||. +|.+|+ ++.+++.||||...
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~---~~~~ll~~~~~~~~ 276 (292)
T cd06657 218 NEPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 276 (292)
T ss_pred CCCHHHHHHHHHhh-CCcccCCcccCCHHHHHHHHHHHhCCcccCc---CHHHHhcChHHhcc
Confidence 87665544433221 112222223678999999999999 999999 89999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=329.28 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=207.1
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||+|+||.||+|..+ +++.||+|.+.+... ....+.+|+.+++.++|+||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999865 567899999876432 2356888999999999999999998875 45789
Q ss_pred EEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 468999999999999999999999999999999999999999999999999987653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. ......++..|+|||++.+..++.++|+|||||++|||
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05067 157 YT----------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196 (260)
T ss_pred cc----------------------------------------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHH
Confidence 00 00123567889999999989999999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++ |++||.+.+.......+.. ....+....++.++.+||.+||+ +|++|+ ++++++.
T Consensus 197 ~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 255 (260)
T cd05067 197 VTYGRIPYPGMTNPEVIQNLER---GYRMPRPDNCPEELYELMRLCWKEKPEERP---TFEYLRS 255 (260)
T ss_pred HhCCCCCCCCCChHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 98 9999988776666555443 22233334678999999999999 999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=331.48 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=206.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++.+.||+|+||.||+|.+..++ .||+|++.+... ..+.+.+|+.++..++||||+++++.+.+ ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 34567999999999999999999887664 599999976432 23457889999999999999999988754 5689
Q ss_pred EEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999653 458999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. ......|+..|+|||++.+..++.++|+|||||++|||
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~el 196 (262)
T cd05071 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (262)
T ss_pred cc----------------------------------------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHH
Confidence 00 00123577889999999999999999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++ |.+||.+.........+... ...+....++..+.+||.+||. +|.+|+ ++.++++
T Consensus 197 lt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~~~~ 255 (262)
T cd05071 197 TTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 255 (262)
T ss_pred HcCCCCCCCCCChHHHHHHHhcC---CCCCCccccCHHHHHHHHHHccCCcccCC---CHHHHHH
Confidence 99 89999888777766666532 1223334688999999999999 999999 6777654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.90 Aligned_cols=248 Identities=21% Similarity=0.382 Sum_probs=206.1
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||+|+||.||+|... ++..||+|.+..... ....+.+|+.+++.++|++|+++++++.+ ...|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 44578999999999999999999876 556799999876432 23458899999999999999999988864 5689
Q ss_pred EEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+||||+++|+|.+++... ..+++..++.++.+++.||.|||+.||+||||||+||+++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999998653 458999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. ......++..|+|||++.+..++.++|+|||||++|+|
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 196 (260)
T cd05070 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred cc----------------------------------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHH
Confidence 00 00123466789999999888899999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
++ |.+||.+.+..+....+... ...|.....+..+.+||.+||+ +|.+|+ ++.++.
T Consensus 197 ~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~ 254 (260)
T cd05070 197 VTKGRVPYPGMNNREVLEQVERG---YRMPCPQDCPISLHELMLQCWKKDPEERP---TFEYLQ 254 (260)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHcccCcccCc---CHHHHH
Confidence 99 99999887777666666532 2333334678999999999999 999999 677765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.06 Aligned_cols=258 Identities=21% Similarity=0.358 Sum_probs=212.8
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREK-------ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKL 182 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 182 (549)
+..+..++|.+.+.||+|+||.||+|+.. .++..||+|.+.... .......+.+|+.++..+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 45677889999999999999999999753 234579999986532 233456788999999999 89999999
Q ss_pred eeeecCCceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 038137 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPD 246 (549)
Q Consensus 183 ~~~f~d~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPe 246 (549)
++++.+...+|+||||+++|+|..++.+. ..++...+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999998653 24778889999999999999999999999999999
Q ss_pred CeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCC
Q 038137 247 NLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIA 326 (549)
Q Consensus 247 NILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~A 326 (549)
|||++.+|.+||+|||+++.+....... ......+++.|+|
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 207 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYK---------------------------------------KTTNGRLPVKWMA 207 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccc---------------------------------------cccCCCCCceeeC
Confidence 9999999999999999998653211000 0012356788999
Q ss_pred chhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccC
Q 038137 327 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 327 PEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
||++.+..|+.++|||||||++|+|++ |.+||.+.+..+....+... .....| ..++.++++||.+||. +|.+|+
T Consensus 208 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccChhhCC
Confidence 999999999999999999999999998 89999888777766665432 222233 3688999999999999 999999
Q ss_pred CCCCHHHHHcC
Q 038137 405 GTKGADEIKAH 415 (549)
Q Consensus 405 ~~~~~~eil~H 415 (549)
++.+|++.
T Consensus 285 ---s~~e~l~~ 292 (304)
T cd05101 285 ---TFKQLVED 292 (304)
T ss_pred ---CHHHHHHH
Confidence 78888763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=328.61 Aligned_cols=251 Identities=21% Similarity=0.371 Sum_probs=211.0
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
++..++|++.+.||.|+||.||+|.+. .+..||||.+..... ....+.+|+.+++.++|+||+++++++.+...+
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356789999999999999999999976 457899999876432 235688899999999999999999999998999
Q ss_pred EEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
|+||||++|++|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++.+||+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999664 36899999999999999999999999999999999999999999999999998765321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 157 ~~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~ 196 (261)
T cd05034 157 EYTA----------------------------------------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTE 196 (261)
T ss_pred hhhh----------------------------------------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHH
Confidence 0000 002235678999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++ |++||.+.+......++.. ....+.....+.++.++|.+||+ +|.+|+ +++++..
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~~ 256 (261)
T cd05034 197 IVTYGRVPYPGMTNREVLEQVER---GYRMPRPPNCPEELYDLMLQCWDKDPEERP---TFEYLQS 256 (261)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 998 9999988777666666653 22333334568999999999999 999999 7877763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=320.48 Aligned_cols=263 Identities=25% Similarity=0.420 Sum_probs=218.9
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC---
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--- 189 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--- 189 (549)
.+..++|.+.+.||.|||+.||+++...+++.||+|++.... ..+.+.+++|++..+.++||||++++.+...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 456788999999999999999999999999999999997653 45678899999999999999999999776543
Q ss_pred --ceEEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEcCCCcEEEeec
Q 038137 190 --EYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 190 --~~lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld~~g~vKL~DF 261 (549)
...||+++|...|+|.+.+.+ ...++|.++..|+.+|+.||++||... ++||||||.|||+...|.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 349999999999999998854 347999999999999999999999998 999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC---CCCcc
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK---GYGME 338 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~---~y~~~ 338 (549)
|.+....- ....+.+.-.++.|-.. --|..|+|||.+.-+ ..+.+
T Consensus 174 GS~~~a~i------------------------~i~~~~~a~~lQe~a~e--------~Ct~pyRAPELf~vk~~~ti~er 221 (302)
T KOG2345|consen 174 GSATQAPI------------------------QIEGSRQALRLQEWAEE--------RCTIPYRAPELFNVKSHCTITER 221 (302)
T ss_pred cCccccce------------------------EeechHHHHHHHHHHHH--------hCCCcccCchheecccCcccccc
Confidence 99876421 11234456677788643 467889999999743 45899
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCch--hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEPM--STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~~--~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
+|||||||+||+|++|..||...-.. ...-.+.+ .++.+|....+|+.+..||..||+ ||.+|| ++.+++.+
T Consensus 222 tDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP---~i~~ll~~ 296 (302)
T KOG2345|consen 222 TDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRP---TIPELLSK 296 (302)
T ss_pred cchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCC---CHHHHHHH
Confidence 99999999999999999999532111 11122333 467888888899999999999999 999999 78888764
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=339.55 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=209.8
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeee
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKA-------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYC 184 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 184 (549)
.+..++|.+.+.||+|+||.||+|++.. .+..||+|.+.... .......+..|+.++..+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4556789999999999999999998642 34579999987532 234456788999999999 6999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
++.+...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999998653 3488899999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
|++.++.+||+|||+++......... ......+++.|+|||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE 206 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK---------------------------------------KTSNGRLPVKWMAPE 206 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc---------------------------------------ccccCCCCccccCHH
Confidence 99999999999999998653211000 000123556899999
Q ss_pred hhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 329 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 329 vl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
++.+..++.++|||||||++|||++ |..||.+.+.......+... ....+| ..++.++++||.+||. +|.+|+
T Consensus 207 ~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp-- 281 (314)
T cd05099 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG-HRMDKP--SNCTHELYMLMRECWHAVPTQRP-- 281 (314)
T ss_pred HHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCcccCc--
Confidence 9999999999999999999999999 99999887776666666542 222333 3678899999999999 999999
Q ss_pred CCHHHHHc
Q 038137 407 KGADEIKA 414 (549)
Q Consensus 407 ~~~~eil~ 414 (549)
++.+++.
T Consensus 282 -s~~~ll~ 288 (314)
T cd05099 282 -TFKQLVE 288 (314)
T ss_pred -CHHHHHH
Confidence 7888774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.84 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=208.1
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
...+|.+.+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567999999999999999999864 3456799998865432 2335688899999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN 253 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~ 253 (549)
..+++||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 9999999999999999998653 248999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC
Q 038137 254 GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333 (549)
Q Consensus 254 g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~ 333 (549)
+.++|+|||+++........ ......+|++.|+|||++.+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~ 200 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYY---------------------------------------RVGGHTMLPIRWMPPESIMYR 200 (291)
T ss_pred CcEEECCCCcccccCCCcee---------------------------------------ecCCCCCcceeecChHHhccC
Confidence 99999999998764321100 001134678899999999999
Q ss_pred CCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHH
Q 038137 334 GYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411 (549)
Q Consensus 334 ~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 411 (549)
.++.++|+|||||++|||++ |.+||...+..+....+... .....+ ..++..+.+||.+||+ +|.+|+ ++.+
T Consensus 201 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---t~~~ 274 (291)
T cd05094 201 KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-RVLERP--RVCPKEVYDIMLGCWQREPQQRL---NIKE 274 (291)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC-CCCCCC--ccCCHHHHHHHHHHcccChhhCc---CHHH
Confidence 99999999999999999998 99999887776665555432 111222 3578899999999999 999999 6777
Q ss_pred HHc
Q 038137 412 IKA 414 (549)
Q Consensus 412 il~ 414 (549)
|++
T Consensus 275 v~~ 277 (291)
T cd05094 275 IYK 277 (291)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.87 Aligned_cols=262 Identities=27% Similarity=0.415 Sum_probs=208.8
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCC--CcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeec----CCc
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKAT--GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQ----DDE 190 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~t--g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~----d~~ 190 (549)
+|++.+.||+|+||.||+|++..+ +..||||++.... ........+.+|+.++..+ +||||+++++.+. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 9999999986432 2222345678899999998 5999999997643 335
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|++|||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999995 689999988888999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
..... ......+||+.|+|||++.+ ..++.++|+|||||++|
T Consensus 159 ~~~~~-------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~ 201 (332)
T cd07857 159 PGENA-------------------------------------GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201 (332)
T ss_pred ccccc-------------------------------------ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHH
Confidence 10000 00113579999999998876 57899999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccc--------------------------cccCCC-CcCCChhHHHHHHHhhh-ccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRT--------------------------HLKFPE-EAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~--------------------------~l~~p~-~~~~s~~~~dLI~~lL~-dp~ 401 (549)
+|++|.+||.+.+.......++.... ...++. ...++..+.+||.+||+ ||.
T Consensus 202 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 281 (332)
T cd07857 202 ELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT 281 (332)
T ss_pred HHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc
Confidence 99999999987664443333322100 011110 12468899999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCC
Q 038137 402 QRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i 421 (549)
+|+ ++.+++.||||+..
T Consensus 282 ~R~---t~~~ll~~~~~~~~ 298 (332)
T cd07857 282 KRI---SVEEALEHPYLAIW 298 (332)
T ss_pred cCC---CHHHHhcChhhhhh
Confidence 999 89999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=365.25 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=212.4
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecC-
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQD- 188 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d- 188 (549)
...+...++++.++|.+|||+.||+|++...|..||+|++--. +....+.+++|+++|+.|. |+|||.++++...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 3455667788999999999999999999988899999998644 4566788999999999996 9999999994321
Q ss_pred ------CceEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEcCCCcEEE
Q 038137 189 ------DEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDRNGHMKL 258 (549)
Q Consensus 189 ------~~~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld~~g~vKL 258 (549)
.-.++|.||||.||.|-+++.. ...|+|.++..|+++++.|+.+||.+. |||||||-|||||+.+|+.||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 2358899999999999999964 456999999999999999999999987 999999999999999999999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccch-HHHHHHHhhhcccceeecccCCCCCCchhhc---cCC
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ-QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKG 334 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~ 334 (549)
||||.|...... ++..+ ...++. + -...-|+.|+|||++. +.+
T Consensus 188 CDFGSatt~~~~-------------------------~~~~~e~~~ve~---e-----I~k~TTp~YRsPEMIDlysg~p 234 (738)
T KOG1989|consen 188 CDFGSATTKILS-------------------------PTSAQEVNYVEE---E-----IEKYTTPQYRSPEMIDLYSGLP 234 (738)
T ss_pred CcccccccccCC-------------------------CccHHHHHHHHH---H-----HHhhCCccccChHHHhhhcCCC
Confidence 999998653211 10000 001110 0 0235799999999975 678
Q ss_pred CCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 335 YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
.+.++|||+|||+||-|++...||..... -.|++ ..+.||..+.+|..+++||+.||. ||.+|+ ++-+++
T Consensus 235 I~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln--g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP---nI~Qv~ 305 (738)
T KOG1989|consen 235 IGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN--GNYSFPPFPNYSDRLKDLIRTMLQPNPDERP---NIYQVL 305 (738)
T ss_pred CcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe--ccccCCCCccHHHHHHHHHHHHhccCcccCC---CHHHHH
Confidence 99999999999999999999999976543 23666 567888878999999999999999 999999 777766
Q ss_pred c
Q 038137 414 A 414 (549)
Q Consensus 414 ~ 414 (549)
.
T Consensus 306 ~ 306 (738)
T KOG1989|consen 306 E 306 (738)
T ss_pred H
Confidence 4
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=333.08 Aligned_cols=254 Identities=34% Similarity=0.554 Sum_probs=212.5
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|++.+.||+|+||.||+|....+++.||+|++.... ........+..|+.+++.++|+||+++++++.+...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998754 2333456678899999999999999999999999999999999
Q ss_pred cCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
++ ++|.+++.+. ..+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.+||+|||+++........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---- 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---- 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc----
Confidence 97 5899999775 58999999999999999999999999999999999999999999999999999865321100
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.....++..|+|||++.+. .++.++|+|||||++|||++|.+
T Consensus 155 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 197 (282)
T cd07829 155 -------------------------------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197 (282)
T ss_pred -------------------------------------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence 0123567889999999876 88999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccc----------------cccCCC---------CcCCChhHHHHHHHhhh-cccccCCCCCHH
Q 038137 357 PFYSDEPMSTCRKIVNWRT----------------HLKFPE---------EAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~----------------~l~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 410 (549)
||.+.+....+.++..... ...+|. .+.++..+.++|.+||. +|.+|+ +++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~~ 274 (282)
T cd07829 198 LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---SAK 274 (282)
T ss_pred CCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC---CHH
Confidence 9988776655555432100 001111 01357899999999999 999999 899
Q ss_pred HHHcCCcc
Q 038137 411 EIKAHPWF 418 (549)
Q Consensus 411 eil~HpfF 418 (549)
+++.||||
T Consensus 275 ~~l~~p~~ 282 (282)
T cd07829 275 EALKHPYF 282 (282)
T ss_pred HHhhCcCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=326.25 Aligned_cols=245 Identities=21% Similarity=0.349 Sum_probs=201.5
Q ss_pred eeeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeec
Q 038137 123 TMIGKGAFGEVRVCREKATG---HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYL 199 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~ 199 (549)
+.||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+++.++|||||++++++.. +..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 46999999999999876554 78999999866543 345668899999999999999999998764 4689999999
Q ss_pred CCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccc
Q 038137 200 PGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279 (549)
Q Consensus 200 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~ 279 (549)
++|+|.+++.+...+++..+..++.|++.||.|||..|++||||||+|||++.++.+||+|||+++.+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~----- 152 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY----- 152 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc-----
Confidence 999999999887789999999999999999999999999999999999999999999999999988653211000
Q ss_pred cCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCC
Q 038137 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPF 358 (549)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF 358 (549)
. ......++..|+|||.+.+..++.++|+|||||++|||++ |.+||
T Consensus 153 ---------------~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 153 ---------------R------------------ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred ---------------c------------------cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 0 0001234568999999999999999999999999999997 99999
Q ss_pred CCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 359 ~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
...+..+....+... ... +....++..++++|.+||+ +|.+|+ ++.++++
T Consensus 200 ~~~~~~~~~~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~~p~~Rp---~~~~l~~ 250 (257)
T cd05060 200 GEMKGAEVIAMLESG-ERL--PRPEECPQEIYSIMLSCWKYRPEDRP---TFSELES 250 (257)
T ss_pred ccCCHHHHHHHHHcC-CcC--CCCCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 877765555544432 222 3334788999999999999 999999 7777764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.08 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=205.1
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeec
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCRE-----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQ 187 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 187 (549)
+..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +|||||++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4567899999999999999999985 3567899999997542 223456688899999999 6899999998876
Q ss_pred C-CceEEEEEeecCCCchhhHhhhc-------------------------------------------------------
Q 038137 188 D-DEYLYLIMEYLPGGDMMTLLMRK------------------------------------------------------- 211 (549)
Q Consensus 188 d-~~~lylVmEy~~gg~L~~~l~~~------------------------------------------------------- 211 (549)
. +..+|+|||||+||+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45689999999999999988542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccc
Q 038137 212 ------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279 (549)
Q Consensus 212 ------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~ 279 (549)
..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++..+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------ 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence 23678888999999999999999999999999999999999999999999998764211000
Q ss_pred cCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCC
Q 038137 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPF 358 (549)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF 358 (549)
.......+++.|+|||++.+..|+.++|+|||||++|+|++ |.+||
T Consensus 236 ---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 282 (343)
T cd05103 236 ---------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282 (343)
T ss_pred ---------------------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 00012346778999999999999999999999999999996 99999
Q ss_pred CCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 359 ~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
.+..........+........| ..+++++.++|.+||+ +|.+|+ ++.+|++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~~p~~Rp---s~~eil~~ 335 (343)
T cd05103 283 PGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 335 (343)
T ss_pred CCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 8765433333333322223333 3578899999999999 999999 89999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=326.78 Aligned_cols=244 Identities=22% Similarity=0.412 Sum_probs=203.7
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee-cCCceE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF-QDDEYL 192 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~d~~~l 192 (549)
+..++|++.+.||+|+||.||+|... |..||+|.+.... ....+.+|+.+++.++|++|+++++++ .++..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 34568999999999999999999765 7789999986432 245688999999999999999999865 566789
Q ss_pred EEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
|+||||+++|+|.+++.... .+++..+..++.+++.||.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999986543 4899999999999999999999999999999999999999999999999998754311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. ....++..|+|||++.+..++.++|+|||||++||
T Consensus 156 ~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~ 191 (256)
T cd05082 156 Q--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191 (256)
T ss_pred C--------------------------------------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHH
Confidence 0 02345678999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++ |++||...+.......+... .....+ ..+++.++++|.+||+ +|.+|+ ++.++++
T Consensus 192 l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---t~~~l~~ 251 (256)
T cd05082 192 IYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPVVYDVMKQCWHLDAATRP---SFLQLRE 251 (256)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 997 99999877665555555432 122222 3678999999999999 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=325.24 Aligned_cols=245 Identities=22% Similarity=0.390 Sum_probs=208.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++.+.||.|+||.||+|... |+.||+|.+..... ...++.+|..++..++|+||+++++++.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999865 78999999976532 4567889999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997655 79999999999999999999999999999999999999999999999999998652110
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
....++..|+|||++.+..++.++|+|||||++|||
T Consensus 157 --------------------------------------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l 192 (256)
T cd05039 157 --------------------------------------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred --------------------------------------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHH
Confidence 012345679999999988899999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++ |.+||...+.......+.. ......| ..+++++.+||.+||. +|++|+ ++.++++
T Consensus 193 ~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 251 (256)
T cd05039 193 YSFGRVPYPRIPLKDVVPHVEK-GYRMEAP--EGCPPEVYKVMKDCWELDPAKRP---TFKQLRE 251 (256)
T ss_pred HhcCCCCCCCCCHHHHHHHHhc-CCCCCCc--cCCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 97 9999987765554444332 1122233 3678999999999999 999999 7888875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=331.57 Aligned_cols=252 Identities=32% Similarity=0.539 Sum_probs=207.7
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEEEe
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmE 197 (549)
|++.+.||.|+||+||+|....+++.||||.+.+.... .......+|...+..++ ||||++++++|.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999999999999998754321 11223456888999998 9999999999999999999999
Q ss_pred ecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 198 YLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 198 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|+ +|+|..++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 889999887654 789999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G 354 (549)
....+|+..|+|||++.+ ..++.++|+|||||++|||++|
T Consensus 155 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 155 ---------------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred ---------------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 013468999999998864 5689999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccc-----------------cCCC---------CcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHL-----------------KFPE---------EAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l-----------------~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
++||.+.+......++....... .+|. ....+.++++||.+||+ +|.+|+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp--- 272 (283)
T cd07830 196 RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP--- 272 (283)
T ss_pred CCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC---
Confidence 99998877666555544311110 0000 01236889999999999 999999
Q ss_pred CHHHHHcCCcc
Q 038137 408 GADEIKAHPWF 418 (549)
Q Consensus 408 ~~~eil~HpfF 418 (549)
+++|++.||||
T Consensus 273 t~~ei~~~~~~ 283 (283)
T cd07830 273 TASQALQHPYF 283 (283)
T ss_pred CHHHHhhCCCC
Confidence 89999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=350.97 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=210.2
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCS 185 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~ 185 (549)
..+..++|.+.+.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.+|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4566778999999999999999999864 356789999997542 2333456889999999997 9999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhc------------------------------------------------------
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 211 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~------------------------------------------------------ 211 (549)
+++...+|+|||||+||+|.+++.+.
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 99999999999999999999998542
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCC
Q 038137 212 --------------------------------------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDN 247 (549)
Q Consensus 212 --------------------------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeN 247 (549)
..+++..+..|+.||+.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 136777888999999999999999999999999999
Q ss_pred eEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCc
Q 038137 248 LLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327 (549)
Q Consensus 248 ILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~AP 327 (549)
||++.++.+||+|||+++.+...... ....+.+|++.|+||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aP 310 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY---------------------------------------ISKGSTFLPLKWMAP 310 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc---------------------------------------ccCCCcCCCCceeCh
Confidence 99999999999999999864311000 000134688999999
Q ss_pred hhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCC
Q 038137 328 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 328 Evl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
|++.+..++.++|||||||++|||++ |.+||......+.....+.....+..| ..++.++.+||.+|++ +|.+|+
T Consensus 311 E~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~~P~~RP- 387 (401)
T cd05107 311 ESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP--AHASDEIYEIMQKCWEEKFEIRP- 387 (401)
T ss_pred HHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHcCCChhHCc-
Confidence 99999899999999999999999998 899998766555444444322223333 3689999999999999 999999
Q ss_pred CCCHHHHHc
Q 038137 406 TKGADEIKA 414 (549)
Q Consensus 406 ~~~~~eil~ 414 (549)
++.+|+.
T Consensus 388 --s~~ell~ 394 (401)
T cd05107 388 --DFSQLVH 394 (401)
T ss_pred --CHHHHHH
Confidence 7888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=328.68 Aligned_cols=253 Identities=29% Similarity=0.471 Sum_probs=211.2
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML--RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
+|.+.+.||+|+||.||+|.+..++..+++|+++..... .......+..|..+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 488899999999999999999888888888887653321 223344577899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 196 MEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 196 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|||+++++|..++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.+||+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 457999999999999999999999999999999999999975 679999999987653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
. ......|++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 160 ~-----------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 160 D-----------------------------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred c-----------------------------------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 0 00134688999999999888899999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
++|..||.+.+......++... ....+| ..++.++.++|.+||. +|++|+ ++.+|+.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~il~~~~~ 260 (260)
T cd08222 199 CCLAHAFEGQNFLSVVLRIVEG-PTPSLP--ETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPFI 260 (260)
T ss_pred HhCCCCCCCccHHHHHHHHHcC-CCCCCc--chhcHHHHHHHHHHhcCChhhCc---CHHHHhhCCCC
Confidence 9999999877666655555432 122223 3678999999999999 999999 89999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=327.77 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=210.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
..+|++.+.||+|+||.||+|..+.+++ .||||++.+.. .......+..|+.+++.++||||+++++++.++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4578999999999999999999987665 69999987542 344556789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|+||||++||+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999865 4568999999999999999999999999999999999999999999999999987653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
... . . .......++..|+|||++.+..++.++|+|||||++|||
T Consensus 161 ~~~-~---------------------~--------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~ 204 (269)
T cd05065 161 SDP-T---------------------Y--------------TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204 (269)
T ss_pred ccc-c---------------------c--------------ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHH
Confidence 000 0 0 000011234579999999999999999999999999998
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++ |.+||.+.+.......+.. ....|....++..+.++|.+||. +|.+|+ ++++|+.
T Consensus 205 l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 263 (269)
T cd05065 205 MSYGERPYWDMSNQDVINAIEQ---DYRLPPPMDCPTALHQLMLDCWQKDRNARP---KFGQIVS 263 (269)
T ss_pred hcCCCCCCCCCCHHHHHHHHHc---CCcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 86 9999988777666666543 23334344678999999999999 999999 7888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=332.93 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=209.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+..++|++++.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 346789999999999999999998753 67899999987542 22334568889999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK----------------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPD 246 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~----------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPe 246 (549)
+..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||..|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999998642 24788899999999999999999999999999999
Q ss_pred CeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCC
Q 038137 247 NLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIA 326 (549)
Q Consensus 247 NILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~A 326 (549)
|||++.+|.++|+|||++..+....... ......+++.|+|
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 200 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYK---------------------------------------ASENDAIPIRWMP 200 (288)
T ss_pred heEecCCCceEECccccceecccCcccc---------------------------------------ccCCCccChhhcC
Confidence 9999999999999999987643211000 0001245677999
Q ss_pred chhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccC
Q 038137 327 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 327 PEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
||++.+..++.++|+|||||++|||++ |..||.+.+..+....+... ..+..| ..++.++.+||.+||+ +|.+|+
T Consensus 201 PE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp 277 (288)
T cd05050 201 PESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG-NVLSCP--DNCPLELYNLMRLCWSKLPSDRP 277 (288)
T ss_pred HHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCC
Confidence 999999999999999999999999997 89999888777766665542 222233 3678999999999999 999999
Q ss_pred CCCCHHHHHc
Q 038137 405 GTKGADEIKA 414 (549)
Q Consensus 405 ~~~~~~eil~ 414 (549)
++.||++
T Consensus 278 ---t~~el~~ 284 (288)
T cd05050 278 ---SFASINR 284 (288)
T ss_pred ---CHHHHHH
Confidence 6777763
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=334.91 Aligned_cols=256 Identities=18% Similarity=0.350 Sum_probs=205.5
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCC--------------cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCcee
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATG--------------HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg--------------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 180 (549)
..++|++.+.||+|+||.||+|++..++ ..||+|++.... .......+.+|+++|..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999875432 359999987542 233456688999999999999999
Q ss_pred eeeeeecCCceEEEEEeecCCCchhhHhhhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 181 ~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
++++++.+...+|+||||++|++|.+++.... .+++..+..++.+++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999985432 468889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
|++.++.+||+|||++..+...... .......+++.|+|||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE 201 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYY---------------------------------------RIQGRAVLPIRWMAWE 201 (295)
T ss_pred EEcCCCcEEecccccccccccCcce---------------------------------------eccCcCcCceeecChh
Confidence 9999999999999998764311100 0001235678999999
Q ss_pred hhccCCCCcccccchhhHHHHHHhh--CCCCCCCCCchhhhhhhhhc---c-ccccCCCCcCCChhHHHHHHHhhh-ccc
Q 038137 329 VLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDEPMSTCRKIVNW---R-THLKFPEEAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 329 vl~~~~y~~~~DiWSlGvilyEml~--G~~PF~~~~~~~~~~~I~~~---~-~~l~~p~~~~~s~~~~dLI~~lL~-dp~ 401 (549)
++.+..++.++|+|||||++|+|++ |..||...+.......+... . ..........+++.+++||.+||. +|.
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCch
Confidence 9999999999999999999999987 77899877665554444321 0 111122233578999999999999 999
Q ss_pred ccCCCCCHHHHHc
Q 038137 402 QRLGTKGADEIKA 414 (549)
Q Consensus 402 ~Rl~~~~~~eil~ 414 (549)
+|+ ++++|++
T Consensus 282 ~RP---s~~~i~~ 291 (295)
T cd05097 282 DRP---TFNKIHH 291 (295)
T ss_pred hCc---CHHHHHH
Confidence 999 7888753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=328.43 Aligned_cols=242 Identities=24% Similarity=0.404 Sum_probs=199.0
Q ss_pred eeeeecCCeEEEEEEEcCCCc--EEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEEeec
Q 038137 123 TMIGKGAFGEVRVCREKATGH--VYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYL 199 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~ 199 (549)
++||+|+||.||+|+.+.+|. .+|+|.+... ........+.+|+.++..+ +||||++++++|.....+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988876 4688887642 2234456788999999999 8999999999999999999999999
Q ss_pred CCCchhhHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 200 PGGDMMTLLMRKD----------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 200 ~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
++|+|.+++.... .+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999986532 478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccch
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWS 343 (549)
+....... ......+++.|+|||++.+..++.++|+||
T Consensus 159 ~~~~~~~~------------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 196 (270)
T cd05047 159 SRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWS 196 (270)
T ss_pred ccccchhh------------------------------------------hccCCCCccccCChHHHccCCCCchhhHHH
Confidence 86321000 000123466799999999899999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 344 LGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 344 lGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++|||++ |.+||.+.+.......+... .....+ ..++.++.+||.+||. +|.+|+ ++++++.
T Consensus 197 lG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (270)
T cd05047 197 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQILV 263 (270)
T ss_pred HHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCC--CcCCHHHHHHHHHHcccChhhCC---CHHHHHH
Confidence 9999999996 99999887766666555431 122223 3578899999999999 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=340.35 Aligned_cols=258 Identities=20% Similarity=0.344 Sum_probs=210.9
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKAT-------GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKL 182 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-------g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 182 (549)
..++...+|++.+.||+|+||.||+|++... +..||+|.+.... .......+.+|+.++..+ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3456667899999999999999999986432 2368999886432 233456788999999999 89999999
Q ss_pred eeeecCCceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 038137 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPD 246 (549)
Q Consensus 183 ~~~f~d~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPe 246 (549)
+++|.+...+|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 99999999999999999999999998653 24778888999999999999999999999999999
Q ss_pred CeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCC
Q 038137 247 NLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIA 326 (549)
Q Consensus 247 NILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~A 326 (549)
|||++.++.+||+|||+++.+....... ......++..|+|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 204 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYK---------------------------------------KTTNGRLPVKWMA 204 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccc---------------------------------------cccCCCcCceEcC
Confidence 9999999999999999998653210000 0012245678999
Q ss_pred chhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccC
Q 038137 327 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 327 PEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
||++.+..++.++|+|||||++|||++ |.+||.+.+.......+... .....| ..++.++.+||.+||. +|.+|+
T Consensus 205 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp 281 (334)
T cd05100 205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTHELYMIMRECWHAVPSQRP 281 (334)
T ss_pred HHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccChhhCc
Confidence 999999999999999999999999998 89999887776666655432 222233 3678899999999999 999999
Q ss_pred CCCCHHHHHcC
Q 038137 405 GTKGADEIKAH 415 (549)
Q Consensus 405 ~~~~~~eil~H 415 (549)
++.+++.+
T Consensus 282 ---s~~ell~~ 289 (334)
T cd05100 282 ---TFKQLVED 289 (334)
T ss_pred ---CHHHHHHH
Confidence 79999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=325.88 Aligned_cols=249 Identities=21% Similarity=0.362 Sum_probs=205.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++...||+|+||.||+|.+..++ .+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 34567999999999999999999886654 589998865432 2345788999999999999999998875 45689
Q ss_pred EEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999999653 348999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. ......++..|+|||++.+..++.++|+|||||++|||
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05069 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred cc----------------------------------------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHH
Confidence 00 00123467789999999988899999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++ |.+||.+....+....+... ...+....++..+++||.+||. +|.+|+ ++++|++
T Consensus 197 ~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 255 (260)
T cd05069 197 VTKGRVPYPGMVNREVLEQVERG---YRMPCPQGCPESLHELMKLCWKKDPDERP---TFEYIQS 255 (260)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcC---CCCCCCcccCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 99 99999988777766665532 2222234688999999999999 999999 6877764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=323.19 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=210.4
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATG----HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
|++.+.||.|+||.||+|.+..++ ..||+|++..... ......+..|+.++..++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 8999999965432 2256778999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 195 IMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
||||++|++|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.+|+++|+|||+++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 99999999999999999999999999999999999999999999999999886542210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.. .....+++.|+|||.+.+..++.++|+|||||++|+|+
T Consensus 159 ~~----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~ 198 (258)
T smart00219 159 YK----------------------------------------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198 (258)
T ss_pred cc----------------------------------------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHH
Confidence 00 00123788999999998888999999999999999999
Q ss_pred h-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 353 V-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 353 ~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+ |.+||.+.+.......+.... ....+ ..++.++.++|.+||+ +|++|+ ++.+++.
T Consensus 199 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp---t~~~ll~ 256 (258)
T smart00219 199 TLGESPYPGMSNEEVLEYLKKGY-RLPKP--ENCPPEIYKLMLQCWAEDPEDRP---TFSELVE 256 (258)
T ss_pred hCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHCcCChhhCc---CHHHHHh
Confidence 8 899998877777666666532 22333 3589999999999999 999999 7998875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.55 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=198.6
Q ss_pred eeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 124 MIGKGAFGEVRVCREK--ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~k--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
.||+|+||.||+|..+ .++..||+|++.... .....+.+.+|+.+++.++||||++++++++. ..+|+||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999765 456679999986542 23345678899999999999999999998864 578999999999
Q ss_pred CchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccccc
Q 038137 202 GDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280 (549)
Q Consensus 202 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~ 280 (549)
|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~----- 153 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----- 153 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee-----
Confidence 999999864 56799999999999999999999999999999999999999999999999999986532210000
Q ss_pred CCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCC
Q 038137 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 359 (549)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~ 359 (549)
......+++.|+|||++.+..++.++|+|||||++|||++ |.+||.
T Consensus 154 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 154 ---------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred ---------------------------------ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 0001234678999999998899999999999999999996 999998
Q ss_pred CCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 360 SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 360 ~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+....+....+... ....+| ...++++.+||.+|+. +|++|+ ++.+|++
T Consensus 201 ~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~c~~~~~~~Rp---~~~~i~~ 250 (257)
T cd05115 201 KMKGPEVMSFIEQG-KRLDCP--AECPPEMYALMKDCWIYKWEDRP---NFAKVEE 250 (257)
T ss_pred cCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 87776665555443 223333 3678999999999999 999999 5666543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.40 Aligned_cols=255 Identities=20% Similarity=0.375 Sum_probs=205.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcC----------------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCce
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKA----------------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~----------------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 179 (549)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+|..++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999986543 34579999987542 23345678899999999999999
Q ss_pred eeeeeeecCCceEEEEEeecCCCchhhHhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-----------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 180 v~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
+++++++.+.+.+|+||||++||+|..++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999986532 367789999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
|++.++.++|+|||+++.+....... ......+++.|+|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe 202 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR---------------------------------------IQGRAVLPIRWMSWE 202 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee---------------------------------------ccCcCcCccccCCHH
Confidence 99999999999999988653211000 001234578899999
Q ss_pred hhccCCCCcccccchhhHHHHHHhh--CCCCCCCCCchhhhhhhhhc----cccccCCCCcCCChhHHHHHHHhhh-ccc
Q 038137 329 VLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDEPMSTCRKIVNW----RTHLKFPEEAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 329 vl~~~~y~~~~DiWSlGvilyEml~--G~~PF~~~~~~~~~~~I~~~----~~~l~~p~~~~~s~~~~dLI~~lL~-dp~ 401 (549)
++.+..++.++|+|||||++|||++ |..||...+..+...+...+ .....+|....+++.+.+||.+||. ||.
T Consensus 203 ~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 282 (296)
T cd05095 203 SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAK 282 (296)
T ss_pred HHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 9988899999999999999999998 78999876665544433211 0122234445678999999999999 999
Q ss_pred ccCCCCCHHHHHc
Q 038137 402 QRLGTKGADEIKA 414 (549)
Q Consensus 402 ~Rl~~~~~~eil~ 414 (549)
+|+ ++.+|.+
T Consensus 283 ~Rp---~~~~i~~ 292 (296)
T cd05095 283 ERP---SFQEIHA 292 (296)
T ss_pred cCC---CHHHHHH
Confidence 999 6777753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=324.23 Aligned_cols=246 Identities=21% Similarity=0.359 Sum_probs=205.5
Q ss_pred eeeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeec
Q 038137 123 TMIGKGAFGEVRVCREKA-TGH--VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYL 199 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~-tg~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~ 199 (549)
++||+|+||.||+|.+.. .+. .||||.+...... .....+.+|..++..++||||+++++.+.+ ..+|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999999876543 556778999999999999999999999998 8999999999
Q ss_pred CCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 200 PGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 200 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
++|+|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+...... +
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~ 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---Y 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc---e
Confidence 9999999997654 6899999999999999999999999999999999999999999999999999876421100 0
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 356 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~ 356 (549)
.......++..|+|||++.+..++.++|+|||||++|||++ |.+
T Consensus 155 -----------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 199 (257)
T cd05040 155 -----------------------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199 (257)
T ss_pred -----------------------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence 00012457889999999999999999999999999999998 999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||...+..+....+......+..| ..++..+.++|.+||+ +|.+|+ ++.+++.
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 253 (257)
T cd05040 200 PWAGLSGSQILKKIDKEGERLERP--EACPQDIYNVMLQCWAHNPADRP---TFAALRE 253 (257)
T ss_pred CCCCCCHHHHHHHHHhcCCcCCCC--ccCCHHHHHHHHHHCCCCcccCC---CHHHHHH
Confidence 998877766666665422333333 3678999999999999 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=321.90 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=204.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg 202 (549)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999887 999999998765432 34567899999999999999999999999999999999999999
Q ss_pred chhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 203 DMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 203 ~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
+|.+++.. ...+++..+..++.+++.||.|||++|++||||||+|||++.++++||+|||++...........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~------ 151 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS------ 151 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec------
Confidence 99999865 45689999999999999999999999999999999999999999999999999876531110000
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 360 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~ 360 (549)
.....++..|+|||++.+..++.++|+|||||++|||++ |.+||.+
T Consensus 152 ---------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 152 ---------------------------------DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred ---------------------------------cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 001234667999999998899999999999999999998 8999988
Q ss_pred CCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 361 ~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
.........+... ...+....++.++.++|.+||+ +|.+|+ +++|++.
T Consensus 199 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~ell~ 247 (251)
T cd05041 199 MSNQQTRERIESG---YRMPAPQLCPEEIYRLMLQCWAYDPENRP---SFSEIYN 247 (251)
T ss_pred CCHHHHHHHHhcC---CCCCCCccCCHHHHHHHHHHhccChhhCc---CHHHHHH
Confidence 7766655555431 2223334678999999999999 999999 7999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.01 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=197.2
Q ss_pred eeeeeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--CceE
Q 038137 119 FEPLTMIGKGAFGEVRVCRE----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD--DEYL 192 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~l 192 (549)
|++++.||+|+||+||++.. ..++..||+|.+.... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 38899999999999988753 4578899999987542 12234567889999999999999999998764 4568
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999999855 4699999999999999999999999999999999999999999999999999886542110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.. .......++..|+|||++.+..++.++|||||||++|||+
T Consensus 163 ~~--------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~ 204 (283)
T cd05080 163 YY--------------------------------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204 (283)
T ss_pred hh--------------------------------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence 00 0001234667799999999889999999999999999999
Q ss_pred hCCCCCCCCCchh--h------------hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 353 VGYPPFYSDEPMS--T------------CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 353 ~G~~PF~~~~~~~--~------------~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|..||....... . ....+... ...|....++.++.++|.+||. +|++|+ ++++|+.
T Consensus 205 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---s~~~i~~ 276 (283)
T cd05080 205 THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG--MRLPCPKNCPQEVYILMKNCWETEAKFRP---TFRSLIP 276 (283)
T ss_pred hCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC--CCCCCCCCCCHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 9999986543210 0 00111111 1122234678999999999999 999999 7888774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=353.78 Aligned_cols=253 Identities=25% Similarity=0.446 Sum_probs=219.0
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce--EEEEE
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY--LYLIM 196 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~--lylVm 196 (549)
..-.+||+|+|-+||+|.+..+|..||--.++-..+. .....+++..|+.+|+.|+|||||++|+++.+..+ +-+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 3446899999999999999999999886554443332 34556889999999999999999999999997765 88999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEcCC-CcEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld~~-g~vKL~DFGlak~~~~~~~~ 273 (549)
|.+..|+|..++.+.+.++...++.+++||+.||.|||++. |||||||-+||+|+.+ |.|||+|+|||+....+
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 99999999999999999999999999999999999999984 9999999999999754 89999999999875422
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.+.+.+|||.|||||++. ..|+..+||||||++|.||+|
T Consensus 200 ----------------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 200 ----------------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred ----------------------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh
Confidence 244789999999999996 899999999999999999999
Q ss_pred CCCCCC-CCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCC
Q 038137 354 GYPPFY-SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 354 G~~PF~-~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+..||. ..++.++|+++..+..+-.|-. -=.+++++||.+||.-.+.|+ ++.|+|.||||..-
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~fIekCl~~~~~R~---sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREFIEKCLATKSERL---SAKELLKDPFFDED 302 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHHHHHHhcCchhcc---CHHHHhhChhhccc
Confidence 999996 4577889999988655444432 126899999999998888999 89999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=329.46 Aligned_cols=254 Identities=33% Similarity=0.550 Sum_probs=211.5
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|++.+.||.|++|.||+|.+..+|+.+|+|.+..... .......+..|..+|+.++|++|+++++++.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6778899999999999999999999999999876532 223456688899999999999999999999999999999999
Q ss_pred cCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
+++ +|..++.. ...+++..+..++.+++.||.|||+.||+|+||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence 965 88887765 46899999999999999999999999999999999999999999999999999876532110
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~~ 356 (549)
......++..|+|||.+.+. .++.++|+|||||++|+|++|++
T Consensus 154 ------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 197 (283)
T cd05118 154 ------------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197 (283)
T ss_pred ------------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 00124688899999999876 78999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccc-----------------cccCCC---------CcCCChhHHHHHHHhhh-cccccCCCCCH
Q 038137 357 PFYSDEPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSPEAKDLISKLLC-NVEQRLGTKGA 409 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~-----------------~l~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 409 (549)
||.+.+..+...++..... ...++. ...++.++++||.+||. ||.+|+ ++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp---~~ 274 (283)
T cd05118 198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI---TA 274 (283)
T ss_pred CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc---CH
Confidence 9988776555544432100 001111 12468899999999999 999999 89
Q ss_pred HHHHcCCcc
Q 038137 410 DEIKAHPWF 418 (549)
Q Consensus 410 ~eil~HpfF 418 (549)
.+++.||||
T Consensus 275 ~~ll~~~~~ 283 (283)
T cd05118 275 EQALAHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=322.84 Aligned_cols=249 Identities=21% Similarity=0.367 Sum_probs=206.0
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.+..++|++.+.||+|+||.||+|... .+..||+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 356788999999999999999999865 45679999887542 234568889999999999999999999988 788
Q ss_pred EEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
|+||||+++|+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999663 45788899999999999999999999999999999999999999999999998765321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... .....++..|+|||++....++.++|+|||||++|+
T Consensus 156 ~~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 195 (260)
T cd05073 156 EYTA----------------------------------------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 195 (260)
T ss_pred Cccc----------------------------------------ccCCcccccccCHhHhccCCcCccccchHHHHHHHH
Confidence 1000 002346678999999998889999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
|++ |.+||.+.+.......+... ...+....++.++.++|.+||+ +|.+|+ ++.+++
T Consensus 196 l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~l~ 254 (260)
T cd05073 196 IVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERP---TFEYIQ 254 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCC---CCCCCcccCCHHHHHHHHHHcccCcccCc---CHHHHH
Confidence 998 99999887766655555432 2223334688999999999999 999999 666665
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=321.95 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=207.4
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
...+|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++..++||+|+++++++.+....|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3568999999999999999999875 467899999875432 12457889999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||++||+|.+++... +.++++.++.++.+++.||.|||+.|++||||||+||+++.++++||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999998654 56899999999999999999999999999999999999999999999999998754211000
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
. .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~----------------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~ 196 (256)
T cd05112 157 S----------------------------------------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196 (256)
T ss_pred c----------------------------------------cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHc
Confidence 0 002346678999999998999999999999999999998
Q ss_pred -CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 354 -GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 354 -G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|++||...........+... .....| ...+..+.+|+.+||+ +|.+|+ ++.+++++
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---~~~~~l~~ 254 (256)
T cd05112 197 EGKTPYENRSNSEVVETINAG-FRLYKP--RLASQSVYELMQHCWKERPEDRP---SFSLLLHQ 254 (256)
T ss_pred CCCCCCCcCCHHHHHHHHhCC-CCCCCC--CCCCHHHHHHHHHHcccChhhCC---CHHHHHHh
Confidence 99999877766555555431 111222 3568999999999999 999999 79888763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.95 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=204.4
Q ss_pred CeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.+.. .......+.+|+.+++.++||||+++++.|...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 33579999886543 123356788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 193 YLIMEYLPGGDMMTLLMRK------------------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999987532 3478899999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
|++.++.+||+|||+++......... ......++..|+|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~apE 199 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV---------------------------------------KRSKGRIPVKWMAIE 199 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh---------------------------------------cccCCCCCccccCHH
Confidence 99999999999999987643111000 001235677899999
Q ss_pred hhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 329 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 329 vl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
++.+..++.++|+|||||++|||++ |.+||.+..+......+.. ....+....++.++.+||.+||+ +|.+|+
T Consensus 200 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp-- 274 (290)
T cd05045 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT---GYRMERPENCSEEMYNLMLTCWKQEPDKRP-- 274 (290)
T ss_pred HHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCCCCCCHHHHHHHHHHccCCcccCC--
Confidence 9999999999999999999999998 9999988776655544332 12233334688999999999999 999999
Q ss_pred CCHHHHHc
Q 038137 407 KGADEIKA 414 (549)
Q Consensus 407 ~~~~eil~ 414 (549)
++.+|++
T Consensus 275 -~~~~i~~ 281 (290)
T cd05045 275 -TFADISK 281 (290)
T ss_pred -CHHHHHH
Confidence 7888764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.62 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=207.4
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
+..++|.+.+.||+|+||.||+|.+..+ ...||||...... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4567799999999999999999987654 4579999886542 23345678899999999999999999998876 4
Q ss_pred eEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..|+||||+++|+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999999764 4689999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
..... .....+++.|+|||++....++.++|+|||||++|
T Consensus 160 ~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 199 (270)
T cd05056 160 ESYYK----------------------------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199 (270)
T ss_pred cccee----------------------------------------cCCCCccccccChhhhccCCCCchhhhHHHHHHHH
Confidence 11000 00223567899999999899999999999999999
Q ss_pred HHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 350 EMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 350 Eml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||++ |.+||.+.+..+....+.+. ..+..| ..+++++.+||.+|+. +|.+|+ ++.+++.
T Consensus 200 el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~P~~Rp---t~~~~~~ 260 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSKRP---RFTELKA 260 (270)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9996 99999887766665555432 223333 4789999999999998 999999 7888775
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=320.46 Aligned_cols=243 Identities=25% Similarity=0.386 Sum_probs=201.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg 202 (549)
++||+|+||.||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++++.+....|+||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36999999999999865 68899999986542 2223346888999999999999999999999999999999999999
Q ss_pred chhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccC
Q 038137 203 DMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 203 ~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
+|.+++.. ...+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------- 150 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc-------
Confidence 99998865 3568999999999999999999999999999999999999999999999999987543211000
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 360 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~ 360 (549)
.....+++.|+|||++.+..++.++|+|||||++|+|++ |.+||.+
T Consensus 151 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 151 ---------------------------------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred ---------------------------------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 001235678999999998889999999999999999998 9999988
Q ss_pred CCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 361 ~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
.........+... ....+| ..++..+.+||.+||. +|++|+ ++.++++
T Consensus 198 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 246 (250)
T cd05085 198 MTNQQAREQVEKG-YRMSCP--QKCPDDVYKVMQRCWDYKPENRP---KFSELQK 246 (250)
T ss_pred CCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCC---CHHHHHH
Confidence 7766665555431 222333 3688999999999999 999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.05 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=201.9
Q ss_pred CeeeeeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--ce
Q 038137 118 DFEPLTMIGKGAFGEVRVCRE----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--EY 191 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~ 191 (549)
.|++++.||+|+||.||+|.. +.++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 478899999999999999984 4678899999986442 233456788999999999999999999988865 67
Q ss_pred EEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+|+||||++|++|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 99999999999999998654 46899999999999999999999999999999999999999999999999998865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... .......|+..|+|||++.+..++.++|+|||||++||
T Consensus 163 ~~~~--------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~e 204 (284)
T cd05079 163 KEYY--------------------------------------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204 (284)
T ss_pred ccce--------------------------------------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhh
Confidence 1000 00013467788999999999899999999999999999
Q ss_pred HhhCCCCCCCCCc--------------hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLVGYPPFYSDEP--------------MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~G~~PF~~~~~--------------~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++|..|+..... .......++ .....|....++..+.+||.+||+ +|.+|+ ++.+++.
T Consensus 205 llt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~ 278 (284)
T cd05079 205 LLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE--EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT---TFQNLIE 278 (284)
T ss_pred hhcCCCCCccccchhhhhcccccccccHHHHHHHHH--cCccCCCCCCCCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 9998877643211 011111111 112233344689999999999999 999999 7998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=326.07 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=209.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGH----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
+...+|++++.||+|+||.||+|.++.+|. .||+|.+.+... ......+.+|..++..++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 456789999999999999999999887765 589998876532 3345678899999999999999999999887
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
...++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 789999999999999999876 3579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... ......++..|+|||.+....++.++|+|||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05057 161 VDEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTV 201 (279)
T ss_pred Ccccce---------------------------------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHH
Confidence 211000 00012346789999999888999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||.+....+....+... ..+..| ...+.++.++|.+||. +|..|+ ++.+++.
T Consensus 202 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp---~~~~l~~ 263 (279)
T cd05057 202 WELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQP--PICTIDVYMVLVKCWMIDAESRP---TFKELIN 263 (279)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHhCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 99998 99999988776666655542 223333 3678899999999999 999999 6776653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.69 Aligned_cols=254 Identities=18% Similarity=0.298 Sum_probs=209.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcC----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKA----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD- 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d- 188 (549)
+..++|++.+.||+|+||.||.|.+.. ++..||+|++... ........+.+|..+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456889999999999999999999876 3688999988643 234556778999999999999999999987654
Q ss_pred CceEEEEEeecCCCchhhHhhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEee
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK--------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSD 260 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~D 260 (549)
....++++||+++|+|..++... ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 67899999999999999998653 4589999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccc
Q 038137 261 FGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340 (549)
Q Consensus 261 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~D 340 (549)
||+++.+....... ......++..|+|||++.+..++.++|
T Consensus 161 ~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~D 201 (280)
T cd05043 161 NALSRDLFPMDYHC---------------------------------------LGDNENRPVKWMALESLVNKEYSSASD 201 (280)
T ss_pred CCCcccccCCceEE---------------------------------------eCCCCCcchhccCHHHHhcCCCCchhh
Confidence 99998653221000 000224567899999999999999999
Q ss_pred cchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 341 WWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 341 iWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||||||++|||++ |.+||...++.+....+.. ....+....+++++.++|.+||+ +|++|+ ++.+++.
T Consensus 202 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~~~ 271 (280)
T cd05043 202 VWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---GYRLAQPINCPDELFAVMACCWALDPEERP---SFSQLVQ 271 (280)
T ss_pred HHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc---CCCCCCCCcCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 9999999999998 9999988777665544443 22333334678999999999999 999999 7888774
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.23 Aligned_cols=253 Identities=19% Similarity=0.329 Sum_probs=202.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHV----YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
+..++|++++.||+|+||+||+|....+|.. ||+|.+.... .......+..|..+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 3457899999999999999999999888774 6666664321 12234567778888999999999999998764
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..+++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 567899999999999999965 4679999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..... .......|+..|+|||++.+..|+.++|+|||||++
T Consensus 161 ~~~~~---------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il 201 (279)
T cd05111 161 PDDKK---------------------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201 (279)
T ss_pred CCCcc---------------------------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHH
Confidence 21100 000123577889999999989999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||.+........ ++.....+..| ...+.++.++|.+|+. +|.+|+ ++.|++.
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~li~~c~~~~p~~Rp---s~~el~~ 263 (279)
T cd05111 202 WEMMSYGAEPYAGMRPHEVPD-LLEKGERLAQP--QICTIDVYMVMVKCWMIDENVRP---TFKELAN 263 (279)
T ss_pred HHHHcCCCCCCCCCCHHHHHH-HHHCCCcCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHHHH
Confidence 99998 999998876554433 33322222222 3567889999999998 999999 7888865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.30 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=194.6
Q ss_pred eeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecC
Q 038137 123 TMIGKGAFGEVRVCREK--ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 3567899998865431 2233468889999999999999999999999999999999999
Q ss_pred CCchhhHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 201 GGDMMTLLMRK-----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 201 gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||+|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++++||+|||+++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 99999998642 24567788899999999999999999999999999999999999999999998753211000
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-------CCCcccccchhhHHH
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-------GYGMECDWWSLGAIM 348 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-------~y~~~~DiWSlGvil 348 (549)
.......|++.|+|||++.+. .++.++|+|||||++
T Consensus 157 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05087 157 -------------------------------------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199 (269)
T ss_pred -------------------------------------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence 000134688899999998642 468899999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCC---cCCChhHHHHHHHhhhcccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEE---AKLSPEAKDLISKLLCNVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~---~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||......+.....+.. ....++.. ..+++.+.+++.+|+.+|++|+ ++++|..
T Consensus 200 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---t~~~l~~ 265 (269)
T cd05087 200 WELFELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRP---SAEEVHL 265 (269)
T ss_pred HHHHhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccCCCCChHHHHHHHHHhcCcccCC---CHHHHHH
Confidence 99996 99999876655544333321 22222221 2467889999999987999999 7888763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=324.58 Aligned_cols=263 Identities=30% Similarity=0.453 Sum_probs=214.0
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD------- 188 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 188 (549)
...|+-+..||+|.||+||+|+.+.+|+.||+|++--. ..+.+.-....+|++||..++|+|++.|+..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 45577788999999999999999999999999865321 1234555667899999999999999999877653
Q ss_pred -CceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 189 -DEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 189 -~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
...+||||.+|. .||..+|... -.|+..+++.++.+++.||.|+|...|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 345999999995 5999999654 6899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhh
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 345 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlG 345 (549)
+..+... +.++ -...|-|.+|++||.+++ ..|+.+.|+|+.|
T Consensus 174 fs~~~n~--------------------~kpr-----------------ytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 174 FSTSKNV--------------------VKPR-----------------YTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred eeccccc--------------------CCCC-----------------cccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 6533110 0111 113588999999999997 6799999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhh---------ccccccC-----------CCC-----------cCCChhHHHHHH
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVN---------WRTHLKF-----------PEE-----------AKLSPEAKDLIS 394 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~---------~~~~l~~-----------p~~-----------~~~s~~~~dLI~ 394 (549)
|||.||.+|.|-|.+.+...++..|.. |...-.+ |.. -.-.+++.||+.
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 999999999999999988777766642 3221111 111 011568999999
Q ss_pred Hhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 395 KLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 395 ~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+||. ||.+|+ +++++++|.||..
T Consensus 297 ~ll~~DP~kR~---~ad~alnh~~F~k 320 (376)
T KOG0669|consen 297 KLLKLDPTKRI---DADQALNHDFFWK 320 (376)
T ss_pred HHhccCcccCc---chHhhhchhhhhc
Confidence 9999 999999 8999999999964
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=326.56 Aligned_cols=236 Identities=18% Similarity=0.278 Sum_probs=193.5
Q ss_pred eeeeecCCeEEEEEEEcCCCc-------EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 123 TMIGKGAFGEVRVCREKATGH-------VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~-------~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
+.||+|+||.||+|.++.++. .||+|.+.+.. ....+.+..|..++..++|||||++++++.++...|+|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 369999999999999866544 48888876542 33445688899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc--------EEEeecCcccc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH--------MKLSDFGLCKP 266 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~--------vKL~DFGlak~ 266 (549)
|||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999999664 46899999999999999999999999999999999999988775 68999998764
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhh
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 345 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlG 345 (549)
.... ....|++.|+|||++.+ ..++.++|+||||
T Consensus 158 ~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (258)
T cd05078 158 VLPK---------------------------------------------EILLERIPWVPPECIENPQNLSLAADKWSFG 192 (258)
T ss_pred cCCc---------------------------------------------hhccccCCccCchhccCCCCCCchhhHHHHH
Confidence 3210 03468899999999987 4589999999999
Q ss_pred HHHHHHhhC-CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 346 AIMYEMLVG-YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 346 vilyEml~G-~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++|||++| .+||...+...... +.. ....+|. ..+.++.+||.+||+ +|.+|+ ++++|++
T Consensus 193 ~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 255 (258)
T cd05078 193 TTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPA--PKWTELANLINQCMDYEPDFRP---SFRAIIR 255 (258)
T ss_pred HHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCC--CCcHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 999999998 57776655443322 222 2334443 467899999999999 999999 7999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=324.16 Aligned_cols=247 Identities=19% Similarity=0.284 Sum_probs=193.7
Q ss_pred eeeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecC
Q 038137 123 TMIGKGAFGEVRVCREKA--TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~--tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||++++++|.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997533 34578888775432 22334567889999999999999999999999999999999999
Q ss_pred CCchhhHhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 201 GGDMMTLLMRKD-----TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 201 gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 999999986532 35688899999999999999999999999999999999999999999999986532110000
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-------CCCCcccccchhhHHH
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-------KGYGMECDWWSLGAIM 348 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-------~~y~~~~DiWSlGvil 348 (549)
......+++.|+|||++.. ..++.++|||||||++
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 158 --------------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred --------------------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence 0013457788999999853 4568899999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCC---CcCCChhHHHHHHHhhhcccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPE---EAKLSPEAKDLISKLLCNVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~---~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||....+.+...+++.. ....+|. ...+++...+++..|+.||++|+ ++++|+.
T Consensus 200 ~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rp---t~~~v~~ 265 (269)
T cd05042 200 WELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRP---TAEEVHE 265 (269)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhhc-cCccCCCCcccccCCHHHHHHHHHHhcCccccc---CHHHHHH
Confidence 99999 88999877766665555442 2222222 23578889999988877999999 6777654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=346.99 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=219.1
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCc---E-EEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGH---V-YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCS 185 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~-vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 185 (549)
+.+++..++-.+.++||+|+||+||+|..+..+. . ||+|..+.+....+.++..+.+|.++|+.++|||||++|++
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445666777778999999999999999876432 3 89999886555667888999999999999999999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
..++.-+|+|||+|+||+|.++|.+.+ .++..+...|+.+.+.||+|||++++|||||-..|+|++.++.+||+|||||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999998876 5999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+....-... . ...--...|+|||.+...-|+.++||||+
T Consensus 310 ~~~~~~~~~-----------------~------------------------~~~klPirWLAPEtl~~~~~s~kTDV~sf 348 (474)
T KOG0194|consen 310 RAGSQYVMK-----------------K------------------------FLKKLPIRWLAPETLNTGIFSFKTDVWSF 348 (474)
T ss_pred cCCcceeec-----------------c------------------------ccccCcceecChhhhccCccccccchhhe
Confidence 754200000 0 00113457999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 345 GAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 345 GvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||++||+++ |..||.+....+...+|+........|. ..+.++..++.+|+. +|++|+ ++.++.+
T Consensus 349 GV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p~~~~~~~~~c~~~~p~~R~---tm~~i~~ 415 (474)
T KOG0194|consen 349 GVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTPKELAKVMKQCWKKDPEDRP---TMSTIKK 415 (474)
T ss_pred eeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCHHHHHHHHHHhccCChhhcc---CHHHHHH
Confidence 999999998 8999999999999999965434444443 677889999999998 999999 6766653
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=324.05 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=200.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec--CC
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCRE----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ--DD 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~ 189 (549)
..+|++++.||+|+||.||+|.. ..++..||||++.... ......+.+|+.+|..++||||+++++++. +.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35799999999999999999984 4578899999986542 344567889999999999999999998764 44
Q ss_pred ceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++..+.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 5799999999999999999654 568999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... .......++..|+|||++.+..++.++|+|||||++
T Consensus 160 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 201 (284)
T cd05081 160 QDKEYY--------------------------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201 (284)
T ss_pred CCCcce--------------------------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHH
Confidence 211000 000012344569999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchh------------h---hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 349 YEMLVGYPPFYSDEPMS------------T---CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~------------~---~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
|||++|..|+....... . ...++. ....+|....++.++.+||.+||. +|++|+ ++.+|
T Consensus 202 ~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei 276 (284)
T cd05081 202 YELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK--NNGRLPAPPGCPAEIYAIMKECWNNDPSQRP---SFSEL 276 (284)
T ss_pred HHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh--cCCcCCCCCCCCHHHHHHHHHHccCChhhCC---CHHHH
Confidence 99999987765432110 0 011111 112333345788999999999999 999999 78888
Q ss_pred Hc
Q 038137 413 KA 414 (549)
Q Consensus 413 l~ 414 (549)
++
T Consensus 277 ~~ 278 (284)
T cd05081 277 AL 278 (284)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=330.43 Aligned_cols=254 Identities=18% Similarity=0.312 Sum_probs=206.0
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGH----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
+..++|+.++.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|..+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999999988776 468888765422 22334578899999999999999999998764
Q ss_pred ceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 477999999999999998664 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... ......++..|+|||++.+..++.++|+|||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l 201 (303)
T cd05110 161 GDEKEY---------------------------------------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201 (303)
T ss_pred Cccccc---------------------------------------ccCCCccccccCCHHHhccCCCChHHHHHHHHHHH
Confidence 211000 00123567899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||++ |..||.+...... ..++.... .+|.....+..+.++|.+|+. +|++|+ ++.+++..
T Consensus 202 ~el~t~g~~p~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp---~~~~l~~~ 264 (303)
T cd05110 202 WELMTFGGKPYDGIPTREI-PDLLEKGE--RLPQPPICTIDVYMVMVKCWMIDADSRP---KFKELAAE 264 (303)
T ss_pred HHHHhCCCCCCCCCCHHHH-HHHHHCCC--CCCCCCCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 99997 9999987654443 33443222 233334678899999999998 999999 78887763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=322.64 Aligned_cols=248 Identities=32% Similarity=0.477 Sum_probs=202.2
Q ss_pred eeeeeeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 120 EPLTMIGKGAFGEVRVCREK----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.+.+.||.|+||.||.|... ..+..||||.++.. ......+.+.+|.++++.++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 45678999999542 2233467789999999999999999999999988889999
Q ss_pred EeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 196 MEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999776 78999999999999999999999999999999999999999999999999999876211100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
. ......+...|+|||++.+..++.++||||||+++|||++
T Consensus 160 ~---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 160 K---------------------------------------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp E---------------------------------------ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred c---------------------------------------cccccccccccccccccccccccccccccccccccccccc
Confidence 0 0012356778999999999999999999999999999999
Q ss_pred -CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 354 -GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 354 -G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|..||...+......++.. ...+.+| ..++..+.++|.+||. +|++|| ++.+|++
T Consensus 201 ~~~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~C~~~~p~~RP---s~~~i~~ 257 (259)
T PF07714_consen 201 LGKFPFSDYDNEEIIEKLKQ-GQRLPIP--DNCPKDIYSLIQQCWSHDPEKRP---SFQEILQ 257 (259)
T ss_dssp TSSGTTTTSCHHHHHHHHHT-TEETTSB--TTSBHHHHHHHHHHT-SSGGGS-----HHHHHH
T ss_pred cccccccccccccccccccc-cccceec--cchhHHHHHHHHHHcCCChhhCc---CHHHHHh
Confidence 7899988877777777743 2333333 4689999999999999 999999 7888864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=322.03 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=200.9
Q ss_pred eeeeecCCeEEEEEEEcCCC------cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 123 TMIGKGAFGEVRVCREKATG------HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+.||+|+||.||+|..+..+ ..||||.+.+.. .......+.+|..+++.++||||++++++|.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36999999999999986544 689999886542 1233456788999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-----cEEEeecCcc
Q 038137 197 EYLPGGDMMTLLMRK-------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-----HMKLSDFGLC 264 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-----~vKL~DFGla 264 (549)
||++||+|.+++.+. ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999888 8999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+.+....... ......++..|+|||++.+..++.++|+|||
T Consensus 159 ~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 199 (269)
T cd05044 159 RDIYKSDYYR---------------------------------------KEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199 (269)
T ss_pred cccccccccc---------------------------------------cCcccCCCccccCHHHHccCCcccchhHHHH
Confidence 7653211000 0012356788999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 345 GAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 345 GvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||++|||++ |.+||...+..+....+.. ...+..+ ..++..+.+||.+||+ +|.+|+ ++++|+.
T Consensus 200 G~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---~~~~i~~ 265 (269)
T cd05044 200 GVLMWEILTLGQQPYPALNNQEVLQHVTA-GGRLQKP--ENCPDKIYQLMTNCWAQDPSERP---TFDRIQE 265 (269)
T ss_pred HHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCccCCc--ccchHHHHHHHHHHcCCCcccCC---CHHHHHH
Confidence 999999998 9999987776666555543 1222333 4688999999999999 999999 7888764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.60 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=210.0
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC--C----ceeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--N----CIVKLYC 184 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p----~Iv~l~~ 184 (549)
.......+|.+++.+|+|.||.|..|.+..++..||||+++.-. ...+..+-|+++|..+.+ | .+|.+.+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 33445788999999999999999999999999999999986432 233456779999998832 2 4889999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC----------
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---------- 252 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---------- 252 (549)
+|.-.++.|||+|.+ |-+++++|..+ .+|+..+++.+.+|++.++.+||+.+++|-||||||||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999988 77999999664 47999999999999999999999999999999999999942
Q ss_pred ----------CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCC
Q 038137 253 ----------NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTP 322 (549)
Q Consensus 253 ----------~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~ 322 (549)
+-+|||+|||.|...... ..+.|.|.
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------------------------------------------hs~iVsTR 273 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH--------------------------------------------HSTIVSTR 273 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC--------------------------------------------cceeeecc
Confidence 336899999988764321 12679999
Q ss_pred CCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchh---hhhhhhhc----------------cccccCCCC-
Q 038137 323 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMS---TCRKIVNW----------------RTHLKFPEE- 382 (549)
Q Consensus 323 ~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~---~~~~I~~~----------------~~~l~~p~~- 382 (549)
.|+|||++++-+++.+||+||+||||+|+.+|...|+..+..+ +.++|+.- ...+..|+.
T Consensus 274 HYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~ 353 (415)
T KOG0671|consen 274 HYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVS 353 (415)
T ss_pred ccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccc
Confidence 9999999999999999999999999999999999999877555 34444310 001111110
Q ss_pred ----------------------cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 383 ----------------------AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 383 ----------------------~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
..--.++.|||++||. ||.+|+ ++.|+|.||||+..
T Consensus 354 ~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri---Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 354 SKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI---TLREALSHPFFARL 412 (415)
T ss_pred ccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc---cHHHHhcCHHhhcC
Confidence 0002358899999999 999999 89999999999864
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=318.10 Aligned_cols=247 Identities=19% Similarity=0.290 Sum_probs=197.2
Q ss_pred eeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec-CCceEEEEEee
Q 038137 123 TMIGKGAFGEVRVCREKA---TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ-DDEYLYLIMEY 198 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-d~~~lylVmEy 198 (549)
+.||+|+||.||+|.+.. .+..||||.+... ........+..|..+++.++||||+++++++. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 3457999988542 12344567888999999999999999999765 56678999999
Q ss_pred cCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
+++|+|..++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~-- 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-- 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence 9999999998653 4567888899999999999999999999999999999999999999999999976532110000
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 356 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~ 356 (549)
.......+++.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 157 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 157 -----------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred -----------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence 00012356788999999999999999999999999999999 577
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||...+.......+..+ ..+..| ..+++.+.++|.+||. +|++|+ ++.+|+.
T Consensus 202 ~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp---~~~~il~ 254 (262)
T cd05058 202 PYPDVDSFDITVYLLQG-RRLLQP--EYCPDPLYEVMLSCWHPKPEMRP---TFSELVS 254 (262)
T ss_pred CCCCCCHHHHHHHHhcC-CCCCCC--CcCCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 88776666655555443 222223 3578999999999999 999999 7888875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=317.75 Aligned_cols=242 Identities=19% Similarity=0.344 Sum_probs=201.6
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++.+.||+|+||.||+|. .+++.||+|++.... ....+.+|+.++..++||||+++++++..+ .+|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34679999999999999999986 468899999986432 235688899999999999999999998765 4799
Q ss_pred EEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 195 IMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
||||++||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||+++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999999996543 58999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
....++..|+|||++.+..++.++|+|||||++|||+
T Consensus 155 -------------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 155 -------------------------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred -------------------------------------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 0123456799999999889999999999999999999
Q ss_pred h-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 353 V-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 353 ~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+ |++||.+.+..+....+... ...+....+++++.+||.+||. +|.+|+ ++++++.
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---~~~~l~~ 249 (254)
T cd05083 192 SYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMTSCWETEPKKRP---SFHKLRE 249 (254)
T ss_pred hCCCCCCccCCHHHHHHHHhCC---CCCCCCCcCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 7 99999887776655554432 2222224678999999999999 999999 6777764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=319.85 Aligned_cols=237 Identities=21% Similarity=0.257 Sum_probs=191.1
Q ss_pred eeeeecCCeEEEEEEEcC------------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 123 TMIGKGAFGEVRVCREKA------------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~------------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
+.||+|+||.||+|.... ....+|+|++.... ......+..|..++..++||||+++++++.++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998532 23358889876542 233456788899999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc-------EEEeecC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH-------MKLSDFG 262 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~-------vKL~DFG 262 (549)
..|+||||+++|+|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888865 457999999999999999999999999999999999999987764 8999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-cCCCCccccc
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDW 341 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-~~~y~~~~Di 341 (549)
++...... ...+||..|+|||++. +..++.++||
T Consensus 158 ~~~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di 192 (262)
T cd05077 158 IPITVLSR---------------------------------------------QECVERIPWIAPECVEDSKNLSIAADK 192 (262)
T ss_pred CCccccCc---------------------------------------------ccccccccccChhhhcCCCCCCchhHH
Confidence 98654211 1346888999999987 4678999999
Q ss_pred chhhHHHHHHh-hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 342 WSLGAIMYEML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 342 WSlGvilyEml-~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||||++|||+ .|.+||......+.. ++.. ...... ...++++.+||.+||. ||.+|+ ++.+|+.+
T Consensus 193 wslG~~l~el~~~~~~p~~~~~~~~~~-~~~~--~~~~~~--~~~~~~~~~li~~cl~~dp~~Rp---~~~~il~~ 260 (262)
T cd05077 193 WSFGTTLWEICYNGEIPLKDKTLAEKE-RFYE--GQCMLV--TPSCKELADLMTHCMNYDPNQRP---FFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHHhCCCCCCCCcchhHHH-HHHh--cCccCC--CCChHHHHHHHHHHcCCChhhCc---CHHHHHHh
Confidence 99999999998 589998776543322 2222 111111 2356789999999999 999999 78998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=318.80 Aligned_cols=251 Identities=30% Similarity=0.521 Sum_probs=207.3
Q ss_pred CeeeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhh-------hchhhHHHHHHHHHHHHh-cCCCceeeeeeeecC
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKA-TGHVYAMKKLKKSEM-------LRRGQVEHVKAERNLLAE-VDSNCIVKLYCSFQD 188 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~-tg~~vAiK~l~k~~~-------~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d 188 (549)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+..|..++.. ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 788999999864321 123344557778888865 799999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
++.+|+||||++|++|.+++.. ...+++..++.++.|++.||.|||. .|++||||+|+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988732 3579999999999999999999996 7899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccch
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWS 343 (549)
+....... ......|+..|+|||++.+..++.++|+||
T Consensus 161 ~~~~~~~~------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s 198 (269)
T cd08528 161 AKQKQPES------------------------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWA 198 (269)
T ss_pred eeeccccc------------------------------------------ccccccCcccCcChhhhcCCCCchHHHHHH
Confidence 87643110 011357899999999999888999999999
Q ss_pred hhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||++|+|++|.+||...+.......+..... ...+ ...+++++.+||.+||. ||.+|+ ++.|+.++
T Consensus 199 lG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~cl~~~p~~Rp---~~~e~~~~ 266 (269)
T cd08528 199 FGCILYQMCTLQPPFYSTNMLSLATKIVEAVY-EPLP-EGMYSEDVTDVITSCLTPDAEARP---DIIQVSAM 266 (269)
T ss_pred HHHHHHHHHhCCCcccccCHHHHHHHHhhccC-CcCC-cccCCHHHHHHHHHHCCCCCccCC---CHHHHHHH
Confidence 99999999999999988776666655554221 1111 23678999999999999 999999 78887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=322.62 Aligned_cols=236 Identities=21% Similarity=0.257 Sum_probs=191.8
Q ss_pred eeeecCCeEEEEEEEcCC------------------------CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCce
Q 038137 124 MIGKGAFGEVRVCREKAT------------------------GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~k~t------------------------g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 179 (549)
.||+|+||.||+|....+ ...||+|++.... ......+.+|..+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999975322 2358999886542 2334567888999999999999
Q ss_pred eeeeeeecCCceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC----
Q 038137 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---- 254 (549)
Q Consensus 180 v~l~~~f~d~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---- 254 (549)
+++++++.+....|+||||++||+|..++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++..|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998865 56799999999999999999999999999999999999998654
Q ss_pred ---cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc
Q 038137 255 ---HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL 331 (549)
Q Consensus 255 ---~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~ 331 (549)
.+||+|||++...... ....|++.|+|||++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---------------------------------------------~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---------------------------------------------EERVERIPWIAPECVP 193 (274)
T ss_pred ccceeeecCCccccccccc---------------------------------------------cccccCCcccCchhhc
Confidence 4899999987643210 0235788899999987
Q ss_pred c-CCCCcccccchhhHHHHHHh-hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 332 K-KGYGMECDWWSLGAIMYEML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 332 ~-~~y~~~~DiWSlGvilyEml-~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
+ ..++.++|+|||||++|||+ +|.+||.+..+.+... +.. ....+|. ..++++.+||.+||+ +|.+|+ +
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp---s 265 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE--KKHRLPE--PSCKELATLISQCLTYEPTQRP---S 265 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH--hccCCCC--CCChHHHHHHHHHcccChhhCc---C
Confidence 6 56899999999999999985 7999998776544322 222 2233443 356789999999999 999998 8
Q ss_pred HHHHHcC
Q 038137 409 ADEIKAH 415 (549)
Q Consensus 409 ~~eil~H 415 (549)
+.+|+++
T Consensus 266 ~~~il~~ 272 (274)
T cd05076 266 FRTILRD 272 (274)
T ss_pred HHHHHHh
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.92 Aligned_cols=234 Identities=20% Similarity=0.270 Sum_probs=192.8
Q ss_pred eeeeecCCeEEEEEEEcCCC----------cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 123 TMIGKGAFGEVRVCREKATG----------HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg----------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
+.||+|+||.||+|.++.++ ..+|+|++..... ....+.+|..+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998777 3578887764431 14668889999999999999999999888 778
Q ss_pred EEEEeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-------cEEEeecCcc
Q 038137 193 YLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-------HMKLSDFGLC 264 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-------~vKL~DFGla 264 (549)
|+||||+++|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999997765 799999999999999999999999999999999999999888 8999999998
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC--CCCcccccc
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWW 342 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~--~y~~~~DiW 342 (549)
...... ...+|+..|+|||++.+. .++.++|+|
T Consensus 156 ~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~ 190 (259)
T cd05037 156 ITVLSR---------------------------------------------EERVERIPWIAPECIRNGQASLTIAADKW 190 (259)
T ss_pred cccccc---------------------------------------------cccccCCCccChhhhcCCCCCcchhhHHH
Confidence 764310 024677889999999876 789999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 343 SLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 343 SlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||||++|||++ |.+||...+........ ........| .+..+.+||.+||. +|.+|+ ++.+|++
T Consensus 191 slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp---t~~~il~ 256 (259)
T cd05037 191 SFGTTLLEICSNGEEPLSTLSSSEKERFY-QDQHRLPMP----DCAELANLINQCWTYDPTKRP---SFRAILR 256 (259)
T ss_pred HHHHHHHHHHhCCCCCcccCCchhHHHHH-hcCCCCCCC----CchHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 99999999999 68888776543332222 222222222 24789999999999 999999 7888874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=321.76 Aligned_cols=268 Identities=28% Similarity=0.478 Sum_probs=220.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
..+|.-++.+|.|+- .|..|-+.-+++.||+|++... ........+..+|..++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 356888899999998 8888999999999999998765 33444556788999999999999999999998644
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||| .++|...+. -.++-+.+++++.|+++|+.|||+.||+||||||+||++..++.+||+|||+|+..+.
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 3589999999 568888775 4577889999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
. ......|.|..|.|||++.+.+|...+||||+|||+.
T Consensus 171 ~------------------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 171 D------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (369)
T ss_pred c------------------------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHH
Confidence 1 0112579999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccc-----------------------------cccCCCC---------cCCChhHHH
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRT-----------------------------HLKFPEE---------AKLSPEAKD 391 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~-----------------------------~l~~p~~---------~~~s~~~~d 391 (549)
||++|...|.|.+..+.+.+|+..-+ .-.||+. ..=+..|+|
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ard 288 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARD 288 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHH
Confidence 99999999999988888877763111 0012211 011456999
Q ss_pred HHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccccccCCCcc
Q 038137 392 LISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIP 435 (549)
Q Consensus 392 LI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p 435 (549)
|+.+||. ||++|. +++++|.||||+ -|-.-.++.+|..|
T Consensus 289 ll~~MLvi~pe~Ri---sv~daL~HPY~~--vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 289 LLSKMLVIDPEKRI---SVDDALRHPYIK--VWYDPDEVEAPPPE 328 (369)
T ss_pred HHHHhhccChhhcc---cHHHHhcCCeee--eecccccccCCCCc
Confidence 9999998 999999 899999999998 57555556666555
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.78 Aligned_cols=270 Identities=31% Similarity=0.503 Sum_probs=202.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD------- 188 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 188 (549)
..||+.+.+||+||||.||+|+++-+|..||||+|.-.. .......+.+|+.+|++++|||||+.|.++..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 467999999999999999999999999999999997653 34455678999999999999999999875410
Q ss_pred ------------------------------------------------C-------------------------------
Q 038137 189 ------------------------------------------------D------------------------------- 189 (549)
Q Consensus 189 ------------------------------------------------~------------------------------- 189 (549)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------ceEEEEEeecCCCchhhHhhhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 038137 190 ---------------------------------EYLYLIMEYLPGGDMMTLLMRKDTL-TEEEARFYVGETVLAIESIHK 235 (549)
Q Consensus 190 ---------------------------------~~lylVmEy~~gg~L~~~l~~~~~l-~e~~~~~~~~qi~~aL~~LH~ 235 (549)
..+||=||||+...+.+++.++... ....++.+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 1379999999887777776555444 478899999999999999999
Q ss_pred CCeeecCCCCCCeEEcCCCcEEEeecCcccccCC-CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccc
Q 038137 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC-SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRML 314 (549)
Q Consensus 236 ~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (549)
.|||||||||.||+||.+++|||+|||+|+.... ............+..+.... .
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~------------------------~ 771 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDG------------------------D 771 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCc------------------------c
Confidence 9999999999999999999999999999987321 00000000000111111100 1
Q ss_pred eeecccCCCCCCchhhccCC---CCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhcc-ccccCCCC--cCCChh
Q 038137 315 AYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWR-THLKFPEE--AKLSPE 388 (549)
Q Consensus 315 ~~s~vGT~~Y~APEvl~~~~---y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~-~~l~~p~~--~~~s~~ 388 (549)
.++.|||.-|+|||++.+.. |+.++|+||||||+|||+ .||.. .++-...+.+.+ ..+++|.. ..--+.
T Consensus 772 ~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~T--sMERa~iL~~LR~g~iP~~~~f~~~~~~~ 846 (1351)
T KOG1035|consen 772 LTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGT--SMERASILTNLRKGSIPEPADFFDPEHPE 846 (1351)
T ss_pred cccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCc--hHHHHHHHHhcccCCCCCCcccccccchH
Confidence 23679999999999998754 999999999999999998 34643 233333333322 23333311 111356
Q ss_pred HHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 389 AKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 389 ~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
...+|++||. ||.+|| ||.|+|++.||-
T Consensus 847 e~slI~~Ll~hdP~kRP---tA~eLL~s~llp 875 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRP---TATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcCCCccCC---CHHHHhhccCCC
Confidence 7789999999 999999 899999999997
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.71 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=204.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--C
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREK----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD--D 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~ 189 (549)
..+|++++.||+|+||.||+|... .++..||+|++.+.... .....+.+|+.+++.+.||||+++++++.+ .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 356888999999999999999864 35889999999765432 345678999999999999999999998877 6
Q ss_pred ceEEEEEeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999996643 69999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... .......++..|+|||.+.+..++.++|+|||||++
T Consensus 161 ~~~~~~--------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 202 (284)
T cd05038 161 EDKDYY--------------------------------------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202 (284)
T ss_pred cCCcce--------------------------------------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhh
Confidence 211000 000012456679999999988999999999999999
Q ss_pred HHHhhCCCCCCCCCchh--------------hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 349 YEMLVGYPPFYSDEPMS--------------TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~--------------~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
|||++|..||....... ....++. ....++....++.++.+||.+||. +|.+|+ ++.||+
T Consensus 203 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---t~~ei~ 277 (284)
T cd05038 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK--EGERLPRPPSCPDEVYDLMKLCWEAEPQDRP---SFADLI 277 (284)
T ss_pred heeeccCCCcccccchhccccccccccccHHHHHHHHH--cCCcCCCCccCCHHHHHHHHHHhccChhhCC---CHHHHH
Confidence 99999999997643221 1112222 122334334678899999999999 999999 788887
Q ss_pred c
Q 038137 414 A 414 (549)
Q Consensus 414 ~ 414 (549)
.
T Consensus 278 ~ 278 (284)
T cd05038 278 L 278 (284)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.96 Aligned_cols=241 Identities=32% Similarity=0.484 Sum_probs=194.0
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc------e
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE------Y 191 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~------~ 191 (549)
.+..-+.||+||||.||.++++.||+.||||.+++.. ....++...+|++||++++|||||+++++=.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3566678999999999999999999999999998754 3345677889999999999999999998876544 4
Q ss_pred EEEEEeecCCCchhhHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC--CCc--EEEeecCcc
Q 038137 192 LYLIMEYLPGGDMMTLLMR---KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR--NGH--MKLSDFGLC 264 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~--~g~--vKL~DFGla 264 (549)
-.+|||||+||||...|.+ ..+|+|.+...++..++.||.|||.+|||||||||+||++-. +|. -||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 5799999999999999965 357999999999999999999999999999999999999843 343 599999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccch
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 343 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWS 343 (549)
+.++... ...|.+||+.|+|||++.. +.|+..||.||
T Consensus 172 rel~d~s------------------------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS 209 (732)
T KOG4250|consen 172 RELDDNS------------------------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWS 209 (732)
T ss_pred ccCCCCC------------------------------------------eeeeecCchhhcChHHHhhccCcCceeehhh
Confidence 9875321 2348999999999999994 88999999999
Q ss_pred hhHHHHHHhhCCCCCCCCCch----hhhhhhh-------------------hccccccCCCCcCCChhHHHHH----HHh
Q 038137 344 LGAIMYEMLVGYPPFYSDEPM----STCRKIV-------------------NWRTHLKFPEEAKLSPEAKDLI----SKL 396 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~----~~~~~I~-------------------~~~~~l~~p~~~~~s~~~~dLI----~~l 396 (549)
+||++|+++||..||...... ++...++ .|...+++| ..+|+.....+ ..+
T Consensus 210 ~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p--~~Ls~~l~~~~~kwLa~~ 287 (732)
T KOG4250|consen 210 FGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQP--NHLSRGLATRLTKWLASM 287 (732)
T ss_pred hhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCc--ccccHHHHhhhhHHHHHH
Confidence 999999999999999643221 2222221 243444443 46776655544 444
Q ss_pred hh-cccccC
Q 038137 397 LC-NVEQRL 404 (549)
Q Consensus 397 L~-dp~~Rl 404 (549)
|. +|.+|-
T Consensus 288 L~~~~~~~~ 296 (732)
T KOG4250|consen 288 LEWNPRKRG 296 (732)
T ss_pred HhhhHHHhC
Confidence 55 888887
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.48 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=203.4
Q ss_pred eeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 119 FEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
|.+.++||+|+||.||+|..+ .++..||||++.... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567889999999999999865 367899999996543 23345667889999999999999999999876432
Q ss_pred -eEEEEEeecCCCchhhHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRK------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
..++++||+++|+|..++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 358899999999998876421 2579999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccch
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWS 343 (549)
++......... ......+++.|++||.+.+..++.++||||
T Consensus 160 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~s 200 (273)
T cd05074 160 SKKIYSGDYYR---------------------------------------QGCASKLPVKWLALESLADNVYTTHSDVWA 200 (273)
T ss_pred cccccCCccee---------------------------------------cCCCccCchhhcCHhHHhcCccchhhhhHH
Confidence 88653211000 001234667899999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 344 LGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 344 lGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++|||++ |.+||.+.+....+..+..+. .+..+ ..+++.+.+++.+||. +|.+|+ ++.+++.
T Consensus 201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp---s~~~~~~ 267 (273)
T cd05074 201 FGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQP--PDCLEDVYELMCQCWSPEPKCRP---SFQHLRD 267 (273)
T ss_pred HHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 9999999999 999998887777666666532 22232 3678999999999998 999999 7888875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=321.20 Aligned_cols=258 Identities=17% Similarity=0.172 Sum_probs=190.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhh--------HHHHHHHHHHHHhcCCCceeee
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQ--------VEHVKAERNLLAEVDSNCIVKL 182 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~--------~~~~~~E~~iL~~l~hp~Iv~l 182 (549)
+...+|++.++||+|+||.||+|.+..+ +..+|+|+........... ......+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4567899999999999999999999887 6778888643221100000 0111223334556789999999
Q ss_pred eeeecCCc----eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEE
Q 038137 183 YCSFQDDE----YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKL 258 (549)
Q Consensus 183 ~~~f~d~~----~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL 258 (549)
++++.... +.|++||++. .++..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765433 4588999884 466667665566789999999999999999999999999999999999999999999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcc
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME 338 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~ 338 (549)
+|||+|+.+....... .. ........+||+.|+|||++.+..|+.+
T Consensus 168 ~DFGla~~~~~~~~~~-~~---------------------------------~~~~~~~~~gt~~y~ape~~~~~~~~~~ 213 (294)
T PHA02882 168 IDYGIASHFIIHGKHI-EY---------------------------------SKEQKDLHRGTLYYAGLDAHNGACVTRR 213 (294)
T ss_pred EEcCCceeeccCCccc-cc---------------------------------ccccccccCCCccccCHHHhCCCCCCcH
Confidence 9999998763211000 00 0000113579999999999999999999
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCchhhh---------hhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTC---------RKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~~~~~---------~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
+|||||||++|||++|.+||.+....... .++.. ....++ ..++++.+++..|+. +|++|| +
T Consensus 214 ~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~rp---~ 285 (294)
T PHA02882 214 GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE--GKIKIK---NANKFIYDFIECVTKLSYEEKP---D 285 (294)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh--hhhccC---CCCHHHHHHHHHHHhCCCCCCC---C
Confidence 99999999999999999999876432211 11211 112222 457899999999998 999999 7
Q ss_pred HHHHHc
Q 038137 409 ADEIKA 414 (549)
Q Consensus 409 ~~eil~ 414 (549)
.++|++
T Consensus 286 ~~~l~~ 291 (294)
T PHA02882 286 YDALIK 291 (294)
T ss_pred HHHHHH
Confidence 888764
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=315.77 Aligned_cols=247 Identities=18% Similarity=0.249 Sum_probs=193.3
Q ss_pred eeeecCCeEEEEEEEcCC--CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 124 MIGKGAFGEVRVCREKAT--GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~k~t--g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
.||+|+||.||+|..... ...+++|.+.... .......+.+|..+++.++||||+++++.|.+...+|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999976433 2356677665432 123456789999999999999999999999999999999999999
Q ss_pred CchhhHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 202 GDMMTLLMRK----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 202 g~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
|+|.+++.+. ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++++||+|||++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~---- 155 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---- 155 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh----
Confidence 9999998653 34677788999999999999999999999999999999999999999999997643211000
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-------CCCCcccccchhhHHHHH
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-------KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-------~~y~~~~DiWSlGvilyE 350 (549)
......+|++.|+|||++.. ..++.++|||||||++||
T Consensus 156 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (268)
T cd05086 156 -----------------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200 (268)
T ss_pred -----------------------------------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHH
Confidence 00013578999999999853 245789999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccc-cccCCC-CcCCChhHHHHHHHhhhcccccCCCCCHHHHHc
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRT-HLKFPE-EAKLSPEAKDLISKLLCNVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~-~l~~p~-~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~ 414 (549)
|++ |.+||...+..+.+.+++.... .+..|. ...+++.+.++|..|+.+|.+|+ ++++|++
T Consensus 201 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp---~~~~i~~ 264 (268)
T cd05086 201 LFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRA---TAEEVHR 264 (268)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccCC---CHHHHHH
Confidence 996 6789987777666666654221 111111 13578899999999988999999 7888764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=348.62 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=185.3
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCC----CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeee-
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKAT----GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCS- 185 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t----g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~- 185 (549)
+.....++|++.+.||+|+||.||+|.+..+ +..||+|++.... ..+....++ +....+.+++.+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~--l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER--VRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH--HHhhchhhHHHHHHhh
Confidence 4556789999999999999999999999998 9999999876432 111111121 111222233332222
Q ss_pred -----ecCCceEEEEEeecCCCchhhHhhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeee
Q 038137 186 -----FQDDEYLYLIMEYLPGGDMMTLLMRKDT--------------------LTEEEARFYVGETVLAIESIHKHNYIH 240 (549)
Q Consensus 186 -----f~d~~~lylVmEy~~gg~L~~~l~~~~~--------------------l~e~~~~~~~~qi~~aL~~LH~~giiH 240 (549)
..+...+|+||||+++++|.+++..... ..+..++.++.||+.||.|||++||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456779999999999999998864321 123457789999999999999999999
Q ss_pred cCCCCCCeEEcC-CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecc
Q 038137 241 RDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTV 319 (549)
Q Consensus 241 RDLKPeNILld~-~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~v 319 (549)
|||||+|||++. ++.+||+|||+|+.+..... ......+
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~----------------------------------------~~~~~~~ 318 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----------------------------------------YIPKEFL 318 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc----------------------------------------cCCcccc
Confidence 999999999986 68999999999986532100 0011468
Q ss_pred cCCCCCCchhhccC----------------------CCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhh-----
Q 038137 320 GTPDYIAPEVLLKK----------------------GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVN----- 372 (549)
Q Consensus 320 GT~~Y~APEvl~~~----------------------~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~----- 372 (549)
||+.|||||.+... .++.++||||||||||||++|..|+.. ....+.+++.
T Consensus 319 ~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~ 396 (566)
T PLN03225 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYD 396 (566)
T ss_pred cCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCc
Confidence 99999999976432 244567999999999999987666532 2222222211
Q ss_pred ---cccccc--CCC--------CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccc
Q 038137 373 ---WRTHLK--FPE--------EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 373 ---~~~~l~--~p~--------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l 426 (549)
|..... .+. ....+..++|||.+||+ ||.+|+ ++.++++||||.+..+..+
T Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~---ta~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 397 LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI---SAKAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC---CHHHHhCCcCcCCCCcccc
Confidence 111000 000 01123456799999999 999999 8999999999999877544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.84 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=208.5
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
..+.+..+++.+...||+|.||+||+|++..+ ||||+++-... ...+.+.|++|+.+|++.+|.||+-+.++|..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 45667778888999999999999999998754 89999987654 445889999999999999999999999999987
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.. .||..+|.|.+|+.+|.- +..|.....+.|+.||++|+.|||.++|||||||..||+|..++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 899999999999999954 4578899999999999999999999999999999999999999999999999986422
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchhh
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLG 345 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSlG 345 (549)
.. ++. .-....-|...|||||+++. .+|++.+||||||
T Consensus 540 ~w-------------~g~--------------------------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFG 580 (678)
T KOG0193|consen 540 RW-------------SGE--------------------------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFG 580 (678)
T ss_pred ee-------------ccc--------------------------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhh
Confidence 10 000 00113468889999999973 6799999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCC----CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE----EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~----~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++|||++|..||...+...++-.+-. +.+ .|. ....+.++++|+..|+. ++++|+ .+.+|+.
T Consensus 581 iV~YELltg~lPysi~~~dqIifmVGr--G~l-~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP---~F~~il~ 648 (678)
T KOG0193|consen 581 IVWYELLTGELPYSIQNRDQIIFMVGR--GYL-MPDLSKIRSNCPKAMKRLLSDCWKFDREERP---LFPQLLS 648 (678)
T ss_pred HHHHHHHhCcCCcCCCChhheEEEecc--ccc-CccchhhhccCHHHHHHHHHHHHhcCcccCc---cHHHHHH
Confidence 999999999999996666555433322 211 121 13456699999999999 999999 5666663
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=329.67 Aligned_cols=201 Identities=28% Similarity=0.376 Sum_probs=174.3
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-eEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE-YLY 193 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-~ly 193 (549)
.+++|..-.+||+|+||.||+|..... ..||||++....... ...+.+|+.+|..++|||+|+|+++|.+.+ ..+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 457898889999999999999987654 899999876543211 345999999999999999999999999888 599
Q ss_pred EEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 194 LIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHN---YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
||+|||++|+|.++|.... .+++.....|+.+++.||+|||... ||||||||.|||||.++..||+|||||+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999997654 8999999999999999999999853 9999999999999999999999999997543
Q ss_pred C-CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeec-ccCCCCCCchhhccCCCCcccccchhhH
Q 038137 269 C-SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 269 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
. ... ..+. .||.+|+|||++..+..+.++|||||||
T Consensus 229 ~~~~~------------------------------------------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGV 266 (361)
T KOG1187|consen 229 EGDTS------------------------------------------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGV 266 (361)
T ss_pred ccccc------------------------------------------eeeecCCCCccCChhhhccCCcCcccccccchH
Confidence 2 100 0122 7999999999999989999999999999
Q ss_pred HHHHHhhCCCCCCCC
Q 038137 347 IMYEMLVGYPPFYSD 361 (549)
Q Consensus 347 ilyEml~G~~PF~~~ 361 (549)
+|.||++|+.|....
T Consensus 267 vllElitgr~~~d~~ 281 (361)
T KOG1187|consen 267 VLLELITGRKAVDQS 281 (361)
T ss_pred HHHHHHhCCcccCCC
Confidence 999999999888753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=315.34 Aligned_cols=262 Identities=29% Similarity=0.486 Sum_probs=213.1
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHH-HHhcCCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL-LAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~~ 190 (549)
+.+..++.+-+..||.|+||+|++..++.+|+..|||.|+.... .....+++.|.+. ++.-+.||||++|++...+.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 45566777888899999999999999999999999999986543 2344567777775 45568899999999999999
Q ss_pred eEEEEEeecCCCchhhHhh-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 191 YLYLIMEYLPGGDMMTLLM-----RKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
..|+.||.| ..+|..+.+ .+..++|...-.+...++.||+||.. +.|||||+||+|||||..|.|||||||+|
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 999999999 456665543 35789999999999999999999985 68999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccc
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWW 342 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiW 342 (549)
..+..+--. .--+|...|||||.+.. .+|+..+|+|
T Consensus 216 GqLv~SiAk------------------------------------------T~daGCrpYmAPERi~p~~~gyDiRSDvW 253 (361)
T KOG1006|consen 216 GQLVDSIAK------------------------------------------TVDAGCRPYMAPERIDPSDKGYDIRSDVW 253 (361)
T ss_pred HhHHHHHHh------------------------------------------hhccCCccccChhccCCccCCcchhhhhh
Confidence 866422100 02378999999999974 6899999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCc-hhhhhhhhhcccc-ccCCCC-cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 343 SLGAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTH-LKFPEE-AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~-l~~p~~-~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|||+.|||+.||..|+.+-+. .+....++....+ +.++.+ ..+|...+.+|.-||. |-..|+ ...+++.|||+
T Consensus 254 SLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp---ky~~Lk~~~fy 330 (361)
T KOG1006|consen 254 SLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP---KYDDLKKFPFY 330 (361)
T ss_pred hhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc---chhhhhcCchh
Confidence 999999999999999988654 3444555543222 223322 4589999999999998 989998 78999999999
Q ss_pred cCC
Q 038137 419 KGI 421 (549)
Q Consensus 419 ~~i 421 (549)
+-.
T Consensus 331 r~y 333 (361)
T KOG1006|consen 331 RMY 333 (361)
T ss_pred hhh
Confidence 754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=340.61 Aligned_cols=260 Identities=32% Similarity=0.518 Sum_probs=222.4
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeec---
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQ--- 187 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~--- 187 (549)
.....+-|+++.+||.|.+|.||+++++.+|+..|+|++.... ...+.+..|.+||+.. +|||++.+|++|.
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3455788999999999999999999999999999999986543 2335578899999876 7999999999886
Q ss_pred --CCceEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 188 --DDEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 188 --d~~~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
.++.++||||||.||+.-+++.+ ...+.|+.+..++.+++.||.+||...+||||||-.||||+.+|.|||+|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 35679999999999999999865 46799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----CCCCcc
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----KGYGME 338 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----~~y~~~ 338 (549)
+..++... ....+.+|||.|||||++.- ..|+..
T Consensus 170 SaQldsT~-----------------------------------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R 208 (953)
T KOG0587|consen 170 SAQLDSTV-----------------------------------------GRRNTFIGTPYWMAPEVIACDESPDATYDYR 208 (953)
T ss_pred eeeeeccc-----------------------------------------ccccCcCCCcccccceeeecccCCCCCcccc
Confidence 98765221 11236899999999999973 458899
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
||+||||++..||.-|.||+.+..+...+.+|... .++.+-.+...|.+..|||+.||. |-++|+ ...+++.|||
T Consensus 209 ~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP---~~~~ll~hpF 284 (953)
T KOG0587|consen 209 SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPKKWSKKFNDFISTCLVKDYEQRP---STEELLKHPF 284 (953)
T ss_pred cchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchhhHHHHHHHHHHHHHhhccccCc---chhhhccCCc
Confidence 99999999999999999999999888887777542 223333334789999999999998 999999 7999999999
Q ss_pred ccC
Q 038137 418 FKG 420 (549)
Q Consensus 418 F~~ 420 (549)
...
T Consensus 285 i~e 287 (953)
T KOG0587|consen 285 ITE 287 (953)
T ss_pred ccc
Confidence 984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=300.91 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=209.2
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCc--e
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDE--Y 191 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~--~ 191 (549)
..++|++++.+|+|-|++|+.|.+..+++.++||+++.-. .+.+.+|+.||..+. ||||++|+++..|.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4688999999999999999999999999999999997532 245899999999996 999999999998764 4
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC-CcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~-g~vKL~DFGlak~~~~~ 270 (549)
..||+||+.+.|...+. ..|+.-.+++|+.|++.||.|+|+.||+|||+||.|++||.. -.++|+|+|||......
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 78999999998887765 678999999999999999999999999999999999999965 47999999999877532
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
. + -.-.|.+..|--||.|.. ..|+.+-|+|||||++.
T Consensus 187 ~----e--------------------------------------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA 224 (338)
T KOG0668|consen 187 K----E--------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224 (338)
T ss_pred c----e--------------------------------------eeeeeehhhcCCchheeechhccccHHHHHHHHHHH
Confidence 1 0 013578889999999987 67899999999999999
Q ss_pred HHhhCCCCCC-CCCchhhhhhhhhc-----------cccccC---------------------CCC-cCCChhHHHHHHH
Q 038137 350 EMLVGYPPFY-SDEPMSTCRKIVNW-----------RTHLKF---------------------PEE-AKLSPEAKDLISK 395 (549)
Q Consensus 350 Eml~G~~PF~-~~~~~~~~~~I~~~-----------~~~l~~---------------------p~~-~~~s~~~~dLI~~ 395 (549)
.|++.+-||. |.+..+.+.+|..- +..+.+ +++ .-+++++.|||.+
T Consensus 225 ~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldk 304 (338)
T KOG0668|consen 225 SMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDK 304 (338)
T ss_pred HHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHH
Confidence 9999988874 55555555555320 000111 111 2347999999999
Q ss_pred hhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 396 LLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 396 lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||. |-.+|+ +|.|++.||||..+
T Consensus 305 lLrYDHqeRl---TakEam~HpyF~~~ 328 (338)
T KOG0668|consen 305 LLRYDHQERL---TAKEAMAHPYFAPV 328 (338)
T ss_pred HHhhcccccc---chHHHhcCchHHHH
Confidence 999 999999 89999999999765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=353.97 Aligned_cols=268 Identities=41% Similarity=0.738 Sum_probs=224.0
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
..-.-++|+.++.|-.|+||-||+++++.|.+.+|| +++|..++-+ +||....+|++|
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilR----------nilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILR----------NILTFAGNPFVV----------- 135 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhh----------ccccccCCccee-----------
Confidence 345568999999999999999999999999999999 5655543322 277777888887
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
||-++++..-+.++.+. +.|++|||+.||+|||+||+|+||+.-||+|++||||++..-...
T Consensus 136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 78888887777777554 899999999999999999999999999999999999998753221
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhh-cccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRN-RRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.. ...... ..+. +.......||||.|+||||+...+|+..+|||++|+|+||
T Consensus 198 at------------nl~eg~---------------I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlye 250 (1205)
T KOG0606|consen 198 AT------------NLKEGH---------------IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 250 (1205)
T ss_pred cc------------hhhhcc---------------hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHH
Confidence 00 000000 0000 0111235799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCC-cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~-~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~ 428 (549)
.++|..||.++++.+.+..++. ....+|+. ..+.++++|+|.+||. +|..|+|+.++-++++|+||+.+||..|.+
T Consensus 251 FLVgcvpffGdtpeelfg~vis--d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llR 328 (1205)
T KOG0606|consen 251 FLVGCVPFFGDTPEELFGQVIS--DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLR 328 (1205)
T ss_pred HheeeeeccCCCHHHHHhhhhh--hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhh
Confidence 9999999999999999988887 45566654 4678999999999998 999999999999999999999999999999
Q ss_pred ccCCCcccCCCccccccccc
Q 038137 429 IKAAFIPEVNDELDTQNFEK 448 (549)
Q Consensus 429 ~~~pf~p~~~~~~d~~~f~~ 448 (549)
.+++|+|.+..+.|+.+|+.
T Consensus 329 qkaefvpql~~eddtsyfdT 348 (1205)
T KOG0606|consen 329 QKAEFVPQLESEDDTSYFDT 348 (1205)
T ss_pred hhccccccccccccchhhcc
Confidence 99999999999999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=329.54 Aligned_cols=265 Identities=25% Similarity=0.448 Sum_probs=217.8
Q ss_pred hhhhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC------Cc
Q 038137 105 EYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS------NC 178 (549)
Q Consensus 105 ~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~ 178 (549)
.|++.+..++...+|.+....|+|-||+|..|.+..-|..||||+|...++.... =+.|+.||+.|+. -+
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhH
Confidence 4566677778888999999999999999999999999999999999987654332 3579999998852 47
Q ss_pred eeeeeeeecCCceEEEEEeecCCCchhhHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-
Q 038137 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG- 254 (549)
Q Consensus 179 Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g- 254 (549)
+++|+-.|...++||||+|-+ ..+|..+|.+.+ .|....++.|+.|++.||..|-.+||+|.||||+|||++..-
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc
Confidence 899999999999999999988 679999997754 689999999999999999999999999999999999998764
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~ 334 (549)
.+||||||.|.......+ ..+.-+..|.|||+++|..
T Consensus 575 iLKLCDfGSA~~~~enei-------------------------------------------tPYLVSRFYRaPEIiLG~~ 611 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI-------------------------------------------TPYLVSRFYRAPEIILGLP 611 (752)
T ss_pred eeeeccCccccccccccc-------------------------------------------cHHHHHHhccCcceeecCc
Confidence 579999999876532211 1245567899999999999
Q ss_pred CCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccc-------------cCCCC-------------------
Q 038137 335 YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL-------------KFPEE------------------- 382 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l-------------~~p~~------------------- 382 (549)
|+...|+||+||+||||.||+..|.|.+...+++-.+..++.+ .|..+
T Consensus 612 yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~v 691 (752)
T KOG0670|consen 612 YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTV 691 (752)
T ss_pred ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEE
Confidence 9999999999999999999999999988776665554321110 00000
Q ss_pred ------------------------cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 383 ------------------------AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 383 ------------------------~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
..+-..++||+.+||. ||++|+ ++.++|+||||.+
T Consensus 692 m~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi---t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 692 MVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI---TVNQALKHPFITE 751 (752)
T ss_pred ecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC---CHHHHhcCCcccC
Confidence 0112458999999999 999999 8999999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=333.15 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=192.0
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEc----------------CCCcEEEEEEeechhhhc-----------hhhHHH
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREK----------------ATGHVYAMKKLKKSEMLR-----------RGQVEH 163 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k----------------~tg~~vAiK~l~k~~~~~-----------~~~~~~ 163 (549)
+.++..++|++.++||+|+||.||+|... ..++.||||.+....... ....+.
T Consensus 139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~ 218 (507)
T PLN03224 139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET 218 (507)
T ss_pred CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence 34567899999999999999999999752 345689999986432110 111223
Q ss_pred HHHHHHHHHhcCCCce-----eeeeeeec--------CCceEEEEEeecCCCchhhHhhhc-------------------
Q 038137 164 VKAERNLLAEVDSNCI-----VKLYCSFQ--------DDEYLYLIMEYLPGGDMMTLLMRK------------------- 211 (549)
Q Consensus 164 ~~~E~~iL~~l~hp~I-----v~l~~~f~--------d~~~lylVmEy~~gg~L~~~l~~~------------------- 211 (549)
...|..++..+.|.++ ++++++|. +....||||||+++|+|.+++...
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 4457777777766554 56665553 235689999999999999988532
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCC
Q 038137 212 -----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286 (549)
Q Consensus 212 -----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~ 286 (549)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+......
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~------------- 365 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF------------- 365 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-------------
Confidence 12456788999999999999999999999999999999999999999999998754311000
Q ss_pred ccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC--------------------CC--cccccchh
Q 038137 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG--------------------YG--MECDWWSL 344 (549)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~--------------------y~--~~~DiWSl 344 (549)
......+|+.|+|||++.... |+ ..+|+||+
T Consensus 366 ---------------------------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSl 418 (507)
T PLN03224 366 ---------------------------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTA 418 (507)
T ss_pred ---------------------------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhH
Confidence 000234589999999986422 22 34799999
Q ss_pred hHHHHHHhhCCC-CCCCCCch----hhhhhhh-hc----cccccCCCCcCCChhHHHHHHHhhh-cc---cccCCCCCHH
Q 038137 345 GAIMYEMLVGYP-PFYSDEPM----STCRKIV-NW----RTHLKFPEEAKLSPEAKDLISKLLC-NV---EQRLGTKGAD 410 (549)
Q Consensus 345 GvilyEml~G~~-PF~~~~~~----~~~~~I~-~~----~~~l~~p~~~~~s~~~~dLI~~lL~-dp---~~Rl~~~~~~ 410 (549)
|||+|+|++|.+ ||.+.... ..+...+ .| .....++....+++.++|||.+||+ +| .+|+ +++
T Consensus 419 Gvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~Rl---Sa~ 495 (507)
T PLN03224 419 GVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRL---SVG 495 (507)
T ss_pred HHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCC---CHH
Confidence 999999999986 77542111 1111111 11 1234555556789999999999998 66 4677 899
Q ss_pred HHHcCCcccC
Q 038137 411 EIKAHPWFKG 420 (549)
Q Consensus 411 eil~HpfF~~ 420 (549)
|+|+||||..
T Consensus 496 eaL~Hp~f~~ 505 (507)
T PLN03224 496 QALSHRFFLP 505 (507)
T ss_pred HHhCCCCcCC
Confidence 9999999953
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=342.15 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=215.7
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 184 (549)
....+...+-+..+.||+|+||+||+|+... ....||||.++... .......|++|+++|+.++|||||+|++
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3445667778889999999999999998642 34679999997653 2335677999999999999999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRK--------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL 250 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl 250 (549)
++..++-+|||+|||..|||..+|... ..|+..+...++.||+.|++||-++.+|||||-..|+|+
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 999999999999999999999999542 128889999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhh
Q 038137 251 DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330 (549)
Q Consensus 251 d~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl 330 (549)
.++-.|||+||||++.+-.+.... ..+ ...-...|||||.+
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk--------------~~~-------------------------~t~lPIRWMppEsI 677 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYK--------------VRG-------------------------NTLLPIRWMPPESI 677 (774)
T ss_pred ccceEEEecccccchhhhhhhhhc--------------ccC-------------------------CceeeeecCCHHHh
Confidence 999999999999999764321100 000 01234579999999
Q ss_pred ccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 331 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 331 ~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
+...|+.++||||+||+|||+++ |..||++....+.+..|.+..- +.-|+ ..+.++.+|+..|+. +|.+|+ +
T Consensus 678 ly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe--~CP~~vY~LM~~CW~~~P~~RP---s 751 (774)
T KOG1026|consen 678 LYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPE--NCPTEVYSLMLECWNENPKRRP---S 751 (774)
T ss_pred hcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCC--CCCHHHHHHHHHHhhcCcccCC---C
Confidence 99999999999999999999996 9999999999999988887533 55565 899999999999999 999999 4
Q ss_pred HHHH
Q 038137 409 ADEI 412 (549)
Q Consensus 409 ~~ei 412 (549)
+.||
T Consensus 752 F~eI 755 (774)
T KOG1026|consen 752 FKEI 755 (774)
T ss_pred HHHH
Confidence 5554
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=344.42 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=214.4
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCC-Cc----EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKAT-GH----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t-g~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+..+.-++.+.||+|+||+||.|....- |. .||||.+.+. .+...+..+.+|..+|+.++|||||+|++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4456788899999999999999998653 32 4999998764 456778889999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeec
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK-------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DF 261 (549)
....+|++|||.||||..+|+.. ..|+......++.+|+.|++||+++++|||||...|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999764 46889999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCccccc
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~Di 341 (549)
|||+.+.... +.. ..+ ...-...|||||.+....++.++||
T Consensus 847 GlArDiy~~~-----yyr---------~~~-------------------------~a~lPvkWm~PEsl~d~iFtskSDv 887 (1025)
T KOG1095|consen 847 GLARDIYDKD-----YYR---------KHG-------------------------EAMLPVKWMPPESLKDGIFTSKSDV 887 (1025)
T ss_pred chhHhhhhch-----hee---------ccC-------------------------ccccceecCCHHHHhhcccccccch
Confidence 9999543211 100 000 0112346999999999999999999
Q ss_pred chhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 342 WSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 342 WSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||||+|||+++ |.+||.+.+..+...-.+... +++.+..+++.+.+++..|+. +|++|+ ++..|++
T Consensus 888 WsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---RL~~P~~CP~~ly~lM~~CW~~~pe~RP---~F~~i~~ 956 (1025)
T KOG1095|consen 888 WSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---RLDPPSYCPEKLYQLMLQCWKHDPEDRP---SFRTIVE 956 (1025)
T ss_pred hhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---ccCCCCCCChHHHHHHHHHccCChhhCc---cHHHHHh
Confidence 999999999998 999999998888777666543 444445899999999999999 999999 6777776
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=291.84 Aligned_cols=241 Identities=48% Similarity=0.850 Sum_probs=204.0
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCchhhHh
Q 038137 129 AFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL 208 (549)
Q Consensus 129 ~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l 208 (549)
+||.||+|....+|+.||+|++........ ...+.+|+.+++.++|++|+++++++.+....++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999976543221 567889999999999999999999999999999999999999999999
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCcc
Q 038137 209 MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288 (549)
Q Consensus 209 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~ 288 (549)
.....+++..+..++.+++.||.+||+.|++|+||+|.||+++.+|.++|+|||++.......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------- 141 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------- 141 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------
Confidence 776669999999999999999999999999999999999999999999999999988754221
Q ss_pred CCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCC-CCchhhh
Q 038137 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS-DEPMSTC 367 (549)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~-~~~~~~~ 367 (549)
......|++.|+|||.+.+..++.++|+||||+++|+|++|.+||.. .+.....
T Consensus 142 -------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 196 (244)
T smart00220 142 -------------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF 196 (244)
T ss_pred -------------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 01135789999999999988899999999999999999999999987 4433333
Q ss_pred hhhhhccccccCCCCc-CCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 368 RKIVNWRTHLKFPEEA-KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 368 ~~I~~~~~~l~~p~~~-~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
..+.. .....+... .++.++.++|.+||+ +|.+|+ ++.++++||||
T Consensus 197 ~~~~~--~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp---~~~~~~~~~~~ 244 (244)
T smart00220 197 KKIGK--PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 244 (244)
T ss_pred HHHhc--cCCCCccccccCCHHHHHHHHHHccCCchhcc---CHHHHhhCCCC
Confidence 33332 112222111 288999999999999 999999 89999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=300.83 Aligned_cols=261 Identities=29% Similarity=0.490 Sum_probs=213.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----e
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE-----Y 191 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-----~ 191 (549)
.|.+.-+.||-|+||.||.+.+..+|+.||+|++..- ..+-...+.+.+|..+|...+|.||+.+.++.|-.. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3455567899999999999999999999999998542 223334567889999999999999999998887543 4
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+|.|.| ..||..++-....|+.++++-+++||+.||.|||+.||+||||||.|+|+++|..+|||||||++..+...
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 79999999 56999999888999999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 350 (549)
+.....-|-|..|+|||++++ ..|+.++||||+|||+.|
T Consensus 211 ----------------------------------------~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 211 ----------------------------------------RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred ----------------------------------------hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 000113477889999999998 679999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhc---------------------cccccCCCC---------cCCChhHHHHHHHhhh-c
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNW---------------------RTHLKFPEE---------AKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~---------------------~~~l~~p~~---------~~~s~~~~dLI~~lL~-d 399 (549)
+|-.+..|...++.+.+..|... +...+-|.- ..-..++.+++.+||. |
T Consensus 251 LLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d 330 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD 330 (449)
T ss_pred HHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC
Confidence 99999999999988877776531 111122211 1224578899999999 9
Q ss_pred ccccCCCCCHHHHHcCCcccCCC
Q 038137 400 VEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 400 p~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
|..|. +.++++.|+|.....
T Consensus 331 ~dkri---s~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 331 PDKRI---SVEEALQHRYLEEGR 350 (449)
T ss_pred Ccccc---cHhhhcccccccccc
Confidence 99999 799999999987653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.52 Aligned_cols=203 Identities=33% Similarity=0.553 Sum_probs=183.6
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhH-----HHHHHHHHHHHhcC---CCceeeeeeee
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQV-----EHVKAERNLLAEVD---SNCIVKLYCSF 186 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~-----~~~~~E~~iL~~l~---hp~Iv~l~~~f 186 (549)
...+|..++.+|.|+||.|++|.++.+...|+||.|.|.+++-...+ -.+-.|+.||+.++ |+||++++.+|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 35679999999999999999999999999999999999887544333 34677999999997 99999999999
Q ss_pred cCCceEEEEEeec-CCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 187 QDDEYLYLIMEYL-PGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 187 ~d~~~lylVmEy~-~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
+|++++||+||-. +|.||++++..+..++|.+++.++.||+.|+++||+.||||||||-+|++++.+|.+||+|||.|.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999976 567999999999999999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-Ccccccchh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSL 344 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSl 344 (549)
...... ...++||.+|.|||+|.+..| +..-|||+|
T Consensus 719 ~~ksgp-------------------------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 719 YTKSGP-------------------------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred hhcCCC-------------------------------------------cceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 553221 126899999999999999998 899999999
Q ss_pred hHHHHHHhhCCCCCCC
Q 038137 345 GAIMYEMLVGYPPFYS 360 (549)
Q Consensus 345 GvilyEml~G~~PF~~ 360 (549)
|++||.++....|||.
T Consensus 756 gillytivykenpyyn 771 (772)
T KOG1152|consen 756 GILLYTIVYKENPYYN 771 (772)
T ss_pred hheeeEEEeccCCCcC
Confidence 9999999999999974
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=277.17 Aligned_cols=231 Identities=28% Similarity=0.502 Sum_probs=187.9
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHH-hcCCCceeeeeeeecC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA-EVDSNCIVKLYCSFQD 188 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~d 188 (549)
...++..++...+..||+|+||.|-+.++..+|...|+|.+...- +....+...+|.++.. ...+|++|.+|+.+.+
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 334566777888899999999999999999999999999996542 3344566778888764 5589999999999999
Q ss_pred CceEEEEEeecCCCchhhHh----hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 189 DEYLYLIMEYLPGGDMMTLL----MRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
...+++.||.| ..+|..+. .+.+.++|..+-.++..++.||+|||+ +.+||||+||+||||+.+|+||+||||+
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999999 45665543 446789999999999999999999997 5899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceee-cccCCCCCCchhhcc----CCCCcc
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYS-TVGTPDYIAPEVLLK----KGYGME 338 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~vGT~~Y~APEvl~~----~~y~~~ 338 (549)
|..+..+- |.+ -.|.-.|||||.+.. .+|+.+
T Consensus 196 sG~L~dSi-------------------------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vk 232 (282)
T KOG0984|consen 196 SGYLVDSI-------------------------------------------AKTMDAGCKPYMAPERINPELNQKGYSVK 232 (282)
T ss_pred ceeehhhh-------------------------------------------HHHHhcCCCccCChhhcCcccCcccceee
Confidence 88764321 112 368889999999863 589999
Q ss_pred cccchhhHHHHHHhhCCCCCCC-CCchhhhhhhhhccccccCCCCcCCChh
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPE 388 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~-~~~~~~~~~I~~~~~~l~~p~~~~~s~~ 388 (549)
+|+||||+.|+||.+++.||.. .++.+.+.+++.. ....+|.. .+|++
T Consensus 233 sDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp~~-~FS~e 281 (282)
T KOG0984|consen 233 SDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLPAD-TFSPE 281 (282)
T ss_pred hhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCccc-ccCCC
Confidence 9999999999999999999976 4677777777763 33344443 35543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.39 Aligned_cols=270 Identities=28% Similarity=0.455 Sum_probs=207.0
Q ss_pred eeeeeeeeecCCeE-EEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEE
Q 038137 119 FEPLTMIGKGAFGE-VRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 119 f~~~~~IG~G~fG~-V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVm 196 (549)
|.--+++|.|+-|+ ||+|.. .|+.||||.+-. +....+.+|+.+|... +|||||+.||.-++..++||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34456889999875 788875 478999997743 2345688999999888 6999999999999999999999
Q ss_pred eecCCCchhhHhhhc--CC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---CC--cEEEeecCccccc
Q 038137 197 EYLPGGDMMTLLMRK--DT--LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NG--HMKLSDFGLCKPL 267 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~--~~--l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~g--~vKL~DFGlak~~ 267 (549)
|.| ..+|.+++... .. ......+..+.|++.||.+||+.+||||||||.||||+. +| .++|+|||+||.+
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 56999999663 11 111456889999999999999999999999999999986 34 6899999999988
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
.....+- + ...+..||-+|+|||+|....-+.++||+||||+
T Consensus 662 ~~~~sS~------------------------------------~--r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCv 703 (903)
T KOG1027|consen 662 AGGKSSF------------------------------------S--RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCV 703 (903)
T ss_pred CCCcchh------------------------------------h--cccCCCCcccccCHHHHhccccCcccchhhcCce
Confidence 6432110 0 0235689999999999999888889999999999
Q ss_pred HHHHhhC-CCCCCCCCchhhhhhhhhcccccc-CCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 348 MYEMLVG-YPPFYSDEPMSTCRKIVNWRTHLK-FPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 348 lyEml~G-~~PF~~~~~~~~~~~I~~~~~~l~-~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
+|..++| ..||.+.- +...+|+.....+. +.... ..+|+|||.+||. +|..|+ +|.++|.||||.. |+
T Consensus 704 fyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~--d~eA~dLI~~ml~~dP~~RP---sa~~VL~HPlFW~--~e 774 (903)
T KOG1027|consen 704 FYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLP--DCEAKDLISRMLNPDPQLRP---SATDVLNHPLFWD--SE 774 (903)
T ss_pred EEEEecCCccCCCchH--HhhhhhhcCccceeeeccCc--hHHHHHHHHHhcCCCcccCC---CHHHHhCCCccCC--hH
Confidence 9999986 89996543 33345665433332 11111 1299999999999 999999 8999999999963 32
Q ss_pred ccccccCCCcccCCCccccccccc
Q 038137 425 KLYQIKAAFIPEVNDELDTQNFEK 448 (549)
Q Consensus 425 ~l~~~~~pf~p~~~~~~d~~~f~~ 448 (549)
+ .-.|.-++.+..+..+.+.
T Consensus 775 k----rL~Fl~dvSDRvE~e~r~~ 794 (903)
T KOG1027|consen 775 K----RLSFLRDVSDRVEKENRDS 794 (903)
T ss_pred H----HHHHHHhhhhhhhhhhccC
Confidence 2 2235566666666666553
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=339.41 Aligned_cols=236 Identities=19% Similarity=0.294 Sum_probs=186.2
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|....+||+|+||.||+|+.+.+|..||||++...... ...|+.+++.++|||||+++++|.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 355667899999999999999999999999998653211 2346788999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH---KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||+||+|.+++. .+++..+..++.+++.||.||| +.+|+||||||+|||++.++..++. ||........
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 999999999995 4899999999999999999999 6699999999999999999888876 6654432100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
...+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 836 -----------------------------------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 836 -----------------------------------------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred -----------------------------------------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence 124789999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhcc-------------cc-c--cCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 355 YPPFYSDEPMSTCRKIVNWR-------------TH-L--KFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~-------------~~-l--~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+.||...... ...+..|. .. + ..+.......++.+++.+|+. +|.+|+ ++.||++
T Consensus 875 ~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---t~~evl~ 946 (968)
T PLN00113 875 KSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP---CANDVLK 946 (968)
T ss_pred CCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc---CHHHHHH
Confidence 9999543211 01111110 00 0 000001112357789999999 999999 7888875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=291.03 Aligned_cols=132 Identities=23% Similarity=0.417 Sum_probs=116.0
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-----C---Cceeeeeeee
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-----S---NCIVKLYCSF 186 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----h---p~Iv~l~~~f 186 (549)
...+|.+.+.||+|-|++||+|.+..+.+.||||+.+... ...+....|+.+|.++. | .+||+|++.|
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 3488999999999999999999999999999999997553 23455778999998872 3 4799999999
Q ss_pred c----CCceEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEc
Q 038137 187 Q----DDEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLD 251 (549)
Q Consensus 187 ~----d~~~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld 251 (549)
. ...++|||+|++ |-+|..+|.+ ...++...++.|+.||+.||.|||. +||||-||||+||||.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 7 457899999999 8899999976 4689999999999999999999996 6999999999999995
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.18 Aligned_cols=261 Identities=29% Similarity=0.495 Sum_probs=223.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
--.++|+++..+|.|+||.||+++++.+++..|+|+++-.. .....-+..|+-+++.++|||||-+++++.-.+.++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 34689999999999999999999999999999999997532 334556788999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
++||||.||+|.+...--++++|.++.+.+++.+.||+|||+.|-+|||||-.|||+++.|.+||+|||.+..+...
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--- 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--- 165 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh---
Confidence 99999999999999888899999999999999999999999999999999999999999999999999988765311
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhhHHHHH
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlGvilyE 350 (549)
++ ...++.|||.|||||+-. ..+|+..||+|++|+...|
T Consensus 166 --------------------i~------------------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAie 207 (829)
T KOG0576|consen 166 --------------------IA------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIE 207 (829)
T ss_pred --------------------hh------------------hhhcccCCccccchhHHHHHhcccccccccccccccchhh
Confidence 00 112789999999999864 6889999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhh-ccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVN-WRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~-~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+---.+|-...-++....-.-. ........+....++..-+|++..|. +|.+|+ +++-++.|||...-
T Consensus 208 l~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRp---taeklL~h~fvs~~ 277 (829)
T KOG0576|consen 208 LGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRP---TAEKLLQHPFVSQT 277 (829)
T ss_pred hhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCC---Chhhheeceeeccc
Confidence 9999999877776655443332 11233333445789999999999999 999999 89999999998753
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=297.43 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=203.7
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcC----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKA----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
+...+.++||.|-||.||.|.... ..--||||..++... ....+.+..|.-||+.++||+||+|++++.+ ...
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 334456799999999999998643 234599999877542 3346789999999999999999999999975 578
Q ss_pred EEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+||||.++-|.|..+|.. +..|+......|+.||+.||.|||+.++|||||-..|||+.+.-.|||+||||++-+....
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999999999965 5789999999999999999999999999999999999999999999999999999875331
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. .+....-..-|||||.+.-..++.++|+|-|||+|||+
T Consensus 546 yY----------------------------------------kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 546 YY----------------------------------------KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred hh----------------------------------------hccccccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence 10 00111234579999999999999999999999999998
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
|. |.-||.+-...+.+-.|-++ ..++.| +.+++.+..|.++|+. +|.+|+..
T Consensus 586 l~lGvkPfqgvkNsDVI~~iEnG-eRlP~P--~nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 586 LSLGVKPFQGVKNSDVIGHIENG-ERLPCP--PNCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred HHhcCCccccccccceEEEecCC-CCCCCC--CCCChHHHHHHHHHhccCcccCCcH
Confidence 85 99999998887777767654 344444 5899999999999999 99999953
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=295.82 Aligned_cols=256 Identities=20% Similarity=0.326 Sum_probs=205.4
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..+...+.+.||+|-||+|.+|.-.. +..||+|+++.... ......+..|+.+|.+++|||||.|+++|..++.++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 344556778999999999999998643 68999999986542 333567999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|||||..|||..+++.. ..+.-.....++.||+.|+.||.+.++|||||.+.|+|+|.++++||+|||+++.+-...
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999999876 334455666799999999999999999999999999999999999999999999664221
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. ...| ..|-...|||||.++.+.++.++|+|++|+.|||+
T Consensus 692 yy--------------~vqg-------------------------r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~ 732 (807)
T KOG1094|consen 692 YY--------------RVQG-------------------------RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEV 732 (807)
T ss_pred ce--------------eeec-------------------------ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHH
Confidence 00 0011 24667789999999999999999999999999997
Q ss_pred h--hCCCCCCCCCchhhhhhhhh---ccc-cccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 352 L--VGYPPFYSDEPMSTCRKIVN---WRT-HLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 352 l--~G~~PF~~~~~~~~~~~I~~---~~~-~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+ +..-||...+..+..++.-. ... ..-.+.+.-++.++..|+.+|+. +.++|+ +++++-.
T Consensus 733 ~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RP---sFe~lh~ 799 (807)
T KOG1094|consen 733 FMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRP---SFEQLHL 799 (807)
T ss_pred HHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCC---CHHHHHH
Confidence 6 57889987666555444322 111 11122234678899999999998 999999 7887643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=291.33 Aligned_cols=295 Identities=25% Similarity=0.436 Sum_probs=207.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCce
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKA---TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 191 (549)
...|.++..||.|+|+.||++.+.. ..+.||+|.+.... ...++.+|.++|..+ .+.||+++.++|...+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3568889999999999999999877 78899999987543 235589999999988 58999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-CCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-~g~vKL~DFGlak~~~~~ 270 (549)
+.+||||++..+..+++. .++-..++.|++.++.||.++|++|||||||||.|+|.+. .+.-.|+|||||...+..
T Consensus 110 v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999999988888874 5678999999999999999999999999999999999985 467899999999842211
Q ss_pred Cccccccc----ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhh
Q 038137 271 NLQEKDFS----IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 345 (549)
Q Consensus 271 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlG 345 (549)
......-. ......+... ...++..............--++......+||++|.|||++.+- ..+.++|+||.|
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~-~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDV-HCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhcccCCccccCcc-cccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 10000000 0000000000 00000000000000000001122334467999999999999874 469999999999
Q ss_pred HHHHHHhhCCCCCCCCC-chhhhhhhh-------------------hcc-c-------------cc--------cCC---
Q 038137 346 AIMYEMLVGYPPFYSDE-PMSTCRKIV-------------------NWR-T-------------HL--------KFP--- 380 (549)
Q Consensus 346 vilyEml~G~~PF~~~~-~~~~~~~I~-------------------~~~-~-------------~l--------~~p--- 380 (549)
||+.-++++..||.... .......|+ -|. . .+ ..|
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999995432 111111111 111 0 00 000
Q ss_pred ---CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 381 ---EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 381 ---~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
....++..+.||+.+||. ||.+|+ +|+++|+||||...+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRi---tAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRI---TAEDALKHPFFDEAD 388 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcc---cHHHHhcCcCCcchh
Confidence 012346689999999999 999999 899999999998553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=304.76 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=221.6
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
..++......+-++||.|.||+||.|+.+..|+ .||||.|+... ..++...|+.|..||-+++||||++|-++..
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 346777888899999999999999999988774 69999997653 3556778999999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
...-+.||.|||++|+|..+|+.+ +.|+..+..-+++.|+.|+.||-+.|+|||||-..|||++.+-.+|++||||++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999764 6799999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeeccc---CCCCCCchhhccCCCCcccccch
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVG---TPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vG---T~~Y~APEvl~~~~y~~~~DiWS 343 (549)
+.... +. +++..| ...|.|||.+....++.++|+||
T Consensus 781 ledd~--~~---------------------------------------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWS 819 (996)
T KOG0196|consen 781 LEDDP--EA---------------------------------------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWS 819 (996)
T ss_pred cccCC--Cc---------------------------------------cccccCCccceeecChhHhhhcccCchhhccc
Confidence 64321 00 112222 24799999999999999999999
Q ss_pred hhHHHHHHh-hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 344 LGAIMYEML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 344 lGvilyEml-~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|++|||.+ +|.-||...+.++.+..|.. .+++|.+..++..+-.|...|++ |-..|+ .+.+|.+
T Consensus 820 yGIVmWEVmSyGERPYWdmSNQdVIkaIe~---gyRLPpPmDCP~aL~qLMldCWqkdR~~RP---~F~qiV~ 886 (996)
T KOG0196|consen 820 YGIVMWEVMSYGERPYWDMSNQDVIKAIEQ---GYRLPPPMDCPAALYQLMLDCWQKDRNRRP---KFAQIVS 886 (996)
T ss_pred cceEEEEecccCCCcccccchHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHHHHHHhhcCC---CHHHHHH
Confidence 999999965 69999999999888888774 57888888999999999999998 888888 6777775
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=291.02 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=211.4
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
.+++...+..+...||-|-||+||.+.++.-.-.||||.++...| .++.|+.|..+|+.++|||+|+|+++|..+-
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 345556667778899999999999999998888999999976654 4678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
-+|||.|||..|+|.++|+.. .-++.-...+++.||..|++||..+++|||||-..|.|+..+..||++||||++.+.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999999764 346777778888999999999999999999999999999999999999999999875
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
....... ...--..-|.|||-|....++.++|||+|||+|
T Consensus 417 gDTYTAH----------------------------------------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLL 456 (1157)
T KOG4278|consen 417 GDTYTAH----------------------------------------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLL 456 (1157)
T ss_pred CCceecc----------------------------------------cCccCcccccCcccccccccccchhhHHHHHHH
Confidence 3321100 011223569999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
||+.| |-.||.+-+....|..+-+ .....-| ..+++.+..|++.|+. .|.+|+...
T Consensus 457 WEIATYGMsPYPGidlSqVY~LLEk-gyRM~~P--eGCPpkVYeLMraCW~WsPsDRPsFa 514 (1157)
T KOG4278|consen 457 WEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGP--EGCPPKVYELMRACWNWSPSDRPSFA 514 (1157)
T ss_pred HHHHhcCCCCCCCccHHHHHHHHhc-cccccCC--CCCCHHHHHHHHHHhcCCcccCccHH
Confidence 99997 9999999888777765543 2333444 4899999999999999 999999543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.37 Aligned_cols=250 Identities=21% Similarity=0.357 Sum_probs=210.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKA-TGH--VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~-tg~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
++..+.+.||+|+||.|+.|.+.. +|+ .||||+++...... ....|++|..+|..++||++++||++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 445667899999999999999865 343 58999997654322 56779999999999999999999999988 7788
Q ss_pred EEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
||||++++|+|.+.|.+ .+.|.......|+.||+.|+.||.++++|||||-..||||-....||||||||.+.+....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999976 5679999999999999999999999999999999999999999999999999999875321
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
+.|. . +-..--...|+|||.|....++.++|+|++||.+|||
T Consensus 267 ---d~Yv---------------m--------------------~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEM 308 (1039)
T KOG0199|consen 267 ---DMYV---------------M--------------------APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEM 308 (1039)
T ss_pred ---cceE---------------e--------------------cCCCcCcccccCHhHhccccccccchhhhhhhhHHhh
Confidence 1110 0 0011234579999999999999999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
++ |.-||.+.....++.+|- ....+.-|. .+|.++.+++..|+. +|.+|+ ++..|.
T Consensus 309 FtyGEePW~G~~g~qIL~~iD-~~erLpRPk--~csedIY~imk~cWah~paDRp---tFsair 366 (1039)
T KOG0199|consen 309 FTYGEEPWVGCRGIQILKNID-AGERLPRPK--YCSEDIYQIMKNCWAHNPADRP---TFSAIR 366 (1039)
T ss_pred hccCCCCCCCCCHHHHHHhcc-ccccCCCCC--CChHHHHHHHHHhccCCccccc---cHHHHH
Confidence 97 899999999999888887 345566664 789999999999999 999999 555554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=256.87 Aligned_cols=212 Identities=43% Similarity=0.680 Sum_probs=181.9
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|.+.+.||.|++|.||+|....+++.+|||.+...... .....+.+|...+..++|+||+++++++......|+||||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999988999999999865432 2456788999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 199 LPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
+++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~---- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA---- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----
Confidence 999999999977666 899999999999999999999999999999999999999999999999998875422100
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhh-ccCCCCcccccchhhHHHHHHhhCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl-~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
......|+..|++||.+ ....++.++|+|||||++|+|++|++
T Consensus 155 ------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~ 198 (225)
T smart00221 155 ------------------------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE 198 (225)
T ss_pred ------------------------------------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 00135788899999999 66778889999999999999999999
Q ss_pred CCCC-CCch-hhhhhhhh
Q 038137 357 PFYS-DEPM-STCRKIVN 372 (549)
Q Consensus 357 PF~~-~~~~-~~~~~I~~ 372 (549)
||.+ .++. .....|..
T Consensus 199 pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 199 PFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred CccccchhHHHHHHHHhc
Confidence 9987 4444 44555543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=272.31 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=194.2
Q ss_pred hhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh--cCCCceeeeee
Q 038137 107 MRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE--VDSNCIVKLYC 184 (549)
Q Consensus 107 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~ 184 (549)
+.+-.++....+..+++.||+|-||+||.|+++ |+.||||++... ......+|.+|... ++|+||+.++.
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhh
Confidence 334444556778999999999999999999987 889999999643 23567889998865 59999999987
Q ss_pred eecCC----ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-----C---CeeecCCCCCCeEEcC
Q 038137 185 SFQDD----EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-----H---NYIHRDIKPDNLLLDR 252 (549)
Q Consensus 185 ~f~d~----~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-----~---giiHRDLKPeNILld~ 252 (549)
+-..+ ..+|||.+|.+.|+|+++|.+ ..++.+....++..++.||.+||. + .|.|||||..|||+.+
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 76533 359999999999999999976 789999999999999999999994 2 3999999999999999
Q ss_pred CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc
Q 038137 253 NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332 (549)
Q Consensus 253 ~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~ 332 (549)
+|.+-|+|+|||....... +... +. .+..|||-.|||||+|..
T Consensus 352 n~~C~IADLGLAv~h~~~t---~~id---------------i~-------------------~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDT---DTID---------------IP-------------------PNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred CCcEEEeeceeeEEecccC---Cccc---------------CC-------------------CCCccceeeccChHHhhh
Confidence 9999999999998765331 0000 00 114699999999999964
Q ss_pred CC----C--CcccccchhhHHHHHHhhC----------CCCCCCC----Cchhhhhhhhhccc-cccCCCCcCCChhHHH
Q 038137 333 KG----Y--GMECDWWSLGAIMYEMLVG----------YPPFYSD----EPMSTCRKIVNWRT-HLKFPEEAKLSPEAKD 391 (549)
Q Consensus 333 ~~----y--~~~~DiWSlGvilyEml~G----------~~PF~~~----~~~~~~~~I~~~~~-~l~~p~~~~~s~~~~d 391 (549)
.- + -..+||||||.+|||++.. .+||++- ...+..++++--+. ...+| +.+-|.++..
T Consensus 395 tin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ip-nrW~s~~~l~ 473 (513)
T KOG2052|consen 395 TINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIP-NRWKSDPALR 473 (513)
T ss_pred hcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCC-cccccCHHHH
Confidence 32 1 1358999999999998852 6799763 34455566553222 22233 2355555544
Q ss_pred H----HHHhhh-cccccCCCCCHHHHHc
Q 038137 392 L----ISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 392 L----I~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
- ++.|+. +|.-|+ +|--|++
T Consensus 474 ~m~klMkeCW~~Np~aRl---tALriKK 498 (513)
T KOG2052|consen 474 VMAKLMKECWYANPAARL---TALRIKK 498 (513)
T ss_pred HHHHHHHHhhcCCchhhh---HHHHHHH
Confidence 4 444555 999999 6666553
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=244.38 Aligned_cols=211 Identities=45% Similarity=0.728 Sum_probs=186.3
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCch
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L 204 (549)
||.|++|.||+|....+|+.+++|++....... ....+.+|..++..+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653211 346788999999999999999999999999999999999999999
Q ss_pred hhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-CCcEEEeecCcccccCCCCcccccccccCC
Q 038137 205 MTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282 (549)
Q Consensus 205 ~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-~g~vKL~DFGlak~~~~~~~~~~~~~~~~~ 282 (549)
..++... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. +++++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999765 57999999999999999999999999999999999999999 89999999999886542210
Q ss_pred CcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
......++..|++||.+... .++.+.|+||||+++|+|
T Consensus 149 -------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------- 187 (215)
T cd00180 149 -------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------- 187 (215)
T ss_pred -------------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------
Confidence 00134688899999999887 889999999999999999
Q ss_pred CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCC
Q 038137 362 EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416 (549)
Q Consensus 362 ~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 416 (549)
..+.++|.+||+ +|.+|+ ++.++++|+
T Consensus 188 -------------------------~~~~~~l~~~l~~~p~~R~---~~~~l~~~~ 215 (215)
T cd00180 188 -------------------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215 (215)
T ss_pred -------------------------HHHHHHHHHHhhCCcccCc---CHHHHhhCC
Confidence 578999999998 999999 899999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=291.56 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=205.2
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKA-------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLY 183 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 183 (549)
.++..++..+.+.||.|+||.|++|.... ....||+|.++.... ..+...+..|+++|..+ .|||||.|.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 34445555667799999999999997531 145799999876543 35677899999999988 599999999
Q ss_pred eeecCCceEEEEEeecCCCchhhHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCC
Q 038137 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKD----------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDN 247 (549)
Q Consensus 184 ~~f~d~~~lylVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeN 247 (549)
+++.....+++|+||+..|+|..+|...+ .++......++.||+.|++||++.++|||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999997655 48899999999999999999999999999999999
Q ss_pred eEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccC--CCCC
Q 038137 248 LLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGT--PDYI 325 (549)
Q Consensus 248 ILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT--~~Y~ 325 (549)
||+..+..+||+|||||+......... .....|| ..||
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~----------------------------------------~~~~~~~LP~kWm 488 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYR----------------------------------------TKSSAGTLPVKWM 488 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceE----------------------------------------ecCCCCccceeec
Confidence 999999999999999999654321100 0011222 2499
Q ss_pred CchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCC-chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccc
Q 038137 326 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDE-PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQ 402 (549)
Q Consensus 326 APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~-~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~ 402 (549)
|||.+....|+.++|+||+||+||||++ |.+||.+-. ..+.+..+.. ...+..|. .++++..++++.|+. +|++
T Consensus 489 ApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~-G~r~~~P~--~c~~eiY~iM~~CW~~~p~~ 565 (609)
T KOG0200|consen 489 APESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE-GNRMEQPE--HCSDEIYDLMKSCWNADPED 565 (609)
T ss_pred CHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHhCCCccc
Confidence 9999999999999999999999999997 899998854 3444443333 33445554 779999999999999 9999
Q ss_pred cCCCCCHHHHH
Q 038137 403 RLGTKGADEIK 413 (549)
Q Consensus 403 Rl~~~~~~eil 413 (549)
|+ ++.++.
T Consensus 566 RP---~F~~~~ 573 (609)
T KOG0200|consen 566 RP---TFSECV 573 (609)
T ss_pred CC---CHHHHH
Confidence 99 566555
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=272.86 Aligned_cols=243 Identities=22% Similarity=0.349 Sum_probs=189.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc--CCCceeeeeeeecCCc---
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV--DSNCIVKLYCSFQDDE--- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~d~~--- 190 (549)
.+..+++.+||+|.||.||+|... ++.||||++... +.+.+.+|++|.+.. .|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 455677889999999999999865 689999998643 456799999998864 8999999998766444
Q ss_pred -eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCeeecCCCCCCeEEcCCCcEEEee
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK---------HNYIHRDIKPDNLLLDRNGHMKLSD 260 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------~giiHRDLKPeNILld~~g~vKL~D 260 (549)
.++||+||.+.|+|.++|. ...+++.....++.-|+.||.|||. ..|+|||||..|||+-.|+++-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 7899999999999999994 5689999999999999999999995 2499999999999999999999999
Q ss_pred cCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCC---
Q 038137 261 FGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYG--- 336 (549)
Q Consensus 261 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~--- 336 (549)
||||..+.... ..++ +..-|||..|||||+|.+. ...
T Consensus 360 FGLAl~~~p~~-~~~d--------------------------------------~~~qVGT~RYMAPEvLEgainl~d~~ 400 (534)
T KOG3653|consen 360 FGLALRLEPGK-PQGD--------------------------------------THGQVGTRRYMAPEVLEGAINLQDRD 400 (534)
T ss_pred cceeEEecCCC-CCcc--------------------------------------hhhhhhhhhhcCHHHHhhhcccccHH
Confidence 99999876321 1100 1146999999999999863 222
Q ss_pred --cccccchhhHHHHHHhhCCC------------CCCC-----CCchhhhhhhhhccccccCCCC---cCCChhHHHHHH
Q 038137 337 --MECDWWSLGAIMYEMLVGYP------------PFYS-----DEPMSTCRKIVNWRTHLKFPEE---AKLSPEAKDLIS 394 (549)
Q Consensus 337 --~~~DiWSlGvilyEml~G~~------------PF~~-----~~~~~~~~~I~~~~~~l~~p~~---~~~s~~~~dLI~ 394 (549)
...||||+|.+||||++... ||.. .+..++...++..+....+|+. ..--.-+++.|.
T Consensus 401 Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~E 480 (534)
T KOG3653|consen 401 AFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIE 480 (534)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHH
Confidence 36899999999999997533 3321 1223445555665566666652 112345788888
Q ss_pred Hhhh-cccccCCC
Q 038137 395 KLLC-NVEQRLGT 406 (549)
Q Consensus 395 ~lL~-dp~~Rl~~ 406 (549)
.|+. |++.|+..
T Consensus 481 eCWDhDaeARLTA 493 (534)
T KOG3653|consen 481 ECWDHDAEARLTA 493 (534)
T ss_pred HHcCCchhhhhhh
Confidence 8888 99999954
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.89 Aligned_cols=242 Identities=19% Similarity=0.284 Sum_probs=198.5
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGH----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
...++||.|+||+||+|.+...|+ +||||++..... ......+..|.-+|..++|||+++|+++++... +-||
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 345789999999999999865554 689999876543 233456889999999999999999999999776 8899
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
.+|||+|.|.++++. ++.+-......|..||+.|+.|||.++++||||-..|+|+..-.|+||+|||+++.+.......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999999965 5789999999999999999999999999999999999999999999999999999875432111
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~- 353 (549)
+ +....-.+-|||-|.+....|+.++||||+||.+||++|
T Consensus 856 ---~------------------------------------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTF 896 (1177)
T KOG1025|consen 856 ---S------------------------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTF 896 (1177)
T ss_pred ---c------------------------------------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhc
Confidence 0 001123356899999999999999999999999999997
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
|.-|+.+....++- +++.....+.- ++..+-++.-++.+|+. |+..|++.
T Consensus 897 Ga~Py~gi~~~eI~-dlle~geRLsq--PpiCtiDVy~~mvkCwmid~~~rp~f 947 (1177)
T KOG1025|consen 897 GAKPYDGIPAEEIP-DLLEKGERLSQ--PPICTIDVYMVMVKCWMIDADSRPTF 947 (1177)
T ss_pred CCCccCCCCHHHhh-HHHhccccCCC--CCCccHHHHHHHHHHhccCcccCccH
Confidence 99999887665544 34443334444 45789999999999998 99998843
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=302.66 Aligned_cols=225 Identities=13% Similarity=0.172 Sum_probs=155.3
Q ss_pred Cceeeeeeee-------cCCceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 177 NCIVKLYCSF-------QDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 177 p~Iv~l~~~f-------~d~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
+||++++++| .....++++|||+ +++|..+|.. ...+++.+++.|+.||+.||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777788777 2335688999988 6799999965 45699999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCC---cccccccccCCCcCCccCCCCCCCCccchHHHHHH-HhhhcccceeecccCCCC
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSN---LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQH-WQRNRRMLAYSTVGTPDY 324 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~vGT~~Y 324 (549)
||+..|.+|++|||+|....... ....+|......... +.+. ...... ............+||+.|
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~---------~~~~-~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEIL---------SERR-IEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccc---------cccc-hhhhhccccCCCcccccccCCCcce
Confidence 99998999999999886542210 011111110000000 0000 000000 000000001135799999
Q ss_pred CCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCC-CcCCChhHHHHHHHhhh-cccc
Q 038137 325 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLLC-NVEQ 402 (549)
Q Consensus 325 ~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~ 402 (549)
||||++.+..|+.++|||||||+||||++|.+||.... .....+... .+|. ...-.+.+.+++.+||+ +|.+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~L~~~P~~ 255 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR----VLPPQILLNWPKEASFCLWLLHPEPSC 255 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh----hcChhhhhcCHHHHHHHHHhCCCChhh
Confidence 99999999999999999999999999999999986432 122222211 1111 11225677899999999 9999
Q ss_pred cCCCCCHHHHHcCCcccCC
Q 038137 403 RLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 403 Rl~~~~~~eil~HpfF~~i 421 (549)
|+ ++.||+.||||...
T Consensus 256 Rp---s~~eil~h~~~~~~ 271 (793)
T PLN00181 256 RP---SMSELLQSEFINEP 271 (793)
T ss_pred Cc---ChHHHhhchhhhhh
Confidence 99 89999999999763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=250.92 Aligned_cols=240 Identities=22% Similarity=0.373 Sum_probs=188.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeee-eeecCCceEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLY-CSFQDDEYLY 193 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~-~~f~d~~~ly 193 (549)
.+.|.+.+.||.|-||++.+|+++.++..+|+|.+.+... ..+.+.+|-.---.+ .|.+|+.-| .+||+.+++.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 4679999999999999999999999999999999877543 234566676654444 588999988 5799999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc-C-CCcEEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD-R-NGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld-~-~g~vKL~DFGlak~~~~~~ 271 (549)
++|||+|-|||.+-+.. ..+-|...+.+++|++.||+|+|++++||||||.+||||- . ...|||||||+.+.....
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 99999999999987744 6789999999999999999999999999999999999983 2 347999999998764311
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CC--CCcccccchhhH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KG--YGMECDWWSLGA 346 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~--y~~~~DiWSlGv 346 (549)
+ + -.--+..|.|||++.. .. ..+..|+|.||+
T Consensus 177 ----------------------V-------~--------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGI 213 (378)
T KOG1345|consen 177 ----------------------V-------K--------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGI 213 (378)
T ss_pred ----------------------e-------h--------------hhhhhcccCCcHHHhhccccceEecccccchheee
Confidence 0 0 0123456999998763 33 378899999999
Q ss_pred HHHHHhhCCCCCCCCCc-hhhhhhhhhcccc--ccCCCC-cCCChhHHHHHHHhhh-cccccC
Q 038137 347 IMYEMLVGYPPFYSDEP-MSTCRKIVNWRTH--LKFPEE-AKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~-~~~~~~I~~~~~~--l~~p~~-~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
|+|.+|+|.+||..... ..-|-+-+.|... ...|.. ..+|+.+..+.++.|. ++++|-
T Consensus 214 i~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 214 IFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred eeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence 99999999999985432 2234444555432 234432 3579999999999998 888883
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=285.20 Aligned_cols=324 Identities=35% Similarity=0.569 Sum_probs=268.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
+...++|.+++-+-+|++|.++.+....+|...++|+..+..++...+.+..+.+.+++-...||.++..++.|.....+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45788999999999999999999999999999999999998888888888899999999889999999999998888999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+|||+|+.||+|...|...+..+++-++.++..++.+++|||...++|||++|.|+|+..+||.+++|||+......-..
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999999999989999999999999999999999999999999999999999999999999996654432110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.. +.+ |....+........ .+..++. ..........+||++|.|||.+.+...+..+|||++|++++|.+
T Consensus 960 ~~-~~s-g~~~~~~~~~~~~~-----~~~~~l~---~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 960 TT-DLS-GPSSSGTPRRLSRS-----ERRPQLS---ADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cC-Ccc-cccccCcccccccc-----ccccccc---cchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 00 000 00000000000000 0000110 00001123679999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCC-cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccccccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIK 430 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~-~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~ 430 (549)
+|.+||.+..+...+++|.+. ....|.. ...+++++++|.++|. ++.+|+|..++.+++.||||++++|+.+....
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~--~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNR--DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred cCCCCCCCcchhhhhhccccC--CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccccc
Confidence 999999999999999999874 3334432 3579999999999999 99999998888899999999999999999999
Q ss_pred CCCcccCCCccccccccc
Q 038137 431 AAFIPEVNDELDTQNFEK 448 (549)
Q Consensus 431 ~pf~p~~~~~~d~~~f~~ 448 (549)
.+|+|...+..|+++|..
T Consensus 1108 ~~~~p~~~s~~dtS~~~~ 1125 (1205)
T KOG0606|consen 1108 AEFVPQPESTQDTSYFES 1125 (1205)
T ss_pred CccCCCCCCCCccchhhc
Confidence 999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-27 Score=237.39 Aligned_cols=261 Identities=39% Similarity=0.616 Sum_probs=206.1
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC-ceeeeeeeecCCceEEEEEe
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~d~~~lylVmE 197 (549)
|.+...||.|+||.||++.+. ..+|+|.+.+...........+.+|..+++.+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788899999999999999987 78999999876654433567789999999999988 79999999988888999999
Q ss_pred ecCCCchhhHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeecCcccccCCCCcc
Q 038137 198 YLPGGDMMTLLMRKD---TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 198 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~~~~~~~ 273 (549)
|+.|+++..++.... .+++..+..++.|++.++.|+|..|++||||||+|||++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776554 799999999999999999999999999999999999999999 7999999999854322100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchhhHHHHH
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSlGvilyE 350 (549)
.... ......+||+.|+|||++.+ ..++...|+||+|+++++
T Consensus 159 ~~~~-----------------------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~ 203 (384)
T COG0515 159 SSIP-----------------------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203 (384)
T ss_pred cccc-----------------------------------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHH
Confidence 0000 01125789999999999988 578999999999999999
Q ss_pred HhhCCCCCCCCCc----hhhhhhhhhcccc-ccCCCCcCC----ChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 351 MLVGYPPFYSDEP----MSTCRKIVNWRTH-LKFPEEAKL----SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 351 ml~G~~PF~~~~~----~~~~~~I~~~~~~-l~~p~~~~~----s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+++|..||..... ......+...... ...+..... ...+.+++.+++. +|..|. +..+...++|...
T Consensus 204 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~---~~~~~~~~~~~~~ 280 (384)
T COG0515 204 LLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL---SSSSDLSHDLLAH 280 (384)
T ss_pred HHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcC---CHHHHhhchHhhC
Confidence 9999999877764 2333333322111 111111111 2579999999998 999999 5666666655543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=276.01 Aligned_cols=262 Identities=25% Similarity=0.403 Sum_probs=204.0
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeech---hhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKS---EMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~---~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
....++|.|++|.|+.+......+.++.|..... ....+.....+..|.-+-..+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999999999888777777777765421 1111112222555666667789999998888888777777779
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||++ ||+.++++.+.++...+..++.|++.||.|||..||.||||||+|+|++.+|.+||+|||.+..+......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~--- 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK--- 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch---
Confidence 99999 99999998889999999999999999999999999999999999999999999999999998765422100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~G~ 355 (549)
.-.....++|+..|+|||++.+..| ...+|+||.|++++.|++|+
T Consensus 477 ----------------------------------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 477 ----------------------------------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred ----------------------------------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 0012336899999999999999999 46799999999999999999
Q ss_pred CCCCCCCchhhh---hhhhhcccccc--CCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 356 PPFYSDEPMSTC---RKIVNWRTHLK--FPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 356 ~PF~~~~~~~~~---~~I~~~~~~l~--~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
.||......+.. ..-..|..... .+....++...+.+|.+||. +|.+|. ++++|++.+||+.|+
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~---ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI---TIEQILNDEWIRSIE 592 (601)
T ss_pred CccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee---cHHHHhhChHhhhcc
Confidence 999654433221 11111111111 11124678899999999999 999999 899999999999886
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=228.78 Aligned_cols=161 Identities=22% Similarity=0.259 Sum_probs=129.5
Q ss_pred CchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccccc
Q 038137 202 GDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280 (549)
Q Consensus 202 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~ 280 (549)
|+|.+++.. ...|++..++.++.||+.||.|||+.+ ||+|||++.+|.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 689999976 456999999999999999999999998 999999999999999 9998764311
Q ss_pred CCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCC
Q 038137 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360 (549)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~ 360 (549)
..+||+.|||||++.+..|+.++|||||||++|||++|.+||..
T Consensus 63 ------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 63 ------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ------------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 23689999999999999999999999999999999999999976
Q ss_pred CCch-hhhhhhhhcccccc---CCCCcCCCh--hHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 361 DEPM-STCRKIVNWRTHLK---FPEEAKLSP--EAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 361 ~~~~-~~~~~I~~~~~~l~---~p~~~~~s~--~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
.... .....++....... .+....++. ++++||.+||. +|.+|+ ++.+++.|+|+.
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp---~~~~ll~~~~~~ 169 (176)
T smart00750 107 ERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRRE---AANHYLAHCRAL 169 (176)
T ss_pred cchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccccccc---CHHHHHHHHHHH
Confidence 5443 23333332111110 011123444 69999999999 999999 899999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=243.21 Aligned_cols=146 Identities=16% Similarity=0.167 Sum_probs=117.8
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhh--hchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKA-TGHVYAMKKLKKSEM--LRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
....++|.+.+.||+|+||+||+|+++. ++..||||++..... ........+.+|+.+|..++|+|||..++.+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999999876 788899998753211 1223345689999999999999998533322
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC-CCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDI-KPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDL-KPeNILld~~g~vKL~DFGlak~~~ 268 (549)
...|||||||+|++|.. +... . ...++.+++.||.|||+.||||||| ||+|||++.+|.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 45799999999999963 2111 1 1467899999999999999999999 9999999999999999999999764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-25 Score=227.22 Aligned_cols=218 Identities=26% Similarity=0.353 Sum_probs=172.7
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhchhhHHHHHHHHHHHHhcC----CCceeeeeeee-cCCce
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATG-HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD----SNCIVKLYCSF-QDDEY 191 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg-~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~----hp~Iv~l~~~f-~d~~~ 191 (549)
.|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|..+|..+. .+++..++..+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998775 6899998876432211 14677888888876 36899999999 58889
Q ss_pred EEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-----cEEEeecCcc
Q 038137 192 LYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-----HMKLSDFGLC 264 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-----~vKL~DFGla 264 (549)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.||++||+.|+|||||||+|+++...+ .+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 89999988543 6899999999999999999999999999999999999998763 6999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+........ +....+.| .....+.||..|+++.+..+...+...|+||+
T Consensus 175 r~~~~~~~~-----------------~~~~~~~r--------------~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~ 223 (322)
T KOG1164|consen 175 RRFKYVGDS-----------------GGNLRPPR--------------PQKGLFRGTLRYASINVHLGIEQGRRDDLESL 223 (322)
T ss_pred ccccccCCC-----------------CcccccCC--------------CCccCCCCccccccHHHhCCCccCCchhhhhH
Confidence 843211000 00000000 00124679999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhh
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKI 370 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I 370 (549)
+.++.||+.|..||.+........++
T Consensus 224 ~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 224 FYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred HHHHHHHhcCCCCCccccccchHHHH
Confidence 99999999999999776544333333
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=222.77 Aligned_cols=257 Identities=19% Similarity=0.273 Sum_probs=203.7
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCC-----cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATG-----HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 184 (549)
+...+..++++...++-+|.||.||.|.++... +.|-+|.++.. ...-++..+..|--+|..+.|||+..+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 334445567888899999999999999776432 23445555332 24556788899999999999999999988
Q ss_pred eec-CCceEEEEEeecCCCchhhHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc
Q 038137 185 SFQ-DDEYLYLIMEYLPGGDMMTLLMR--------KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH 255 (549)
Q Consensus 185 ~f~-d~~~lylVmEy~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~ 255 (549)
+.. +....++++.++.-|+|..+|.. ...++-.+...++.|+..|++|||++|+||.||-..|.+||+.-.
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 765 55667888999989999999962 235778888999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC
Q 038137 256 MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY 335 (549)
Q Consensus 256 vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y 335 (549)
|||+|=.|++.+-+....- .|. .--....||+||.+.+..|
T Consensus 435 VkltDsaLSRDLFP~DYhc----LGD-----------------------------------nEnRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHC----LGD-----------------------------------NENRPVKWMSLEALQNSHY 475 (563)
T ss_pred EEeccchhccccCcccccc----cCC-----------------------------------CCCCcccccCHHHHhhhhh
Confidence 9999999998764321110 000 0012346999999999999
Q ss_pred CcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 336 GMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
+.++|+|||||+||||++ |+.|+..-++.++..-+..+ ..+.-| .++++++..++-.|+. +|++|+ +.+|+.
T Consensus 476 ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-yRlaQP--~NCPDeLf~vMacCWallpeeRP---sf~Qlv 549 (563)
T KOG1024|consen 476 SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-YRLAQP--FNCPDELFTVMACCWALLPEERP---SFSQLV 549 (563)
T ss_pred cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-ceecCC--CCCcHHHHHHHHHHHhcCcccCC---CHHHHH
Confidence 999999999999999997 99999999998888777653 334444 4789999999999999 999999 566653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=208.60 Aligned_cols=219 Identities=23% Similarity=0.320 Sum_probs=178.6
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCceE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCIVKLYCSFQDDEYL 192 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~l 192 (549)
+....|.+++.||.|+||.+|+|....+|..||||+-....- .-++..|..+...+.+ ..|..++.++....+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 456789999999999999999999999999999998654321 1236778888888865 6788999999999999
Q ss_pred EEEEeecCCCchhhHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEEeecCcccccC
Q 038137 193 YLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKLSDFGLCKPLD 268 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL~DFGlak~~~ 268 (549)
.|||+.+ |-+|.+++. ....|+-..+.-++-|++.-|+|+|.+++|||||||+|+|+.-+- .+.|+|||||+.+-
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 889999884 467899999999999999999999999999999999999997655 47899999999874
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.... ....|-|. -....||..|.+--...+...+..-|+=|+|.+|
T Consensus 166 d~~t-------------------~~HIpyre---------------~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 166 DIRT-------------------RQHIPYRE---------------DRNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred cccc-------------------cccCcccc---------------CCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 3210 00111111 0146899999998888888889999999999999
Q ss_pred HHHhhCCCCCCCCC---chhhhhhhhh
Q 038137 349 YEMLVGYPPFYSDE---PMSTCRKIVN 372 (549)
Q Consensus 349 yEml~G~~PF~~~~---~~~~~~~I~~ 372 (549)
..+..|..||.+-. ..+-+.+|..
T Consensus 212 mYfnrG~LPWQglka~tk~QKyEkI~E 238 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKKQKYEKISE 238 (341)
T ss_pred eeeecCCCcccccchhhHHHHHHHHHH
Confidence 99999999998754 3455666665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=208.89 Aligned_cols=143 Identities=18% Similarity=0.193 Sum_probs=113.3
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchh-----------------------hHHHHHHHHHHHHhcCCCc
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRG-----------------------QVEHVKAERNLLAEVDSNC 178 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~-----------------------~~~~~~~E~~iL~~l~hp~ 178 (549)
...||+|+||.||+|.+. +|+.||||+++........ .......|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 8999999999865321111 0123456999999998777
Q ss_pred eeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCCCCCeEEcCCCcEE
Q 038137 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI-HKHNYIHRDIKPDNLLLDRNGHMK 257 (549)
Q Consensus 179 Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~giiHRDLKPeNILld~~g~vK 257 (549)
|...+..... . .||||||++|+++...+.....+++..+..++.|++.||.+| |+.|||||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6433322222 2 389999999988776655567899999999999999999999 799999999999999998 58999
Q ss_pred EeecCcccccC
Q 038137 258 LSDFGLCKPLD 268 (549)
Q Consensus 258 L~DFGlak~~~ 268 (549)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=210.09 Aligned_cols=218 Identities=23% Similarity=0.355 Sum_probs=178.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~l 192 (549)
+..-.|.+.+.||+|+||+.++|.+.-++++||||.-... ...-.++.|....+.+ ..+.|...||+-+...+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4456799999999999999999999999999999975432 1223466677777666 468999999999999999
Q ss_pred EEEEeecCCCchhhHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-----cEEEeecCcccc
Q 038137 193 YLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-----HMKLSDFGLCKP 266 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-----~vKL~DFGlak~ 266 (549)
.||||++ |-+|.+++. ..+.|+...+..++.|++.-++|+|++.+|+|||||+|+||..-| .|-|+|||+||.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 888888874 356899999999999999999999999999999999999997654 489999999998
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
....... ...|-|. ..+..||..||+--..++...+..-|+=|||=
T Consensus 179 YrDp~Tk-------------------qHIPYrE---------------~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 179 YRDPKTK-------------------QHIPYRE---------------HKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred hcCcccc-------------------ccCcccc---------------ccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 7432110 0111111 12678999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCC---CCchhhhhhhh
Q 038137 347 IMYEMLVGYPPFYS---DEPMSTCRKIV 371 (549)
Q Consensus 347 ilyEml~G~~PF~~---~~~~~~~~~I~ 371 (549)
+++..|-|..||.+ ++..+-+++|-
T Consensus 225 vFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 225 VFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred hhhhhccCCCccccccCcchHHHHHHhc
Confidence 99999999999986 34556666664
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=207.46 Aligned_cols=143 Identities=14% Similarity=0.198 Sum_probs=116.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHH------HHHHHHHHHhcCCCceeeeeeeec
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEH------VKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~------~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
+...+|.++++||.|+||.||++.. ++..||+|++............. +.+|...+..+.||+|+.+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3467899999999999999999755 46689999997654433333333 578888999999999999988766
Q ss_pred CC--------ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEe
Q 038137 188 DD--------EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLS 259 (549)
Q Consensus 188 d~--------~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~ 259 (549)
+. ...||||||++|.+|.++. .+++. .+.+++.+|..||..|++||||||+||+++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 43 3589999999999998773 23443 456999999999999999999999999999999 9999
Q ss_pred ecCccccc
Q 038137 260 DFGLCKPL 267 (549)
Q Consensus 260 DFGlak~~ 267 (549)
|||.++..
T Consensus 177 Dfg~~~~~ 184 (232)
T PRK10359 177 DLSGKRCT 184 (232)
T ss_pred ECCCcccc
Confidence 99987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=200.47 Aligned_cols=143 Identities=20% Similarity=0.193 Sum_probs=114.3
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchh-----------------------hHHHHHHHHHHHHhcCCCc
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRG-----------------------QVEHVKAERNLLAEVDSNC 178 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~-----------------------~~~~~~~E~~iL~~l~hp~ 178 (549)
.+.||+|+||.||+|.+. +|+.||||+++........ .......|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 8999999999865321000 0123467889999999988
Q ss_pred eeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEE
Q 038137 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMK 257 (549)
Q Consensus 179 Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vK 257 (549)
|.....+.... .||||||++|+++.........+++..+..++.+++.+|.+||+ .||+||||||+|||++ +|.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 74433322222 48999999988665443355678999999999999999999999 9999999999999999 89999
Q ss_pred EeecCcccccC
Q 038137 258 LSDFGLCKPLD 268 (549)
Q Consensus 258 L~DFGlak~~~ 268 (549)
|+|||+|+.+.
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999998765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=197.81 Aligned_cols=204 Identities=18% Similarity=0.217 Sum_probs=146.6
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhh-HHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEEE
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ-VEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~-~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVm 196 (549)
+.+...||+|+||+|+++.. .+..++.+.+.-.....+.. -..+.+|+++|+.+. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999998765 56788877776554432221 224789999999995 4789999875 4479999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC-CCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDI-KPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDL-KPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||+.|.+|...+.. . ...++.|++.+|.++|.+||||||| ||+|||++.+|+++|+|||+|..........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~- 149 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM- 149 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH-
Confidence 99999998654321 1 2357889999999999999999999 7999999999999999999998543211000
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCC-cccccchhhHHHHHHhh
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYG-MECDWWSLGAIMYEMLV 353 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~-~~~DiWSlGvilyEml~ 353 (549)
..-..+-+.+..+. -..+++.|++|+--.-. ..+ ...+|++.|+-+|.|+|
T Consensus 150 ---------------------r~L~~rDl~~llk~------~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~ 202 (218)
T PRK12274 150 ---------------------RLLAREDLRHLLKH------KRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVT 202 (218)
T ss_pred ---------------------HHHHHHHHHHHHHH------HHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHh
Confidence 00000111111111 12378999999865321 223 67899999999999999
Q ss_pred CCCCCCCCCc
Q 038137 354 GYPPFYSDEP 363 (549)
Q Consensus 354 G~~PF~~~~~ 363 (549)
|..|+.+++.
T Consensus 203 ~~~~~~~~~~ 212 (218)
T PRK12274 203 RRVLHWEDNE 212 (218)
T ss_pred ccCCccccCC
Confidence 9999987764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-22 Score=198.74 Aligned_cols=232 Identities=24% Similarity=0.345 Sum_probs=150.1
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-----------Ccee-----ee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-----------NCIV-----KL 182 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-----------p~Iv-----~l 182 (549)
+.....||.|+||.||.|.+..||+.+|+|+..-.........+.+++|.-....+.+ ..++ ++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4557899999999999999999999999999865544444556667666644433222 1222 21
Q ss_pred e---eeecCC---c-----eEEEEEeecCCCchhhHhh---hcCCC---CHHHHHHH-HHHHHHHHHHHHhCCeeecCCC
Q 038137 183 Y---CSFQDD---E-----YLYLIMEYLPGGDMMTLLM---RKDTL---TEEEARFY-VGETVLAIESIHKHNYIHRDIK 244 (549)
Q Consensus 183 ~---~~f~d~---~-----~lylVmEy~~gg~L~~~l~---~~~~l---~e~~~~~~-~~qi~~aL~~LH~~giiHRDLK 244 (549)
- -++... . +.+++|+-+ -+||..++. ..... ....|+.+ ..|++..+.+||+.|++|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1 011111 1 347888877 568877753 22222 22334344 4899999999999999999999
Q ss_pred CCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCC
Q 038137 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDY 324 (549)
Q Consensus 245 PeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y 324 (549)
|+|++++.+|.+.|+||+........ ......+..|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~--------------------------------------------~~~~~~~~~~ 208 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR--------------------------------------------YRCSEFPVAF 208 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE--------------------------------------------EEGGGS-TTT
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce--------------------------------------------eeccCCCccc
Confidence 99999999999999999976653210 0012455789
Q ss_pred CCchhhcc--------CCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHh
Q 038137 325 IAPEVLLK--------KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKL 396 (549)
Q Consensus 325 ~APEvl~~--------~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~l 396 (549)
.+||.... -.|+.+.|.|+||+++|.|.+|..||....+...... .|-.-..+++..++||.+|
T Consensus 209 ~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~l 280 (288)
T PF14531_consen 209 TPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGL 280 (288)
T ss_dssp S-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHH
T ss_pred CChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHH
Confidence 99998754 2578999999999999999999999986654332221 1222225778999999999
Q ss_pred hh-ccccc
Q 038137 397 LC-NVEQR 403 (549)
Q Consensus 397 L~-dp~~R 403 (549)
|. +|.+|
T Consensus 281 L~~~~~~R 288 (288)
T PF14531_consen 281 LQRNPEDR 288 (288)
T ss_dssp T-SSGGGS
T ss_pred ccCCcccC
Confidence 99 99887
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=203.82 Aligned_cols=275 Identities=25% Similarity=0.346 Sum_probs=187.4
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCC-----------------------------------cEEEEEEeechh
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATG-----------------------------------HVYAMKKLKKSE 154 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-----------------------------------~~vAiK~l~k~~ 154 (549)
...++..++|++...||+|.-..||.|+....| -+.|||.|..-+
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 456788899999999999999999998754311 135666654322
Q ss_pred hhch--hhHHHHHHHH------HHH--------H--------hcCCCceeeeeeeecCC---------------------
Q 038137 155 MLRR--GQVEHVKAER------NLL--------A--------EVDSNCIVKLYCSFQDD--------------------- 189 (549)
Q Consensus 155 ~~~~--~~~~~~~~E~------~iL--------~--------~l~hp~Iv~l~~~f~d~--------------------- 189 (549)
.... ...+.+-+|. ..+ + ...|||||+++.+|.|.
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 2110 0111111221 011 0 13699999999988652
Q ss_pred ------ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE--cCCC--cEEEe
Q 038137 190 ------EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL--DRNG--HMKLS 259 (549)
Q Consensus 190 ------~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl--d~~g--~vKL~ 259 (549)
..+|+||.-.+ .+|..++-. ...+-...+-+++|++.|+.|||++||.|||||.+|||| |+++ .+.|+
T Consensus 310 ~g~g~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 24899999884 588888844 456778889999999999999999999999999999998 4444 57899
Q ss_pred ecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-----
Q 038137 260 DFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG----- 334 (549)
Q Consensus 260 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~----- 334 (549)
|||.|---+.....- .|. +| -...-|...-||||+....+
T Consensus 388 DFGCcLAd~~hGlql-py~---------------------------S~-------~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQL-PYE---------------------------SD-------EVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred ccceeeecccccccc-ccc---------------------------cc-------cccCCCcceecchhhhhcCCCCcee
Confidence 999986433211110 000 00 01345777899999987422
Q ss_pred -CCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 335 -YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 335 -y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
--.++|.|+.|.+.||++....|||+......-..-.+..+-..+|+ .+++.+++||..||. ||.+|....-|..+
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~--~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPS--RVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcc--cCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 12478999999999999999999998544322211122112233443 789999999999999 99999976556777
Q ss_pred HcCCcccCCCc
Q 038137 413 KAHPWFKGIEW 423 (549)
Q Consensus 413 l~HpfF~~i~w 423 (549)
++-..|..-+|
T Consensus 511 l~LsLw~~~~~ 521 (598)
T KOG4158|consen 511 LNLSLWRMGED 521 (598)
T ss_pred HHHHHhcCchH
Confidence 76555554444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-23 Score=230.33 Aligned_cols=247 Identities=20% Similarity=0.309 Sum_probs=182.9
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechh-hhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE-MLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+|...+.||++-|=+|.+|++.. | .|+||++-+.. ...-........|+. ....++||++.+.-.-..+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 67888999999999999998764 3 58999987654 222222233333444 56678999999888878888999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
+|+ ..+|.+.|..+..+..-+.++|+.|++.||.-+|..||+|+|||.+||||+.-.-+.|+||..-|+.--......+
T Consensus 101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999 5589999988888999999999999999999999999999999999999999999999999987764322211111
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-----------CCcccccchhh
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-----------YGMECDWWSLG 345 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-----------y~~~~DiWSlG 345 (549)
|.. ..| +----.+|+|||.+.... .+++.||||+|
T Consensus 180 f~f--------FFD--------------------------TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G 225 (1431)
T KOG1240|consen 180 FTF--------FFD--------------------------TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG 225 (1431)
T ss_pred ceE--------EEe--------------------------cCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence 110 000 011123799999986522 57889999999
Q ss_pred HHHHHHhh-CCCCCCCC-------CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 346 AIMYEMLV-GYPPFYSD-------EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 346 vilyEml~-G~~PF~~~-------~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|+++||++ |.|||.-. .........+. .++ +...+.||..||. ||++|+ +|++.|+-
T Consensus 226 CViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le-----~Ie-----d~~~Rnlil~Mi~rdPs~Rl---SAedyL~~ 291 (1431)
T KOG1240|consen 226 CVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLE-----KIE-----DVSLRNLILSMIQRDPSKRL---SAEDYLQK 291 (1431)
T ss_pred HHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHH-----hCc-----CccHHHHHHHHHccCchhcc---CHHHHHHh
Confidence 99999987 79999310 00111111111 011 3478999999999 999999 89999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=189.19 Aligned_cols=136 Identities=15% Similarity=0.231 Sum_probs=109.6
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-----CCCceeeeeeeecCCc---eEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-----DSNCIVKLYCSFQDDE---YLY 193 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~f~d~~---~ly 193 (549)
...||+|+||.||. +..++.. +||++.... ....+.+.+|+.++..+ +||||+++|++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 7777666 699886542 22345689999999999 6799999999999874 444
Q ss_pred -EEEee--cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCeeecCCCCCCeEEcCC----CcEEEeecCccc
Q 038137 194 -LIMEY--LPGGDMMTLLMRKDTLTEEEARFYVGETVLAI-ESIHKHNYIHRDIKPDNLLLDRN----GHMKLSDFGLCK 265 (549)
Q Consensus 194 -lVmEy--~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL-~~LH~~giiHRDLKPeNILld~~----g~vKL~DFGlak 265 (549)
+|||| +++|+|.+++.+ +.+++. ..++.+++.++ +|||+++||||||||+|||++.. +.++|+||+.++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 568999999965 457766 36688888888 99999999999999999999743 379999955444
Q ss_pred c
Q 038137 266 P 266 (549)
Q Consensus 266 ~ 266 (549)
.
T Consensus 158 ~ 158 (210)
T PRK10345 158 T 158 (210)
T ss_pred c
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-21 Score=188.07 Aligned_cols=146 Identities=17% Similarity=0.155 Sum_probs=116.6
Q ss_pred CeeeeeeeeecCCeEEEEEE-EcCCCcEEEEEEeechhhhch--------------------h-hHHHHHHHHHHHHhcC
Q 038137 118 DFEPLTMIGKGAFGEVRVCR-EKATGHVYAMKKLKKSEMLRR--------------------G-QVEHVKAERNLLAEVD 175 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~-~k~tg~~vAiK~l~k~~~~~~--------------------~-~~~~~~~E~~iL~~l~ 175 (549)
.|.+.+.||+|+||.||+|. +..+|+.||||++........ . ....+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 677999999999975431100 0 1123568999999987
Q ss_pred CCc--eeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeecCCCCCCeEEcC
Q 038137 176 SNC--IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN-YIHRDIKPDNLLLDR 252 (549)
Q Consensus 176 hp~--Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHRDLKPeNILld~ 252 (549)
+.+ +++++.. ...|+||||++|++|...+.....+.+..+..++.||+.+|.+||..| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3444432 234899999999888776655566777788899999999999999999 99999999999999
Q ss_pred CCcEEEeecCcccccC
Q 038137 253 NGHMKLSDFGLCKPLD 268 (549)
Q Consensus 253 ~g~vKL~DFGlak~~~ 268 (549)
++.++|+|||+|....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999998654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-22 Score=222.44 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=212.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREK-ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~ly 193 (549)
...|.+.+.||+|+|+.|.++... .+...+|+|.+.... .......++..|..+-..+. |+|++++++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 567889999999999999998874 455678888776543 23445567777888888886 999999999999999999
Q ss_pred EEEeecCCCchhhHh-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCCeEEcCCC-cEEEeecCcccccCC
Q 038137 194 LIMEYLPGGDMMTLL-MRKD-TLTEEEARFYVGETVLAIESIH-KHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDC 269 (549)
Q Consensus 194 lVmEy~~gg~L~~~l-~~~~-~l~e~~~~~~~~qi~~aL~~LH-~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~~~ 269 (549)
++++|..||++...+ .... ..+...+.+|+.|+..+|.|+| ..++.||||||+|.+++..| .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999998 5544 7889999999999999999999 99999999999999999999 999999999987643
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeeccc-CCCCCCchhhccCCC-CcccccchhhHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVG-TPDYIAPEVLLKKGY-GMECDWWSLGAI 347 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vG-T~~Y~APEvl~~~~y-~~~~DiWSlGvi 347 (549)
.. | ........+| ++.|+|||.+.+..| +...|+||.|++
T Consensus 178 ~~-------------------g-------------------~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~ 219 (601)
T KOG0590|consen 178 KN-------------------G-------------------AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIV 219 (601)
T ss_pred cC-------------------C-------------------cceeeecccCCCCCCCCcccccchhhcCCCccccccccc
Confidence 10 0 0011224688 999999999998655 889999999999
Q ss_pred HHHHhhCCCCCCCCCchhh-hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 348 MYEMLVGYPPFYSDEPMST-CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~-~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+.-|++|..|+........ +..............+..++..+.+++.++|+ +|..|. +.+++..+||+..
T Consensus 220 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~---s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 220 LSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL---SIEELKLDNWLSS 291 (601)
T ss_pred ccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhcc---ccccccccccccc
Confidence 9999999999865443321 11112211222233345789999999999998 999999 7999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=213.20 Aligned_cols=199 Identities=24% Similarity=0.339 Sum_probs=158.5
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC---CCceeeeeeeecC
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD---SNCIVKLYCSFQD 188 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d 188 (549)
.++..+.|.|-+.||+|+||.||.|.... |+.||+|+-+......--. =.+++.+|+ -+.|..+..++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHHcc
Confidence 35667889999999999999999999877 9999999876654322111 112222332 2456666666555
Q ss_pred CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-------CCcEEEeec
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-------NGHMKLSDF 261 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-------~g~vKL~DF 261 (549)
.+.-+||+||.+.|+|.+++...+.++|..+.+++.|++.-|+.||..+|||+||||+|+||.. +--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 6667899999999999999998899999999999999999999999999999999999999942 235899999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCccccc
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~Di 341 (549)
|-+-.+.. ..++ ......++|-.+--+|++.|..+++.+|.
T Consensus 846 G~siDm~l------------------fp~~---------------------~~F~~~~~td~f~C~EM~~grpWtYq~Dy 886 (974)
T KOG1166|consen 846 GRSIDMKL------------------FPDG---------------------TKFKAVWHTDLFDCIEMREGRPWTYQIDY 886 (974)
T ss_pred ccceeeeE------------------cCCC---------------------cEEeeeeccccchhHHHhcCCCCchhhhh
Confidence 98764421 0111 11235688999999999999999999999
Q ss_pred chhhHHHHHHhhCCC
Q 038137 342 WSLGAIMYEMLVGYP 356 (549)
Q Consensus 342 WSlGvilyEml~G~~ 356 (549)
|.|..+++-||+|+.
T Consensus 887 fGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 887 FGLAATVHVMLFGKY 901 (974)
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999999964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=181.50 Aligned_cols=138 Identities=22% Similarity=0.313 Sum_probs=114.3
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-----hchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM-----LRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++.||+|++|.||+|.. .|..+++|+...... ........+.+|..++..+.|++|+....++.+....++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 35799999999999987 677899998653321 11122345788999999999998877766666777889999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
||++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999854322 7788999999999999999999999999999999 88999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=173.69 Aligned_cols=134 Identities=21% Similarity=0.276 Sum_probs=106.6
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-----RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
.||+|+||.||+|.. +|..+++|+....... ......++.+|..++..+.|+++.....++.+....++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 5788999986542211 112235678899999999887654444444456667899999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
++|++|..++..... .++.+++.+|.+||+.|++|||++|+|||++ ++.++++|||+++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988754321 7899999999999999999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=172.16 Aligned_cols=139 Identities=20% Similarity=0.186 Sum_probs=109.5
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch-------------------hhHHHHHHHHHHHHhcCCC--
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR-------------------GQVEHVKAERNLLAEVDSN-- 177 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~-------------------~~~~~~~~E~~iL~~l~hp-- 177 (549)
|.+.+.||+|+||.||+|... +|+.||||++......-. ........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777889999999999999875 799999999765321000 0112366788888888776
Q ss_pred ceeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEE
Q 038137 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMK 257 (549)
Q Consensus 178 ~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vK 257 (549)
.++..+. ....|+||||++|++|..+... ..+..++.+++.++.++|..||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 3444443 2345899999999998765421 35667889999999999999999999999999999999999
Q ss_pred EeecCcccccC
Q 038137 258 LSDFGLCKPLD 268 (549)
Q Consensus 258 L~DFGlak~~~ 268 (549)
|+|||+|....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999997664
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-19 Score=166.70 Aligned_cols=140 Identities=17% Similarity=0.228 Sum_probs=101.0
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHH---------------------HHHHHHHHHHhcCCCc--
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE---------------------HVKAERNLLAEVDSNC-- 178 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~---------------------~~~~E~~iL~~l~hp~-- 178 (549)
.+.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999986 8999999998764321111111 1134555565554432
Q ss_pred eeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEE
Q 038137 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMK 257 (549)
Q Consensus 179 Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vK 257 (549)
+.+.++. ...++||||++|+.+........... ..++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4444443 23589999999965432211111111 6788999999999999999 9999999999999999 99999
Q ss_pred EeecCcccccC
Q 038137 258 LSDFGLCKPLD 268 (549)
Q Consensus 258 L~DFGlak~~~ 268 (549)
|+|||+|....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-19 Score=173.16 Aligned_cols=240 Identities=18% Similarity=0.255 Sum_probs=189.7
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+...+..++..|.....|+.|.|++.. .-++.|++.-.+...+ ..+.+..|.--|+-+.||||+.++++++...++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 344556678889999999999999874 4566787765544322 3345777888888889999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-eee-cCCCCCCeEEcCCCcEEEe--ecCccccc
Q 038137 194 LIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHN-YIH-RDIKPDNLLLDRNGHMKLS--DFGLCKPL 267 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g-iiH-RDLKPeNILld~~g~vKL~--DFGlak~~ 267 (549)
+|..|||.|+|+.+|.... ..+..++..++..|+.|+.|||+.. +|- --|....++||.+-+.+|+ |--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999999999996643 4677899999999999999999974 443 3678888999998877764 2111100
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC---Ccccccchh
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY---GMECDWWSL 344 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y---~~~~DiWSl 344 (549)
.....-.|.||+||.+..++- -.++|+|||
T Consensus 343 -----------------------------------------------e~gr~y~pawmspealqrkped~n~raadmwsf 375 (448)
T KOG0195|consen 343 -----------------------------------------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSF 375 (448)
T ss_pred -----------------------------------------------ccccccCcccCCHHHHhcCchhcchhhhhHHHH
Confidence 002345789999999987654 368999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
.+++||+.|...||..-.+.+.-.+|.-..-.+.+| +.+|+....|+.-|+. ||.+|+..
T Consensus 376 aillwel~trevpfadlspmecgmkialeglrv~ip--pgis~hm~klm~icmnedpgkrpkf 436 (448)
T KOG0195|consen 376 AILLWELNTREVPFADLSPMECGMKIALEGLRVHIP--PGISRHMNKLMNICMNEDPGKRPKF 436 (448)
T ss_pred HHHHHHhhccccccccCCchhhhhhhhhccccccCC--CCccHHHHHHHHHHhcCCCCcCCCc
Confidence 999999999999999999999888887644444555 4899999999999998 99999943
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=191.64 Aligned_cols=139 Identities=26% Similarity=0.322 Sum_probs=111.8
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechh-----hhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE-----MLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
|...+.||+|+||.||+|..... .+++|+..... .......+.+.+|..++..++|++|+..+.++.+....|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34578999999999999987543 34444332211 111123456889999999999999988777777777789
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||+ .++.++|+|||+|+...
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999999884 457789999999999999999999999999999 68899999999998643
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.3e-17 Score=144.82 Aligned_cols=133 Identities=20% Similarity=0.287 Sum_probs=113.8
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC--CceeeeeeeecCCceEEEEEee
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--NCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~~~lylVmEy 198 (549)
+++.||.|+++.||++.... ..+++|....... ...+..|..++..+.+ .++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999753 6899999865432 3567889999999976 5899999999888899999999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH---NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++++|||+|...
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999877654 5567778899999999999985 7999999999999999999999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=158.83 Aligned_cols=138 Identities=20% Similarity=0.308 Sum_probs=106.1
Q ss_pred eeee-ecCCeEEEEEEEcCCCcEEEEEEeechhhh----c------hhhHHHHHHHHHHHHhcCCCce--eeeeeeecCC
Q 038137 123 TMIG-KGAFGEVRVCREKATGHVYAMKKLKKSEML----R------RGQVEHVKAERNLLAEVDSNCI--VKLYCSFQDD 189 (549)
Q Consensus 123 ~~IG-~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~----~------~~~~~~~~~E~~iL~~l~hp~I--v~l~~~f~d~ 189 (549)
.+|| .||.|+||.+... +..+|||.+....+. . ......+.+|..++..+.|++| +..+.+....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4688 8888999988764 778999988653221 1 1223567889999999988774 6666554322
Q ss_pred -ce---EEEEEeecCC-CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 190 -EY---LYLIMEYLPG-GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 190 -~~---lylVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
.. .++||||++| .+|..++.. ..+++.. +.+++.+|.+||..||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999998 688888754 4566654 568999999999999999999999999999999999999998
Q ss_pred ccc
Q 038137 265 KPL 267 (549)
Q Consensus 265 k~~ 267 (549)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.5e-18 Score=180.27 Aligned_cols=181 Identities=28% Similarity=0.417 Sum_probs=135.5
Q ss_pred ceEEEEEeecCCCchhhHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.++|+.|++|.-.+|.++|.+.. ..+......++.|+..|++| +|.||||+||.||.+..++.+||.||||...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 46999999999999999997543 35667888899999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
..... ...+.... ...-+||..||+||.+.+..|+.++||||||+
T Consensus 406 ~~~~~------------------~~~~~~a~-----------------~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGl 450 (516)
T KOG1033|consen 406 QDKDE------------------TVAPAAAS-----------------HTQQVGTLLYMSPEQIRGQQYSEKVDIYALGL 450 (516)
T ss_pred cccCC------------------cccchhhh-----------------hhhcccccccCCHHHHhhhhhhhhcchhhHHH
Confidence 54221 00000000 11358999999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCC-ChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 347 IMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKL-SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 347 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~-s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
||||++. -..+|.. ..+...|- ...+|+.... -++..+|+.+||. .|.+|| ++.+.--|+|.
T Consensus 451 il~EL~~~f~T~~er---~~t~~d~r----~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP---~~~~~~~~~~~ 515 (516)
T KOG1033|consen 451 ILAELLIQFSTQFER---IATLTDIR----DGIIPPEFLQDYPEEYTLLQQLLSPSPEERP---SAIEVALHEFL 515 (516)
T ss_pred HHHHHHHHhccHHHH---HHhhhhhh----cCCCChHHhhcCcHHHHHHHHhcCCCcccCc---hHHHHhhhhhc
Confidence 9999997 4444432 11222222 2334421111 2556799999998 999999 67777777764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=163.06 Aligned_cols=201 Identities=23% Similarity=0.279 Sum_probs=151.3
Q ss_pred HHhcCCCceeeeeeeecCCceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCe-eecCCCCCCe
Q 038137 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNY-IHRDIKPDNL 248 (549)
Q Consensus 171 L~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~gi-iHRDLKPeNI 248 (549)
|+.+.|.|+.++++.+.+...+++|-+||..|+|.+.+.. .-.++.--...++.+|+.||.|||...| .|+.|++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999966 4567777888899999999999998765 9999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
++|....+||+|||+........ .+ .. .....-..-|.|||
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~----~~----------------~~-------------------~~~~~~~~lw~aPe 121 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETA----EP----------------EA-------------------HHPIRKALLWTAPE 121 (484)
T ss_pred eeeeeEEEEechhhhcccccccc----cc----------------cc-------------------cchhHHHHhccCHH
Confidence 99999999999999977653100 00 00 00011223589999
Q ss_pred hhccCC-------CCcccccchhhHHHHHHhhCCCCCCCCCc----hhhhhhhhhccccccCCCC---cCCChhHHHHHH
Q 038137 329 VLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYSDEP----MSTCRKIVNWRTHLKFPEE---AKLSPEAKDLIS 394 (549)
Q Consensus 329 vl~~~~-------y~~~~DiWSlGvilyEml~G~~PF~~~~~----~~~~~~I~~~~~~l~~p~~---~~~s~~~~dLI~ 394 (549)
.+.... -+.+.|+||+|+|++|+++..-||..... .+...++.+.......|.- ..+.+++..++.
T Consensus 122 llr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~ 201 (484)
T KOG1023|consen 122 LLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVA 201 (484)
T ss_pred HhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHH
Confidence 998632 36679999999999999999999976432 2344444431222222321 145667999999
Q ss_pred Hhhh-cccccCCCCCHHHHH
Q 038137 395 KLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 395 ~lL~-dp~~Rl~~~~~~eil 413 (549)
.|+. +|..|+ ++++|.
T Consensus 202 ~cw~e~P~~rP---s~~~i~ 218 (484)
T KOG1023|consen 202 RCWEEIPEKRP---SIEQIR 218 (484)
T ss_pred HhcccChhhCc---cHHHHH
Confidence 9998 999999 455443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.4e-16 Score=167.20 Aligned_cols=142 Identities=20% Similarity=0.369 Sum_probs=102.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------------------------------chhhHHHHH
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-------------------------------RRGQVEHVK 165 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-------------------------------~~~~~~~~~ 165 (549)
.+|+. +.||.|++|.||.|+.+.+|+.||||++++.... -.+..+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 7899999999999999988999999999754100 002233455
Q ss_pred HHHHHHHhcCCCceeeeeeeecCCce-------------EEEEEeecCCCchhhH--hhhcC----CCCHHHHHHHHHHH
Q 038137 166 AERNLLAEVDSNCIVKLYCSFQDDEY-------------LYLIMEYLPGGDMMTL--LMRKD----TLTEEEARFYVGET 226 (549)
Q Consensus 166 ~E~~iL~~l~hp~Iv~l~~~f~d~~~-------------lylVmEy~~gg~L~~~--l~~~~----~l~e~~~~~~~~qi 226 (549)
+|.+++.+. .|+.++...|.+... -+|||||+.|+.+.++ +...+ .+.+..+..|+.|+
T Consensus 199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 666665554 355555544444433 4599999999999764 33333 25555566666665
Q ss_pred HHHHHHHHhCCeeecCCCCCCeEEcCCC----cEEEeecCcccccC
Q 038137 227 VLAIESIHKHNYIHRDIKPDNLLLDRNG----HMKLSDFGLCKPLD 268 (549)
Q Consensus 227 ~~aL~~LH~~giiHRDLKPeNILld~~g----~vKL~DFGlak~~~ 268 (549)
+ ..|++|+|+||.||+++.+| .++++|||++..++
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 58999999999999999988 99999999998775
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.1e-14 Score=155.76 Aligned_cols=260 Identities=20% Similarity=0.214 Sum_probs=192.6
Q ss_pred CCCeeeeeeeee--cCCeEEEEEEE--cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 116 ADDFEPLTMIGK--GAFGEVRVCRE--KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 116 ~~~f~~~~~IG~--G~fG~V~l~~~--k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+... .....-.+-.+|......+ .|++.|+.+..+.+.+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCC
Confidence 344677889999 99999999998 8899999999733211 1111112233455555555 4899999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHH----HHHHHHhCCeeecCCCCCCeEEcCC-CcEEEeecCcc
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVL----AIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLC 264 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~----aL~~LH~~giiHRDLKPeNILld~~-g~vKL~DFGla 264 (549)
.+|+-.|+| |.+|..+..... .+++..++.++..... ||.++|+.+++|-|+||+||++..+ ..++++|||+.
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 999999998 678888775544 4889999999999999 9999999999999999999999999 78999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
..+...++...- ...+..-|..-|++||++ +.-|+...|++||
T Consensus 271 ~~i~~~~~~~~~------------------------------------~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl 313 (524)
T KOG0601|consen 271 SKISDGNFSSVF------------------------------------KVSKRPEGDCIYAAKELL-NGLATFASDIFSL 313 (524)
T ss_pred EEccCCccccce------------------------------------eeeecCCCCceEeChhhh-ccccchHhhhcch
Confidence 887644321100 000123467789999988 5678999999999
Q ss_pred hHHHHHHhhCCCCCCCC--CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 345 GAIMYEMLVGYPPFYSD--EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 345 GvilyEml~G~~PF~~~--~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|.++.+-.+|..++... +.... +-++-.+..|- ...+.++...+..++. ++..|+ +++.+++|++....
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~---~r~~~ip~e~~--~~~s~~l~~~~~~~~d~~~~~~~---~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQ---LRQGYIPLEFC--EGGSSSLRSVTSQMLDEDPRLRL---TAQILTALNVIHSK 385 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccc---cccccCchhhh--cCcchhhhhHHHHhcCcchhhhh---HHHHHhccccccch
Confidence 99999999988776543 22222 22211122222 2456677778888887 888888 79999999999855
Q ss_pred C
Q 038137 422 E 422 (549)
Q Consensus 422 ~ 422 (549)
.
T Consensus 386 ~ 386 (524)
T KOG0601|consen 386 L 386 (524)
T ss_pred h
Confidence 4
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.2e-14 Score=149.52 Aligned_cols=140 Identities=16% Similarity=0.285 Sum_probs=94.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-------------------------------hhhHH------HHH
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR-------------------------------RGQVE------HVK 165 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~-------------------------------~~~~~------~~~ 165 (549)
+.||.|++|.||+|+.+ +|+.||||+.+...... ..... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 78999999986531000 00001 133
Q ss_pred HHHHHHHhc-----CCCce--eeeeeeecCCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 038137 166 AERNLLAEV-----DSNCI--VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVL-AIESIHKH 236 (549)
Q Consensus 166 ~E~~iL~~l-----~hp~I--v~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~-aL~~LH~~ 236 (549)
+|...+..+ ++++| .++|..+ ...-+|||||++|++|.++.... ..++ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 344444333 23332 3333222 23468999999999998876432 2222 2334444444 46789999
Q ss_pred CeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 237 giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
|++|+|+||.||+++.+|.++|+|||++..++
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998775
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-13 Score=127.38 Aligned_cols=129 Identities=17% Similarity=0.202 Sum_probs=96.9
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc-eeeeeeeecCCceEEEEEeecC
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC-IVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
++.|+.|.++.||.++.. +..|++|+...... .......|..++..+.+.. ++++++.+.+ .-++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence 567899999999999864 77899998765421 1123567888888875444 4455555432 3479999999
Q ss_pred CCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCe-----eecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 201 GGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY-----IHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 201 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~gi-----iHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.|...
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 9887643 11123457899999999999885 9999999999999 778999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-12 Score=124.48 Aligned_cols=142 Identities=14% Similarity=0.157 Sum_probs=104.2
Q ss_pred eeeeeecCCeEEEEEEEcC------CCcEEEEEEeechhh--------h-----------chhhHHH----HHHHHHHHH
Q 038137 122 LTMIGKGAFGEVRVCREKA------TGHVYAMKKLKKSEM--------L-----------RRGQVEH----VKAERNLLA 172 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~------tg~~vAiK~l~k~~~--------~-----------~~~~~~~----~~~E~~iL~ 172 (549)
...||.|-=+.||.|.... .+..+|||+.+-+.. . +.+.... ..+|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998653 357999998753211 0 1111223 338888888
Q ss_pred hcCC--CceeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCCCCCeE
Q 038137 173 EVDS--NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI-HKHNYIHRDIKPDNLL 249 (549)
Q Consensus 173 ~l~h--p~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~giiHRDLKPeNIL 249 (549)
.+.. -.+..++.+ ..-+|||||+.|+.+..-..+...+++..+..+..+++.+|..| |..||||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8743 355666654 34679999997655543333444567777788889999999998 8999999999999999
Q ss_pred EcCCCcEEEeecCcccccC
Q 038137 250 LDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 250 ld~~g~vKL~DFGlak~~~ 268 (549)
++ +|.+.|+|||.|...+
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 5789999999988764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.6e-13 Score=143.32 Aligned_cols=251 Identities=22% Similarity=0.235 Sum_probs=183.1
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREK-ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
.....+|..+..||.|.|+.|+.+..+ .++..||+|-+.+.......++. -..|..+...+ -|.+++..+..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence 344678999999999999999998866 67889999988765443333333 33455555555 5889999998888888
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC-CcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~-g~vKL~DFGlak~~~~ 269 (549)
..|+=.|||.|+++...+.-...+.+...+....|++.|+.++|+..++|+|+||+||++..+ +-.++.|||+.+.+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 889999999999887776555678899999999999999999999999999999999999886 7789999998875432
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCC--CchhhccCCCCcccccchhhHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYI--APEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~--APEvl~~~~y~~~~DiWSlGvi 347 (549)
... ...++-.++ +|..+....+..+.|++|||.-
T Consensus 420 ~~~--------------------------------------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~ 455 (524)
T KOG0601|consen 420 SSG--------------------------------------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLS 455 (524)
T ss_pred ecc--------------------------------------------cccccccccccchhhcccccccccccccccccc
Confidence 110 112222333 5555667889999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
++|.++|.+.=..... ...|.. + ..|.....+.++..+...++. ++..|. .+.++..|+=|
T Consensus 456 ~~e~~~~~~ls~~~~~---~~~i~~--~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~---l~~~l~~~~~~ 517 (524)
T KOG0601|consen 456 VDEAITGSPLSESGVQ---SLTIRS--G--DTPNLPGLKLQLQVLLKVMINPDRKRRP---SAVELSLHSEF 517 (524)
T ss_pred ccccccCcccCccccc---ceeeec--c--cccCCCchHHhhhhhhhhhcCCccccch---hhhhhcccchh
Confidence 9999998864333222 112222 1 122222444677777777776 666665 56666666555
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-11 Score=133.77 Aligned_cols=169 Identities=22% Similarity=0.282 Sum_probs=129.9
Q ss_pred EEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCC
Q 038137 135 VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTL 214 (549)
Q Consensus 135 l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l 214 (549)
.|..+.++.+|.+.+.+.+.- .....+.+-..-|+.++||||++++..+..+..+|||.|-+. -|..++...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 456678899999998875432 345557778888999999999999999999999999999984 455566443
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCC
Q 038137 215 TEEEARFYVGETVLAIESIH-KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293 (549)
Q Consensus 215 ~e~~~~~~~~qi~~aL~~LH-~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (549)
+......-+.||+.||.||| ..+++|++|.-+.|+++..|+.||.+|-++......+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------------------- 160 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------------------- 160 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---------------------
Confidence 37788888999999999998 67899999999999999999999999998865421100
Q ss_pred CCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
+ +....---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 161 --~------------------~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 --P------------------AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --c------------------cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 0 00111222466676553332 568999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.8e-12 Score=126.87 Aligned_cols=213 Identities=21% Similarity=0.281 Sum_probs=152.2
Q ss_pred HHHHHhcCCCceeeeeeeecCCce-----EEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 038137 168 RNLLAEVDSNCIVKLYCSFQDDEY-----LYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKH-- 236 (549)
Q Consensus 168 ~~iL~~l~hp~Iv~l~~~f~d~~~-----lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-- 236 (549)
.+-|-.+.|.|||+++.++.|..+ ..++.|||..|+|..+|++ ...+.....+.++-||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 344556679999999988876544 7899999999999999965 34688889999999999999999987
Q ss_pred CeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhccccee
Q 038137 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAY 316 (549)
Q Consensus 237 giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (549)
-|||+++..+-|.+..+|-||+. ...+-. ....+...++.. + .
T Consensus 198 piihgnlTc~tifiq~ngLIkig---~~ap~s---------------------~h~s~~~~~~~E-------k------~ 240 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIG---SVAPDS---------------------THPSVNSTREAE-------K------S 240 (458)
T ss_pred ccccCCcchhheeecCCceEEec---ccCccc---------------------cchhhhhhhHhh-------h------h
Confidence 49999999999999999999874 211100 000000111100 0 0
Q ss_pred ecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCC-CCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHH
Q 038137 317 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP-FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISK 395 (549)
Q Consensus 317 s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~P-F~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~ 395 (549)
-..|-++|.|||.=.....+.++|||++|....||..|..- -.+......-..|.+-...+. .+--+++|.+
T Consensus 241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~k 313 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITK 313 (458)
T ss_pred ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccCcCcc
Confidence 12467899999987667778899999999999999998764 333332222223322111111 1234678999
Q ss_pred hhh-cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 396 LLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 396 lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
||. .|..|+ ++.+++.||..-++.-.++.
T Consensus 314 cl~~eP~~rp---~ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 314 CLEGEPNGRP---DARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred cccCCCCCCc---chhhhhcCceeeecchHHHH
Confidence 999 999998 89999999998888766654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.6e-11 Score=117.52 Aligned_cols=142 Identities=17% Similarity=0.245 Sum_probs=108.3
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC--CceeeeeeeecCC---ceEEEEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--NCIVKLYCSFQDD---EYLYLIM 196 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~---~~lylVm 196 (549)
++.||.|.++.||++.... |..|++|+....... .....+..|..++..+.+ ..+.+++.+.... +..|+||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3578999999999998743 678999998654321 123457889999998865 3456677766653 3678999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK----------------------------------------- 235 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~----------------------------------------- 235 (549)
||++|+++...+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988776532 457777777777788888777773
Q ss_pred ---------------CCeeecCCCCCCeEEcC--CCcEEEeecCccccc
Q 038137 236 ---------------HNYIHRDIKPDNLLLDR--NGHMKLSDFGLCKPL 267 (549)
Q Consensus 236 ---------------~giiHRDLKPeNILld~--~g~vKL~DFGlak~~ 267 (549)
..++|+|++|.|||++. ++.+.|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 677899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.6e-11 Score=110.36 Aligned_cols=134 Identities=20% Similarity=0.241 Sum_probs=97.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeech-----hhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKS-----EMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~-----~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
..|++|+=+.++.+... |..+.+|.=.++ ++..+-...+..+|..+|+.+.--.|.--+-++.|.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46889999999998664 445566643221 22122223457788889888754444333444556677789999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
|++|-.|.+.+... .-.++..+-.-+.-||..||||+||.++||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888654 245677777888899999999999999999997654 99999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.7e-10 Score=103.31 Aligned_cols=144 Identities=24% Similarity=0.299 Sum_probs=103.9
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEe-----echhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKL-----KKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l-----~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.+.+|-+|+-+.|+.+.. .|+.+.||.= +...+..+-...+.++|..+|.++.--.|.--.-+|.|...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 677899999999998875 4788888743 222222222345688899999887543433333345566677899
Q ss_pred EeecCC-CchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEEeecCcccc
Q 038137 196 MEYLPG-GDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKLSDFGLCKP 266 (549)
Q Consensus 196 mEy~~g-g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL~DFGlak~ 266 (549)
|||++| .++.+++... ..........++..|-..|.-||..+|||+||..+||||..+| .+-|+||||+..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4677776442 2333333477888899999999999999999999999997766 358999999764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.8e-09 Score=110.74 Aligned_cols=210 Identities=17% Similarity=0.246 Sum_probs=149.9
Q ss_pred CeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC----CceEEEEEeecCC-Cch
Q 038137 130 FGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD----DEYLYLIMEYLPG-GDM 204 (549)
Q Consensus 130 fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~~lylVmEy~~g-g~L 204 (549)
-.+.|+|....+|..|++|.+.-......+. ...-.++++++.|+|||.+..+|.+ +..++||++|.|+ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3578999999999999999995433322222 2234678899999999999999983 4569999999987 477
Q ss_pred hhHhhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 205 MTLLMR---------------KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 205 ~~~l~~---------------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
+++... ....+|...+.|+.|+..||.+||+.|+.-+-|.|.+||++.+-.|+|+..|..-.+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 766522 23467999999999999999999999999999999999999888888887776544321
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. . |-+.. -..-|.=.||.+++
T Consensus 446 d~-----------------------------------------------------~--~~le~---~Qq~D~~~lG~ll~ 467 (655)
T KOG3741|consen 446 DP-----------------------------------------------------T--EPLES---QQQNDLRDLGLLLL 467 (655)
T ss_pred CC-----------------------------------------------------C--cchhH---HhhhhHHHHHHHHH
Confidence 10 0 00000 12357778999999
Q ss_pred HHhhCCCC-CCCCCchhh-hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 350 EMLVGYPP-FYSDEPMST-CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 350 Eml~G~~P-F~~~~~~~~-~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
.|.+|..- +..+...+. ...|- ..+|.+++++|.-|.. ++.++ ++++++.|
T Consensus 468 aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~k----sI~~llp~ 521 (655)
T KOG3741|consen 468 ALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFREK----SIQDLLPM 521 (655)
T ss_pred HHhhcccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCcccc----cHHHHHHH
Confidence 99999643 222222222 22221 2578999999998877 66653 57887764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-10 Score=123.90 Aligned_cols=169 Identities=21% Similarity=0.323 Sum_probs=122.7
Q ss_pred HHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHH
Q 038137 225 ETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQ 303 (549)
Q Consensus 225 qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (549)
+++.|+.|+|. .++||++|.|++|.++.+|.+||+.|++|.......- +. .....+-.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~----~p---------~~~yd~~l-------- 165 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE----YP---------FSEYDPPL-------- 165 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc----cc---------cccCCCCC--------
Confidence 44499999996 5899999999999999999999999999876543110 00 00000000
Q ss_pred HHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh-hCCCCCCCCCchhhhhhhhhccccccCCCC
Q 038137 304 LQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEE 382 (549)
Q Consensus 304 ~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml-~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~ 382 (549)
.-...-...|.|||++.+...+.++|++||||++|-+. .|+.-|.+......+..-.+..+.-.+-..
T Consensus 166 -----------p~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s 234 (700)
T KOG2137|consen 166 -----------PLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS 234 (700)
T ss_pred -----------ChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc
Confidence 01224556899999999988899999999999999999 677777666554444433332222222223
Q ss_pred cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccccc
Q 038137 383 AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 383 ~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~ 428 (549)
..+++++++-+.++|. ++.-|+ ++.+++.-|||.+.--..|..
T Consensus 235 ~~~p~el~~~l~k~l~~~~~~rp---~~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 235 NNLPSELRESLKKLLNGDSAVRP---TLDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred ccCcHHHHHHHHHHhcCCcccCc---chhhhhcccccCCchhhhhhh
Confidence 4789999999999998 999998 799999999999876555543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=9e-09 Score=98.17 Aligned_cols=129 Identities=24% Similarity=0.264 Sum_probs=83.5
Q ss_pred EEEEEEEcCCCcEEEEEEeechhh-----------------------hchhhHHHHHHHHHHHHhcCCC--ceeeeeeee
Q 038137 132 EVRVCREKATGHVYAMKKLKKSEM-----------------------LRRGQVEHVKAERNLLAEVDSN--CIVKLYCSF 186 (549)
Q Consensus 132 ~V~l~~~k~tg~~vAiK~l~k~~~-----------------------~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f 186 (549)
.||.|.. ..|..+|+|+.+.... ...-......+|...|..+..- ++.+++.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888886 4577999998753210 0011124578899999998765 466666443
Q ss_pred cCCceEEEEEeecC--CCchhhHhhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 187 QDDEYLYLIMEYLP--GGDMMTLLMRKDTLTEEEARFYVGETVLAIES-IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 187 ~d~~~lylVmEy~~--gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~-LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
.-+|||||++ |..+..+... .++.+....++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 5555444321 22245567777888886655 579999999999999999876 999999999
Q ss_pred ccccC
Q 038137 264 CKPLD 268 (549)
Q Consensus 264 ak~~~ 268 (549)
|....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=2e-08 Score=101.17 Aligned_cols=132 Identities=12% Similarity=0.104 Sum_probs=91.1
Q ss_pred EEEEEEcCCCcEEEEEEeechhh---hch-----hhHHHHHHHHHHHHhcCCCc--eeeeeeeecC-----CceEEEEEe
Q 038137 133 VRVCREKATGHVYAMKKLKKSEM---LRR-----GQVEHVKAERNLLAEVDSNC--IVKLYCSFQD-----DEYLYLIME 197 (549)
Q Consensus 133 V~l~~~k~tg~~vAiK~l~k~~~---~~~-----~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~d-----~~~lylVmE 197 (549)
|..+. -.|+.|.||....... .+. .-...+.+|...+..+..-. ++.+..++.. ...-|||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44443 3467888997643221 110 11124678888776663222 2223222321 235789999
Q ss_pred ecCCC-chhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-------CCcEEEeecCcccc
Q 038137 198 YLPGG-DMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-------NGHMKLSDFGLCKP 266 (549)
Q Consensus 198 y~~gg-~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-------~g~vKL~DFGlak~ 266 (549)
+++|. +|.+++.. ....++.....++.+++..+.-||..||+|+||+|.|||++. ++.+.|+||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99886 78888753 345677788899999999999999999999999999999985 46899999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.8e-10 Score=120.05 Aligned_cols=245 Identities=20% Similarity=0.220 Sum_probs=165.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc-eeeeeeeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC-IVKLYCSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~~lyl 194 (549)
..-+....-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .|..++.++-+.++.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 444667778999999999999877665554 5655433 33566899999999999 7777888888999999
Q ss_pred EEeecCCC-chhhHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 195 IMEYLPGG-DMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 195 VmEy~~gg-~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+|+|+.+| +-.... ...-.|.+-+.....+.-+.+++++|+.--+||| |||... +..|+.|||....++...
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999887 221111 1112344445555667777899999998778999 887754 788999999876654210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
...+..||+.++|||+.....|....|.||+|+--.+|.
T Consensus 386 -----------------------------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a 424 (829)
T KOG0576|consen 386 -----------------------------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA 424 (829)
T ss_pred -----------------------------------------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcC
Confidence 112678999999999999999999999999999888888
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCCh-hHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSP-EAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~-~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
-|-+|-.+ +......+-+.............++ .-.|+...|+. .|..|. ....++-|.+|.+.
T Consensus 425 p~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pk---v~mgacfsKvfngC 490 (829)
T KOG0576|consen 425 PGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPK---VHMGACFSKVFNGC 490 (829)
T ss_pred CCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCc---chhhHHHHHHhccC
Confidence 88887654 2211111211111111111001111 11235555665 565555 56777888888765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=7e-08 Score=93.62 Aligned_cols=127 Identities=23% Similarity=0.264 Sum_probs=90.2
Q ss_pred CCcEEEEEEeechh----hhchhhHHHHHHHHHHHHhcCCCc--eeeeeeeecC----CceEEEEEeecCCC-chhhHhh
Q 038137 141 TGHVYAMKKLKKSE----MLRRGQVEHVKAERNLLAEVDSNC--IVKLYCSFQD----DEYLYLIMEYLPGG-DMMTLLM 209 (549)
Q Consensus 141 tg~~vAiK~l~k~~----~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~d----~~~lylVmEy~~gg-~L~~~l~ 209 (549)
.++.|-+|.+...- ....-......+|...+..+..-. ++..+++... ...-|||+|+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543221 111122334667777766553221 2333333322 13468999999985 8999987
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEEeecCccccc
Q 038137 210 RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKLSDFGLCKPL 267 (549)
Q Consensus 210 ~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL~DFGlak~~ 267 (549)
....++......++.+++..+.-||..||+|+|++|.|||++.++ .+.|+||+-++..
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 755578888899999999999999999999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-07 Score=96.73 Aligned_cols=231 Identities=16% Similarity=0.228 Sum_probs=146.6
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceee--------eeeeecCCce
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVK--------LYCSFQDDEY 191 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~--------l~~~f~d~~~ 191 (549)
..+.||+|+-+.+|-.-.- +.. +-|++.+.... +-..-+..|... .||-+-. |++. .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa------~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPA------AQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh--hch-hheeecCCCch------HHHHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 3568999999999965432 223 34777654321 112223334433 5654322 1111 11233
Q ss_pred EEEEEeecCCCchhhHh-------hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 192 LYLIMEYLPGGDMMTLL-------MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l-------~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
+-+.|..++|-.--..+ +....+.++.+...++.++.|...||..|.+-+|+.++|||+.+++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 78899998875222222 11234678888999999999999999999999999999999999999999873321
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCccc
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMEC 339 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~ 339 (549)
..... + ......||.+.|.+||.-. +.+-+...
T Consensus 165 qi~~n---------------------g---------------------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~h 202 (637)
T COG4248 165 QINAN---------------------G---------------------TLHLCPVGVSEFTPPELQTLPSFVGFERTANH 202 (637)
T ss_pred eeccC---------------------C---------------------ceEecccCccccCCHHHhccccccccCCCccc
Confidence 11000 0 0122568999999999875 34457789
Q ss_pred ccchhhHHHHHHhhC-CCCCCCCC-------chhhhhhhhhcc-------ccccCC-----CCcCCChhHHHHHHHhhhc
Q 038137 340 DWWSLGAIMYEMLVG-YPPFYSDE-------PMSTCRKIVNWR-------THLKFP-----EEAKLSPEAKDLISKLLCN 399 (549)
Q Consensus 340 DiWSlGvilyEml~G-~~PF~~~~-------~~~~~~~I~~~~-------~~l~~p-----~~~~~s~~~~dLI~~lL~d 399 (549)
|-|.|||++|++|.| +.||.+-. +.++ .|.... .....| ...-+++++..|..++..+
T Consensus 203 D~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~ 280 (637)
T COG4248 203 DNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTE 280 (637)
T ss_pred cchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcc
Confidence 999999999999987 99997631 2221 232210 000111 1235788999999999874
Q ss_pred c---cccCC
Q 038137 400 V---EQRLG 405 (549)
Q Consensus 400 p---~~Rl~ 405 (549)
+ .-|+.
T Consensus 281 ~~~~~~RP~ 289 (637)
T COG4248 281 SGVATPRPT 289 (637)
T ss_pred cCCCCCCCC
Confidence 4 45663
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=5.4e-07 Score=87.32 Aligned_cols=142 Identities=18% Similarity=0.297 Sum_probs=91.0
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHH------HHHHHHHHHhc---CCCceeeeee
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEH------VKAERNLLAEV---DSNCIVKLYC 184 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~------~~~E~~iL~~l---~hp~Iv~l~~ 184 (549)
+...+|.+++++-......|.+.. -.|+.|.+|..+............ ..++...+..+ .-...+.+|.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 446779999999888888777664 457899999876432211111111 12222222222 2222233222
Q ss_pred eec-----CCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEe
Q 038137 185 SFQ-----DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLS 259 (549)
Q Consensus 185 ~f~-----d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~ 259 (549)
+.. -....+|||||++|..|.++. .+++. +...++.+|.-||+.|+.|+|..|.|++++.++ ++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIE----DIDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccch----hcCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 221 223456899999998886654 23332 445677889999999999999999999998655 9999
Q ss_pred ecCcccc
Q 038137 260 DFGLCKP 266 (549)
Q Consensus 260 DFGlak~ 266 (549)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=7e-07 Score=88.38 Aligned_cols=139 Identities=19% Similarity=0.222 Sum_probs=100.5
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh------------hc-------hhhHHHHHHHHHHHHhcCCC--c
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM------------LR-------RGQVEHVKAERNLLAEVDSN--C 178 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~------------~~-------~~~~~~~~~E~~iL~~l~hp--~ 178 (549)
.+...||-|-=|.||.|.+. .|..+|||.=+-... .. --......+|..+|..+... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34678999999999999876 688999996432100 00 01123467788888887544 4
Q ss_pred eeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEE
Q 038137 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKL 258 (549)
Q Consensus 179 Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL 258 (549)
|.+.++ -+.-.+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+=|||++.+|.+.+
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 555543 35667999999987765442 245555566666666666666899999999999999999999999
Q ss_pred eecCcccccC
Q 038137 259 SDFGLCKPLD 268 (549)
Q Consensus 259 ~DFGlak~~~ 268 (549)
+||--|....
T Consensus 244 IDwPQ~v~~~ 253 (304)
T COG0478 244 IDWPQAVPIS 253 (304)
T ss_pred EeCcccccCC
Confidence 9999887654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.1e-06 Score=96.00 Aligned_cols=141 Identities=19% Similarity=0.323 Sum_probs=90.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--------------------hc-----------hhhHHHHHHH----
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM--------------------LR-----------RGQVEHVKAE---- 167 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~--------------------~~-----------~~~~~~~~~E---- 167 (549)
..|+.++-|.||.|+.+. |+.||||+.+..-. .. .+..+.+..|
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999865 99999999864210 00 0111222233
Q ss_pred --HHHHHhc-----CCCc--eeeeeeeecCCceEEEEEeecCCCchhhHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 038137 168 --RNLLAEV-----DSNC--IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHN 237 (549)
Q Consensus 168 --~~iL~~l-----~hp~--Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g 237 (549)
..-+..+ ++++ |.++|.-+ ...-.|+|||+.|--+.+.. .+...++...+.....++. +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~--t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY--TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc--cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 3333332 2333 23333222 23346999999999888874 2335566333333222222 23344589
Q ss_pred eeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 238 iiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
++|.|.+|.||+++.+|++-+.|||+...++
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999988765
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-06 Score=84.81 Aligned_cols=134 Identities=21% Similarity=0.174 Sum_probs=84.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCceEEEEEeecC
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC--IVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
..||.|..+.||++ .|..+++|...... ....+.+|.+++..+..-. +.+.+++..+.+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999984 24567888875422 2344688999998875332 5677777777788899999999
Q ss_pred CCc-hhhHh--------------hh------c---C--CCCHHHHHHHHH----------HHHH-HHHHHHh----CCee
Q 038137 201 GGD-MMTLL--------------MR------K---D--TLTEEEARFYVG----------ETVL-AIESIHK----HNYI 239 (549)
Q Consensus 201 gg~-L~~~l--------------~~------~---~--~l~e~~~~~~~~----------qi~~-aL~~LH~----~gii 239 (549)
|.+ +...+ -+ . . .++... ..+.. .+.. ...+|.. ..++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 864 11111 00 0 0 111100 00100 0111 1222221 2478
Q ss_pred ecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 240 HRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
|+|+.|.||+++.+| +.|+||+.|...
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~G 183 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGYG 183 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence 999999999999888 999999988653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.7e-06 Score=80.86 Aligned_cols=138 Identities=20% Similarity=0.329 Sum_probs=82.3
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC--ceeeeeeeec---CCceEEEEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN--CIVKLYCSFQ---DDEYLYLIM 196 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f~---d~~~lylVm 196 (549)
++.|+.|..+.||.+.... ..|++|..... .....+..|..++..+... -+.+++.... .....|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998765 48899987554 2345577888888777432 2556665332 234579999
Q ss_pred eecCCCchhh----------------Hhhh---c----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 038137 197 EYLPGGDMMT----------------LLMR---K----DTLTEEE------ARFY---------------VGETVL-AIE 231 (549)
Q Consensus 197 Ey~~gg~L~~----------------~l~~---~----~~l~e~~------~~~~---------------~~qi~~-aL~ 231 (549)
++++|..+.. .+.. . ..+.... .... +..+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 1111 1 0111000 0000 111222 233
Q ss_pred HHH-------hCCeeecCCCCCCeEEc-CCCcEEEeecCcccc
Q 038137 232 SIH-------KHNYIHRDIKPDNLLLD-RNGHMKLSDFGLCKP 266 (549)
Q Consensus 232 ~LH-------~~giiHRDLKPeNILld-~~g~vKL~DFGlak~ 266 (549)
.++ ...++|+|+.|.|||++ .+|.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 24599999999999999 677778999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.7e-06 Score=79.92 Aligned_cols=140 Identities=12% Similarity=0.166 Sum_probs=100.2
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeech---hhhchhhHHHHHHHHHHHHhcCCCc--eeeeeeeecC----CceEEEE
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKS---EMLRRGQVEHVKAERNLLAEVDSNC--IVKLYCSFQD----DEYLYLI 195 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~---~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~d----~~~lylV 195 (549)
-|+||-+-|+..... |+.|=+|.-... .+........+.+|...|..+..-. +.+..+.-.. ...-+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 367888889886643 446778875421 1111234456889999988774322 4444422111 2236899
Q ss_pred EeecCC-CchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc--EEEeecCcccc
Q 038137 196 MEYLPG-GDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH--MKLSDFGLCKP 266 (549)
Q Consensus 196 mEy~~g-g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~--vKL~DFGlak~ 266 (549)
+|-++| -||.+++... ...++.....++.+++.+|.-||..|+.|+|+-+.|||++.+|. |+++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998854 4888887552 35577788899999999999999999999999999999997787 99999997764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.3e-06 Score=92.10 Aligned_cols=141 Identities=23% Similarity=0.301 Sum_probs=90.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhh----------------------------hchhhHHHHHHHHH-----
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM----------------------------LRRGQVEHVKAERN----- 169 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~----------------------------~~~~~~~~~~~E~~----- 169 (549)
+.||.-+.|.|+.|+.+. |+.||||+-+..-- .-.+..+.+..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 479999999999999886 99999999754200 00011112222222
Q ss_pred -----HHHhcCCCc------eeeeeeeecCCceEEEEEeecCCCchhhHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 038137 170 -----LLAEVDSNC------IVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHN 237 (549)
Q Consensus 170 -----iL~~l~hp~------Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g 237 (549)
+...+.|-. |.++|..+. ..-.|+||||+|.-+.++- .+...++...+...+.++.. +-|-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 222333433 455554443 2357999999998776654 23455666544443333222 3344578
Q ss_pred eeecCCCCCCeEEcC----CCcEEEeecCcccccC
Q 038137 238 YIHRDIKPDNLLLDR----NGHMKLSDFGLCKPLD 268 (549)
Q Consensus 238 iiHRDLKPeNILld~----~g~vKL~DFGlak~~~ 268 (549)
++|.|=+|.|||++. ++.+.+-|||+.+.+.
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999984 5689999999998765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=9.7e-06 Score=79.59 Aligned_cols=140 Identities=18% Similarity=0.202 Sum_probs=93.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchh-------------------hH--HHHHHHHHHHHhcC--CCce
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRG-------------------QV--EHVKAERNLLAEVD--SNCI 179 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~-------------------~~--~~~~~E~~iL~~l~--hp~I 179 (549)
..|..|--+.||+|.. .++..+|+|+++.....-+. ++ .-...|..-|..+. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677788888999875 46789999998754322111 11 11334444444442 2233
Q ss_pred eeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEE
Q 038137 180 VKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKL 258 (549)
Q Consensus 180 v~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL 258 (549)
.+-+.++. -.|||||+...-...=..+.-.+..+++..+..+++..+.-|-. .|+||+||..=|||+. +|.+.|
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 34444432 35999999543111111122334455788889999999988877 8999999999999999 889999
Q ss_pred eecCcccccC
Q 038137 259 SDFGLCKPLD 268 (549)
Q Consensus 259 ~DFGlak~~~ 268 (549)
+|||-|....
T Consensus 208 ID~~QaV~~~ 217 (268)
T COG1718 208 IDVSQAVTID 217 (268)
T ss_pred EECccccccC
Confidence 9999988765
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.7e-05 Score=78.65 Aligned_cols=136 Identities=18% Similarity=0.137 Sum_probs=83.2
Q ss_pred eeeecCC-eEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEEEeecCC
Q 038137 124 MIGKGAF-GEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 124 ~IG~G~f-G~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
.|-.|.+ ..||.+... +..+.+|...... ...+.+|..++..+. +--+.+++++..+.+.-++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 789988643 3577888765432 234667888887773 33466778877776778999999999
Q ss_pred CchhhHh----------------hhcCCC-------CHH------HHHHH-------------------HHHHHHHHHHH
Q 038137 202 GDMMTLL----------------MRKDTL-------TEE------EARFY-------------------VGETVLAIESI 233 (549)
Q Consensus 202 g~L~~~l----------------~~~~~l-------~e~------~~~~~-------------------~~qi~~aL~~L 233 (549)
..+.... .+-..+ ... ..... +.++...|...
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7765431 000011 100 00000 01111111111
Q ss_pred ----HhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 234 ----HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 234 ----H~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
....++|+|+.|.|||++.++.+.|+||+.|...
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 1234999999999999999888899999988643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.13 E-value=7.6e-06 Score=94.21 Aligned_cols=202 Identities=20% Similarity=0.245 Sum_probs=143.6
Q ss_pred HHHHHHHHHHHHhcCCCceeeeeeeecCCc----eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 038137 161 VEHVKAERNLLAEVDSNCIVKLYCSFQDDE----YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236 (549)
Q Consensus 161 ~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~ 236 (549)
+.....|...+....|+|++.++.+--... .+++.-+||++-++..++...+.++.+.++.+..+++.||.|+|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 334455667778889999999886544322 3456678999999999999999999999999999999999999998
Q ss_pred CeeecCCCCC---CeEEcCCCcEEEe--ecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhc
Q 038137 237 NYIHRDIKPD---NLLLDRNGHMKLS--DFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNR 311 (549)
Q Consensus 237 giiHRDLKPe---NILld~~g~vKL~--DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (549)
...|.-|--. +-..+..+++.++ ||+.++.+.....
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--------------------------------------- 346 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--------------------------------------- 346 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCccc---------------------------------------
Confidence 6555544444 4445566777777 8888776542211
Q ss_pred ccceeecccCCCCCCchhhccCCCCcc--cccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCCh-h
Q 038137 312 RMLAYSTVGTPDYIAPEVLLKKGYGME--CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSP-E 388 (549)
Q Consensus 312 ~~~~~s~vGT~~Y~APEvl~~~~y~~~--~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~-~ 388 (549)
..+..-+..+.|||.+....+..+ .|+|++|.....+..|..+-.-. .....++ ...+. +
T Consensus 347 ---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l-----------~~~~~~~ 409 (1351)
T KOG1035|consen 347 ---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLL-----------DVLSTSE 409 (1351)
T ss_pred ---chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhh-----------ccccchh
Confidence 012345566888998887776655 69999999999998876542111 0001111 01222 6
Q ss_pred HHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 389 AKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 389 ~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
..+++.+|+. ++++|+ ++.+++.|||.+.-
T Consensus 410 ~~d~~~~~~~~~~~~Rl---~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 410 LLDALPKCLDEDSEERL---SALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhhhcchhhhhcc---chhhhhhchhcccc
Confidence 7788888887 899999 79999999998743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.4e-05 Score=89.92 Aligned_cols=81 Identities=23% Similarity=0.408 Sum_probs=57.3
Q ss_pred eeeeeeecCCeEEEEEEEcCCC--cEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCce--eeeeeeecCC---ceE
Q 038137 121 PLTMIGKGAFGEVRVCREKATG--HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCI--VKLYCSFQDD---EYL 192 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg--~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~I--v~l~~~f~d~---~~l 192 (549)
.++.|+.|.++.+|+......+ ..|++|+........ ....+.+|..+|..+. |++| .++++++.+. ...
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3678899999999998765432 467788764432211 1235788999999885 6654 7778877764 457
Q ss_pred EEEEeecCCCc
Q 038137 193 YLIMEYLPGGD 203 (549)
Q Consensus 193 ylVmEy~~gg~ 203 (549)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.8e-07 Score=104.83 Aligned_cols=202 Identities=15% Similarity=0.092 Sum_probs=142.7
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--Cce
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM--LRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD--DEY 191 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~ 191 (549)
..++++.--||-|.++.--.-+.+.. -+-+|+.+.... ..+-..+....|++.++...|++++..+.-..+ ...
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 45666665666666553222111211 234555443322 222334556778888888899998887766553 345
Q ss_pred EEEEEeecCCCchhhHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCCCCeEEcCCCcEEEeecC
Q 038137 192 LYLIMEYLPGGDMMTLLMRK----DTLTEEEARFYVGETVLAIESIHKHN-----YIHRDIKPDNLLLDRNGHMKLSDFG 262 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHRDLKPeNILld~~g~vKL~DFG 262 (549)
.|.+|+|+.+|++++.|.+. ..+.+.-+-....+.+.+..-+|+.. -+|++||+-|.+|..+..+|+.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 79999999999999999763 33444444444444488888888642 7899999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccc
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiW 342 (549)
+.+..... .......++++.|++|++...-.++.++|+|
T Consensus 1386 LdKIknp~-----------------------------------------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1386 LDKIKNPV-----------------------------------------LSFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred cccccCch-----------------------------------------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence 99833211 1112357899999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCC
Q 038137 343 SLGAIMYEMLVGYPPFYS 360 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~ 360 (549)
+.|+-+|+...|.++|..
T Consensus 1425 r~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred HHHHHHHHHhcccHHHHH
Confidence 999999999999999853
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.09 E-value=4.6e-05 Score=73.15 Aligned_cols=129 Identities=22% Similarity=0.324 Sum_probs=89.4
Q ss_pred CCCeeeeeeeeecCC-eEEEEEEEcCCCcEEEEEEeechhh----------hch--------hhHHHHHHHHHHHHhc--
Q 038137 116 ADDFEPLTMIGKGAF-GEVRVCREKATGHVYAMKKLKKSEM----------LRR--------GQVEHVKAERNLLAEV-- 174 (549)
Q Consensus 116 ~~~f~~~~~IG~G~f-G~V~l~~~k~tg~~vAiK~l~k~~~----------~~~--------~~~~~~~~E~~iL~~l-- 174 (549)
..+++.++.||.|+- |.||+++.. |+.||+|+.+.-.. ... ....-+..|-....++
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 478999999999999 999999764 77999999432110 000 1223456666665544
Q ss_pred -CCCce--eeeeeeecCC------------------ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHH
Q 038137 175 -DSNCI--VKLYCSFQDD------------------EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233 (549)
Q Consensus 175 -~hp~I--v~l~~~f~d~------------------~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L 233 (549)
.+..+ |+.++++.-. -...||.||++... .++ ..-+.+|..-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHH
Confidence 45555 8988877311 12467888886643 222 23356778888899
Q ss_pred HhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 234 H~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
|..||+-+|+++.|.. + -||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc---C--CEEEecccC
Confidence 9999999999999987 2 389999964
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.6e-05 Score=74.10 Aligned_cols=74 Identities=8% Similarity=0.119 Sum_probs=45.7
Q ss_pred eeeeeecCCe-EEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC---ceeeeeeeecCC---ceEEE
Q 038137 122 LTMIGKGAFG-EVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN---CIVKLYCSFQDD---EYLYL 194 (549)
Q Consensus 122 ~~~IG~G~fG-~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~f~d~---~~lyl 194 (549)
+..|+.|+.. .||.+. ..+.+|...... ....+.+|..+|..+... -+.+.++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567877776 599762 346778654321 234688899999877532 244444443332 24589
Q ss_pred EEeecCCCchh
Q 038137 195 IMEYLPGGDMM 205 (549)
Q Consensus 195 VmEy~~gg~L~ 205 (549)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999996663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=5e-05 Score=70.94 Aligned_cols=129 Identities=16% Similarity=0.221 Sum_probs=90.5
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCcee-eeeeeecCCceEEEEEee
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV-KLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv-~l~~~f~d~~~lylVmEy 198 (549)
...+.||+|.+|.||+|... |..+|+|+-+... ....+..|.++|..+...++. ++|.+-.+ ++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence 34578999999999999876 6689999865432 235588899999988776654 44433222 355999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC-CCCeEEcCCCcEEEeecCcccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK-PDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLK-PeNILld~~g~vKL~DFGlak~ 266 (549)
+.|-.|..+-... + +.-+..++.+-.-|-..||-|..|. |..++|..++.+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998887765321 2 2233344555445667899999986 5656666666999999998874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00014 Score=71.44 Aligned_cols=137 Identities=15% Similarity=0.235 Sum_probs=82.4
Q ss_pred eeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEEEeec
Q 038137 122 LTMIGKGAFGEVRVCREKA-TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLIMEYL 199 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~-tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmEy~ 199 (549)
++.|..|-...||++.... .++.|++|+...... . .-...+|..++..+. +..++++++.+.+ .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678889999999987543 356888997754311 1 112346888888773 3445666665542 3799999
Q ss_pred CCCchhhH--------------hhh----cCCC----------C-HHHHHHHHHH----------------------H--
Q 038137 200 PGGDMMTL--------------LMR----KDTL----------T-EEEARFYVGE----------------------T-- 226 (549)
Q Consensus 200 ~gg~L~~~--------------l~~----~~~l----------~-e~~~~~~~~q----------------------i-- 226 (549)
+|..+... +.+ .... . .+.+..|... +
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665311 111 0011 0 1122222211 1
Q ss_pred -HHHHHH-HH----hCCeeecCCCCCCeEEcC-CCcEEEeecCcccc
Q 038137 227 -VLAIES-IH----KHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKP 266 (549)
Q Consensus 227 -~~aL~~-LH----~~giiHRDLKPeNILld~-~g~vKL~DFGlak~ 266 (549)
+..|.. +- ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111111 11 236999999999999998 57899999998865
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00038 Score=67.05 Aligned_cols=134 Identities=18% Similarity=0.260 Sum_probs=90.7
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-------------hchhhHHHHHHHHHHHHhcC------CCceeee
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM-------------LRRGQVEHVKAERNLLAEVD------SNCIVKL 182 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~-------------~~~~~~~~~~~E~~iL~~l~------hp~Iv~l 182 (549)
...||+|+.=.||.- . ...-..||++..... ..........+|..-...+. +..|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357999999888853 2 233457898876540 01112344556665554444 7889999
Q ss_pred eeeecCCceEEEEEeecCC------CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC--
Q 038137 183 YCSFQDDEYLYLIMEYLPG------GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-- 254 (549)
Q Consensus 183 ~~~f~d~~~lylVmEy~~g------g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-- 254 (549)
|+..+++.-+-+|+|.+.. -+|.+++ ..+.+++ ..+..+ -.-..||-.++|+.+||+|.||++...+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHHHH---HHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998743 2566666 4455666 333333 3344678899999999999999996432
Q ss_pred --cEEEee-cCc
Q 038137 255 --HMKLSD-FGL 263 (549)
Q Consensus 255 --~vKL~D-FGl 263 (549)
.+.|+| ||-
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 577777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.0008 Score=71.60 Aligned_cols=81 Identities=19% Similarity=0.214 Sum_probs=55.3
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--c--hhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCceEE
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML--R--RGQVEHVKAERNLLAEVD---SNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~--~--~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d~~~ly 193 (549)
..+.||.|.++.||.+.....++.|.||.-...... . .-..++...|...|..+. ...++++|++ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 357899999999999998654458999974311100 0 123456777888887652 3467777776 446678
Q ss_pred EEEeecCCCc
Q 038137 194 LIMEYLPGGD 203 (549)
Q Consensus 194 lVmEy~~gg~ 203 (549)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998743
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00045 Score=70.75 Aligned_cols=76 Identities=18% Similarity=0.181 Sum_probs=50.4
Q ss_pred eeeeeecCCeEEEEEEEcC------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCceEEE
Q 038137 122 LTMIGKGAFGEVRVCREKA------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lyl 194 (549)
++.|..|-...||++.... +++.|++|+..... .......+|..++..+.. ....++++++.+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4567778888999987543 36789999976532 112235678888877743 234566777653 26
Q ss_pred EEeecCCCchh
Q 038137 195 IMEYLPGGDMM 205 (549)
Q Consensus 195 VmEy~~gg~L~ 205 (549)
||||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999987654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00027 Score=67.57 Aligned_cols=99 Identities=20% Similarity=0.245 Sum_probs=79.5
Q ss_pred HHHHHHHHhcCC-CceeeeeeeecCCceEEEEEeecCCCchhhH---hhhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 038137 165 KAERNLLAEVDS-NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL---LMRKDTLTEEEARFYVGETVLAIESIHK---HN 237 (549)
Q Consensus 165 ~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~---l~~~~~l~e~~~~~~~~qi~~aL~~LH~---~g 237 (549)
..|.-+|..+.+ +++++++++|-+ ++|.||++.+++... +.....-++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347778888865 699999999954 579999987766532 2222346899999999999999999997 34
Q ss_pred eeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 238 iiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+.-.|++|+||-++.+|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00076 Score=69.38 Aligned_cols=142 Identities=18% Similarity=0.187 Sum_probs=83.8
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC--ceeeeeeee------cCC
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN--CIVKLYCSF------QDD 189 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f------~d~ 189 (549)
....++.|+.|.-..||++.. .+| .|.+|+..... ....+..|..++..+... .|++++... ...
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 355577888888899998864 333 57888765421 123455666777666321 144444321 224
Q ss_pred ceEEEEEeecCCCchhh-----------Hh---hh-cCCCC--------HHH-----HH----------HHHHHHHHHHH
Q 038137 190 EYLYLIMEYLPGGDMMT-----------LL---MR-KDTLT--------EEE-----AR----------FYVGETVLAIE 231 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~-----------~l---~~-~~~l~--------e~~-----~~----------~~~~qi~~aL~ 231 (549)
+..|+||+|++|..+.. .+ .. ...++ ... .. .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 56789999999854321 11 00 01110 000 00 00112233455
Q ss_pred HHH-------hCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 232 SIH-------KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 232 ~LH-------~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
++. ..++||+|+.+.||+++.++.+.|+||+.|..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 553 26899999999999999988779999998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0011 Score=67.96 Aligned_cols=77 Identities=13% Similarity=0.084 Sum_probs=53.6
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC---CceeeeeeeecC---CceEEE
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS---NCIVKLYCSFQD---DEYLYL 194 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~f~d---~~~lyl 194 (549)
-++.||.|..+.||..... ++ .+.+|.. +.. .....+.+|...|+.+.. -.|+++++++.+ .+.-||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~-~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMA-RSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEe-ccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3568999999999988543 23 4666764 321 012457889999987743 357788877654 356899
Q ss_pred EEeecCCCch
Q 038137 195 IMEYLPGGDM 204 (549)
Q Consensus 195 VmEy~~gg~L 204 (549)
|||+++|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00033 Score=69.98 Aligned_cols=133 Identities=17% Similarity=0.196 Sum_probs=78.0
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC-ceeeeeeeecCCceEEEEEeecCCCc
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKLYCSFQDDEYLYLIMEYLPGGD 203 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~d~~~lylVmEy~~gg~ 203 (549)
+..|-.+.+|++. .++..|++|........ -.+ ...+|..+|..+... -..++++.+. -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 5568888999886 45678889876543110 001 246688888877532 2345555443 268999999865
Q ss_pred hhh--------------Hhhh---c----CCCC-HHHHHHHHHHH---------HHHHHHHHh--------CCeeecCCC
Q 038137 204 MMT--------------LLMR---K----DTLT-EEEARFYVGET---------VLAIESIHK--------HNYIHRDIK 244 (549)
Q Consensus 204 L~~--------------~l~~---~----~~l~-e~~~~~~~~qi---------~~aL~~LH~--------~giiHRDLK 244 (549)
+.. .+.+ . ..++ ...+..|..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 432 1111 0 0111 12222332222 111222211 258999999
Q ss_pred CCCeEEcCCCcEEEeecCccccc
Q 038137 245 PDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 245 PeNILld~~g~vKL~DFGlak~~ 267 (549)
|.|||++.+| +.|+||..|..-
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcC
Confidence 9999999887 789999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.002 Score=65.67 Aligned_cols=139 Identities=15% Similarity=0.134 Sum_probs=83.1
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC--ceeeeeee------ecCCce
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN--CIVKLYCS------FQDDEY 191 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~------f~d~~~ 191 (549)
.-++.|..|....||++.. .+..+++|+.... ....+..|..++..+.+. .+++++.. ....+.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 3366788888899999864 3457899987541 123456677777766322 24454432 123456
Q ss_pred EEEEEeecCCCchhh----H-------hhh----cCCCCH--------HHH----H--------HHHHHHHHHHHHHHh-
Q 038137 192 LYLIMEYLPGGDMMT----L-------LMR----KDTLTE--------EEA----R--------FYVGETVLAIESIHK- 235 (549)
Q Consensus 192 lylVmEy~~gg~L~~----~-------l~~----~~~l~e--------~~~----~--------~~~~qi~~aL~~LH~- 235 (549)
.++||+|++|..+.. . +.+ ...+.. ... . .....+..++.++-.
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999876532 0 100 000100 000 0 011112233444442
Q ss_pred ------CCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 236 ------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 236 ------~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.+++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887789999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0024 Score=65.93 Aligned_cols=31 Identities=26% Similarity=0.368 Sum_probs=26.6
Q ss_pred CCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 236 ~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.++||+|+.|.|||++.+..+-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999998665568999998864
|
|
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00025 Score=54.94 Aligned_cols=59 Identities=32% Similarity=0.682 Sum_probs=39.1
Q ss_pred cCCCccccc--cccCCCcccCCCccccccccc-cccccccccccccCCcccccccc-cccccccceee
Q 038137 419 KGIEWDKLY--QIKAAFIPEVNDELDTQNFEK-FEEADNQIQTSAKSGPWRKMLSS-KDINFVGYTYK 482 (549)
Q Consensus 419 ~~i~w~~l~--~~~~pf~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~ 482 (549)
++|+|+.|. ++.|||+|.+.+..|+++|+. +...... .+... + .+... ....|.||||.
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~-~s~~~--~--~~~~~~~~~~F~gfsy~ 63 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPV-LTPVD--S--PASGGSQQEPFRGFSYV 63 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCC-CCCCC--c--cccccccccccCCCccc
Confidence 479999996 589999999999999999986 4443221 11111 1 11111 14689999985
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0092 Score=62.58 Aligned_cols=141 Identities=13% Similarity=0.171 Sum_probs=83.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcC----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCce
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKA----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCIVKLYCSFQDDEY 191 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~ 191 (549)
+...+ ..|-.|-...||++.... +++.|++|+..... ...+. ..+|..++..+.. .--.++++.|...
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 34444 455558889999987432 34689999886532 12222 2568888877743 3334666777543
Q ss_pred EEEEEeecCCCchhhH--------------hhh---cC------CCCHHHHHHHHHHH-----------------HHHHH
Q 038137 192 LYLIMEYLPGGDMMTL--------------LMR---KD------TLTEEEARFYVGET-----------------VLAIE 231 (549)
Q Consensus 192 lylVmEy~~gg~L~~~--------------l~~---~~------~l~e~~~~~~~~qi-----------------~~aL~ 231 (549)
.|.+|++|..|... +.+ .. ....+.+..++.++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 68999987665321 000 00 01122233332211 11111
Q ss_pred HH--------HhCCeeecCCCCCCeEEcC-CCcEEEeecCcccc
Q 038137 232 SI--------HKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKP 266 (549)
Q Consensus 232 ~L--------H~~giiHRDLKPeNILld~-~g~vKL~DFGlak~ 266 (549)
.| +...++|+|+++.|||++. ++.+.|+||..|..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 1236899999999999986 47899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0081 Score=62.89 Aligned_cols=83 Identities=14% Similarity=0.114 Sum_probs=51.9
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhh----chhhHHHHHHHHHHHHhcC--CC-ceeeeeeeecCCceEEEEE
Q 038137 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEML----RRGQVEHVKAERNLLAEVD--SN-CIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 124 ~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~----~~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~f~d~~~lylVm 196 (549)
.||-|.-..||.+.....++-++||.-....-. -.-...+...|...|.... .| .++++|++ |++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997644467899864321110 0223456677888887653 24 45555543 455566999
Q ss_pred eecCCC-chhhHh
Q 038137 197 EYLPGG-DMMTLL 208 (549)
Q Consensus 197 Ey~~gg-~L~~~l 208 (549)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 333444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0099 Score=61.79 Aligned_cols=146 Identities=21% Similarity=0.228 Sum_probs=94.3
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch----------------------hhHH-HHHHHHHHHHhcCC
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR----------------------GQVE-HVKAERNLLAEVDS 176 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~----------------------~~~~-~~~~E~~iL~~l~h 176 (549)
++-.+|..|--+.||.|.. .+|..+|||+++.+-+.-+ ..+. -...|..-|.+++.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3446788888899999875 4678899999865432110 1111 12334444555533
Q ss_pred CceeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCCCeEEcCCCc
Q 038137 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH-KHNYIHRDIKPDNLLLDRNGH 255 (549)
Q Consensus 177 p~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHRDLKPeNILld~~g~ 255 (549)
..|..---+. -..-.|||+|+.+.....=..+.-.++...++.+-.+++.-+.-|- .+++||.||.-=|+|+ .+|+
T Consensus 226 aGIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 2221100000 0234699999953222222234557888889998888888887764 5799999999999999 5789
Q ss_pred EEEeecCcccccCC
Q 038137 256 MKLSDFGLCKPLDC 269 (549)
Q Consensus 256 vKL~DFGlak~~~~ 269 (549)
+.|+|.+-+...+.
T Consensus 303 lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEccccccCCC
Confidence 99999998876543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.018 Score=58.89 Aligned_cols=30 Identities=27% Similarity=0.548 Sum_probs=26.5
Q ss_pred CCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 236 ~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.++||+|+.+.|||++. +.+.|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57999999999999987 6789999997754
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.019 Score=61.24 Aligned_cols=77 Identities=16% Similarity=0.146 Sum_probs=51.0
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch----hhHHHHHHHHHHHHhcC---CCceeeeeeeecCCceEE
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR----GQVEHVKAERNLLAEVD---SNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~----~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d~~~ly 193 (549)
..+.||.|....||++... +..|+||.-........ -...+...|...|..+. ...++++|++..+ .-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 3678999999999998863 45688987542111000 12344555677776553 2478888888774 456
Q ss_pred EEEeecCC
Q 038137 194 LIMEYLPG 201 (549)
Q Consensus 194 lVmEy~~g 201 (549)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.015 Score=59.01 Aligned_cols=32 Identities=28% Similarity=0.501 Sum_probs=26.8
Q ss_pred CeeecCCCCCCeEEcCCCc-EEEeecCcccccC
Q 038137 237 NYIHRDIKPDNLLLDRNGH-MKLSDFGLCKPLD 268 (549)
Q Consensus 237 giiHRDLKPeNILld~~g~-vKL~DFGlak~~~ 268 (549)
.++|+|+.|.|||++.+|. +-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 4899999999999997565 5699999887643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0024 Score=65.25 Aligned_cols=134 Identities=16% Similarity=0.206 Sum_probs=90.7
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHH-----------------------HHHHHHHHHhcC
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEH-----------------------VKAERNLLAEVD 175 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~-----------------------~~~E~~iL~~l~ 175 (549)
+.+...||-|--+-||.+-+. .|+++++|.-+... ..... ..+|...|+.+.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGR----tSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGR----TSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhh----hhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 567789999999999999764 57889998643211 11112 334555555442
Q ss_pred -CCc-eeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC
Q 038137 176 -SNC-IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN 253 (549)
Q Consensus 176 -hp~-Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~ 253 (549)
|.+ |.+.+ |-+..++|||++.|-.|...-.- ..+..+...+..-|--|-.+|+||+|..-=||+++.+
T Consensus 169 e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 169 ERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred HcCCCCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence 222 22222 34567899999988777654311 1233344455555667889999999999999999999
Q ss_pred CcEEEeecCccccc
Q 038137 254 GHMKLSDFGLCKPL 267 (549)
Q Consensus 254 g~vKL~DFGlak~~ 267 (549)
++++++||--+...
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 99999999876544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.02 Score=59.66 Aligned_cols=142 Identities=15% Similarity=0.209 Sum_probs=81.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCce-eeeeeeecCCce
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI-VKLYCSFQDDEY 191 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~f~d~~~ 191 (549)
.++.++. .|..|=...+|++..... +..|.+|+..... ...+ .-.+|..++..+..-.+ +++++++...
T Consensus 14 ~~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~G-- 86 (330)
T PLN02421 14 DSDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFGNG-- 86 (330)
T ss_pred cCceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeCCc--
Confidence 3445544 444488888999875432 3478899876532 1111 23567888877754333 5667776433
Q ss_pred EEEEEeecCCCchhh--------------Hhhh--cCC------C-CHHHHHHHHHHH----------------------
Q 038137 192 LYLIMEYLPGGDMMT--------------LLMR--KDT------L-TEEEARFYVGET---------------------- 226 (549)
Q Consensus 192 lylVmEy~~gg~L~~--------------~l~~--~~~------l-~e~~~~~~~~qi---------------------- 226 (549)
+|.+|++|-.|.. .+.+ ... . ....+..|..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 5899998765421 1111 001 1 122233333222
Q ss_pred ---HHHHHHHH-hC----CeeecCCCCCCeEEcC-CCcEEEeecCcccc
Q 038137 227 ---VLAIESIH-KH----NYIHRDIKPDNLLLDR-NGHMKLSDFGLCKP 266 (549)
Q Consensus 227 ---~~aL~~LH-~~----giiHRDLKPeNILld~-~g~vKL~DFGlak~ 266 (549)
+..+..+. .. -++|.||.|.|||++. ++.++++||..|..
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111121 22 2799999999999975 57899999998864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.019 Score=59.65 Aligned_cols=73 Identities=26% Similarity=0.473 Sum_probs=54.4
Q ss_pred CCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
...++|++|++- |+.+... ..-..+++..++.+.+.-+.-+.. -.+=||||.-+||||+ +|+|.|+||-+|+.
T Consensus 297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 446789999986 6555322 223455666677776666655554 3689999999999999 99999999999984
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.07 Score=55.13 Aligned_cols=149 Identities=15% Similarity=0.163 Sum_probs=86.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC--ceeeeeeeecCCc--eE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN--CIVKLYCSFQDDE--YL 192 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f~d~~--~l 192 (549)
....++..+-.|..-.+|..... ++.+++. ... ............+|..+|+.+..- -+...++.+.++. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 34455555544444445544433 7788888 321 222233455567788888776432 2345566666665 67
Q ss_pred EEEEeecCCCchhhHhhhc--------------------------------CCCCHHHHHHHHHHH--------------
Q 038137 193 YLIMEYLPGGDMMTLLMRK--------------------------------DTLTEEEARFYVGET-------------- 226 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~--------------------------------~~l~e~~~~~~~~qi-------------- 226 (549)
|.||+|+.|..+.+.+... +.+...+...+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 9999999884332221100 001111122222222
Q ss_pred HHHHHHHHh--------CCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 227 VLAIESIHK--------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 227 ~~aL~~LH~--------~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..-..+|+. -.++|+|+.+.|||++.++-+=+.||+++...+.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 112344443 2489999999999999999999999999987553
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.098 Score=53.43 Aligned_cols=135 Identities=19% Similarity=0.253 Sum_probs=72.2
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc---CCCceeeeeeeecCCceEEEEE
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV---DSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+-.+.||.|....+|... .+++.|.+|+-.... ...+..|..-|+.+ ..-.+++.+.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345688999999999876 678889999876321 23467788877777 3345778887777666679999
Q ss_pred eecCCC--------chhhHh---hh---cCC-----------------CCHHHHHHHHHH--------------------
Q 038137 197 EYLPGG--------DMMTLL---MR---KDT-----------------LTEEEARFYVGE-------------------- 225 (549)
Q Consensus 197 Ey~~gg--------~L~~~l---~~---~~~-----------------l~e~~~~~~~~q-------------------- 225 (549)
||++.+ .|...| .+ .+. -......||+.+
T Consensus 92 e~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~ 171 (288)
T PF03881_consen 92 EFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELE 171 (288)
T ss_dssp E--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHH
T ss_pred EeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHH
Confidence 999766 111111 11 111 123334444332
Q ss_pred -HHHHHH-HHHhC----CeeecCCCCCCeEEcCCCcEEEeecC
Q 038137 226 -TVLAIE-SIHKH----NYIHRDIKPDNLLLDRNGHMKLSDFG 262 (549)
Q Consensus 226 -i~~aL~-~LH~~----giiHRDLKPeNILld~~g~vKL~DFG 262 (549)
++..|. .|+.. -+||+||-+.|++.+.+|...|.|=.
T Consensus 172 ~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 172 RLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 111111 12222 38999999999999999989998854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.059 Score=57.31 Aligned_cols=80 Identities=19% Similarity=0.195 Sum_probs=47.7
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCC-CcE-----EEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCC
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKAT-GHV-----YAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDD 189 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~t-g~~-----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~ 189 (549)
++++ ++.|..|-.+.+|+|..... +.. |.+.+.... ....-.-.+|..++..+. +..-.++++.|..
T Consensus 51 ~~i~-i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIE-IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEE-EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 3444 44565588999999975432 222 444432111 111112356888888875 4455677888864
Q ss_pred ceEEEEEeecCCCchh
Q 038137 190 EYLYLIMEYLPGGDMM 205 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~ 205 (549)
++|.||++|-.|.
T Consensus 125 ---g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 ---FTIQEWVEGNTMG 137 (383)
T ss_pred ---EEEEEEeccccCC
Confidence 5999999987653
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.053 Score=57.58 Aligned_cols=85 Identities=18% Similarity=0.202 Sum_probs=55.2
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc---hhhHHHHHHHHHHHHhcC--CC-ceeeeeeeecCCceEEEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR---RGQVEHVKAERNLLAEVD--SN-CIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~f~d~~~lylV 195 (549)
++.||-|.-.-||.+.+...++-++||.-..---.. .-..++...|..+|+... .| .++++|++ |++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999985445678888643211110 223566777888887653 24 46666544 55667799
Q ss_pred EeecCCC-chhhHh
Q 038137 196 MEYLPGG-DMMTLL 208 (549)
Q Consensus 196 mEy~~gg-~L~~~l 208 (549)
||+++.. .|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9999653 344444
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.099 Score=53.78 Aligned_cols=30 Identities=13% Similarity=0.175 Sum_probs=28.0
Q ss_pred CeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 237 giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
++||+|+.++|||++.+|.+-++||..|..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.044 Score=52.98 Aligned_cols=31 Identities=32% Similarity=0.687 Sum_probs=22.3
Q ss_pred CCeeecCCCCCCeEE-cCCCcEEEeecCcccc
Q 038137 236 HNYIHRDIKPDNLLL-DRNGHMKLSDFGLCKP 266 (549)
Q Consensus 236 ~giiHRDLKPeNILl-d~~g~vKL~DFGlak~ 266 (549)
..++|.||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8899999999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.0069 Score=44.32 Aligned_cols=46 Identities=33% Similarity=0.390 Sum_probs=23.7
Q ss_pred CCCccccccccccccccccccccccCCcccccccccccccccceeeCc
Q 038137 437 VNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNF 484 (549)
Q Consensus 437 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~ 484 (549)
++++.|++|||.....+....+.. ..+..+..+.+.+|.||||.++
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~t~~--~~~~~~~~~~~~~F~GFTy~~~ 47 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVDTPP--SDPSPLSSSMQENFQGFTYVNP 47 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS--S----HHHHCTSSGGGGTT-CEETC
T ss_pred CCchhhhhhcCcccccCCCCCCCc--ccCCcccccccCcCCCCeecCC
Confidence 678899999998333222211111 1122233445567999999875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.46 Score=49.50 Aligned_cols=136 Identities=19% Similarity=0.200 Sum_probs=77.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC---CCceee---ee----eeecCCceE
Q 038137 123 TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD---SNCIVK---LY----CSFQDDEYL 192 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~---l~----~~f~d~~~l 192 (549)
..|.+ .-..||++... +..|++|+.... ... ..+.-|..+|..+. .+-.+. +- ..+....+.
T Consensus 32 ~~l~s-~eN~~f~~~~~--~g~~iLki~~~~--~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 32 RGLNS-EENSNFRVQTE--DGRYILKIYRPG--WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccccc-ccCceEEEEec--CCCeEEEEecCC--CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 34554 55678888754 334589988764 222 33555666666552 222222 22 222222478
Q ss_pred EEEEeecCCCchhh-H----hh----------h-cCC-----------CCHH----HHH---------HHHHHHHHHHHH
Q 038137 193 YLIMEYLPGGDMMT-L----LM----------R-KDT-----------LTEE----EAR---------FYVGETVLAIES 232 (549)
Q Consensus 193 ylVmEy~~gg~L~~-~----l~----------~-~~~-----------l~e~----~~~---------~~~~qi~~aL~~ 232 (549)
+-|++|++|..+.. . +. . ... ..+. ... ...+++...+..
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 89999999987762 1 00 0 000 1111 111 122333344444
Q ss_pred HH--------hCC--eeecCCCCCCeEEcCCCc-EEEeecCcccc
Q 038137 233 IH--------KHN--YIHRDIKPDNLLLDRNGH-MKLSDFGLCKP 266 (549)
Q Consensus 233 LH--------~~g--iiHRDLKPeNILld~~g~-vKL~DFGlak~ 266 (549)
+. ..+ +||+|+.|+|||++.+.. +-+.|||-|..
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 43 234 999999999999998885 89999998763
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.63 Score=55.81 Aligned_cols=31 Identities=32% Similarity=0.501 Sum_probs=26.5
Q ss_pred CCeeecCCCCCCeEEcCCC--cEE-EeecCcccc
Q 038137 236 HNYIHRDIKPDNLLLDRNG--HMK-LSDFGLCKP 266 (549)
Q Consensus 236 ~giiHRDLKPeNILld~~g--~vK-L~DFGlak~ 266 (549)
.++||.|+.+.|||++.++ .+. |+|||-|..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999876 565 999998754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.14 Score=50.01 Aligned_cols=101 Identities=19% Similarity=0.223 Sum_probs=65.3
Q ss_pred EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHH
Q 038137 144 VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYV 223 (549)
Q Consensus 144 ~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~ 223 (549)
...+|++....+.- ....+.++..|++++. .|++|..- +...+-+|.|+|-.-... ..-++.
T Consensus 87 ~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~------------~~N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN------------FSNFIT 148 (308)
T ss_pred hhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc------------hhHHHH
Confidence 34566665433220 1233577888998774 57888732 344577999998321111 111222
Q ss_pred HHHHHHHHHHHh--CCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 224 GETVLAIESIHK--HNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 224 ~qi~~aL~~LH~--~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
+ =+.+|.-.|+ .+.+|+|-.|+||+-|+.|.+||.|=+.
T Consensus 149 a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 A-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred H-hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 2 2456777884 4799999999999999999999999764
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.49 Score=51.36 Aligned_cols=81 Identities=17% Similarity=0.134 Sum_probs=49.7
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcC--------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCce-eeeeee
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKA--------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI-VKLYCS 185 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~--------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~ 185 (549)
..++. -++.|..|-...+|++.... +++.|.+++..... ...+ .-..|..++..+..-.| .++++.
T Consensus 104 ~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~ 178 (442)
T PTZ00296 104 TEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNT 178 (442)
T ss_pred CcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEE
Confidence 34455 56778788888999997542 25678999875431 1111 23456666666643222 356666
Q ss_pred ecCCceEEEEEeecCCCch
Q 038137 186 FQDDEYLYLIMEYLPGGDM 204 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L 204 (549)
|.. +.|.||++|..|
T Consensus 179 f~g----g~I~efi~g~~l 193 (442)
T PTZ00296 179 FSG----GRIEEWLYGDPL 193 (442)
T ss_pred eCC----CEEEEeeCCccC
Confidence 643 368999988643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.09 Score=57.01 Aligned_cols=79 Identities=19% Similarity=0.177 Sum_probs=53.3
Q ss_pred cccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCC-----------cCCChhHHHHHHHhhh-cccccC
Q 038137 337 MECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-----------AKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~-----------~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
+++||||+|.|+.|+..|...+......+....|... ...+.. -.++.-..++..+|+. .|..|+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~---~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY---YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh---ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 3999999999999999998887665555544444321 111110 0234455667777777 788887
Q ss_pred CCCCHHHHHcCCcccCC
Q 038137 405 GTKGADEIKAHPWFKGI 421 (549)
Q Consensus 405 ~~~~~~eil~HpfF~~i 421 (549)
...+..+|+-|..+
T Consensus 187 ---l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 ---LPMELSKRCSFTEV 200 (725)
T ss_pred ---chhHHhcCccHHHH
Confidence 57788888888766
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 549 | ||||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-82 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-81 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-80 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-80 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-80 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-76 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-76 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-75 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-64 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-64 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-64 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-64 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-64 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-63 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-63 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-63 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-63 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-63 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-63 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-63 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-63 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-63 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-63 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-63 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-63 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-63 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-63 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-63 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-63 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-63 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-63 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-62 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-62 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-62 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-62 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-62 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-62 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-62 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-62 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-62 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-62 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-62 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-62 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-62 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-62 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-62 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-62 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-62 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-62 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-62 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-62 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-62 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-61 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-61 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-61 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-61 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-61 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-61 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-61 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-61 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-60 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-53 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-53 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-53 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-53 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-52 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-52 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-52 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-52 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-52 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-52 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-52 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-52 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-52 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-51 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-50 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-50 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-50 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-50 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-50 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-50 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-49 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-49 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-48 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-46 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-45 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-45 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-45 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-45 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-45 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-45 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-45 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-45 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-45 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-45 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-45 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-45 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-45 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-45 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-45 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-45 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-45 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-45 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-45 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-44 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-44 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-44 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-44 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-44 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-43 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-40 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-40 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-37 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-35 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-35 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-35 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-35 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-35 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-35 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-35 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-35 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-35 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-35 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-35 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-34 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-34 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-34 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-34 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-34 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-34 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-33 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-33 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-33 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-33 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-33 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-33 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-33 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-32 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-32 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-32 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-32 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-32 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-32 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-32 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-32 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-32 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-32 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-32 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-32 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-32 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-32 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-32 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-31 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-31 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-31 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-31 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-31 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-31 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-31 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-31 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-31 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-31 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-31 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-31 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-31 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-31 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-31 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-31 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-31 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-31 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-31 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-31 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-31 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-31 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-31 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-30 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-30 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-30 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-30 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-30 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-30 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-29 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-29 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-29 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-29 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-29 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-29 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-29 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-29 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-29 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-29 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-29 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-29 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-29 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-29 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-29 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-29 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-29 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-29 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-29 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-29 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-29 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-29 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-29 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-29 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-29 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-29 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-29 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-29 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-29 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-29 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-29 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-29 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-29 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-28 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-28 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-28 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-28 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-28 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-28 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-28 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-28 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-28 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-28 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-28 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-27 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-27 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-27 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-27 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-27 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-27 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-27 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-27 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-26 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-26 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-26 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-26 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-26 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-26 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-26 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-26 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-26 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-26 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-26 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-26 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-25 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-25 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-25 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-24 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-24 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-24 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-24 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-24 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-24 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-23 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-22 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-22 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-22 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-21 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-21 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-21 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-21 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-21 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-21 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-21 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-21 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-21 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-21 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-21 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-21 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-21 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-21 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-20 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-20 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-19 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-17 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-17 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-17 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-07 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 4ax8_A | 569 | Medium Resolution Structure Of The Bifunctional Kin | 6e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-06 | ||
| 4azs_A | 569 | High Resolution (2.2 A) Crystal Structure Of Wbdd. | 6e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 7e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 8e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 9e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-05 | ||
| 4azw_A | 471 | Crystal Structure Of Monomeric Wbdd Length = 471 | 2e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-04 |
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AX8|A Chain A, Medium Resolution Structure Of The Bifunctional Kinase- Methyltransferase Wbdd Length = 569 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4AZS|A Chain A, High Resolution (2.2 A) Crystal Structure Of Wbdd. Length = 569 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4AZW|A Chain A, Crystal Structure Of Monomeric Wbdd Length = 471 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 488 bits (1259), Expect = e-171
Identities = 152/418 (36%), Positives = 219/418 (52%), Gaps = 52/418 (12%)
Query: 88 SEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAM 147
+ + +L+ E +RL+ ++ DDFE L +IG+GAF EV V + K TG VYAM
Sbjct: 32 ELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 148 KKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL 207
K + K +ML+RG+V + ER++L D I +L+ +FQD+ YLYL+MEY GGD++TL
Sbjct: 92 KIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTL 151
Query: 208 LMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266
L + + + E ARFY+ E V+AI+S+H+ Y+HRDIKPDN+LLDR GH++L+DFG C
Sbjct: 152 LSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIA 326
L + + + VGTPDY++
Sbjct: 212 LR----------------------------------------ADGTVRSLVAVGTPDYLS 231
Query: 327 PEVLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKF 379
PE+L G YG ECDWW+LG YEM G PFY+D T KIV+++ HL
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 380 PEEAK-LSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVN 438
P + + EA+D I +LLC E RLG GA + + HP+F G++WD L F P+
Sbjct: 292 PLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFE 351
Query: 439 DELDTQNFEKFEEADNQIQT---SAKSGPWRKMLSSKDINFVGYTYKNFEIVNDHQLP 493
DT NF+ E+ + + S + FVGY+Y + +
Sbjct: 352 GATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALRDSEVPG 409
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 479 bits (1235), Expect = e-167
Identities = 161/429 (37%), Positives = 237/429 (55%), Gaps = 49/429 (11%)
Query: 88 SEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAM 147
+ N+L+YLE + ++++ ++ +DFE L +IG+GAFGEV V + K V+AM
Sbjct: 45 PLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAM 104
Query: 148 KKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL 207
K L K EML+R + + ER++L DS I L+ +FQDD LYL+M+Y GGD++TL
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 208 LMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266
L + +D L EE ARFY+ E V+AI+S+H+ +Y+HRDIKPDN+L+D NGH++L+DFG C
Sbjct: 165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIA 326
L + + + VGTPDYI+
Sbjct: 225 LM----------------------------------------EDGTVQSSVAVGTPDYIS 244
Query: 327 PEVLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE 381
PE+L K YG ECDWWSLG MYEML G PFY++ + T KI+N + +FP
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 382 E-AKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDE 440
+ +S AKDLI +L+C+ E RLG G ++ K HP+F GI+WD + +A +IPEV+
Sbjct: 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSP 364
Query: 441 LDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFEIVNDHQLPGIAELKK 500
DT NF+ ++ +T P S + FVG+TY + +++D +
Sbjct: 365 TDTSNFDVDDDCLKNSETM--PPPTHTAFSGHHLPFVGFTYTSSCVLSDRSCLRVTAGPT 422
Query: 501 KSTKPKRPS 509
+ S
Sbjct: 423 SAENLYFQS 431
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 476 bits (1228), Expect = e-166
Identities = 152/402 (37%), Positives = 231/402 (57%), Gaps = 51/402 (12%)
Query: 88 SEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAM 147
+ + N+ +L + + +++ +M A+D+E + +IG+GAFGEV++ R K+T VYAM
Sbjct: 40 ALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 148 KKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL 207
K L K EM++R ER+++A +S +V+L+ +FQDD YLY++MEY+PGGD++ L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 208 LMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267
+ D + E+ ARFY E VLA+++IH +IHRD+KPDN+LLD++GH+KL+DFG C +
Sbjct: 160 MSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218
Query: 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327
+ + + + VGTPDYI+P
Sbjct: 219 N----------------------------------------KEGMVRCDTAVGTPDYISP 238
Query: 328 EVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEA 383
EVL +G YG ECDWWS+G +YEMLVG PFY+D + T KI+N + L FP++
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298
Query: 384 KLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQ--IKAAFIPEVNDEL 441
+S EAK+LI L + E RLG G +EIK H +FK +W A +P+++ ++
Sbjct: 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDI 358
Query: 442 DTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKN 483
DT NF+ EE + +T P K + FVG+TY +
Sbjct: 359 DTSNFDDLEEDKGEEETF----PIPKAFVGNQLPFVGFTYYS 396
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-135
Identities = 127/347 (36%), Positives = 187/347 (53%), Gaps = 54/347 (15%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
K DF+ L +G G+FG V + R + G YAMK LKK ++R QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES 232
V I++++ +FQD + +++IM+Y+ GG++ +LL + A+FY E LA+E
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+H + I+RD+KP+N+LLD+NGH+K++DFG K
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAK--------------------------- 154
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
P T Y+ GTPDYIAPEV+ K Y DWWS G ++YEML
Sbjct: 155 -YVPDVT----------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197
Query: 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGA 409
GY PFY M T KI+N L+FP + + KDL+S+L+ ++ QRLG G
Sbjct: 198 AGYTPFYDSNTMKTYEKILNAE--LRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGT 253
Query: 410 DEIKAHPWFKGIEWDKLYQ--IKAAFIPEV-NDELDTQNFEKFEEAD 453
+++K HPWFK + W+KL I+ + P + + DT F+K+ E D
Sbjct: 254 EDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED 300
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-134
Identities = 125/381 (32%), Positives = 205/381 (53%), Gaps = 53/381 (13%)
Query: 88 SEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAM 147
E + L K E ++ ++ D F+ + +G G+FG V + + K +G+ YAM
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 148 KKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL 207
K L K ++++ Q+EH E+ +L V+ +VKL SF+D+ LY++MEY+ GG+M +
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131
Query: 208 LMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267
L R +E ARFY + VL E +H + I+RD+KP+NLL+D+ G+++++DFG K +
Sbjct: 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327
RT ++ GTP+ +AP
Sbjct: 192 K----------------------------GRT----------------WTLCGTPEALAP 207
Query: 328 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSP 387
E++L KGY DWW+LG ++YEM GYPPF++D+P+ KIV+ + ++FP + S
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFP--SHFSS 263
Query: 388 EAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLYQ--IKAAFIPEVNDELD 442
+ KDL+ LL ++ +R G G ++IK H WF +W +YQ ++A FIP+ D
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGD 323
Query: 443 TQNFEKFEEADNQIQTSAKSG 463
T NF+ +EE + ++ + K G
Sbjct: 324 TSNFDDYEEEEIRVSINEKCG 344
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-128
Identities = 104/337 (30%), Positives = 171/337 (50%), Gaps = 47/337 (13%)
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
+ Q K +DF+ ++G+G+F V + RE AT YA+K L+K +++ +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
+V ER++++ +D VKLY +FQDDE LY + Y G+++ + + + E RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
E V A+E +H IHRD+KP+N+LL+ + H++++DFG K L + Q +
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------- 188
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
A S VGT Y++PE+L +K D W
Sbjct: 189 --------------------------------ANSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVE 401
+LG I+Y+++ G PPF + +KI+ FPE+ P+A+DL+ KLL +
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEK--FFPKARDLVEKLLVLDAT 272
Query: 402 QRLGTK---GADEIKAHPWFKGIEWDKLYQIKAAFIP 435
+RLG + G +KAHP+F+ + W+ L+Q +
Sbjct: 273 KRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 309
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-125
Identities = 125/406 (30%), Positives = 190/406 (46%), Gaps = 53/406 (13%)
Query: 86 EVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVY 145
E N ++ DF L +IGKG+FG+V + R KA Y
Sbjct: 7 EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66
Query: 146 AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC-IVKLYCSFQDDEYLYLIMEYLPGGDM 204
A+K L+K +L++ + +H+ +ERN+L + + +V L+ SFQ + LY +++Y+ GG++
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 205 MTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264
L R+ E ARFY E A+ +H N ++RD+KP+N+LLD GH+ L+DFGLC
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
Query: 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDY 324
K N++ + GTP+Y
Sbjct: 187 KE----NIEHNS-------------------------------------TTSTFCGTPEY 205
Query: 325 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAK 384
+APEVL K+ Y DWW LGA++YEML G PPFYS I+N L+
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPN-- 261
Query: 385 LSPEAKDLISKLLC-NVEQRLGTK-GADEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDE 440
++ A+ L+ LL + +RLG K EIK+H +F I WD L +I F P V+
Sbjct: 262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGP 321
Query: 441 LDTQNFEKF---EEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKN 483
D ++F+ E N I + S + F+G++Y
Sbjct: 322 NDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAP 367
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-124
Identities = 123/356 (34%), Positives = 182/356 (51%), Gaps = 54/356 (15%)
Query: 102 KETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCRE---KATGHVYAMKKLKKSEMLRR 158
+ K+ + FE L ++GKG +G+V R+ TG ++AMK LKK+ ++R
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 159 G-QVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEE 217
H KAERN+L EV IV L +FQ LYLI+EYL GG++ L R+ E+
Sbjct: 62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 218 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
A FY+ E +A+ +H+ I+RD+KP+N++L+ GH+KL+DFGLCK
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------------ 169
Query: 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337
E + ++ GT +Y+APE+L++ G+
Sbjct: 170 ------------------------ESIHDGTV-----THTFCGTIEYMAPEILMRSGHNR 200
Query: 338 ECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL 397
DWWSLGA+MY+ML G PPF + T KI+ L P L+ EA+DL+ KLL
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPY--LTQEARDLLKKLL 256
Query: 398 C-NVEQRLGT--KGADEIKAHPWFKGIEWDKLYQ--IKAAFIPEVNDELDTQNFEK 448
N RLG A E++AHP+F+ I W++L ++ F P + E D F+
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDS 312
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-123
Identities = 122/380 (32%), Positives = 185/380 (48%), Gaps = 54/380 (14%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
K+ +DF+ L ++GKG FG+V + REKATG YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES 232
+ L +FQ + L +MEY GG++ L R+ TEE ARFY E V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+H + ++RDIK +NL+LD++GH+K++DFGLCK + +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGA---------------- 160
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
+ GTP+Y+APEVL YG DWW LG +MYEM+
Sbjct: 161 ---------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG--TKGA 409
G PFY+ + I+ ++FP LSPEAK L++ LL + +QRLG A
Sbjct: 200 CGRLPFYNQDHERLFELILM--EEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 410 DEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFEKF---EEADNQIQTSAKSGP 464
E+ H +F I W + ++ F P+V E+DT+ F+ + S
Sbjct: 256 KEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLG 315
Query: 465 WRKMLSSKD-INFVGYTYKN 483
++ ++ F + Y
Sbjct: 316 LLELDQREEQEMFEDFDYIA 335
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-122
Identities = 125/353 (35%), Positives = 186/353 (52%), Gaps = 54/353 (15%)
Query: 104 TEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCRE---KATGHVYAMKKLKKSEMLRRGQ 160
T +++ K FE L ++G+G+FG+V + ++ +YAMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 161 VEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEAR 220
V K ER++L EV+ IVKL+ +FQ + LYLI+++L GGD+ T L ++ TEE+ +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
FY+ E LA++ +H I+RD+KP+N+LLD GH+KL+DFGL K
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 174
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340
E + H ++ AYS GT +Y+APEV+ ++G+ D
Sbjct: 175 ---------------------ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSAD 208
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-N 399
WWS G +M+EML G PF + T I+ L P+ LSPEA+ L+ L N
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQF--LSPEAQSLLRMLFKRN 264
Query: 400 VEQRLG--TKGADEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFEK 448
RLG G +EIK H +F I+W+KLY +I F P DT F+
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDP 317
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-121
Identities = 129/373 (34%), Positives = 197/373 (52%), Gaps = 56/373 (15%)
Query: 88 SEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCRE---KATGHV 144
+ LL + T + K+G ++FE L ++G GA+G+V + R+ TG +
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 145 YAMKKLKKSEMLRRG-QVEHVKAERNLLAEVDSNC-IVKLYCSFQDDEYLYLIMEYLPGG 202
YAMK LKK+ ++++ EH + ER +L + + +V L+ +FQ + L+LI++Y+ GG
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144
Query: 203 DMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFG 262
++ T L +++ TE E + YVGE VLA+E +HK I+RDIK +N+LLD NGH+ L+DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTP 322
L K E + R AY GT
Sbjct: 205 LSK------------------------------------EFV--ADETER--AYDFCGTI 224
Query: 323 DYIAPEVLL--KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTH--LK 378
+Y+AP+++ G+ DWWSLG +MYE+L G PF D ++ +I
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 379 FPEEAKLSPEAKDLISKLLC-NVEQRLG--TKGADEIKAHPWFKGIEWDKLY--QIKAAF 433
+P+E +S AKDLI +LL + ++RLG + ADEIK H +F+ I WD L ++ A F
Sbjct: 285 YPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPF 342
Query: 434 IPEVNDELDTQNF 446
P + DELD NF
Sbjct: 343 KPVIRDELDVSNF 355
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-121
Identities = 119/383 (31%), Positives = 183/383 (47%), Gaps = 64/383 (16%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
+ K+ +DF M+GKG+FG+V + K T +A+K LKK +L VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 170 LLAEVDSN-CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL 228
+L+ + + ++C+FQ E L+ +MEYL GGD+M + A FY E +L
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
++ +H ++RD+K DN+LLD++GH+K++DFG+CK N+
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE----NMLGDA------------ 173
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
+ GTPDYIAPE+LL + Y DWWS G ++
Sbjct: 174 -------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 208
Query: 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK 407
YEML+G PF+ + I + +P L EAKDL+ KL E+RLG
Sbjct: 209 YEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRW--LEKEAKDLLVKLFVREPEKRLG-- 262
Query: 408 GADEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFEK-FEEADNQIQTSAK--- 461
+I+ HP F+ I W++L +I F P+V D NF+K F + K
Sbjct: 263 VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEF--------LNEKPRL 314
Query: 462 SGPWRKMLSSKD-INFVGYTYKN 483
S R +++S D F +++ N
Sbjct: 315 SFADRALINSMDQNMFRNFSFMN 337
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-120
Identities = 114/386 (29%), Positives = 181/386 (46%), Gaps = 65/386 (16%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
+++G D+FE + ++GKG+FG+V + R K TG +YA+K LKK +L+ VE E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 170 LLAEVDSNC-IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL 228
+L+ ++ + +L+C FQ + L+ +ME++ GGD+M + + E ARFY E +
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
A+ +H I+RD+K DN+LLD GH KL+DFG+CK +
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE----GICNGV------------ 179
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
+ GTPDYIAPE+L + YG DWW++G ++
Sbjct: 180 -------------------------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG-- 405
YEML G+ PF ++ I+N + +P L +A ++ + N RLG
Sbjct: 215 YEMLCGHAPFEAENEDDLFEAILN--DEVVYPTW--LHEDATGILKSFMTKNPTMRLGSL 270
Query: 406 -TKGADEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFEK-FEEADNQIQTSAK 461
G I HP+FK I+W +L QI+ F P + D NF+ F +
Sbjct: 271 TQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDF--------IKEE 322
Query: 462 ---SGPWRKMLSSKD-INFVGYTYKN 483
+ L + F + Y +
Sbjct: 323 PVLTPIDEGHLPMINQDEFRNFEYVS 348
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-120
Identities = 94/346 (27%), Positives = 154/346 (44%), Gaps = 61/346 (17%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
+ + D FE L IGKG+FG+V + ++ T +YAMK + K + + R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 170 LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
++ ++ +V L+ SFQD+E ++++++ L GGD+ L + EE + ++ E V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
++ + IHRD+KPDN+LLD +GH+ ++DF + L
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML---------------------P 166
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGA 346
+ GT Y+APE+ + GY DWWSLG
Sbjct: 167 RETQ---------------------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGV 205
Query: 347 IMYEMLVGYPPFY---SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQ 402
YE+L G P++ S T + +P S E L+ KLL N +Q
Sbjct: 206 TAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSA--WSQEMVSLLKKLLEPNPDQ 261
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQ--IKAAFIPEVNDELDTQNF 446
R +++ P+ I WD ++Q + FIP N
Sbjct: 262 RFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK----GRLNC 301
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-119
Identities = 110/393 (27%), Positives = 188/393 (47%), Gaps = 65/393 (16%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
R +M DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 170 LLAEVDSNC-IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL 228
+LA + +L+ FQ + LY +MEY+ GGD+M + + E A FY E +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+ + I+RD+K DN++LD GH+K++DFG+CK
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------------------- 169
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
E + + GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 170 -------------ENIWDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 211
Query: 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT- 406
YEML G PF ++ + I+ ++ +P+ +S EA + L+ + +RLG
Sbjct: 212 YEMLAGQAPFEGEDEDELFQSIME--HNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCG 267
Query: 407 -KGADEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFEK-FEEADNQIQTSAK- 461
+G +IK H +F+ I+W+KL +I+ + P+ + +NF++ F T
Sbjct: 268 PEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFF--------TRHPP 318
Query: 462 --SGPWRKMLSSKD-INFVGYTYKNFEIVNDHQ 491
+ P ++++ + D F G+++ N E +
Sbjct: 319 VLTPPDQEVIRNIDQSEFEGFSFVNSEFLKPEV 351
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-117
Identities = 114/393 (29%), Positives = 187/393 (47%), Gaps = 76/393 (19%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
+G DF+ L +IG+G++ +V + R K T +YAMK +KK + ++ V+ E+++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 173 EVDSNC--IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAI 230
+ SN +V L+ FQ + L+ ++EY+ GGD+M + R+ L EE ARFY E LA+
Sbjct: 65 QA-SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
+H+ I+RD+K DN+LLD GH+KL+D+G+CK L+ D
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE----GLRPGD-------------- 165
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
+ GTP+YIAPE+L + YG DWW+LG +M+E
Sbjct: 166 -----------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 351 MLVGYPPFYSDEPMSTC---------RKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NV 400
M+ G PF + I+ ++ P LS +A ++ L +
Sbjct: 203 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS--LSVKAASVLKSFLNKDP 258
Query: 401 EQRLG---TKGADEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNF-EKFEEADN 454
++RLG G +I+ HP+F+ ++WD + Q+ F P ++ E NF +F
Sbjct: 259 KERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQF----- 313
Query: 455 QIQTSAK---SGPWRKMLSSKD-INFVGYTYKN 483
T+ + ++ D F G+ Y N
Sbjct: 314 ---TNEPVQLTPDDDDIVRKIDQSEFEGFEYIN 343
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-115
Identities = 124/393 (31%), Positives = 196/393 (49%), Gaps = 55/393 (13%)
Query: 62 KKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEP 121
++ +++ + D N+ + +E + +H++ ++FE
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAK----PKHRVTMNEFEY 152
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
L ++GKG FG+V + +EKATG YAMK LKK ++ + +V H E +L +
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH-KHNYIH 240
L SFQ + L +MEY GG++ L R+ +E+ ARFY E V A++ +H + N ++
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RD+K +NL+LD++GH+K++DFGLCK
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCK----------------------------------- 297
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360
E ++ + GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 298 -EGIKDGAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG--TKGADEIKAHPW 417
+ I+ ++FP L PEAK L+S LL + +QRLG ++ A EI H +
Sbjct: 352 QDHEKLFELILM--EEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
Query: 418 FKGIEWDKLY--QIKAAFIPEVNDELDTQNFEK 448
F GI W +Y ++ F P+V E DT+ F++
Sbjct: 408 FAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 440
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 344 bits (885), Expect = e-114
Identities = 113/421 (26%), Positives = 193/421 (45%), Gaps = 74/421 (17%)
Query: 84 DAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGH 143
+ + + + E T +G DF+ L +IG+G++ +V + R K T
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDR 78
Query: 144 VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKLYCSFQDDEYLYLIMEYLPGG 202
+YAM+ +KK + ++ V+ E+++ + ++ +V L+ FQ + L+ ++EY+ GG
Sbjct: 79 IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 138
Query: 203 DMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFG 262
D+M + R+ L EE ARFY E LA+ +H+ I+RD+K DN+LLD GH+KL+D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTP 322
+CK L+ D + GTP
Sbjct: 199 MCKE----GLRPGD-------------------------------------TTSTFCGTP 217
Query: 323 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTC---------RKIVNW 373
+YIAPE+L + YG DWW+LG +M+EM+ G PF + I+
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE- 276
Query: 374 RTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG---TKGADEIKAHPWFKGIEWDKLY-- 427
++ P LS +A ++ L + ++RLG G +I+ HP+F+ ++WD +
Sbjct: 277 -KQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQK 333
Query: 428 QIKAAFIPEVNDELDTQNF-EKFEEADNQIQTSAK---SGPWRKMLSSKD-INFVGYTYK 482
Q+ F P ++ E NF +F T+ + ++ D F G+ Y
Sbjct: 334 QVVPPFKPNISGEFGLDNFDSQF--------TNEPVQLTPDDDDIVRKIDQSEFEGFEYI 385
Query: 483 N 483
N
Sbjct: 386 N 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 346 bits (888), Expect = e-112
Identities = 129/548 (23%), Positives = 222/548 (40%), Gaps = 96/548 (17%)
Query: 20 SKKKETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILE 79
K+K + + + T ++ V +Q V Q +E K + R +
Sbjct: 96 DKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSV 155
Query: 80 KKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREK 139
AD S L ++ L+R + + F ++GKG FGEV C+ +
Sbjct: 156 APFADYLDSIYFNRFL---------QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206
Query: 140 ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYL 199
ATG +YA KKL+K + +R E+ +L +V+S +V L +++ + L L++ +
Sbjct: 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266
Query: 200 PGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMK 257
GGD+ + M + E A FY E +E +H+ ++RD+KP+N+LLD +GH++
Sbjct: 267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIR 326
Query: 258 LSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYS 317
+SD GL ++ E
Sbjct: 327 ISDLGLAV-----HVPEGQ-------------------------------------TIKG 344
Query: 318 TVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTC----RKIVNW 373
VGT Y+APEV+ + Y DWW+LG ++YEM+ G PF + R +
Sbjct: 345 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE- 403
Query: 374 RTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLY--Q 428
++ E + SP+A+ L S+LLC + +RLG + A E+K HP FK + + +L
Sbjct: 404 -VPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGM 460
Query: 429 IKAAFIPEVNDE--LDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDIN-FVGYTYKN-- 483
++ F P+ D + E+F S G L D + + + +
Sbjct: 461 LEPPFKPDPQAIYCKDVLDIEQF---------STVKGV---ELEPTDQDFYQKFATGSVP 508
Query: 484 ------------FEIVNDHQLPG-IAELKKKSTKPKRPSIKSLFEDESATVNQPVHGGSF 530
F+ +N L G + +P P K L + + + +
Sbjct: 509 IPWQNEMVETECFQELNVFGLDGSVPPDLDWKGQPPAPPKKGLLQRLFSRQDSSGNSSDS 568
Query: 531 LNLLPPQI 538
LP ++
Sbjct: 569 EEELPTRL 576
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 348 bits (893), Expect = e-112
Identities = 116/439 (26%), Positives = 201/439 (45%), Gaps = 65/439 (14%)
Query: 64 QMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLT 123
+ E E L +K A++ + + K R +M DF L
Sbjct: 288 NVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM 347
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKL 182
++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA + +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ FQ + LY +MEY+ GGD+M + + E A FY E + + + I+RD
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQE 302
+K DN++LD GH+K++DFG+CK E
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCK------------------------------------E 491
Query: 303 QLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
+ + GTPDYIAPE++ + YG DWW+ G ++YEML G PF ++
Sbjct: 492 NIWDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG--TKGADEIKAHPWFK 419
+ I+ ++ +P+ +S EA + L+ + +RLG +G +IK H +F+
Sbjct: 547 EDELFQSIME--HNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602
Query: 420 GIEWDKLY--QIKAAFIPEVNDELDTQNFEK-FEEADNQIQTSAK---SGPWRKMLSSKD 473
I+W+KL +I+ + P+ + + +NF++ F T + P ++++ + D
Sbjct: 603 YIDWEKLERKEIQPPYKPKASGR-NAENFDRFF--------TRHPPVLTPPDQEVIRNID 653
Query: 474 -INFVGYTYKNFEIVNDHQ 491
F G+++ N E +
Sbjct: 654 QSEFEGFSFVNSEFLKPEV 672
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 341 bits (877), Expect = e-111
Identities = 113/476 (23%), Positives = 191/476 (40%), Gaps = 89/476 (18%)
Query: 47 KQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETE- 105
+ A + + A + + +L +L + +
Sbjct: 102 LRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQE 161
Query: 106 ------------YMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKS 153
+ L+ MG D F ++G+G FGEV C+ KATG +YA KKL K
Sbjct: 162 FLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK 221
Query: 154 EMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMM----TLLM 209
+ +R + E+ +LA+V S IV L +F+ L L+M + GGD+ +
Sbjct: 222 RLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE 281
Query: 210 RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269
E A FY + V +E +H+ N I+RD+KP+N+LLD +G++++SD GL
Sbjct: 282 DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE--- 338
Query: 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEV 329
+ GTP ++APE+
Sbjct: 339 -LKAGQT-------------------------------------KTKGYAGTPGFMAPEL 360
Query: 330 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTC----RKIVNWRTHLKFPEEAKL 385
LL + Y D+++LG +YEM+ PF + ++++ + +P+ K
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPD--KF 416
Query: 386 SPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLY--QIKAAFIPEVN-- 438
SP +KD LL + E+RLG + D ++ HP F+ I W +L + F+P+
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTV 476
Query: 439 ---DELDTQNFE-----KFEEADNQI----QTSAKSGPW-RKMLSS---KDINFVG 478
+ D F FE+AD + + PW +M+ + D+N
Sbjct: 477 YAKNIQDVGAFSTVKGVAFEKADTEFFQEFASGTCPIPWQEEMIETGVFGDLNVWR 532
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-111
Identities = 116/549 (21%), Positives = 217/549 (39%), Gaps = 89/549 (16%)
Query: 8 FNKLRSKDKVKPSKKKETAGHG-KEVSKAQTSEEVPSNVTKQKVAAAKQYIENHYKKQMK 66
+ +++ +K++ +++ + + +K + + ++
Sbjct: 86 YEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDL 145
Query: 67 SLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIG 126
+E L + + ++ ++ + K E + +DF +IG
Sbjct: 146 FQPYIEEICQNLRGDVFQKFIESDKFT---RFCQWKNVE----LNIHLTMNDFSVHRIIG 198
Query: 127 KGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC---IVKLY 183
+G FGEV CR+ TG +YAMK L K + + ER +L+ V + IV +
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258
Query: 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDI 243
+F + L I++ + GGD+ L + +E + RFY E +L +E +H ++RD+
Sbjct: 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 318
Query: 244 KPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQ 303
KP N+LLD +GH+++SD GL +P
Sbjct: 319 KPANILLDEHGHVRISDLGLACDFS---------------------KKKP---------- 347
Query: 304 LQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDE 362
+++VGT Y+APEVL K Y DW+SLG +++++L G+ PF +
Sbjct: 348 ------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395
Query: 363 PMST---CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG--TKGADEIKAHP 416
R + ++ P+ SPE + L+ LL +V +RLG +GA E+K P
Sbjct: 396 TKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451
Query: 417 WFKGIEWDKLY--QIKAAFIPEVN-----DELDTQNFEKFEEADNQIQTSAKSGPWRKML 469
+F+ ++W ++ + IP D D +F+ EE I+
Sbjct: 452 FFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFD--EEDTKGIKLL---------- 499
Query: 470 SSKDINFVGYTYKNFEIVNDHQLPGI-----AELKKKSTKPKRPSIKSLFEDESATVNQP 524
S + + E + AE + + K + + E++ A
Sbjct: 500 DSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKTKNKQLGHEEDYALGKDC 559
Query: 525 VHGGSFLNL 533
+ G +
Sbjct: 560 IMHGYMSKM 568
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 7e-98
Identities = 97/339 (28%), Positives = 148/339 (43%), Gaps = 57/339 (16%)
Query: 104 TEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEH 163
T + + K DDF+ +GKG FG V + REK + A+K L KS++ + G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 164 VKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYV 223
++ E + + + I+++Y F D + +YL++E+ P G++ L + E+ + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
E A+ H+ IHRDIKP+NLL+ G +K++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343
H RR + GT DY+ PE++ K + + D W
Sbjct: 163 ----------------------HAPSLRR---RTMCGTLDYLPPEMIEGKTHDEKVDLWC 197
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQ 402
G + YE LVG PPF S T R+IV LKFP LS +KDLISKLL + Q
Sbjct: 198 AGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPP--FLSDGSKDLISKLLRYHPPQ 253
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLY-QIKAAFIPEVNDE 440
RL + HPW K ++ +
Sbjct: 254 RL---PLKGVMEHPWVK-----ANSRRVLPPVYQSTQSK 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 1e-97
Identities = 93/311 (29%), Positives = 142/311 (45%), Gaps = 51/311 (16%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
++ + +DFE +GKG FG V + REK + + A+K L K+++ + G ++ E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 170 LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
+ + + I++LY F D +YLI+EY P G + L + E+ Y+ E A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+ H IHRDIKP+NLLL G +K++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------------------ 157
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
H +RR GT DY+ PE++ + + + D WSLG + Y
Sbjct: 158 ----------------HAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408
E LVG PPF ++ T ++I R FP+ ++ A+DLIS+LL N QR
Sbjct: 199 EFLVGKPPFEANTYQETYKRIS--RVEFTFPD--FVTEGARDLISRLLKHNPSQRP---M 251
Query: 409 ADEIKAHPWFK 419
E+ HPW
Sbjct: 252 LREVLEHPWIT 262
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 4e-83
Identities = 90/305 (29%), Positives = 143/305 (46%), Gaps = 50/305 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+DF+ ++GKG+F V TG A+K + K M + G V+ V+ E + ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHK 235
I++LY F+D Y+YL++E G+M L + +E EAR ++ + + + +H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
H +HRD+ NLLL RN ++K++DFGL + + +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGL------ATQLKMP-------------HEK--- 168
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
T GTP+YI+PE+ + +G+E D WSLG + Y +L+G
Sbjct: 169 -HYT------------------LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414
PPF +D +T K+V + P LS EAKDLI +LL N RL +
Sbjct: 210 PPFDTDTVKNTLNKVV--LADYEMPSF--LSIEAKDLIHQLLRRNPADRLSL---SSVLD 262
Query: 415 HPWFK 419
HP+
Sbjct: 263 HPFMS 267
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 6e-83
Identities = 79/329 (24%), Positives = 137/329 (41%), Gaps = 52/329 (15%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
A DFE + ++G+GAFG+V R YA+KK++ +E ++ + +E LLA ++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLN 60
Query: 176 SNCIVKLYCSFQDDE-------------YLYLIMEYLPGGDMMTLLMRKDTLTEE-EARF 221
+V+ Y ++ + L++ MEY G + L+ ++ + E
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 222 YVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
+ + A+ IH IHRD+KP N+ +D + ++K+ DFGL K + S K S
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECD 340
S S +GT Y+A EVL G Y + D
Sbjct: 181 PGSS---------------------------DNLTSAIGTAMYVATEVLDGTGHYNEKID 213
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-N 399
+SLG I +EM+ YP E ++ +K+ + + K +I L+ +
Sbjct: 214 MYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 400 VEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428
+R GA + W D++ +
Sbjct: 272 PNKRP---GARTLLNSGWLPVKHQDEVIK 297
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 3e-82
Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 49/304 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ +GKG F + + T V+A K + KS +L+ Q E + E ++ +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+V + F+D++++++++E ++ L R+ LTE EAR+Y+ + VL + +H++
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
IHRD+K NL L+ + +K+ DFGL + E D R
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYD-------------GER---- 171
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
++ GTP+YIAPEVL KKG+ E D WS+G IMY +LVG P
Sbjct: 172 KKV------------------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415
PF + T +I + P+ ++P A LI K+L + R +E+
Sbjct: 214 PFETSCLKETYLRIK--KNEYSIPKH--INPVAASLIQKMLQTDPTARP---TINELLND 266
Query: 416 PWFK 419
+F
Sbjct: 267 EFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 2e-81
Identities = 85/305 (27%), Positives = 141/305 (46%), Gaps = 51/305 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ +GKG F + + T V+A K + KS +L+ Q E + E ++ +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+V + F+D++++++++E ++ L R+ LTE EAR+Y+ + VL + +H++
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
IHRD+K NL L+ + +K+ DFGL + E D
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYD-------------------- 194
Query: 297 RRTQQEQLQHWQRNRRMLAYSTV-GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
R+ + GTP+YIAPEVL KKG+ E D WS+G IMY +LVG
Sbjct: 195 ------------GERKK----VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414
PPF + T +I + P+ ++P A LI K+L + R +E+
Sbjct: 239 PPFETSCLKETYLRIK--KNEYSIPKH--INPVAASLIQKMLQTDPTARP---TINELLN 291
Query: 415 HPWFK 419
+F
Sbjct: 292 DEFFT 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 4e-81
Identities = 67/320 (20%), Positives = 117/320 (36%), Gaps = 54/320 (16%)
Query: 102 KETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQV 161
+ Y + F+ L+ +G G++GEV R K G +YA+K+ + +
Sbjct: 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA 101
Query: 162 EHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEAR 220
+ + C V+L ++++ LYL E G + +L E +
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW 160
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
Y+ +T+LA+ +H +H D+KP N+ L G KL DFGL L
Sbjct: 161 GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL------------- 207
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340
G P Y+APE+ L+ YG D
Sbjct: 208 -----------------------------GTAGAGEVQEGDPRYMAPEL-LQGSYGTAAD 237
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-N 399
+SLG + E+ + E +++ +F LS E + ++ +L +
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTA--GLSSELRSVLVMMLEPD 292
Query: 400 VEQRLGTKGADEIKAHPWFK 419
+ R A+ + A P +
Sbjct: 293 PKLRA---TAEALLALPVLR 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 4e-78
Identities = 64/393 (16%), Positives = 132/393 (33%), Gaps = 94/393 (23%)
Query: 90 EEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKK 149
++L ++ +D+ + + +G F ++ +C + YA+KK
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKK 61
Query: 150 LKKSEMLR--------------RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195
+KS + + + + + K E ++ ++ + + + + +Y+I
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 196 MEYLPGGDMMTLL--------MRKDTLTEEEARFYVGETVLAIESIHKHNYI-HRDIKPD 246
EY+ ++ + + + + + + IH I HRD+KP
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 247 NLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQH 306
N+L+D+NG +KLSDFG S D + +
Sbjct: 182 NILMDKNGRVKLSDFGE------SEYMV---------------DKK----IKG------- 209
Query: 307 WQRNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYEMLVGYPPFYSDE-P 363
+ GT +++ PE + G + D WSLG +Y M PF
Sbjct: 210 -----------SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
Query: 364 MSTCRKIVNWRTHLKFPEEAK-----------------LSPEAKDLISKLLC-NVEQRLG 405
+ I ++++P + LS E D + L N +R+
Sbjct: 259 VELFNNIRT--KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI- 315
Query: 406 TKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVN 438
+++ H W + L + +
Sbjct: 316 --TSEDALKHEWLADTNIEDLREFSKELYKKRK 346
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 4e-74
Identities = 81/310 (26%), Positives = 143/310 (46%), Gaps = 54/310 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D+++ +GKGAF VR C K TG +A K + ++ R + ++ E + ++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV+L+ S Q++ + YL+ + + GG++ ++ ++ +E +A + + + +I H +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+HR++KP+NLLL + +KL+DFGL ++
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN------------------------- 159
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
E + GTP Y++PEVL K Y D W+ G I+Y +LV
Sbjct: 160 ------DSEAW-----------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
GYPPF+ ++ +I +P ++PEAK LI +L N ++R+ AD
Sbjct: 203 GYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TAD 257
Query: 411 EIKAHPWFKG 420
+ PW
Sbjct: 258 QALKVPWICN 267
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 5e-74
Identities = 78/332 (23%), Positives = 137/332 (41%), Gaps = 63/332 (18%)
Query: 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE 162
TE + Q + + L IG G +V + +YA+K + E ++
Sbjct: 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLD 71
Query: 163 HVKAERNLLAEVD--SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEAR 220
+ E L ++ S+ I++LY D+Y+Y++ME D+ + L +K ++ E +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 130
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
Y + A+ +IH+H +H D+KP N L+ +G +KL DFG+
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN--------------- 174
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL--------- 331
+Q D V + S VGT +Y+ PE +
Sbjct: 175 -----QMQPDTTSV-------------------VKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 332 --KKGYGMECDWWSLGAIMYEMLVGYPPFYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPE 388
K + D WSLG I+Y M G PF +S I++ ++FP+ +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKD 268
Query: 389 AKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+D++ L + +QR+ E+ AHP+ +
Sbjct: 269 LQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 297
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 9e-74
Identities = 90/326 (27%), Positives = 147/326 (45%), Gaps = 63/326 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD- 175
+++EP ++G+G VR C K T YA+K + + E + L EVD
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 176 ------SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
I++L +++ + + +L+ + + G++ L K TL+E+E R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
I ++HK N +HRD+KP+N+LLD + ++KL+DFG LD
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--------------------- 175
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL------LKKGYGMECDWWS 343
E+L GTP Y+APE++ GYG E D WS
Sbjct: 176 ----------PGEKL-----------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NV 400
G IMY +L G PPF+ + M R I+ + +F S KDL+S+ L
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQMLMLRMIM--SGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 401 EQRLGTKGADEIKAHPWFKGIEWDKL 426
++R A+E AHP+F+ +++
Sbjct: 273 QKRY---TAEEALAHPFFQQYVVEEV 295
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 6e-73
Identities = 84/376 (22%), Positives = 148/376 (39%), Gaps = 68/376 (18%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-- 175
+ L IG G +V + +YA+K + E ++ + E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
S+ I++LY D+Y+Y++ME D+ + L +K ++ E + Y + A+ +IH+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
H +H D+KP N L+ +G +KL DFG+ +Q D V
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIAN--------------------QMQPDTTSV- 164
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWSL 344
+ S VGT +Y+ PE + K + D WSL
Sbjct: 165 ------------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 345 GAIMYEMLVGYPPFYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQ 402
G I+Y M G PF +S I++ ++FP+ + +D++ L + +Q
Sbjct: 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQ 264
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDT----QNFEKFEEADNQIQT 458
R+ E+ AHP+ + I+ + Q+ E+ L + +A +
Sbjct: 265 RI---SIPELLAHPYVQ-IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 320
Query: 459 SAKSGPWRKMLSSKDI 474
G SSK
Sbjct: 321 HYSGGESHNSSSSKTF 336
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 6e-72
Identities = 69/306 (22%), Positives = 131/306 (42%), Gaps = 51/306 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + L IG+G+FG+ + + G Y +K++ S M + + E + E +LA +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKH 82
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIH 234
IV+ SF+++ LY++M+Y GGD+ + E++ + + LA++ +H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
+HRDIK N+ L ++G ++L DFG+ + L+
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-------------------------- 176
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
+ LA + +GTP Y++PE+ K Y + D W+LG ++YE+
Sbjct: 177 ---------------STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413
F + + KI++ + S + + L+S+L N R + I
Sbjct: 222 KHAFEAGSMKNLVLKIIS-GSFPPVSL--HYSYDLRSLVSQLFKRNPRDRP---SVNSIL 275
Query: 414 AHPWFK 419
+
Sbjct: 276 EKGFIA 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 7e-72
Identities = 84/310 (27%), Positives = 141/310 (45%), Gaps = 55/310 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + + M+GKG+FGEV C+++ T YA+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I+KL+ +D Y++ E GG++ ++++ +E +A + + I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
N +HRD+KP+N+LL +++ +K+ DFGL F + +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGL----------STCFQQNTKMKDR------- 183
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+GT YIAPEV L+ Y +CD WS G I+Y +L
Sbjct: 184 -------------------------IGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLS 217
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
G PPFY +++ F +S +AKDLI K+L + R+ A
Sbjct: 218 GTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TAT 272
Query: 411 EIKAHPWFKG 420
+ HPW +
Sbjct: 273 QCLEHPWIQK 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-71
Identities = 82/310 (26%), Positives = 144/310 (46%), Gaps = 54/310 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D+++ +GKGAF VR C K TG +A K + ++ R + ++ E + ++
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 87
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV+L+ S Q++ + YL+ + + GG++ ++ ++ +E +A + + + +I H +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+HR++KP+NLLL + +KL+DFGL ++
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN------------------------- 182
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
E + GTP Y++PEVL K Y D W+ G I+Y +LV
Sbjct: 183 ------DSEAW-----------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
GYPPF+ ++ +I +P ++PEAK LI +L N ++R+ T AD
Sbjct: 226 GYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI-T--AD 280
Query: 411 EIKAHPWFKG 420
+ PW
Sbjct: 281 QALKVPWICN 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 228 bits (585), Expect = 4e-71
Identities = 83/310 (26%), Positives = 142/310 (45%), Gaps = 57/310 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
F + ++G GAF EV + +++ TG ++A+K +KKS + ++ E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV L ++ + YL+M+ + GG++ ++ + TE++A + + + A++ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+HRD+KP+NLL + N + ++DFGL K +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST------------------- 166
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
GTP Y+APEVL +K Y D WS+G I Y +L
Sbjct: 167 ------------------------ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
GYPPFY + KI + +F +S AKD I LL + +R T +
Sbjct: 203 GYPPFYEETESKLFEKIK--EGYYEFESPFWDDISESAKDFICHLLEKDPNERY-T--CE 257
Query: 411 EIKAHPWFKG 420
+ +HPW G
Sbjct: 258 KALSHPWIDG 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-70
Identities = 77/304 (25%), Positives = 135/304 (44%), Gaps = 59/304 (19%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G GAFG+V + E+++G +K + K + +E ++AE +L +D I+K++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 185 SFQDDEYLYLIMEYLPGGD----MMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
F+D +Y++ME GG+ +++ R L+E + + + A+ H + +H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 241 RDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
+D+KP+N+L + +K+ DFGL + L F + + A
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGL------AEL----FKSDEHSTNA----------- 186
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
GT Y+APEV K+ +CD WS G +MY +L G P
Sbjct: 187 ---------------------AGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLP 224
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415
F +K + E L+P+A DL+ ++L + E+R A ++ H
Sbjct: 225 FTGTSLEEVQQKAT--YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHH 279
Query: 416 PWFK 419
WFK
Sbjct: 280 EWFK 283
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-70
Identities = 85/314 (27%), Positives = 140/314 (44%), Gaps = 57/314 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML---RRGQVEHVKAERNLLAE 173
D +E +G G F VR CR+K TG YA K +KK + R E ++ E N+L E
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+ I+ L+ F++ + LI+E + GG++ L K++LTE+EA ++ + + + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 234 HKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
H H D+KP+N++L N +KL DFG+ ++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--------------------- 163
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
+ + + GTP+++APE++ + G+E D WS+G I Y
Sbjct: 164 ----------AGNEFK-----------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEA--KLSPEAKDLISKLLC-NVEQRLGT 406
+L G PF + T I + F EE S AKD I +LL + ++R+
Sbjct: 203 ILLSGASPFLGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM-- 258
Query: 407 KGADEIKAHPWFKG 420
+ H W K
Sbjct: 259 -TIAQSLEHSWIKA 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-70
Identities = 100/412 (24%), Positives = 165/412 (40%), Gaps = 64/412 (15%)
Query: 23 KETAGHGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKL 82
H V E + + + + + + ++ + KKL
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKL 61
Query: 83 ADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATG 142
DA+ E E E K ++P +IG+G VR C +ATG
Sbjct: 62 NDAQPKGTENLYFQS--MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 143 HVYAMK-----KLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIM 196
H +A+K + S E + E ++L +V I+ L S++ +++L+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHM 256
+ + G++ L K L+E+E R + + A+ +H +N +HRD+KP+N+LLD N +
Sbjct: 180 DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI 239
Query: 257 KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAY 316
+LSDFG H + ++
Sbjct: 240 RLSDFGFSC----------------------------------------HLEPGEKL--R 257
Query: 317 STVGTPDYIAPEVL------LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKI 370
GTP Y+APE+L GYG E D W+ G I++ +L G PPF+ + R I
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317
Query: 371 VNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+ +F S KDLIS+LL + E RL T A++ HP+F+
Sbjct: 318 M--EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL-T--AEQALQHPFFE 364
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-70
Identities = 90/343 (26%), Positives = 149/343 (43%), Gaps = 64/343 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ---VEHVKAERNLLAE 173
D ++ +G G F V+ CREK+TG YA K +KK + + E ++ E ++L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
V + ++ L+ +++ + LI+E + GG++ L +K++L+EEEA ++ + + + +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 234 HKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
H H D+KP+N++L H+KL DFGL ++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------------------- 170
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
DG + GTP+++APE++ + G+E D WS+G I Y
Sbjct: 171 DGVEF---------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEA--KLSPEAKDLISKLLC-NVEQRLGT 406
+L G PF D T I F EE S AKD I KLL +RL
Sbjct: 210 ILLSGASPFLGDTKQETLANIT--SVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL-- 265
Query: 407 KGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKF 449
E HPW ++ + ++ +NF K
Sbjct: 266 -TIQEALRHPWITPVD-------NQQAMVRRESVVNLENFRKQ 300
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 5e-70
Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 57/302 (18%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+G++GEV++ +K T A KK+ K + V+ K E ++ +D I++LY
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
+F+D+ +YL+ME GG++ ++ K E +A + + + A+ HK N HRD+K
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 245 PDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
P+N L + +KL DFGL F G +
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGL----------AARFKPGKMMRTK--------------- 168
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361
VGTP Y++P+V L+ YG ECD WS G +MY +L GYPPF +
Sbjct: 169 -----------------VGTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLCGYPPFSAP 210
Query: 362 EPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
KI FPE+ +SP+A+ LI +LL + +QR+ + + H WF
Sbjct: 211 TDSEVMLKIR--EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWF 265
Query: 419 KG 420
+
Sbjct: 266 EK 267
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 6e-70
Identities = 81/316 (25%), Positives = 136/316 (43%), Gaps = 59/316 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ--VEHVKAERNLLAEV 174
D +E +IGKG F VR C + TG +A+K + ++ E +K E ++ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK----DTLTEEEARFYVGETVLAI 230
IV+L ++ D LY++ E++ G D+ ++++ +E A Y+ + + A+
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 231 ESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
H +N IHRD+KP +LL + + +KL FG+ L S L
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR---------- 193
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
VGTP ++APEV+ ++ YG D W G I
Sbjct: 194 -------------------------------VGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRL 404
++ +L G PFY + I+ + K + +S AKDL+ ++L + +R+
Sbjct: 223 LFILLSGCLPFYGTKER-LFEGII--KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI 279
Query: 405 GTKGADEIKAHPWFKG 420
T E HPW K
Sbjct: 280 -T--VYEALNHPWLKE 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-70
Identities = 83/376 (22%), Positives = 147/376 (39%), Gaps = 68/376 (18%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-- 175
+ L IG G +V + +YA+K + E ++ + E L ++
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 114
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
S+ I++LY D+Y+Y++ME D+ + L +K ++ E + Y + A+ +IH+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
H +H D+KP N L+ +G +KL DFG+ +Q D V
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIAN--------------------QMQPDTTSV- 211
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWSL 344
+ S VG +Y+ PE + K + D WSL
Sbjct: 212 ------------------VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 345 GAIMYEMLVGYPPFYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQ 402
G I+Y M G PF +S I++ ++FP+ + +D++ L + +Q
Sbjct: 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQ 311
Query: 403 RLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDT----QNFEKFEEADNQIQT 458
R+ E+ AHP+ + I+ + Q+ E+ L + +A +
Sbjct: 312 RI---SIPELLAHPYVQ-IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 367
Query: 459 SAKSGPWRKMLSSKDI 474
G SSK
Sbjct: 368 HYSGGESHNSSSSKTF 383
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 8e-70
Identities = 89/312 (28%), Positives = 147/312 (47%), Gaps = 54/312 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D ++ ++GKG+FGEV +C++K TG A+K + K ++ ++ E + E LL ++D
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I+KLY F+D Y YL+ E GG++ ++ + +E +A + + + I +HK+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+HRD+KP+NLLL ++ ++++ DFGL
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLST---------------------------- 177
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
H++ +++M +GT YIAPEV L Y +CD WS G I+Y +L
Sbjct: 178 ------------HFEASKKM--KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLS 222
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
G PPF +K+ + F K+S AKDLI K+L R+ A
Sbjct: 223 GCPPFNGANEYDILKKVE--KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI---SAR 277
Query: 411 EIKAHPWFKGIE 422
+ H W +
Sbjct: 278 DALDHEWIQTYT 289
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-69
Identities = 83/322 (25%), Positives = 145/322 (45%), Gaps = 59/322 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMK-----KLKKSEMLRRGQVEHVKAERNLL 171
D++ +G GA GEV++ E+ T A+K K +V+ E +L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
+++ CI+K+ F ++Y Y+++E + GG++ ++ L E + Y + +LA++
Sbjct: 70 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 232 SIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+H++ IHRD+KP+N+LL + + +K++DFG S + + S +
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH------SKILGE----TSLMRTL-- 176
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLG 345
GTP Y+APEVL GY D WSLG
Sbjct: 177 ------------------------------CGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 346 AIMYEMLVGYPPFYSDE-PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
I++ L GYPPF +S +I + + + A++S +A DL+ KLL + + R
Sbjct: 207 VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
Query: 404 LGTKGADEIKAHPWFKGIEWDK 425
+E HPW + + +
Sbjct: 267 F---TTEEALRHPWLQDEDMKR 285
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-69
Identities = 87/374 (23%), Positives = 143/374 (38%), Gaps = 87/374 (23%)
Query: 93 NNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK 152
++ + +E Y + + IG+G++G VRV E T + A+K + K
Sbjct: 2 HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61
Query: 153 SEMLRR--GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGD------- 203
+++ + VE +K E L+ ++ I +LY ++D++Y+ L+ME GG
Sbjct: 62 NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 204 ---------------------------------MMTLLMRKDTLTEEEARFYVGETVLAI 230
E+ + + A+
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 231 ESIHKHNYIHRDIKPDNLLL--DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+H HRDIKP+N L +++ +KL DFGL K N E
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG----------- 230
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGA 346
+ GTP ++APEVL + YG +CD WS G
Sbjct: 231 --------------------------MTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG 405
+++ +L+G PF T +++N + + P LSP A+DL+S LL NV++R
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF- 323
Query: 406 TKGADEIKAHPWFK 419
A HPW
Sbjct: 324 --DAMRALQHPWIS 335
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-69
Identities = 89/401 (22%), Positives = 170/401 (42%), Gaps = 64/401 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
++++ +GKGAF VR C + G YA + L + ++ E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKH 69
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV+L+ S ++ + YLI + + GG++ ++ ++ +E +A + + + A+ H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+HR++KP+NLLL + +KL+DFG L+ ++ + +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFG--------------------LAIEVEGEQQA 169
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+ GTP Y++PEVL K YG D W+ G I+Y +LV
Sbjct: 170 W---------------------FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
GYPPF+ ++ ++I FP ++PEAKDLI+K+L N +R+ A
Sbjct: 209 GYPPFWDEDQHRLYQQIK--AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI---TAA 263
Query: 411 EIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSG-PWRKML 469
E HPW ++ ++ + +KF A +++ + + +
Sbjct: 264 EALKHPWISH---------RSTVASCMHRQETVDCLKKF-NARRKLKGAILTVMLATRNF 313
Query: 470 SSKDINFVGYTYKNFEIVNDHQLPGIAELKKKSTKPKRPSI 510
S + + T + E +++ ++ P
Sbjct: 314 SVRKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEPEA 354
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 7e-69
Identities = 83/317 (26%), Positives = 142/317 (44%), Gaps = 59/317 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMK-----KLKKSEMLRRGQVEHVKAERNLL 171
D++ +G GA GEV++ E+ T A++ K +V+ E +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
+++ CI+K+ F D E Y+++E + GG++ ++ L E + Y + +LA++
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 232 SIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+H++ IHRD+KP+N+LL + + +K++DFG S + + S +
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH------SKILGE----TSLMRTL-- 301
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLG 345
GTP Y+APEVL GY D WSLG
Sbjct: 302 ------------------------------CGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 346 AIMYEMLVGYPPFYSDE-PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
I++ L GYPPF +S +I + + + A++S +A DL+ KLL + + R
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391
Query: 404 LGTKGADEIKAHPWFKG 420
+E HPW +
Sbjct: 392 F---TTEEALRHPWLQD 405
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 7e-69
Identities = 93/390 (23%), Positives = 167/390 (42%), Gaps = 62/390 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + + M+GKG+FGEV C+++ T YA+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I+KL+ +D Y++ E GG++ ++++ +E +A + + I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
N +HRD+KP+N+LL +++ +K+ DFGL F + +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLS----------TCFQQNTKMKDR------- 183
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+GT YIAPEV L+ Y +CD WS G I+Y +L
Sbjct: 184 -------------------------IGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLS 217
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
G PPFY +++ F +S +AKDLI K+L + R+ A
Sbjct: 218 GTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TAT 272
Query: 411 EIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLS 470
+ HPW + + + + + F +A+ ++ +A K+ +
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPSLESAMTNI--RQF----QAEKKLAQAALLYMASKLTT 326
Query: 471 SKDINFVGYTYKNFEIVNDHQLPGIAELKK 500
+ + ++ + ND L EL +
Sbjct: 327 LDETKQLTEIFRKLDTNNDGMLD-RDELVR 355
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 8e-69
Identities = 90/326 (27%), Positives = 145/326 (44%), Gaps = 57/326 (17%)
Query: 107 MRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML---RRGQVEH 163
M + + D ++ +G G F V+ CREK+TG YA K +KK + R E
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 164 VKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYV 223
++ E ++L +V I+ L+ +++ + LI+E + GG++ L +K++L+EEEA ++
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
+ + + +H H D+KP+N++L H+KL DFGL ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----------- 170
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 339
DG + GTP+++APE++ + G+E
Sbjct: 171 ----------DGVEF---------------------KNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEA--KLSPEAKDLISKLL 397
D WS+G I Y +L G PF D T I F EE + S AKD I KLL
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANIT--AVSYDFDEEFFSQTSELAKDFIRKLL 257
Query: 398 C-NVEQRLGTKGADEIKAHPWFKGIE 422
+RL E HPW ++
Sbjct: 258 VKETRKRL---TIQEALRHPWITPVD 280
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 9e-69
Identities = 74/304 (24%), Positives = 131/304 (43%), Gaps = 57/304 (18%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKLY 183
+G+G F VR C K+TG YA K LKK + + E +L S ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIHKHNYIHR 241
+++ + LI+EY GG++ +L + + ++E + + + + + +H++N +H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 242 DIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
D+KP N+LL G +K+ DFG+ + +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG------------------------------ 185
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
+L+ +GTP+Y+APE+L D W++G I Y +L PF
Sbjct: 186 -HACELR-----------EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233
Query: 359 YSDEPMSTCRKIVNWRTHLKFPEEA--KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415
++ T I + ++ + EE +S A D I LL N E+R A+ +H
Sbjct: 234 VGEDNQETYLNIS--QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSH 288
Query: 416 PWFK 419
W +
Sbjct: 289 SWLQ 292
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-68
Identities = 82/309 (26%), Positives = 131/309 (42%), Gaps = 64/309 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--NCIVKL 182
+G+G+F R C K + +A+K + K + + E L + N IVKL
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPN-IVKL 71
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
+ F D + +L+ME L GG++ + +K +E EA + + + V A+ +H +HRD
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 243 IKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
+KP+NLL + N +K+ DFG +
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLK------------------------------PP 161
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 359
+ L+ + T Y APE+L + GY CD WSLG I+Y ML G PF
Sbjct: 162 DNQPLK-----------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
Query: 360 S---DEPMSTCRKIVN--WRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGADE 411
S ++ +I+ + F E +S EAKDLI LL + +RL
Sbjct: 211 SHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL-K--MSG 267
Query: 412 IKAHPWFKG 420
++ + W +
Sbjct: 268 LRYNEWLQD 276
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-68
Identities = 81/314 (25%), Positives = 141/314 (44%), Gaps = 57/314 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ---VEHVKAERNLLAE 173
D ++ +G G F V+ CREK+TG YA K +KK + E ++ E ++L E
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+ ++ L+ +++ + LI+E + GG++ L K++LTEEEA ++ + + + +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 234 HKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
H H D+KP+N++L +K+ DFGL +D
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------------------- 169
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
+ + + GTP+++APE++ + G+E D WS+G I Y
Sbjct: 170 ----------FGNEFK-----------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEA--KLSPEAKDLISKLLC-NVEQRLGT 406
+L G PF D T + + +F +E S AKD I +LL + ++R+
Sbjct: 209 ILLSGASPFLGDTKQETLANVS--AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM-- 264
Query: 407 KGADEIKAHPWFKG 420
+ HPW K
Sbjct: 265 -TIQDSLQHPWIKP 277
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-67
Identities = 67/324 (20%), Positives = 112/324 (34%), Gaps = 81/324 (25%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
DF+ + +IG G FG+V + + G Y +K++K + E + E LA++D
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62
Query: 176 SNCIVKLYCSFQDDE----------------YLYLIMEYLPGGDMMTLL--MRKDTLTEE 217
IV + + L++ ME+ G + + R + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 218 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
A + ++ IH I+RD+KP N+ L +K+ DFGL L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---------- 172
Query: 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337
+ GT Y++PE + + YG
Sbjct: 173 --------------------------------KNDGKRTRSKGTLRYMSPEQISSQDYGK 200
Query: 338 ECDWWSLGAIMYEML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKL 396
E D ++LG I+ E+L V F + + + R + + K L+ KL
Sbjct: 201 EVDLYALGLILAELLHVCDTAFETSKFFTDLRDG-------IISD--IFDKKEKTLLQKL 251
Query: 397 LC-NVEQRLGTKGADEIKAHPWFK 419
L E R EI
Sbjct: 252 LSKKPEDRP---NTSEILRTLTVW 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 9e-67
Identities = 81/315 (25%), Positives = 137/315 (43%), Gaps = 60/315 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+D+E L IG G++G + R K+ G + K+L M + + + +E NLL E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 177 NCIVKLYCSFQD--DEYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAI 230
IV+ Y D + LY++MEY GGD+ +++ + + L EE + + LA+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 231 ESIHKHNY-----IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ H+ + +HRD+KP N+ LD ++KL DFGL + L+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------------- 167
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
+ A + VGTP Y++PE + + Y + D WSLG
Sbjct: 168 ------------------------HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404
++YE+ PPF + KI + P + S E ++I+++L R
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPY--RYSDELNEIITRMLNLKDYHRP 260
Query: 405 GTKGADEIKAHPWFK 419
+EI +P
Sbjct: 261 ---SVEEILENPLIL 272
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 9e-67
Identities = 91/336 (27%), Positives = 153/336 (45%), Gaps = 57/336 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ ++ + +G GA+GEV +CR+K T A+K ++K+ + + E +L +D
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDH 95
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I+KLY F+D YL+ME GG++ ++ + E +A + + + + +HKH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
N +HRD+KP+NLLL +++ +K+ DFGL F +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLS----------AVFENQKKMKER------- 198
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+GT YIAPEV L+K Y +CD WS+G I++ +L
Sbjct: 199 -------------------------LGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLA 232
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
GYPPF RK+ + F +S AKDLI ++L + ++R+ A
Sbjct: 233 GYPPFGGQTDQEILRKVE--KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI---SAQ 287
Query: 411 EIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNF 446
+ HPW K + K I+ + + + + F
Sbjct: 288 QALEHPWIKEMCSKKESGIELPSLANAIENM--RKF 321
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-66
Identities = 94/320 (29%), Positives = 142/320 (44%), Gaps = 64/320 (20%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM----------LRRGQVEHVKA 166
+ + + +G GA+GEV +C+EK A+K +KKS+ E +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 167 ERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGET 226
E +LL +D I+KL+ F+D +Y YL+ E+ GG++ ++ + E +A + +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 227 VLAIESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ I +HKHN +HRDIKP+N+LL + ++K+ DFGL FS L
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS----------SFFSKDYKL 205
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343
+GT YIAPEV LKK Y +CD WS
Sbjct: 206 RDR--------------------------------LGTAYYIAPEV-LKKKYNEKCDVWS 232
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NV 400
G IMY +L GYPPF +K+ + F +S EAK+LI +L +
Sbjct: 233 CGVIMYILLCGYPPFGGQNDQDIIKKVE--KGKYYFDFNDWKNISDEAKELIKLMLTYDY 290
Query: 401 EQRLGTKGADEIKAHPWFKG 420
+R A+E W K
Sbjct: 291 NKRC---TAEEALNSRWIKK 307
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-66
Identities = 84/303 (27%), Positives = 138/303 (45%), Gaps = 59/303 (19%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G+GA V C++K T YA+K LKK+ + V+ E +L + I+KL
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
F+ + L++E + GG++ ++ K +E +A V + + A+ +H++ +HRD+K
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 245 PDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
P+NLL + +K++DFGL K ++ Q
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVE-------------------------------HQ 204
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361
+ + GTP Y APE+L YG E D WS+G I Y +L G+ PFY +
Sbjct: 205 VLM-----------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253
Query: 362 -EPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417
R+I+ F ++S AKDL+ KL+ + ++RL T + HPW
Sbjct: 254 RGDQFMFRRIL--NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL-T--TFQALQHPW 308
Query: 418 FKG 420
G
Sbjct: 309 VTG 311
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-66
Identities = 86/362 (23%), Positives = 159/362 (43%), Gaps = 58/362 (16%)
Query: 65 MKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTM 124
M+ + + K ++++ ++ + + KK + D ++ L
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDK--FYEDIWKKYVPQPVEVKQGSVYDYYDILEE 58
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G GAFG V C EKATG V+ K + VK E +++ ++ ++ L+
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDI 243
+F+D + LI+E+L GG++ + +D ++E E Y+ + ++ +H+H+ +H DI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 244 KPDNLLL--DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQ 301
KP+N++ + +K+ DFGL L+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLN-------------------------------PD 204
Query: 302 EQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361
E ++ T T ++ APE++ ++ G D W++G + Y +L G PF +
Sbjct: 205 EIVK-----------VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253
Query: 362 EPMSTCRKIVNWRTHLKFPEEA--KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
+ + T + + R +F E+A +SPEAKD I LL +RL + HPW
Sbjct: 254 DDLETLQNVK--RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWL 308
Query: 419 KG 420
KG
Sbjct: 309 KG 310
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-66
Identities = 77/310 (24%), Positives = 123/310 (39%), Gaps = 57/310 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + +G+G FG V C E ++ Y K +K + VK E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMM-TLLMRKDTLTEEEARFYVGETVLAIESIHK 235
I+ L+ SF+ E L +I E++ G D+ + L E E YV + A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 236 HNYIHRDIKPDNLLL--DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
HN H DI+P+N++ R+ +K+ +FG + L
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------------------------- 155
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+ + P+Y APEV D WSLG ++Y +L
Sbjct: 156 ------PGDNFR-----------LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEA--KLSPEAKDLISKLLC-NVEQRLGTKGAD 410
G PF ++ I+ F EEA ++S EA D + +LL + R+ A
Sbjct: 199 GINPFLAETNQQIIENIM--NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TAS 253
Query: 411 EIKAHPWFKG 420
E HPW K
Sbjct: 254 EALQHPWLKQ 263
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 4e-66
Identities = 73/323 (22%), Positives = 129/323 (39%), Gaps = 57/323 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DFEP+ +G+G FG V + K YA+K+++ E V E LA+++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 177 NCIVKLYCSFQDDE------------YLYLIMEYLPGGDMMTLLMRKDTLTEEEARF--- 221
IV+ + ++ + YLY+ M+ ++ + + T+ E E
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 222 YVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
+ A+E +H +HRD+KP N+ + +K+ DFGL +D
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD------------- 169
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341
+ ++EQ VGT Y++PE + Y + D
Sbjct: 170 ----------------QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213
Query: 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLC-N 399
+SLG I++E+L YP E + T + N LKFP + P ++ +L +
Sbjct: 214 FSLGLILFELL--YPFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPS 267
Query: 400 VEQRLGTKGADEIKAHPWFKGIE 422
+R A I + F+ ++
Sbjct: 268 PMERP---EAINIIENAVFEDLD 287
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 5e-66
Identities = 80/314 (25%), Positives = 128/314 (40%), Gaps = 62/314 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D +E IG G++ + C KAT +A+K + KS+ ++E LL
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------LLRYGQH 75
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I+ L + D +Y+Y++ E + GG+++ ++R+ +E EA + +E +H
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 237 NYIHRDIKPDNLLL----DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+HRD+KP N+L +++ DFG K L N
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--------------- 180
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
T +++APEVL ++GY CD WSLG ++Y ML
Sbjct: 181 --------------------------CYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
Query: 353 VGYPPFYSDEPMSTC---RKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGT 406
GY PF + + +I +S AKDL+SK+L + QRL
Sbjct: 215 TGYTPFANGPDDTPEEILARIG--SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL-- 270
Query: 407 KGADEIKAHPWFKG 420
A + HPW
Sbjct: 271 -TAALVLRHPWIVH 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 7e-66
Identities = 86/311 (27%), Positives = 132/311 (42%), Gaps = 67/311 (21%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY 183
++G G G+V C + TG A+K L S R+ +V+H IV +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-EVDH------HWQASGGPHIVCIL 88
Query: 184 CSFQD----DEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHN 237
+++ L +IME + GG++ + + + TE EA + + AI+ +H HN
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148
Query: 238 YIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
HRD+KP+NLL +++ +KL+DFG K + LQ
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ--------------------- 187
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
+ TP Y+APEVL + Y CD WSLG IMY +L G
Sbjct: 188 ----------------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
Query: 355 YPPFYSDEPMSTCRKIVN--WRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGA 409
+PPFYS+ + + FP +++S +AK LI LL + +RL
Sbjct: 226 FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL---TI 282
Query: 410 DEIKAHPWFKG 420
+ HPW
Sbjct: 283 TQFMNHPWINQ 293
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 8e-66
Identities = 83/360 (23%), Positives = 147/360 (40%), Gaps = 58/360 (16%)
Query: 69 EERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMG--ADDFEPLTMIG 126
+R+ ++ E+ N + + Y + K D ++ +G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 127 KGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF 186
GAFG V E+ATG+ +A K + E V+ E ++ + +V L+ +F
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 187 QDDEYLYLIMEYLPGGDMM-TLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKP 245
+DD + +I E++ GG++ + + ++E+EA Y+ + + +H++NY+H D+KP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 246 DNLLL--DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQ 303
+N++ R+ +KL DFGL LD ++
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLD-------------------------------PKQS 312
Query: 304 LQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEP 363
++ T GT ++ APEV K G D WS+G + Y +L G PF +
Sbjct: 313 VKV-----------TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 364 MSTCRKIVNWRTHLKFPEEA--KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
T R + + A +S + KD I KLL + R+ + HPW
Sbjct: 362 DETLRNVK--SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTP 416
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 8e-66
Identities = 87/390 (22%), Positives = 155/390 (39%), Gaps = 57/390 (14%)
Query: 38 SEEVPSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLK 97
S V + K + + +E ++ E+ ++ + ++
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 98 YLEKKETEYMRLQRHKMGAD-DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML 156
+ + ++ + + ++G G FG+V C E ATG A K +K M
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK 128
Query: 157 RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLT 215
+ E VK E +++ ++D +++LY +F+ + L+MEY+ GG++ ++ + LT
Sbjct: 129 DK---EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 216 EEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR--NGHMKLSDFGLCKPLDCSNLQ 273
E + ++ + I +H+ +H D+KP+N+L +K+ DFGL +
Sbjct: 186 ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK----- 240
Query: 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333
+E+L+ GTP+++APEV+
Sbjct: 241 --------------------------PREKLK-----------VNFGTPEFLAPEVVNYD 263
Query: 334 GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEA--KLSPEAKD 391
D WS+G I Y +L G PF D T I+ +E +S EAK+
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL--ACRWDLEDEEFQDISEEAKE 321
Query: 392 LISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
ISKLL R+ A E HPW
Sbjct: 322 FISKLLIKEKSWRI---SASEALKHPWLSD 348
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 9e-66
Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 65/322 (20%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKL 182
++G+GA V+ C T YA+K ++K R V E +L + +++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLEL 76
Query: 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRD 242
F++++ YL+ E + GG +++ + ++ E EA V + A++ +H HRD
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 243 IKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
+KP+N+L ++ +K+ DF L + +P T
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIK---------------------LNGDCSPIST 175
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYEMLVG 354
+ + G+ +Y+APEV+ Y CD WSLG I+Y +L G
Sbjct: 176 PE-------------LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
Query: 355 YPPFYSDEPMSTCRKIVNWRT-------------HLKFPEE--AKLSPEAKDLISKLLC- 398
YPPF +FP++ A +S AKDLISKLL
Sbjct: 223 YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVR 282
Query: 399 NVEQRLGTKGADEIKAHPWFKG 420
+ +QRL A ++ HPW +G
Sbjct: 283 DAKQRL---SAAQVLQHPWVQG 301
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 4e-65
Identities = 91/324 (28%), Positives = 142/324 (43%), Gaps = 76/324 (23%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC------ 178
IGKG++G V++ + YAMK L K +++R+ R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 179 -----------------IVKLYCSFQD--DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEA 219
+VKL D +++LY++ E + G +M + L+E++A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQA 139
Query: 220 RFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
RFY + + IE +H IHRDIKP NLL+ +GH+K++DFG+ SN +
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV------SNEFKG---- 189
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL--LKKGY-G 336
SD L +TVGTP ++APE L +K + G
Sbjct: 190 ---------SDA----------------------LLSNTVGTPAFMAPESLSETRKIFSG 218
Query: 337 MECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKL 396
D W++G +Y + G PF + M KI L+FP++ ++ + KDLI+++
Sbjct: 219 KALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK--SQALEFPDQPDIAEDLKDLITRM 276
Query: 397 LC-NVEQRLGTKGADEIKAHPWFK 419
L N E R+ EIK HPW
Sbjct: 277 LDKNPESRIVV---PEIKLHPWVT 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-64
Identities = 70/349 (20%), Positives = 119/349 (34%), Gaps = 90/349 (25%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
+ ++G+GA V R K TG ++A+K LR V+ E +L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLK 62
Query: 173 EVDSNCIVKLYCSFQDD--EYLYLIMEYLPGGDMMTLLMRKDT---LTEEEARFYVGETV 227
+++ IVKL+ ++ + LIME+ P G + T+L L E E + + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 228 LAIESIHKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ + ++ +HR+IKP N++ D KL+DFG + L+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------------ 170
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL--------LKKGY 335
S GT +Y+ P++ +K Y
Sbjct: 171 ------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 336 GMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVN---------------------WR 374
G D WS+G Y G PF E ++++
Sbjct: 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260
Query: 375 THLKFPEEAKLSPEAKDLISKLL-----CNVEQRLGTKGADEIKAHPWF 418
P LS + L++ +L + E+ G D+ A
Sbjct: 261 WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETSD 306
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 8e-64
Identities = 37/344 (10%), Positives = 93/344 (27%), Gaps = 101/344 (29%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAER--------------- 168
++G+ ++ TG + + +E ++ +K E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 169 ----------NLLAEVDSNCIVKLYCSFQDDEYL--YLIME------YLPGGDMMTLLMR 210
+L+ + ++++ +D L + + G +++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 211 KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270
+L + + + S+H + +H ++P +++LD+ G + L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 257
Query: 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330
+ + + PE+
Sbjct: 258 -------------------------------------------ARVVSSVSRGFEPPELE 274
Query: 331 L-----------KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKF 379
+ D W+LG ++Y + P D + I F
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--------F 326
Query: 380 PEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422
+ + L+ L E RL + P ++ +
Sbjct: 327 RSCKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLR 367
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 8e-64
Identities = 91/315 (28%), Positives = 125/315 (39%), Gaps = 76/315 (24%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC--IVKL 182
+G G G+V K T +A+K L+ RR E L S C IV++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA-SQCPHIVRI 120
Query: 183 YCSFQD----DEYLYLIMEYLPGGDMMTLLMR-----KDTLTEEEARFYVGETVLAIESI 233
+++ + L ++ME L GG+ L R TE EA + AI+ +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 234 HKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
H N HRD+KP+NLL N +KL+DFG
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------------- 210
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
A T L + TP Y+APEVL + Y CD WSLG IMY
Sbjct: 211 ----AKETTSHNSLT-----------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255
Query: 351 MLVGYPPFYSDEPMSTCRKIVN--WRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLG 405
+L GYPPFYS+ ++ + +FP +++S E K LI LL QR+
Sbjct: 256 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM- 314
Query: 406 TKGADEIKAHPWFKG 420
E HPW
Sbjct: 315 --TITEFMNHPWIMQ 327
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-63
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 49/298 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G+GA+GEV++ + T A+K + + E++K E + ++ +VK Y
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYG 72
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
++ YL +EY GG++ + + E +A+ + + + + +H HRDIK
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P+NLLLD ++K+SDFGL + + +
Sbjct: 133 PENLLLDERDNLKISDFGL-----------------ATVFRYNNRER------------- 162
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYPPFY-SDE 362
L GT Y+APE+L ++ + D WS G ++ ML G P+ +
Sbjct: 163 ---------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
K+ L+ K+L N R+ +IK W+
Sbjct: 214 SCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARITI---PDIKKDRWYN 266
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-63
Identities = 80/315 (25%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE---HVKAERNLLAE 173
++ ++GKG FG V A+K + ++ +L + E LL +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 174 VDSNC----IVKLYCSFQDDEYLYLIMEY-LPGGDMMTLLMRKDTLTEEEARFYVGETVL 228
V + +++L F+ E L++E LP D+ + K L E +R + G+ V
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 229 AIESIHKHNYIHRDIKPDNLLLD-RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
AI+ H +HRDIK +N+L+D R G KL DFG GAL
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS---------------------GAL 189
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLLKKGY-GMECDWWSLG 345
D Y+ GT Y PE + + Y + WSLG
Sbjct: 190 LHDE-----------------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLG 226
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404
++Y+M+ G PF D ++I+ L FP +SP+ LI + L R
Sbjct: 227 ILLYDMVCGDIPFERD------QEILEAE--LHFPA--HVSPDCCALIRRCLAPKPSSRP 276
Query: 405 GTKGADEIKAHPWFK 419
+EI PW +
Sbjct: 277 SL---EEILLDPWMQ 288
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 6e-63
Identities = 81/297 (27%), Positives = 133/297 (44%), Gaps = 51/297 (17%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FG+V++ + TGH A+K L + ++ V +K E L I+KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
+++MEY+ GG++ + + + E EAR + + A++ H+H +HRD+K
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P+N+LLD + + K++DFGL + SDG
Sbjct: 139 PENVLLDAHMNAKIADFGLS---------------------NMMSDGE------------ 165
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYPPFYSDEP 363
++ G+P+Y APEV+ + Y G E D WS G I+Y +L G PF +
Sbjct: 166 ---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216
Query: 364 MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+ +KI PE L+ L+ +L + +R +I+ H WFK
Sbjct: 217 PTLFKKIR--GGVFYIPEY--LNRSVATLLMHMLQVDPLKRATI---KDIREHEWFK 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 86/406 (21%), Positives = 144/406 (35%), Gaps = 93/406 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ ++G G+ G V V + G A+K++ + E LL E D
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67
Query: 177 -NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-------TLTEEEARFYVGETVL 228
+++ YCS D +LY+ +E ++ L+ K+ E + +
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 229 AIESIHKHNYIHRDIKPDNLLLD-------------RNGHMKLSDFGLCKPLDCSNLQEK 275
+ +H IHRD+KP N+L+ N + +SDFGLCK LD
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD-----SG 181
Query: 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---- 331
S +NL+ GT + APE+L
Sbjct: 182 QSSFRTNLNNP--------------------------------SGTSGWRAPELLEESNN 209
Query: 332 ---KKGYGMECDWWSLGAIMYEMLV-GYPPFYSD-EPMSTCRKIVNWRTHLKFPEEAKLS 386
K+ D +S+G + Y +L G PF S + + +K + L
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLI 269
Query: 387 PEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQN 445
EA DLIS+++ + +R A ++ HP F W K K F+ +V+D L+ +N
Sbjct: 270 AEATDLISQMIDHDPLKRP---TAMKVLRHPLF----WPK--SKKLEFLLKVSDRLEIEN 320
Query: 446 FEKFEEADNQIQTSAK----SGPWRKMLSSKDI----NFVGYTYKN 483
+ + + SG W + + Y
Sbjct: 321 RDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSK 366
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-62
Identities = 63/330 (19%), Positives = 115/330 (34%), Gaps = 53/330 (16%)
Query: 102 KETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQV 161
+E Y + + + + +G+G F V + GH YA+K++ E
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDR 70
Query: 162 EHVKAERNLLAEVDSNCIVKLYCSFQDDE----YLYLIMEYLPGGD----MMTLLMRKDT 213
E + E ++ + I++L + +L++ + G + L + +
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 214 LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273
LTE++ + + +E+IH Y HRD+KP N+LL G L D G
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA------ 184
Query: 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333
Q LQ W + T Y APE+ +
Sbjct: 185 ------------------CIHVEGSRQALTLQDW--------AAQRCTISYRAPELFSVQ 218
Query: 334 GY---GMECDWWSLGAIMYEMLVGYPPF-YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEA 389
+ D WSLG ++Y M+ G P+ + + V L P+ + S
Sbjct: 219 SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--NQLSIPQSPRHSSAL 276
Query: 390 KDLISKLLC-NVEQRLGTKGADEIKAHPWF 418
L++ ++ + QR + +
Sbjct: 277 WQLLNSMMTVDPHQRP---HIPLLLSQLEA 303
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-62
Identities = 75/310 (24%), Positives = 123/310 (39%), Gaps = 57/310 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+F IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL----MRKDTLTEEEARFYVGETVLAIES 232
++K Y SF +D L +++E GD+ ++ +K + E Y + A+E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+H +HRDIKP N+ + G +KL D GL +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 190
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 191 --------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 353 VGYPPFYSD--EPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTK 407
PFY D S C+KI +P S E + L++ + + E+R
Sbjct: 231 ALQSPFYGDKMNLYSLCKKIEQ----CDYPPLPSDHYSEELRQLVNMCINPDPEKRP--- 283
Query: 408 GADEIKAHPW 417
+
Sbjct: 284 DVTYVYDVAK 293
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-62
Identities = 92/355 (25%), Positives = 140/355 (39%), Gaps = 57/355 (16%)
Query: 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
H ++ + IG G FG R+ R+K T + A+K +++ + E+V+ E
Sbjct: 17 HDSD--RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINH 70
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
+ IV+ +L +IMEY GG++ + +E+EARF+ + + +
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHM--KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
H HRD+K +N LLD + K+ DFG S
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY------SKSSVLH------------- 171
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 348
Q + STVGTP YIAPEVLL++ Y G D WS G +
Sbjct: 172 ------------SQPK-----------STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
Query: 349 YEMLVGYPPFYSDEPMSTCRKIVNW--RTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG 405
Y MLVG PF E RK + P++ ++SPE LIS++ + R+
Sbjct: 209 YVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRIS 268
Query: 406 TKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSA 460
EIK H WF L E Q+ + + ++ A
Sbjct: 269 IP---EIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPA 320
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 8e-62
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 49/298 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G+GA+GEV++ + T A+K + + E++K E + ++ +VK Y
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYG 72
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
++ YL +EY GG++ + + E +A+ + + + + +H HRDIK
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P+NLLLD ++K+SDFGL + + +
Sbjct: 133 PENLLLDERDNLKISDFGL-----------------ATVFRYNNRER------------- 162
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYPPFY-SDE 362
L GT Y+APE+L ++ + D WS G ++ ML G P+ +
Sbjct: 163 ---------LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213
Query: 363 PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
K+ L+ K+L N R+ +IK W+
Sbjct: 214 SCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARITI---PDIKKDRWYN 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-61
Identities = 72/310 (23%), Positives = 123/310 (39%), Gaps = 63/310 (20%)
Query: 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMK-----KLKKSEMLRRGQVEHVKAERNLLA 172
+ ++ +G GAFG V +K +K K+ + + ++ V E +L+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIME-YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
V+ I+K+ F++ + L+ME + G D+ + R L E A + + V A+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
+ + IHRDIK +N+++ + +KL DFG + E+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS------AAYLERG--------------- 183
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYE 350
L Y+ GT +Y APEVL+ Y G E + WSLG +Y
Sbjct: 184 ---------------------KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222
Query: 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA 409
++ PF + V + P +S E L+S LL E+R
Sbjct: 223 LVFEENPFCEL------EETV--EAAIHPPY--LVSKELMSLVSGLLQPVPERRTTL--- 269
Query: 410 DEIKAHPWFK 419
+++ PW
Sbjct: 270 EKLVTDPWVT 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-61
Identities = 78/394 (19%), Positives = 138/394 (35%), Gaps = 85/394 (21%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
+G F P ++G GA G + V R A+K++ E LL
Sbjct: 20 IVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPE------CFSFADREVQLLR 72
Query: 173 EVDS--NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLA 229
E D N +++ +C+ +D ++ Y+ +E + + +KD E + +T
Sbjct: 73 ESDEHPN-VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGH-----MKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+ +H N +HRD+KP N+L+ +SDFGLCK L
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA---------------- 174
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDW 341
+ GT +IAPE+L K+ D
Sbjct: 175 --------------VGRHSFSRR--------SGVPGTEGWIAPEMLSEDCKENPTYTVDI 212
Query: 342 WSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLLC- 398
+S G + Y ++ G PF I+ L E A++LI K++
Sbjct: 213 FSAGCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAM 270
Query: 399 NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDEL-----DTQNFEKFEEAD 453
+ ++R A + HP+F +E + F +V+D + D ++ E
Sbjct: 271 DPQKRP---SAKHVLKHPFFWSLE------KQLQFFQDVSDRIEKESLDGPIVKQLERGG 321
Query: 454 NQIQTSAKSGPWRKMLSSKDINFVG----YTYKN 483
+ WR+ ++ + Y +
Sbjct: 322 RAVVK----MDWRENITVPLQTDLRKFRTYKGGS 351
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 3e-61
Identities = 79/314 (25%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEH---VKAERNLLAE 173
++ ++G G FG V + A+K ++K + G++ + V E LL +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 174 VDSNC--IVKLYCSFQDDEYLYLIMEY-LPGGDMMTLLMRKDTLTEEEARFYVGETVLAI 230
V S +++L F+ + LI+E P D+ + + L EE AR + + + A+
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 231 ESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
H +HRDIK +N+L+D N G +KL DFG GAL
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS---------------------GALLK 201
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLLKKGY-GMECDWWSLGAI 347
D Y+ GT Y PE + Y G WSLG +
Sbjct: 202 DT-----------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 238
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406
+Y+M+ G PF D +I+ + + F + ++S E + LI L R
Sbjct: 239 LYDMVCGDIPFEHD------EEIIRGQ--VFFRQ--RVSSECQHLIRWCLALRPSDRPTF 288
Query: 407 KGADEIKAHPWFKG 420
+EI+ HPW +
Sbjct: 289 ---EEIQNHPWMQD 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-60
Identities = 72/344 (20%), Positives = 121/344 (35%), Gaps = 90/344 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ ++G+GA V R K TG ++A+K LR V+ E +L +++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 177 NCIVKLYCSFQDD--EYLYLIMEYLPGGDMMTLLMRKDT---LTEEEARFYVGETVLAIE 231
IVKL+ ++ + LIME+ P G + T+L L E E + + V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 232 SIHKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+ ++ +HR+IKP N++ D KL+DFG + L+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------------------- 167
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL--------LKKGYGMEC 339
EQ S GT +Y+ P++ +K YG
Sbjct: 168 ------------DDEQFV-----------SLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVN---------------------WRTHLK 378
D WS+G Y G PF E ++++
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
Query: 379 FPEEAKLSPEAKDLISKLL-----CNVEQRLGTKGADEIKAHPW 417
P LS + L++ +L + E+ G D+ A
Sbjct: 265 MPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETS 305
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-60
Identities = 88/337 (26%), Positives = 155/337 (45%), Gaps = 52/337 (15%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G+G+FG+V++ T A+K + + + + V+ E + L + I+KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
+ +++EY GG++ ++ K +TE+E R + + + AIE H+H +HRD+K
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P+NLLLD N ++K++DFGL + +DG
Sbjct: 136 PENLLLDDNLNVKIADFGLS---------------------NIMTDGN------------ 162
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYPPFYSDEP 363
++ G+P+Y APEV+ K Y G E D WS G ++Y MLVG PF +
Sbjct: 163 ---------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213
Query: 364 MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422
+ +K+ P+ LSP A+ LI +++ + QR+ EI+ PWF
Sbjct: 214 PNLFKKVN--SCVYVMPDF--LSPGAQSLIRRMIVADPMQRITI---QEIRRDPWFNVNL 266
Query: 423 WDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTS 459
D L ++ + + ++ E +++ I +
Sbjct: 267 PDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEA 303
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 5e-60
Identities = 85/337 (25%), Positives = 148/337 (43%), Gaps = 52/337 (15%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IGKG F +V++ R TG A+K + K++ L ++ + E ++ ++ IVKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
+ ++ LYLIMEY GG++ L+ + E+EAR + V A++ H+ +HRD+K
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
+NLLLD + ++K++DFG SN F++G L
Sbjct: 142 AENLLLDADMNIKIADFGF------SNE----FTVGGKLD-------------------- 171
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYPPFYSDEP 363
+ G P Y APE+ K Y G E D WSLG I+Y ++ G PF
Sbjct: 172 ------------AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219
Query: 364 MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422
+++ K+ +S + ++L+ + L N +R ++I W
Sbjct: 220 KELRERVLR----GKYRIPFYMSTDCENLLKRFLVLNPIKRGTL---EQIMKDRWINAGH 272
Query: 423 WDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTS 459
+ + +++D+ + +IQ S
Sbjct: 273 EEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQES 309
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 5e-59
Identities = 87/342 (25%), Positives = 155/342 (45%), Gaps = 52/342 (15%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
+G G FG+V+V + + TGH A+K L + ++ V ++ E L I+KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIK 244
++++MEY+ GG++ + + L E+E+R + + ++ H+H +HRD+K
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 245 PDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQL 304
P+N+LLD + + K++DFGL + SDG
Sbjct: 144 PENVLLDAHMNAKIADFGLS---------------------NMMSDGE------------ 170
Query: 305 QHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYPPFYSDEP 363
++ G+P+Y APEV+ + Y G E D WS G I+Y +L G PF D
Sbjct: 171 ---------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221
Query: 364 MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF-KGI 421
+ +KI P+ L+P L+ +L + +R K +I+ H WF + +
Sbjct: 222 PTLFKKIC--DGIFYTPQY--LNPSVISLLKHMLQVDPMKRATIK---DIREHEWFKQDL 274
Query: 422 EWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSG 463
+ + ++DE + EKFE ++ ++ + +
Sbjct: 275 PKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNR 316
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-59
Identities = 42/340 (12%), Positives = 91/340 (26%), Gaps = 90/340 (26%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE---------- 173
++G+ ++ TG + + +E ++ +K E L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 174 ------------VDSNCIVKLYCSFQDDEYLYLIMEYL----PGGDMMTLL------MRK 211
V K+ D+ ++++ + ++ T
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 212 DTLTEEEARFYVG-ETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270
AR + + + + S+H + +H ++P +++LD+ G + L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR---- 260
Query: 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330
DG P+ A +L
Sbjct: 261 -------------------DGASAVSPIG-----------------RGFAPPETTAERML 284
Query: 331 L-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKL 385
D W+LG +Y + P D + I F +
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--------FRSCKNI 336
Query: 386 SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424
+ L+ L E RL + P ++ + +
Sbjct: 337 PQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLRTE 373
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 7e-58
Identities = 78/345 (22%), Positives = 125/345 (36%), Gaps = 56/345 (16%)
Query: 86 EVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVY 145
E + E L + L+ + EY + +G+G+FGEV ++K TG
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEY------REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 146 AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMM 205
A+KK++ E A + S IV LY + ++ ++ + ME L GG +
Sbjct: 87 AVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 206 TLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLC 264
L+ + L E+ A +Y+G+ + +E +H +H D+K DN+LL +G L DFG
Sbjct: 139 QLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDY 324
L L + GT +
Sbjct: 199 LCLQPDGLG------------------------------------KSLLTGDYIPGTETH 222
Query: 325 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAK 384
+APEV++ K + D WS +M ML G P+ C KI +
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPIREIPPS 281
Query: 385 LSPEAKDLISK-LLCNVEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428
+P I + L R A E++ E L
Sbjct: 282 CAPLTAQAIQEGLRKEPVHR---ASAMELRRKVGKALQEVGGLKS 323
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-57
Identities = 70/327 (21%), Positives = 126/327 (38%), Gaps = 55/327 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE-HVKAERNLLAEVDSNCIVKLY 183
+G+G++G+V+ + T A+K LKK ++ R E +VK E LL + +++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 184 --CSFQDDEYLYLIMEYLPGG--DMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYI 239
++ + +Y++MEY G +M+ + K +A Y + + +E +H +
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRT 299
H+DIKP NLLL G +K+S G+ + +D
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGV-----------------AEALHPFAADD-------- 166
Query: 300 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGY-GMECDWWSLGAIMYEMLVGYPP 357
++ G+P + PE+ + G + D WS G +Y + G P
Sbjct: 167 --------------TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416
F D I + P + P DL+ +L +R +I+ H
Sbjct: 213 FEGDNIYKLFENIG--KGSYAIPGD--CGPPLSDLLKGMLEYEPAKRFSI---RQIRQHS 265
Query: 417 WFKGIEWDKLYQIKAAFIPEVNDELDT 443
WF+ + P+ D +
Sbjct: 266 WFRKKHPPAEAPVPIPPSPDTKDRWRS 292
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-57
Identities = 53/314 (16%), Positives = 107/314 (34%), Gaps = 49/314 (15%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
+F L IG G FG V C ++ G +YA+K+ KK + ++
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL----MRKDTLTEEEARFYVGETVLAIE 231
+ +V+ + ++ +D+++ + EY GG + + E E + + + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP-LDCSNLQEK--DFSIGSNLSGALQ 288
IH + +H DIKP N+ + R + + + + K D + +S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--- 186
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 347
G ++A EVL + + D ++L
Sbjct: 187 --------------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALT 220
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLLC-NVEQRLG 405
+ P + + +I + P LS E +L+ ++ + E+R
Sbjct: 221 VVCAAGAEPLPRNGDQW---HEIRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERR-- 271
Query: 406 TKGADEIKAHPWFK 419
A + H
Sbjct: 272 -PSAMALVKHSVLL 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 192 bits (488), Expect = 3e-56
Identities = 42/340 (12%), Positives = 78/340 (22%), Gaps = 89/340 (26%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY 183
+ G V + R+ +A+K R ++E + A + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 184 CSFQ--------------------------DDEYLYLIMEYLPGGDMMTLL-------MR 210
+ L+M D+ L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVF 187
Query: 211 KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270
+ + + ++ +H PDNL + +G + L D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-- 245
Query: 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330
++ Y E L
Sbjct: 246 ------------------------------------------TRGPASSVPVTYAPREFL 263
Query: 331 LKKG--YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNW-----RTHLKFPEEA 383
+ + W LG +Y + + PF P L F
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT 323
Query: 384 KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422
L K LI + L + +RL E P F ++
Sbjct: 324 PLPDFVKTLIGRFLNFDRRRRL---LPLEAMETPEFLQLQ 360
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-55
Identities = 75/384 (19%), Positives = 129/384 (33%), Gaps = 88/384 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+E +G G FG V + TG A+K+ ++ L E E ++ +++
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNH 71
Query: 177 NCIVKLYCSFQDDEYL------YLIMEYLPGGDMMTLLMRKDT---LTEEEARFYVGETV 227
+V + L L MEY GGD+ L + + L E R + +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
A+ +H++ IHRD+KP+N++L K+ D G K LD
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---------------- 175
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344
Q E VGT Y+APE+L +K Y + D+WS
Sbjct: 176 ---------------QGELCT-----------EFVGTLQYLAPELLEQKKYTVTVDYWSF 209
Query: 345 GAIMYEMLVGYPPFYSDEPMSTCRKIV----------------NWRTHLKFPEEAKLSPE 388
G + +E + G+ PF + V + P LS
Sbjct: 210 GTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGI 269
Query: 389 AKDLISKLL-----CNVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIP-------- 435
+ + L + QR + F+ ++ ++ +
Sbjct: 270 LAGKLERWLQCMLMWHQRQRG---TDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTY 326
Query: 436 EVNDELDTQNFEKFEEADNQIQTS 459
V + + QN + + + D I
Sbjct: 327 PVTENENLQNLKSWLQQDTGIPEE 350
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-53
Identities = 50/345 (14%), Positives = 100/345 (28%), Gaps = 74/345 (21%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAE 167
++G+ ++G+GAF +V + + +K K + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117
Query: 168 RNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK-----DTLTEEEARFY 222
L + +K Y + L+ E G ++ + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLL-----------DRNGHMKLSDFGLCKPLDCSN 271
+ IE +H IH DIKPDN +L D + + L D G +
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM---K 234
Query: 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL 331
L K + + T + E+L
Sbjct: 235 LFPKG------------------------------------TIFTAKCETSGFQCVEMLS 258
Query: 332 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKD 391
K + + D++ + A +Y ML G +E + F +
Sbjct: 259 NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------CKPEGLFRRLPH-LDMWNE 310
Query: 392 LISKLLCNVEQRLGTKGADEIKA--HPWFKGIEWDKLYQIKAAFI 434
+L N+ D ++ F+ +K+ ++ I
Sbjct: 311 FFHVML-NIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLI 354
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-52
Identities = 88/305 (28%), Positives = 143/305 (46%), Gaps = 52/305 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ IG+GA G V + ATG A++++ + ++ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV S+ + L+++MEYL GG + T ++ + + E + E + A+E +H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
IHRDIK DN+LL +G +KL+DFG C
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA------------------------------- 164
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
Q+ Q R + VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 165 ------QITPEQSKRS----TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 357 PFYSDEPMSTCRKIVNWRT-HLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414
P+ ++ P+ I T L+ PE KLS +D +++ L +VE+R A E+
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKR---GSAKELLQ 269
Query: 415 HPWFK 419
H + K
Sbjct: 270 HQFLK 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 86/305 (28%), Positives = 144/305 (47%), Gaps = 52/305 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ IG+G+ G V + REK +G A+K + + RR E + E ++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQH 101
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+V++Y S+ E L+++ME+L GG + T ++ + L EE+ + A+ +H
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
IHRDIK D++LL +G +KLSDFG C
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA------------------------------- 189
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
Q+ R+ S VGTP ++APEV+ + Y E D WSLG ++ EM+ G P
Sbjct: 190 ------QISKDVPKRK----SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 357 PFYSDEPMSTCRKIVNWRT-HLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414
P++SD P+ +++ + LK K+SP +D + ++L + ++R A E+
Sbjct: 240 PYFSDSPVQAMKRLRDSPPPKLKNSH--KVSPVLRDFLERMLVRDPQER---ATAQELLD 294
Query: 415 HPWFK 419
HP+
Sbjct: 295 HPFLL 299
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-52
Identities = 82/308 (26%), Positives = 133/308 (43%), Gaps = 61/308 (19%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMK--KLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
++GKG +G V R+ + A+K + S + + E L + IV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQ 83
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGETVLAIESIHKHNY 238
SF ++ ++ + ME +PGG + LL K E+ FY + + ++ +H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 239 IHRDIKPDNLLLD-RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
+HRDIK DN+L++ +G +K+SDFG K L N + F
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-------------------- 183
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGY 355
GT Y+APE++ K +GYG D WSLG + EM G
Sbjct: 184 ---------------------TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
Query: 356 PPFYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISK-LLCNVEQRLGTKGADEIK 413
PPFY EP + K+ ++ H + PE +S EAK I K + ++R A+++
Sbjct: 223 PPFYELGEPQAAMFKVGMFKVHPEIPES--MSAEAKAFILKCFEPDPDKRA---CANDLL 277
Query: 414 AHPWFKGI 421
+ K
Sbjct: 278 VDEFLKVS 285
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 85/308 (27%), Positives = 129/308 (41%), Gaps = 57/308 (18%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMK--KLKKSEMLRRGQVEHVKAERNLLAE 173
+ F L IGKG+FGEV + T V A+K L+++E ++E ++ E +L++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQ 76
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
DS + K Y S+ D L++IMEYL GG + L + L E + + E + ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYL 135
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H IHRDIK N+LL +G +KL+DFG+ L + ++ F
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF---------------- 179
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
VGTP ++APEV+ + Y + D WSLG E+
Sbjct: 180 -------------------------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411
G PP PM I P E S K+ + L R A E
Sbjct: 215 GEPPHSELHPMKVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRP---TAKE 267
Query: 412 IKAHPWFK 419
+ H +
Sbjct: 268 LLKHKFIL 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-49
Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 58/308 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ F+ L +G+G++G V K TG + A+K++ ++ + E +++ + DS
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGG---DMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+VK Y S+ + L+++MEY G D++ L R TLTE+E + T+ +E +
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYL 141
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H IHRDIK N+LL+ GH KL+DFG+ L + +
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV---------------- 185
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+GTP ++APEV+ + GY D WSLG EM
Sbjct: 186 -------------------------IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 354 GYPPFYSDEPMSTCRKIVNWRT-HLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411
G PP+ PM I + PE S D + + L + EQR A +
Sbjct: 221 GKPPYADIHPMRAIFMIPTNPPPTFRKPE--LWSDNFTDFVKQCLVKSPEQR---ATATQ 275
Query: 412 IKAHPWFK 419
+ HP+ +
Sbjct: 276 LLQHPFVR 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-49
Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 63/323 (19%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMK--KLKKSEMLRRGQVEHVKAERNLLAE 173
DD+E +IG GA V+ A+K L+K + ++ + E +++
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQ 69
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGG---DMMTLLMRKD-----TLTEEEARFYVGE 225
IV Y SF + L+L+M+ L GG D++ ++ K L E + E
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
+ +E +HK+ IHRD+K N+LL +G ++++DFG+
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA-------------------- 169
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWS 343
L R T VGTP ++APEV+ + +GY + D WS
Sbjct: 170 -----------------FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS 212
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT------HLKFPEEAKLSPEAKDLISKLL 397
G E+ G P++ PM + K + +IS L
Sbjct: 213 FGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCL 272
Query: 398 C-NVEQRLGTKGADEIKAHPWFK 419
+ E+R A E+ H +F+
Sbjct: 273 QKDPEKRP---TAAELLRHKFFQ 292
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 85/330 (25%), Positives = 136/330 (41%), Gaps = 61/330 (18%)
Query: 100 EKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRG 159
+K EY ++R + +E + +G GAFG+V + K TG + A K ++
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EE 58
Query: 160 QVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG---DMMTLLMRKDTLTE 216
++E E +LA D IVKL ++ D L++++E+ PGG +M L LTE
Sbjct: 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTE 116
Query: 217 EEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276
+ + + + A+ +H IHRD+K N+L+ G ++L+DFG+ + +
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176
Query: 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL----- 331
F +GTP ++APEV++
Sbjct: 177 F-----------------------------------------IGTPYWMAPEVVMCETMK 195
Query: 332 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT-HLKFPEEAKLSPEAK 390
Y + D WSLG + EM PP + PM KI L P K S E +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--KWSVEFR 253
Query: 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
D + L N E R A ++ HP+
Sbjct: 254 DFLKIALDKNPETR---PSAAQLLEHPFVS 280
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 68/365 (18%), Positives = 121/365 (33%), Gaps = 98/365 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVC----------------------REKATGHVYAMKKLK--- 151
DFEP+ +G+G FG V REK V A+ KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 152 ------------------------------KSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+ ++ + + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEE---ARFYVGETVLAIESIHKHNY 238
YLY+ M+ ++ + R+ +L + E + A+E +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HRD+KP N+ + +K+ DFGL +D ++ + P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT------------PMPAYATH 233
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
T VGT Y++PE + Y + D +SLG I++E+L Y
Sbjct: 234 T-----------------GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSFS 274
Query: 359 YSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416
E + + N LKFP + P+ ++ +L + +R A +I +
Sbjct: 275 TQMERVRIITDVRN----LKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENA 327
Query: 417 WFKGI 421
F+ +
Sbjct: 328 IFENL 332
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-48
Identities = 64/325 (19%), Positives = 115/325 (35%), Gaps = 58/325 (17%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
Q ++G ++ +G F V ++ +G YA+K+L +E + + E
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVC 77
Query: 170 LLAEVDSN-CIVKLYCSF-------QDDEYLYLIMEYLPGGDMMTLLMR---KDTLTEEE 218
+ ++ + IV+ + + +L++ L G ++ L + + L+ +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 219 ARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276
+T A++ +H+ IHRD+K +NLLL G +KL DFG
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT---------- 187
Query: 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL---LKK 333
+R + TP Y PE++
Sbjct: 188 -------------------ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 334 GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLI 393
G + D W+LG I+Y + PF + +IVN + P LI
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGK--YSIPPHDTQYTVFHSLI 282
Query: 394 SKLLC-NVEQRLGTKGADEIKAHPW 417
+L N E+RL E+
Sbjct: 283 RAMLQVNPEERL---SIAEVVHQLQ 304
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 77/367 (20%), Positives = 127/367 (34%), Gaps = 64/367 (17%)
Query: 59 NHYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADD 118
++Y + N+ + D + +L K+ + L
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSL------KDPDVAELFFKDDPEKL 55
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
++ + + +L+MEY G L + K L E E + + +H HN
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
IHRD+K N+LL G +KL DFG
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA---------------------------------- 201
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 355
+ N S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 202 ---SIMA--PAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFP--EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412
PP ++ MS I + P + S ++ + L + R ++ +
Sbjct: 251 PPLFNMNAMSALYHIAQNES----PALQSGHWSEYFRNFVDSCLQKIPQDR---PTSEVL 303
Query: 413 KAHPWFK 419
H +
Sbjct: 304 LKHRFVL 310
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 70/324 (21%), Positives = 120/324 (37%), Gaps = 61/324 (18%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK---KSEMLRRGQVEHVKA 166
QR++ +D E L +G G G+V R + TGHV A+K+++ E +R ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL--- 74
Query: 167 ERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGET 226
+L D IV+ + +F + +++ ME + + + E
Sbjct: 75 -DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 227 VLAIESIH-KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSG 285
V A+ + KH IHRD+KP N+LLD G +KL DFG+ L
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--------------- 178
Query: 286 ALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 340
+ G Y+APE + K Y + D
Sbjct: 179 ---------------------------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 341 WWSLGAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC- 398
WSLG + E+ G P+ + + K++ P S + + + L
Sbjct: 212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 399 NVEQRLGTKGADEIKAHPWFKGIE 422
+ +R +++ H + K E
Sbjct: 271 DHRKR---PKYNKLLEHSFIKRYE 291
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-45
Identities = 76/328 (23%), Positives = 128/328 (39%), Gaps = 64/328 (19%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK---KSEMLRRGQVEHVKA 166
Q A+D + L IG+GA+G V K +G + A+K+++ + ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--- 71
Query: 167 ERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG--DMMTLLM--RKDTLTEEEARFY 222
++ D IV+ Y + + ++ ME + + D + EE
Sbjct: 72 -DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 223 VGETVLAIESIH-KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
TV A+ + IHRDIKP N+LLDR+G++KL DFG+ L S
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS----------- 179
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL----LKKGYGM 337
+A R G Y+APE + ++GY +
Sbjct: 180 ------------IAKTR-------------------DAGCRPYMAPERIDPSASRQGYDV 208
Query: 338 ECDWWSLGAIMYEMLVGYPPFYSDEPM-STCRKIVNWRT-HLKFPEEAKLSPEAKDLISK 395
D WSLG +YE+ G P+ + ++V L EE + SP + ++
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNL 268
Query: 396 LLC-NVEQRLGTKGADEIKAHPWFKGIE 422
L + +R E+ HP+ E
Sbjct: 269 CLTKDESKR---PKYKELLKHPFILMYE 293
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-45
Identities = 76/326 (23%), Positives = 129/326 (39%), Gaps = 76/326 (23%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN------ 169
ADD EP+ +G+GA+G V R +G + A+K++ + E+
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI---------RATVNSQEQKRLLMDL 56
Query: 170 --LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGG---DMMTLLMRKDTLTEEEARFYVG 224
+ VD V Y + + +++ ME + ++ + T+ E+
Sbjct: 57 DISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 225 ETVLAIESIH-KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
V A+E +H K + IHRD+KP N+L++ G +K+ DFG+ L
Sbjct: 117 SIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------------- 163
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL----KKGYGME 338
+A G Y+APE + +KGY ++
Sbjct: 164 ------------------------------VAKDIDAGCKPYMAPERINPELNQKGYSVK 193
Query: 339 CDWWSLGAIMYEMLVGYPPFYSDE-PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLL 397
D WSLG M E+ + P+ S P +++V + + P + K S E D S+ L
Sbjct: 194 SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPAD-KFSAEFVDFTSQCL 251
Query: 398 C-NVEQRLGTKGADEIKAHPWFKGIE 422
N ++R E+ HP+F E
Sbjct: 252 KKNSKER---PTYPELMQHPFFTLHE 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 59/303 (19%), Positives = 117/303 (38%), Gaps = 57/303 (18%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+G+F V + T A +L+ ++ + + + K E +L + IV+ Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 185 SFQD----DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY-- 238
S++ + + L+ E + G + T L R + + R + + + ++ +H
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 239 IHRDIKPDNLLLD-RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
IHRD+K DN+ + G +K+ D GL S
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-------------------------- 186
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
A + +GTP+++APE+ ++ Y D ++ G M EM P
Sbjct: 187 -----------------AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416
+ + + + V ++ PE K++I + N ++R ++ H
Sbjct: 229 YSECQNAAQIYRRVTSGVKPASFDK-VAIPEVKEIIEGCIRQNKDERY---SIKDLLNHA 284
Query: 417 WFK 419
+F+
Sbjct: 285 FFQ 287
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 63/355 (17%), Positives = 112/355 (31%), Gaps = 87/355 (24%)
Query: 116 ADDFEPLTMIGKGA--FGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE 173
+E LT+IGKG V + R K TG ++++ E V ++ E ++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKL 82
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIE 231
+ IV +F D L+++ ++ G L+ D + E + + + A++
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
IH Y+HR +K ++L+ +G + LS
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSN--------------------------- 175
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGAIMY 349
QR +V +++PEVL +GY + D +S+G
Sbjct: 176 -------LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228
Query: 350 EMLVGYPPFYSDEPM------------------------------------------STC 367
E+ G+ PF +T
Sbjct: 229 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS 288
Query: 368 RKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421
+ P SP + + L N + R A + H +FK I
Sbjct: 289 TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFKQI 340
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-44
Identities = 86/321 (26%), Positives = 131/321 (40%), Gaps = 69/321 (21%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV- 174
A FE + ++G G +G+V R TG + A+K + + + E +K E N+L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYS 78
Query: 175 DSNCIVKLYCSF------QDDEYLYLIMEYLPGGDMMTLLM--RKDTLTEEEARFYVGET 226
I Y +F D+ L+L+ME+ G + L+ + +TL EE + E
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 227 VLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
+ + +H+H IHRDIK N+LL N +KL DFG+ LD
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD------------------ 180
Query: 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-----GYGMECDW 341
RT +RN + +GTP ++APEV+ Y + D
Sbjct: 181 -----------RTVG------RRN------TFIGTPYWMAPEVIACDENPDATYDFKSDL 217
Query: 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFP--EEAKLSPEAKDLISKLLC- 398
WSLG EM G PP PM I P + K S + + I L
Sbjct: 218 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA----PRLKSKKWSKKFQSFIESCLVK 273
Query: 399 NVEQRLGTKGADEIKAHPWFK 419
N QR +++ HP+ +
Sbjct: 274 NHSQR---PATEQLMKHPFIR 291
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 56/287 (19%)
Query: 80 KKLADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREK 139
KKL + E+ E+++ L +L +K+ + ++ DDFE ++ +G G G V K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQ------KVGELKDDDFEKISELGAGNGGVVFKVSHK 55
Query: 140 ATGHVYAMKK--LKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197
+G V A K L+ +R + E +L E +S IV Y +F D + + ME
Sbjct: 56 PSGLVMARKLIHLEIKPAIRN----QIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH-KHNYIHRDIKPDNLLLDRNGHM 256
++ GG + +L + + E+ + + + KH +HRD+KP N+L++ G +
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
Query: 257 KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAY 316
KL DFG+ L S +A
Sbjct: 172 KLCDFGVSGQLIDS-------------------------------------------MAN 188
Query: 317 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEP 363
S VGT Y++PE L Y ++ D WS+G + EM VG P +
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-38
Identities = 77/345 (22%), Positives = 132/345 (38%), Gaps = 96/345 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKA----ERNLLA 172
+ +E + IG+G++G V CR + TG + A+KK +SE +K E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRMLK 57
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIE 231
++ +V L F+ L+L+ EY ++ L + + E + +T+ A+
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
HKHN IHRD+KP+N+L+ ++ +KL DFG + +
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL----------LTG------------ 154
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349
P Y V T Y +PE+L+ YG D W++G +
Sbjct: 155 ----PSDY----------------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 350 EMLVGYP--------------------------------PFYSDEPMSTCRKIVNWRTHL 377
E+L G P ++S + +
Sbjct: 195 ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL-- 252
Query: 378 KFPEEAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFKGI 421
KFP +S A L+ L + +RL +++ HP+F+ I
Sbjct: 253 KFP---NISYPALGLLKGCLHMDPTERL---TCEQLLHHPYFENI 291
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 80/346 (23%), Positives = 136/346 (39%), Gaps = 102/346 (29%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKA----ERNLLA 172
+ +E L ++G+G++G V CR K TG + A+KK +S+ + VK E LL
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKLLK 79
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIE 231
++ +V L + + YL+ E++ ++ L + + L + + Y+ + + I
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
H HN IHRDIKP+N+L+ ++G +KL DFG + L + G
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFG--------------------FARTLAAPG 178
Query: 292 RP----VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGA 346
VA R W R APE+L+ YG D W++G
Sbjct: 179 EVYDDEVATR---------WYR----------------APELLVGDVKYGKAVDVWAIGC 213
Query: 347 IMYEMLVGYP--------------------------------PFYSDEPMSTCRKIVNWR 374
++ EM +G P P ++ + ++
Sbjct: 214 LVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLE 273
Query: 375 THLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+P KLS DL K L + ++R E+ H +F+
Sbjct: 274 RR--YP---KLSEVVIDLAKKCLHIDPDKRP---FCAELLHHDFFQ 311
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 76/350 (21%), Positives = 129/350 (36%), Gaps = 97/350 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSE-------MLRRGQVEHVKAER 168
D + +T +G+G +GEV + T A+K+++ + E +R E
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---------EV 84
Query: 169 NLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL 228
+LL E+ I++L + L+LI EY D+ + + ++ + ++ + +
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRN-----GHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ H +HRD+KP NLLL + +K+ DFGL + F I
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----------FGI---- 189
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDW 341
P R ++ + T Y PE+LL + Y D
Sbjct: 190 ------------PIRQ----------------FTHEIITLWYRPPEILLGSRHYSTSVDI 221
Query: 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKI---------VNWRTHLKFPE----------- 381
WS+ I EML+ P F D + KI W P+
Sbjct: 222 WSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGK 281
Query: 382 ------EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424
A L E DL++ +L + +R+ A HP+F ++D
Sbjct: 282 TLKRVLGALLDDEGLDLLTAMLEMDPVKRI---SAKNALEHPYFSHNDFD 328
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 85/340 (25%), Positives = 134/340 (39%), Gaps = 93/340 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEM-------LRRGQVEHVKAER 168
+ + L IG+G +G V + G +A+KK++ + E +R E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR---------EI 51
Query: 169 NLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETV 227
++L E+ + IVKLY + L L+ E+L D+ LL + + L A+ ++ + +
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
I H +HRD+KP NLL++R G +K++DFGL + F I
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA----------FGI-------- 152
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 345
P R Y+ + T Y AP+VL+ K Y D WS+G
Sbjct: 153 --------PVRK----------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKI---------VNWRTHLKFPE--------------- 381
I EM+ G P F +I NW + P+
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248
Query: 382 -EAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
L DL+SK+L + QR+ A + H +FK
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRI---TAKQALEHAYFK 285
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 71/340 (20%), Positives = 121/340 (35%), Gaps = 84/340 (24%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVE-HVKAER--NLLAE 173
+EP+ IG GA+G V R+ +GH A+K ++ G + R LL
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVREVALLRR 67
Query: 174 VDSNC---IVKLYCSFQDDEY-----LYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYV 223
+++ +V+L + L+ E++ D+ T L L E + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ + ++ +H + +HRD+KP+N+L+ G +KL+DFGL + +S
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI----------YSY---- 172
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343
+ W Y APEVLL+ Y D WS
Sbjct: 173 ------------QMALTPVVVTLW----------------YRAPEVLLQSTYATPVDMWS 204
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIV---------NWRTHLKFPEEA----------- 383
+G I EM P F + KI +W + P A
Sbjct: 205 VGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQS 264
Query: 384 ---KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
++ L+ ++L N +R+ A H +
Sbjct: 265 VVPEMEESGAQLLLEMLTFNPHKRI---SAFRALQHSYLH 301
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 76/340 (22%), Positives = 126/340 (37%), Gaps = 92/340 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSE------MLRRGQVEHVKAERN 169
+ + L +G+G + V + K T ++ A+K+++ + E +R E +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---------EVS 52
Query: 170 LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVL 228
LL ++ IV L+ ++ L L+ EYL D+ L + + + ++ + +
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+ H+ +HRD+KP NLL++ G +KL+DFGL + SI
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA----------KSI--------- 152
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGA 346
P +T Y V T Y P++LL Y + D W +G
Sbjct: 153 -------PTKT----------------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGC 189
Query: 347 IMYEMLVGYPPFYSDEPMSTCRKI---------VNWRTHLKFPEEAK------------- 384
I YEM G P F I W L E
Sbjct: 190 IFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLS 249
Query: 385 ----LSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
L + DL++KLL R+ A++ HP+F
Sbjct: 250 HAPRLDSDGADLLTKLLQFEGRNRI---SAEDAMKHPFFL 286
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 80/350 (22%), Positives = 127/350 (36%), Gaps = 101/350 (28%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSE------MLRRGQVEHVKAER 168
+ F+ L +G G + V K TG A+K++K SE +R E
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---------EI 54
Query: 169 NLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL------MRKDTLTEEEARFY 222
+L+ E+ IV+LY + L L+ E++ D+ + L +++
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ + + H++ +HRD+KP NLL+++ G +KL DFGL + F I
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA----------FGI--- 160
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECD 340
P T +S+ V T Y AP+VL+ + Y D
Sbjct: 161 -------------PVNT----------------FSSEVVTLWYRAPDVLMGSRTYSTSID 191
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKI------------------------------ 370
WS G I+ EM+ G P F + I
Sbjct: 192 IWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPP 251
Query: 371 VNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+ R L+ + L D + LL N + RL A + HPWF
Sbjct: 252 RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL---SAKQALHHPWFA 298
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 93/380 (24%), Positives = 141/380 (37%), Gaps = 107/380 (28%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK--KSEMLRRGQVEHVKAERNLLAEVDS 176
+ +IG G+FG V + +G + A+KK+ K R E ++ ++D
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---------ELQIMRKLDH 106
Query: 177 NCIVKLYCSF------QDDEYLYLIMEYLPGGDMMTL--LMR-----KDTLTEEEARFYV 223
IV+L F +D+ YL L+++Y+P T+ + R K TL + Y+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ ++ IH HRDIKP NLLLD + +KL DFG K L
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------- 208
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 341
R ++Y + + Y APE++ Y D
Sbjct: 209 --------------------------RGEPNVSY--ICSRYYRAPELIFGATDYTSSIDV 240
Query: 342 WSLGAIMYEMLVGYPPF----YSDE-----------PMSTCRKIVNWRTHLKFPE----- 381
WS G ++ E+L+G P F D+ R++ T KFP+
Sbjct: 241 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 300
Query: 382 -----EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIP 435
+ PEA L S+LL RL E AH +F D+L +P
Sbjct: 301 WTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFF-----DELRDP-NVKLP 351
Query: 436 EVNDELDTQNFEKFEEADNQ 455
D NF E + N
Sbjct: 352 NGRDTPALFNFTTQELSSNP 371
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 84/341 (24%), Positives = 133/341 (39%), Gaps = 93/341 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEM-------LRRGQVEHVKAER 168
+E L IG+G +G V + + T + A+K+++ + LR E
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EI 52
Query: 169 NLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETV 227
LL E+ IV+L+ D+ L L+ E+ D+ L E + ++ + +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+ H N +HRD+KP NLL++RNG +KL++FGL + F I
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA----------FGI-------- 153
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 345
P R YS V T Y P+VL K Y D WS G
Sbjct: 154 --------PVRC----------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189
Query: 346 AIMYEML-VGYPPFYSDEPMSTCRKIV------------------NWRTHLKFPEE---- 382
I E+ G P F ++ ++I +++ + +P
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249
Query: 383 ---AKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
KL+ +DL+ LL CN QR+ A+E HP+F
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRI---SAEEALQHPYFS 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 82/341 (24%), Positives = 134/341 (39%), Gaps = 94/341 (27%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEM-------LRRGQVEHVKAER 168
+ ++ L +G+G +G V ++ G + A+K+++ +E +R E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR---------EI 70
Query: 169 NLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETV 227
+LL E+ IV L + L L+ E++ D+ +L K L + + + Y+ + +
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+ H+H +HRD+KP NLL++ +G +KL+DFGL + F I
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA----------FGI-------- 171
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 345
P R+ Y+ V T Y AP+VL+ K Y D WS+G
Sbjct: 172 --------PVRS----------------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKI---------VNWRTH--------LKFPEEAK---- 384
I EM+ G P F KI W F K
Sbjct: 208 CIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWS 267
Query: 385 -----LSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
E DL+S +L + +R+ A + HP+FK
Sbjct: 268 SIIPGFCQEGIDLLSNMLCFDPNKRI---SARDAMNHPYFK 305
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 83/337 (24%), Positives = 131/337 (38%), Gaps = 82/337 (24%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEH---VKAER--NL 170
A +E L +G+G F V R+K T + A+KK+K + R + + A R L
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKL 65
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYVGETVLA 229
L E+ I+ L +F + L+ +++ D+ ++ LT + Y+ T+
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+E +H+H +HRD+KP+NLLLD NG +KL+DFGL K F
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGS---------- 164
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGAI 347
P R Y+ V T Y APE+L + YG+ D W++G I
Sbjct: 165 ------PNRA----------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 202
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIV---------NWRTHLKFPEEA--------------- 383
+ E+L+ P D + +I W P+
Sbjct: 203 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFS 262
Query: 384 KLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFK 419
+ DLI L N R+ A + +F
Sbjct: 263 AAGDDLLDLIQGLFLFNPCARI---TATQALKMKYFS 296
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 83/346 (23%), Positives = 126/346 (36%), Gaps = 102/346 (29%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK--KSEMLRRGQVEHVKAERNLLAEVDS 176
+ +IG G+FG V + + V A+KK+ K R E ++ V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR---------ELQIMRIVKH 91
Query: 177 NCIVKLYCSF------QDDEYLYLIMEYLPGGDMMTL--LMR-----KDTLTEEEARFYV 223
+V L F +D+ +L L++EY+P T+ R K T+ + Y+
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ + ++ IH HRDIKP NLLLD G +KL DFG K L
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-------------- 193
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 341
++Y + + Y APE++ Y D
Sbjct: 194 --------------------------AGEPNVSY--ICSRYYRAPELIFGATNYTTNIDI 225
Query: 342 WSLGAIMYEMLVGYPPF----YSDE-----------PMSTCRKIVNWRTHLKFPE----- 381
WS G +M E++ G P F D+ + + KFP+
Sbjct: 226 WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP 285
Query: 382 -----EAKLSPEAKDLISKLL-CNVEQRLGTKGADEIKAHPWFKGI 421
+ P+A DLIS+LL RL A E HP+F +
Sbjct: 286 FSKVFRPRTPPDAIDLISRLLEYTPSARL---TAIEALCHPFFDEL 328
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 72/348 (20%), Positives = 124/348 (35%), Gaps = 100/348 (28%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK---KSEMLRRGQVEHVKAERNLLAE 173
DD++ + +G+G + EV +K LK K ++ R E +L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---------EIKILEN 86
Query: 174 V-DSNCIVKLYCSFQDDE--YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAI 230
+ I+ L +D L+ E++ D L TLT+ + RFY+ E + A+
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 143
Query: 231 ESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+ H +HRD+KP N+++D + ++L D+GL
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-------------------------- 177
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348
P + V + + PE+L+ + Y D WSLG ++
Sbjct: 178 -AEFYHP-------------GQEYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCML 221
Query: 349 YEMLVGYPPFY-----------------SDEPMSTCRKI-----------------VNWR 374
M+ PF+ +++ K W
Sbjct: 222 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 281
Query: 375 THLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421
+ + +SPEA D + KLL + + RL T A E HP+F +
Sbjct: 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRL-T--AREAMEHPYFYTV 326
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 75/346 (21%), Positives = 134/346 (38%), Gaps = 98/346 (28%)
Query: 117 DDFEPLTMIGKGAFGEVRVCRE-KATGHVYAMKKLK-KSEM-------LRRGQVEHVKAE 167
+E + IG+GA+G+V R+ K G A+K+++ ++ +R E
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---------E 61
Query: 168 RNLLAEVDSNC---IVKLY-----CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEE 217
+L +++ +V+L+ + L L+ E++ D+ T L + + + E
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 218 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
+ + + + ++ +H H +HRD+KP N+L+ +G +KL+DFGL + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI----------Y 170
Query: 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337
S + W Y APEVLL+ Y
Sbjct: 171 SF----------------QMALTSVVVTLW----------------YRAPEVLLQSSYAT 198
Query: 338 ECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIV---------NWRTHLKFPEEA----- 383
D WS+G I EM P F + KI+ +W + P +A
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 258
Query: 384 ---------KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+ KDL+ K L N +R+ A +HP+F+
Sbjct: 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 81/377 (21%), Positives = 128/377 (33%), Gaps = 113/377 (29%)
Query: 95 LLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK--- 151
+ K + E + +E L IG+G FGEV R + TG A+KK+
Sbjct: 1 MAKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN 54
Query: 152 -----KSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY--------CSFQDDEYLYLIMEY 198
LR E +L + +V L + +YL+ ++
Sbjct: 55 EKEGFPITALR---------EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF 105
Query: 199 LPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMK 257
D+ LL T E + + + + IH++ +HRD+K N+L+ R+G +K
Sbjct: 106 CEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164
Query: 258 LSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQH-----WQRNRR 312
L+DFGL + FS+ + +Q + + W
Sbjct: 165 LADFGLARA----------FSL----------------AKNSQPNRYTNRVVTLW----- 193
Query: 313 MLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIV 371
Y PE+LL ++ YG D W G IM EM P + I
Sbjct: 194 -----------YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 372 N-----------------WRTHLKFPEEAK-----------LSPEAKDLISKLLC-NVEQ 402
L+ + K P A DLI KLL + Q
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 403 RLGTKGADEIKAHPWFK 419
R+ +D+ H +F
Sbjct: 303 RI---DSDDALNHDFFW 316
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 84/352 (23%), Positives = 130/352 (36%), Gaps = 98/352 (27%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKK--LKKSEMLRRGQVEHVKAERNLLAE 173
D F+ M G+G FG V++ +EK+TG A+KK R Q LA
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ------IMQDLAV 75
Query: 174 VDSNCIVKLYCSF-------QDDEYLYLIMEYLPGGD----MMTLLMRKDTLTEEEARFY 222
+ IV+L F + D YL ++MEY+P R+ + +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134
Query: 223 VGETVLAIESIHK--HNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSNLQEKDFSI 279
+ + + +I +H N HRDIKP N+L++ +G +KL DFG K L
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS----------- 183
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 338
+ +AY + + Y APE++ + Y
Sbjct: 184 -----------------------------PSEPNVAY--ICSRYYRAPELIFGNQHYTTA 212
Query: 339 CDWWSLGAIMYEMLVGYPPF----YSDE-----------PMSTCRKIVNWRTHLKFP--- 380
D WS+G I EM++G P F + + RK+ T +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSK 272
Query: 381 ----------EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421
K + EA DL+S LL E+R+ E HP+F +
Sbjct: 273 GIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFDEL 321
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 57/250 (22%), Positives = 103/250 (41%), Gaps = 33/250 (13%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK-SEMLRRGQVEHVKAERNLLAEVD 175
D ++GKG FG+ + TG V MK+L + E +R E ++ ++
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR----TFLKEVKVMRCLE 65
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETV-LAIESIH 234
++K D+ L I EY+ GG + ++ D+ R + + + +H
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
N IHRD+ N L+ N ++ ++DFGL R +
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGL---------------------------ARLM 158
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
+TQ E L+ ++ R Y+ VG P ++APE++ + Y + D +S G ++ E++
Sbjct: 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218
Query: 355 YPPFYSDEPM 364
P
Sbjct: 219 VNADPDYLPR 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 45/183 (24%), Positives = 72/183 (39%), Gaps = 40/183 (21%)
Query: 179 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
+V ++ + D LY+ M + G D+ +L R+ L A V + A+++ H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
HRD+KP+N+L+ + L DFG+ L
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKL-------------------------- 189
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
TQ +TVGT Y+APE + D ++L ++YE L G PP+
Sbjct: 190 TQ--------------LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY 235
Query: 359 YSD 361
D
Sbjct: 236 QGD 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 64/289 (22%), Positives = 106/289 (36%), Gaps = 67/289 (23%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ E ++G+GAFG V C+ K A+K+++ + E L+ V+
Sbjct: 8 KEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNH 60
Query: 177 NCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVG---ETVLAIE 231
IVKLY C + L+MEY GG + +L + L A + + +
Sbjct: 61 PNIVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 232 SIHKHNY---IHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+H IHRD+KP NLLL G +K+ DFG
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----------------------- 153
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
+ + + G+ ++APEV Y +CD +S G I
Sbjct: 154 ---------------------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGII 192
Query: 348 MYEMLVGYPPFYS-DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISK 395
++E++ PF P V+ T + L + L+++
Sbjct: 193 LWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN--LPKPIESLMTR 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 45/153 (29%), Positives = 67/153 (43%), Gaps = 26/153 (16%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--NCIVKL 182
+G G G+V K T +A+K L+ RR E L + IV++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPH-IVRI 76
Query: 183 YCSFQD----DEYLYLIMEYLPGGDMMTLLMR-----KDTLTEEEARFYVGETVLAIESI 233
+++ + L ++ME L GG+ L R TE EA + AI+ +
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 234 HKHNYIHRDIKPDNLLL---DRNGHMKLSDFGL 263
H N HRD+KP+NLL N +KL+DFG
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 325 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVN--WRTHLKFPEE 382
A E + Y CD WSLG IMY +L GYPPFYS+ ++ + +FP
Sbjct: 166 FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 383 --AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
+++S E K LI LL QR+ E HPW
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 262
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 59/252 (23%), Positives = 104/252 (41%), Gaps = 50/252 (19%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKS-----EMLRRGQVEHVKAERNLLAE 173
++ + +G G V + + A+K + E L+R + E + ++
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS-----SQ 67
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+ IV + ++D+ YL+MEY+ G + + L+ + A + + + I+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H +HRDIKP N+L+D N +K+ DFG+ K L ++L
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--------------------- 166
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
TQ +GT Y +PE + D +S+G ++YEMLV
Sbjct: 167 -----TQTN--------------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 354 GYPPFYSDEPMS 365
G PPF + +S
Sbjct: 208 GEPPFNGETAVS 219
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 58/250 (23%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK--------SEMLRRGQVEHVKAER 168
D +E +IG G++G V +K V A+KK+ + +LR E
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR---------EI 103
Query: 169 NLLAEVDSNCIVKLY-----CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYV 223
+L ++ + +VK+ + + LY+++E D L LTE + +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
++ ++ +H +HRD+KP N L++++ +K+ DFGL + ++
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR------------TVDYPE 210
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWW 342
+G Q P R++ + V T Y APE++L ++ Y D W
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH--VVTRWYRAPELILLQENYTEAIDVW 268
Query: 343 SLGAIMYEML 352
S+G I E+L
Sbjct: 269 SIGCIFAELL 278
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 61/297 (20%), Positives = 103/297 (34%), Gaps = 68/297 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK----SEMLRRGQVEHVKAERNLLA 172
++ E IGKG FG V R V A+K L E + + + E +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 173 EVDSNCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLA 229
++ IVKLY ++ME++P GD+ L+ K + + + L
Sbjct: 79 NLNHPNIVKLYGLMH----NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 230 IESIHKHNY--IHRDIKPDNLLLDRNG-----HMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
IE + N +HRD++ N+ L K++DFGL
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS------------------ 176
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECD 340
+ +G ++APE + + Y + D
Sbjct: 177 --------------------------QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKAD 210
Query: 341 WWSLGAIMYEMLVGYPPF--YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISK 395
+S I+Y +L G PF YS + I PE+ P +++I
Sbjct: 211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED--CPPRLRNVIEL 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 62/286 (21%), Positives = 104/286 (36%), Gaps = 55/286 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D IG G+FG V R + G A+K L + + +V E ++ +
Sbjct: 37 CDLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRH 93
Query: 177 NCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDT---LTEEEARFYVGETVLAIE 231
IV + L ++ EYL G + LL + L E + +
Sbjct: 94 PNIVLFMGAVT--QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 232 SIHKHNY--IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+H N +HR++K NLL+D+ +K+ DFGL + + L K
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-------------- 197
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
S GTP+++APEVL + + D +S G I++
Sbjct: 198 ---------------------------SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISK 395
E+ P+ + P + L+ P L+P+ +I
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN--LNPQVAAIIEG 274
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 69/366 (18%), Positives = 120/366 (32%), Gaps = 109/366 (29%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKL------------------------- 150
+ + +G G+FG V + +G +A+KK+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 151 ------KKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGD- 203
E + Q + +N + + ++YL +IMEY+P
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124
Query: 204 ---MMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLS 259
+ + + ++ Y+ + A+ IH HRDIKP NLL++ +KL
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 260 DFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTV 319
DFG K L + +AY +
Sbjct: 185 DFGSAKKLI----------------------------------------PSEPSVAY--I 202
Query: 320 GTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPF----YSDE-----------P 363
+ Y APE++L Y D WS+G + E+++G P F D+
Sbjct: 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT 262
Query: 364 MSTCRKIVNWRTHLKFPEEAKLS----------PEAKDLISKLLC-NVEQRLGTKGADEI 412
++ T ++FP A DL+ ++L + R+ E
Sbjct: 263 KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEA 319
Query: 413 KAHPWF 418
AHP+F
Sbjct: 320 MAHPFF 325
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 42/191 (21%)
Query: 179 IVKLYCSFQDD----EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
IV +Y + + + Y++MEY+ G + ++ + +T + A + + A+ H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
++ IHRD+KP N+++ +K+ DFG+ + A+ G V
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIAR--------------------AIADSGNSV 173
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
TQ + +GT Y++PE D +SLG ++YE+L G
Sbjct: 174 ----TQ--------------TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215
Query: 355 YPPFYSDEPMS 365
PPF D P+S
Sbjct: 216 EPPFTGDSPVS 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 79/355 (22%), Positives = 140/355 (39%), Gaps = 103/355 (29%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE-------MLRRGQVEHVKAER 168
+ DF+ +++G+GA+G V K TG + A+KK++ + LR E
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR---------EI 60
Query: 169 NLLAEVDSNCIVKLY-----CSFQDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEAR 220
+L I+ ++ SF++ +Y+I E M T L + L+++ +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQ 115
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
+++ +T+ A++ +H N IHRD+KP NLL++ N +K+ DFGL
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA---------------- 159
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 339
R + + + M+ + V T Y APEV+L Y
Sbjct: 160 -----------RIIDESAADNSEPTG--QQSGMVEF--VATRWYRAPEVMLTSAKYSRAM 204
Query: 340 DWWSLGAIMYEMLVGYPPF-------------------YSDEPMSTC------------- 367
D WS G I+ E+ + P F +SD +
Sbjct: 205 DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLP 264
Query: 368 -RKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
FP +++P+ DL+ ++L + +R+ T A E HP+ +
Sbjct: 265 MYPAAPLEK--MFP---RVNPKGIDLLQRMLVFDPAKRI-T--AKEALEHPYLQT 311
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 50/250 (20%), Positives = 98/250 (39%), Gaps = 55/250 (22%)
Query: 118 DFEPLTM---IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV 174
+T+ IG G+FG V + K G V A+K L + + Q++ K E +L +
Sbjct: 22 PDGQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRKT 77
Query: 175 DSNCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVG-ETVLAIE 231
I+ + L ++ ++ G + L +T E + + +T ++
Sbjct: 78 RHVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
+H + IHRD+K +N+ L + +K+ DFGL
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT-------------------------- 168
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIM 348
+ W + + G+ ++APEV+ + Y + D ++ G ++
Sbjct: 169 -----------EKSRWSGSHQFEQ--LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215
Query: 349 YEMLVGYPPF 358
YE++ G P+
Sbjct: 216 YELMTGQLPY 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 42/290 (14%), Positives = 86/290 (29%), Gaps = 64/290 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKAT--GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV 174
LT + + GE+ K G+ +K LK + R + E L
Sbjct: 10 KQLNFLTKLNENHSGELW----KGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIF 64
Query: 175 DSNCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAI 230
++ + C + LI ++P G + +L + + +A + + +
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 231 ESIHKHNY--IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+H + ++++D + ++S +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV------------------------- 159
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME---CDWWSLG 345
+ + Q + P ++APE L KK D WS
Sbjct: 160 --------KFSFQSP-------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISK 395
+++E++ PF M K+ P +SP L+
Sbjct: 199 VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG--ISPHVSKLMKI 246
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 53/256 (20%), Positives = 90/256 (35%), Gaps = 58/256 (22%)
Query: 118 DFEPLTM---IGKGAFGEVRVCREKAT--GHVYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
FE L + IGKG FG+V G V A++ + Q++ K E
Sbjct: 31 PFEQLEIGELIGKGRFGQVY----HGRWHGEV-AIRLIDIERDNED-QLKAFKREVMAYR 84
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIE 231
+ +V + +L +I G + +++ K L + R E V +
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMG 144
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
+H +H+D+K N+ D NG + ++DFGL
Sbjct: 145 YLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS-------------------------- 177
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL---------LKKGYGMECDWW 342
LQ +R ++ G ++APE++ K + D +
Sbjct: 178 --------ISGVLQAGRREDKLRI--QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 343 SLGAIMYEMLVGYPPF 358
+LG I YE+ PF
Sbjct: 228 ALGTIWYELHAREWPF 243
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-26
Identities = 52/265 (19%), Positives = 89/265 (33%), Gaps = 63/265 (23%)
Query: 108 RLQRHKMGADDFEPLTMIGKGAFGEVRVCR-EKATGHVYAMKKLKKS---EMLRRGQVEH 163
+L + A +E I G G + + G +K L S E
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----- 125
Query: 164 VKAERNLLAEVDSNCIVKLY-----CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEE 218
AER LAEV IV+++ D Y++MEY+ G + L E
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 219 ARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278
A Y+ E + A+ +H ++ D+KP+N++L +KL D G ++
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG------- 235
Query: 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME 338
GTP + APE+ ++ G +
Sbjct: 236 --------------------------------------YLYGTPGFQAPEI-VRTGPTVA 256
Query: 339 CDWWSLGAIMYEMLVGYPPFYSDEP 363
D +++G + + + P
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNGRYV 281
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 61/261 (23%), Positives = 110/261 (42%), Gaps = 43/261 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK---SEM-----LRRGQVEHVKAER 168
D++ +IG+G++G V + +K T A+KK+ + + LR E
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR---------EI 76
Query: 169 NLLAEVDSNCIVKLY-----CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYV 223
+L + S+ I++LY + LY+++E D+ L LTEE + +
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+L IH+ IHRD+KP N LL+++ +K+ DFGL + ++
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE------------- 182
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 342
+ ++ + +++ ++ V T Y APE++L + Y D W
Sbjct: 183 ----KDTNIVNDLEENEEPGPHNKNLKKQLTSH--VVTRWYRAPELILLQENYTKSIDIW 236
Query: 343 SLGAIMYEMLVGYPPFYSDEP 363
S G I E+L +D
Sbjct: 237 STGCIFAELLNMLQSHINDPT 257
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 63/295 (21%), Positives = 107/295 (36%), Gaps = 67/295 (22%)
Query: 118 DFEPLTM---IGKGAFGEVRVCREKAT--GHVYAMKKLKKSEM-LRRGQVEHVKAERNLL 171
DF LT+ IG G FG+V +A G A+K + +E+V+ E L
Sbjct: 5 DFAELTLEEIIGIGGFGKVY----RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
A + I+ L + L L+ME+ GG + +L + + + + +
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMN 119
Query: 232 SIHKHNY---IHRDIKPDNLLLDR--------NGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
+H IHRD+K N+L+ + N +K++DFGL +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--------------- 164
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340
W R +M S G ++APEV+ + D
Sbjct: 165 -------------------------EWHRTTKM---SAAGAYAWMAPEVIRASMFSKGSD 196
Query: 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISK 395
WS G +++E+L G PF + ++ + + L P L+
Sbjct: 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST--CPEPFAKLMED 249
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 77/349 (22%), Positives = 133/349 (38%), Gaps = 107/349 (30%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK---SEM-----LRRGQVEHVKAER 168
+ ++ L+ +G GA+G V + TG A+KKL + S + R E
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---------EL 79
Query: 169 NLLAEVDSNCIVKLY------CSFQDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEA 219
LL + ++ L S ++ +YL+ M L ++ LT++
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHV 134
Query: 220 RFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
+F + + + ++ IH + IHRD+KP NL ++ + +K+ DFGL
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL---------------- 178
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 338
R A T Y V T Y APE++L Y
Sbjct: 179 -----------ARHTADEMTG---------------Y--VATRWYRAPEIMLNWMHYNQT 210
Query: 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNW-----------------RTHLK-FP 380
D WS+G IM E+L G F + + + I+ R +++
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 381 EEAKL---------SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+ K+ +P A DL+ K+L + ++R+ A + AH +F
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---TAAQALAHAYFA 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 80/347 (23%), Positives = 136/347 (39%), Gaps = 102/347 (29%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK---SEM-----LRRGQVEHVKAER 168
+ T +G GA+G V +K +G A+KKL + SE+ R E
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR---------EL 74
Query: 169 NLLAEVDSNCIVKLY------CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
LL + ++ L S ++ YL+M ++ D+ ++ +EE+ ++
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYL 131
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
V + + ++ IH +HRD+KP NL ++ + +K+ DFGL
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL------------------- 172
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 341
R T Y V T Y APEV+L Y D
Sbjct: 173 --------ARHADAEMTG---------------Y--VVTRWYRAPEVILSWMHYNQTVDI 207
Query: 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIV-----------------NWRTHLK-FPEEA 383
WS+G IM EML G F + + +I+ +++++ P+
Sbjct: 208 WSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 267
Query: 384 KL---------SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
+ SP+A DL+ K+L +V++RL A + HP+F+
Sbjct: 268 RKDFTQLFPRASPQAADLLEKMLELDVDKRL---TAAQALTHPFFEP 311
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 77/351 (21%), Positives = 128/351 (36%), Gaps = 105/351 (29%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE-------MLRRGQVEHVKAERN 169
+ L+ IG+GA+G V + A+KK+ E LR E
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR---------EIK 77
Query: 170 LLAEVDSNCIVKLY-----CSFQDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEARF 221
+L I+ + + + + +Y++ + M T L ++ L+ + +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICY 132
Query: 222 YVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
++ + + ++ IH N +HRD+KP NLLL+ +K+ DFGL
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA----------------- 175
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECD 340
R H + Y V T Y APE++L KGY D
Sbjct: 176 ----------------RVADPDHDHTG---FLTEY--VATRWYRAPEIMLNSKGYTKSID 214
Query: 341 WWSLGAIMYEMLVGYPPF----YSDE-----------PMSTCRKIVNWRT---------- 375
WS+G I+ EML P F Y D+ I+N +
Sbjct: 215 IWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274
Query: 376 -----HLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
+ FP +A DL+ K+L N +R+ ++ AHP+ +
Sbjct: 275 NKVPWNRLFP---NADSKALDLLDKMLTFNPHKRI---EVEQALAHPYLEQ 319
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 86/373 (23%), Positives = 134/373 (35%), Gaps = 116/373 (31%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKS--------------EMLRRGQVE 162
+E + +GKGA+G V ++ TG V A+KK+ + +L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT----- 63
Query: 163 HVKAERNLLAEVDSNCIVKLYCSFQDDEY--LYLIMEYLPGGDMMTLL---MRKDTLTEE 217
+ N IV L + D +YL+ +Y M T L +R + L
Sbjct: 64 ELSGHEN---------IVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPV 109
Query: 218 EARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
++ V + + I+ +H +HRD+KP N+LL+ H+K++DFGL + +
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 278 SIGSNLSGALQSDGRP-----VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332
+ N + D +P VA R W Y APE+LL
Sbjct: 170 PLSINENTENFDDDQPILTDYVATR---------W----------------YRAPEILLG 204
Query: 333 -KGYGMECDWWSLGAIMYEMLVGYP----------------------------------- 356
Y D WSLG I+ E+L G P
Sbjct: 205 STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAK 264
Query: 357 ------PFYSDEPMSTCRKIVNWRTHL--KFPEEAKLSPEAKDLISKLLC-NVEQRLGTK 407
+ S R I +L K +A + EA DL+ KLL N +R+
Sbjct: 265 TMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI--- 321
Query: 408 GADEIKAHPWFKG 420
A++ HP+
Sbjct: 322 SANDALKHPFVSI 334
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 71/356 (19%), Positives = 124/356 (34%), Gaps = 111/356 (31%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKL---KKSEMLR--RGQVEHVKAERNLLAE 173
+ L +G G G V + A+KK+ + R E ++
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR--------EIKIIRR 64
Query: 174 VDSNCIVKLY--------------CSFQDDEYLYLIMEYLPGGDMMTLL---MRKDTLTE 216
+D + IVK++ S + +Y++ EY M T L + + L E
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLE 119
Query: 217 EEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD-RNGHMKLSDFGLCKPLDCSNLQEK 275
E AR ++ + + ++ IH N +HRD+KP NL ++ + +K+ DFGL + +D
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------- 172
Query: 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KG 334
H+ + + T Y +P +LL
Sbjct: 173 -----------------------------PHYSHKGHLSEG--LVTKWYRSPRLLLSPNN 201
Query: 335 YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIV----------------NWRTHLK 378
Y D W+ G I EML G F + + I+ +++
Sbjct: 202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIR 261
Query: 379 -------------FPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
P +S EA D + ++L + RL A+E +HP+
Sbjct: 262 NDMTEPHKPLTQLLP---GISREAVDFLEQILTFSPMDRL---TAEEALSHPYMSI 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 67/401 (16%), Positives = 132/401 (32%), Gaps = 117/401 (29%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQV---EHVKAER----- 168
+ I G++G V + G A+K++ + R + +R
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 169 NLLAEVDSNCIVKLY-----CSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFY 222
LL I+ L LYL+ E + D+ ++ ++ ++ + +++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ +L + +H+ +HRD+ P N+LL N + + DF L
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL------------------- 180
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 341
R + Y V Y APE++++ KG+ D
Sbjct: 181 --------AREDTA-------------DANKTHY--VTHRWYRAPELVMQFKGFTKLVDM 217
Query: 342 WSLGAIMYEMLVGYPPF----YSDE-----------PMSTCRKIVNW--RTHLK------ 378
WS G +M EM F + ++ + + R +L+
Sbjct: 218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277
Query: 379 --------FPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQI 429
P P A DLI+K+L N ++R+ ++ HP+F+ +
Sbjct: 278 PARAWTAVVP---TADPVALDLIAKMLEFNPQRRI---STEQALRHPYFESLF------- 324
Query: 430 KAAFIPEVNDELDTQNFE-KFEEADNQIQTSAKSGPWRKML 469
+ D + + F+E+ + K+
Sbjct: 325 ------DPLDLTEGLSERFHFDESVTDVYD------MHKIF 353
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 95/400 (23%), Positives = 149/400 (37%), Gaps = 127/400 (31%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK---SEM-----LRRGQVEHVKAER 168
+ L +G GA+G V + TG A+KKL + SE+ R E
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR---------EL 75
Query: 169 NLLAEVDSNCIVKLY------CSFQDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEA 219
LL + ++ L + D YL+M + M T L M+ + L E+
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRI 130
Query: 220 RFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
+F V + + + IH IHRD+KP NL ++ + +K+ DFGL
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL---------------- 174
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 338
R T Y V T Y APEV+L Y
Sbjct: 175 -----------ARQADSEMTG---------------Y--VVTRWYRAPEVILNWMRYTQT 206
Query: 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIV-----------------NWRTHLK-FP 380
D WS+G IM EM+ G F + + ++I+ + ++K P
Sbjct: 207 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 266
Query: 381 EEAKL---------SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIK 430
E K SP A +L+ K+L + EQR+ A E AHP+F+ L+
Sbjct: 267 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYFE-----SLH--- 315
Query: 431 AAFIPEVNDELDTQNFE-KFEEADNQIQTSAKSGPWRKML 469
+ DE Q ++ F++ D + W+++
Sbjct: 316 -----DTEDEPQVQKYDDSFDDVDRTLDE------WKRVT 344
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 78/359 (21%), Positives = 124/359 (34%), Gaps = 114/359 (31%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK---SEM-----LRRGQVEHVKAER 168
++ L IG GA G V + A+KKL + ++ R E
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR---------EL 112
Query: 169 NLLAEVDSNCIVKLY------CSFQDDEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEAR 220
L+ V+ I+ L + ++ + +YL+ME M L + + L E
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMS 167
Query: 221 FYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
+ + + + I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG------------ 215
Query: 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340
+ M Y V T Y APEV+L GY D
Sbjct: 216 ----------------------------TSFMMTPY--VVTRYYRAPEVILGMGYKENVD 245
Query: 341 WWSLGAIMYEMLVGYPPFY------------------SDEPM----STCRKIVNWRTHLK 378
WS+G IM EM+ F E M T R V R
Sbjct: 246 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA 305
Query: 379 -------FP---------EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
FP + +A+DL+SK+L + +R+ D+ HP+
Sbjct: 306 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 75/357 (21%), Positives = 125/357 (35%), Gaps = 110/357 (30%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK---SEM-----LRRGQVEHVKAER 168
++ L IG GA G V + A+KKL + ++ R E
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR---------EL 75
Query: 169 NLLAEVDSNCIVKLY------CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY 222
L+ V+ I+ L S ++ + +Y++ME + ++ ++ + L E +
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYL 132
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ + + I+ +H IHRD+KP N+++ + +K+ DFGL +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------------- 178
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
+ M Y V T Y APEV+L GY D W
Sbjct: 179 --------------------------TSFMMTPY--VVTRYYRAPEVILGMGYKENVDIW 210
Query: 343 SLGAIMYEMLVGYPPFY------------------SDEPM----STCRKIV--------- 371
S+G IM EM+ G F E M T R V
Sbjct: 211 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGY 270
Query: 372 -------NWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420
+ + +A+DL+SK+L + +R+ DE HP+
Sbjct: 271 SFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI---SVDEALQHPYINV 324
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 64/357 (17%), Positives = 121/357 (33%), Gaps = 109/357 (30%)
Query: 125 IGKGAFGEV--RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKL 182
+G+G +G V ++ YA+K+++ + + E LL E+ ++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI-----ALLRELKHPNVISL 83
Query: 183 Y--CSFQDDEYLYLIMEYLPGGDMMTLL---------MRKDTLTEEEARFYVGETVLAIE 231
D ++L+ +Y D+ ++ + L + + + + I
Sbjct: 84 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 232 SIHKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+H + +HRD+KP N+L+ G +K++D G + F+
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL----------FNS-------- 184
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGA 346
P + L V T Y APE+LL + Y D W++G
Sbjct: 185 --------PLKP----LADLDPV--------VVTFWYRAPELLLGARHYTKAIDIWAIGC 224
Query: 347 IMYEMLVGYPPFYSDEPMSTCR---------KIV---------NWRTHLKFPE------- 381
I E+L P F+ + +I +W K PE
Sbjct: 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD 284
Query: 382 ------------------EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+ K +A L+ KLL + +R+ +++ P+F
Sbjct: 285 FRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYFL 338
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 9e-21
Identities = 52/273 (19%), Positives = 92/273 (33%), Gaps = 69/273 (25%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKAT--GHVYAMKKLKKSEMLRRGQVEHVKAERN--LLA 172
D+ + L +IG+G +G V K + A+K + ++ E+N +
Sbjct: 13 DNLKLLELIGRGRYGAVY----KGSLDERPVAVKVFSFANR------QNFINEKNIYRVP 62
Query: 173 EVDSNCIVKLY-----CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETV 227
++ + I + + L+MEY P G + L T +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVT 121
Query: 228 LAIESIH---------KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278
+ +H K HRD+ N+L+ +G +SDFGL L + L
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-------L 331
+ + S VGT Y+APEVL
Sbjct: 182 DNAAI---------------------------------SEVGTIRYMAPEVLEGAVNLRD 208
Query: 332 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
+ + D ++LG I +E+ + + E +
Sbjct: 209 XESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 49/235 (20%)
Query: 125 IGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+G+G FG+V + TG + A+K LK + K E ++L + I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILRTLYHEHII 96
Query: 181 KLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
K C L L+MEY+P G + L + ++ + + + + +H +Y
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR-PVAPR 297
IHRD+ N+LLD + +K+ DFGL K + + + ++ DG PV
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-----------VREDGDSPVF-- 202
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
W APE L + + D WS G +YE+L
Sbjct: 203 ---------W-----------------YAPECLKEYKFYYASDVWSFGVTLYELL 231
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 65/236 (27%), Positives = 100/236 (42%), Gaps = 50/236 (21%)
Query: 125 IGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+GKG FG V +CR + TG V A+KKL+ S + + E +L + + IV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIV 74
Query: 181 KLY--CSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHN 237
K C L LIMEYLP G + L + K+ + + Y + +E +
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR-PVAP 296
YIHRD+ N+L++ +K+ DFGL K L Q+K+F ++ G P+
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFK-------VKEPGESPIF- 182
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
W APE L + + + D WS G ++YE+
Sbjct: 183 ----------W-----------------YAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 64/236 (27%), Positives = 98/236 (41%), Gaps = 50/236 (21%)
Query: 125 IGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+GKG FG V +CR + TG V A+KKL+ S + + E +L + + IV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIV 105
Query: 181 KLY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
K C L LIMEYLP G + L K+ + + Y + +E +
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR-PVAP 296
YIHRD+ N+L++ +K+ DFGL K L Q+K++ + G P+
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEYYKV-------KEPGESPIF- 213
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
W APE L + + + D WS G ++YE+
Sbjct: 214 ----------W-----------------YAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 54/269 (20%), Positives = 82/269 (30%), Gaps = 66/269 (24%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKAT--GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE 173
A D L +GKG +GEV + + G A+K + + + E
Sbjct: 7 ARDITLLECVGKGRYGEVW----RGSWQGENVAVKIFSSRDE----KSWFRETELYNTVM 58
Query: 174 VDSNCIVKLY----CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
+ I+ S L+LI Y G + L + TL V
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASG 117
Query: 230 IESIH--------KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
+ +H K HRD+K N+L+ +NG ++D GL
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL------------------ 159
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL------LKKGY 335
A +Q N VGT Y+APEVL
Sbjct: 160 -------------AVMHSQSTNQLDVGNN------PRVGTKRYMAPEVLDETIQVDCFDS 200
Query: 336 GMECDWWSLGAIMYEMLVGYPPFYSDEPM 364
D W+ G +++E+ E
Sbjct: 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 26/255 (10%), Positives = 62/255 (24%), Gaps = 70/255 (27%)
Query: 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
++ + L G + + A A+ + +L ++ + L
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
+ +D + ++ ++ E++ GG + + + + A + A +
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAAD 143
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
+ H+ P + + DG
Sbjct: 144 AAHRAGVALSIDHPSRVRVS-------------------------------------IDG 166
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351
V + P + + D +GA +Y +
Sbjct: 167 DVV------------------------LAYPATMPDA-------NPQDDIRGIGASLYAL 195
Query: 352 LVGYPPFYSDEPMST 366
LV P S
Sbjct: 196 LVNRWPLPEAGVRSG 210
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 49/266 (18%), Positives = 87/266 (32%), Gaps = 65/266 (24%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ L + +G FG V + A+K + Q + E L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKH 77
Query: 177 NCIVKL--YC--SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEE--------AR--FY 222
I++ D L+LI + G + L + + ++ E AR Y
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAY 136
Query: 223 VGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+ E + ++ HK HRDIK N+LL N ++DFGL
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA------------------ 178
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL-----LKKGYGM 337
+ + + VGT Y+APEVL ++ +
Sbjct: 179 ---------------LKFEAGKSAGDTHGQ------VGTRRYMAPEVLEGAINFQRDAFL 217
Query: 338 ECDWWSLGAIMYEMLVGYPPFYSDEP 363
D +++G +++E+
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVD 243
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 55/267 (20%), Positives = 85/267 (31%), Gaps = 65/267 (24%)
Query: 118 DFEPLTM---IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV 174
+ + IGKG FGEV R K G A+K E + +AE +
Sbjct: 40 IARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVML 93
Query: 175 DSNCIVKLYCS----FQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAI 230
I+ + L+L+ +Y G + L + T+T E T +
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGL 152
Query: 231 ESIH--------KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSN 282
+H K HRD+K N+L+ +NG ++D GL D S D
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD-SATDTID------ 205
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG------YG 336
+ VGT Y+APEVL
Sbjct: 206 ------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 337 MECDWWSLGAIMYEMLVGYPPFYSDEP 363
D +++G + +E+ E
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 60/250 (24%), Positives = 107/250 (42%), Gaps = 59/250 (23%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEMLRRGQVEHVKAERNLLAE--VD 175
+E L +IGKG+FG+V + A+K ++ + R+ E ++ +L + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDN 157
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL--LMRKDT---LTEEEARFYVGETVLAI 230
+ ++ + +F ++ + E L M L L++K+ + R + + +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGH--MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+++HK+ IH D+KP+N+LL + G +K+ DF GS +
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDF------------------GS----SCY 251
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348
R Y+ + + Y APEV+L YGM D WSLG I+
Sbjct: 252 EHQRV----------------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
Query: 349 YEMLVGYPPF 358
E+L GYP
Sbjct: 290 AELLTGYPLL 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 51/268 (19%), Positives = 80/268 (29%), Gaps = 66/268 (24%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKAT--GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE 173
A + + IGKG +GEV G A+K +E + E
Sbjct: 36 AKQIQMVKQIGKGRYGEVW----MGKWRGEKVAVKVFFTTEE----ASWFRETEIYQTVL 87
Query: 174 VDSNCIVKLYCSFQDDEY----LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
+ I+ + LYLI +Y G + L + TL + +V
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSG 146
Query: 230 IESIH--------KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
+ +H K HRD+K N+L+ +NG ++D GL +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT- 205
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL------LKKGY 335
VGT Y+ PEVL
Sbjct: 206 ------------------------------------RVGTKRYMPPEVLDESLNRNHFQS 229
Query: 336 GMECDWWSLGAIMYEMLVGYPPFYSDEP 363
+ D +S G I++E+ E
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 50/236 (21%)
Query: 125 IGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+GKG FG V +CR TG + A+K+L+ S Q + E +L + S+ IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD---QQRDFQREIQILKALHSDFIV 87
Query: 181 KLY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
K + L L+MEYLP G + L + L Y + +E +
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR-PVAP 296
+HRD+ N+L++ H+K++DFGL K L +KD+ + ++ G+ P+
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDYYV-------VREPGQSPIF- 195
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
W APE L + + D WS G ++YE+
Sbjct: 196 ----------W-----------------YAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 9/151 (5%)
Query: 125 IGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+G+G FG+V +CR TG A+K LK + +K E +L + IV
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 86
Query: 181 KLY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
K C+ + LIME+LP G + L K+ + ++ Y + ++ +
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
Y+HRD+ N+L++ +K+ DFGL K ++
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 43/186 (23%), Positives = 72/186 (38%), Gaps = 48/186 (25%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE--------VDS 176
IG+G+FG + A+K E +++ L +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPG---GDMMTLLMRKDTLTEEEARFYVGETVL----- 228
I +Y Q+ + L+++ L G D++ L RK ++ +TV
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV----------KTVAMAAKQ 114
Query: 229 ---AIESIHKHNYIHRDIKPDNLLLDRNGHMK-----LSDFGLCKP-LDCSNLQEKDFSI 279
++SIH+ + ++RDIKPDN L+ R + DFG+ K D Q +
Sbjct: 115 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 280 GSNLSG 285
NLSG
Sbjct: 175 KKNLSG 180
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 66/368 (17%), Positives = 126/368 (34%), Gaps = 121/368 (32%)
Query: 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV------- 174
+ +G G F V + ++ AMK ++ ++ E + E LL V
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDADNTK 79
Query: 175 ----DSNCIVKLYCSFQ----DDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVG 224
+N I+KL F + ++ ++ E L G +++ L+ + + + +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 225 ETVLAIESIHKH-NYIHRDIKPDNLLLDR------NGHMKLSDFGLCKPLDCSNLQEKDF 277
+ +L ++ +H+ IH DIKP+N+L++ +K++D G + ++ +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG------NACWYDEHY 192
Query: 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337
+++ T +Y +PEVLL +G
Sbjct: 193 --------------------------------------TNSIQTREYRSPEVLLGAPWGC 214
Query: 338 ECDWWSLGAIMYEMLVGYPPFYSDEPMST------------------------------- 366
D WS +++E++ G F DE S
Sbjct: 215 GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTF 274
Query: 367 ------CRKIVN---WRTHLKFPEEAKLSPEA----KDLISKLLC-NVEQRLGTKGADEI 412
R I W E+ K S + D +S +L + +R A +
Sbjct: 275 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA-D--AGGL 331
Query: 413 KAHPWFKG 420
HPW K
Sbjct: 332 VNHPWLKD 339
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 61/360 (16%), Positives = 115/360 (31%), Gaps = 95/360 (26%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEMLRRGQVEHVKAERNL-LAEVDS 176
F + +G G FG V +C+ YA+K ++ + R ++E + + ++++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINN 95
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL--LMRKDT---LTEEEARFYVGETVLAIE 231
N IVK + F +++ LI E L +L ++ ++ E+ + Y E + A+
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLG----PSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK---------DFSIGSN 282
+ K + H D+KP+N+LLD K + DF G
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF--GC- 208
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
+ H S + T Y APEV+L G+ + D W
Sbjct: 209 ----------------ATFKSDYH---------GSIINTRQYRAPEVILNLGWDVSSDMW 243
Query: 343 SLGAIMYEMLVGYPPF------------------------------------------YS 360
S G ++ E+ G F +
Sbjct: 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303
Query: 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
++ + + D + +L + R E+ H + +
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 65/356 (18%), Positives = 126/356 (35%), Gaps = 89/356 (25%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVY-AMKKLK-KSEMLRRGQVEHVKAERNLLAE--V 174
+E + +G+G FG+V C + A G A+K ++ + ++E + + + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-INVLKKIKEKDKE 79
Query: 175 DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL--LMRKDT---LTEEEARFYVGETVLA 229
+ V + F ++ + E L ++++ R + A
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLG----KNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFG---LCKPLDCSNLQEKDFSIGSNLSGA 286
+ +H++ H D+KP+N+L + L + K + ++++ DF GS
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF--GS----- 188
Query: 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346
+ H + V T Y PEV+L+ G+ CD WS+G
Sbjct: 189 ------------ATFDHEHH---------TTIVATRHYRPPEVILELGWAQPCDVWSIGC 227
Query: 347 IMYEMLVGYPPF--------------------------------------YSDEPMSTCR 368
I++E G+ F DE S R
Sbjct: 228 ILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGR 287
Query: 369 KIVNWRTHLK--FPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421
+ LK +++ + DL+ ++L + QR+ E HP+F G+
Sbjct: 288 YVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLHPFFAGL 340
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 49/166 (29%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE--------VDS 176
IG G FGE+R+ + T A+K +E +K+ L
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGG----DMMTLLMRKDTLTEEEARFYVGETVL---- 228
+ I ++Y +Y +++E L G D+ L R +L +TVL
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL----------KTVLMIAI 112
Query: 229 ----AIESIHKHNYIHRDIKPDNLLLDRNGHMK-----LSDFGLCK 265
+E +H N I+RD+KP+N L+ R G+ + DF L K
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 65/265 (24%), Positives = 103/265 (38%), Gaps = 61/265 (23%)
Query: 106 YMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK-KSEMLRRGQVEHV 164
++ + D +E ++IGKG+FG+V ++ A+K +K K L + Q+E V
Sbjct: 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-V 101
Query: 165 KAERNLLAE--VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL--LMRKDT---LTEE 217
+ + IV L F +L L+ E L L L+R ++
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS----YNLYDLLRNTNFRGVSLN 157
Query: 218 EARFYVGETVLAIESIH--KHNYIHRDIKPDNLLLDRNGH--MKLSDFGLCKPLDCSNLQ 273
R + + A+ + + + IH D+KP+N+LL +K+ DFG S+ Q
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-------SSCQ 210
Query: 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333
+ +QS R R +PEVLL
Sbjct: 211 LGQ-----RIYQYIQS-------------------RFYR-------------SPEVLLGM 233
Query: 334 GYGMECDWWSLGAIMYEMLVGYPPF 358
Y + D WSLG I+ EM G P F
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 46/163 (28%), Positives = 65/163 (39%), Gaps = 45/163 (27%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAER-NLLAEV-------DS 176
IG G+FG++ + + A G A+K E VK + L E
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIYKMMQGG 64
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPG---GDMMTLLMRKDTLTEEEARFYVGETVL----- 228
I + + +Y ++ME L G D+ RK +L +TVL
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL----------KTVLLLADQ 113
Query: 229 ---AIESIHKHNYIHRDIKPDNLLLDRNGHMK---LSDFGLCK 265
IE IH N+IHRD+KPDN L+ + DFGL K
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/246 (23%), Positives = 95/246 (38%), Gaps = 47/246 (19%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+D IG+G FGEV R +A + A+K +++ E +L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 177 NCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESI 233
IV+L C+ + +Y++ME + GGD +T L L + VG+ +E +
Sbjct: 172 PNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
IHRD+ N L+ +K+SDFG+ + + ++ S G
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYA---------ASGGLR 275
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML- 352
P + W APE L Y E D WS G +++E
Sbjct: 276 QVPVK--------W-----------------TAPEALNYGRYSSESDVWSFGILLWETFS 310
Query: 353 VGYPPF 358
+G P+
Sbjct: 311 LGASPY 316
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 50/263 (19%), Positives = 90/263 (34%), Gaps = 31/263 (11%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL---AEVD 175
+ + +G G F V + + AMK +K +E E E LL D
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT----ETALDEIRLLKSVRNSD 94
Query: 176 SN-----CIVKLYCSFQ----DDEYLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVG 224
N +V+L F+ + ++ ++ E L G ++ +++ + L + +
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 225 ETVLAIESIHKH-NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ + ++ +H IH DIKP+N+LL N S S S
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 284 SGALQSDGRPVAPRRTQQEQLQH--------WQRNRRMLAYSTVGTPDYIAPEVLLKKGY 335
+ + ++ W + T Y + EVL+ GY
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGSGY 270
Query: 336 GMECDWWSLGAIMYEMLVGYPPF 358
D WS + +E+ G F
Sbjct: 271 NTPADIWSTACMAFELATGDYLF 293
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 50/256 (19%), Positives = 103/256 (40%), Gaps = 53/256 (20%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVY-AMKKLK-KSEMLRRGQVEHVKAERNLLAEV-- 174
+E + +G+GAFG+V C + G + A+K +K + E +L +
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70
Query: 175 ----DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTL--LMRKDT---LTEEEARFYVGE 225
+ V++ F+ ++ ++ E L ++ ++++ + R +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELLG----LSTYDFIKENGFLPFRLDHIRKMAYQ 126
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL---CKPLDCSNLQEKDFSIGSN 282
++ +H + H D+KP+N+L ++ + + + + + L +++ DF GS
Sbjct: 127 ICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF--GS- 183
Query: 283 LSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 342
+ H + V T Y APEV+L G+ CD W
Sbjct: 184 ----------------ATYDDEHH---------STLVSTRHYRAPEVILALGWSQPCDVW 218
Query: 343 SLGAIMYEMLVGYPPF 358
S+G I+ E +G+ F
Sbjct: 219 SIGCILIEYYLGFTVF 234
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 52/252 (20%), Positives = 100/252 (39%), Gaps = 56/252 (22%)
Query: 117 DDFEPLTMIGKGAFGEV-----RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
+F+ + ++G GAFG V EK V A+K+L+++ + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATS--PKANKEILDEAYVM 71
Query: 172 AEVDSNCIVKLY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVL 228
A VD+ + +L C + LI + +P G ++ + KD + + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+ + +HRD+ N+L+ H+K++DFGL K L +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH------------A 176
Query: 289 SDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
G+ P+ W +A E +L + Y + D WS G
Sbjct: 177 EGGKVPIK-----------W-----------------MALESILHRIYTHQSDVWSYGVT 208
Query: 348 MYEML-VGYPPF 358
++E++ G P+
Sbjct: 209 VWELMTFGSKPY 220
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 50/242 (20%), Positives = 82/242 (33%), Gaps = 47/242 (19%)
Query: 117 DDFEPLTMIGKGAFGEVR--VCREKATGHVY-AMKKLKKSEMLRRGQVEHVKAERNLLAE 173
D L +G G+FG VR + V A+K LK + + ++ E N +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 174 VDSNCIVKLY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAI 230
+D +++LY + ++ E P G ++ L + Y + +
Sbjct: 78 LDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
+ +IHRD+ NLLL +K+ DFGL + L N +
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP-QNDDHYVMQEHRKV------- 186
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
P A W APE L + + D W G ++E
Sbjct: 187 --PFA-----------W-----------------CAPESLKTRTFSHASDTWMFGVTLWE 216
Query: 351 ML 352
M
Sbjct: 217 MF 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 45/164 (27%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAE-RNLLAEV-------DS 176
IG G+FGE+ + T A+K E+VK + LL E
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIYRILQGG 62
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPG---GDMMTLLMRKDTLTEEEARFYVGETVL----- 228
I + + +Y L+M+ L G D+ RK +L +TVL
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL----------KTVLMLADQ 111
Query: 229 ---AIESIHKHNYIHRDIKPDNLLLDRNGHMK---LSDFGLCKP 266
+E +H +++HRDIKPDN L+ + DFGL K
Sbjct: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 10/149 (6%)
Query: 125 IGKGAFGEV---RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+G G FG V +K V A+K LK + E + E N++ ++D+ IV+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTV-AVKILKNEANDPALKDELLA-EANVMQQLDNPYIVR 82
Query: 182 LY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYI 239
+ C E L+ME G + L + + ++ V + + ++ + + N++
Sbjct: 83 MIGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
HRD+ N+LL + K+SDFGL K L
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALR 168
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 10/151 (6%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 177 NCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIES 232
+V+L C+ + Y+I E++ G+++ L + ++ + + A+E
Sbjct: 276 PNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263
+ K N+IHR++ N L+ N +K++DFGL
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGL 364
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 41/166 (24%), Positives = 65/166 (39%), Gaps = 34/166 (20%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLK---------KSEM--LRRGQVEHVKAERNLLAE 173
IG G FG + + A +K SE+ +R + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 174 VDSNCIVKLYCS----FQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL- 228
+D I Y S F+ Y +++ME L G D+ + + T + TVL
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS--------TVLQ 155
Query: 229 -------AIESIHKHNYIHRDIKPDNLLLDRNGHMK--LSDFGLCK 265
+E IH++ Y+H DIK NLLL + L+D+GL
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 52/252 (20%), Positives = 100/252 (39%), Gaps = 56/252 (22%)
Query: 117 DDFEPLTMIGKGAFGEV-----RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
+F+ + ++G GAFG V EK V A+K+L+++ + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATS--PKANKEILDEAYVM 71
Query: 172 AEVDSNCIVKLY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVL 228
A VD+ + +L C + LI + +P G ++ + KD + + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+ + +HRD+ N+L+ H+K++DFGL K L +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH------------A 176
Query: 289 SDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
G+ P+ W +A E +L + Y + D WS G
Sbjct: 177 EGGKVPIK-----------W-----------------MALESILHRIYTHQSDVWSYGVT 208
Query: 348 MYEML-VGYPPF 358
++E++ G P+
Sbjct: 209 VWELMTFGSKPY 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 33/142 (23%), Positives = 61/142 (42%), Gaps = 10/142 (7%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
IG G FG V + V A+K +++ M E E ++ ++ +V+LY
Sbjct: 16 IGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
C + + L+ E++ G + L ++ E + + + + IHR
Sbjct: 71 VCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 242 DIKPDNLLLDRNGHMKLSDFGL 263
D+ N L+ N +K+SDFG+
Sbjct: 129 DLAARNCLVGENQVIKVSDFGM 150
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 56/241 (23%), Positives = 93/241 (38%), Gaps = 52/241 (21%)
Query: 125 IGKGAFGEVR--VCREKATGHVY-AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
IG+G FG+V + + A+K K E E + + D IVK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQFDHPHIVK 455
Query: 182 LY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
L + + +++IME G++ + L +RK +L Y + A+ + +
Sbjct: 456 LIGVIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HRDI N+L+ N +KL DFGL + +++ + S G L P+
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKASK--GKL-----PIK--- 557
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPP 357
W +APE + + + D W G M+E+L G P
Sbjct: 558 --------W-----------------MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
Query: 358 F 358
F
Sbjct: 593 F 593
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 53/239 (22%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
+G+G FGEV + T V A+K LK M E E ++ ++ +V+LY
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIH 240
S +E +Y++ EY+ G ++ L + L + + + + + NY+H
Sbjct: 330 VVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 386
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RD++ N+L+ N K++DFGL + ++ + + G+ P+
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ---GAKF---------PIK----- 429
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 358
W APE L + ++ D WS G ++ E+ G P+
Sbjct: 430 ------W-----------------TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 53/239 (22%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
+G+G FGEV + T V A+K LK M E E ++ ++ +V+LY
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIH 240
S +E +Y++ EY+ G ++ L + L + + + + + NY+H
Sbjct: 247 VVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 303
Query: 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQ 300
RD++ N+L+ N K++DFGL + ++ + + G+ P+
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ---GAKF---------PIK----- 346
Query: 301 QEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 358
W APE L + ++ D WS G ++ E+ G P+
Sbjct: 347 ------W-----------------TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 36/143 (25%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
IGKG FG+V G+ A+K +K + AE +++ ++ + +V+L
Sbjct: 29 IGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
++ LY++ EY+ G ++ L + L + + + A+E + +N++H
Sbjct: 82 VIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 241 RDIKPDNLLLDRNGHMKLSDFGL 263
RD+ N+L+ + K+SDFGL
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGL 163
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 55/243 (22%), Positives = 93/243 (38%), Gaps = 54/243 (22%)
Query: 125 IGKGAFGEVR--VCREKATGHVY-AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
IG+G FG+V + + A+K K E E + + D IVK
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQFDHPHIVK 80
Query: 182 LY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
L + + +++IME G++ + L +RK +L Y + A+ + +
Sbjct: 81 LIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR-PVAPR 297
+HRDI N+L+ N +KL DFGL + +++ + S G+ P+
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKASK--------GKLPIK-- 182
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYP 356
W +APE + + + D W G M+E+L G
Sbjct: 183 ---------W-----------------MAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
Query: 357 PFY 359
PF
Sbjct: 217 PFQ 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 10/143 (6%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
+G G +GEV K A+K LK+ M +VE E ++ E+ +V+L
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
C+ + Y+I E++ G+++ L + ++ + + A+E + K N+IH
Sbjct: 77 VCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 241 RDIKPDNLLLDRNGHMKLSDFGL 263
RD+ N L+ N +K++DFGL
Sbjct: 135 RDLAARNCLVGENHLVKVADFGL 157
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 55/339 (16%), Positives = 121/339 (35%), Gaps = 61/339 (17%)
Query: 28 HGKEVSKAQTSEEVPSNVTKQKVAAAKQYIENHYKKQMKSLEERKERRNILEKKLADAEV 87
HG+ + VP + + + K+ S + N + + +
Sbjct: 14 HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN--TVHIDLSAL 71
Query: 88 SEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVR----VCREKATGH 143
+ E + + + + +IG+G FG V + + H
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNE------------VIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 144 VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY-CSFQDDEYLYLIMEYLPGG 202
A+K L + + +V E ++ + ++ L + + +++ Y+ G
Sbjct: 120 C-AVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 176
Query: 203 DMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDF 261
D+ + T ++ + + ++ + ++HRD+ N +LD +K++DF
Sbjct: 177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGT 321
GL + ++ +K+F N +GA PV W
Sbjct: 237 GLAR-----DMYDKEFDSVHNKTGAKL----PV-----------KW-------------- 262
Query: 322 PDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFY 359
+A E L + + + D WS G +++E++ G PP+
Sbjct: 263 ---MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 58/242 (23%), Positives = 95/242 (39%), Gaps = 52/242 (21%)
Query: 125 IGKGAFGEVR--VCREKATGHVY-AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+G+G FGEV V + A+K KK L E +E ++ +D IVK
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKNLDHPHIVK 77
Query: 182 LY--CSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNY 238
L +E ++IME P G++ L R K++L Y + A+ + N
Sbjct: 78 LIGIIE---EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HRDI N+L+ +KL DFGL + ++++D+ S P+
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSR-----YIEDEDYYKA---SVTRL----PIK--- 179
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPP 357
W ++PE + + + D W M+E+L G P
Sbjct: 180 --------W-----------------MSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
Query: 358 FY 359
F+
Sbjct: 215 FF 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 45/244 (18%), Positives = 87/244 (35%), Gaps = 56/244 (22%)
Query: 125 IGKGAFGEV-----RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+G G FG V E V +K ++ + + V + +D I
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPV-CIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHI 77
Query: 180 VKLY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKH 236
V+L C L L+ +YLP G ++ + + L + + + + + +H
Sbjct: 78 VRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR-PVA 295
+HR++ N+LL ++++DFG+ L + Q S+ + P+
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL------------YSEAKTPIK 182
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VG 354
W +A E + Y + D WS G ++E++ G
Sbjct: 183 -----------W-----------------MALESIHFGKYTHQSDVWSYGVTVWELMTFG 214
Query: 355 YPPF 358
P+
Sbjct: 215 AEPY 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 37/142 (26%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
+G G FG V++ + K V A+K +K+ M + E + ++ +VK Y
Sbjct: 16 LGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
CS + +Y++ EY+ G ++ L L + + + + H +IHR
Sbjct: 71 VCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 242 DIKPDNLLLDRNGHMKLSDFGL 263
D+ N L+DR+ +K+SDFG+
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGM 150
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 36/143 (25%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
IGKG FG+V G+ A+K +K + AE +++ ++ + +V+L
Sbjct: 201 IGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLG 253
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
++ LY++ EY+ G ++ L + L + + + A+E + +N++H
Sbjct: 254 VIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312
Query: 241 RDIKPDNLLLDRNGHMKLSDFGL 263
RD+ N+L+ + K+SDFGL
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGL 335
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 45/244 (18%), Positives = 98/244 (40%), Gaps = 49/244 (20%)
Query: 124 MIGKGAFGEVR----VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+IG+G FG V + + H A+K L + + +V E ++ + +
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 88
Query: 180 VKLY-CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
+ L + + +++ Y+ GD+ + T ++ + + ++ +
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD-FSIGSNLSGALQSDGRPVAP 296
++HRD+ N +LD +K++DFGL + ++ +K+ +S+ + L PV
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL-----PV-- 196
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGY 355
+ M A E L + + + D WS G +++E++ G
Sbjct: 197 --------------KWM------------ALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230
Query: 356 PPFY 359
PP+
Sbjct: 231 PPYP 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 34/171 (19%), Positives = 61/171 (35%), Gaps = 41/171 (23%)
Query: 125 IGKGAFGEVRVCR-----EKATGHVYAMKKLKK--------SEMLRRGQVEHVKAERNLL 171
IG+G FG + + + +K + +R +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 172 AEVDSNCIVKLYCS----FQDDEYLYLIMEYLPGGDMMTLLM---RKDTLTEEEARFYVG 224
++ + K + S Y ++IM+ G D+ + ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR---------- 151
Query: 225 ETVL--------AIESIHKHNYIHRDIKPDNLLLDRNGHMK--LSDFGLCK 265
+TVL +E IH+H Y+H DIK NLLL+ + L D+GL
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 48/243 (19%), Positives = 100/243 (41%), Gaps = 47/243 (19%)
Query: 124 MIGKGAFGEVR----VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
+IGKG FG V + + + A+K L + ++ QVE E L+ ++ +
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQ--QVEAFLREGLLMRGLNHPNV 84
Query: 180 VKLY-CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
+ L + ++++ Y+ GD++ + + T ++ + + +E + +
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
++HRD+ N +LD + +K++DFGL + ++ ++++ A PV
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLAR-----DILDREYYSVQQHRHARL----PV--- 192
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYP 356
W A E L + + D WS G +++E+L G P
Sbjct: 193 --------KW-----------------TALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
Query: 357 PFY 359
P+
Sbjct: 228 PYR 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 34/142 (23%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
+G G FG V+ + + V A+K +K+ M + E ++ + +V+LY
Sbjct: 32 LGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNYIHR 241
C+ +++I EY+ G ++ L + ++ + A+E + ++HR
Sbjct: 87 VCT--KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 242 DIKPDNLLLDRNGHMKLSDFGL 263
D+ N L++ G +K+SDFGL
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGL 166
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 29/170 (17%), Positives = 58/170 (34%), Gaps = 39/170 (22%)
Query: 125 IGKGAFGEVRVCREKATGHV--------YAMKKLKKSEML--------RRGQVEHVKAER 168
+ G + +T +++K K L R + V +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 169 NLLAEVDSNCIVKLYCS-FQDDEYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGE 225
L I D+Y +L++ L G + + L K L+E
Sbjct: 110 KL-YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER-------- 159
Query: 226 TVL--------AIESIHKHNYIHRDIKPDNLLLDRNGHMK--LSDFGLCK 265
+VL A+E +H++ Y+H ++ +N+ +D + L+ +G
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 51/252 (20%), Positives = 95/252 (37%), Gaps = 68/252 (26%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+GAFG+V + + V A+K LK+ + + +E +L + +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHS--EHRALMSELKILIHIGHHL 91
Query: 179 -IVKLY-CSFQDDEYLYLIMEYLPGGDMMTLLM--RKDTLTEEEARFYVGETVLAIESIH 234
+V L + L +I+E+ G++ T L R + + + A + + L +E +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 235 K--------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
IHRD+ N+LL +K+ DFGL + + +
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR----- 206
Query: 281 SNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 339
+ D R P+ W M APE + + Y ++
Sbjct: 207 -------KGDARLPL-----------KW-----M------------APETIFDRVYTIQS 231
Query: 340 DWWSLGAIMYEM 351
D WS G +++E+
Sbjct: 232 DVWSFGVLLWEI 243
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 57/252 (22%), Positives = 96/252 (38%), Gaps = 71/252 (28%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-- 176
+G GAFG+V + +E A V A+K LK + + E + +E +++ +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHAD--EKEALMSELKIMSHLGQHE 110
Query: 177 NCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
N IV L C+ + +I EY GD++ L RK + E + F + + + +
Sbjct: 111 N-IVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 235 K--------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280
N IHRD+ N+LL K+ DFGL + + +
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV----- 222
Query: 281 SNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 339
+ + R PV W M APE + Y ++
Sbjct: 223 -------KGNARLPV-----------KW-----M------------APESIFDCVYTVQS 247
Query: 340 DWWSLGAIMYEM 351
D WS G +++E+
Sbjct: 248 DVWSYGILLWEI 259
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
+G G FGEV + V A+K LK+ M + AE NL+ ++ +V+LY
Sbjct: 21 LGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYA 75
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
+ E +Y+I EY+ G ++ L LT + + + I + NYIH
Sbjct: 76 VVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 241 RDIKPDNLLLDRNGHMKLSDFGL 263
RD++ N+L+ K++DFGL
Sbjct: 133 RDLRAANILVSDTLSCKIADFGL 155
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 49/245 (20%), Positives = 93/245 (37%), Gaps = 55/245 (22%)
Query: 125 IGKGAFGEVR--VCREKATGHVY-AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+G G FGEV + + + A+K LK + Q E +++ + D I++
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMGQFDHPNIIR 110
Query: 182 LY--CSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNY 238
L + + + ++ EY+ G + + L T + + ++ + Y
Sbjct: 111 LEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HRD+ N+L++ N K+SDFG L L+ D
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFG--------------------LGRVLEDDPEA----- 203
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLGAIMYEML-VG 354
AY+T G I +PE + + + D WS G +++E++ G
Sbjct: 204 ----------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 355 YPPFY 359
P++
Sbjct: 248 ERPYW 252
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 10/145 (6%)
Query: 125 IGKGAFGEVR--VCREKATGHVY-AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
IG G GEV R V A+K LK R Q +E +++ + D I++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQFDHPNIIR 114
Query: 182 LY--CSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNY 238
L + ++ EY+ G + T L T + + + + Y
Sbjct: 115 LEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGL 263
+HRD+ N+L+D N K+SDFGL
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGL 197
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 55/247 (22%), Positives = 93/247 (37%), Gaps = 58/247 (23%)
Query: 125 IGKGAFGEV-----RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
IG G FGEV + K V A+K LK + Q E ++ + + I
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPV-AIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNI 108
Query: 180 VKLY--CSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKH 236
++L S + + +I EY+ G + L + + + + ++ +
Sbjct: 109 IRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
NY+HRD+ N+L++ N K+SDFGL S + E D
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGL------SRVLEDDPE------------------ 202
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLGAIMYEML- 352
Y+T G I APE + + + D WS G +M+E++
Sbjct: 203 -----------------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
Query: 353 VGYPPFY 359
G P++
Sbjct: 246 YGERPYW 252
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY- 183
+G G FGEV + V A+K +K M VE AE N++ + + +VKL+
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 184 -CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHKHNYIH 240
+ E +Y+I E++ G ++ L + + + + I + NYIH
Sbjct: 251 VVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307
Query: 241 RDIKPDNLLLDRNGHMKLSDFGL 263
RD++ N+L+ + K++DFGL
Sbjct: 308 RDLRAANILVSASLVCKIADFGL 330
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 9e-14
Identities = 57/241 (23%), Positives = 96/241 (39%), Gaps = 51/241 (21%)
Query: 125 IGKGAFGEVRV---CREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK 181
+G G FG VR K V A+K LK+ E + E ++ ++D+ IV+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVR 400
Query: 182 LY--CSFQDDEYLYLIMEYLPGGDMMT-LLMRKDTLTEEEARFYVGETVLAIESIHKHNY 238
L C E L L+ME GG + L+ +++ + + + + ++ + + N+
Sbjct: 401 LIGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HR++ N+LL + K+SDFGL K L D + +G P+
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKA-----LGADDSYYTARSAGKW-----PLK--- 504
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPP 357
W APE + + + D WS G M+E L G P
Sbjct: 505 --------W-----------------YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
Query: 358 F 358
+
Sbjct: 540 Y 540
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 125 IGKGAFGEVR--VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKL 182
+G G FG VR V R + A+K LK+ E + E ++ ++D+ IV+L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 75
Query: 183 Y--CSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYI 239
C E L L+ME GG + L+ +++ + + + + ++ + + N++
Sbjct: 76 IGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 240 HRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
HRD+ N+LL + K+SDFGL K L
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALG 161
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 50/254 (19%), Positives = 87/254 (34%), Gaps = 62/254 (24%)
Query: 125 IGKGAFGEVR----VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+GKG FG VR + + V A+K LK + +E E + E D +
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKV-AVKMLKADIIASS-DIEEFLREAACMKEFDHPHVA 88
Query: 181 KLY-CSFQDD-----EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
KL S + +I+ ++ GD+ L + E + V + I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIA 147
Query: 235 K-------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
N+IHRD+ N +L + + ++DFGL + + + +
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ------------ 195
Query: 288 QSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346
+ PV + + A E L Y + D W+ G
Sbjct: 196 GCASKLPV----------------KWL------------ALESLADNLYTVHSDVWAFGV 227
Query: 347 IMYEML-VGYPPFY 359
M+E++ G P+
Sbjct: 228 TMWEIMTRGQTPYA 241
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 66/337 (19%), Positives = 117/337 (34%), Gaps = 90/337 (26%)
Query: 60 HYKKQMKSLEERKERRNILEKKLADAEVSEEEQNNLLKYLEKKET---------EYMRLQ 110
H+ K + I ++ N L + T +
Sbjct: 7 HHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS 66
Query: 111 RHKMGADDF-----EPLTM---IGKGAFGEV--------RVCREKATGHVYAMKKLKKSE 154
+++ D + LT+ +G+G FG+V + K V A+K LK
Sbjct: 67 EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDDA 125
Query: 155 MLRRGQVEHVKAERNLLAEVDSNC-IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLM-- 209
+ + + +E ++ + + I+ L C+ D LY+I+EY G++ L
Sbjct: 126 TEK--DLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRAR 181
Query: 210 RKDTLTEEEARFYVGETVLAIESIHK--------------HNYIHRDIKPDNLLLDRNGH 255
R + V E + + + IHRD+ N+L+ N
Sbjct: 182 RPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV 241
Query: 256 MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRML 314
MK++DFGL + ++ + +K ++GR PV W M
Sbjct: 242 MKIADFGLARDINNIDYYKK------------TTNGRLPV-----------KW-----M- 272
Query: 315 AYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351
APE L + Y + D WS G +M+E+
Sbjct: 273 -----------APEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 58/255 (22%), Positives = 98/255 (38%), Gaps = 73/255 (28%)
Query: 125 IGKGAFGEV--------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+G+GAFG+V + K V A+K LK + + + +E ++ +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEK--DLSDLVSEMEMMKMIGK 99
Query: 177 NC-IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIE 231
+ I+ L C+ D LY+I+EY G++ L R + V E + +
Sbjct: 100 HKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 232 SIHK--------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
+ IHRD+ N+L+ N MK++DFGL + ++ + +K
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK-- 215
Query: 278 SIGSNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYG 336
++GR PV W M APE L + Y
Sbjct: 216 ----------TTNGRLPV-----------KW-----M------------APEALFDRVYT 237
Query: 337 MECDWWSLGAIMYEM 351
+ D WS G +M+E+
Sbjct: 238 HQSDVWSFGVLMWEI 252
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-13
Identities = 44/175 (25%), Positives = 67/175 (38%), Gaps = 52/175 (29%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKS------------EMLRRGQV 161
++F+ +IG G FG+V K G A+K+ E L
Sbjct: 39 NNFDHKFLIGHGVFGKVY----KGVLRDGAKVALKRRTPESSQGIEEFETEIETL--SFC 92
Query: 162 EHVKAERNLLAEVDSNCIVKL--YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEE-- 217
H +L V L +C + + LI +Y+ G++ L D T
Sbjct: 93 RH----PHL---------VSLIGFC--DERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137
Query: 218 -EARFYVGETVLAIES------IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
E R + I + +H IHRD+K N+LLD N K++DFG+ K
Sbjct: 138 WEQRLEI-----CIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 29/167 (17%)
Query: 125 IGKGAFGEV---RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--NCI 179
IG+G FG+V R+ ++ A+K++K+ E +L ++ N I
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKD--DHRDFAGELEVLCKLGHHPN-I 88
Query: 180 VKLY--CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIESIHK 235
+ L C YLYL +EY P G+++ L R A + L+ + +
Sbjct: 89 INLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 236 --------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
+IHRD+ N+L+ N K++DFGL + +
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 59/256 (23%), Positives = 95/256 (37%), Gaps = 75/256 (29%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-- 176
+G GAFG+V + + A V A+K LK S L + E + +E +L+ + +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTV-AVKMLKPSAHLT--EREALMSELKVLSYLGNHM 87
Query: 177 NCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLL--MRKDTLTEEEARFYVGETVLAIES 232
N IV L C+ +I EY GD++ L R + + + + + LA++
Sbjct: 88 N-IVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 233 ----------------IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276
+ N IHRD+ N+LL K+ DFGL + + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV- 203
Query: 277 FSIGSNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY 335
+ + R PV W M APE + Y
Sbjct: 204 -----------KGNARLPV-----------KW-----M------------APESIFNCVY 224
Query: 336 GMECDWWSLGAIMYEM 351
E D WS G ++E+
Sbjct: 225 TFESDVWSYGIFLWEL 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 45/255 (17%), Positives = 96/255 (37%), Gaps = 65/255 (25%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+G+FG V V +++ V A+K + ++ +R + E +++ E + +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMR--ERIEFLNEASVMKEFNCHH 89
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLM--RKDTLTEEEARFYVGETVLAI---- 230
+V+L S + +IME + GD+ + L R ++ +
Sbjct: 90 VVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 231 ----ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
++ + ++HRD+ N ++ + +K+ DFG+ + + ++ K
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----------- 196
Query: 287 LQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
G PV R M +PE L + D WS G
Sbjct: 197 -GGKGLLPV----------------RWM------------SPESLKDGVFTTYSDVWSFG 227
Query: 346 AIMYEML-VGYPPFY 359
+++E+ + P+
Sbjct: 228 VVLWEIATLAEQPYQ 242
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 48/255 (18%), Positives = 96/255 (37%), Gaps = 65/255 (25%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G GAFGEV + + + V A+K L + + E ++++ +
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQ--DELDFLMEALIISKFNHQN 94
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETV-LAI----- 230
IV+ +++ME + GGD+ + L + + + + + +A
Sbjct: 95 IVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 231 -ESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
+ + ++++IHRDI N LL G K+ DFG+ + + ++ K
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK----------- 201
Query: 287 LQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
PV + M PE ++ + + D WS G
Sbjct: 202 -GGCAMLPV----------------KWM------------PPEAFMEGIFTSKTDTWSFG 232
Query: 346 AIMYEML-VGYPPFY 359
+++E+ +GY P+
Sbjct: 233 VLLWEIFSLGYMPYP 247
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 47/255 (18%), Positives = 91/255 (35%), Gaps = 65/255 (25%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G GAFGEV + + + V A+K L + + E ++++ +
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQ--DELDFLMEALIISKFNHQN 135
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK- 235
IV+ ++++E + GGD+ + L + + + + + I
Sbjct: 136 IVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 236 ------HNYIHRDIKPDNLLLDRNGH---MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
+++IHRDI N LL G K+ DFG+ + + + K
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----------- 242
Query: 287 LQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345
PV + M PE ++ + + D WS G
Sbjct: 243 -GGCAMLPV----------------KWM------------PPEAFMEGIFTSKTDTWSFG 273
Query: 346 AIMYEML-VGYPPFY 359
+++E+ +GY P+
Sbjct: 274 VLLWEIFSLGYMPYP 288
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 29/157 (18%), Positives = 61/157 (38%), Gaps = 23/157 (14%)
Query: 125 IGKGAFGEVRVCREKATGHVY-------AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 177
+G+G F ++ + G +K L K+ E ++++++
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAASMMSKLSHK 72
Query: 178 CIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIH 234
+V Y C + L+ E++ G + T L + K+ + + A+ +
Sbjct: 73 HLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 235 KHNYIHRDIKPDNLLLDR--------NGHMKLSDFGL 263
++ IH ++ N+LL R +KLSD G+
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 30/163 (18%)
Query: 125 IGKGAFGEVRVCR------EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+GAFG+V + K V A+K LK + R + + E LL +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLV-AVKALKDPTLAAR---KDFQREAELLTNLQHEH 78
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLM--RKDTLTEEEARFYVGETVLAIESIH 234
IVK Y C D + L ++ EY+ GD+ L D + + + + L + +
Sbjct: 79 IVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 235 K--------------HNYIHRDIKPDNLLLDRNGHMKLSDFGL 263
+++HRD+ N L+ N +K+ DFG+
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 35/163 (21%), Positives = 62/163 (38%), Gaps = 29/163 (17%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+ FG+V + T V A+K LK E + E L A +
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGP--LREEFRHEAMLRARLQHPN 73
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH-- 234
+V L + D+ L +I Y GD+ L+ + ++ + A+E
Sbjct: 74 VVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 235 --------------KHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263
H+ +H+D+ N+L+ ++K+SD GL
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 57/256 (22%), Positives = 97/256 (37%), Gaps = 75/256 (29%)
Query: 125 IGKGAFGEV--------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+G+GAFG+V + V A+K LK + + + +E ++ +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKV-AVKMLKSDATEK--DLSDLISEMEMMKMIGK 133
Query: 177 --NCIVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLM--RKDTLTEEEARFYVGETVLAI 230
N I+ L C+ D LY+I+EY G++ L R L + E L+
Sbjct: 134 HKN-IINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 231 ESIHK--------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276
+ + IHRD+ N+L+ + MK++DFGL + + + +K
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK- 249
Query: 277 FSIGSNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY 335
++GR PV W M APE L + Y
Sbjct: 250 -----------TTNGRLPV-----------KW-----M------------APEALFDRIY 270
Query: 336 GMECDWWSLGAIMYEM 351
+ D WS G +++E+
Sbjct: 271 THQSDVWSFGVLLWEI 286
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 46/253 (18%), Positives = 86/253 (33%), Gaps = 61/253 (24%)
Query: 125 IGKGAFGEVR----VCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+G+G FG V + + V A+K +K +R E + E + + ++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLS-EAACMKDFSHPNVI 99
Query: 181 KLY-CSFQDD----EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
+L + +I+ ++ GD+ T L L + + + I
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 236 -------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
N++HRD+ N +L + + ++DFGL K + + +
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ------------G 206
Query: 289 SDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
+ PV W IA E L + Y + D W+ G
Sbjct: 207 RIAKMPV-----------KW-----------------IAIESLADRVYTSKSDVWAFGVT 238
Query: 348 MYEML-VGYPPFY 359
M+E+ G P+
Sbjct: 239 MWEIATRGMTPYP 251
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 29/162 (17%)
Query: 125 IGKGAFGEVRVCR------EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+GAFG+V + E+ V A+K LK++ R + + E LL +
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLV-AVKALKEASESAR---QDFQREAELLTMLQHQH 104
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHK 235
IV+ + C+ + L ++ EY+ GD+ L V L + +
Sbjct: 105 IVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 236 --------------HNYIHRDIKPDNLLLDRNGHMKLSDFGL 263
+++HRD+ N L+ + +K+ DFG+
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 55/272 (20%), Positives = 96/272 (35%), Gaps = 85/272 (31%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEH-VKAERNLLAEVDSNCIVKL 182
+G+G FG V + A+KKL + +++ E ++A+ +V+L
Sbjct: 38 KMGEGGFG--VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 183 Y-CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL--------AIES- 232
S D+ L+ Y+P G ++ L D G L A +
Sbjct: 96 LGFSSDGDDLC-LVYVYMPNGSLLDRLSCLD-----------GTPPLSWHMRCKIAQGAA 143
Query: 233 -----IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+H++++IHRDIK N+LLD K+SDFGL + +
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA----------RASEKFAQ----- 188
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYST--VGTPDYIAPE----VLLKKGYGMECDW 341
++ VGT Y+APE + K D
Sbjct: 189 -----------------TV---------MTSRIVGTTAYMAPEALRGEITPK-----SDI 217
Query: 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNW 373
+S G ++ E++ G P + +++
Sbjct: 218 YSFGVVLLEIITGLPAVDEHREP---QLLLDI 246
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 56/260 (21%), Positives = 96/260 (36%), Gaps = 78/260 (30%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G GAFG+V + + + V A+K LK+ + E + +E ++ ++ S+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSS--EREALMSELKMMTQLGSHE 109
Query: 179 -IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
IV L C+ +YLI EY GD++ L K E+ Y + L E
Sbjct: 110 NIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 236 -----------------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272
+ +HRD+ N+L+ +K+ DFGL + + +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 273 QEKDFSIGSNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL 331
+ + R PV W M APE L
Sbjct: 228 YVV------------RGNARLPV-----------KW-----M------------APESLF 247
Query: 332 KKGYGMECDWWSLGAIMYEM 351
+ Y ++ D WS G +++E+
Sbjct: 248 EGIYTIKSDVWSYGILLWEI 267
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 58/260 (22%), Positives = 93/260 (35%), Gaps = 78/260 (30%)
Query: 125 IGKGAFGEV------RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
+G+G FG+V + V A+K LK++ ++ + +E N+L +V+
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPS--ELRDLLSEFNVLKQVNHPH 87
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLM--RKDTLTEEEARFYVGETVLAIESIH 234
++KLY CS D L LI+EY G + L RK + + L
Sbjct: 88 VIKLYGACS--QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 235 K----------------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272
+HRD+ N+L+ MK+SDFGL + + +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 273 QEKDFSIGSNLSGALQSDGR-PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL 331
K +S GR PV W +A E L
Sbjct: 206 YVK------------RSQGRIPV-----------KW-----------------MAIESLF 225
Query: 332 KKGYGMECDWWSLGAIMYEM 351
Y + D WS G +++E+
Sbjct: 226 DHIYTTQSDVWSFGVLLWEI 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 43/171 (25%), Positives = 64/171 (37%), Gaps = 37/171 (21%)
Query: 125 IGKGAFGEVRVCR------EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 178
IG+GAFG V R + V A+K LK+ + E L+AE D+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMV-AVKMLKEEASAD--MQADFQREAALMAEFDNPN 111
Query: 179 IVKLY--CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK- 235
IVKL C+ + + L+ EY+ GD+ L T T + S
Sbjct: 112 IVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 236 -----------------------HNYIHRDIKPDNLLLDRNGHMKLSDFGL 263
++HRD+ N L+ N +K++DFGL
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 7e-11
Identities = 79/532 (14%), Positives = 147/532 (27%), Gaps = 161/532 (30%)
Query: 57 IENHYKKQMKSLEER-------KERRNILEKKLADAEV-------SEEEQNNLL--KYLE 100
+ YK + E+ K+ +++ + L+ E+ L L
Sbjct: 14 HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73
Query: 101 KKETEYMRLQRHKMGAD-DF--EPLTMIGKGAFGEVRV---CREKATGHVYAMKKLKKSE 154
K+E + + + F P+ + R+ R++ K
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN--- 130
Query: 155 MLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTL 214
+ R ++ R L E+ V + + G
Sbjct: 131 -VSR--LQPYLKLRQALLELRPAKNVLIDG-----------V----LG------------ 160
Query: 215 TEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC-KPLDC-SNL 272
G+T +A++ K + + + + C P L
Sbjct: 161 --------SGKTWVALDVC-------LSYK---VQCKMDFKIFWLNLKNCNSPETVLEML 202
Query: 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL- 331
Q+ + I N + +SD R Q RR+L + Y LL
Sbjct: 203 QKLLYQIDPNWTS--RSDHSSNIKLRIHSIQ----AELRRLLK-----SKPY--ENCLLV 249
Query: 332 ---------KKGYGMEC------------DWWSLGAIMYEMLVGY-PPFYSDEPMSTCRK 369
+ + C D+ S + L + DE S K
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 370 IVNWRTHLKFPEEA-KLSPEAKDLISKLLCNVEQRLGTKGADEIKAHP--W--FKGIEWD 424
++ R P E +P +I A+ I+ W +K + D
Sbjct: 310 YLDCRPQ-DLPREVLTTNPRRLSII---------------AESIRDGLATWDNWKHVNCD 353
Query: 425 KLYQIKAAFIPEVNDELDTQNFEK---FEEADNQIQTSAKSGPWRKMLSSKDINFVGYTY 481
KL I + + + + F++ F I T S W ++ S +
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPP-SAHIPTILLSLIWFDVIKSDVM------- 405
Query: 482 KNFEIVNDHQLPGIAELKKKS-----TKPKRPSIKSLFEDESATVN--QPVH 526
+VN +L K S K SI S++ + + +H
Sbjct: 406 ---VVVN--------KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 7e-09
Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 48/178 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKS-------------EMLRRGQ 160
D+F ++G+G FG+V K G + A+K+LK+ EM+
Sbjct: 30 DNFSNKNILGRGGFGKVY----KGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI--SM 83
Query: 161 VEHVKAERNLLAEVDSNCIVKL--YCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEE- 217
H RNL ++L +C L+ Y+ G + + L +
Sbjct: 84 AVH----RNL---------LRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 218 --EARFY--VGETVLAIESIHKH---NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268
R +G + + +H H IHRD+K N+LLD + DFGL K +D
Sbjct: 129 DWPKRQRIALG-SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 1e-08
Identities = 33/197 (16%), Positives = 61/197 (30%), Gaps = 48/197 (24%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKL-----KKSEMLRRGQVEHVKAERNLL 171
+ + IG+G FGEV + A A+K + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 172 AEVD-----------------SNCIVKLYC----------------------SFQDDEYL 192
E+ S V+ F D+ L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLD 251
++++E+ GG + MR + A+ + + ++ + HRD+ N+LL
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 252 RNGHMKLSDFGLCKPLD 268
+ KL K
Sbjct: 197 KTSLKKLHYTLNGKSST 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 33/160 (20%), Positives = 57/160 (35%), Gaps = 13/160 (8%)
Query: 125 IGKGAFGEVRVCR-----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--N 177
+G+GAFG+V + AT A+K LK+ + + +E +L + N
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLN 87
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
+ L + L +I+E+ G++ T L K E Y + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK----RNEFVPYKTKGARFRQGKDYVG 143
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277
I D+K + + S F K L +E
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 41/160 (25%), Positives = 64/160 (40%), Gaps = 25/160 (15%)
Query: 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKK-LKKS-------EMLRRGQVEHVKA 166
G P +IGKGA E + R+ +K+ +KK E +R+
Sbjct: 334 GKKRKIPEHLIGKGA--EADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAR 388
Query: 167 ERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFY-VGE 225
E LA V I Y D + ++M Y+ G KD + + Y +GE
Sbjct: 389 EARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLA------KDVIEDNLDIAYKIGE 442
Query: 226 TVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265
+ +HK++ IH D+ N + D + + DFGL K
Sbjct: 443 ---IVGKLHKNDVIHNDLTTSNFIFD--KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 549 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.77 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.52 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.52 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.51 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.13 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.99 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.2 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-73 Score=579.00 Aligned_cols=279 Identities=37% Similarity=0.688 Sum_probs=253.4
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
+...+||++++.||+|+||+||+|+++.||+.||||++.+..+......+.+.+|+++|+.++|||||+++++|++++++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34568899999999999999999999999999999999988777777788999999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|||||||+||||.+++.+.+.|+|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997642210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
...+.+.|||+.|||||++.+..|+.++|||||||++|||+
T Consensus 188 ---------------------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 228 (311)
T 4aw0_A 188 ---------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228 (311)
T ss_dssp ---------------------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 01123689999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC---CHHHHHcCCcccCCCcccccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK---GADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~---~~~eil~HpfF~~i~w~~l~~ 428 (549)
+|++||.+.+..+++.+|++ ..+.+|. .+|++++|||.+||+ ||.+|++.. +..+|++||||++++|+.|++
T Consensus 229 ~G~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 229 AGLPPFRAGNEGLIFAKIIK--LEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 304 (311)
T ss_dssp HSSCSSCCSSHHHHHHHHHH--TCCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred hCCCCCCCCCHHHHHHHHHc--CCCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence 99999999999999999987 4466775 799999999999999 999999531 334589999999999999998
Q ss_pred ccCCCc
Q 038137 429 IKAAFI 434 (549)
Q Consensus 429 ~~~pf~ 434 (549)
..||.+
T Consensus 305 ~~pP~l 310 (311)
T 4aw0_A 305 QTPPKL 310 (311)
T ss_dssp SCCCCC
T ss_pred CCCCCC
Confidence 888764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-70 Score=606.35 Aligned_cols=290 Identities=33% Similarity=0.647 Sum_probs=256.7
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHH---HhcCCCceeeeeeeecC
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL---AEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL---~~l~hp~Iv~l~~~f~d 188 (549)
..++.+||+++++||+|+||+||+|+++.||+.||||++.+..+........+.+|+.++ ..++|||||+|+++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 478889999999999999999999999999999999999998877777777777776554 56689999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+++|||||||+||+|.++|.+.+.|+|..+++|++||+.||+|||++|||||||||+||||+.+|+|||+|||+|+.+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998753
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 347 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvi 347 (549)
.. .+.+.||||.|||||++.+ .+|+.++||||||||
T Consensus 344 ~~-------------------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvi 380 (689)
T 3v5w_A 344 KK-------------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380 (689)
T ss_dssp SC-------------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHH
T ss_pred CC-------------------------------------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 21 1236799999999999974 689999999999999
Q ss_pred HHHHhhCCCCCCCCCch---hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCC
Q 038137 348 MYEMLVGYPPFYSDEPM---STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGI 421 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~---~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i 421 (549)
||||++|++||.+.+.. .+...+.. ..+.+|. .+|++++|||.+||+ ||.+|+++ .+++||++||||++|
T Consensus 381 lYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 381 LFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999999999875433 34445554 4455664 799999999999999 99999985 579999999999999
Q ss_pred Cccccc--cccCCCcccCCCccccccccc
Q 038137 422 EWDKLY--QIKAAFIPEVNDELDTQNFEK 448 (549)
Q Consensus 422 ~w~~l~--~~~~pf~p~~~~~~d~~~f~~ 448 (549)
||+.+. ++.|||+|.+.+..++.+||.
T Consensus 457 dW~~l~~~~~~pP~~P~~~~~~~~~~fD~ 485 (689)
T 3v5w_A 457 DWQMVFLQKYPPPLIPPRGEVNAADAFDI 485 (689)
T ss_dssp CHHHHHTTCSCCSCCCCTTCSSTTBCCC-
T ss_pred CHHHHHcCCCCcCccCCCCCCCcCCCCCC
Confidence 999996 588999999988887777763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-71 Score=564.04 Aligned_cols=280 Identities=42% Similarity=0.756 Sum_probs=243.6
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF 186 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 186 (549)
...++..++|++++.||+|+||+||+|++. .+++.||||++.+...... ....+.+|+.+|+.++|||||+++++|
T Consensus 17 ~~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 17 GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp TCCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEE
T ss_pred ccccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 344566789999999999999999999984 4789999999987654332 234578899999999999999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
++++.+|||||||+||+|.+++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
..... ....+.|||+.|||||++.+.+|+.++|||||||
T Consensus 176 ~~~~~-----------------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGv 214 (304)
T 3ubd_A 176 SIDHE-----------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGV 214 (304)
T ss_dssp ----------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHH
T ss_pred ccCCC-----------------------------------------ccccccccCcccCCHHHhccCCCCCCCcccchHH
Confidence 43210 0123679999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCc
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEW 423 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w 423 (549)
++|||++|++||.+.+..+++.+|.+ ..+.+|. .+|++++|||.+||+ ||.+|+++ .+++||++||||+++||
T Consensus 215 ilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 215 LMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 99999999999999999999999987 4456664 799999999999999 99999975 35899999999999999
Q ss_pred cccc--cccCCCcc
Q 038137 424 DKLY--QIKAAFIP 435 (549)
Q Consensus 424 ~~l~--~~~~pf~p 435 (549)
+.+. ++.|||+|
T Consensus 291 ~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 291 NKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHTTCSCCSSCC
T ss_pred HHHHhCCCCcCcCC
Confidence 9986 57899998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-68 Score=563.99 Aligned_cols=351 Identities=44% Similarity=0.829 Sum_probs=287.7
Q ss_pred hhhhhhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeee
Q 038137 103 ETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKL 182 (549)
Q Consensus 103 e~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 182 (549)
+....++.+.++..++|+++++||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|..++|||||++
T Consensus 47 ~~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l 126 (412)
T 2vd5_A 47 EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126 (412)
T ss_dssp HHHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred hhhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 34445667778889999999999999999999999999999999999998776666677789999999999999999999
Q ss_pred eeeecCCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeec
Q 038137 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 183 ~~~f~d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DF 261 (549)
+++|++.+.+|||||||+||+|.+++.+. ..+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999999999775 48999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-------cCC
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-------KKG 334 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-------~~~ 334 (549)
|+|+.+..... ....+.+||+.|+|||++. ...
T Consensus 207 Gla~~~~~~~~----------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~ 246 (412)
T 2vd5_A 207 GSCLKLRADGT----------------------------------------VRSLVAVGTPDYLSPEILQAVGGGPGTGS 246 (412)
T ss_dssp TTCEECCTTSC----------------------------------------EECSSCCSCGGGCCHHHHHHHHTCTTCSE
T ss_pred hhheeccCCCc----------------------------------------cccceeccccCcCCHHHHhhcccCcCCCC
Confidence 99987542110 0012468999999999998 357
Q ss_pred CCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCC-CcCCChhHHHHHHHhhhcccccCCCCCHHHHH
Q 038137 335 YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLLCNVEQRLGTKGADEIK 413 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~-~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil 413 (549)
|+.++|||||||++|||++|++||.+.+..+++.+|+++...+.+|. ...+|+++++||.+||++|.+|+|+.+++||+
T Consensus 247 ~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~ 326 (412)
T 2vd5_A 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFR 326 (412)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHH
T ss_pred CChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHh
Confidence 99999999999999999999999999999999999998766666664 24799999999999999999999988999999
Q ss_pred cCCcccCCCccccccccCCCcccCCCccccccccccccccccccccc--cCCccc-ccccccccccccceeeCccccCCC
Q 038137 414 AHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSA--KSGPWR-KMLSSKDINFVGYTYKNFEIVNDH 490 (549)
Q Consensus 414 ~HpfF~~i~w~~l~~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~f~g~~~~~~~~~~~~ 490 (549)
+||||++++|+.+....|||+|.+.++.|++||+.+.+......... ...+.. ......+..|.||||.+.. +.+.
T Consensus 327 ~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~-~~~~ 405 (412)
T 2vd5_A 327 THPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMA-LRDS 405 (412)
T ss_dssp TSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCCC-CCGG
T ss_pred cCCCcCCCCHHHHhhcCCCCCCcCCCcccccccCcccccccccccccCCCcccccCCCccccCCCCCCCcccCcc-cccc
Confidence 99999999999999999999999999999999997644322111000 000000 1112356789999998744 3344
Q ss_pred CCch
Q 038137 491 QLPG 494 (549)
Q Consensus 491 ~~~~ 494 (549)
.+|+
T Consensus 406 ~~~~ 409 (412)
T 2vd5_A 406 EVPG 409 (412)
T ss_dssp GCC-
T ss_pred cCCC
Confidence 4444
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-67 Score=561.59 Aligned_cols=335 Identities=44% Similarity=0.843 Sum_probs=290.2
Q ss_pred hhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 038137 107 MRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF 186 (549)
Q Consensus 107 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 186 (549)
..+...++..++|+++++||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|..++|||||+++++|
T Consensus 59 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 138 (410)
T 3v8s_A 59 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 138 (410)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34456678889999999999999999999999999999999999987766666667789999999999999999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
++...+|||||||+||+|.+++.+ ..+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 139 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 139 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999999999999999999854 5799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC----CCcccccc
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWW 342 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~----y~~~~DiW 342 (549)
+..... ....+.+||+.|+|||++.+.+ |+.++|||
T Consensus 218 ~~~~~~----------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~Diw 257 (410)
T 3v8s_A 218 MNKEGM----------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257 (410)
T ss_dssp CCTTSE----------------------------------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHH
T ss_pred eccCCc----------------------------------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEe
Confidence 542210 0122579999999999998766 89999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCCC
Q 038137 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
||||+||||++|++||.+.+...++.+|+++...+.+|....+|+++++||.+||+++.+|+|+.+++||++||||++++
T Consensus 258 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 258 SVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred cchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 99999999999999999999999999999877778888877899999999999999767787777999999999999999
Q ss_pred ccccc--cccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceeeCccc
Q 038137 423 WDKLY--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFEI 486 (549)
Q Consensus 423 w~~l~--~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~ 486 (549)
|+.+. ++.|||+|.+.++.|++||+++++......+. +........+..|.||||.+...
T Consensus 338 w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~----~~~~~~~~~~~~f~~f~~~~~~~ 399 (410)
T 3v8s_A 338 WAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETF----PIPKAFVGNQLPFVGFTYYSNRR 399 (410)
T ss_dssp CCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCC----CCCSSCCCTTGGGTTCCEECC--
T ss_pred HHHHhhcccCCCCCCcCCCccchhhcCCccccccccccC----CCchhhcccccccccceEeCccc
Confidence 97654 68999999999999999999876654322221 11122334578899999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-66 Score=558.59 Aligned_cols=338 Identities=46% Similarity=0.846 Sum_probs=286.5
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+...++..++|+++++||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|..++|||||+++++|++
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44556778999999999999999999999999999999999998776666666778999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
.+.+|||||||+||+|.+++.+ .+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999999999977 578999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccc
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWW 342 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiW 342 (549)
..... ......+||+.|+|||++. ...|+.++|||
T Consensus 226 ~~~~~----------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~Dvw 265 (437)
T 4aw2_A 226 MEDGT----------------------------------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265 (437)
T ss_dssp CTTSC----------------------------------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHH
T ss_pred ccCCC----------------------------------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeH
Confidence 42110 0112468999999999997 46799999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCC-cCCChhHHHHHHHhhhcccccCCCCCHHHHHcCCcccCC
Q 038137 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE-AKLSPEAKDLISKLLCNVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~-~~~s~~~~dLI~~lL~dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||||++|||++|++||.+.+..+++.+|+++...+.+|.. ..+|+++++||++||+.+.+|+++.+++||++||||+++
T Consensus 266 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 266 SLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 9999999999999999999999999999987666777764 468999999999999966678777799999999999999
Q ss_pred CccccccccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceeeCccccC
Q 038137 422 EWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFEIVN 488 (549)
Q Consensus 422 ~w~~l~~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~ 488 (549)
+|+.+..+.|||+|.+.++.|++||+..+.......+. ..+......+.+..|.||||..+..+.
T Consensus 346 ~w~~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~--~~~~~~~~~~~~~~f~~~~~~~~~~~~ 410 (437)
T 4aw2_A 346 DWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETM--PPPTHTAFSGHHLPFVGFTYTSSCVLS 410 (437)
T ss_dssp CTTTGGGSCCSCCCCCSSTTCCTTSCCC--------------------CCTTGGGTTCCEESSCTTS
T ss_pred CHHHHhhCCCCCCCcCCCccchhhcCCcccccccccCC--CCCccccccccCccccCCCcCCchhhc
Confidence 99999999999999999999999998754432211111 111112344567899999999876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-65 Score=518.09 Aligned_cols=254 Identities=32% Similarity=0.607 Sum_probs=216.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999987766666677899999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||| +|+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---- 166 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence 9999 78999999999999999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~G 354 (549)
...+.+||+.|||||++.+..| +.++|||||||++|||++|
T Consensus 167 --------------------------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg 208 (275)
T 3hyh_A 167 --------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 208 (275)
T ss_dssp ----------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence 0125799999999999999887 6899999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
++||.+.+....+.+|.+ ....+|. .+|+++++||.+||+ ||.+|+ +++|+++||||+
T Consensus 209 ~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~---s~~eil~hpw~k 267 (275)
T 3hyh_A 209 RLPFDDESIPVLFKNISN--GVYTLPK--FLSPGAAGLIKRMLIVNPLNRI---SIHEIMQDDWFK 267 (275)
T ss_dssp SCSSCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHSCSSGGGSC---CHHHHHHCHHHH
T ss_pred CCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCChhHCc---CHHHHHcCcccc
Confidence 999999988888888876 3455664 799999999999999 999999 899999999997
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-65 Score=530.47 Aligned_cols=256 Identities=30% Similarity=0.550 Sum_probs=229.2
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+.|++++.||+|+||+||+|+++.||+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|++++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999999865432 3345789999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||+||+|.+++.+ +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----- 224 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 224 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-----
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-----
Confidence 99999999998854 679999999999999999999999999999999999999999999999999998764221
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
....+.|||+.|||||++.+.+|+.++||||||||+|||++|++
T Consensus 225 ------------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 225 ------------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp ------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 01226799999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||.+.+..+.+..|... ....++....+|++++|||.+||+ ||.+|+ +++|||+||||+..
T Consensus 269 PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 269 PYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 330 (346)
T ss_dssp TTTTSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CCCCcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhcCC
Confidence 99999988888888753 233444446799999999999999 999999 89999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=528.53 Aligned_cols=326 Identities=36% Similarity=0.693 Sum_probs=274.5
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
.++..++|+++++||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|..+ +|||||+++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 456789999999999999999999999999999999999988776777788899999999988 7999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+|||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999854211
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 178 ~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 216 (353)
T 3txo_A 178 G-----------------------------------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216 (353)
T ss_dssp -------------------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHH
Confidence 0 01225799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC---CCHHHHHcCCcccCCCcccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~HpfF~~i~w~~l 426 (549)
|++|.+||.+.+..+.+.+|.+ ..+.+|. .+++++++||.+||+ ||.+|++. .+++||++||||++++|+.+
T Consensus 217 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l 292 (353)
T 3txo_A 217 MLCGHAPFEAENEDDLFEAILN--DEVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292 (353)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence 9999999999999999999987 4456664 689999999999999 99999975 35599999999999999998
Q ss_pred c--cccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceeeCcc
Q 038137 427 Y--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFE 485 (549)
Q Consensus 427 ~--~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 485 (549)
. ++.|||+|.+.++.|++||+.....+....+...... +....+..|.||+|.+..
T Consensus 293 ~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~---~~~~~~~~f~~f~~~~~~ 350 (353)
T 3txo_A 293 NHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGH---LPMINQDEFRNFEYVSPE 350 (353)
T ss_dssp HTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTS---GGGSCGGGGTTCCEECC-
T ss_pred hcCcCCCCccCCCCCcccccccCcccccCCCcCCCccccc---cCcccccccCCceeeCcc
Confidence 6 5889999999999999999963332222111111111 111234679999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-65 Score=530.44 Aligned_cols=258 Identities=27% Similarity=0.500 Sum_probs=225.5
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||+|+||+||+|+++.+|+.||||++.+..+ .....+.+.+|+.+|+.++|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35799999999999999999999999999999999987654 34456789999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 195 IMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|||||+||+|.++|... ..++|..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999999653 467999999999999999999999999999999999999999999999999998753110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
..+.+.|||+.|||||++.+..|+.++||||||||||||+
T Consensus 180 ----------------------------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml 219 (350)
T 4b9d_A 180 ----------------------------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219 (350)
T ss_dssp ----------------------------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 0122579999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+|++||.+.+..+++.+|++... ..+ +..+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 220 tG~~PF~~~~~~~~~~~i~~~~~-~~~--~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 220 TLKHAFEAGSMKNLVLKIISGSF-PPV--SLHYSYDLRSLVSQLFKRNPRDRP---SVNSILEKGFIAK 282 (350)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCC-CCC--CTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHT
T ss_pred HCCCCCCCcCHHHHHHHHHcCCC-CCC--CccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHHhhc
Confidence 99999999999999999987432 122 34799999999999999 999999 8999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-64 Score=523.64 Aligned_cols=326 Identities=37% Similarity=0.684 Sum_probs=276.5
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|..++||||++++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 56789999999999999999999999999999999999877666777888999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
+||||++||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence 999999999999999888999999999999999999999999999999999999999999999999999998642110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 160 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 200 (337)
T 1o6l_A 160 ---------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200 (337)
T ss_dssp ---------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc
Confidence 00125789999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--c
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--Q 428 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~ 428 (549)
|.+||.+.+....+..|.. ..+.+|. .+|+++++||.+||+ ||.+|+|. .+++||++||||++++|+.+. .
T Consensus 201 g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~ 276 (337)
T 1o6l_A 201 GRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 276 (337)
T ss_dssp SSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 9999999988888888876 4556664 789999999999999 99999975 379999999999999999986 4
Q ss_pred ccCCCcccCCCccccccccc-cccccccccccccCCcccccc---cccccccccceeeCc
Q 038137 429 IKAAFIPEVNDELDTQNFEK-FEEADNQIQTSAKSGPWRKML---SSKDINFVGYTYKNF 484 (549)
Q Consensus 429 ~~~pf~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~f~g~~~~~~ 484 (549)
+.|||+|.+.++.|+++|+. |..................+. ...+..|.||+|.+.
T Consensus 277 ~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 277 LLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp SCCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECC
T ss_pred CCCCCCCCCCCcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCC
Confidence 78999999999999999986 433221111110011111111 114568999999763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-64 Score=526.45 Aligned_cols=326 Identities=33% Similarity=0.644 Sum_probs=277.4
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
.++..++|+++++||+|+||+||+|+++.+|+.||||++.+.........+++.+|+.+|..+ +||||++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 456789999999999999999999999999999999999988766667788899999999887 8999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999864211
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 175 ~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (353)
T 2i0e_A 175 G-----------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213 (353)
T ss_dssp T-----------------------------------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHH
Confidence 0 00125789999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~ 427 (549)
|++|++||.+.+..+++.+|+. ..+.+|. .+|+++++||.+||+ ||.+|++. .++++|++||||++++|+.+.
T Consensus 214 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~ 289 (353)
T 2i0e_A 214 MLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 289 (353)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHH
T ss_pred HHcCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 9999999999999899999987 4456664 789999999999999 99999976 468999999999999999995
Q ss_pred --cccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceeeCccc
Q 038137 428 --QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFEI 486 (549)
Q Consensus 428 --~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~ 486 (549)
++.|||+|.+.++ |++||+.+........+... . ..+.......|.||+|.+.+.
T Consensus 290 ~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~--~-~~~~~~~~~~f~~f~~~~~~~ 346 (353)
T 2i0e_A 290 RKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPD--Q-EVIRNIDQSEFEGFSFVNSEF 346 (353)
T ss_dssp TTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCC--H-HHHHHSCTTTTCSCCEECTTC
T ss_pred hCCCCCCcCCCCCCc-chhhccchhccCCcccCCcc--c-cccccccccccCCCeeeCccc
Confidence 5899999999988 99999975433322111110 0 001112456899999998665
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-64 Score=533.62 Aligned_cols=327 Identities=33% Similarity=0.654 Sum_probs=269.8
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
..+..++|+++++||+|+||+||+|+++.+++.||||++++...........+.+|+.+|..+ +|||||+++++|++..
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 346678999999999999999999999999999999999987766666677889999999877 8999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|||||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 207 ~-----------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllye 245 (396)
T 4dc2_A 207 G-----------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245 (396)
T ss_dssp T-----------------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHH
Confidence 0 01225799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCC---------chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC---CCHHHHHcCCc
Q 038137 351 MLVGYPPFYSDE---------PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPW 417 (549)
Q Consensus 351 ml~G~~PF~~~~---------~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~Hpf 417 (549)
|++|++||.+.. ....+..|.. ..+.+|. .+|+++++||.+||+ ||.+|++. .+++||++|||
T Consensus 246 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 246 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp HHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred HHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 999999996432 1223444554 4556665 799999999999999 99999976 35799999999
Q ss_pred ccCCCccccc--cccCCCcccCCCccccccccccccccccccccccCCcccccc-cccccccccceeeCcccc
Q 038137 418 FKGIEWDKLY--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKML-SSKDINFVGYTYKNFEIV 487 (549)
Q Consensus 418 F~~i~w~~l~--~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~g~~~~~~~~~ 487 (549)
|++++|+.+. ++.|||+|.+.++.|++||+.....+....+. .. ...+ ...+..|.||+|.+...+
T Consensus 322 f~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~~~~-~~---~~~~~~~~~~~f~~f~~~~~~~~ 390 (396)
T 4dc2_A 322 FRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTP-DD---DDIVRKIDQSEFEGFEYINPLLM 390 (396)
T ss_dssp TTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCCCCC-CC---HHHHTTSCGGGGTTCCEECC---
T ss_pred ccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCccCC-Cc---chhhccccccccCCcEeECcccc
Confidence 9999999986 47899999999999999999633322211111 11 0111 123467999999986653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-64 Score=531.98 Aligned_cols=256 Identities=30% Similarity=0.550 Sum_probs=229.2
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+.|++++.||+|+||+||+|+++.||+.||||++.+.... ..+.+.+|+.+|+.++|||||++|++|++++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999865432 3355889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||+||+|.+++. .+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|+|||+|||+|+.+....
T Consensus 228 Ey~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~----- 301 (423)
T 4fie_A 228 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 301 (423)
T ss_dssp ECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-----
T ss_pred eCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-----
Confidence 9999999999885 4679999999999999999999999999999999999999999999999999998764221
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
....+.|||+.|||||++.+..|+.++||||||||+|||++|++
T Consensus 302 ------------------------------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 302 ------------------------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp ------------------------------------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 01226799999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||.+.+..+.+..|... ....++....+|++++|||.+||+ ||.+|+ +++|||+||||+..
T Consensus 346 PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 346 PYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA---TAAELLKHPFLAKA 407 (423)
T ss_dssp TTTTSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CCCCcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHHhcCC
Confidence 99999998888888753 223344445899999999999999 999999 89999999999854
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-63 Score=518.52 Aligned_cols=321 Identities=36% Similarity=0.675 Sum_probs=251.7
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
.++..++|+++++||+|+||.||+|+++.+|+.||||++++..........++..|+.+|..+ +|||||+++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999999999999999999987766666778899999999877 9999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+|||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999864211
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 172 ~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (345)
T 1xjd_A 172 D-----------------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210 (345)
T ss_dssp T-----------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHH
Confidence 0 00125799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHH-HHHcCCcccCCCccccc-
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD-EIKAHPWFKGIEWDKLY- 427 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~-eil~HpfF~~i~w~~l~- 427 (549)
|++|.+||.+.+....+.+|... ...+|. .+|+++++||.+||+ ||.+|+ ++. +|++||||++++|+.+.
T Consensus 211 ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dp~~R~---~~~~~i~~hp~f~~~~w~~l~~ 283 (345)
T 1xjd_A 211 MLIGQSPFHGQDEEELFHSIRMD--NPFYPR--WLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFREINWEELER 283 (345)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTTCCHHHHHT
T ss_pred HhcCCCCCCCCCHHHHHHHHHhC--CCCCCc--ccCHHHHHHHHHHhcCCHhHcC---CChHHHHcCccccCCCHHHHhh
Confidence 99999999999988888888763 445554 689999999999999 999999 455 99999999999999996
Q ss_pred -cccCCCcccCCCccccccccc-cccccccccccccCCccccccc-ccccccccceeeCcc
Q 038137 428 -QIKAAFIPEVNDELDTQNFEK-FEEADNQIQTSAKSGPWRKMLS-SKDINFVGYTYKNFE 485 (549)
Q Consensus 428 -~~~~pf~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~~~ 485 (549)
++.|||+|.+.++.|++||+. |..... ..+... ...+. ..+..|.||+|.+..
T Consensus 284 ~~~~~p~~p~~~~~~d~~~f~~~~~~~~~-~~~~~~----~~~~~~~~~~~f~~f~~~~~~ 339 (345)
T 1xjd_A 284 KEIDPPFRPKVKSPFDCSNFDKEFLNEKP-RLSFAD----RALINSMDQNMFRNFSFMNPG 339 (345)
T ss_dssp TCSCC-------------------------------------------CCTTTTCCC----
T ss_pred CCCCCCcCCCCCCcchhhhcchhhcccCc-cCCccc----ccccccccccccCCCeeeChh
Confidence 478999999999999999996 433221 111111 11111 245689999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-63 Score=523.44 Aligned_cols=328 Identities=37% Similarity=0.659 Sum_probs=246.1
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHH-HHhcCCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL-LAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~~ 190 (549)
..+..++|+++++||+|+||+||+|+++.+++.||||++.+..........++..|+.+ ++.++|||||+++++|++.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45677899999999999999999999999999999999998877666677788888887 47789999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||++||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999863211
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 193 ~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 231 (373)
T 2r5t_A 193 N-----------------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231 (373)
T ss_dssp C-----------------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHH
Confidence 0 00125799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC-CCHHHHHcCCcccCCCccccc-
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT-KGADEIKAHPWFKGIEWDKLY- 427 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~-~~~~eil~HpfF~~i~w~~l~- 427 (549)
|++|.+||.+.+..+++.+|++. .+.+|. .+++++++||.+||+ ||.+|++. .++++|++||||++++|+.+.
T Consensus 232 ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~ 307 (373)
T 2r5t_A 232 MLYGLPPFYSRNTAEMYDNILNK--PLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLIN 307 (373)
T ss_dssp HHHSSCTTCCSBHHHHHHHHHHS--CCCCCS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHcCCCCCCCCCHHHHHHHHHhc--ccCCCC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHh
Confidence 99999999999999999999874 455554 789999999999999 99999986 467999999999999999985
Q ss_pred -cccCCCcccCCCccccccccc-cccccccccc--cccCCcccccccccccccccceeeCc
Q 038137 428 -QIKAAFIPEVNDELDTQNFEK-FEEADNQIQT--SAKSGPWRKMLSSKDINFVGYTYKNF 484 (549)
Q Consensus 428 -~~~~pf~p~~~~~~d~~~f~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~f~g~~~~~~ 484 (549)
.+.|||+|.+.++.|++||+. |.+....... +.........+...+..|.||||.+.
T Consensus 308 ~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 368 (373)
T 2r5t_A 308 KKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPP 368 (373)
T ss_dssp TCSCCSCCCSCCC------------------------------------------------
T ss_pred CCCCCCCCCCCCCcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCc
Confidence 478999999999999999995 4433211100 00000001111224567999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-63 Score=511.98 Aligned_cols=250 Identities=28% Similarity=0.437 Sum_probs=218.6
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++.+.||+|+||+||+|+++.+|+.||||++++... ..+|+.+|+.++|||||++|++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999986543 2469999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~~~~~~~ 273 (549)
|||||+||+|.++|.+.+.|++..++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999889999999999999999999999999999999999999999998 6999999999976432110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
. ......+.|||+.|||||++.+..|+.++|||||||+||||++
T Consensus 208 ~------------------------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt 251 (336)
T 4g3f_A 208 K------------------------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251 (336)
T ss_dssp ------------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred c------------------------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 0 0001225789999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccc-cCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHL-KFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l-~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
|++||.+.+...++.+|......+ .+| ..+|+++++||.+||+ ||.+|+ ++.||+
T Consensus 252 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~---sa~el~ 308 (336)
T 4g3f_A 252 GCHPWTQYFRGPLCLKIASEPPPIREIP--PSCAPLTAQAIQEGLRKEPVHRA---SAMELR 308 (336)
T ss_dssp SSCSSTTTCCSCCHHHHHHSCCGGGGSC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred CcCCCCCCCHHHHHHHHHcCCCCchhcC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHH
Confidence 999999999888898888743322 233 4799999999999999 999999 799984
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-62 Score=498.51 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=218.2
Q ss_pred CCe-eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC----Cce
Q 038137 117 DDF-EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD----DEY 191 (549)
Q Consensus 117 ~~f-~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~~ 191 (549)
.+| ++.+.||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+.+|+.++|||||+++++|++ +..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 677889999999999999999999999999987654 34456779999999999999999999999875 467
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEcC-CCcEEEeecCcccccC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLD 268 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld~-~g~vKL~DFGlak~~~ 268 (549)
+|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999999999999999999999999999999998 999999999999985 8999999999997532
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.. .+.+.||||.|||||++.+ +|+.++|||||||+|
T Consensus 184 ~~-------------------------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvil 219 (290)
T 3fpq_A 184 AS-------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM 219 (290)
T ss_dssp TT-------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred CC-------------------------------------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHH
Confidence 11 1236799999999999865 699999999999999
Q ss_pred HHHhhCCCCCCCCCchh-hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 349 YEMLVGYPPFYSDEPMS-TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~-~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|||++|++||.+.+... .+..+........++ ..+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 220 yelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~---s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC-
T ss_pred HHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC--ccCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccC
Confidence 99999999998765544 444454432222333 4688999999999999 999999 8999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-62 Score=502.40 Aligned_cols=292 Identities=42% Similarity=0.854 Sum_probs=254.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||+|+||.||+|+++.+|+.||||++.+.........+++.+|+.+|..++|||||+++++|++...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45688999999999999999999999999999999999877666667788999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999865311
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
..+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 160 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 198 (318)
T 1fot_A 160 -----------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198 (318)
T ss_dssp -----------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh
Confidence 125689999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--c
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--Q 428 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~ 428 (549)
|.+||.+.+....+.+|++. .+.+|. .+++++++||.+||+ ||.+|++. .++++|++||||++++|+.+. .
T Consensus 199 g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~ 274 (318)
T 1fot_A 199 GYTPFYDSNTMKTYEKILNA--ELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 274 (318)
T ss_dssp SSCTTCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCC
Confidence 99999999988899999874 456664 789999999999999 99999975 379999999999999999986 4
Q ss_pred ccCCCcccCC-Ccccccccccccccc
Q 038137 429 IKAAFIPEVN-DELDTQNFEKFEEAD 453 (549)
Q Consensus 429 ~~~pf~p~~~-~~~d~~~f~~~~~~~ 453 (549)
+.|||+|.+. ++.|+++|+.+.+..
T Consensus 275 ~~~p~~p~~~~~~~d~~~f~~~~~~~ 300 (318)
T 1fot_A 275 IETPYEPPIQQGQGDTSQFDKYPEED 300 (318)
T ss_dssp SCCSCCCCC----------------C
T ss_pred CCCCCCCCcCCCccchhhcCCCCccc
Confidence 7899999998 589999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-62 Score=508.27 Aligned_cols=323 Identities=34% Similarity=0.669 Sum_probs=271.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCce
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 191 (549)
.+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|..+ +|||||+++++|++...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999987766667778899999999987 89999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+||||++||+|..++.+.+.+++..+++|++||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998542110
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 165 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 203 (345)
T 3a8x_A 165 -----------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 203 (345)
T ss_dssp -----------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred -----------------------------------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHH
Confidence 001256899999999999999999999999999999999
Q ss_pred hhCCCCCCCC---------CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC---CCHHHHHcCCcc
Q 038137 352 LVGYPPFYSD---------EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT---KGADEIKAHPWF 418 (549)
Q Consensus 352 l~G~~PF~~~---------~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~---~~~~eil~HpfF 418 (549)
++|++||... .....+..|.. ..+.+|. .+|+++++||.+||+ ||.+|++. .+++||++||||
T Consensus 204 l~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 204 MAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp HHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred HhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 9999999752 22334445554 3455664 789999999999999 99999975 257999999999
Q ss_pred cCCCccccc--cccCCCcccCCCccccccccc-cccccccccccccCCcccccccccccccccceeeCc
Q 038137 419 KGIEWDKLY--QIKAAFIPEVNDELDTQNFEK-FEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNF 484 (549)
Q Consensus 419 ~~i~w~~l~--~~~~pf~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~ 484 (549)
++++|+.+. ++.|||+|.+.++.|++||+. |...... .+. . .+ ..........|.||+|.+.
T Consensus 280 ~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~-~~~-~-~~-~~~~~~~~~~f~~f~~~~~ 344 (345)
T 3a8x_A 280 RNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQ-LTP-D-DD-DIVRKIDQSEFEGFEYINP 344 (345)
T ss_dssp TTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSS-CCC-C-CH-HHHTTSCGGGGTTCCEECC
T ss_pred CCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCccc-CCC-c-cc-cccccccccccCCCEeeCC
Confidence 999999986 478999999999999999986 4332211 110 0 00 0011124467999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=551.21 Aligned_cols=328 Identities=32% Similarity=0.643 Sum_probs=282.1
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
..+..++|+++++||+|+||+||+|+++.+++.||||++.+.........+.+..|+.+|..+ +||+|++++++|++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 456788999999999999999999999999999999999987766667778899999999987 7999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+||||||++||+|..++...+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999864211
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.. ...+.+||+.|+|||++.+..|+.++|||||||||||
T Consensus 496 ~~-----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilye 534 (674)
T 3pfq_A 496 GV-----------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534 (674)
T ss_dssp TC-----------------------------------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHH
T ss_pred Cc-----------------------------------------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHH
Confidence 10 0125799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~ 427 (549)
|++|.+||.+.+..+++.+|+. ..+.+|. .+|+++++||.+||+ ||.+|++. .+++||++||||++++|+.+.
T Consensus 535 lltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~ 610 (674)
T 3pfq_A 535 MLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 610 (674)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHS--SCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHT
T ss_pred HHcCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHH
Confidence 9999999999999999999987 4566765 799999999999999 99999975 457999999999999999996
Q ss_pred --cccCCCcccCCCccccccccccccccccccccccCCcccccccccccccccceeeCccccC
Q 038137 428 --QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSKDINFVGYTYKNFEIVN 488 (549)
Q Consensus 428 --~~~~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~ 488 (549)
++.|||+|.+.+ .|++||+.+........+.... ..+....+..|.||+|.+..++.
T Consensus 611 ~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~---~~~~~~~~~~f~~f~~~~~~~~~ 669 (674)
T 3pfq_A 611 RKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQ---EVIRNIDQSEFEGFSFVNSEFLK 669 (674)
T ss_dssp TTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCH---HHHTTCCGGGGTTCCEECSSCCC
T ss_pred hCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCch---hhhhcccccccCCCcccChhhhc
Confidence 488999999988 8999999865543322211111 01112245689999999877643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=504.29 Aligned_cols=293 Identities=40% Similarity=0.829 Sum_probs=268.7
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
.....++|++++.||+|+||.||+|+++.+|+.||||++.+.........+++.+|+.+|..++|||||+++++|++...
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34567899999999999999999999999999999999998876666778889999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999999865311
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
..+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 195 -------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 231 (350)
T 1rdq_E 195 -------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp -------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred -------------------------------------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHH
Confidence 1256899999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc-
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY- 427 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~- 427 (549)
++|.+||.+.+....+.+|... .+.+|. .+|+++++||.+||+ ||.+|+++ .++++|++||||++++|+.+.
T Consensus 232 l~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~ 307 (350)
T 1rdq_E 232 AAGYPPFFADQPIQIYEKIVSG--KVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307 (350)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHT
T ss_pred hhCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhh
Confidence 9999999999998889888874 456664 789999999999999 99999973 459999999999999999986
Q ss_pred -cccCCCcccCCCccccccccccccc
Q 038137 428 -QIKAAFIPEVNDELDTQNFEKFEEA 452 (549)
Q Consensus 428 -~~~~pf~p~~~~~~d~~~f~~~~~~ 452 (549)
.+.|||+|.+.++.|++||+.|.+.
T Consensus 308 ~~~~~p~~p~~~~~~~~~~f~~~~~~ 333 (350)
T 1rdq_E 308 RKVEAPFIPKFKGPGDTSNFDDYEEE 333 (350)
T ss_dssp TCSCCSCCCCCCSTTCCTTSCCCCCC
T ss_pred ccCCCCCCCCCCCccccccccccccc
Confidence 5889999999999999999977554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-61 Score=510.81 Aligned_cols=266 Identities=25% Similarity=0.418 Sum_probs=226.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec------CC
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ------DD 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------d~ 189 (549)
.++|++++.||+|+||+||+|+++.||+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|. +.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 4689999999999999999999999999999999976542 3345677889999999999999999999875 44
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
+.+|||||||. |+|..++.+.+.|++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 68999999995 78999999889999999999999999999999999999999999999999999999999999987642
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvil 348 (549)
..... .....+.|||+.|||||++.+. .|+.++||||||||+
T Consensus 211 ~~~~~-------------------------------------~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il 253 (398)
T 4b99_A 211 SPAEH-------------------------------------QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253 (398)
T ss_dssp ------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred Ccccc-------------------------------------ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHH
Confidence 21000 0112367999999999999875 569999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhcccccc------------------CCC---------CcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLK------------------FPE---------EAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~------------------~p~---------~~~~s~~~~dLI~~lL~-dp 400 (549)
|||++|++||.+.+..+.+.+|+....... +|. .+.+|++++|||.+||+ ||
T Consensus 254 ~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 333 (398)
T 4b99_A 254 GEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEP 333 (398)
T ss_dssp HHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSST
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCCh
Confidence 999999999999999888888865322111 111 12579999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCCc
Q 038137 401 EQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
.+|+ ||+|+|+||||+.+.+
T Consensus 334 ~~R~---ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 334 SARI---SAAAALRHPFLAKYHD 353 (398)
T ss_dssp TTSC---CHHHHTTSGGGTTTCC
T ss_pred hHCc---CHHHHhcCHhhCcCCC
Confidence 9999 8999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-60 Score=496.40 Aligned_cols=283 Identities=27% Similarity=0.435 Sum_probs=214.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCce
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 191 (549)
.++|++++.||+|+||+||+|+++ .+++.||||++.+.. ....+.+|+.+|..+ +|||||+++++|++.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 467999999999999999999985 468899999986642 235678899999988 69999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC-CcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~-g~vKL~DFGlak~~~~~ 270 (549)
+|||||||+||+|.+++ +.+++.+++.|+.||+.||.|||++|||||||||+||||+.+ |++||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999998 469999999999999999999999999999999999999877 89999999999876543
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvily 349 (549)
.....++................ .-..+.....+.|||+.|||||++.+. .|+.++||||+|||+|
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCS-------------ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp SCGGGGGC---------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccc-------------ccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 32221111100000000000000 000111223467999999999999875 5899999999999999
Q ss_pred HHhhCCCCCCCCC-chhhhhhhhhccc--------------------------------------------------ccc
Q 038137 350 EMLVGYPPFYSDE-PMSTCRKIVNWRT--------------------------------------------------HLK 378 (549)
Q Consensus 350 Eml~G~~PF~~~~-~~~~~~~I~~~~~--------------------------------------------------~l~ 378 (549)
||++|++||...+ ..+.+.+|....+ ...
T Consensus 239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 318 (361)
T 4f9c_A 239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN 318 (361)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence 9999999996543 3344444432100 000
Q ss_pred CCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 379 FPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 379 ~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
.+....+|++++|||.+||+ ||.+|+ ||+|+|+||||++++
T Consensus 319 ~~~~~~is~~a~DLl~~lL~~dP~~R~---ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 319 LEGWNEVPDEAYDLLDKLLDLNPASRI---TAEEALLHPFFKDMS 360 (361)
T ss_dssp ---CTTCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGTTC-
T ss_pred ccccccCCHHHHHHHHHHCcCChhHCc---CHHHHhcCcccCCCC
Confidence 11124689999999999999 999999 899999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-61 Score=489.73 Aligned_cols=268 Identities=26% Similarity=0.456 Sum_probs=204.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc------
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE------ 190 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~------ 190 (549)
+||++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 46999999999999999999999999999999997643 2334567899999999999999999999987543
Q ss_pred ------eEEEEEeecCCCchhhHhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeec
Q 038137 191 ------YLYLIMEYLPGGDMMTLLMRKDT---LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 191 ------~lylVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DF 261 (549)
++|||||||+||+|.+++..... .++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 48999999999999999977654 455678999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCccccc
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~Di 341 (549)
|+|+.+........... + ........+.|||+.|||||++.+..|+.++||
T Consensus 163 Gla~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 213 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLT-----------------P------------MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213 (299)
T ss_dssp CCC-------------------------------------------------------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred ccceecCCCcccccccc-----------------c------------cccccccCCcccCccccCHHHHcCCCCCCHHHH
Confidence 99998753211100000 0 000011236799999999999999999999999
Q ss_pred chhhHHHHHHhhCCCCCCCCCc-hhhhhhhhhccccccCCC-CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|||||++|||++ ||.+... ......+.+ ..+|. ....++.+++||.+||+ ||.+|+ ++.||++||||
T Consensus 214 wSlGvilyell~---Pf~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~eil~h~~~ 283 (299)
T 4g31_A 214 FSLGLILFELLY---PFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERP---EAINIIENAVF 283 (299)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGG
T ss_pred HHHHHHHHHHcc---CCCCccHHHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhh
Confidence 999999999996 8865322 122233322 33432 13467889999999999 999999 89999999999
Q ss_pred cCCCccc
Q 038137 419 KGIEWDK 425 (549)
Q Consensus 419 ~~i~w~~ 425 (549)
++++|..
T Consensus 284 ~~~~~p~ 290 (299)
T 4g31_A 284 EDLDFPG 290 (299)
T ss_dssp CCC----
T ss_pred CCCCCCC
Confidence 9999853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-60 Score=522.13 Aligned_cols=264 Identities=29% Similarity=0.497 Sum_probs=236.7
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||+||+|+++.||+.||||++.+... ...+.+.+|+.+|+.++|||||+|+++|+++..+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999976542 3346788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC--CcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN--GHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~--g~vKL~DFGlak~~~~~~~ 272 (549)
||||+||+|.++|.. .+.|++.++++|++||+.||.|||++|||||||||+||||+.+ |++||+|||+|+.+....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999999864 4689999999999999999999999999999999999999864 899999999999764221
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
...+.|||+.|||||++.+..|+.++||||||||||||+
T Consensus 312 -----------------------------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 312 -----------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp -----------------------------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 123679999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
+|++||.+.+..+++.+|......+..+....+|++++|||.+||+ ||.+|+ +++|+|+||||+..+|....
T Consensus 351 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~---t~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 351 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTSCCCCTTTT
T ss_pred HCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcCcCCCCCCCch
Confidence 9999999999999999998754443333345799999999999999 999999 89999999999999886543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=518.87 Aligned_cols=362 Identities=31% Similarity=0.623 Sum_probs=260.2
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
+.+..+..++|+++++||+|+||.||+|+++.+|+.||||++.+..+.......++.+|+.+|..++|||||+++++|++
T Consensus 176 l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp HHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 45667888999999999999999999999999999999999998877666777889999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.+.+|+|||||+||+|..++...+ .+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999999997654 499999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
+.... ...+.+||+.|+|||++.+..|+.++|||||||
T Consensus 336 ~~~~~------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGv 373 (576)
T 2acx_A 336 VPEGQ------------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 373 (576)
T ss_dssp CCTTC------------------------------------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHH
T ss_pred cccCc------------------------------------------cccccCCCccccCHHHHcCCCCCccchHHHHHH
Confidence 53210 012468999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCc----hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCccc
Q 038137 347 IMYEMLVGYPPFYSDEP----MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFK 419 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~----~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~ 419 (549)
++|||++|.+||.+.+. ......+.. ....+| ..+|+++++||.+||+ ||.+|+|.. +++||++||||+
T Consensus 374 ilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 374 LLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp HHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred HHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 99999999999988653 233444443 234455 3789999999999999 999999763 799999999999
Q ss_pred CCCccccc--cccCCCcccCC-----Ccccccccccccccc---------ccccccccCCcccc-cccccccccccceee
Q 038137 420 GIEWDKLY--QIKAAFIPEVN-----DELDTQNFEKFEEAD---------NQIQTSAKSGPWRK-MLSSKDINFVGYTYK 482 (549)
Q Consensus 420 ~i~w~~l~--~~~~pf~p~~~-----~~~d~~~f~~~~~~~---------~~~~~~~~~~~~~~-~~~~~~~~f~g~~~~ 482 (549)
+++|+.+. .+.|||+|... +..|..+|+...... ....+.+.+.||+. |++.. .|..+ .
T Consensus 450 ~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~e~~~~~--~~~~l--~ 525 (576)
T 2acx_A 450 KLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQDFYQKFATGSVPIPWQNEMVETE--CFQEL--N 525 (576)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCCCCC-----------------CHHHHHHHHHHCCEECHHHHHHHHHHTT--HHHHH--H
T ss_pred cCCHHHHhcCCCCCCCCCCccccccCCcccHhhccccCCCCCCccHHHHHhhhccCCCCcccchhhhhcc--hhhhh--c
Confidence 99999997 47899999864 344555565321110 01223344456654 33221 11100 0
Q ss_pred CccccCCCCCchhhhhh-cccCCCCCCccccccccCCCCCC
Q 038137 483 NFEIVNDHQLPGIAELK-KKSTKPKRPSIKSLFEDESATVN 522 (549)
Q Consensus 483 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 522 (549)
.+. .+...++...+. .....++.+.+.+||.+..+...
T Consensus 526 ~~~--~~g~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (576)
T 2acx_A 526 VFG--LDGSVPPDLDWKGQPPAPPKKGLLQRLFSRQDSSGN 564 (576)
T ss_dssp CBS--SSCC--------------------------------
T ss_pred ccC--CCCCCCCccccccCCCCCCCccchhhhhccCCCCCC
Confidence 111 123344444433 23345677888999998875543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=495.04 Aligned_cols=294 Identities=41% Similarity=0.758 Sum_probs=251.2
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|..++|||||+++++|.+.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 34566789999999999999999999999999999999998876656666778889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|+|||||+||+|..++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999888999999999999999999999998 9999999999999999999999999999985421
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. ....+.+||+.|+|||++.+..|+.++|||||||++|
T Consensus 302 ~~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 340 (446)
T 4ejn_A 302 DG-----------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340 (446)
T ss_dssp ----------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred CC-----------------------------------------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHH
Confidence 10 0012568999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l 426 (549)
||++|.+||.+.+.......|.. ..+.+|. .+++++++||.+||. ||.+|++. .+++|+++||||++++|+.+
T Consensus 341 ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 341 EMMCGRLPFYNQDHEKLFELILM--EEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHhhCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence 99999999999988888888876 3455664 689999999999999 99999965 37999999999999999998
Q ss_pred c--cccCCCcccCCCcccccccccc
Q 038137 427 Y--QIKAAFIPEVNDELDTQNFEKF 449 (549)
Q Consensus 427 ~--~~~~pf~p~~~~~~d~~~f~~~ 449 (549)
. .+.|||+|.+.++.|+++|++.
T Consensus 417 ~~~~~~pp~~p~~~~~~~~~~~~~~ 441 (446)
T 4ejn_A 417 YEKKLSPPFKPQVTSETDTRYFDEE 441 (446)
T ss_dssp HTTCSCCSCCCSCSSTTCCTTC---
T ss_pred hhCcCCCCccCCCCCccchhhcchh
Confidence 6 4789999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=481.46 Aligned_cols=281 Identities=32% Similarity=0.655 Sum_probs=247.3
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|..++|||||+++++|++..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567789999999999999999999999999999999999887777777888999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+|||||+||+|..++.....+++..+++|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchhhHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAI 347 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSlGvi 347 (549)
. ...+.+||+.|+|||++.+ .+|+.++|||||||+
T Consensus 169 ~------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i 206 (384)
T 4fr4_A 169 T------------------------------------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206 (384)
T ss_dssp C------------------------------------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred C------------------------------------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence 1 0125789999999999974 569999999999999
Q ss_pred HHHHhhCCCCCCCCCch---hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 348 MYEMLVGYPPFYSDEPM---STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~---~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
+|||++|.+||...+.. .....+.. ....+|. .+|+++.+||.+||+ ||.+|++ ++++|++||||++++|
T Consensus 207 l~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 207 AYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPS--AWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTSGGGTTCCH
T ss_pred HHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCC--cCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcChhhhcCCH
Confidence 99999999999865432 22333332 3344553 789999999999999 9999995 3999999999999999
Q ss_pred cccc--cccCCCcccCCC
Q 038137 424 DKLY--QIKAAFIPEVND 439 (549)
Q Consensus 424 ~~l~--~~~~pf~p~~~~ 439 (549)
+.+. .+.|||+|....
T Consensus 281 ~~~~~~~~~p~~~p~~~~ 298 (384)
T 4fr4_A 281 DAVFQKRLIPGFIPNKGR 298 (384)
T ss_dssp HHHHTTCSCCCCCCSCCS
T ss_pred HHHHhCCCCCCCCCCCCC
Confidence 9987 478999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=500.70 Aligned_cols=293 Identities=34% Similarity=0.654 Sum_probs=253.7
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
....+..++|+++++||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|..++|||||+++++|++.
T Consensus 178 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp HTSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 34668889999999999999999999999999999999999988776667778899999999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
..+|+|||||+||+|..++... ..+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999999998653 469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlG 345 (549)
.+..... ...+.+||+.|+|||++.+..|+.++||||||
T Consensus 338 ~~~~~~~-----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlG 376 (543)
T 3c4z_A 338 ELKAGQT-----------------------------------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALG 376 (543)
T ss_dssp ECCTTCC-----------------------------------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHH
T ss_pred eccCCCc-----------------------------------------ccccccCCccccChhhhcCCCCChHHhcCcch
Confidence 7542110 01246899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCCc----hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcc
Q 038137 346 AIMYEMLVGYPPFYSDEP----MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWF 418 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~----~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF 418 (549)
|++|||++|++||.+.+. ......|.. ....+|. .+|+++++||.+||+ ||.+|++.. ++++|++||||
T Consensus 377 vilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 377 VTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPD--KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp HHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred HHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCc--ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 999999999999987643 345555554 3445553 789999999999999 999999863 68999999999
Q ss_pred cCCCccccc--cccCCCcccCC-----Ccccccccc
Q 038137 419 KGIEWDKLY--QIKAAFIPEVN-----DELDTQNFE 447 (549)
Q Consensus 419 ~~i~w~~l~--~~~~pf~p~~~-----~~~d~~~f~ 447 (549)
++++|+.+. .+.|||+|... +..|+.+|+
T Consensus 453 ~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~ 488 (543)
T 3c4z_A 453 RDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFS 488 (543)
T ss_dssp TTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC
T ss_pred cCCCHHHHHcCCCCCCCCCCccccccCCchhhhhcc
Confidence 999999997 47899999874 344455554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=467.84 Aligned_cols=292 Identities=42% Similarity=0.780 Sum_probs=238.7
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLR-RGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
.++..++|++++.||+|+||.||+|++. .+|+.||||++.+..... ......+.+|+.+|+.++|||||+++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3566789999999999999999999985 689999999998764432 234566889999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+.+.+|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
.... ......+||+.|+|||++.+..|+.++|||||||+
T Consensus 172 ~~~~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 210 (327)
T 3a62_A 172 IHDG-----------------------------------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210 (327)
T ss_dssp ------------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHH
T ss_pred ccCC-----------------------------------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHH
Confidence 2110 00124689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCcccCCCcc
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWD 424 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~~i~w~ 424 (549)
+|||++|.+||.+.+......+|... .+.+|. .+++++++||.+||. ||.+|++.. +++|+++||||++++|+
T Consensus 211 l~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 211 MYDMLTGAPPFTGENRKKTIDKILKC--KLNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 99999999999999888888888763 445554 789999999999999 999999764 79999999999999999
Q ss_pred ccc--cccCCCcccCCCccccccccc
Q 038137 425 KLY--QIKAAFIPEVNDELDTQNFEK 448 (549)
Q Consensus 425 ~l~--~~~~pf~p~~~~~~d~~~f~~ 448 (549)
.+. .+.|||.|.+..+.|.++|+.
T Consensus 287 ~~~~~~~~~p~~p~~~~~~~~~~~~~ 312 (327)
T 3a62_A 287 ELLARKVEPPFKPLLQSEEDVSQFDS 312 (327)
T ss_dssp HHHTTCSCCSCCCC------------
T ss_pred HHhhccCCCCCCCCcCChhhhhhcch
Confidence 886 478999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=469.26 Aligned_cols=258 Identities=22% Similarity=0.381 Sum_probs=220.9
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
.+..++|.+.+.||+|+||+||+|++. .+|..||||+++... ....+.+.+|+.+|+.++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 466788999999999999999999875 468899999997642 344567999999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK-------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG 254 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~-------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g 254 (549)
+++.+|||||||+||+|.++|.+. ..|++..+..++.||+.||.|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999653 3699999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~ 334 (549)
++||+|||+|+........ ......+||+.|||||++.+..
T Consensus 166 ~~Ki~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~~~~~~ 206 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYY---------------------------------------RVGGHTMLPIRWMPPESIMYRK 206 (299)
T ss_dssp CEEECCCSCHHHHTGGGCE---------------------------------------EETTTEEECGGGCCHHHHHHCC
T ss_pred cEEECCcccceecCCCCce---------------------------------------eecCceecChhhcCHHHHcCCC
Confidence 9999999999865321100 0111457999999999999999
Q ss_pred CCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 335 YGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
|+.++|||||||+||||+| |++||.+.+..+....|... ..+..| ..+|+++.+||.+||. ||.+|+ ++.+|
T Consensus 207 ~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~~i 280 (299)
T 4asz_A 207 FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG-RVLQRP--RTCPQEVYELMLGCWQREPHMRK---NIKGI 280 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccchHHHHHHHHHHcCCChhHCc---CHHHH
Confidence 9999999999999999998 99999999888888888764 234445 3789999999999999 999999 79998
Q ss_pred HcCCcccC
Q 038137 413 KAHPWFKG 420 (549)
Q Consensus 413 l~HpfF~~ 420 (549)
|+|++.
T Consensus 281 --~~~L~~ 286 (299)
T 4asz_A 281 --HTLLQN 286 (299)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 456653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=462.92 Aligned_cols=256 Identities=21% Similarity=0.383 Sum_probs=215.6
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF 186 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 186 (549)
..+..++|.+.+.||+|+||+||+|+.+ .++..||||+++... ....+.+.+|+.+|+.++|||||+++++|
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3466688999999999999999999875 468899999997642 34456799999999999999999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRK---------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD 251 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld 251 (549)
.+.+.+|||||||+||+|.++|.+. +.|++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999998653 3599999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc
Q 038137 252 RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL 331 (549)
Q Consensus 252 ~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~ 331 (549)
.++++||+|||+|+.+...... ......+||+.|||||++.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~~~ 233 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY---------------------------------------RVGGRTMLPIRWMPPESIL 233 (329)
T ss_dssp TTTEEEECCCC-------------------------------------------------------CCCCGGGCCHHHHT
T ss_pred CCCcEEEcccccceeccCCCcc---------------------------------------eecCcccccccccChhhhc
Confidence 9999999999999865322100 0112468999999999999
Q ss_pred cCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCH
Q 038137 332 KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA 409 (549)
Q Consensus 332 ~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 409 (549)
+..|+.++|||||||+||||+| |++||.+.+..+....|... ..+.+|. .+|+++.+||.+||. ||++|+ ++
T Consensus 234 ~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~~p~--~~~~~~~~li~~cl~~dP~~RP---s~ 307 (329)
T 4aoj_A 234 YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELERPR--ACPPEVYAIMRGCWQREPQQRH---SI 307 (329)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CCCCCCT--TCCHHHHHHHHHHCCSSTTTSC---CH
T ss_pred CCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCcc--cccHHHHHHHHHHcCcChhHCc---CH
Confidence 9999999999999999999998 99999999888888887763 3345554 789999999999999 999999 89
Q ss_pred HHHHcC
Q 038137 410 DEIKAH 415 (549)
Q Consensus 410 ~eil~H 415 (549)
.||+.|
T Consensus 308 ~ei~~~ 313 (329)
T 4aoj_A 308 KDVHAR 313 (329)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=455.03 Aligned_cols=257 Identities=20% Similarity=0.264 Sum_probs=209.9
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
.+++..++|++.+.||+|+||+||+|+.+. .||||+++... ......+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 357788999999999999999999998643 58999997543 234556789999999999999999999998754 5
Q ss_pred eEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|||||||+||+|.++|.. ...+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 68999999999999999965 46799999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchhhH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 346 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSlGv 346 (549)
... .....+.+||+.|||||++.+ ..|+.++|||||||
T Consensus 185 ~~~---------------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv 225 (307)
T 3omv_A 185 WSG---------------------------------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI 225 (307)
T ss_dssp ------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred CCc---------------------------------------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence 110 001225699999999999974 35999999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhccc-cccCC-CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRT-HLKFP-EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~-~l~~p-~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+||||++|++||.+.+.......++.... ....+ ....+|+++++||.+||. ||.+|+ ++.||+.
T Consensus 226 vl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~ 293 (307)
T 3omv_A 226 VLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERP---LFPQILS 293 (307)
T ss_dssp HHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSC---CHHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 99999999999998777665555554221 11111 124689999999999999 999999 7777653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-56 Score=455.94 Aligned_cols=257 Identities=20% Similarity=0.331 Sum_probs=219.8
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF 186 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 186 (549)
.++..+++++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|+.++|||||+++++|
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3466788999999999999999999863 467899999997542 233456799999999999999999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL 250 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl 250 (549)
.+++.+|||||||+||+|.++|... ..|++..+..++.||+.||.|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999542 469999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhh
Q 038137 251 DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330 (549)
Q Consensus 251 d~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl 330 (549)
+.++++||+|||+|+.+...... ....+.+||+.|||||++
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~l 219 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY---------------------------------------KLLGNSLLPIRWMAPEAI 219 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB---------------------------------------CSSSSSCBCGGGCCHHHH
T ss_pred CCCCCEEECCcccceeccCCCce---------------------------------------eEecccccCCcccCHHHH
Confidence 99999999999999875321100 011246899999999999
Q ss_pred ccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 331 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 331 ~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
.+..|+.++|||||||+||||++ |.+||.+.+..+....|.+. ..++.| ..+++++.+||.+||. ||.+|| +
T Consensus 220 ~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~C~~~dP~~RP---s 293 (308)
T 4gt4_A 220 MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLPCP--DDCPAWVYALMIECWNEFPSRRP---R 293 (308)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---C
T ss_pred hCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCc--ccchHHHHHHHHHHcCCChhHCc---C
Confidence 99999999999999999999998 99999999888888877753 233444 4789999999999999 999999 7
Q ss_pred HHHHHcC
Q 038137 409 ADEIKAH 415 (549)
Q Consensus 409 ~~eil~H 415 (549)
+.||+++
T Consensus 294 ~~ei~~~ 300 (308)
T 4gt4_A 294 FKDIHSR 300 (308)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=459.68 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=219.8
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-Cceeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKAT-----GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCIVKLYC 184 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~ 184 (549)
++++..++|++.+.||+|+||+||+|.+..+ ++.||||++.... .....+.+.+|+.+|..+.| ||||++++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4567788999999999999999999998654 4689999997643 23345678999999999976 89999999
Q ss_pred eecC-CceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCC
Q 038137 185 SFQD-DEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDN 247 (549)
Q Consensus 185 ~f~d-~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeN 247 (549)
+|.+ .+.+|||||||+||+|.++|... ..|++..+..|+.||+.||.|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9865 56799999999999999999652 358999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCc
Q 038137 248 LLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327 (549)
Q Consensus 248 ILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~AP 327 (549)
|||+.+|++||+|||+|+.+...... ....+.+||+.||||
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~---------------------------------------~~~~~~~gt~~ymAP 256 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMAP 256 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTS---------------------------------------EEETTEEECGGGCCH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCc---------------------------------------eeeccccccccccCH
Confidence 99999999999999999876422100 011256899999999
Q ss_pred hhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCC
Q 038137 328 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 328 Evl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
|++.+..|+.++|||||||+||||++ |.+||.+.+..+.+.+++.....+..|. .+|+++.+||.+||. ||.+|+
T Consensus 257 E~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~--~~~~~~~~li~~c~~~dP~~RP- 333 (353)
T 4ase_A 257 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRP- 333 (353)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSC-
T ss_pred HHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc--cCCHHHHHHHHHHcCcChhHCc-
Confidence 99999999999999999999999998 9999998776665555555334455554 789999999999999 999999
Q ss_pred CCCHHHHHcC
Q 038137 406 TKGADEIKAH 415 (549)
Q Consensus 406 ~~~~~eil~H 415 (549)
++.||++|
T Consensus 334 --t~~eil~~ 341 (353)
T 4ase_A 334 --TFSELVEH 341 (353)
T ss_dssp --CHHHHHHH
T ss_pred --CHHHHHHH
Confidence 89999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=455.13 Aligned_cols=265 Identities=32% Similarity=0.547 Sum_probs=236.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR---GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.++|++++.||+|+||.||+|+++.+|+.||||++.+...... ...+.+.+|+.+|..++|||||+++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 5679999999999999999999999999999999987653221 1356789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC----cEEEeecCcccccC
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG----HMKLSDFGLCKPLD 268 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g----~vKL~DFGlak~~~ 268 (549)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.+.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888999999999999999999999999999999999999998887 89999999998754
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
... ...+.+||+.|+|||++.+..|+.++||||||||+
T Consensus 171 ~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 208 (361)
T 2yab_A 171 DGV------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (361)
T ss_dssp TTC------------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCC------------------------------------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHH
Confidence 211 01146899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
|+|++|.+||.+.+..+.+.+|.... ..++. ...+|+++++||.+||+ ||.+|+ +++|+++||||++++|..
T Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 209 YILLSGASPFLGDTKQETLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDTQQ 283 (361)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSTTTSCSSHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCc---CHHHHhcCcCcCCCchhh
Confidence 99999999999999888888887643 33332 24789999999999999 999999 899999999999999976
Q ss_pred cc
Q 038137 426 LY 427 (549)
Q Consensus 426 l~ 427 (549)
..
T Consensus 284 ~~ 285 (361)
T 2yab_A 284 AM 285 (361)
T ss_dssp HH
T ss_pred hh
Confidence 54
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=440.91 Aligned_cols=261 Identities=29% Similarity=0.524 Sum_probs=233.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
....++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 3446789999999999999999999999999999999987643 344567788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 9999999999999999888999999999999999999999999999999999999999999999999999997653211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCC-cccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~-~~~DiWSlGvilyEm 351 (549)
.....+||+.|+|||++.+..|. .++|||||||++|||
T Consensus 169 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 169 -----------------------------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp -----------------------------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHH
Confidence 01246899999999999988875 899999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
++|.+||.+.+......++... ...+|. .+|+++.+||.+||+ ||.+|+ +++||++||||+...+
T Consensus 208 l~g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 208 VSGSLPFDGQNLKELRERVLRG--KYRIPF--YMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWINAGHE 273 (328)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHCCSSTTTSC---CHHHHTTCTTTTTTCT
T ss_pred HhCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHCCCChhHCc---CHHHHhcCHhhcCCCc
Confidence 9999999999988888888763 344554 689999999999999 999999 8999999999987643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=451.58 Aligned_cols=293 Identities=42% Similarity=0.751 Sum_probs=241.6
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhh-chhhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEML-RRGQVEHVKAERNLLAEV-DSNCIVKLYCSF 186 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 186 (549)
..+..++|++++.||+|+||.||+|++. .+|+.||||++.+.... .....+.+.+|+.+|..+ +||||++++++|
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3455689999999999999999999984 58999999999765432 122334577899999999 699999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.+...+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchh
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSL 344 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSl 344 (549)
+..... ......+||+.|+|||++.+ ..++.++|||||
T Consensus 209 ~~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 209 FVADET----------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248 (355)
T ss_dssp CCGGGG----------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred cccCCC----------------------------------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHH
Confidence 532110 01124689999999999986 457999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhcc--ccccCCCCcCCChhHHHHHHHhhh-cccccCCCC--CHHHHHcCCccc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWR--THLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFK 419 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~--~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~--~~~eil~HpfF~ 419 (549)
||++|||++|..||...........+.... ....+| ..+++.+++||.+||. ||.+|++.. +++|+++||||.
T Consensus 249 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 249 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp HHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred HHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 999999999999998654433332222211 223334 4789999999999999 999999753 799999999999
Q ss_pred CCCcccccc--ccCCCcccCCCccccccc
Q 038137 420 GIEWDKLYQ--IKAAFIPEVNDELDTQNF 446 (549)
Q Consensus 420 ~i~w~~l~~--~~~pf~p~~~~~~d~~~f 446 (549)
.++|+.+.. +.+||.|.+.++.|.+||
T Consensus 327 ~~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 327 KINWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred cCChhHhhhccCCCCCCCccccccccccC
Confidence 999999874 679999999999999887
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=430.80 Aligned_cols=264 Identities=31% Similarity=0.555 Sum_probs=232.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR---GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++|||||+++++|.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4569999999999999999999999999999999987543221 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC----cEEEeecCcccccC
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG----HMKLSDFGLCKPLD 268 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g----~vKL~DFGlak~~~ 268 (549)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+.+.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888999999999999999999999999999999999999999888 89999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.... ....+||+.|+|||++.+..|+.++|||||||++
T Consensus 170 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 207 (326)
T 2y0a_A 170 FGNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207 (326)
T ss_dssp TTSC------------------------------------------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCc------------------------------------------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHH
Confidence 2110 1145899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
|+|++|.+||.+.+..+....+.... ..++. ...+|+++++||.+||+ ||.+|+ +++|+++||||++.+|..
T Consensus 208 ~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~~~ 282 (326)
T 2y0a_A 208 YILLSGASPFLGDTKQETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQ 282 (326)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTSCCSHHH
T ss_pred HHHHHCcCCCCCCCHHHHHHHHHhcC--CCcCccccccCCHHHHHHHHHHccCChhhCC---CHHHHhcCCCccCCcchh
Confidence 99999999999988887777776532 23332 24689999999999999 999999 899999999999988765
Q ss_pred c
Q 038137 426 L 426 (549)
Q Consensus 426 l 426 (549)
.
T Consensus 283 ~ 283 (326)
T 2y0a_A 283 A 283 (326)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=437.08 Aligned_cols=259 Identities=31% Similarity=0.589 Sum_probs=230.2
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+|..++|||||+++++|.+.+.+|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999999999999999999987543 3345577899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL~DFGlak~~~~~~~~ 273 (549)
|||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-- 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence 9999999999998888999999999999999999999999999999999999998654 59999999998654211
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 186 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 225 (362)
T 2bdw_A 186 ----------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225 (362)
T ss_dssp ----------------------------------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH
Confidence 0114689999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|++||.+.+....+..|......+..+....+|+++++||.+||+ ||.+|+ ++.++++||||...
T Consensus 226 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 226 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICNR 291 (362)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSHHHHTH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCcccCCC
Confidence 999999998888888887744333444445789999999999999 999999 89999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=442.73 Aligned_cols=279 Identities=31% Similarity=0.559 Sum_probs=230.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lyl 194 (549)
.++|++++.||+|+||.||+|.++.+|+.||||++.+... ...+|+.+|..+ +|||||+++++|++...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3569999999999999999999999999999999977532 134678888777 79999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC----CcEEEeecCcccccCCC
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN----GHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~----g~vKL~DFGlak~~~~~ 270 (549)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +++||+|||+|+.+...
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999999888899999999999999999999999999999999999998443 35999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.. ...+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 174 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 212 (342)
T 2qr7_A 174 NG-----------------------------------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYT 212 (342)
T ss_dssp TC-----------------------------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHH
Confidence 10 0125689999999999999889999999999999999
Q ss_pred HhhCCCCCCCC---CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccc
Q 038137 351 MLVGYPPFYSD---EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 351 ml~G~~PF~~~---~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l 426 (549)
|++|.+||.+. +..+....|......+..+.+..+|+++++||.+||+ ||.+|+ ++.++++||||. +|+.+
T Consensus 213 ll~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~~il~hp~~~--~~~~~ 287 (342)
T 2qr7_A 213 MLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL---TAALVLRHPWIV--HWDQL 287 (342)
T ss_dssp HHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHH--TGGGS
T ss_pred HhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCCeec--Ccccc
Confidence 99999999863 3445556665533222222335789999999999999 999999 899999999995 68776
Q ss_pred c--cccCCCcccCCCcccccccc
Q 038137 427 Y--QIKAAFIPEVNDELDTQNFE 447 (549)
Q Consensus 427 ~--~~~~pf~p~~~~~~d~~~f~ 447 (549)
. .+.+|+.|......+..+|.
T Consensus 288 ~~~~~~~~~~p~~~~~~~~~~~~ 310 (342)
T 2qr7_A 288 PQYQLNRQDAPHLVKGAMAATYS 310 (342)
T ss_dssp CCSCCCCCCCHHHHHHHHHHHHH
T ss_pred ccccCCCccchhhhhhHHHHHHh
Confidence 5 35677777644333333444
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=434.45 Aligned_cols=256 Identities=32% Similarity=0.576 Sum_probs=227.0
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999987655444445678999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--- 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--- 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc---
Confidence 99999 78999999888999999999999999999999999999999999999999999999999999998653211
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~ 353 (549)
...+.+||+.|+|||++.+..| +.++|||||||++|+|++
T Consensus 163 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 203 (336)
T 3h4j_B 163 ---------------------------------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203 (336)
T ss_dssp ---------------------------------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh
Confidence 0124689999999999998887 789999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|.+||.+........++.. ....+| ..+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 204 g~~Pf~~~~~~~~~~~i~~--~~~~~p--~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~ 264 (336)
T 3h4j_B 204 GRLPFDDEFIPNLFKKVNS--CVYVMP--DFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFNV 264 (336)
T ss_dssp SSCSSBCSSSTTCBCCCCS--SCCCCC--TTSCHHHHHHHHTTSCSSGGGSC---CHHHHTTCHHHHT
T ss_pred CCCCCCCccHHHHHHHHHc--CCCCCc--ccCCHHHHHHHHHHcCCChhHCc---CHHHHHhChhhcc
Confidence 9999988777666665543 233444 3789999999999999 999999 8999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=446.78 Aligned_cols=259 Identities=31% Similarity=0.603 Sum_probs=230.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999987653 2334567899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc---CCCcEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD---RNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld---~~g~vKL~DFGlak~~~~~~~~ 273 (549)
|||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~- 168 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ- 168 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence 9999999999999889999999999999999999999999999999999999998 468899999999986542110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
...+.+||+.|+|||++.+..|+.++||||||||+|+|++
T Consensus 169 ----------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~ 208 (444)
T 3soa_A 169 ----------------------------------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208 (444)
T ss_dssp ----------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh
Confidence 0124689999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|.+||.+.+....+..|......+..|....+|+++++||.+||. ||.+|+ ++.|+++||||+.
T Consensus 209 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---ta~e~L~hp~~~~ 273 (444)
T 3soa_A 209 GYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273 (444)
T ss_dssp SSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSCTTHH
T ss_pred CCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCC---CHHHHhcCccccC
Confidence 999999999888888888754444455556899999999999999 999999 8999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=437.39 Aligned_cols=281 Identities=28% Similarity=0.463 Sum_probs=213.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCC--ceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDD--EYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~--~~l 192 (549)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|..+. |||||+++++|.++ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 468999999999999999999999999999999997542 33445567889999999997 99999999999754 479
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+|||||+ |+|..++.. +.+++..++.++.||+.||.|||+.|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999996 689888854 6899999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHH
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEm 351 (549)
.......... .... .+ ..........+||++|+|||++.+ ..|+.++||||||||+|||
T Consensus 165 ~~~~~~~~~~------~~~~-------------~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 224 (388)
T 3oz6_A 165 VTNNIPLSIN------ENTE-------------NF-DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224 (388)
T ss_dssp CCCCGGGCCC-----------------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccc------cccc-------------cc-ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence 1100000000 0000 00 000111235799999999999987 6799999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhcccccc-------------------------------------------CCCCcCCChh
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLK-------------------------------------------FPEEAKLSPE 388 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~-------------------------------------------~p~~~~~s~~ 388 (549)
++|++||.+.+....+.+|+....... .+....++++
T Consensus 225 l~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (388)
T 3oz6_A 225 LCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304 (388)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHH
Confidence 999999999988887777763211000 0011267899
Q ss_pred HHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 389 AKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 389 ~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+.|||.+||+ ||.+|+ +++|+++||||+.+.
T Consensus 305 ~~dll~~~L~~dP~~R~---t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 305 ALDLLDKLLQFNPNKRI---SANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHHCCSSGGGSC---CHHHHTTSTTTTTTC
T ss_pred HHHHHHHhhccCcccCC---CHHHHhCCHHHHHhc
Confidence 9999999999 999999 899999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=427.61 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=226.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||.||+|.++.+|+.||+|++.... .....+.+|+.+|..++|||||+++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 578999999999999999999999999999999987542 3345688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC--CCcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR--NGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~--~g~vKL~DFGlak~~~~~~~ 272 (549)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999999765 47999999999999999999999999999999999999997 7899999999998754211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 159 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 159 -----------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp -----------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 012468999999999999998999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+|.+||.+.+.......+.... ..++. ...+|+++++||.+||+ ||.+|+ ++.|+++||||+..
T Consensus 198 ~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp---t~~e~l~hp~~~~~ 264 (321)
T 1tki_A 198 SGINPFLAETNQQIIENIMNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQK 264 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHSC
T ss_pred hCCCCCcCCCHHHHHHHHHcCC--CCCChhhhccCCHHHHHHHHHHcCCChhHCc---CHHHHhcChhhccC
Confidence 9999999998888888887643 33332 24789999999999999 999999 89999999999853
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=419.17 Aligned_cols=257 Identities=31% Similarity=0.530 Sum_probs=225.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++|||||+++++|.+.+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4679999999999999999999999999999999976542 2345688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||||+||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (297)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---
T ss_pred EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc---
Confidence 999999999999865 4799999999999999999999999999999999999999999999999999986542210
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 172 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 172 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp --------------------------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 012468999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||.+.+.......+... ....++....+++.+++||.+||. ||.+|+ +++|+++||||+..
T Consensus 214 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 214 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRG---SAKELLQHQFLKIA 276 (297)
T ss_dssp CTTTTSCHHHHHHHHHHH-CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCGGGGGC
T ss_pred CCCCCCCHHHHHHHHHhC-CCCCCCCccccCHHHHHHHHHHccCChhHCc---CHHHHhhChhhccc
Confidence 999988877666655542 222333335789999999999999 999999 89999999999854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=444.74 Aligned_cols=295 Identities=25% Similarity=0.372 Sum_probs=209.4
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec-----CC
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ-----DD 189 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-----d~ 189 (549)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|..++|||||+++++|. +.
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3578999999999999999999999999999999997642 33445677899999999999999999999994 44
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||+ +|+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 6799999998 689999998888899999999999999999999999999999999999999999999999999997653
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-cCCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-~~~y~~~~DiWSlGvil 348 (549)
............. . .+...... .-.........+.+||++|+|||++. +..|+.++|||||||||
T Consensus 209 ~~~~~~~~~~~~~----~-~~~~~~~~---------~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il 274 (458)
T 3rp9_A 209 PENGNSQLPISPR----E-DDMNLVTF---------PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274 (458)
T ss_dssp CTTCCCCCC-----------------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred ccccccccccCcc----c-cccccccc---------cccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHH
Confidence 2111000000000 0 00000000 00000111234679999999999874 56799999999999999
Q ss_pred HHHhh-----------CCCCCCCCCc--------------------hhhhhhhhhcccc------------------ccC
Q 038137 349 YEMLV-----------GYPPFYSDEP--------------------MSTCRKIVNWRTH------------------LKF 379 (549)
Q Consensus 349 yEml~-----------G~~PF~~~~~--------------------~~~~~~I~~~~~~------------------l~~ 379 (549)
|||++ |.+||.+.+. ...+..|++.... ..+
T Consensus 275 ~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 354 (458)
T 3rp9_A 275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF 354 (458)
T ss_dssp HHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTS
T ss_pred HHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhc
Confidence 99999 7888876542 1112222110000 000
Q ss_pred C---------CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccccc
Q 038137 380 P---------EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 380 p---------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~ 428 (549)
| ....+++++.|||.+||+ ||.+|+ +++|+|+||||++++|..+..
T Consensus 355 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---t~~e~L~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 355 PKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI---TINECLAHPFFKEVRIAEVET 410 (458)
T ss_dssp CCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGTTTCCGGGCC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccC---CHHHHhcCHhhhhcCCCccCC
Confidence 0 013569999999999999 999999 899999999999999988764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=419.79 Aligned_cols=266 Identities=28% Similarity=0.503 Sum_probs=220.5
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
.+...++|++++.||+|+||.||+|++. +|+.||+|++.... ........+.+|+.+|+.++|||||+++++|.++..
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 3445788999999999999999999985 58999999997643 233445678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+|+||||++| +|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999975 77777755 456999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 173 ~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 211 (311)
T 3niz_A 173 VR-----------------------------------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211 (311)
T ss_dssp CC--------------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred cc-----------------------------------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHH
Confidence 10 0113589999999999987 56899999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhcccccc---CC-----------------------CCcCCChhHHHHHHHhhh-cccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLK---FP-----------------------EEAKLSPEAKDLISKLLC-NVEQ 402 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~---~p-----------------------~~~~~s~~~~dLI~~lL~-dp~~ 402 (549)
+|++|.+||.+.+......++........ ++ ....+++++++||.+||+ ||.+
T Consensus 212 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 291 (311)
T 3niz_A 212 EMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291 (311)
T ss_dssp HHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTT
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhH
Confidence 99999999998887777666654211100 00 012478899999999999 9999
Q ss_pred cCCCCCHHHHHcCCcccCCCcc
Q 038137 403 RLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 403 Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|+ +++|+++||||++++++
T Consensus 292 Rp---t~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 292 RI---SARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp SC---CHHHHHTSGGGTTSCTT
T ss_pred CC---CHHHHhcCcccccCCcc
Confidence 99 89999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=444.15 Aligned_cols=261 Identities=30% Similarity=0.560 Sum_probs=234.7
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
...+..++|.+.+.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34566789999999999999999999999999999999998876555556778999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvily 349 (549)
. ...+.+||+.|+|||++.+..| +.++|||||||++|
T Consensus 170 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 170 E------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207 (476)
T ss_dssp C------------------------------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred c------------------------------------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHH
Confidence 1 0124689999999999998876 78999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||++|.+||.+.+....+.+|... ....| ..+++++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 208 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~~L~~dP~~Rp---t~~eil~hp~~~~ 272 (476)
T 2y94_A 208 ALLCGTLPFDDDHVPTLFKKICDG--IFYTP--QYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFKQ 272 (476)
T ss_dssp HHHHSSCSSCCSSSHHHHHHHHTT--CCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHT
T ss_pred HHhhCCCCCCCCCHHHHHHHHhcC--CcCCC--ccCCHHHHHHHHHHcCCCchhCc---CHHHHHhCHHhhh
Confidence 999999999998888888888763 33444 3789999999999999 999999 8999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=431.16 Aligned_cols=262 Identities=31% Similarity=0.557 Sum_probs=222.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch--hhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR--GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
++|++++.||+|+||.||+|.++.+|+.||||++.+...... ...+.+.+|+.+|..++|||||+++++|.+++.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 569999999999999999999999999999999976543322 235678999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc---EEEeecCccccc
Q 038137 195 IMEYLPGGDMMTLLMRK----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGLCKPL 267 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~---vKL~DFGlak~~ 267 (549)
|||||+||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998887543 35899999999999999999999999999999999999987665 999999999876
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
..... .....+||+.|+|||++.+..|+.++||||||||
T Consensus 184 ~~~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 222 (351)
T 3c0i_A 184 GESGL-----------------------------------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222 (351)
T ss_dssp CTTSC-----------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred cCCCe-----------------------------------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHH
Confidence 42210 0114689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
+|+|++|.+||.+.. ......+.........+....+|+++++||.+||. ||.+|+ ++.|+++||||++.++
T Consensus 223 l~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 223 LFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI---TVYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHTHHH
T ss_pred HHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcChhhcCCcc
Confidence 999999999998753 45555665532222111224689999999999999 999999 8999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=412.21 Aligned_cols=259 Identities=29% Similarity=0.474 Sum_probs=215.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||+++++|.++..+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999976542 3445567889999999999999999999999999999999
Q ss_pred eecCCCchhhHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++| ++...+ ...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 156 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--- 156 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS---
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc---
Confidence 99976 555544 4467899999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-CCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEml~G 354 (549)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|
T Consensus 157 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~ 198 (292)
T 3o0g_A 157 --------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp --------------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred --------------------------------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence 011458999999999998765 89999999999999999987
Q ss_pred CCC-CCCCCchhhhhhhhhccccc---------------cCC----------CCcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 355 YPP-FYSDEPMSTCRKIVNWRTHL---------------KFP----------EEAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 355 ~~P-F~~~~~~~~~~~I~~~~~~l---------------~~p----------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
..| |.+.+.......+....... .++ ....+++++++||.+||+ ||.+|+
T Consensus 199 ~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~--- 275 (292)
T 3o0g_A 199 GRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI--- 275 (292)
T ss_dssp SCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---
T ss_pred CCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC---
Confidence 777 55555555555554311100 000 012578999999999999 999999
Q ss_pred CHHHHHcCCcccCC
Q 038137 408 GADEIKAHPWFKGI 421 (549)
Q Consensus 408 ~~~eil~HpfF~~i 421 (549)
+++|+++||||+++
T Consensus 276 t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 276 SAEEALQHPYFSDF 289 (292)
T ss_dssp CHHHHHTSGGGTTC
T ss_pred CHHHHhcCcccccC
Confidence 89999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=430.67 Aligned_cols=260 Identities=29% Similarity=0.540 Sum_probs=227.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+|+.+|..++|||||+++++|.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999976532 2335688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC--CCcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR--NGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~--~g~vKL~DFGlak~~~~~~~ 272 (549)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++++||+|||+|+.+....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999999998765 47999999999999999999999999999999999999974 5789999999998754211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 206 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 206 -----------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp -----------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
+|.+||.+.+......++......+..+....+|+++++||.+||+ ||.+|+ ++.|+++||||++..+
T Consensus 245 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 245 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGDHS 313 (387)
T ss_dssp HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSCCT
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhhCccccCCcc
Confidence 9999999988888887777643332222234789999999999999 999999 8999999999997654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=431.75 Aligned_cols=276 Identities=22% Similarity=0.349 Sum_probs=225.4
Q ss_pred CCCCCeeeeeeeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 114 MGADDFEPLTMIGKG--AFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G--~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
...++|++++.||+| +||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 356789999999999 999999999999999999999987543 34556778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999765 7799999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAI 347 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvi 347 (549)
....... ........+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 181 ~~~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 181 HGQRQRV----------------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226 (389)
T ss_dssp TTEECSC----------------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHH
T ss_pred ccccccc----------------------------------cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHH
Confidence 1100000 0000113589999999999987 689999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhcccc------------------------------------------ccCCCCcCC
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTH------------------------------------------LKFPEEAKL 385 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~------------------------------------------l~~p~~~~~ 385 (549)
+|||++|++||.+.+.......++..... ...+....+
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 99999999999987766665554431100 011122357
Q ss_pred ChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 386 SPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 386 s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
++++++||.+||. ||.+|+ +++|+++||||+.+.|....
T Consensus 307 s~~~~~li~~~L~~dP~~Rp---ta~ell~hp~f~~~~~~~~~ 346 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARP---SASTLLNHSFFKQIKRRASE 346 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGGGC---CCS
T ss_pred CHHHHHHHHHHhhcCcccCC---CHHHHhcCHHHHHHhhcchh
Confidence 8999999999999 999999 89999999999998875543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=448.38 Aligned_cols=264 Identities=33% Similarity=0.632 Sum_probs=236.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46799999999999999999999999999999999877655556677899999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE---cCCCcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl---d~~g~vKL~DFGlak~~~~~~~ 272 (549)
||||.||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||+ +.++++||+|||+|+.+.....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999999999888999999999999999999999999999999999999999 5678999999999986542210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
....+||+.|+|||++.+ .|+.++|||||||++|+|+
T Consensus 185 ------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 185 ------------------------------------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL 221 (484)
T ss_dssp ------------------------------------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHH
Confidence 114589999999999976 6999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
+|.+||.+.+..+...+|......+..|....+|+++++||.+||+ ||.+|+ ++.|+++||||+...++.
T Consensus 222 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 222 SGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSHHHHHHTC--
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhhChhhccccccc
Confidence 9999999999988888888765555566666899999999999999 999999 899999999998776544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=427.48 Aligned_cols=258 Identities=33% Similarity=0.556 Sum_probs=213.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...++|++++.||+|+||.||+|+++.+|+.||||++.+.... .+.+.+|+.+++.++|||||+++++|.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3468899999999999999999999999999999999765432 245789999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc--EEEeecCcccccCCCC
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH--MKLSDFGLCKPLDCSN 271 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~--vKL~DFGlak~~~~~~ 271 (549)
+|||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999988889999999999999999999999999999999999999988775 9999999987432110
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcc-cccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME-CDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~-~DiWSlGvilyE 350 (549)
...+.+||+.|+|||++.+..|+.+ +|||||||++|+
T Consensus 173 ------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 210 (361)
T 3uc3_A 173 ------------------------------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210 (361)
T ss_dssp --------------------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHH
Confidence 0124689999999999998888655 899999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhc--cccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNW--RTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~--~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|++|++||.+.+....+.+++.. .....+|....+|+++++||.+||. ||.+|+ +++||++||||..
T Consensus 211 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~~ 280 (361)
T 3uc3_A 211 MLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI---SIPEIKTHSWFLK 280 (361)
T ss_dssp HHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSC---CHHHHHTSHHHHT
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCc---CHHHHHhCcchhc
Confidence 99999999886654444443321 1344566666789999999999999 999999 8999999999954
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=414.53 Aligned_cols=259 Identities=36% Similarity=0.667 Sum_probs=219.7
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-----------------------hhhHHHHHHHHHH
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR-----------------------RGQVEHVKAERNL 170 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~-----------------------~~~~~~~~~E~~i 170 (549)
+..++|++.+.||+|+||.||+|+++.+|+.||||++.+..... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34678999999999999999999999999999999998754322 1224568899999
Q ss_pred HHhcCCCceeeeeeeecC--CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 171 LAEVDSNCIVKLYCSFQD--DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 171 L~~l~hp~Iv~l~~~f~d--~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
|+.++||||+++++++.+ ...+|+||||++||+|..++ ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999986 67899999999999998875 456899999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
|++.+|++||+|||+++.+..... .....+||+.|+|||
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------~~~~~~gt~~y~aPE 207 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-----------------------------------------LLSNTVGTPAFMAPE 207 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-----------------------------------------EECCCCSCGGGCCGG
T ss_pred EECCCCCEEEecCCCccccccccc-----------------------------------------cccCCcCCccccChh
Confidence 999999999999999987542110 012458999999999
Q ss_pred hhccCC---CCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccC
Q 038137 329 VLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 329 vl~~~~---y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
++.+.. ++.++|||||||++|||++|.+||.+.+.......+.. ..+.+|....+++++++||.+||. ||.+|+
T Consensus 208 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~ 285 (298)
T 2zv2_A 208 SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS--QALEFPDQPDIAEDLKDLITRMLDKNPESRI 285 (298)
T ss_dssp GCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC
T ss_pred hhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc--ccCCCCCccccCHHHHHHHHHHhhcChhhCC
Confidence 998765 47889999999999999999999998877766666655 345566666899999999999999 999999
Q ss_pred CCCCHHHHHcCCccc
Q 038137 405 GTKGADEIKAHPWFK 419 (549)
Q Consensus 405 ~~~~~~eil~HpfF~ 419 (549)
++.||++||||.
T Consensus 286 ---s~~e~l~hp~~~ 297 (298)
T 2zv2_A 286 ---VVPEIKLHPWVT 297 (298)
T ss_dssp ---CHHHHTTCHHHH
T ss_pred ---CHHHHhcCcccc
Confidence 899999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=421.05 Aligned_cols=251 Identities=24% Similarity=0.285 Sum_probs=191.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc----eE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----YL 192 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----~l 192 (549)
.+|.+.+.||+|+||+||+|++ +|+.||||++..... ......+|+.++..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688899999999999999987 588999999975431 1122334555567889999999999997553 68
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH--------NYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
|||||||+||+|.++|.+ ..++++.+..++.|++.||.|||++ +||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999964 5799999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC------CCCcc
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK------GYGME 338 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~------~y~~~ 338 (549)
+......... .....+.+||+.|||||++.+. .|+.+
T Consensus 156 ~~~~~~~~~~-------------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k 198 (303)
T 3hmm_A 156 VRHDSATDTI-------------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp EEEETTTTEE-------------------------------------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred ccccCCCCce-------------------------------------eeecccccccccccCHHHhcccccccCCccChh
Confidence 8764221000 0011246899999999999764 46789
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCch--------------h-hhhhhhhccccccCCCC---cCCChhHHHHHHHhhh-c
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEPM--------------S-TCRKIVNWRTHLKFPEE---AKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~~--------------~-~~~~I~~~~~~l~~p~~---~~~s~~~~dLI~~lL~-d 399 (549)
+|||||||+||||++|.+||...... . ....+......+.+|.. ...+..+.+||.+||. |
T Consensus 199 ~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~d 278 (303)
T 3hmm_A 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSS
T ss_pred HhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccC
Confidence 99999999999999998877533211 1 11222222222333331 1123468899999999 9
Q ss_pred ccccCCCCCHHHHHc
Q 038137 400 VEQRLGTKGADEIKA 414 (549)
Q Consensus 400 p~~Rl~~~~~~eil~ 414 (549)
|.+|+ ++.||++
T Consensus 279 P~~RP---t~~ei~~ 290 (303)
T 3hmm_A 279 GAARL---TALRIKK 290 (303)
T ss_dssp GGGSC---CHHHHHH
T ss_pred HhHCc---CHHHHHH
Confidence 99999 7998875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=404.50 Aligned_cols=264 Identities=31% Similarity=0.580 Sum_probs=233.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++..++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 5789999999999999999999999999999999976543 344557788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc---EEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~---vKL~DFGlak~~~~~~~ 272 (549)
|||++||+|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988889999999999999999999999999999999999999987665 99999999976532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 164 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 201 (284)
T 3kk8_A 164 ------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201 (284)
T ss_dssp ------------------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHH
Confidence 11457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
+|.+||.+.+.......+.........+....+++++.+||.+||. ||.+|+ +++|+++||||++..+..
T Consensus 202 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 202 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TADQALKVPWICNRERVA 272 (284)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSHHHHSCCCGG
T ss_pred HCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC---CHHHHhcCccccCChhHH
Confidence 9999999988888887777644444444445789999999999999 999999 899999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=407.70 Aligned_cols=260 Identities=35% Similarity=0.592 Sum_probs=231.3
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
..+..++|++++.||+|+||.||+|.+..++..||+|++.+...........+.+|+.++..++||||++++++|.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 35678899999999999999999999999999999999987665555556778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+||||++||+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999986542110
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
....+||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 164 -------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 200 (279)
T 3fdn_A 164 -------------------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200 (279)
T ss_dssp -----------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred -------------------------------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHH
Confidence 1145899999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
++|.+||.+.+.......+.. ....+|. .+++++++||.+||. ||.+|+ +++||++||||++.
T Consensus 201 ~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 201 LVGKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITAN 264 (279)
T ss_dssp HHSSCTTCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHCCSSGGGSC---CHHHHHHCHHHHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHhccChhhCC---CHHHHhhCccccCC
Confidence 999999998888777777765 2334443 689999999999999 999999 89999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=421.71 Aligned_cols=266 Identities=27% Similarity=0.439 Sum_probs=216.9
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
....++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++|||||+++++|.+...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3456789999999999999999999999999999999976532 233445678899999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE-----cCCCcEEEeecCccccc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL-----DRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl-----d~~g~vKL~DFGlak~~ 267 (549)
|+||||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999997 5999999888899999999999999999999999999999999999999 45556999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 346 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGv 346 (549)
..... .....+||+.|+|||++.+. .|+.++|||||||
T Consensus 188 ~~~~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 226 (329)
T 3gbz_A 188 GIPIR-----------------------------------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226 (329)
T ss_dssp C----------------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred CCccc-----------------------------------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHH
Confidence 32100 01145899999999999874 5899999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhcccccc----------------CCC----------CcCCChhHHHHHHHhhh-c
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLK----------------FPE----------EAKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~----------------~p~----------~~~~s~~~~dLI~~lL~-d 399 (549)
++|||++|.+||.+.+......+++....... +|. ...+++++++||.+||+ |
T Consensus 227 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 306 (329)
T 3gbz_A 227 IWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306 (329)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC
Confidence 99999999999999888777777654211000 000 01278999999999999 9
Q ss_pred ccccCCCCCHHHHHcCCcccCCCcc
Q 038137 400 VEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 400 p~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|.+|+ +++|+++||||++++|+
T Consensus 307 P~~R~---t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 307 PVKRI---SAKNALEHPYFSHNDFD 328 (329)
T ss_dssp GGGSC---CHHHHHTSGGGSSSCSC
T ss_pred hhhCC---CHHHHhCCcccCCCCCC
Confidence 99999 89999999999999996
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=407.76 Aligned_cols=261 Identities=36% Similarity=0.620 Sum_probs=232.8
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
...+..++|++.+.||+|+||.||+|++..++..||||++.+...........+.+|+.++..++||||+++++++.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 34567789999999999999999999999999999999998766544555677899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998754311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. ....+||+.|+|||++.+..++.++|+|||||++|+
T Consensus 168 ~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 204 (284)
T 2vgo_A 168 R-------------------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204 (284)
T ss_dssp C-------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHH
T ss_pred c-------------------------------------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHH
Confidence 0 014579999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|++|.+||.+.+.......+.. ....+|. .+++++++||.+||. ||.+|+ +++++++||||+..
T Consensus 205 l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 205 FLVGMPPFDSPSHTETHRRIVN--VDLKFPP--FLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHSCSSGGGSC---CHHHHHTCHHHHHH
T ss_pred HHHCCCCCCCCCHhHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhhcCHhhCC---CHHHHhhCHHHHhh
Confidence 9999999998887777777765 3344553 789999999999999 999999 89999999999854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=418.98 Aligned_cols=260 Identities=26% Similarity=0.470 Sum_probs=219.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||+||+|+++.+++.||||++...... ...+.+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 57899999999999999999999999999999999754322 2235588999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~G 354 (549)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus 161 ------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 161 ------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp ------------------------------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 001124689999999999988776 7899999999999999999
Q ss_pred CCCCCCCCchhh-hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 355 YPPFYSDEPMST-CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 355 ~~PF~~~~~~~~-~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
.+||.+.+.... +..+.. .....+....+++++.+||.+||. ||.+|+ +++||++||||+..
T Consensus 205 ~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~eil~h~~~~~~ 268 (323)
T 3tki_A 205 ELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (323)
T ss_dssp SCSCSSSCTTSHHHHHHHT--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred CCCCCCCchHHHHHHHHhc--ccccCCccccCCHHHHHHHHHHccCChhhCc---CHHHHhhChhhccc
Confidence 999987655432 222222 122233335789999999999999 999999 89999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=431.43 Aligned_cols=290 Identities=27% Similarity=0.416 Sum_probs=218.4
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-----
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD----- 189 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~----- 189 (549)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||++++++.+.
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3678999999999999999999999999999999997642 3344557789999999999999999999999876
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||+. |+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999995 69999998888899999999999999999999999999999999999999999999999999997643
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-cCCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-~~~y~~~~DiWSlGvil 348 (549)
....... ........+... .........+.+||++|+|||++. +..|+.++||||||||+
T Consensus 182 ~~~~~~~--------~~~~~~~~~~~~-----------~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il 242 (432)
T 3n9x_A 182 EKDTNIV--------NDLEENEEPGPH-----------NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242 (432)
T ss_dssp ------------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred ccccccc--------cccccccccccc-----------ccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHH
Confidence 2110000 000000000000 000111234679999999999974 56799999999999999
Q ss_pred HHHhh-----------CCCCCCCCCc-----------------hhhhhhhhhccc--------------------cc--c
Q 038137 349 YEMLV-----------GYPPFYSDEP-----------------MSTCRKIVNWRT--------------------HL--K 378 (549)
Q Consensus 349 yEml~-----------G~~PF~~~~~-----------------~~~~~~I~~~~~--------------------~l--~ 378 (549)
|||++ |+++|.+.+. ......|+...+ .+ .
T Consensus 243 ~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 322 (432)
T 3n9x_A 243 AELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR 322 (432)
T ss_dssp HHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC
T ss_pred HHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCC
Confidence 99998 5555555431 111111111000 00 0
Q ss_pred CCC-----CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccccc
Q 038137 379 FPE-----EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 379 ~p~-----~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~ 428 (549)
.+. ...+|+++.+||.+||+ ||.+|+ +++|+++||||++++|.....
T Consensus 323 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~---ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 323 KPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp CCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTCGGGTTTCCTTTC-
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhcCCcccCC---CHHHHhcChhhhhccCcccCc
Confidence 010 13589999999999999 999999 899999999999999987764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=417.57 Aligned_cols=265 Identities=32% Similarity=0.552 Sum_probs=232.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR---GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4569999999999999999999999999999999987543221 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC----cEEEeecCcccccC
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG----HMKLSDFGLCKPLD 268 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g----~vKL~DFGlak~~~ 268 (549)
|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+| ++||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999998888999999999999999999999999999999999999999988 89999999998654
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.... ....+||+.|+|||++.+..|+.++|+|||||++
T Consensus 171 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 171 DGVE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (321)
T ss_dssp TTCC------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cccc------------------------------------------ccccCCCCCccCcccccCCCCCCccccHHHHHHH
Confidence 2110 1145799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
|+|++|.+||.+.+..+....+.... ..++. ...+++.+++||.+||+ ||.+|+ +++|+++||||.+++|..
T Consensus 209 ~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~hp~~~~~~~~~ 283 (321)
T 2a2a_A 209 YILLSGASPFLGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRL---TIQEALRHPWITPVDNQQ 283 (321)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSC---CHHHHHHSTTTSCSSHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhcc--cccChhhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhcCccccCCCccc
Confidence 99999999999988888777776532 22322 14689999999999999 999999 899999999999998876
Q ss_pred cc
Q 038137 426 LY 427 (549)
Q Consensus 426 l~ 427 (549)
..
T Consensus 284 ~~ 285 (321)
T 2a2a_A 284 AM 285 (321)
T ss_dssp HH
T ss_pred cc
Confidence 54
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=440.12 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=211.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 478999999999999999999999999999999998653 3444567788999999999999999999999754
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|||||||+| +|...+. ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 468999999965 5666663 3599999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. .....+||+.|+|||++.+..|+.++||||||||+|
T Consensus 217 ~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 217 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp CC------------------------------------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred Cc------------------------------------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 10 012468999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccc-------------------------c----CCCC---------cCCChhHHH
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHL-------------------------K----FPEE---------AKLSPEAKD 391 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l-------------------------~----~p~~---------~~~s~~~~d 391 (549)
||++|++||.+.+..+.+.+|+...... . +|.. ...+++++|
T Consensus 255 ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 9999999999998877777776421110 0 0100 001567999
Q ss_pred HHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 392 LISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 392 LI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||.+||+ ||.+|+ +++|+++||||+.
T Consensus 335 Ll~~mL~~dP~~R~---ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 335 LLSKMLVIDPAKRI---SVDDALQHPYINV 361 (464)
T ss_dssp HHHHHSCSSTTTSC---CHHHHHTSTTTGG
T ss_pred HHHHHcCCChhhCC---CHHHHhcChhhhh
Confidence 9999999 999999 8999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=443.00 Aligned_cols=261 Identities=32% Similarity=0.633 Sum_probs=232.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3569999999999999999999999999999999987543 233457789999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc---CCCcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD---RNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld---~~g~vKL~DFGlak~~~~~~~ 272 (549)
||||+||+|.+.+...+.+++..++.++.||+.||.|||++|||||||||+|||++ .++++||+|||+|+.+....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 99999999999998889999999999999999999999999999999999999995 45689999999998653211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.....+||+.|+|||++.+ .|+.++||||||||+|+|+
T Consensus 179 -----------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 179 -----------------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp --------------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH
Confidence 0114689999999999975 5999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
+|.+||.+.+..+...++.........|....+|+++++||.+||+ ||.+|+ ++.++++||||+....
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSS 285 (486)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHHHCHHHHHTCC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCc---CHHHHhcCHhhccCcc
Confidence 9999999999988888888765555666667899999999999999 999999 8999999999987643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=421.62 Aligned_cols=260 Identities=33% Similarity=0.556 Sum_probs=213.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...++|++.+.||+|+||.||+|+++.+++.||||++.+.. ..+.+.+|+.+|..++|||||+++++|.+...+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34577999999999999999999999999999999997643 2345788999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---CCcEEEeecCcccccCCC
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~g~vKL~DFGlak~~~~~ 270 (549)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999976 899999999998865311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. .....+||+.|+|||++.+..|+.++|||||||++||
T Consensus 205 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 242 (349)
T 2w4o_A 205 V------------------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242 (349)
T ss_dssp --------------------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHH
Confidence 0 0114689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchh-hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 351 MLVGYPPFYSDEPMS-TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 351 ml~G~~PF~~~~~~~-~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
|++|..||.+..... ....+.........|....++.++++||.+||+ ||.+|+ ++.|+++||||.+..+
T Consensus 243 ll~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 243 LLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTTSTTC
T ss_pred HHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc---CHHHHhcCcccCCCcc
Confidence 999999998766554 556666543333333345789999999999999 999999 8999999999987653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=415.68 Aligned_cols=263 Identities=28% Similarity=0.481 Sum_probs=207.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999997653 223345678899999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 196 MEYLPGGDMMTLLMRK------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999988653 3699999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
... .....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 161 ~~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 199 (317)
T 2pmi_A 161 PVN-----------------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199 (317)
T ss_dssp CCC-----------------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred Ccc-----------------------------------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHH
Confidence 110 0114589999999999987 4689999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccc---------cCC---------------------CCcCCChhHHHHHHHhhh
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHL---------KFP---------------------EEAKLSPEAKDLISKLLC 398 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l---------~~p---------------------~~~~~s~~~~dLI~~lL~ 398 (549)
|||++|.+||.+.+..+....|....... ..| ....+++++++||.+||+
T Consensus 200 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 279 (317)
T 2pmi_A 200 AEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279 (317)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSC
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCC
Confidence 99999999999988777766665321100 000 012578999999999999
Q ss_pred -cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 399 -NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 399 -dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
||.+|+ +++|+++||||+++.|..
T Consensus 280 ~dP~~Rp---t~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 280 LNPDMRL---SAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp SSGGGSC---CHHHHTTSGGGGGGCC--
T ss_pred CCcccCC---CHHHHhCChhhhcccchh
Confidence 999999 899999999999876653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=429.46 Aligned_cols=254 Identities=34% Similarity=0.550 Sum_probs=210.0
Q ss_pred CCCCeeee-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHH-HhcCCCceeeeeeeecC----
Q 038137 115 GADDFEPL-TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL-AEVDSNCIVKLYCSFQD---- 188 (549)
Q Consensus 115 ~~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f~d---- 188 (549)
..++|.++ ++||+|+||+||+|.++.+|+.||||++.+. ..+.+|+.++ +..+|||||+++++|.+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 35678887 7999999999999999999999999999643 2356788887 45589999999998865
Q ss_pred CceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---CCcEEEeecCc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NGHMKLSDFGL 263 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~g~vKL~DFGl 263 (549)
..++|||||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++. +|++||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 67899999999999999999764 35999999999999999999999999999999999999998 78999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccch
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWS 343 (549)
|+...... ...+.+||+.|+|||++.+..|+.++||||
T Consensus 211 a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 248 (400)
T 1nxk_A 211 AKETTSHN------------------------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248 (400)
T ss_dssp CEECC-----------------------------------------------------CTTCCGGGSCCCCSSSHHHHHH
T ss_pred ccccCCCC------------------------------------------ccccCCCCCCccCHhhcCCCCCCCcccHHH
Confidence 98653110 012568999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCCchh----hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMS----TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~----~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
||||+|||++|++||.+.+... ...++......+..+....+|+++++||.+||+ ||.+|+ +++||++||||
T Consensus 249 lG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~ 325 (400)
T 1nxk_A 249 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWI 325 (400)
T ss_dssp HHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHH
T ss_pred HHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCccc
Confidence 9999999999999998765433 344455433333334445789999999999999 999999 89999999999
Q ss_pred cCC
Q 038137 419 KGI 421 (549)
Q Consensus 419 ~~i 421 (549)
...
T Consensus 326 ~~~ 328 (400)
T 1nxk_A 326 MQS 328 (400)
T ss_dssp HTT
T ss_pred cCC
Confidence 753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=408.20 Aligned_cols=259 Identities=30% Similarity=0.460 Sum_probs=214.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|++ .+|+.||+|++..... .......+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 6789999999976432 2233456789999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++| +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--- 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc---
Confidence 99975 89888865 47899999999999999999999999999999999999999999999999999986532100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G 354 (549)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 156 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (288)
T 1ob3_A 156 --------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (288)
T ss_dssp --------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 0114579999999999986 4589999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccc---------c-------CC---------CCcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHL---------K-------FP---------EEAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l---------~-------~p---------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
.+||.+.+......++....... . ++ ....+++++++||.+||+ ||.+|+ +
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t 274 (288)
T 1ob3_A 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---T 274 (288)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---C
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC---C
Confidence 99999887776666654311100 0 00 012578999999999999 999999 8
Q ss_pred HHHHHcCCcccCCC
Q 038137 409 ADEIKAHPWFKGIE 422 (549)
Q Consensus 409 ~~eil~HpfF~~i~ 422 (549)
++|+++||||++.+
T Consensus 275 ~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 275 AKQALEHAYFKENN 288 (288)
T ss_dssp HHHHHTSGGGGC--
T ss_pred HHHHhcCcchhhcC
Confidence 99999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=441.64 Aligned_cols=262 Identities=34% Similarity=0.604 Sum_probs=227.3
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch----------hhHHHHHHHHHHHHhcCCCceeeeee
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR----------GQVEHVKAERNLLAEVDSNCIVKLYC 184 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~ 184 (549)
..++|++++.||+|+||+||+|+++.++..||||++.+...... ...+.+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999999999999999987653321 34567899999999999999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEEeec
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKLSDF 261 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL~DF 261 (549)
+|.+...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999998889999999999999999999999999999999999999999876 6999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCccccc
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~Di 341 (549)
|+|+.+.... .....+||+.|+|||++. ..|+.++||
T Consensus 194 g~a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di 230 (504)
T 3q5i_A 194 GLSSFFSKDY------------------------------------------KLRDRLGTAYYIAPEVLK-KKYNEKCDV 230 (504)
T ss_dssp TTCEECCTTS------------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHH
T ss_pred CCCEEcCCCC------------------------------------------ccccccCCcCCCCHHHhc-cCCCchHHH
Confidence 9998654211 011468999999999986 569999999
Q ss_pred chhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|||||++|+|++|.+||.+.+..+...+|......+..+....+|+++++||.+||+ ||.+|+ +++|+++||||+.
T Consensus 231 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 231 WSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKK 307 (504)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC---CHHHHhcCHhhhh
Confidence 999999999999999999999888888888754433444445789999999999999 999999 8999999999986
Q ss_pred CC
Q 038137 421 IE 422 (549)
Q Consensus 421 i~ 422 (549)
..
T Consensus 308 ~~ 309 (504)
T 3q5i_A 308 YA 309 (504)
T ss_dssp TC
T ss_pred ch
Confidence 53
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=440.47 Aligned_cols=261 Identities=34% Similarity=0.620 Sum_probs=225.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|+++.++..||||++.+..... .....+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999998765322 23466889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC---CcEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN---GHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~---g~vKL~DFGlak~~~~~~~~ 273 (549)
|||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.. +.+||+|||+|+.+....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 999999999999888999999999999999999999999999999999999999764 559999999998654211
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
...+.+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 194 ----------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 194 ----------------------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp ----------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh
Confidence 012468999999999986 579999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|++||.+.+..+...++......+..|....+|+++++||.+||+ ||.+|+ +++|+++||||+...+.
T Consensus 233 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI---SAQQALEHPWIKEMCSK 301 (494)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTCHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCc---cHHHHhcCcccccCccc
Confidence 999999999988888888755444445556799999999999999 999999 89999999999875443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=413.14 Aligned_cols=265 Identities=27% Similarity=0.485 Sum_probs=228.5
Q ss_pred CCeeee-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEE
Q 038137 117 DDFEPL-TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 117 ~~f~~~-~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lyl 194 (549)
+.|.+. +.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.++..+ .||||++++++|.+...+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 457777 899999999999999999999999999987543 223456788999999998 46999999999999999999
Q ss_pred EEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---CCcEEEeecCcccccCC
Q 038137 195 IMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~g~vKL~DFGlak~~~~ 269 (549)
||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 9999999999999855 367999999999999999999999999999999999999998 79999999999986532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 187 ~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 224 (327)
T 3lm5_A 187 AC------------------------------------------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224 (327)
T ss_dssp -------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred cc------------------------------------------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHH
Confidence 10 011458999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
+|++|.+||.+.+.......+.........+....+++.+++||.+||+ ||.+|+ +++++++||||++++|+.+.
T Consensus 225 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 225 MLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP---TAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTCGGGCCCCTTCC-
T ss_pred HHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc---CHHHHhCCHhhccccccccc
Confidence 9999999999988888877777644444333345789999999999999 999999 89999999999999998774
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=408.63 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=214.0
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHhc---CCCceeeeeeeecC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML--RRGQVEHVKAERNLLAEV---DSNCIVKLYCSFQD 188 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d 188 (549)
+..++|++++.||+|+||+||+|+++.+|+.||||++...... .......+.+|+.+++.+ +||||++++++|.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567899999999999999999999999999999999754321 111223466777777666 59999999999976
Q ss_pred Cc-----eEEEEEeecCCCchhhHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeec
Q 038137 189 DE-----YLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 189 ~~-----~lylVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DF 261 (549)
.. .+|+||||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+|++||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 5899999996 699999976544 999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCccccc
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~Di 341 (549)
|+|+...... .....+||+.|+|||++.+..|+.++||
T Consensus 165 g~a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 202 (308)
T 3g33_A 165 GLARIYSYQM------------------------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDM 202 (308)
T ss_dssp SCTTTSTTCC------------------------------------------CSGGGGCCCSSCCHHHHHTSCCCSTHHH
T ss_pred ccccccCCCc------------------------------------------ccCCccccccccCchHHcCCCCCchHHH
Confidence 9998653211 0114689999999999999999999999
Q ss_pred chhhHHHHHHhhCCCCCCCCCchhhhhhhhhccc---------cccCC-----C---------CcCCChhHHHHHHHhhh
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT---------HLKFP-----E---------EAKLSPEAKDLISKLLC 398 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~---------~l~~p-----~---------~~~~s~~~~dLI~~lL~ 398 (549)
|||||++|||++|.+||.+.+......+++.... ...++ . ...+++++.+||.+||+
T Consensus 203 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 282 (308)
T 3g33_A 203 WSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLT 282 (308)
T ss_dssp HHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhc
Confidence 9999999999999999999888887777764211 11111 0 12578999999999999
Q ss_pred -cccccCCCCCHHHHHcCCcccCC
Q 038137 399 -NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 399 -dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||.+|+ ++.|+++||||+..
T Consensus 283 ~dP~~R~---t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 283 FNPHKRI---SAFRALQHSYLHKD 303 (308)
T ss_dssp SSTTTSC---CHHHHHTSTTC---
T ss_pred CCCccCC---CHHHHhcCccccCC
Confidence 999999 89999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=418.92 Aligned_cols=268 Identities=32% Similarity=0.533 Sum_probs=227.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML--RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
++|++++.||+|+||.||+|.++.++..||+|++.+.... .....+.+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 4699999999999999999999999999999999876432 34556789999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 038137 195 IMEYLPGGDMMTLLMR----------------------------------------KDTLTEEEARFYVGETVLAIESIH 234 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~----------------------------------------~~~l~e~~~~~~~~qi~~aL~~LH 234 (549)
|||||+||+|.+++.. ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 112468889999999999999999
Q ss_pred hCCeeecCCCCCCeEEcCCC--cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcc
Q 038137 235 KHNYIHRDIKPDNLLLDRNG--HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRR 312 (549)
Q Consensus 235 ~~giiHRDLKPeNILld~~g--~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (549)
++||+||||||+|||++.++ .+||+|||+|+.+....... .
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-------------------------------------~ 228 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-------------------------------------Y 228 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc-------------------------------------c
Confidence 99999999999999998777 89999999998653211000 0
Q ss_pred cceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHH
Q 038137 313 MLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAK 390 (549)
Q Consensus 313 ~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~ 390 (549)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....++.....+..|....++++++
T Consensus 229 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (345)
T 3hko_A 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR 308 (345)
T ss_dssp ------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHH
T ss_pred ccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHH
Confidence 00124689999999999975 6789999999999999999999999999988888888887555455555456899999
Q ss_pred HHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 391 dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
+||.+||+ ||.+|+ ++.++++||||+++.|.
T Consensus 309 ~li~~~l~~~p~~Rp---s~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 309 DLLSNLLNRNVDERF---DAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHSCSCTTTSC---CHHHHHHSHHHHTTSSC
T ss_pred HHHHHHcCCChhHCC---CHHHHhcChhhccChHh
Confidence 99999999 999999 89999999999987643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=402.44 Aligned_cols=268 Identities=33% Similarity=0.576 Sum_probs=230.4
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh------hchhhHHHHHHHHHHHHhcC-CCceeeeeeeec
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM------LRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQ 187 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~------~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~ 187 (549)
..++|++.+.||+|+||.||+|.++.+|+.||||++..... ......+.+.+|+.+|..+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 36789999999999999999999999999999999975421 11233456889999999995 999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+...+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc------cCCCCccccc
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDW 341 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~------~~~y~~~~Di 341 (549)
..... ....+||+.|+|||++. ...++.++|+
T Consensus 175 ~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di 212 (298)
T 1phk_A 175 DPGEK------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212 (298)
T ss_dssp CTTCC------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHH
T ss_pred CCCcc------------------------------------------cccccCCccccCHHHhccccccccccCCccccc
Confidence 42110 11457999999999986 4568999999
Q ss_pred chhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|||||++|+|++|.+||.+.+.......+.........|....+++++.+||.+||. ||.+|+ ++.|+++||||++
T Consensus 213 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~ 289 (298)
T 1phk_A 213 WSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQ 289 (298)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCT
T ss_pred HhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCC---CHHHHHhChHhhh
Confidence 999999999999999999988877777777644444444445789999999999999 999999 8999999999999
Q ss_pred CCccccc
Q 038137 421 IEWDKLY 427 (549)
Q Consensus 421 i~w~~l~ 427 (549)
..|+.+.
T Consensus 290 ~~~~~~~ 296 (298)
T 1phk_A 290 YVVEEVR 296 (298)
T ss_dssp TC-----
T ss_pred ccchhhc
Confidence 9887664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=423.92 Aligned_cols=255 Identities=32% Similarity=0.566 Sum_probs=218.8
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCC
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+|..++|||||+++++|.+.+.+|||||||+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 6789999999999999999999999999986532 3346788999999999999999999999999999999999999
Q ss_pred CchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE--cCCCcEEEeecCcccccCCCCccccccc
Q 038137 202 GDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL--DRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 202 g~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl--d~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~------ 244 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK------ 244 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB------
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc------
Confidence 9999988654 579999999999999999999999999999999999999 6678999999999987542110
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF 358 (549)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+||
T Consensus 245 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 288 (373)
T 2x4f_A 245 ------------------------------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288 (373)
T ss_dssp ------------------------------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------------------------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCC
Confidence 11457999999999999999999999999999999999999999
Q ss_pred CCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 359 ~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
.+.+..+.+.+|+.....+..+....+++++++||.+||+ ||.+|+ +++|+++||||.+..|.
T Consensus 289 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---s~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 289 LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKLH 352 (373)
T ss_dssp CCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHCHHHH
T ss_pred CCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCC---CHHHHhcCcCcCCCchh
Confidence 9999888888888643333222234789999999999999 999999 89999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=416.55 Aligned_cols=252 Identities=32% Similarity=0.545 Sum_probs=197.7
Q ss_pred Ceeee---eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEE
Q 038137 118 DFEPL---TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 118 ~f~~~---~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~ly 193 (549)
+|++. +.||+|+||.||+|.++.+|+.||||++.+. ....+.+|+.+|..+. |||||+++++|.+...+|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 35554 7899999999999999999999999999754 2355778999999997 999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEEeecCcccccCCC
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKLSDFGLCKPLDCS 270 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL~DFGlak~~~~~ 270 (549)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999999889999999999999999999999999999999999999998766 8999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.. ...+.+||+.|+|||++.+..|+.++|||||||++|+
T Consensus 163 ~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ 201 (325)
T 3kn6_A 163 NQ-----------------------------------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYT 201 (325)
T ss_dssp --------------------------------------------------------------CCCCHHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHH
Confidence 10 0124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCc-------hhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 351 MLVGYPPFYSDEP-------MSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 351 ml~G~~PF~~~~~-------~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|++|.+||.+.+. .+...++... ...++. ...+|+++++||.+||+ ||.+|+ +++|+++||||++
T Consensus 202 ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~h~w~~~ 276 (325)
T 3kn6_A 202 MLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQD 276 (325)
T ss_dssp HHHSSCTTC-------CCCHHHHHHHHTTT--CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCC---CTTTSTTCGGGCT
T ss_pred HHhCCCCCCCCccccccccHHHHHHHHHcC--CCCCCcccccCCCHHHHHHHHHHCCCChhHCC---CHHHHhcChhhcc
Confidence 9999999987543 2344445442 223332 24689999999999999 999999 8999999999986
Q ss_pred C
Q 038137 421 I 421 (549)
Q Consensus 421 i 421 (549)
.
T Consensus 277 ~ 277 (325)
T 3kn6_A 277 G 277 (325)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=420.09 Aligned_cols=260 Identities=32% Similarity=0.502 Sum_probs=215.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 578999999999999999999999999999999996543 23445567889999999999999999999998653
Q ss_pred -eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8999999865 6799999999999999999999999999999999999999999999999999986531
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
. ....+||+.|+|||++.+ ..|+.++||||||||+
T Consensus 181 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 181 E--------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216 (367)
T ss_dssp S--------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence 1 014589999999999987 7899999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccc------------------cCCC---------CcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHL------------------KFPE---------EAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l------------------~~p~---------~~~~s~~~~dLI~~lL~-dp 400 (549)
|||++|++||.+.+....+.+|+...... .+|. ...+++++.+||.+||+ ||
T Consensus 217 ~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP 296 (367)
T 1cm8_A 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296 (367)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCCh
Confidence 99999999999988877777665421110 0000 13578999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCCccc
Q 038137 401 EQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
.+|+ +++|+++||||+.+.+..
T Consensus 297 ~~R~---t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 297 EQRV---TAGEALAHPYFESLHDTE 318 (367)
T ss_dssp TTSC---CHHHHHHSGGGTTTC---
T ss_pred hHCC---CHHHHhcChHHHhhcCCc
Confidence 9999 899999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=405.65 Aligned_cols=265 Identities=28% Similarity=0.446 Sum_probs=219.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.++..++||||++++++|.+...+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999987653 2233456688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++|++|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--- 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---
Confidence 99999999999988888899999999999999999999999999999999999999999999999999986542110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G 354 (549)
.....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 199 (311)
T 4agu_A 158 --------------------------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199 (311)
T ss_dssp ----------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 0114589999999999986 6789999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhcc-----------------ccccCCCC----------cCCChhHHHHHHHhhh-cccccCCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWR-----------------THLKFPEE----------AKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~-----------------~~l~~p~~----------~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
.+||.+.+..+....+.... .....|.. ..+|+++.+||.+||+ ||.+|+
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-- 277 (311)
T 4agu_A 200 VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL-- 277 (311)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC--
T ss_pred CCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC--
Confidence 99999887766555443211 01111111 3578999999999999 999999
Q ss_pred CCHHHHHcCCcccCCCccc
Q 038137 407 KGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 407 ~~~~eil~HpfF~~i~w~~ 425 (549)
+++|+++||||+++.|..
T Consensus 278 -t~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 278 -TCEQLLHHPYFENIREIE 295 (311)
T ss_dssp -CHHHHHTSGGGTTCC---
T ss_pred -CHHHHhcChHHHhccCHH
Confidence 899999999999987654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=418.46 Aligned_cols=289 Identities=28% Similarity=0.440 Sum_probs=236.4
Q ss_pred hhhccCCHHHHHHHHHHHHhhhhhhhhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhH
Q 038137 82 LADAEVSEEEQNNLLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQV 161 (549)
Q Consensus 82 ~~~~~~~~ee~~~~~~~~~~~e~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~ 161 (549)
+...++.++........+..+ .....+..++|++++.||+|+||.||+|++..+|..||+|++.... .....
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~ 75 (360)
T 3eqc_A 4 LEELELDEQQRKRLEAFLTQK------QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIR 75 (360)
T ss_dssp --CCCCCHHHHHHHHHHHHHH------HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHH
T ss_pred hhhhhhhhhhhhhHHHHhhhh------hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHH
Confidence 344555555555544443322 2345677889999999999999999999999999999999997642 33445
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Q 038137 162 EHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH-NYIH 240 (549)
Q Consensus 162 ~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiH 240 (549)
..+.+|+.+|..++||||++++++|.+++.+|+||||++||+|.+++...+.+++..++.++.+++.||.|||+. ||+|
T Consensus 76 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H 155 (360)
T 3eqc_A 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMH 155 (360)
T ss_dssp HHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred HHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 678999999999999999999999999999999999999999999998888999999999999999999999995 9999
Q ss_pred cCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeeccc
Q 038137 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVG 320 (549)
Q Consensus 241 RDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vG 320 (549)
|||||+|||++.+|++||+|||+++..... .....+|
T Consensus 156 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------~~~~~~g 192 (360)
T 3eqc_A 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------------------------------------MANSFVG 192 (360)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHH-------------------------------------------C----CC
T ss_pred CCccHHHEEECCCCCEEEEECCCCcccccc-------------------------------------------cccCCCC
Confidence 999999999999999999999998754210 0124689
Q ss_pred CCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhh--------------------------------
Q 038137 321 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCR-------------------------------- 368 (549)
Q Consensus 321 T~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~-------------------------------- 368 (549)
|+.|+|||++.+..|+.++|||||||++|+|++|..||...+......
T Consensus 193 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (360)
T 3eqc_A 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272 (360)
T ss_dssp CCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------------
T ss_pred CCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCC
Confidence 999999999999999999999999999999999999998765433221
Q ss_pred ----------hhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccc
Q 038137 369 ----------KIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 369 ----------~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l 426 (549)
.+.+. .....+ ...+|+++++||.+||. ||.+|+ +++|+++||||++.+|+.+
T Consensus 273 ~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 273 PPMAIFELLDYIVNE-PPPKLP-SGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp -CCCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHHHHHSCC
T ss_pred CcccchhhhhHHhcc-CCCCCC-cccccHHHHHHHHHHhhcChhhCC---CHHHHhhChHhhcchHhhh
Confidence 11111 111112 23578999999999999 999999 8999999999998877655
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=399.42 Aligned_cols=258 Identities=35% Similarity=0.639 Sum_probs=203.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999999999999999999876655555567899999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||+++|+|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 9999999999999765 6799999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
.....+||+.|+|||++.+..++.++|+|||||++|||++|
T Consensus 168 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (278)
T 3cok_A 168 ---------------------------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208 (278)
T ss_dssp ---------------------------------------------------------------CTHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 01145799999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
.+||...+......++.. .....| ..+++++++||.+||. ||.+|+ +++++++||||...
T Consensus 209 ~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 209 RPPFDTDTVKNTLNKVVL--ADYEMP--SFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSCCCSCC-----CCS--SCCCCC--TTSCHHHHHHHHHHSCSSGGGSC---CHHHHTTSTTTC--
T ss_pred CCCCCChhHHHHHHHHhh--cccCCc--cccCHHHHHHHHHHcccCHhhCC---CHHHHhcCccccCC
Confidence 999988776666555543 223334 3689999999999999 999999 89999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=419.65 Aligned_cols=274 Identities=27% Similarity=0.427 Sum_probs=218.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.++||||++++++|.+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 478999999999999999999999999999999997643 23445567889999999999999999999998665
Q ss_pred -eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|+||||++ |+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 7999999996 57888774 4699999999999999999999999999999999999999999999999999976431
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 180 ~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 217 (371)
T 2xrw_A 180 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217 (371)
T ss_dssp ----------------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cc------------------------------------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHH
Confidence 10 011468999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhcccc----------------------------------ccCCCC----cCCChhHHH
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTH----------------------------------LKFPEE----AKLSPEAKD 391 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~----------------------------------l~~p~~----~~~s~~~~d 391 (549)
||++|.+||.+.+....+.+++..... ..+|.. ...++++++
T Consensus 218 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (371)
T 2xrw_A 218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297 (371)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHH
Confidence 999999999998877777666542110 001100 012578999
Q ss_pred HHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccccccCCCcccCC
Q 038137 392 LISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVN 438 (549)
Q Consensus 392 LI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p~~~ 438 (549)
||.+||+ ||.+|+ +++|+++||||+...........+|++|...
T Consensus 298 li~~mL~~dP~~R~---t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 342 (371)
T 2xrw_A 298 LLSKMLVIDASKRI---SVDEALQHPYINVWYDPSEAEAPPPKIPDKQ 342 (371)
T ss_dssp HHHHHSCSSGGGSC---CHHHHHHSHHHHTTCCHHHHTCCCCCCCTTT
T ss_pred HHHHHCcCChhhCC---CHHHHhCCcchhhhcCccccCCCCCCCCChh
Confidence 9999999 999999 8999999999986433333345667776643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=398.94 Aligned_cols=254 Identities=35% Similarity=0.628 Sum_probs=225.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++.+.||+|+||.||+|.++.++..||+|++.+... ...+.+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 469999999999999999999999999999999976542 33567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE---cCCCcEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl---d~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||++|++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~- 164 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM- 164 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC-
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc-
Confidence 999999999999888899999999999999999999999999999999999999 8889999999999986542210
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
....+||+.|+|||++.+. ++.++|+|||||++|+|++
T Consensus 165 -----------------------------------------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~ 202 (277)
T 3f3z_A 165 -----------------------------------------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLC 202 (277)
T ss_dssp -----------------------------------------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHH
Confidence 1145799999999998654 9999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCC--cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~--~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|.+||.+.+..+...++... ...+|.. ..+++++.+||.+||+ ||.+|+ ++.++++||||+..
T Consensus 203 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 203 GYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEKQ 268 (277)
T ss_dssp SSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHTTSHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHHhcc
Confidence 99999998888877777763 3334432 3689999999999999 999999 89999999999753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=410.01 Aligned_cols=268 Identities=31% Similarity=0.571 Sum_probs=214.5
Q ss_pred CCCeeee-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEE
Q 038137 116 ADDFEPL-TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 116 ~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ly 193 (549)
.+.|++. +.||+|+||.||+|.++.+|+.||||++.+.. ......+.+|+.+|..+ +||||++++++|.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4678886 78999999999999999999999999997653 23456788999999884 7999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc---EEEeecCcccccCCC
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGLCKPLDCS 270 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~---vKL~DFGlak~~~~~ 270 (549)
+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..+...
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999988889999999999999999999999999999999999999998876 999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----CCCCcccccchhh
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLG 345 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----~~y~~~~DiWSlG 345 (549)
.... .. ........+||+.|+|||++.+ ..|+.++||||||
T Consensus 168 ~~~~------------------~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 213 (316)
T 2ac3_A 168 GDCS------------------PI----------------STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213 (316)
T ss_dssp ------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHH
T ss_pred Cccc------------------cc----------------cccccccccCCcCccChHHhhcccccccCCCcccccHhHH
Confidence 1000 00 0001124689999999999975 5689999999999
Q ss_pred HHHHHHhhCCCCCCCCCch---------------hhhhhhhhccccccCCCC--cCCChhHHHHHHHhhh-cccccCCCC
Q 038137 346 AIMYEMLVGYPPFYSDEPM---------------STCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~---------------~~~~~I~~~~~~l~~p~~--~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
|++|||++|.+||.+.... .....+.. ....+|.. ..+++++++||.+||+ ||.+|+
T Consensus 214 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp--- 288 (316)
T 2ac3_A 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL--- 288 (316)
T ss_dssp HHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---
T ss_pred HHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCC---
Confidence 9999999999999876532 23344443 23344432 4689999999999999 999999
Q ss_pred CHHHHHcCCcccCCCccc
Q 038137 408 GADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 408 ~~~eil~HpfF~~i~w~~ 425 (549)
+++|+++||||++..|+.
T Consensus 289 s~~e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 289 SAAQVLQHPWVQGCAPEN 306 (316)
T ss_dssp CHHHHHHSTTCC------
T ss_pred CHHHHhcChhhcCCCCcc
Confidence 899999999999887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=398.97 Aligned_cols=261 Identities=31% Similarity=0.532 Sum_probs=232.5
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...++|.+.+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34678999999999999999999999999999999998776555666778899999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 171 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 210 (294)
T 2rku_A 171 ----------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210 (294)
T ss_dssp ----------------------------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh
Confidence 0113579999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
|.+||.+....+.+..+.. ....+|. .+++++.+||.+||+ ||.+|+ +++|+++||||....
T Consensus 211 g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 211 GKPPFETSCLKETYLRIKK--NEYSIPK--HINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSGY 273 (294)
T ss_dssp SSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHhh--ccCCCcc--ccCHHHHHHHHHHcccChhhCc---CHHHHhhChheecCC
Confidence 9999998887777766655 2344443 789999999999999 999999 899999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=427.57 Aligned_cols=264 Identities=31% Similarity=0.595 Sum_probs=214.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-----hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR-----RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
.++|.+.+.||+|+||.||+|.++.+++.||||++.+..... ......+.+|+.+|+.++|||||+++++|.++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 467999999999999999999999999999999998754321 12223478999999999999999999998654
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cEEEeecCccccc
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HMKLSDFGLCKPL 267 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~vKL~DFGlak~~ 267 (549)
.+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5799999999999999998888999999999999999999999999999999999999997654 5999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchh
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSL 344 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSl 344 (549)
.... ...+.+||+.|+|||++.+ ..|+.++|||||
T Consensus 293 ~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 330 (419)
T 3i6u_A 293 GETS------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330 (419)
T ss_dssp C-----------------------------------------------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred CCCc------------------------------------------cccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence 3210 0124689999999999864 678899999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||++|+|++|++||.+..........+.. ....++. ...+++++++||.+||. ||.+|+ +++|+++||||++.
T Consensus 331 G~il~~lltg~~pf~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 331 GVILFICLSGYPPFSEHRTQVSLKDQITS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHHHHHHSSCSSCCCSSSCCHHHHHHT-TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGCCH
T ss_pred HHHHHHHHHCCCCCCCCcchHHHHHHHhc-CCCCCCchhhcccCHHHHHHHHHHccCChhHCc---CHHHHhCCcccCCh
Confidence 99999999999999876554443333321 2222221 24689999999999999 999999 89999999999988
Q ss_pred Ccccc
Q 038137 422 EWDKL 426 (549)
Q Consensus 422 ~w~~l 426 (549)
+|...
T Consensus 407 ~~~~~ 411 (419)
T 3i6u_A 407 DMKRK 411 (419)
T ss_dssp HHHHH
T ss_pred hHHHH
Confidence 77543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=411.90 Aligned_cols=260 Identities=26% Similarity=0.465 Sum_probs=213.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999999999999999975431 111123457999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||++ |+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--- 155 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--- 155 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---
Confidence 9996 5888888664 5699999999999999999999999999999999999999999999999999976432100
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G 354 (549)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|
T Consensus 156 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (324)
T 3mtl_A 156 --------------------------------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197 (324)
T ss_dssp ---------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 0114589999999999987 6789999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccc-----------------cCC---------CCcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHL-----------------KFP---------EEAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l-----------------~~p---------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
.+||.+.+..+....+....... .+| ....+++++++||.+||+ ||.+|+
T Consensus 198 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~--- 274 (324)
T 3mtl_A 198 RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI--- 274 (324)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC---
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC---
Confidence 99999988777766665421110 011 012578999999999999 999999
Q ss_pred CHHHHHcCCcccCCCc
Q 038137 408 GADEIKAHPWFKGIEW 423 (549)
Q Consensus 408 ~~~eil~HpfF~~i~w 423 (549)
+++|+++||||.++.+
T Consensus 275 t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 275 SAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CHHHHTTSGGGGGGCS
T ss_pred CHHHHhcChhhhhccc
Confidence 8999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=415.82 Aligned_cols=258 Identities=34% Similarity=0.621 Sum_probs=225.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-----hchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM-----LRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
++|++.+.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|..++..+ +||||++++++|.+..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 469999999999999999999999999999999976431 1122245678999999999 8999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999875421
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc------CCCCcccccchh
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWWSL 344 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~------~~y~~~~DiWSl 344 (549)
. .....+||+.|+|||++.+ ..|+.++|||||
T Consensus 254 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 291 (365)
T 2y7j_A 254 E------------------------------------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291 (365)
T ss_dssp C------------------------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHH
T ss_pred c------------------------------------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhH
Confidence 1 0114689999999999973 368999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
||++|||++|.+||.+.+.......+.........|....+++++.+||.+||+ ||.+|+ +++++++||||+
T Consensus 292 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~f~ 364 (365)
T 2y7j_A 292 GVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSGGGC
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCcccC
Confidence 999999999999999988877777777644333333335789999999999999 999999 899999999996
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=414.99 Aligned_cols=259 Identities=29% Similarity=0.528 Sum_probs=219.7
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch-----hhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR-----GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
++|++++.||+|+||.||+|+++.+|+.||||++.+...... .....+.+|+.+|..++|||||+++++|.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 469999999999999999999999999999999987643221 133457789999999999999999999999999
Q ss_pred EEEEEeecCCC-chhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGG-DMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg-~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+|+||||+.+| +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999777 99999988889999999999999999999999999999999999999999999999999999865421
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvily 349 (549)
. ...+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 184 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 221 (335)
T 3dls_A 184 K------------------------------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLY 221 (335)
T ss_dssp C------------------------------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred C------------------------------------------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHH
Confidence 1 0125689999999999998887 88999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC------CC
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG------IE 422 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~------i~ 422 (549)
||++|.+||..... +.. .....| ..+|+++++||.+||. ||.+|+ +++++++||||+. ++
T Consensus 222 el~~g~~pf~~~~~------~~~--~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---s~~ell~hp~~~~~~~~~~~~ 288 (335)
T 3dls_A 222 TLVFEENPFCELEE------TVE--AAIHPP--YLVSKELMSLVSGLLQPVPERRT---TLEKLVTDPWVTQPVNLADYT 288 (335)
T ss_dssp HHHHSSCSCSSGGG------GTT--TCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHHCTTTTCCCCGGGCC
T ss_pred HHHhCCCchhhHHH------HHh--hccCCC--cccCHHHHHHHHHHccCChhhCc---CHHHHhcCccccCCccccccC
Confidence 99999999975321 221 122223 3689999999999999 999999 8999999999965 45
Q ss_pred cccccccc
Q 038137 423 WDKLYQIK 430 (549)
Q Consensus 423 w~~l~~~~ 430 (549)
|+.+....
T Consensus 289 ~~~~~~~~ 296 (335)
T 3dls_A 289 WEEVFRVN 296 (335)
T ss_dssp HHHHC---
T ss_pred HHHHhhhc
Confidence 55554433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=403.44 Aligned_cols=256 Identities=32% Similarity=0.603 Sum_probs=224.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|.+++.||+|+||.||+|+++.+|+.||+|++..... .....+.+|+.+|..++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 469999999999999999999999999999999986532 22345789999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE---cCCCcEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl---d~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-- 163 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence 999999999999888899999999999999999999999999999999999999 788999999999987542110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
....+||+.|+|||++.+..|+.++|+|||||++|+|++
T Consensus 164 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (304)
T 2jam_A 164 -----------------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202 (304)
T ss_dssp -----------------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 013579999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|.+||.+.+.......+.........+....+++++++||.+||+ ||.+|+ +++++++||||.+.
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~ 268 (304)
T 2jam_A 203 GYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY---TCEKALSHPWIDGN 268 (304)
T ss_dssp SSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC---CHHHHHTSHHHHSS
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCccccCC
Confidence 999999988877777777643333333335789999999999999 999999 89999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=401.19 Aligned_cols=265 Identities=31% Similarity=0.547 Sum_probs=227.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR---GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 469999999999999999999999999999999987543321 13567899999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC----cEEEeecCcccccCC
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG----HMKLSDFGLCKPLDC 269 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g----~vKL~DFGlak~~~~ 269 (549)
+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999999887 899999999986532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.. .....+||+.|+|||++.+..++.++|+|||||++|
T Consensus 165 ~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 202 (283)
T 3bhy_A 165 GN------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202 (283)
T ss_dssp -------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CC------------------------------------------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHH
Confidence 10 001357999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l 426 (549)
+|++|.+||.+.+.......+.........+....+++.+.+||.+||+ ||.+|+ ++.++++||||+.+.|...
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 203 ILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM---TIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC---CHHHHHHCHHHHHHHHCCC
T ss_pred HHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc---CHHHHHhCHHHHHHHHHhh
Confidence 9999999999988777777766532222111124689999999999999 999999 8999999999998765543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=406.98 Aligned_cols=261 Identities=31% Similarity=0.532 Sum_probs=232.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...++|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..++||||++++++|.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999999999999999998776555666778999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999986542110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 197 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 236 (335)
T 2owb_A 197 ----------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236 (335)
T ss_dssp ----------------------------------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 0114579999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
|..||.+....+.+..+.. ....+|. .+++++.+||.+||. ||.+|+ +++|+++||||....
T Consensus 237 g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~Rp---s~~ell~~~~~~~~~ 299 (335)
T 2owb_A 237 GKPPFETSCLKETYLRIKK--NEYSIPK--HINPVAASLIQKMLQTDPTARP---TINELLNDEFFTSGY 299 (335)
T ss_dssp SSCTTCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CGGGGGGSHHHHTSC
T ss_pred CcCCCCCCCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHHHccCChhHCc---CHHHHhcCccccCCC
Confidence 9999998887777766665 2344443 789999999999999 999999 899999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=404.68 Aligned_cols=255 Identities=31% Similarity=0.562 Sum_probs=222.8
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 198 (549)
|+..+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+.+.+|+||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 788889999999999999999999999999997543 23456688999999999999999999999999999999999
Q ss_pred cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccc
Q 038137 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFS 278 (549)
Q Consensus 199 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~ 278 (549)
++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~------ 196 (321)
T 2c30_A 124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------ 196 (321)
T ss_dssp CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC------
T ss_pred CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc------
Confidence 999999998854 5799999999999999999999999999999999999999999999999999986542110
Q ss_pred ccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCC
Q 038137 279 IGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358 (549)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF 358 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||
T Consensus 197 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 197 -----------------------------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp -----------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred -----------------------------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 011468999999999999999999999999999999999999999
Q ss_pred CCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 359 YSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 359 ~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
.+.+.......+.... ...++....+++++++||.+||+ ||.+|+ +++|+++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~ 302 (321)
T 2c30_A 242 FSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLLQTG 302 (321)
T ss_dssp TTSCHHHHHHHHHHSS-CCCCTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGGGCC
T ss_pred CCCCHHHHHHHHhcCC-CCCcCccccCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhccCC
Confidence 9888777776666532 22233334689999999999999 999999 899999999997643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=411.51 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=221.2
Q ss_pred hhhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-----CCcee
Q 038137 106 YMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-----SNCIV 180 (549)
Q Consensus 106 ~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----hp~Iv 180 (549)
.+..+...+..++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+..|..+|..+. |||||
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3445666677899999999999999999999999999999999997532 23455778999999886 99999
Q ss_pred eeeeeecCCceEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC------
Q 038137 181 KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR------ 252 (549)
Q Consensus 181 ~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~------ 252 (549)
+++++|.+.+.+|+||||+ |++|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 9999999999999999999 999999997654 5999999999999999999999999999999999999975
Q ss_pred -------------------CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhccc
Q 038137 253 -------------------NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRM 313 (549)
Q Consensus 253 -------------------~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (549)
++.+||+|||+|+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------------------------------------------- 215 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------------------------------------------- 215 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------------------------------------------
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-------------------------------------------
Confidence 889999999999754211
Q ss_pred ceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccc----------------
Q 038137 314 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL---------------- 377 (549)
Q Consensus 314 ~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l---------------- 377 (549)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+......+
T Consensus 216 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 294 (360)
T 3llt_A 216 -HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKY 294 (360)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGG
T ss_pred -CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccc
Confidence 014689999999999999999999999999999999999999999887766665554321110
Q ss_pred --------cCCCC------------------cCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 378 --------KFPEE------------------AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 378 --------~~p~~------------------~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
.+|.. ...++.+.+||.+||+ ||.+|+ ++.|+++||||+
T Consensus 295 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---ta~elL~hp~f~ 360 (360)
T 3llt_A 295 VNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360 (360)
T ss_dssp EETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGC
T ss_pred cCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC---CHHHHhcCcccC
Confidence 11110 0124778899999999 999999 899999999996
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=394.83 Aligned_cols=260 Identities=30% Similarity=0.543 Sum_probs=222.5
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
..+..++|.+.+.||+|+||.||+|.++.+|+.||||++.............+.+|+.+++.++||||+++++++.+...
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 34567899999999999999999999999999999999987655455566788999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999987653210
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyE 350 (549)
.....+||+.|+|||++.+..+ +.++|+|||||++|+
T Consensus 166 ------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 203 (276)
T 2h6d_A 166 ------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203 (276)
T ss_dssp -----------------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHH
Confidence 0114579999999999988776 689999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|++|..||.+.+.......+... ...+| ..+++++.+||.+||. ||.+|+ ++++|++||||+.
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~~l~h~~~~~ 267 (276)
T 2h6d_A 204 LLCGTLPFDDEHVPTLFKKIRGG--VFYIP--EYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFKQ 267 (276)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHC--CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHT
T ss_pred HHhCCCCCCCCcHHHHHHHhhcC--cccCc--hhcCHHHHHHHHHHccCChhhCC---CHHHHHhChhhcc
Confidence 99999999888777766666542 23344 3689999999999999 999999 8999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=410.86 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=220.8
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc----
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE---- 190 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~---- 190 (549)
..++|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.++..++|||||++++++.+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4678999999999999999999999999999999998765555556677899999999999999999999987654
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 45999999999999999988889999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... ......+||+.|+|||++.+..|+.++|||||||++||
T Consensus 170 ~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 211 (311)
T 3ork_A 170 GNSV--------------------------------------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211 (311)
T ss_dssp --------------------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred cccc--------------------------------------ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 1000 01124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|++|.+||.+.+.......+..............+|+++.+||.+||. ||.+|+ ++.+++.|+|++.
T Consensus 212 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l~~~ 279 (311)
T 3ork_A 212 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY---QTAAEMRADLVRV 279 (311)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh---hhHHHHHHHHHHH
Confidence 999999999988777766666532222111224689999999999999 999999 7889999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=418.82 Aligned_cols=259 Identities=30% Similarity=0.460 Sum_probs=212.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec------CC
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ------DD 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------d~ 189 (549)
..+|+++++||+|+||.||+|++..++. ||+|++.+.... ..+|+.+|+.++|||||+++++|. +.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4569999999999999999999988776 788877654321 236999999999999999999984 44
Q ss_pred ceEEEEEeecCCCchhhHh---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc-CCCcEEEeecCccc
Q 038137 190 EYLYLIMEYLPGGDMMTLL---MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD-RNGHMKLSDFGLCK 265 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld-~~g~vKL~DFGlak 265 (549)
.++|+|||||+++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++ .+|++||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 4599999999775443332 2357899999999999999999999999999999999999999 79999999999998
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSL 344 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSl 344 (549)
.+..... ..+.+||+.|+|||++.+. .|+.++|||||
T Consensus 191 ~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 228 (394)
T 4e7w_A 191 ILIAGEP------------------------------------------NVSYICSRYYRAPELIFGATNYTTNIDIWST 228 (394)
T ss_dssp ECCTTCC------------------------------------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred cccCCCC------------------------------------------CcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence 7532110 1146899999999999864 59999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccc---------------cccCCC----------CcCCChhHHHHHHHhhh-
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT---------------HLKFPE----------EAKLSPEAKDLISKLLC- 398 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~---------------~l~~p~----------~~~~s~~~~dLI~~lL~- 398 (549)
||++|||++|++||.+.+....+..|+.... ...+|. ...+++++++||.+||+
T Consensus 229 G~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (394)
T 4e7w_A 229 GCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY 308 (394)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCC
Confidence 9999999999999999887777766654211 011111 12478999999999999
Q ss_pred cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 399 NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 399 dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
||.+|+ ++.|+++||||+++.|....
T Consensus 309 dP~~R~---t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 309 TPSARL---TAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp SGGGSC---CHHHHHTSGGGSTTTSSCCC
T ss_pred ChhhCC---CHHHHhcChhhhhhcccccc
Confidence 999999 89999999999999886553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=419.63 Aligned_cols=256 Identities=31% Similarity=0.495 Sum_probs=212.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec------CCc
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ------DDE 190 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------d~~ 190 (549)
.+|++++.||+|+||.||+|+++.+|+.||||++.+... ...+|+.+|+.++|||||+++++|. +..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 469999999999999999999999999999999875431 1346999999999999999998884 334
Q ss_pred eEEEEEeecCCCchhhHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC-CcEEEeecCccc
Q 038137 191 YLYLIMEYLPGGDMMTLLM----RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCK 265 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~-g~vKL~DFGlak 265 (549)
++|+||||+++ +|..++. ....+++..++.++.||+.||.|||++|||||||||+||||+.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 58899999975 5665553 35689999999999999999999999999999999999999965 578999999998
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSL 344 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSl 344 (549)
.+..... ..+.+||+.|+|||++.+. .|+.++|||||
T Consensus 206 ~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 243 (420)
T 1j1b_A 206 QLVRGEP------------------------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWSA 243 (420)
T ss_dssp ECCTTCC------------------------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred hcccCCC------------------------------------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHH
Confidence 6532110 1146899999999999874 79999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhcc---------------ccccCCC----------CcCCChhHHHHHHHhhh-
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWR---------------THLKFPE----------EAKLSPEAKDLISKLLC- 398 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~---------------~~l~~p~----------~~~~s~~~~dLI~~lL~- 398 (549)
|||+|||++|++||.+.+..+.+.+|+... ..+.+|. ...+++++++||.+||+
T Consensus 244 G~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~ 323 (420)
T 1j1b_A 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323 (420)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccC
Confidence 999999999999999988777776665421 1112221 12568999999999999
Q ss_pred cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 399 NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 399 dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
||.+|+ ++.|+++||||+++.+..
T Consensus 324 dP~~R~---t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 324 TPTARL---TPLEACAHSFFDELRDPN 347 (420)
T ss_dssp SGGGSC---CHHHHHTSGGGGGGGCTT
T ss_pred ChhHCC---CHHHHhCCHhhccccccc
Confidence 999999 899999999999876554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=397.41 Aligned_cols=256 Identities=29% Similarity=0.545 Sum_probs=216.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|.+.+.||+|+||.||+|+++.+|..||+|++.+.. .....+.+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 367999999999999999999999999999999998754 233456788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE---cCCCcEEEeecCcccccC
Q 038137 196 MEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 196 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl---d~~g~vKL~DFGlak~~~ 268 (549)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999998854 3679999999999999999999999999999999999999 556899999999997653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
... .....+||+.|+|||++. ..++.++|||||||++
T Consensus 179 ~~~------------------------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il 215 (285)
T 3is5_A 179 SDE------------------------------------------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215 (285)
T ss_dssp --------------------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHH
T ss_pred Ccc------------------------------------------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHH
Confidence 210 011457999999999985 5789999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|||++|.+||.+.+.......+......... ....+++++.+||.+||. ||.+|+ ++.||++||||+.
T Consensus 216 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp---s~~e~l~hp~f~~ 284 (285)
T 3is5_A 216 YFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSC---CHHHHHTSGGGGC
T ss_pred HHHHhCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCc---CHHHHhcCHHhhc
Confidence 9999999999988777666655542222211 123579999999999999 999999 8999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=413.45 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=205.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 478999999999999999999999999999999997542 2334556788999999999999999999998754
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 8899998854 6799999999999999999999999999999999999999999999999999976421
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
. ....+||+.|+|||++.+ ..|+.++||||||||+
T Consensus 185 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (367)
T 2fst_X 185 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220 (367)
T ss_dssp --------------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHH
Confidence 1 114689999999999987 7899999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccc---------------------cCCC------CcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHL---------------------KFPE------EAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l---------------------~~p~------~~~~s~~~~dLI~~lL~-dp 400 (549)
|||++|++||.+.+....+..|+...... ..|. ...+++++.|||.+||+ ||
T Consensus 221 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 300 (367)
T 2fst_X 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 300 (367)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCc
Confidence 99999999999988777766665421110 0010 12568999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCCccc
Q 038137 401 EQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
.+|+ +++|+++||||+.+....
T Consensus 301 ~~R~---t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 301 DKRI---TAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp GGSC---CHHHHHTSGGGTTTCCGG
T ss_pred ccCc---CHHHHhcChhhhhccCCC
Confidence 9999 899999999999875443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=414.82 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=211.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee-------
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF------- 186 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f------- 186 (549)
...++|++++.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.++|||||+++++|
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 456789999999999999999999999999999999875432 123699999999999999999998
Q ss_pred -------------------------------cCCceEEEEEeecCCCchhhHhh----hcCCCCHHHHHHHHHHHHHHHH
Q 038137 187 -------------------------------QDDEYLYLIMEYLPGGDMMTLLM----RKDTLTEEEARFYVGETVLAIE 231 (549)
Q Consensus 187 -------------------------------~d~~~lylVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ 231 (549)
.+..++|+||||++ |+|...+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 34456999999997 47666654 3578999999999999999999
Q ss_pred HHHhCCeeecCCCCCCeEEc-CCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhh
Q 038137 232 SIHKHNYIHRDIKPDNLLLD-RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRN 310 (549)
Q Consensus 232 ~LH~~giiHRDLKPeNILld-~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (549)
|||++||+||||||+|||++ .+|.+||+|||+|+.+.....
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-------------------------------------- 197 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-------------------------------------- 197 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--------------------------------------
Confidence 99999999999999999998 689999999999986532210
Q ss_pred cccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccc--------------
Q 038137 311 RRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT-------------- 375 (549)
Q Consensus 311 ~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~-------------- 375 (549)
..+.+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....|+....
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 273 (383)
T 3eb0_A 198 ----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY 273 (383)
T ss_dssp ----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC
T ss_pred ----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccc
Confidence 1146899999999999875 599999999999999999999999999888777777654211
Q ss_pred -cccCCC----------CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 376 -HLKFPE----------EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 376 -~l~~p~----------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
...+|. ...+|+++++||.+||. ||.+|+ ++.|+++||||+.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 274 TEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHLR 329 (383)
T ss_dssp --CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC---CHHHHHTSGGGHHHH
T ss_pred ccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC---CHHHHhcCHHHHHHH
Confidence 111111 12578999999999999 999999 899999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=401.97 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=212.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecC--CceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQD--DEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d--~~~l 192 (549)
.++|++++.||+|+||.||+|++..+|+.||||++.... ...+.+|+.+|..+. ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 478999999999999999999999999999999986432 356889999999997 9999999999987 6789
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~~~~~ 271 (549)
|+||||++|++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999884 489999999999999999999999999999999999999777 89999999998654211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 350 (549)
. ....+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 186 ~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 223 (330)
T 3nsz_A 186 E------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223 (330)
T ss_dssp C------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHH
Confidence 0 114579999999999987 679999999999999999
Q ss_pred HhhCCCCCCCCCc-hhhhhhhhh---------------------------------ccccccCCCCcCCChhHHHHHHHh
Q 038137 351 MLVGYPPFYSDEP-MSTCRKIVN---------------------------------WRTHLKFPEEAKLSPEAKDLISKL 396 (549)
Q Consensus 351 ml~G~~PF~~~~~-~~~~~~I~~---------------------------------~~~~l~~p~~~~~s~~~~dLI~~l 396 (549)
|++|..||..... ......+.. |...........+++++++||.+|
T Consensus 224 ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 303 (330)
T 3nsz_A 224 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303 (330)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTT
T ss_pred HHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHH
Confidence 9999999965432 222222211 000011111224799999999999
Q ss_pred hh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 397 LC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 397 L~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|+ ||.+|+ +++|+++||||+++.|+
T Consensus 304 L~~dP~~Rp---ta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 304 LRYDHQSRL---TAREAMEHPYFYTVVKD 329 (330)
T ss_dssp SCSSGGGSC---CHHHHHTSGGGTTCC--
T ss_pred hcCCcccCC---CHHHHhcCccHhhhccC
Confidence 99 999999 89999999999999876
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=409.56 Aligned_cols=266 Identities=28% Similarity=0.414 Sum_probs=217.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD------- 188 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 188 (549)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+|..++|||||++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4689999999999999999999999999999999976542 22334567789999999999999999999886
Q ss_pred -CceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 189 -DEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 189 -~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.+.+|+||||++| +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4569999999975 67666644 46799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhh
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 345 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlG 345 (549)
+........ ......+||+.|+|||++.+ ..|+.++||||||
T Consensus 174 ~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 216 (351)
T 3mi9_A 174 FSLAKNSQP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216 (351)
T ss_dssp CCCCSSSSC-------------------------------------CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred ccccccccc-------------------------------------cccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence 642210000 00124689999999999986 5689999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhccccccC---CCCc-------------------------CCChhHHHHHHHhh
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKF---PEEA-------------------------KLSPEAKDLISKLL 397 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~---p~~~-------------------------~~s~~~~dLI~~lL 397 (549)
|++|||++|.+||.+.+.......+......+.. |... ..++++++||.+||
T Consensus 217 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 296 (351)
T 3mi9_A 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296 (351)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHh
Confidence 9999999999999998877776666542221111 1100 12788999999999
Q ss_pred h-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 398 C-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 398 ~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
+ ||.+|+ +++|+++||||.+..+
T Consensus 297 ~~dP~~R~---t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 297 VLDPAQRI---DSDDALNHDFFWSDPM 320 (351)
T ss_dssp CSSGGGSC---CHHHHHTSGGGGSSSC
T ss_pred cCChhhCC---CHHHHhCCCCcCCCCC
Confidence 9 999999 8999999999987543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=409.45 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=221.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+.|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.+|..++|||||+++++|.+.+.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 34999999999999999999999999999999997654444455677899999999999999999999999999999999
Q ss_pred eecCCCchhhHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||+. |+|.+++. ....+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9997 57777774 4578999999999999999999999999999999999999999999999999998764311
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhhHHHHHHh
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEml 352 (549)
.+.+||+.|+|||++. +..|+.++|||||||++|||+
T Consensus 208 ----------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 208 ----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp ----------------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence 1458999999999995 467899999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+|.+||.+.+.......+....... .....+++.+++||.+||. ||.+|+ +++++++||||...
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLRE 312 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHSC
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCc---CHHHHhhChhhhcc
Confidence 9999999888777776666532221 1224689999999999999 999999 89999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=392.04 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=217.8
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC----Cc
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD----DE 190 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~ 190 (549)
....|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|..+|+.++||||++++++|.+ ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34568999999999999999999999999999999976543 34456778999999999999999999998864 56
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEc-CCCcEEEeecCccccc
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLD-RNGHMKLSDFGLCKPL 267 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld-~~g~vKL~DFGlak~~ 267 (549)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++ .+|.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999988889999999999999999999999999 99999999999998 7899999999998754
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
... .....+||+.|+|||++. ..++.++|+|||||+
T Consensus 183 ~~~-------------------------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~ 218 (290)
T 1t4h_A 183 RAS-------------------------------------------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMC 218 (290)
T ss_dssp CTT-------------------------------------------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHH
T ss_pred ccc-------------------------------------------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHH
Confidence 211 012468999999999886 459999999999999
Q ss_pred HHHHhhCCCCCCCCCchh-hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 348 MYEMLVGYPPFYSDEPMS-TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~-~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+|+|++|..||.+..... ....+........++ ...++++.+||.+||. ||.+|+ +++|+++||||++
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~h~~f~~ 288 (290)
T 1t4h_A 219 MLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC-
T ss_pred HHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC--CCCCHHHHHHHHHHccCChhhCC---CHHHHhhCccccc
Confidence 999999999998755443 333343322222222 3678999999999999 999999 8999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=402.53 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=205.2
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHH-hcCCCceeeeeeeecCCceEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA-EVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
++|++++.||+|+||+||+|+++.+|+.||||++........ .......|...+. ...|||||+++++|.+...+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 569999999999999999999999999999999865432222 2233444554444 44999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||+ +|+|..++... ..+++..++.++.||+.||.|||+.|||||||||+|||++.+|++||+|||+++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--- 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--- 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---
Confidence 9999 77888888654 569999999999999999999999999999999999999999999999999987653211
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|
T Consensus 212 ---------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g 251 (311)
T 3p1a_A 212 ---------------------------------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACN 251 (311)
T ss_dssp ------------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHT
T ss_pred ---------------------------------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhC
Confidence 0114579999999999876 799999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
..||.+... ...+........++ ..+++++.+||.+||+ ||.+|+ +++|+++||||+.
T Consensus 252 ~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~~~~ 310 (311)
T 3p1a_A 252 MELPHGGEG---WQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRA---TAEALLALPVLRQ 310 (311)
T ss_dssp CCCCSSHHH---HHHHTTTCCCHHHH--TTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGSC
T ss_pred CCCCCCccH---HHHHhccCCCcccc--cCCCHHHHHHHHHHcCCChhhCc---CHHHHHhCccccC
Confidence 877765432 23333321111222 3689999999999999 999999 8999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=398.26 Aligned_cols=263 Identities=22% Similarity=0.377 Sum_probs=218.6
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.+..++|++++.||+|+||.||+|++..++..||+|++...........+.+.+|..++..++||||+++++++.+.+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34467899999999999999999999999999999999765554555667899999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 167 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 206 (294)
T 4eqm_A 167 ----------------------------------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206 (294)
T ss_dssp ------------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 0012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhcccc-ccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTH-LKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~-l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
+|.+||.+.+......+++..... +.......+++.+.++|.+||. ||.+|+. +++++ .+.|.
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~--~~~~l-~~~l~ 271 (294)
T 4eqm_A 207 VGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK--TIQEM-KDDLS 271 (294)
T ss_dssp HSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS--SHHHH-HHHHH
T ss_pred hCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc--cHHHH-HHHHH
Confidence 999999988876665555442111 1111124689999999999999 9999994 34444 44444
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=420.17 Aligned_cols=262 Identities=17% Similarity=0.193 Sum_probs=203.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc--CCCceeeeeeeec------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV--DSNCIVKLYCSFQ------ 187 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~------ 187 (549)
..+|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|..++..+ +|||||+++..|.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999987654556667788886555444 6999888664442
Q ss_pred -CC-----------------ceEEEEEeecCCCchhhHhhhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCeeecC
Q 038137 188 -DD-----------------EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEA------RFYVGETVLAIESIHKHNYIHRD 242 (549)
Q Consensus 188 -d~-----------------~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~------~~~~~qi~~aL~~LH~~giiHRD 242 (549)
.. ..+|||||||+ |+|.+++... ..+++... ..++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 11 45899999998 8999999764 34444444 46669999999999999999999
Q ss_pred CCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCC
Q 038137 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTP 322 (549)
Q Consensus 243 LKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~ 322 (549)
|||+||||+.+|++||+|||+|+..... .....||+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~~t~ 255 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--------------------------------------------GPASSVPV 255 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE--------------------------------------------EEGGGSCG
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC--------------------------------------------ccCccCCc
Confidence 9999999999999999999999865311 01346779
Q ss_pred CCCCchhhcc--CCCCcccccchhhHHHHHHhhCCCCCCCCCchh--hhhh---hhhccccccCCCCcCCChhHHHHHHH
Q 038137 323 DYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMS--TCRK---IVNWRTHLKFPEEAKLSPEAKDLISK 395 (549)
Q Consensus 323 ~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~--~~~~---I~~~~~~l~~p~~~~~s~~~~dLI~~ 395 (549)
.|+|||++.+ ..|+.++|||||||+||||++|++||.+..+.. .+.. +......+.+|....+++++++||.+
T Consensus 256 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp GGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHH
T ss_pred CCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHH
Confidence 9999999987 789999999999999999999999998774432 1111 11222344555556899999999999
Q ss_pred hhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 396 LLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 396 lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
||+ ||.+|+ ++.++++||||+++.|..
T Consensus 336 ~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 336 FLNFDRRRRL---LPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp HTCSSTTTCC---CHHHHTTSHHHHHHHHHH
T ss_pred HcCCChhhCC---CHHHHhcCHHHHHHHHHH
Confidence 999 999999 899999999999987753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=421.51 Aligned_cols=249 Identities=16% Similarity=0.213 Sum_probs=207.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHH---HHHhcCCCceeeee-------ee
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN---LLAEVDSNCIVKLY-------CS 185 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~---iL~~l~hp~Iv~l~-------~~ 185 (549)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999998765555666788999994 55566899999998 55
Q ss_pred ecCCc-----------------eEEEEEeecCCCchhhHhhhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCeeec
Q 038137 186 FQDDE-----------------YLYLIMEYLPGGDMMTLLMRKDTLTE-------EEARFYVGETVLAIESIHKHNYIHR 241 (549)
Q Consensus 186 f~d~~-----------------~lylVmEy~~gg~L~~~l~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~giiHR 241 (549)
+.+.+ ..||||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++|||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 55443 389999999 7899999987666666 7788899999999999999999999
Q ss_pred CCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccC
Q 038137 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGT 321 (549)
Q Consensus 242 DLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT 321 (549)
||||+||||+.+|.+||+|||+|+.... ...+.+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~--------------------------------------------~~~~~~g- 265 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA--------------------------------------------RVVSSVS- 265 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC--------------------------------------------EEECCCC-
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC--------------------------------------------cccCCCC-
Confidence 9999999999999999999999985321 0124678
Q ss_pred CCCCCchhhccC-----------CCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHH
Q 038137 322 PDYIAPEVLLKK-----------GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAK 390 (549)
Q Consensus 322 ~~Y~APEvl~~~-----------~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~ 390 (549)
+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+.......+... ...++++++
T Consensus 266 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~ 337 (377)
T 3byv_A 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS--------CKNIPQPVR 337 (377)
T ss_dssp TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS--------CCCCCHHHH
T ss_pred cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh--------ccCCCHHHH
Confidence 999999999987 8999999999999999999999999887766655555431 136899999
Q ss_pred HHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 391 dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||.+||+ ||.+|+ ++.|+++||||+++
T Consensus 338 ~li~~~L~~dp~~Rp---t~~e~l~hp~f~~~ 366 (377)
T 3byv_A 338 ALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHTCSSGGGCC---CHHHHHTSHHHHHH
T ss_pred HHHHHHcCCCchhCC---CHHHHhhChHHHHH
Confidence 99999999 999999 89999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=404.40 Aligned_cols=265 Identities=25% Similarity=0.458 Sum_probs=209.9
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc------
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE------ 190 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~------ 190 (549)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 46999999999999999999999999999999997643 2345577899999999999999999999885432
Q ss_pred ---------------------------------------------------eEEEEEeecCCCchhhHhhhcC---CCCH
Q 038137 191 ---------------------------------------------------YLYLIMEYLPGGDMMTLLMRKD---TLTE 216 (549)
Q Consensus 191 ---------------------------------------------------~lylVmEy~~gg~L~~~l~~~~---~l~e 216 (549)
++|+|||||+||+|.+++.+.. ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 4899999999999999997653 3566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCC
Q 038137 217 EEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296 (549)
Q Consensus 217 ~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (549)
..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+............. +
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~--------------~--- 226 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT--------------P--- 226 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc--------------c---
Confidence 77999999999999999999999999999999999999999999999987653211000000 0
Q ss_pred ccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhcccc
Q 038137 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTH 376 (549)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~ 376 (549)
..........+||+.|+|||++.+..|+.++|||||||++|||++|..|+... ......+..
T Consensus 227 ------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~---- 288 (332)
T 3qd2_B 227 ------------MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN---- 288 (332)
T ss_dssp -----------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT----
T ss_pred ------------ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc----
Confidence 00001112468999999999999999999999999999999999998876321 112222222
Q ss_pred ccCCC-CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 377 LKFPE-EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 377 l~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
..+|. ....++++++||.+||. ||.+|+ +++|+++||||+++
T Consensus 289 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 289 LKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENAIFENL 332 (332)
T ss_dssp TCCCHHHHHHCHHHHHHHHHHHCSSGGGSC---CHHHHHHSTTCCCC
T ss_pred cCCCcccccCChhHHHHHHHHccCCCCcCC---CHHHHhhchhhhcC
Confidence 22332 13467889999999999 999999 89999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=407.39 Aligned_cols=266 Identities=29% Similarity=0.460 Sum_probs=216.3
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc--hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR--RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
..++|++++.||+|+||.||+|+++.+|+.||||++....... ......+.+|+.+|..++|||||+++++|.+...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999999999999999997643221 11224578899999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|+||||++| +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999975 888887654 479999999999999999999999999999999999999999999999999998753211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 350 (549)
. .....+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 167 ~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 205 (346)
T 1ua2_A 167 R-----------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 205 (346)
T ss_dssp C-----------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHH
Confidence 0 0114589999999999976 458999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccc---------cCCC---------------CcCCChhHHHHHHHhhh-cccccCC
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHL---------KFPE---------------EAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l---------~~p~---------------~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
|++|.+||.+.+....+.+|+...... ..|. ...+++++++||.+||+ ||.+|+
T Consensus 206 ll~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp- 284 (346)
T 1ua2_A 206 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 284 (346)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC-
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC-
Confidence 999999999988887777776421110 1110 03567899999999999 999999
Q ss_pred CCCHHHHHcCCcccCCCccc
Q 038137 406 TKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 406 ~~~~~eil~HpfF~~i~w~~ 425 (549)
+++|+++||||.+..|..
T Consensus 285 --t~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 285 --TATQALKMKYFSNRPGPT 302 (346)
T ss_dssp --CHHHHHTSGGGTSSSCCC
T ss_pred --CHHHHhcChhhhcCCCCC
Confidence 899999999999876544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=405.72 Aligned_cols=261 Identities=26% Similarity=0.452 Sum_probs=219.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-----c
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD-----E 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 190 (549)
.++|++++.||+|+||.||+|++..++..||||++.... .......+.+|+.+|..++||||+++++++.+. .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 468999999999999999999999999999999997532 334456788999999999999999999998755 4
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||||+. |+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 7999999996 699998854 57999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 182 ~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 223 (364)
T 3qyz_A 182 HDHT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223 (364)
T ss_dssp GCBC--------------------------------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHH
T ss_pred CCcc--------------------------------------ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHH
Confidence 1000 00124689999999998765 55899999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccc------------------cCCC---------CcCCChhHHHHHHHhhh-ccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHL------------------KFPE---------EAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l------------------~~p~---------~~~~s~~~~dLI~~lL~-dp~ 401 (549)
||++|.+||.+.+..+....|+...... .+|. ...+++++.+||.+||+ ||.
T Consensus 224 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 303 (364)
T 3qyz_A 224 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 303 (364)
T ss_dssp HHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTT
T ss_pred HHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999988877777765321110 0110 13578999999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCC
Q 038137 402 QRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i 421 (549)
+|+ +++|+++||||+..
T Consensus 304 ~R~---t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 304 KRI---EVEQALAHPYLEQY 320 (364)
T ss_dssp TSC---CHHHHHTSGGGTTT
T ss_pred hCC---CHHHHhcCcchhhc
Confidence 999 89999999999976
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=389.07 Aligned_cols=259 Identities=26% Similarity=0.464 Sum_probs=221.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|.++.+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 569999999999999999999999999999999976542 234567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..+......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch---
Confidence 99999999999987788999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~G~ 355 (549)
......+||+.|+|||++.+..+ +.++|||||||++|||++|.
T Consensus 162 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 205 (276)
T 2yex_A 162 ------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205 (276)
T ss_dssp ------------------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred ------------------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCC
Confidence 00124689999999999988776 78999999999999999999
Q ss_pred CCCCCCCchh-hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 356 PPFYSDEPMS-TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 356 ~PF~~~~~~~-~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
.||.+.+... .+..+... ....+....+++++++||.+||. ||.+|+ +++||++||||+..
T Consensus 206 ~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 268 (276)
T 2yex_A 206 LPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKP 268 (276)
T ss_dssp CCCSCSCTTSHHHHHHHTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTCC
T ss_pred CCCCCCchHHHHHHHhhhc--ccccCchhhcCHHHHHHHHHHCCCCchhCC---CHHHHhcCccccCh
Confidence 9998765432 23333321 12233335789999999999999 999999 89999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=406.74 Aligned_cols=267 Identities=23% Similarity=0.469 Sum_probs=229.9
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhh--------------HHHHHHHHHHHHhcCCC
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ--------------VEHVKAERNLLAEVDSN 177 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~--------------~~~~~~E~~iL~~l~hp 177 (549)
.....++|++++.||+|+||.||+|.+ +|+.||||++.......... ...+.+|+.++..++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 344568999999999999999999998 89999999998765432221 26789999999999999
Q ss_pred ceeeeeeeecCCceEEEEEeecCCCchhhH------hhh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCe
Q 038137 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTL------LMR--KDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNL 248 (549)
Q Consensus 178 ~Iv~l~~~f~d~~~lylVmEy~~gg~L~~~------l~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNI 248 (549)
||+++++++.+.+.+|+||||++||+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 655 5789999999999999999999999 9999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
|++.+|++||+|||++....... ....+||+.|+|||
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~y~aPE 220 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKK-------------------------------------------IKGSRGTYEFMPPE 220 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTE-------------------------------------------ECSSCSCGGGCCGG
T ss_pred EEcCCCcEEEecccccccccccc-------------------------------------------ccCCCCCcCccCch
Confidence 99999999999999998653210 11457999999999
Q ss_pred hhccC-CCCc-ccccchhhHHHHHHhhCCCCCCCCCc-hhhhhhhhhccccccCCCC-----------------cCCChh
Q 038137 329 VLLKK-GYGM-ECDWWSLGAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFPEE-----------------AKLSPE 388 (549)
Q Consensus 329 vl~~~-~y~~-~~DiWSlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~l~~p~~-----------------~~~s~~ 388 (549)
++.+. .|+. ++|||||||++|||++|.+||.+.+. ......+... ...+|.. ..++++
T Consensus 221 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (348)
T 2pml_X 221 FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNE 298 (348)
T ss_dssp GGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC--CCCCCCSSSSSTTTTCC--------CCCHH
T ss_pred hhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CcCCccchhhhhccccccccccchhhcCHH
Confidence 99887 6766 99999999999999999999998776 5666666543 3344421 468999
Q ss_pred HHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccccc
Q 038137 389 AKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 389 ~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~ 428 (549)
+.+||.+||+ ||.+|+ +++|+++||||.+++|..+..
T Consensus 299 l~~li~~~L~~dP~~Rp---s~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 299 DIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp HHHHHHHHCCSSGGGSC---CHHHHHTSGGGTTCCHHHHHH
T ss_pred HHHHHHHHccCChhhCC---CHHHHhcCccccCCCHHHHHH
Confidence 9999999999 999999 899999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=404.97 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=215.1
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC--CceeeeeeeecCCc
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--NCIVKLYCSFQDDE 190 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~~ 190 (549)
.+..++|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+|..+.| |||+++++++.++.
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 356778999999999999999999874 689999999976542 34455778999999999976 99999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|+.+...
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999999 55889999999889999999999999999999999999999999999999997 789999999999875421
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----------CCCCccc
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----------KGYGMEC 339 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----------~~y~~~~ 339 (549)
... ....+.+||+.|+|||++.+ ..|+.++
T Consensus 161 ~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 161 TTS---------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp ------------------------------------------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred ccc---------------------------------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 100 00124689999999999975 6789999
Q ss_pred ccchhhHHHHHHhhCCCCCCCCCc-hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 340 DWWSLGAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 340 DiWSlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
|||||||++|||++|.+||..... ......++.......+|. ..++++.+||.+||. ||.+|+ ++.|+++|||
T Consensus 202 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rp---t~~e~l~hp~ 276 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPY 276 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHH
T ss_pred hHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCC---CHHHHHhCcc
Confidence 999999999999999999986433 234444444333444443 567899999999999 999999 8999999999
Q ss_pred ccC
Q 038137 418 FKG 420 (549)
Q Consensus 418 F~~ 420 (549)
|+.
T Consensus 277 ~~~ 279 (343)
T 3dbq_A 277 VQI 279 (343)
T ss_dssp HHS
T ss_pred ccc
Confidence 974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=393.88 Aligned_cols=261 Identities=32% Similarity=0.628 Sum_probs=228.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 469999999999999999999999999999999976543 2344567889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC---CcEEEeecCcccccCCCCcc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN---GHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~---g~vKL~DFGlak~~~~~~~~ 273 (549)
||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~- 179 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence 999999999999888899999999999999999999999999999999999999764 4799999999886532110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
....+||+.|+|||++.+ .++.++|+|||||++|+|++
T Consensus 180 -----------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~ 217 (287)
T 2wei_A 180 -----------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217 (287)
T ss_dssp -----------------------------------------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHh
Confidence 013478999999999875 49999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|.+||.+.+.......+.........|....+|+++.+||.+||. ||.+|+ ++.|+++||||+...|+
T Consensus 218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 218 GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYSSE 286 (287)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHSHHHHHHCCC
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCc---CHHHHhcCHHHhccccC
Confidence 999999988877777777654444445445789999999999999 999999 89999999999877654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=414.97 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=198.1
Q ss_pred CCeee-eeeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee--cCCce
Q 038137 117 DDFEP-LTMIGKGAFGEVRVCREK--ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF--QDDEY 191 (549)
Q Consensus 117 ~~f~~-~~~IG~G~fG~V~l~~~k--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f--~d~~~ 191 (549)
+.|++ .++||+|+||.||+|+++ .+++.||||++..... ...+.+|+.+|+.++|||||+++++| .+...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34666 458999999999999976 5789999999975432 23578899999999999999999999 56789
Q ss_pred EEEEEeecCCCchhhHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE----cCCCcEEE
Q 038137 192 LYLIMEYLPGGDMMTLLMRK---------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL----DRNGHMKL 258 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl----d~~g~vKL 258 (549)
+|+||||+. |+|..++... ..+++..++.++.||+.||.|||++|||||||||+|||| +.+|.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 5888877532 249999999999999999999999999999999999999 77899999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCc
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGM 337 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~ 337 (549)
+|||+|+.+....... ......+||+.|+|||++.+. .|+.
T Consensus 174 ~Dfg~a~~~~~~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 215 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTK 215 (405)
T ss_dssp CCTTCCC------------------------------------------------------CCCTTCCHHHHTTCCSCCH
T ss_pred EECCCceecCCCCccc--------------------------------------ccCCCceecCcccCchhhcCCCcccc
Confidence 9999998754211000 011256899999999999874 5899
Q ss_pred ccccchhhHHHHHHhhCCCCCCCCCch---------hhhhhhhhcccc---------ccCCC------------------
Q 038137 338 ECDWWSLGAIMYEMLVGYPPFYSDEPM---------STCRKIVNWRTH---------LKFPE------------------ 381 (549)
Q Consensus 338 ~~DiWSlGvilyEml~G~~PF~~~~~~---------~~~~~I~~~~~~---------l~~p~------------------ 381 (549)
++||||||||+|||++|.+||.+.... ..+..|+..... ..+|.
T Consensus 216 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (405)
T 3rgf_A 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 295 (405)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCH
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchh
Confidence 999999999999999999999875542 333333321100 00000
Q ss_pred -------CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 382 -------EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 382 -------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
....++++.+||.+||+ ||.+|+ +++|+++||||.+..|....
T Consensus 296 ~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~---ta~e~L~hp~f~~~~~~~~~ 346 (405)
T 3rgf_A 296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYFLEDPLPTSD 346 (405)
T ss_dssp HHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGTSSSCCCSS
T ss_pred hhhHhhcCCCCCHHHHHHHHHHccCCcccCC---CHHHHhcChhhccCCCCccc
Confidence 01237899999999999 999999 89999999999987765543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=395.67 Aligned_cols=272 Identities=30% Similarity=0.474 Sum_probs=225.5
Q ss_pred hhhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeee
Q 038137 106 YMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCS 185 (549)
Q Consensus 106 ~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 185 (549)
|....+.....++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.++..++||||++++++
T Consensus 8 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 84 (302)
T 2j7t_A 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGA 84 (302)
T ss_dssp --CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeee
Confidence 3333444445678999999999999999999999999999999987543 3345678899999999999999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
|.+.+.+|+||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred eeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 9999999999999999999998865 567999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCccc
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMEC 339 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~ 339 (549)
....... ......+||+.|+|||++. +..++.++
T Consensus 165 ~~~~~~~-----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 203 (302)
T 2j7t_A 165 AKNLKTL-----------------------------------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203 (302)
T ss_dssp HHHHHHH-----------------------------------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHH
T ss_pred ccccccc-----------------------------------------cccccccCChhhcCCeeeccccCCCCCCchhh
Confidence 6421000 0011458999999999984 67789999
Q ss_pred ccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 340 DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
|+|||||++|+|++|.+||...+......++.... ....+....++.++.+||.+||. ||.+|+ ++.++++||||
T Consensus 204 Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~ 279 (302)
T 2j7t_A 204 DIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD-PPTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFV 279 (302)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHSCSCTTTSC---CHHHHTTSTTT
T ss_pred hHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC-CcccCCccccCHHHHHHHHHHcccChhhCC---CHHHHhcChHH
Confidence 99999999999999999999888777766665532 22222335789999999999999 999999 89999999999
Q ss_pred cCCCccc
Q 038137 419 KGIEWDK 425 (549)
Q Consensus 419 ~~i~w~~ 425 (549)
.++.|..
T Consensus 280 ~~~~~~~ 286 (302)
T 2j7t_A 280 SSITSNK 286 (302)
T ss_dssp TTCCCCH
T ss_pred hhhccch
Confidence 9998765
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=399.82 Aligned_cols=276 Identities=26% Similarity=0.445 Sum_probs=221.0
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-----
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD----- 189 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~----- 189 (549)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|..++||||+++++++.+.
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4688999999999999999999999999999999996532 233456678999999999999999999887654
Q ss_pred ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
..+|+||||+. |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+..
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 77999999996 689988855 6799999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
....... .. .........+||+.|+|||++.+ ..++.++|||||||++
T Consensus 165 ~~~~~~~------------~~-------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 213 (353)
T 2b9h_A 165 SAADNSE------------PT-------------------GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213 (353)
T ss_dssp ----------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHH
T ss_pred ccccccC------------cc-------------------ccccchhhccccccccCCeeeccCCCccchhhHHHHHHHH
Confidence 2110000 00 00001124689999999999875 7789999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccc----------------------cCCC------CcCCChhHHHHHHHhhh-c
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHL----------------------KFPE------EAKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l----------------------~~p~------~~~~s~~~~dLI~~lL~-d 399 (549)
|+|++|.+||.+.+.......+....... .++. ...+++++++||.+||. |
T Consensus 214 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 99999999999887655544443211100 0110 13689999999999999 9
Q ss_pred ccccCCCCCHHHHHcCCcccCCCcccccc
Q 038137 400 VEQRLGTKGADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 400 p~~Rl~~~~~~eil~HpfF~~i~w~~l~~ 428 (549)
|.+|+ +++||++||||+.+.|.....
T Consensus 294 P~~Rp---t~~ell~hp~~~~~~~~~~~~ 319 (353)
T 2b9h_A 294 PAKRI---TAKEALEHPYLQTYHDPNDEP 319 (353)
T ss_dssp GGGSC---CHHHHHTSGGGTTTCCTTSSC
T ss_pred cccCC---CHHHHhcCccccccCCccccc
Confidence 99999 899999999999988765433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=412.61 Aligned_cols=261 Identities=27% Similarity=0.470 Sum_probs=217.6
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC--CCceeeeeeeecCCc
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD--SNCIVKLYCSFQDDE 190 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~d~~ 190 (549)
.+...+|++++.||+|+||.||+|.+.. ++.||||++.+... .......+.+|+.+|..+. |||||++++++.+++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 3445679999999999999999999865 89999999976543 3445677899999999996 599999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++ +|.+||+|||+|+.+...
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999999 56899999998888999999999999999999999999999999999999995 689999999999875421
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----------CCCCccc
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----------KGYGMEC 339 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----------~~y~~~~ 339 (549)
... ....+.+||+.|+|||++.+ ..|+.++
T Consensus 208 ~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 208 TTS---------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp ---------------------------------------------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred Ccc---------------------------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 100 00124689999999999975 4689999
Q ss_pred ccchhhHHHHHHhhCCCCCCCCCc-hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 340 DWWSLGAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 340 DiWSlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
||||||||+|||++|++||.+... ......++.....+.+|. ..++++++||.+||. ||.+|+ ++.|+++|||
T Consensus 249 DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rp---s~~ell~hp~ 323 (390)
T 2zmd_A 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPY 323 (390)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHH
T ss_pred hHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc--cchHHHHHHHHHHcccChhhCC---CHHHHhhCcC
Confidence 999999999999999999987543 344555555434444553 568899999999999 999999 8999999999
Q ss_pred ccCC
Q 038137 418 FKGI 421 (549)
Q Consensus 418 F~~i 421 (549)
|+..
T Consensus 324 ~~~~ 327 (390)
T 2zmd_A 324 VQIQ 327 (390)
T ss_dssp HHSC
T ss_pred cccc
Confidence 9753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=405.87 Aligned_cols=266 Identities=29% Similarity=0.480 Sum_probs=222.7
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.++..++||||++++++|.+...+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 45789999999999999999999999999999999876532 23344567899999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||++|++|..++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence 999999999999887788899999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 180 ---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 180 ---------------------------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp -------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 01145799999999999875 78999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhcccc-----------------ccCCC----------CcCCChhHHHHHHHhhh-cccccCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTH-----------------LKFPE----------EAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~-----------------l~~p~----------~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
|.+||.+.+.......++..... ...|. ...+++++.+||.+||. ||.+|+
T Consensus 221 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp- 299 (331)
T 4aaa_A 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP- 299 (331)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC-
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC-
Confidence 99999998877666555431110 11111 12578999999999999 999999
Q ss_pred CCCHHHHHcCCcccCCCccc
Q 038137 406 TKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 406 ~~~~~eil~HpfF~~i~w~~ 425 (549)
++.|+++||||+..+|..
T Consensus 300 --t~~ell~hp~f~~~~~~~ 317 (331)
T 4aaa_A 300 --FCAELLHHDFFQMDGFAE 317 (331)
T ss_dssp --CGGGGGGSHHHHGGGHHH
T ss_pred --CHHHHhcCchhccCChhh
Confidence 899999999999776543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=402.44 Aligned_cols=261 Identities=32% Similarity=0.625 Sum_probs=215.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-----RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
++|++++.||+|+||.||+|.++.+|+.||||++.+.... .......+.+|+.+|..++||||+++++++.++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5699999999999999999999999999999999765321 1222345789999999999999999999998765
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc---EEEeecCcccccC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGLCKPLD 268 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~---vKL~DFGlak~~~ 268 (549)
+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987765 9999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhh
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLG 345 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlG 345 (549)
... .....+||+.|+|||++. ...|+.++||||||
T Consensus 169 ~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 206 (322)
T 2ycf_A 169 ETS------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206 (322)
T ss_dssp CCH------------------------------------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHH
T ss_pred ccc------------------------------------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHH
Confidence 210 011457999999999985 46789999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhh-hhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCR-KIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~-~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|++|+|++|.+||.......... .+... ...++. ...+++++.+||.+||. ||.+|+ +++++++||||++.
T Consensus 207 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 207 VILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHHHSSCSSCSTTCSSCHHHHHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC---CHHHHHTSGGGCCH
T ss_pred HHHHHHHhCCCCCcccchHHHHHHHHHhC--ccccCchhhhhcCHHHHHHHHHHcccCHhhCC---CHHHHhhCcCcCCH
Confidence 99999999999998765543333 33321 122211 13689999999999999 999999 89999999999987
Q ss_pred Cccc
Q 038137 422 EWDK 425 (549)
Q Consensus 422 ~w~~ 425 (549)
+|..
T Consensus 282 ~~~~ 285 (322)
T 2ycf_A 282 DMKR 285 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=391.40 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=204.7
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
++..++|++++.||+|+||.||+|++..+|+.||||++..... .......+..+..+++.++||||+++++++.+.+.+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4667899999999999999999999999999999999976432 223334455556668889999999999999999999
Q ss_pred EEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 193 YLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKH-NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
|+||||++ |+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++++||+|||+++..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999997 587776643 56899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhh----ccCCCCcccccch
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL----LKKGYGMECDWWS 343 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl----~~~~y~~~~DiWS 343 (549)
..... ....+||+.|+|||++ .+..|+.++||||
T Consensus 161 ~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~s 198 (290)
T 3fme_A 161 VDDVA------------------------------------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198 (290)
T ss_dssp ---------------------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHH
T ss_pred ccccc------------------------------------------ccccCCCccccChhhcChhhcCcCCCcHHHHHH
Confidence 32110 0134799999999996 4667899999999
Q ss_pred hhHHHHHHhhCCCCCCCC-CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 344 LGAIMYEMLVGYPPFYSD-EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~-~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|||++|+|++|.+||... ........++.. .....+ ...+++++.+||.+||. ||.+|+ +++|+++||||+..
T Consensus 199 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp---t~~e~l~hp~f~~~ 273 (290)
T 3fme_A 199 LGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQLP-ADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCCCcc-cccCCHHHHHHHHHHhhcChhhCc---CHHHHHhCcccccC
Confidence 999999999999999863 333444444432 222222 24689999999999999 999999 89999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=387.97 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=210.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylV 195 (549)
++|++++.||+|+||.||+|.++.+|+.||||++.+... .......+.+|..++..+ +||||++++++|.+.+.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 569999999999999999999999999999999986532 223445678899999988 999999999999999999999
Q ss_pred EeecCCCchhhHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-----------------
Q 038137 196 MEYLPGGDMMTLLMRK----DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG----------------- 254 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g----------------- 254 (549)
|||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999764 6799999999999999999999999999999999999998544
Q ss_pred --cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc
Q 038137 255 --HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332 (549)
Q Consensus 255 --~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~ 332 (549)
.+||+|||++...... ...+||+.|+|||++.+
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---------------------------------------------~~~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---------------------------------------------QVEEGDSRFLANEVLQE 204 (289)
T ss_dssp CCCEEECCCTTCEETTCS---------------------------------------------CCCCCCGGGCCHHHHTT
T ss_pred ceEEEEcccccccccCCc---------------------------------------------cccCCCccccChhHhcC
Confidence 7999999998865321 03469999999999987
Q ss_pred C-CCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHH
Q 038137 333 K-GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410 (549)
Q Consensus 333 ~-~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 410 (549)
. .++.++|||||||++|+|++|.+||..... ...+... ....+| ..+++++.+||.+||. ||.+|+ ++.
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~ 275 (289)
T 1x8b_A 205 NYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG-RLPRIP--QVLSQEFTELLKVMIHPDPERRP---SAM 275 (289)
T ss_dssp CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTT-CCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHH
T ss_pred CCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcC-CCCCCC--cccCHHHHHHHHHHhCCCcccCC---CHH
Confidence 5 667899999999999999999998865432 3333331 122333 3789999999999999 999999 899
Q ss_pred HHHcCCcccCC
Q 038137 411 EIKAHPWFKGI 421 (549)
Q Consensus 411 eil~HpfF~~i 421 (549)
++++||||.+.
T Consensus 276 ~ll~h~~~~~~ 286 (289)
T 1x8b_A 276 ALVKHSVLLSA 286 (289)
T ss_dssp HHHTCTTC---
T ss_pred HHhhChHhhhh
Confidence 99999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=405.50 Aligned_cols=270 Identities=29% Similarity=0.454 Sum_probs=221.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE---
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL--- 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l--- 192 (549)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+++.++||||++++++|.+....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 468999999999999999999999999999999997643 2334456788999999999999999999999877655
Q ss_pred ---EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 193 ---YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 193 ---ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
|+||||+. |+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999996 68888773 4599999999999999999999999999999999999999999999999999975431
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
. ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 197 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (371)
T 4exu_A 197 E--------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232 (371)
T ss_dssp -----------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred C--------------------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHH
Confidence 1 114689999999999987 7899999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccc---------------------cCCC------CcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHL---------------------KFPE------EAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l---------------------~~p~------~~~~s~~~~dLI~~lL~-dp 400 (549)
|+|++|.+||.+.+..+.+..++...... ..+. ...+++++++||.+||+ ||
T Consensus 233 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (371)
T 4exu_A 233 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 312 (371)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCCh
Confidence 99999999999988777776665421100 0000 12578999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCCccccc-cccCCCccc
Q 038137 401 EQRLGTKGADEIKAHPWFKGIEWDKLY-QIKAAFIPE 436 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~w~~l~-~~~~pf~p~ 436 (549)
.+|+ +++|+++||||+.+...... ....||.+.
T Consensus 313 ~~Rp---t~~ell~hp~f~~~~~~~~~~~~~~~~~~~ 346 (371)
T 4exu_A 313 DKRL---TAAQALTHPFFEPFRDPEEETEAQQPFDDS 346 (371)
T ss_dssp TTSC---CHHHHHTSGGGTTTCCGGGCCCCSSCCCCT
T ss_pred hhcC---CHHHHhcCcccccCCCcccccccccCcCcc
Confidence 9999 89999999999987654433 233344433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=414.04 Aligned_cols=255 Identities=25% Similarity=0.450 Sum_probs=214.1
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc------CCCceeeeeeeecC
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV------DSNCIVKLYCSFQD 188 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~f~d 188 (549)
...+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+ +|+||++++++|..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3567999999999999999999999999999999997642 2335577788888776 67799999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc--EEEeecCcc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH--MKLSDFGLC 264 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~--vKL~DFGla 264 (549)
...+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|. +||+|||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999995 6899988664 35999999999999999999999999999999999999999987 999999998
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
...... ..+.+||+.|+|||++.+..|+.++|||||
T Consensus 250 ~~~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 285 (429)
T 3kvw_A 250 CYEHQR--------------------------------------------VYTYIQSRFYRAPEVILGARYGMPIDMWSL 285 (429)
T ss_dssp EETTCC--------------------------------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHH
T ss_pred eecCCc--------------------------------------------ccccCCCCCccChHHHhCCCCCchHHHHhH
Confidence 754211 124689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccc------------------cCC--------------------------
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL------------------KFP-------------------------- 380 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l------------------~~p-------------------------- 380 (549)
||++|||++|++||.+.+..+.+..++...... .+|
T Consensus 286 G~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (429)
T 3kvw_A 286 GCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLR 365 (429)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEE
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhcc
Confidence 999999999999999988776666554310000 000
Q ss_pred --C---------CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 381 --E---------EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 381 --~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
. ....++++.|||.+||+ ||.+|+ +++|+++||||+..
T Consensus 366 ~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp---ta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 366 GPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM---TPGQALRHPWLRRR 415 (429)
T ss_dssp CSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC---CHHHHHTSTTTC--
T ss_pred CCccchhhHhhccccchHHHHHHHHHHCCCChhhCC---CHHHHhCChhhccC
Confidence 0 01237889999999999 999999 89999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=390.18 Aligned_cols=262 Identities=26% Similarity=0.454 Sum_probs=220.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHhcCCCceeeeeeee--cCCceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR-RGQVEHVKAERNLLAEVDSNCIVKLYCSF--QDDEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f--~d~~~l 192 (549)
.++|++++.||+|+||.||+|.+..++..||+|++.+..... ......+.+|+.++..++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999998765432 34557789999999999999999999998 455689
Q ss_pred EEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 193 YLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
|+||||+++| |.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 6666654 467999999999999999999999999999999999999999999999999999865421
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC--CCcccccchhhHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIM 348 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~--y~~~~DiWSlGvil 348 (549)
... .......||+.|+|||++.+.. ++.++|||||||++
T Consensus 163 ~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 163 AAD---------------------------------------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp CSS---------------------------------------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred ccc---------------------------------------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 100 0012457999999999998644 47899999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|||++|..||.+.+.......+... ...+| ..+++++.+||.+||. ||.+|+ +++|+++||||+.....
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 204 YNITTGLYPFEGDNIYKLFENIGKG--SYAIP--GDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHC--CCCCC--SSSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSHHHHSCCCC
T ss_pred HHHHhCCCCCCCchHHHHHHHHhcC--CCCCC--CccCHHHHHHHHHHccCChhhCC---CHHHHhcCcccccCCCC
Confidence 9999999999998877777777653 33444 3689999999999999 999999 89999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=407.32 Aligned_cols=263 Identities=23% Similarity=0.371 Sum_probs=212.3
Q ss_pred hhhhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC--------CC
Q 038137 106 YMRLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD--------SN 177 (549)
Q Consensus 106 ~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--------hp 177 (549)
+..+....+..++|++++.||+|+||.||+|++..+|+.||||++.+.. ...+.+.+|+.+|+.+. |+
T Consensus 26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~ 101 (397)
T 1wak_A 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNRE 101 (397)
T ss_dssp CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence 3334444555688999999999999999999999999999999997542 33456888999998885 78
Q ss_pred ceeeeeeeec----CCceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCCeEE
Q 038137 178 CIVKLYCSFQ----DDEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKH-NYIHRDIKPDNLLL 250 (549)
Q Consensus 178 ~Iv~l~~~f~----d~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-giiHRDLKPeNILl 250 (549)
||++++++|. +...+|+||||+ +|+|...+... ..+++..++.++.||+.||.|||++ |||||||||+||||
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll 180 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred eeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence 8999999998 677899999999 66676666543 5799999999999999999999998 99999999999999
Q ss_pred cCCC-------------------------------------------------cEEEeecCcccccCCCCcccccccccC
Q 038137 251 DRNG-------------------------------------------------HMKLSDFGLCKPLDCSNLQEKDFSIGS 281 (549)
Q Consensus 251 d~~g-------------------------------------------------~vKL~DFGlak~~~~~~~~~~~~~~~~ 281 (549)
+.+| .+||+|||+|+.....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------- 249 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------- 249 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----------
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----------
Confidence 9876 7999999999865311
Q ss_pred CCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCC
Q 038137 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 361 (549)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~ 361 (549)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 250 ---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 250 ---------------------------------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp ---------------------------------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred ---------------------------------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 01458999999999999999999999999999999999999999875
Q ss_pred Cchh------hhhhhhhccccc--------------------------------------cCCCCcCCChhHHHHHHHhh
Q 038137 362 EPMS------TCRKIVNWRTHL--------------------------------------KFPEEAKLSPEAKDLISKLL 397 (549)
Q Consensus 362 ~~~~------~~~~I~~~~~~l--------------------------------------~~p~~~~~s~~~~dLI~~lL 397 (549)
+... ....+......+ .++.....++++++||.+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 376 (397)
T 1wak_A 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 376 (397)
T ss_dssp CCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGG
T ss_pred cccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHh
Confidence 5322 122221110000 00001233567899999999
Q ss_pred h-cccccCCCCCHHHHHcCCcccC
Q 038137 398 C-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 398 ~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+ ||.+|+ +++||++||||++
T Consensus 377 ~~dP~~Rp---t~~e~l~hp~~~~ 397 (397)
T 1wak_A 377 ELIPEKRA---TAAECLRHPWLNS 397 (397)
T ss_dssp CSSGGGSC---CHHHHHTSGGGGC
T ss_pred ccChhhcC---CHHHHhhCccccC
Confidence 9 999999 8999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=393.69 Aligned_cols=265 Identities=31% Similarity=0.495 Sum_probs=219.1
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecC-
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQD- 188 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d- 188 (549)
......++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+|+.++..+ +||||++++++|.+
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34456789999999999999999999999999999999997542 2335688999999998 89999999999976
Q ss_pred -----CceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeec
Q 038137 189 -----DEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 189 -----~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DF 261 (549)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 56899999999999999999653 57999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCC
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYG 336 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~ 336 (549)
|++..+..... .....+||+.|+|||++. +..++
T Consensus 174 g~~~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 212 (326)
T 2x7f_A 174 GVSAQLDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYD 212 (326)
T ss_dssp TTTC------------------------------------------------------CCGGGCCHHHHC--------CC
T ss_pred cCceecCcCcc-----------------------------------------ccccccCCccccChhhhccccccCcCCC
Confidence 99876532100 011457999999999997 56789
Q ss_pred cccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 337 MECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
.++|||||||++|+|++|.+||.+.+.......+.... ........+++.+++||.+||. ||.+|+ +++++++|
T Consensus 213 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h 287 (326)
T 2x7f_A 213 FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKH 287 (326)
T ss_dssp TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCCCSCSCSCHHHHHHHHHHCCSSGGGSC---CHHHHHTS
T ss_pred ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cccCCccccCHHHHHHHHHHhccChhhCC---CHHHHhhC
Confidence 99999999999999999999998887766665555422 1112234689999999999999 999999 89999999
Q ss_pred CcccCCCccc
Q 038137 416 PWFKGIEWDK 425 (549)
Q Consensus 416 pfF~~i~w~~ 425 (549)
|||++..+..
T Consensus 288 p~~~~~~~~~ 297 (326)
T 2x7f_A 288 PFIRDQPNER 297 (326)
T ss_dssp HHHHCCTTHH
T ss_pred hHHhhCcccc
Confidence 9999876544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=404.44 Aligned_cols=261 Identities=31% Similarity=0.447 Sum_probs=202.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD------ 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 189 (549)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.... .....++...+..++|||||+++++|.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 46899999999999999999999999999999998664322 23456677888889999999999998643
Q ss_pred -ceEEEEEeecCCCchh---hHhhhcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCCCCeEEcC-CCcEEEeecC
Q 038137 190 -EYLYLIMEYLPGGDMM---TLLMRKDTLTEEEARFYVGETVLAIESIH--KHNYIHRDIKPDNLLLDR-NGHMKLSDFG 262 (549)
Q Consensus 190 -~~lylVmEy~~gg~L~---~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--~~giiHRDLKPeNILld~-~g~vKL~DFG 262 (549)
.++|+||||++|+.+. ..+.....+++..++.++.|++.||.||| ++||+||||||+|||++. +|++||+|||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 2489999999875332 22335678999999999999999999999 999999999999999997 8999999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-CCccccc
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDW 341 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-y~~~~Di 341 (549)
+|+.+..... ....+||+.|+|||++.+.. |+.++||
T Consensus 178 ~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di 215 (360)
T 3e3p_A 178 SAKKLSPSEP------------------------------------------NVAYICSRYYRAPELIFGNQHYTTAVDI 215 (360)
T ss_dssp TCBCCCTTSC------------------------------------------CCSTTSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred CceecCCCCC------------------------------------------cccccCCcceeCHHHHcCCCCCCcHHHH
Confidence 9986542210 11457999999999997654 8999999
Q ss_pred chhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccc---------------c------------CC-CCcCCChhHHHHH
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL---------------K------------FP-EEAKLSPEAKDLI 393 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l---------------~------------~p-~~~~~s~~~~dLI 393 (549)
|||||++|||++|.+||.+.+....+..++...... . ++ .....++++++||
T Consensus 216 ~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (360)
T 3e3p_A 216 WSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295 (360)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHH
Confidence 999999999999999999988877777665421100 0 00 0112578999999
Q ss_pred HHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 394 SKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 394 ~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
.+||+ ||.+|+ ++.|+++||||+++.+..
T Consensus 296 ~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 296 SALLQYLPEERM---KPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHTCSSGGGSC---CHHHHTTSGGGGGGGCTT
T ss_pred HHHhccCccccC---CHHHHhcCccccccCCcc
Confidence 99999 999999 899999999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=396.81 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=216.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY---- 191 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~---- 191 (549)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997643 233445678899999999999999999999987654
Q ss_pred --EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 192 --LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 192 --lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
+|+||||+. |+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999996 68888874 3599999999999999999999999999999999999999999999999999875431
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvil 348 (549)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 179 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il 214 (353)
T 3coi_A 179 E--------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214 (353)
T ss_dssp -------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred C--------------------------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHH
Confidence 1 014589999999999987 7889999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhcccc--------------------------ccCC-CCcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTH--------------------------LKFP-EEAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~--------------------------l~~p-~~~~~s~~~~dLI~~lL~-dp 400 (549)
|+|++|.+||.+.+..+.+..++..... ..++ ....+++++++||.+||+ ||
T Consensus 215 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 294 (353)
T 3coi_A 215 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 294 (353)
T ss_dssp HHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCc
Confidence 9999999999988876666555431100 0011 113578999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCCccc
Q 038137 401 EQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
.+|+ +++++++||||+.+.+..
T Consensus 295 ~~Rp---t~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 295 DKRL---TAAQALTHPFFEPFRDPE 316 (353)
T ss_dssp TTSC---CHHHHHTSGGGTTTCCGG
T ss_pred ccCC---CHHHHhcCcchhhccCcc
Confidence 9999 899999999999876544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=391.22 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=213.9
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
....+..++|++.+.||+|+||.||+|++ +|..||||++.+... .....+.+.+|+.+|..++|||||+++++|.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34456778999999999999999999976 588999999976543 344567789999999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKDT---LTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
..+|+||||++||+|.+++...+. +++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999976543 999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+....... .....+||+.|+|||++.+..++.++|||||
T Consensus 187 ~~~~~~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (309)
T 3p86_A 187 RLKASTFL-----------------------------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225 (309)
T ss_dssp --------------------------------------------------------CCTTSCHHHHTTCCCCTTHHHHHH
T ss_pred cccccccc-----------------------------------------ccccCCCCccccChhhhcCCCCCchhhHHHH
Confidence 75431100 0114689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||++|||++|..||.+.+.......+........+|. .+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 226 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rp---s~~~ll~ 291 (309)
T 3p86_A 226 GVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR--NLNPQVAAIIEGCWTNEPWKRP---SFATIMD 291 (309)
T ss_dssp HHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 9999999999999999888777766654444455554 789999999999999 999999 7999886
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=393.81 Aligned_cols=273 Identities=23% Similarity=0.361 Sum_probs=204.8
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeee
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCS 185 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 185 (549)
+....+..++|++++.||+|+||.||+|+++.++. .||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 34556778899999999999999999999887765 899999976532 33456779999999999999999999999
Q ss_pred ecCCceE------EEEEeecCCCchhhHhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC
Q 038137 186 FQDDEYL------YLIMEYLPGGDMMTLLMRKD------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN 253 (549)
Q Consensus 186 f~d~~~l------ylVmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~ 253 (549)
+.+.... |+||||++||+|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9877665 99999999999999986533 69999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC
Q 038137 254 GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333 (549)
Q Consensus 254 g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~ 333 (549)
|.+||+|||+|+......... ......||+.|+|||++.+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 214 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYR---------------------------------------QGCASKLPVKWLALESLADN 214 (323)
T ss_dssp SCEEECCCCC--------------------------------------------------------CCGGGCCHHHHHHC
T ss_pred CCEEEeecccccccccccccc---------------------------------------ccccccCcccccCchhhcCC
Confidence 999999999998654221000 01134678899999999999
Q ss_pred CCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCC---
Q 038137 334 GYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG--- 408 (549)
Q Consensus 334 ~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~--- 408 (549)
.|+.++|||||||++|||++ |.+||.+.+.......+.... ....| ..+++++.+||.+||. ||.+|+ +
T Consensus 215 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ 288 (323)
T 3qup_A 215 LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQP--PECMEEVYDLMYQCWSADPKQRP---SFTC 288 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHH
T ss_pred CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCCC--CccCHHHHHHHHHHccCChhhCc---CHHH
Confidence 99999999999999999999 999999988888777776532 23333 4789999999999999 999999 6
Q ss_pred ----HHHHHcCCcccCCCccccc
Q 038137 409 ----ADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 409 ----~~eil~HpfF~~i~w~~l~ 427 (549)
+++++.|||+.+..++.+.
T Consensus 289 l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 289 LRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp HHHHHHHHHHC------------
T ss_pred HHHHHHHHHHHhhhcCCCCCCCC
Confidence 7889999999887665554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=390.51 Aligned_cols=262 Identities=31% Similarity=0.515 Sum_probs=220.5
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||+|+||.||+|.++.+|+.||||++.... ....+.+|+.++..++||||+++++++.+...+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4678999999999999999999999999999999997642 23568899999999999999999999999999999
Q ss_pred EEeecCCCchhhHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||++||+|.+++. ....+++..++.++.+|+.||.|||+.||+||||||+|||++.+|++||+|||++..+.....
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 999999999999986 457899999999999999999999999999999999999999999999999999976532110
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 181 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 220 (314)
T 3com_A 181 ----------------------------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220 (314)
T ss_dssp ----------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh
Confidence 0114579999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l 426 (549)
|.+||.+.+.......+... ....+.....+++++.+||.+||. ||.+|+ ++.++++||||++..+...
T Consensus 221 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~~ll~~~~~~~~~~~~~ 290 (314)
T 3com_A 221 GKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVRSAKGVSI 290 (314)
T ss_dssp SSCTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHTCCCGGG
T ss_pred CCCCCCCCChHHHHHHHhcC-CCcccCCcccCCHHHHHHHHHHccCChhhCc---CHHHHHhCHHHhcCCcchH
Confidence 99999887765555444332 222233334689999999999999 999999 8999999999998876544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=391.79 Aligned_cols=263 Identities=29% Similarity=0.452 Sum_probs=218.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc---CCCceeeeeeeec----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREK-ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV---DSNCIVKLYCSFQ---- 187 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~---- 187 (549)
.++|++++.||+|+||.||+|++. .+|+.||||++...... ......+.+|+.+++.+ +||||++++++|.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 478999999999999999999995 77899999999764321 11223456677777666 8999999999987
Q ss_pred -CCceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 188 -DDEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 188 -d~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
+...+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 6678999999997 6999998764 35999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+...... .....+||+.|+|||++.+..|+.++|||||
T Consensus 168 ~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (326)
T 1blx_A 168 RIYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 205 (326)
T ss_dssp CCCCGGG------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccCCC------------------------------------------CccccccccceeCHHHHhcCCCCcchhHHHH
Confidence 7653110 0114689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhc---------cccccCC--------------CCcCCChhHHHHHHHhhh-cc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNW---------RTHLKFP--------------EEAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~---------~~~l~~p--------------~~~~~s~~~~dLI~~lL~-dp 400 (549)
||++|+|++|.+||.+.+......+++.. ......+ ....+++++++||.+||. ||
T Consensus 206 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (326)
T 1blx_A 206 GCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285 (326)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSST
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCc
Confidence 99999999999999998877777666531 1111000 013578999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCCccc
Q 038137 401 EQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
.+|+ ++.|+++||||++++|..
T Consensus 286 ~~Rp---t~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 286 AKRI---SAYSALSHPYFQDLERCK 307 (326)
T ss_dssp TTSC---CHHHHHTSGGGTTCCCCC
T ss_pred ccCC---CHHHHhcCccccccchhh
Confidence 9999 899999999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=396.68 Aligned_cols=256 Identities=19% Similarity=0.293 Sum_probs=211.0
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHV----YAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~----vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
..+..++|++++.||+|+||.||+|.+..+|.. ||+|++.... .......+.+|..++..++|||||++++++.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 356678999999999999999999999988876 6666664332 1222345678999999999999999999886
Q ss_pred CCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
+..+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45689999999999999999764 6899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
+...... .......||+.|+|||++.+..|+.++|||||||
T Consensus 165 ~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (325)
T 3kex_A 165 LPPDDKQ---------------------------------------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205 (325)
T ss_dssp SCCCTTC---------------------------------------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCccccc---------------------------------------ccccCCCCcccccChHHhccCCCChhhHhHHhHH
Confidence 6422100 0011457889999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 347 IMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 347 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
++|||++ |.+||.+.........+... .....| ..+++++.+||.+||. ||.+|+ ++.++++|
T Consensus 206 ~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~el~~~ 270 (325)
T 3kex_A 206 TVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQP--QICTIDVYMVMVKCWMIDENIRP---TFKELANE 270 (325)
T ss_dssp HHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCC--TTBCTTTTHHHHHHTCSCTTTSC---CHHHHHHH
T ss_pred HHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCC--CcCcHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999999 99999988776666555542 233334 3688999999999999 999998 78888764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=390.70 Aligned_cols=274 Identities=26% Similarity=0.442 Sum_probs=200.3
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
..+..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.++..++||||++++++|.+.+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 45678899999999999999999999999999999999875432 2334568889999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 192 LYLIMEYLPGGDMMTLLMR--------KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
+|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999863 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccc
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 342 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiW 342 (549)
+..+....... ........+||+.|+|||++.+ ..++.++|+|
T Consensus 168 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 211 (303)
T 2vwi_A 168 SAFLATGGDIT------------------------------------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211 (303)
T ss_dssp HHHCC---------------------------------------------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred hheeccCCCcc------------------------------------chhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence 98654211000 0000124689999999999976 6789999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCchhhhhhhhhccc-ccc-----CCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT-HLK-----FPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~-~l~-----~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
||||++|||++|.+||.+.+............. .+. ......+++++++||.+||+ ||.+|+ ++.++++|
T Consensus 212 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h 288 (303)
T 2vwi_A 212 SFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP---TAAELLRH 288 (303)
T ss_dssp HHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC---CHHHHHTS
T ss_pred HHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc---CHHHHhhC
Confidence 999999999999999988776655544433211 000 01113678999999999999 999999 89999999
Q ss_pred CcccCCCcccc
Q 038137 416 PWFKGIEWDKL 426 (549)
Q Consensus 416 pfF~~i~w~~l 426 (549)
|||+...+..+
T Consensus 289 ~~~~~~~~~~~ 299 (303)
T 2vwi_A 289 KFFQKAKNKEF 299 (303)
T ss_dssp TTC--------
T ss_pred hhhhcCCCCcc
Confidence 99998776543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=392.95 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=216.2
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEE-cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC------ceeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCRE-KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN------CIVKL 182 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~-k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp------~Iv~l 182 (549)
+...+..++|++++.||+|+||.||+|.+ +.+|+.||||++.... ...+.+.+|+.++..++|+ +|+++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 34455578999999999999999999998 5689999999997542 3346688899999888665 49999
Q ss_pred eeeecCCceEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC--------
Q 038137 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-------- 252 (549)
Q Consensus 183 ~~~f~d~~~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-------- 252 (549)
+++|.+.+.+|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 899999997665 6899999999999999999999999999999999999987
Q ss_pred -----------CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccC
Q 038137 253 -----------NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGT 321 (549)
Q Consensus 253 -----------~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT 321 (549)
++.+||+|||+++..... ..+.+||
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~gt 197 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH--------------------------------------------HSTLVST 197 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC--------------------------------------------CCSSCSC
T ss_pred CccccccccccCCCceEeeCcccccCccc--------------------------------------------cccccCC
Confidence 678999999998754311 0145899
Q ss_pred CCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccc-------------------cC---
Q 038137 322 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL-------------------KF--- 379 (549)
Q Consensus 322 ~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l-------------------~~--- 379 (549)
+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+......+ .+
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
T 1z57_A 198 RHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277 (339)
T ss_dssp GGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTT
T ss_pred ccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccccccc
Confidence 99999999999999999999999999999999999999877665544332211100 00
Q ss_pred ------------------CCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 380 ------------------PEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 380 ------------------p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
......++++.+||.+||+ ||.+|+ ++.|+++||||+.+.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~~ 336 (339)
T 1z57_A 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFDLLK 336 (339)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGGG
T ss_pred ccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc---CHHHHhcCHHHHHHh
Confidence 0011235678999999999 999999 899999999998763
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=390.39 Aligned_cols=264 Identities=26% Similarity=0.425 Sum_probs=213.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec--------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ-------- 187 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-------- 187 (549)
.++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 57899999999999999999999999999999998754 2345677889999999999999999998874
Q ss_pred ------CCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc-CCCcEEEee
Q 038137 188 ------DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD-RNGHMKLSD 260 (549)
Q Consensus 188 ------d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld-~~g~vKL~D 260 (549)
+...+|+||||++ |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4578999999997 69999885 46799999999999999999999999999999999999997 567999999
Q ss_pred cCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCccc
Q 038137 261 FGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 339 (549)
Q Consensus 261 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~ 339 (549)
||+++......... .......||+.|+|||++.+ ..++.++
T Consensus 165 fg~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 206 (320)
T 2i6l_A 165 FGLARIMDPHYSHK--------------------------------------GHLSEGLVTKWYRSPRLLLSPNNYTKAI 206 (320)
T ss_dssp CTTCBCC----------------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHH
T ss_pred CccccccCCCcccc--------------------------------------cccccccccccccCcHHhcCcccCCchh
Confidence 99998754211000 00114578999999999876 7799999
Q ss_pred ccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhcccc--------------------ccCCC------CcCCChhHHHHH
Q 038137 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTH--------------------LKFPE------EAKLSPEAKDLI 393 (549)
Q Consensus 340 DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~--------------------l~~p~------~~~~s~~~~dLI 393 (549)
|||||||++|||++|.+||.+.+.......++..... ...+. ...+++++++||
T Consensus 207 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 286 (320)
T 2i6l_A 207 DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFL 286 (320)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHH
T ss_pred hhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHH
Confidence 9999999999999999999998877776666542110 00010 135899999999
Q ss_pred HHhhh-cccccCCCCCHHHHHcCCcccCCCccc
Q 038137 394 SKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425 (549)
Q Consensus 394 ~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~ 425 (549)
.+||+ ||.+|+ +++|+++||||+.++|..
T Consensus 287 ~~~L~~dP~~Rp---t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 287 EQILTFSPMDRL---TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HTTSCSSGGGSC---CHHHHHTSHHHHTTCC--
T ss_pred HHHcCCCccccC---CHHHHhCCcccccccCcc
Confidence 99999 999999 899999999999988754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=398.96 Aligned_cols=257 Identities=21% Similarity=0.350 Sum_probs=218.2
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREK-------ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLY 183 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 183 (549)
..+..++|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+|..+ +|||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3456789999999999999999999975 355689999997642 344567799999999999 899999999
Q ss_pred eeecCCceEEEEEeecCCCchhhHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCC
Q 038137 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKD----------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDN 247 (549)
Q Consensus 184 ~~f~d~~~lylVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeN 247 (549)
++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 48999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCc
Q 038137 248 LLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327 (549)
Q Consensus 248 ILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~AP 327 (549)
||++.+|++||+|||+|+.+....... ......||+.|+||
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~aP 274 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYK---------------------------------------KTTNGRLPVKWMAP 274 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTC---------------------------------------TTTTTTSCGGGCCH
T ss_pred EEECCCCCEEEccccCCcccCccccee---------------------------------------cccCCCcccceECH
Confidence 999999999999999998654211000 00134688999999
Q ss_pred hhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCC
Q 038137 328 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 328 Evl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
|++.+..|+.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+|+
T Consensus 275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp- 350 (370)
T 2psq_A 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHAVPSQRP- 350 (370)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSC-
T ss_pred hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc-
Confidence 99999999999999999999999999 99999988777766655542 223333 4789999999999999 999998
Q ss_pred CCCHHHHHcC
Q 038137 406 TKGADEIKAH 415 (549)
Q Consensus 406 ~~~~~eil~H 415 (549)
++.|++++
T Consensus 351 --t~~ell~~ 358 (370)
T 2psq_A 351 --TFKQLVED 358 (370)
T ss_dssp --CHHHHHHH
T ss_pred --CHHHHHHH
Confidence 79998863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=384.79 Aligned_cols=255 Identities=32% Similarity=0.503 Sum_probs=222.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.+.|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.++..++||||++++++|.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3569999999999999999999999999999999976542 33467789999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||++|++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 99 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 174 (303)
T 3a7i_A 99 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--- 174 (303)
T ss_dssp EECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---
T ss_pred EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc---
Confidence 99999999999985 46799999999999999999999999999999999999999999999999999986542110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 175 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (303)
T 3a7i_A 175 --------------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216 (303)
T ss_dssp --------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCC
Confidence 011458999999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+||...+.......+... ....++ ..+++++.+||.+||+ ||.+|+ ++.+|++||||..
T Consensus 217 ~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~ 276 (303)
T 3a7i_A 217 PPHSELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFILR 276 (303)
T ss_dssp CTTTTSCHHHHHHHHHHS-CCCCCC--SSCCHHHHHHHHHHCCSSGGGSC---CHHHHTTCHHHHH
T ss_pred CCCCCcCHHHHHHHhhcC-CCCCCc--cccCHHHHHHHHHHcCCChhhCc---CHHHHhhChhhhc
Confidence 999887776655555432 122222 3789999999999999 999999 8999999999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=397.71 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=210.6
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--------hchhhHHHHHHHHHHHHhcCCCceeeeeee
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM--------LRRGQVEHVKAERNLLAEVDSNCIVKLYCS 185 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~--------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 185 (549)
...++|++++.||+|+||.||+|.+.. |..||||++.+... ......+.+.+|+.+|..++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346789999999999999999999865 89999999965322 122334778999999999999999999999
Q ss_pred e-----cCCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEe
Q 038137 186 F-----QDDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLS 259 (549)
Q Consensus 186 f-----~d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~ 259 (549)
| .....+|+||||++ |+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 8 44557999999997 6787777543 579999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcc
Q 038137 260 DFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 338 (549)
Q Consensus 260 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~ 338 (549)
|||+|+...... .....+||+.|+|||++.+ ..++.+
T Consensus 177 Dfg~~~~~~~~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~ 214 (362)
T 3pg1_A 177 DFNLAREDTADA------------------------------------------NKTHYVTHRWYRAPELVMQFKGFTKL 214 (362)
T ss_dssp CTTC---------------------------------------------------------CGGGCCHHHHTTCTTCCTH
T ss_pred ecCccccccccc------------------------------------------ccceecccceecCcHHhcCCCCCCcH
Confidence 999997542110 0114589999999999987 779999
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccc----------------------cCCC------CcCCChhHH
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL----------------------KFPE------EAKLSPEAK 390 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l----------------------~~p~------~~~~s~~~~ 390 (549)
+|||||||++|+|++|.+||.+.+......+++...... ..|. ...+++.+.
T Consensus 215 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (362)
T 3pg1_A 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL 294 (362)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHH
T ss_pred hHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHH
Confidence 999999999999999999999988777766665321111 0111 135688999
Q ss_pred HHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 391 dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+||.+||. ||.+|+ +++|+++||||+++
T Consensus 295 ~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 323 (362)
T 3pg1_A 295 DLIAKMLEFNPQRRI---STEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHTCSSGGGSC---CHHHHHTSGGGTTT
T ss_pred HHHHHHhcCChhhCC---CHHHHHcCchhhhc
Confidence 99999999 999999 89999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=391.81 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=211.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc--e
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE--Y 191 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~--~ 191 (549)
...++|++.+.||+|+||.||+|+++.+|+.||||++...... ...+.+.+|+.+|..++|||||++++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 4567899999999999999999999999999999999865432 33566789999999999999999999988654 8
Q ss_pred EEEEEeecCCCchhhHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE----cCCCcEEEeecCcc
Q 038137 192 LYLIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLC 264 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl----d~~g~vKL~DFGla 264 (549)
+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999999997643 39999999999999999999999999999999999999 88889999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc--------cCCCC
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL--------KKGYG 336 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~--------~~~y~ 336 (549)
+....... ..+.+||+.|+|||++. +..|+
T Consensus 164 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 201 (319)
T 4euu_A 164 RELEDDEQ------------------------------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201 (319)
T ss_dssp EECCTTCC------------------------------------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBC
T ss_pred eecCCCCc------------------------------------------eeecccCCCccCHHHhhhccccccccCCCC
Confidence 87542210 11457999999999997 57899
Q ss_pred cccccchhhHHHHHHhhCCCCCCCCCc----hhhhhhhhhcccc-----------------ccCCCC----cCCChhHHH
Q 038137 337 MECDWWSLGAIMYEMLVGYPPFYSDEP----MSTCRKIVNWRTH-----------------LKFPEE----AKLSPEAKD 391 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~G~~PF~~~~~----~~~~~~I~~~~~~-----------------l~~p~~----~~~s~~~~d 391 (549)
.++|||||||++|||++|.+||..... .....+++..... ..+|.. ..+++.+.+
T Consensus 202 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 281 (319)
T 4euu_A 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281 (319)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHH
Confidence 999999999999999999999975443 2333333321110 011211 234568999
Q ss_pred HHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 392 LISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 392 LI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
||.+||. ||.+|+ +++|+++||=
T Consensus 282 ll~~~L~~dP~~R~---s~~ell~h~~ 305 (319)
T 4euu_A 282 VLANILEADQEKCW---GFDQFFAETS 305 (319)
T ss_dssp HHHHHSCCCTTTSC---CHHHHHHHHH
T ss_pred HHHHhccCChhhhc---cHHHhhhccH
Confidence 9999999 999999 8999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=401.63 Aligned_cols=260 Identities=28% Similarity=0.403 Sum_probs=213.6
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CC-----ceeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SN-----CIVKLYCS 185 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp-----~Iv~l~~~ 185 (549)
.....++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.++..+. |+ +|++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3444689999999999999999999999999999999997542 23456778888888774 44 59999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCCCCeEEc--CCCcEEEe
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIH--KHNYIHRDIKPDNLLLD--RNGHMKLS 259 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH--~~giiHRDLKPeNILld--~~g~vKL~ 259 (549)
|.+.+.+|+||||++ |+|.+++... ..+++..++.++.||+.||.||| ..|||||||||+||||+ .++.+||+
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 999999999999995 5999998764 56999999999999999999999 57999999999999994 57889999
Q ss_pred ecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCccc
Q 038137 260 DFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 339 (549)
Q Consensus 260 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~ 339 (549)
|||+|+..... ....+||+.|+|||++.+..|+.++
T Consensus 204 DFG~a~~~~~~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~ 239 (382)
T 2vx3_A 204 DFGSSCQLGQR--------------------------------------------IYQYIQSRFYRSPEVLLGMPYDLAI 239 (382)
T ss_dssp CCTTCEETTCC--------------------------------------------CCSSCSCGGGCCHHHHTTCCCCTHH
T ss_pred eccCceecccc--------------------------------------------cccccCCccccChHHHcCCCCCcHH
Confidence 99999865311 1146899999999999999999999
Q ss_pred ccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccc----------------cCCCC-------------------cC
Q 038137 340 DWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL----------------KFPEE-------------------AK 384 (549)
Q Consensus 340 DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l----------------~~p~~-------------------~~ 384 (549)
|||||||++|||++|++||.+.+..+...+|+...... .+|.. ..
T Consensus 240 DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (382)
T 2vx3_A 240 DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRK 319 (382)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSC
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhh
Confidence 99999999999999999999988877777665421100 00000 00
Q ss_pred -------------------------CChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCc
Q 038137 385 -------------------------LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEW 423 (549)
Q Consensus 385 -------------------------~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w 423 (549)
.++++++||.+||+ ||.+|+ +++|+++||||+...|
T Consensus 320 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp---ta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 320 LHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI---QPYYALQHSFFKKTAD 381 (382)
T ss_dssp HHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC---CHHHHTTSGGGCC---
T ss_pred HHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC---CHHHHhcCcccccCCC
Confidence 01378999999999 999999 8999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=391.99 Aligned_cols=273 Identities=21% Similarity=0.280 Sum_probs=218.2
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ly 193 (549)
..++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+.++..+ +||||+++++++.+...+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 35789999999999999999999999999999999875432 12477899999999 9999999999999999999
Q ss_pred EEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc-----EEEeecCccccc
Q 038137 194 LIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH-----MKLSDFGLCKPL 267 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~-----vKL~DFGlak~~ 267 (549)
+||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|+ +||+|||+|+.+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999976 478999999999999999999999999999999999999999988 999999999875
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
........ .+ .......+||+.|+|||++.+..|+.++|||||||+
T Consensus 161 ~~~~~~~~-------------------~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 206 (330)
T 2izr_A 161 IDPETKKH-------------------IP---------------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHM 206 (330)
T ss_dssp BCTTTCCB-------------------CC---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred ecCCCCcc-------------------cc---------------ccccCCcCCCccccChHHHcCCCCCchhHHHHHHHH
Confidence 42210000 00 000125789999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCch---hhhhhhhhccccccCCCC--cCCChhHHHHHHHhhh-cccccCCCCCHHHHHc-------
Q 038137 348 MYEMLVGYPPFYSDEPM---STCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA------- 414 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~---~~~~~I~~~~~~l~~p~~--~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~------- 414 (549)
+|||++|.+||.+.+.. +.+.++.... ...|.. ....+++.+||.+||. ||.+|+ ++++|++
T Consensus 207 l~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP---~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 207 FMYFLRGSLPWQGLKADTLKERYQKIGDTK--RATPIEVLCENFPEMATYLRYVRRLDFFEKP---DYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHHSSCTTTTCCCSSHHHHHHHHHHHH--HHSCHHHHTTTCHHHHHHHHHHHHCCTTCCC---CHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCccccccccHHHHHHHHHhhh--ccCCHHHHhccChHHHHHHHHHHhCCCCCCC---CHHHHHHHHHHHHH
Confidence 99999999999885443 3344443321 122211 1123499999999999 999999 6666654
Q ss_pred ---CCcccCCCccccccccCCC
Q 038137 415 ---HPWFKGIEWDKLYQIKAAF 433 (549)
Q Consensus 415 ---HpfF~~i~w~~l~~~~~pf 433 (549)
.++...++|+. ..+.+|+
T Consensus 282 ~~~~~~~~~~dw~~-~~~~~p~ 302 (330)
T 2izr_A 282 RKGYMFDYEYDWIG-KQLPTPV 302 (330)
T ss_dssp HTTCCCSCCCTTTT-SCCCCCC
T ss_pred HcCCCCCCCccCCC-CCcCCCC
Confidence 34555678873 2344554
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=381.76 Aligned_cols=258 Identities=31% Similarity=0.556 Sum_probs=220.8
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec--CCceE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ--DDEYL 192 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~l 192 (549)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|. +...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 35789999999999999999999999999999999986543 3345667899999999999999999999874 56789
Q ss_pred EEEEeecCCCchhhHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 193 YLIMEYLPGGDMMTLLMRK----DTLTEEEARFYVGETVLAIESIHKHN-----YIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
|+||||++||+|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+|||++.+|++||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999653 34999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccch
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWS 343 (549)
++...... ......+||+.|+|||++.+..++.++||||
T Consensus 163 ~~~~~~~~-----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 201 (279)
T 2w5a_A 163 ARILNHDT-----------------------------------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201 (279)
T ss_dssp HHHC---C-----------------------------------------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred heeecccc-----------------------------------------ccccccCCCccccChHHhccCCCCchhhHHH
Confidence 87653210 0011357999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|||++|+|++|.+||.+.+.......+.... ...+| ..+++++.+||.+||. ||.+|+ +++||++||||.+
T Consensus 202 lG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~~~~~~ 273 (279)
T 2w5a_A 202 LGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILENPLILE 273 (279)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTCCG
T ss_pred HHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cccCC--cccCHHHHHHHHHHcCCCcccCC---CHHHHHhChhhhh
Confidence 9999999999999999888777766666532 22333 3689999999999999 999999 8999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=394.40 Aligned_cols=264 Identities=23% Similarity=0.401 Sum_probs=216.9
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc------eeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATG-HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC------IVKLY 183 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~------Iv~l~ 183 (549)
......++|++++.||+|+||.||+|.+..++ ..||+|++.+.. .....+.+|+.+|..+.|++ |+.++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 34455689999999999999999999998877 689999997542 23456788999998887655 89999
Q ss_pred eeecCCceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE-----------
Q 038137 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL----------- 250 (549)
Q Consensus 184 ~~f~d~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl----------- 250 (549)
++|.....+|+||||+ +|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 66777777554 479999999999999999999999999999999999999
Q ss_pred --------cCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCC
Q 038137 251 --------DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTP 322 (549)
Q Consensus 251 --------d~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~ 322 (549)
+.++.+||+|||+++..... ....+||+
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~gt~ 203 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH--------------------------------------------HTTIVATR 203 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC--------------------------------------------CCSSCSCG
T ss_pred cccccccccCCCcEEEeecCcccccccc--------------------------------------------ccCCcCCC
Confidence 67889999999999754211 01458999
Q ss_pred CCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccc-------------------cC----
Q 038137 323 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHL-------------------KF---- 379 (549)
Q Consensus 323 ~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l-------------------~~---- 379 (549)
.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.......+......+ .+
T Consensus 204 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (355)
T 2eu9_A 204 HYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS 283 (355)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTS
T ss_pred cccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccccccc
Confidence 9999999999999999999999999999999999999877665544433211100 00
Q ss_pred -----------------CCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccc
Q 038137 380 -----------------PEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 380 -----------------p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l 426 (549)
......++++.+||.+||+ ||.+|+ ++.|+++||||++++|+..
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---t~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 284 SDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI---TLAEALLHPFFAGLTPEER 345 (355)
T ss_dssp HHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC---CHHHHTTSGGGGGCCHHHH
T ss_pred chhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc---CHHHHhcChhhcCCChhhc
Confidence 0011224588999999999 999999 8999999999999988654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=396.80 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=218.1
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCR-----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYC 184 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~-----~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 184 (549)
...+..++|++.+.||+|+||.||+|+ +..+++.||||++.+.. .....+.+.+|+.+|..+ +|||||++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 345677899999999999999999999 45677999999997643 234456789999999999 7899999999
Q ss_pred eecCCc-eEEEEEeecCCCchhhHhhhcCC--------------------------------------------------
Q 038137 185 SFQDDE-YLYLIMEYLPGGDMMTLLMRKDT-------------------------------------------------- 213 (549)
Q Consensus 185 ~f~d~~-~lylVmEy~~gg~L~~~l~~~~~-------------------------------------------------- 213 (549)
+|.+.+ .+|+|||||+||+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 988754 49999999999999999966432
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 214 ----------------LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 214 ----------------l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+......
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~---- 249 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 249 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC----
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc----
Confidence 899999999999999999999999999999999999999999999999999865321100
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 356 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~ 356 (549)
.......||+.|+|||++.+..|+.++|||||||++|||++ |.+
T Consensus 250 -----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 294 (359)
T 3vhe_A 250 -----------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 294 (359)
T ss_dssp -----------------------------------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred -----------------------------------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCC
Confidence 00124578999999999999999999999999999999998 999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
||.+..........+........| ..+++++.+||.+||. ||.+|+ ++.||++|
T Consensus 295 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~ell~~ 349 (359)
T 3vhe_A 295 PYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP---TFSELVEH 349 (359)
T ss_dssp SSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCccchhHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHccCChhhCC---CHHHHHHH
Confidence 999877666555555433344444 4789999999999999 999999 79999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=404.06 Aligned_cols=264 Identities=18% Similarity=0.295 Sum_probs=221.7
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCR-----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF 186 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~-----~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 186 (549)
..+..++|++++.||+|+||.||+|+ +..++..||||++.... .......+.+|+.+|..++|||||+++++|
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 35667889999999999999999999 45678899999996532 234455688999999999999999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---cE
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRK-------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG---HM 256 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g---~v 256 (549)
.+....|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999999764 3599999999999999999999999999999999999999666 49
Q ss_pred EEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCC
Q 038137 257 KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYG 336 (549)
Q Consensus 257 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~ 336 (549)
||+|||+|+.+...... ......+||+.|+|||++.+..|+
T Consensus 224 kL~DFG~a~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 264 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY---------------------------------------RKGGCAMLPVKWMPPEAFMEGIFT 264 (367)
T ss_dssp EECCCHHHHHHHHHSSC---------------------------------------TTCCGGGSCGGGCCHHHHHHCCCC
T ss_pred EECCCcccccccccccc---------------------------------------ccCCCcCCcccEECHHHhcCCCCC
Confidence 99999999854311100 001246789999999999999999
Q ss_pred cccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 337 MECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 265 ~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~eil~ 338 (367)
T 3l9p_A 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRP---NFAIILE 338 (367)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 99999999999999998 999999988887777776532 22233 4789999999999999 999999 8999999
Q ss_pred CCcccCCC
Q 038137 415 HPWFKGIE 422 (549)
Q Consensus 415 HpfF~~i~ 422 (549)
|.++-.-+
T Consensus 339 ~l~~~~~~ 346 (367)
T 3l9p_A 339 RIEYCTQD 346 (367)
T ss_dssp HHHHHHHC
T ss_pred HHHHHhhC
Confidence 98875433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=389.40 Aligned_cols=257 Identities=22% Similarity=0.328 Sum_probs=218.3
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
..+..++|++.+.||+|+||.||+|+++.+|. .||||++.... .....+.+.+|+.+|..++|||||+++++|.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677899999999999999999999986655 59999997542 33445678999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
...+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999654 68999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
....... .......||+.|+|||++.+..|+.++|||||||+
T Consensus 202 ~~~~~~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 243 (325)
T 3kul_A 202 EDDPDAA--------------------------------------YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243 (325)
T ss_dssp C----CC--------------------------------------EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHH
T ss_pred ccCccce--------------------------------------eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHH
Confidence 4221000 00113467889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|||++ |.+||.+.+.......+... ...|....+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 244 l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~eil~ 306 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRDVISSVEEG---YRLPAPMGCPHALHQLMLDCWHKDRAQRP---RFSQIVS 306 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcC---CCCCCCCCcCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999999 99999998887777776643 3334445789999999999999 999999 7888875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=393.83 Aligned_cols=254 Identities=33% Similarity=0.553 Sum_probs=186.7
Q ss_pred CCCCeeeee-eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC----C
Q 038137 115 GADDFEPLT-MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD----D 189 (549)
Q Consensus 115 ~~~~f~~~~-~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~ 189 (549)
..++|.+++ +||+|+||.||+|+++.+|+.||||++..... ........+..+.||||++++++|.+ .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 457899965 69999999999999999999999999975421 12223334567799999999999876 5
Q ss_pred ceEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---CCcEEEeecCcc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NGHMKLSDFGLC 264 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~g~vKL~DFGla 264 (549)
..+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 66999999999999999997653 6999999999999999999999999999999999999986 456999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+...... ....+||+.|+|||++.+..|+.++|||||
T Consensus 179 ~~~~~~~-------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 215 (336)
T 3fhr_A 179 KETTQNA-------------------------------------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215 (336)
T ss_dssp EEC-----------------------------------------------------------------CHHHHHHHHHHH
T ss_pred eeccccc-------------------------------------------cccCCCCcCccChhhhCCCCCCchhhHHHH
Confidence 7643110 114589999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhh----hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMST----CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~----~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
||++|+|++|.+||.+...... ...+......+..+....+++++++||.+||. ||.+|+ +++|+++||||+
T Consensus 216 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~~~ 292 (336)
T 3fhr_A 216 GVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL---TITQFMNHPWIN 292 (336)
T ss_dssp HHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---CHHHHHHSHHHH
T ss_pred HHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc---CHHHHhcCcccc
Confidence 9999999999999987665443 22222222223334445789999999999999 999999 899999999998
Q ss_pred CC
Q 038137 420 GI 421 (549)
Q Consensus 420 ~i 421 (549)
..
T Consensus 293 ~~ 294 (336)
T 3fhr_A 293 QS 294 (336)
T ss_dssp TG
T ss_pred cc
Confidence 63
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=383.55 Aligned_cols=266 Identities=20% Similarity=0.327 Sum_probs=214.0
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|.+.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+|..++|||||+++++|.++..+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4568899999999999999999999999999999998653 3445677899999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 194 LIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999976 57899999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
..... ............+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 164 ~~~~~---------------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 216 (310)
T 3s95_A 164 QPEGL---------------------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216 (310)
T ss_dssp -------------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccc---------------------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh
Confidence 10000 000000111223578999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhh-hhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 353 VGYPPFYSDEPMSTCRKI-VNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I-~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|.+||...........+ .........| ..+++++.+||.+||. ||.+|+ ++.++++
T Consensus 217 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~l~~ 275 (310)
T 3s95_A 217 GRVNADPDYLPRTMDFGLNVRGFLDRYCP--PNCPPSFFPITVRCCDLDPEKRP---SFVKLEH 275 (310)
T ss_dssp HTCCSSTTTSCBCTTSSBCHHHHHHHTCC--TTCCTTHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred cCCCCCcchhhhHHHHhhhhhccccccCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 999999765433221111 0000011122 3688999999999999 999999 7999886
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=375.62 Aligned_cols=253 Identities=19% Similarity=0.296 Sum_probs=217.9
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
..+..++|++++.||+|+||.||+|.+. ++..||+|++.+... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3566789999999999999999999987 467899999976532 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999999965 456999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.. .......||+.|+|||++.+..++.++|+|||||++|+
T Consensus 160 ~~----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 199 (269)
T 4hcu_A 160 QY----------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 199 (269)
T ss_dssp HH----------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cc----------------------------------------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHH
Confidence 00 00113567889999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|++ |.+||.+.+.......+... ...+.+..+++++.+||.+||. ||.+|+ ++.++++|
T Consensus 200 ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~ll~~ 260 (269)
T 4hcu_A 200 VFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 260 (269)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HhcCCCCCCCCCCHHHHHHHHhcC---ccCCCCCcCCHHHHHHHHHHccCCcccCc---CHHHHHHH
Confidence 999 99999998888777777653 2222234689999999999999 999999 79999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=381.84 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=220.2
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 184 (549)
....+..++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+|+.++|||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 344667789999999999999999999983 456899999997542 3445677899999999999999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeee
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKDT------------------------LTEEEARFYVGETVLAIESIHKHNYIH 240 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~~~------------------------l~e~~~~~~~~qi~~aL~~LH~~giiH 240 (549)
++.+.+.+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999976433 899999999999999999999999999
Q ss_pred cCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeeccc
Q 038137 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVG 320 (549)
Q Consensus 241 RDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vG 320 (549)
|||||+|||++.+|++||+|||+++......... ......|
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~ 214 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV---------------------------------------KRSQGRI 214 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE---------------------------------------CSSCCCS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccce---------------------------------------eccCCCC
Confidence 9999999999999999999999998654221000 0113468
Q ss_pred CCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-
Q 038137 321 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC- 398 (549)
Q Consensus 321 T~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~- 398 (549)
|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.......+... .....| ..+++++.+||.+||.
T Consensus 215 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~ 291 (314)
T 2ivs_A 215 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG-HRMERP--DNCSEEMYRLMLQCWKQ 291 (314)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCS
T ss_pred cccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC-CcCCCC--ccCCHHHHHHHHHHccC
Confidence 899999999999999999999999999999999 99999988877766655542 223333 4789999999999999
Q ss_pred cccccCCCCCHHHHHcC
Q 038137 399 NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 399 dp~~Rl~~~~~~eil~H 415 (549)
||.+|+ ++.+|++|
T Consensus 292 dp~~Rp---s~~~l~~~ 305 (314)
T 2ivs_A 292 EPDKRP---VFADISKD 305 (314)
T ss_dssp SGGGSC---CHHHHHHH
T ss_pred ChhhCc---CHHHHHHH
Confidence 999999 79998864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.18 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=216.6
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.+..++|++++.||+|+||.||+|.++ ++..||+|++..... ....+.+|+.++..++||||+++++++.+...+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 566789999999999999999999876 567899999976542 235588999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|+||||++||+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999999999765 459999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 159 ~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 198 (268)
T 3sxs_A 159 YV----------------------------------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198 (268)
T ss_dssp EE----------------------------------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHH
T ss_pred hh----------------------------------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHH
Confidence 00 01134677889999999999999999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
++ |.+||...+......++... .....| ..+++++.+||.+||+ ||.+|+ ++.++++|
T Consensus 199 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (268)
T 3sxs_A 199 FSLGKMPYDLYTNSEVVLKVSQG-HRLYRP--HLASDTIYQIMYSCWHELPEKRP---TFQQLLSS 258 (268)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HcCCCCCccccChHHHHHHHHcC-CCCCCC--CcChHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 99 99999988877777666542 222223 3679999999999999 999999 89999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=378.35 Aligned_cols=271 Identities=29% Similarity=0.507 Sum_probs=208.8
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--------
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-------- 188 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-------- 188 (549)
++|++++.||+|+||.||+|++..+|+.||||++... ......+.+|+.++..++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4699999999999999999999999999999999653 2345678899999999999999999988754
Q ss_pred -----CceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecC
Q 038137 189 -----DEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFG 262 (549)
Q Consensus 189 -----~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFG 262 (549)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 56799999999999999999754 468899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCccccc
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDW 341 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~Di 341 (549)
+++.......... . ..... + .........+||+.|+|||++.+. .++.++||
T Consensus 162 ~~~~~~~~~~~~~-~------------~~~~~-~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 214 (303)
T 1zy4_A 162 LAKNVHRSLDILK-L------------DSQNL-P-------------GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214 (303)
T ss_dssp CCSCTTC----------------------------------------------------CTTSCHHHHTSCSCCCTHHHH
T ss_pred chhhcccccchhc-c------------ccccc-c-------------ccccccccCCCcccccCcccccCCCCCcchhhH
Confidence 9987642210000 0 00000 0 000011256899999999999865 68999999
Q ss_pred chhhHHHHHHhhCCCCCCCC-CchhhhhhhhhccccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 342 WSLGAIMYEMLVGYPPFYSD-EPMSTCRKIVNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~-~~~~~~~~I~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
|||||++|||++ ||... +.......+... ...+|. ....++.+++||.+||+ ||.+|+ ++.++++|||
T Consensus 215 ~slG~il~~l~~---p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~h~~ 286 (303)
T 1zy4_A 215 YSLGIIFFEMIY---PFSTGMERVNILKKLRSV--SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLLNSGW 286 (303)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHST--TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC---CHHHHHHSSC
T ss_pred HHHHHHHHHHHh---ccCCchhHHHHHHhcccc--ccccCccccccchHHHHHHHHHHHhcCcccCc---CHHHHhCCCC
Confidence 999999999998 55432 233334444332 223332 23567889999999999 999999 8999999999
Q ss_pred ccCCCcccc
Q 038137 418 FKGIEWDKL 426 (549)
Q Consensus 418 F~~i~w~~l 426 (549)
|....++..
T Consensus 287 ~~~~~~~~~ 295 (303)
T 1zy4_A 287 LPVKHQDEV 295 (303)
T ss_dssp SCCCCHHHH
T ss_pred cCCCChHHH
Confidence 987766543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=393.21 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=208.4
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-----------CCcee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-----------SNCIV 180 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv 180 (549)
..+..++|++++.||+|+||.||+|++..+|+.||||++.+.. .....+.+|+.++..+. ||||+
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~ 89 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 89 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHH
Confidence 3456789999999999999999999999999999999997543 23456788999988876 89999
Q ss_pred eeeeeecCCc----eEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCCeEEc--
Q 038137 181 KLYCSFQDDE----YLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKH-NYIHRDIKPDNLLLD-- 251 (549)
Q Consensus 181 ~l~~~f~d~~----~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHRDLKPeNILld-- 251 (549)
+++++|.+.. .+|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence 9999998654 899999999 9999999976 35699999999999999999999998 999999999999995
Q ss_pred ----CCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCc
Q 038137 252 ----RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327 (549)
Q Consensus 252 ----~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~AP 327 (549)
..+.+||+|||+|+..... ....+||+.|+||
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------~~~~~~t~~y~aP 204 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH--------------------------------------------YTNSIQTREYRSP 204 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC--------------------------------------------CCSCCSCGGGCCH
T ss_pred CCCcCcceEEEcccccccccCCC--------------------------------------------CCCCCCCccccCc
Confidence 4458999999999865321 0135799999999
Q ss_pred hhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCc------hhhhhhhhhccc--------------------------
Q 038137 328 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEP------MSTCRKIVNWRT-------------------------- 375 (549)
Q Consensus 328 Evl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~------~~~~~~I~~~~~-------------------------- 375 (549)
|++.+..|+.++|||||||++|||++|.+||.+.+. ......++....
T Consensus 205 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 284 (373)
T 1q8y_A 205 EVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI 284 (373)
T ss_dssp HHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSC
T ss_pred HHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccc
Confidence 999999999999999999999999999999986542 122222221100
Q ss_pred --------------cccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 376 --------------HLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 376 --------------~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
...+| ..+++++.+||.+||+ ||.+|+ +++||++||||++.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rp---t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 285 SKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 340 (373)
T ss_dssp CCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTC
T ss_pred ccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccC---CHHHHhhChhhhcc
Confidence 01111 2456789999999999 999999 89999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=387.22 Aligned_cols=260 Identities=21% Similarity=0.340 Sum_probs=217.6
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYC 184 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 184 (549)
...+..++|++.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|..+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34567789999999999999999999973 466789999997543 233446788999999999 9999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKD-----------------------TLTEEEARFYVGETVLAIESIHKHNYIHR 241 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~~-----------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHR 241 (549)
+|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 38999999999999999999999999999
Q ss_pred CCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccC
Q 038137 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGT 321 (549)
Q Consensus 242 DLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT 321 (549)
||||+|||++.+|++||+|||+++.+...... .......||
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~t 237 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY---------------------------------------VVRGNARLP 237 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---------------------------------------EEETTEEEC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc---------------------------------------eeccCccCc
Confidence 99999999999999999999999865321100 001145789
Q ss_pred CCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-c
Q 038137 322 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 322 ~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-d 399 (549)
+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.........++........| ..+++++.+||.+||. |
T Consensus 238 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~d 315 (344)
T 1rjb_A 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFD 315 (344)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSS
T ss_pred cCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999998 999999887766666666533233333 4789999999999999 9
Q ss_pred ccccCCCCCHHHHHcCC
Q 038137 400 VEQRLGTKGADEIKAHP 416 (549)
Q Consensus 400 p~~Rl~~~~~~eil~Hp 416 (549)
|.+|+ ++.+|++|-
T Consensus 316 p~~Rp---s~~~l~~~l 329 (344)
T 1rjb_A 316 SRKRP---SFPNLTSFL 329 (344)
T ss_dssp GGGSC---CHHHHHHHH
T ss_pred chhCc---CHHHHHHHH
Confidence 99999 799998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=375.92 Aligned_cols=256 Identities=20% Similarity=0.353 Sum_probs=217.6
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
.....+..++|++++.||+|+||.||+|.+. ++..||||++..... ....+.+|+.++..++||||++++++|.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3455678889999999999999999999876 677899999976532 23568899999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
...+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999976 567999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
...... ......||+.|+|||++.+..|+.++|||||||+
T Consensus 171 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 210 (283)
T 3gen_A 171 LDDEYT----------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210 (283)
T ss_dssp CCHHHH----------------------------------------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred cccccc----------------------------------------cccCCccCcccCCHHHhccCCCCchhhHHHHHHH
Confidence 321000 0113467889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
+|+|++ |.+||...+.......+... ...+.+..+++.+.+||.+||. ||.+|+ ++.++++|
T Consensus 211 l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 274 (283)
T 3gen_A 211 MWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 274 (283)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHhCCCCCccccChhHHHHHHhcc---cCCCCCCcCCHHHHHHHHHHccCChhHCc---CHHHHHHH
Confidence 999998 99999998887777777653 2222234679999999999999 999999 89999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=371.34 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=206.1
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR-RGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
++..++|++.+.||+|+||.||+|.+. |..||+|++....... ....+.+.+|..+++.++||||+++++++.+...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456789999999999999999999975 8899999987653322 2335678999999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCCCCeEEcC--------CCcEEEee
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN---YIHRDIKPDNLLLDR--------NGHMKLSD 260 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHRDLKPeNILld~--------~g~vKL~D 260 (549)
+|+||||++||+|..++. ...+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999884 568999999999999999999999999 999999999999986 78899999
Q ss_pred cCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccc
Q 038137 261 FGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340 (549)
Q Consensus 261 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~D 340 (549)
||+++...... .....||+.|+|||++.+..++.++|
T Consensus 160 fg~~~~~~~~~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~D 196 (271)
T 3dtc_A 160 FGLAREWHRTT-------------------------------------------KMSAAGAYAWMAPEVIRASMFSKGSD 196 (271)
T ss_dssp CCC--------------------------------------------------------CCGGGSCHHHHHHCCCSHHHH
T ss_pred CCccccccccc-------------------------------------------ccCCCCccceeCHHHhccCCCCchhh
Confidence 99997643110 01357999999999999999999999
Q ss_pred cchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 341 WWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 341 iWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
+|||||++|+|++|.+||.+.+.......+........+ ...+++++.+||.+||. ||.+|+ ++.|+++|
T Consensus 197 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~ 267 (271)
T 3dtc_A 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--PSTCPEPFAKLMEDCWNPDPHSRP---SFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--CcccCHHHHHHHHHHhcCCcccCc---CHHHHHHH
Confidence 999999999999999999988877766666553333333 35789999999999999 999999 89998864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=377.39 Aligned_cols=261 Identities=30% Similarity=0.502 Sum_probs=213.8
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
....++|....+||+|+||.||+|.+..++..||||++.... ....+.+.+|+.+++.++||||++++++|.+.+.+
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 344566666779999999999999999999999999997643 23456688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-CCcEEEeecCcccccC
Q 038137 193 YLIMEYLPGGDMMTLLMRK---DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLD 268 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-~g~vKL~DFGlak~~~ 268 (549)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||+++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 9999999999999999664 25679999999999999999999999999999999999988 8999999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC--CCCcccccchhhH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGA 346 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~--~y~~~~DiWSlGv 346 (549)
.... .....+||+.|+|||++.+. .++.++|||||||
T Consensus 175 ~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 213 (295)
T 2clq_A 175 GINP-----------------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213 (295)
T ss_dssp C----------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHH
T ss_pred CCCC-----------------------------------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHH
Confidence 2100 01145799999999999864 4899999999999
Q ss_pred HHHHHhhCCCCCCCCCchh-hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 347 IMYEMLVGYPPFYSDEPMS-TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~-~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
++|+|++|.+||....... .............+| ..+++++.+||.+||. ||.+|+ ++++++.||||+...
T Consensus 214 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 214 TIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP--ESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC--TTSCHHHHHHHHHTTCSSTTTSC---CHHHHHTSGGGCC--
T ss_pred HHHHHHHCCCCccCCCchhHHHHhhcccccccccc--ccCCHHHHHHHHHHccCChhhCC---CHHHHhcChhhhhcc
Confidence 9999999999997644322 122221111223333 3789999999999999 999999 899999999998653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=385.79 Aligned_cols=267 Identities=27% Similarity=0.464 Sum_probs=198.5
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHH-HHHhcCCCceeeeeeeecC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN-LLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~d 188 (549)
....+..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+..|.. +++.++||||+++++++.+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 445678899999999999999999999999999999999997642 1223334455555 7778899999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCCeEEcCCCcEEEeecC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMR-----KDTLTEEEARFYVGETVLAIESIHKH-NYIHRDIKPDNLLLDRNGHMKLSDFG 262 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHRDLKPeNILld~~g~vKL~DFG 262 (549)
.+.+|+||||++| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 77777753 57899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhh----ccCCCCcc
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL----LKKGYGME 338 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl----~~~~y~~~ 338 (549)
+++.+.... .....+||+.|+|||++ .+..|+.+
T Consensus 172 ~~~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 209 (327)
T 3aln_A 172 ISGQLVDSI------------------------------------------AKTRDAGCRPYMAPERIDPSASRQGYDVR 209 (327)
T ss_dssp SSCC------------------------------------------------------------------------CCSH
T ss_pred Cceeccccc------------------------------------------ccccCCCCccccCceeeccccCcCCCCch
Confidence 997653210 00134799999999999 46679999
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCc-hhhhhhhhhccccccCC--CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFP--EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~l~~p--~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|||||||++|+|++|..||.+.+. ......++.. ....++ ....+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 210 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 285 (327)
T 3aln_A 210 SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRP---KYKELLK 285 (327)
T ss_dssp HHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC---CHHHHTT
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCCCcccccCCHHHHHHHHHHhhCChhhCc---CHHHHHh
Confidence 9999999999999999999987543 2233333321 111222 224689999999999999 999999 8999999
Q ss_pred CCcccCCCccc
Q 038137 415 HPWFKGIEWDK 425 (549)
Q Consensus 415 HpfF~~i~w~~ 425 (549)
||||...++..
T Consensus 286 hp~~~~~~~~~ 296 (327)
T 3aln_A 286 HPFILMYEERA 296 (327)
T ss_dssp SHHHHHHHHSC
T ss_pred ChHHHHhHhhH
Confidence 99998766544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=383.63 Aligned_cols=270 Identities=17% Similarity=0.268 Sum_probs=226.8
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 184 (549)
....+..++|++.+.||+|+||.||+|.++ .+++.||||++.... .......+.+|+.+|+.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 344667788999999999999999999887 467899999997543 2334456889999999999999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRK----------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG 254 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g 254 (549)
++.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999998652 4679999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~ 334 (549)
++||+|||+++........ ......+||+.|+|||++.+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~ 216 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYY---------------------------------------RKGGKGLLPVRWMSPESLKDGV 216 (322)
T ss_dssp CEEECCTTCCCGGGGGGCE---------------------------------------EGGGSSEECGGGCCHHHHHHCC
T ss_pred eEEECcCcccccccccccc---------------------------------------ccccCCCCCCCccChhhhccCC
Confidence 9999999999865321100 0011347899999999999999
Q ss_pred CCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 335 YGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
|+.++|||||||++|+|++ |.+||.+.+.......+... .....| ..+++++.+||.+||. ||.+|+ ++.|+
T Consensus 217 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~e~ 290 (322)
T 1p4o_A 217 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GLLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEI 290 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCc---CHHHH
Confidence 9999999999999999999 89999988877777766653 122233 4789999999999999 999999 79998
Q ss_pred HcC------CcccCCCcccc
Q 038137 413 KAH------PWFKGIEWDKL 426 (549)
Q Consensus 413 l~H------pfF~~i~w~~l 426 (549)
++| |+|+.++|...
T Consensus 291 l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 291 ISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp HHHHGGGSCTTHHHHCSTTS
T ss_pred HHHHHHhhccCCcccccccc
Confidence 876 77777665543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=386.86 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=218.5
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHhcC--CCceeeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR---GQVEHVKAERNLLAEVD--SNCIVKLYCS 185 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~--hp~Iv~l~~~ 185 (549)
......++|++.+.||+|+||.||+|++..+|+.||||++.+...... .....+.+|+.++..+. ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 345567889999999999999999999999999999999987643221 11234667999999996 5999999999
Q ss_pred ecCCceEEEEEeecCC-CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc-CCCcEEEeecCc
Q 038137 186 FQDDEYLYLIMEYLPG-GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD-RNGHMKLSDFGL 263 (549)
Q Consensus 186 f~d~~~lylVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld-~~g~vKL~DFGl 263 (549)
|.+.+.+|+||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999976 89999998888999999999999999999999999999999999999999 789999999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-Ccccccc
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWW 342 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiW 342 (549)
++...... ....+||+.|+|||++.+..+ +.++|||
T Consensus 197 ~~~~~~~~-------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~ 233 (320)
T 3a99_A 197 GALLKDTV-------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVW 233 (320)
T ss_dssp CEECCSSC-------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHH
T ss_pred cccccccc-------------------------------------------ccCCCCCccCCChHHhccCCCCCccchHH
Confidence 98654210 114579999999999987776 7889999
Q ss_pred hhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
||||++|||++|..||...+ .+.. ....++ ..+++++.+||.+||. ||.+|+ ++++|++||||+++
T Consensus 234 slG~il~el~~g~~pf~~~~------~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~hp~~~~~ 300 (320)
T 3a99_A 234 SLGILLYDMVCGDIPFEHDE------EIIR--GQVFFR--QRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHHHHSSCSCCSHH------HHHH--CCCCCS--SCCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSC
T ss_pred hHHHHHHHHHHCCCCCCChh------hhhc--cccccc--ccCCHHHHHHHHHHccCChhhCc---CHHHHhcCHhhcCc
Confidence 99999999999999997542 2222 223333 3789999999999999 999999 89999999999987
Q ss_pred Ccc
Q 038137 422 EWD 424 (549)
Q Consensus 422 ~w~ 424 (549)
.+.
T Consensus 301 ~~~ 303 (320)
T 3a99_A 301 LLP 303 (320)
T ss_dssp CCH
T ss_pred cCc
Confidence 643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=385.98 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=220.0
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCS 185 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 185 (549)
...+..++|++++.||+|+||.||+|++. .+++.||||++.+.. .......+.+|+.+|..++||||++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34567789999999999999999999997 456899999997643 23445678999999999999999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRK------------------------DTLTEEEARFYVGETVLAIESIHKHNYIHR 241 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHR 241 (549)
|.+.+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999763 579999999999999999999999999999
Q ss_pred CCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccC
Q 038137 242 DIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGT 321 (549)
Q Consensus 242 DLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT 321 (549)
||||+|||++.+|.+||+|||+++.+...... .......||
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~t 239 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY---------------------------------------KADGNDAIP 239 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---------------------------------------C----CCBC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc---------------------------------------cccCCCccc
Confidence 99999999999999999999999865321100 001135789
Q ss_pred CCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-c
Q 038137 322 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 322 ~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-d 399 (549)
+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..+....+... ....+| ..+++++.+||.+||. |
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~ 316 (343)
T 1luf_A 240 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-NILACP--ENCPLELYNLMRLCWSKL 316 (343)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSS
T ss_pred ceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC-CcCCCC--CCCCHHHHHHHHHHcccC
Confidence 99999999999999999999999999999999 99999998887777766653 222334 3789999999999999 9
Q ss_pred ccccCCCCCHHHHHc
Q 038137 400 VEQRLGTKGADEIKA 414 (549)
Q Consensus 400 p~~Rl~~~~~~eil~ 414 (549)
|.+|+ ++.+|++
T Consensus 317 p~~Rp---s~~~~~~ 328 (343)
T 1luf_A 317 PADRP---SFCSIHR 328 (343)
T ss_dssp GGGSC---CHHHHHH
T ss_pred cccCC---CHHHHHH
Confidence 99999 7888875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=378.68 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=207.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...++|++++.||+|+||.||+|++..+++.||||++.+.........+.+.+|+.++..++||||+++++++.+++.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34688999999999999999999999999999999998765544555677999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998765321100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 191 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 230 (309)
T 2h34_A 191 ----------------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230 (309)
T ss_dssp ----------------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHH
Confidence 0114579999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|.+||.+.+.......+.. ...........+++++.+||.+||. ||.+|+. ++++++.
T Consensus 231 g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~--s~~~l~~ 289 (309)
T 2h34_A 231 GSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYV--TCGDLSA 289 (309)
T ss_dssp SSCSSCSCHHHHHHHHHHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCS--SHHHHHH
T ss_pred CCCCCCCchHHHHHHHhcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHH--hHHHHHH
Confidence 9999988765533333322 1111111224789999999999999 9999995 4777664
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=376.14 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=209.3
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCC-------cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeee
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATG-------HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCS 185 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 185 (549)
++..++|++.+.||+|+||.||+|+++.++ ..||+|++.+.. ....+.+.+|+.+|..++|||||+++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999998877 479999997643 3445678999999999999999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc--------E
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH--------M 256 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~--------v 256 (549)
+.+.+..|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999976554 999999999999999999999999999999999999999987 9
Q ss_pred EEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCC
Q 038137 257 KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGY 335 (549)
Q Consensus 257 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y 335 (549)
||+|||++...... ....||+.|+|||++.+ ..+
T Consensus 161 kl~Dfg~~~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~ 195 (289)
T 4fvq_A 161 KLSDPGISITVLPK---------------------------------------------DILQERIPWVPPECIENPKNL 195 (289)
T ss_dssp EECCCCSCTTTSCH---------------------------------------------HHHHHTTTTSCHHHHHCGGGC
T ss_pred eeccCcccccccCc---------------------------------------------cccCCcCcccCHHHhCCCCCC
Confidence 99999998754211 13468999999999988 779
Q ss_pred CcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 336 GMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+.++|||||||++|||++|..|+...........+.. ....+|. ..++++.+||.+||. ||.+|+ ++.++++
T Consensus 196 ~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~ 268 (289)
T 4fvq_A 196 NLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--DRHQLPA--PKAAELANLINNCMDYEPDHRP---SFRAIIR 268 (289)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TTCCCCC--CSSCTTHHHHHHHSCSSGGGSC---CHHHHHH
T ss_pred CchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--ccCCCCC--CCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 9999999999999999995544444433333333333 2333443 568899999999999 999998 8999986
Q ss_pred C
Q 038137 415 H 415 (549)
Q Consensus 415 H 415 (549)
|
T Consensus 269 ~ 269 (289)
T 4fvq_A 269 D 269 (289)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=379.74 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=204.2
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
+.....++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+..+..++..++||||+++++++.+.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 344567899999999999999999999999999999999976532 1222334455556788889999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKH-NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+||||+ ++.+..++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.+|++||+|||++..+.
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 6666666543 57899999999999999999999995 99999999999999999999999999987653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccch
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 343 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiWS 343 (549)
... .....+||+.|+|||++. +..|+.++||||
T Consensus 177 ~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 214 (318)
T 2dyl_A 177 DDK------------------------------------------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214 (318)
T ss_dssp ----------------------------------------------------CCTTCCHHHHC--------CCTHHHHHH
T ss_pred CCc------------------------------------------cccccCCCccccChhhcccccccccCCccccchhh
Confidence 210 001357999999999995 567899999999
Q ss_pred hhHHHHHHhhCCCCCCCC-CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 344 LGAIMYEMLVGYPPFYSD-EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~-~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
|||++|||++|..||... ........+... ....+|....+++++.+||.+||. ||.+|+ ++++|++||||++.
T Consensus 215 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP---KYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC---CHHHHTTSHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCc---CHHHHhhCHHHHhc
Confidence 999999999999999874 344455555542 233445445789999999999999 999999 89999999999865
Q ss_pred C
Q 038137 422 E 422 (549)
Q Consensus 422 ~ 422 (549)
+
T Consensus 291 ~ 291 (318)
T 2dyl_A 291 E 291 (318)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=374.84 Aligned_cols=255 Identities=21% Similarity=0.344 Sum_probs=221.2
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
...++..++|++.+.||+|+||.||+|.++.++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 456678889999999999999999999999999999999997542 3456788999999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
..+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999763 45999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 162 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 201 (288)
T 3kfa_A 162 TGDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201 (288)
T ss_dssp CSSSSE----------------------------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cCCccc----------------------------------------cccCCccccCcCChhhhccCCCCchhhHHHHHHH
Confidence 422100 0113568899999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|+|++ |.+||.+.+.......+... ...+....+++++.+||.+||. ||.+|+ ++.++++
T Consensus 202 l~~ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~~~ 264 (288)
T 3kfa_A 202 LWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 264 (288)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhcc---CCCCCCCCCCHHHHHHHHHHhCCChhhCc---CHHHHHH
Confidence 999999 99999988777666655432 2223334789999999999999 999999 7888875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=374.34 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=206.8
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
...+..++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|..++..++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3456678999999999999999999998654 5579999987542 2344567889999999999999999999985
Q ss_pred CCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
++.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 46789999999999999999764 4799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
....... ......||+.|+|||++.+..|+.++|||||||
T Consensus 166 ~~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (281)
T 1mp8_A 166 MEDSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205 (281)
T ss_dssp -----------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred cCccccc----------------------------------------ccccCCCcccccChhhcccCCCCCccCchHHHH
Confidence 5421100 011346788999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 347 IMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 347 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++|||++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+|+ ++.++++
T Consensus 206 ~l~ell~~g~~pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 269 (281)
T 1mp8_A 206 CMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKA 269 (281)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHhcCCCCCCcCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 9999996 99999988877777777653 223333 4789999999999999 999999 7988876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.13 Aligned_cols=259 Identities=19% Similarity=0.225 Sum_probs=210.7
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCce
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 191 (549)
.+..++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|..++..+ +|++|+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4557889999999999999999999999999999999875432 23477899999998 79999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc-----EEEeecCccc
Q 038137 192 LYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH-----MKLSDFGLCK 265 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~-----vKL~DFGlak 265 (549)
.|+||||+ ||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|. +||+|||+|+
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 99999999764 46999999999999999999999999999999999999988776 9999999998
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlG 345 (549)
........... + .......+||+.|+|||++.+..++.++||||||
T Consensus 160 ~~~~~~~~~~~-------------------~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 205 (298)
T 1csn_A 160 FYRDPVTKQHI-------------------P---------------YREKKNLSGTARYMSINTHLGREQSRRDDLEALG 205 (298)
T ss_dssp ESBCTTTCCBC-------------------C---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred ccccccccccc-------------------c---------------ccCccCCCCCcccCCchhhcCCCCChHHHHHHHH
Confidence 76432110000 0 0001256899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCCch---hhhhhhhhccccccCCC-CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 346 AIMYEMLVGYPPFYSDEPM---STCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~---~~~~~I~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++|||++|.+||.+.+.. ..+..+.........+. ...+++++.+||.+||. ||.+|+ ++++|++
T Consensus 206 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP---~~~~l~~ 276 (298)
T 1csn_A 206 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP---DYDYLQG 276 (298)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC---CHHHHHH
T ss_pred HHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCC---CHHHHHH
Confidence 9999999999999885432 33333332211111111 13689999999999999 999999 6777653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=388.92 Aligned_cols=259 Identities=20% Similarity=0.347 Sum_probs=220.5
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKAT-------GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVK 181 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-------g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~ 181 (549)
.+..+..++|.+.+.||+|+||.||+|++..+ +..||||++.... .......+.+|+.++..+ +|||||+
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 44567778999999999999999999997543 3579999997652 344557789999999999 9999999
Q ss_pred eeeeecCCceEEEEEeecCCCchhhHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCC
Q 038137 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD----------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKP 245 (549)
Q Consensus 182 l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKP 245 (549)
++++|.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.|||||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999997643 499999999999999999999999999999999
Q ss_pred CCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCC
Q 038137 246 DNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYI 325 (549)
Q Consensus 246 eNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~ 325 (549)
+||||+.+|.+||+|||+|+.+....... ......||+.|+
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~ 260 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWM 260 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTC---------------------------------------CCTTCCCGGGGS
T ss_pred ceEEEcCCCcEEEcccCcccccccccccc---------------------------------------cccCCCCCccee
Confidence 99999999999999999998654221000 011346889999
Q ss_pred CchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-ccccc
Q 038137 326 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 326 APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+|
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~R 337 (382)
T 3tt0_A 261 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDCWHAVPSQR 337 (382)
T ss_dssp CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--SSCCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999999999999999999 99999988877766666542 223333 4789999999999999 99999
Q ss_pred CCCCCHHHHHcC
Q 038137 404 LGTKGADEIKAH 415 (549)
Q Consensus 404 l~~~~~~eil~H 415 (549)
+ ++.||++|
T Consensus 338 p---s~~ell~~ 346 (382)
T 3tt0_A 338 P---TFKQLVED 346 (382)
T ss_dssp C---CHHHHHHH
T ss_pred c---CHHHHHHH
Confidence 9 89999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=393.57 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=217.3
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
..+..++|++.+.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+|+.++|||||++++++.+.+.
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 4566788999999999999999999999999999999987542 23344568899999999999999999999999999
Q ss_pred EEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999999765 46999999999999999999999999999999999999999999999999999864321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... ......+|+.|+|||++.+..|+.++|||||||++||
T Consensus 267 ~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~e 307 (377)
T 3cbl_A 267 VYAA---------------------------------------SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307 (377)
T ss_dssp EEEC---------------------------------------CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred ceee---------------------------------------cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHH
Confidence 1000 0002346778999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++ |.+||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+|+ ++++|+.
T Consensus 308 l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~ 367 (377)
T 3cbl_A 308 TFSLGASPYPNLSNQQTREFVEKG-GRLPCP--ELCPDAVFRLMEQCWAYEPGQRP---SFSTIYQ 367 (377)
T ss_dssp HHTTSCCSSTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCchhCc---CHHHHHH
Confidence 998 99999988776666555432 233344 4789999999999999 999999 7888874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=369.95 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=211.4
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhh----HHHHHHHHHHHHhcCCCceeeeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ----VEHVKAERNLLAEVDSNCIVKLYCSF 186 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~----~~~~~~E~~iL~~l~hp~Iv~l~~~f 186 (549)
...+..++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|+.++..++||||+++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 34567899999999999999999999999999999999997654322221 26788999999999999999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEcCCCc-----EEE
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDRNGH-----MKL 258 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld~~g~-----vKL 258 (549)
.+.. |+||||++||+|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 8776 6999999999998887554 57999999999999999999999999 999999999999998887 999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc--cCCCC
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL--KKGYG 336 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~--~~~y~ 336 (549)
+|||+++..... ....+||+.|+|||++. ...|+
T Consensus 171 ~Dfg~~~~~~~~--------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~ 206 (287)
T 4f0f_A 171 ADFGLSQQSVHS--------------------------------------------VSGLLGNFQWMAPETIGAEEESYT 206 (287)
T ss_dssp CCCTTCBCCSSC--------------------------------------------EECCCCCCTTSCGGGSSCSSCEEC
T ss_pred CCCCcccccccc--------------------------------------------ccccCCCccccCchhhccCCCCcC
Confidence 999998753211 11468999999999994 45689
Q ss_pred cccccchhhHHHHHHhhCCCCCCCCCchhh--hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 337 MECDWWSLGAIMYEMLVGYPPFYSDEPMST--CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~G~~PF~~~~~~~~--~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
.++|||||||++|||++|.+||...+.... ...+........+| ..+++++.+||.+||. ||.+|+ ++++|+
T Consensus 207 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll 281 (287)
T 4f0f_A 207 EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP--EDCPPRLRNVIELCWSGDPKKRP---HFSYIV 281 (287)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred chhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHhcCChhhCc---CHHHHH
Confidence 999999999999999999999987654433 33333322223333 4789999999999999 999999 798887
Q ss_pred c
Q 038137 414 A 414 (549)
Q Consensus 414 ~ 414 (549)
+
T Consensus 282 ~ 282 (287)
T 4f0f_A 282 K 282 (287)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=377.76 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=219.2
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCRE-----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYC 184 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 184 (549)
...+..++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+|..+ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3456678999999999999999999985 4578899999997653 223456789999999999 9999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKD------------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPD 246 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPe 246 (549)
+|.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999997643 4899999999999999999999999999999999
Q ss_pred CeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCC
Q 038137 247 NLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIA 326 (549)
Q Consensus 247 NILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~A 326 (549)
|||++.+|.+||+|||+++........ .......||+.|+|
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~a 215 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNY---------------------------------------VVKGNARLPVKWMA 215 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTS---------------------------------------EECSSSEECGGGCC
T ss_pred eEEEcCCCCEEEccccccccccccccc---------------------------------------eeccCCCCcceeeC
Confidence 999999999999999999876422100 00113568899999
Q ss_pred chhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccC
Q 038137 327 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 327 PEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
||++.+..++.++|||||||++|||++ |.+||.+.........++... ...+....+++++.+||.+||. ||.+|+
T Consensus 216 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG--FRMLSPEHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC--CCCCCcccCCHHHHHHHHHHcCCCchhCc
Confidence 999999999999999999999999998 999998877666665555432 2223334789999999999999 999999
Q ss_pred CCCCHHHHHcC
Q 038137 405 GTKGADEIKAH 415 (549)
Q Consensus 405 ~~~~~~eil~H 415 (549)
++.||+++
T Consensus 294 ---s~~ell~~ 301 (313)
T 1t46_A 294 ---TFKQIVQL 301 (313)
T ss_dssp ---CHHHHHHH
T ss_pred ---CHHHHHHH
Confidence 79998864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=368.36 Aligned_cols=249 Identities=17% Similarity=0.246 Sum_probs=215.6
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC--
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD-- 189 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-- 189 (549)
..+..++|++++.||+|+||.||+|++. |..||+|++..... .....+.+.+|+.+|..++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567789999999999999999999985 88999999976532 334456789999999999999999999999887
Q ss_pred ceEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
..+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999997755 5999999999999999999999999 9999999999999999999999999865
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCc---ccccc
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM---ECDWW 342 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~---~~DiW 342 (549)
.... ...+||+.|+|||++.+..++. ++|||
T Consensus 162 ~~~~----------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~ 195 (271)
T 3kmu_A 162 SFQS----------------------------------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMW 195 (271)
T ss_dssp TTSC----------------------------------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHH
T ss_pred eecc----------------------------------------------cCccCCccccChhhhccCCCCCCCchhhHH
Confidence 4321 1357999999999998766554 79999
Q ss_pred hhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||||++|||++|.+||.+.+.......+........+| ..+++++.+||.+||. ||.+|+ +++++++
T Consensus 196 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~ 263 (271)
T 3kmu_A 196 SFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP--PGISPHVSKLMKICMNEDPAKRP---KFDMIVP 263 (271)
T ss_dssp HHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 99999999999999999888877777776543344444 4789999999999999 999999 7888875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=382.43 Aligned_cols=254 Identities=20% Similarity=0.347 Sum_probs=206.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEE----EEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVY----AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~v----AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
+..++|++++.||+|+||.||+|++..+|+.+ |+|.+.... .......+.+|+.+|+.++|||||+++++|.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 55688999999999999999999998888765 666665432 233456789999999999999999999999876
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
. .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999976 4679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..... .......||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~~---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3poz_A 169 AEEKE---------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp TTCC----------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCccc---------------------------------------ccccCCCccccccChHHhccCCCCchhhhhhhHHHH
Confidence 22100 001134678899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||++ |.+||.+.+.......+.. .. ..+....++.++.+||.+||+ ||.+|+ ++.+++.|
T Consensus 210 ~ellt~g~~p~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~ell~~ 272 (327)
T 3poz_A 210 WELMTFGSKPYDGIPASEISSILEK-GE--RLPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIE 272 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHT-TC--CCCCCTTBCHHHHHHHHHHTCSCGGGSC---CHHHHHHH
T ss_pred HHHHhcCCCCccCCCHHHHHHHHHc-CC--CCCCCccCCHHHHHHHHHHcCCChhhCC---CHHHHHHH
Confidence 99999 9999988777665554443 22 233334789999999999999 999999 79999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=379.03 Aligned_cols=265 Identities=27% Similarity=0.470 Sum_probs=216.4
Q ss_pred hhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC--CCceeeeeeee
Q 038137 109 LQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD--SNCIVKLYCSF 186 (549)
Q Consensus 109 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f 186 (549)
.+...+..++|++++.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+|..+. ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4455677788999999999999999999985 589999999976532 3345677899999999997 59999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.+...+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++.
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 99999999999 56899999998888999999999999999999999999999999999999996 58999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----------CCC
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----------KGY 335 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----------~~y 335 (549)
+...... ......+||+.|+|||++.+ ..+
T Consensus 176 ~~~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 216 (313)
T 3cek_A 176 MQPDTTS---------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216 (313)
T ss_dssp -----------------------------------------------------CCGGGCCHHHHTTCC----------CC
T ss_pred ccCcccc---------------------------------------ccccCCCCCCCcCCHHHHhhcccccccccccccC
Confidence 5321100 00114579999999999976 478
Q ss_pred CcccccchhhHHHHHHhhCCCCCCCCCc-hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 336 GMECDWWSLGAIMYEMLVGYPPFYSDEP-MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~G~~PF~~~~~-~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
+.++|||||||++|||++|..||..... ......++.......+|. ..++++.+||.+||. ||.+|+ ++.|++
T Consensus 217 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rp---s~~ell 291 (313)
T 3cek_A 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRI---SIPELL 291 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSC---CHHHHH
T ss_pred CchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc--cchHHHHHHHHHHccCCcccCc---CHHHHh
Confidence 9999999999999999999999976543 233444444333334443 568899999999999 999999 899999
Q ss_pred cCCcccCC
Q 038137 414 AHPWFKGI 421 (549)
Q Consensus 414 ~HpfF~~i 421 (549)
+||||+..
T Consensus 292 ~h~~~~~~ 299 (313)
T 3cek_A 292 AHPYVQIQ 299 (313)
T ss_dssp TSHHHHCC
T ss_pred cCccccCC
Confidence 99999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=403.02 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=203.3
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
..+...+|.+.++||+|+||+|+. ....+|+.||||++.+... ..+.+|+.+|..+ +|||||++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 345566799999999999999764 4567899999999976432 1256799999998 7999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---C--CcEEEeecCcc
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---N--GHMKLSDFGLC 264 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~--g~vKL~DFGla 264 (549)
.+|+|||||. |+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++. + ..+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999995 69999986643 5667778899999999999999999999999999999953 3 35889999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCccccc
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDW 341 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~Di 341 (549)
+.+....... ......+||+.|+|||++. ...++.++||
T Consensus 171 ~~~~~~~~~~--------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Di 212 (432)
T 3p23_A 171 KKLAVGRHSF--------------------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI 212 (432)
T ss_dssp ECC--------------------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHH
T ss_pred eeccCCCcce--------------------------------------eeccccCCCcCccChhhhhcccccCCCcHHHH
Confidence 8764221000 0012468999999999998 4667889999
Q ss_pred chhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 342 WSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 342 WSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
|||||++|||++ |.+||.......... +.........+.....+..+++||.+||+ ||.+|+ ++++|++||||.
T Consensus 213 wSlG~il~ellt~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---s~~evl~hp~f~ 288 (432)
T 3p23_A 213 FSAGCVFYYVISEGSHPFGKSLQRQANI-LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAKHVLKHPFFW 288 (432)
T ss_dssp HHHHHHHHHHHTTSCBTTBSTTTHHHHH-HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSC---CHHHHHTSTTTC
T ss_pred HHHHHHHHHHHcCCCCCcchhhHHHHHH-HhccCCccccCccccccHHHHHHHHHHHhCCHhhCC---CHHHHHhCcccc
Confidence 999999999999 999996654433222 22111111111122456779999999999 999999 899999999999
Q ss_pred CCCc
Q 038137 420 GIEW 423 (549)
Q Consensus 420 ~i~w 423 (549)
+++|
T Consensus 289 ~~~~ 292 (432)
T 3p23_A 289 SLEK 292 (432)
T ss_dssp CHHH
T ss_pred ChHH
Confidence 9988
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=377.72 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=216.0
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCRE-----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCS 185 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 185 (549)
..+..++|++.+.||+|+||.||+|++ ..+++.||||++.+.. .......+.+|+.+|..+ +||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 356678999999999999999999985 3577899999997653 233456788999999999 78999999999
Q ss_pred ecCCc-eEEEEEeecCCCchhhHhhhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 186 FQDDE-YLYLIMEYLPGGDMMTLLMRKDT----------------LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 186 f~d~~-~lylVmEy~~gg~L~~~l~~~~~----------------l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
|.+.+ .+|+||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 88654 59999999999999999976543 89999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
|++.+|++||+|||+++.+...... .......||+.|+|||
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aPE 220 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMAPE 220 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTS---------------------------------------EEETTEEECGGGCCHH
T ss_pred EECCCCCEEECCCccccccccCccc---------------------------------------eeccCCCcceeecCch
Confidence 9999999999999999865321100 0011457899999999
Q ss_pred hhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 329 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 329 vl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
++.+..|+.++|||||||++|||++ |.+||.+..........+........| ..+++++.+||.+||. ||.+|+
T Consensus 221 ~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp-- 296 (316)
T 2xir_A 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP-- 296 (316)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC--
T ss_pred hhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC--CCCCHHHHHHHHHHcCCChhhCc--
Confidence 9999999999999999999999998 999998877555544444333333344 3689999999999999 999999
Q ss_pred CCHHHHHcC
Q 038137 407 KGADEIKAH 415 (549)
Q Consensus 407 ~~~~eil~H 415 (549)
++.+|++|
T Consensus 297 -s~~ell~~ 304 (316)
T 2xir_A 297 -TFSELVEH 304 (316)
T ss_dssp -CHHHHHHH
T ss_pred -CHHHHHHH
Confidence 89999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=378.58 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=219.0
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCc-----EEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGH-----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYC 184 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~-----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 184 (549)
...+..++|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+|..+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 456778899999999999999999999987664 79999997643 233456789999999999 8999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRK--------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL 250 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl 250 (549)
+|.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999998653 368999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhh
Q 038137 251 DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL 330 (549)
Q Consensus 251 d~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl 330 (549)
+.+|++||+|||+++........ .......||+.|+|||++
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY---------------------------------------IVKGNARLPVKWMAPESI 238 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS---------------------------------------EECSSCEECGGGSCHHHH
T ss_pred CCCCeEEECccccccccccccce---------------------------------------eecCCCCCCccccCHHHh
Confidence 99999999999999865321100 001135688999999999
Q ss_pred ccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 331 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 331 ~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
.+..|+.++|||||||++|||++ |.+||.+.........++........| ..+++++.+||.+||. ||.+|+ +
T Consensus 239 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s 313 (333)
T 2i1m_A 239 FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP--AFAPKNIYSIMQACWALEPTHRP---T 313 (333)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---C
T ss_pred ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCc---C
Confidence 99999999999999999999998 999999877666666665533333333 4679999999999999 999999 7
Q ss_pred HHHHHc
Q 038137 409 ADEIKA 414 (549)
Q Consensus 409 ~~eil~ 414 (549)
+.+|++
T Consensus 314 ~~~l~~ 319 (333)
T 2i1m_A 314 FQQICS 319 (333)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999886
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=378.74 Aligned_cols=253 Identities=30% Similarity=0.507 Sum_probs=206.7
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHhc----CCCceeeeeeee
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR---GQVEHVKAERNLLAEV----DSNCIVKLYCSF 186 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l----~hp~Iv~l~~~f 186 (549)
...++|++.+.||+|+||.||+|+++.+|+.||||++........ .....+.+|+.++..+ +||||++++++|
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 346789999999999999999999999999999999976543221 1223356788899888 899999999999
Q ss_pred cCCceEEEEEee-cCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc-CCCcEEEeecCcc
Q 038137 187 QDDEYLYLIMEY-LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD-RNGHMKLSDFGLC 264 (549)
Q Consensus 187 ~d~~~lylVmEy-~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld-~~g~vKL~DFGla 264 (549)
.+.+..|+|||| +.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .+|.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 78999999998888999999999999999999999999999999999999999 8999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-Ccccccch
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWS 343 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWS 343 (549)
+...... ....+||+.|+|||++.+..+ +.++||||
T Consensus 188 ~~~~~~~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 224 (312)
T 2iwi_A 188 ALLHDEP-------------------------------------------YTDFDGTRVYSPPEWISRHQYHALPATVWS 224 (312)
T ss_dssp EECCSSC-------------------------------------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHH
T ss_pred hhcccCc-------------------------------------------ccccCCcccccCceeeecCCCCCccchHHH
Confidence 8654211 114579999999999987776 45899999
Q ss_pred hhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
|||++|||++|+.||.... .+.. ....+|. .+++++++||.+||. ||.+|+ +++|+++||||+...
T Consensus 225 lG~il~~l~~g~~pf~~~~------~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp---s~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 225 LGILLYDMVCGDIPFERDQ------EILE--AELHFPA--HVSPDCCALIRRCLAPKPSSRP---SLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHHHHSSCSCCSHH------HHHH--TCCCCCT--TSCHHHHHHHHHHTCSSTTTSC---CHHHHHHSTTTCC--
T ss_pred HHHHHHHHHHCCCCCCChH------HHhh--hccCCcc--cCCHHHHHHHHHHccCChhhCc---CHHHHhcChhhcCch
Confidence 9999999999999996532 2332 2334443 689999999999999 999999 899999999998653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=379.77 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=213.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEE--EEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVY--AMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~v--AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
+..++|++.+.||+|+||.||+|+++.+|..+ |+|.+.... .......+.+|+.+|..+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55688999999999999999999999999866 999987532 233455688999999999 9999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKD----------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG 254 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g 254 (549)
.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997653 799999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~ 334 (549)
.+||+|||+++...... ......+|+.|+|||++.+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp CEEECCTTCEESSCEEC------------------------------------------CC----CCTTTCCHHHHHHCE
T ss_pred eEEEcccCcCccccccc------------------------------------------cccCCCCCccccChhhhcccc
Confidence 99999999987432110 001346889999999999999
Q ss_pred CCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 335 YGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
|+.++|||||||++|||++ |.+||.+.+.......+... ...+....+++++.+||.+||+ ||.+|+ +++++
T Consensus 218 ~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~el 291 (327)
T 1fvr_A 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERP---SFAQI 291 (327)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT---CCCCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC---CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHH
Confidence 9999999999999999998 99999998877777666542 2222234789999999999999 999999 89999
Q ss_pred HcC
Q 038137 413 KAH 415 (549)
Q Consensus 413 l~H 415 (549)
+.|
T Consensus 292 l~~ 294 (327)
T 1fvr_A 292 LVS 294 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=365.51 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=216.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.+..++|++++.||+|+||.||+|.+. ++..||+|++.+... ..+.+.+|..++..++||||+++++++.+.+.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 456788999999999999999999986 677899999986542 235688999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999999999764 569999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
. .......||+.|+|||++.+..++.++|+|||||++|+|
T Consensus 159 ~----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 198 (267)
T 3t9t_A 159 Y----------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEV 198 (267)
T ss_dssp H----------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred c----------------------------------------cccccccccccccChhhhcCCCccchhchhhhHHHHHHH
Confidence 0 001134688899999999999999999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
++ |.+||.+.+.......+.... ....| ..+++++.+||.+||. ||.+|+ ++.+++++
T Consensus 199 ~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~~ 258 (267)
T 3t9t_A 199 FSEGKIPYENRSNSEVVEDISTGF-RLYKP--RLASTHVYQIMNHCWRERPEDRP---AFSRLLRQ 258 (267)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hccCCCCCCCCCHHHHHHHHhcCC-cCCCC--ccCcHHHHHHHHHHccCChhhCc---CHHHHHHH
Confidence 99 999999888777777766531 22222 3679999999999999 999999 79998863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=373.11 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=206.8
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~----~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
.+..++|++++.||+|+||.||+|+ +..+|+.||||++... .....+.+.+|+.+|..++||||++++++|.+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567889999999999999999998 5678999999999754 23445678899999999999999999998854
Q ss_pred --CceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 189 --DEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 189 --~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
...+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 45699999999999999999764 459999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlG 345 (549)
......... .......||+.|+|||++.+..|+.++||||||
T Consensus 163 ~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 204 (295)
T 3ugc_A 163 VLPQDKEFF--------------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFG 204 (295)
T ss_dssp ---------------------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred cccCCccee--------------------------------------eeccCCCCccceeCcHHhcCCCCChHHHHHHHH
Confidence 754221000 001134688889999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCCchh---------------hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCH
Q 038137 346 AIMYEMLVGYPPFYSDEPMS---------------TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA 409 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~---------------~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 409 (549)
|++|||++|..||....... .....+. .....|....+++++.+||.+||. ||.+|+ ++
T Consensus 205 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~ 279 (295)
T 3ugc_A 205 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK--NNGRLPRPDGCPDEIYMIMTECWNNNVNQRP---SF 279 (295)
T ss_dssp HHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC---CH
T ss_pred HHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh--ccCcCCCCcCcCHHHHHHHHHHcCCChhhCC---CH
Confidence 99999999999986532110 0011111 122333345789999999999999 999999 78
Q ss_pred HHHHc
Q 038137 410 DEIKA 414 (549)
Q Consensus 410 ~eil~ 414 (549)
.|+++
T Consensus 280 ~el~~ 284 (295)
T 3ugc_A 280 RDLAL 284 (295)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=387.29 Aligned_cols=257 Identities=19% Similarity=0.327 Sum_probs=207.7
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREK---ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
.++..++|++.+.||+|+||.||+|+++ .++..||||++.... .....+.+.+|+.+|..++|||||++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 4566789999999999999999999987 467789999997542 33455678999999999999999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999765 47999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
....... .......||+.|+|||++.+..|+.++|||||||+
T Consensus 198 ~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~i 239 (373)
T 2qol_A 198 EDDPEAA--------------------------------------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239 (373)
T ss_dssp ------------------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred ccCCccc--------------------------------------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHH
Confidence 4211000 00112356889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|||++ |..||.+.+.......+.. ....|....++.++.+||.+||. ||.+|+ ++.+|++
T Consensus 240 l~ellt~g~~P~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~i~~ 302 (373)
T 2qol_A 240 LWEVMSYGERPYWEMSNQDVIKAVDE---GYRLPPPMDCPAALYQLMLDCWQKDRNNRP---KFEQIVS 302 (373)
T ss_dssp HHHHHTTC-CTTTTCCHHHHHHHHHT---TEECCCCTTCBHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCccccHHHHHHHHHHhCcChhhCc---CHHHHHH
Confidence 999997 9999998887776666654 23344445789999999999999 999999 7888875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=378.08 Aligned_cols=254 Identities=20% Similarity=0.341 Sum_probs=208.2
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEE----EEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVY----AMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~v----AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
.+..++|++++.||+|+||.||+|++..+++.| |+|.+.... .......+.+|+.+|..++||||++++++|.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 356789999999999999999999999888766 555554321 23455778999999999999999999999987
Q ss_pred CceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
.. .++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 65 8899999999999999976 467999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
...... .......||+.|+|||++.+..|+.++|||||||+
T Consensus 168 ~~~~~~---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 208 (327)
T 3lzb_A 168 GAEEKE---------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVT 208 (327)
T ss_dssp ---------------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cCcccc---------------------------------------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHH
Confidence 422100 00113467889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|||++ |.+||.+.+.......+... . ..+....+++++.+||.+||. ||.+|+ ++.|++.
T Consensus 209 l~ell~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 271 (327)
T 3lzb_A 209 VWELMTFGSKPYDGIPASEISSILEKG-E--RLPQPPICTIDVYMIMRKCWMIDADSRP---KFRELII 271 (327)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTT-C--CCCCCTTBCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHcC-C--CCCCCccCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999 99999988776665555432 2 333334789999999999999 999999 7999886
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=377.14 Aligned_cols=259 Identities=21% Similarity=0.353 Sum_probs=217.8
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREK-------ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVK 181 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~ 181 (549)
....+..++|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+|..+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 344567789999999999999999999985 467899999997543 334556788999999999 8999999
Q ss_pred eeeeecCCceEEEEEeecCCCchhhHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCC
Q 038137 182 LYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD----------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKP 245 (549)
Q Consensus 182 l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKP 245 (549)
++++|.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999997643 389999999999999999999999999999999
Q ss_pred CCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCC
Q 038137 246 DNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYI 325 (549)
Q Consensus 246 eNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~ 325 (549)
+|||++.+|++||+|||+++......... ......||+.|+
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~ 226 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYK---------------------------------------KTTNGRLPVKWM 226 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEE---------------------------------------CCSCCCCCGGGC
T ss_pred ceEEEcCCCCEEEcccccccccccccccc---------------------------------------ccCCCCccccee
Confidence 99999999999999999998654221000 011346788999
Q ss_pred CchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-ccccc
Q 038137 326 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403 (549)
Q Consensus 326 APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~R 403 (549)
|||++.+..|+.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+|
T Consensus 227 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~R 303 (334)
T 2pvf_A 227 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHAVPSQR 303 (334)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGS
T ss_pred ChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC-CCCCCC--ccCCHHHHHHHHHHccCChhhC
Confidence 9999999999999999999999999999 99999988777766666543 222333 4789999999999999 99999
Q ss_pred CCCCCHHHHHcC
Q 038137 404 LGTKGADEIKAH 415 (549)
Q Consensus 404 l~~~~~~eil~H 415 (549)
+ ++.+|+++
T Consensus 304 p---s~~ell~~ 312 (334)
T 2pvf_A 304 P---TFKQLVED 312 (334)
T ss_dssp C---CHHHHHHH
T ss_pred c---CHHHHHHH
Confidence 9 79998864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=369.56 Aligned_cols=255 Identities=29% Similarity=0.499 Sum_probs=204.4
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.++..++||||++++++|.+.+.+|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34578999999999999999999999999999999998755555556677899999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 194 LIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999854 46799999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
... .....+||+.|+|||++.+..++.++|+|||||++|
T Consensus 189 ~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 227 (310)
T 2wqm_A 189 KTT-----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227 (310)
T ss_dssp ---------------------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CCc-----------------------------------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHH
Confidence 100 011457999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCc--hhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 350 EMLVGYPPFYSDEP--MSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 350 Eml~G~~PF~~~~~--~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|++|..||.+... ......+... .....+ ...+++++.+||.+||. ||.+|+ ++.+|+.
T Consensus 228 ~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp---s~~~il~ 290 (310)
T 2wqm_A 228 EMAALQSPFYGDKMNLYSLCKKIEQC-DYPPLP-SDHYSEELRQLVNMCINPDPEKRP---DVTYVYD 290 (310)
T ss_dssp HHHHSSCTTC---CCHHHHHHHHHTT-CSCCCC-TTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHhCCCCCcccchhHHHHHHHhhcc-cCCCCc-ccccCHHHHHHHHHHcCCChhhCC---CHHHHHH
Confidence 99999999987542 2333333332 111111 24689999999999999 999999 7998885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=392.27 Aligned_cols=248 Identities=17% Similarity=0.255 Sum_probs=196.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHhcC-------------
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-----RRGQVEHVKAERNLLAEVD------------- 175 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~------------- 175 (549)
+..++|++++.||+|+||+||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3456799999999999999999997 7899999999875421 2334467889999998886
Q ss_pred -------------CCceeeeeeeecC-------------CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHH
Q 038137 176 -------------SNCIVKLYCSFQD-------------DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229 (549)
Q Consensus 176 -------------hp~Iv~l~~~f~d-------------~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~a 229 (549)
|||||+++++|.+ ...+|||||||+||++...+.+ ..+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 5666666666664 7899999999999987777744 679999999999999999
Q ss_pred HHHHH-hCCeeecCCCCCCeEEcCCC--------------------cEEEeecCcccccCCCCcccccccccCCCcCCcc
Q 038137 230 IESIH-KHNYIHRDIKPDNLLLDRNG--------------------HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288 (549)
Q Consensus 230 L~~LH-~~giiHRDLKPeNILld~~g--------------------~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~ 288 (549)
|.||| ++|||||||||+||||+.+| ++||+|||+|+.....
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------ 235 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------ 235 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------------
Confidence 99999 99999999999999999988 9999999999865311
Q ss_pred CCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH-HHHHhhCCCCCCCCCc-hhh
Q 038137 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI-MYEMLVGYPPFYSDEP-MST 366 (549)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi-lyEml~G~~PF~~~~~-~~~ 366 (549)
..+||+.|||||++.+.. +.++||||||++ .++++.|.+||.+... ...
T Consensus 236 ----------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~ 286 (336)
T 2vuw_A 236 ----------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYL 286 (336)
T ss_dssp ----------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHH
T ss_pred ----------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHH
Confidence 358999999999998776 899999998777 8889999999954211 112
Q ss_pred hhhhhh---ccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH-cCCccc
Q 038137 367 CRKIVN---WRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK-AHPWFK 419 (549)
Q Consensus 367 ~~~I~~---~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil-~HpfF~ 419 (549)
...+.. +......+....+|++++|||.+||+ | +|+|++ +||||+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--------sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 287 TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--------SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--------SHHHHHHHCGGGC
T ss_pred HHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--------CHHHHHhcCCCcC
Confidence 223331 11111111123578999999999997 4 699999 999995
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=399.33 Aligned_cols=254 Identities=21% Similarity=0.348 Sum_probs=219.0
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
..++..++|++.+.||+|+||.||+|.++.++..||||++.... ...+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34566788999999999999999999999999999999997643 23567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|||||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999753 469999999999999999999999999999999999999999999999999998754
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..... ......||+.|+|||++.+..|+.++|||||||+|
T Consensus 370 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l 409 (495)
T 1opk_A 370 GDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409 (495)
T ss_dssp TCCEE----------------------------------------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHH
Confidence 21100 00134578899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||.+.+.......+.. ....+.+..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 410 ~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~el~~ 471 (495)
T 1opk_A 410 WEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 471 (495)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcCcChhHCc---CHHHHHH
Confidence 99999 9999998887766665543 22333334789999999999999 999999 7888875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=365.71 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=212.9
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKA---TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
..+..++|++.+.||+|+||.||+|.+.. ++..||+|++.+.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 35667899999999999999999998754 34579999997653 23345678999999999999999999999876
Q ss_pred CceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+ ..|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 5 568999999999999999664 46999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 164 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 203 (281)
T 3cc6_A 164 EDEDYY----------------------------------------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVC 203 (281)
T ss_dssp -------------------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cccccc----------------------------------------ccccCCCCcceeCchhhccCCCCchhccHHHHHH
Confidence 421100 0113467889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
+|||++ |.+||...+.......+... ..... ...+++.+.+||.+||. ||.+|+ ++.|+++|
T Consensus 204 l~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~~ 267 (281)
T 3cc6_A 204 MWEILSFGKQPFFWLENKDVIGVLEKG-DRLPK--PDLCPPVLYTLMTRCWDYDPSDRP---RFTELVCS 267 (281)
T ss_dssp HHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHhCCCCCcccCChHHHHHHHhcC-CCCCC--CCCCCHHHHHHHHHHccCCchhCc---CHHHHHHH
Confidence 999998 99999887776666555542 22333 34789999999999999 999999 79998864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=375.06 Aligned_cols=259 Identities=22% Similarity=0.299 Sum_probs=211.4
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
......++|++.+.||+|+||.||+|.++ +|+.||||++.... ....+.+.+|+.+|..++|||||+++++|.+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34456789999999999999999999964 68999999987542 344567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKD----TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999986543 599999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
....... ......+||+.|+|||++.+..|+.++|||||||
T Consensus 189 ~~~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 229 (321)
T 2qkw_B 189 GTELDQT---------------------------------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229 (321)
T ss_dssp CSSSSCC---------------------------------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHH
T ss_pred ccccccc---------------------------------------ccccccCCCccccCHHHhcCCCCCcccchHhHHH
Confidence 4321100 0011457999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhh-----hcccc--------ccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIV-----NWRTH--------LKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~-----~~~~~--------l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
++|||++|++||.+..+......+. ..... +........+..+.+||.+||. ||.+|+ ++.|+
T Consensus 230 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~el 306 (321)
T 2qkw_B 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP---SMGDV 306 (321)
T ss_dssp HHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred HHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc---CHHHH
Confidence 9999999999998765543322110 00000 0001112345678999999999 999999 89999
Q ss_pred HcC
Q 038137 413 KAH 415 (549)
Q Consensus 413 l~H 415 (549)
+.|
T Consensus 307 l~~ 309 (321)
T 2qkw_B 307 LWK 309 (321)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=377.58 Aligned_cols=260 Identities=18% Similarity=0.292 Sum_probs=215.2
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCR-----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~-----~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
.+..++|++++.||+|+||.||+|+ +..++..||||++.... .......+.+|+.++..++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4667899999999999999999999 56788999999996432 2334567889999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC---CcEE
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK-------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN---GHMK 257 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~---g~vK 257 (549)
+...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999999764 349999999999999999999999999999999999999954 4699
Q ss_pred EeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCc
Q 038137 258 LSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGM 337 (549)
Q Consensus 258 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~ 337 (549)
|+|||+++........ ......+||+.|+|||++.+..|+.
T Consensus 184 l~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 224 (327)
T 2yfx_A 184 IGDFGMARDIYRASYY---------------------------------------RKGGCAMLPVKWMPPEAFMEGIFTS 224 (327)
T ss_dssp ECCCHHHHHHHC---------------------------------------------CCGGGSCGGGCCHHHHHHCCCCH
T ss_pred ECcccccccccccccc---------------------------------------ccCCCcCCCcceeCHhHhcCCCCCc
Confidence 9999998754321100 0011457899999999999999999
Q ss_pred ccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 338 ECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 338 ~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
++|||||||++|+|++ |.+||.+.+.......+... .....| ..+++.+.+||.+||. ||.+|+ ++.+|++|
T Consensus 225 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 298 (327)
T 2yfx_A 225 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPP--KNCPGPVYRIMTQCWQHQPEDRP---NFAIILER 298 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHhcCChhhCc---CHHHHHHH
Confidence 9999999999999998 99999988777666666543 222233 4789999999999999 999999 89999999
Q ss_pred Cccc
Q 038137 416 PWFK 419 (549)
Q Consensus 416 pfF~ 419 (549)
.|+-
T Consensus 299 l~~~ 302 (327)
T 2yfx_A 299 IEYC 302 (327)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=365.83 Aligned_cols=257 Identities=24% Similarity=0.355 Sum_probs=216.3
Q ss_pred cCCCCCeeeee-eeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 113 KMGADDFEPLT-MIGKGAFGEVRVCREK--ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 113 ~~~~~~f~~~~-~IG~G~fG~V~l~~~k--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
.+..++|.++. .||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+.+|..++||||+++++++. .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence 45667898887 9999999999999864 468899999997642 3345677899999999999999999999995 4
Q ss_pred ceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+.+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 5699999999999999998653 569999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... .......||+.|+|||++.+..++.++|||||||++
T Consensus 162 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 203 (287)
T 1u59_A 162 ADDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203 (287)
T ss_dssp TCSCEE--------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred cCccee--------------------------------------eccccccccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 221000 001134678999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 416 (549)
|||++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+|+ ++.++++|.
T Consensus 204 ~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~l 267 (287)
T 1u59_A 204 WEALSYGQKPYKKMKGPEVMAFIEQG-KRMECP--PECPPELYALMSDCWIYKWEDRP---DFLTVEQRM 267 (287)
T ss_dssp HHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHHH
T ss_pred HHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCC--CCcCHHHHHHHHHHcCCChhhCc---CHHHHHHHH
Confidence 99998 99999988877776666553 223444 3789999999999999 999999 899998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=388.96 Aligned_cols=247 Identities=22% Similarity=0.403 Sum_probs=212.4
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
...+..++|++++.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|+.++|||||++++++.+..
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 45677889999999999999999999875 7799999997643 3456889999999999999999999876554
Q ss_pred -eEEEEEeecCCCchhhHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRKDT--LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
.+|+|||||+||+|.+++...+. +++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999976543 899999999999999999999999999999999999999999999999999854
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
... .....+|+.|+|||++.+..|+.++|||||||+
T Consensus 340 ~~~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~ 375 (450)
T 1k9a_A 340 SST--------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375 (450)
T ss_dssp C--------------------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHH
T ss_pred ccc--------------------------------------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHH
Confidence 211 012367899999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||||++ |.+||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+|+ ++.+|+.
T Consensus 376 l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dp~~Rp---t~~~l~~ 438 (450)
T 1k9a_A 376 LWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYDVMKNCWHLDAATRP---TFLQLRE 438 (450)
T ss_dssp HHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999998 99999988877777666542 223334 4789999999999999 999999 7888764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=367.41 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=214.2
Q ss_pred cccCCCCCeeeee-eeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 111 RHKMGADDFEPLT-MIGKGAFGEVRVCRE--KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 111 ~~~~~~~~f~~~~-~IG~G~fG~V~l~~~--k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
...+..++|++.+ .||+|+||.||+|.+ ..+++.||||++.... ......+.+.+|+.++..++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 4456667899998 999999999999954 5678899999997653 2334457789999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+.+.+|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 56678999999999999999988888999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
....... .......||+.|+|||++.+..++.++|||||||+
T Consensus 168 ~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 209 (291)
T 1xbb_A 168 RADENYY--------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209 (291)
T ss_dssp CTTCSEE--------------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred ccCCCcc--------------------------------------cccccCCCCceeeChHHhccCCCChhhhHHHHHHH
Confidence 4221000 00012457889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|+|++ |.+||.+.+.......+... ....+| ..+++++.+||.+||. ||.+|+ ++.++++
T Consensus 210 l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 272 (291)
T 1xbb_A 210 MWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 272 (291)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 999999 99999988877666665542 233333 4789999999999999 999999 7888875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=368.13 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=208.0
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD 188 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~----~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 188 (549)
.+....|++++.||+|+||.||+|+ +..+|+.||||++.... .......+.+|+.+|..++||||++++++|.+
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3445679999999999999999999 56789999999997653 23445778999999999999999999999987
Q ss_pred C--ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 189 D--EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 189 ~--~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
. ..+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 679999999999999999954 4679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlG 345 (549)
......... .......||+.|+|||++.+..++.++|+||||
T Consensus 175 ~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 216 (302)
T 4e5w_A 175 AIETDKEYY--------------------------------------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFG 216 (302)
T ss_dssp ECCTTCCEE--------------------------------------ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHH
T ss_pred cccCCCcce--------------------------------------eccCCCCCCccccCCeeecCCCCCcchhHHHHH
Confidence 764321000 001145789999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCC--------------chhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHH
Q 038137 346 AIMYEMLVGYPPFYSDE--------------PMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410 (549)
Q Consensus 346 vilyEml~G~~PF~~~~--------------~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ 410 (549)
|++|+|++|..||.... ........+. .....+....+++++.+||.+||. ||.+|+ ++.
T Consensus 217 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ 291 (302)
T 4e5w_A 217 VTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK--EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT---SFQ 291 (302)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC---CHH
T ss_pred HHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh--ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC---CHH
Confidence 99999999999864321 1111112222 222333335789999999999999 999999 788
Q ss_pred HHHc
Q 038137 411 EIKA 414 (549)
Q Consensus 411 eil~ 414 (549)
++++
T Consensus 292 ~ll~ 295 (302)
T 4e5w_A 292 NLIE 295 (302)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=377.28 Aligned_cols=253 Identities=19% Similarity=0.235 Sum_probs=200.2
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC---
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD--- 189 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--- 189 (549)
.+..++|++++.||+|+||.||+|++. ++.||||++.... .......+|+.+|..++|||||+++++|.+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 356778999999999999999999875 7899999997543 2234456688889999999999999999864
Q ss_pred -ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CeeecCCCCCCeEEcCCCcEEE
Q 038137 190 -EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH----------NYIHRDIKPDNLLLDRNGHMKL 258 (549)
Q Consensus 190 -~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------giiHRDLKPeNILld~~g~vKL 258 (549)
..+|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.+|++||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 358999999999999999955 5699999999999999999999999 9999999999999999999999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-----C
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-----K 333 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-----~ 333 (549)
+|||+|+.+....... .....+||+.|+|||++.+ .
T Consensus 173 ~DFg~a~~~~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~ 213 (322)
T 3soc_A 173 ADFGLALKFEAGKSAG---------------------------------------DTHGQVGTRRYMAPEVLEGAINFQR 213 (322)
T ss_dssp CCCTTCEEECTTSCCC---------------------------------------CCTTCCCCGGGCCHHHHTTCCCCCH
T ss_pred ccCCcccccccccCcc---------------------------------------ccccCccCccccCHhhcccccccCc
Confidence 9999998764221000 0113589999999999987 3
Q ss_pred CCCcccccchhhHHHHHHhhCCCCCCCCCchhh----------------hhhhhhccccccCCC---CcCCChhHHHHHH
Q 038137 334 GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMST----------------CRKIVNWRTHLKFPE---EAKLSPEAKDLIS 394 (549)
Q Consensus 334 ~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~----------------~~~I~~~~~~l~~p~---~~~~s~~~~dLI~ 394 (549)
.++.++|||||||++|||++|++||.+...... ...+........++. ....++++.+||.
T Consensus 214 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (322)
T 3soc_A 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHH
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHH
Confidence 567789999999999999999999987543211 111111111111111 0122355999999
Q ss_pred Hhhh-cccccCCCCCHHHHHc
Q 038137 395 KLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 395 ~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+||. ||.+|+ ++.||++
T Consensus 294 ~cl~~dP~~Rp---s~~ell~ 311 (322)
T 3soc_A 294 ECWDHDAEARL---SAGCVGE 311 (322)
T ss_dssp HHTCSSGGGSC---CHHHHHH
T ss_pred HHccCChhhCc---CHHHHHH
Confidence 9999 999999 7888875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=383.37 Aligned_cols=262 Identities=18% Similarity=0.214 Sum_probs=202.6
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhch--------hhHHHHHHHHHHHHhcCCCcee
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKAT-----GHVYAMKKLKKSEMLRR--------GQVEHVKAERNLLAEVDSNCIV 180 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~vAiK~l~k~~~~~~--------~~~~~~~~E~~iL~~l~hp~Iv 180 (549)
+..++|++++.||+|+||.||+|.++.+ ++.||||++........ .....+..|..++..++|||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4566899999999999999999998765 58899999876431111 1112244456667788999999
Q ss_pred eeeeeecCC----ceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc--CC
Q 038137 181 KLYCSFQDD----EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD--RN 253 (549)
Q Consensus 181 ~l~~~f~d~----~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld--~~ 253 (549)
++++++.+. .++||||||| ||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5699999999 99999999765 6899999999999999999999999999999999999999 88
Q ss_pred CcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC
Q 038137 254 GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333 (549)
Q Consensus 254 g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~ 333 (549)
+++||+|||+|+.+......... ........+||+.|+|||++.+.
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 236 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAY----------------------------------AADPKRCHDGTIEFTSIDAHNGV 236 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCS----------------------------------SCCSSCCCCCCTTTCCHHHHTTC
T ss_pred CeEEEEECCcceecccCCccccc----------------------------------ccCcccccCCCCCccCHHHhCCC
Confidence 99999999999876432110000 00001246799999999999999
Q ss_pred CCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhcc--ccc------cCCCCcCCChhHHHHHHHhhh-cccccC
Q 038137 334 GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWR--THL------KFPEEAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 334 ~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~--~~l------~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
.|+.++|||||||++|||++|.+||.+.............. ..+ .++ ...+++++.+||..||. +|.+|+
T Consensus 237 ~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP 315 (364)
T 3op5_A 237 APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKP 315 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999999998644333222221100 000 111 13678999999999999 999999
Q ss_pred CCCCHHHHHc
Q 038137 405 GTKGADEIKA 414 (549)
Q Consensus 405 ~~~~~~eil~ 414 (549)
++.+|+.
T Consensus 316 ---~~~~l~~ 322 (364)
T 3op5_A 316 ---LYENLRD 322 (364)
T ss_dssp ---CHHHHHH
T ss_pred ---CHHHHHH
Confidence 6777664
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=369.60 Aligned_cols=260 Identities=18% Similarity=0.294 Sum_probs=209.5
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKA---TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF 186 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 186 (549)
....+..++|.+.+.||+|+||.||+|.... ++..||+|++..... .....+.+.+|+.++..++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 4456677899999999999999999998865 566899999975432 334456789999999999999999999999
Q ss_pred cCCc-----eEEEEEeecCCCchhhHhh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc
Q 038137 187 QDDE-----YLYLIMEYLPGGDMMTLLM------RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH 255 (549)
Q Consensus 187 ~d~~-----~lylVmEy~~gg~L~~~l~------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~ 255 (549)
.+.. ..|+||||+++|+|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.+|+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 8654 4599999999999999983 3357999999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC
Q 038137 256 MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY 335 (549)
Q Consensus 256 vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y 335 (549)
+||+|||+++.+....... ......||+.|+|||++.+..|
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 226 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRVY 226 (313)
T ss_dssp EEECSCSCC-------------------------------------------------------CCGGGSCHHHHHSSCC
T ss_pred EEEeecCcceecccccccC---------------------------------------cccccCCCccccCchhhcCCCc
Confidence 9999999998653211000 0113468889999999999999
Q ss_pred CcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 336 GMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
+.++|||||||++|+|++ |.+||.+.+.......+... ....+| ..+++++.+||.+||. ||.+|+ ++.+++
T Consensus 227 ~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~ 300 (313)
T 3brb_A 227 TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-HRLKQP--EDCLDELYEIMYSCWRTDPLDRP---TFSVLR 300 (313)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCB--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHH
T ss_pred cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC-CCCCCC--ccccHHHHHHHHHHcCCChhhCc---CHHHHH
Confidence 999999999999999999 99999988887777766653 222333 4789999999999999 999999 799988
Q ss_pred cC
Q 038137 414 AH 415 (549)
Q Consensus 414 ~H 415 (549)
.|
T Consensus 301 ~~ 302 (313)
T 3brb_A 301 LQ 302 (313)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=361.33 Aligned_cols=252 Identities=22% Similarity=0.372 Sum_probs=213.4
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
...+..++|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+|..++||||+++++++.+ +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 34566789999999999999999999975 567899999976432 24568899999999999999999999875 4
Q ss_pred eEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6899999999999999996543 79999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... .....||+.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 200 (279)
T 1qpc_A 161 DNEYTA----------------------------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (279)
T ss_dssp SSCEEC----------------------------------------CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred Cccccc----------------------------------------ccCCCCccCccChhhhccCCCCchhhhHHHHHHH
Confidence 221000 0134678899999999989999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||.+.+..+....+... ...+....+++++.+||.+||. ||.+|+ +++++++
T Consensus 201 ~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 262 (279)
T 1qpc_A 201 TEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRS 262 (279)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHhCCCCCCcccCHHHHHHHHhcc---cCCCCcccccHHHHHHHHHHhccChhhCC---CHHHHHH
Confidence 99999 99999988877776666542 2222234789999999999999 999999 7888875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.29 Aligned_cols=266 Identities=19% Similarity=0.299 Sum_probs=209.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeee-eeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY-CSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~-~~f~d~~~lyl 194 (549)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|..++..+.|++++..+ .++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 47899999999999999999999999999999987654322 2377899999999887766555 45567888999
Q ss_pred EEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE---cCCCcEEEeecCcccccCCC
Q 038137 195 IMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl---d~~g~vKL~DFGlak~~~~~ 270 (549)
||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999964 5679999999999999999999999999999999999999 88999999999999876432
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
..... .+. ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 162 ~~~~~----------------~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 4hgt_A 162 RTHQH----------------IPY------------------RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp TTCCB----------------CCC------------------CCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCcc----------------CCC------------------CcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHH
Confidence 11000 000 00124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchh---hhhhhhhccccccCCC---CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc---------
Q 038137 351 MLVGYPPFYSDEPMS---TCRKIVNWRTHLKFPE---EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA--------- 414 (549)
Q Consensus 351 ml~G~~PF~~~~~~~---~~~~I~~~~~~l~~p~---~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~--------- 414 (549)
|++|.+||.+.+... .+..+.. .....|. ...+++++.+||.+||. ||.+|+ ++++|++
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 208 FNLGSLPWQGLKAATKRQKYERISE--KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHH--HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcccchhhhhhhhhhhhc--ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCC---CHHHHHHHHHHHHHHh
Confidence 999999998754432 3333332 1222221 13679999999999999 999999 6777764
Q ss_pred -CCcccCCCcccc
Q 038137 415 -HPWFKGIEWDKL 426 (549)
Q Consensus 415 -HpfF~~i~w~~l 426 (549)
.+|-..++|+.+
T Consensus 283 ~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 283 GFSYDYVFDWNML 295 (296)
T ss_dssp TCCTTCCCGGGGC
T ss_pred CCCccCccchhhc
Confidence 455566777765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=373.01 Aligned_cols=258 Identities=21% Similarity=0.315 Sum_probs=212.6
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATG----HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
.++..++|.+.+.||+|+||.||+|.++.++ ..||||++.... .......+.+|+.++..++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3567889999999999999999999987653 469999997542 2334556889999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999764 6799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
........ .......||+.|+|||++.+..++.++|||||||
T Consensus 197 ~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 238 (333)
T 1mqb_A 197 LEDDPEAT--------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238 (333)
T ss_dssp ----------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred hccccccc--------------------------------------cccCCCCccccccCchhcccCCCCchhhhHHHHH
Confidence 54211000 0011345788999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 347 IMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 347 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
++|||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+|+ ++.+|+++
T Consensus 239 il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~~ 303 (333)
T 1mqb_A 239 VMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRP---KFADIVSI 303 (333)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHCC---CcCCCcccCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 9999998 99999988877777666542 2333345789999999999999 999999 78888763
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=367.80 Aligned_cols=258 Identities=21% Similarity=0.356 Sum_probs=208.4
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKA-TGH--VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-tg~--~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
.+..++|++++.||+|+||.||+|++.. ++. .||+|++...........+.+.+|+.++..++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4556789999999999999999998653 333 6999999876544455667899999999999999999999999876
Q ss_pred ceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
. +|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 89999999999999999664 679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... .......||+.|+|||++.+..++.++|||||||++
T Consensus 173 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (291)
T 1u46_A 173 QNDDHY--------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214 (291)
T ss_dssp C-CCEE--------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred ccccch--------------------------------------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHH
Confidence 221000 001135688899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|+|++ |.+||.+.+.......+..... ..+....+++++.+||.+||. ||.+|+ ++.++++
T Consensus 215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 277 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNGSQILHKIDKEGE--RLPRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALRD 277 (291)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTSCC--CCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHhCCCCCcccCCHHHHHHHHHccCC--CCCCCcCcCHHHHHHHHHHccCCcccCc---CHHHHHH
Confidence 99999 9999999888877777765433 333345789999999999999 999999 7999886
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=388.94 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=196.0
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lyl 194 (549)
.+.|.+.++||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.+...+|+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 344566789999999999875 45689999999986532 34577899999876 89999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC-------------C
Q 038137 195 IMEYLPGGDMMTLLMRKDTL-------TEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-------------G 254 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l-------~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~-------------g 254 (549)
|||||. |+|.+++...... ++..+..++.||+.||.|||++|||||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 6999999765433 233457799999999999999999999999999999754 4
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-- 332 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-- 332 (549)
++||+|||+|+.+....... .......+||+.|+|||++.+
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 208 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSF-------------------------------------RTNLNNPSGTSGWRAPELLEESN 208 (434)
T ss_dssp EEEECCCTTCEECCC---------------------------------------------------CCTTSCHHHHSCCC
T ss_pred EEEEcccccceecCCCCccc-------------------------------------eeeecCCCCCCCccCHHHhcccc
Confidence 89999999998764221000 000124689999999999976
Q ss_pred -----CCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhcccccc---CCCCcCCChhHHHHHHHhhh-cccc
Q 038137 333 -----KGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLK---FPEEAKLSPEAKDLISKLLC-NVEQ 402 (549)
Q Consensus 333 -----~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~---~p~~~~~s~~~~dLI~~lL~-dp~~ 402 (549)
..++.++|||||||++|||++ |.+||.+..... ..++.....+. ......+++++++||.+||+ ||.+
T Consensus 209 ~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 286 (434)
T 2rio_A 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286 (434)
T ss_dssp TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGG
T ss_pred ccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhh
Confidence 678999999999999999999 999997654432 33443221111 11122456899999999999 9999
Q ss_pred cCCCCCHHHHHcCCcccCC
Q 038137 403 RLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 403 Rl~~~~~~eil~HpfF~~i 421 (549)
|+ ++.+|++||||.+.
T Consensus 287 Rp---s~~eil~hp~f~~~ 302 (434)
T 2rio_A 287 RP---TAMKVLRHPLFWPK 302 (434)
T ss_dssp SC---CHHHHHTSGGGSCH
T ss_pred CC---CHHHHHhCCccCCc
Confidence 99 89999999999754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=377.87 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=210.1
Q ss_pred hhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 108 RLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 108 ~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
.+....+..++|++.+.||+|+||.||+|++ .+|+.||||++....... ....+.+|+.++..++||||++++++|.
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 3455567789999999999999999999985 468999999997654221 1235789999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCCCCeEEcCCCcEEEee
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRKD----TLTEEEARFYVGETVLAIESIHKH---NYIHRDIKPDNLLLDRNGHMKLSD 260 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~---giiHRDLKPeNILld~~g~vKL~D 260 (549)
+....|+||||++||+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.+|++||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999996543 499999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccc
Q 038137 261 FGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 340 (549)
Q Consensus 261 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~D 340 (549)
||+|+........ .....+||+.|+|||++.+..++.++|
T Consensus 178 fg~~~~~~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 217 (326)
T 3uim_A 178 FGLAKLMDYKDTH----------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTD 217 (326)
T ss_dssp CSSCEECCSSSSC----------------------------------------EECCCCSCGGGCCHHHHHHSEECHHHH
T ss_pred CccccccCccccc----------------------------------------ccccccCCcCccCHHHhccCCCCcccc
Confidence 9999876422100 012457999999999999999999999
Q ss_pred cchhhHHHHHHhhCCCCCCCC----Cchhhhhhhhh----cc-------ccccCCCCcCCChhHHHHHHHhhh-cccccC
Q 038137 341 WWSLGAIMYEMLVGYPPFYSD----EPMSTCRKIVN----WR-------THLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 341 iWSlGvilyEml~G~~PF~~~----~~~~~~~~I~~----~~-------~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
||||||++|||++|.+||... .........+. .. ..+..+.....+.++.+||.+||. ||.+|+
T Consensus 218 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 297 (326)
T 3uim_A 218 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297 (326)
T ss_dssp HHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC
T ss_pred chhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC
Confidence 999999999999999999521 11111111110 00 000000111234789999999999 999999
Q ss_pred CCCCHHHHHcCCccc
Q 038137 405 GTKGADEIKAHPWFK 419 (549)
Q Consensus 405 ~~~~~~eil~HpfF~ 419 (549)
++.||++|-.-.
T Consensus 298 ---s~~ell~~L~~~ 309 (326)
T 3uim_A 298 ---KMSEVVRMLEGD 309 (326)
T ss_dssp ---CHHHHHHHHHTS
T ss_pred ---CHHHHHHHhcCc
Confidence 899999875543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=388.43 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=207.6
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc--e
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE--Y 191 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~--~ 191 (549)
...++|.+.+.||+|+||.||+|+++.+|+.||||++..... ....+.+.+|+.+|+.++|||||++++++.+.. .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 456789999999999999999999999999999999986543 233566789999999999999999999988655 7
Q ss_pred EEEEEeecCCCchhhHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE----cCCCcEEEeecCcc
Q 038137 192 LYLIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL----DRNGHMKLSDFGLC 264 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl----d~~g~vKL~DFGla 264 (549)
+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999996643 39999999999999999999999999999999999999 88889999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--------CCCC
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--------KGYG 336 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--------~~y~ 336 (549)
+...... ...+.+||+.|+|||++.+ ..|+
T Consensus 164 ~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 201 (396)
T 4eut_A 164 RELEDDE------------------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201 (396)
T ss_dssp EECCCGG------------------------------------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHH
T ss_pred eEccCCC------------------------------------------ccccccCCccccCHHHhhccccccccccCCC
Confidence 8654211 0114689999999999975 5788
Q ss_pred cccccchhhHHHHHHhhCCCCCCCCC----chhhhhhhhhcccc-----------------ccCCCC----cCCChhHHH
Q 038137 337 MECDWWSLGAIMYEMLVGYPPFYSDE----PMSTCRKIVNWRTH-----------------LKFPEE----AKLSPEAKD 391 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~G~~PF~~~~----~~~~~~~I~~~~~~-----------------l~~p~~----~~~s~~~~d 391 (549)
.++|||||||++|||++|.+||.... ..+...+++..... ..+|.. ..+++.+.+
T Consensus 202 ~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 281 (396)
T 4eut_A 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281 (396)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchH
Confidence 99999999999999999999997533 23334444432110 011111 234567899
Q ss_pred HHHHhhh-cccccCCCCCHHHHHc
Q 038137 392 LISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 392 LI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||.+||. ||++|+ +++++++
T Consensus 282 ll~~~L~~dP~~R~---s~~e~l~ 302 (396)
T 4eut_A 282 VLANILEADQEKCW---GFDQFFA 302 (396)
T ss_dssp HHHHHSCCCTTTSC---CHHHHHH
T ss_pred HHHHhhccChhhhc---cHHHHHH
Confidence 9999999 999999 7888754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=391.32 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=215.4
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
...+..++|++.+.||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.+|+.++|||||++++++. .+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 34667788999999999999999999986 46789999997643 23567899999999999999999999987 56
Q ss_pred eEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 789999999999999999654 378999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..... ......+|+.|+|||++....|+.++|||||||+|
T Consensus 336 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 375 (454)
T 1qcf_A 336 DNEYT----------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375 (454)
T ss_dssp CHHHH----------------------------------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHH
Confidence 21000 00134578899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||.+.+..+....+... ...|.+..+++++.+||.+||. ||.+|+ ++++|+.
T Consensus 376 ~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~i~~ 437 (454)
T 1qcf_A 376 MEIVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERP---TFEYIQS 437 (454)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHHT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhHCc---CHHHHHH
Confidence 99999 99999998887777766642 3334445789999999999999 999999 7888874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=379.83 Aligned_cols=263 Identities=18% Similarity=0.188 Sum_probs=202.7
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhh--------chhhHHHHHHHHHHHHhcCCCceeee
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKA---TGHVYAMKKLKKSEML--------RRGQVEHVKAERNLLAEVDSNCIVKL 182 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~---tg~~vAiK~l~k~~~~--------~~~~~~~~~~E~~iL~~l~hp~Iv~l 182 (549)
+..++|++.+.||+|+||.||+|++.. ++..||||++.+.... .......+.+|..++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456789999999999999999999987 8889999999764311 11112346678888999999999999
Q ss_pred eeeecC----CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC--cE
Q 038137 183 YCSFQD----DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG--HM 256 (549)
Q Consensus 183 ~~~f~d----~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g--~v 256 (549)
++++.+ ...+|+||||+ ||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999887 78999999999 999999998878999999999999999999999999999999999999999888 99
Q ss_pred EEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCC
Q 038137 257 KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYG 336 (549)
Q Consensus 257 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~ 336 (549)
||+|||+|+.+........ . ........+||+.|+|||++.+..|+
T Consensus 193 kL~Dfg~a~~~~~~~~~~~------------------~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 238 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQ------------------Y----------------QENPRKGHNGTIEFTSLDAHKGVALS 238 (345)
T ss_dssp EECCCTTCEESSGGGCCCC------------------C----------------CCCGGGCSCSCTTTCCHHHHHTCCCC
T ss_pred EEEeCCCceeccccccccc------------------c----------------hhccccccCCCccccCHHHhcCCCCC
Confidence 9999999987642210000 0 00001256899999999999999999
Q ss_pred cccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCC-------CcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 337 MECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPE-------EAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~-------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
.++|||||||++|||++|.+||.+..................+|. ...+++++.+||.+||. ||.+|+ +
T Consensus 239 ~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s 315 (345)
T 2v62_A 239 RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP---N 315 (345)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC---C
T ss_pred chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC---C
Confidence 999999999999999999999965322221111111011111221 12688999999999999 999999 7
Q ss_pred HHHHHc
Q 038137 409 ADEIKA 414 (549)
Q Consensus 409 ~~eil~ 414 (549)
+++|++
T Consensus 316 ~~~l~~ 321 (345)
T 2v62_A 316 YQALKK 321 (345)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=373.63 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=210.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec--
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ-- 187 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~----~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-- 187 (549)
+..++|++++.||+|+||.||+|+ +..+++.||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 456789999999999999999999 46789999999997652 344567899999999999999999999876
Q ss_pred CCceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
+...+|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 56779999999999999999976 45699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
........ .......||+.|+|||++.+..|+.++|||||||
T Consensus 177 ~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 218 (327)
T 3lxl_A 177 LPLDKDYY--------------------------------------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218 (327)
T ss_dssp CCTTCSEE--------------------------------------ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHH
T ss_pred cccCCccc--------------------------------------eeeccCCccccccCHHHhccCCCChHHhHHHHHH
Confidence 64221000 0011356899999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCch--------------hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHH
Q 038137 347 IMYEMLVGYPPFYSDEPM--------------STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~--------------~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 411 (549)
++|+|++|..||...... ......+. .....+....+++++.+||.+||. ||.+|+ ++.+
T Consensus 219 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~e 293 (327)
T 3lxl_A 219 VLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE--EGQRLPAPPACPAEVHELMKLCWAPSPQDRP---SFSA 293 (327)
T ss_dssp HHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHH
T ss_pred HHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh--cccCCCCCCcccHHHHHHHHHHcCCChhhCc---CHHH
Confidence 999999999999654321 11111122 122333345789999999999999 999999 7888
Q ss_pred HHc
Q 038137 412 IKA 414 (549)
Q Consensus 412 il~ 414 (549)
+++
T Consensus 294 ll~ 296 (327)
T 3lxl_A 294 LGP 296 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=360.79 Aligned_cols=252 Identities=19% Similarity=0.291 Sum_probs=208.0
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE-E
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL-Y 193 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l-y 193 (549)
.|.+.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+|+.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46777999999999999999866554 79999987532 344567789999999999999999999999876665 9
Q ss_pred EEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 194 LIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+||||+.||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 46799999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
.. ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 180 ~~-------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 222 (298)
T 3pls_A 180 YS-------------------------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222 (298)
T ss_dssp GC-------------------------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cc-------------------------------------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHh
Confidence 00 00011457899999999999999999999999999999999
Q ss_pred h-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 353 V-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 353 ~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+ |.+||...+.......+... . ..+....+++++.+||.+||. ||.+|+ ++.++++
T Consensus 223 ~g~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~ll~ 280 (298)
T 3pls_A 223 TRGAPPYRHIDPFDLTHFLAQG-R--RLPQPEYCPDSLYQVMQQCWEADPAVRP---TFRVLVG 280 (298)
T ss_dssp HTSCCTTTTSCGGGHHHHHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred hCCCCCCccCCHHHHHHHhhcC-C--CCCCCccchHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 9 55666666665555555432 2 233334789999999999999 999999 7888875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=377.86 Aligned_cols=248 Identities=18% Similarity=0.244 Sum_probs=200.6
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEE-----EEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC---CCceeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVC-----REKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD---SNCIVKL 182 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~-----~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l 182 (549)
...+..++|.+.+.||+|+||.||+| .+..+++.||||++.... ...+..|..++..+. |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 34566788999999999999999999 467889999999997542 345677888888876 8999999
Q ss_pred eeeecCCceEEEEEeecCCCchhhHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-----
Q 038137 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMR-----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR----- 252 (549)
Q Consensus 183 ~~~f~d~~~lylVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~----- 252 (549)
++++.+.+..|||||||+||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999999964 467999999999999999999999999999999999999998
Q ss_pred ------CCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCC
Q 038137 253 ------NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIA 326 (549)
Q Consensus 253 ------~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~A 326 (549)
++++||+|||+|+.+..... .....+.+||+.|+|
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~---------------------------------------~~~~~~~~gt~~y~a 253 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPK---------------------------------------GTIFTAKCETSGFQC 253 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCT---------------------------------------TEEECCSSCTTSCCC
T ss_pred cccccccCCEEEeeCchhhhhhccCC---------------------------------------CceeeeecCCCCCCC
Confidence 89999999999976431100 001225689999999
Q ss_pred chhhccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCC
Q 038137 327 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 327 PEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
||++.+..|+.++|||||||++|||++|++||......... + ...++. ...++...+++.+||. +|.+|+.
T Consensus 254 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~-----~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--P-----EGLFRR-LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--E-----CSCCTT-CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred hHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--e-----chhccc-cCcHHHHHHHHHHHcCCCCCCcch
Confidence 99999999999999999999999999999999654332111 1 111111 1346789999999999 9999974
Q ss_pred CCCHHHHH
Q 038137 406 TKGADEIK 413 (549)
Q Consensus 406 ~~~~~eil 413 (549)
++.++.
T Consensus 326 --~~~~l~ 331 (365)
T 3e7e_A 326 --SLDLLR 331 (365)
T ss_dssp --CHHHHH
T ss_pred --HHHHHH
Confidence 355444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=371.12 Aligned_cols=263 Identities=23% Similarity=0.387 Sum_probs=209.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec----C
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ----D 188 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~----d 188 (549)
.+..++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 356678999999999999999999999999999999986542 344567889999999999999999999986 4
Q ss_pred CceEEEEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
...+|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 5689999999999999999865 467999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC---CCccccc
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDW 341 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~---y~~~~Di 341 (549)
.......... ........| ....||+.|+|||++.+.. ++.++||
T Consensus 182 ~~~~~~~~~~------------------------~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 229 (317)
T 2buj_A 182 NQACIHVEGS------------------------RQALTLQDW--------AAQRCTISYRAPELFSVQSHCVIDERTDV 229 (317)
T ss_dssp EESCEEEESH------------------------HHHHHHHHH--------HHHHSCGGGCCGGGSSCCSEEEECTHHHH
T ss_pred hhcccccccc------------------------ccccccccc--------ccccCCcccCCHhHhccCCCcCCCchhhH
Confidence 7653110000 000000011 1357899999999998654 7999999
Q ss_pred chhhHHHHHHhhCCCCCCCCCch-hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 342 WSLGAIMYEMLVGYPPFYSDEPM-STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 342 WSlGvilyEml~G~~PF~~~~~~-~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||||++|||++|..||...... ......+. ....+|....+++++.+||.+||. ||.+|+ ++.++++|
T Consensus 230 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 300 (317)
T 2buj_A 230 WSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--NQLSIPQSPRHSSALWQLLNSMMTVDPHQRP---HIPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--CC--CCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHHHHHHhCCCChhhhhcccchhhHHhh--ccCCCCccccCCHHHHHHHHHHhhcChhhCC---CHHHHHHH
Confidence 99999999999999999542111 11111222 234455556789999999999999 999999 89999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.60 Aligned_cols=243 Identities=26% Similarity=0.437 Sum_probs=207.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--------
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-------- 188 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-------- 188 (549)
.+|++++.||+|+||.||+|.+..+|+.||+|++.... ..+.+|..++..++||||++++++|.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 46999999999999999999999999999999997542 236689999999999999999998864
Q ss_pred --------CceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEE
Q 038137 189 --------DEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKL 258 (549)
Q Consensus 189 --------~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL 258 (549)
...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45689999999999999999653 67999999999999999999999999999999999999999999999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcc
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME 338 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~ 338 (549)
+|||+++....... ....+||+.|+|||++.+..++.+
T Consensus 164 ~Dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 201 (284)
T 2a19_B 164 GDFGLVTSLKNDGK------------------------------------------RTRSKGTLRYMSPEQISSQDYGKE 201 (284)
T ss_dssp CCCTTCEESSCCSC------------------------------------------CCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred Ccchhheecccccc------------------------------------------ccccCCcccccChhhhccCCCcch
Confidence 99999987542110 013579999999999999999999
Q ss_pred cccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCc
Q 038137 339 CDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPW 417 (549)
Q Consensus 339 ~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hpf 417 (549)
+|+|||||++|+|++|..||.... .....+.. ..++ ..+++++++||.+||. ||.+|+ ++.|+++|++
T Consensus 202 ~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~dp~~Rp---s~~e~l~~l~ 270 (284)
T 2a19_B 202 VDLYALGLILAELLHVCDTAFETS--KFFTDLRD----GIIS--DIFDKKEKTLLQKLLSKKPEDRP---NTSEILRTLT 270 (284)
T ss_dssp HHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT----TCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc----cccc--ccCCHHHHHHHHHHccCChhhCc---CHHHHHHHHH
Confidence 999999999999999999985421 22222221 1223 3678999999999999 999999 8999999987
Q ss_pred cc
Q 038137 418 FK 419 (549)
Q Consensus 418 F~ 419 (549)
+-
T Consensus 271 ~~ 272 (284)
T 2a19_B 271 VW 272 (284)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=365.01 Aligned_cols=253 Identities=27% Similarity=0.365 Sum_probs=200.0
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh--cCCCceeeeeeeec---
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE--VDSNCIVKLYCSFQ--- 187 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~--- 187 (549)
++..++|++++.||+|+||.||+|++ +|+.||||++.... ......|.+++.. ++||||+++++++.
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567899999999999999999987 68999999986542 3445667777776 79999999998854
Q ss_pred -CCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeecCCCCCCeEEcCCCcEEE
Q 038137 188 -DDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH--------KHNYIHRDIKPDNLLLDRNGHMKL 258 (549)
Q Consensus 188 -d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~giiHRDLKPeNILld~~g~vKL 258 (549)
+...+|+||||++||+|.+++. ...+++..+..++.||+.||.||| +.||+||||||+|||++.+|++||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3567999999999999999994 467999999999999999999999 999999999999999999999999
Q ss_pred eecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-----
Q 038137 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK----- 333 (549)
Q Consensus 259 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~----- 333 (549)
+|||+|+......... .......+||+.|+|||++.+.
T Consensus 155 ~Dfg~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 197 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQL-------------------------------------DVGNNPRVGTKRYMAPEVLDETIQVDC 197 (301)
T ss_dssp CCCTTCEEEETTTTEE-------------------------------------ECCCCCCCCCGGGCCHHHHTTCCCTTC
T ss_pred eeCCCeeecccccccc-------------------------------------cccccccccccceeChhhhcCcCCCCc
Confidence 9999997654221000 0001245899999999999876
Q ss_pred -CCCcccccchhhHHHHHHhhC----------CCCCCCCCch----hhhhhhhhc-cccccCCCC---cCCChhHHHHHH
Q 038137 334 -GYGMECDWWSLGAIMYEMLVG----------YPPFYSDEPM----STCRKIVNW-RTHLKFPEE---AKLSPEAKDLIS 394 (549)
Q Consensus 334 -~y~~~~DiWSlGvilyEml~G----------~~PF~~~~~~----~~~~~I~~~-~~~l~~p~~---~~~s~~~~dLI~ 394 (549)
.++.++|||||||++|||++| .+||...... ....+++.. .....+|.. ..+++++.+||.
T Consensus 198 ~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 277 (301)
T 3q4u_A 198 FDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHH
T ss_pred ccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHH
Confidence 556799999999999999999 8999764332 222222221 112222221 124578999999
Q ss_pred Hhhh-cccccCCCCCHHHHHc
Q 038137 395 KLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 395 ~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+||. ||.+|+ ++.+|++
T Consensus 278 ~cl~~dP~~Rp---s~~~i~~ 295 (301)
T 3q4u_A 278 ECWYQNPSARL---TALRIKK 295 (301)
T ss_dssp HHCCSSGGGSC---CHHHHHH
T ss_pred HHhhcChhhCC---CHHHHHH
Confidence 9999 999999 7998875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=361.99 Aligned_cols=258 Identities=19% Similarity=0.289 Sum_probs=201.6
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
...++..++|++.+.||+|+||.||+|++.. .||+|++.... ......+.+.+|+.+|+.++||||+++++++ ..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 4567888999999999999999999998643 59999997543 2344567789999999999999999999855 55
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 678999999999999999854 4679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc---cCCCCcccccchhh
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLG 345 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~---~~~y~~~~DiWSlG 345 (549)
..... ......+||+.|+|||++. +..|+.++||||||
T Consensus 172 ~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 212 (289)
T 3og7_A 172 RWSGS---------------------------------------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212 (289)
T ss_dssp ---------------------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHH
T ss_pred ccccc---------------------------------------ccccccCCCccccCchhhcccCCCCCCcccchHHHH
Confidence 21000 0011457999999999997 56789999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhcccc-ccCC-CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWRTH-LKFP-EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~~~-l~~p-~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++|+|++|..||.+.+.......++..... ...+ ....+++++.+||.+||. ||.+|+ ++.++++
T Consensus 213 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 281 (289)
T 3og7_A 213 IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP---SFPRILA 281 (289)
T ss_dssp HHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC---CHHHHHH
Confidence 9999999999999887666555554432111 1111 113678999999999999 999999 7888875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=364.62 Aligned_cols=232 Identities=33% Similarity=0.573 Sum_probs=192.0
Q ss_pred CCCeeee-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHH-HhcCCCceeeeeeeecC----C
Q 038137 116 ADDFEPL-TMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL-AEVDSNCIVKLYCSFQD----D 189 (549)
Q Consensus 116 ~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f~d----~ 189 (549)
.++|.++ ++||+|+||.||+|.++.+|+.||||++... ..+.+|+.++ +..+||||++++++|.+ .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4678888 7899999999999999999999999999653 2356788887 66699999999999876 7
Q ss_pred ceEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---CCcEEEeecCcc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NGHMKLSDFGLC 264 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~g~vKL~DFGla 264 (549)
..+|+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 88999999999999999997754 6999999999999999999999999999999999999998 789999999998
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
.... +..|+.++|||||
T Consensus 168 ~~~~---------------------------------------------------------------~~~~~~~~Diwsl 184 (299)
T 3m2w_A 168 KETT---------------------------------------------------------------GEKYDKSCDMWSL 184 (299)
T ss_dssp EECT---------------------------------------------------------------TCGGGGHHHHHHH
T ss_pred cccc---------------------------------------------------------------cccCCchhhHHHH
Confidence 6431 2347789999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhcc--ccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWR--THLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~--~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
||++|||++|.+||.+.+.......+.... ....+|. ...+++++++||.+||+ ||.+|+ ++.|+++||||.
T Consensus 185 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~e~l~hp~~~ 261 (299)
T 3m2w_A 185 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIM 261 (299)
T ss_dssp HHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC---CHHHHHTSHHHH
T ss_pred HHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC---CHHHHhcChhhc
Confidence 999999999999998766544322222111 1222232 14689999999999999 999999 899999999998
Q ss_pred CC
Q 038137 420 GI 421 (549)
Q Consensus 420 ~i 421 (549)
+.
T Consensus 262 ~~ 263 (299)
T 3m2w_A 262 QS 263 (299)
T ss_dssp TG
T ss_pred cc
Confidence 64
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=359.52 Aligned_cols=246 Identities=21% Similarity=0.388 Sum_probs=204.4
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-Cc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD-DE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-~~ 190 (549)
..+..++|++++.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.++..++||||+++++++.+ ..
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 4566789999999999999999999874 8899999987542 34668899999999999999999998654 45
Q ss_pred eEEEEEeecCCCchhhHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 7999999999999999997654 38999999999999999999999999999999999999999999999999987543
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
... ....||+.|+|||++.+..++.++|||||||++
T Consensus 169 ~~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 204 (278)
T 1byg_A 169 STQ--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204 (278)
T ss_dssp ---------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccc--------------------------------------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHH
Confidence 110 134688999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||...+.......+... ..... ...+++++.+||.+||. ||.+|+ ++.++++
T Consensus 205 ~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp---s~~~l~~ 266 (278)
T 1byg_A 205 WEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA--PDGCPPAVYEVMKNCWHLDAAMRP---SFLQLRE 266 (278)
T ss_dssp HHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCC--CTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCC--cccCCHHHHHHHHHHhcCChhhCC---CHHHHHH
Confidence 99998 99999988777666666542 12233 34789999999999999 999999 7888775
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=360.76 Aligned_cols=254 Identities=18% Similarity=0.289 Sum_probs=209.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeee-ecCCce
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCS-FQDDEY 191 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~-f~d~~~ 191 (549)
..+|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|..+++.++||||++++++ +.++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 34699999999999999999997543 3468999987532 34456778999999999999999999998 456778
Q ss_pred EEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+...
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999999965 456899999999999999999999999999999999999999999999999999876422
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
.... ........||+.|+|||++.+..++.++|+|||||++|+
T Consensus 182 ~~~~-------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 224 (298)
T 3f66_A 182 EYYS-------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224 (298)
T ss_dssp GGCB-------------------------------------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred chhc-------------------------------------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHH
Confidence 1000 000124578999999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++ |.+||.+.+.......+.... ....| ..+++++.+||.+||. ||.+|+ ++.++++
T Consensus 225 l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp---s~~ell~ 284 (298)
T 3f66_A 225 LMTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVS 284 (298)
T ss_dssp HHTTSCCSSTTSCTTTHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHhCCCCCCccCCHHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHcCCChhhCc---CHHHHHH
Confidence 999 778888777777666666532 22223 3689999999999999 999999 7888875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.11 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=205.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeee-eeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLY-CSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~-~~f~d~~~lyl 194 (549)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|..++..+.|++++..+ .++.+...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 5789999999999999999999999999999999876432 23478899999999987755554 44567788999
Q ss_pred EEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE---cCCCcEEEeecCcccccCCC
Q 038137 195 IMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl---d~~g~vKL~DFGlak~~~~~ 270 (549)
||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999963 5679999999999999999999999999999999999999 58899999999999876432
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
..... .+. ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 162 ~~~~~----------------~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 162 RTHQH----------------IPY------------------RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp TTCCB----------------CCC------------------CCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccc----------------ccc------------------ccccccccccccCChhhhcCCCCCcchhhHHHHHHHHH
Confidence 11000 000 00124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCc---hhhhhhhhhccccccCCC---CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 351 MLVGYPPFYSDEP---MSTCRKIVNWRTHLKFPE---EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 351 ml~G~~PF~~~~~---~~~~~~I~~~~~~l~~p~---~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++|++||.+.+. ...+..+... ....|. ...+|+++.+||.+||+ ||.+|+ ++++|++
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~l~~ 273 (296)
T 3uzp_A 208 FNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP---DYSYLRQ 273 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCC---CHHHHHH
T ss_pred HHhCCCCCCCcCchhhhhhhhhhccc--ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCC---CHHHHHH
Confidence 9999999987433 3344444431 222221 13689999999999999 999999 7777764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=360.73 Aligned_cols=242 Identities=27% Similarity=0.438 Sum_probs=197.8
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|+.+|..++|||||++++++.+. +|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cE
Confidence 55678999999999999999999875 789999998643 2346688999999999999999999998854 78
Q ss_pred EEEeecCCCchhhHhhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCCCCeEEcCCCc-EEEeecCcccc
Q 038137 194 LIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGETVLAIESIHK---HNYIHRDIKPDNLLLDRNGH-MKLSDFGLCKP 266 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~giiHRDLKPeNILld~~g~-vKL~DFGlak~ 266 (549)
+||||++||+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.+|. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999997654 47899999999999999999999 89999999999999999887 79999999875
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
.... ....+||+.|+|||++.+..|+.++|||||||
T Consensus 156 ~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 191 (307)
T 2eva_A 156 IQTH--------------------------------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191 (307)
T ss_dssp -----------------------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHH
T ss_pred cccc--------------------------------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHH
Confidence 4211 01347999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCchh--hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 347 IMYEMLVGYPPFYSDEPMS--TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~--~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++|||++|..||....... ....+.. .... +....+++.+.+||.+||. ||.+|+ +++++++
T Consensus 192 il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~ell~ 256 (307)
T 2eva_A 192 ILWEVITRRKPFDEIGGPAFRIMWAVHN-GTRP--PLIKNLPKPIESLMTRCWSKDPSQRP---SMEEIVK 256 (307)
T ss_dssp HHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCCC--CCBTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHCCCCchhhCccHHHHHHHHhc-CCCC--CcccccCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 9999999999997643322 2222222 1122 2234789999999999999 999999 7888886
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=365.47 Aligned_cols=263 Identities=23% Similarity=0.375 Sum_probs=193.1
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeee---
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSF--- 186 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f--- 186 (549)
...+...+|++.+.||+|+||.||+|++..+|+.||||++.+.. ......+.+|+.++..+. |||||++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34556678999999999999999999999999999999986543 334566889999999995 99999999988
Q ss_pred -----cCCceEEEEEeecCCCchhhHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEcCCCcE
Q 038137 187 -----QDDEYLYLIMEYLPGGDMMTLLMR---KDTLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLDRNGHM 256 (549)
Q Consensus 187 -----~d~~~lylVmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld~~g~v 256 (549)
.+...+|+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.+|++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 45567999999995 789888854 467999999999999999999999999 9999999999999999999
Q ss_pred EEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhh---ccC
Q 038137 257 KLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVL---LKK 333 (549)
Q Consensus 257 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl---~~~ 333 (549)
||+|||+++........... .. ...........+||+.|+|||++ .+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~-------------------~~----------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWS-------------------AQ----------RRALVEEEITRNTTPMYRTPEIIDLYSNF 228 (337)
T ss_dssp EBCCCTTCBCCSSCC------------------------------------------------------------CCTTS
T ss_pred EEecCccceeccccCccccc-------------------cc----------ccccchhhccccCCCCcCChhhhhccccC
Confidence 99999999876432100000 00 00000011246799999999999 567
Q ss_pred CCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 334 GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 334 ~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
.++.++|||||||++|||++|.+||.+....... . .....+.....++.+.+||.+||. ||.+|+ ++.|+
T Consensus 229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~e~ 299 (337)
T 3ll6_A 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV----N--GKYSIPPHDTQYTVFHSLIRAMLQVNPEERL---SIAEV 299 (337)
T ss_dssp CSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC---CHHHH
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh----c--CcccCCcccccchHHHHHHHHHccCChhhCc---CHHHH
Confidence 7899999999999999999999999775543322 2 223344445778899999999999 999999 89999
Q ss_pred HcC
Q 038137 413 KAH 415 (549)
Q Consensus 413 l~H 415 (549)
++|
T Consensus 300 l~~ 302 (337)
T 3ll6_A 300 VHQ 302 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=384.56 Aligned_cols=252 Identities=21% Similarity=0.366 Sum_probs=210.9
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
...+..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345667889999999999999999999875 45699999976532 23568899999999999999999999876 6
Q ss_pred eEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+|||||+||+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999964 3569999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..... ......||+.|+|||++.+..|+.++|||||||++
T Consensus 332 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l 371 (452)
T 1fmk_A 332 DNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371 (452)
T ss_dssp ---------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------cccCCcccccccCHhHHhcCCCCccccHHhHHHHH
Confidence 21100 00134678899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|||++ |.+||.+.+..+....+... ...|.+..+++++.+||.+||. ||.+|+ ++++|+.
T Consensus 372 ~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~~l~~ 433 (452)
T 1fmk_A 372 TELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 433 (452)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCc---CHHHHHH
Confidence 99999 99999988877777766542 2333334789999999999999 999999 7888876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=385.89 Aligned_cols=271 Identities=20% Similarity=0.258 Sum_probs=217.2
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCceEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~ly 193 (549)
..++|++++.||+|+||.||+|++..+|+.||||++...... ..+..|..++..+.| ++|+.+..++.+.+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 357899999999999999999999999999999998754322 237789999999987 56666777777888999
Q ss_pred EEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEE---cCCCcEEEeecCcccccCC
Q 038137 194 LIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILl---d~~g~vKL~DFGlak~~~~ 269 (549)
|||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++++||+|||+|+.+..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999965 5689999999999999999999999999999999999999 6899999999999987643
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
...... . + .......+||+.|+|||++.+..|+.++||||||||||
T Consensus 159 ~~~~~~----------------~---~---------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ 204 (483)
T 3sv0_A 159 TSTHQH----------------I---P---------------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204 (483)
T ss_dssp TTTCCB----------------C---C---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred Cccccc----------------c---c---------------cccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHH
Confidence 211000 0 0 00012568999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCch---hhhhhhhhccccccCC-CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH----------c
Q 038137 350 EMLVGYPPFYSDEPM---STCRKIVNWRTHLKFP-EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK----------A 414 (549)
Q Consensus 350 Eml~G~~PF~~~~~~---~~~~~I~~~~~~l~~p-~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil----------~ 414 (549)
||++|.+||.+.... ..+.++.........+ ....+++++.+||.+||. +|.+|+ ++++|+ .
T Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RP---s~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCC---CHHHHHHHHHHHHHHTT
T ss_pred HHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCc---CHHHHHHHHHHHHHHcC
Confidence 999999999875543 2333333211100000 013678999999999999 999999 565543 5
Q ss_pred CCcccCCCcccccc
Q 038137 415 HPWFKGIEWDKLYQ 428 (549)
Q Consensus 415 HpfF~~i~w~~l~~ 428 (549)
|+|+..+||+.+..
T Consensus 282 ~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 282 FQFDYVFDWTILKY 295 (483)
T ss_dssp CCCSSCCHHHHHTC
T ss_pred CCccCCcCchhhcc
Confidence 89999999998763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=394.68 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=210.4
Q ss_pred cCCCCCeeeee-eeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 113 KMGADDFEPLT-MIGKGAFGEVRVCREK--ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 113 ~~~~~~f~~~~-~IG~G~fG~V~l~~~k--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
.+..+++.+.. .||+|+||.||+|.++ .++..||||++++.. .....+.+.+|+.+|..++|||||+++++|.+
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 34556677777 8999999999999876 356679999997652 33456779999999999999999999999987
Q ss_pred ceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 5699999999999999998654 569999999999999999999999999999999999999999999999999998753
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... .......||+.|+|||++.+..|+.++|||||||+|
T Consensus 488 ~~~~~~--------------------------------------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l 529 (613)
T 2ozo_A 488 ADDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529 (613)
T ss_dssp ----------------------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCcee--------------------------------------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHH
Confidence 211000 000123577899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
|||++ |.+||.+.+..+....|... ..+.+| ..+++++.+||.+||. ||.+|+ ++.+|+
T Consensus 530 ~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~~l~ 590 (613)
T 2ozo_A 530 WEALSYGQKPYKKMKGPEVMAFIEQG-KRMECP--PECPPELYALMSDCWIYKWEDRP---DFLTVE 590 (613)
T ss_dssp HHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSTTTSC---CHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 99998 99999998888877777653 234444 3789999999999999 999999 677764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=370.86 Aligned_cols=253 Identities=15% Similarity=0.205 Sum_probs=201.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCC--------CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceee------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKAT--------GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVK------ 181 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~t--------g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~------ 181 (549)
.++|++.+.||+|+||.||+|+++.+ ++.||||++.+. ..+.+|+.++..++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 57899999999999999999999874 889999999754 24778999999999999998
Q ss_pred ---------eeeeecC-CceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeE
Q 038137 182 ---------LYCSFQD-DEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLL 249 (549)
Q Consensus 182 ---------l~~~f~d-~~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNIL 249 (549)
+++++.. +..+|+||||+ ||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 4445543 78899999999 99999999875 78999999999999999999999999999999999999
Q ss_pred EcCCC--cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCc
Q 038137 250 LDRNG--HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327 (549)
Q Consensus 250 ld~~g--~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~AP 327 (549)
++.++ .+||+|||+|+.+......... ........+||+.|+||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~----------------------------------~~~~~~~~~gt~~y~aP 237 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY----------------------------------VEGSRSPHEGDLEFISM 237 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCC----------------------------------CTTSSCTTCSCTTTCCH
T ss_pred EcCCCCceEEEecCcceeeccCCCccccc----------------------------------cccccccccCCccccCH
Confidence 99998 9999999999876432100000 00001245899999999
Q ss_pred hhhccCCCCcccccchhhHHHHHHhhCCCCCCCCC-chh-hhhhhhhcc-ccccCCC----CcCCChhHHHHHHHhhh-c
Q 038137 328 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDE-PMS-TCRKIVNWR-THLKFPE----EAKLSPEAKDLISKLLC-N 399 (549)
Q Consensus 328 Evl~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~-~~~-~~~~I~~~~-~~l~~p~----~~~~s~~~~dLI~~lL~-d 399 (549)
|++.+..|+.++|||||||++|||++|..||.+.. ... ....+.... ....++. ...+++++.+||.+||. |
T Consensus 238 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 238 DLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCC
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCC
Confidence 99999999999999999999999999999998764 222 222221111 1111111 13579999999999999 9
Q ss_pred ccccCCCCCHHHHHc
Q 038137 400 VEQRLGTKGADEIKA 414 (549)
Q Consensus 400 p~~Rl~~~~~~eil~ 414 (549)
|.+|+ ++++|++
T Consensus 318 p~~Rp---s~~~l~~ 329 (352)
T 2jii_A 318 YEEKP---PYAMLRN 329 (352)
T ss_dssp TTCCC---CHHHHHH
T ss_pred hhhCC---CHHHHHH
Confidence 99999 7888764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=366.20 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=193.9
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHH--HhcCCCceeeeeeee---
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL--AEVDSNCIVKLYCSF--- 186 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL--~~l~hp~Iv~l~~~f--- 186 (549)
..+..++|++++.||+|+||.||+|+. +++.||||++.... ...+..|..++ ..++||||+++++.+
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 356789999999999999999999976 68999999997543 23344455554 458999999998733
Q ss_pred --cCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeecCCCCCCeEEcCCCc
Q 038137 187 --QDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH---------NYIHRDIKPDNLLLDRNGH 255 (549)
Q Consensus 187 --~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------giiHRDLKPeNILld~~g~ 255 (549)
.+...+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||+. |||||||||+|||++.+|.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 345578999999999999999954 4569999999999999999999999 9999999999999999999
Q ss_pred EEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---
Q 038137 256 MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--- 332 (549)
Q Consensus 256 vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--- 332 (549)
+||+|||+|+.+......... .......+.+||+.|+|||++.+
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~---------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPG---------------------------------EEDNAAISEVGTIRYMAPEVLEGAVN 205 (336)
T ss_dssp EEECCCTTCEECSSSSCC------------------------------------------CCTTSCGGGCCHHHHTTCCC
T ss_pred EEEeeccceeecccccccCcc---------------------------------ccccccccCCCccceeCchhhcCCcc
Confidence 999999999876532111000 00001125689999999999987
Q ss_pred ----CCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhh------------------hhhccccccCCC----CcCCC
Q 038137 333 ----KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRK------------------IVNWRTHLKFPE----EAKLS 386 (549)
Q Consensus 333 ----~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~------------------I~~~~~~l~~p~----~~~~s 386 (549)
..++.++|||||||++|||++|..||........+.. +........+|. ...++
T Consensus 206 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
T 3g2f_A 206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285 (336)
T ss_dssp GGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHH
T ss_pred cccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchH
Confidence 4677899999999999999999777654332211111 111111222332 12244
Q ss_pred hhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 387 PEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 387 ~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+++.+||.+||. ||.+|+ ++.|+++
T Consensus 286 ~~l~~li~~cl~~dP~~Rp---s~~e~l~ 311 (336)
T 3g2f_A 286 RSLKETIEDCWDQDAEARL---TAQXAEE 311 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCc---chHHHHH
Confidence 579999999999 999999 7888853
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=374.18 Aligned_cols=254 Identities=18% Similarity=0.291 Sum_probs=202.6
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeee-cCCceE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATG---HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSF-QDDEYL 192 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~d~~~l 192 (549)
..|++.+.||+|+||.||+|....++ ..||+|.+... ......+.+.+|..+|+.++|||||++++++ .+++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 34888999999999999999986443 46899998653 2345567799999999999999999999975 456788
Q ss_pred EEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999654 468999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
... ........||+.|+|||++.+..|+.++|||||||++|||
T Consensus 247 ~~~-------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 289 (373)
T 3c1x_A 247 FDS-------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289 (373)
T ss_dssp ------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ccc-------------------------------------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 000 0001135688999999999999999999999999999999
Q ss_pred hh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 352 LV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 352 l~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+|+ ++.+++++
T Consensus 290 lt~~~~p~~~~~~~~~~~~~~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~RP---s~~ell~~ 349 (373)
T 3c1x_A 290 MTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 349 (373)
T ss_dssp HTTSCCSCTTSCSSCHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HhCcCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCc---CHHHHHHH
Confidence 99 788998877777666665532 22333 4789999999999999 999999 78888863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=396.48 Aligned_cols=246 Identities=24% Similarity=0.345 Sum_probs=206.6
Q ss_pred eeeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecC
Q 038137 123 TMIGKGAFGEVRVCRE--KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~--k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
+.||+|+||.||+|.+ +.+++.||||+++... ......+.+.+|+.+|..++|||||++++++.+ +.+|+|||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999955 4677899999997653 334456789999999999999999999999975 45899999999
Q ss_pred CCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccccc
Q 038137 201 GGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280 (549)
Q Consensus 201 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~ 280 (549)
||+|.+++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~------ 526 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 526 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc------
Confidence 99999999888899999999999999999999999999999999999999999999999999998764221000
Q ss_pred CCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCC
Q 038137 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 359 (549)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~ 359 (549)
.......||+.|+|||++.+..|+.++|||||||+||||++ |.+||.
T Consensus 527 --------------------------------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 527 --------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp ----------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred --------------------------------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 00113467889999999999999999999999999999998 999999
Q ss_pred CCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 360 SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 360 ~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+.+..+....+... .....| ..+++++.+||.+||. ||.+|+ ++++|+.
T Consensus 575 ~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~~l~~ 624 (635)
T 4fl3_A 575 GMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVEL 624 (635)
T ss_dssp TCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred CCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 98887777766653 233444 4789999999999999 999999 7888764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.43 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=205.7
Q ss_pred CCCCe-eeeeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-
Q 038137 115 GADDF-EPLTMIGKGAFGEVRVCRE----KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD- 188 (549)
Q Consensus 115 ~~~~f-~~~~~IG~G~fG~V~l~~~----k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d- 188 (549)
..++| ++++.||+|+||.||+|.. ..+|+.||||++.+.. .......+.+|+.+|+.++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34444 9999999999999988864 4578999999997652 33445678999999999999999999999986
Q ss_pred -CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 189 -DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 189 -~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
...+|+||||++||+|.+++.+ ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 4789999999999999999965 45999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
....... .......||+.|+|||++.+..++.++|||||||+
T Consensus 185 ~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 226 (318)
T 3lxp_A 185 PEGHEYY--------------------------------------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226 (318)
T ss_dssp CTTCSEE--------------------------------------EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred ccccccc--------------------------------------ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHH
Confidence 4221000 00113578899999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCchh--------------hhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 348 MYEMLVGYPPFYSDEPMS--------------TCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~--------------~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
+|+|++|..||....... .....+. .....+....+++++.+||.+||. ||.+|+ ++.++
T Consensus 227 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---s~~el 301 (318)
T 3lxp_A 227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE--RGERLPRPDKCPAEVYHLMKNCWETEASFRP---TFENL 301 (318)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred HHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh--cccCCCCCccccHHHHHHHHHHcCCCcccCc---CHHHH
Confidence 999999999997542210 1111222 122333345789999999999999 999999 79988
Q ss_pred Hc
Q 038137 413 KA 414 (549)
Q Consensus 413 l~ 414 (549)
++
T Consensus 302 l~ 303 (318)
T 3lxp_A 302 IP 303 (318)
T ss_dssp HH
T ss_pred HH
Confidence 84
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=404.55 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=209.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC------C
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD------D 189 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------~ 189 (549)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... .....+.+.+|+.+|..++|||||++++++.+ .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478999999999999999999999999999999987542 34455678999999999999999999998876 6
Q ss_pred ceEEEEEeecCCCchhhHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc---EEEeecCc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH---MKLSDFGL 263 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~---vKL~DFGl 263 (549)
+..|+|||||+||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+|. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999997644 6999999999999999999999999999999999999998775 99999999
Q ss_pred ccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccch
Q 038137 264 CKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343 (549)
Q Consensus 264 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWS 343 (549)
+........ ....+||+.|+|||++.+..|+.++||||
T Consensus 171 a~~~~~~~~------------------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwS 208 (676)
T 3qa8_A 171 AKELDQGEL------------------------------------------CTEFVGTLQYLAPELLEQKKYTVTVDYWS 208 (676)
T ss_dssp CCBTTSCCC------------------------------------------CCCCCSCCTTCSSCSSCCSCCSTTHHHHH
T ss_pred ccccccccc------------------------------------------cccccCCcccCChHHhccCCCCchhHHHH
Confidence 986542210 11468999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCCchhhhhhh------------------hhccccccCCC--CcCCChhHHHHHHHhhh-cccc
Q 038137 344 LGAIMYEMLVGYPPFYSDEPMSTCRKI------------------VNWRTHLKFPE--EAKLSPEAKDLISKLLC-NVEQ 402 (549)
Q Consensus 344 lGvilyEml~G~~PF~~~~~~~~~~~I------------------~~~~~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~ 402 (549)
|||++|+|++|..||.+......+... ..+...++.|. ...+++.+.+||.+||+ ||.+
T Consensus 209 LGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~k 288 (676)
T 3qa8_A 209 FGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ 288 (676)
T ss_dssp HHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC-
T ss_pred HHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhh
Confidence 999999999999999764322111100 01111111111 12367889999999999 9999
Q ss_pred cCCCCCHHHHHcCCcccCC
Q 038137 403 RLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 403 Rl~~~~~~eil~HpfF~~i 421 (549)
|+ ++.+++.||||+.+
T Consensus 289 RP---Ta~elL~hp~F~~l 304 (676)
T 3qa8_A 289 RG---TDPQNPNVGCFQAL 304 (676)
T ss_dssp -----CCTTCCCCTTHHHH
T ss_pred Cc---CHHHHhcCHHHHHH
Confidence 99 79999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=381.00 Aligned_cols=251 Identities=17% Similarity=0.210 Sum_probs=199.5
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-Cce--------------
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCI-------------- 179 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~I-------------- 179 (549)
....|...++||+|+||.||+|++..+|+.||||++...........+.+.+|..++..+.| +++
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34558889999999999999999999999999999985443333445678899999998876 211
Q ss_pred -ee------eeeeecC-----CceEEEEEeecCCCchhhHhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Q 038137 180 -VK------LYCSFQD-----DEYLYLIMEYLPGGDMMTLLMR-------KDTLTEEEARFYVGETVLAIESIHKHNYIH 240 (549)
Q Consensus 180 -v~------l~~~f~d-----~~~lylVmEy~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~giiH 240 (549)
+. ++..+.. ...+|++|+++ +|+|.+++.. ...+++..+..++.||+.||.|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11 1111121 22467888876 7899998841 345788889999999999999999999999
Q ss_pred cCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeeccc
Q 038137 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVG 320 (549)
Q Consensus 241 RDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vG 320 (549)
|||||+||||+.+|.+||+|||+|+..... ..+.+|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~g 270 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------------------------------------------AVSPIG 270 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--------------------------------------------ECCCCC
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--------------------------------------------cccCCC
Confidence 999999999999999999999998864311 124688
Q ss_pred CCCCCCchhh----------ccCCCCcccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHH
Q 038137 321 TPDYIAPEVL----------LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAK 390 (549)
Q Consensus 321 T~~Y~APEvl----------~~~~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~ 390 (549)
+.|+|||++ .+..|+.++|||||||++|||++|+.||.+.+.......++. ....+|++++
T Consensus 271 -~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~ 341 (413)
T 3dzo_A 271 -RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVR 341 (413)
T ss_dssp -TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHH
T ss_pred -CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHH
Confidence 999999999 556689999999999999999999999998777666555543 2236789999
Q ss_pred HHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 391 dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+||.+||. ||.+|+ ++.++++||||+.+.
T Consensus 342 ~li~~~l~~dP~~Rp---t~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 342 ALLEGFLRYPKEDRL---LPLQAMETPEYEQLR 371 (413)
T ss_dssp HHHHHHTCSSGGGSC---CHHHHTTSHHHHHHH
T ss_pred HHHHHHccCChhhCc---CHHHHHhCHHHHHHH
Confidence 99999999 999999 899999999998763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=360.37 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=197.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc--CCCceeeeeeeecCC--
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV--DSNCIVKLYCSFQDD-- 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~d~-- 189 (549)
...++|++++.||+|+||.||+|++. |+.||||++.... ......|.+++..+ +||||+++++++.+.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33467999999999999999999875 8899999986542 23345566666554 999999999998876
Q ss_pred --ceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeecCCCCCCeEEcCCCcEEEe
Q 038137 190 --EYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH--------NYIHRDIKPDNLLLDRNGHMKLS 259 (549)
Q Consensus 190 --~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------giiHRDLKPeNILld~~g~vKL~ 259 (549)
..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||++ |||||||||+|||++.+|++||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999954 5799999999999999999999998 99999999999999999999999
Q ss_pred ecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcc-
Q 038137 260 DFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGME- 338 (549)
Q Consensus 260 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~- 338 (549)
|||+|+.+....... .....+.+||+.|+|||++.+..++..
T Consensus 185 Dfg~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 227 (337)
T 3mdy_A 185 DLGLAVKFISDTNEV-------------------------------------DIPPNTRVGTKRYMPPEVLDESLNRNHF 227 (337)
T ss_dssp CCTTCEECC----------------------------------------------CCSSCSCGGGCCHHHHTTCCCTTCT
T ss_pred eCCCceeeccccccc-------------------------------------cCCCCCCccCcceeChhhcccccCCccc
Confidence 999998654221000 000124589999999999988777665
Q ss_pred -----cccchhhHHHHHHhhC----------CCCCCCCCch----hhhhhhhhc-cccccCCC---CcCCChhHHHHHHH
Q 038137 339 -----CDWWSLGAIMYEMLVG----------YPPFYSDEPM----STCRKIVNW-RTHLKFPE---EAKLSPEAKDLISK 395 (549)
Q Consensus 339 -----~DiWSlGvilyEml~G----------~~PF~~~~~~----~~~~~I~~~-~~~l~~p~---~~~~s~~~~dLI~~ 395 (549)
+|||||||++|||++| ..||...... .....++.. .....+|. ...+++++.+||.+
T Consensus 228 ~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 307 (337)
T 3mdy_A 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHH
T ss_pred cCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHH
Confidence 9999999999999999 7777653322 122222211 11222222 12456779999999
Q ss_pred hhh-cccccCCCCCHHHHHcC
Q 038137 396 LLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 396 lL~-dp~~Rl~~~~~~eil~H 415 (549)
||+ ||.+|+ ++.+|++|
T Consensus 308 ~l~~dP~~Rp---s~~ell~~ 325 (337)
T 3mdy_A 308 CWAHNPASRL---TALRVKKT 325 (337)
T ss_dssp HSCSSGGGSC---CHHHHHHH
T ss_pred hhhhChhhCC---CHHHHHHH
Confidence 999 999999 79998874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=387.79 Aligned_cols=253 Identities=21% Similarity=0.369 Sum_probs=215.0
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
...++..++|++.+.||+|+||.||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++|||||++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3455677889999999999999999999875 45799999976532 23568899999999999999999999876
Q ss_pred ceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 6789999999999999999643 56999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
...... ......||+.|+|||++.+..|+.++|||||||+
T Consensus 414 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~ 453 (535)
T 2h8h_A 414 EDNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 453 (535)
T ss_dssp CCHHHH----------------------------------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CCCcee----------------------------------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHH
Confidence 321000 0013467889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 348 MYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 348 lyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
||||++ |..||.+....+....+... ...+....+++++.+||.+||. ||.+|+ ++++|+.
T Consensus 454 l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~~l~~ 516 (535)
T 2h8h_A 454 LTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQA 516 (535)
T ss_dssp HHHHTTTTCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 999999 99999988877777766542 2333334789999999999999 999999 7888876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=355.78 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=203.1
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-hchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM-LRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
|...+.||+|+||.||+|.. ++..||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 33458999999999999985 688999999976432 233445778999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 198 YLPGGDMMTLLMR---KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 198 y~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT- 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-
Confidence 9999999999864 346999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
......+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 190 --------------------------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 190 --------------------------------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp --------------------------------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred --------------------------------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence 00113579999999999865 589999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhcccc----------ccCC-CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTH----------LKFP-EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~----------l~~p-~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
.+||.+.........+...... ..++ .....++.+.+||.+||. ||.+|+ ++.+|++|
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~l~~~ 300 (307)
T 2nru_A 231 LPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP---DIKKVQQL 300 (307)
T ss_dssp CCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred CCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCc---CHHHHHHH
Confidence 9999876655444333221000 0011 112345779999999999 999999 79988863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.88 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=211.3
Q ss_pred hhhcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 108 RLQRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 108 ~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
.+....+..++|++.+.||+|+||.||+|.+.. .||+|++..... .....+.+.+|+.++..++||||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 446677889999999999999999999999864 399999976432 2223345778999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
+...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++.
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999999997654 799999999999999999999999999999999999998 78999999999876
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---------CCCCc
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---------KGYGM 337 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---------~~y~~ 337 (549)
........ .........||+.|+|||++.+ ..|+.
T Consensus 179 ~~~~~~~~------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~ 222 (319)
T 2y4i_B 179 SGVLQAGR------------------------------------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222 (319)
T ss_dssp ---------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCH
T ss_pred cccccccc------------------------------------cccccccCCCcccccChHHhhhccccccccccCCCc
Confidence 43111000 0001124579999999999975 45799
Q ss_pred ccccchhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 338 ECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 338 ~~DiWSlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++|||||||++|||++|..||.+.+.......+..... .......+++++.+||.+||. ||.+|+ ++.++++
T Consensus 223 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~l~~ 295 (319)
T 2y4i_B 223 HSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK--PNLSQIGMGKEISDILLFCWAFEQEERP---TFTKLMD 295 (319)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC--CCCCCSSCCTTHHHHHHHHHCSSTTTSC---CHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC--CCCCcCCCCHHHHHHHHHHhcCChhhCc---CHHHHHH
Confidence 99999999999999999999998887777666654322 112223688999999999999 999999 7999886
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=358.77 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=208.0
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCR----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~----~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
..+..++|++++.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 34566789999999999999999998 4668999999999764 2345567899999999999999999999887
Q ss_pred CCc--eEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 188 DDE--YLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 188 d~~--~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
+.+ .+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 654 789999999999999999765 56999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+......... .......||+.|+|||++.+..++.++|||||
T Consensus 193 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (326)
T 2w1i_A 193 KVLPQDKEYY--------------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSF 234 (326)
T ss_dssp EECCSSCSEE--------------------------------------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred hhcccccccc--------------------------------------ccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence 8764221000 00013467888999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCch------------hh---hhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 345 GAIMYEMLVGYPPFYSDEPM------------ST---CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~------------~~---~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
||++|||++|..||...... .. ....+. .....|....+++++.+||.+||. ||.+|+ +
T Consensus 235 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s 309 (326)
T 2w1i_A 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK--NNGRLPRPDGCPDEIYMIMTECWNNNVNQRP---S 309 (326)
T ss_dssp HHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH--TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC---C
T ss_pred HHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh--cCCCCCCCCcccHHHHHHHHHHcCCChhhCc---C
Confidence 99999999999998643110 00 111111 112233335789999999999999 999999 7
Q ss_pred HHHHHc
Q 038137 409 ADEIKA 414 (549)
Q Consensus 409 ~~eil~ 414 (549)
+.+|++
T Consensus 310 ~~el~~ 315 (326)
T 2w1i_A 310 FRDLAL 315 (326)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=390.05 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=213.7
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
...+..++|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.+|+.++|||||++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3455667899999999999999999998654 4679999986532 2344567899999999999999999999985
Q ss_pred CCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
+ +.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 4 5689999999999999999754 4799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
....... ......||+.|+|||++.+..|+.++|||||||
T Consensus 541 ~~~~~~~----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 580 (656)
T 2j0j_A 541 MEDSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580 (656)
T ss_dssp CCC--------------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCCcce----------------------------------------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHH
Confidence 5421100 011346788999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 347 IMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 347 ilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++|||++ |.+||.+.+..+....+... ..+.+| ..+++++.+||.+||. ||.+|+ ++.+|++
T Consensus 581 il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~RP---s~~el~~ 644 (656)
T 2j0j_A 581 CMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKA 644 (656)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccccHHHHHHHHHHcCCChhHCc---CHHHHHH
Confidence 9999997 99999998888777777653 223344 4789999999999999 999999 7888875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=356.42 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=200.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh--cCCCceeeeeeeecCCc---
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE--VDSNCIVKLYCSFQDDE--- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~d~~--- 190 (549)
.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|..++.. ++||||+++++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 35799999999999999999987 58999999986542 3457788999887 79999999999998776
Q ss_pred -eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeecCCCCCCeEEcCCCcEEEeec
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH--------KHNYIHRDIKPDNLLLDRNGHMKLSDF 261 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~giiHRDLKPeNILld~~g~vKL~DF 261 (549)
.+|+||||++||+|.+++.+ ..+++..+..++.|++.||.||| +.||+||||||+|||++.+|++||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999965 57999999999999999999999 899999999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC------CC
Q 038137 262 GLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK------GY 335 (549)
Q Consensus 262 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~------~y 335 (549)
|+++......... .......+||+.|+|||++.+. .+
T Consensus 192 g~~~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 234 (342)
T 1b6c_B 192 GLAVRHDSATDTI-------------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFES 234 (342)
T ss_dssp TTCEEEETTTTEE-------------------------------------EECCCSCCCCGGGCCHHHHTSCCCTTCHHH
T ss_pred CCceecccccccc-------------------------------------ccccccCCcCcccCCHhhhccccccccccc
Confidence 9998654221000 0001245899999999999875 33
Q ss_pred CcccccchhhHHHHHHhhC----------CCCCCCCCch-----hhhhhhhhccccccCCCC---cCCChhHHHHHHHhh
Q 038137 336 GMECDWWSLGAIMYEMLVG----------YPPFYSDEPM-----STCRKIVNWRTHLKFPEE---AKLSPEAKDLISKLL 397 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~G----------~~PF~~~~~~-----~~~~~I~~~~~~l~~p~~---~~~s~~~~dLI~~lL 397 (549)
+.++|||||||++|||++| ..||...... .....+........+|.. ..+++.+.+||.+||
T Consensus 235 ~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (342)
T 1b6c_B 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 314 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHC
T ss_pred CCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHh
Confidence 4789999999999999999 7899765332 222223222222233321 133467899999999
Q ss_pred h-cccccCCCCCHHHHHcC
Q 038137 398 C-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 398 ~-dp~~Rl~~~~~~eil~H 415 (549)
. ||.+|+ ++.+|++|
T Consensus 315 ~~dp~~Rp---s~~~i~~~ 330 (342)
T 1b6c_B 315 YANGAARL---TALRIKKT 330 (342)
T ss_dssp CSSGGGSC---CHHHHHHH
T ss_pred ccChhhCC---CHHHHHHH
Confidence 9 999999 79998875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.54 Aligned_cols=225 Identities=12% Similarity=0.111 Sum_probs=189.9
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||+|+||.||+|++..+|+.||||++.............+.+|..++..++|||||++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 55678999999999999999999999999999999998765544556678899999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
+||||++|++|.+++.+ + .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999854 3 4666788899999999999999999999999999999999999987544
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
|++ .++.++|||||||++|||++
T Consensus 175 --------------------------------------------------~~~-------~~~~~~Di~slG~il~ellt 197 (286)
T 3uqc_A 175 --------------------------------------------------TMP-------DANPQDDIRGIGASLYALLV 197 (286)
T ss_dssp --------------------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------------------------ccC-------CCCchhHHHHHHHHHHHHHH
Confidence 333 37899999999999999999
Q ss_pred CCCCCCCCCchhhhh---hhhhccccccCC--CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 354 GYPPFYSDEPMSTCR---KIVNWRTHLKFP--EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 354 G~~PF~~~~~~~~~~---~I~~~~~~l~~p--~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
|++||.+.+...... +++. .....+ ....+++++++||.+||. ||.+| ++.|+++
T Consensus 198 g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R----s~~el~~ 258 (286)
T 3uqc_A 198 NRWPLPEAGVRSGLAPAERDTA--GQPIEPADIDRDIPFQISAVAARSVQGDGGIR----SASTLLN 258 (286)
T ss_dssp SEECSCCCSBCCCSEECCBCTT--SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC----CHHHHHH
T ss_pred CCCCCCcCCcchhhHHHHHHhc--cCCCChhhcccCCCHHHHHHHHHHcccCCccC----CHHHHHH
Confidence 999999877654331 2222 111111 124689999999999999 99999 4888875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=387.92 Aligned_cols=243 Identities=22% Similarity=0.303 Sum_probs=200.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKA-TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
.+..++|++++.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+|..++|||||+++++|.+.+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 3446899999999999999999999976 79999999987532 23445678899999999999999999999986655
Q ss_pred -----EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 192 -----LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 192 -----lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
+||||||++|++|..++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ ++||+|||+++.
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 79999999999999999999999999999999999999875 999999999986
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
+... ...+||+.|+|||++.+. ++.++|||||||
T Consensus 231 ~~~~---------------------------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~ 264 (681)
T 2pzi_A 231 INSF---------------------------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGR 264 (681)
T ss_dssp TTCC---------------------------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHH
T ss_pred cccC---------------------------------------------CccCCCccccCHHHHcCC-CCCceehhhhHH
Confidence 5321 145799999999999764 589999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
++|+|++|.+||.+....... .......+++.+.+||.+||. ||.+|+ +..+++.|+|+.
T Consensus 265 ~l~~l~~g~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~R~---~~~~~l~~~l~~ 325 (681)
T 2pzi_A 265 TLAALTLDLPTRNGRYVDGLP----------EDDPVLKTYDSYGRLLRRAIDPDPRQRF---TTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHSCCCEETTEECSSCC----------TTCHHHHHCHHHHHHHHHHTCSSGGGSC---SSHHHHHHHHHH
T ss_pred HHHHHHhCCCCCccccccccc----------ccccccccCHHHHHHHhhhccCChhhCC---CHHHHHHHHHHH
Confidence 999999999999763211110 000111357889999999999 999999 667788888875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=333.08 Aligned_cols=189 Identities=17% Similarity=0.196 Sum_probs=139.5
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------chhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCceEEEEE
Q 038137 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEML-------RRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 125 IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++.|++|.+..++...+|+.||||++.+.... .....+.+.+|+++|+++ .|+||++++++|+++..+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 46788888888888889999999999865321 223345689999999999 7999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||+||+|.++|.+.+.+++. .|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~----- 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC----- 393 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--------
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-----
Confidence 999999999999988889875 478999999999999999999999999999999999999999998754211
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
....+.|||+.|||||++.+ .+..++|+||+|+++|+|++|..
T Consensus 394 ------------------------------------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 ------------------------------------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ------------------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred ------------------------------------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 01125799999999999975 46788999999999999988776
Q ss_pred CC
Q 038137 357 PF 358 (549)
Q Consensus 357 PF 358 (549)
||
T Consensus 437 ~~ 438 (569)
T 4azs_A 437 NW 438 (569)
T ss_dssp HH
T ss_pred hh
Confidence 65
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=284.20 Aligned_cols=192 Identities=18% Similarity=0.201 Sum_probs=148.3
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-----RRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
.++||+|+||.||+| ...+..+|+|++...... .....+.+.+|+.+|..++||||+++..++.+.+..||||
T Consensus 341 ~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 468999999999999 445788999987543221 1223456899999999999999995555555666779999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||+||+|.+++.. +..++.|++.||.|||++|||||||||+|||++. ++||+|||+|+........
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~--- 485 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK--- 485 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH---
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc---
Confidence 99999999999865 6789999999999999999999999999999998 9999999999876421000
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc--CCCCcccccchhhHHHHHHhhC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEml~G 354 (549)
.. +......+.+||+.|||||++.. .+|+..+|+||.++-..+.+.+
T Consensus 486 ---------------------------~~----~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~ 534 (540)
T 3en9_A 486 ---------------------------AV----DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVER 534 (540)
T ss_dssp ---------------------------HH----HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHT
T ss_pred ---------------------------cc----chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHh
Confidence 00 00001226799999999999987 7899999999999999999888
Q ss_pred CCCCC
Q 038137 355 YPPFY 359 (549)
Q Consensus 355 ~~PF~ 359 (549)
+.+|.
T Consensus 535 r~rY~ 539 (540)
T 3en9_A 535 RARYV 539 (540)
T ss_dssp CSCCC
T ss_pred ccccC
Confidence 87763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=241.47 Aligned_cols=133 Identities=14% Similarity=0.130 Sum_probs=108.9
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---------------hhHHHHHHHHHHHHhcCCCceeeeeee
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR---------------GQVEHVKAERNLLAEVDSNCIVKLYCS 185 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~---------------~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 185 (549)
+.+.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|..+|..++ | ++++.+
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 349999999999999999 8899999999975432111 13456889999999998 4 666665
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
+.. +.+|+|||||+||+|.+ +. ...+..++.|++.||.|||++|||||||||+|||++ +|++||+|||+|+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred Eec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 543 56799999999999988 42 134567999999999999999999999999999999 9999999999875
Q ss_pred c
Q 038137 266 P 266 (549)
Q Consensus 266 ~ 266 (549)
.
T Consensus 241 ~ 241 (282)
T 1zar_A 241 E 241 (282)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=200.91 Aligned_cols=142 Identities=15% Similarity=0.128 Sum_probs=110.5
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhc---------------------hhhHHHHHHHHHHHHhc
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHV--YAMKKLKKSEMLR---------------------RGQVEHVKAERNLLAEV 174 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~--vAiK~l~k~~~~~---------------------~~~~~~~~~E~~iL~~l 174 (549)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|..+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999999888999 9999976532110 01123578899999999
Q ss_pred CCCce--eeeeeeecCCceEEEEEeecCC-C----chhhHhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCCC
Q 038137 175 DSNCI--VKLYCSFQDDEYLYLIMEYLPG-G----DMMTLLMRKDTLTEEEARFYVGETVLAIESIH-KHNYIHRDIKPD 246 (549)
Q Consensus 175 ~hp~I--v~l~~~f~d~~~lylVmEy~~g-g----~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHRDLKPe 246 (549)
.|++| +.++.. ...||||||+.+ | .|..+... +++..+..++.|++.||.||| ++|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87754 334432 356899999942 4 55554422 345678899999999999999 999999999999
Q ss_pred CeEEcCCCcEEEeecCcccccC
Q 038137 247 NLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 247 NILld~~g~vKL~DFGlak~~~ 268 (549)
|||++. +++|+|||+|....
T Consensus 201 NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SEEESS--SEEECCCTTCEETT
T ss_pred HEEEcC--cEEEEECcccccCC
Confidence 999998 99999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=8.6e-20 Score=190.88 Aligned_cols=139 Identities=14% Similarity=0.178 Sum_probs=99.7
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----------chhhHHH--------HHHHHHHHHhcCCCce
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML-----------RRGQVEH--------VKAERNLLAEVDSNCI 179 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~-----------~~~~~~~--------~~~E~~iL~~l~hp~I 179 (549)
|.+...||.|+||.||+|.+. +|+.||||+++..... ....... ...|...|..+.+..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999975 6999999998643211 0001111 2334555555533332
Q ss_pred e--eeeeeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC---
Q 038137 180 V--KLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG--- 254 (549)
Q Consensus 180 v--~l~~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g--- 254 (549)
. ..+.. ...+|||||++|+.|..+.. .+.++.++.||+.||.+||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 1 11111 12369999999998876542 234567889999999999999999999999999999887
Q ss_pred -------cEEEeecCcccccC
Q 038137 255 -------HMKLSDFGLCKPLD 268 (549)
Q Consensus 255 -------~vKL~DFGlak~~~ 268 (549)
.+.|+||+-+....
T Consensus 246 d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CTTSEEEEEEECCCTTCEETT
T ss_pred cccccccceEEEEeCCcccCC
Confidence 48999999887643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.1e-12 Score=129.35 Aligned_cols=140 Identities=12% Similarity=0.072 Sum_probs=111.4
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylV 195 (549)
+.|++...+|.|+++.||.+.. .+..|++|+....... ....+.+|..+|..+. +..++++++++.+.+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 4688899999999999999874 3678999998653211 1234788999998884 66788999998888899999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK---------------------------------------- 235 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 235 (549)
|||++|.+|...+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999877531 223345678889999999998
Q ss_pred -------------------CCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 236 -------------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 236 -------------------~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
..++|+|++|.|||++.++.+.|+||+.|..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765667999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=4.5e-12 Score=123.97 Aligned_cols=136 Identities=13% Similarity=0.090 Sum_probs=100.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc--eeeeeeeecCCceEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC--IVKLYCSFQDDEYLY 193 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~d~~~ly 193 (549)
..+|.+..+.+.|..+.||++.. .+|..|++|+..... ...+.+|..+|..+.+.. ++++++++.+.+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34566654445666799999864 567789999875431 134678888888875433 567888888888899
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN------------------------------------ 237 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g------------------------------------ 237 (549)
+||||++|.+|. .. ..+ ...++.+++.+|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998884 21 122 2245667777777777643
Q ss_pred ----------------------eeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 238 ----------------------YIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 238 ----------------------iiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=4.7e-11 Score=123.55 Aligned_cols=143 Identities=18% Similarity=0.274 Sum_probs=108.1
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEee--chhhhchhhHHHHHHHHHHHHhcC--CCceeeeeeeecCC---ce
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLK--KSEMLRRGQVEHVKAERNLLAEVD--SNCIVKLYCSFQDD---EY 191 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~--k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~d~---~~ 191 (549)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+|..+. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 334678999999999998754 4678899875 33211 11235778999999886 34588888888776 45
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK------------------------------------ 235 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------ 235 (549)
.|+||||++|..+.+.. ...+++.....++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 89999999998875422 2357888889999999999999997
Q ss_pred ----------------------CCeeecCCCCCCeEEcCCCc--EEEeecCccccc
Q 038137 236 ----------------------HNYIHRDIKPDNLLLDRNGH--MKLSDFGLCKPL 267 (549)
Q Consensus 236 ----------------------~giiHRDLKPeNILld~~g~--vKL~DFGlak~~ 267 (549)
.++||+|++|.|||++.++. +.|+||+.|...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999998763 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2.6e-11 Score=122.57 Aligned_cols=134 Identities=19% Similarity=0.223 Sum_probs=99.6
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCc--eeeeeeeecCCc---eEEEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNC--IVKLYCSFQDDE---YLYLI 195 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~--Iv~l~~~f~d~~---~lylV 195 (549)
++.++.|.++.||++. ..+++|+.... .....+.+|..+|..+. +.. +.+++....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999874 45889986433 23456888999998873 322 445555544433 34899
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK---------------------------------------- 235 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 235 (549)
|++++|..|..... ..++.++...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875432 457788888888888888888885
Q ss_pred ------------------CCeeecCCCCCCeEEcC--CCcEEEeecCccccc
Q 038137 236 ------------------HNYIHRDIKPDNLLLDR--NGHMKLSDFGLCKPL 267 (549)
Q Consensus 236 ------------------~giiHRDLKPeNILld~--~g~vKL~DFGlak~~ 267 (549)
..++|+|++|.|||++. .+.+.|+||+.+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 23799999999999998 456799999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=3e-07 Score=92.96 Aligned_cols=134 Identities=15% Similarity=0.155 Sum_probs=92.8
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC---ceeeeeeeec-CCceEEEEEe
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN---CIVKLYCSFQ-DDEYLYLIME 197 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~f~-d~~~lylVmE 197 (549)
++.++.|....||++ |..+++|+-... .....+.+|..+|..+.+. .|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 567899999999988 566888885322 2345688999999988642 2556555553 4566789999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK------------------------------------------ 235 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------------ 235 (549)
|++|..+..... ..++......++.++...|..||+
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988765321 233444444444555444444443
Q ss_pred ------------------CCeeecCCCCCCeEEcC---CCcE-EEeecCccccc
Q 038137 236 ------------------HNYIHRDIKPDNLLLDR---NGHM-KLSDFGLCKPL 267 (549)
Q Consensus 236 ------------------~giiHRDLKPeNILld~---~g~v-KL~DFGlak~~ 267 (549)
..++|+|++|.|||++. +|.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24699999999999987 4554 89999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=8.5e-07 Score=87.26 Aligned_cols=134 Identities=17% Similarity=0.168 Sum_probs=92.3
Q ss_pred eeeecCCe-EEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCceEEEEEeecCC
Q 038137 124 MIGKGAFG-EVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCIVKLYCSFQDDEYLYLIMEYLPG 201 (549)
Q Consensus 124 ~IG~G~fG-~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lylVmEy~~g 201 (549)
.+..|..| .||.......+..+.+|+-... ....+.+|..+|+.+.. --|.+++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 45556555 6898877777778999986533 33457889999887742 2367788888888999999999999
Q ss_pred CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 038137 202 GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK---------------------------------------------- 235 (549)
Q Consensus 202 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------------- 235 (549)
.++....... ......++.++...|..||.
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8776654221 11112233333333333332
Q ss_pred ------------CCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 236 ------------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 236 ------------~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
..++|+|+.|.|||++.++.+-|+||+.|...
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 12799999999999998777789999988753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=3.5e-07 Score=95.62 Aligned_cols=81 Identities=16% Similarity=0.191 Sum_probs=51.0
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-hch---hhHHHHHHHHHHHHhcCC--C-ceeeeeeeecCCceEE
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM-LRR---GQVEHVKAERNLLAEVDS--N-CIVKLYCSFQDDEYLY 193 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~-~~~---~~~~~~~~E~~iL~~l~h--p-~Iv~l~~~f~d~~~ly 193 (549)
.++.||.|.++.||++....+++.|++|....... ... .....+..|..+|..+.. | .+.+++++ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997666678899998653211 000 123456778888887632 3 34556654 334468
Q ss_pred EEEeecCCCc
Q 038137 194 LIMEYLPGGD 203 (549)
Q Consensus 194 lVmEy~~gg~ 203 (549)
+||||++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.31 E-value=5.6e-06 Score=83.82 Aligned_cols=137 Identities=11% Similarity=0.155 Sum_probs=78.9
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC--CCceeeeeee------ecCCceE
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD--SNCIVKLYCS------FQDDEYL 192 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~------f~d~~~l 192 (549)
-++.|+.|..+.||++... +..|++|+..... ..+..|..++..+. .-.|++++.. ..+.+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456777889999998753 3358999987521 22334555554442 1123444431 2345678
Q ss_pred EEEEeecCCCchh-----------hHh---hh-cCCC--C-----------HH--------H------------------
Q 038137 193 YLIMEYLPGGDMM-----------TLL---MR-KDTL--T-----------EE--------E------------------ 218 (549)
Q Consensus 193 ylVmEy~~gg~L~-----------~~l---~~-~~~l--~-----------e~--------~------------------ 218 (549)
|+||+|++|..+. ..| .. ...+ + .. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 111 11 0111 0 00 0
Q ss_pred -----HHHHHHHHHHHHHHHH-------------hCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 219 -----ARFYVGETVLAIESIH-------------KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 219 -----~~~~~~qi~~aL~~LH-------------~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
...++..+..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.|..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112222334566665 35799999999999998888999999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=6.6e-06 Score=84.39 Aligned_cols=84 Identities=8% Similarity=0.087 Sum_probs=56.3
Q ss_pred eeeeeee-eecCCeEEEEEEEc--C----CCcEEEEEEeechh---hhchhhHHHHHHHHHHHHhcCC---Cceeeeeee
Q 038137 119 FEPLTMI-GKGAFGEVRVCREK--A----TGHVYAMKKLKKSE---MLRRGQVEHVKAERNLLAEVDS---NCIVKLYCS 185 (549)
Q Consensus 119 f~~~~~I-G~G~fG~V~l~~~k--~----tg~~vAiK~l~k~~---~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~ 185 (549)
...++.| +.|..+.||++... . ++..+++|+..... .... ..+.+|..+|..+.. -.+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~---~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT---YRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC---CCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch---hHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3446778 88999999988653 1 25678899865432 1111 236678888877632 346778877
Q ss_pred ecCC---ceEEEEEeecCCCchh
Q 038137 186 FQDD---EYLYLIMEYLPGGDMM 205 (549)
Q Consensus 186 f~d~---~~lylVmEy~~gg~L~ 205 (549)
..+. ...|+||||++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 7665 3568999999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.90 E-value=4.3e-05 Score=80.46 Aligned_cols=33 Identities=12% Similarity=0.225 Sum_probs=29.0
Q ss_pred HhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 234 H~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+...++|+|++|.|||++.++ +.|+||+.|...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456799999999999999877 999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00019 Score=72.64 Aligned_cols=76 Identities=17% Similarity=0.143 Sum_probs=59.3
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC---CCceeeeeeeecCCceEEEEEe
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD---SNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d~~~lylVmE 197 (549)
-++.|+.|.+..||++.. ++..|++|+.... ....+..|...|+.+. ...|++++....+.+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457899999999999874 4678889987543 2455788888887773 3567888888887888999999
Q ss_pred ecCCCch
Q 038137 198 YLPGGDM 204 (549)
Q Consensus 198 y~~gg~L 204 (549)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00022 Score=71.33 Aligned_cols=133 Identities=12% Similarity=-0.018 Sum_probs=74.9
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEEEeec-
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLIMEYL- 199 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmEy~- 199 (549)
++.|+.|....+|++ ..|++|+....... .....+|..++..+. +....++++.+.+ .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecC
Confidence 788999999999998 45788987643110 011245776666553 2222566665543 346899999
Q ss_pred CCCchhhH---------------hh---hcC-CCC-----HHHHHHHHHH--------------HHHHHHHH----H---
Q 038137 200 PGGDMMTL---------------LM---RKD-TLT-----EEEARFYVGE--------------TVLAIESI----H--- 234 (549)
Q Consensus 200 ~gg~L~~~---------------l~---~~~-~l~-----e~~~~~~~~q--------------i~~aL~~L----H--- 234 (549)
+|..+... |. ..+ .+. ...+..+... +...+..| .
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66544321 10 000 011 1112222111 11111111 1
Q ss_pred -hCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 235 -KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 235 -~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
...++|+|+.|.||| ..+|.+.|+||..|...
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 124899999999999 56778999999988643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00022 Score=71.70 Aligned_cols=142 Identities=11% Similarity=0.076 Sum_probs=79.0
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc--eeeeeeee------cCC
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC--IVKLYCSF------QDD 189 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f------~d~ 189 (549)
...-++.|+.|....||++... +| .|++|+..... .. ..+..|..++..+.... +.+++... ...
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 3445678888999999998753 33 68899886521 11 23456777776653211 33443221 123
Q ss_pred ceEEEEEeecCCCchhh-----------H---hhh-cCCC--------CHHHHHH---------------HHHHHHHHHH
Q 038137 190 EYLYLIMEYLPGGDMMT-----------L---LMR-KDTL--------TEEEARF---------------YVGETVLAIE 231 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~-----------~---l~~-~~~l--------~e~~~~~---------------~~~qi~~aL~ 231 (549)
+..++||+|++|..+.. . +.. ...+ ....-.. +...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 56789999999865321 0 111 0011 1000000 0011333445
Q ss_pred HHHh-------CCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 232 SIHK-------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 232 ~LH~-------~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.++. .++||+|+.|.|||++.++.+.|+||+.|..
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5542 4699999999999998776668999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00031 Score=73.07 Aligned_cols=137 Identities=16% Similarity=0.211 Sum_probs=83.8
Q ss_pred eeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEE
Q 038137 122 LTMIGKGAFGEVRVCREKA-------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~-------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~ly 193 (549)
++.|..|-...+|++.... ++..|.+|+.... . .....+.+|..+++.+. +....++++.+.+.
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g---- 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--L--QGVDSLVLESVMFAILAERSLGPQLYGVFPEG---- 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--c--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----
Confidence 3567778899999998642 3578999986431 1 12344568888887763 33447778877653
Q ss_pred EEEeecCCCchhhH--------------hhh---c-----CCC--CHHHHHHHHHHHHH-------------------HH
Q 038137 194 LIMEYLPGGDMMTL--------------LMR---K-----DTL--TEEEARFYVGETVL-------------------AI 230 (549)
Q Consensus 194 lVmEy~~gg~L~~~--------------l~~---~-----~~l--~e~~~~~~~~qi~~-------------------aL 230 (549)
+||||++|..|..- |.+ . ... -..++..|+.++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 99999998654311 110 0 011 13455555544321 23
Q ss_pred HHHH----h----CCeeecCCCCCCeEEcCC----CcEEEeecCcccc
Q 038137 231 ESIH----K----HNYIHRDIKPDNLLLDRN----GHMKLSDFGLCKP 266 (549)
Q Consensus 231 ~~LH----~----~giiHRDLKPeNILld~~----g~vKL~DFGlak~ 266 (549)
..|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 359999999999999876 7899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00035 Score=73.87 Aligned_cols=75 Identities=20% Similarity=0.296 Sum_probs=51.2
Q ss_pred eeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceE
Q 038137 121 PLTMIGKGAFGEVRVCREKA-------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~-------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~l 192 (549)
.++.|+.|....||++.... ++..|.+|+..... ....+..|..++..+. +...+++++.+.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g--- 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSGG--- 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETTE---
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCCC---
Confidence 35678889999999998653 35789999874311 1134557888887763 33346777777642
Q ss_pred EEEEeecCCCch
Q 038137 193 YLIMEYLPGGDM 204 (549)
Q Consensus 193 ylVmEy~~gg~L 204 (549)
+||||++|..|
T Consensus 149 -~v~e~l~G~~l 159 (429)
T 1nw1_A 149 -RLEEYIPSRPL 159 (429)
T ss_dssp -EEECCCCEEEC
T ss_pred -EEEEEeCCccc
Confidence 89999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00065 Score=68.42 Aligned_cols=138 Identities=13% Similarity=0.183 Sum_probs=79.0
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC--ceeeeeee-----ecCCceEEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN--CIVKLYCS-----FQDDEYLYL 194 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~-----f~d~~~lyl 194 (549)
+..|+ |....||++.. .+|+.|++|+...... ....+..|..++..+... .+++++.. ....+..|+
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 34567 88899998754 3466789999863321 123466677777766321 24445443 112345689
Q ss_pred EEeecCCCchhh-----------Hh---hh---c------CCCCHHH----HH------------------HHHHHHHHH
Q 038137 195 IMEYLPGGDMMT-----------LL---MR---K------DTLTEEE----AR------------------FYVGETVLA 229 (549)
Q Consensus 195 VmEy~~gg~L~~-----------~l---~~---~------~~l~e~~----~~------------------~~~~qi~~a 229 (549)
||+|++|..+.. .| .. . ..++... .+ ..+..++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 999998854320 11 00 0 0111111 01 111122222
Q ss_pred HHHH----HhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 230 IESI----HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 230 L~~L----H~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+..+ +...++|+|++|.|||++ + .+.|+||+.|...
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 2222 234689999999999998 4 8999999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00055 Score=70.45 Aligned_cols=75 Identities=15% Similarity=0.096 Sum_probs=44.7
Q ss_pred eeeeeecCCeEEEEEEEcC--------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceE
Q 038137 122 LTMIGKGAFGEVRVCREKA--------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~--------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~l 192 (549)
++.|+.|....||++.... .+..|++|+.....- .......|..++..+. +..+.++++.+. +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN--G-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC--C--
Confidence 5678889899999998643 136888998754311 1111356777777663 222456776653 2
Q ss_pred EEEEeecCCCch
Q 038137 193 YLIMEYLPGGDM 204 (549)
Q Consensus 193 ylVmEy~~gg~L 204 (549)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999998543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00069 Score=68.58 Aligned_cols=32 Identities=28% Similarity=0.369 Sum_probs=28.0
Q ss_pred CCeeecCCCCCCeEEcCC----CcEEEeecCccccc
Q 038137 236 HNYIHRDIKPDNLLLDRN----GHMKLSDFGLCKPL 267 (549)
Q Consensus 236 ~giiHRDLKPeNILld~~----g~vKL~DFGlak~~ 267 (549)
..++|+|+.|.|||++.+ +.+.|+||+.|...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999875 78999999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0023 Score=65.25 Aligned_cols=32 Identities=19% Similarity=0.217 Sum_probs=28.4
Q ss_pred CCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 236 ~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
..++|+|+.|.|||++.++.+.|+||+.|...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998889999999987653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0046 Score=61.16 Aligned_cols=81 Identities=15% Similarity=0.025 Sum_probs=55.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC---CceeeeeeeecCCceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS---NCIVKLYCSFQDDEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~f~d~~~l 192 (549)
.....-+..+|.|..+.||++.. .+|+.|.+|+-..... .....+..|...|+.+.. --++++++.. . -
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--R 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--c
Confidence 34566788999999999999875 5688999998654321 112346789988887732 1245555542 2 3
Q ss_pred EEEEeecCCCch
Q 038137 193 YLIMEYLPGGDM 204 (549)
Q Consensus 193 ylVmEy~~gg~L 204 (549)
++||||+.++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 689999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.003 Score=67.34 Aligned_cols=76 Identities=13% Similarity=0.223 Sum_probs=49.6
Q ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCC-ceeeeeeeecCCceEEEEEeec
Q 038137 121 PLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKLYCSFQDDEYLYLIMEYL 199 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~d~~~lylVmEy~ 199 (549)
-++.|+.|-...||++.....+..|++|+..... ...+ ...+|..+|..+... ..+++++.|.+ .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 3567888999999999876545788999875421 1111 125788888887543 34678887743 2599999
Q ss_pred CCCch
Q 038137 200 PGGDM 204 (549)
Q Consensus 200 ~gg~L 204 (549)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0046 Score=58.94 Aligned_cols=121 Identities=22% Similarity=0.218 Sum_probs=79.2
Q ss_pred chhhHhhh-cCCCCHHHHHHHHHHHHHHHHHH-HhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccccc
Q 038137 203 DMMTLLMR-KDTLTEEEARFYVGETVLAIESI-HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280 (549)
Q Consensus 203 ~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~L-H~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~ 280 (549)
+|.++|.. ..+|+|++++-++.|.+.+|.-+ +...-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 78888855 57899999999999999998776 211112333457899999999998763 2110
Q ss_pred CCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCCCCCC
Q 038137 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 360 (549)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~PF~~ 360 (549)
.....+.|||.+. .+.+.+.=|||||+++|.-+-=.
T Consensus 98 --------------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg----- 133 (229)
T 2yle_A 98 --------------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG----- 133 (229)
T ss_dssp -----------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT-----
T ss_pred --------------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC-----
Confidence 1112355777763 45567788999999999876211
Q ss_pred CCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhhc
Q 038137 361 DEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCN 399 (549)
Q Consensus 361 ~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~d 399 (549)
++-..+..+|+++..||..|..+
T Consensus 134 ----------------L~e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 134 ----------------LKENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ----------------CCTTEEECCCHHHHHHHHHHTTC
T ss_pred ----------------CCcccchhhCHHHHHHHHHHHhc
Confidence 11112347999999999988743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0093 Score=62.82 Aligned_cols=76 Identities=14% Similarity=0.113 Sum_probs=49.3
Q ss_pred eeeeeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceE
Q 038137 121 PLTMIGKGAFGEVRVCREKAT-------GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 121 ~~~~IG~G~fG~V~l~~~k~t-------g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~l 192 (549)
-++.|..|-...+|++..... +..|++++..... ... -...+|..+++.+. +....++++.+..
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~~---- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKF-YDSKVELDVFRYLSNINIAPNIIADFPE---- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CC-CCHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chh-cCHHHHHHHHHHHHhcCCCCCEEEEcCC----
Confidence 356777788999999987521 5789999865421 111 11346777777663 3345667765543
Q ss_pred EEEEeecCCCch
Q 038137 193 YLIMEYLPGGDM 204 (549)
Q Consensus 193 ylVmEy~~gg~L 204 (549)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.20 E-value=0.31 Score=50.54 Aligned_cols=29 Identities=28% Similarity=0.489 Sum_probs=25.5
Q ss_pred eeecCCCCCCeEE------cCCCcEEEeecCcccc
Q 038137 238 YIHRDIKPDNLLL------DRNGHMKLSDFGLCKP 266 (549)
Q Consensus 238 iiHRDLKPeNILl------d~~g~vKL~DFGlak~ 266 (549)
++|+|+.+.|||+ +.++.+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 549 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-89 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-88 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-85 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-84 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-80 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-79 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-76 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-76 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-74 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-74 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-73 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-73 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-72 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-72 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-70 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-70 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-69 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-66 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-64 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-60 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-55 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-55 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-53 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-52 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-51 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-50 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-14 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (698), Expect = 9e-89
Identities = 103/330 (31%), Positives = 169/330 (51%), Gaps = 47/330 (14%)
Query: 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN 169
Q K +DF+ ++G+G+F V + RE AT YA+K L+K +++ +V +V ER+
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 170 LLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
+++ +D VKLY +FQDDE LY + Y G+++ + + + E RFY E V A
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+E +H IHRD+KP+N+LL+ + H++++DFG K
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK------------------------ 156
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
+++ A S VGT Y++PE+L +K D W+LG I+Y
Sbjct: 157 ---------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 201
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK- 407
+++ G PPF + +KI+ FPE K P+A+DL+ KLL + +RLG +
Sbjct: 202 QLVAGLPPFRAGNEYLIFQKIIKLE--YDFPE--KFFPKARDLVEKLLVLDATKRLGCEE 257
Query: 408 --GADEIKAHPWFKGIEWDKLYQIKAAFIP 435
G +KAHP+F+ + W+ L+Q +
Sbjct: 258 MEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 271 bits (695), Expect = 9e-88
Identities = 116/370 (31%), Positives = 178/370 (48%), Gaps = 56/370 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-D 175
+DF M+GKG+FG+V + K T +A+K LKK +L VE E+ +L+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK 235
+ ++C+FQ E L+ +MEYL GGD+M + A FY E +L ++ +H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
++RD+K DN+LLD++GH+K++DFG+CK + + F
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------------------ 163
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
GTPDYIAPE+LL + Y DWWS G ++YEML+G
Sbjct: 164 -----------------------CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414
PF+ + I +P L EAKDL+ KL E+RLG +I+
Sbjct: 201 SPFHGQDEEELFHSIRMDN--PFYPR--WLEKEAKDLLVKLFVREPEKRLGV--RGDIRQ 254
Query: 415 HPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSSK 472
HP F+ I W++L +I F P+V D NF+K + + A R +++S
Sbjct: 255 HPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFAD----RALINSM 310
Query: 473 DIN-FVGYTY 481
D N F +++
Sbjct: 311 DQNMFRNFSF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (681), Expect = 1e-85
Identities = 125/378 (33%), Positives = 182/378 (48%), Gaps = 54/378 (14%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
K+ +DF+ L ++GKG FG+V + REKATG YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES 232
+ L +FQ + L +MEY GG++ L R+ TEE ARFY E V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+H + ++RDIK +NL+LD++GH+K++DFGLCK
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------------------- 159
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
+ GTP+Y+APEVL YG DWW LG +MYEM+
Sbjct: 160 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GA 409
G PFY+ + I+ ++FP LSPEAK L++ LL + +QRLG A
Sbjct: 200 CGRLPFYNQDHERLFELILMEE--IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 410 DEIKAHPWFKGIEWDKLYQ--IKAAFIPEVNDELDTQNFEKFEEADNQIQTSA----KSG 463
E+ H +F I W + Q + F P+V E+DT+ F+ A + T G
Sbjct: 256 KEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLG 315
Query: 464 PWRKMLSSKDINFVGYTY 481
+ F + Y
Sbjct: 316 LLELDQREEQEMFEDFDY 333
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 262 bits (670), Expect = 4e-84
Identities = 124/343 (36%), Positives = 185/343 (53%), Gaps = 54/343 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DF+ L +G G+FG V + R + G YAMK LKK ++R QVEH ER +L+ V
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I++++ +FQD + +++IM+Y+ GG++ +LL + A+FY E LA+E +H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+ I+RD+KP+N+LLD+NGH+K++DFG K +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------------------------- 158
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
Y+ GTPDYIAPEV+ K Y DWWS G ++YEML GY
Sbjct: 159 -------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIK 413
PFY M T KI+N L+FP + + KDL+S+L+ ++ QRLG G +++K
Sbjct: 200 PFYDSNTMKTYEKILNAE--LRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255
Query: 414 AHPWFKGIEWDKLY--QIKAAFIPEV-NDELDTQNFEKFEEAD 453
HPWFK + W+KL I+ + P + + DT F+K+ E D
Sbjct: 256 NHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 252 bits (644), Expect = 8e-80
Identities = 124/390 (31%), Positives = 207/390 (53%), Gaps = 57/390 (14%)
Query: 83 ADAEVSEEEQNNLLKYLEKKETEYMR----LQRHKMGADDFEPLTMIGKGAFGEVRVCRE 138
A A EQ ++ ++L K + ++++ ++ D F+ + +G G+FG V + +
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 139 KATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEY 198
K +G+ YAMK L K ++++ Q+EH E+ +L V+ +VKL SF+D+ LY++MEY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 199 LPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKL 258
+ GG+M + L R +E ARFY + VL E +H + I+RD+KP+NLL+D+ G++++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 259 SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYST 318
+DFG K + ++
Sbjct: 183 TDFGFAKRVKGRT--------------------------------------------WTL 198
Query: 319 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLK 378
GTP+ +APE++L KGY DWW+LG ++YEM GYPPF++D+P+ KI ++
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVR 256
Query: 379 FPEEAKLSPEAKDLISKLLC-NVEQRLGTK--GADEIKAHPWFKGIEWDKLYQ--IKAAF 433
FP S + KDL+ LL ++ +R G G ++IK H WF +W +YQ ++A F
Sbjct: 257 FPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314
Query: 434 IPEVNDELDTQNFEKFEEADNQIQTSAKSG 463
IP+ DT NF+ +EE + ++ + K G
Sbjct: 315 IPKFKGPGDTSNFDDYEEEEIRVSINEKCG 344
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 3e-79
Identities = 90/305 (29%), Positives = 136/305 (44%), Gaps = 51/305 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+DFE +GKG FG V + REK + + A+K L K+++ + G ++ E + + +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
I++LY F D +YLI+EY P G + L + E+ Y+ E A+ H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
IHRDIKP+NLLL G +K++DFG S
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------------------------ 161
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
+ GT DY+ PE++ + + + D WSLG + YE LVG P
Sbjct: 162 -------------------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202
Query: 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415
PF ++ T ++I FP+ ++ A+DLIS+LL N QR E+ H
Sbjct: 203 PFEANTYQETYKRISRVE--FTFPD--FVTEGARDLISRLLKHNPSQRP---MLREVLEH 255
Query: 416 PWFKG 420
PW
Sbjct: 256 PWITA 260
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 242 bits (618), Expect = 6e-76
Identities = 85/362 (23%), Positives = 154/362 (42%), Gaps = 54/362 (14%)
Query: 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL 170
+H D ++ +G GAFG V E+ATG+ +A K + E V+ E
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLA 229
++ + +V L+ +F+DD + +I E++ GG++ + + ++E+EA Y+ +
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 230 IESIHKHNYIHRDIKPDNLLL--DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
+ +H++NY+H D+KP+N++ R+ +KL DFGL LD
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD------------------- 177
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
+ T GT ++ APEV K G D WS+G +
Sbjct: 178 -----------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406
Y +L G PF + T R + + ++ + +S + KD I KLL + R+
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM-- 272
Query: 407 KGADEIKAHPWFKGIEW-DKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPW 465
+ HPW + QI ++ ++ D + T+ ++ + E + +
Sbjct: 273 -TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTK-YDAWPEPLPPLGRISNYSSL 330
Query: 466 RK 467
RK
Sbjct: 331 RK 332
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 242 bits (618), Expect = 8e-76
Identities = 102/380 (26%), Positives = 165/380 (43%), Gaps = 64/380 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN---LLAE 173
+DF +IG+G FGEV CR+ TG +YAMK L K + + ER L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
D IV + +F + L I++ + GGD+ L + +E + RFY E +L +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H ++RD+KP N+LLD +GH+++SD GL
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---------------------- 161
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 352
+++VGT Y+APEVL K Y DW+SLG +++++L
Sbjct: 162 ---------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200
Query: 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGA 409
G+ PF + +I + SPE + L+ LL +V +RLG +GA
Sbjct: 201 RGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259
Query: 410 DEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELDTQNF--EKFEEADNQIQTSAKSGPW 465
E+K P+F+ ++W ++ + IP + F F+E D +
Sbjct: 260 QEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI-------- 311
Query: 466 RKMLSSKDINFVGYTYKNFE 485
K+L S + + E
Sbjct: 312 -KLLDSDQELYRNFPLTISE 330
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 235 bits (601), Expect = 2e-74
Identities = 89/317 (28%), Positives = 141/317 (44%), Gaps = 59/317 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD- 175
+++EP ++G+G VR C K T YA+K + + E + L EVD
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 176 ------SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
I++L +++ + + +L+ + + G++ L K TL+E+E R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
I ++HK N +HRD+KP+N+LLD + ++KL+DFG LD
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE------------------ 164
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWS 343
GTP Y+APE++ GYG E D WS
Sbjct: 165 ------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 200
Query: 344 LGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQ 402
G IMY +L G PPF+ + M R I++ PE S KDL+S+ L ++
Sbjct: 201 TGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260
Query: 403 RLGTKGADEIKAHPWFK 419
R A+E AHP+F+
Sbjct: 261 RY---TAEEALAHPFFQ 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 237 bits (605), Expect = 5e-74
Identities = 83/356 (23%), Positives = 155/356 (43%), Gaps = 53/356 (14%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D ++ L +G GAFG V C EKATG V+ K + L + VK E +++ ++
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHK 235
++ L+ +F+D + LI+E+L GG++ + +D ++E E Y+ + ++ +H+
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 236 HNYIHRDIKPDNLLLD--RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
H+ +H DIKP+N++ + + +K+ DFGL L+
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---------------------- 183
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+ T T ++ APE++ ++ G D W++G + Y +L
Sbjct: 184 --------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412
G PF ++ + T + + + +SPEAKD I LL +RL +
Sbjct: 224 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDA 280
Query: 413 KAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKM 468
HPW KG + +I ++ ++ ++ + + + I A RK
Sbjct: 281 LEHPWLKGDHSNLTSRIPSSRYNKIRQKIK-EKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 233 bits (596), Expect = 3e-73
Identities = 88/337 (26%), Positives = 148/337 (43%), Gaps = 54/337 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D ++ ++G GAF EV + +K T + A+K + K + G+ ++ E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV L ++ +LYLIM+ + GG++ ++ K TE +A + + + A++ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 237 NYIHRDIKPDNLLL---DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+HRD+KP+NLL D + + +SDFGL K D +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---------------------- 164
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+ + GTP Y+APEVL +K Y D WS+G I Y +L
Sbjct: 165 --------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412
GYPPFY + +I+ P +S AKD I L+ + E+R ++
Sbjct: 205 GYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQA 261
Query: 413 KAHPWFKG-IEWDKLYQIKAAFIPEVNDELDTQNFEK 448
HPW G DK I + ++ +++
Sbjct: 262 LQHPWIAGDTALDK--NIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 4e-73
Identities = 124/360 (34%), Positives = 193/360 (53%), Gaps = 52/360 (14%)
Query: 95 LLKYLEKKETEYMRLQRHKMGADDFEPLTMIGKGAFGEVRVCRE---KATGHVYAMKKLK 151
LL + T + K+G ++FE L ++G GA+G+V + R+ TG +YAMK LK
Sbjct: 2 LLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK 61
Query: 152 KSEMLRRGQ-VEHVKAERNLLAEV-DSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM 209
K+ ++++ + EH + ER +L + S +V L+ +FQ + L+LI++Y+ GG++ T L
Sbjct: 62 KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS 121
Query: 210 RKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269
+++ TE E + YVGE VLA+E +HK I+RDIK +N+LLD NGH+ L+DFGL
Sbjct: 122 QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS----- 176
Query: 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEV 329
+ + + AY GT +Y+AP++
Sbjct: 177 -----------------------------------KEFVADETERAYDFCGTIEYMAPDI 201
Query: 330 LL--KKGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSP 387
+ G+ DWWSLG +MYE+L G PF D ++ +I + P ++S
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261
Query: 388 EAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QIKAAFIPEVNDELD 442
AKDLI +LL + ++RLG + ADEIK H +F+ I WD L ++ A F P + DELD
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 1e-72
Identities = 78/316 (24%), Positives = 134/316 (42%), Gaps = 56/316 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D +E + +G GAFG+V + K T + A K + ++E E ++LA D
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHK 235
IVKL +F + L++++E+ GG + +++ + LTE + + +T+ A+ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+ IHRD+K N+L +G +KL+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------------------------- 161
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 350
S +GTP ++APEV++ + Y + D WSLG + E
Sbjct: 162 --------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207
Query: 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGA 409
M PP + PM KI + ++ S KD + K L NV+ R
Sbjct: 208 MAEIEPPHHELNPMRVLLKIAKSEPP-TLAQPSRWSSNFKDFLKKCLEKNVDARW---TT 263
Query: 410 DEIKAHPWFKGIEWDK 425
++ HP+ ++ +K
Sbjct: 264 SQLLQHPFVT-VDSNK 278
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 5e-72
Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 47/305 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+D++ + +G+GA+GEV++ + T A+K + + E++K E + ++
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 62
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
HRDIKP+NLLLD ++K+SDFGL +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYN-------------------------- 156
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 355
NR L GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 157 -------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414
P+ K+ L+ K+L N R+ +IK
Sbjct: 204 LPWDQPSDSCQEYSDWK-EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKK 259
Query: 415 HPWFK 419
W+
Sbjct: 260 DRWYN 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 9e-72
Identities = 75/351 (21%), Positives = 130/351 (37%), Gaps = 90/351 (25%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
DDFE ++ +G G G V K +G V A K + ++ + E +L E +S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH-K 235
IV Y +F D + + ME++ GG + +L + + E+ + + + K
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
H +HRD+KP N+L++ G +KL DFG+ L S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------------------- 158
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
+A S VGT Y++PE L Y ++ D WS+G + EM VG
Sbjct: 159 ------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
Query: 356 PPFYSDE--------------------------------------PMSTCRKIVNWRTHL 377
P + P +++++ +
Sbjct: 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE 260
Query: 378 KFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425
P+ S E +D ++K L N +R ++ H + K + ++
Sbjct: 261 PPPKLPSGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEE 308
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 3e-70
Identities = 84/305 (27%), Positives = 137/305 (44%), Gaps = 52/305 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ IG+GA G V + ATG A++++ + ++ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV S+ + L+++MEYL GG + ++ E + E + A+E +H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
IHRDIK DN+LL +G +KL+DFG C +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------------------------- 170
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 171 ----------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 357 PFYSDEPMSTCRKIV-NWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414
P+ ++ P+ I N L+ PE KLS +D +++ L +VE+R A E+
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRG---SAKELLQ 269
Query: 415 HPWFK 419
H + K
Sbjct: 270 HQFLK 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 225 bits (574), Expect = 5e-70
Identities = 74/339 (21%), Positives = 121/339 (35%), Gaps = 54/339 (15%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
++ + + +L+MEY G L + K L E E + + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
N IHRD+K N+LL G +KL DFG + +N
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------------------- 169
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLV 353
S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 170 --------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412
PP ++ MS I + + S ++ + L + R ++ +
Sbjct: 210 RKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVL 264
Query: 413 KAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEE 451
H + + + ELD + K ++
Sbjct: 265 LKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-69
Identities = 83/314 (26%), Positives = 139/314 (44%), Gaps = 60/314 (19%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
A+D+E L IG G++G + R K+ G + K+L M + + + +E NLL E+
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK 61
Query: 176 SNCIVKLYCSFQD--DEYLYLIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLA 229
IV+ Y D + LY++MEY GGD+ +++ + + L EE + + LA
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 230 IESIHK-----HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
++ H+ H +HRD+KP N+ LD ++KL DFGL + L+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN---------------- 165
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344
+ A + VGTP Y++PE + + Y + D WSL
Sbjct: 166 -------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200
Query: 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
G ++YE+ PPF + KI + + P + S E ++I+++L R
Sbjct: 201 GCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPY--RYSDELNEIITRMLNLKDYHR 257
Query: 404 LGTKGADEIKAHPW 417
+EI +P
Sbjct: 258 P---SVEEILENPL 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 4e-68
Identities = 81/320 (25%), Positives = 139/320 (43%), Gaps = 53/320 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML---RRGQVEHVKAERNLLAE 173
D ++ +G G F V+ CREK+TG YA K +KK R E ++ E ++L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
+ ++ L+ +++ + LI+E + GG++ L K++LTEEEA ++ + + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 234 HKHNYIHRDIKPDNLLLDRNG----HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
H H D+KP+N++L +K+ DFGL +D N
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---------------- 173
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 174 --------------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKG 408
+L G PF D T + + + S AKD I +LL + ++R+
Sbjct: 208 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---T 264
Query: 409 ADEIKAHPWFKGIEWDKLYQ 428
+ HPW K + +
Sbjct: 265 IQDSLQHPWIKPKDTQQALS 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-66
Identities = 74/307 (24%), Positives = 118/307 (38%), Gaps = 53/307 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + +G+G FG V C E ++ Y K +K VK E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHK 235
I+ L+ SF+ E L +I E++ G D+ + L E E YV + A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 236 HNYIHRDIKPDNLLLD--RNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
HN H DI+P+N++ R+ +K+ +FG + L +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------------------- 158
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
P+Y APEV D WSLG ++Y +L
Sbjct: 159 --------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412
G PF ++ I+N ++S EA D + +LL + R+ A E
Sbjct: 199 GINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEA 255
Query: 413 KAHPWFK 419
HPW K
Sbjct: 256 LQHPWLK 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 4e-64
Identities = 60/304 (19%), Positives = 119/304 (39%), Gaps = 59/304 (19%)
Query: 125 IGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184
IG+G+F V + T A +L+ ++ + + + K E +L + IV+ Y
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 185 SFQD----DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNY-- 238
S++ + + L+ E + G + T L R + + R + + + ++ +H
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 135
Query: 239 IHRDIKPDNLLL-DRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
IHRD+K DN+ + G +K+ D GL S
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--------------------------- 168
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 357
A + +GTP+++APE+ ++ Y D ++ G M EM P
Sbjct: 169 ----------------FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 211
Query: 358 FYSDEPMST-CRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415
+ + + R++ + F + PE K++I + N ++R ++ H
Sbjct: 212 YSECQNAAQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQNKDERY---SIKDLLNH 266
Query: 416 PWFK 419
+F+
Sbjct: 267 AFFQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 204 bits (521), Expect = 1e-62
Identities = 68/304 (22%), Positives = 121/304 (39%), Gaps = 45/304 (14%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
+D +E ++G G EV + R+ A+K L+ + E A ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 176 SNCIVKLYCSFQDDE----YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
IV +Y + + + Y++MEY+ G + ++ + +T + A + + A+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
H++ IHRD+KP N+++ +K+ DFG+ + + S
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-------------------- 165
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351
N + +GT Y++PE D +SLG ++YE+
Sbjct: 166 ------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207
Query: 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
L G PPF D P+S + V LS + ++ K L N E R T A
Sbjct: 208 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AA 265
Query: 411 EIKA 414
E++A
Sbjct: 266 EMRA 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-60
Identities = 91/371 (24%), Positives = 151/371 (40%), Gaps = 75/371 (20%)
Query: 107 MRLQRHKMGADDFEPLT-MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVK 165
++++++ + DD++ + ++G G G+V K T +A+K L+ RR
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 53
Query: 166 AERNLLAEVDSNCIVKLYCSFQD----DEYLYLIMEYLPGGDMMTLLMRK--DTLTEEEA 219
IV++ +++ + L ++ME L GG++ + + + TE EA
Sbjct: 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 220 RFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NGHMKLSDFGLCKPLDCSNLQEKD 276
+ AI+ +H N HRD+KP+NLL N +KL+DFG K N
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--- 170
Query: 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYG 336
+ TP Y+APEVL + Y
Sbjct: 171 ---------------------------------------TTPCYTPYYVAPEVLGPEKYD 191
Query: 337 MECDWWSLGAIMYEMLVGYPPFYSDEPMSTC----RKIVNWRTHLKFPEEAKLSPEAKDL 392
CD WSLG IMY +L GYPPFYS+ ++ +I + PE +++S E K L
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 251
Query: 393 ISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEE 451
I LL QR+ E HPW K P + ++ E++E+
Sbjct: 252 IRNLLKTEPTQRM---TITEFMNHPWIMQ-------STKVPQTPLHTSRVLKEDKERWED 301
Query: 452 ADNQIQTSAKS 462
++ ++ +
Sbjct: 302 VKEEMTSALAT 312
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 9e-60
Identities = 76/315 (24%), Positives = 123/315 (39%), Gaps = 65/315 (20%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEH---VKAERNLLA 172
++ ++G G FG V + A+K ++K + G++ + V E LL
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 173 EVDSNC--IVKLYCSFQDDEYLYLIMEYL-PGGDMMTLLMRKDTLTEEEARFYVGETVLA 229
+V S +++L F+ + LI+E P D+ + + L EE AR + + + A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 230 IESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+ H +HRDIK +N+L+D N G +KL DFG L +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---------------- 166
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 347
GT Y PE + Y G WSLG +
Sbjct: 167 ---------------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406
+Y+M+ G PF DE + R + F + ++S E + LI L R
Sbjct: 200 LYDMVCGDIPFEHDEEII--------RGQVFFRQ--RVSSECQHLIRWCLALRPSDRP-- 247
Query: 407 KGADEIKAHPWFKGI 421
+EI+ HPW + +
Sbjct: 248 -TFEEIQNHPWMQDV 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-57
Identities = 76/328 (23%), Positives = 120/328 (36%), Gaps = 72/328 (21%)
Query: 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEM--LRRGQVEHVKAERNLLAEVDSN 177
E L +G+G F V R+K T + A+KK+K + G E LL E+
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
I+ L +F + L+ +++ + + LT + Y+ T+ +E +H+H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 238 YIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPR 297
+HRD+KP+NLLLD NG +KL+DFGL K
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----------------------------- 151
Query: 298 RTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYP 356
+ V T Y APE+L + YG+ D W++G I+ E+L+ P
Sbjct: 152 ------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199
Query: 357 PFYSDEPMSTCRKIVN---------WRTHLKFPEEA---------------KLSPEAKDL 392
D + +I W P+ + DL
Sbjct: 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
Query: 393 ISKLLC-NVEQRLGTKGADEIKAHPWFK 419
I L N R+ A + +F
Sbjct: 260 IQGLFLFNPCARI---TATQALKMKYFS 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-55
Identities = 86/376 (22%), Positives = 134/376 (35%), Gaps = 95/376 (25%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ +IG G+FG V + +G + A+KK+ + + + E ++ ++D
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDH 72
Query: 177 NCIVKLYCSF------QDDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEARFYVGETV 227
IV+L F +D+ YL L+++Y+P K TL + Y+ +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
++ IH HRDIKP NLLLD + +KL DFG K L
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN------------- 179
Query: 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 345
S + + Y APE++ Y D WS G
Sbjct: 180 -----------------------------VSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 346 AIMYEMLVGYPPFYSDEPMSTCRKIVN---------------WRTHLKFPE--------- 381
++ E+L+G P F D + +I+ T KFP+
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 270
Query: 382 -EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVND 439
+ PEA L S+LL RL E AH +F + + +P D
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNV------KLPNGRD 321
Query: 440 ELDTQNFEKFEEADNQ 455
NF E + N
Sbjct: 322 TPALFNFTTQELSSNP 337
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (474), Expect = 3e-55
Identities = 73/341 (21%), Positives = 116/341 (34%), Gaps = 79/341 (23%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+E L IG+G FGEV R + TG A+KK+ + G E +L +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKH 68
Query: 177 NCIVKLYCSFQDDE--------YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL 228
+V L + +YL+ ++ L T E + + +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQ 288
+ IH++ +HRD+K N+L+ R+G +KL+DFGL + +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA------------------ 170
Query: 289 SDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 347
+ ++ + V T Y PE+LL ++ YG D W G I
Sbjct: 171 -------------------KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIVN----------------------------WRTHLKF 379
M EM P + I R
Sbjct: 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271
Query: 380 PEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+ P A DLI KLL + QR+ +D+ H +F
Sbjct: 272 LKAYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFFW 309
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-54
Identities = 79/370 (21%), Positives = 135/370 (36%), Gaps = 78/370 (21%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
+ L+ IG+GA+G V + A+KK+ E + + E +L
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFR 64
Query: 176 SNCIVKLYCSFQDDEY----LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
I+ + + ++ +L G D+ LL + L+ + +++ + + ++
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLK 123
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
IH N +HRD+KP NLLL+ +K+ DFGL + D +
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-------------------- 163
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 350
+ V T Y APE++L GY D WS+G I+ E
Sbjct: 164 ------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 351 MLVGYPPFYSDEPMSTCRKIVN------------------WRTHLKFPEEAK-------- 384
ML P F + I+ L P + K
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 385 -LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELD 442
+A DL+ K+L N +R+ ++ AHP+ + +D + A + + ELD
Sbjct: 266 NADSKALDLLDKMLTFNPHKRI---EVEQALAHPYLEQY-YDPSDEPIAEAPFKFDMELD 321
Query: 443 TQNFEKFEEA 452
EK +E
Sbjct: 322 DLPKEKLKEL 331
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-54
Identities = 79/333 (23%), Positives = 125/333 (37%), Gaps = 73/333 (21%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
++F+ + IG+G +G V R K TG V A+KK++ + G E +LL E++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHK 235
IVKL + LYL+ E+L + T + + Y+ + + + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
H +HRD+KP NLL++ G +KL+DFGL +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--------------------- 159
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 354
V T Y APE+LL Y D WSLG I EM+
Sbjct: 160 --------------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 355 YPPFYSDEPMSTCRKIVN---------WRTHLKFPEE----------------AKLSPEA 389
F D + +I W P+ L +
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 390 KDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421
+ L+S++L + +R+ A AHP+F+ +
Sbjct: 260 RSLLSQMLHYDPNKRI---SAKAALAHPFFQDV 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-54
Identities = 62/320 (19%), Positives = 116/320 (36%), Gaps = 51/320 (15%)
Query: 109 LQRHKMGADDFEPLTMIGKGAFGEVR--VCREKATGHVYAMKKLKKSEMLRRGQVEHVKA 166
L R + +D E +G G FG V+ + K A+K LK E + + A
Sbjct: 3 LDRKLLTLEDKE----LGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 57
Query: 167 ERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGET 226
E N++ ++D+ IV++ + + + L+ME G + L + + ++ V +
Sbjct: 58 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 227 VLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGA 286
+ ++ + + N++HRD+ N+LL + K+SDFGL K L
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------------- 161
Query: 287 LQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346
N + APE + + + D WS G
Sbjct: 162 -----------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGV 198
Query: 347 IMYEML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404
+M+E G P+ + + + P E DL++ +VE R
Sbjct: 199 LMWEAFSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAG--CPREMYDLMNLCWTYDVENRP 255
Query: 405 GTKGADEIKAHPWFKGIEWD 424
G + + ++ +
Sbjct: 256 GFAAVELRLRNYYYDVVNEG 275
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-54
Identities = 50/294 (17%), Positives = 102/294 (34%), Gaps = 51/294 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
IG G+FG V + A+K L + + Q++ K E +L +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 63
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDT-LTEEEARFYVGETVLAIESIHK 235
I+ + L ++ ++ G + L +T + +T ++ +H
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
+ IHRD+K +N+ L + +K+ DFGL + +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ-------------------- 162
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 352
G+ ++APEV+ K Y + D ++ G ++YE++
Sbjct: 163 -------------------FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEE--AKLSPEAKDLISKLLC-NVEQR 403
G P+ + +V + + K L+++ L ++R
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-53
Identities = 66/318 (20%), Positives = 120/318 (37%), Gaps = 53/318 (16%)
Query: 107 MRLQRHKMGADDFEPLTMIGKGAFGEVR--VCREKATGHVYAMKKLKKSEMLRRGQVEHV 164
+ L+R + D E +G G FG VR V R + A+K LK+ + E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 165 KAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYV 223
E ++ ++D+ IV+L Q + L L+ME GG + L+ +++ + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 224 GETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+ + ++ + + N++HRD+ N+LL + K+SDFGL K L +
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD------------ 163
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 343
+ + + APE + + + D WS
Sbjct: 164 --------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 197
Query: 344 LGAIMYEML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVE 401
G M+E L G P+ + I + ++ P E PE L+S E
Sbjct: 198 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPE--CPPELYALMSDCWIYKWE 254
Query: 402 QRLGTKGADEIKAHPWFK 419
R ++ ++
Sbjct: 255 DRPDFLTVEQRMRACYYS 272
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 179 bits (454), Expect = 8e-53
Identities = 77/330 (23%), Positives = 123/330 (37%), Gaps = 73/330 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + L IG+G +G V + G +A+KK++ E G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
+ IVKLY + L L+ E+L L + + L A+ ++ + + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
+HRD+KP NLL++R G +K++DFGL + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK----------------------- 156
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 355
+ T Y AP+VL+ Y D WS+G I EM+ G
Sbjct: 157 ------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 356 PPFYSDEPMSTCRKIV---------NWRTHLKFPEE----------------AKLSPEAK 390
P F +I NW + P+ L
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258
Query: 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
DL+SK+L + QR+ A + H +FK
Sbjct: 259 DLLSKMLKLDPNQRI---TAKQALEHAYFK 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-52
Identities = 56/296 (18%), Positives = 100/296 (33%), Gaps = 47/296 (15%)
Query: 114 MGADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNL 170
+G D L +G G+FG VR A A+K LK + + ++ E N
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 171 LAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLA 229
+ +D +++LY + ++ E P G ++ L + Y +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 230 IESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQS 289
+ + +IHRD+ NLLL +K+ DFGL + L ++
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND------------------ 165
Query: 290 DGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349
+ ++ + APE L + + D W G ++
Sbjct: 166 --------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205
Query: 350 EMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
EM G P+ KI L PE+ + +++ + E R
Sbjct: 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED--CPQDIYNVMVQCWAHKPEDR 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-52
Identities = 76/342 (22%), Positives = 129/342 (37%), Gaps = 78/342 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCRE-KATGHVYAMKKLKKSEMLRRGQVEHVK--AERNLLAE 173
+E + IG+GA+G+V R+ K G A+K+++ + ++ A L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 174 VDSNCIVKLYCSFQDDE-----YLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETV 227
+ +V+L+ L L+ E++ L + + E + + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 228 LAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGAL 287
++ +H H +HRD+KP N+L+ +G +KL+DFGL +
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------------------- 167
Query: 288 QSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347
+M S V T Y APEVLL+ Y D WS+G I
Sbjct: 168 -----------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 204
Query: 348 MYEMLVGYPPFYSDEPMSTCRKIVN---------WRTHLKFPEEA--------------K 384
EM P F + KI++ W + P +A
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 385 LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDK 425
+ KDL+ K L N +R+ A +HP+F+ +E K
Sbjct: 265 IDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLERCK 303
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-51
Identities = 50/302 (16%), Positives = 107/302 (35%), Gaps = 54/302 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D L +G G FG V+ + + + A+K +K+ M + E ++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHK 235
+V+LY +++I EY+ G ++ L + ++ + A+E +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
++HRD+ N L++ G +K+SDFGL +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR------------------------------ 148
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VG 354
+ + + + + PEVL+ + + D W+ G +M+E+ +G
Sbjct: 149 ----------YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413
P+ T I L+ S + ++ ++R +
Sbjct: 199 KMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADERP---TFKILL 252
Query: 414 AH 415
++
Sbjct: 253 SN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 5e-51
Identities = 54/290 (18%), Positives = 104/290 (35%), Gaps = 49/290 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
D +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 72
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIH 234
+V+L + Y+I E++ G+++ L + ++ + + A+E +
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
K N+IHRD+ N L+ N +K++DFGL +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSR----------------------------- 163
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
+ + APE L + ++ D W+ G +++E+
Sbjct: 164 -----------LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
Y +S +++ ++ PE + +L+ N R
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEG--CPEKVYELMRACWQWNPSDR 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 8e-51
Identities = 53/304 (17%), Positives = 111/304 (36%), Gaps = 62/304 (20%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + L IGKG FG+V + + G+ A+K +K + AE +++ ++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 59
Query: 177 NCIVKLY-CSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESI 233
+ +V+L ++ LY++ EY+ G ++ L + L + + + A+E +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+N++HRD+ N+L+ + K+SDFGL K +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------------------- 157
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML- 352
+ + APE L +K + + D WS G +++E+
Sbjct: 158 ----------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
Query: 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411
G P+ ++ K P +++ + R +
Sbjct: 196 FGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRP---SFLQ 249
Query: 412 IKAH 415
++
Sbjct: 250 LREQ 253
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 174 bits (441), Expect = 2e-50
Identities = 72/368 (19%), Positives = 127/368 (34%), Gaps = 97/368 (26%)
Query: 100 EKKETEYMRLQRHKM---GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML 156
+ EY + H + DD++ + +G+G + EV +K LK
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--- 71
Query: 157 RRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQD--DEYLYLIMEYLPGGDMMTLLMRKDT 213
+ + +K E +L + I+ L +D L+ E++ D L
Sbjct: 72 ---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--- 125
Query: 214 LTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-NGHMKLSDFGLCKPLDCSNL 272
LT+ + RFY+ E + A++ H +HRD+KP N+++D + ++L D+GL +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332
V + + PE+L+
Sbjct: 186 Y------------------------------------------NVRVASRYFKGPELLVD 203
Query: 333 -KGYGMECDWWSLGAIMYEMLVGYPPFY-SDEPMSTCRKIVN------------------ 372
+ Y D WSLG ++ M+ PF+ + +I
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 373 ---------------WRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416
W + + +SPEA D + KLL + + RL A E HP
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL---TAREAMEHP 320
Query: 417 WFKGIEWD 424
+F + D
Sbjct: 321 YFYTVVKD 328
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-49
Identities = 90/396 (22%), Positives = 145/396 (36%), Gaps = 105/396 (26%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ L +G GA+G V + TG A+KKL + + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 177 NCIVKLYCSFQDDE------YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAI 230
++ L F DE YL+M ++ G + LM+ + L E+ +F V + + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
IH IHRD+KP NL ++ + +K+ DFGL + D
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-------------------- 174
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349
V T Y APEV+L Y D WS+G IM
Sbjct: 175 ------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 350 EMLVGYPPFYSDEPMSTCRKIVN------------------WRTHLKFPEEAK------- 384
EM+ G F + + ++I+ PE K
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 270
Query: 385 --LSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDEL 441
SP A +L+ K+L + EQR+ A E AHP+F+ + DE
Sbjct: 271 TNASPLAVNLLEKMLVLDAEQRV---TAGEALAHPYFESLHDT-------------EDEP 314
Query: 442 DTQNFEK-FEEADNQIQTSAKSGPWRKMLSSKDINF 476
Q ++ F++ D + W+++ + ++F
Sbjct: 315 QVQKYDDSFDDVDRTLD------EWKRVTYKEVLSF 344
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 61/365 (16%), Positives = 126/365 (34%), Gaps = 85/365 (23%)
Query: 90 EEQNNLLKYLEKKETEYMRLQRHKMGAD--------DFEPLTMIGKGAFGEVRVCREKAT 141
E Q +++ + EY + + D + E ++G GAFG+V
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 142 GH-----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN-CIVKLYCSFQDDEYLYLI 195
A+K LK+ + E + +E ++ ++ S+ IV L + +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 196 MEYLPGGDMMTLLMRK-----------------------DTLTEEEARFYVGETVLAIES 232
EY GD++ L K + LT E+ + + +E
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+ + +HRD+ N+L+ +K+ DFGL + +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM------------------------ 215
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
+ ++ + ++APE L + Y ++ D WS G +++E+
Sbjct: 216 ---------------SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 353 -VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
+G P+ + K++ + P + E ++ + +R
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPF--YATEEIYIIMQSCWAFDSRKRP---SFP 315
Query: 411 EIKAH 415
+ +
Sbjct: 316 NLTSF 320
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-49
Identities = 52/343 (15%), Positives = 108/343 (31%), Gaps = 47/343 (13%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK--SEMLRRGQVEHVKAERNLLAE 173
+F+ + ++G GAFG V G + K E + + E ++A
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESI 233
VD+ + +L + G + + KD + + + + + +
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 234 HKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRP 293
+HRD+ N+L+ H+K++DFGL K L
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----------------------- 164
Query: 294 VAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353
+ A ++A E +L + Y + D WS G ++E++
Sbjct: 165 ----------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208
Query: 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412
Y P S I+ L P + + ++ K + + R E+
Sbjct: 209 FGSKPYDGIPASEISSILEKGERLPQPPI--CTIDVYMIMVKCWMIDADSRP---KFREL 263
Query: 413 KAHPWFKGIEWDKLYQIKAAFIPEVNDELDTQNFEKFEEADNQ 455
+ + I+ + D+ + + ++
Sbjct: 264 IIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDM 306
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-49
Identities = 51/289 (17%), Positives = 97/289 (33%), Gaps = 49/289 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + IG G FG V + A+K +++ M E E ++ ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSH 59
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL-AIESIHK 235
+V+LY + + L+ E++ G + L + L E + V + + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 236 HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVA 295
IHRD+ N L+ N +K+SDFG+ +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTR------------------------------ 149
Query: 296 PRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 355
++ + T + +PEV Y + D WS G +M+E+
Sbjct: 150 ----------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 356 PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
Y + S + ++ L P S +++ E R
Sbjct: 200 KIPYENRSNSEVVEDISTGFRLYKPRL--ASTHVYQIMNHCWKERPEDR 246
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 5e-49
Identities = 52/322 (16%), Positives = 100/322 (31%), Gaps = 49/322 (15%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
+ + IG G+FG++ + + A G A+K + + E + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQ 60
Query: 176 S-NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIH 234
I + + +Y ++ME L + + + + IE IH
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKL---SDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
N+IHRD+KPDN L+ L DFGL K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA--------------------- 159
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351
+ Q + GT Y + L D SLG ++
Sbjct: 160 -------------RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206
Query: 352 LVGYPPFYSDEPMSTCRKIVNW-RTHLKFPEEA---KLSPEAKDLISKLLC-NVEQRLGT 406
+G P+ + + +K + P E E ++ + +
Sbjct: 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266
Query: 407 KGADEIKAHPWFK-GIEWDKLY 427
++ + + + G +D ++
Sbjct: 267 SYLRQLFRNLFHRQGFSYDYVF 288
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 6e-49
Identities = 51/295 (17%), Positives = 96/295 (32%), Gaps = 43/295 (14%)
Query: 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKK-SEMLRRGQVEHVKAERNLL 171
++ + +IG G FGEV K G +K Q +E +++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAI 230
+ D ++ L + +I E++ G + + L + D T + + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
+ + NY+HRD+ N+L++ N K+SDFGL + L+ S
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG-------- 193
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
+ APE + + + D WS G +M+E
Sbjct: 194 ----------------------------KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
Query: 351 ML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
++ G P++ I + P L+ + R
Sbjct: 226 VMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 9e-49
Identities = 57/311 (18%), Positives = 109/311 (35%), Gaps = 56/311 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 71
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIH 234
+V+LY ++ +Y++ EY+ G ++ L + L + + + +
Sbjct: 72 EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
+ NY+HRD++ N+L+ N K++DFGL + ++ + +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------------------ 172
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
+ APE L + ++ D WS G ++ E+
Sbjct: 173 ----------------------GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413
Y V + P E DL+ + E+R + ++
Sbjct: 211 GRVPYPGMVNREVLDQVERGYRMPCPPE--CPESLHDLMCQCWRKEPEERP---TFEYLQ 265
Query: 414 A--HPWFKGIE 422
A +F E
Sbjct: 266 AFLEDYFTSTE 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 6e-48
Identities = 55/290 (18%), Positives = 101/290 (34%), Gaps = 51/290 (17%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ + + +G G FGEV + A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD--TLTEEEARFYVGETVLAIESIH 234
+V+LY + +Y+I EY+ G ++ L LT + + + I
Sbjct: 68 QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 235 KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPV 294
+ NYIHRD++ N+L+ K++DFGL + ++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-------------------------- 160
Query: 295 APRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354
N + APE + + ++ D WS G ++ E++
Sbjct: 161 --------------DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206
Query: 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
Y + + + P+ E L+ E R
Sbjct: 207 GRIPYPGMTNPEVIQNLERGYRMVRPD--NCPEELYQLMRLCWKERPEDR 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 9e-48
Identities = 75/331 (22%), Positives = 121/331 (36%), Gaps = 73/331 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+E L IG+G +G V + + T + A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 177 NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKH 236
IV+L+ D+ L L+ E+ L E + ++ + + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 237 NYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAP 296
N +HRD+KP NLL++RNG +KL++FGL +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV------------------------- 155
Query: 297 RRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG- 354
+ V T Y P+VL Y D WS G I E+
Sbjct: 156 ----------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
Query: 355 YPPFYSDEPMSTCRKIVN---------WRTHLKFPEEA----------------KLSPEA 389
P F ++ ++I W + K P+ KL+
Sbjct: 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
Query: 390 KDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+DL+ LL N QR+ A+E HP+F
Sbjct: 260 RDLLQNLLKCNPVQRI---SAEEALQHPYFS 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (412), Expect = 2e-46
Identities = 58/318 (18%), Positives = 103/318 (32%), Gaps = 75/318 (23%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
++ E + IG+GAFG V R + A+K LK+ + E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 70
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD------------------- 212
AE D+ IVKL + + L+ EY+ GD+ L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 213 -----TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267
L+ E + + + + ++HRD+ N L+ N +K++DFGL + +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327
+ + + ++ P
Sbjct: 191 YSA---------------------------------------DYYKADGNDAIPIRWMPP 211
Query: 328 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLS 386
E + Y E D W+ G +++E+ G P+Y + + L PE
Sbjct: 212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPEN--CP 268
Query: 387 PEAKDLISKLLC-NVEQR 403
E +L+ R
Sbjct: 269 LELYNLMRLCWSKLPADR 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 76/377 (20%), Positives = 132/377 (35%), Gaps = 96/377 (25%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
++ L IG GA G V + A+KKL + + + E L+ V+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 177 NCIVKLYCSF------QDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAI 230
I+ L F ++ + +YL+ME + + M D E + + + + I
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGI 132
Query: 231 ESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSD 290
+ +H IHRD+KP N+++ + +K+ DFGL + S
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------------------- 172
Query: 291 GRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350
+ V T Y APEV+L GY D WS+G IM E
Sbjct: 173 ----------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 351 MLVGYPPFYSDEPMSTCRKIVNW-------------------------RTHLKFPE---- 381
M+ F + + K++ L FP+
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 382 ---------EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKA 431
+ +A+DL+SK+L + +R+ D+ HP+ W +++A
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN--VWYDPAEVEA 325
Query: 432 AFIPEVNDELDTQNFEK 448
+ +LD +
Sbjct: 326 PPPQIYDKQLDEREHTI 342
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-46
Identities = 62/305 (20%), Positives = 106/305 (34%), Gaps = 55/305 (18%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE 173
+ E IG+G FG+V + A+K K E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQ 64
Query: 174 VDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIES 232
D IVKL ++ +++IME G++ + L + +L Y + A+
Sbjct: 65 FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 233 IHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
+ ++HRDI N+L+ N +KL DFGL + ++ S
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--------------------- 162
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
A ++APE + + + D W G M+E+L
Sbjct: 163 -------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203
Query: 353 V-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD 410
+ G PF + +I N + P P L++K + +R
Sbjct: 204 MHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRP---RFT 257
Query: 411 EIKAH 415
E+KA
Sbjct: 258 ELKAQ 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-45
Identities = 54/306 (17%), Positives = 104/306 (33%), Gaps = 64/306 (20%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-D 175
+D + +IG+G FG+V R K G + E + E +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 176 SNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD----------------TLTEEEA 219
I+ L + + YLYL +EY P G+++ L + TL+ ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 220 RFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSI 279
+ + ++ + + +IHRD+ N+L+ N K++DFGL +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------------- 175
Query: 280 GSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 339
+ + ++A E L Y
Sbjct: 176 ----------------------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 207
Query: 340 DWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC 398
D WS G +++E++ G P+ K+ + + E DL+ +
Sbjct: 208 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWR 264
Query: 399 -NVEQR 403
+R
Sbjct: 265 EKPYER 270
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-45
Identities = 71/337 (21%), Positives = 128/337 (37%), Gaps = 83/337 (24%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS 176
+ ++ L+ +G GA+G V + TG A+KKL + + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 177 NCIVKLYCSFQDDEYL-----YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
++ L F L ++ +L G D+ + ++ LT++ +F + + + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
IH + IHRD+KP NL ++ + +K+ DFGL + D
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------------------- 175
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYE 350
V T Y APE++L Y D WS+G IM E
Sbjct: 176 ------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 351 MLVGYPPFYSDEPMSTCRKIVN---------------------WRTHLKFPEE------A 383
+L G F + + + I+ ++ + P+
Sbjct: 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 271
Query: 384 KLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
+P A DL+ K+L + ++R+ A + AH +F
Sbjct: 272 GANPLAVDLLEKMLVLDSDKRI---TAAQALAHAYFA 305
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (400), Expect = 6e-45
Identities = 44/289 (15%), Positives = 90/289 (31%), Gaps = 49/289 (16%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-N 177
++ IG+G+FG + A+K + R ++ E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 178 CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN 237
I +Y Q+ + L+++ L L + + + + + ++SIH+ +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 238 YIHRDIKPDNLLLDR-----NGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGR 292
++RDIKPDN L+ R + + DFG+ K ++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY-------------- 167
Query: 293 PVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352
+ GT Y++ L + D +LG + L
Sbjct: 168 --------------------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 207
Query: 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKL----SPEAKDLISKLL 397
G P+ + + +K + +L E +
Sbjct: 208 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 256
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-44
Identities = 60/313 (19%), Positives = 106/313 (33%), Gaps = 69/313 (22%)
Query: 117 DDFEPLTMIGKGAFGEVRVCR-----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
+ +G GAFG+V + A+K LK S L + E + +E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVL 80
Query: 172 AEVDSN-CIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD------------------ 212
+ + ++ IV L + +I EY GD++ L RK
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 213 TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272
L E+ + + + + N IHRD+ N+LL K+ DFGL + +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND-- 198
Query: 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332
+ ++ + ++APE +
Sbjct: 199 -------------------------------------SNYVVKGNARLPVKWMAPESIFN 221
Query: 333 KGYGMECDWWSLGAIMYEML-VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKD 391
Y E D WS G ++E+ +G P+ S K++ + PE E D
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH--APAEMYD 279
Query: 392 LISKLLC-NVEQR 403
++ + +R
Sbjct: 280 IMKTCWDADPLKR 292
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-44
Identities = 55/293 (18%), Positives = 97/293 (33%), Gaps = 48/293 (16%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKATGH----VYAMKKLKKSEMLRRGQVEHVKAERNLLA 172
+IG G FGEV K + A+K LK Q E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMG 64
Query: 173 EVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIE 231
+ + I++L + + +I EY+ G + L KD + + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 232 SIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDG 291
+ NY+HRD+ N+L++ N K+SDFGL + L+ S
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS------------- 171
Query: 292 RPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351
+ APE + + + D WS G +M+E+
Sbjct: 172 -------------------------GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206
Query: 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
+ Y + K +N L P + L+ + +R
Sbjct: 207 MTYGERPYWELSNHEVMKAINDGFRLPTPMD--CPSAIYQLMMQCWQQERARR 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-43
Identities = 44/287 (15%), Positives = 97/287 (33%), Gaps = 49/287 (17%)
Query: 124 MIGKGAFGEV---RVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIV 180
+IG+G FG V + A+K L + G+V E ++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 181 KLY-CSFQDDEYLYLIMEYLPGGDMMTLLM-RKDTLTEEEARFYVGETVLAIESIHKHNY 238
L + + +++ Y+ GD+ + T ++ + + ++ + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 239 IHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRR 298
+HRD+ N +LD +K++DFGL + + G
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG------------------ 193
Query: 299 TQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPP 357
++A E L + + + D WS G +++E++ G PP
Sbjct: 194 -------------------AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 358 FYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQR 403
+ ++ R + + +++ K E R
Sbjct: 235 YPDVNTFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-41
Identities = 54/312 (17%), Positives = 105/312 (33%), Gaps = 68/312 (21%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKAT-------GHVYAMKKLKKSEMLRRGQVEHVKAERN 169
D +G+GAFG+V + A+K LK + + +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEME 70
Query: 170 LLAEVDS-NCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRK----------------D 212
++ + I+ L + D LY+I+EY G++ L + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 213 TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272
L+ ++ + +E + IHRD+ N+L+ + MK++DFGL + + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK 332
+K + ++APE L
Sbjct: 191 YKK---------------------------------------TTNGRLPVKWMAPEALFD 211
Query: 333 KGYGMECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDL 392
+ Y + D WS G +++E+ Y P+ K++ + P + E +
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN--CTNELYMM 269
Query: 393 ISKLLC-NVEQR 403
+ QR
Sbjct: 270 MRDCWHAVPSQR 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-41
Identities = 49/327 (14%), Positives = 107/327 (32%), Gaps = 68/327 (20%)
Query: 117 DDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
+ +G+G+FG V K A+K + ++ +R + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 172 AEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKD----------TLTEEEARF 221
E + + +V+L + +IME + GD+ + L + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 222 YVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGS 281
GE + ++ + ++HRD+ N ++ + +K+ DFG+ + + ++ K
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG-- 195
Query: 282 NLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 341
+ +++PE L + D
Sbjct: 196 -------------------------------------LLPVRWMSPESLKDGVFTTYSDV 218
Query: 342 WSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NV 400
WS G +++E+ Y + V L P+ +L+ N
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN--CPDMLFELMRMCWQYNP 276
Query: 401 EQRLGTKGADEI------KAHPWFKGI 421
+ R EI + P F+ +
Sbjct: 277 KMRP---SFLEIISSIKEEMEPGFREV 300
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-41
Identities = 59/323 (18%), Positives = 108/323 (33%), Gaps = 69/323 (21%)
Query: 117 DDFEPLTMIGKGAFGEVRVCR-----EKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLL 171
D + +G+GAFG+V + AT A+K LK+ + + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI 71
Query: 172 AEVDSNCIVKL-YCSFQDDEYLYLIMEYLPGGDMMTLL----------------MRKDTL 214
+V L + L +I+E+ G++ T L + KD L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 215 TEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274
T E Y + +E + IHRD+ N+LL +K+ DFGL + +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY------ 185
Query: 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334
+ + ++APE + +
Sbjct: 186 ---------------------------------KDPDYVRKGDARLPLKWMAPETIFDRV 212
Query: 335 YGMECDWWSLGAIMYEMLVGY-PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLI 393
Y ++ D WS G +++E+ P+ + + + T ++ P+ +PE +
Sbjct: 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTM 270
Query: 394 SKLLC-NVEQRLGTKGADEIKAH 415
QR E+ H
Sbjct: 271 LDCWHGEPSQRP---TFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-36
Identities = 55/278 (19%), Positives = 85/278 (30%), Gaps = 62/278 (22%)
Query: 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD 175
A IGKG FGEV R K G A+K E + +AE +
Sbjct: 2 ARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLR 55
Query: 176 SNCIVKLYCSFQDDE----YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIE 231
I+ + D L+L+ +Y G + L + T+T E T +
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 114
Query: 232 SIH--------KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNL 283
+H K HRD+K N+L+ +NG ++D GL D +
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA------------- 161
Query: 284 SGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL------KKGYGM 337
+ VGT Y+APEVL
Sbjct: 162 ------------------------TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197
Query: 338 ECDWWSLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRT 375
D +++G + +E+ E +
Sbjct: 198 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (336), Expect = 2e-35
Identities = 64/392 (16%), Positives = 127/392 (32%), Gaps = 105/392 (26%)
Query: 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNL-------L 171
+ + +G G F V + ++ AMK ++ ++ + +K + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 172 AEVDSNCIVKLYCSFQD--DEYLYLIMEYLPGGDMMTLLMRKD---TLTEEEARFYVGET 226
+ +N I+KL F ++++M + G+ + L++K + + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 227 VLAIESI-HKHNYIHRDIKPDNLLLDRNGHM-KLSDFGLCKPLDCSNLQEKDFSIGSNLS 284
+L ++ + + IH DIKP+N+L++ L + + E
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-------- 186
Query: 285 GALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344
+++ T +Y +PEVLL +G D WS
Sbjct: 187 -------------------------------TNSIQTREYRSPEVLLGAPWGCGADIWST 215
Query: 345 GAIMYEMLVGYPPFYSDE---------------------PMSTCRKIVNWRTHL------ 377
+++E++ G F DE P R RT
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 378 -----------------KFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419
K+ + E D +S +L + +R A + HPW K
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLK 332
Query: 420 GIEWDKLYQIKAAFIPEVNDELDTQNFEKFEE 451
+ + +I+ D + FEE
Sbjct: 333 --DTLGMEEIRVPDRELYGSGSDIPGW--FEE 360
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.2 bits (171), Expect = 2e-14
Identities = 21/166 (12%), Positives = 50/166 (30%), Gaps = 28/166 (16%)
Query: 124 MIGKGAFGEVRVCREKATGHVYAMKKLKKS---------------EMLRRGQVEHVKAER 168
++G+G V C + +K K + + E
Sbjct: 7 LMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 169 NLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVL 228
L ++ + K+Y + ++ME + ++ + E + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILE 114
Query: 229 AIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274
+ + +H D+ N+L+ G + DF + +E
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWRE 159
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 549 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.14 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.84 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.12 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.97 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.56 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-71 Score=574.95 Aligned_cols=292 Identities=41% Similarity=0.746 Sum_probs=268.8
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
+++.++|++++.||+|+||+||+|+++.||+.||||++.+..+......+++.+|+.+|+.++|||||+++++|++++.+
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 46778999999999999999999999999999999999988777777888999999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+|||||+||+|..++.+.+.++|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998653211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
....+.|||+.|||||++.+.+|+.++|||||||++|||+
T Consensus 160 ----------------------------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml 199 (337)
T d1o6la_ 160 ----------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp ----------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHH
Confidence 0123579999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY-- 427 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~-- 427 (549)
+|++||.+.+..+.+.++.. ..+.+|. .+|++++|||.+||+ ||.+|++. .+++||++||||++++|+.+.
T Consensus 200 ~G~~pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~ 275 (337)
T d1o6la_ 200 CGRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 275 (337)
T ss_dssp HSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred HCCCCCCCcCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhC
Confidence 99999999999988888887 4566775 799999999999999 99999974 369999999999999999986
Q ss_pred cccCCCcccCCCcccccccccc
Q 038137 428 QIKAAFIPEVNDELDTQNFEKF 449 (549)
Q Consensus 428 ~~~~pf~p~~~~~~d~~~f~~~ 449 (549)
++.|||+|.+..+.|+++|++.
T Consensus 276 ~~~~p~~P~~~~~~~~~~f~~~ 297 (337)
T d1o6la_ 276 KLLPPFKPQVTSEVDTRYFDDE 297 (337)
T ss_dssp CSCCSCCCCCSSTTCCTTSCHH
T ss_pred CCCCCCCCCCCChhhhhhcCch
Confidence 4789999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-68 Score=550.19 Aligned_cols=293 Identities=40% Similarity=0.832 Sum_probs=268.1
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
....++|++++.||+|+||+||+|+++.||+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 34468999999999999999999999999999999999887766667778899999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999999999999899999999999999999999999999999999999999999999999999999876421
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
..+.+||+.|||||++.+.+|+.++|||||||++|||+
T Consensus 195 ------------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 195 ------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp ------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHH
Confidence 12568999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcccccc-
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLYQ- 428 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~~- 428 (549)
+|++||.+.+....+.+|... .+.+|. .+|+++.+||++||+ ||.+|++. .++++|++||||++++|+.+.+
T Consensus 233 tG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~ 308 (350)
T d1rdqe_ 233 AGYPPFFADQPIQIYEKIVSG--KVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC--CCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTT
T ss_pred hCCCCCCCcCHHHHHHHHhcC--CCCCCc--cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhc
Confidence 999999999998888888873 445554 799999999999999 99999853 5899999999999999999874
Q ss_pred -ccCCCcccCCCcccccccccccccc
Q 038137 429 -IKAAFIPEVNDELDTQNFEKFEEAD 453 (549)
Q Consensus 429 -~~~pf~p~~~~~~d~~~f~~~~~~~ 453 (549)
+.|||+|.+.++.|++||+.+++.+
T Consensus 309 ~~~~p~~p~~~~~~d~s~~~~~~~~~ 334 (350)
T d1rdqe_ 309 KVEAPFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp CSCCSCCCCCCSTTCCTTSCCCCCCC
T ss_pred CCCcCccCCCCCcchhhhcCCCCccc
Confidence 7899999999999999999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.1e-68 Score=542.34 Aligned_cols=291 Identities=43% Similarity=0.857 Sum_probs=254.0
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+++.+|+.+|+.++|||||+++++|++++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999998776666778889999999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||||+||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999875321
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
..+.+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 158 ----------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG 197 (316)
T d1fota_ 158 ----------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197 (316)
T ss_dssp ----------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ----------------------------------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC
Confidence 1257899999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCccccc--cc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWDKLY--QI 429 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~~l~--~~ 429 (549)
++||.+.+..+.+.+|.+. ...+|. .+|+++++||.+||+ ||.+|++. .++++|++||||++++|+.+. .+
T Consensus 198 ~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~ 273 (316)
T d1fota_ 198 YTPFYDSNTMKTYEKILNA--ELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273 (316)
T ss_dssp SCTTCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred CCCCCCcCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCC
Confidence 9999999999999998874 445554 799999999999999 99999864 489999999999999999986 57
Q ss_pred cCCCcccCC-Ccccccccccccccc
Q 038137 430 KAAFIPEVN-DELDTQNFEKFEEAD 453 (549)
Q Consensus 430 ~~pf~p~~~-~~~d~~~f~~~~~~~ 453 (549)
.+||+|.+. ...|+++|+++.+++
T Consensus 274 ~~p~~p~~~~~~~d~~~f~~~~~~~ 298 (316)
T d1fota_ 274 ETPYEPPIQQGQGDTSQFDKYPEED 298 (316)
T ss_dssp CCSCCCCC----------------C
T ss_pred CcCCCCCcCCCcchhhhcCCCcccc
Confidence 899999864 456899998876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-68 Score=535.97 Aligned_cols=280 Identities=37% Similarity=0.694 Sum_probs=249.7
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|++++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 34568999999999999999999999999999999999987776677778899999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
|||||||+||+|.+++...+.+++..++.++.|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987642210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
. ....+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 164 ~---------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell 204 (288)
T d1uu3a_ 164 Q---------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204 (288)
T ss_dssp ---------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHh
Confidence 0 0122568999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCC---CHHHHHcCCcccCCCcccccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTK---GADEIKAHPWFKGIEWDKLYQ 428 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~---~~~eil~HpfF~~i~w~~l~~ 428 (549)
+|++||.+.+..+.+.+|.+. .+.+|. .+|++++|||.+||+ ||.+|++.. ....|++||||++++|++|.+
T Consensus 205 ~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 205 AGLPPFRAGNEYLIFQKIIKL--EYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280 (288)
T ss_dssp HSSCSSCCSSHHHHHHHHHTT--CCCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred hCCCCCCCcCHHHHHHHHHcC--CCCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence 999999999999999999874 456664 799999999999999 999999421 223479999999999999999
Q ss_pred ccCCCcc
Q 038137 429 IKAAFIP 435 (549)
Q Consensus 429 ~~~pf~p 435 (549)
..||-+|
T Consensus 281 ~~pP~l~ 287 (288)
T d1uu3a_ 281 QTPPKLT 287 (288)
T ss_dssp SCCCCCC
T ss_pred CCCCCCC
Confidence 8888776
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-67 Score=542.57 Aligned_cols=314 Identities=36% Similarity=0.678 Sum_probs=249.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHH-hcCCCceeeeeeeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLA-EVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.........+++..|..++. .++|||||+++++|++++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 378999999999999999999999999999999999877666667778888888775 6899999999999999999999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
|||||+||+|..++.....+++.+++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-- 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-- 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhC
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G 354 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 159 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG 199 (320)
T d1xjda_ 159 ---------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199 (320)
T ss_dssp ---------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC
Confidence 01246899999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHH-HHHcCCcccCCCccccc--ccc
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGAD-EIKAHPWFKGIEWDKLY--QIK 430 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~-eil~HpfF~~i~w~~l~--~~~ 430 (549)
++||.+.+..+.+.+|.. ..+.+|. .+|+++++||++||+ ||.+|+ +++ ++++||||++++|+.+. ++.
T Consensus 200 ~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~---s~~~~l~~hpff~~~~~~~l~~~~~~ 272 (320)
T d1xjda_ 200 QSPFHGQDEEELFHSIRM--DNPFYPR--WLEKEAKDLLVKLFVREPEKRL---GVRGDIRQHPLFREINWEELERKEID 272 (320)
T ss_dssp SCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSB---TTBSCGGGSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHhcccCCCCCc---CHHHHHHhCchhccCCHHHHHhcCCC
Confidence 999999999998888876 3455664 789999999999999 999999 564 89999999999999885 478
Q ss_pred CCCcccCCCccccccccccccccccccccccCCcccccccc-ccccccccee
Q 038137 431 AAFIPEVNDELDTQNFEKFEEADNQIQTSAKSGPWRKMLSS-KDINFVGYTY 481 (549)
Q Consensus 431 ~pf~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~ 481 (549)
||++|.+.++.|++||+.....+.+.. +. .-+.++.+ .+..|.||+|
T Consensus 273 pp~~p~~~~~~d~~~f~~~~~~~~~~~-~~---~~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 273 PPFRPKVKSPFDCSNFDKEFLNEKPRL-SF---ADRALINSMDQNMFRNFSF 320 (320)
T ss_dssp C------------------------------------------CCTTTTCCC
T ss_pred CCCCCCCCCccchhhcChHhhhCCccC-CC---CcccccCchhhcccCcCcC
Confidence 999999999999999986432222111 11 11123333 3456889987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-64 Score=527.70 Aligned_cols=288 Identities=33% Similarity=0.649 Sum_probs=239.3
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHH---HHHHHhcCCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAE---RNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
++.++|+++++||+|+||+||+|+++.||+.||||++.+..+........+.+| ..+++.++|||||+++++|.+++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 457899999999999999999999999999999999988766544444445555 55666778999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
.+|+|||||+||+|..+|.+...+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999865421
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
. ....+||+.|||||++.+ ..|+.++|||||||++|
T Consensus 161 ~-------------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvily 197 (364)
T d1omwa3 161 K-------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197 (364)
T ss_dssp C-------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHH
T ss_pred c-------------------------------------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHH
Confidence 1 124689999999999974 67999999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhc--cccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCCCcc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNW--RTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~--~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i~w~ 424 (549)
||++|++||.+.+...... +... .....+| ..+|+++++||.+||+ ||.+|++. .+|+||++||||++++|.
T Consensus 198 emltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 198 KLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHSSCSSCSSCSSCHHH-HHHHSSSCCCCCC--SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHhCCCCCCCCCHHHHHH-HHHhcccCCCCCC--CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 9999999998765543322 2221 1233344 4799999999999999 99999964 348999999999999999
Q ss_pred ccc--cccCCCcccCCCcccccccc
Q 038137 425 KLY--QIKAAFIPEVNDELDTQNFE 447 (549)
Q Consensus 425 ~l~--~~~~pf~p~~~~~~d~~~f~ 447 (549)
.+. ++.|||+|..........|+
T Consensus 275 ~~~~~~~~~p~~p~~~~~~~~~~~d 299 (364)
T d1omwa3 275 MVFLQKYPPPLIPPRGEVNAADAFD 299 (364)
T ss_dssp HHHTTCSCCSCCCCCC---------
T ss_pred HHhcCCCCcCcCCCCCCCCcCCccc
Confidence 886 47899999876655555544
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-64 Score=504.43 Aligned_cols=257 Identities=35% Similarity=0.601 Sum_probs=236.4
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999999877666667788999999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 194 LIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
+|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 999999999999999988999999999999999999999999999999999999999999999999999998653210
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
....+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 161 -----------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 199 (263)
T d2j4za1 161 -----------------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199 (263)
T ss_dssp -----------------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc
Confidence 125689999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|++||.+.+..+.+.+|.+ ..+.+|. .+|+++++||.+||+ ||.+|+ +++||++||||.+
T Consensus 200 G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dp~~R~---t~~eil~hp~~~~ 260 (263)
T d2j4za1 200 GKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260 (263)
T ss_dssp SSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSC---CHHHHHTCHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHHccCCHhHCc---CHHHHHcCcCcCC
Confidence 9999999998888888876 3455664 789999999999999 999999 8999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-63 Score=496.03 Aligned_cols=260 Identities=26% Similarity=0.454 Sum_probs=221.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5789999999999999999999999999999999987543 22345688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987642210
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhhC
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~G 354 (549)
.....+.+||+.|||||++.+..| +.++|||||||++|||++|
T Consensus 159 ------------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G 202 (271)
T d1nvra_ 159 ------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202 (271)
T ss_dssp ------------------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence 011235799999999999998886 6789999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
++||.+.+.......+... .....+....+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 203 ~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hpwf~~ 265 (271)
T d1nvra_ 203 ELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNK 265 (271)
T ss_dssp SCSCSSSSTTSHHHHHHHT-TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTCTTTTC
T ss_pred CCCCCCCChHHHHHHHHhc-CCCCCCccccCCHHHHHHHHHHcCCChhHCc---CHHHHhcCHhhCc
Confidence 9999876554433333322 122233335789999999999999 999999 8999999999973
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-62 Score=502.38 Aligned_cols=259 Identities=32% Similarity=0.566 Sum_probs=218.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 466999999999999999999999999999999998765432 335688999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc---CCCcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD---RNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld---~~g~vKL~DFGlak~~~~~~~ 272 (549)
||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||+. .+|++||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99999999999999889999999999999999999999999999999999999995 57899999999998653211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
...+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 165 -----------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 165 -----------------------------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp -------------------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH
Confidence 012568999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+|++||.+.+..++..+|......+..|....+|+++++||.+||. ||.+|+ +++|+++||||++.
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 204 CGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGD 270 (307)
T ss_dssp HSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC---CHHHHHHSTTTTSS
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCCC
Confidence 9999999999889999998865555555556899999999999999 999999 89999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-62 Score=496.24 Aligned_cols=267 Identities=30% Similarity=0.528 Sum_probs=232.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR---GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999987654322 2357789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC----cEEEeecCcccccC
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG----HMKLSDFGLCKPLD 268 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g----~vKL~DFGlak~~~ 268 (549)
|||||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+| ++||+|||+|+.+.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999998889999999999999999999999999999999999999999877 59999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.... ..+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~------------------------------------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 169 FGNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206 (293)
T ss_dssp TSCB------------------------------------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CCcc------------------------------------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHH
Confidence 2210 1146899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLY 427 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~ 427 (549)
|||++|.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+|+ +++||++||||++.+|....
T Consensus 207 yell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 207 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSTTTCC-------
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCChhHhh
Confidence 99999999999999999988888743332222235789999999999999 999999 89999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-62 Score=493.66 Aligned_cols=255 Identities=31% Similarity=0.536 Sum_probs=226.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 479999999999999999999999999999999986543 23467899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
|||+||+|..++. .+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 97 Ey~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---- 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (293)
T ss_dssp ECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred EecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc----
Confidence 9999999998875 46799999999999999999999999999999999999999999999999999987642210
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.....+||+.|||||++.+..|+.++|||||||++|||++|++
T Consensus 172 -------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 172 -------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp -------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 0125689999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 357 PFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||.+.+......++.... ...++.+..+|+++++||.+||. ||.+|+ +++||++||||+.
T Consensus 215 Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 215 PYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLKI 275 (293)
T ss_dssp TTTTSCHHHHHHHHHHHC-SCCCSSGGGSCHHHHHHHHHHTCSSTTTSC---CHHHHTTCGGGGG
T ss_pred CCCCCCHHHHHHHHHhCC-CCCCCCcccCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCC
Confidence 999988877777776532 23333345799999999999999 999999 8999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.4e-62 Score=504.25 Aligned_cols=263 Identities=29% Similarity=0.503 Sum_probs=234.1
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976543 3346788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC--CCcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR--NGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~--~g~vKL~DFGlak~~~~~~~ 272 (549)
||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+||||+. +|++||+|||+|+.+....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 999999999999854 567999999999999999999999999999999999999964 6899999999998764221
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
...+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 181 -----------------------------------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 181 -----------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp -----------------------------------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 122578999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccc
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l 426 (549)
+|++||.+.+..+.+.+|......+..+....+|+++++||.+||+ ||.+|+ +++||++||||+..+|...
T Consensus 220 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 220 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSC---CHHHHHHSTTTSCTTCCSC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCCCCCCCc
Confidence 9999999999999999998754433333335799999999999999 999999 8999999999998887554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-62 Score=504.10 Aligned_cols=265 Identities=28% Similarity=0.429 Sum_probs=225.1
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceE
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYL 192 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 192 (549)
++..++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456789999999999999999999999999999999997642 334456789999999999999999999999999999
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
|||||||+||+|..++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999988999999999999999999999997 59999999999999999999999999999864211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
...+.+||+.|||||++.+..|+.++|||||||++|||
T Consensus 159 ------------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~el 196 (322)
T d1s9ja_ 159 ------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196 (322)
T ss_dssp ------------------------------------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHH
Confidence 12257999999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhh-----------------------------------------hccccccCCCCcCCChhHH
Q 038137 352 LVGYPPFYSDEPMSTCRKIV-----------------------------------------NWRTHLKFPEEAKLSPEAK 390 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~-----------------------------------------~~~~~l~~p~~~~~s~~~~ 390 (549)
++|++||.+.+......... .......+|. ..+|++++
T Consensus 197 l~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~ 275 (322)
T d1s9ja_ 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS-GVFSLEFQ 275 (322)
T ss_dssp HHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCB-TTBCHHHH
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCcc-ccCCHHHH
Confidence 99999998765432110000 0000111121 24689999
Q ss_pred HHHHHhhh-cccccCCCCCHHHHHcCCcccCCCcccc
Q 038137 391 DLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKL 426 (549)
Q Consensus 391 dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l 426 (549)
|||.+||+ ||.+|+ +|+|+|+||||+..+|+.+
T Consensus 276 dli~~~L~~dP~~R~---ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 276 DFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp HHHHHHTCSSTTTSC---CHHHHHTSHHHHHHHHSCC
T ss_pred HHHHHHcCCChhHCc---CHHHHhhCHhhCcCCcccc
Confidence 99999999 999999 8999999999998877654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-61 Score=487.53 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=226.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 56899999999999999999999999999999997653 334566889999999999999999999999999999999
Q ss_pred eecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccc
Q 038137 197 EYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEK 275 (549)
Q Consensus 197 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~ 275 (549)
|||+||+|..++.+ .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999765 4679999999999999999999999999999999999999999999999999997642110
Q ss_pred cccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhc-----cCCCCcccccchhhHHHHH
Q 038137 276 DFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~-----~~~y~~~~DiWSlGvilyE 350 (549)
....+.+||+.|||||++. +..|+.++|||||||++||
T Consensus 165 -------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 165 -------------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp -------------------------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred -------------------------------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence 0112578999999999994 4678999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|++|++||.+.+..+.+.+|.... ...++.+..+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 208 mltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---t~~ell~hp~~~~ 274 (288)
T d2jfla1 208 MAEIEPPHHELNPMRVLLKIAKSE-PPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274 (288)
T ss_dssp HHHSSCTTTTSCGGGHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHSCSSTTTSC---CHHHHTTSGGGCC
T ss_pred HhhCCCCCCCCCHHHHHHHHHcCC-CCCCCccccCCHHHHHHHHHHccCChhHCc---CHHHHhcCcccCC
Confidence 999999999999988888888743 22333345799999999999999 999999 8999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-61 Score=491.80 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=228.3
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 39999999999999999999999999999999988766556667789999999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
||+||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-------
Confidence 9999999888878889999999999999999999999999999999999999999999999999999864311
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchhhHHHHHHhhC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVG 354 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSlGvilyEml~G 354 (549)
.+.+||+.|||||++.+ ..|+.++|||||||++|||++|
T Consensus 169 --------------------------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g 210 (309)
T d1u5ra_ 169 --------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (309)
T ss_dssp --------------------------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence 14689999999999974 4689999999999999999999
Q ss_pred CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 355 YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 355 ~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
.+||.+.+..+...++..... ..+....+|+++++||.+||+ ||.+|+ +++|+++||||..
T Consensus 211 ~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 211 KPPLFNMNAMSALYHIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272 (309)
T ss_dssp SCTTTTSCHHHHHHHHHHSCC--CCCSCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHTTCHHHHS
T ss_pred CCCCCCCCHHHHHHHHHhCCC--CCCCCCCCCHHHHHHHHHHCcCChhHCc---CHHHHHhCHHhcC
Confidence 999999888888888876432 223334789999999999999 999999 8999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-60 Score=494.41 Aligned_cols=258 Identities=30% Similarity=0.562 Sum_probs=229.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999875432 335678999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEc--CCCcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLD--RNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld--~~g~vKL~DFGlak~~~~~~~ 272 (549)
||||+||+|.+++... ..|++.+++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+.+....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999999887654 4699999999999999999999999999999999999998 67899999999998764221
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
...+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 184 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 222 (352)
T d1koba_ 184 -----------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222 (352)
T ss_dssp -----------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH
Confidence 123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i 421 (549)
+|.+||.+.+..+.+.+|......+..+....+|+++++||.+||+ ||.+|+ +++||++||||++.
T Consensus 223 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 223 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKGD 289 (352)
T ss_dssp HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHTSTTTSSC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhCCC
Confidence 9999999999988888888743333332335799999999999999 999999 89999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-61 Score=478.83 Aligned_cols=255 Identities=32% Similarity=0.578 Sum_probs=215.9
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC--CceEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD--DEYLY 193 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~ly 193 (549)
.++|++++.||+|+||+||+|+++.||+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+ +..+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 5789999999999999999999999999999999987654 34456778999999999999999999999865 56799
Q ss_pred EEEeecCCCchhhHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeecCCCCCCeEEcCCCcEEEeecCcc
Q 038137 194 LIMEYLPGGDMMTLLMR----KDTLTEEEARFYVGETVLAIESIHKHN-----YIHRDIKPDNLLLDRNGHMKLSDFGLC 264 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHRDLKPeNILld~~g~vKL~DFGla 264 (549)
+|||||+||+|.+++.+ ...+++..++.++.||+.||.|||+.| ||||||||+||||+.+|++||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999854 467999999999999999999999876 999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+.+.... ....+.+||+.|||||++.+..|+.++|||||
T Consensus 162 ~~~~~~~-----------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 200 (269)
T d2java1 162 RILNHDT-----------------------------------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200 (269)
T ss_dssp HHC----------------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred eecccCC-----------------------------------------CccccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence 8764211 01125789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
||++|||++|.+||.+.+..+...+|.+.. ...+| ..+|+++++||.+||. ||.+|+ +++||++|||.
T Consensus 201 Gvilyel~tg~~Pf~~~~~~~~~~~i~~~~-~~~~~--~~~s~~l~~li~~~L~~dp~~Rp---s~~ell~hp~i 269 (269)
T d2java1 201 GCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIP--YRYSDELNEIITRMLNLKDYHRP---SVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHTSTTC
T ss_pred CHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCC--cccCHHHHHHHHHHcCCChhHCc---CHHHHHhCCcC
Confidence 999999999999999998888888887642 22334 3789999999999999 999999 89999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.8e-60 Score=475.08 Aligned_cols=260 Identities=34% Similarity=0.597 Sum_probs=232.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc------hhhHHHHHHHHHHHHhcC-CCceeeeeeeecC
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLR------RGQVEHVKAERNLLAEVD-SNCIVKLYCSFQD 188 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~------~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d 188 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+.++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999998754322 223456889999999997 9999999999999
Q ss_pred CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 189 DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
++++|||||||+||||.++|...+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc------CCCCcccccc
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWW 342 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~------~~y~~~~DiW 342 (549)
.... ....+||+.|+|||++.+ ..|+.++|||
T Consensus 162 ~~~~------------------------------------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diw 199 (277)
T d1phka_ 162 PGEK------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199 (277)
T ss_dssp TTCC------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred CCCc------------------------------------------eeeeeccCCCCCHHHhhccccccCCCCCchheEc
Confidence 2110 114689999999999973 4578999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 343 SLGAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 343 SlGvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
|+||++|||++|++||.+.+......+|++....+..|....+|+++++||.+||+ ||.+|+ +++||++||||+.
T Consensus 200 slGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~---s~~eil~h~~~~~ 275 (277)
T d1phka_ 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC---CHHHHTTSGGGCT
T ss_pred ccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHHcCHHHHH
Confidence 99999999999999999999988888888865555555556899999999999999 999999 8999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-60 Score=488.98 Aligned_cols=292 Identities=41% Similarity=0.734 Sum_probs=247.8
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhc-hhhHHHHHHHHHHHHhcCC-Cceeeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCRE---KATGHVYAMKKLKKSEMLR-RGQVEHVKAERNLLAEVDS-NCIVKLYCSF 186 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~---k~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f 186 (549)
.++..++|++++.||+|+||+||+|++ +.+|+.||||++++..... ....+.+.+|+.+|+.++| |||++++++|
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 345678999999999999999999998 4479999999998754322 2334568899999999977 8999999999
Q ss_pred cCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 187 QDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 187 ~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
.+...+|+||||+.||+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC--CCCcccccchh
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSL 344 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~--~y~~~~DiWSl 344 (549)
+...... ...+.+||+.|+|||++.+. .|+.++|||||
T Consensus 179 ~~~~~~~----------------------------------------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSl 218 (322)
T d1vzoa_ 179 FVADETE----------------------------------------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218 (322)
T ss_dssp CCGGGGG----------------------------------------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred hcccccc----------------------------------------cccccccccccchhHHhhcCCcCCCchhhhHHH
Confidence 6422100 11256899999999999864 46889999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC--CCHHHHHcCCcccCC
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT--KGADEIKAHPWFKGI 421 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~--~~~~eil~HpfF~~i 421 (549)
||+||||++|.+||.+.+.......+.........+.+..+|+++++||.+||. ||.+|++. .+++|+++||||+++
T Consensus 219 G~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 999999999999999887777766665432222222234799999999999999 99999975 369999999999999
Q ss_pred Cccccc--cccCCCcccCCCcccc
Q 038137 422 EWDKLY--QIKAAFIPEVNDELDT 443 (549)
Q Consensus 422 ~w~~l~--~~~~pf~p~~~~~~d~ 443 (549)
+|+.+. ++++||+|.+.++.|.
T Consensus 299 ~~~~l~~~~~~~p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 299 NWDDLAAKKVPAPFKPVIRDELDV 322 (322)
T ss_dssp CHHHHHTTCSCCSCCCCCCC-CCC
T ss_pred CHHHHHhCCCCcCCCCCCCCCCCC
Confidence 999987 4899999999998773
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=470.16 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=216.8
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC----CceEEE
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD----DEYLYL 194 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~~lyl 194 (549)
|++.+.||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+++|+.++|||||+++++|.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4677789999999999999999999999999987654 34456778999999999999999999999864 567999
Q ss_pred EEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCCCCeEEc-CCCcEEEeecCcccccCCCC
Q 038137 195 IMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHN--YIHRDIKPDNLLLD-RNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHRDLKPeNILld-~~g~vKL~DFGlak~~~~~~ 271 (549)
|||||+||+|.+++.+...+++..++.++.||+.||.|||++| ||||||||+||||+ .+|++||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999998899999999999999999999999998 99999999999996 5899999999999754211
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.+.+.+||+.|||||++.+ +|+.++|||||||++|||
T Consensus 169 ------------------------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 169 ------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp ------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHH
Confidence 1226799999999999865 699999999999999999
Q ss_pred hhCCCCCCCCCch-hhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 352 LVGYPPFYSDEPM-STCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 352 l~G~~PF~~~~~~-~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
++|++||.+.... ..+.++........++ ..+++++++||.+||. ||++|+ +++||++||||+
T Consensus 206 ~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~---s~~ell~Hp~fk 270 (270)
T d1t4ha_ 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 270 (270)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSC---CHHHHHTSGGGC
T ss_pred HHCCCCCCCcccHHHHHHHHHcCCCCcccC--ccCCHHHHHHHHHHccCCHhHCc---CHHHHhCCcccC
Confidence 9999999876544 4455555433333333 3689999999999999 999999 899999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=482.39 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=227.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.++|++++.||+|+||+||+|+++.||+.||||++++.. .....+.+|+.+|+.++|||||+++++|++++++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999997653 2234588999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC--CcEEEeecCcccccCCCCc
Q 038137 196 MEYLPGGDMMTLLMRKD-TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN--GHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 196 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~--g~vKL~DFGlak~~~~~~~ 272 (549)
||||+||+|.+++...+ .+++.+++.|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 99999999999997655 79999999999999999999999999999999999999854 489999999998653211
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
...+.+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 159 -----------------------------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll 197 (321)
T d1tkia_ 159 -----------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp -----------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHH
Confidence 123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccC
Q 038137 353 VGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 353 ~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
+|.+||.+.+..+.+.+|.+....+..+....+|+++++||.+||+ ||.+|+ +++|+++||||+.
T Consensus 198 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~ 263 (321)
T d1tkia_ 198 SGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC---CHHHHHHSHHHHS
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCc---CHHHHhcCHhhcc
Confidence 9999999999999999998743332222224789999999999999 999999 8999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=469.77 Aligned_cols=259 Identities=30% Similarity=0.451 Sum_probs=217.2
Q ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch--hhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEe
Q 038137 120 EPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRR--GQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIME 197 (549)
Q Consensus 120 ~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 197 (549)
+.+++||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|+.++|||||+++++|.+++++|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 357899999999999999999999999999976543222 123468899999999999999999999999999999999
Q ss_pred ecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccc
Q 038137 198 YLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDF 277 (549)
Q Consensus 198 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~ 277 (549)
||.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~----- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-----
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-----
Confidence 999998888887788899999999999999999999999999999999999999999999999999986542210
Q ss_pred cccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHHHHhhCCC
Q 038137 278 SIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+
T Consensus 156 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 156 ------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp ------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence 0125689999999999975 568999999999999999999999
Q ss_pred CCCCCCchhhhhhhhhcccc---------c---------cCCC------CcCCChhHHHHHHHhhh-cccccCCCCCHHH
Q 038137 357 PFYSDEPMSTCRKIVNWRTH---------L---------KFPE------EAKLSPEAKDLISKLLC-NVEQRLGTKGADE 411 (549)
Q Consensus 357 PF~~~~~~~~~~~I~~~~~~---------l---------~~p~------~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~e 411 (549)
||.+.+..+++.+|...... . .+|. ...+|++++|||.+||+ ||.+|+ ||+|
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~---sa~e 276 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI---TATQ 276 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC---CHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc---CHHH
Confidence 99999888887777642110 0 0010 12568999999999999 999999 8999
Q ss_pred HHcCCcccCCC
Q 038137 412 IKAHPWFKGIE 422 (549)
Q Consensus 412 il~HpfF~~i~ 422 (549)
+|+||||++..
T Consensus 277 ~L~Hp~f~~~p 287 (299)
T d1ua2a_ 277 ALKMKYFSNRP 287 (299)
T ss_dssp HHTSGGGTSSS
T ss_pred HhCCHhhCCCC
Confidence 99999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=477.13 Aligned_cols=252 Identities=34% Similarity=0.571 Sum_probs=211.4
Q ss_pred CCCeeeee-eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHh-cCCCceeeeeeeecC----C
Q 038137 116 ADDFEPLT-MIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAE-VDSNCIVKLYCSFQD----D 189 (549)
Q Consensus 116 ~~~f~~~~-~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d----~ 189 (549)
.++|+++. +||+|+||+||+|+++.||+.||||++++. ..+.+|+.++.. .+|||||+++++|++ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 57899985 699999999999999999999999999754 236679988754 589999999999975 5
Q ss_pred ceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---CCcEEEeecCcc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NGHMKLSDFGLC 264 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~g~vKL~DFGla 264 (549)
.++|||||||+||+|.++|.+. ..|+|.+++.|+.||+.||.|||++|||||||||+|||++. ++++||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 7799999999999999999764 46999999999999999999999999999999999999985 568999999999
Q ss_pred cccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchh
Q 038137 265 KPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 344 (549)
Q Consensus 265 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSl 344 (549)
+....... ..+.+||+.|||||++.+..|+.++|||||
T Consensus 162 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl 199 (335)
T d2ozaa1 162 KETTSHNS------------------------------------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199 (335)
T ss_dssp EECCCCCC------------------------------------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred eeccCCCc------------------------------------------cccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence 87542210 125689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCchhhhhhhhhcc--ccccCCC--CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 345 GAIMYEMLVGYPPFYSDEPMSTCRKIVNWR--THLKFPE--EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 345 GvilyEml~G~~PF~~~~~~~~~~~I~~~~--~~l~~p~--~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
||++|+|++|++||.+.+.......+.... ....+|. ...+|+++++||++||+ ||.+|+ +++||++||||.
T Consensus 200 Gvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~eil~hp~~~ 276 (335)
T d2ozaa1 200 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIM 276 (335)
T ss_dssp HHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC---CHHHHHHSHHHH
T ss_pred chhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc---CHHHHHcCHHhh
Confidence 999999999999998877655444333211 2233443 34689999999999999 999999 899999999996
Q ss_pred C
Q 038137 420 G 420 (549)
Q Consensus 420 ~ 420 (549)
.
T Consensus 277 ~ 277 (335)
T d2ozaa1 277 Q 277 (335)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=459.50 Aligned_cols=262 Identities=30% Similarity=0.471 Sum_probs=216.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 195 (549)
.|+|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.++|||||+++++|++++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 378999999999999999999999999999999997653 2333456788999999999999999999999999999999
Q ss_pred EeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccc
Q 038137 196 MEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQE 274 (549)
Q Consensus 196 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~ 274 (549)
||||.|+.+..+... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++++||+|||+|+.......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-- 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc--
Confidence 999966544444333 46799999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHHHHHHhh
Q 038137 275 KDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++....| +.++|+|||||++|+|++
T Consensus 158 ---------------------------------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~ 198 (298)
T d1gz8a_ 158 ---------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198 (298)
T ss_dssp ---------------------------------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------cceeecccceeeehhhhccccCCCccccccccchhhhHHhh
Confidence 0114689999999999887665 899999999999999999
Q ss_pred CCCCCCCCCchhhhhhhhhcccc----------------ccCCC---------CcCCChhHHHHHHHhhh-cccccCCCC
Q 038137 354 GYPPFYSDEPMSTCRKIVNWRTH----------------LKFPE---------EAKLSPEAKDLISKLLC-NVEQRLGTK 407 (549)
Q Consensus 354 G~~PF~~~~~~~~~~~I~~~~~~----------------l~~p~---------~~~~s~~~~dLI~~lL~-dp~~Rl~~~ 407 (549)
|++||.+.+......++...... ..++. ...+|++++|||++||+ ||.+|+
T Consensus 199 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~--- 275 (298)
T d1gz8a_ 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI--- 275 (298)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC---
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc---
Confidence 99999988877766665431100 00110 12578999999999999 999999
Q ss_pred CHHHHHcCCcccCCC
Q 038137 408 GADEIKAHPWFKGIE 422 (549)
Q Consensus 408 ~~~eil~HpfF~~i~ 422 (549)
|++||++||||++++
T Consensus 276 t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 276 SAKAALAHPFFQDVT 290 (298)
T ss_dssp CHHHHHTSGGGTTCC
T ss_pred CHHHHhCCHhhccCC
Confidence 899999999998873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=456.25 Aligned_cols=251 Identities=29% Similarity=0.482 Sum_probs=216.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhh---HHHHHHHHHHHHhcC--CCceeeeeeeecCCc
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQ---VEHVKAERNLLAEVD--SNCIVKLYCSFQDDE 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~---~~~~~~E~~iL~~l~--hp~Iv~l~~~f~d~~ 190 (549)
.++|++.++||+|+||+||+|+++.+|+.||||++.+........ ...+.+|+.+|+.++ |||||+++++|.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999999999999999998765433221 233668999999986 899999999999999
Q ss_pred eEEEEEeecCC-CchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCC-CcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPG-GDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRN-GHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~-g~vKL~DFGlak~~~ 268 (549)
.+|+||||+.| +++..++.+...+++..++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 6888888888999999999999999999999999999999999999999854 799999999998643
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC-CcccccchhhHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 347 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y-~~~~DiWSlGvi 347 (549)
... ..+.+||+.|||||++.+..| +.++|||||||+
T Consensus 163 ~~~-------------------------------------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvi 199 (273)
T d1xwsa_ 163 DTV-------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199 (273)
T ss_dssp SSC-------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHH
T ss_pred ccc-------------------------------------------ccccccCCCcCCHHHHcCCCCCCcccccccceee
Confidence 210 125689999999999988765 678999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCC
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
+|||++|++||.+.+ .+.. ....+|. .+|+++++||.+||. ||.+|+ +++||++||||+++-
T Consensus 200 lyell~g~~Pf~~~~------~i~~--~~~~~~~--~~s~~~~~li~~~L~~dp~~R~---s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 200 LYDMVCGDIPFEHDE------EIIR--GQVFFRQ--RVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHSSCSCCSHH------HHHH--CCCCCSS--CCCHHHHHHHHHHTCSSGGGSC---CHHHHHTSGGGSSCC
T ss_pred ehhHhhCCCCCCCch------HHhh--cccCCCC--CCCHHHHHHHHHHccCCHhHCc---CHHHHhcCHhhCCCC
Confidence 999999999997642 3443 2344553 799999999999999 999999 899999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-57 Score=458.11 Aligned_cols=263 Identities=27% Similarity=0.427 Sum_probs=216.8
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCC-CcEEEEEEeechhhhchhhHHHHHHHHHHHHhc---CCCceeeeeeeec----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKAT-GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV---DSNCIVKLYCSFQ---- 187 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~t-g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~---- 187 (549)
.++|++++.||+|+||+||+|+++.+ ++.||||++.+.... ......+.+|+.+|+.+ +|||||+++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 36899999999999999999999765 678999999764322 22223456777777655 8999999999985
Q ss_pred -CCceEEEEEeecCCCchhhHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccc
Q 038137 188 -DDEYLYLIMEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCK 265 (549)
Q Consensus 188 -d~~~lylVmEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak 265 (549)
....+|+|||||.||++.... .....+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 346799999999988775444 345679999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhh
Q 038137 266 PLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 345 (549)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlG 345 (549)
...... ...+.+||+.|||||++.+..|+.++||||||
T Consensus 165 ~~~~~~------------------------------------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG 202 (305)
T d1blxa_ 165 IYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 202 (305)
T ss_dssp CCCGGG------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHH
T ss_pred hhcccc------------------------------------------cCCCcccChhhcCcchhcCCCCChhehhhchH
Confidence 643211 01256899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCCchhhhhhhhhcc---------ccccCC--------------CCcCCChhHHHHHHHhhh-ccc
Q 038137 346 AIMYEMLVGYPPFYSDEPMSTCRKIVNWR---------THLKFP--------------EEAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 346 vilyEml~G~~PF~~~~~~~~~~~I~~~~---------~~l~~p--------------~~~~~s~~~~dLI~~lL~-dp~ 401 (549)
|++|||++|++||.+.+..++..+|+... .....+ ....+|++++|||.+||+ ||.
T Consensus 203 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 282 (305)
T d1blxa_ 203 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282 (305)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChh
Confidence 99999999999999998888777775421 000000 013578999999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCCCcc
Q 038137 402 QRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
+|+ ||+|+++||||+++++.
T Consensus 283 ~R~---sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 283 KRI---SAYSALSHPYFQDLERC 302 (305)
T ss_dssp TSC---CHHHHHTSGGGTTCCCC
T ss_pred HCc---CHHHHhcChhhcCchhh
Confidence 999 89999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.8e-57 Score=452.14 Aligned_cols=262 Identities=25% Similarity=0.403 Sum_probs=220.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc----e
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----Y 191 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----~ 191 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 477999999999999999999999999999999998876656666778999999999999999999999987543 4
Q ss_pred EEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~ 271 (549)
+|||||||+||+|..++...+.+++.+++.++.||+.||.|||++|||||||||+||||+.++.++|+|||+++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999888999999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
.. .....+.+||+.|||||++.+..|+.++|||||||++|||
T Consensus 166 ~~--------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyel 207 (277)
T d1o6ya_ 166 NS--------------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207 (277)
T ss_dssp ---------------------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cc--------------------------------------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHH
Confidence 00 0112257999999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWF 418 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF 418 (549)
++|++||.+.+..+...+++.............+|+++++||.+||. ||.+|+. ++++++ |+|.
T Consensus 208 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~--sa~~l~-~~l~ 272 (277)
T d1o6ya_ 208 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMR-ADLV 272 (277)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS--SHHHHH-HHHH
T ss_pred HhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh--HHHHHH-HHHH
Confidence 99999999999888888887754333333345799999999999999 9999994 466654 5554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-56 Score=447.07 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=218.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||+||+|+++ +|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999986 789999999976543 3344567899999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||+.|+++..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---- 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---- 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc----
Confidence 9998888888887788999999999999999999999999999999999999999999999999999987542210
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml~G~ 355 (549)
.....+||+.|+|||++.+. .|+.++|+|||||++|||++|+
T Consensus 156 -------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 156 -------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp -------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 01145899999999999864 5699999999999999999999
Q ss_pred CCCCCCCchhhhhhhhhccccc---------cC-------------C---CCcCCChhHHHHHHHhhh-cccccCCCCCH
Q 038137 356 PPFYSDEPMSTCRKIVNWRTHL---------KF-------------P---EEAKLSPEAKDLISKLLC-NVEQRLGTKGA 409 (549)
Q Consensus 356 ~PF~~~~~~~~~~~I~~~~~~l---------~~-------------p---~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~ 409 (549)
+||.+.+..+.+.++....... .. | ....+|++++|||++||. ||++|+ ++
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~---s~ 275 (286)
T d1ob3a_ 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---TA 275 (286)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC---CH
T ss_pred CCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc---CH
Confidence 9999888777766654311100 00 0 013578999999999999 999999 89
Q ss_pred HHHHcCCcccC
Q 038137 410 DEIKAHPWFKG 420 (549)
Q Consensus 410 ~eil~HpfF~~ 420 (549)
+|+++||||+.
T Consensus 276 ~ell~Hp~f~~ 286 (286)
T d1ob3a_ 276 KQALEHAYFKE 286 (286)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhcCcccCc
Confidence 99999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=453.81 Aligned_cols=258 Identities=21% Similarity=0.348 Sum_probs=218.8
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCc-----EEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGH-----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCS 185 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~-----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 185 (549)
.++..++|++.++||+|+||+||+|+++.+++ .||+|++.+.. .......+.+|+.+|..+ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 34667899999999999999999999876654 69999987543 233445688999999988 89999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRK-----------------------DTLTEEEARFYVGETVLAIESIHKHNYIHRD 242 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~-----------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRD 242 (549)
|.+.+.+|||||||+||+|.++|... +.+++..++.|+.||+.||.|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999653 3589999999999999999999999999999
Q ss_pred CCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCC
Q 038137 243 IKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTP 322 (549)
Q Consensus 243 LKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~ 322 (549)
|||+|||++.+|++||+|||+|+....... .....+.+||+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~---------------------------------------~~~~~~~~gt~ 230 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN---------------------------------------YVVRGNARLPV 230 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT---------------------------------------SEEETTEEECG
T ss_pred CchhccccccCCeEEEeeccccccccCCCc---------------------------------------eeeeccccCCC
Confidence 999999999999999999999986542110 00112467999
Q ss_pred CCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cc
Q 038137 323 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 323 ~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp 400 (549)
.|||||++.+..|+.++|||||||++|||++ |.+||.+.+....+.+++.....+..| ..+|+++++||.+||. ||
T Consensus 231 ~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP 308 (325)
T d1rjba_ 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDS 308 (325)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSG
T ss_pred ccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999997 899999988777777777644444444 4789999999999999 99
Q ss_pred cccCCCCCHHHHHcC
Q 038137 401 EQRLGTKGADEIKAH 415 (549)
Q Consensus 401 ~~Rl~~~~~~eil~H 415 (549)
++|+ +++||++|
T Consensus 309 ~~RP---t~~ei~~~ 320 (325)
T d1rjba_ 309 RKRP---SFPNLTSF 320 (325)
T ss_dssp GGSC---CHHHHHHH
T ss_pred hHCc---CHHHHHHH
Confidence 9999 89999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-56 Score=447.46 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=218.9
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
.+.++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++|||||+++++|.++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 456778889999999999999999999999999999999997643 2346789999999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+.+|+|||||++|+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999653 67999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
...... ......||+.|||||++.+..|+.++|||||||+
T Consensus 166 ~~~~~~----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~ 205 (287)
T d1opja_ 166 TGDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 205 (287)
T ss_dssp CSSSSE----------------------------------------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred CCCCce----------------------------------------eeccccccccccChHHHcCCCCCchhhhhhHHHH
Confidence 422100 0113568999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
+|||++|..||..........+++.....+.+| ..+|+++++||.+||. ||.+|+ +++||++
T Consensus 206 l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp---s~~ei~~ 268 (287)
T d1opja_ 206 LWEIATYGMSPYPGIDLSQVYELLEKDYRMERP--EGCPEKVYELMRACWQWNPSDRP---SFAEIHQ 268 (287)
T ss_dssp HHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHH
T ss_pred HHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC--ccchHHHHHHHHHHcCCCHhHCc---CHHHHHH
Confidence 999999766655544444444444433334444 4789999999999999 999999 7999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-55 Score=449.93 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=212.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeec--CCceE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQ--DDEYL 192 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~--d~~~l 192 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .+.+.+|+.+|..+. ||||++++++|. +...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 478999999999999999999999999999999997542 356889999999985 999999999997 44679
Q ss_pred EEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeecCcccccCCCC
Q 038137 193 YLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 193 ylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~~~~~ 271 (549)
|+|||||.+|+|..+. +.+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999999998764 5699999999999999999999999999999999999998765 69999999998754221
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 350 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvilyE 350 (549)
. ....+||+.|+|||++.+. .|+.++|+|||||++||
T Consensus 185 ~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e 222 (328)
T d3bqca1 185 E------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222 (328)
T ss_dssp C------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccCccccCcccccCCCCCCcccchhhhhhhhHH
Confidence 0 1146899999999998874 58999999999999999
Q ss_pred HhhCCCCCCCCCchh-hhhhhhh---------------------------------ccccccCCCCcCCChhHHHHHHHh
Q 038137 351 MLVGYPPFYSDEPMS-TCRKIVN---------------------------------WRTHLKFPEEAKLSPEAKDLISKL 396 (549)
Q Consensus 351 ml~G~~PF~~~~~~~-~~~~I~~---------------------------------~~~~l~~p~~~~~s~~~~dLI~~l 396 (549)
|++|..||....... ....+.. +......+....+|++++|||++|
T Consensus 223 ~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 302 (328)
T d3bqca1 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302 (328)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHH
T ss_pred hccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHH
Confidence 999999997654322 2211111 000011112245799999999999
Q ss_pred hh-cccccCCCCCHHHHHcCCcccCCCcc
Q 038137 397 LC-NVEQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 397 L~-dp~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
|+ ||.+|+ ||+|||+||||+++.|+
T Consensus 303 L~~dP~~R~---ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 303 LRYDHQSRL---TAREAMEHPYFYTVVKD 328 (328)
T ss_dssp SCSSGGGSC---CHHHHHTSGGGTTSCCC
T ss_pred ccCChhHCc---CHHHHhcCcccCCCCCC
Confidence 99 999999 89999999999999996
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=452.77 Aligned_cols=253 Identities=32% Similarity=0.498 Sum_probs=211.3
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec------CCce
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ------DDEY 191 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------d~~~ 191 (549)
+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+.+|+.++|||||+++++|. +..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999765321 346999999999999999999884 4457
Q ss_pred EEEEEeecCCCchhhHh---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC-cEEEeecCccccc
Q 038137 192 LYLIMEYLPGGDMMTLL---MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG-HMKLSDFGLCKPL 267 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g-~vKL~DFGlak~~ 267 (549)
+|||||||++|.+..+. .....+++..++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999999876444433 3456799999999999999999999999999999999999999876 8999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 346 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGv 346 (549)
.... ...+.+||+.|+|||++.+ ..|+.++|||||||
T Consensus 174 ~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~ 211 (350)
T d1q5ka_ 174 VRGE------------------------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211 (350)
T ss_dssp CTTS------------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cCCc------------------------------------------ccccccccccccChHHhhcccCCCcceeecccce
Confidence 3211 0125689999999999875 57899999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhcc---------------ccccCCC----------CcCCChhHHHHHHHhhh-cc
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWR---------------THLKFPE----------EAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~---------------~~l~~p~----------~~~~s~~~~dLI~~lL~-dp 400 (549)
++|||++|++||.+.+..+.+.+|+... ....+|. ...+|++++|||.+||+ ||
T Consensus 212 il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 291 (350)
T d1q5ka_ 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291 (350)
T ss_dssp HHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSG
T ss_pred EEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCCh
Confidence 9999999999999888777776665310 0111111 13579999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCC
Q 038137 401 EQRLGTKGADEIKAHPWFKGIE 422 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~ 422 (549)
.+|+ ||.|+++||||+++.
T Consensus 292 ~~R~---ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 292 TARL---TPLEACAHSFFDELR 310 (350)
T ss_dssp GGSC---CHHHHHTSGGGGGGG
T ss_pred hHCc---CHHHHhcCHhhcccc
Confidence 9999 899999999998763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=453.06 Aligned_cols=259 Identities=31% Similarity=0.489 Sum_probs=213.2
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 578999999999999999999999999999999997653 34455678899999999999999999999998655
Q ss_pred -eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 -YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 -~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|+||||| |++|..++ +.+.|++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 66777665 557899999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 348 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGvil 348 (549)
. ..+.+||+.|+|||++.+. .++.++|||||||++
T Consensus 174 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 174 E--------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209 (346)
T ss_dssp S--------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------cccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence 1 1146899999999999874 569999999999999
Q ss_pred HHHhhCCCCCCCCCchhhhhhhhhccccc---------------------cCC------CCcCCChhHHHHHHHhhh-cc
Q 038137 349 YEMLVGYPPFYSDEPMSTCRKIVNWRTHL---------------------KFP------EEAKLSPEAKDLISKLLC-NV 400 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~~~~~I~~~~~~l---------------------~~p------~~~~~s~~~~dLI~~lL~-dp 400 (549)
|||++|++||.+.+.......+....... ... ....+|++++|||.+||+ ||
T Consensus 210 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 289 (346)
T d1cm8a_ 210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289 (346)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCCh
Confidence 99999999999887766555443211100 000 013579999999999999 99
Q ss_pred cccCCCCCHHHHHcCCcccCCCcc
Q 038137 401 EQRLGTKGADEIKAHPWFKGIEWD 424 (549)
Q Consensus 401 ~~Rl~~~~~~eil~HpfF~~i~w~ 424 (549)
.+|+ ||+|||+||||+++.+.
T Consensus 290 ~~R~---ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 290 EQRV---TAGEALAHPYFESLHDT 310 (346)
T ss_dssp TTSC---CHHHHHHSGGGTTTC--
T ss_pred hHCc---CHHHHhcChhhCcCCCc
Confidence 9999 89999999999988643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=445.77 Aligned_cols=264 Identities=27% Similarity=0.372 Sum_probs=216.3
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecC-------
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQD------- 188 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 188 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4789999999999999999999999999999999976543 33445668899999999999999999998865
Q ss_pred -CceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 189 -DEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 189 -~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+..+|+|||||.++++.........+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 4568999999988887777777788999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC-CCCcccccchhhH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 346 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~-~y~~~~DiWSlGv 346 (549)
........ ....+.+||+.|+|||++.+. .|+.++|||||||
T Consensus 168 ~~~~~~~~-------------------------------------~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGv 210 (318)
T d3blha1 168 SLAKNSQP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210 (318)
T ss_dssp CC-----C-------------------------------------CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cccccccc-------------------------------------ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCc
Confidence 43211100 011256899999999999864 7899999999999
Q ss_pred HHHHHhhCCCCCCCCCchhhhhhhhhccccccCCCC----------------------------cCCChhHHHHHHHhhh
Q 038137 347 IMYEMLVGYPPFYSDEPMSTCRKIVNWRTHLKFPEE----------------------------AKLSPEAKDLISKLLC 398 (549)
Q Consensus 347 ilyEml~G~~PF~~~~~~~~~~~I~~~~~~l~~p~~----------------------------~~~s~~~~dLI~~lL~ 398 (549)
++|||++|++||.+.+.......+........-... ...+++++|||.+||.
T Consensus 211 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~ 290 (318)
T d3blha1 211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290 (318)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSC
T ss_pred eeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCc
Confidence 999999999999988877776666542211110000 1237889999999999
Q ss_pred -cccccCCCCCHHHHHcCCcccC
Q 038137 399 -NVEQRLGTKGADEIKAHPWFKG 420 (549)
Q Consensus 399 -dp~~Rl~~~~~~eil~HpfF~~ 420 (549)
||++|+ ||+|++.||||+.
T Consensus 291 ~dP~~R~---sa~elL~Hpff~~ 310 (318)
T d3blha1 291 LDPAQRI---DSDDALNHDFFWS 310 (318)
T ss_dssp SSTTTSC---CHHHHHHSGGGSS
T ss_pred CChhHCc---CHHHHHcChhhcc
Confidence 999999 8999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=435.45 Aligned_cols=258 Identities=22% Similarity=0.372 Sum_probs=217.9
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
..++..++|++++.||+|+||+||+|+++ ++..||||++.+... ..+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34567789999999999999999999976 577899999976432 23568999999999999999999998765 5
Q ss_pred eEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 679999999999999977543 469999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..... ...+.+||+.|||||++.+..|+.++|||||||++
T Consensus 161 ~~~~~----------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl 200 (272)
T d1qpca_ 161 DNEYT----------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (272)
T ss_dssp SSCEE----------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCccc----------------------------------------cccccCCcccccChHHHhCCCCCchhhhhhhHHHH
Confidence 32110 01145799999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc--CCcccC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA--HPWFKG 420 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~--HpfF~~ 420 (549)
|||++ |.+||...+..+....+... ..+..| ..+++++++||.+||. ||++|+ ++++|++ |+||..
T Consensus 201 ~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~P~~Rp---t~~ei~~~L~~~fts 270 (272)
T d1qpca_ 201 TEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRP--DNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCc--ccChHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhhhhhc
Confidence 99999 56667666666666666653 233334 4799999999999999 999999 8999988 888853
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=429.86 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=208.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEE
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLY 193 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 193 (549)
+..++|++++.||+|+||+||+|+++ ++..||||++.+... ..+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 35678999999999999999999986 567899999976432 2356889999999999999999999999999999
Q ss_pred EEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCc
Q 038137 194 LIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNL 272 (549)
Q Consensus 194 lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~ 272 (549)
+|||||++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+|||++.+|++||+|||+|+.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999988654 6789999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHh
Q 038137 273 QEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 352 (549)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 352 (549)
......+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 157 ----------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 157 ----------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196 (263)
T ss_dssp ------------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHH
Confidence 0012457999999999999999999999999999999999
Q ss_pred h-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 353 V-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 353 ~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
+ |.+||.+.+..+....|... ..+..| ..+++++.+||.+||. ||.+|+ +++||++|
T Consensus 197 t~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~p~~Rp---s~~~il~~ 255 (263)
T d1sm2a_ 197 SEGKIPYENRSNSEVVEDISTG-FRLYKP--RLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255 (263)
T ss_dssp TTSCCTTCSCCHHHHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHhc-CCCCCc--cccCHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 9 67778777777777777653 233334 4689999999999999 999999 89999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-54 Score=438.98 Aligned_cols=259 Identities=21% Similarity=0.321 Sum_probs=209.1
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKATGH---VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
++..++|++.++||+|+||+||+|+++.+|+ .||||++.... .....+.+.+|+.+|+.++|||||+++++|.++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4667889999999999999999999987765 68999886543 234556789999999999999999999999999
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+.+|+|||||+||+|..++.. .+.+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999999998866 4579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
...... ........+||+.|||||++.+..|+.++|||||||+|
T Consensus 180 ~~~~~~------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 180 DDTSDP------------------------------------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp ----------------------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CCCCcc------------------------------------eeeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 221000 00001135789999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||++ |.+||.+.+..+....|... ...|.+..+++++.+||.+||. ||.+|+ ++.||+++
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~ei~~~ 286 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQD---YRLPPPMDCPSALHQLMLDCWQKDRNHRP---KFGQIVNT 286 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 99998 89999998888877777652 2333345789999999999999 999999 78887753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=438.60 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=211.9
Q ss_pred eeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEEeecC
Q 038137 123 TMIGKGAFGEVRVCREK--ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 123 ~~IG~G~fG~V~l~~~k--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
+.||+|+||+||+|.++ .+++.||||+++... ......+.+.+|+.+|+.++|||||+++++|.++ .+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999865 456789999997543 3344567799999999999999999999999765 5789999999
Q ss_pred CCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccccccc
Q 038137 201 GGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIG 280 (549)
Q Consensus 201 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~ 280 (549)
||+|.+++.+...+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 164 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence 99999999888999999999999999999999999999999999999999999999999999998764221000
Q ss_pred CCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh-CCCCCC
Q 038137 281 SNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 359 (549)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~ 359 (549)
......+||+.|||||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 165 --------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 165 --------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp --------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred --------------------------------ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 00124579999999999999999999999999999999997 999999
Q ss_pred CCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH---HcCCcccCCC
Q 038137 360 SDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI---KAHPWFKGIE 422 (549)
Q Consensus 360 ~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei---l~HpfF~~i~ 422 (549)
+.+..+....|.+. ..+.+| ..+|+++++||.+||. ||.+|| ++++| |+|+||.-++
T Consensus 213 ~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dp~~RP---s~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 213 GMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRP---GFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp TCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSC---CHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHHcCCCHhHCc---CHHHHHHHhhCHHhhcCC
Confidence 98887777766653 334444 4789999999999999 999999 67776 5677775443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=437.04 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=218.3
Q ss_pred CCCCCeeeeee-eeecCCeEEEEEEEcC--CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTM-IGKGAFGEVRVCREKA--TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~-IG~G~fG~V~l~~~k~--tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
+..++|.+... ||+|+||+||+|.++. ++..||||++++.. .....+.+.+|+.+|+.++|||||++++++.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 44577888885 9999999999998764 45589999997642 344567799999999999999999999999764
Q ss_pred eEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|||||||+||+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 58999999999999998755 46799999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
..... ......+||+.|||||++.+..|+.++|||||||++|
T Consensus 162 ~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 162 DDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp CSCEE--------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred ccccc--------------------------------------ccccccccCccccChHHHhCCCCCccchhhcchHHHH
Confidence 21000 0011457999999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 350 EMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 350 Eml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
||++ |.+||.+.+..+....|.+. ..+.+| ..+|+++.+||.+||. ||++||...++.+.|+|+|+.
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQG-KRMECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9998 99999988887777777653 334555 3799999999999999 999999322334447788874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=434.62 Aligned_cols=257 Identities=19% Similarity=0.250 Sum_probs=210.4
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCce
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEY 191 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 191 (549)
+++..++|++.+.||+|+||+||+|+.+ ..||||+++.... .....+.+.+|+.+|..++|||||++++++. +..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4677889999999999999999999753 3599999976543 3456678999999999999999999998765 456
Q ss_pred EEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 192 LYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 192 lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
+|||||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999654 67999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc---CCCCcccccchhhHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAI 347 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~---~~y~~~~DiWSlGvi 347 (549)
... ....+.+||+.|||||++.+ ..|+.++|||||||+
T Consensus 158 ~~~---------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~ 198 (276)
T d1uwha_ 158 SGS---------------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198 (276)
T ss_dssp -----------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHH
T ss_pred CCc---------------------------------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHH
Confidence 100 01125689999999999974 358999999999999
Q ss_pred HHHHhhCCCCCCCCCchhhhhhhhhccccc-cCC-CCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 348 MYEMLVGYPPFYSDEPMSTCRKIVNWRTHL-KFP-EEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 348 lyEml~G~~PF~~~~~~~~~~~I~~~~~~l-~~p-~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
||||++|++||.+.+.......++...... ..+ ....+|+++++||.+||. ||.+|+ ++.||++|
T Consensus 199 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~~il~~ 266 (276)
T d1uwha_ 199 LYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266 (276)
T ss_dssp HHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 999999999999877766555554422111 111 124689999999999999 999999 89999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-54 Score=425.80 Aligned_cols=250 Identities=20% Similarity=0.359 Sum_probs=220.4
Q ss_pred CCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEE
Q 038137 115 GADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 115 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 194 (549)
..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.++..++|||||+++++|.+++.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 5689999999999999999999985 778999999987643 23568899999999999999999999999999999
Q ss_pred EEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCcc
Q 038137 195 IMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQ 273 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~ 273 (549)
||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999998654 577999999999999999999999999999999999999999999999999999876422100
Q ss_pred cccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhh
Q 038137 274 EKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 353 (549)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~ 353 (549)
.....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 157 ----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 157 ----------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp ----------------------------------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ----------------------------------------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence 0113579999999999999999999999999999999998
Q ss_pred -CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 354 -GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 354 -G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|+.||.+.+..++..+|.+. ..+..| ..+++++++||.+||. ||++|+ ++++|++|
T Consensus 197 ~g~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~RP---t~~eil~~ 254 (258)
T d1k2pa_ 197 LGKMPYERFTNSETAEHIAQG-LRLYRP--HLASEKVYTIMYSCWHEKADERP---TFKILLSN 254 (258)
T ss_dssp TSCCTTTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSC---CHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHhC-CCCCCc--ccccHHHHHHHHHHccCCHhHCc---CHHHHHHH
Confidence 89999999988888888763 233444 4789999999999999 999999 89999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=448.30 Aligned_cols=271 Identities=26% Similarity=0.407 Sum_probs=213.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec------CCc
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ------DDE 190 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------d~~ 190 (549)
++|++++.||+|+||+||+|+++.||+.||||++.+... .......+.+|+.+|+.++|||||+++++|. +..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 679999999999999999999999999999999987543 4555677899999999999999999999996 347
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
++|+|||||.|+ +...+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999665 44444 357999999999999999999999999999999999999999999999999998764321
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 350 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 350 (549)
. .....+||+.|+|||++.+..|+.++||||+||++||
T Consensus 173 ~------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e 210 (355)
T d2b1pa1 173 F------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_dssp --------------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence 1 0124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCchhhhhhhhhcccc--------------------c---------cCCC---------CcCCChhHHHH
Q 038137 351 MLVGYPPFYSDEPMSTCRKIVNWRTH--------------------L---------KFPE---------EAKLSPEAKDL 392 (549)
Q Consensus 351 ml~G~~PF~~~~~~~~~~~I~~~~~~--------------------l---------~~p~---------~~~~s~~~~dL 392 (549)
|++|++||.+.+......+++..... . .++. ...+|++++||
T Consensus 211 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHH
Confidence 99999999988877666655421100 0 0000 01247889999
Q ss_pred HHHhhh-cccccCCCCCHHHHHcCCcccCCCccccccccCCCccc
Q 038137 393 ISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPE 436 (549)
Q Consensus 393 I~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p~ 436 (549)
|++||+ ||++|+ +|+|||+||||+...|.......+|.+.+
T Consensus 291 l~~mL~~dP~~R~---ta~elL~Hpw~~~~~~~~~~~~~~~~~~~ 332 (355)
T d2b1pa1 291 LSKMLVIDPAKRI---SVDDALQHPYINVWYDPAEVEAPPPQIYD 332 (355)
T ss_dssp HHHHSCSSTTTSC---CHHHHHTSTTTGGGCCHHHHTCCCC----
T ss_pred HHHHCcCChhHCc---CHHHHhcCcccCCCCCcccccCCCCCCCC
Confidence 999999 999999 89999999999976555554555555544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=428.43 Aligned_cols=260 Identities=28% Similarity=0.452 Sum_probs=221.1
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCceEEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 196 (549)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 68999999999999999999999999999999997654 34456778999999999999999999999999999999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||+.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||+|+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--- 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--- 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc---
Confidence 99999999999988899999999999999999999999999999999999999999999999999999876422100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-CCcccccchhhHHHHHHhhCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 355 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEml~G~ 355 (549)
....++++.|+|||++.+.. ++.++|||||||++|||++|+
T Consensus 158 --------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~ 199 (292)
T d1unla_ 158 --------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp --------------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred --------------------------------------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence 11346888999999998765 699999999999999999999
Q ss_pred CCCC-CCCchhhhhhhhhcccc---------ccCC----------------CCcCCChhHHHHHHHhhh-cccccCCCCC
Q 038137 356 PPFY-SDEPMSTCRKIVNWRTH---------LKFP----------------EEAKLSPEAKDLISKLLC-NVEQRLGTKG 408 (549)
Q Consensus 356 ~PF~-~~~~~~~~~~I~~~~~~---------l~~p----------------~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~ 408 (549)
.||. +.+..+...++...... ...+ ....+|++++|||.+||+ ||.+|+ |
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~---s 276 (292)
T d1unla_ 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI---S 276 (292)
T ss_dssp CCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC---C
T ss_pred CCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc---C
Confidence 8864 44555555554321110 0000 013578999999999999 999999 8
Q ss_pred HHHHHcCCcccCC
Q 038137 409 ADEIKAHPWFKGI 421 (549)
Q Consensus 409 ~~eil~HpfF~~i 421 (549)
|+|||+||||+++
T Consensus 277 a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 277 AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHTTSGGGSSC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=441.81 Aligned_cols=261 Identities=28% Similarity=0.466 Sum_probs=211.6
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc-----
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE----- 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 190 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++|||||++++++..+.
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 357999999999999999999999999999999997653 3445567899999999999999999999987653
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
++|+| +|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 85 ~~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 85 DVYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CEEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 35555 55679999999854 57999999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhcc-CCCCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~-~~y~~~~DiWSlGvily 349 (549)
... .......+||+.|+|||++.. ..|+.++|+||+||++|
T Consensus 163 ~~~--------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~ 204 (345)
T d1pmea_ 163 HDH--------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204 (345)
T ss_dssp GCB--------------------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHH
T ss_pred Ccc--------------------------------------ceeeccccccceechHHHhhcCCCCCchhhhhccCceeh
Confidence 110 001125689999999999854 57899999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhcccc------------------ccCCC---------CcCCChhHHHHHHHhhh-ccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTH------------------LKFPE---------EAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~------------------l~~p~---------~~~~s~~~~dLI~~lL~-dp~ 401 (549)
||++|.+||.+.+...+...+...... ...+. ...+|+++++||.+||+ ||.
T Consensus 205 eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 284 (345)
T d1pmea_ 205 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284 (345)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTT
T ss_pred HHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChh
Confidence 999999999988765555444321000 00110 13678999999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCC
Q 038137 402 QRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i 421 (549)
+|+ +|+|+|+||||+..
T Consensus 285 ~R~---ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 285 KRI---EVEQALAHPYLEQY 301 (345)
T ss_dssp TSC---CHHHHHTSGGGTTT
T ss_pred HCc---CHHHHhcCHhhccC
Confidence 999 89999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=443.95 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=214.5
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC-----c
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD-----E 190 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 190 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 478999999999999999999999999999999998653 2344556788999999999999999999998643 3
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCS 270 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~ 270 (549)
..++||+|+.||+|.+++. .+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++|++|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 3466677788999999885 457999999999999999999999999999999999999999999999999998754311
Q ss_pred CcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC-CCcccccchhhHHHH
Q 038137 271 NLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMY 349 (549)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~-y~~~~DiWSlGvily 349 (549)
..+.+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 175 --------------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~ 210 (348)
T d2gfsa1 175 --------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210 (348)
T ss_dssp --------------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHH
T ss_pred --------------------------------------------cccccccccccCchhhcCCccCCcccchhhhhHHHH
Confidence 12568999999999988754 689999999999999
Q ss_pred HHhhCCCCCCCCCchhhhhhhhhccccc---------------------cCCC------CcCCChhHHHHHHHhhh-ccc
Q 038137 350 EMLVGYPPFYSDEPMSTCRKIVNWRTHL---------------------KFPE------EAKLSPEAKDLISKLLC-NVE 401 (549)
Q Consensus 350 Eml~G~~PF~~~~~~~~~~~I~~~~~~l---------------------~~p~------~~~~s~~~~dLI~~lL~-dp~ 401 (549)
+|++|.+||.+.+.......|....... ..+. ...+|++++|||.+||+ ||.
T Consensus 211 ~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 290 (348)
T d2gfsa1 211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290 (348)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChh
Confidence 9999999999988777777665421110 0110 13579999999999999 999
Q ss_pred ccCCCCCHHHHHcCCcccCC
Q 038137 402 QRLGTKGADEIKAHPWFKGI 421 (549)
Q Consensus 402 ~Rl~~~~~~eil~HpfF~~i 421 (549)
+|+ ||+|||+||||+.+
T Consensus 291 ~R~---ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 291 KRI---TAAQALAHAYFAQY 307 (348)
T ss_dssp GSC---CHHHHHTSGGGTTT
T ss_pred hCc---CHHHHhcCHhhCCC
Confidence 999 89999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=426.33 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=209.5
Q ss_pred cCCCCCeeeeeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 113 KMGADDFEPLTMIGKGAFGEVRVCREKAT---GHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 113 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
++..++|++.+.||+|+||+||+|++..+ +..||||++.... .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE- 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 45668899999999999999999998754 3568999886532 34445679999999999999999999999964
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
+.+|+|||||+||+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 678999999999999998755 4679999999999999999999999999999999999999999999999999998754
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.... ......+||+.|+|||++.+..|+.++|||||||++
T Consensus 160 ~~~~----------------------------------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 160 DSTY----------------------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 199 (273)
T ss_dssp ---------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred CCcc----------------------------------------eeccceecCcccchhhHhccCCCCCccccccchHHH
Confidence 2110 001245799999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||++ |.+||.+.+..+.+.+|.+. ..+++| ..+|+++++||.+||+ ||.+|+ +++||++|
T Consensus 200 ~e~lt~g~~P~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dp~~Rp---s~~ei~~~ 262 (273)
T d1mp8a_ 200 WEILMHGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262 (273)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 99998 99999999998888888764 233444 4799999999999999 999999 89999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=427.01 Aligned_cols=260 Identities=21% Similarity=0.362 Sum_probs=214.7
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
...++..++|++.+.||+|+||+||+|+++.+ ..||||++..... ..+.+.+|+.+|..++|||||+++++|.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 44567788999999999999999999998765 5699999976532 23568899999999999999999999965
Q ss_pred ceEEEEEeecCCCchhhHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCccccc
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR--KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPL 267 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~ 267 (549)
+.+|+|||||++|+|..++.. ...+++.++..++.||+.||.|||++||+||||||+|||||.+|++||+|||+|+.+
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 457899999999999988854 457999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHH
Q 038137 268 DCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 347 (549)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvi 347 (549)
..+... .....+||+.|+|||++.+..|+.++|||||||+
T Consensus 164 ~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Gii 203 (285)
T d1fmka3 164 EDNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 203 (285)
T ss_dssp ----------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cCCCce----------------------------------------eeccccccccccChHHHhCCCCCcHHhhhcchHH
Confidence 322100 0124579999999999999999999999999999
Q ss_pred HHHHhhC-CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc--CCcccCC
Q 038137 348 MYEMLVG-YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA--HPWFKGI 421 (549)
Q Consensus 348 lyEml~G-~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~--HpfF~~i 421 (549)
+|||++| .+||.+....+....+... . ..|.+..+|+++++||.+||. ||++|+ ++++|++ |+||...
T Consensus 204 l~el~t~~~p~~~~~~~~~~~~~i~~~-~--~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 204 LTELTTKGRVPYPGMVNREVLDQVERG-Y--RMPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTT-C--CCCCCTTSCHHHHHHHHHHTCSSGGGSC---CHHHHHHHHHTTTSCS
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhc-C--CCCCCcccCHHHHHHHHHHcccCHhHCc---CHHHHHHHHhhhhcCC
Confidence 9999995 5666666666666666542 2 333345799999999999999 999999 8999988 8899764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=432.56 Aligned_cols=255 Identities=20% Similarity=0.332 Sum_probs=210.2
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCC
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGH----VYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDD 189 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 189 (549)
+..++|+++++||+|+||+||+|+++.+|+ .||+|++.... .....+.+.+|+.+|+.++|||||+++++|.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345789999999999999999999988886 57888776542 334567799999999999999999999999875
Q ss_pred ceEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 190 EYLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 190 ~~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
..++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 56788999999999988765 4689999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
..... ......+||+.|||||++.+..|+.++|||||||++
T Consensus 163 ~~~~~---------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 163 AEEKE---------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203 (317)
T ss_dssp TTCC-----------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccccc---------------------------------------ccccccccCccccChHHHhcCCCChhhhhhhHHHHH
Confidence 22100 011245799999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHP 416 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~Hp 416 (549)
|||+| |.+||.+.+..+....+.. ...+..| ..+++++.+||.+||. ||.+|+ ++.||+.|.
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~p--~~~~~~~~~li~~cl~~dP~~RP---s~~eil~~l 267 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEK-GERLPQP--PICTIDVYMIMVKCWMIDADSRP---KFRELIIEF 267 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHH-TCCCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCC--cccCHHHHHHHHHhCCCChhhCc---CHHHHHHHH
Confidence 99998 8999988877776665554 2334444 4789999999999999 999999 899999883
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-53 Score=426.75 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=205.8
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCS 185 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 185 (549)
.++..++|++++.||+|+||+||+|++.. +++.||||++++.. .....+.+.+|..++..+ +|+|||.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 34666889999999999999999999764 45789999997543 233445677777777766 68999999988
Q ss_pred ecC-CceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCe
Q 038137 186 FQD-DEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNL 248 (549)
Q Consensus 186 f~d-~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNI 248 (549)
+.+ +..+|+|||||+||+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 765 45799999999999999999643 3589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCch
Q 038137 249 LLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPE 328 (549)
Q Consensus 249 Lld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APE 328 (549)
||+.+|++||+|||+|+........ ....+.+||+.|||||
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~y~APE 206 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMAPE 206 (299)
T ss_dssp EECGGGCEEECC------CCSCTTS---------------------------------------CCTTSCCCGGGGCCHH
T ss_pred eECCCCcEEEccCcchhhccccccc---------------------------------------cccCceeeCccccchh
Confidence 9999999999999999865422100 0011468999999999
Q ss_pred hhccCCCCcccccchhhHHHHHHhhC-CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCC
Q 038137 329 VLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGT 406 (549)
Q Consensus 329 vl~~~~y~~~~DiWSlGvilyEml~G-~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~ 406 (549)
++.+..|+.++|||||||++|||++| .+||.+.+....+.+++.....+..| ..+|+++++||.+||+ ||.+|+
T Consensus 207 ~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rp-- 282 (299)
T d1ywna1 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRP-- 282 (299)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSC--
T ss_pred HhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHcCCChhHCc--
Confidence 99999999999999999999999986 67888877666666666544444555 3789999999999999 999999
Q ss_pred CCHHHHHcC
Q 038137 407 KGADEIKAH 415 (549)
Q Consensus 407 ~~~~eil~H 415 (549)
+++||++|
T Consensus 283 -t~~eil~~ 290 (299)
T d1ywna1 283 -TFSELVEH 290 (299)
T ss_dssp -CHHHHHHH
T ss_pred -CHHHHHHH
Confidence 89999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=420.26 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=208.1
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATG----HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ 187 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 187 (549)
.++..+.|++.++||+|+||+||+|.++.++ ..||||++.... .......+.+|+.+|+.++|||||++++++.
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 3567788999999999999999999987665 479999997543 2344556889999999999999999999999
Q ss_pred CCceEEEEEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 188 DDEYLYLIMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
+.+.+|+|||||.+|++..++... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999999987654 6799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhH
Q 038137 267 LDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 346 (549)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGv 346 (549)
+....... .......||+.|||||++.+..|+.++|||||||
T Consensus 160 ~~~~~~~~--------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gv 201 (283)
T d1mqba_ 160 LEDDPEAT--------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 201 (283)
T ss_dssp ----------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred ccCCCccc--------------------------------------eEeccCCCCccccCHHHHccCCCCCcccccccHH
Confidence 64221000 0011457999999999999999999999999999
Q ss_pred HHHHHhhC-CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHc
Q 038137 347 IMYEMLVG-YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKA 414 (549)
Q Consensus 347 ilyEml~G-~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~ 414 (549)
++|||++| .+||.+.+..+.+..+.. ...+..| ..+++++++||.+||. ||.+|+ ++.||++
T Consensus 202 il~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~~--~~~~~~l~~li~~cl~~~p~~RP---t~~eil~ 265 (283)
T d1mqba_ 202 VMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTP--MDCPSAIYQLMMQCWQQERARRP---KFADIVS 265 (283)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCC--TTCBHHHHHHHHHHTCSSTTTSC---CHHHHHH
T ss_pred HHHHHHhCCCCccccCCHHHHHHHHhc-cCCCCCc--hhhHHHHHHHHHHHCcCCHhHCc---CHHHHHH
Confidence 99999995 555555555555555543 2333333 4789999999999999 999999 7888875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=420.09 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=208.1
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcC-CC--cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKA-TG--HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~-tg--~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 190 (549)
+..+||++++.||+|+||+||+|+... ++ ..||||++.+.........+.+.+|+.+|+.++|||||++|++|.++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 345789999999999999999998753 33 36899999877665666677899999999999999999999999764
Q ss_pred eEEEEEeecCCCchhhHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMR-KDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDC 269 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~ 269 (549)
.+|+|||||++|++.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999987755 46799999999999999999999999999999999999999999999999999997643
Q ss_pred CCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHH
Q 038137 270 SNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 349 (549)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvily 349 (549)
.... .......+||+.|+|||++.+..|+.++|||||||++|
T Consensus 164 ~~~~--------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 164 NDDH--------------------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp -CCE--------------------------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred CCCc--------------------------------------ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHH
Confidence 2100 00112357888999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 350 EMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 350 Eml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
||++ |.+||.+.+..+...+|......+ |....+|+++++||.+||. ||.+|+ ++.||+
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RP---t~~ei~ 266 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCPQDIYNVMVQCWAHKPEDRP---TFVALR 266 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTTCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred HHHhCCCCCCCCcCHHHHHHHHHhCCCCC--CCcccccHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 9998 899999999999888888754433 3345789999999999999 999999 788886
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=423.68 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=214.5
Q ss_pred CCCCCeeeeeeeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeeeecCCc
Q 038137 114 MGADDFEPLTMIGKGAFGEVRVCREKATGHV--YAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCSFQDDE 190 (549)
Q Consensus 114 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~--vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 190 (549)
+..++|++.++||+|+||+||+|+++.+|.. ||||++.+.. .....+.+.+|+.+|..+ +|||||+++++|.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5668999999999999999999999998875 6777765432 233456789999999998 7999999999999999
Q ss_pred eEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNG 254 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g 254 (549)
.+|+||||++||+|.++|... ..|++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999653 5799999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC
Q 038137 255 HMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG 334 (549)
Q Consensus 255 ~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~ 334 (549)
.+||+|||+|+...... .....+||+.|+|||++.+..
T Consensus 165 ~~kl~DfG~a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~l~~~~ 202 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 202 (309)
T ss_dssp CEEECCTTCEESSCEEC------------------------------------------CC----CCTTTCCHHHHHHCE
T ss_pred ceEEccccccccccccc------------------------------------------cccceecCCcccchHHhccCC
Confidence 99999999998653211 011457999999999999999
Q ss_pred CCcccccchhhHHHHHHhhC-CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHH
Q 038137 335 YGMECDWWSLGAIMYEMLVG-YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEI 412 (549)
Q Consensus 335 y~~~~DiWSlGvilyEml~G-~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~ei 412 (549)
|+.++|||||||++|||++| .+||.+.+..+.+..|.++ ..+.+| ..+++++++||.+||. ||++|+ +++||
T Consensus 203 ~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dP~~RP---s~~ei 276 (309)
T d1fvra_ 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERP---SFAQI 276 (309)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSC---CHHHH
T ss_pred CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCCCCC--ccCCHHHHHHHHHHcCCChhHCc---CHHHH
Confidence 99999999999999999996 5688888888888887763 233344 4789999999999999 999999 89999
Q ss_pred HcC
Q 038137 413 KAH 415 (549)
Q Consensus 413 l~H 415 (549)
++|
T Consensus 277 l~~ 279 (309)
T d1fvra_ 277 LVS 279 (309)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-52 Score=420.02 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=219.7
Q ss_pred hcccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeee
Q 038137 110 QRHKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYC 184 (549)
Q Consensus 110 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 184 (549)
...++..++|++++.||+|+||+||+|+.+ .++..||||++.+.. .......+.+|+.+|+.++||||+++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 334566788999999999999999999976 356899999997543 3344567999999999999999999999
Q ss_pred eecCCceEEEEEeecCCCchhhHhhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeee
Q 038137 185 SFQDDEYLYLIMEYLPGGDMMTLLMRKD------------------------TLTEEEARFYVGETVLAIESIHKHNYIH 240 (549)
Q Consensus 185 ~f~d~~~lylVmEy~~gg~L~~~l~~~~------------------------~l~e~~~~~~~~qi~~aL~~LH~~giiH 240 (549)
+|.+.+.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||||
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 9999999999999999999999996432 4899999999999999999999999999
Q ss_pred cCCCCCCeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeeccc
Q 038137 241 RDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVG 320 (549)
Q Consensus 241 RDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vG 320 (549)
|||||+|||||.++++||+|||+|+.+..... .....+.+|
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~---------------------------------------~~~~~~~~~ 204 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADY---------------------------------------YKADGNDAI 204 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC---------------------------------------BC----CCB
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCcc---------------------------------------ccccCCCCc
Confidence 99999999999999999999999986542210 001125689
Q ss_pred CCCCCCchhhccCCCCcccccchhhHHHHHHhhCC-CCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-
Q 038137 321 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY-PPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC- 398 (549)
Q Consensus 321 T~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~-~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~- 398 (549)
|+.|+|||++.+..|+.++|||||||++|||++|. +||.+.+..+...++.... .+..| ..+++++.+||.+||+
T Consensus 205 ~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p--~~~~~~~~~li~~cl~~ 281 (301)
T d1lufa_ 205 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWSK 281 (301)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCS
T ss_pred CcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHcCC
Confidence 99999999999999999999999999999999984 7899988888888877632 33344 4789999999999999
Q ss_pred cccccCCCCCHHHHHc
Q 038137 399 NVEQRLGTKGADEIKA 414 (549)
Q Consensus 399 dp~~Rl~~~~~~eil~ 414 (549)
+|.+|+ ++.||++
T Consensus 282 ~P~~RP---t~~ev~~ 294 (301)
T d1lufa_ 282 LPADRP---SFCSIHR 294 (301)
T ss_dssp SGGGSC---CHHHHHH
T ss_pred ChhHCc---CHHHHHH
Confidence 999999 7998854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-52 Score=411.89 Aligned_cols=247 Identities=21% Similarity=0.399 Sum_probs=208.1
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec-CCc
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ-DDE 190 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-d~~ 190 (549)
+++..++|++++.||+|+||.||+|+.+ |..||||++++.. ..+.+.+|+.+|+.++|||||+++++|. +.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 3567789999999999999999999985 7799999997643 3456889999999999999999999885 456
Q ss_pred eEEEEEeecCCCchhhHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRK--DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLD 268 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~ 268 (549)
.+|+||||+++|+|.++|... ..+++..++.++.||+.||.|||+.+||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 789999999999999999654 359999999999999999999999999999999999999999999999999998643
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
.. ....+||+.|+|||++.+..|+.++|||||||++
T Consensus 155 ~~--------------------------------------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il 190 (262)
T d1byga_ 155 ST--------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190 (262)
T ss_dssp ---------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CC--------------------------------------------CccccccccCCChHHHhCCCCChHHHHHhHHHHH
Confidence 11 0135789999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 349 YEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 349 yEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
|||++ |++||...+..+...+|.+. ..+.+| ..+++++++||.+||. ||.+|+ ++.+|++|
T Consensus 191 ~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dP~~Rp---s~~~l~~~ 253 (262)
T d1byga_ 191 WEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253 (262)
T ss_dssp HHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcccCHhHCc---CHHHHHHH
Confidence 99998 89999988888888777653 334444 3789999999999999 999999 78888763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=415.34 Aligned_cols=257 Identities=21% Similarity=0.361 Sum_probs=214.2
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcCCC-------cEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKATG-------HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKL 182 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-------~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 182 (549)
+..+..++|++++.||+|+||.||+|++..++ ..||||++++.. .......+.+|..++..+ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 45567789999999999999999999987654 479999997643 334456788888888887 89999999
Q ss_pred eeeecCCceEEEEEeecCCCchhhHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCC
Q 038137 183 YCSFQDDEYLYLIMEYLPGGDMMTLLMRK----------------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPD 246 (549)
Q Consensus 183 ~~~f~d~~~lylVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPe 246 (549)
+++|.++..+|+|||||.||+|..+|... ..+++..+..++.||+.||.|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999644 35899999999999999999999999999999999
Q ss_pred CeEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCC
Q 038137 247 NLLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIA 326 (549)
Q Consensus 247 NILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~A 326 (549)
|||++.+|.+||+|||+++......... .....+||+.|+|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 205 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWMA 205 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTC---------------------------------------CCTTSCCGGGGSC
T ss_pred ceeecCCCCeEeccchhhcccccccccc---------------------------------------ccccCCCChhhhh
Confidence 9999999999999999998764321100 0124689999999
Q ss_pred chhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccC
Q 038137 327 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 327 PEvl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
||++.+..|+.++|||||||++|||++ |.+||.+.+....+..+.+ ...+.+| ..+|+++++||.+||. ||.+|+
T Consensus 206 PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~p--~~~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1fgka_ 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GHRMDKP--SNCTNELYMMMRDCWHAVPSQRP 282 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TCCCCCC--SSCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHc-CCCCCCC--ccchHHHHHHHHHHccCCHhHCc
Confidence 999999999999999999999999998 7999988887777666654 3344444 4799999999999999 999999
Q ss_pred CCCCHHHHHc
Q 038137 405 GTKGADEIKA 414 (549)
Q Consensus 405 ~~~~~~eil~ 414 (549)
++.||++
T Consensus 283 ---s~~eil~ 289 (299)
T d1fgka_ 283 ---TFKQLVE 289 (299)
T ss_dssp ---CHHHHHH
T ss_pred ---CHHHHHH
Confidence 7999885
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=414.66 Aligned_cols=257 Identities=23% Similarity=0.315 Sum_probs=221.1
Q ss_pred ccCCCCCeeeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhc-CCCceeeeeee
Q 038137 112 HKMGADDFEPLTMIGKGAFGEVRVCREK-----ATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEV-DSNCIVKLYCS 185 (549)
Q Consensus 112 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 185 (549)
+++..++|++.+.||+|+||.||+|+.+ .+++.||||++++.. .......+.+|..+++.+ +|||||+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4566789999999999999999999864 467899999997653 234556789999999998 69999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCC
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRKD------------------TLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDN 247 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeN 247 (549)
+.+...+|+|||||+||+|..++.+.. .+++..+..|+.||+.||.|||++|||||||||+|
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 999999999999999999999996543 58999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCc
Q 038137 248 LLLDRNGHMKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAP 327 (549)
Q Consensus 248 ILld~~g~vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~AP 327 (549)
||++.++++||+|||+++........ ......+||+.|+||
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~---------------------------------------~~~~~~~gt~~y~aP 216 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNY---------------------------------------VVKGNARLPVKWMAP 216 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS---------------------------------------EECSSSEECGGGCCH
T ss_pred ccccccCcccccccchheeccCCCcc---------------------------------------eEeeecccChHHcCH
Confidence 99999999999999999875422100 011246899999999
Q ss_pred hhhccCCCCcccccchhhHHHHHHhh-CCCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCC
Q 038137 328 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLG 405 (549)
Q Consensus 328 Evl~~~~y~~~~DiWSlGvilyEml~-G~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~ 405 (549)
|++.+..|+.++|||||||++|||++ |.+||.+.+..+.+.+++.....+..| ..+|+++.+||.+||. ||.+|+
T Consensus 217 E~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RP- 293 (311)
T d1t46a_ 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRP- 293 (311)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC-
T ss_pred HHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCc-
Confidence 99999999999999999999999998 778888877777777787754444444 4789999999999999 999999
Q ss_pred CCCHHHHHc
Q 038137 406 TKGADEIKA 414 (549)
Q Consensus 406 ~~~~~eil~ 414 (549)
++++|+.
T Consensus 294 --s~~~il~ 300 (311)
T d1t46a_ 294 --TFKQIVQ 300 (311)
T ss_dssp --CHHHHHH
T ss_pred --CHHHHHH
Confidence 7999885
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=414.93 Aligned_cols=264 Identities=18% Similarity=0.272 Sum_probs=224.9
Q ss_pred cccCCCCCeeeeeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeee
Q 038137 111 RHKMGADDFEPLTMIGKGAFGEVRVCREKA-----TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCS 185 (549)
Q Consensus 111 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 185 (549)
.+++..++|++.+.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.+++.++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 356777999999999999999999999853 35789999997643 33445678999999999999999999999
Q ss_pred ecCCceEEEEEeecCCCchhhHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCc
Q 038137 186 FQDDEYLYLIMEYLPGGDMMTLLMRK----------DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGH 255 (549)
Q Consensus 186 f~d~~~lylVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~ 255 (549)
+..++.+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++||||||||+||||+.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998542 34789999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCC
Q 038137 256 MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGY 335 (549)
Q Consensus 256 vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y 335 (549)
+||+|||+|+.+..... .......+||+.|+|||.+.+..|
T Consensus 172 ~Kl~DFGla~~~~~~~~---------------------------------------~~~~~~~~~t~~y~aPe~l~~~~~ 212 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDY---------------------------------------YRKGGKGLLPVRWMSPESLKDGVF 212 (308)
T ss_dssp EEECCTTCCCGGGGGGC---------------------------------------EEGGGSSEECGGGCCHHHHHHCCC
T ss_pred EEEeecccceeccCCcc---------------------------------------eeeccceecccccCCHHHHccCCC
Confidence 99999999987542210 001124579999999999999999
Q ss_pred CcccccchhhHHHHHHhhC-CCCCCCCCchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHH
Q 038137 336 GMECDWWSLGAIMYEMLVG-YPPFYSDEPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIK 413 (549)
Q Consensus 336 ~~~~DiWSlGvilyEml~G-~~PF~~~~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil 413 (549)
+.++|||||||++|||++| .+||.+.+..+.+..+.+.. .+..| ..+++.+.+||.+||. +|.+|+ ++++|+
T Consensus 213 ~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RP---s~~~il 286 (308)
T d1p4oa_ 213 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRP---SFLEII 286 (308)
T ss_dssp CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHH
T ss_pred CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccchHHHHHHHHHHcCCChhHCc---CHHHHH
Confidence 9999999999999999998 58898888888888887632 23333 4789999999999999 999999 899988
Q ss_pred c------CCcccCC
Q 038137 414 A------HPWFKGI 421 (549)
Q Consensus 414 ~------HpfF~~i 421 (549)
+ +|+|+.+
T Consensus 287 ~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 287 SSIKEEMEPGFREV 300 (308)
T ss_dssp HHHGGGSCTTHHHH
T ss_pred HHHHHhcCCCCcCC
Confidence 7 6666544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-50 Score=406.61 Aligned_cols=263 Identities=19% Similarity=0.262 Sum_probs=202.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCc-eeeeeeeecCCceEEEE
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC-IVKLYCSFQDDEYLYLI 195 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~~lylV 195 (549)
++|++++.||+|+||+||+|+++.+|+.||||++...... ..+..|..+++.++|++ |+.+++++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999999999999999998765321 23678999999998765 55556777888899999
Q ss_pred EeecCCCchhhHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC---CCcEEEeecCcccccCCCC
Q 038137 196 MEYLPGGDMMTLL-MRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR---NGHMKLSDFGLCKPLDCSN 271 (549)
Q Consensus 196 mEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~---~g~vKL~DFGlak~~~~~~ 271 (549)
|||+. |+|...+ .....+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+.+....
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99995 5555554 45678999999999999999999999999999999999999864 4579999999999765321
Q ss_pred cccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHH
Q 038137 272 LQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 351 (549)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 351 (549)
..... + .....+.+||+.|||||++.+..|+.++|||||||++|||
T Consensus 161 ~~~~~-------------------~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 161 THQHI-------------------P---------------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206 (299)
T ss_dssp TCCBC-------------------C---------------CCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHH
T ss_pred cccce-------------------e---------------ccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHH
Confidence 10000 0 0011256899999999999999999999999999999999
Q ss_pred hhCCCCCCCCCchhhhhhhhhccc-cccCCC---CcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCccc
Q 038137 352 LVGYPPFYSDEPMSTCRKIVNWRT-HLKFPE---EAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFK 419 (549)
Q Consensus 352 l~G~~PF~~~~~~~~~~~I~~~~~-~l~~p~---~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~ 419 (549)
++|.+||.+.........+..... .+..|. ...+|+++.+||.+||. +|.+|+....+.++++|+|.+
T Consensus 207 ~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 999999988665554444332211 111221 13689999999999999 999999322244667887764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=395.05 Aligned_cols=249 Identities=18% Similarity=0.291 Sum_probs=203.1
Q ss_pred eeeeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhchhhHHHHHHHHHHHHhcCCCceeeeeeeec-CCceEEEEEe
Q 038137 122 LTMIGKGAFGEVRVCREKATG---HVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCIVKLYCSFQ-DDEYLYLIME 197 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-d~~~lylVmE 197 (549)
-++||+|+||+||+|++..++ ..||||++++. ......+.+.+|+++|+.++|||||++++++. .+..+|+|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 578999999999999986643 36999999753 24555678999999999999999999999875 4668999999
Q ss_pred ecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCcccccCCCCccccc
Q 038137 198 YLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKPLDCSNLQEKD 276 (549)
Q Consensus 198 y~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGlak~~~~~~~~~~~ 276 (549)
||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||+.++++||+|||+++..........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~- 188 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV- 188 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT-
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc-
Confidence 99999999988654 5688889999999999999999999999999999999999999999999999987643211100
Q ss_pred ccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHHHHHhhCCC
Q 038137 277 FSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356 (549)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml~G~~ 356 (549)
.......||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 189 ------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~ 232 (311)
T d1r0pa_ 189 ------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232 (311)
T ss_dssp ------------------------------------TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ------------------------------------eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCC
Confidence 00113579999999999999999999999999999999999766
Q ss_pred CCCCC-CchhhhhhhhhccccccCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcC
Q 038137 357 PFYSD-EPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAH 415 (549)
Q Consensus 357 PF~~~-~~~~~~~~I~~~~~~l~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~H 415 (549)
||... +..+....+.+. ..+..| ..+++++.+||.+||. ||.+|+ ++.||++|
T Consensus 233 p~~~~~~~~~~~~~i~~g-~~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~ei~~~ 287 (311)
T d1r0pa_ 233 PPYPDVNTFDITVYLLQG-RRLLQP--EYCPDPLYEVMLKCWHPKAEMRP---SFSELVSR 287 (311)
T ss_dssp CSCC------CHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSC---CHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcC-CCCCCc--ccCcHHHHHHHHHHcCCCHhHCc---CHHHHHHH
Confidence 66543 444555555553 233344 4789999999999999 999999 89999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-48 Score=390.00 Aligned_cols=249 Identities=19% Similarity=0.234 Sum_probs=202.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-CceeeeeeeecCCceEEE
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-NCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lyl 194 (549)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+|..++..+.| ++|+.+++++.+....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 5689999999999999999999999999999999865432 1236778899988876 899999999999999999
Q ss_pred EEeecCCCchhhHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcC-----CCcEEEeecCcccccC
Q 038137 195 IMEYLPGGDMMTLLMRK-DTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDR-----NGHMKLSDFGLCKPLD 268 (549)
Q Consensus 195 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~-----~g~vKL~DFGlak~~~ 268 (549)
||||+ ||+|..++... ..+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988664 57999999999999999999999999999999999999974 6789999999999764
Q ss_pred CCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCCCCcccccchhhHHH
Q 038137 269 CSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 348 (549)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~y~~~~DiWSlGvil 348 (549)
....... .+ .....+.+||+.|||||++.+..|+.++|||||||++
T Consensus 158 ~~~~~~~-------------------~~---------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (293)
T d1csna_ 158 DPVTKQH-------------------IP---------------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203 (293)
T ss_dssp CTTTCCB-------------------CC---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cCccccc-------------------ee---------------ecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHH
Confidence 3211000 00 0012257899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCchh---hhhhhhhccccccCCC-CcCCChhHHHHHHHhhh-cccccC
Q 038137 349 YEMLVGYPPFYSDEPMS---TCRKIVNWRTHLKFPE-EAKLSPEAKDLISKLLC-NVEQRL 404 (549)
Q Consensus 349 yEml~G~~PF~~~~~~~---~~~~I~~~~~~l~~p~-~~~~s~~~~dLI~~lL~-dp~~Rl 404 (549)
|||++|.+||.+..... .+.++.........+. ...+++++.++|..|+. +|.+||
T Consensus 204 ~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP 264 (293)
T d1csna_ 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATP 264 (293)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred HHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 99999999998765433 3333433221111110 13688999999999998 999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-47 Score=393.52 Aligned_cols=274 Identities=24% Similarity=0.367 Sum_probs=207.5
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-----------CCceeeeeee
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-----------SNCIVKLYCS 185 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l~~~ 185 (549)
.+|++++.||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+|+.++ |+|||+++.+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 469999999999999999999999999999999987542 2345677888887764 5789999887
Q ss_pred ec--CCceEEEEEeecCCCchhhHh---hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCCCCeEEcCCCc----
Q 038137 186 FQ--DDEYLYLIMEYLPGGDMMTLL---MRKDTLTEEEARFYVGETVLAIESIHK-HNYIHRDIKPDNLLLDRNGH---- 255 (549)
Q Consensus 186 f~--d~~~lylVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHRDLKPeNILld~~g~---- 255 (549)
+. .....++||+++.++...... .....+++..++.++.||+.||.|||+ .||+||||||+||||+.+|.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 75 456778888887666544333 234689999999999999999999998 89999999999999987764
Q ss_pred --EEEeecCcccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccC
Q 038137 256 --MKLSDFGLCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKK 333 (549)
Q Consensus 256 --vKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~ 333 (549)
+||+|||.|...... ....+||+.|+|||++.+.
T Consensus 169 ~~~kl~dfg~s~~~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH--------------------------------------------YTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp EEEEECCCTTCEETTBC--------------------------------------------CCSCCSCGGGCCHHHHHTC
T ss_pred ceeeEeecccccccccc--------------------------------------------cccccccccccChhhcccc
Confidence 999999998764311 1246899999999999999
Q ss_pred CCCcccccchhhHHHHHHhhCCCCCCCCCchh------hhhhhhh---------------------------ccccc---
Q 038137 334 GYGMECDWWSLGAIMYEMLVGYPPFYSDEPMS------TCRKIVN---------------------------WRTHL--- 377 (549)
Q Consensus 334 ~y~~~~DiWSlGvilyEml~G~~PF~~~~~~~------~~~~I~~---------------------------~~~~l--- 377 (549)
.|+.++|+|||||++++|++|++||...+... ....++. .....
T Consensus 205 ~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
T d1q8ya_ 205 PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284 (362)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC
T ss_pred CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCC
Confidence 99999999999999999999999997543211 1111100 00000
Q ss_pred --------cCCCCcCCChhHHHHHHHhhh-cccccCCCCCHHHHHcCCcccCCCccccccccCCCcccCCCcccc
Q 038137 378 --------KFPEEAKLSPEAKDLISKLLC-NVEQRLGTKGADEIKAHPWFKGIEWDKLYQIKAAFIPEVNDELDT 443 (549)
Q Consensus 378 --------~~p~~~~~s~~~~dLI~~lL~-dp~~Rl~~~~~~eil~HpfF~~i~w~~l~~~~~pf~p~~~~~~d~ 443 (549)
.+......+++++|||.+||+ ||.+|+ ||+|||+||||+++.+. ..+..|..|...+..|.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp---ta~e~L~Hp~f~~~~~~--~~~~~p~~~~~~~~~~~ 354 (362)
T d1q8ya_ 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDTLGM--EEIRVPDRELYGSGSDI 354 (362)
T ss_dssp CHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB---CHHHHHTCGGGTTCTTC--TTCCCTTSCTTCBSTTS
T ss_pred chhhhcccccccCcccCHHHHHHHHHHCCCChhHCc---CHHHHhcCcccCCCCCc--ccCCCCCcccCCCCCCC
Confidence 000112346889999999999 999999 89999999999976533 33555666655544443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=385.84 Aligned_cols=249 Identities=24% Similarity=0.291 Sum_probs=190.0
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHH--HHHhcCCCceeeeeeeecCCc----
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERN--LLAEVDSNCIVKLYCSFQDDE---- 190 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~--iL~~l~hp~Iv~l~~~f~d~~---- 190 (549)
.+|.+.+.||+|+||.||+|+. +|+.||||++.... ......|++ .+..++|||||++++++.+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4688999999999999999986 58899999986542 223344444 446789999999999987543
Q ss_pred eEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCeeecCCCCCCeEEcCCCcEEEeecC
Q 038137 191 YLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHK--------HNYIHRDIKPDNLLLDRNGHMKLSDFG 262 (549)
Q Consensus 191 ~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~--------~giiHRDLKPeNILld~~g~vKL~DFG 262 (549)
.+|+|||||++|+|..+|.+ ..+++..+..++.+++.||.|||+ +|||||||||+||||+.+|++||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 68999999999999999965 479999999999999999999996 599999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCcCCccCCCCCCCCccchHHHHHHHhhhcccceeecccCCCCCCchhhccCC------CC
Q 038137 263 LCKPLDCSNLQEKDFSIGSNLSGALQSDGRPVAPRRTQQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKG------YG 336 (549)
Q Consensus 263 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGT~~Y~APEvl~~~~------y~ 336 (549)
+|+......... .......+||+.|||||++.+.. |+
T Consensus 154 l~~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 196 (303)
T d1vjya_ 154 LAVRHDSATDTI-------------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196 (303)
T ss_dssp TCEEEETTTTEE-------------------------------------CC----CCSCGGGCCHHHHTTCSCTTCHHHH
T ss_pred ccccccCCCcce-------------------------------------eccccceecccCcCChhhccccccccCCCcC
Confidence 998764321000 00112468999999999997643 67
Q ss_pred cccccchhhHHHHHHhhCCCCCCCCCchh--------------hhhhhhhc-cccccCCCC---cCCChhHHHHHHHhhh
Q 038137 337 MECDWWSLGAIMYEMLVGYPPFYSDEPMS--------------TCRKIVNW-RTHLKFPEE---AKLSPEAKDLISKLLC 398 (549)
Q Consensus 337 ~~~DiWSlGvilyEml~G~~PF~~~~~~~--------------~~~~I~~~-~~~l~~p~~---~~~s~~~~dLI~~lL~ 398 (549)
.++|||||||+||||++|.+||....... ...+.+.. .....+|.. ......+.+||.+||.
T Consensus 197 ~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~ 276 (303)
T d1vjya_ 197 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCC
T ss_pred cchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcc
Confidence 89999999999999999999885432211 11111111 111222221 1123458999999999
Q ss_pred -cccccCCCCCHHHHHc
Q 038137 399 -NVEQRLGTKGADEIKA 414 (549)
Q Consensus 399 -dp~~Rl~~~~~~eil~ 414 (549)
||.+|+ ++.||++
T Consensus 277 ~dp~~Rp---s~~ei~~ 290 (303)
T d1vjya_ 277 ANGAARL---TALRIKK 290 (303)
T ss_dssp SSGGGSC---CHHHHHH
T ss_pred cCHhHCc---CHHHHHH
Confidence 999999 7999876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2e-26 Score=216.75 Aligned_cols=137 Identities=14% Similarity=0.152 Sum_probs=108.5
Q ss_pred eeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh---------------chhhHHHHHHHHHHHHhcCCCceeeee
Q 038137 119 FEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEML---------------RRGQVEHVKAERNLLAEVDSNCIVKLY 183 (549)
Q Consensus 119 f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~---------------~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 183 (549)
+.+.+.||+|+||+||+|++. +|+.||||+++..... .........+|..+|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 356789999999999999985 6899999987642110 011123456688889999999999988
Q ss_pred eeecCCceEEEEEeecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCCCCeEEcCCCcEEEeecCc
Q 038137 184 CSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIESIHKHNYIHRDIKPDNLLLDRNGHMKLSDFGL 263 (549)
Q Consensus 184 ~~f~d~~~lylVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHRDLKPeNILld~~g~vKL~DFGl 263 (549)
++.. .++||||++++.+.. +++..+..++.|++.||.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6643 279999998866533 4566678899999999999999999999999999999865 489999999
Q ss_pred ccccC
Q 038137 264 CKPLD 268 (549)
Q Consensus 264 ak~~~ 268 (549)
|+...
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 97653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=4.1e-07 Score=86.74 Aligned_cols=139 Identities=12% Similarity=0.081 Sum_probs=89.6
Q ss_pred CeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecCCceEEEEE
Q 038137 118 DFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQDDEYLYLIM 196 (549)
Q Consensus 118 ~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVm 196 (549)
.|+..+..+.|+.+.||.+. ..+..+.+|+...... .....+.+|..+|..+. +--+.++++++.+++..|+||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 46666665556667899875 4566788888765432 12234677888887663 333677788888888999999
Q ss_pred eecCCCchhhHhhhcCCCCHHHHHHHHHHHHHHHHH--------------------------------------------
Q 038137 197 EYLPGGDMMTLLMRKDTLTEEEARFYVGETVLAIES-------------------------------------------- 232 (549)
Q Consensus 197 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~-------------------------------------------- 232 (549)
++++|..+........ . ...++.++...|..
T Consensus 90 ~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eecccccccccccccc--c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 9999987755432110 0 11111111122222
Q ss_pred ---------HHh------CCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 233 ---------IHK------HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 233 ---------LH~------~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
+.. ..++|+|+.|.|||++.++.+-|+||+.|..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 221 1389999999999998776667999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.14 E-value=3.7e-06 Score=85.63 Aligned_cols=81 Identities=15% Similarity=0.177 Sum_probs=49.8
Q ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeechh-hhc---hhhHHHHHHHHHHHHhcC-C--CceeeeeeeecCCceEEE
Q 038137 122 LTMIGKGAFGEVRVCREKATGHVYAMKKLKKSE-MLR---RGQVEHVKAERNLLAEVD-S--NCIVKLYCSFQDDEYLYL 194 (549)
Q Consensus 122 ~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~-~~~---~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~f~d~~~lyl 194 (549)
.+.||.|....||.+....+++.|++|.-.... ... .....+...|..+|..+. + ..++++|++. +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 567899999999999988788889999643211 100 112334566888776652 2 3466666553 344578
Q ss_pred EEeecCCCch
Q 038137 195 IMEYLPGGDM 204 (549)
Q Consensus 195 VmEy~~gg~L 204 (549)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.84 E-value=5.3e-05 Score=71.12 Aligned_cols=136 Identities=12% Similarity=0.073 Sum_probs=81.2
Q ss_pred eeeecCC-eEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC--CceeeeeeeecCCceEEEEEeecC
Q 038137 124 MIGKGAF-GEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS--NCIVKLYCSFQDDEYLYLIMEYLP 200 (549)
Q Consensus 124 ~IG~G~f-G~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~~~lylVmEy~~ 200 (549)
.+..|.. +.||++.. .++..+.+|.-.... ...+..|..+|+.+.. --+.+++++..+++..|+||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455554 67898864 456668888764432 1235667777766532 236777888888889999999999
Q ss_pred CCchhhHh--------------hhcC-------CCC--HH-----HHHHHH---------------HHHHHHHHHHHh--
Q 038137 201 GGDMMTLL--------------MRKD-------TLT--EE-----EARFYV---------------GETVLAIESIHK-- 235 (549)
Q Consensus 201 gg~L~~~l--------------~~~~-------~l~--e~-----~~~~~~---------------~qi~~aL~~LH~-- 235 (549)
|-++.... .+-. .+. .. ....+. ......+..+..
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 86653311 0100 000 00 000000 001112233322
Q ss_pred -----CCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 236 -----HNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 236 -----~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
..+||+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2389999999999998876678999998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.12 E-value=0.0011 Score=66.62 Aligned_cols=78 Identities=19% Similarity=0.305 Sum_probs=53.3
Q ss_pred CCeeeeeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcC-CCceeeeeeeecC
Q 038137 117 DDFEPLTMIGKGAFGEVRVCREKA-------TGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVD-SNCIVKLYCSFQD 188 (549)
Q Consensus 117 ~~f~~~~~IG~G~fG~V~l~~~k~-------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d 188 (549)
++++ ++.|+.|-.-.+|++.... ..+.|.+++..... .. ....+|..+++.+. +.-..+++++|.+
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 3444 4678889999999998753 34567788765321 12 23557888887763 4455688888865
Q ss_pred CceEEEEEeecCCCch
Q 038137 189 DEYLYLIMEYLPGGDM 204 (549)
Q Consensus 189 ~~~lylVmEy~~gg~L 204 (549)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 589999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.97 E-value=0.00071 Score=66.17 Aligned_cols=130 Identities=10% Similarity=0.184 Sum_probs=73.4
Q ss_pred CeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC---Cceeeee----eeecCCceEEEEEeecCCC
Q 038137 130 FGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS---NCIVKLY----CSFQDDEYLYLIMEYLPGG 202 (549)
Q Consensus 130 fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~----~~f~d~~~lylVmEy~~gg 202 (549)
--.||++.. .+|..|++|+.+.... ..+.+..|...|..+.. |-.+.+. ..+......+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368999875 4688899999865421 23446678887776632 2111111 1223456789999999874
Q ss_pred chhh-----------Hh---hh----c------------------------CCCCHHHHHHH---HHHHHHHHHHHH---
Q 038137 203 DMMT-----------LL---MR----K------------------------DTLTEEEARFY---VGETVLAIESIH--- 234 (549)
Q Consensus 203 ~L~~-----------~l---~~----~------------------------~~l~e~~~~~~---~~qi~~aL~~LH--- 234 (549)
.+.. .+ .. . ..++......+ +..++..+.-+-
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 3210 00 00 0 01111111222 223333332221
Q ss_pred -hCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 235 -KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 235 -~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
..++||+|+.|.|||++. | ..++||+-|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 136899999999999974 4 45899998874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.56 E-value=0.014 Score=55.82 Aligned_cols=144 Identities=12% Similarity=0.068 Sum_probs=76.4
Q ss_pred CCCeeeeeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhhHHHHHHHHHHHHhcCC-----Cceeeee-e--eec
Q 038137 116 ADDFEPLTMIGKGAFGEVRVCREKATGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDS-----NCIVKLY-C--SFQ 187 (549)
Q Consensus 116 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-----p~Iv~l~-~--~f~ 187 (549)
.....-++.|..|---+.|++... +| .|++|+..+.. .. ..+..|..+|..+.. |..+... + ...
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CH---HHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 344555666778888899998754 34 58999986532 22 234456666655532 2222111 1 111
Q ss_pred CCceEEEEEeecCCCchhhH--------------hhh---c------CCCC------------------HHHHHHHHHHH
Q 038137 188 DDEYLYLIMEYLPGGDMMTL--------------LMR---K------DTLT------------------EEEARFYVGET 226 (549)
Q Consensus 188 d~~~lylVmEy~~gg~L~~~--------------l~~---~------~~l~------------------e~~~~~~~~qi 226 (549)
-....+.++.++.|...... +.. . .... .......+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 23456677777776433210 000 0 0000 11112223333
Q ss_pred HHHHHHHH----hCCeeecCCCCCCeEEcCCCcEEEeecCcccc
Q 038137 227 VLAIESIH----KHNYIHRDIKPDNLLLDRNGHMKLSDFGLCKP 266 (549)
Q Consensus 227 ~~aL~~LH----~~giiHRDLKPeNILld~~g~vKL~DFGlak~ 266 (549)
...+...+ ..|+||+|+.++|||++.++.+-|.||+.|..
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 33333333 25799999999999999887778999998863
|